PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sinhal, M; Meir, Z; Najafian, K; Hegi, G; Willitsch, S				Sinhal, Mudit; Meir, Ziv; Najafian, Kaveh; Hegi, Gregor; Willitsch, Stefan			Quantum-nondemolition state detection and spectroscopy of single trapped molecules	SCIENCE			English	Article							BAND; SYSTEM; MANIPULATION; LASER; TRANSITIONS; MOMENTS; IONS; N-2+	Trapped atoms and ions, which are among the best-controlled quantum systems, find widespread applications in quantum science. For molecules, a similar degree of control is currently lacking owing to their complex energy-level structure. Quantum-logic protocols in which atomic ions serve as probes for molecular ions are a promising route for achieving this level of control, especially for homonuclear species that decouple from blackbody radiation. Here, a quantum-nondemolition protocol on single trapped N-2(+) molecules is demonstrated. The spin-rovibronic state of the molecule is detected with >99% fidelity, and a spectroscopic transition is measured without destroying the quantum state. This method lays the foundations for new approaches to molecular spectroscopy, state-to-state chemistry, and the implementation of molecular qubits.	[Sinhal, Mudit; Meir, Ziv; Najafian, Kaveh; Hegi, Gregor; Willitsch, Stefan] Univ Basel, Dept Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland; [Hegi, Gregor] RUAG Schweiz AG, Allmendstr 86, CH-3602 Thun, Switzerland	University of Basel	Willitsch, S (corresponding author), Univ Basel, Dept Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland.	stefan.willitsch@unibas.ch		Willitsch, Stefan/0000-0002-8376-0579; Sinhal, Mudit/0000-0002-6699-0604; meir, ziv/0000-0002-9321-8687	Swiss National Science Foundation as part of the National Centre of Competence in Research, Quantum Science and Technology (NCCR-QSIT) [CRSII5_183579]; University of Basel	Swiss National Science Foundation as part of the National Centre of Competence in Research, Quantum Science and Technology (NCCR-QSIT); University of Basel	Funding was provided by the Swiss National Science Foundation as part of the National Centre of Competence in Research, Quantum Science and Technology (NCCR-QSIT), grant CRSII5_183579, and by the University of Basel.	Alighanbari S, 2018, NAT PHYS, V14, P555, DOI 10.1038/s41567-018-0074-3; Anderegg L, 2018, NAT PHYS, V14, P890, DOI 10.1038/s41567-018-0191-z; BACHIR IH, 1994, J MOL SPECTROSC, V166, P88, DOI 10.1006/jmsp.1994.1174; Barry JF, 2014, NATURE, V512, P286, DOI 10.1038/nature13634; Beloy K, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.062514; BENNETT RJM, 1970, MON NOT R ASTRON SOC, V147, P35, DOI 10.1093/mnras/147.1.35; Biercuk MJ, 2010, NAT NANOTECHNOL, V5, P646, DOI [10.1038/NNANO.2010.165, 10.1038/nnano.2010.165]; Biesheuvel J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10385; Braginsky VB, 1996, REV MOD PHYS, V68, P1, DOI 10.1103/RevModPhys.68.1; BRAGINSKY VB, 1980, SCIENCE, V209, P547, DOI 10.1126/science.209.4456.547; Bruna PJ, 2008, J MOL SPECTROSC, V250, P75, DOI 10.1016/j.jms.2008.04.013; CARTWRIGHT DC, 1973, J CHEM PHYS, V58, P178, DOI 10.1063/1.1678902; Chou C. W., 2019, ARXIV191112808PHYSIC; Chou CW, 2017, NATURE, V545, P203, DOI 10.1038/nature22338; Christensen J. E., 2019, ARXIV190713331QUANTP; DeMille D, 2017, SCIENCE, V357, P990, DOI 10.1126/science.aal3003; Dorfler AD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13218-x; Gardner A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36783-5; Germann M., 2016, THESIS; Germann M, 2014, NAT PHYS, V10, P820, DOI [10.1038/NPHYS3085, 10.1038/nphys3085]; GILMORE FR, 1992, J PHYS CHEM REF DATA, V21, P1005, DOI 10.1063/1.555910; Grimm R, 2000, ADV ATOM MOL OPT PHY, V42, P95, DOI 10.1016/S1049-250X(08)60186-X; HARADA K, 1994, J MOL SPECTROSC, V163, P436, DOI 10.1006/jmsp.1994.1038; Harty TP, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.220501; Herzberg G., 1991, MOL SPECTRA MOL STRU; Herzberg G., 1991, MOL SPECTRA MOL STRU, VI; Home JP, 2013, ADV ATOM MOL OPT PHY, V62, P231, DOI 10.1016/B978-0-12-408090-4.00004-9; Hume DB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.120502; Hume DB, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.243902; Kajita M, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.043423; Kajita M, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.032509; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Koelemeij JCJ, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.023413; LANGHOFF SR, 1987, J CHEM PHYS, V87, P4716, DOI 10.1063/1.452835; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Lien CY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5783; Liu LR, 2018, SCIENCE, V360, P900, DOI 10.1126/science.aar7797; Marquet C, 2003, APPL PHYS B-LASERS O, V76, P199, DOI 10.1007/s00340-003-1097-7; Meekhof DM, 1996, PHYS REV LETT, V76, P1796, DOI 10.1103/PhysRevLett.76.1796; Meir Z, 2019, FARADAY DISCUSS, V217, P561, DOI 10.1039/c8fd00195b; Molhave K, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.011401; Morigi G, 2001, EUR PHYS J D, V13, P261, DOI 10.1007/s100530170275; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; Ospelkaus S, 2010, SCIENCE, V327, P853, DOI 10.1126/science.1184121; Safronova MS, 2018, REV MOD PHYS, V90, DOI 10.1103/RevModPhys.90.025008; Sage JM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.203001; Schiller S, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.032505; Schiller S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.023004; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Schneider T, 2010, NAT PHYS, V6, P275, DOI 10.1038/NPHYS1605; Sikorsky T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03373-y; Sinhal M., 2019, RAW DATA QUANTUM NON, DOI [10.5281/zenodo.3532942., DOI 10.5281/ZENODO.3532942]; Staanum PF, 2010, NAT PHYS, V6, P271, DOI 10.1038/NPHYS1604; Tong X, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.143001; van de Meerakker SYT, 2012, CHEM REV, V112, P4828, DOI 10.1021/cr200349r; Wehner S, 2018, SCIENCE, V362, DOI 10.1126/science.aam9288; Willitsch S, 2012, INT REV PHYS CHEM, V31, P175, DOI 10.1080/0144235X.2012.667221; Wolf F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10576-4; Wolf F, 2016, NATURE, V530, P457, DOI 10.1038/nature16513; Wu YD, 2007, CHINESE J CHEM PHYS, V20, P285, DOI 10.1088/1674-0068/20/03/285-290; Zhou XJ, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.012115	62	24	24	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1213	+		10.1126/science.aaz9837	http://dx.doi.org/10.1126/science.aaz9837			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9DP	32165581	Green Submitted			2022-12-28	WOS:000520023800035
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Doctors should campaign for adult social care reform	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Bottery S., 2019, WHATS YOUR PROBLEM S; Carers UK, STAT CAR SURV; OLIVER D, 2019, BMJ-BRIT MED J, V367, P97635, DOI DOI 10.1136/BMJ.L5870; Oliver D, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m761	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2020	368								m862	10.1136/bmj.m862	http://dx.doi.org/10.1136/bmj.m862			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AU	32165405	Bronze			2022-12-28	WOS:000520013500004
J	Kurian, AW; Bernhisel, R; Larson, K; Caswell-Jin, JL; Shadyab, AH; Ochs-Balcom, H; Stefanick, ML				Kurian, Allison W.; Bernhisel, Ryan; Larson, Katie; Caswell-Jin, Jennifer L.; Shadyab, Aladdin H.; Ochs-Balcom, Heather; Stefanick, Marcia L.			Prevalence of Pathogenic Variants in Cancer Susceptibility Genes Among Women With Postmenopausal Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Kurian, Allison W.; Caswell-Jin, Jennifer L.; Stefanick, Marcia L.] Stanford Univ, Stanford, CA 94305 USA; [Bernhisel, Ryan; Larson, Katie] Myriad Genet, Salt Lake City, UT USA; [Shadyab, Aladdin H.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Ochs-Balcom, Heather] SUNY Buffalo, Buffalo, NY USA	Stanford University; Myriad Genetics, Inc; University of California System; University of California San Diego; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kurian, AW (corresponding author), Stanford Univ, Sch Med, 150 Governors Ln,HRP Redwood Bldg,Room T254A, Stanford, CA 94305 USA.	akurian@stanford.edu	Ochs-Balcom, Heather M/F-3500-2012; Kurian, Allison/A-4560-2019	Kurian, Allison/0000-0002-6175-9470; Caswell-Jin, Jennifer/0000-0002-5711-8355	Myriad Genetics; Suzanne Pride Bryan Fund for Breast Cancer Research; Jan Weimer Faculty Chair in Breast Oncology; BRCA Foundation; National Heart, Lung, and Blood Institute, National Institutes of Health; US Department of Health and Human Services [HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, HHSN268201600004C]	Myriad Genetics; Suzanne Pride Bryan Fund for Breast Cancer Research; Jan Weimer Faculty Chair in Breast Oncology; BRCA Foundation; National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US Department of Health and Human Services	Funding was provided by Myriad Genetics, by the Suzanne Pride Bryan Fund for Breast Cancer Research, the Jan Weimer Faculty Chair in Breast Oncology, and the BRCA Foundation. The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, and the US Department of Health and Human Services (HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, and HHSN268201600004C).	[Anonymous], 2019, CONS GUID GEN TEST H; Daly MB, 2017, J NATL COMPR CANC NE, V15, P9, DOI 10.6004/jnccn.2017.0003; Easton DF, 2015, NEW ENGL J MED, V372, P2243, DOI 10.1056/NEJMsr1501341; Eggington JM, 2014, CLIN GENET, V86, P229, DOI 10.1111/cge.12315; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; Owens DK, 2019, JAMA-J AM MED ASSOC, V322, P652, DOI 10.1001/jama.2019.10987	6	19	19	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2020	323	10					995	997		10.1001/jama.2020.0229	http://dx.doi.org/10.1001/jama.2020.0229			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KW1LV	32154851	Green Published, Bronze			2022-12-28	WOS:000520933900024
J	Lettre, G				Lettre, Guillaume			Blocking HbS Polymerization in SCD	CELL			English	Editorial Material									[Lettre, Guillaume] Univ Montreal, Montreal, PQ, Canada; [Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Lettre, G (corresponding author), Univ Montreal, Montreal, PQ, Canada.; Lettre, G (corresponding author), Montreal Heart Inst, Montreal, PQ, Canada.	guillaume.lettre@umontreal.ca							0	0	0	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2020	180	5					819	819		10.1016/j.cell.2020.01.019	http://dx.doi.org/10.1016/j.cell.2020.01.019			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KT7JN	32142671	Bronze			2022-12-28	WOS:000519189800019
J	Mayor, S				Mayor, Susan			Targeted screening in routine primary care detects lung cancer in 2% of high risk patients, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Grover H, 2020, THORAX, V75, P348, DOI 10.1136/thoraxjnl-2019-214303	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2020	368								m823	10.1136/bmj.m823	http://dx.doi.org/10.1136/bmj.m823			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KE	32131995				2022-12-28	WOS:000519536600013
J	Rollie, C; Chevallereau, A; Watson, BNJ; Chyou, TY; Fradet, O; McLeod, I; Fineran, PC; Brown, CM; Gandon, S; Westra, ER				Rollie, Clare; Chevallereau, Anne; Watson, Bridget N. J.; Chyou, Te-yuan; Fradet, Olivier; McLeod, Isobel; Fineran, Peter C.; Brown, Chris M.; Gandon, Sylvain; Westra, Edze R.			Targeting of temperate phages drives loss of type I CRISPR-Cas systems (vol 578, pg 149, 2020)	NATURE			English	Correction												C.Rollie@exeter.ac.uk; A.Chevallereau@exeter.ac.uk; E.R.Westra@exeter.ac.uk	Fineran, Peter C/A-5766-2012; GANDON, Sylvain/AHC-0976-2022	Fineran, Peter C/0000-0002-4639-6704; GANDON, Sylvain/0000-0003-2624-7856				Rollie C, 2020, NATURE, V578, P149, DOI 10.1038/s41586-020-1936-2	1	0	0	0	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					E10	E10		10.1038/s41586-020-2089-z	http://dx.doi.org/10.1038/s41586-020-2089-z		MAR 2020	1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32123354	Bronze			2022-12-28	WOS:000517742700001
J	Voelker, R				Voelker, Rebecca			FDA Policies Address Development of Gene Therapies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2020	323	9			SI		817	817		10.1001/jama.2020.1784	http://dx.doi.org/10.1001/jama.2020.1784			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU3SD	32125387				2022-12-28	WOS:000519630600004
J	Sen, A; Jette, N; Husain, M; Sander, JW				Sen, Arjune; Jette, Nathalie; Husain, Masud; Sander, Josemir W.			Epilepsy in older people	LANCET			English	Review							TEMPORAL-LOBE EPILEPSY; NEW-ONSET EPILEPSY; ALZHEIMERS-DISEASE; STATUS EPILEPTICUS; COGNITIVE IMPAIRMENTS; SURGICAL-TREATMENT; LASER-ABLATION; ADULT EPILEPSY; RISK-FACTORS; FOLLOW-UP	Globally, as populations age there will be challenges and opportunities to deliver optimal health care to senior citizens. Epilepsy, a condition characterised by spontaneous recurrent seizures, is common in older adults (aged >65 years) and yet has received comparatively little attention in this age group. In this Review, we evaluate the underlying causes of epilepsy in older people, explore difficulties in establishing a diagnosis of epilepsy in this population, discuss appropriate antiseizure medications, and evaluate potential surgical treatment options. We consider cognitive, psychological, and psychosocial comorbidities and the effect that epilepsy might have on an older person's broader social or care network in high-income versus middle-income and low-income countries. We emphasise the need for clinical trials to be more inclusive of older people with epilepsy to help inform therapeutic decision making and discuss whether measures to improve vascular risk factors might be an important strategy to reduce the probability of developing epilepsy.	[Sen, Arjune] John Radcliffe Hosp, Oxford Epilepsy Res Grp, Natl Inst Hlth Res, Oxford Biomed Res Ctr,Nuffield Dept Clin Neurosci, Oxford, England; [Jette, Nathalie] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Jette, Nathalie] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Husain, Masud] Univ Oxford, Dept Psychol, Oxford, England; [Sander, Josemir W.] Univ Coll London Hosp, Natl Inst Hlth Res, Biomed Res Ctr, UCL Queen Sq Inst Neurol, London, England; [Sander, Josemir W.] Chalfont Ctr Epilepsy, Gerrards Cross, England; [Sander, Josemir W.] SEIN, Heemstede, Netherlands	University of Oxford; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Oxford; University College London Hospitals NHS Foundation Trust; University of London; University College London	Sen, A (corresponding author), John Radcliffe Hosp, Oxford Epilepsy Res Grp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England.	arjune.sen@ndcn.ox.ac.uk	Jette, Nathalie/HCH-4827-2022; Husain, Masud/C-2074-2008; Sander, Josemir W/C-1576-2008	Jette, Nathalie/0000-0003-1351-5866; Husain, Masud/0000-0002-6850-9255; Sander, Josemir W/0000-0001-6041-9661	National Institute for Health Research (NIHR), Oxford Biomedical Research Centre, John Radcliffe Hospital; NIHR University College London Hospitals Biomedical Research Centre from the UK Department of Health's Research Centres funding scheme; Bludhorn Professor of International Medicine Chair; NINDS; Patient-Centered Outcomes Research Institute; Wellcome Trust; Dr Marvin Weil Epilepsy Research Fund; UK Epilepsy Society; Christelijke Vereniging voor de Verpleging van Lijders aan Epilepsie	National Institute for Health Research (NIHR), Oxford Biomedical Research Centre, John Radcliffe Hospital; NIHR University College London Hospitals Biomedical Research Centre from the UK Department of Health's Research Centres funding scheme; Bludhorn Professor of International Medicine Chair; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); Wellcome Trust(Wellcome Trust); Dr Marvin Weil Epilepsy Research Fund; UK Epilepsy Society; Christelijke Vereniging voor de Verpleging van Lijders aan Epilepsie	This Review was supported by the National Institute for Health Research (NIHR), Oxford Biomedical Research Centre, John Radcliffe Hospital and the NIHR University College London Hospitals Biomedical Research Centre, which receive a proportion of funding from the UK Department of Health's Research Centres funding scheme. NJ holds the Bludhorn Professor of International Medicine Chair and receives research support from NINDS and Patient-Centered Outcomes Research Institute. MH is supported by a Wellcome Trust Principal Research Fellowship. JWS receives research support from the Dr Marvin Weil Epilepsy Research Fund, the UK Epilepsy Society, and the Christelijke Vereniging voor de Verpleging van Lijders aan Epilepsie. For this Review, we did not receive any specific grant from funding agencies in the public, commercial, or charitable sectors.	Acosta I, 2008, EPILEPSY BEHAV, V12, P324, DOI 10.1016/j.yebeh.2007.10.009; Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; [Anonymous], ACTA NEUROL SCAND; [Anonymous], EPILEPSY BEHAV; [Anonymous], IMPACT CARBAMAZEPINE; [Anonymous], EPILEPSIA; [Anonymous], NEUROLOGY; [Anonymous], 2013, EPILEPSY RES TREAT; [Anonymous], LANCET; [Anonymous], SEIZURE; [Anonymous], NEUROLOGY; Baker GA, 2001, SEIZURE-EUR J EPILEP, V10, P92, DOI 10.1053/seiz.2000.0465; Bakpa OD, 2016, SEIZURE-EUR J EPILEP, V41, P26, DOI 10.1016/j.seizure.2016.07.002; BAQUIS GD, 1985, STROKE, V16, P444, DOI 10.1161/01.STR.16.3.444; Beghi E, 2019, LANCET NEUROL, V18, P357, DOI 10.1016/S1474-4422(18)30454-X; Beghi E, 2010, EPILEPSIA, V51, P671, DOI 10.1111/j.1528-1167.2009.02285.x; Belcastro V, 2008, EPILEPSY RES, V82, P223, DOI 10.1016/j.eplepsyres.2008.08.008; Bialek F, 2014, SEIZURE-EUR J EPILEP, V23, P641, DOI 10.1016/j.seizure.2014.05.003; Binks S, 2018, BRAIN, V141, P2263, DOI 10.1093/brain/awy109; Birnbaum AK, 2017, NEUROLOGY, V88, P750, DOI 10.1212/WNL.0000000000003629; Breteler MMB, 1995, AM J EPIDEMIOL, V142, P1300, DOI 10.1093/oxfordjournals.aje.a117597; Breuer LEM, 2016, NEUROSCI BIOBEHAV R, V64, P1, DOI 10.1016/j.neubiorev.2016.02.004; Brodie MJ, 2009, LANCET NEUROL, V8, P1019, DOI 10.1016/S1474-4422(09)70240-6; Canter RG, 2016, NATURE, V539, P187, DOI 10.1038/nature20412; Chapin JS, 2013, CLIN NEUROPSYCHOL, V27, P1316, DOI 10.1080/13854046.2013.850535; Charlesworth CJ, 2015, J GERONTOL A-BIOL, V70, P989, DOI 10.1093/gerona/glv013; Chen LA, 2012, INT J GERONTOL, V6, P63, DOI 10.1016/j.ijge.2012.05.013; Cheng CH, 2015, EPILEPSY RES, V115, P63, DOI 10.1016/j.eplepsyres.2015.05.009; Cheng SL, 2014, EPILEPTIC DISORD, V16, P385, DOI 10.1684/epd.2014.0709; Choi H, 2017, NEUROLOGY, V88, P870, DOI 10.1212/WNL.0000000000003662; Cloyd J, 2006, EPILEPSY RES, V68, pS39, DOI 10.1016/j.eplepsyres.2005.07.016; Cook M, 2015, AGE AGEING, V44, P695, DOI 10.1093/ageing/afv061; Copeland LA, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-84; Costa C, 2019, NEUROBIOL AGING, V73, P61, DOI 10.1016/j.neurobiolaging.2018.09.006; de Assis TR, 2015, ARQ NEURO-PSIQUIAT, V73, P83, DOI 10.1590/0004-282X20140217; de Tisi J, 2011, LANCET, V378, P1388, DOI 10.1016/S0140-6736(11)60890-8; Deckers K, 2015, INT J GERIATR PSYCH, V30, P234, DOI 10.1002/gps.4245; Deli A, 2019, EPILEPSY BEHAV, V94, P204, DOI 10.1016/j.yebeh.2019.03.012; DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; Dewar S, 2016, J NEUROSURG, V124, P945, DOI 10.3171/2015.3.JNS142317; Dobson Ruth, 2018, Pract Neurol, V18, P35, DOI 10.1136/practneurol-2017-001720; Dodrill CB, 2004, EPILEPSY BEHAV, V5, pS21, DOI 10.1016/j.yebeh.2003.11.004; Faught E, 2012, NEUROLOGY, V78, P448, DOI 10.1212/WNL.0b013e3182477edc; Fiest KM, 2017, NEUROLOGY, V88, P296, DOI 10.1212/WNL.0000000000003509; Fillenbaum GG, 2000, J GERONTOL A-BIOL, V55, pM84; Freitas ME, 2019, J NEUROL NEUROSUR PS, V90, P920, DOI 10.1136/jnnp-2018-320039; Gheyara AL, 2014, ANN NEUROL, V76, P443, DOI 10.1002/ana.24230; GODFREY JBW, 1989, AGE AGEING, V18, P17, DOI 10.1093/ageing/18.1.17; GODFREY JW, 1982, AGE AGEING, V11, P29, DOI 10.1093/ageing/11.1.29; Govoni V, 2008, EUR NEUROL, V59, P120, DOI 10.1159/000111873; Graus F, 2016, LANCET NEUROL, V15, P391, DOI 10.1016/S1474-4422(15)00401-9; Greenlund SF, 2017, EPILEPSY BEHAV, V69, P28, DOI 10.1016/j.yebeh.2017.01.016; Griffith HR, 2007, EPILEPSY RES, V74, P91, DOI 10.1016/j.eplepsyres.2007.01.002; Griffith HR, 2006, EPILEPSY BEHAV, V8, P161, DOI 10.1016/j.yebeh.2005.09.004; Grivas A, 2006, EPILEPSIA, V47, P1364, DOI 10.1111/j.1528-1167.2006.00608.x; Hanby MF, 2015, NEUROIMAGE-CLIN, V9, P128, DOI 10.1016/j.nicl.2015.07.016; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Haut SR, 2009, EPILEPSY BEHAV, V14, P540, DOI 10.1016/j.yebeh.2009.01.005; Helmstaedter C, 2009, BRAIN, V132, P2822, DOI 10.1093/brain/awp182; Helmstaedter C, 2017, SEIZURE-EUR J EPILEP, V49, P83, DOI 10.1016/j.seizure.2017.02.017; Hermann B, 2008, EPILEPSIA, V49, P731, DOI 10.1111/j.1528-1167.2007.01435.x; Hernandez-Ronquillo L, 2018, EPILEPSY RES, V140, P90, DOI 10.1016/j.eplepsyres.2017.12.016; Hesdorffer DC, 1996, NEUROLOGY, V46, P727, DOI 10.1212/WNL.46.3.727; Holley-Moore G., 2015, FUTURE TRANSPORT AGE; Hommet C, 2008, DEMENT GERIATR COGN, V25, P293, DOI 10.1159/000119103; Hussain SA, 2006, EPILEPSY RES, V71, P195, DOI 10.1016/j.eplepsyres.2006.06.018; Imfeld P, 2013, EPILEPSIA, V54, P700, DOI 10.1111/epi.12045; Irani SR, 2011, CURR NEUROL NEUROSCI, V11, P298, DOI 10.1007/s11910-011-0186-y; Irizarry MC, 2012, ARCH NEUROL-CHICAGO, V69, P368, DOI 10.1001/archneurol.2011.830; Jette N, 2016, LANCET NEUROL, V15, P982, DOI 10.1016/S1474-4422(16)30127-2; Johnson EL, 2018, JAMA NEUROL, V75, P1375, DOI 10.1001/jamaneurol.2018.1935; Josephson CB, 2016, EPILEPSIA, V57, P298, DOI 10.1111/epi.13266; Keezer MR, 2015, LANCET NEUROL, V14, P683, DOI 10.1016/S1474-4422(15)00100-3; Kellinghaus C, 2004, J NEUROL, V251, P704, DOI 10.1007/s00415-004-0406-3; Kowski AB, 2016, EPILEPSY BEHAV, V54, P150, DOI 10.1016/j.yebeh.2015.11.009; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Lam AD, 2017, NAT MED, V23, P678, DOI 10.1038/nm.4330; Lattanzi S, 2019, EPILEPSIA, V60, P2245, DOI 10.1111/epi.16366; Lee S, 2016, ANN NEUROL, V79, P929, DOI 10.1002/ana.24647; Lezaic N, 2019, EPILEPSIA, V60, P1325, DOI 10.1111/epi.16068; Lin JJ, 2012, LANCET, V380, P1180, DOI 10.1016/S0140-6736(12)61455-X; Liu SS, 2016, NEUROPSYCH DIS TREAT, V12, P1425, DOI 10.2147/NDT.S107905; Lutz MT, 2005, EPILEPSY BEHAV, V7, P708, DOI 10.1016/j.yebeh.2005.08.015; Martin R, 2005, EPILEPSY BEHAV, V7, P297, DOI 10.1016/j.yebeh.2005.05.003; Martin RC, 2005, EPILEPSIA, V46, P298, DOI 10.1111/j.0013-9580.2005.02104.x; Miller LA, 2016, EPILEPSY BEHAV, V56, P113, DOI 10.1016/j.yebeh.2016.01.011; Murphy M, 2010, EPILEPSIA, V51, P1024, DOI 10.1111/j.1528-1167.2009.02430.x; Newton CR, 2012, LANCET, V380, P1193, DOI 10.1016/S0140-6736(12)61381-6; Noebels J, 2011, EPILEPSIA, V52, P39, DOI 10.1111/j.1528-1167.2010.02909.x; Ortinski P, 2004, EPILEPSY BEHAV, V5, pS60, DOI 10.1016/j.yebeh.2003.11.008; Ortman BJM, 2014, P EC STAT ADM US DEP, V1964, P1; Palace J, 2000, J NEUROL NEUROSUR PS, V69, P711, DOI 10.1136/jnnp.69.6.711; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Pandis D, 2012, EPILEPSY CURR, V12, P184, DOI 10.5698/1535-7511-12.5.184; Perucca E, 2006, EPILEPSY RES, V68, pS49, DOI 10.1016/j.eplepsyres.2005.07.017; Petito GT, 2018, EPILEPSY BEHAV, V78, P37, DOI 10.1016/j.yebeh.2017.10.041; Piazzini A, 2006, EPILEPSIA, V47, P82, DOI 10.1111/j.1528-1167.2006.00884.x; Pohlmann-Eden B, 2006, BMJ-BRIT MED J, V332, P339, DOI 10.1136/bmj.332.7537.339; Pugh MJV, 2009, J AM GERIATR SOC, V57, P237, DOI 10.1111/j.1532-5415.2008.02124.x; Punia Vineet, 2018, Epilepsia Open, V3, P73, DOI 10.1002/epi4.12099; Punia V, 2017, EPILEPSY BEHAV, V70, P94, DOI 10.1016/j.yebeh.2017.03.017; Ramsay RE, 2004, NEUROLOGY, V62, pS24, DOI 10.1212/WNL.62.5_suppl_2.S24; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Sander JW, 2003, CURR OPIN NEUROL, V16, P165, DOI 10.1097/00019052-200304000-00008; Savage SA, 2016, SEIZURE-EUR J EPILEP, V43, P48, DOI 10.1016/j.seizure.2016.10.022; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Schulz UGR, 2002, POSTGRAD MED J, V78, P246, DOI 10.1136/pmj.78.918.246; Seidenberg M, 2007, NEUROPSYCHOL REV, V17, P445, DOI 10.1007/s11065-007-9042-x; Sen A, 2006, J NEUROPATH EXP NEUR, V65, P55, DOI 10.1097/01.jnen.0000195940.48033.a2; Sen A, 2008, DEV NEUROSCI-BASEL, V30, P96, DOI 10.1159/000109855; Sen A, 2007, NEUROREPORT, V18, P511, DOI 10.1097/WNR.0b013e3280586879; Sen A, 2007, EPILEPSIA, V48, P1447, DOI 10.1111/j.1528-1167.2007.01107.x; Sen A, 2018, BRAIN, V141, P1592, DOI 10.1093/brain/awy022; Sirven JI, 2000, NEUROLOGY, V54, P2166, DOI 10.1212/WNL.54.11.2166; Sirven JI, 2000, NEUROLOGY, V54, P1179, DOI 10.1212/WNL.54.5.1179; Sleeth C, 2016, EPILEPSY BEHAV, V55, P108, DOI 10.1016/j.yebeh.2015.12.026; So EL, 1996, NEUROLOGY, V46, P350, DOI 10.1212/WNL.46.2.350; Srikijvilaikul T, 2011, SEIZURE-EUR J EPILEP, V20, P276, DOI 10.1016/j.seizure.2010.12.008; Subota A, 2017, EPILEPSIA, V58, P962, DOI 10.1111/epi.13744; Sung C, 2013, EPILEPSY RES, V103, P231, DOI 10.1016/j.eplepsyres.2012.08.011; Sveinsson O, 2017, NEUROLOGY, V89, P170, DOI 10.1212/WNL.0000000000004094; Swayne A, 2018, EUR J NEUROL, V25, P1290, DOI 10.1111/ene.13721; Tai XY, 2016, BRAIN, V139, P2441, DOI 10.1093/brain/aww187; Thijs RD, 2019, LANCET, V393, P689, DOI 10.1016/S0140-6736(18)32596-0; Thom M, 2011, BRAIN, V134, P2969, DOI 10.1093/brain/awr209; Thompson J, 2018, BRAIN, V141, P348, DOI 10.1093/brain/awx323; Thompson PJ, 2015, SEIZURE-EUR J EPILEP, V29, P41, DOI 10.1016/j.seizure.2015.03.017; Trinka E, 2003, ACTA NEUROL SCAND, V108, P33, DOI 10.1034/j.1600-0404.108.s180.5.x; Voglein J, 2019, NEUROBIOL AGING, V76, P18, DOI 10.1016/j.neurobiolaging.2018.11.022; Vossel KA, 2016, ANN NEUROL, V80, P858, DOI 10.1002/ana.24794; Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136; Vu LC, 2018, BRIT J CLIN PHARMACO, V84, P2208, DOI 10.1111/bcp.13653; Wandschneider B, 2014, NEUROLOGY, V83, P1508, DOI 10.1212/WNL.0000000000000910; Waseem H, 2015, EPILEPSY BEHAV, V51, P152, DOI 10.1016/j.yebeh.2015.07.022; Werhahn KJ, 2011, SEIZURE-EUR J EPILEP, V20, P305, DOI 10.1016/j.seizure.2010.12.015; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Witt JA, 2014, ACTA NEUROL SCAND, V130, P172, DOI 10.1111/ane.12260; World Bank, MOB CELL SUBSCR; World Health Organization, 2019, WHOMSDMER192; Yuen AWC, 2018, EPILEPSY BEHAV, V78, P57, DOI 10.1016/j.yebeh.2017.10.010; Zeman AZJ, 1998, J NEUROL NEUROSUR PS, V64, P435, DOI 10.1136/jnnp.64.4.435	143	97	100	5	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 29	2020	395	10225					735	748						14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KQ2JO	32113502				2022-12-28	WOS:000516755200031
J	Albouy, P; Benjamin, L; Morillon, B; Zatorre, RJ				Albouy, Philippe; Benjamin, Lucas; Morillon, Benjamin; Zatorre, Robert J.			Distinct sensitivity to spectrotemporal modulation supports brain asymmetry for speech and melody	SCIENCE			English	Article							AUDITORY-CORTEX; MUSIC	Does brain asymmetry for speech and music emerge from acoustical cues or from domain-specific neural networks? We selectively filtered temporal or spectral modulations in sung speech stimuli for which verbal and melodic content was crossed and balanced. Perception of speech decreased only with degradation of temporal information, whereas perception of melodies decreased only with spectral degradation. Functional magnetic resonance imaging data showed that the neural decoding of speech and melodies depends on activity patterns in left and right auditory regions, respectively. This asymmetry is supported by specific sensitivity to spectrotemporal modulation rates within each region. Finally, the effects of degradation on perception were paralleled by their effects on neural classification. Our results suggest a match between acoustical properties of communicative signals and neural specializations adapted to that purpose.	[Albouy, Philippe; Benjamin, Lucas; Zatorre, Robert J.] McGill Univ, Montreal Neurol Inst, Cognit Neurosci Unit, Montreal, PQ, Canada; [Albouy, Philippe; Zatorre, Robert J.] Ctr Interdisciplinary Res Mus Media & Technol, Ctr Res Brain Language & Mus, Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada; [Albouy, Philippe] Laval Univ, Sch Psychol, CERVO Brain Res Ctr, Quebec City, PQ, Canada; [Morillon, Benjamin] Aix Marseille Univ, INSERM, INS, Marseille, France	McGill University; Universite de Montreal; Laval University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Albouy, P (corresponding author), McGill Univ, Montreal Neurol Inst, Cognit Neurosci Unit, Montreal, PQ, Canada.; Albouy, P (corresponding author), Ctr Interdisciplinary Res Mus Media & Technol, Ctr Res Brain Language & Mus, Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada.; Albouy, P (corresponding author), Laval Univ, Sch Psychol, CERVO Brain Res Ctr, Quebec City, PQ, Canada.	philippe.albouy@psy.ulaval.ca	Morillon, Benjamin/H-4788-2019	Morillon, Benjamin/0000-0002-0049-064X; ALBOUY, Philippe/0000-0001-8549-6954; Benjamin, Lucas/0000-0002-9578-6039	Canadian Institute for Health Research; Banting Fellowship; Excellence Initiative of Aix-Marseille University (A*MIDEX);  [ANR-16-CONV-0002];  [ANR-11-LABX-0036]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Banting Fellowship; Excellence Initiative of Aix-Marseille University (A*MIDEX)(French National Research Agency (ANR)); ; 	This work was supported by a foundation grant from the Canadian Institute for Health Research to R.J.Z. P.A. is funded by a Banting Fellowship. R.J.Z. is a senior fellow of the Canadian Institute for Advanced Research. B.M.'s research is supported by grants ANR-16-CONV-0002 (ILCB) and ANR-11-LABX-0036 (BLRI) and the Excellence Initiative of Aix-Marseille University (A*MIDEX).	Allefeld C, 2016, NEUROIMAGE, V141, P378, DOI 10.1016/j.neuroimage.2016.07.040; Arnal LH, 2015, CURR BIOL, V25, P2051, DOI 10.1016/j.cub.2015.06.043; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; Chevillet M, 2011, J NEUROSCI, V31, P9345, DOI 10.1523/JNEUROSCI.1448-11.2011; Chi T, 2005, J ACOUST SOC AM, V118, P887, DOI 10.1121/1.1945807; Ding N, 2017, NEUROSCI BIOBEHAV R, V81, P181, DOI 10.1016/j.neubiorev.2017.02.011; Elliott TM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000302; Flinker A, 2019, NAT HUM BEHAV, V3, P393, DOI 10.1038/s41562-019-0548-z; Friederici AD, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2018.0391; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Gervain J, 2019, TRENDS NEUROSCI, V42, P56, DOI 10.1016/j.tins.2018.09.004; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Hebart MN, 2015, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00088; Ince RAA, 2017, HUM BRAIN MAPP, V38, P1541, DOI 10.1002/hbm.23471; Kim D, 2012, J MEM LANG, V66, P509, DOI 10.1016/j.jml.2011.12.007; Leaver AM, 2010, J NEUROSCI, V30, P7604, DOI 10.1523/JNEUROSCI.0296-10.2010; McGettigan C, 2012, TRENDS COGN SCI, V16, P269, DOI 10.1016/j.tics.2012.04.006; Messori A, 2022, OPEN SCI FRAMEWORK, DOI 10.17605/OSF.IO/RSYP9; Morillon B, 2010, P NATL ACAD SCI USA, V107, P18688, DOI 10.1073/pnas.1007189107; Norman-Haignere S, 2015, NEURON, V88, P1281, DOI 10.1016/j.neuron.2015.11.035; Obleser J, 2008, J NEUROSCI, V28, P8116, DOI 10.1523/JNEUROSCI.1290-08.2008; Overath T, 2015, NAT NEUROSCI, V18, P903, DOI 10.1038/nn.4021; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Rodriguez FA, 2010, J NEUROPHYSIOL, V103, P887, DOI 10.1152/jn.00813.2009; Santoro R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003412; Schonwiesner M, 2009, P NATL ACAD SCI USA, V106, P14611, DOI 10.1073/pnas.0907682106; Schon D, 2010, NEUROIMAGE, V51, P450, DOI 10.1016/j.neuroimage.2010.02.023; Schonwiesner M, 2005, EUR J NEUROSCI, V22, P1521, DOI 10.1111/j.1460-9568.2005.04315.x; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	32	54	54	6	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2020	367	6481					1043	+		10.1126/science.aaz3468	http://dx.doi.org/10.1126/science.aaz3468			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KS0CO	32108113				2022-12-28	WOS:000517979600043
J	Haas, KT; Wightman, R; Meyerowitz, EM; Peaucelle, A				Haas, Kalina T.; Wightman, Raymond; Meyerowitz, Elliot M.; Peaucelle, Alexis			Pectin homogalacturonan nanofilament expansion drives morphogenesis in plant epidermal cells	SCIENCE			English	Article							MATRIX POLYSACCHARIDES; CORTICAL MICROTUBULES; WALL; CELLULOSE; GROWTH; CONFORMATIONS; ORIENTATION; MECHANICS; CALCIUM; PECTATE	The process by which plant cells expand and gain shape has presented a challenge for researchers. Current models propose that these processes are driven by turgor pressure acting on the cell wall. Using nanoimaging, we show that the cell wall contains pectin nanofilaments that possess an intrinsic expansion capacity. Additionally, we use growth models containing such structures to show that a complex plant cell shape can derive from chemically induced local and polarized expansion of the pectin nanofilaments without turgor-driven growth. Thus, the plant cell wall, outside of the cell itself, is an active participant in shaping plant cells. Extracellular matrix function may similarly guide cell shape in other kingdoms, including Animalia.	[Haas, Kalina T.] Univ Cambridge, Hutchison MRC Res Ctr, Med Res Council Canc Unit, Hills Rd, Cambridge CB2 0XZ, England; [Haas, Kalina T.] Univ Paris Diderot, Lab Mat & Syst Complexes, 10 Rue Alice Domon & Leonie Duquet, F-75013 Paris, France; [Haas, Kalina T.] CNRS, UMR7057, 10 Rue Alice Domon & Leonie Duquet, F-75013 Paris, France; [Wightman, Raymond] Univ Cambridge, Sainsbury Lab, Microscopy Core Facil, 47 Bateman St, Cambridge CB2 1LR, England; [Meyerowitz, Elliot M.] CALTECH, Howard Hughes Med Inst, 1200 E Calif Blvd, Pasadena, CA 91125 USA; [Meyerowitz, Elliot M.] CALTECH, Div Biol & Biol Engn 156 29, 1200 E Calif Blvd, Pasadena, CA 91125 USA; [Haas, Kalina T.; Peaucelle, Alexis] Univ Paris Saclay, Inst Jean Pierre Bourgin, INRAE, AgroParisTech, F-78000 Versailles, France	University of Cambridge; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; University of Cambridge; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Haas, KT (corresponding author), Univ Cambridge, Hutchison MRC Res Ctr, Med Res Council Canc Unit, Hills Rd, Cambridge CB2 0XZ, England.; Haas, KT (corresponding author), Univ Paris Diderot, Lab Mat & Syst Complexes, 10 Rue Alice Domon & Leonie Duquet, F-75013 Paris, France.; Haas, KT (corresponding author), CNRS, UMR7057, 10 Rue Alice Domon & Leonie Duquet, F-75013 Paris, France.; Haas, KT; Peaucelle, A (corresponding author), Univ Paris Saclay, Inst Jean Pierre Bourgin, INRAE, AgroParisTech, F-78000 Versailles, France.	kalina.haas@inrae.fr; alexis.peaucelle@inrae.fr	Haas, Kalina/AAA-3190-2022; Wightman, Raymond/G-1054-2017	Haas, Kalina/0000-0002-3511-5719; Meyerowitz, Elliot/0000-0003-4798-5153; Peaucelle, Alexis/0000-0002-8582-6500; Wightman, Raymond/0000-0003-1295-4875	French National Research Agency (ANR) GoodVibration [ANR-17-CE13-0007]; European Union [201310]; Saclay Plant Sciences-SPS [ANR-17-EUR-0007]; Gatsby Charitable Foundation; Gatsby Charitable Foundation [GAT3395/DAA]; Howard Hughes Medical Institute; IJPB's Plant Observatory technological platforms	French National Research Agency (ANR) GoodVibration(French National Research Agency (ANR)); European Union(European Commission); Saclay Plant Sciences-SPS; Gatsby Charitable Foundation; Gatsby Charitable Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); IJPB's Plant Observatory technological platforms	A. P. has received support from the French National Research Agency (ANR) GoodVibration ANR-17-CE13-0007 and the European Union in the framework of the Marie-Curie FP7 COFUND People Program, through the award of an AgreenSkills+ fellowship (under grant agreement 201310). The Institut Jean-Pierre Bourgin (IJPB) benefits from the support of Saclay Plant Sciences-SPS (ANR-17-EUR-0007). The Microscopy Facility at the Sainsbury Laboratory is supported by the Gatsby Charitable Foundation, and work at the Sainsbury Laboratory was supported by the Gatsby Charitable Foundation (through fellowship GAT3395/DAA). The Meyerowitz Laboratory has support from the Howard Hughes Medical Institute. This work has benefited from the support of IJPB's Plant Observatory technological platforms.	Altartouri B, 2019, PLANT PHYSIOL, V181, P127, DOI 10.1104/pp.19.00303; Atmodjo MA, 2013, ANNU REV PLANT BIOL, V64, P747, DOI 10.1146/annurev-arplant-042811-105534; Baskin TI, 2005, ANNU REV CELL DEV BI, V21, P203, DOI 10.1146/annurev.cellbio.20.082503.103053; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bichet A, 2001, PLANT J, V25, P137, DOI 10.1046/j.1365-313x.2001.00946.x; Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865; Cosgrove DJ, 2016, J EXP BOT, V67, P463, DOI 10.1093/jxb/erv511; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/nmeth.1768, 10.1038/NMETH.1768]; Ficko-Blean E., 2015, PERSPECTIVES PHYCOLO, V2, P51, DOI [10.1127/pip/2015/0028, DOI 10.1127/PIP/2015/0028]; Fu Y, 2009, CURR BIOL, V19, P1827, DOI 10.1016/j.cub.2009.08.052; Haas K. T., 2020, PECTIN HOMOGALACTURO, DOI [10.17632/xb3f5jrbwv.1, DOI 10.17632/XB3F5JRBWV.1]; Haas KT, 2018, NUCLEIC ACIDS RES, V46, P2398, DOI 10.1093/nar/gkx1303; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Kim NH., 2015, ANALYSIS-UK; LINERS F, 1989, PLANT PHYSIOL, V91, P1419, DOI 10.1104/pp.91.4.1419; Majda M, 2017, DEV CELL, V43, P290, DOI 10.1016/j.devcel.2017.10.017; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Peaucelle A, 2015, CURR BIOL, V25, P1746, DOI 10.1016/j.cub.2015.05.022; Peaucelle A, 2011, CURR BIOL, V21, P1720, DOI 10.1016/j.cub.2011.08.057; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; RODRIGUEZ EK, 1994, J BIOMECH, V27, P455, DOI 10.1016/0021-9290(94)90021-3; Rui Y, 2019, PLANT PHYSIOL, V180, P66, DOI 10.1104/pp.19.00135; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sahi VP, 2018, PLANT CELL MONOGR, V23, P139, DOI 10.1007/978-3-319-69944-8_7; Sampathkumar A, 2014, ELIFE, V3, DOI 10.7554/eLife.01967; Sapala A, 2019, CURR OPIN PLANT BIOL, V47, P1, DOI 10.1016/j.pbi.2018.07.017; Sotiriou P, 2018, PLANT BIOLOGY, V20, P223, DOI 10.1111/plb.12681; Tan L, 2013, PLANT CELL, V25, P270, DOI 10.1105/tpc.112.107334; Terauchi M, 2016, PLANTA, V244, P361, DOI 10.1007/s00425-016-2516-4; Verhertbruggen Y, 2009, CARBOHYD RES, V344, P1858, DOI 10.1016/j.carres.2008.11.010; WALKINSHAW MD, 1981, J MOL BIOL, V153, P1055, DOI 10.1016/0022-2836(81)90467-8; WALKINSHAW MD, 1981, J MOL BIOL, V153, P1075, DOI 10.1016/0022-2836(81)90468-X; Wang T, 2016, J EXP BOT, V67, P503, DOI 10.1093/jxb/erv416; Wiedemeier AMD, 2002, DEVELOPMENT, V129, P4821; Wightman R, 2017, FLORA, V233, P99, DOI 10.1016/j.flora.2017.05.018; Zhang T, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.56	40	98	100	19	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2020	367	6481					1003	+		10.1126/science.aaz5103	http://dx.doi.org/10.1126/science.aaz5103			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KS0CO	32108107	Green Accepted, Green Submitted			2022-12-28	WOS:000517979600034
J	Sammler, D				Sammler, Daniela			Splitting speech and music	SCIENCE			English	Editorial Material							AUDITORY-CORTEX; PATHWAYS						Sammler, Daniela/V-9044-2019	Sammler, Daniela/0000-0001-7458-0229				Albouy P, 2020, SCIENCE, V367, P1043, DOI 10.1126/science.aaz3468; Broca P., 1861, B SOC ANAT PARIS, V6, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018; Feuchtwanger E., 1930, AMUSIE STUDIEN PATHO; Fitch WT, 2006, COGNITION, V100, P173, DOI 10.1016/j.cognition.2005.11.009; Flinker A, 2019, NAT HUM BEHAV, V3, P393, DOI 10.1038/s41562-019-0548-z; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Koelsch S, 2005, TRENDS COGN SCI, V9, P578, DOI 10.1016/j.tics.2005.10.001; McGettigan C, 2012, TRENDS COGN SCI, V16, P269, DOI 10.1016/j.tics.2012.04.006; Norman-Haignere S, 2015, NEURON, V88, P1281, DOI 10.1016/j.neuron.2015.11.035; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Sammler D, 2015, CURR BIOL, V25, P3079, DOI 10.1016/j.cub.2015.10.009; Santoro R, 2017, P NATL ACAD SCI USA, V114, P4799, DOI 10.1073/pnas.1617622114; Savage PE, 2015, P NATL ACAD SCI USA, V112, P8987, DOI 10.1073/pnas.1414495112; Schonwiesner M, 2009, P NATL ACAD SCI USA, V106, P14611, DOI 10.1073/pnas.0907682106; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	15	4	4	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2020	367	6481					974	976		10.1126/science.aba7913	http://dx.doi.org/10.1126/science.aba7913			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KS0CO	32108099				2022-12-28	WOS:000517979600017
J	Peled, JU; Gomes, ALC; Devlin, SM; Littmann, ER; Taur, Y; Sung, AD; Weber, D; Hashimoto, D; Slingerland, AE; Slingerland, JB; Maloy, M; Clurman, AG; Stein-Thoeringer, CK; Markey, KA; Docampo, MD; da Silva, MB; Khan, N; Gessner, A; Messina, JA; Romero, K; Lew, MV; Bush, A; Bohannon, L; Brereton, DG; Fontana, E; Amoretti, LA; Wright, RJ; Armijo, GK; Shono, Y; Sanchez-Escamilla, M; Flores, NC; Tomas, AA; Lin, RJ; San Segundo, LY; Shah, GJL; Cho, CT; Scordo, M; Politikos, I; Hayasaka, K; Hasegawa, Y; Gyurkocza, B; Ponce, DM; Barker, JN; Perales, MA; Giralt, SA; Jenq, RR; Teshima, T; Chao, NJ; Holler, E; Xavier, JB; Pamer, EG; van den Brink, MRM				Peled, Jonathan U.; Gomes, Antonio L. C.; Devlin, Sean M.; Littmann, Eric R.; Taur, Ying; Sung, Anthony D.; Weber, Daniela; Hashimoto, Daigo; Slingerland, Ann E.; Slingerland, John B.; Maloy, Molly; Clurman, Annelie G.; Stein-Thoeringer, Christoph K.; Markey, Kate A.; Docampo, Melissa D.; Burgos da Silva, Marina; Khan, Niloufer; Gessner, Andre; Messina, Julia A.; Romero, Kristi; Lew, Meagan V.; Bush, Amy; Bohannon, Lauren; Brereton, Daniel G.; Fontana, Emily; Amoretti, Luigi A.; Wright, Roberta J.; Armijo, Gabriel K.; Shono, Yusuke; Sanchez-Escamilla, Miriam; Castillo Flores, Nerea; Alarcon Tomas, Ana; Lin, Richard J.; Yanez San Segundo, Lucrecia; Shah, Gunjan L.; Cho, Christina; Scordo, Michael; Politikos, Ioannis; Hayasaka, Kasumi; Hasegawa, Yuta; Gyurkocza, Boglarka; Ponce, Doris M.; Barker, Juliet N.; Perales, Miguel-Angel; Giralt, Sergio A.; Jenq, Robert R.; Teshima, Takanori; Chao, Nelson J.; Holler, Ernst; Xavier, Joao B.; Pamer, Eric G.; van den Brink, Marcel R. M.			Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTESTINAL MICROBIOTA; HOST-DISEASE; DIVERSITY; RISK; COLONIZATION; ANTIBIOTICS; DOMINATION	In this study, the gastrointestinal microbiome was serially monitored in patients undergoing allogeneic hematopoietic-cell transplantation at four centers. Lower microbial diversity was associated with poorer outcomes after HCT. Background Relationships between microbiota composition and clinical outcomes after allogeneic hematopoietic-cell transplantation have been described in single-center studies. Geographic variations in the composition of human microbial communities and differences in clinical practices across institutions raise the question of whether these associations are generalizable. Methods The microbiota composition of fecal samples obtained from patients who were undergoing allogeneic hematopoietic-cell transplantation at four centers was profiled by means of 16S ribosomal RNA gene sequencing. In an observational study, we examined associations between microbiota diversity and mortality using Cox proportional-hazards analysis. For stratification of the cohorts into higher- and lower-diversity groups, the median diversity value that was observed at the study center in New York was used. In the analysis of independent cohorts, the New York center was cohort 1, and three centers in Germany, Japan, and North Carolina composed cohort 2. Cohort 1 and subgroups within it were analyzed for additional outcomes, including transplantation-related death. Results We profiled 8767 fecal samples obtained from 1362 patients undergoing allogeneic hematopoietic-cell transplantation at the four centers. We observed patterns of microbiota disruption characterized by loss of diversity and domination by single taxa. Higher diversity of intestinal microbiota was associated with a lower risk of death in independent cohorts (cohort 1: 104 deaths among 354 patients in the higher-diversity group vs. 136 deaths among 350 patients in the lower-diversity group; adjusted hazard ratio, 0.71; 95% confidence interval [CI], 0.55 to 0.92; cohort 2: 18 deaths among 87 patients in the higher-diversity group vs. 35 deaths among 92 patients in the lower-diversity group; adjusted hazard ratio, 0.49; 95% CI, 0.27 to 0.90). Subgroup analyses identified an association between lower intestinal diversity and higher risks of transplantation-related death and death attributable to graft-versus-host disease. Baseline samples obtained before transplantation already showed evidence of microbiome disruption, and lower diversity before transplantation was associated with poor survival. Conclusions Patterns of microbiota disruption during allogeneic hematopoietic-cell transplantation were similar across transplantation centers and geographic locations; patterns were characterized by loss of diversity and domination by single taxa. Higher diversity of intestinal microbiota at the time of neutrophil engraftment was associated with lower mortality. (Funded by the National Cancer Institute and others.)	[Peled, Jonathan U.; Maloy, Molly; Clurman, Annelie G.; Markey, Kate A.; Khan, Niloufer; Brereton, Daniel G.; Sanchez-Escamilla, Miriam; Castillo Flores, Nerea; Alarcon Tomas, Ana; Lin, Richard J.; Yanez San Segundo, Lucrecia; Shah, Gunjan L.; Cho, Christina; Scordo, Michael; Politikos, Ioannis; Gyurkocza, Boglarka; Ponce, Doris M.; Barker, Juliet N.; Perales, Miguel-Angel; Giralt, Sergio A.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Adult Bone Marrow Transplantat Serv, 1275 York Ave, New York, NY 10021 USA; [Taur, Ying; Fontana, Emily; Amoretti, Luigi A.; Wright, Roberta J.; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Infect Dis Serv, New York, NY 10021 USA; [Devlin, Sean M.] Mem Sloan Kettering Canc Ctr, Dept Med, Dept Epidemiol & Biostat, 1275 York Ave, New York, NY 10021 USA; [Gomes, Antonio L. C.; Littmann, Eric R.; Slingerland, Ann E.; Slingerland, John B.; Stein-Thoeringer, Christoph K.; Docampo, Melissa D.; Burgos da Silva, Marina; Armijo, Gabriel K.; Shono, Yusuke; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Immunol, Sloan Kettering Inst, New York, NY 10021 USA; [Xavier, Joao B.] Mem Sloan Kettering Canc Ctr, Program Computat & Syst Biol, 1275 York Ave, New York, NY 10021 USA; [Peled, Jonathan U.; Taur, Ying; Markey, Kate A.; Docampo, Melissa D.; Lin, Richard J.; Shah, Gunjan L.; Cho, Christina; Scordo, Michael; Politikos, Ioannis; Gyurkocza, Boglarka; Ponce, Doris M.; Barker, Juliet N.; Perales, Miguel-Angel; Giralt, Sergio A.; van den Brink, Marcel R. M.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Littmann, Eric R.; Pamer, Eric G.] Univ Chicago, Duchossois Family Inst, Chicago, IL 60637 USA; [Sung, Anthony D.; Lew, Meagan V.; Bush, Amy; Bohannon, Lauren; Chao, Nelson J.] Duke Univ, Med Ctr, Dept Med, Div Hematol Malignancies & Cellular Therapy, Durham, NC 27710 USA; [Messina, Julia A.] Duke Univ, Dept Med, Div Infect Dis, Durham, NC USA; [Romero, Kristi] Duke Univ, Sch Med, Duke Off Clin Res, Durham, NC USA; [Weber, Daniela; Holler, Ernst] Univ Med Ctr, Dept Hematol & Oncol, Internal Med 3, Regensburg, Germany; [Weber, Daniela; Gessner, Andre; Holler, Ernst] Collaborat Res Ctr Transregio 221, Regensburg, Germany; [Gessner, Andre] Univ Hosp Regensburg, Inst Clin Microbiol & Hyg, Regensburg, Germany; [Hashimoto, Daigo; Hasegawa, Yuta; Teshima, Takanori] Hokkaido Univ, Fac Med, Dept Hematol, Sapporo, Hokkaido, Japan; [Hayasaka, Kasumi; Teshima, Takanori] Hokkaido Univ Hosp, Div Lab & Transfus Med, Sapporo, Hokkaido, Japan; [Sanchez-Escamilla, Miriam] Res Inst Marques de Valdecilla IDIVAL, Santander, Spain; [Yanez San Segundo, Lucrecia] Univ Cantabria, Dept Hematol, Hosp Univ Marques de Valdecilla IDIVAL, Santander, Spain; [Alarcon Tomas, Ana] Hosp Univ Puerta de Hierro, Madrid, Spain; [Jenq, Robert R.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Div Canc Med, Houston, TX 77030 USA; [Jenq, Robert R.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat Cellular Therapy, Div Canc Med, Houston, TX 77030 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; University of Chicago; Duke University; Duke University; Duke University; University of Regensburg; University of Regensburg; Hokkaido University; Hokkaido University; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Hospital Puerta de Hierro-Majadahonda; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	van den Brink, MRM (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave,Box 111, New York, NY 10065 USA.	vandenbm@mskcc.org	Sung, Anthony/GPT-4489-2022; Hashimoto, Daigo/O-1013-2013; van den Brink, Marcel R. M./HGB-9434-2022; da Silva, Marina Burgos/C-3026-2012; Yáñez San Segundo, Lucrecia/G-4662-2016; Xavier, Joao/H-5471-2011; da Silva, Marina Burgos/AAR-5639-2020; Markey, Kate/A-5385-2016	Hashimoto, Daigo/0000-0001-9489-9704; da Silva, Marina Burgos/0000-0001-8630-7211; Yáñez San Segundo, Lucrecia/0000-0001-9925-3048; Xavier, Joao/0000-0003-3592-1689; Khan, Niloufer/0000-0002-8631-5710; Brereton, Daniel/0000-0003-3392-6312; Peled, Jonathan/0000-0002-4029-7625; Shah, Gunjan/0000-0002-9977-0456; Messina, Julia/0000-0001-6411-198X; Hasegawa, Yuta/0000-0002-9925-2093; Lin, Richard/0000-0002-0834-7880; Gomes, Antonio LC/0000-0003-3790-3724; Bush, Amy/0000-0002-4495-3765; Amoretti, Luigi/0000-0002-4625-5119; ALARCON TOMAS, ANA/0000-0002-6290-1061; Markey, Kate/0000-0002-7064-2362	National Cancer Institute [R01-CA228308, R01 CA203950-01, R01CA203950-01, P30 CA008748, P01-CA023766]; National Heart, Lung, and Blood Institute [K08HL143189-01A1, 1R01HL124112]; National Institute of Allergy and Infectious Diseases [U01 AI124275, R01 AI032135, AI095706, R01 AI137269-01, 9R01AI100288]; National Institutes of Health [KL2 TR001115-03]; Claude D. Pepper Older Americans Independence Center of the National Institute on Aging [2P30AG028716-11]; Lymphoma Foundation; Sawiris Foundation; Society of MSK; Empire Clinical Research Investigator Program; Seres Therapeutics; Japan Society for the Promotion of Science [17H04206, 17K09945]; Japan Science and Technology Agency; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Conquer Cancer Foundation; Gilead Sciences; Alfonso Martin Escudero Foundation; MSK Cycle for Survival; Collaborative Research Center Transregio 221	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Claude D. Pepper Older Americans Independence Center of the National Institute on Aging; Lymphoma Foundation; Sawiris Foundation; Society of MSK; Empire Clinical Research Investigator Program; Seres Therapeutics; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Conquer Cancer Foundation; Gilead Sciences(Gilead Sciences); Alfonso Martin Escudero Foundation; MSK Cycle for Survival; Collaborative Research Center Transregio 221	Supported by grants from the National Cancer Institute (R01-CA228308, to Dr. van den Brink; R01 CA203950-01, to Drs. Sung and Chao; R01CA203950-01, to Dr. Sung, Dr. Chao, Ms. Bush, and Ms. Bohannon; P30 CA008748 [Cancer Center Core Grant]; and P01-CA023766, to Dr. van den Brink), by grants from the National Heart, Lung, and Blood Institute (K08HL143189-01A1, to Dr. Peled; and 1R01HL124112, to Drs. Peled, Sung, and Jenq), by grants from the National Institute of Allergy and Infectious Diseases (U01 AI124275, to Drs. Xavier and van den Brink; R01 AI032135 and AI095706, to Dr. Pamer; R01 AI137269-01, to Drs. Taur and Xavier; and 9R01AI100288, to Drs. Peled, Shono, and van den Brink), by a grant from the National Institutes of Health (KL2 TR001115-03 [National Center for Advancing Translational Sciences Clinical and Translational Science Award], to Dr. Sung), by a grant from the Claude D. Pepper Older Americans Independence Center of the National Institute on Aging (2P30AG028716-11, to Dr. Sung), by the Lymphoma Foundation (to Dr. Khan), by the Parker Institute for Cancer Immunotherapy at MSK (to Drs. Peled and van den Brink), by the Sawiris Foundation (to Dr. Peled), by the Society of MSK (to Dr. Peled), by the Empire Clinical Research Investigator Program (to Dr. Peled), by Seres Therapeutics (to Dr. Peled, Dr. Gomes, Mr. Slingerland, Ms. Clurman and Dr. van den Brink, and to Dr. Sung and Ms. Slingerland), by grants from the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI) (17H04206, to Dr. Teshima; and 17K09945 to Dr. Hashimoto), by the Center of Innovation Program from Japan Science and Technology Agency (to Dr. Teshima), by grants from the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to Dr. Hashimoto), by the Conquer Cancer Foundation Young Investigator Award and Gilead Sciences (to Dr. Khan), by the Alfonso Martin Escudero Foundation (to Dr. Castillo Flores), by grants from MSK Cycle for Survival (to Dr. Peled), and by funding from the Collaborative Research Center Transregio 221 (to Drs. Weber, Gessner, and Holler).	[Anonymous], 2018, J ORTHOP TRAUMA, V32, pS141; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilinski J, 2016, BIOL BLOOD MARROW TR, V22, P1087, DOI 10.1016/j.bbmt.2016.02.009; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Costea PI, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0072-8; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; DeFilipp Z, 2018, BLOOD ADV, V2, P745, DOI 10.1182/bloodadvances.2018017731; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Golob JL, 2017, CLIN INFECT DIS, V65, P1984, DOI 10.1093/cid/cix699; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Haak BW, 2018, BLOOD, V131, P2978, DOI 10.1182/blood-2018-01-828996; Harris B, 2016, AM J RESP CRIT CARE, V194, P450, DOI 10.1164/rccm.201507-1491OC; He Y, 2018, NAT MED, V24, P1532, DOI 10.1038/s41591-018-0164-x; Holler E, 2014, BIOL BLOOD MARROW TR, V20, P640, DOI 10.1016/j.bbmt.2014.01.030; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jenq RR, 2015, BIOL BLOOD MARROW TR, V21, P1373, DOI 10.1016/j.bbmt.2015.04.016; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Kakihana K, 2016, BLOOD, V128, P2083, DOI 10.1182/blood-2016-05-717652; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Mathewson ND, 2016, NAT IMMUNOL, V17, P505, DOI 10.1038/ni.3400; Montassier E, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0301-4; Peled JU, 2017, J CLIN ONCOL, V35, P1650, DOI 10.1200/JCO.2016.70.3348; Peled JU, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.36, 10.1038/nmicrobiol.2016.36]; Peric Z, 2018, BONE MARROW TRANSPL, V53, P1030, DOI 10.1038/s41409-018-0137-1; Rashidi A, 2018, AM J HEMATOL, V93, pE348, DOI 10.1002/ajh.25236; Rashidi A, 2018, BIOL BLOOD MARROW TR, V24, P1260, DOI 10.1016/j.bbmt.2018.01.025; Shono Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2311; Sinha R, 2017, NAT BIOTECHNOL, V35, P1077, DOI 10.1038/nbt.3981; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Stein-Thoeringer CK, 2019, SCIENCE, V366, P1143, DOI 10.1126/science.aax3760; Stoma I, 2020, CLIN INFECT DIS; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Taur Y, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9489; Taur Y, 2014, BLOOD, V124, P1174, DOI 10.1182/blood-2014-02-554725; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; The Lancet Public H, 2018, LANCET PUBLIC HEALTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; VANBEKKU.DW, 1974, J NATL CANCER I, V52, P401, DOI 10.1093/jnci/52.2.401; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Weber D, 2019, CLIN INFECT DIS, V68, P1303, DOI 10.1093/cid/ciy711; Weber D, 2017, BIOL BLOOD MARROW TR, V23, P845, DOI 10.1016/j.bbmt.2017.02.006; Weber D, 2015, BLOOD, V126, P1723, DOI 10.1182/blood-2015-04-638858; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800; Zirakzadeh A, 2008, BONE MARROW TRANSPL, V41, P385, DOI 10.1038/sj.bmt.1705912	46	216	220	4	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2020	382	9					822	834		10.1056/NEJMoa1900623	http://dx.doi.org/10.1056/NEJMoa1900623			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KS8TT	32101664	Green Accepted, Bronze			2022-12-28	WOS:000518581500008
J	Liu, ZD; Fu, YX				Liu, Zhida; Fu, Yang-Xin			Chemotherapy Induces Cancer-Fighting B Cells	CELL			English	Editorial Material							TERTIARY LYMPHOID STRUCTURES; IMMUNOTHERAPY	Tumor-infiltrating B cells are heterogeneous, and their roles in tumor immunity are controversial. In this issue of Cell, Lu and colleagues demonstrate that chemotherapy-induced complement signals promote the generation of ICOSL+B cells, which enhance tumor-specific T cell responses.	[Liu, Zhida; Fu, Yang-Xin] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75235 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Fu, YX (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75235 USA.	Yang-Xin.Fu@utsouthwestern.edu						Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Guo FF, 2019, J ONCOL, V2019, DOI 10.1155/2019/2592419; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Liu ZD, 2020, CELL MOL IMMUNOL, V17, P13, DOI 10.1038/s41423-019-0341-y; Lu YW, 2020, CELL, V180, P1081, DOI 10.1016/j.cell.2020.02.015; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Roumenina LT, 2019, NAT REV CANCER, V19, P698, DOI 10.1038/s41568-019-0210-0; Sautes-Fridman C, 2019, NAT REV CANCER, V19, P307, DOI 10.1038/s41568-019-0144-6; Shalapour S, 2015, NATURE, V521, P94, DOI 10.1038/nature14395; Tang HD, 2017, CELL MOL IMMUNOL, V14, P809, DOI 10.1038/cmi.2017.13; Yuen GJ, 2016, TRENDS CANCER, V2, P747, DOI 10.1016/j.trecan.2016.10.010	11	10	10	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2020	180	6					1037	1039		10.1016/j.cell.2020.02.046	http://dx.doi.org/10.1016/j.cell.2020.02.046			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KW1IO	32142652	Bronze			2022-12-28	WOS:000520925300003
J	Bierman, P				Bierman, Paul			Teamwork, the Cuban way	SCIENCE			English	Editorial Material								settled into my seat on a plane bound for Cuba feeling frustrated. When I planned the trip, I had assumed that my Cuban collaborators and I would hit the ground running, heading out into the field straight away to collect water and sediment samples from rivers. That's how I'd done fieldwork in Namibia, Bolivia, and Greenland. But not in Cuba, it seemed. Five days earlier, a Cuban scientist emailed to inform me that we'd only be meeting to talk about our planned project. Sampling would happen during a later trip, she wrote. That left me feeling impatient and unhappy. Why did I need to travel there to have a meeting? But I had something to learn in Cuba.	[Bierman, Paul] Univ Vermont, Burlington, VT 05405 USA	University of Vermont	Bierman, P (corresponding author), Univ Vermont, Burlington, VT 05405 USA.								0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1274	1274		10.1126/science.367.6483.1274	http://dx.doi.org/10.1126/science.367.6483.1274			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU9DP	32165589				2022-12-28	WOS:000520023800046
J	Dyer, O				Dyer, Owen			Covid-19: China's president Xi visits Wuhan amid confidence that virus is under control	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Jiaxu J., 2020, XINHUANET       0310; Yang DL, 2020, WASHINGTON POST	2	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2020	368								m995	10.1136/bmj.m995	http://dx.doi.org/10.1136/bmj.m995			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AR	32160997	Bronze			2022-12-28	WOS:000520012800015
J	Mitchell, C; Dolan, N; Dursteler, KM				Mitchell, Caroline; Dolan, Neil; Dursteler, Kenneth M.			Management of dependent use of illicit opioids	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INJECT DRUGS; INTERVENTIONS; DISORDERS; METHADONE; DEATHS; PEOPLE; HEALTH		[Mitchell, Caroline] Univ Sheffield, Fac Med Dent & Hlth, Acad Unit Primary Med Care, Sheffield, S Yorkshire, England; [Dolan, Neil] Univ Sheffield, Sheffield, S Yorkshire, England; [Dursteler, Kenneth M.] Univ Basel, Psychiat Hosp, Ctr Addict Disorders, Basel, Switzerland; [Dursteler, Kenneth M.] Univ Hosp Psychiat Zurich, Dept Psychiat Psychotherapy & Psychosomat, Ctr Addict Disorders, Zurich, Switzerland	University of Sheffield; University of Sheffield; University of Basel	Mitchell, C (corresponding author), Univ Sheffield, Fac Med Dent & Hlth, Acad Unit Primary Med Care, Sheffield, S Yorkshire, England.	c.mitchell@sheffield.ac.uk	Dürsteler, Kenneth Michael/AAJ-2374-2021	Dürsteler, Kenneth Michael/0000-0003-1552-5822; Mitchell, Caroline/0000-0002-4790-0095				Advisory Council on the Misuse of Drugs, 2011, HIDD HARM REP CHILDR; Advisory Council on the Misuse of Drugs, 2010, CONS US FOIL INT RED; Amato L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003409.pub4; [Anonymous], OP DEP CLIN KNOWL SU; [Anonymous], 2018, AD SUBST MIS STAT NA; [Anonymous], 2019, EUROPEAN DRUG REPORT; Banerjee G, 2016, ADDICTION, V111, P2021, DOI 10.1111/add.13491; Bawor M, 2015, DRUG ALCOHOL DEPEN, V149, P1, DOI 10.1016/j.drugalcdep.2015.01.038; Beletsky L, 2012, JAMA-J AM MED ASSOC, V308, P1863, DOI 10.1001/jama.2012.14205; Blanco C, 2019, LANCET, V393, P1760, DOI 10.1016/S0140-6736(18)33078-2; Clinical Guidelines on Drug Misuse and Dependence Update, 2017, CLIN GUID DRUG MIS D; Collins FS, 2018, JAMA-J AM MED ASSOC, V320, P129, DOI 10.1001/jama.2018.8826; Cornish R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5475; Degenhardt L, 2017, LANCET GLOB HEALTH, V5, pE1192, DOI 10.1016/S2214-109X(17)30375-3; Drake RE, 1998, SCHIZOPHRENIA BULL, V24, P589, DOI 10.1093/oxfordjournals.schbul.a033351; Dunn C, 2001, ADDICTION, V96, P1725, DOI 10.1046/j.1360-0443.2001.961217253.x; European Monitoring Centre for Drugs and Drug Addiction, 2017, EUR DRUG REP 2017 TR; Grischott T, 2019, ADDICTION, V114, P868, DOI 10.1111/add.14559; Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence, GUID PSYCH ASS PHARM; Hallinan R, 2008, J SEX MED, V5, P684, DOI 10.1111/j.1743-6109.2007.00702.x; Hulin J, 2020, ADDICTION, V115, P832, DOI 10.1111/add.14870; Livingston JD, 2012, ADDICTION, V107, P39, DOI 10.1111/j.1360-0443.2011.03601.x; Mathers BM, 2013, B WORLD HEALTH ORGAN, V91, P102, DOI 10.2471/BLT.12.108282; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; McConnaughy E, 1983, HLTH BEHAV THEORY RE, V20, P3; McDonald R, 2016, ADDICTION, V111, P1177, DOI 10.1111/add.13326; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Mitchell CA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012823; National Institute for Health and Care Excellence, 2007, NALTR MAN OP DEP TEC; National Institute for Health and Care Excellence, 2007, DRUG MIS 16S OP DET; National Institute for Health and Care Excellence, 2007, METH BUPR MAN OP DEP; National Institute for Health and Care Excellence, 2007, DRUG MIS 16S PSYCH I; Nordt C, 2019, ADDICTION, V114, P103, DOI 10.1111/add.14442; Oliver P, 2007, BENZODIAZEPINES COCA; Parmenter J, 2013, BRIT J GEN PRACT, V63, pE499, DOI 10.3399/bjgp13X669220; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Public Health Agency of Canada, 2016, NAT REP APP OP REL D; Public Health England, 2018, DRUGS COMM SUPP PACK; Rollnick S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1900; Rosic T, 2017, NEUROPSYCH DIS TREAT, V13, P1399, DOI 10.2147/NDT.S129480; Roxburgh A., 2018, OPIOID AMPHETAMINE C; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Sohal H, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-49; Sordo L, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1550; Strang J, ANN REPORT CHIEF MED; STRANG J, 2010, BMJ-BRIT MED J, V341, DOI DOI 10.1136/BMJ.C4851; Substance abuse and mental health services administration, 2016, HHS PUBL; Taft A, 2013, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD007007.PUB2; World Health Organization, ICD 10 CLASS MENT BE; World Health Organization, 2009, GUID PSYCH ASS PHARM	50	0	0	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2020	368								m710	10.1136/bmj.m710	http://dx.doi.org/10.1136/bmj.m710			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU9AK	32152035	Green Accepted			2022-12-28	WOS:000520012000001
J	Spring, LM; Wander, SA; Andre, F; Moy, B; Turner, NC; Bardia, A				Spring, Laura M.; Wander, Seth A.; Andre, Fabrice; Moy, Beverly; Turner, Nicholas C.; Bardia, Aditya			Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future	LANCET			English	Review							CDK4/6 INHIBITION; RETINOBLASTOMA PROTEIN; ENDOCRINE RESISTANCE; ANTITUMOR-ACTIVITY; PHASE-II; PALBOCICLIB; THERAPY; ABEMACICLIB; COMBINATION; D1	The development and approval of cyclin-dependent kinase (CDK) 4 and 6 inhibitors for hormone receptor-positive and human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer represents a major milestone in cancer therapeutics. Three different oral CDK4/6 inhibitors, palbociclib, ribociclib, and abemaciclib, have significantly improved progression-free survival by a number of months when combined with endocrine therapy. More recently, improvement in overall survival has been reported with ribociclib and abemaciclib. The toxicity profile of all three drugs is well described and generally easily manageable with dose reductions when indicated. More myelotoxicity is observed with palbociclib and ribociclib, but more gastrointestinal toxicity is observed with abemaciclib. Emerging data is shedding light on the resistance mechanisms associated with CDK4/6 inhibitors, including cell cycle alterations and activation of upstream tyrosine kinase receptors. A number of clinical trials are exploring several important questions regarding treatment sequencing, combinatorial strategies, and the use of CDK4/6 inhibitors in the adjuvant and neoadjuvant settings, thereby further expanding and refining the clinical application of CDK4/6 inhibitors for patients with breast cancer.	[Spring, Laura M.; Wander, Seth A.; Moy, Beverly; Bardia, Aditya] Harvard Med Sch, Massachusetts Gen Hosp Canc Ctr, Dept Med Oncol, Boston, MA 02114 USA; [Andre, Fabrice] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France; [Turner, Nicholas C.] Royal Marsden Hosp, Inst Canc Res, Dept Med Oncol, London, England	Harvard University; Harvard Medical School; Massachusetts General Hospital; UNICANCER; Gustave Roussy; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Bardia, A (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp Canc Ctr, Dept Med Oncol, Boston, MA 02114 USA.	bardia.aditya@mgh.harvard.edu	ANDRE, Fabrice/AAL-2683-2020	ANDRE, Fabrice/0000-0001-5795-8357; Wander, Seth/0000-0002-4127-4708; Turner, Nicholas/0000-0001-8937-0873	National Cancer Institute [KL2 TR002542]; Terri Brodeur Breast Cancer Foundation; Massachusetts General Hospital Electronic Space Systems Corporation Breast Cancer Research Fund grant	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Terri Brodeur Breast Cancer Foundation; Massachusetts General Hospital Electronic Space Systems Corporation Breast Cancer Research Fund grant	LMS is supported by National Cancer Institute grant KL2 TR002542, a Terri Brodeur Breast Cancer Foundation grant, and a Massachusetts General Hospital Electronic Space Systems Corporation Breast Cancer Research Fund grant.	Altucci L, 1997, ENDOCRINOLOGY, V138, P978, DOI 10.1210/en.138.3.978; Andre F, 2019, NEW ENGL J MED, V380, P1929, DOI 10.1056/NEJMoa1813904; [Anonymous], LANCET ONCOL; [Anonymous], 2017 SAN ANT BREAST; Arima Y, 2008, CANCER RES, V68, P5104, DOI 10.1158/0008-5472.CAN-07-5680; Arnedos M, 2018, ANN ONCOL, V29, P1755, DOI 10.1093/annonc/mdy202; Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Bardia A, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.1016; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Bertucci F, 2019, NATURE, V569, P560, DOI 10.1038/s41586-019-1056-z; Bosco EE, 2007, CELL CYCLE, V6, P667, DOI 10.4161/cc.6.6.3988; Brufsky AM, 2017, CANCER TREAT REV, V59, P22, DOI 10.1016/j.ctrv.2017.06.004; Butt AJ, 2005, ENDOCR-RELAT CANCER, V12, pS47, DOI 10.1677/erc.1.00993; Caldon CE, 2012, MOL CANCER THER, V11, P1488, DOI 10.1158/1535-7163.MCT-11-0963; Condorelli R, 2018, ANN ONCOL, V29, P640, DOI 10.1093/annonc/mdx784; Cornell L, 2019, CELL REP, V26, P2667, DOI 10.1016/j.celrep.2019.02.023; Costa C, 2020, CANCER DISCOV, V10, P72, DOI 10.1158/2159-8290.CD-18-0830; Cottu P, 2018, ANN ONCOL, V29, P2334, DOI 10.1093/annonc/mdy448; Cristofanilli M, 2016, LANCET ONCOL, V17, P425, DOI 10.1016/S1470-2045(15)00613-0; Dean JL, 2010, ONCOGENE, V29, P4018, DOI 10.1038/onc.2010.154; Dickler MN, 2017, CLIN CANCER RES, V23, P5218, DOI 10.1158/1078-0432.CCR-17-0754; Dickson MA, 2014, CLIN CANCER RES, V20, P3379, DOI 10.1158/1078-0432.CCR-13-1551; dos Anjos CH, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.1053; Drago JZ, 2019, CLIN CANCER RES, V25, P6443, DOI 10.1158/1078-0432.CCR-19-0138; Finn RS, 2016, NEW ENGL J MED, V375, P1925, DOI 10.1056/NEJMoa1607303; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Formisano L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09068-2; Fry DW, 2004, MOL CANCER THER, V3, P1427; Gelbert LM, 2014, INVEST NEW DRUG, V32, P825, DOI 10.1007/s10637-014-0120-7; Geum DH, 1997, MOL REPROD DEV, V46, P450, DOI 10.1002/(SICI)1098-2795(199704)46:4&lt;450::AID-MRD2&gt;3.0.CO;2-N; Goel S, 2017, NATURE, V548, P471, DOI 10.1038/nature23465; Goetz MP, 2017, J CLIN ONCOL, V35, P3638, DOI 10.1200/JCO.2017.75.6155; Herrera-Abreu MT, 2016, CANCER RES, V76, P2301, DOI 10.1158/0008-5472.CAN-15-0728; Hortobagyi GN, 2016, NEW ENGL J MED, V375, P1738, DOI 10.1056/NEJMoa1609709; Im SA, 2019, NEW ENGL J MED, V381, P307, DOI 10.1056/NEJMoa1903765; Johnston S, 2019, J CLIN ONCOL, V37, P178, DOI 10.1200/JCO.18.01624; Kim S, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-4; Li ZQ, 2018, CANCER CELL, V34, P893, DOI 10.1016/j.ccell.2018.11.006; Ma CX, 2017, CLIN CANCER RES, V23, P4055, DOI 10.1158/1078-0432.CCR-16-3206; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Mao PP, 2018, CANCER RES, V78; Matutino A, 2018, THER ADV MED ONCOL, V10, DOI 10.1177/1758835918818346; Medford AJ, 2019, NPJ PRECIS ONCOL, V3, DOI 10.1038/s41698-019-0090-5; Millar EKA, 2009, ONCOGENE, V28, P1812, DOI 10.1038/onc.2009.13; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; Nair BC, 2008, GENE THER MOL BIOL, V12B, P395; Nayar U, 2019, NAT GENET, V51, P207, DOI 10.1038/s41588-018-0287-5; O'Leary B, 2018, CANCER DISCOV, V8, P1390, DOI 10.1158/2159-8290.CD-18-0264; Olson CM, 2019, CELL CHEM BIOL, V26, P792, DOI 10.1016/j.chembiol.2019.02.012; Pan HC, 2017, NEW ENGL J MED, V377, P1836, DOI 10.1056/NEJMoa1701830; Park D, 1997, 1997 2ND INTERNATIONAL SYMPOSIUM ON PLASMA PROCESS-INDUCED DAMAGE, P15; Prat A, 2020, LANCET ONCOL, V21, P33, DOI 10.1016/S1470-2045(19)30786-7; Rader J, 2013, CLIN CANCER RES, V19, P6173, DOI 10.1158/1078-0432.CCR-13-1675; Roberts PJ, 2012, JNCI-J NATL CANCER I, V104, P476, DOI 10.1093/jnci/djs002; Singh H, 2018, CANCER RES, V78; Slamon DJ, 2020, NEW ENGL J MED, V382, P514, DOI 10.1056/NEJMoa1911149; Slamon DJ, 2018, J CLIN ONCOL, V36, P2465, DOI 10.1200/JCO.2018.78.9909; Sledge GW, 2020, JAMA ONCOL, V6, P116, DOI 10.1001/jamaoncol.2019.4782; Sledge GW, 2017, J CLIN ONCOL, V35, P2875, DOI 10.1200/JCO.2017.73.7585; Spring LM, 2017, ONCOLOGIST, V22, P1039, DOI 10.1634/theoncologist.2017-0142; Tan AR, 2019, LANCET ONCOL, V20, P1587, DOI 10.1016/S1470-2045(19)30616-3; Tate SC, 2014, CLIN CANCER RES, V20, P3763, DOI 10.1158/1078-0432.CCR-13-2846; Thangavel C, 2011, ENDOCR-RELAT CANCER, V18, P333, DOI 10.1530/ERC-10-0262; Tolaney SM, 2019, ANN ONCOL, V30, P861; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; Trere D, 2009, ANN ONCOL, V20, P1818, DOI 10.1093/annonc/mdp209; Tripathy D, 2018, LANCET ONCOL, V19, P904, DOI 10.1016/S1470-2045(18)30292-4; Turner NC, 2018, NEW ENGL J MED, V379, P1926, DOI 10.1056/NEJMoa1810527; Turner NC, 2019, J CLIN ONCOL, V37, P1169, DOI 10.1200/JCO.18.00925; Turner NC, 2015, NEW ENGL J MED, V373, P209, DOI 10.1056/NEJMoa1505270; US Food and Drug Administration, 2019, FDA WARNS RAR SEV LU; Wander SA, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.1057; Wander SA, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.12016; WANG JYJ, 1994, ADV CANCER RES, V64, P25, DOI 10.1016/S0065-230X(08)60834-9; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yang C, 2017, ONCOGENE, V36, P2255, DOI 10.1038/onc.2016.379; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012; Zhang YX, 2014, MOL CANCER THER, V13, P2184, DOI 10.1158/1535-7163.MCT-14-0387	81	147	155	11	64	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2020	395	10226					817	827						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KH	32145796				2022-12-28	WOS:000519536900039
J	Chen, J; Brunner, AD; Cogan, JZ; Nunez, JK; Fields, AP; Adamson, B; Itzhak, DN; Li, JY; Mann, M; Leonetti, MD; Weissman, JS				Chen, Jin; Brunner, Andreas-David; Cogan, J. Zachery; Nunez, James K.; Fields, Alexander P.; Adamson, Britt; Itzhak, Daniel N.; Li, Jason Y.; Mann, Matthias; Leonetti, Manuel D.; Weissman, Jonathan S.			Pervasive functional translation of noncanonical human open reading frames	SCIENCE			English	Article							MASS-SPECTROMETRY; GENETIC SCREENS; NONCODING RNAS; UPSTREAM ORFS; STEM-CELLS; PROTEIN; REVEALS; SINGLE; MICROPEPTIDE; PEPTIDES	Ribosome profiling has revealed pervasive but largely uncharacterized translation outside of canonical coding sequences (CDSs). In this work, we exploit a systematic CRISPR-based screening strategy to identify hundreds of noncanonical CDSs that are essential for cellular growth and whose disruption elicits specific, robust transcriptomic and phenotypic changes in human cells. Functional characterization of the encoded microproteins reveals distinct cellular localizations, specific protein binding partners, and hundreds of microproteins that are presented by the human leukocyte antigen system. We find multiple microproteins encoded in upstream open reading frames, which form stable complexes with the main, canonical protein encoded on the same messenger RNA, thereby revealing the use of functional bicistronic operons in mammals. Together, our results point to a family of functional human microproteins that play critical and diverse cellular roles.	[Chen, Jin; Cogan, J. Zachery; Nunez, James K.; Fields, Alexander P.; Adamson, Britt; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Chen, Jin; Cogan, J. Zachery; Nunez, James K.; Fields, Alexander P.; Adamson, Britt; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Brunner, Andreas-David; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Itzhak, Daniel N.; Li, Jason Y.; Leonetti, Manuel D.] Chan Zuckerberg Biohub, Cell Atlas Initiat, San Francisco, CA 94158 USA; [Mann, Matthias] Univ Copenhagen, Novo Nordisk Fdn, Prote Program, Clin Prote Grp,Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Fields, Alexander P.] GRAIL Inc, Menlo Pk, CA 94025 USA; [Adamson, Britt] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Adamson, Britt] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Max Planck Society; Novo Nordisk Foundation; University of Copenhagen; Princeton University; Princeton University	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.; Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	jonathan.weissman@ucsf.edu	Hou, Yi/AAE-9581-2019; Adamson, Britt/GPP-4018-2022; Aydin, Erkan/AAZ-4740-2021	Hou, Yi/0000-0002-1532-816X; Adamson, Britt/0000-0002-9451-5819; Aydin, Erkan/0000-0002-8849-2788; Weissman, Jonathan/0000-0003-2445-670X; Brunner, Andreas-David/0000-0002-2733-7899; Nunez, James/0000-0002-7396-6119	NIH [RM1 HG009490, K99 GM134154]; DARPA [HR0011-17-2-0043]; Chan-Zuckerberg Initiative; Max Planck Society; Jane Coffin Childs Memorial Fund for Medical Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Chan-Zuckerberg Initiative; Max Planck Society(Max Planck SocietyFoundation CELLEX); Jane Coffin Childs Memorial Fund for Medical Research	This work was funded by NIH (RM1 HG009490), DARPA (HR0011-17-2-0043), and the Chan-Zuckerberg Initiative. J.S.W. is a HHMI Investigator. A.-D.B. and M.M. are supported by the Max Planck Society. J.C. is funded by the Jane Coffin Childs Memorial Fund for Medical Research and the NIH K99/R00 Pathway to Independence Award (K99 GM134154). J.K.N. is a fellow of the Hanna H. Gray Fellows Program. Oligonucleotide pools were courtesy of the Innovative Genomics Institute.	Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Andreatta M, 2017, NUCLEIC ACIDS RES, V45, pW458, DOI 10.1093/nar/gkx248; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Basrai MA, 1997, GENOME RES, V7, P768, DOI 10.1101/gr.7.8.768; Bassani-Sternberg M, 2015, MOL CELL PROTEOMICS, V14, P658, DOI 10.1074/mcp.M114.042812; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bazzini AA, 2014, EMBO J, V33, P981, DOI 10.1002/embj.201488411; Bergeron D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.472654; Bi P, 2017, SCIENCE, V356, P323, DOI 10.1126/science.aam9361; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chan MM, 2019, NATURE, V570, P77, DOI 10.1038/s41586-019-1184-5; Chew GL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11663; D'Lima NG, 2017, NAT CHEM BIOL, V13, P174, DOI [10.1038/NCHEMBIO.2249, 10.1038/nchembio.2249]; Datlinger P, 2017, NAT METHODS, V14, P297, DOI [10.1038/NMETH.4177, 10.1038/nmeth.4177]; Delcourt V, 2018, MOL CELL PROTEOMICS, V17, P2402, DOI 10.1074/mcp.RA118.000593; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dunn JG, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3278-x; Feng SY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00494-8; Fields AP, 2015, MOL CELL, V60, P816, DOI 10.1016/j.molcel.2015.11.013; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Huang JZ, 2017, MOL CELL, V68, P171, DOI 10.1016/j.molcel.2017.09.015; Ingolia NT, 2014, CELL REP, V8, P1365, DOI 10.1016/j.celrep.2014.07.045; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jackson R, 2018, NATURE, V564, P434, DOI 10.1038/s41586-018-0794-7; Ji Z, 2015, ELIFE, V4, DOI 10.7554/eLife.08890; Johnstone TG, 2016, EMBO J, V35, P706, DOI 10.15252/embj.201592759; Jost M, 2017, MOL CELL, V68, P210, DOI 10.1016/j.molcel.2017.09.012; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kulak NA, 2017, MOL CELL PROTEOMICS, V16, P694, DOI 10.1074/mcp.O116.065136; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lareau LF, 2014, ELIFE, V3, DOI 10.7554/eLife.01257; Lee CF, 2014, J BIOL CHEM, V289, P1257, DOI 10.1074/jbc.M113.509059; Leonetti MD, 2016, P NATL ACAD SCI USA, V113, pE3501, DOI 10.1073/pnas.1606731113; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/nmeth.3453, 10.1038/NMETH.3453]; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; Makarewich CA, 2018, CELL REP, V23, P3701, DOI 10.1016/j.celrep.2018.05.058; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; Mas-Ponte D, 2017, RNA, V23, P1080, DOI 10.1261/rna.060814.117; Matsumoto A, 2017, NATURE, V541, P228, DOI 10.1038/nature21034; McGlincy NJ, 2017, METHODS, V126, P112, DOI 10.1016/j.ymeth.2017.05.028; Nelson BR, 2016, SCIENCE, V351, P271, DOI 10.1126/science.aad4076; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Perez AR, 2017, NAT BIOTECHNOL, V35, P347, DOI 10.1038/nbt.3804; Rathore A, 2018, BIOCHEMISTRY-US, V57, P5564, DOI 10.1021/acs.biochem.8b00726; Samandi S, 2017, ELIFE, V6, DOI [10.7754/eLife.27860, 10.7554/eLife.27860]; Sendoel A, 2017, NATURE, V541, P494, DOI 10.1038/nature21036; Slavoff SA, 2014, J BIOL CHEM, V289, P10950, DOI 10.1074/jbc.C113.533968; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Starck SR, 2016, SCIENCE, V351, DOI 10.1126/science.aad3867; Stein CS, 2018, CELL REP, V23, P3710, DOI 10.1016/j.celrep.2018.06.002; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Yu R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00853-x; Zhang Q, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15664	70	203	207	20	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1140	+		10.1126/science.aay0262	http://dx.doi.org/10.1126/science.aay0262			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9CD	32139545	Green Accepted			2022-12-28	WOS:000520018400044
J	Duclos, G; Adkins, R; Banerjee, D; Peterson, MSE; Varghese, M; Kolvin, I; Baskaran, A; Pelcovits, RA; Powers, TR; Baskaran, A; Toschi, F; Hagan, MF; Streichan, SJ; Vitelli, V; Beller, DA; Dogic, Z				Duclos, Guillaume; Adkins, Raymond; Banerjee, Debarghya; Peterson, Matthew S. E.; Varghese, Minu; Kolvin, Itamar; Baskaran, Arvind; Pelcovits, Robert A.; Powers, Thomas R.; Baskaran, Aparna; Toschi, Federico; Hagan, Michael F.; Streichan, Sebastian J.; Vitelli, Vincenzo; Beller, Daniel A.; Dogic, Zvonimir			Topological structure and dynamics of three-dimensional active nematics	SCIENCE			English	Article							DISCLINATION LOOPS; DEFECTS	Topological structures are effective descriptors of the nonequilibrium dynamics of diverse many-body systems. For example, motile, point-like topological defects capture the salient features of two-dimensional active liquid crystals composed of energy-consuming anisotropic units. We dispersed force-generating microtubule bundles in a passive colloidal liquid crystal to form a three-dimensional active nematic. Light-sheet microscopy revealed the temporal evolution of the millimeter-scale structure of these active nematics with single-bundle resolution. The primary topological excitations are extended, charge-neutral disclination loops that undergo complex dynamics and recombination events. Our work suggests a framework for analyzing the nonequilibrium dynamics of bulk anisotropic systems as diverse as driven complex fluids, active metamaterials, biological tissues, and collections of robots or organisms.	[Duclos, Guillaume; Peterson, Matthew S. E.; Varghese, Minu; Baskaran, Arvind; Baskaran, Aparna; Hagan, Michael F.; Dogic, Zvonimir] Brandeis Univ, Dept Phys, Waltham, MA 02453 USA; [Adkins, Raymond; Kolvin, Itamar; Streichan, Sebastian J.; Dogic, Zvonimir] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93111 USA; [Banerjee, Debarghya] Max Planck Inst Dynam & Self Org, D-37077 Gottingen, Germany; [Banerjee, Debarghya] Leiden Univ, Inst Lorentz, NL-2300 RA Leiden, Netherlands; [Pelcovits, Robert A.; Powers, Thomas R.] Brown Univ, Dept Phys, Providence, RI 02912 USA; [Powers, Thomas R.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Toschi, Federico] Eindhoven Univ Technol, Dept Appl Phys, NL-5600 MB Eindhoven, Netherlands; [Toschi, Federico] CNR, Inst Applicaz Calcolo, I-00185 Rome, Italy; [Vitelli, Vincenzo] Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Vitelli, Vincenzo] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Beller, Daniel A.] Univ Calif, Dept Phys, Merced, CA 95343 USA	Brandeis University; University of California System; University of California Santa Barbara; Max Planck Society; Leiden University; Leiden University - Excl LUMC; Brown University; Brown University; Eindhoven University of Technology; Consiglio Nazionale delle Ricerche (CNR); University of Chicago; University of Chicago; University of California System; University of California Merced	Dogic, Z (corresponding author), Brandeis Univ, Dept Phys, Waltham, MA 02453 USA.; Dogic, Z (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93111 USA.; Beller, DA (corresponding author), Univ Calif, Dept Phys, Merced, CA 95343 USA.	dbeller@ucmerced.edu; zdogic@ucsb.edu	Pelcovits, Robert/AAH-6664-2021; Powers, Thomas R/K-1451-2015; Toschi, Federico/A-1552-2009	Adkins, Raymond/0000-0001-7622-2812; Peterson, Matthew/0000-0002-5749-7770; Pelcovits, Robert/0000-0002-0520-7516; Toschi, Federico/0000-0001-5935-2332; Beller, Daniel/0000-0003-1957-164X; Powers, Thomas/0000-0003-3432-8226; Varghese, Minu/0000-0003-4410-0233	U.S. Department of Energy, Office of Basic Energy Sciences [DE-SC0019733]; HFSP fellowships; NSF-GRFP; FOM; NWO; Army Research Office [W911NF-19-1-0268]; NSF-MRSEC [DMR-1420709]; NIH-R00 award [5R00HD088708-05]; Isaac Newton Institute for Mathematical Sciences - EPSRC [EP/R014604/1];  [NSF-DMR-1855914];  [NSF-MRSEC-1420382];  [NSF-CBET-1437195]	U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); HFSP fellowships; NSF-GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); FOM(FOM (The Netherlands)); NWO(Netherlands Organization for Scientific Research (NWO)); Army Research Office; NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NIH-R00 award; Isaac Newton Institute for Mathematical Sciences - EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ; ; 	Experimental work was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, through award DE-SC0019733 (G.D., R.A., I.K., and Z.D.). G.D. and I.K. also acknowledge support from HFSP fellowships. R.A. acknowledges support from NSF-GRFP. Theoretical modeling was supported by NSF-DMR-1855914, NSF-MRSEC-1420382, and NSF-CBET-1437195 (D.A.B., M.P., M.V., Ar.B., Ap.B., M.F.H., R.A.P., and T.R.P.). Computational resources were provided by the NSF through XSEDE computing resources (MCB090163) and TU/e through the F&F computing cluster. We also acknowledge use of the Brandeis optical, HPCC, and biosynthesis facilities supported by NSF-MRSEC-1420382. D.B. was supported by FOM and NWO. V.V. was supported by the Army Research Office under grant W911NF-19-1-0268 and NSF-MRSEC (DMR-1420709). S.J.S. was supported by NIH-R00 award 5R00HD088708-05. D.A.B. thanks the Isaac Newton Institute for Mathematical Sciences for support during the program "The Mathematical Design of New Materials," supported by EPSRC grant EP/R014604/1.	Alexander GP, 2012, REV MOD PHYS, V84, P497, DOI 10.1103/RevModPhys.84.497; Banerjee D., 2020, DATA NUMERICAL SIMUL, DOI [10.4121/uuid:5c8ea40a-19d5-4ecb-893a-c93f238a494c., DOI 10.4121/UUID:5C8EA40A-19D5-4ECB-893A-C93F238A494C]; Barry E, 2009, SOFT MATTER, V5, P2563, DOI 10.1039/b822478a; Bausch AR, 2003, SCIENCE, V299, P1716, DOI 10.1126/science.1081160; Blanch-Mercader C, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.208101; BOWICK MJ, 1994, SCIENCE, V263, P943, DOI 10.1126/science.263.5149.943; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chandrakar P., 2018, ARXIV181105026CONDMA; Copar S, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.031051; Copar S, 2013, P ROY SOC A-MATH PHY, V469, DOI 10.1098/rspa.2013.0204; DeCamp SJ, 2015, NAT MATER, V14, P1110, DOI [10.1038/nmat4387, 10.1038/NMAT4387]; Duclos G., 2020, DRYAD, DOI [10.25349/D9CS31, DOI 10.25349/D9CS31]; Emersic T, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4283; FRIEDEL J, 1969, CR ACAD SCI B PHYS, V268, P257; Galtier S, 2016, INTRODUCTION TO MODERN MAGNETOHYDRODYNAMICS, P1; Gao T, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.048101; Giomi L, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0365; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Irvine WTM, 2010, NATURE, V468, P947, DOI 10.1038/nature09620; JANICH K, 1987, ACTA APPL MATH, V8, P65, DOI 10.1007/BF00046687; Kawaguchi K, 2017, NATURE, V545, P327, DOI 10.1038/nature22321; Kleman M, 2008, REV MOD PHYS, V80, P61, DOI 10.1103/RevModPhys.80.61; Krzic U, 2012, NAT METHODS, V9, P730, DOI [10.1038/nmeth.2064, 10.1038/NMETH.2064]; Kumar N, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat7779; Lavine MS, 1997, MACROMOL SYMP, V124, P35, DOI 10.1002/masy.19971240107; Li H, 2019, P NATL ACAD SCI USA, V116, P777, DOI 10.1073/pnas.1812570116; Lozano-Duran A, 2016, ACM T MATH SOFTWARE, V42, DOI [10.1145/28450760, 10.1145/2845076]; Marenduzzo D, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031921; Martin DS, 2010, P NATL ACAD SCI USA, V107, P5453, DOI 10.1073/pnas.0914924107; Martinez A, 2014, NAT MATER, V13, P259, DOI [10.1038/NMAT3840, 10.1038/nmat3840]; Narayan V, 2007, SCIENCE, V317, P105, DOI 10.1126/science.1140414; Poulin P, 1997, SCIENCE, V275, P1770, DOI 10.1126/science.275.5307.1770; Preibisch S, 2014, NAT METHODS, V11, P645, DOI [10.1038/NMETH.2929, 10.1038/nmeth.2929]; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanchez T, 2012, NATURE, V491, P431, DOI 10.1038/nature11591; Saw TB, 2017, NATURE, V544, P212, DOI 10.1038/nature21718; Scheeler MW, 2017, SCIENCE, V357, P487, DOI 10.1126/science.aam6897; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shankar S, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.108002; Shendruk TN, 2018, PHYS REV E, V98, DOI 10.1103/PhysRevE.98.010601; Shi XQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4013; Simha RA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.058101; Streichan SJ, 2018, ELIFE, V7, DOI 10.7554/eLife.27454; Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012; TERENTJEV EM, 1995, PHYS REV E, V51, P1330, DOI 10.1103/PhysRevE.51.1330; Thampi SP, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/18001; Tkalec U, 2011, SCIENCE, V333, P62, DOI 10.1126/science.1205705; Toriwaki J., 2002, FORMA, V17, P183; Tran L, 2016, P NATL ACAD SCI USA, V113, P7106, DOI 10.1073/pnas.1602703113; VANKA SP, 1986, COMPUT METHOD APPL M, V59, P29, DOI 10.1016/0045-7825(86)90022-8; Zhao J, 2016, J SCI COMPUT, V68, P1241, DOI 10.1007/s10915-016-0177-x; Zhou S, 2014, P NATL ACAD SCI USA, V111, P1265, DOI 10.1073/pnas.1321926111	53	79	80	14	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1120	+		10.1126/science.aaz4547	http://dx.doi.org/10.1126/science.aaz4547			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9CD	32139540	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000520018400039
J	Dyer, C				Dyer, Clare			Doctors must not delay treating patients who are unable to consent over concerns of coercion	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M527	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2020	368								m933	10.1136/bmj.m933	http://dx.doi.org/10.1136/bmj.m933			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2LJ	32144170				2022-12-28	WOS:000519539700010
J	Vaz, AP; Wittig, JH; Inati, SK; Zaghloul, KA				Vaz, Alex P.; Wittig, John H., Jr.; Inati, Sara K.; Zaghloul, Kareem A.			Replay of cortical spiking sequences during human memory retrieval	SCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; PLACE-CELL SEQUENCES; RIPPLE OSCILLATIONS; HIPPOCAMPUS; REINSTATEMENT; CONSOLIDATION; NEOCORTEX; NEURONS; TIME	Episodic memory retrieval is thought to rely on the replay of past experiences, yet it remains unknown how human single-unit activity is temporally organized during episodic memory encoding and retrieval. We found that ripple oscillations in the human cortex reflect underlying bursts of single-unit spiking activity that are organized into memory-specific sequences. Spiking sequences occurred repeatedly during memory formation and were replayed during successful memory retrieval, and this replay was associated with ripples in the medial temporal lobe. Together, these data demonstrate that human episodic memory is encoded by specific sequences of neural activity and that memory recall involves reinstating this temporal order of activity.	[Vaz, Alex P.; Wittig, John H., Jr.; Zaghloul, Kareem A.] NINDS, Surg Neurol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Vaz, Alex P.] Duke Univ, Sch Med, Med Scientist Training Program, Durham, NC 27710 USA; [Vaz, Alex P.] Duke Univ, Dept Neurobiol, Durham, NC 27710 USA; [Inati, Sara K.] NINDS, NIH, Off Clin Director, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Zaghloul, KA (corresponding author), NINDS, Surg Neurol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	kareem.zaghloul@nih.gov	Hauke, Philipp/H-5304-2015; Vaz, Alex/AAW-4543-2020; Zaghloul, Kareem/AAV-4208-2020	Hauke, Philipp/0000-0002-0414-1754; Vaz, Alex/0000-0001-8820-7927; Wittig, Jr, John/0000-0003-0465-1022; Inati, Sara/0000-0002-7587-5085; Zaghloul, Kareem/0000-0001-8575-3578	Intramural Research Program of the National Institute for Neurological Disorders and Stroke (NINDS); National Institute of General Medical Sciences [T32 GM007171]; NINDS [F31 NS113400]	Intramural Research Program of the National Institute for Neurological Disorders and Stroke (NINDS); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Intramural Research Program of the National Institute for Neurological Disorders and Stroke (NINDS). This work was also supported by National Institute of General Medical Sciences grant T32 GM007171 and NINDS grant F31 NS113400 to A.P.V.	Aronov D, 2017, NATURE, V543, P719, DOI 10.1038/nature21692; Axmacher N, 2008, BRAIN, V131, P1806, DOI 10.1093/brain/awn103; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Buzsaki G, 2018, TRENDS COGN SCI, V22, P853, DOI 10.1016/j.tics.2018.07.006; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Deuker L, 2013, J NEUROSCI, V33, P19373, DOI 10.1523/JNEUROSCI.0414-13.2013; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Fernandez-Ruiz A, 2019, SCIENCE, V364, P1082, DOI 10.1126/science.aax0758; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Jang AI, 2017, CURR BIOL, V27, P1700, DOI 10.1016/j.cub.2017.05.014; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Johnson JD, 2007, CEREB CORTEX, V17, P2507, DOI 10.1093/cercor/bhl156; Joo HR, 2018, NAT REV NEUROSCI, V19, P744, DOI 10.1038/s41583-018-0077-1; Khodagholy D, 2017, SCIENCE, V358, P369, DOI 10.1126/science.aan6203; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Liu YZ, 2019, CELL, V178, P640, DOI 10.1016/j.cell.2019.06.012; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Naya Y, 1996, P NATL ACAD SCI USA, V93, P2664, DOI 10.1073/pnas.93.7.2664; Norman TM, 2019, SCIENCE, V365, P786, DOI 10.1126/science.aax4438; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Staresina BP, 2015, NAT NEUROSCI, V18, P1679, DOI 10.1038/nn.4119; Staresina BP, 2012, J NEUROSCI, V32, P18150, DOI 10.1523/JNEUROSCI.4156-12.2012; Trotta MS, 2018, HUM BRAIN MAPP, V39, P709, DOI 10.1002/hbm.23876; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; Van Quyen ML, 2008, J NEUROSCI, V28, P6104, DOI 10.1523/JNEUROSCI.0437-08.2008; Vaz AP, 2019, SCIENCE, V363, P975, DOI 10.1126/science.aau8956; Wittig JH, 2018, NAT NEUROSCI, V21, P808, DOI 10.1038/s41593-018-0148-7; Yaffe RB, 2014, P NATL ACAD SCI USA, V111, P18727, DOI 10.1073/pnas.1417017112; Zhang H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06553-y	37	43	44	4	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1131	+		10.1126/science.aba0672	http://dx.doi.org/10.1126/science.aba0672			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9CD	32139543	Green Accepted			2022-12-28	WOS:000520018400042
J	Arenas, OM; Lumpkin, EA				Arenas, Oscar M.; Lumpkin, Ellen A.			Touching Base with Mechanical Pain	CELL			English	Editorial Material								Unrelieved pain is a widespread condition that fuels the opioid crisis. Molecules that initiate painful sensations are intensively sought as therapeutic targets for improved pain interventions. In this issue of Cell, Beaulieu-Laroche et al. (2020) describe TACAN, a putative ion channel that mediates mechanical pain in mice.	[Arenas, Oscar M.; Lumpkin, Ellen A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Lumpkin, Ellen A.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Lumpkin, Ellen A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10027 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Columbia University	Lumpkin, EA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Lumpkin, EA (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.; Lumpkin, EA (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10027 USA.	ellen.a.lumpkin@gmail.com		Lumpkin, Ellen/0000-0002-1166-3374	NIH [R01NS105241, R01AR051219]; Thompson Family Foundation Initiative in CIPN and Sensory Neuroscience at Columbia University	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thompson Family Foundation Initiative in CIPN and Sensory Neuroscience at Columbia University	The authors are supported by NIH (R01NS105241, R01AR051219) and the Thompson Family Foundation Initiative in CIPN and Sensory Neuroscience at Columbia University.	Beaulieu-Laroche L, 2020, CELL, V180, P956, DOI 10.1016/j.cell.2020.01.033; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Jia YY, 2020, NEURON, V105, P310, DOI 10.1016/j.neuron.2019.10.017; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Murthy S.E., 2018, ELIFE, V7, P7; Murthy SE, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat9897; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Szczot M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat9892; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	10	4	4	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2020	180	5					824	826		10.1016/j.cell.2020.02.022	http://dx.doi.org/10.1016/j.cell.2020.02.022			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KT7JN	32142674	Bronze			2022-12-28	WOS:000519189800003
J	Nemet, I; Saha, PP; Gupta, N; Zhu, WF; Romano, KA; Skye, SM; Cajka, T; Mohan, ML; Li, L; Wu, YP; Funabashi, M; Ramer-Tait, AE; Prasad, SVN; Fiehn, O; Rey, FE; Tang, WHW; Fischbach, MA; DiDonato, JA; Hazen, SL				Nemet, Ina; Saha, Prasenjit Prasad; Gupta, Nilaksh; Zhu, Weifei; Romano, Kymberleigh A.; Skye, Sarah M.; Cajka, Tomas; Mohan, Maradumane L.; Li, Lin; Wu, Yuping; Funabashi, Masanori; Ramer-Tait, Amanda E.; Prasad, Sathyamangla Venkata Naga; Fiehn, Oliver; Rey, Federico E.; Tang, W. H. Wilson; Fischbach, Michael A.; DiDonato, Joseph A.; Hazen, Stanley L.			A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors	CELL			English	Article							CHRONIC HEART-FAILURE; AROMATIC-AMINO-ACIDS; PHOSPHOINOSITIDE 3-KINASE; ALLOSTERIC MODULATOR; AGONIST; BINDING; PHENYLACETYLGLUTAMINE; PHOSPHATIDYLCHOLINE; CATECHOLAMINES; DECONVOLUTION	Using untargeted metabolomics (n = 1,162 subjects), the plasma metabolite (m/z = 265.1188) phenylacetylglutamine (PAGln) was discovered and then shown in an independent cohort (n = 4,000 subjects) to be associated with cardiovascular disease (CVD) and incident major adverse cardiovascular events (myocardial infarction, stroke, or death). A gut microbiota-derived metabolite, PAGln, was shown to enhance platelet activation-related phenotypes and thrombosis potential in whole blood, isolated platelets, and animal models of arterial injury. Functional and genetic engineering studies with human commensals, coupled with microbial colonization of germ-free mice, showed the microbial porA gene facilitates dietary phenylalanine conversion into phenylacetic acid, with subsequent host generation of PAGln and phenylacetylglycine (PAGly) fostering platelet responsiveness and thrombosis potential. Both gain- and loss-of-function studies employing genetic and pharmacological tools reveal PAGln mediates cellular events through G-protein coupled receptors, including alpha 2A, alpha 2B, and beta 2-adrenergic receptors. PAGln thus represents a new CVD-promoting gut microbiota-dependent metabolite that signals via adrenergic receptors.	[Nemet, Ina; Saha, Prasenjit Prasad; Gupta, Nilaksh; Zhu, Weifei; Romano, Kymberleigh A.; Skye, Sarah M.; Mohan, Maradumane L.; Li, Lin; Prasad, Sathyamangla Venkata Naga; Tang, W. H. Wilson; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc & Metab Sci, Lerner Res Inst, Cleveland, OH 44106 USA; [Nemet, Ina; Saha, Prasenjit Prasad; Gupta, Nilaksh; Zhu, Weifei; Romano, Kymberleigh A.; Skye, Sarah M.; Li, Lin; Tang, W. H. Wilson; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Ctr Microbiome & Human Hlth, Cleveland, OH 44106 USA; [Cajka, Tomas; Fiehn, Oliver] Univ Calif Davis, West Coast Metabol Ctr, Davis, CA 95616 USA; [Wu, Yuping] Cleveland State Univ, Dept Math, Cleveland, OH 44115 USA; [Tang, W. H. Wilson; Hazen, Stanley L.] Cleveland Clin, Heart & Vasc Inst, Cleveland, OH 44106 USA; [Ramer-Tait, Amanda E.] Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68588 USA; [Rey, Federico E.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Funabashi, Masanori; Fischbach, Michael A.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Funabashi, Masanori; Fischbach, Michael A.] Stanford Univ, ChEM H, Stanford, CA 94305 USA; [Cajka, Tomas] Czech Acad Sci, Inst Physiol, Prague 14200, Czech Republic; [Funabashi, Masanori] Daiichi Sankyo RD Novare Co, Translat Res Dept, Tokyo 1348630, Japan	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of California System; University of California Davis; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation; University of Nebraska System; University of Nebraska Lincoln; University of Wisconsin System; University of Wisconsin Madison; Stanford University; Stanford University; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Daiichi Sankyo Company Limited	Hazen, SL (corresponding author), Cleveland Clin, Dept Cardiovasc & Metab Sci, Lerner Res Inst, Cleveland, OH 44106 USA.; Hazen, SL (corresponding author), Cleveland Clin, Ctr Microbiome & Human Hlth, Cleveland, OH 44106 USA.; Hazen, SL (corresponding author), Cleveland Clin, Heart & Vasc Inst, Cleveland, OH 44106 USA.	hazens@ccf.org	Gupta, Nilaksh/AAC-5005-2020; Funabashi, Masanori/GQZ-8735-2022; Cajka, Tomas/A-8914-2008; Saha, Prasenjit/ABC-6481-2020; Nemet, Ina/ABG-2855-2021; Hazen, Stanley L/ABD-5845-2021	Gupta, Nilaksh/0000-0002-9449-2610; Cajka, Tomas/0000-0002-9728-3355; Fischbach, Michael/0000-0003-3079-8247; Ramer-Tait, Amanda/0000-0003-0950-7548; Saha, Prasenjit/0000-0003-4679-2368; Nemet, Ina/0000-0002-0657-7121; Tang, W. H. Wilson/0000-0002-8335-735X	NIH [P01HL147823, R01HL103866, R01HL126827]; Office of Dietary Supplements [P01HL147823, R01HL103866, R01HL126827]; Foundation Leducq; NIH/NHLBI training grant [HL134622]; Shimadzu Center of Excellence award; NIH shared instrumentation grant [1S10OD016346]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Leducq(Leducq Foundation); NIH/NHLBI training grant; Shimadzu Center of Excellence award; NIH shared instrumentation grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by grants from the NIH and Office of Dietary Supplements (P01HL147823, R01HL103866, R01HL126827) and the Foundation Leducq. K.A.R. was supported in part by NIH/NHLBI training grant HL134622. Mass spectrometry studies were performed on instrumentation housed in a facility supported in part through a Shimadzu Center of Excellence award and NIH shared instrumentation grant 1S10OD016346. Microfluidic shear flow experiments were done with the help from the Lerner Research Institute Imaging Core.	Amrani Y, 2017, ADV IMMUNOL, V136, P1, DOI 10.1016/bs.ai.2017.06.003; Anfossi G, 1996, EUR J CLIN INVEST, V26, P353, DOI 10.1046/j.1365-2362.1996.150293.x; Aron-Wisnewsky J, 2016, NAT REV NEPHROL, V12, P169, DOI 10.1038/nrneph.2015.191; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; BARNETT DB, 1985, ADV EXP MED BIOL, V192, P97; Barrios C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134311; BILSKI AJ, 1983, J CARDIOVASC PHARM, V5, P430, DOI 10.1097/00005344-198305000-00013; Black HR, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2010.08.003; Blazenovic I, 2018, METABOLITES, V8, DOI 10.3390/metabo8020031; Brown JM, 2018, NAT REV MICROBIOL, V16, P171, DOI 10.1038/nrmicro.2017.149; BRUSILOW S, 1980, SCIENCE, V207, P659, DOI 10.1126/science.6243418; Burnett H, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003529; Cameron SJ, 2018, ARTERIOSCL THROM VAS, V38, P1594, DOI 10.1161/ATVBAHA.118.311186; Campbell AP, 2018, NAT REV DRUG DISCOV, V17, P789, DOI 10.1038/nrd.2018.135; Ciccarelli M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00265; COLMAN RW, 1990, HEMATOL ONCOL CLIN N, V4, P27, DOI 10.1016/S0889-8588(18)30504-5; da Silva RR, 2015, P NATL ACAD SCI USA, V112, P12549, DOI 10.1073/pnas.1516878112; Devlin AS, 2016, CELL HOST MICROBE, V20, P709, DOI 10.1016/j.chom.2016.10.021; Dickert S, 2002, MOL MICROBIOL, V44, P49, DOI 10.1046/j.1365-2958.2002.02867.x; Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Elliott P, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5680; ELSDEN SR, 1976, ARCH MICROBIOL, V107, P283, DOI 10.1007/BF00425340; Fawzi AB, 2001, MOL PHARMACOL, V59, P30, DOI 10.1124/mol.59.1.30; Fu Q, 2017, TRENDS ENDOCRIN MET, V28, P416, DOI 10.1016/j.tem.2017.02.002; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gonzalez-Guardia L, 2015, J GERONTOL A-BIOL, V70, P78, DOI 10.1093/gerona/glu098; Guo CJ, 2019, SCIENCE, V366, P1331, DOI 10.1126/science.aav1282; Gupta N, 2015, ARTERIOSCL THROM VAS, V35, P2657, DOI 10.1161/ATVBAHA.115.306054; Gupta R, 2004, AM HEART J, V147, P79, DOI 10.1016/j.ahj.2003.07.022; Hein L, 1997, TRENDS CARDIOVAS MED, V7, P137, DOI 10.1016/S1050-1738(97)00034-0; Hein L, 2006, CELL TISSUE RES, V326, P541, DOI 10.1007/s00441-006-0285-2; Ilardi F, 2018, AM J CARDIOL, V122, P6, DOI 10.1016/j.amjcard.2018.03.004; Jonsson AL, 2017, NAT REV CARDIOL, V14, P79, DOI 10.1038/nrcardio.2016.183; Koeth RA, 2019, J CLIN INVEST, V129, P373, DOI 10.1172/JCI94601; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Koh A, 2018, CELL, V175, P947, DOI 10.1016/j.cell.2018.09.055; Koopen AM, 2016, CURR OPIN LIPIDOL, V27, P615, DOI 10.1097/MOL.0000000000000357; Koryakina Y, 2012, CELL BIOL INT, V36, P1171, DOI 10.1042/CBI20120134; Lefkowitz RJ, 2000, CIRCULATION, V101, P1634; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Lewandowicz AM, 2006, BRIT J PHARMACOL, V147, P422, DOI 10.1038/sj.bjp.0706624; Li XMS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99096; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; Loo RL, 2018, AM J CLIN NUTR, V107, P323, DOI 10.1093/ajcn/nqx072; Masureel M, 2018, NAT CHEM BIOL, V14, P1059, DOI 10.1038/s41589-018-0145-x; Meyer TW, 2016, J AM SOC NEPHROL, V27, P3469, DOI 10.1681/ASN.2015091035; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; MOLDAVE K, 1957, J BIOL CHEM, V229, P463; OROURKE MF, 1994, J PHARMACOL EXP THER, V268, P1362; Petrikova M, 2005, Bratisl Lek Listy, V106, P20; Piarulli F, 2009, DIABETOLOGIA, V52, P1419, DOI 10.1007/s00125-009-1367-y; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Poesen R, 2016, J AM SOC NEPHROL, V27, P3479, DOI 10.1681/ASN.2015121302; Prasad SVN, 2001, J BIOL CHEM, V276, P18953, DOI 10.1074/jbc.M102376200; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Schmidt RA, 2018, TRANSL RES, V195, P1, DOI 10.1016/j.trsl.2017.11.006; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Shafi T, 2017, KIDNEY INT, V92, P1484, DOI 10.1016/j.kint.2017.05.012; Shafi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126048; Skye SM, 2018, CIRC RES, V123, P1164, DOI 10.1161/CIRCRESAHA.118.313142; Small KM, 2003, ANNU REV PHARMACOL, V43, P381, DOI 10.1146/annurev.pharmtox.43.100901.135823; Srikanthan S, 2014, J THROMB HAEMOST, V12, P1906, DOI 10.1111/jth.12712; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; Urpi-Sarda M, 2019, DIABETES METAB, V45, P167, DOI 10.1016/j.diabet.2018.02.006; Wang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065675; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Watson LJ, 2016, CELL SIGNAL, V28, P1580, DOI 10.1016/j.cellsig.2016.05.006; WEBSTER LT, 1976, J BIOL CHEM, V251, P3352; Witte KK, 2018, DIABETES CARE, V41, P136, DOI 10.2337/dc17-1406; Yang DW, 1996, AM J PHYSIOL-ENDOC M, V270, pE882, DOI 10.1152/ajpendo.1996.270.5.E882; Zhang L, 2018, CIRCULATION, V137, P1374, DOI 10.1161/CIRCULATIONAHA.117.031139; Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011	77	186	195	40	229	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2020	180	5					862	+		10.1016/j.cell.2020.02.016	http://dx.doi.org/10.1016/j.cell.2020.02.016			38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KT7JN	32142679	Bronze, Green Accepted			2022-12-28	WOS:000519189800008
J	Dyer, O				Dyer, Owen			Covid-19: US health department staff sent to meet citizens returning from China weren't protected, claims whistleblower	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2020	368								m833	10.1136/bmj.m833	http://dx.doi.org/10.1136/bmj.m833			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KC	32122875	Bronze			2022-12-28	WOS:000519536400010
J	Davies, R				Davies, Rachael			Profile Sai Subhasree Raghavan: building health solidarity in India	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 29	2020	395	10225					679	679						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KQ2JO	32113498				2022-12-28	WOS:000516755200016
J	Fabien				Fabien			Patient commentary: Incarceration is dehumanising, but good healthcare can restore dignity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2020	368								m732	10.1136/bmj.m732	http://dx.doi.org/10.1136/bmj.m732			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2JV	32102835	Bronze			2022-12-28	WOS:000519535600009
J	Wu, TD; Madireddi, S; de Almeida, PE; Banchereau, R; Chen, YJJ; Chitre, AS; Chiang, EY; Iftikhar, H; O'Gorman, WE; Au-Yeung, A; Takahashi, C; Goldstein, LD; Poon, C; Keerthivasan, S; Nagata, DED; Du, XN; Lee, HM; Banta, KL; Mariathasan, S; Das Thakur, M; Huseni, MA; Ballinger, M; Estay, I; Caplazi, P; Modrusan, Z; Delamarre, L; Mellman, I; Bourgon, R; Grogan, JL				Wu, Thomas D.; Madireddi, Shravan; de Almeida, Patricia E.; Banchereau, Romain; Chen, Ying-Jiun J.; Chitre, Avantika S.; Chiang, Eugene Y.; Iftikhar, Hina; O'Gorman, William E.; Au-Yeung, Amelia; Takahashi, Chikara; Goldstein, Leonard D.; Poon, Chungkee; Keerthivasan, Shilpa; Nagata, Denise E. de Almeida; Du, Xiangnan; Lee, Hyang-Mi; Banta, Karl L.; Mariathasan, Sanjeev; Das Thakur, Meghna; Huseni, Mahrukh A.; Ballinger, Marcus; Estay, Ivette; Caplazi, Patrick; Modrusan, Zora; Delamarre, Lelia; Mellman, Ira; Bourgon, Richard; Grogan, Jane L.			Peripheral T cell expansion predicts tumour infiltration and clinical response	NATURE			English	Article							SET ENRICHMENT ANALYSIS; BLOCKADE; IMMUNOTHERAPY; SIGNATURES; DATABASE	Despite the resounding clinical success in cancer treatment of antibodies that block the interaction of PD1 with its ligand PDL1(1), the mechanisms involved remain unknown. A major limitation to understanding the origin and fate of T cells in tumour immunity is the lack of quantitative information on the distribution of individual clonotypes of T cells in patients with cancer. Here, by performing deep single-cell sequencing of RNA and T cell receptors in patients with different types of cancer, we survey the profiles of various populations of T cells and T cell receptors in tumours, normal adjacent tissue, and peripheral blood. We find clear evidence of clonotypic expansion of effector-like T cells not only within the tumour but also in normal adjacent tissue. Patients with gene signatures of such clonotypic expansion respond best to anti-PDL1 therapy. Notably, expanded clonotypes found in the tumour and normal adjacent tissue can also typically be detected in peripheral blood, which suggests a convenient approach to patient identification. Analyses of our data together with several external datasets suggest that intratumoural T cells, especially in responsive patients, are replenished with fresh, non-exhausted replacement cells from sites outside the tumour, suggesting continued activity of the cancer immunity cycle in these patients, the acceleration of which may be associated with clinical response.	[Wu, Thomas D.; Goldstein, Leonard D.; Bourgon, Richard] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Madireddi, Shravan; de Almeida, Patricia E.; Chitre, Avantika S.; Chiang, Eugene Y.; Iftikhar, Hina; Keerthivasan, Shilpa; Nagata, Denise E. de Almeida; Du, Xiangnan; Lee, Hyang-Mi; Banta, Karl L.; Delamarre, Lelia; Mellman, Ira; Grogan, Jane L.] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA; [Banchereau, Romain; Mariathasan, Sanjeev] Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Chen, Ying-Jiun J.; Modrusan, Zora] Genentech Inc, Dept Microchem Prote Lipid & Next Generat Sequenc, San Francisco, CA 94080 USA; [O'Gorman, William E.; Au-Yeung, Amelia; Takahashi, Chikara] Genentech Inc, Dept OMNI Biomarker Dev, San Francisco, CA 94080 USA; [Poon, Chungkee] Genentech Inc, Dept Res Biol, San Francisco, CA 94080 USA; [Das Thakur, Meghna; Huseni, Mahrukh A.; Ballinger, Marcus; Estay, Ivette] Genentech Inc, Dept Dev Sci, San Francisco, CA 94080 USA; [Caplazi, Patrick] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Grogan, Jane L.] ArsenalBio, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Wu, TD (corresponding author), Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA.; Grogan, JL (corresponding author), Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA.; Grogan, JL (corresponding author), ArsenalBio, San Francisco, CA 94080 USA.	twu@gene.com; jane@arsenalbio.com	Mellman, Ira/ABG-5896-2020	Bourgon, Richard/0000-0002-5890-4374; MADIREDDI, SHRAVAN/0000-0002-7069-1252				Andreani V, 2018, P NATL ACAD SCI USA, V115, pE9630, DOI 10.1073/pnas.1809739115; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Araujo JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23099-7; Balin SJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat7668; Barter RL, 2018, J COMPUT GRAPH STAT, V27, P910, DOI 10.1080/10618600.2018.1473780; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Beham AW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002375; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Del Carratore F, 2017, BIOINFORMATICS, V33, P2774, DOI 10.1093/bioinformatics/btx292; DELMAS V, 1993, P NATL ACAD SCI USA, V90, P2414, DOI 10.1073/pnas.90.6.2414; Diedenhofen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121945; Fuchs T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204108; Gaide O, 2015, NAT MED, V21, P647, DOI 10.1038/nm.3860; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Hogan SA, 2019, CANCER IMMUNOL RES, V7, P77, DOI 10.1158/2326-6066.CIR-18-0136; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Irizarry RA, 2009, STAT METHODS MED RES, V18, P565, DOI 10.1177/0962280209351908; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Li B, 2016, NAT GENET, V48, P725, DOI 10.1038/ng.3581; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; McDermott DF, 2018, NAT MED, V24, P749, DOI 10.1038/s41591-018-0053-3; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Morgan M. T., 2017, GENOMICDATACOMMONS B, DOI [https://www.bioRxiv.org/content/10.1101/117200v1, DOI 10.1101/117200V1]; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Scheper W, 2019, NAT MED, V25, P89, DOI 10.1038/s41591-018-0266-5; Schuette W, 2005, J CLIN ONCOL, V23, P8389, DOI 10.1200/JCO.2005.02.3739; Schumacher TN, 2016, NAT MED, V22, P340, DOI 10.1038/nm.4074; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shan GG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188709; Shimizu Y, 2009, P NATL ACAD SCI USA, V106, P17013, DOI 10.1073/pnas.0811591106; Shugay M, 2018, NUCLEIC ACIDS RES, V46, pD419, DOI 10.1093/nar/gkx760; Shulman Z, 2012, NAT IMMUNOL, V13, P67, DOI 10.1038/ni.2173; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun QY, 2018, TRENDS GENET, V34, P142, DOI 10.1016/j.tig.2017.11.005; Therneau TM, 2000, MODELING SURVIVAL DA; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Yan YY, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97828; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Zeileis A., 2019, COLORSPACE TOOLBOX M; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; ZHENG GX, 2017, NATURE, V0008	56	237	239	13	85	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7798					274	+		10.1038/s41586-020-2056-8	http://dx.doi.org/10.1038/s41586-020-2056-8		FEB 2020	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU0CC	32103181				2022-12-28	WOS:000516702000003
J	Perl, TM; Price, CS				Perl, Trish M.; Price, Connie Savor			Managing Emerging Infectious Diseases: Should Travel Be the Fifth Vital Sign?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Perl, Trish M.] Univ Texas Southwestern Med Ctr Dallas, 5323 Harry Hines Blvd Y7-312, Dallas, TX 75390 USA; [Price, Connie Savor] Denver Hlth & Hosp, 777 Bannock St MC-2600, Denver, CO 80204 USA; [Price, Connie Savor] Univ Colorado, Sch Med, Aurora, CO USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Perl, TM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, 5323 Harry Hines Blvd Y7-312, Dallas, TX 75390 USA.	Trish.Perl@UTSouthwestern.edu						Chinazzi Matteo, 2020, medRxiv, DOI 10.1101/2020.02.09.20021261; Chung WM, 2015, ANN INTERN MED, V163, P164, DOI 10.7326/M15-0968; Demeester RP, 2011, J TRAVEL MED, V18, P386, DOI 10.1111/j.1708-8305.2011.00566.x; Edberg SC, 2005, CLIN INFECT DIS, V40, P123, DOI 10.1086/426549; Errett Nicole A, 2020, J Emerg Manag, V18, P7, DOI 10.5055/jem.2020.0446; Jefferson T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006207.pub4; Mateus ALP, 2014, B WORLD HEALTH ORGAN, V92, P868, DOI 10.2471/BLT.14.135590; Quilty BJ, 2020, EUROSURVEILLANCE, V25, P4, DOI 10.2807/1560-7917.ES.2020.25.5.2000080; Read J. M., 2020, MEDRXIV, DOI 10.1101/2020.01.23.20018549	9	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2020	172	8					560	+		10.7326/M20-0643	http://dx.doi.org/10.7326/M20-0643			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LF9LH	32120386	Green Published			2022-12-28	WOS:000527733800018
J	Kaye, EC				Kaye, Erica C.			One in Four - The Importance of Comprehensive Fertility Benefits for the Medical Workforce	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Despite recognition that infertility disproportionately affects women in medicine, and despite the precedent for successful subsidization of medical therapies, few medical professionals have access to affordable treatment for infertility.	[Kaye, Erica C.] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Kaye, EC (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.							Chandra Anjani, 2014, Natl Health Stat Report, P1; DOMAR AD, 1993, J PSYCHOSOM OBST GYN, V14, P45; Gyorffy Z, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-121; Stentz NC, 2016, J WOMENS HEALTH, V25, P1059, DOI 10.1089/jwh.2015.5638; Stillman RJ, 2009, FERTIL STERIL, V92, P1895, DOI 10.1016/j.fertnstert.2008.09.023	5	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2020	382	16					1491	1493		10.1056/NEJMp1915331	http://dx.doi.org/10.1056/NEJMp1915331			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LF9LC	32101658				2022-12-28	WOS:000527733300006
J	Legido-Quigley, H; Asgari, N; Teo, YY; Leung, GM; Oshitani, H; Fukuda, K; Cook, AR; Hsu, LY; Shibuya, K; Heymann, D				Legido-Quigley, Helena; Asgari, Nima; Teo, Yik Ying; Leung, Gabriel M.; Oshitani, Hitoshi; Fukuda, Keiji; Cook, Alex R.; Hsu, Li Yang; Shibuya, Kenji; Heymann, David			Are high-performing health systems resilient against the COVID-19 epidemic?	LANCET			English	Editorial Material									[Legido-Quigley, Helena; Teo, Yik Ying; Cook, Alex R.; Hsu, Li Yang] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Legido-Quigley, Helena; Teo, Yik Ying; Cook, Alex R.; Hsu, Li Yang] Natl Univ Hlth Syst, Singapore, Singapore; [Asgari, Nima] WHO Reg Off South East Asia, Asia Pacific Observ Hlth Syst & Policies, New Delhi, India; [Leung, Gabriel M.] Univ Hong Kong, Sch Publ Hlth, LKS Fac Med, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Hong Kong, Peoples R China; [Oshitani, Hitoshi] Tohoku Univ, Sch Med, Sendai, Miyagi, Japan; [Fukuda, Keiji] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Peoples R China; [Shibuya, Kenji] Kings Coll London, Inst Populat Hlth, London, England; [Heymann, David] London Sch Hyg & Trop Med, London, England	National University of Singapore; National University of Singapore; University of Hong Kong; World Health Organization; Tohoku University; University of Hong Kong; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine	Legido-Quigley, H (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Legido-Quigley, H (corresponding author), Natl Univ Hlth Syst, Singapore, Singapore.	ephhlq@nus.edu.sg	; Cook, Alex/B-5941-2011	Asgari-Jirhandeh, Nima/0000-0002-4743-4194; Fukuda, Keiji/0000-0002-9598-9565; Leung, Gabriel/0000-0002-2503-6283; Cook, Alex/0000-0002-6271-5832				[Anonymous], BMJ; Blanchet K, 2017, INT J HEALTH POLICY, V6, P431, DOI 10.15171/ijhpm.2017.36; Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902; Hanefeld J, 2018, HEALTH POLICY PLANN, V33, P1144, DOI 10.1093/heapol/czy087; Lau C., 2020, S CHINA MORNING POST; Ni MY, 2020, LANCET, V395, P273, DOI 10.1016/S0140-6736(19)33160-5; Vinck P, 2019, LANCET INFECT DIS, V19, P529, DOI 10.1016/S1473-3099(19)30063-5; WHO, 2010, MONITORING BUILDING; WHO, 2020, WEEKLY EPIDEMIOLOGIC	9	218	232	2	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2020	395	10227					848	850		10.1016/S0140-6736(20)30551-1	http://dx.doi.org/10.1016/S0140-6736(20)30551-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU9DZ	32151326	Green Published, Bronze			2022-12-28	WOS:000520024900013
J	Genov, GR; Douthwaite, JL; Lahdenpera, ASK; Gibson, DC; Phipps, RJ				Genov, Georgi R.; Douthwaite, James L.; Lahdenpera, Antti S. K.; Gibson, David C.; Phipps, Robert J.			Enantioselective remote C-H activation directed by a chiral cation	SCIENCE			English	Article							TRANSITION-METAL CATALYSIS; PHASE-TRANSFER; LIGANDS; BORYLATION; ALLYLATION; REAGENTS; ARENES	Chiral cations have been used extensively as organocatalysts, but their application to rendering transition metal-catalyzed processes enantioselective remains rare. This is despite the success of the analogous charge-inverted strategy in which cationic metal complexes are paired with chiral anions. We report here a strategy to render a common bipyridine ligand anionic and pair its iridium complexes with a chiral cation derived from quinine. We have applied these ion-paired complexes to long-range asymmetric induction in the desymmetrization of the geminal diaryl motif, located on a carbon or phosphorus center, by enantioselective C-H borylation. In principle, numerous common classes of ligand could likewise be amenable to this approach.	[Genov, Georgi R.; Douthwaite, James L.; Lahdenpera, Antti S. K.; Gibson, David C.; Phipps, Robert J.] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England	University of Cambridge	Phipps, RJ (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	rjp71@cam.ac.uk		Genov, Georgi/0000-0002-8039-3160; Douthwaite, James/0000-0002-4478-9010; Gibson, David/0000-0003-1542-3105	Royal Society [UF130004]; EPSRC [EP/N005422/1]; European Research Council under the Horizon 2020 Program [757381]; AstraZeneca; Emil Aaltonen Foundation; EPSR; Syngenta; EPSRC [1918558, 1943646] Funding Source: UKRI	Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council under the Horizon 2020 Program; AstraZeneca(AstraZeneca); Emil Aaltonen Foundation; EPSR(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Syngenta(Syngenta); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are grateful to The Royal Society for a University Research Fellowship (R.J.P., UF130004), the EPSRC (EP/N005422/1), the European Research Council under the Horizon 2020 Program (Starting Grant no. 757381), the EPSRC and AstraZeneca for a CASE studentship (J.L.D.), The Emil Aaltonen Foundation for a fellowship (A.S.K.L.), and the EPSR, and Syngenta for a CASE studentship (D.C.G.).	Asghar S, 2018, SYNTHESIS-STUTTGART, V50, P2211, DOI 10.1055/s-0036-1591968; Brak K, 2013, ANGEW CHEM INT EDIT, V52, P534, DOI 10.1002/anie.201205449; Brown RCD, 2001, ANGEW CHEM INT EDIT, V40, P4496, DOI 10.1002/1521-3773(20011203)40:23<4496::AID-ANIE4496>3.0.CO;2-F; Cheng XF, 2013, J AM CHEM SOC, V135, P1236, DOI 10.1021/ja311259x; Cho JY, 2002, SCIENCE, V295, P305, DOI 10.1126/science.1067074; Chu L, 2014, SCIENCE, V346, P451, DOI 10.1126/science.1258538; Cox JR, 2013, J AM CHEM SOC, V135, P640, DOI 10.1021/ja312090p; Das SK, 2018, J AM CHEM SOC, V140, P8429, DOI 10.1021/jacs.8b05343; Davis HJ, 2017, ANGEW CHEM INT EDIT, V56, P13351, DOI 10.1002/anie.201708967; Davis HJ, 2016, J AM CHEM SOC, V138, P12759, DOI 10.1021/jacs.6b08164; DiRocco DA, 2017, SCIENCE, V356, P426, DOI 10.1126/science.aam7936; DOLLING UH, 1984, J AM CHEM SOC, V106, P446, DOI 10.1021/ja00314a045; Du ZJ, 2015, J AM CHEM SOC, V137, P632, DOI 10.1021/ja512029x; Dutartre M, 2016, CHEM SOC REV, V45, P5771, DOI 10.1039/c6cs00031b; Finke AD, 2008, ORG LETT, V10, P4851, DOI 10.1021/ol8019605; Goforth SK, 2013, INORG CHEM, V52, P5692, DOI 10.1021/ic301810y; Hamilton GL, 2008, J AM CHEM SOC, V130, P14984, DOI 10.1021/ja806431d; Hamilton GL, 2007, SCIENCE, V317, P496, DOI 10.1126/science.1145229; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; Hartwig JF, 2011, CHEM SOC REV, V40, P1992, DOI 10.1039/c0cs00156b; Hsieh SY, 2019, J AM CHEM SOC, V141, P18624, DOI 10.1021/jacs.9b10414; Ishiyama T, 2002, J AM CHEM SOC, V124, P390, DOI 10.1021/ja0173019; Kim B, 2016, J AM CHEM SOC, V138, P7939, DOI 10.1021/jacs.6b03444; Liao SH, 2010, ANGEW CHEM INT EDIT, V49, P628, DOI 10.1002/anie.200905332; Lin LQ, 2018, ANGEW CHEM INT EDIT, V57, P12048, DOI 10.1002/anie.201807610; Lindner M, 2016, CHEM-EUR J, V22, P13218, DOI 10.1002/chem.201602019; Liskey CW, 2010, J AM CHEM SOC, V132, P11389, DOI 10.1021/ja104442v; Mahlau M, 2013, ANGEW CHEM INT EDIT, V52, P518, DOI 10.1002/anie.201205343; Malapit CA, 2015, ADV SYNTH CATAL, V357, P2199, DOI 10.1002/adsc.201500304; Mayer S, 2006, ANGEW CHEM INT EDIT, V45, P4193, DOI 10.1002/anie.200600512; Metrano AJ, 2019, ACCOUNTS CHEM RES, V52, P199, DOI 10.1021/acs.accounts.8b00473; Mihai MT, 2018, ACS CATAL, V8, P3764, DOI 10.1021/acscatal.8b00423; Mukherjee S, 2007, J AM CHEM SOC, V129, P11336, DOI 10.1021/ja074678r; Newton CG, 2017, CHEM REV, V117, P8908, DOI 10.1021/acs.chemrev.6b00692; Ohmatsu K, 2019, TOPICS CURR CHEM, V377, DOI 10.1007/s41061-019-0256-1; Ohmatsu K, 2014, ACS CATAL, V4, P4304, DOI 10.1021/cs501369z; Ohmatsu K, 2014, NAT CHEM, V6, P47, DOI [10.1038/NCHEM.1796, 10.1038/nchem.1796]; Ohmatsu K, 2013, J AM CHEM SOC, V135, P590, DOI 10.1021/ja312125a; Ohmatsu K, 2012, NAT CHEM, V4, P473, DOI [10.1038/NCHEM.1311, 10.1038/nchem.1311]; Oliveira MT, 2017, CHEMCATCHEM, V9, P377, DOI 10.1002/cctc.201601441; Ooi T, 2007, ANGEW CHEM INT EDIT, V46, P4222, DOI 10.1002/anie.200601737; Paria S, 2019, ACS CATAL, V9, P2395, DOI 10.1021/acscatal.8b04949; Park H.-G., 2009, CINCHONA ALKALOIDS S, P131; Phipps RJ, 2012, NAT CHEM, V4, P603, DOI [10.1038/NCHEM.1405, 10.1038/nchem.1405]; Pregosin PS, 2017, MAGN RESON CHEM, V55, P405, DOI 10.1002/mrc.4394; Rerat A, 2016, EUR J ORG CHEM, V2016, P4554, DOI 10.1002/ejoc.201600738; Santra S, 2015, EUR J ORG CHEM, V2015, P7253, DOI 10.1002/ejoc.201501222; Shaughnessy KH, 2009, CHEM REV, V109, P643, DOI 10.1021/cr800403r; Shi H, 2018, NATURE, V558, P581, DOI 10.1038/s41586-018-0220-1; Shimada S, 2003, ANGEW CHEM INT EDIT, V42, P1845, DOI 10.1002/anie.200250205; Shirakawa S, 2013, ANGEW CHEM INT EDIT, V52, P4312, DOI 10.1002/anie.201206835; Siles R., 2009, U.S. Patent, Patent No. [US 2009/0076076 A1, 20090076076A1]; Su B, 2017, ANGEW CHEM INT EDIT, V56, P7205, DOI 10.1002/anie.201702628; Sun Y, 2017, ANGEW CHEM INT EDIT, V56, P364, DOI 10.1002/anie.201606637; Uyanik M, 2010, SCIENCE, V328, P1376, DOI 10.1126/science.1188217; Wang C, 2015, J AM CHEM SOC, V137, P10677, DOI 10.1021/jacs.5b05792; Ye BH, 2015, ACCOUNTS CHEM RES, V48, P1308, DOI 10.1021/acs.accounts.5b00092; Ye BH, 2012, SCIENCE, V338, P504, DOI 10.1126/science.1226938; Ye XY, 2016, ANGEW CHEM INT EDIT, V55, P7101, DOI 10.1002/anie.201601574; Zielinska-Blajet M, 2006, SYNTHESIS-STUTTGART, P1176, DOI 10.1055/s-2006-926382; Zong LL, 2017, ACCOUNTS CHEM RES, V50, P842, DOI 10.1021/acs.accounts.6b00604; Zong L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13455; Zou XL, 2019, J AM CHEM SOC, V141, P5334, DOI 10.1021/jacs.8b13756	63	104	103	23	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1246	+		10.1126/science.aba1120	http://dx.doi.org/10.1126/science.aba1120			726	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9DP	32165586	Green Submitted			2022-12-28	WOS:000520023800041
J	Barrot, L; Asfar, P; Mauny, F; Winiszewski, H; Montini, F; Badie, J; Quenot, JP; Pili-Floury, S; Bouhemad, B; Louis, G; Souweine, B; Collange, O; Pottecher, J; Levy, B; Puyraveau, M; Vettoretti, L; Constantin, JM; Capellier, G				Barrot, Loic; Asfar, Pierre; Mauny, Frederic; Winiszewski, Hadrien; Montini, Florent; Badie, Julio; Quenot, Jean-Pierre; Pili-Floury, Sebastien; Bouhemad, Belaid; Louis, Guillaume; Souweine, Bertrand; Collange, Olivier; Pottecher, Julien; Levy, Bruno; Puyraveau, Marc; Vettoretti, Lucie; Constantin, Jean-Michel; Capellier, Gilles		LOCO2 Investigators; REVA Res Network	Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CRITICALLY-ILL PATIENTS; CLINICAL-OUTCOMES; LUNG INJURY; MORTALITY; CARE; TARGETS; ADULTS	Background In patients with acute respiratory distress syndrome (ARDS), the National Heart, Lung, and Blood Institute ARDS Clinical Trials Network recommends a target partial pressure of arterial oxygen (Pao(2)) between 55 and 80 mm Hg. Prospective validation of this range in patients with ARDS is lacking. We hypothesized that targeting the lower limit of this range would improve outcomes in patients with ARDS. Methods In this multicenter, randomized trial, we assigned patients with ARDS to receive either conservative oxygen therapy (target Pao(2), 55 to 70 mm Hg; oxygen saturation as measured by pulse oximetry [Spo(2)], 88 to 92%) or liberal oxygen therapy (target Pao(2), 90 to 105 mm Hg; Spo(2), >= 96%) for 7 days. The same mechanical-ventilation strategies were used in both groups. The primary outcome was death from any cause at 28 days. Results After the enrollment of 205 patients, the trial was prematurely stopped by the data and safety monitoring board because of safety concerns and a low likelihood of a significant difference between the two groups in the primary outcome. Four patients who did not meet the eligibility criteria were excluded. At day 28, a total of 34 of 99 patients (34.3%) in the conservative-oxygen group and 27 of 102 patients (26.5%) in the liberal-oxygen group had died (difference, 7.8 percentage points; 95% confidence interval [CI], -4.8 to 20.6). At day 90, 44.4% of the patients in the conservative-oxygen group and 30.4% of the patients in the liberal-oxygen group had died (difference, 14.0 percentage points; 95% CI, 0.7 to 27.2). Five mesenteric ischemic events occurred in the conservative-oxygen group. Conclusions Among patients with ARDS, early exposure to a conservative-oxygenation strategy with a Pao(2) between 55 and 70 mm Hg did not increase survival at 28 days. (Funded by the French Ministry of Health; LOCO2 ClinicalTrials.gov number, NCT02713451.)	[Barrot, Loic; Winiszewski, Hadrien; Vettoretti, Lucie; Capellier, Gilles] Univ Hosp, Med Intens Care Unit, Besancon, France; [Barrot, Loic; Pili-Floury, Sebastien] Univ Hosp, Anesthesia & Intens Care Unit, Besancon, France; [Mauny, Frederic; Puyraveau, Marc] Univ Hosp, INSERM Clin Invest Ctr 1431, Unite Methodol, Besancon, France; [Barrot, Loic; Winiszewski, Hadrien; Pili-Floury, Sebastien; Capellier, Gilles] Univ Franche Comte, Res Unit EA3920, Besancon, France; [Asfar, Pierre] Univ Hosp Angers, Med Intens Care Unit, Angers, France; [Montini, Florent] Gen Hosp Avignon, Intens Care Unit, Avignon, France; [Badie, Julio] Gen Hosp Nord Franche Comte, Intens Care Unit, Trevenans, France; [Quenot, Jean-Pierre] Univ Hosp Dijon, Med Intens Care Unit, Dijon, France; [Bouhemad, Belaid] Univ Hosp Dijon, Anesthesia & Intens Care Unit, Dijon, France; [Louis, Guillaume] Gen Hosp Metz Thionville, Intens Care Unit, Metz, France; [Souweine, Bertrand] Univ Hosp Clermont Ferrand, Med Intens Care Unit, Clermont Ferrand, France; [Constantin, Jean-Michel] Univ Hosp Clermont Ferrand, Anesthesia & Intens Care Unit, Clermont Ferrand, France; [Collange, Olivier; Pottecher, Julien] Univ Hosp Strasbourg, Anesthesia & Intens Care Unit, Strasbourg, France; [Levy, Bruno] Univ Hosp Nancy, Med Intens Care Unit, Nancy, France; [Capellier, Gilles] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia	Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Strasbourg; CHU de Nancy; Universite de Lorraine; Monash University	Capellier, G (corresponding author), Ctr Hosp Reg Univ Besancon, Reanimat Med, Blvd Fleming, F-25000 Besancon, France.	gilles.capellier@univ-fcomte.fr	souweine, bertrand/HHR-8972-2022; Louis, Guillaume/AAF-4340-2021	Louis, Guillaume/0000-0002-4208-8122; QUENOT, Jean-Pierre/0000-0003-2351-682X; Koszutski, Matthieu/0000-0002-4382-972X	French Ministry of Health Programme Hospitalier de Recherche Clinique Interregional 2015 [B09]	French Ministry of Health Programme Hospitalier de Recherche Clinique Interregional 2015	Supported by a grant (B09) from the French Ministry of Health Programme Hospitalier de Recherche Clinique Interregional 2015.	Aboab J, 2006, INTENS CARE MED, V32, P1979, DOI 10.1007/s00134-006-0382-4; Aggarwal NR, 2018, CRIT CARE MED, V46, P517, DOI 10.1097/CCM.0000000000002886; ARDSnet, NIH NHLBI ARDS CLIN; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Calfee CS, 2018, LANCET RESP MED, V6, P691, DOI 10.1016/S2213-2600(18)30177-2; Chu DK, 2018, LANCET, V391, P1693, DOI 10.1016/S0140-6736(18)30479-3; de Jonge E, 2008, CRIT CARE, V12, DOI 10.1186/cc7150; Ferguson ND, 2016, JAMA-J AM MED ASSOC, V316, P1553, DOI 10.1001/jama.2016.13800; Girardis M, 2016, JAMA-J AM MED ASSOC, V316, P1583, DOI 10.1001/jama.2016.11993; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Helmerhorst HJF, 2016, CRIT CARE MED, V44, P554, DOI 10.1097/CCM.0000000000001461; LUNDGREN O, 1974, GUT, V15, P1005, DOI 10.1136/gut.15.12.1005; Mackle D, 2020, NEW ENGL J MED, V382, P989, DOI 10.1056/NEJMoa1903297; Mercat A, 2008, JAMA-J AM MED ASSOC, V299, P646, DOI 10.1001/jama.299.6.646; Mikkelsen Mark E, 2014, Ann Am Thorac Soc, V11, P613, DOI 10.1513/AnnalsATS.201401-001PS; Panwar R, 2016, AM J RESP CRIT CARE, V193, P43, DOI 10.1164/rccm.201505-1019OC; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Radermacher P, 2017, AM J RESP CRIT CARE, V196, P964, DOI 10.1164/rccm.201610-2156SO; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Richard JC, 2005, REANIMATION, V14, P313; Sander O, 2005, CRIT CARE MED, V33, P81, DOI 10.1097/01.CCM.0000150028.64264.14; Siemieniuk RAC, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4169; Sinclair SE, 2004, CRIT CARE MED, V32, P2496, DOI 10.1097/01.CCM.0000148231.04642.8D; Young P, 2020, INTENS CARE MED, V46, P17, DOI 10.1007/s00134-019-05857-x	25	163	172	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2020	382	11					999	1008		10.1056/NEJMoa1916431	http://dx.doi.org/10.1056/NEJMoa1916431			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU7TA	32160661	Bronze			2022-12-28	WOS:000519914300006
J	Thornton, J				Thornton, Jacqui			Judgment in ABC case rules on confidentiality	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2020	395	10226					771	772						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU2KH	32145779				2022-12-28	WOS:000519536900015
J	Hage, FS; Radtke, G; Kepaptsoglou, DM; Lazzeri, M; Ramasse, QM				Hage, F. S.; Radtke, G.; Kepaptsoglou, D. M.; Lazzeri, M.; Ramasse, Q. M.			Single-atom vibrational spectroscopy in the scanning transmission electron microscope	SCIENCE			English	Article							MODES	Single-atom impurities and other atomic-scale defects can notably alter the local vibrational responses of solids and, ultimately, their macroscopic properties. Using high-resolution electron energy-loss spectroscopy in the electron microscope, we show that a single substitutional silicon impurity in graphene induces a characteristic, localized modification of the vibrational response. Extensive ab initio calculations reveal that the measured spectroscopic signature arises from defect-induced pseudo-localized phonon modes-that is, resonant states resulting from the hybridization of the defect modes and the bulk continuum-with energies that can be directly matched to the experiments. This finding realizes the promise of vibrational spectroscopy in the electron microscope with single-atom sensitivity and has broad implications across the fields of physics, chemistry, and materials science.	[Hage, F. S.; Kepaptsoglou, D. M.; Ramasse, Q. M.] SuperSTEM Lab, SciTech Daresbury Campus, Daresbury WA4 4AD, England; [Radtke, G.; Lazzeri, M.] Sorbonne Univ, CNRS, Inst Mineral Phys Mat & Cosmochim, Museum Natl Hist Nat,UMR 7590, F-75005 Paris, France; [Kepaptsoglou, D. M.] Univ York, York Nanoctr, York YO10 5DD, N Yorkshire, England; [Kepaptsoglou, D. M.] Univ York, Dept Phys, York YO10 5DD, N Yorkshire, England; [Ramasse, Q. M.] Univ Leeds, Sch Chem & Proc Engn, Leeds LS2 9JT, W Yorkshire, England; [Ramasse, Q. M.] Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of York - UK; University of York - UK; University of Leeds; University of Leeds	Ramasse, QM (corresponding author), SuperSTEM Lab, SciTech Daresbury Campus, Daresbury WA4 4AD, England.; Radtke, G (corresponding author), Sorbonne Univ, CNRS, Inst Mineral Phys Mat & Cosmochim, Museum Natl Hist Nat,UMR 7590, F-75005 Paris, France.; Ramasse, QM (corresponding author), Univ Leeds, Sch Chem & Proc Engn, Leeds LS2 9JT, W Yorkshire, England.; Ramasse, QM (corresponding author), Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England.	guillaume.radtke@sorbonne-universite.fr; qmramasse@superstem.org	Lazzeri, Michele/N-7615-2016; Lazzeri, Massimo/AAB-6955-2021; Lazzeri, Massimo/K-5004-2016; Radtke, Guillaume/F-7650-2019	Lazzeri, Michele/0000-0002-6644-6617; Lazzeri, Massimo/0000-0002-4411-3715; Lazzeri, Massimo/0000-0002-4411-3715; Kepaptsoglou, Demie/0000-0003-0499-0470; Radtke, Guillaume/0000-0002-4738-7332; Ramasse, Quentin/0000-0001-7466-2283	Engineering and Physical Sciences Research Council (EPSRC)	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	SuperSTEM is the UK National Research Facility for Advanced Electron Microscopy, supported by the Engineering and Physical Sciences Research Council (EPSRC). This work was granted access to the High-Performance Computing resources of the Institut du Developpement et des Ressources en Informatique Scientifique (IDRIS) under allocation 2019-A0060910820, attributed by the Grand Equipement National de Calcul Intensif (GENCI).	Bangert U, 2013, NANO LETT, V13, P4902, DOI 10.1021/nl402812y; BARKER AS, 1975, REV MOD PHYS, V47, pS1, DOI 10.1103/RevModPhys.47.S1.2; Baroni S, 2001, REV MOD PHYS, V73, P515, DOI 10.1103/RevModPhys.73.515; BROUT R, 1962, PHYS REV LETT, V9, P54, DOI 10.1103/PhysRevLett.9.54; Brun C, 2014, NAT PHYS, V10, P444, DOI [10.1038/nphys2937, 10.1038/NPHYS2937]; Bungaro C, 1996, PHYS REV LETT, V77, P2491, DOI 10.1103/PhysRevLett.77.2491; Dwyer C, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.256101; El-Khoury PZ, 2016, ADV PHYS-X, V1, P35, DOI 10.1080/23746149.2016.1140010; Gawronski H, 2008, SCIENCE, V319, P930, DOI 10.1126/science.1152473; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Hachtel JA, 2019, SCIENCE, V363, P525, DOI 10.1126/science.aav5845; Hage FS, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.016103; Hage FS, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar7495; Hage FS, 2018, ACS NANO, V12, P1837, DOI 10.1021/acsnano.7b08650; Hamilton W. R., 1834, PHILOS T ROY SOC LON, V124, P247, DOI 10.1098/rstl.1834.0017; Hotz M. T., 2018, MICROSC MICROANA SS1, V24, P1132; Idrobo JC, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.095901; Krivanek OL, 2014, NATURE, V514, P209, DOI 10.1038/nature13870; Lagos MJ, 2017, NATURE, V543, P529, DOI 10.1038/nature21699; Lazzeri M, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.140301; Lifschitz I. M., 1956, NUOVO CIM          S, V3, P716, DOI DOI 10.1007/BF02746071; Lovejoy TC, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3701598; Miyata T, 2014, MICROSCOPY-JPN, V63, P377, DOI 10.1093/jmicro/dfu023; MONTROLL EW, 1955, PHYS REV, V100, P525, DOI 10.1103/PhysRev.100.525; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Ramasse QM, 2013, NANO LETT, V13, P4989, DOI 10.1021/nl304187e; Schlipf M, 2015, COMPUT PHYS COMMUN, V196, P36, DOI 10.1016/j.cpc.2015.05.011; Senga R, 2019, NATURE, V573, P247, DOI 10.1038/s41586-019-1477-8; Shao M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4180; Strutt J. W., 1887, THEORY SOUND; Suenaga K, 2010, NATURE, V468, P1088, DOI 10.1038/nature09664; Susi T, 2017, 2D MATER, V4, DOI 10.1088/2053-1583/aa878f; Susi T, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.115501; Volgmann K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6089; Voneshen DJ, 2013, NAT MATER, V12, P1027, DOI [10.1038/NMAT3739, 10.1038/nmat3739]; Wallis RF, 1968, LOCALIZED EXCITATION; WANG CZ, 1993, PHYS REV LETT, V71, P1184, DOI 10.1103/PhysRevLett.71.1184; Watanabe M, 2007, MICROSC MICROANAL, V13, P1264; WEGNER F, 1980, Z PHYS B CON MAT, V36, P209, DOI 10.1007/BF01325284; Zhou W, 2012, NAT NANOTECHNOL, V7, P161, DOI [10.1038/nnano.2011.252, 10.1038/NNANO.2011.252]	40	75	77	28	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1124	+		10.1126/science.aba1136	http://dx.doi.org/10.1126/science.aba1136			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9CD	32139541	Green Accepted, Green Submitted			2022-12-28	WOS:000520018400040
J	Chew, HY; De Lima, PO; Cruz, JLG; Banushi, B; Echejoh, G; Hu, LB; Joseph, SR; Lum, B; Rae, J; O'Donnell, JS; de Long, LM; Okano, S; King, B; Barry, R; Moi, D; Mazzieri, R; Thomas, R; Souza-Fonseca-Guimaraes, F; Foote, M; McCluskey, A; Robinson, PJ; Frazer, IH; Saunders, NA; Parton, RG; Dolcetti, R; Cuff, K; Martin, JH; Panizza, B; Walpole, E; Wells, JW; Simpson, F				Chew, Hui Yi; De Lima, Priscila O.; Cruz, Jazmina L. Gonzalez; Banushi, Blerida; Echejoh, Godwins; Hu, Lingbo; Joseph, Shannon R.; Lum, Benedict; Rae, James; O'Donnell, Jake S.; de Long, Lilia Merida; Okano, Satomi; King, Brigid; Barry, Rachael; Moi, Davide; Mazzieri, Roberta; Thomas, Ranjeny; Souza-Fonseca-Guimaraes, Fernando; Foote, Matthew; McCluskey, Adam; Robinson, Phillip J.; Frazer, Ian H.; Saunders, Nicholas A.; Parton, Robert G.; Dolcetti, Riccardo; Cuff, Katharine; Martin, Jennifer H.; Panizza, Benedict; Walpole, Euan; Wells, James W.; Simpson, Fiona			Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies	CELL			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; EPIDERMAL-GROWTH-FACTOR; ACQUIRED-RESISTANCE; ANTITUMOR-ACTIVITY; MAMMALIAN TARGET; FACTOR RECEPTOR; RAPAMYCIN MTOR; TUMOR; DYNAMIN; EGFR	A safe and controlled manipulation of endocytosis in vivo may have disruptive therapeutic potential. Here, we demonstrate that the anti-emetic/anti-psychotic prochlorperazine can be repurposed to reversibly inhibit the in vivo endocytosis of membrane proteins targeted by therapeutic monoclonal antibodies, as directly demonstrated by our human tumor ex vivo assay. Temporary endocytosis inhibition results in enhanced target availability and improved efficiency of natural killer cell-mediated antibody-dependent cellular cytotoxicity (ADCC), a mediator of clinical responses induced by IgG1 antibodies, demonstrated here for cetuximab, trastuzumab, and avelumab. Extensive analysis of downstream signaling pathways ruled out on-target toxicities. By overcoming the heterogeneity of drug target availability that frequently characterizes poorly responsive or resistant tumors, clinical application of reversible endocytosis inhibition may considerably improve the clinical benefit of ADCC-mediating therapeutic antibodies.	[Chew, Hui Yi; De Lima, Priscila O.; Cruz, Jazmina L. Gonzalez; Banushi, Blerida; Echejoh, Godwins; Hu, Lingbo; Joseph, Shannon R.; Lum, Benedict; O'Donnell, Jake S.; de Long, Lilia Merida; Okano, Satomi; King, Brigid; Barry, Rachael; Moi, Davide; Mazzieri, Roberta; Thomas, Ranjeny; Souza-Fonseca-Guimaraes, Fernando; Frazer, Ian H.; Saunders, Nicholas A.; Dolcetti, Riccardo; Wells, James W.; Simpson, Fiona] Univ Queensland, Diamantina Inst, Woolloongabba, Qld 4102, Australia; [Rae, James; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Cell Biol & Mol Med Div, St Lucia, Qld 4072, Australia; [Rae, James; Parton, Robert G.] Univ Queensland, Australia Ctr Microscopy & Microanal, St Lucia, Qld 4072, Australia; [Foote, Matthew; Cuff, Katharine; Martin, Jennifer H.; Panizza, Benedict; Walpole, Euan] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [McCluskey, Adam; Martin, Jennifer H.] Univ Newcastle, Ctr Chem Biol & Clin Pharmacol, Callaghan, NSW 2308, Australia; [Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Cell Signaling Unit, Sydney, NSW 2145, Australia; [Cuff, Katharine; Panizza, Benedict; Walpole, Euan] Univ Queensland, Fac Med, Woolloongabba, Qld 4102, Australia	University of Queensland; University of Queensland; University of Queensland; University of Newcastle; Children's Medical Research Institute - Australia; University of Sydney; University of Queensland	Simpson, F (corresponding author), Univ Queensland, Diamantina Inst, Woolloongabba, Qld 4102, Australia.	f.simpson@uq.edu.au	Wells, James W./C-7480-2011; Thomas, Ranjeny/B-4504-2013; Simpson, Fiona/ABE-1276-2020; Martin, Jennifer/O-5029-2019; Dolcetti, Riccardo/O-3832-2015; Robinson, Phillip J/G-4008-2011; Guimarães, Fernando/AAQ-2535-2021; Panizza, Benedict/G-6590-2012; Walpole, Euan T/B-4005-2014; Okano, Satomi/AAX-9546-2021; Mazzieri, Roberta/C-9773-2015; saunders, nicholas/E-1544-2014; Banushi, Blerida/D-1422-2019	Wells, James W./0000-0002-9618-6940; Thomas, Ranjeny/0000-0002-0518-8386; Simpson, Fiona/0000-0002-0271-781X; Martin, Jennifer/0000-0002-8614-0199; Dolcetti, Riccardo/0000-0003-1625-9853; Robinson, Phillip J/0000-0002-7878-0313; Guimarães, Fernando/0000-0002-2718-8993; Panizza, Benedict/0000-0002-3724-3773; Walpole, Euan T/0000-0001-6105-9039; Okano, Satomi/0000-0003-4913-9612; Mazzieri, Roberta/0000-0002-5172-0927; Souza-Fonseca-Guimaraes, Fernando/0000-0002-2037-8946; de Lima, Priscila/0000-0002-4018-1219; Gonzalez Cruz, Jazmina Libertad/0000-0003-2671-7408; Moi, Davide/0000-0002-1198-5146; Chew, Hui Yi/0000-0001-7186-9895; saunders, nicholas/0000-0002-2478-3420; Banushi, Blerida/0000-0002-4314-8369; Barry, Rachael/0000-0001-8168-3226	University of Queensland (UQ) IPRS scholarship; UQ International scholarships; NHMRC Career Development Award [456155]; Cancer Council Queensland [1041390]; National Breast Cancer Foundation [IN-15003]; Queensland Head and Neck Cancer Centre; Princess Alexandra Research Foundation; International Rotary Club (Nundah)	University of Queensland (UQ) IPRS scholarship; UQ International scholarships; NHMRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland); National Breast Cancer Foundation; Queensland Head and Neck Cancer Centre; Princess Alexandra Research Foundation; International Rotary Club (Nundah)	We thank the participants, families, and support staff who contributed to the pilot clinical study. The authors acknowledge the Translational Research Institute for providing the excellent research environment and core facilities that enabled this research: Microscopy, Flow Cytometry, Histology and Biological Resource Core Facilities. This work was supported by University of Queensland (UQ) IPRS scholarship (G.E.), UQ International scholarships (L.H., P.O.D.L., and H.Y.C.), NHMRC Career Development Award (456155), Cancer Council Queensland (1041390), the National Breast Cancer Foundation IN-15003, Queensland Head and Neck Cancer Centre and International Rotary Club (Nundah) to F.S., and the Princess Alexandra Research Foundation (B.B., S.R.J., and F.S.).	Alderson KL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/379123; Austin CD, 2004, MOL BIOL CELL, V15, P5268, DOI 10.1091/mbc.E04-07-0591; Baldassarre T., 2017, ENDOPHILIN A2 PROMOT; Bar-Yosef H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05741-y; Bardelli A, 2012, NAT MED, V18, P199, DOI 10.1038/nm.2646; Boero S, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0680-0; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; Boyerinas B, 2015, CANCER IMMUNOL RES, V3, P1148, DOI 10.1158/2326-6066.CIR-15-0059; Cameron SR, 2010, LAB INVEST, V90, P1594, DOI 10.1038/labinvest.2010.131; Carro AC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006685; Center for Drug Evaluation and Research, 2016, 761049 BLA CTR DRUG; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Chong ZZ, 2016, DRUG DISCOV TODAY, V21, P1222, DOI 10.1016/j.drudis.2016.04.005; Chung BM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-84; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Daniel JA, 2015, TRAFFIC, V16, P635, DOI 10.1111/tra.12272; DiLillo DJ, 2015, CELL, V161, P1035, DOI 10.1016/j.cell.2015.04.016; Dong WJ, 2019, CANCER DISCOV, V9, P1422, DOI 10.1158/2159-8290.CD-18-1259; Facompre ND, 2017, LARYNGOSCOPE, V127, P2777, DOI 10.1002/lary.26679; Figueroa C, 2017, J NEUROIMMUNOL, V303, P99, DOI 10.1016/j.jneuroim.2016.12.014; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Garay C, 2015, MOL BIOL CELL, V26, P3504, DOI 10.1091/mbc.E14-09-1412; Gennari R, 2004, CLIN CANCER RES, V10, P5650, DOI 10.1158/1078-0432.CCR-04-0225; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Hamilton G, 2017, EXPERT OPIN BIOL TH, V17, P515, DOI 10.1080/14712598.2017.1294156; Hara M, 2008, CANCER SCI, V99, P1471, DOI 10.1111/j.1349-7006.2008.00821.x; Harper CB, 2013, TRENDS CELL BIOL, V23, P90, DOI 10.1016/j.tcb.2012.10.007; He Xuzhi, 2018, Oncotarget, V9, P12250, DOI 10.18632/oncotarget.24242; Helman EE, 2010, CANCER BIOL THER, V10, P166, DOI 10.4161/cbt.10.2.12164; Hernaez B, 2010, J VIROL, V84, P2100, DOI 10.1128/JVI.01557-09; Ho MR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07023-z; Imai K, 2006, NAT REV CANCER, V6, P714, DOI 10.1038/nrc1913; Iqbal Nida, 2014, Mol Biol Int, V2014, P852748, DOI 10.1155/2014/852748; Jenkins RW, 2018, BRIT J CANCER, V118, P9, DOI 10.1038/bjc.2017.434; Joseph SR, 2019, J INVEST DERMATOL, V139, P213, DOI 10.1016/j.jid.2018.06.190; Kaufman HL, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-017-0310-x; Kawaguchi Y, 2007, INT J CANCER, V120, P781, DOI 10.1002/ijc.22370; Kelly K, 2018, CANCER-AM CANCER SOC, V124, P2010, DOI 10.1002/cncr.31293; Kim DH, 2017, CHEM SCI, V8, P4823, DOI 10.1039/c7sc01159h; Kimura H, 2007, CANCER SCI, V98, P1275, DOI 10.1111/j.1349-7006.2007.00510.x; Klapper LN, 2000, CANCER RES, V60, P3384; Kohrt HE, 2019, J CLIN INVEST, V129, P2595, DOI 10.1172/JCI129689; Kurai J, 2007, CLIN CANCER RES, V13, P1552, DOI 10.1158/1078-0432.CCR-06-1726; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Lee WS, 2018, CURR OPIN HIV AIDS, V13, P160, DOI [10.1097/COH.0000000000000439, 10.1097/coh.0000000000000439]; Li YY, 2015, SYNAPSE, V69, P67, DOI 10.1002/syn.21788; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; Madrid PB, 2015, ACS INFECT DIS, V1, P317, DOI 10.1021/acsinfecdis.5b00030; Mall C, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1075114; Mayr LM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12883-6; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; Mellman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016949; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; MOTOHASHI N, 1991, ANTICANCER RES, V11, P1933; Muntasell A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01544; NARAMURA M, 1993, CANCER IMMUNOL IMMUN, V37, P343, DOI 10.1007/BF01518458; Nascimento EBM, 2006, DIABETES, V55, P3221, DOI 10.2337/db05-1390; Nascimento Emmani B. M., 2009, Archives of Physiology and Biochemistry, V115, P163, DOI 10.1080/13813450902988580; O'Donnell JS, 2017, CANCER TREAT REV, V52, P71, DOI 10.1016/j.ctrv.2016.11.007; O'Shaughnessy MJ, 2018, CLIN CANCER RES, V24, P592, DOI 10.1158/1078-0432.CCR-17-0186; Ohno Y, 2017, CANCER SCI, V108, P1959, DOI 10.1111/cas.13330; Ongkeko WM, 2005, AM J CLIN PATHOL, V124, P71, DOI 10.1309/BTLN5WTMJ3PCNRRC; Pahl JHW, 2012, CLIN CANCER RES, V18, P432, DOI 10.1158/1078-0432.CCR-11-2277; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Peng SH, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-198; Pinilla-Macua I, 2017, ELIFE, V6, DOI 10.7554/eLife.31993; Pitt JM, 2016, IMMUNITY, V44, P1255, DOI 10.1016/j.immuni.2016.06.001; Restifo NP, 2016, NAT REV CANCER, V16, P121, DOI 10.1038/nrc.2016.2; Ribas A, 2016, CANCER IMMUNOL RES, V4, P194, DOI 10.1158/2326-6066.CIR-15-0210; Roghanian A, 2015, CANCER CELL, V27, P473, DOI 10.1016/j.ccell.2015.03.005; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Schiffer M, 2015, NAT MED, V21, P601, DOI 10.1038/nm.3843; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Seidel UJE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00076; SELINFREUND R, 1986, AM J PHYSIOL, V251, pC904, DOI 10.1152/ajpcell.1986.251.6.C904; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Seo Y, 2014, ONCOL REP, V31, P2115, DOI 10.3892/or.2014.3077; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Simanjuntak Y, 2015, J INFECT DIS, V211, P394, DOI 10.1093/infdis/jiu377; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Sondel PM, 2001, HEMATOL ONCOL CLIN N, V15, P703, DOI 10.1016/S0889-8588(05)70243-4; Spiridon CI, 2004, CLIN CANCER RES, V10, P3542, DOI 10.1158/1078-0432.CCR-03-0549; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; THONNARDNEUMANN E, 1968, AM J PSYCHIAT, V124, P978, DOI 10.1176/ajp.124.7.978; Trivedi S, 2016, CLIN CANCER RES, V22, P5229, DOI 10.1158/1078-0432.CCR-15-2971; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; von Bredow B, 2016, J VIROL, V90, P6127, DOI 10.1128/JVI.00347-16; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wang W, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00368; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Zhang F, 2009, CANCER BIOL THER, V8, P846, DOI 10.4161/cbt.8.9.8210; Zhang X, 2017, J CANCER, V8, P2966, DOI 10.7150/jca.20850	97	56	56	6	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2020	180	5					895	+		10.1016/j.cell.2020.02.019	http://dx.doi.org/10.1016/j.cell.2020.02.019			47	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KT7JN	32142680	Bronze			2022-12-28	WOS:000519189800010
J	Rosenberg, LB				Rosenberg, Leah B.			What Are Two Days Worth? Facing Dilemmas Together at the End of Life	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenberg, Leah B.] Massachusetts Gen Hosp, Dept Palliat Care & Geriatr Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Rosenberg, LB (corresponding author), Massachusetts Gen Hosp, Dept Palliat Care & Geriatr Med, Boston, MA 02114 USA.							[Anonymous], 2015, TRANSPLANTATION DIRE, V1, pe2, DOI 10.1097/TXD.0000000000000509; Kawashima H, 2019, J PALLIAT MED, V22, P908, DOI 10.1089/jpm.2018.0415; Maiser S, 2017, J PALLIAT MED, V20, P915, DOI 10.1089/jpm.2016.0464	3	3	3	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2020	382	10					890	891		10.1056/NEJMp1913106	http://dx.doi.org/10.1056/NEJMp1913106			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KT7TC	32130812				2022-12-28	WOS:000519214900004
J	Li, ZH; Zhong, WF; Liu, SM; Kraus, VB; Zhang, YJ; Gao, X; Lv, YB; Shen, D; Zhang, XR; Zhang, PD; Huang, QM; Chen, Q; Wu, XB; Shi, XM; Wang, D; Mao, C				Li, Zhi-Hao; Zhong, Wen-Fang; Liu, Simin; Kraus, Virginia Byers; Zhang, Yu-Jie; Gao, Xiang; Lv, Yue-Bin; Shen, Dong; Zhang, Xi-Ru; Zhang, Pei-Dong; Huang, Qing-Mei; Chen, Qing; Wu, Xian-Bo; Shi, Xiao-Ming; Wang, Dong; Mao, Chen			Associations of habitual fish oil supplementation with cardiovascular outcomes and all cause mortality: evidence from a large population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; N-3 FATTY-ACIDS; OMEGA-3-FATTY-ACID SUPPLEMENTATION; EICOSAPENTAENOIC ACID; MYOCARDIAL-INFARCTION; CONTROLLED-TRIAL; RISK; METAANALYSIS; EVENTS; CONSUMPTION	OBJECTIVES To evaluate the associations of habitual fish oil supplementation with cardiovascular disease (CVD) and mortality in a large prospective cohort. DESIGN Population based, prospective cohort study. SETTING UK Biobank. PARTICIPANTS A total of 427 678 men and women aged between 40 and 69 who had no CVD or cancer at baseline were enrolled between 2006 and 2010 and followed up to the end of 2018. MAIN EXPOSURE All participants answered questions on the habitual use of supplements, including fish oil. MAIN OUTCOME MEASURES All cause mortality, CVD mortality, and CVD events. RESULTS At baseline, 133 438 (31.2%) of the 427 678 participants reported habitual use of fish oil supplements. The multivariable adjusted hazard ratios for habitual users of fish oil versus non-users were 0.87 (95% confidence interval 0.83 to 0.90) for all cause mortality, 0.84 (0.78 to 0.91) for CVD mortality, and 0.93 (0.90 to 0.96) for incident CVD events. For CVD events, the association seemed to be stronger among those with prevalent hypertension (P for interaction=0.005). CONCLUSIONS Habitual use of fish oil seems to be associated with a lower risk of all cause and CVD mortality and to provide a marginal benefit against CVD events among the general population.	[Li, Zhi-Hao; Zhong, Wen-Fang; Zhang, Yu-Jie; Shen, Dong; Zhang, Xi-Ru; Zhang, Pei-Dong; Huang, Qing-Mei; Chen, Qing; Wu, Xian-Bo; Mao, Chen] Southern Med Univ, Sch Publ Hlth, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China; [Liu, Simin] Brown Univ, Dept Epidemiol, Ctr Global Cardiometab Hlth, Providence, RI 02912 USA; [Liu, Simin] Brown Univ, Dept Med, Ctr Global Cardiometab Hlth, Providence, RI 02912 USA; [Liu, Simin] Brown Univ, Dept Surg, Ctr Global Cardiometab Hlth, Providence, RI 02912 USA; [Kraus, Virginia Byers] Duke Univ, Sch Med, Dept Med, Duke Mol Physiol Inst, Durham, NC 27706 USA; [Kraus, Virginia Byers] Duke Univ, Sch Med, Dept Med, Div Rheumatol, Durham, NC 27706 USA; [Gao, Xiang] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Lv, Yue-Bin; Shi, Xiao-Ming] Chinese Ctr Dis Control & Prevent, Natl Inst Environm Hlth, Beijing, Peoples R China; [Wang, Dong] Southern Med Univ, Sch Hlth Serv Management, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Brown University; Brown University; Brown University; Duke University; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Chinese Center for Disease Control & Prevention; National Institute of Environmental Health, Chinese Center for Disease Control & Prevention; Southern Medical University - China	Mao, C (corresponding author), Southern Med Univ, Sch Publ Hlth, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China.	maochen9@smu.edu.cn	Zhang, Peidong/ABI-3294-2020; Zhong, Wen-Fang/ABG-5242-2020; Li, Zhi-Hao/GVU-9321-2022; Li, Zhi-Hao/AAX-2941-2020; Shi, Xiaoming/V-2119-2018; Liu, Simin/I-3689-2014; Wu, Xianbo/AAL-2948-2020; Liu, Simin/GSN-4159-2022; Mao, Chen/AAW-2742-2020	Zhang, Peidong/0000-0003-4847-2296; Li, Zhi-Hao/0000-0002-1597-2676; Shi, Xiaoming/0000-0002-7071-571X; Liu, Simin/0000-0003-2098-3844; Mao, Chen/0000-0002-6537-6215; , Xiang/0000-0003-2617-6509	Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2019); Construction of High-level University of Guangdong [G619339521, G618339167]; US National Institutes of Health/National Institute on Ageing [P30-AG028716]; National Natural Science Foundation of China [81973109]	Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2019); Construction of High-level University of Guangdong; US National Institutes of Health/National Institute on Ageing; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2019), Construction of High-level University of Guangdong (G619339521 and G618339167), US National Institutes of Health/National Institute on Ageing (P30-AG028716), and National Natural Science Foundation of China (81973109). The funders had no role in the study design or implementation; data collection, management, analysis, or interpretation; manuscript preparation, review, or approval; or the decision to submit the manuscript for publication.	Abdelhamid R, 2018, CASE REP PERINAT MED, V7, DOI 10.1515/crpm-2018-0003; Adams J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002292; Albert BB, 2015, SCI REP-UK, V5, DOI 10.1038/srep07928; ASCHERIO A, 1995, NEW ENGL J MED, V332, P977, DOI 10.1056/NEJM199504133321501; Balk Ethan M, 2016, Evid Rep Technol Assess (Full Rep), P1, DOI 10.23970/AHRQEPCERTA223; Bhatt DL, 2019, NEW ENGL J MED, V380, P11, DOI 10.1056/NEJMoa1812792; Bonutti PM, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.11.22; Bowman L, 2018, NEW ENGL J MED, V379, P1540, DOI 10.1056/NEJMoa1804989; Calviello G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/743171; Celis-Morales Carlos A, 2017, BMJ, V357, pj1456, DOI 10.1136/bmj.j1456; Dangardt F, 2010, ATHEROSCLEROSIS, V212, P580, DOI 10.1016/j.atherosclerosis.2010.06.046; Del Gobbo LC, 2016, JAMA INTERN MED, V176, P1155, DOI 10.1001/jamainternmed.2016.2925; Eussen SRBM, 2012, EUR HEART J, V33, P1582, DOI 10.1093/eurheartj/ehr499; Geleijnse JM, 2002, J HYPERTENS, V20, P1493, DOI 10.1097/00004872-200208000-00010; Gerber M, 2012, BRIT J NUTR, V107, pS228, DOI 10.1017/S0007114512001614; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Harris W S, 1997, J Cardiovasc Risk, V4, P385, DOI 10.1097/00043798-199710000-00011; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Hu Y, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.013543; Iso H, 2006, CIRCULATION, V113, P195, DOI 10.1161/CIRCULATIONAHA.105.581355; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Leon H, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2931; Lev-Tzion R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006320.pub4; Manson JE, 2019, NEW ENGL J MED, V380, P23, DOI 10.1056/NEJMoa1811403; Manson JE, 2012, CONTEMP CLIN TRIALS, V33, P159, DOI 10.1016/j.cct.2011.09.009; Mazereeuw G, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.014; Mozaffarian D, 2005, CIRCULATION, V112, P1945, DOI 10.1161/CIRCULATIONAHA.105.556886; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Palmer LJ, 2007, LANCET, V369, P1980, DOI 10.1016/S0140-6736(07)60924-6; Rauch B, 2010, CIRCULATION, V122, P2152, DOI 10.1161/CIRCULATIONAHA.110.948562; Ritter JCS, 2012, LIPIDS, V47, P1169, DOI 10.1007/s11745-012-3733-7; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Saravanan P, 2010, LANCET, V376, P540, DOI 10.1016/S0140-6736(10)60445-X; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; Siscovick DS, 2017, CIRCULATION, V135, pe867, DOI 10.1161/CIR.0000000000000482; Stirban A, 2010, AM J CLIN NUTR, V91, P808, DOI 10.3945/ajcn.2009.28374; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Aung T, 2018, JAMA CARDIOL, V3, P225, DOI 10.1001/jamacardio.2017.5205; Tribulova N, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111191; Tyrrell J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i582; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; van Buuren S, 2011, J STAT SOFTW, V45, P1; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; WHO, 2015, GLOB REC PHYS ACT HL; Xun P, 2012, EUR J CLIN NUTR, V66, P1199, DOI 10.1038/ejcn.2012.133; Yamanushi TT, 2014, J NUTR, V144, P467, DOI 10.3945/jn.113.175125; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	48	27	28	6	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2020	368								m456	10.1136/bmj.m456	http://dx.doi.org/10.1136/bmj.m456			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KE	32131999	hybrid, Green Published			2022-12-28	WOS:000519536600002
J	Mahase, E				Mahase, Elisabeth			Half of smokers think nicotine vaping products are at least as harmful as smoking	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Public Health England, 2020, VAP ENGL EV UPD INCL	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2020	368								m873	10.1136/bmj.m873	http://dx.doi.org/10.1136/bmj.m873			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KE	32131998				2022-12-28	WOS:000519536600018
J	Hernandez, I; San-Juan-Rodriguez, A; Good, CB; Gellad, WF				Hernandez, Inmaculada; San-Juan-Rodriguez, Alvaro; Good, Chester B.; Gellad, Walid F.			Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFLATION	Question To what extent have manufacturer discounts offset increases in list prices of branded pharmaceutical products in the US? Findings Using 2007-2018 net pricing data on branded pharmaceutical products in the US, list prices increased by 159% and net prices increased by 60%. Discounts increased from 40% in 2007 to 76% in 2018 in Medicaid and increased from 23% to 51% in other payers, offsetting 62% of increases in list prices for drugs. Meaning Although discounts partially offset list price increases of branded products from 2007 to 2018, there was still a substantial increase in net prices over this period. Importance Most studies that have examined drug prices have focused on list prices, without accounting for manufacturer rebates and other discounts, which have substantially increased in the last decade. Objective To describe changes in list prices, net prices, and discounts for branded pharmaceutical products for which US sales are reported by publicly traded companies, and to determine the extent to which list price increases were offset by increases in discounts. Design, Setting, and Participants Retrospective descriptive study using 2007-2018 pricing data from the investment firm SSR Health for branded products available before January 2007 with US sales reported by publicly traded companies (n = 602 drugs). Net prices were estimated by compiling company-reported sales for each product and number of units sold in the US. Exposures Calendar year. Main Outcomes and Measures Outcomes included list and net prices and discounts in Medicaid and other payers. List prices represent manufacturers' price to wholesalers or direct purchasers but do not account for discounts. Net prices represent revenue per unit of the product after all manufacturer concessions are accounted for (including rebates, coupon cards, and any other discount). Means of outcomes were calculated each year for the overall sample and 6 therapeutic classes, weighting each product by utilization and adjusting for inflation. Results From 2007 to 2018, list prices increased by 159% (95% CI, 137%-181%), or 9.1% per year, while net prices increased by 60% (95% CI, 36%-84%), or 4.5% per year, with stable net prices between 2015 and 2018. Discounts increased from 40% to 76% in Medicaid and from 23% to 51% for other payers. Increases in discounts offset 62% of list price increases. There was large variability across classes. Multiple sclerosis treatments (n = 4) had the greatest increases in list (439%) and net (157%) prices. List prices of lipid-lowering agents (n = 11) increased by 278% and net prices by 95%. List prices of tumor necrosis factor inhibitors (n = 3) increased by 166% and net prices by 73%. List prices of insulins (n = 7) increased by 262%, and net prices by 51%. List prices of noninsulin antidiabetic agents (n = 10) increased by 165%, and net prices decreased by 1%. List price increases were lowest (59%) for antineoplastic agents (n = 44), but discounts only offset 41% of list price increases, leading to 35% increase in net prices. Conclusions and Relevance In this analysis of branded drugs in the US from 2007 to 2018, mean increases in list and net prices were substantial, although discounts offset an estimated 62% of list price increases with substantial variation across classes. This study describes changes in list prices, net prices, and discounts for branded pharmaceutical products in the US between 2007 and 2018 and estimates the extent to which list price increases were offset by increases in discounts.	[Hernandez, Inmaculada; San-Juan-Rodriguez, Alvaro] Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, 3609 Forbes Ave,Room 103, Pittsburgh, PA 15261 USA; [Hernandez, Inmaculada; San-Juan-Rodriguez, Alvaro; Good, Chester B.; Gellad, Walid F.] Univ Pittsburgh, Ctr Pharmaceut Policy & Prescribing, Pittsburgh, PA USA; [Good, Chester B.; Gellad, Walid F.] Univ Pittsburgh, Sch Med, Div Gen Internal Med, Pittsburgh, PA USA; [Good, Chester B.] UPMC Hlth Plan, Insurance Serv Div, Pittsburgh, PA USA; [Good, Chester B.; Gellad, Walid F.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Hernandez, I (corresponding author), Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, 3609 Forbes Ave,Room 103, Pittsburgh, PA 15261 USA.	inh3@pitt.edu	Hernandez, Inmaculada/AGZ-4219-2022	Hernandez, Inmaculada/0000-0002-0118-4986	National Heart, Lung, and Blood Institute [K01HL142847]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Hernandez is funded by the National Heart, Lung, and Blood Institute (grant No. K01HL142847).	Board of Trustees Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds, 2017, 2017 ANN REP BOARD T; Bureau of Labor Statistics, DAT TAB CALC SUBJ CO; Eli Lilly and Co, 2018, 2018 INT SUMM REP; First Databank, DRUG PRIC POL; Hernandez I, 2019, HLTH AFFAIRS BLOG; Hernandez I, 2019, HEALTH AFFAIR, V38, P76, DOI 10.1377/hlthaff.2018.05147; Hwang TJ, 2019, JAMA-J AM MED ASSOC, V322, P267, DOI 10.1001/jama.2019.7521; Hwang TJ, 2019, JAMA INTERN MED, V179, P374, DOI 10.1001/jamainternmed.2018.6417; Institute for Clinical and Economic Review, 2019, UNS PRIC INCR REP; IQVIA, MED US SPEND US; Kirzinger A., 2019, KFF HLTH TRACKING PO; Pharmaceutical Research and Manufacturers of America, LETS TALK COST; Reed T, 2019, MACPAC CALLS C ELIMI; Roehrig C, 2018, IMPACT PRESCRIPION D; San-Juan-Rodriguez A, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.17379; San-Juan-Rodriguez A, 2019, JAMA INTERN MED, V179, P713, DOI 10.1001/jamainternmed.2018.7656; Silverman E, 2019, WHOLESALE DRUG PRICE; SSR Health, US PRESCR BRAND NET; US Department of Health and Human Services Office of the Inspector General, 2019, REB BRAND NAM DRUG D; US Senate Committee on Finance, FULL COMM HEAR DRUG; Venker B, 2019, JAMA INTERN MED, V179, P431, DOI 10.1001/jamainternmed.2018.5874; Whittington MD, 2019, J MANAG CARE SPEC PH, V25, P80, DOI 10.18553/jmcp.2019.25.1.080; Wineinger NE, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.4791	23	71	69	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2020	323	9			SI		854	862		10.1001/jama.2020.1012	http://dx.doi.org/10.1001/jama.2020.1012			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU3SD	32125403	Bronze, Green Published			2022-12-28	WOS:000519630600016
J	Voelker, R				Voelker, Rebecca			Drug Approved to Aid Youths With Peanut Allergy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2020	323	9			SI		817	817		10.1001/jama.2020.1785	http://dx.doi.org/10.1001/jama.2020.1785			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU3SD	32125388				2022-12-28	WOS:000519630600006
J	Pan, J; Ivanov, YP; Zhou, WH; Li, Y; Greer, AL				Pan, J.; Ivanov, Yu. P.; Zhou, W. H.; Li, Y.; Greer, A. L.			Strain-hardening and suppression of shear-banding in rejuvenated bulk metallic glass	NATURE			English	Article							TENSILE DUCTILITY; FRACTURE; MECHANISMS; TRANSITION; NECKING; STATE	Strain-hardening (the increase of flow stress with plastic strain) is the most important phenomenon in the mechanical behaviour of engineering alloys because it ensures that flow is delocalized, enhances tensile ductility and inhibits catastrophic mechanical failure(1,2). Metallic glasses (MGs) lack the crystallinity of conventional engineering alloys, and some of their properties-such as higher yield stress and elastic strain limit(3)-are greatly improved relative to their crystalline counterparts. MGs can have high fracture toughness and have the highest known 'damage tolerance' (defined as the product of yield stress and fracture toughness)(4) among all structural materials. However, the use of MGs in structural applications is largely limited by the fact that they show strain-softening instead of strain-hardening; this leads to extreme localization of plastic flow in shear bands, and is associated with early catastrophic failure in tension. Although rejuvenation of an MG (raising its energy to values that are typical of glass formation at a higher cooling rate) lowers its yield stress, which might enable strain-hardening(5), it is unclear whether sufficient rejuvenation can be achieved in bulk samples while retaining their glassy structure. Here we show that plastic deformation under triaxial compression at room temperature can rejuvenate bulk MG samples sufficiently to enable strain-hardening through a mechanism that has not been previously observed in the metallic state. This transformed behaviour suppresses shear-banding in bulk samples in normal uniaxial (tensile or compressive) tests, prevents catastrophic failure and leads to higher ultimate flow stress. The rejuvenated MGs are stable at room temperature and show exceptionally efficient strain-hardening, greatly increasing their potential use in structural applications. Bulk metallic glasses can acquire the ability to strain-harden through a mechanical rejuvenation treatment at room temperature that retains their non-crystalline structure.	[Pan, J.; Zhou, W. H.; Li, Y.] Chinese Acad Sci, Shenyang Natl Lab Mat Sci, Inst Met Res, Shenyang, Peoples R China; [Ivanov, Yu. P.; Greer, A. L.] Univ Cambridge, Dept Mat Sci & Met, Cambridge, England; [Ivanov, Yu. P.] Far Eastern Fed Univ, Sch Nat Sci, Vladivostok, Russia; [Zhou, W. H.] Univ Sci & Technol China, Sch Mat Sci & Engn, Hefei, Peoples R China	Chinese Academy of Sciences; Institute of Metal Research, CAS; University of Cambridge; Far Eastern Federal University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Li, Y (corresponding author), Chinese Acad Sci, Shenyang Natl Lab Mat Sci, Inst Met Res, Shenyang, Peoples R China.; Greer, AL (corresponding author), Univ Cambridge, Dept Mat Sci & Met, Cambridge, England.	liyi@imr.ac.cn; alg13@cam.ac.uk	Li, Yi/K-8838-2012; zhou, weihua/GXG-8771-2022; Li, Y/J-9029-2016; Pan, Jie/L-3928-2017; Ivanov, Iurii/G-1241-2014	Li, Yi/0000-0001-7123-681X; zhou, weihua/0000-0001-9296-818X; Li, Y/0000-0001-7123-681X; Pan, Jie/0000-0001-5465-0736; Ivanov, Iurii/0000-0003-0271-5504	National Natural Science Foundation of China [51871217]; Shenyang National Laboratory for Materials Science; European Research Council under the European Union [ERC-2015-AdG-695487]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenyang National Laboratory for Materials Science; European Research Council under the European Union(European Research Council (ERC))	Y.L. and J.P. acknowledge support from National Natural Science Foundation of China under grant number 51871217 and from the Shenyang National Laboratory for Materials Science. A.L.G. and Yu.P.I. acknowledge support from the European Research Council under the European Union's Horizon 2020 Research and Innovation programme (grant ERC-2015-AdG-695487: ExtendGlass). We thank A. Chuvilin for technical support of HRTEM (CIC, NanoGUNE, Spain), and J. Zhang for technical support and W. Huang for casting the rod samples (IMR, Shenyang, China).	[Anonymous], 1934, P R SOC LOND A, DOI [10.1098/rspa.1934.0107, DOI 10.1098/RSPA.1934.0107, DOI 10.1098/RSPA.1934.0106]; Ashby MF, 2006, SCRIPTA MATER, V54, P321, DOI 10.1016/j.scriptamat.2005.09.051; BENNETT CH, 1972, J APPL PHYS, V43, P2727, DOI 10.1063/1.1661585; Boyer H. F., 2002, ATL STRESS STRAIN CU; Chen DZ, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4907773; Cottrell, 1981, MECH PROPERTIES MATT; Das J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.205501; Demetriou MD, 2011, NAT MATER, V10, P123, DOI [10.1038/nmat2930, 10.1038/NMAT2930]; Dieter G. E., 1961, MECH METALLURGY; Greer AL, 2013, MAT SCI ENG R, V74, P71, DOI 10.1016/j.mser.2013.04.001; Guo H, 2007, NAT MATER, V6, P735, DOI 10.1038/nmat1984; Guo W, 2019, METALL MATER TRANS A, V50A, P1125, DOI 10.1007/s11661-018-5062-9; He Q, 2012, ACTA MATER, V60, P4940, DOI 10.1016/j.actamat.2012.05.028; Hofmann DC, 2010, SCIENCE, V329, P1294, DOI 10.1126/science.1193522; Jang DC, 2010, NAT MATER, V9, P215, DOI [10.1038/NMAT2622, 10.1038/nmat2622]; Januchta K, 2019, ADV SCI, V6, DOI 10.1002/advs.201901281; Joo SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep09660; Kelton KF, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.195504; Ketkaew J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05682-8; Kim CP, 2011, SCRIPTA MATER, V65, P304, DOI 10.1016/j.scriptamat.2011.04.037; Ma D, 2009, NAT MATER, V8, P30, DOI [10.1038/nmat2340, 10.1038/NMAT2340]; Pan J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02943-4; Pan J, 2017, ACTA MATER, V136, P126, DOI 10.1016/j.actamat.2017.06.048; Pan J, 2015, J MECH PHYS SOLIDS, V84, P85, DOI 10.1016/j.jmps.2015.07.006; Pan SP, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.092201; Pauly S, 2010, NAT MATER, V9, P473, DOI [10.1038/NMAT2767, 10.1038/nmat2767]; Qu RT, 2015, ACTA MATER, V91, P19, DOI 10.1016/j.actamat.2015.03.026; Rashidi R, 2018, MAT SCI ENG A-STRUCT, V729, P433, DOI 10.1016/j.msea.2018.05.082; Shanmugam J, 2017, SOFTWAREX, V6, P185, DOI 10.1016/j.softx.2017.07.001; Song KK, 2012, ACTA MATER, V60, P6000, DOI 10.1016/j.actamat.2012.07.015; SPAEPEN F, 1977, ACTA METALL MATER, V25, P407, DOI 10.1016/0001-6160(77)90232-2; Sun YH, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.39; Tian L, 2013, ACTA MATER, V61, P4823, DOI 10.1016/j.actamat.2013.05.001; Tian L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1619; Volkert CA, 2008, J APPL PHYS, V103, DOI 10.1063/1.2884584; Wang JG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07669-9; Wang T, 2018, SCRIPTA MATER, V150, P106, DOI 10.1016/j.scriptamat.2018.03.006; Wang WH, 2002, J MATER RES, V17, P1385, DOI 10.1557/JMR.2002.0206; Wang ZT, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.135504; Wu YA, 2010, ADV MATER, V22, P2770, DOI 10.1002/adma.201000482; Xie SH, 2018, J ALLOY COMPD, V735, P1576, DOI 10.1016/j.jallcom.2017.11.223; Yao KF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2437722; Zhang ZF, 2003, ACTA MATER, V51, P1167, DOI 10.1016/S1359-6454(02)00521-9	43	321	323	78	429	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB	2020	578	7796					559	+		10.1038/s41586-020-2016-3	http://dx.doi.org/10.1038/s41586-020-2016-3			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KP9SJ	32103194	Green Accepted			2022-12-28	WOS:000516571100016
J	Bajo, P; Drysdale, RN; Woodhead, JD; Hellstrom, JC; Hodell, D; Ferretti, P; Voelker, AHL; Zanchetta, G; Rodrigues, T; Wolff, E; Tyler, J; Frisia, S; Spotl, C; Fallick, AE				Bajo, Petra; Drysdale, Russell N.; Woodhead, Jon D.; Hellstrom, John C.; Hodell, David; Ferretti, Patrizia; Voelker, Antje H. L.; Zanchetta, Giovanni; Rodrigues, Teresa; Wolff, Eric; Tyler, Jonathan; Frisia, Silvia; Spotl, Christoph; Fallick, Anthony E.			Persistent influence of obliquity on ice age terminations since the Middle Pleistocene transition	SCIENCE			English	Article							NORTH-ATLANTIC; CLIMATE VARIABILITY; STALAGMITE EVIDENCE; TEMPERATURE; SPELEOTHEMS; CYCLES; CIRCULATION; CALIBRATION; EVOLUTION; EVENTS	Radiometric dating of glacial terminations over the past 640,000 years suggests pacing by Earth's climatic precession, with each glacial-interglacial period spanning four or five cycles of similar to 20,000 years. However, the lack of firm age estimates for older Pleistocene terminations confounds attempts to test the persistence of precession forcing. We combine an Italian speleothem record anchored by a uranium-lead chronology with North Atlantic ocean data to show that the first two deglaciations of the so-called 100,000-year world are separated by two obliquity cycles, with each termination starting at the same high phase of obliquity, but at opposing phases of precession. An assessment of 11 radiometrically dated terminations spanning the past million years suggests that obliquity exerted a persistent influence on not only their initiation but also their duration.	[Bajo, Petra; Drysdale, Russell N.] Univ Melbourne, Sch Geog, Carlton, Vic 3053, Australia; [Bajo, Petra] Australian Nucl Sci & Technol Org, Lucas Heights, NSW 2234, Australia; [Bajo, Petra] Croatian Geol Survey, Zagreb 10000, Croatia; [Drysdale, Russell N.] Univ Savoie Mt Blanc, Lab EDYTEM UMR5204, F-73376 Le Bourget Du Lac, France; [Woodhead, Jon D.; Hellstrom, John C.] Univ Melbourne, Sch Earth Sci, Parkville, Vic 3010, Australia; [Hodell, David; Wolff, Eric] Univ Cambridge, Dept Earth Sci, Godwin Lab Palaeoclimate Res, Cambridge CB2 3EQ, England; [Ferretti, Patrizia] CNR, IDPA, I-30172 Venice, Italy; [Ferretti, Patrizia] Univ Ca Foscari, Dipartimento Sci Ambientali Informat & Stat, I-30172 Venice, Italy; [Voelker, Antje H. L.; Rodrigues, Teresa] IPMA, Div Geol & Georecursos Marinhos, P-1495165 Alges, Portugal; [Voelker, Antje H. L.; Rodrigues, Teresa] Univ Algarve, Ctr Marine Sci CCMAR, P-8005139 Faro, Portugal; [Zanchetta, Giovanni] Univ Pisa, Dept Earth Sci, I-56100 Pisa, Italy; [Tyler, Jonathan] Univ Adelaide, Dept Earth Sci, North Terrace, SA 5005, Australia; [Frisia, Silvia] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Spotl, Christoph] Univ Innsbruck, Inst Geol, A-6020 Innsbruck, Austria; [Fallick, Anthony E.] Scottish Univ, Environm Res Ctr, E Kilbride G75 0QF, Lanark, Scotland	University of Melbourne; Australian Nuclear Science & Technology Organisation; Croatian Geological Survey; University of Melbourne; University of Cambridge; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Dinamica dei Processi Ambientali (IDPA-CNR); Universita Ca Foscari Venezia; Instituto Portugues do Mar e da Atmosfera; Universidade do Algarve; University of Pisa; University of Adelaide; University of Newcastle; University of Innsbruck; Scottish Universities Research & Reactor Center	Drysdale, RN (corresponding author), Univ Melbourne, Sch Geog, Carlton, Vic 3053, Australia.; Drysdale, RN (corresponding author), Univ Savoie Mt Blanc, Lab EDYTEM UMR5204, F-73376 Le Bourget Du Lac, France.	rnd@unimelb.edu.au	Wolff, Eric/AAB-1097-2021; Voelker, Antje H L/C-5427-2012; Rodrigues, Teresa/G-2912-2013	Wolff, Eric/0000-0002-5914-8531; Voelker, Antje H L/0000-0001-6465-6023; Zanchetta, Giovanni/0000-0002-7080-9599; Rodrigues, Teresa/0000-0001-7811-7506; FERRETTI, Patrizia/0000-0002-4814-3655; Drysdale, Russell/0000-0001-7867-031X; Woodhead, Jon/0000-0002-7614-0136; Frisia, Silvia/0000-0001-6568-2696	Australian Research Council [0664621, 110102185, 160102969, FT130100801]; Gruppo Speleologico Lucchese; Federazione Speleologica Toscana; University of Melbourne; Albert Shimmins Fund; European Union through a Marie-Curie Reintegration grant [PERG-GA-2010-272134 MILLEVARIABILI]; UK Natural Environmental Research Council; Royal Society Professorship; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) project MOWCADYN [PTDC/MAR-PRO/3761/2012]; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) project WarmWorld [PTDC/CTA-GEO/29897/2017]; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) project CCMAR [UID/Multi/04326/2019]; NERC [NE/R000204/1] Funding Source: UKRI; Fundação para a Ciência e a Tecnologia [PTDC/MAR-PRO/3761/2012] Funding Source: FCT	Australian Research Council(Australian Research Council); Gruppo Speleologico Lucchese; Federazione Speleologica Toscana; University of Melbourne(University of Melbourne); Albert Shimmins Fund; European Union through a Marie-Curie Reintegration grant; UK Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society Professorship; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) project MOWCADYN; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) project WarmWorld; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) project CCMAR; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Fundação para a Ciência e a Tecnologia	We acknowledge financial support from Australian Research Council Discovery Project grants 0664621 (to J. D.W.), 110102185 (to R.N.D., J.D.W., J.C.H., E.W., A. E.F., and S.F.), and 160102969 (to R.N.D., J.D.W., G.Z., E.W., and P. F.). We thank the Gruppo Speleologico Lucchese and the Federazione Speleologica Toscana for logistic and funding support. The SUERC contribution to this study falls within the framework of the Scottish Alliance for Geoscience, Environment and Society (SAGES). P. B. was the recipient of a University of Melbourne International Postgraduate Research Scholarship and Postgraduate Writing-Up Award supported by the Albert Shimmins Fund. J.C.H. was the recipient of an Australian Research Council Future Fellowship (FT130100801). P. F. acknowledges support from the European Union through a Marie-Curie Reintegration grant (PERG-GA-2010-272134 MILLEVARIABILI). D. H. acknowledges support from the UK Natural Environmental Research Council. E.W. is supported by a Royal Society Professorship. A.H.L.V. and T.R. received financial support from Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) projects MOWCADYN (PTDC/MAR-PRO/3761/2012), WarmWorld (PTDC/CTA-GEO/29897/2017), and CCMAR (UID/Multi/04326/2019). Samples from the marine sites were provided by the Integrated Ocean Drilling Program to D. H., A.H. L.V., and T.R.	Alonso-Garcia M, 2011, QUATERNARY SCI REV, V30, P3234, DOI 10.1016/j.quascirev.2011.08.005; Bajo P, 2012, QUAT GEOCHRONOL, V14, P5, DOI 10.1016/j.quageo.2012.10.005; Barker S, 2011, SCIENCE, V334, P347, DOI 10.1126/science.1203580; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Berger A, 2016, REV GEOPHYS, V54, P162, DOI 10.1002/2015RG000482; Blaauw M, 2011, BAYESIAN ANAL, V6, P457, DOI 10.1214/ba/1339616472; Cheng H, 2016, NATURE, V534, P640, DOI 10.1038/nature18591; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; Dansgaard W, 1954, GEOCHIM COSMOCHIM AC, V6, P241, DOI 10.1016/0016-7037(54)90003-4; Denton GH, 2010, SCIENCE, V328, P1652, DOI 10.1126/science.1184119; Drysdale RN, 2009, SCIENCE, V325, P1527, DOI 10.1126/science.1170371; Drysdale RN, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024658; Drysdale RN, 2004, EARTH PLANET SC LETT, V227, P215, DOI 10.1016/j.epsl.2004.09.010; Drysdale RN, 2007, GEOLOGY, V35, P77, DOI 10.1130/G23161A.1; Drysdale RN, 2019, GEOCHIM COSMOCHIM AC, V264, P67, DOI 10.1016/j.gca.2019.08.001; Drysdale RN, 2012, QUAT GEOCHRONOL, V14, P38, DOI 10.1016/j.quageo.2012.06.009; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Head MJ, 2015, QUATERN INT, V389, P7, DOI 10.1016/j.quaint.2015.09.042; Hellstrom J, 2003, J ANAL ATOM SPECTROM, V18, P1346, DOI 10.1039/b308781f; Hellstrom J, 2006, QUAT GEOCHRONOL, V1, P289, DOI 10.1016/j.quageo.2007.01.004; Hendy EJ, 2012, GEOCHIM COSMOCHIM AC, V86, P338, DOI 10.1016/j.gca.2012.02.020; Hernandez-Almeida I, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2011PA002209; Hodell D, 2015, GLOBAL PLANET CHANGE, V133, P49, DOI 10.1016/j.gloplacha.2015.07.002; Huybers P, 2005, NATURE, V434, P491, DOI 10.1038/nature03401; Huybers P, 2007, QUATERNARY SCI REV, V26, P37, DOI 10.1016/j.quascirev.2006.07.013; Huybers P, 2006, SCIENCE, V313, P508, DOI 10.1126/science.1125249; Huybers P, 2011, NATURE, V480, P229, DOI 10.1038/nature10626; IMBRIE J, 1980, SCIENCE, V207, P943, DOI 10.1126/science.207.4434.943; Lambeck K, 2014, P NATL ACAD SCI USA, V111, P15296, DOI 10.1073/pnas.1411762111; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Lisiecki LE, 2010, NAT GEOSCI, V3, P349, DOI 10.1038/NGEO828; Ludwig K. R., 2001, USERS MANUAL ISOPLOT; Marino G, 2015, NATURE, V522, P197, DOI 10.1038/nature14499; Martrat B, 2004, SCIENCE, V306, P1762, DOI 10.1126/science.1101706; Martrat B, 2007, SCIENCE, V317, P502, DOI 10.1126/science.1139994; Martrat B, 2014, QUATERNARY SCI REV, V99, P122, DOI 10.1016/j.quascirev.2014.06.016; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Menviel L, 2019, GEOSCI MODEL DEV, V12, P3649, DOI 10.5194/gmd-12-3649-2019; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Pena LD, 2014, SCIENCE, V345, P318, DOI 10.1126/science.1249770; Piccini L, 2008, INT J SPELEOL, V37, P153, DOI 10.5038/1827-806X.37.3.2; PISIAS NG, 1981, EARTH PLANET SC LETT, V52, P450, DOI 10.1016/0012-821X(81)90197-7; PRAHL FG, 1987, NATURE, V330, P367, DOI 10.1038/330367a0; Richards DA, 1998, GEOCHIM COSMOCHIM AC, V62, P3683, DOI 10.1016/S0016-7037(98)00256-7; Richards DA, 2003, REV MINERAL GEOCHEM, V52, P407, DOI 10.2113/0520407; Rodrigues T, 2017, QUATERNARY SCI REV, V172, P118, DOI 10.1016/j.quascirev.2017.07.004; Rodrigues T, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA001927; Schmitz MD, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001492; Scholz D, 2012, QUAT GEOCHRONOL, V14, P94, DOI 10.1016/j.quageo.2012.03.015; Shackleton N. J., 1976, GEOL SOC AM MEM, V145, P449, DOI DOI 10.1130/MEM145-P449; Skinner LC, 2014, P NATL ACAD SCI USA, V111, P5480, DOI 10.1073/pnas.1400668111; Spotl C, 2011, RAPID COMMUN MASS SP, V25, P1683, DOI 10.1002/rcm.5037; Spotl C, 2003, RAPID COMMUN MASS SP, V17, P1004, DOI 10.1002/rcm.1010; Tzedakis PC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06683-3; Tzedakis PC, 2017, NATURE, V542, P427, DOI 10.1038/nature21364; Villanueva J, 1997, GEOCHIM COSMOCHIM AC, V61, P4633, DOI 10.1016/S0016-7037(97)83123-7; Voelker A.H.L., 2018, PROC INTEGR OCEAN DR, V339, P1, DOI [10.2204/iodp.proc.339.204.2018, DOI 10.2204/IODP.PROC.339.204.2018]; Voelker AHL, 2015, GLOBAL PLANET CHANGE, V133, P223, DOI 10.1016/j.gloplacha.2015.08.015; Voelker AHL, 2015, DEEP-SEA RES PT II, V116, P89, DOI 10.1016/j.dsr2.2014.11.006; Woodhead J, 2006, QUAT GEOCHRONOL, V1, P208, DOI 10.1016/j.quageo.2006.08.002; Woodhead J, 2012, QUAT GEOCHRONOL, V14, P105, DOI 10.1016/j.quageo.2012.02.028; Zhang HB, 2018, SCIENCE, V362, P580, DOI 10.1126/science.aat9393; Zhu J, 2017, GEOPHYS RES LETT, V44, P12501, DOI 10.1002/2017GL076253	67	27	28	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1235	+		10.1126/science.aaw1114	http://dx.doi.org/10.1126/science.aaw1114			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9DP	32165584	Green Submitted			2022-12-28	WOS:000520023800039
J	Sharma, A				Sharma, Arun			Stem cells to help the heart	SCIENCE			English	Editorial Material									[Sharma, Arun] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA; [Sharma, Arun] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center	Sharma, A (corresponding author), Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA.; Sharma, A (corresponding author), Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA.	arun.sharma1490@gmail.com		Sharma, Arun/0000-0002-0607-5455				Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Groarke JD, 2013, NEW ENGL J MED, V369, P1779, DOI 10.1056/NEJMp1313140; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Rao M, 2013, CELL STEM CELL, V12, P149, DOI 10.1016/j.stem.2013.01.010; Sharma A, 2018, NAT PROTOC, V13, P3018, DOI 10.1038/s41596-018-0076-8; Sharma A, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf2584; Sharma A, 2014, CIRC RES, V115, P556, DOI 10.1161/CIRCRESAHA.115.303810; Sharma A, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt380; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wnorowski A, 2019, STEM CELL REP, V13, P960, DOI 10.1016/j.stemcr.2019.10.006	13	0	0	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1206	1206		10.1126/science.aba6111	http://dx.doi.org/10.1126/science.aba6111			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU9DP	32165579				2022-12-28	WOS:000520023800029
J	Harris, LH; Grossman, D				Harris, Lisa H.; Grossman, Daniel			Complications of Unsafe and Self-Managed Abortion	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MEDICAL ABORTION; REDUCTION STRATEGY; EARLY-PREGNANCY; UNITED-STATES; WOMEN; MIFEPRISTONE; TERMINATION; MISOPROSTOL; RISK	As U.S. abortion laws become more restrictive, women will end pregnancies without clinical supervision. Clinicians must recognize the normal course of self-managed, medication-induced abortion and its rare complications, as well as the complications of unsafe methods.	[Harris, Lisa H.] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Harris, Lisa H.] Univ Michigan, Dept Womens Studies, Ann Arbor, MI 48109 USA; [Grossman, Daniel] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, ANSIRH, San Francisco, CA USA; [Grossman, Daniel] Univ Calif San Francisco, Bixby Ctr Global Reprod Hlth, San Francisco, CA 94143 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Harris, LH (corresponding author), Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA.; Harris, LH (corresponding author), Univ Michigan, Dept Womens Studies, Ann Arbor, MI 48109 USA.	lhharris@med.umich.edu						ABERNATHY JR, 1970, DEMOGRAPHY, V7, P19, DOI 10.2307/2060019; Advancing New Standards in Reproductive Health (ANSIRH), 2019, AN MED AB RISK FDA R; Aiken ARA, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2011; American College of Obstetricians and Gynecologists, 2017, DESCR SELF IND AB PO; [Anonymous], 2013, Obstet Gynecol, V121, P1394, DOI 10.1097/01.AOG.0000431056.79334.cc; [Anonymous], 2011, CONTRACEPTION, V83, P295, DOI 10.1016/j.contraception.2010.11.006; [Anonymous], 2014, OBSTET GYNECOL, V123, P676, DOI DOI 10.1097/01.AOG.0000444454.67279.7d; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Benson J, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-39; Borgatta L, 2004, OBSTET GYNECOLOGIC E, P65; Briozzo L, 2006, INT J GYNECOL OBSTET, V95, P221, DOI 10.1016/j.ijgo.2006.07.013; Bronstein JM, 2018, NEW ENGL J MED, V379, P706, DOI 10.1056/NEJMp1807125; CATES W, 1976, FAM PLANN PERSPECT, V8, P86, DOI 10.2307/2133995; Centre for Disease Control and Prevention, 2015, SEXUALLY; Chervenak FA, 2019, INT J GYNECOL OBSTET, V146, P269, DOI 10.1002/ijgo.12899; CONWAY GA, 1979, J ETHNOPHARMACOL, V1, P241, DOI 10.1016/S0378-8741(79)80014-8; Creinin MD, 2004, OBSTET GYNECOL, V103, P851, DOI 10.1097/01.AOG.0000124271.23499.84; Diop A, 2009, CONTRACEPTION, V79, P456, DOI 10.1016/j.contraception.2008.11.016; Faundes A, 1996, ADV CONTRACEPT, V12, P1, DOI 10.1007/BF01849540; Fiala C, 2003, EUR J OBSTET GYN R B, V109, P190, DOI 10.1016/S0301-2115(03)00012-5; Fjerstad M, 2009, NEW ENGL J MED, V361, P145, DOI 10.1056/NEJMoa0809146; Footman K, 2018, STUD FAMILY PLANN, V49, P57, DOI 10.1111/sifp.12049; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Grossman D, 2014, CONTRACEPTION, V89, P73, DOI 10.1016/j.contraception.2013.10.012; Grossman D, 2010, REPROD HEALTH MATTER, V18, P136, DOI 10.1016/S0968-8080(10)36534-7; Harris LH, 2011, INT J GYNECOL OBSTET, V115, P77, DOI 10.1016/j.ijgo.2011.05.018; Honigman Benjamin, 1993, Journal of Emergency Medicine, V11, P105, DOI 10.1016/0736-4679(93)90021-X; Huber D, 2016, GLOB HEALTH-SCI PRAC, V4, P481, DOI 10.9745/GHSP-D-16-00052; Jerman J., 2016, CHARACTERISTICS US A; Joffe, 1996, DOCTORS CONSCIENCE S; Kapp N, 2019, CONTRACEPTION, V99, P77, DOI 10.1016/j.contraception.2018.11.002; Kapp N, 2013, CONTRACEPTION, V88, P350, DOI 10.1016/j.contraception.2012.10.027; Kerns J, 2013, CONTRACEPTION, V87, P331, DOI 10.1016/j.contraception.2012.10.024; Labandera A, 2016, INT J GYNECOL OBSTET, V134, pS7, DOI 10.1016/j.ijgo.2016.06.007; Mandondo SD, 2018, SAMJ S AFR MED J, V108, P965, DOI [10.7196/SAMJ.2018.v108i11.12979, 10.7196/samj.2018.v108i11.12979]; Mark A, 2019, CONTRACEPTION, V99, P265, DOI 10.1016/j.contraception.2019.02.008; Paltrow LM, 2013, J HEALTH POLIT POLIC, V38, P299, DOI 10.1215/03616878-1966324; Raymond EG, 2012, OBSTET GYNECOL, V119, P215, DOI 10.1097/AOG.0b013e31823fe923; Reeves MF, 2009, ULTRASOUND OBST GYN, V34, P104, DOI 10.1002/uog.6404; Rosenbaum L, 2019, NEW ENGL J MED, V381, P893, DOI 10.1056/NEJMp1910010; Russo JA, 2013, CONTRACEPTION, V87, P497, DOI 10.1016/j.contraception.2012.04.005; Schreiber CA, 2018, NEW ENGL J MED, V378, P2161, DOI 10.1056/NEJMoa1715726; Self-Induced Abortion (SIA) Legal Team, 2018, ROES UNF PROM DESCR; Sheldon WR, 2019, CONTRACEPTION, V99, P272, DOI 10.1016/j.contraception.2019.02.002; SK AZ, 2016, DIABETOL STOFFWECHS, V11, pS01; Stevenson AJ, 2016, NEW ENGL J MED, V374, P853, DOI 10.1056/NEJMsa1511902; Upadhyay UD, 2015, OBSTET GYNECOL, V125, P175, DOI 10.1097/AOG.0000000000000603; von Hertzen H, 2007, LANCET, V369, P1938, DOI 10.1016/S0140-6736(07)60914-3; Winikoff B, 2012, OBSTET GYNECOL, V120, P1070, DOI [10.1097/AOG.0b013e31826c315f, http://10.1097/AOG.0b013e31826c315f]; World Health Organization, 2018, MEDICAL MANAGEMENT A	50	29	30	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2020	382	11					1029	1040		10.1056/NEJMra1908412	http://dx.doi.org/10.1056/NEJMra1908412			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU7TA	32160664				2022-12-28	WOS:000519914300009
J	Mahase, E				Mahase, Elisabeth			Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inaction	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer O, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m941; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m986; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m959	3	231	236	2	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2020	368								m1036	10.1136/bmj.m1036	http://dx.doi.org/10.1136/bmj.m1036			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AU	32165426	Bronze			2022-12-28	WOS:000520013500011
J	Massoth, LR; Louissaint, A				Massoth, Lucas R.; Louissaint, Abner, Jr.			Massive Splenomegaly from Disseminated Mycobacterium avium-intracellulare Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Massoth, Lucas R.; Louissaint, Abner, Jr.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Louissaint, A (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	alouissaint@partners.org							0	0	0	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2020	382	11					1041	1041		10.1056/NEJMicm1905550	http://dx.doi.org/10.1056/NEJMicm1905550			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU7TA	32160665				2022-12-28	WOS:000519914300010
J	Nehring, P; Przbylkowski, A				Nehring, Piotr; Przbylkowski, Adam			Think twice before operating on a pancreatic mass: could it be IgG4-related disease?	LANCET			English	Editorial Material									[Nehring, Piotr; Przbylkowski, Adam] Med Univ Warsaw, Dept Gastroenteiolooy & Internal Med, PL-02097 Warsaw, Poland	Medical University of Warsaw	Przbylkowski, A (corresponding author), Med Univ Warsaw, Dept Gastroenteiolooy & Internal Med, PL-02097 Warsaw, Poland.	aprzybylkowski@wum.edu.pl	Przybyłkowski, Adam M/U-4964-2018; Nehring, Piotr/H-7071-2013	Przybyłkowski, Adam M/0000-0002-5851-2856; Nehring, Piotr/0000-0003-3118-7843					0	2	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2020	395	10226					816	816						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU2KH	32145795				2022-12-28	WOS:000519536900038
J	Linneweber, GA; Andriatsilavo, M; Dutta, SB; Bengochea, M; Hellbruegge, L; Liu, GD; Ejsmont, RK; Straw, AD; Wernet, M; Hiesinger, PR; Hassan, BA				Linneweber, Gerit Arne; Andriatsilavo, Maheva; Dutta, Suchetana Bias; Bengochea, Mercedes; Hellbruegge, Liz; Liu, Guangda; Ejsmont, Radoslaw K.; Straw, Andrew D.; Wernet, Mathias; Hiesinger, Peter Robin; Hassan, Bassem A.			A neurodevelopmental origin of behavioral individuality in the Drosophila visual system	SCIENCE			English	Article							NEURONAL CONTROL; BRAIN; ORIENTATION; VARIABILITY; PERSONALITY; FLY; MELANOGASTER; EXPRESSION; MORPHOLOGY; REQUIRES	The genome versus experience dichotomy has dominated understanding of behavioral individuality. By contrast, the role of nonheritable noise during brain development in behavioral variation is understudied. Using Drosophila melanogaster, we demonstrate a link between stochastic variation in brain wiring and behavioral individuality. A visual system circuit called the dorsal cluster neurons (DCN) shows nonheritable, interindividual variation in right/left wiring asymmetry and controls object orientation in freely walking flies. We show that DCN wiring asymmetry instructs an individual's object responses: The greater the asymmetry, the better the individual orients toward a visual object. Silencing DCNs abolishes correlations between anatomy and behavior, whereas inducing DCN asymmetry suffices to improve object responses.	[Linneweber, Gerit Arne; Andriatsilavo, Maheva; Dutta, Suchetana Bias; Bengochea, Mercedes; Ejsmont, Radoslaw K.; Hassan, Bassem A.] Sorbonne Univ, CNRS, Inst Cerveau & Moelle Epiniere ICM, Hop Pitie Salpetriere,INSERM, Paris, France; [Linneweber, Gerit Arne; Andriatsilavo, Maheva; Dutta, Suchetana Bias; Hellbruegge, Liz; Wernet, Mathias; Hiesinger, Peter Robin; Hassan, Bassem A.] Free Univ, Inst Biol, Div Neurobiol, Berlin, Germany; [Linneweber, Gerit Arne; Andriatsilavo, Maheva; Dutta, Suchetana Bias; Hellbruegge, Liz; Hiesinger, Peter Robin; Hassan, Bassem A.] Charite, Einstein BIH, Berlin, Germany; [Liu, Guangda] VIB, Ctr Biol Dis, B-3000 Leuven, Belgium; [Liu, Guangda] Univ Leuven, Ctr Human Genet, Sch Med, B-3000 Leuven, Belgium; [Straw, Andrew D.] Albert Ludwigs Univ Freiburg, Inst Biol 1, Fac Biol, Freiburg, Germany; [Straw, Andrew D.] Albert Ludwigs Univ Freiburg, Bernstein Ctr Freiburg, Fac Biol, Freiburg, Germany; [Ejsmont, Radoslaw K.] CRI, 10 Rue Charles V, F-75004 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Freiburg; University of Freiburg	Hassan, BA (corresponding author), Sorbonne Univ, CNRS, Inst Cerveau & Moelle Epiniere ICM, Hop Pitie Salpetriere,INSERM, Paris, France.; Hassan, BA (corresponding author), Free Univ, Inst Biol, Div Neurobiol, Berlin, Germany.; Hassan, BA (corresponding author), Charite, Einstein BIH, Berlin, Germany.	bassem.hassan@icm-institute.org	Straw, Andrew D/A-1244-2007; Hassan, Bassem A/D-5221-2012; Linneweber, Gerit A/B-1797-2014	Straw, Andrew D/0000-0001-8381-0858; Hassan, Bassem A/0000-0001-9533-4908; Linneweber, Gerit A/0000-0001-8393-6426; Ejsmont, Radoslaw/0000-0001-7176-7848; Bengochea, Mercedes/0000-0002-6446-5021; Hellbrugge, Liz/0000-0002-0301-7145	ICM Big Brain Theory Program; program "Investissements d'avenir" [ANR-10-IAIHU-06]; ANR [ANR-19-CE16-0009-01]; Einstein-BIH program; Paul G. Allen Frontiers Group; VIB; WiBrain Interuniversity Attraction Pole network (Belspo); FLiACT Marie-Curie Initial Training Network (FP7/2007-2013); NIH [R01EY018884]; German Research Foundation [DFG: SFB 958, SFB186]; FU Berlin; EMBO Long Term Postdoctoral Fellowships; VIB Omics postdoctoral fellowship; Marie Sklodowska Curie Actions postdoctoral fellowship in FP7; Marie Sklodowska Curie Actions postdoctoral fellowship in Horizon 2020	ICM Big Brain Theory Program; program "Investissements d'avenir"(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); Einstein-BIH program; Paul G. Allen Frontiers Group; VIB; WiBrain Interuniversity Attraction Pole network (Belspo); FLiACT Marie-Curie Initial Training Network (FP7/2007-2013); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); FU Berlin; EMBO Long Term Postdoctoral Fellowships; VIB Omics postdoctoral fellowship; Marie Sklodowska Curie Actions postdoctoral fellowship in FP7; Marie Sklodowska Curie Actions postdoctoral fellowship in Horizon 2020	This work was supported by the ICM Big Brain Theory Program, the program "Investissements d'avenir" (ANR-10-IAIHU-06), an ANR grant (ANR-19-CE16-0009-01), The Einstein-BIH program, the Paul G. Allen Frontiers Group, VIB, the WiBrain Interuniversity Attraction Pole network (Belspo), the FLiACT Marie-Curie Initial Training Network (FP7/2007-2013) (to B.A.H.), NIH (R01EY018884) and the German Research Foundation (DFG: SFB 958, SFB186) (to P.R.H.), FU Berlin (to P.R.H. and M.W.), as well as EMBO Long Term Postdoctoral Fellowships (to G.A.L. and R.K.E.), VIB Omics postdoctoral fellowship (to R.K.E.), and the Marie Sklodowska Curie Actions postdoctoral fellowship in FP7 and Horizon 2020. Further support for G.A.L. was provided by FU Berlin (to P.R.H.). B.A.H. is an Allen Distinguished Investigator and a BIH-Einstein Visiting Fellow.	Allen JS, 2002, AM J PHYS ANTHROPOL, V118, P341, DOI 10.1002/ajpa.10092; Ayroles JF, 2015, P NATL ACAD SCI USA, V112, P6706, DOI 10.1073/pnas.1503830112; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; BAUSENWEIN B, 1986, J NEUROGENET, V3, P87, DOI 10.3109/01677068609106897; Bohm RA, 2010, P NATL ACAD SCI USA, V107, P16378, DOI 10.1073/pnas.1004669107; Buchanan SM, 2015, P NATL ACAD SCI USA, V112, P6700, DOI 10.1073/pnas.1500804112; BUDNIK V, 1990, J NEUROSCI, V10, P3754; BULTHOFF H, 1982, BIOL CYBERN, V45, P71, DOI 10.1007/BF00387216; BULTHOFF H, 1982, J COMP PHYSIOL, V148, P471; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; Colomb J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042247; Evans JD, 1996, STRAIGHTFORWARD STAT, pxxii; Fisher DN, 2018, ANIM BEHAV, V138, pE1, DOI 10.1016/j.anbehav.2018.02.015; Franken TP, 2015, NAT NEUROSCI, V18, P444, DOI 10.1038/nn.3948; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; GOODMAN CS, 1978, J COMP NEUROL, V182, P681, DOI 10.1002/cne.901820408; Gosling SD, 2008, SOC PERSONAL PSYCHOL, V2, P985, DOI 10.1111/j.1751-9004.2008.00087.x; GOTZ KG, 1975, NATURWISSENSCHAFTEN, V62, P468; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Han C, 2011, P NATL ACAD SCI USA, V108, P9673, DOI 10.1073/pnas.1106386108; HARDELAND R, 1971, J INSECT PHYSIOL, V17, P427, DOI 10.1016/0022-1910(71)90022-9; Hassan BA, 2000, NEURON, V25, P549, DOI 10.1016/S0896-6273(00)81059-4; Hiesinger PR, 2018, TRENDS NEUROSCI, V41, P577, DOI 10.1016/j.tins.2018.05.007; Honegger K, 2018, CURR BIOL, V28, pR8, DOI 10.1016/j.cub.2017.11.058; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Kain JS, 2012, P NATL ACAD SCI USA, V109, P19834, DOI 10.1073/pnas.1211988109; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Langen M, 2015, CELL, V162, P120, DOI 10.1016/j.cell.2015.05.055; Langen M, 2013, ELIFE, V2, DOI 10.7554/eLife.00337; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Linneweber GA, 2014, CELL, V156, P69, DOI 10.1016/j.cell.2013.12.008; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Marder E, 2012, NEURON, V76, P1, DOI 10.1016/j.neuron.2012.09.010; Mohr A, 2004, COGNITIVE BRAIN RES, V20, P106, DOI 10.1016/j.cogbrainres.2004.02.001; Ozel MN, 2015, ELIFE, V4, DOI 10.7554/eLife.10721; Otsuna H, 2006, J COMP NEUROL, V497, P928, DOI 10.1002/cne.21015; PAKKENBERG H, 1964, ACTA ANAT, V56, P297; Pantoja C, 2016, NEURON, V91, P587, DOI 10.1016/j.neuron.2016.06.016; Poe AR, 2017, P NATL ACAD SCI USA, V114, pE8062, DOI 10.1073/pnas.1707467114; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; REICHARDT W, 1973, NATURWISSENSCHAFTEN, V60, P122, DOI 10.1007/BF00594781; Renart A, 2014, CURR OPIN NEUROBIOL, V25, P211, DOI 10.1016/j.conb.2014.02.013; Schuett W, 2011, DEV PSYCHOBIOL, V53, P631, DOI 10.1002/dev.20538; Stern S, 2017, CELL, V171, P1649, DOI 10.1016/j.cell.2017.10.041; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Talay M, 2017, NEURON, V96, P783, DOI 10.1016/j.neuron.2017.10.011; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Vogt G, 2008, J EXP BIOL, V211, P510, DOI 10.1242/jeb.008755; Vollmer J, 2016, DEVELOPMENT, V143, P1482, DOI 10.1242/dev.129775; White TJH, 2019, J AM ACAD CHILD PSY, V58, P1042, DOI 10.1016/j.jaac.2019.02.010; Zheng XY, 2006, EMBO J, V25, P615, DOI 10.1038/sj.emboj.7600962; Zimmermann G., 1975, THESIS; Zschatzsch M, 2014, ELIFE, V3, DOI 10.7554/eLife.01699	54	41	41	6	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1112	+		10.1126/science.aaw7182	http://dx.doi.org/10.1126/science.aaw7182			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9CD	32139539	Green Submitted			2022-12-28	WOS:000520018400038
J	Ahdoot, M; Wilbur, AR; Reese, SE; Lebastchi, AH; Mehralivand, S; Gomella, PT; Bloom, J; Gurram, S; Siddiqui, M; Pinsky, P; Parnes, H; Linehan, WM; Merino, M; Choyke, PL; Shih, JNH; Turkbey, B; Wood, BJ; Pinto, PA				Ahdoot, Michael; Wilbur, Andrew R.; Reese, Sarah E.; Lebastchi, Amir H.; Mehralivand, Sherif; Gomella, Patrick T.; Bloom, Jonathan; Gurram, Sandeep; Siddiqui, Minhaj; Pinsky, Paul; Parnes, Howard; Linehan, W. Marston; Merino, Maria; Choyke, Peter L.; Shih, Joanna H.; Turkbey, Baris; Wood, Bradford J.; Pinto, Peter A.			MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACTIVE-SURVEILLANCE; RADICAL PROSTATECTOMY; INTERNATIONAL SOCIETY; CONFIDENCE-INTERVALS; ISUP CONSENSUS; MANAGEMENT; OUTCOMES	Background The use of 12-core systematic prostate biopsy is associated with diagnostic inaccuracy that contributes to both overdiagnosis and underdiagnosis of prostate cancer. Biopsies performed with magnetic resonance imaging (MRI) targeting may reduce the misclassification of prostate cancer in men with MRI-visible lesions. Methods Men with MRI-visible prostate lesions underwent both MRI-targeted and systematic biopsy. The primary outcome was cancer detection according to grade group (i.e., a clustering of Gleason grades). Grade group 1 refers to clinically insignificant disease; grade group 2 or higher, cancer with favorable intermediate risk or worse; and grade group 3 or higher, cancer with unfavorable intermediate risk or worse. Among the men who underwent subsequent radical prostatectomy, upgrading and downgrading of grade group from biopsy to whole-mount histopathological analysis of surgical specimens were recorded. Secondary outcomes were the detection of cancers of grade group 2 or higher and grade group 3 or higher, cancer detection stratified by previous biopsy status, and grade reclassification between biopsy and radical prostatectomy. Results A total of 2103 men underwent both biopsy methods; cancer was diagnosed in 1312 (62.4%) by a combination of the two methods (combined biopsy), and 404 (19.2%) underwent radical prostatectomy. Cancer detection rates on MRI-targeted biopsy were significantly lower than on systematic biopsy for grade group 1 cancers and significantly higher for grade groups 3 through 5 (P<0.01 for all comparisons). Combined biopsy led to cancer diagnoses in 208 more men (9.9%) than with either method alone and to upgrading to a higher grade group in 458 men (21.8%). However, if only MRI-target biopsies had been performed, 8.8% of clinically significant cancers (grade group >= 3) would have been misclassified. Among the 404 men who underwent subsequent radical prostatectomy, combined biopsy was associated with the fewest upgrades to grade group 3 or higher on histopathological analysis of surgical specimens (3.5%), as compared with MRI-targeted biopsy (8.7%) and systematic biopsy (16.8%). Conclusions Among patients with MRI-visible lesions, combined biopsy led to more detection of all prostate cancers. However, MRI-targeted biopsy alone underestimated the histologic grade of some tumors. After radical prostatectomy, upgrades to grade group 3 or higher on histopathological analysis were substantially lower after combined biopsy. (Funded by the National Institutes of Health and others; Trio Study ClinicalTrials.gov number, .) In this study involving 2103 men with elevated PSA levels, the use of both MRI-targeted and 12-core systematic biopsies was more effective at detecting clinically significant prostate cancers than either biopsy method alone.	[Ahdoot, Michael; Wilbur, Andrew R.; Lebastchi, Amir H.; Gomella, Patrick T.; Bloom, Jonathan; Gurram, Sandeep; Siddiqui, Minhaj; Linehan, W. Marston; Pinto, Peter A.] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA; [Reese, Sarah E.; Shih, Joanna H.] NCI, Biometr Res Program, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA; [Mehralivand, Sherif; Choyke, Peter L.; Turkbey, Baris] NCI, Mol Imaging Program, NIH, Bethesda, MD 20892 USA; [Merino, Maria] NCI, Translat Surg Pathol Sect, NIH, Bethesda, MD 20892 USA; [Pinsky, Paul; Parnes, Howard] NCI, Ctr Canc Res, Div Canc Prevent, NIH, Bethesda, MD 20892 USA; [Wood, Bradford J.] NCI, Ctr Intervent Oncol, NIH, Bethesda, MD 20892 USA; [Wood, Bradford J.] NCI, Intervent Radiol Radiol & Imaging Sci, Natl Inst Hlth Clin Ctr, NIH, Bethesda, MD 20892 USA; [Siddiqui, Minhaj] Univ Maryland, Sch Med, Dept Surg, Div Urol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore	Pinto, PA (corresponding author), NCI, 10 Ctr Dr,Bldg 10,Rm 2W-5940, Baltimore, MD 20892 USA.	pintop@mail.nih.gov	Mehralivand, Sherif/AAS-7841-2021; Gomella, Patrick/M-4978-2019; Wood, Bradford/M-7995-2017	Mehralivand, Sherif/0000-0003-1405-3683; Gomella, Patrick/0000-0002-2162-8150; Wood, Bradford/0000-0002-4297-0051	Intramural Research Program of the NIH; National Cancer Institute; Center for Cancer Research; NIH Clinical Center; NIH Center for Interventional Oncology; Philips; Dr. Mildred Scheel Foundation for Cancer Research	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center for Interventional Oncology; Philips; Dr. Mildred Scheel Foundation for Cancer Research(Deutsche Krebshilfe)	Supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, NIH Clinical Center, and NIH Center for Interventional Oncology; by Philips, which provided materials and technical support as part of a Cooperative Research and Development Agreement; and by a research grant (to Dr. Mehralivand) from the Dr. Mildred Scheel Foundation for Cancer Research.	Agresti A, 2000, AM STAT, V54, P280, DOI 10.2307/2685779; Agresti A, 2005, STAT MED, V24, P729, DOI 10.1002/sim.1781; Ahmed HU, 2017, LANCET, V389, P815, DOI 10.1016/S0140-6736(16)32401-1; Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; American Cancer Society, 2019, CANC FACTS FIG 2019; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; Antar E, 2019, ENERGIES, V12, DOI 10.3390/en12081446; Bill-Axelson A, 2018, NEW ENGL J MED, V379, P2319, DOI 10.1056/NEJMoa1807801; Bittner N, 2018, AM J CLIN ONCOL-CANC, V41, P723, DOI 10.1097/COC.0000000000000352; Bittner N, 2013, J UROLOGY, V190, P509, DOI 10.1016/j.juro.2013.02.021; Bjurlin MA, 2013, J UROLOGY, V189, P2039, DOI 10.1016/j.juro.2013.02.072; Calio BP, 2018, J UROLOGY, V199, P976, DOI 10.1016/j.juro.2017.10.048; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Egevad L, 2016, APMIS, V124, P433, DOI 10.1111/apm.12533; Epstein JI, 2016, AM J SURG PATHOL, V40, P244, DOI 10.1097/PAS.0000000000000530; Epstein JI, 2016, EUR UROL, V69, P428, DOI 10.1016/j.eururo.2015.06.046; Epstein JI, 2012, EUR UROL, V61, P1019, DOI 10.1016/j.eururo.2012.01.050; Exterkate L, 2019, EUR UROL ONCOL; Filson CP, 2016, CANCER-AM CANCER SOC, V122, P884, DOI 10.1002/cncr.29874; Fulgham PF, 2017, J UROLOGY, V198, P832, DOI 10.1016/j.juro.2017.04.101; Gaur S, 2018, J MAGN RESON IMAGING, V48, P1326, DOI 10.1002/jmri.26025; Godtman RA, 2013, EUR UROL, V63, P101, DOI 10.1016/j.eururo.2012.08.066; Hamdy FC, 2016, NEW ENGL J MED, V375, P1415, DOI 10.1056/NEJMoa1606220; He JM, 2017, EUR UROL, V71, P760, DOI 10.1016/j.eururo.2016.11.031; Johnson DC, 2019, EUR UROL, V75, P712, DOI 10.1016/j.eururo.2018.11.031; Kasivisvanathan V, 2018, NEW ENGL J MED, V378, P1767, DOI 10.1056/NEJMoa1801993; Kasivisvanathan V, 2018, NEW ENGL J MED, V379, P589, DOI 10.1056/NEJMc1807507; Klotz L, 2019, EUR UROL, V75, P300, DOI 10.1016/j.eururo.2018.06.025; Klotz L, 2015, J CLIN ONCOL, V33, P272, DOI 10.1200/JCO.2014.55.1192; Meng XS, 2018, J UROLOGY, V200, P1022, DOI 10.1016/j.juro.2018.06.012; Moore CM, 2013, EUR UROL, V64, P544, DOI 10.1016/j.eururo.2013.03.030; Osses Daniel F, 2018, Curr Urol, V11, P182, DOI 10.1159/000447216; Panebianco V, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2014.09.013; Pierorazio PM, 2013, BJU INT, V111, P753, DOI 10.1111/j.1464-410X.2012.11611.x; Rais-Bahrami S, 2013, J UROLOGY, V190, P1721, DOI 10.1016/j.juro.2013.05.052; Rouviere O, 2019, LANCET ONCOL, V20, P100, DOI 10.1016/S1470-2045(18)30569-2; Siddiqui MM, 2015, JAMA-J AM MED ASSOC, V313, P390, DOI 10.1001/jama.2014.17942; Tosoian JJ, 2015, J CLIN ONCOL, V33, P3379, DOI 10.1200/JCO.2015.62.5764; Turkbey B, 2013, RADIOLOGY, V268, P144, DOI 10.1148/radiol.13121325; Walz J, 2006, EUR UROL, V50, P498, DOI 10.1016/j.eururo.2006.03.026; Weinreb JC, 2016, EUR UROL, V69, P16, DOI 10.1016/j.eururo.2015.08.052; Yerram NK, 2012, BJU INT, V110, pE783, DOI 10.1111/j.1464-410X.2012.11646.x	42	320	327	7	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2020	382	10					917	928		10.1056/NEJMoa1910038	http://dx.doi.org/10.1056/NEJMoa1910038			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KT7TC	32130814	Green Accepted, Bronze			2022-12-28	WOS:000519214900007
J	Oliver, D				Oliver, David			David Oliver: Social care-back to an uncertain future	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Department of Health, 2000, NHS PLAN A PLAN INV; Department of Health and Social Care, 2010, BUILD NAT CAR SERV; Hemmings N., 2020, PUBLIC POLICY BLIND; King's Fund, 2019, WHATS YOUR PROBL SOC; King's Fund, 2011, DILN COMM REP SOC CA; Mason R., 2017, GUARDIAN; Oliver D, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2745; Royal Commission on Long Term Care, 1999, RESP OLD AG LONG TER; The King's Fund, 2019, KEY FACTS FIG AD SOC; Watt N, 2010, SPECTRE DEATH TAX HA; Weaver M, 2017, GUARDIAN; Zeffman H., 2020, TIMES	12	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2020	368								m761	10.1136/bmj.m761	http://dx.doi.org/10.1136/bmj.m761			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KE	32132094	Bronze			2022-12-28	WOS:000519536600007
J	Chatterjee, P				Chatterjee, Patralekha			Indian pharma threatened by COVID-19 shutdowns in China	LANCET			English	Editorial Material																			0	28	30	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 29	2020	395	10225					675	675						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KQ2JO	32113494	Green Published, Bronze			2022-12-28	WOS:000516755200013
J	Moberly, T				Moberly, Tom			Covid-19: school closures and bans on mass gatherings will need to be considered, says England's CMO	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	4	4	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2020	368								m806	10.1136/bmj.m806	http://dx.doi.org/10.1136/bmj.m806			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KA	32111656	Bronze			2022-12-28	WOS:000519536200013
J	Wade, L				Wade, Lizzie			THE ARRIVAL OF STRANGERS	SCIENCE			English	Editorial Material																			0	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2020	367	6481					968	973		10.1126/science.367.6481.968	http://dx.doi.org/10.1126/science.367.6481.968			0	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KS0CO	32108098				2022-12-28	WOS:000517979600016
J	Pazhenkottil, AP; Bode, PK				Pazhenkottil, Aju P.; Bode, Peter K.			Angiosarcoma Involving the Heart	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 66-year-old man presented with a 4-day history of shortness of breath and swelling in the legs. Transthoracic echocardiography and computed tomography of the chest revealed a mass in the right atrium, and a diagnosis of angiosarcoma was made.	[Pazhenkottil, Aju P.; Bode, Peter K.] Univ Hosp Zurich, Zurich, Switzerland	University of Zurich; University Zurich Hospital	Pazhenkottil, AP (corresponding author), Univ Hosp Zurich, Zurich, Switzerland.	aju.pazhenkottil@usz.ch		Pazhenkottil, Aju/0000-0002-8847-2154					0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2020	382	9					855	855		10.1056/NEJMicm1910259	http://dx.doi.org/10.1056/NEJMicm1910259			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KS8TT	32101667	Green Accepted			2022-12-28	WOS:000518581500011
J	Day, M				Day, Michael			Covid-19: Italy confirms 11 deaths as cases spread from north	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2020	368								m757	10.1136/bmj.m757	http://dx.doi.org/10.1136/bmj.m757			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2JV	32102793	Bronze			2022-12-28	WOS:000519535600012
J	Spence, D				Spence, Des			Des Spence: Why #healthbeliefs should be top of all our communications	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2020	368								m695	10.1136/bmj.m695	http://dx.doi.org/10.1136/bmj.m695			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2JV	32102834	Bronze			2022-12-28	WOS:000519535600005
J	Jones, DS				Jones, David S.			History in a Crisis - Lessons for Covid-19	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The history of human responses to epidemics carries various lessons for our current situation. Two of the more disheartening ones are that stigmatization follows closely on the heels of pathogens and that outbreaks too often claim the lives of health care providers. The article is accompanied by a slide show.	[Jones, David S.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Jones, David S.] Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Jones, DS (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA.; Jones, DS (corresponding author), Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA.			Jones, David/0000-0003-0039-7784				Brandt Allan M, 1985, NO MAGIC BULLET SOCI; Burnet M., 1972, NATURAL HIST INFECT; Li J., 2014, J CHINA RAILWAY SOC, V36, P38, DOI [10.3969/j.issn.1001-8361.2014.03.007, DOI 10.3969/J.ISSN.1001-8361.2014.03.007]; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; ROSENBERG CE, 1989, DAEDALUS-US, V118, P1	5	171	177	3	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2020	382	18					1681	1683		10.1056/NEJMp2004361	http://dx.doi.org/10.1056/NEJMp2004361			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LL1YQ	32163699	Bronze			2022-12-28	WOS:000531351300010
J	DeMets, DL; Psaty, BM; Fleming, TR				DeMets, David L.; Psaty, Bruce M.; Fleming, Thomas R.			When Can Intermediate Outcomes Be Used as Surrogate Outcomes?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLINICAL-TRIALS; END-POINTS; ENDPOINTS	This JAMA Guide to Statistics and Methods reviews how and under what conditions surrogate outcomes can replace patient-centered outcomes in randomized trials and stresses the importance of properly validating outcomes as surrogates for direct measures of patient experiences.	[DeMets, David L.] Univ Wisconsin, Dept Biostat & Med Informat, 610 Walnut St,WARF Bldg,Second Floor, Madison, WI 53726 USA; [Psaty, Bruce M.] Univ Washington, Dept Med & Epidemiol, Seattle, WA 98195 USA; [Fleming, Thomas R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Wisconsin System; University of Wisconsin Madison; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	DeMets, DL (corresponding author), Univ Wisconsin, Dept Biostat & Med Informat, 610 Walnut St,WARF Bldg,Second Floor, Madison, WI 53726 USA.	demets@biostat.wisc.edu			National Institutes of Health (NIH) [R37-AI29168]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Work on this article was supported by National Institutes of Health (NIH) grant R37-AI29168 (Dr Fleming).	[Anonymous], 1989, NEW ENGL J MED, V321, P406; Barst RJ, 2012, CIRCULATION, V125, P324, DOI 10.1161/CIRCULATIONAHA.110.016667; Fleming TR, 2012, STAT MED, V31, P2973, DOI 10.1002/sim.5403; Fleming TR, 2005, HEALTH AFFAIR, V24, P67, DOI 10.1377/hlthaff.24.1.67; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; PRENTICE RL, 1989, STAT MED, V8, P431, DOI 10.1002/sim.4780080407; Ritchie G, 2018, JAMA ONCOL, V4, P522, DOI 10.1001/jamaoncol.2017.5236; WITTES J, 1989, STAT MED, V8, P415, DOI 10.1002/sim.4780080405	8	20	20	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1184	1185		10.1001/jama.2020.1176	http://dx.doi.org/10.1001/jama.2020.1176			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK4BZ	32105291				2022-12-28	WOS:000530807000021
J	Gou, LT; Lim, DH; Ma, WB; Aubol, BE; Hao, YJ; Wang, X; Zhao, J; Liang, ZY; Shao, CW; Zhang, X; Meng, F; Li, HR; Zhang, XR; Xu, RM; Li, DS; Rosenfeld, MG; Mellon, PL; Adams, JA; Liu, MF; Fu, XD				Gou, Lan-Tao; Lim, Do-Hwan; Ma, Wubin; Aubol, Brandon E.; Hao, Yajing; Wang, Xin; Zhao, Jun; Liang, Zhengyu; Shao, Changwei; Zhang, Xuan; Meng, Fan; Li, Hairi; Zhang, Xiaorong; Xu, Ruiming; Li, Dangsheng; Rosenfeld, Michael G.; Mellon, Pamela L.; Adams, Joseph A.; Liu, Mo-Fang; Fu, Xiang-Dong			Initiation of Parental Genome Reprogramming in Fertilized Oocyte by Splicing Kinase SRPK1-Catalyzed Protamine Phosphorylation	CELL			English	Article							PRE-MESSENGER-RNA; PROTEIN-KINASE; SPERM CHROMATIN; SR PROTEINS; IN-VITRO; GENE-EXPRESSION; SERINE-RICH; MOUSE; DECONDENSATION; NUCLEOPLASMIN	The paternal genome undergoes a massive exchange of histone with protamine for compaction into sperm during spermiogenesis. Upon fertilization, this process is potently reversed, which is essential for parental genome reprogramming and subsequent activation; however, it remains poorly understood how this fundamental process is initiated and regulated. Here, we report that the previously characterized splicing kinase SRPK1 initiates this life-beginning event by catalyzing site-specific phosphorylation of protamine, thereby triggering protamine-to-histone exchange in the fertilized oocyte. Interestingly, protamine undergoes a DNA-dependent phase transition to gel-like condensates and SRPK1-mediated phosphorylation likely helps open up such structures to enhance protamine dismissal by nucleoplasmin (NPM2) and enable the recruitment of HIRA for H3.3 deposition. Remarkably, genome-wide assay for transposase-accessible chromatin sequencing (ATAC-seq) analysis reveals that selective chromatin accessibility in both sperm and MII oocytes is largely erased in early pronuclei in a protamine phosphorylation-dependent manner, suggesting that SRPK1-catalyzed phosphorylation initiates a highly synchronized reorganization program in both parental genomes.	[Gou, Lan-Tao; Lim, Do-Hwan; Hao, Yajing; Liang, Zhengyu; Shao, Changwei; Zhang, Xuan; Meng, Fan; Li, Hairi; Fu, Xiang-Dong] Univ Calif San Diego, Inst Genom Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ma, Wubin; Rosenfeld, Michael G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; [Aubol, Brandon E.; Adams, Joseph A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Wang, Xin; Liu, Mo-Fang] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol,CAS Ctr Excelle, State Key Lab Mol Biol,Shanghai Key Lab Mol Andro, Shanghai 200031, Peoples R China; [Zhao, Jun; Mellon, Pamela L.] Univ Calif San Diego, Transgen & Knockout Mouse Core, La Jolla, CA 92093 USA; [Zhang, Xiaorong; Xu, Ruiming] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Li, Dangsheng] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Mellon, Pamela L.] Univ Calif San Diego, Dept Obstet Gynecol & Reprod Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; University of California System; University of California San Diego; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California San Diego	Fu, XD (corresponding author), Univ Calif San Diego, Inst Genom Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	xdfu@ucsd.edu	Shao, Changwei/AAV-1901-2021; Hao, Yajing/AGU-7499-2022; Wang, Xin/K-9666-2019; Lim, Dohwan/ABA-2685-2020; xu, rui/GRX-5734-2022	Shao, Changwei/0000-0002-4082-7200; Wang, Xin/0000-0003-3807-9319; Lim, Do-Hwan/0000-0002-2054-1416; Zhang, Xiaorong/0000-0002-6194-7746	NIH [GM067969, HG004659, P30 DK063491, P30 CA023100, P42 ES010337, GM052872]; NICHD [K99HD094901]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Dr. Christopher Akey of Boston University for the gift of NPM2 vectors; Dr. Peter Adams of Sanford Burnham Prebys Medical Discovery Institute for the gift of the HA-HIRA vector; Dr. Bang-An Wang of the Salk Institute, Dr. Man Zhang of GRMH-GDL, Dr. Chen Chu of Harvard Medical School, Drs. Ian Huggins and Marten Hoeksema of UC San Diego for helpful comments on manuscript and experimental assistance. The authors are grateful to members of the Fu lab for cooperation, reagent sharing, and insightful discussion. This project was supported by grants from NIH (GM052872 and HG004659 to X.-D.F.). J.Z. and P.L.M. were partially supported by NIH grants P30 DK063491, P30 CA023100, and P42 ES010337. B.E.A. and J.A.A. were supported by NIH grant GM067969. L.-T.G. and this research were supported by NICHD under award number K99HD094901.	ADENOT PG, 1991, MOL REPROD DEV, V28, P23, DOI 10.1002/mrd.1080280105; Aubol BE, 2012, BIOCHEMISTRY-US, V51, P6584, DOI 10.1021/bi300876h; BALHORN R, 1982, J CELL BIOL, V93, P298, DOI 10.1083/jcb.93.2.298; Balhorn R., 1989, MOL BIOL CHROMOSOME; Balhorn R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-227; Banuelos S, 2007, J BIOL CHEM, V282, P21213, DOI 10.1074/jbc.M702842200; Bouniol-Baly C, 1999, BIOL REPROD, V60, P580, DOI 10.1095/biolreprod60.3.580; Burns KH, 2003, SCIENCE, V300, P633, DOI 10.1126/science.1081813; CHIRAT F, 1993, BIOCHIM BIOPHYS ACTA, V1203, P109, DOI 10.1016/0167-4838(93)90043-Q; Colwill K, 1996, J BIOL CHEM, V271, P24569, DOI 10.1074/jbc.271.40.24569; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Dahl JA, 2016, NATURE, V537, P548, DOI 10.1038/nature19360; Ding JH, 2006, MOL BIOL CELL, V17, P876, DOI 10.1091/mbc.E05-10-0963; Du ZH, 2017, NATURE, V547, P232, DOI 10.1038/nature23263; Ellard Katherine, 2016, Biochem Biophys Rep, V6, P165, DOI 10.1016/j.bbrep.2016.04.002; Emelyanov AV, 2016, GENE DEV, V30, P2651, DOI 10.1101/gad.290916.116; FU XD, 1995, RNA, V1, P663; Giannakouros T, 2011, FEBS J, V278, P570, DOI 10.1111/j.1742-4658.2010.07987.x; Gou LT, 2017, CELL, V169, P1090, DOI 10.1016/j.cell.2017.04.034; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; Hall C, 2001, MOL CELL BIOL, V21, P1854, DOI 10.1128/MCB.21.5.1854-1865.2001; Hatcher JM, 2018, CELL CHEM BIOL, V25, P460, DOI 10.1016/j.chembiol.2018.01.013; Inoue A., 2014, PROTOC EXCH, DOI [10.1038/protex.2014.024, DOI 10.1038/PROTEX.2014.024.]; Inoue A, 2014, NAT STRUCT MOL BIOL, V21, P609, DOI 10.1038/nsmb.2839; Itoh K, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aao7232; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Jung YH, 2019, MOL CELL, V75, P154, DOI 10.1016/j.molcel.2019.04.014; Jung YH, 2017, CELL REP, V18, P1366, DOI 10.1016/j.celrep.2017.01.034; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Lavanchy G, 2019, CURR BIOL, V29, pR9, DOI 10.1016/j.cub.2018.11.046; Lee CH, 1999, MOL CELLS, V9, P556; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Leno GH, 1996, J BIOL CHEM, V271, P7253, DOI 10.1074/jbc.271.13.7253; Lin CJ, 2014, DEV CELL, V30, P268, DOI 10.1016/j.devcel.2014.06.022; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Link VM, 2018, CELL, V173, P1796, DOI 10.1016/j.cell.2018.04.018; Loppin B, 2005, NATURE, V437, P1386, DOI 10.1038/nature04059; Lu FL, 2016, CELL, V165, P1375, DOI 10.1016/j.cell.2016.05.050; Matsumoto K, 1999, MOL CELL BIOL, V19, P6940; Mo SD, 2013, TRANSCR-AUSTIN, V4, P251, DOI 10.4161/trns.26932; Nakagawa O, 2005, GENE DEV, V19, P2066, DOI 10.1101/gad.1338705; Okuwaki M, 2012, NUCLEIC ACIDS RES, V40, P4861, DOI 10.1093/nar/gks162; Oliva R, 2006, HUM REPROD UPDATE, V12, P417, DOI 10.1093/humupd/dml009; Papoutsopoulou S, 1999, NUCLEIC ACIDS RES, V27, P2972, DOI 10.1093/nar/27.14.2972; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; PHILPOTT A, 1991, CELL, V65, P569, DOI 10.1016/0092-8674(91)90089-H; PIRHONEN A, 1993, BIOL REPROD, V48, P821, DOI 10.1095/biolreprod48.4.821; PIRHONEN A, 1994, EUR J BIOCHEM, V223, P165, DOI 10.1111/j.1432-1033.1994.tb18979.x; Platonova O, 2011, BIOCHEMISTRY-US, V50, P8078, DOI 10.1021/bi2006652; Prado A, 2004, BIOCHEM CELL BIOL, V82, P437, DOI 10.1139/O04-042; Sato T, 2011, BIOL REPROD, V85, DOI 10.1095/biolreprod.110.089342; Shintomi K, 2017, SCIENCE, V356, P1284, DOI 10.1126/science.aam9702; Shintomi K, 2015, NAT CELL BIOL, V17, P1014, DOI 10.1038/ncb3187; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; Sztein JM, 2000, BIOL REPROD, V63, P1774, DOI 10.1095/biolreprod63.6.1774; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Wang PP, 2014, MOL CELL, V54, P378, DOI 10.1016/j.molcel.2014.03.007; Waterborg J. H., 2002, PROTEIN PROTOCOLS HD, P113; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Wu JY, 2018, NATURE, V557, P256, DOI 10.1038/s41586-018-0080-8; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; Xia WK, 2019, SCIENCE, V365, P353, DOI 10.1126/science.aaw5118; Xiao R, 2019, CELL, V178, P107, DOI 10.1016/j.cell.2019.06.001; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yamaguchi K, 2018, CELL REP, V23, P3920, DOI 10.1016/j.celrep.2018.05.094; Zhang BJ, 2016, NATURE, V537, P553, DOI 10.1038/nature19361; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016; Zhou LQ, 2015, TRENDS CELL BIOL, V25, P82, DOI 10.1016/j.tcb.2014.09.006; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z	75	25	25	4	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2020	180	6					1212	+		10.1016/j.cell.2020.02.020	http://dx.doi.org/10.1016/j.cell.2020.02.020			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KW1IO	32169215	Green Accepted, Bronze			2022-12-28	WOS:000520925300016
J	Swindells, S; Andrade-Villanueva, JF; Richmond, GJ; Rizzardini, G; Baumgarten, A; Masia, M; Latiff, G; Pokrovsky, V; Bredeek, F; Smith, G; Cahn, P; Kim, YS; Ford, SL; Talarico, CL; Patel, P; Chounta, V; Crauwels, H; Parys, W; Vanveggel, S; Mrus, J; Huang, J; Harrington, CM; Hudson, KJ; Margolis, DA; Smith, KY; Williams, PE; Spreen, WR				Swindells, Susan; Andrade-Villanueva, Jaime-Federico; Richmond, Gary J.; Rizzardini, Giuliano; Baumgarten, Axel; Masia, Mar; Latiff, Gulam; Pokrovsky, Vadim; Bredeek, Fritz; Smith, Graham; Cahn, Pedro; Kim, Yeon-Sook; Ford, Susan L.; Talarico, Christine L.; Patel, Parul; Chounta, Vasiliki; Crauwels, Herta; Parys, Wim; Vanveggel, Simon; Mrus, Joseph; Huang, Jenny; Harrington, Conn M.; Hudson, Krischan J.; Margolis, David A.; Smith, Kimberly Y.; Williams, Peter E.; Spreen, William R.			Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIRETROVIRAL THERAPY; PHASE 2B; ADULTS; DOLUTEGRAVIR; EFFICACY; SAFETY	Background Simplified regimens for the treatment of human immunodeficiency virus type 1 (HIV-1) infection may increase patient satisfaction and facilitate adherence. Methods In this phase 3, open-label, multicenter, noninferiority trial involving patients who had had plasma HIV-1 RNA levels of less than 50 copies per milliliter for at least 6 months while taking standard oral antiretroviral therapy, we randomly assigned participants (1:1) to either continue their oral therapy or switch to monthly intramuscular injections of long-acting cabotegravir, an HIV-1 integrase strand-transfer inhibitor, and long-acting rilpivirine, a nonnucleoside reverse-transcriptase inhibitor. The primary end point was the percentage of participants with an HIV-1 RNA level of 50 copies per milliliter or higher at week 48, determined with the use of the Food and Drug Administration snapshot algorithm. Results Treatment was initiated in 308 participants per group. At week 48, HIV-1 RNA levels of 50 copies per milliliter or higher were found in 5 participants (1.6%) receiving long-acting therapy and in 3 (1.0%) receiving oral therapy (adjusted difference, 0.6 percentage points; 95% confidence interval [CI], -1.2 to 2.5), a result that met the criterion for noninferiority for the primary end point (noninferiority margin, 6 percentage points). An HIV-1 RNA level of less than 50 copies per milliliter at week 48 was found in 92.5% of participants receiving long-acting therapy and in 95.5% of those receiving oral therapy (adjusted difference, -3.0 percentage points; 95% CI, -6.7 to 0.7), a result that met the criterion for noninferiority for this end point (noninferiority margin, -10 percentage points). Virologic failure was confirmed in 3 participants who received long-acting therapy and 4 participants who received oral therapy. Adverse events were more common in the long-acting-therapy group and included injection-site pain, which occurred in 231 recipients (75%) of long-acting therapy and was mild or moderate in most cases; 1% withdrew because of this event. Serious adverse events were reported in no more than 5% of participants in each group. Conclusions Monthly injections of long-acting cabotegravir and rilpivirine were noninferior to standard oral therapy for maintaining HIV-1 suppression. Injection-related adverse events were common but only infrequently led to medication withdrawal. (Funded by ViiV Healthcare and Janssen; ATLAS ClinicalTrials.gov number, NCT02951052.)	[Swindells, Susan] Univ Nebraska Med Ctr, Omaha, NE USA; [Andrade-Villanueva, Jaime-Federico] Univ Guadalajara, Ctr Univ Ciencias Salud, Guadalajara, Mexico; [Richmond, Gary J.] Broward Hlth Imperial Point, Broward Hlth Med Ctr, Ft Lauderdale, FL USA; [Rizzardini, Giuliano] Fatebenefratelli Sacco Hosp, Milan, Italy; [Baumgarten, Axel] Ctr Infect Dis, Berlin, Germany; [Masia, Mar] Hosp Elche, Elche, Spain; [Latiff, Gulam] Maxwell Ctr, Durban, South Africa; [Pokrovsky, Vadim] Cent Res Inst Epidemiol, Moscow, Russia; [Bredeek, Fritz] Metropolis Med Grp, San Francisco, CA USA; [Smith, Graham] Maple Leaf Res, Toronto, ON, Canada; [Huang, Jenny] GlaxoSmithKline, Mississauga, ON, Canada; [Cahn, Pedro] Fdn Huesped, Buenos Aires, DF, Argentina; [Kim, Yeon-Sook] Chungnam Natl Univ, Sch Med, Daejeon, South Korea; [Ford, Susan L.] GlaxoSmithKline, Res Triangle Pk, NC USA; [Talarico, Christine L.; Patel, Parul; Mrus, Joseph; Harrington, Conn M.; Hudson, Krischan J.; Margolis, David A.; Smith, Kimberly Y.; Spreen, William R.] ViiV Healthcare, Res Triangle Pk, NC USA; [Chounta, Vasiliki] ViiV Healthcare, Brentford, England; [Crauwels, Herta; Parys, Wim; Vanveggel, Simon; Williams, Peter E.] Janssen Res & Dev, Beerse, Belgium	University of Nebraska System; University of Nebraska Medical Center; Universidad de Guadalajara; University of Milan; Luigi Sacco Hospital; GlaxoSmithKline; Chungnam National University; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Johnson & Johnson; Janssen Pharmaceuticals	Swindells, S (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, 988106 Nebraska Med Ctr, Omaha, NE 68198 USA.	sswindells@unmc.edu	Masia, Mar/U-7510-2017; Andrade-Villanueva, Jaime Federico/GPK-6845-2022	Masia, Mar/0000-0001-9878-2458; Kim, Yeon-Sook/0000-0003-1142-5488; Andrade-Villanueva, Jaime Federico/0000-0003-1948-655X	ViiV Healthcare; Janssen	ViiV Healthcare; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Supported by ViiV Healthcare and Janssen.	AIDSinfo, 2018, GUID US ANT AG AD AD; [Anonymous], 2019, ED RILP PRESCR INF; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Cohen CJ, 2012, JAIDS-J ACQ IMM DEF, V60, P33, DOI 10.1097/QAI.0b013e31824d006e; Crauwels HM, 2010, J INT AIDS SOC, V13, pP186; European Medicines Agency, 2000, POINTS CONS SWITCH S; FDA Center for Drug Evaluation and Research, 2015, HUM IMM VIR 1 INF DE; Flexner C, 2019, CURR OPIN HIV AIDS, V14, P13, DOI 10.1097/COH.0000000000000510; Gardner EA, 2008, AIDS, V22, P75, DOI 10.1097/QAD.0b013e3282f366ff; Kerrigan D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190487; Llibre JM, 2018, LANCET, V391, P839, DOI 10.1016/S0140-6736(17)33095-7; Margolis DA, 2017, LANCET, V390, P1499, DOI 10.1016/S0140-6736(17)31917-7; Margolis DA, 2015, LANCET INFECT DIS, V15, P1145, DOI 10.1016/S1473-3099(15)00152-8; National Institute of Allergy and Infectious Diseases, 2004, DIV AIDS TABL GRAD S; Oliveira M, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0440-3; Orkin C, 2020, NEW ENGL J MED, V382, P1124, DOI 10.1056/NEJMoa1909512; Ortego C, 2011, AIDS BEHAV, V15, P1381, DOI 10.1007/s10461-011-9942-x; Singh S, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-138; Spreen WR, 2013, CURR OPIN HIV AIDS, V8, P565, DOI 10.1097/COH.0000000000000002; Weld ED, 2019, JAIDS-J ACQ IMM DEF, V80, P190, DOI 10.1097/QAI.0000000000001896; Wensing AM, 2017, TOP ANTIVIR MED, V24, P132; Williams J, 2013, NANOMEDICINE-UK, V8, P1807, DOI 10.2217/nnm.12.214; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	23	159	162	2	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2020	382	12					1112	1123		10.1056/NEJMoa1904398	http://dx.doi.org/10.1056/NEJMoa1904398			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KW7AJ	32130809	Bronze			2022-12-28	WOS:000521333700011
J	Quiroz, FG; Fiore, VF; Levorse, J; Polak, L; Wong, E; Pasolli, HA; Fuchs, E				Quiroz, Felipe Garcia; Fiore, Vincent F.; Levorse, John; Polak, Lisa; Wong, Ellen; Pasolli, H. Amalia; Fuchs, Elaine			Liquid-liquid phase separation drives skin barrier formation	SCIENCE			English	Article							CRYSTAL-STRUCTURE; ATOPIC-DERMATITIS; KERATIN SCAFFOLD; PROTEIN; BEHAVIOR; TRANSITION; FILAGGRIN; ORGANIZATION; DROPLETS; GRANULES	At the body surface, skin's stratified squamous epithelium is challenged by environmental extremes. The surface of the skin is composed of enucleated, flattened surface squames. They derive from underlying, transcriptionally active keratinocytes that display filaggrin-containing keratohyalin granules (KGs) whose function is unclear. Here, we found that filaggrin assembles KGs through liquid-liquid phase separation. The dynamics of phase separation governed terminal differentiation and were disrupted by human skin barrier disease-associated mutations. We used fluorescent sensors to investigate endogenous phase behavior in mice. Phase transitions during epidermal stratification crowded cellular spaces with liquid-like KGs whose coalescence was restricted by keratin filament bundles. We imaged cells as they neared the skin surface and found that environmentally regulated KG phase dynamics drive squame formation. Thus, epidermal structure and function are driven by phase-separation dynamics.	[Quiroz, Felipe Garcia; Fiore, Vincent F.; Levorse, John; Polak, Lisa; Wong, Ellen; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Robin Chemers Neustein Lab Mammalian Cell Biol &, New York, NY 10065 USA; [Pasolli, H. Amalia] Rockefeller Univ, Electron Microscopy Resource Ctr, New York, NY 10065 USA; [Quiroz, Felipe Garcia] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Quiroz, Felipe Garcia] Emory Univ, Atlanta, GA 30322 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; University System of Georgia; Georgia Institute of Technology; Emory University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Robin Chemers Neustein Lab Mammalian Cell Biol &, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Pasolli, Hilda Amalia/0000-0003-3899-3530; Wong, Ellen/0000-0001-5183-2884; Fiore, Vincent/0000-0002-2828-766X; Garcia Quiroz, Felipe/0000-0001-6454-9615	NIH [R01AR27883]; Robertson Therapeutic Development Fund; Tri-Institutional Starr Stem Cell Scholars Fellowship at The Rockefeller University; Burroughs Wellcome Fund	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robertson Therapeutic Development Fund; Tri-Institutional Starr Stem Cell Scholars Fellowship at The Rockefeller University; Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was funded by NIH (R01AR27883 to E.F.) and partly supported by the Robertson Therapeutic Development Fund and by a Tri-Institutional Starr Stem Cell Scholars Fellowship at The Rockefeller University. E.F. is an HHMI investigator. F.G.Q. holds a Career Award at the Scientific Interface from Burroughs Wellcome Fund.	Alberti S, 2019, CELL, V176, P419, DOI 10.1016/j.cell.2018.12.035; Alberti S, 2018, MOL CELL, V69, P349, DOI 10.1016/j.molcel.2018.01.020; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Beutel O, 2019, CELL, V179, P923, DOI 10.1016/j.cell.2019.10.011; Bonnart C, 2010, J CLIN INVEST, V120, P871, DOI 10.1172/JCI41440; Boudko SP, 2009, J MOL BIOL, V392, P787, DOI 10.1016/j.jmb.2009.07.057; Bracha D, 2018, CELL, V175, P1467, DOI 10.1016/j.cell.2018.10.048; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; BRODY I, 1959, J ULTRA MOL STRUCT R, V3, P84, DOI 10.1016/S0022-5320(59)80018-6; Brown SJ, 2012, J INVEST DERMATOL, V132, P751, DOI 10.1038/jid.2011.393; Bunick CG, 2015, J INVEST DERMATOL, V135, P1801, DOI 10.1038/jid.2015.102; Cho WK, 2018, SCIENCE, V361, P412, DOI 10.1126/science.aar4199; Christensen T, 2013, BIOMACROMOLECULES, V14, P1514, DOI 10.1021/bm400167h; Dale B. A., 1994, KERATINOCYTE HDB, P323; Dzuricky M, 2018, BIOCHEMISTRY-US, V57, P2405, DOI 10.1021/acs.biochem.8b00056; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Ghoorchian A, 2011, BIOMACROMOLECULES, V12, P4022, DOI 10.1021/bm201031m; Gibson BA, 2019, CELL, V179, P470, DOI 10.1016/j.cell.2019.08.037; Hughes MP, 2018, SCIENCE, V359, P698, DOI 10.1126/science.aan6398; Jaubert J, 2004, J INVEST DERMATOL, V123, P313, DOI 10.1111/j.0022-202X.2004.23203.x; Jiang H, 2015, CELL, V163, P108, DOI 10.1016/j.cell.2015.08.010; Johnson DE, 2009, J BIOL CHEM, V284, P20499, DOI 10.1074/jbc.M109.019042; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; KARTASOVA T, 1993, J CELL BIOL, V120, P1251, DOI 10.1083/jcb.120.5.1251; Kumar V, 2015, J CELL BIOL, V211, P1057, DOI 10.1083/jcb.201404147; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee CH, 2012, NAT STRUCT MOL BIOL, V19, P707, DOI 10.1038/nsmb.2330; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Lo CA, 2015, CELL REP, V13, P2634, DOI 10.1016/j.celrep.2015.11.048; Maas-Szabowski N, 2003, J CELL SCI, V116, P2937, DOI 10.1242/jcs.00474; MacKay JA, 2010, BIOMACROMOLECULES, V11, P2873, DOI 10.1021/bm100571j; Makino T, 2001, J BIOL CHEM, V276, P47445, DOI 10.1074/jbc.M107512200; Margolis DJ, 2014, J ALLERGY CLIN IMMUN, V133, P784, DOI 10.1016/j.jaci.2013.09.015; Markmiller S, 2018, CELL, V172, P590, DOI 10.1016/j.cell.2017.12.032; McDaniel JR, 2010, BIOMACROMOLECULES, V11, P944, DOI 10.1021/bm901387t; McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106; Meszaros B, 2020, NUCLEIC ACIDS RES, V48, pD360, DOI 10.1093/nar/gkz848; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Nemoto-Hasebe I, 2009, BRIT J DERMATOL, V161, P1387, DOI 10.1111/j.1365-2133.2009.09406.x; Niesner R, 2005, PHARM RES, V22, P1079, DOI 10.1007/s11095-005-5304-6; Noda S, 2015, J ALLERGY CLIN IMMUN, V136, P1254, DOI 10.1016/j.jaci.2015.08.015; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; Nunn CM, 2005, J MOL BIOL, V350, P145, DOI 10.1016/j.jmb.2005.04.013; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Quiroz FG, 2015, NAT MATER, V14, P1164, DOI [10.1038/nmat4418, 10.1038/NMAT4418]; Rahrig S, 2019, ALLERGY, V74, P1327, DOI 10.1111/all.13756; Rai AK, 2018, NATURE, V559, P211, DOI 10.1038/s41586-018-0279-8; Rompolas P, 2016, SCIENCE, V352, P1471, DOI 10.1126/science.aaf7012; Rosenzweig ESF, 2017, CELL, V171, P148, DOI 10.1016/j.cell.2017.08.008; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Schmidt HB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12740-2; Schuster BS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05403-1; Scott DJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18045-y; Segre JA, 2006, J CLIN INVEST, V116, P1150, DOI 10.1172/JCI28521; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Steinert PM, 2003, J BIOL CHEM, V278, P41409, DOI 10.1074/jbc.M302037200; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Wan G, 2018, NATURE, V557, P679, DOI 10.1038/s41586-018-0132-0; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Wang W, 2017, NAT BIOTECHNOL, V35, P864, DOI 10.1038/nbt.3909; Wei MT, 2017, NAT CHEM, V9, P1118, DOI [10.1038/NCHEM.2803, 10.1038/nchem.2803]; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; Wong XFCC, 2018, J ALLERGY CLIN IMMUN, V141, P814, DOI 10.1016/j.jaci.2017.10.001	67	88	88	10	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1210	+	eaax9554	10.1126/science.aax9554	http://dx.doi.org/10.1126/science.aax9554			94	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9DP	32165560	Green Accepted			2022-12-28	WOS:000520023800032
J	O'Dowd, A				O'Dowd, Adrian			Budget 2020: pension changes mean most doctors won't be penalised for extra work	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		IACOBUCCI G, 2019, BMJ-BRIT MED J, V367, P44324, DOI DOI 10.1136/BMJ.L6463; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1001; Treasury HM, 2020, BUDGET 2020 DOCUMENT	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2020	368								m1042	10.1136/bmj.m1042	http://dx.doi.org/10.1136/bmj.m1042			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AU	32165368				2022-12-28	WOS:000520013500015
J	Campbell, JR; Winters, N; Menzies, D				Campbell, Jonathon R.; Winters, Nicholas; Menzies, Dick			Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INFECTION; QUALITY	OBJECTIVE To determine the annual rate of tuberculosis development after a positive tuberculin skin test (TST) or interferon-gamma release assay result (IGRA), or both, among untreated populations with characteristics believed to increase the risk of tuberculosis (at risk populations). DESIGN Systematic review and meta-analysis. DATA SOURCES Embase, Medline, and Cochrane Controlled Register of Trials from 1 January 1990 to 17 May 2019, for studies in humans published in English or French. Reference lists were reviewed. ELIGIBILITY CRITERIA AND DATA ANALYSIS Retrospective or prospective cohorts and randomised trials that included at least 10 untreated participants who tested positive to tuberculosis antigens (contained in TST or IGRA, or both) followed for at least 12 months. Following the preferred reporting items for systematic reviews and meta-analyses (PRISMA) and meta-analyses of observational studies in epidemiology (MOOSE) guidelines, two reviewers independently extracted study data and assessed quality using a modified quality assessment of diagnostic accuracy studies (QUADAS-2) tool. Data were pooled using random effects generalised linear mixed models. MAIN OUTCOME MEASURES The primary outcome was tuberculosis incidence per 1000 person years among untreated participants who tested positive (TST or IGRA, or both) in different at risk subgroups. Secondary outcomes were the cumulative incidence of tuberculosis and incidence rate ratios among participants with a positive test result for latent tuberculosis infection compared with those with a negative test result in at risk subgroups. RESULTS 122 of 5166 identified studies were included. In three general population studies, the incidence of tuberculosis among 33?811 participants with a TST induration of >= 10 mm was 0.3 (95% confidence interval 0.1 to 1.1) per 1000 person years. Among 116?197 positive test results for latent tuberculosis infection in 19 different at risk populations, incidence rates were consistently higher than those in the general population. Among all types of tuberculosis contacts, the incidence of tuberculosis was 17.0 (95% confidence interval 12.9 to 22.4) per 1000 person years for participants with a positive IGRA result and 8.4 (5.6 to 12.6) per 1000 person years for participants with a positive TST result of >= 5 mm. Among people living with HIV, the incidence of tuberculosis was 16.9 (10.5 to 27.3) for participants with a positive IGRA result and 27.1 (15.0 to 49.0) for participants with a positive TST result of >= 5 mm. Rates were also high for immigrants, people with silicosis or requiring dialysis, transplant recipients, and prisoners. Incidence rate ratios among test positive versus test negative participants were significantly greater than 1.0 in almost all risk groups, for all tests. CONCLUSIONS The incidence of tuberculosis is substantial in numerous at risk populations after a positive TST or IGRA result. The information from this review should help inform clinical decisions to test and treat for latent tuberculosis infection.	[Campbell, Jonathon R.; Winters, Nicholas; Menzies, Dick] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Campbell, Jonathon R.; Winters, Nicholas; Menzies, Dick] McGill Int TB Ctr, Montreal, PQ, Canada; [Menzies, Dick] Montreal Chest Inst, Montreal, PQ, Canada	McGill University; McGill University	Menzies, D (corresponding author), McGill Univ, Off 3D-58,5252 Blvd Maisonneuve O, Montreal, PQ H4A 3S5, Canada.	dick.menzies@mcgill.ca	Campbell, Jonathon/AAN-4252-2021	Campbell, Jonathon/0000-0003-2341-2166	Fonds de Recherche du Quebec Sante [258907]; Canadian Institutes of Health Research grant [FRD331745]	Fonds de Recherche du Quebec Sante(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR))	JRC is supported by a postdoctoral fellowship from the Fonds de Recherche du Quebec Sante (award #258907) and NW is supported through a Canadian Institutes of Health Research grant (FRD331745). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Andrade RJ, 2011, J ANTIMICROB CHEMOTH, V66, P1431, DOI 10.1093/jac/dkr159; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Atun R, 2010, LANCET, V375, P2169, DOI 10.1016/S0140-6736(10)60493-X; Auguste P, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2301-4; Australian Government Department of Health, 2015, CDNA NAT GUID PUBL H; Briggs MA, 2015, JAIDS-J ACQ IMM DEF, V68, pS297, DOI 10.1097/QAI.0000000000000497; Campbell JR, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002824; Campbell JR, 2019, AM J KIDNEY DIS, V73, P39, DOI 10.1053/j.ajkd.2018.07.014; Chaisson RE, 2010, J INFECT DIS, V201, P653, DOI 10.1086/650531; Chia S, 1998, INT J TUBERC LUNG D, V2, P989; Dobler CC, 2018, ERJ OPEN RES, V4, DOI 10.1183/23120541.00146-2017; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hamza TH, 2008, J CLIN EPIDEMIOL, V61, P41, DOI 10.1016/j.jclinepi.2007.03.016; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kiazyk S, 2017, Can Commun Dis Rep, V43, P62; Macaskill P, 2001, STAT MED, V20, P641, DOI 10.1002/sim.698; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mahomed H, 2006, INT J TUBERC LUNG D, V10, P310; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Mueller M, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0495-9; Munoz L, 2015, COLD SPRING HARB PER, V5, P5; National Institute for Health and Care Excellence, 2016, TUB GUID GUID; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Public Health Agency of Canada, 2014, CANADIAN TUBERCULOSI; Slovis BS, 2000, JAMA-J AM MED ASSOC, V283, P2003, DOI 10.1001/jama.283.15.2003; Spittal MJ, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0031-0; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tiruneh Gemechu, 2019, Interdiscip Perspect Infect Dis, V2019, P1413427, DOI 10.1155/2019/1413427; Van Leth F, 2008, B WORLD HEALTH ORGAN, V86, P20, DOI 10.2471/BLT.06.037804; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wilkinson D, 1998, BRIT MED J, V317, P625, DOI 10.1136/bmj.317.7159.625; World Health Organization, 2018, LAT TUB INF UPD CONS; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	40	35	36	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2020	368								m549	10.1136/bmj.m549	http://dx.doi.org/10.1136/bmj.m549			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AO	32156698	Green Published, hybrid			2022-12-28	WOS:000520012500001
J	Hong, F; Ma, D; Wu, KY; Mina, LA; Luiten, RC; Liu, Y; Yan, H; Green, AA				Hong, Fan; Ma, Duo; Wu, Kaiyue; Mina, Lida A.; Luiten, Rebecca C.; Liu, Yan; Yan, Hao; Green, Alexander A.			Precise and Programmable Detection of Mutations Using Ultraspecific Riboregulators	CELL			English	Article							GREEN FLUORESCENT PROTEIN; NUCLEIC-ACID DETECTION; ZIKA VIRUS; RNA MODIFICATIONS; MAMMALIAN-CELLS; GENE-EXPRESSION; REGULATORS; DESIGN; THERMODYNAMICS; PREDICTION	The ability to identify single-nucleotide mutations is critical for probing cell biology and for precise detection of disease. However, the small differences in hybridization energy provided by single-base changes makes identification of these mutations challenging in living cells and complex reaction environments. Here, we report a class of de novodesigned prokaryotic riboregulators that provide ultraspecific RNA detection capabilities in vivo and in cell-free transcription-translation reactions. These single-nucleotide-specific programmable riboregulators (SNIPRs) provide over 100-fold differences in gene expression in response to target RNAs differing by a single nucleotide in E. coli and resolve single epitranscriptomic marks in vitro. By exploiting the programmable SNIPR design, we implement an automated design algorithm to develop riboregulators for a range of mutations associated with cancer, drug resistance, and genetic disorders. Integrating SNIPRs with portable paper-based cell-free reactions enables convenient isothermal detection of cancer-associated mutations from clinical samples and identification of Zika strains through unambiguous colorimetric reactions.	[Hong, Fan; Ma, Duo; Wu, Kaiyue; Liu, Yan; Yan, Hao; Green, Alexander A.] Arizona State Univ, Biodesign Ctr Mol Design & Biomimet, Biodesign Inst, Tempe, AZ 85287 USA; [Hong, Fan; Ma, Duo; Wu, Kaiyue; Liu, Yan; Yan, Hao; Green, Alexander A.] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA; [Mina, Lida A.] Banner MD Anderson Canc Ctr, Hematol Oncol Dept, Gilbert, AZ 85234 USA; [Luiten, Rebecca C.] Banner MD Anderson Canc Ctr, Genet Dept, Gilbert, AZ 85234 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Banner Research; Banner Health; University of Texas System; UTMD Anderson Cancer Center; Banner Research; Banner Health; University of Texas System; UTMD Anderson Cancer Center	Yan, H; Green, AA (corresponding author), Arizona State Univ, Biodesign Ctr Mol Design & Biomimet, Biodesign Inst, Tempe, AZ 85287 USA.; Yan, H; Green, AA (corresponding author), Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA.	hao.yan@asu.edu; alexgreen@asu.edu	Liu, Yan/K-1999-2014; Green, Alexander/B-6512-2008	Liu, Yan/0000-0003-0906-2606; Hong, Fan/0000-0002-3370-7833; Green, Alexander/0000-0003-2058-1204	NIH Director's New Innovator Award [1DP2GM126892]; Gates Foundation [OPP1160667]; Arizona Biomedical Research Commission New Investigator Award [ADHS16-162400]; Alfred P. Sloan Fellowship [FG-2017-9108]; Gordon and Betty Moore Foundation [6984]; NIH [1R21AI136571]; DARPA Young Faculty Award [D17AP00026]; Arizona State University	NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gates Foundation(Bill & Melinda Gates Foundation); Arizona Biomedical Research Commission New Investigator Award; Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA Young Faculty Award; Arizona State University	This work was supported by funds to A.A.G. from an NIH Director's New Innovator Award (1DP2GM126892), the Gates Foundation (OPP1160667), an Arizona Biomedical Research Commission New Investigator Award (ADHS16-162400), an Alfred P. Sloan Fellowship (FG-2017-9108), Gordon and Betty Moore Foundation (6984), NIH (1R21AI136571), a DARPA Young Faculty Award (D17AP00026), and Arizona State University. The views, opinions, and/or findings contained in this article are those of the authors and should not be interpreted as representing the official views or policies, either expressed or implied, of the NIH, DARPA, or the Department of Defense.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; [Anonymous], 2018, SEER CANC STAT REV; Antoniou AC, 2005, J MED GENET, V42, P602, DOI 10.1136/jmg.2004.024133; Braselmann E, 2018, NAT CHEM BIOL, V14, P964, DOI 10.1038/s41589-018-0103-7; Chappell J, 2015, NAT CHEM BIOL, V11, P214, DOI 10.1038/nchembio.1737; Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245; Chen SX, 2016, J AM CHEM SOC, V138, P5076, DOI 10.1021/jacs.6b00277; Chen SX, 2013, NAT CHEM, V5, P782, DOI [10.1038/NCHEM.1713, 10.1038/nchem.1713]; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Dai Q, 2017, NAT METHODS, V14, P695, DOI 10.1038/nmeth.4294; Das R, 2010, NAT METHODS, V7, P291, DOI [10.1038/nmeth.1433, 10.1038/NMETH.1433]; Davis AR, 2007, BIOCHEMISTRY-US, V46, P13425, DOI 10.1021/bi701311c; Filonov GS, 2014, J AM CHEM SOC, V136, P16299, DOI 10.1021/ja508478x; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Green AA, 2017, METHODS MOL BIOL, V1632, P285, DOI 10.1007/978-1-4939-7138-1_19; Green AA, 2017, NATURE, V548, P117, DOI 10.1038/nature23271; Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002; Grunweller A, 2003, NUCLEIC ACIDS RES, V31, P3185, DOI 10.1093/nar/gkg409; Hanewich-Hollatz MH, 2019, ACS CENTRAL SCI, V5, P1241, DOI 10.1021/acscentsci.9b00340; Harrington LB, 2018, SCIENCE, V362, P839, DOI 10.1126/science.aav4294; Imwong M, 2017, LANCET INFECT DIS, V17, P1022, DOI 10.1016/S1473-3099(17)30524-8; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Kim J, 2019, NAT CHEM BIOL, V15, P1173, DOI 10.1038/s41589-019-0388-1; Lavickova B, 2019, ACS SYNTH BIOL, V8, P455, DOI 10.1021/acssynbio.8b00427; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Ma D, 2018, SYN BIOL, V3, DOI 10.1093/synbio/ysy018; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Miller V, 2000, AIDS, V14, P163, DOI 10.1097/00002030-200001280-00012; Mousavi PS, 2020, NAT CHEM, V12, P48, DOI 10.1038/s41557-019-0366-y; Mutalik VK, 2012, NAT CHEM BIOL, V8, P447, DOI [10.1038/NCHEMBIO.919, 10.1038/nchembio.919]; Myhrvold C, 2018, SCIENCE, V360, P444, DOI 10.1126/science.aas8836; Natoli ME, 2018, ANAL BIOCHEM, V544, P64, DOI 10.1016/j.ab.2017.12.008; Oesinghaus L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09953-w; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Panpradist N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145962; Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059; Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Pilling LC, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5222; Ranasinghe RT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02714-7; Rebbeck TR, 2015, JAMA-J AM MED ASSOC, V313, P1347, DOI 10.1001/jama.2014.5985; Roberts L, 2017, SCIENCE, V358, P155, DOI 10.1126/science.358.6360.155; Rodrigo G, 2012, P NATL ACAD SCI USA, V109, P15271, DOI 10.1073/pnas.1203831109; Roost C, 2015, J AM CHEM SOC, V137, P2107, DOI 10.1021/ja513080v; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Serra MJ, 1995, METHOD ENZYMOL, V259, P242; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Siu KH, 2019, NAT CHEM BIOL, V15, P217, DOI 10.1038/s41589-018-0186-1; Sulc P, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4881424; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; Takou D, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3871-0; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; Villarreal F, 2018, NAT CHEM BIOL, V14, P29, DOI [10.1038/NCHEMBIO.2514, 10.1038/nchembio.2514]; Wang JS, 2015, NAT CHEM, V7, P545, DOI [10.1038/NCHEM.2266, 10.1038/nchem.2266]; Weinreb C, 2016, CELL, V165, P963, DOI 10.1016/j.cell.2016.03.030; Xu HT, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-14; Xuan JJ, 2018, NUCLEIC ACIDS RES, V46, pD327, DOI 10.1093/nar/gkx934; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zhang DY, 2012, NAT CHEM, V4, P208, DOI [10.1038/NCHEM.1246, 10.1038/nchem.1246]; Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019; Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11	65	24	25	3	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2020	180	5					1018	+		10.1016/j.cell.2020.02.011	http://dx.doi.org/10.1016/j.cell.2020.02.011			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KT7JN	32109416	Green Published, hybrid			2022-12-28	WOS:000519189800018
J	Razai, MS; Doerholt, K; Ladhani, S; Oakeshott, P				Razai, Mohammad S.; Doerholt, Katja; Ladhani, Shamez; Oakeshott, Pippa			Coronavirus disease 2019 (covid-19): a guide for UK GPs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Razai, Mohammad S.; Oakeshott, Pippa] St George Univ London, Populat Hlth Res Inst, London, England; [Doerholt, Katja] St Georges Univ Hosp NHS Fdn Trust, London, England; [Ladhani, Shamez] Publ Hlth England, London, England	St Georges University London; Public Health England	Razai, MS (corresponding author), St George Univ London, Populat Hlth Res Inst, London, England.	mrazai@sgul.ac.uk	Razai, Mohammad S/AAW-4269-2020	Razai, Mohammad S/0000-0002-6671-5557; Oakeshott, Pippa/0000-0003-2568-8211				Briefing NHS, 2020, PRIM CAR PROV COR CO; Public Health England, 2020, COV 19 EP VIR CLIN F; Public Health England, COV 19 INT GUID PRIM; Public Health England, 2020, GUID NHS CLIN HOM IS; Public Health England Guidance, 2020, COVID 19 INVESTIGATI; Shen L, 2020, J MED ECON, V23, P456, DOI 10.1080/13696998.2020.1717500; WHO, 2020, COR DIS 2019 COV 19; Wu Z, 2020, JAMA	8	77	84	0	41	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2020	368								m800	10.1136/bmj.m800	http://dx.doi.org/10.1136/bmj.m800			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KI	32144127	Bronze, Green Accepted			2022-12-28	WOS:000519537000006
J	Auer, TO; Khallaf, MA; Silbering, AF; Zappia, G; Ellis, K; Alvarez-Ocana, R; Arguello, JR; Hansson, BS; Jefferis, GSXE; Caron, SJC; Knaden, M; Benton, R				Auer, Thomas O.; Khallaf, Mohammed A.; Silbering, Ana F.; Zappia, Giovanna; Ellis, Kaitlyn; Alvarez-Ocana, Raquel; Arguello, J. Roman; Hansson, Bill S.; Jefferis, Gregory S. X. E.; Caron, Sophie J. C.; Knaden, Markus; Benton, Richard			Olfactory receptor and circuit evolution promote host specialization	NATURE			English	Article							DROSOPHILA-SECHELLIA; REFERENCE PANEL; TOXIC FRUIT; ARCHITECTURE; SIMULANS; COMPLEX; CRISPR; DISSECTION; PREFERENCE; DIVERSITY	The evolution of animal behaviour is poorly understood(1,2). Despite numerous correlations between interspecific divergence in behaviour and nervous system structure and function, demonstrations of the genetic basis of these behavioural differences remain rare(3-5). Here we develop a neurogenetic model, Drosophila sechellia, a species that displays marked differences in behaviour compared to its close cousin Drosophila melanogaster(6,7), which are linked to its extreme specialization on noni fruit (Morinda citrifolia)(8-16). Using calcium imaging, we identify olfactory pathways in D. sechellia that detect volatiles emitted by the noni host. Our mutational analysis indicates roles for different olfactory receptors in long- and short-range attraction to noni, and our cross-species allele-transfer experiments demonstrate that the tuning of one of these receptors is important for species-specific host-seeking. We identify the molecular determinants of this functional change, and characterize their evolutionary origin and behavioural importance. We perform circuit tracing in the D. sechellia brain, and find that receptor adaptations are accompanied by increased sensory pooling onto interneurons as well as species-specific central projection patterns. This work reveals an accumulation of molecular, physiological and anatomical traits that are linked to behavioural divergence between species, and defines a model for investigating speciation and the evolution of the nervous system. A neurogenetic model, Drosophila sechellia-a relative of Drosophila melanogaster that has developed an extreme specialization for a single host plant-sheds light on the evolution of interspecific differences in behaviour.	[Auer, Thomas O.; Silbering, Ana F.; Zappia, Giovanna; Alvarez-Ocana, Raquel; Benton, Richard] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, Lausanne, Switzerland; [Khallaf, Mohammed A.; Hansson, Bill S.; Knaden, Markus] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany; [Ellis, Kaitlyn; Caron, Sophie J. C.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Arguello, J. Roman] Univ Lausanne, Fac Biol & Med, Dept Ecol & Evolut, Lausanne, Switzerland; [Jefferis, Gregory S. X. E.] MRC Lab Mol Biol, Div Neurobiol, Cambridge, England	University of Lausanne; Max Planck Society; Utah System of Higher Education; University of Utah; University of Lausanne; MRC Laboratory Molecular Biology	Auer, TO; Benton, R (corresponding author), Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, Lausanne, Switzerland.	Thomas.Auer@unil.ch; Richard.Benton@unil.ch	Hansson, Bill/G-2774-2013; Knaden, Markus/E-2151-2015	Hansson, Bill/0000-0002-4811-1223; Knaden, Markus/0000-0002-6710-1071; Auer, Thomas Oliver/0000-0003-3442-0567; Benton, Richard/0000-0003-4305-8301; Khallaf, Mohammed A./0000-0002-1402-3858; Arguello, J. Roman/0000-0001-7353-6023	National Institute of Health (NIH) [P40OD018537]; Human Frontier Science Program Long-Term Fellowship [LT000461/2015-L]; Max Planck Society; NIH [1 R01 NS 167970]; Eunice Kennedy Shriver National Institute of Child Health & Human Development Award of the NIH [5 T32 HD 007491]; Swiss National Science Professorship Grant [PP00P3 176956]; ERC Consolidator Grant [649111]; MRC [MC_U105188491]; ERC [615094, 833548]; Swiss National Science Foundation; Fondation Herbette	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); Max Planck Society(Max Planck SocietyFoundation CELLEX); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health & Human Development Award of the NIH; Swiss National Science Professorship Grant; ERC Consolidator Grant(European Research Council (ERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Herbette	We thank Y. Bellaiche, B. Deplancke, K. S. Douglas, S. Lavista-Llanos, K. O'Connor-Giles, J. Posakony, V. Ruta, D. Stern, G. Suh, A. Yassin, the Bloomington Drosophila Stock Center (National Institute of Health (NIH) P40OD018537) and the Developmental Studies Hybridoma Bank (NICHD of the NIH, University of Iowa) for reagents, B. Prud'homme for instruction on Drosophila microinjections, B. Sutcliffe and S. Cachero for advice on the generation of reference brains, I. Alali and K. Weniger for technical assistance, J. Simpson for details of the nSyb promoter construct; P. C. Chai for assistance with glomerular identification; and I. Rentero Rebollo, J. Sanchez-Alcaniz, L. Prieto-Godino and members of the Benton laboratory for discussions and comments on the manuscript. T.O.A. is supported by a Human Frontier Science Program Long-Term Fellowship (LT000461/2015-L). M.A.K., B.S.H. and M.K. are supported by the Max Planck Society. K.E. and S.J.C.C. are supported by a NIH Award (1 R01 NS 167970) and a Eunice Kennedy Shriver National Institute of Child Health & Human Development Award of the NIH (5 T32 HD 007491). J.R.A. is supported by a Swiss National Science Professorship Grant (PP00P3 176956). G.S.X.E.J. is supported by an ERC Consolidator Grant (649111) and the MRC (MC_U105188491). Research in R.B.'s laboratory is supported by ERC Consolidator and Advanced Grants (615094 and 833548, respectively), the Swiss National Science Foundation and the Fondation Herbette.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aguade M, 2009, MOL BIOL EVOL, V26, P61, DOI 10.1093/molbev/msn227; Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; AMBROSE D, 1975, J CHEM THERMODYN, V7, P453, DOI 10.1016/0021-9614(75)90275-X; Amlou M, 1998, BEHAV GENET, V28, P455, DOI 10.1023/A:1021689312582; Arguello JR, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0369-3; Arnoult L, 2013, SCIENCE, V339, P1423, DOI 10.1126/science.1233749; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Bateman JR, 2008, GENETICS, V180, P1763, DOI 10.1534/genetics.108.094508; Bendesky A, 2017, NATURE, V544, P434, DOI 10.1038/nature22074; Bendesky A, 2011, NAT REV GENET, V12, P809, DOI 10.1038/nrg3065; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton Richard, 2011, Cold Spring Harb Protoc, V2011, P824, DOI 10.1101/pdb.prot5630; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bumbarger DJ, 2013, CELL, V152, P109, DOI 10.1016/j.cell.2012.12.013; Butterwick JA, 2018, NATURE, V560, P447, DOI 10.1038/s41586-018-0420-8; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caron SJC, 2013, NATURE, V497, P113, DOI 10.1038/nature12063; COBB M, 1989, J INSECT BEHAV, V2, P63, DOI 10.1007/BF01053619; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; COYNE JA, 1992, GENET RES, V60, P25, DOI 10.1017/S0016672300030639; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Daubert T.E., 1997, PHYS THERMODYNAMIC P; Dekker T, 2006, CURR BIOL, V16, P101, DOI 10.1016/j.cub.2005.11.075; Ding Y, 2016, NATURE, V536, P329, DOI 10.1038/nature19093; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Dweck HKM, 2016, ELIFE, V5, DOI 10.7554/eLife.14925; Feng LQ, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0049-14.2014; Garrigan D, 2012, GENOME RES, V22, P1499, DOI 10.1101/gr.130922.111; Gohl DM, 2011, NAT METHODS, V8, P231, DOI 10.1038/NMETH.1561; Goldman-Huertas B, 2015, P NATL ACAD SCI USA, V112, P3026, DOI 10.1073/pnas.1424656112; Grabe V, 2018, BIOSYSTEMS, V164, P94, DOI 10.1016/j.biosystems.2017.10.010; Grabe V, 2016, CELL REP, V16, P3401, DOI 10.1016/j.celrep.2016.08.063; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Grenier JK, 2015, G3-GENES GENOM GENET, V5, P593, DOI 10.1534/g3.114.015883; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Han C, 2011, P NATL ACAD SCI USA, V108, P9673, DOI 10.1073/pnas.1106386108; HIGA I, 1993, GENETICA, V88, P129, DOI 10.1007/BF02424469; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Ibba I, 2010, NATURWISSENSCHAFTEN, V97, P1059, DOI 10.1007/s00114-010-0727-2; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Knecht ZA, 2016, ELIFE, V5, DOI 10.7554/eLife.17879; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Linz J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0626; Manton JD, 2014, BIORXIV, DOI [10.1101/006353, DOI 10.1101/006353]; Markow TA, 2008, FUNCT ECOL, V22, P747, DOI 10.1111/j.1365-2435.2008.01457.x; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Matute DR, 2014, J EVOLUTION BIOL, V27, P1057, DOI 10.1111/jeb.12391; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P7122, DOI 10.1073/pnas.0702133104; Ostrovsky Aaron, 2013, Cold Spring Harb Protoc, V2013, P342, DOI 10.1101/pdb.prot071720; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Port F, 2016, NAT METHODS, V13, P852, DOI 10.1038/nmeth.3972; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Prieto-Godino LL, 2017, NEURON, V93, P661, DOI 10.1016/j.neuron.2016.12.024; Prieto-Godino LL, 2016, NATURE, V539, P93, DOI 10.1038/nature19824; RKHA S, 1991, P NATL ACAD SCI USA, V88, P1835, DOI 10.1073/pnas.88.5.1835; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Saina Michael, 2013, Methods Mol Biol, V1003, P211, DOI 10.1007/978-1-62703-377-0_16; Sanchez-Alcaniz JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14192; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schrider DR, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007341; Seeholzer LF, 2018, NATURE, V559, P564, DOI 10.1038/s41586-018-0322-9; Shiao MS, 2015, GENOME BIOL EVOL, V7, P2843, DOI 10.1093/gbe/evv183; Signor SA, 2018, GENOME BIOL EVOL, V10, P189, DOI 10.1093/gbe/evx262; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; Stensmyr MC, 2003, P ROY SOC B-BIOL SCI, V270, P2333, DOI 10.1098/rspb.2003.2512; Stern DL, 2017, BIORXIV, DOI [10.1101/037762, DOI 10.1101/037762]; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Weber JN, 2013, NATURE, V493, P402, DOI 10.1038/nature11816; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; Yassin A, 2016, P NATL ACAD SCI USA, V113, P4771, DOI 10.1073/pnas.1522559113; Zhang X, 2014, G3-GENES GENOM GENET, V4, P2409, DOI 10.1534/g3.114.013979	83	68	69	4	141	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					402	+		10.1038/s41586-020-2073-7	http://dx.doi.org/10.1038/s41586-020-2073-7		MAR 2020	29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32132713	Green Accepted, Green Submitted			2022-12-28	WOS:000518098200006
J	Perry, RJ; Zhang, DY; Guerra, MT; Brill, AL; Goedeke, L; Nasiri, AR; Rabin-Court, A; Wang, YL; Peng, L; Dufour, S; Zhang, Y; Zhang, XM; Butrico, GM; Toussaint, K; Nozaki, Y; Cline, GW; Petersen, KF; Nathanson, MH; Ehrlich, BE; Shulman, GI				Perry, Rachel J.; Zhang, Dongyan; Guerra, Mateus T.; Brill, Allison L.; Goedeke, Leigh; Nasiri, Ali R.; Rabin-Court, Aviva; Wang, Yongliang; Peng, Liang; Dufour, Sylvie; Zhang, Ye; Zhang, Xian-Man; Butrico, Gina M.; Toussaint, Keshia; Nozaki, Yuichi; Cline, Gary W.; Petersen, Kitt Falk; Nathanson, Michael H.; Ehrlich, Barbara E.; Shulman, Gerald I.			Glucagon stimulates gluconeogenesis by INSP3R1-mediated hepatic lipolysis	NATURE			English	Article							RECEPTOR ANTAGONIST LY2409021; GLUCOSE-HOMEOSTASIS; INSULIN SENSITIVITY; ENDOGENOUS GLUCAGON; ADIPOSE-TISSUE; IMMUNONEUTRALIZATION; ACTIVATION; MECHANISM; PROTEIN; OB/OB	Although it is well-established that reductions in the ratio of insulin to glucagon in the portal vein have a major role in the dysregulation of hepatic glucose metabolism in type-2 diabetes(1-3), the mechanisms by which glucagon affects hepatic glucose production and mitochondrial oxidation are poorly understood. Here we show that glucagon stimulates hepatic gluconeogenesis by increasing the activity of hepatic adipose triglyceride lipase, intrahepatic lipolysis, hepatic acetyl-CoA content and pyruvate carboxylase flux, while also increasing mitochondrial fat oxidation-all of which are mediated by stimulation of the inositol triphosphate receptor 1 (INSP3R1). In rats and mice, chronic physiological increases in plasma glucagon concentrations increased mitochondrial oxidation of fat in the liver and reversed diet-induced hepatic steatosis and insulin resistance. However, these effects of chronic glucagon treatment-reversing hepatic steatosis and glucose intolerance-were abrogated in Insp3r1 (also known as Itpr1)-knockout mice. These results provide insights into glucagon biology and suggest that INSP3R1 may represent a target for therapies that aim to reverse nonalcoholic fatty liver disease and type-2 diabetes.	[Perry, Rachel J.; Zhang, Dongyan; Guerra, Mateus T.; Goedeke, Leigh; Nasiri, Ali R.; Rabin-Court, Aviva; Wang, Yongliang; Peng, Liang; Dufour, Sylvie; Zhang, Ye; Zhang, Xian-Man; Butrico, Gina M.; Toussaint, Keshia; Nozaki, Yuichi; Cline, Gary W.; Petersen, Kitt Falk; Nathanson, Michael H.; Shulman, Gerald I.] Yale Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Perry, Rachel J.; Brill, Allison L.; Ehrlich, Barbara E.; Shulman, Gerald I.] Yale Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Ehrlich, Barbara E.] Yale Sch Med, Dept Pharmacol, New Haven, CT USA	Yale University; Yale University; Yale University	Shulman, GI (corresponding author), Yale Sch Med, Dept Internal Med, New Haven, CT 06510 USA.; Shulman, GI (corresponding author), Yale Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA.	gerald.shulman@yale.edu	/AAX-8408-2021	/0000-0001-9657-9704; Brill, Allison/0000-0002-5046-3578; Wang, Yongliang/0000-0002-1494-0496; Guerra, Mateus/0000-0002-8187-2753; Perry, Rachel/0000-0003-0748-8064	United States Public Health Service [R01 DK113984, P30 DK059635, P30 DK034989, T32 DK101019, K99/R00 CA215315, R01 NS087568, UL1TR000142, T32 DK007058, F32 DK114954]	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service)	We thank M. Montminy, T. Sonntag and Y.-S. Yoon for kindly providing the CRTC2 antibody and control samples, and for their advice on the interpretation of the CRTC2 blots; H. S. Sui for generously providing the pATGL antibody; D. Vatner for his advice on these studies; and X. Ma, J. Dong, W. Zhu, M. Kahn, K. Harry and M. Batsu for their expert technical assistance. These studies were funded by grants from the United States Public Health Service (R01 DK113984, P30 DK059635, P30 DK034989, T32 DK101019, K99/R00 CA215315, R01 NS087568, UL1TR000142, T32 DK007058 and F32 DK114954). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRAND CL, 1994, DIABETOLOGIA, V37, P985, DOI 10.1007/BF00400461; Camporez JPG, 2015, J LIPID RES, V56, P526, DOI 10.1194/jlr.M054080; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P3099, DOI 10.1210/en.2013-1191; Feriod CN, 2017, HEPATOL COMMUN, V1, P23, DOI 10.1002/hep4.1012; Foster DW, 2012, J CLIN INVEST, V122, P1958, DOI 10.1172/JCI63967; Gravholt CH, 2001, J CLIN ENDOCR METAB, V86, P2085, DOI 10.1210/jc.86.5.2085; Guzman CB, 2017, DIABETES OBES METAB, V19, P1521, DOI 10.1111/dom.12958; Henderson SJ, 2016, DIABETES OBES METAB, V18, P1176, DOI 10.1111/dom.12735; JENSEN MD, 1991, J CLIN ENDOCR METAB, V72, P308, DOI 10.1210/jcem-72-2-308; Jurczak MJ, 2011, DIABETES, V60, P890, DOI 10.2337/db10-1328; Kadam Prashant, 2010, Int J Ayurveda Res, V1, P55, DOI 10.4103/0974-7788.59946; Kazda CM, 2017, DIABETES OBES METAB, V19, P1071, DOI 10.1111/dom.12904; Kazda CM, 2016, DIABETES CARE, V39, P1241, DOI 10.2337/dc15-1643; Liang Y, 2004, DIABETES, V53, pA134, DOI 10.2337/diabetes.53.2.410; LILJENQUIST JE, 1974, J CLIN INVEST, V53, P190, DOI 10.1172/JCI107537; Muller TD, 2017, PHYSIOL REV, V97, P721, DOI 10.1152/physrev.00025.2016; NICHOLS BJ, 1995, MOL CELL BIOCHEM, V149, P203, DOI 10.1007/BF01076578; Okamoto H, 2017, P NATL ACAD SCI USA, V114, P2753, DOI 10.1073/pnas.1621069114; Ozcan L, 2013, CELL METAB, V18, P803, DOI 10.1016/j.cmet.2013.10.011; Ozcan L, 2012, CELL METAB, V15, P739, DOI 10.1016/j.cmet.2012.03.002; Pagnon J, 2012, ENDOCRINOLOGY, V153, P4278, DOI 10.1210/en.2012-1127; Perry RJ, 2018, CELL, V172, P234, DOI 10.1016/j.cell.2017.12.001; Perry RJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01143-w; Perry RJ, 2017, J CLIN INVEST, V127, P657, DOI 10.1172/JCI88477; Perry RJ, 2016, J BIOL CHEM, V291, P12161, DOI 10.1074/jbc.M116.720631; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Petersen KF, 2019, J CLIN INVEST, V129, P4671, DOI 10.1172/JCI129913; Sloop KW, 2004, J CLIN INVEST, V113, P1571, DOI 10.1172/JCI200420911; Sorensen H, 2006, DIABETES, V55, P2843, DOI 10.2337/db06-0222; Unger R H, 1971, Adv Intern Med, V17, P265; UNGER RH, 1966, DIABETES, V15, P500, DOI 10.2337/diab.15.7.500; Wang YG, 2012, NATURE, V485, P128, DOI 10.1038/nature10988; WU MS, 1990, J CLIN ENDOCR METAB, V70, P410, DOI 10.1210/jcem-70-2-410; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	35	41	42	2	58	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7798					279	+		10.1038/s41586-020-2074-6	http://dx.doi.org/10.1038/s41586-020-2074-6		MAR 2020	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU0CC	32132708	Green Accepted			2022-12-28	WOS:000518098200008
J	Zhou, S; Carroll, E; Nicholson, S; Vize, CJ				Zhou, Sean; Carroll, Emma; Nicholson, Sandra; Vize, Colin J.			Blurred vision	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Zhou, Sean] Hlth Educ England, Colchester, Essex, England; [Carroll, Emma] Sheffield Teaching Hosp NHS Trust, Sheffield, S Yorkshire, England; [Nicholson, Sandra] Queen Mary Univ London, Barts & London, London, England; [Vize, Colin J.] Hull Univ Teaching Hosp NHS Trust, Kingston Upon Hull, N Humberside, England	University of Sheffield; University of London; Queen Mary University London	Vize, CJ (corresponding author), Hull Univ Teaching Hosp NHS Trust, Kingston Upon Hull, N Humberside, England.	colin.vize@hey.nhs.uk		Zhou, Sean/0000-0002-8953-8100				Dasgupta B, 2010, CLIN MED, V10, P381, DOI 10.7861/clinmedicine.10-4-381; Denniston A, 2014, OXFORD HDB OPHTHALMO, DOI [10.1093/med/9780199679980.001.0001, DOI 10.1093/MED/9780199679980.001.0001]; DVLA, DRIV EYES RUL; Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5; Fraser S, 2001, EYE KNOW; James B, 2011, LECT NOTES OPHTHALMO; Kanski J., 2007, CLIN OPHTHALMOLOGY S; National Institute for Health and Care Excellence, 2016, HYP AD DIAGN MAN CLI; Root T, 2018, OPHTHOBOOK; Royal College of Ophthalmologists, 2012, DIAB RET GUID; Royal College of Ophthalmologists, 2017, OPHTH SERV GUID EM E; Royal College of Ophthalmologists, 2019, PRIM CAR OPHTH CAR G; Willacy H, 2019, VIS PROBL BLURR VIS	13	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2020	368								m569	10.1136/bmj.m569	http://dx.doi.org/10.1136/bmj.m569			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KE	32132015				2022-12-28	WOS:000519536600005
J	Ledley, FD; McCoy, SS; Vaughan, G; Cleary, EG				Ledley, Fred D.; McCoy, Sarah Shonka; Vaughan, Gregory; Cleary, Ekaterina Galkina			Profitability of Large Pharmaceutical Companies Compared With Other Large Public Companies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DRUGS; COST	Question How do the profits of large pharmaceutical companies compare with those of other companies from the S&P 500 Index? Findings In this cross-sectional study that compared the profits of 35 large pharmaceutical companies with those of 357 large, nonpharmaceutical companies from 2000 to 2018, the median net income (earnings) expressed as a fraction of revenue was significantly greater for pharmaceutical companies compared with nonpharmaceutical companies (13.8% vs 7.7%). Meaning Large pharmaceutical companies were more profitable than other large companies, although the difference was smaller when controlling for differences in company size, research and development expense, and time trends. This study uses data from annual financial reports to compare the profitability of large pharmaceutical companies vs other large companies in the S&P 500 Index from 2000 to 2018, measured via gross profit; earnings before interest, taxes, depreciation, and amortization; and net income (earnings). Importance Understanding the profitability of pharmaceutical companies is essential to formulating evidence-based policies to reduce drug costs while maintaining the industry's ability to innovate and provide essential medicines. Objective To compare the profitability of large pharmaceutical companies with other large companies. Design, Setting, and Participants This cross-sectional study compared the annual profits of 35 large pharmaceutical companies with 357 companies in the S&P 500 Index from 2000 to 2018 using information from annual financial reports. A statistically significant differential profit margin favoring pharmaceutical companies was evidence of greater profitability. Exposures Large pharmaceutical vs nonpharmaceutical companies. Main Outcomes and Measures The main outcomes were revenue and 3 measures of annual profit: gross profit (revenue minus the cost of goods sold); earnings before interest, taxes, depreciation, and amortization (EBITDA; pretax profit from core business activities); and net income, also referred to as earnings (difference between all revenues and expenses). Profit measures are described as cumulative for all companies from 2000 to 2018 or annual profit as a fraction of revenue (margin). Results From 2000 to 2018, 35 large pharmaceutical companies reported cumulative revenue of $11.5 trillion, gross profit of $8.6 trillion, EBITDA of $3.7 trillion, and net income of $1.9 trillion, while 357 S&P 500 companies reported cumulative revenue of $130.5 trillion, gross profit of $42.1 trillion, EBITDA of $22.8 trillion, and net income of $9.4 trillion. In bivariable regression models, the median annual profit margins of pharmaceutical companies were significantly greater than those of S&P 500 companies (gross profit margin: 76.5% vs 37.4%; difference, 39.1% [95% CI, 32.5%-45.7%]; P < .001; EBITDA margin: 29.4% vs 19%; difference, 10.4% [95% CI, 7.1%-13.7%]; P < .001; net income margin: 13.8% vs 7.7%; difference, 6.1% [95% CI, 2.5%-9.7%]; P < .001). The differences were smaller in regression models controlling for company size and year and when considering only companies reporting research and development expense (gross profit margin: difference, 30.5% [95% CI, 20.9%-40.1%]; P < .001; EBITDA margin: difference, 9.2% [95% CI, 5.2%-13.2%]; P < .001; net income margin: difference, 3.6% [95% CI, 0.011%-7.2%]; P = .05). Conclusions and Relevance From 2000 to 2018, the profitability of large pharmaceutical companies was significantly greater than other large, public companies, but the difference was less pronounced when considering company size, year, or research and development expense. Data on the profitability of large pharmaceutical companies may be relevant to formulating evidence-based policies to make medicines more affordable.	[Ledley, Fred D.] Bentley Univ, Ctr Integrat Sci & Ind, Dept Nat & Appl Sci, Waltham, MA 02452 USA; [Ledley, Fred D.] Bentley Univ, Dept Management, Waltham, MA 02452 USA; [McCoy, Sarah Shonka] Bentley Univ, Dept Accountancy, Waltham, MA 02452 USA; [McCoy, Sarah Shonka] Univ New Mexico, Dept Accounting, Albuquerque, NM 87131 USA; [Vaughan, Gregory] Bentley Univ, Dept Math Sci, Waltham, MA 02452 USA; [Cleary, Ekaterina Galkina] Bentley Univ, Dept Math Sci, Ctr Integrat Sci & Ind, Waltham, MA 02452 USA	Bentley University; Bentley University; Bentley University; University of New Mexico; Bentley University; Bentley University	Ledley, FD (corresponding author), Bentley Univ, Ctr Integrat Sci & Ind, Jennison Hall 144,175 Forest St, Waltham, MA 02452 USA.	fledley@bentley.edu			National Biomedical Research Foundation	National Biomedical Research Foundation	This work was supported by the National Biomedical Research Foundation.	Anderson Richard, 2014, BBC NEWS; Angell M, 2000, NEW ENGL J MED, V342, P1902, DOI 10.1056/NEJM200006223422509; [Anonymous], GLOB PHARM SAL 2016; [Anonymous], 2018, CONC FRAM FIN REP; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Califf R, 2019, JAMA-J AM MED ASSOC, V321, P1571, DOI 10.1001/jama.2019.3846; Chen L, 2015, FORBES          1221; Dusetzina SB, 2019, JAMA-J AM MED ASSOC, V321, P1563, DOI 10.1001/jama.2019.2445; Kamal R., 2018, KAISER FAMILY FDN BL; Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V316, P858, DOI 10.1001/jama.2016.11237; Kinch MS, 2014, DRUG DISCOV TODAY, V19, P1033, DOI 10.1016/j.drudis.2014.03.018; Kirzinger A., 2019, KFF HLTH TRACKING PO; Koenker R., 2005, ECONOMETRIC SOC MONO; Lazonick William., 2017, 60 I NEW EC THINK; National Academies of Sciences Engineering Medicine, 2018, MAK MED AFF NAT IMP; Pisano G., 2006, SCI BUSINESS PROMISE; Sachs R, 2019, PRESCRIPTION DRUG PO; Sood N., 2017, FLOW MONEY PHARM DIS; US Government Accountability Office, 2017, DRUG IND PROF RES DE; Yu N, 2018, HLTH AFFAIRS BLOG, DOI 10.1377/hblog20180726.670593	20	45	45	3	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2020	323	9			SI		834	843		10.1001/jama.2020.0442	http://dx.doi.org/10.1001/jama.2020.0442			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU3SD	32125401	Bronze, Green Published			2022-12-28	WOS:000519630600014
J	Rubin, R				Rubin, Rita			Rebates-The Little-Known Factor Behind Increasing Drug List Prices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item								This Medical News story examines the role of rebates in drug pricing.											0	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2020	323	9			SI		812	813		10.1001/jama.2020.1208	http://dx.doi.org/10.1001/jama.2020.1208			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU3SD	32125400				2022-12-28	WOS:000519630600001
J	Aryal, DR				Aryal, Deb Raj			INTERCONTINENTAL CULTURE CLASH	NATURE			English	Editorial Material									[Aryal, Deb Raj] Autonomous Univ Chiapas, Mexico City, DF, Mexico	Universidad Autonoma de Chiapas	Aryal, DR (corresponding author), Autonomous Univ Chiapas, Mexico City, DF, Mexico.		Aryal, Deb Raj/E-6589-2019	Aryal, Deb Raj/0000-0003-4188-3084					0	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7798					310	310		10.1038/d41586-020-00537-z	http://dx.doi.org/10.1038/d41586-020-00537-z			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU0CC	32152602				2022-12-28	WOS:000519378900038
J	Borzenets, IV; Shim, J; Chen, JCH; Ludwig, A; Wieck, AD; Tarucha, S; Sim, HS; Yamamoto, M				Borzenets, Ivan; Shim, Jeongmin; Chen, Jason C. H.; Ludwig, Arne; Wieck, Andreas D.; Tarucha, Seigo; Sim, H. -S.; Yamamoto, Michihisa			Observation of the Kondo screening cloud	NATURE			English	Article							IMPURITIES; TRANSPORT; SPIN	When a magnetic impurity exists in a metal, conduction electrons form a spin cloud that screens the impurity spin. This basic phenomenon is called the Kondo effect(1,2). Unlike electric-charge screening, the spin-screening cloud(3-6) occurs quantum coherently, forming spin-singlet entanglement with the impurity. Although the spins interact locally around the impurity, the Kondo cloud can theoretically spread out over several micrometres. The cloud has not so far been detected, and so its physical existence-a fundamental aspect of the Kondo effect-remains controversial(7,8). Here we present experimental evidence of a Kondo cloud extending over a length of micrometres, comparable to the theoretical length xi(K). In our device, a Kondo impurity is formed in a quantum dot(2,9-11), coupling on one side to a quasi-one-dimensional channel(12) that houses a Fabry-Perot interferometer of various gate-defined lengths L exceeding one micrometre. When we sweep a voltage on the interferometer end gate-separated by L from the quantum dot-to induce Fabry-Perot oscillations in conductance we observe oscillations in the measured Kondo temperature T-K, which is a signature of the Kondo cloud at distance L. When L is less than xi(K) the T-K oscillation amplitude becomes larger as L becomes smaller, obeying a scaling function of a single parameter L/xi(K), whereas when L is greater than xi(K) the oscillation is much weaker. Our results reveal that xi(K) is the only length parameter associated with the Kondo effect, and that the cloud lies mostly within a length of xi(K). Our experimental method offers a way of detecting the spatial distribution of exotic non-Fermi liquids formed by multiple magnetic impurities or multiple screening channels(13-16) and of studying spin-correlated systems.	[Borzenets, Ivan] City Univ Hong Kong, Dept Phys, Kowloon, Hong Kong, Peoples R China; [Shim, Jeongmin; Sim, H. -S.] Korea Adv Inst Sci & Technol, Dept Phys, Daejeon, South Korea; [Chen, Jason C. H.] Univ Tokyo, Dept Appl Phys, Tokyo, Japan; [Ludwig, Arne; Wieck, Andreas D.] Ruhr Univ Bochum, Fac Phys & Astron, Chair Appl Solid State Phys, Bochum, Germany; [Tarucha, Seigo; Yamamoto, Michihisa] RIKEN, CEMS, Saitama, Japan	City University of Hong Kong; Korea Advanced Institute of Science & Technology (KAIST); University of Tokyo; Ruhr University Bochum; RIKEN	Borzenets, IV (corresponding author), City Univ Hong Kong, Dept Phys, Kowloon, Hong Kong, Peoples R China.; Sim, HS (corresponding author), Korea Adv Inst Sci & Technol, Dept Phys, Daejeon, South Korea.; Yamamoto, M (corresponding author), RIKEN, CEMS, Saitama, Japan.	iborzene@cityu.edu.hk; hssim@kaist.ac.kr; michihisa.yamamoto@riken.jp	Shim, Jeongmin/ABF-5319-2021; Ludwig, Arne/G-2700-2013; Yamamoto, Michihisa/E-6850-2017; TARUCHA, SEIGO/I-7030-2012; Sim, Heung-Sun/C-1624-2011; Borzenets, Ivan/M-9912-2015; Wieck, Andreas Dirk/C-5129-2009	Ludwig, Arne/0000-0002-2871-7789; Yamamoto, Michihisa/0000-0001-9113-6461; Sim, Heung-Sun/0000-0002-1678-874X; Borzenets, Ivan/0000-0002-1577-8312; Shim, Jeongmin/0000-0002-0589-0001; Wieck, Andreas Dirk/0000-0001-9776-2922	CityU New Research Initiatives/Infrastructure Support from Central (APRC) [9610395]; Hong Kong Research Grants Council (ECS) Project [21301818]; KAKENHI [18H04284]; CREST-JST [JPMJCR1675]; Korea NRF via the SRC Center for Quantum Coherence in Condensed Matter [2016R1A5A1008184, DFG-TRR160]; BMBF-Q; DFH/UFA [CDFA-05-06]	CityU New Research Initiatives/Infrastructure Support from Central (APRC); Hong Kong Research Grants Council (ECS) Project(Hong Kong Research Grants Council); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST-JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Korea NRF via the SRC Center for Quantum Coherence in Condensed Matter; BMBF-Q; DFH/UFA	I.V.B. acknowledges CityU New Research Initiatives/Infrastructure Support from Central (APRC) (grant number 9610395), and the Hong Kong Research Grants Council (ECS) Project (grant number 21301818). S.T. and M.Y. acknowledge KAKENHI (grant number 38000131). M.Y. acknowledges KAKENHI (grant number 18H04284) and CREST-JST (grant number JPMJCR1876). S.T. acknowledges CREST-JST (grant number JPMJCR1675). M.Y. acknowledges discussions with R. Sakano. H.-S.S. acknowledges support by Korea NRF via the SRC Center for Quantum Coherence in Condensed Matter (grant number 2016R1A5A1008184). A.L. and A.D.W. acknowledge support from DFG-TRR160,BMBF-Q.Link.X16KIS0867 and DFH/UFA CDFA-05-06.	Affleck I, 2005, J PHYS SOC JPN, V74, P59, DOI 10.1143/JPSJ.74.59; Affleck Ian, 2010, Perspectives of Mesoscopic Physics: Dedicated to Yoseph Imry's 70th Birthday, P1, DOI 10.1142/9789814299442_0001; Barzykin V, 1996, PHYS REV LETT, V76, P4959, DOI 10.1103/PhysRevLett.76.4959; Bomze Y, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.161411; Borda L, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.041307; BOYCE JB, 1974, PHYS REV LETT, V32, P61, DOI 10.1103/PhysRevLett.32.61; Busser CA, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.045111; Cox DL, 1996, J PHYS-CONDENS MAT, V8, P9825, DOI 10.1088/0953-8984/8/48/012; Cronenwett SM, 1998, SCIENCE, V281, P540, DOI 10.1126/science.281.5376.540; Glazman LI, 2005, LES HOUCH S, V81, P427; Goldhaber-Gordon D, 1998, NATURE, V391, P156, DOI 10.1038/34373; Goldhaber-Gordon D, 1998, PHYS REV LETT, V81, P5225, DOI 10.1103/PhysRevLett.81.5225; GRUNER G, 1974, REP PROG PHYS, V37, P1497, DOI 10.1088/0034-4885/37/12/001; GUBERNATIS JE, 1987, PHYS REV B, V35, P8478, DOI 10.1103/PhysRevB.35.8478; Hewson A C, 1993, KONDO PROBLEM HEAVY; Holzner A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.205114; Iftikhar Z, 2015, NATURE, V526, P233, DOI 10.1038/nature15384; Kouwenhoven L, 2001, PHYS WORLD, V14, P33; Kouwenhoven LP, 1997, NATO ADV SCI I E-APP, V345, P105; Lee SSB, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.057203; Mitchell AK, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.115120; NOZIERES P, 1974, J LOW TEMP PHYS, V17, P31, DOI 10.1007/BF00654541; Park J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.246603; Pruser H, 2011, NAT PHYS, V7, P203, DOI [10.1038/nphys1876, 10.1038/NPHYS1876]; Simon P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.206602; Sorensen ES, 1996, PHYS REV B, V53, P9153, DOI 10.1103/PhysRevB.53.9153; Takada S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.126601; Thimm WB, 1999, PHYS REV LETT, V82, P2143, DOI 10.1103/PhysRevLett.82.2143; van der Wiel WG, 2000, SCIENCE, V289, P2105, DOI 10.1126/science.289.5487.2105; VANHOUTEN H, 1989, PHYS REV B, V39, P8556, DOI 10.1103/PhysRevB.39.8556; Yoo G, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.146801	32	31	31	2	30	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7798					210	+		10.1038/s41586-020-2058-6	http://dx.doi.org/10.1038/s41586-020-2058-6			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU0CC	32161385				2022-12-28	WOS:000519378900018
J	Chica, DG; He, YH; McCall, KM; Chung, DY; Pak, RO; Trimarchi, G; Liu, ZF; De Lurgio, PM; Wessels, BW; Kanatzidis, MG				Chica, Daniel G.; He, Yihui; McCall, Kyle M.; Chung, Duck Young; Pak, Rahmi O.; Trimarchi, Giancarlo; Liu, Zhifu; De Lurgio, Patrick M.; Wessels, Bruce W.; Kanatzidis, Mercouri G.			Direct thermal neutron detection by the 2D semiconductor (LiInP2Se6)-Li-6 (vol 577, pg 346, 2020)	NATURE			English	Correction								An amendment to this paper has been published and can be accessed via a link at the top of the paper.				m-kanatzidis@northwestern.edu	Wessels, Bruce W/B-7541-2009; McCall, Kyle/AAE-5534-2022					Chica DG, 2020, NATURE, V577, P346, DOI 10.1038/s41586-019-1886-8	1	2	2	5	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					E9	E9		10.1038/s41586-020-2065-7	http://dx.doi.org/10.1038/s41586-020-2065-7		FEB 2020	1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32112062	Bronze			2022-12-28	WOS:000517049600001
J	Li, M; Lu, J				Li, Matthew; Lu, Jun			Cobalt in lithium-ion batteries	SCIENCE			English	Editorial Material							LI		[Li, Matthew; Lu, Jun] Argonne Natl Lab, Chem Sci & Engn Div, Lemont, IL 60439 USA; [Lu, Jun] Univ Waterloo, Waterloo Inst Nanotechnol, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada	United States Department of Energy (DOE); Argonne National Laboratory; University of Waterloo	Lu, J (corresponding author), Argonne Natl Lab, Chem Sci & Engn Div, Lemont, IL 60439 USA.; Lu, J (corresponding author), Univ Waterloo, Waterloo Inst Nanotechnol, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.	junlu@anl.gov			U.S. Department of Energy (DOE), Office of Energy Efficiency and Renewable Energy,Vehicle Technologies Office; DOE Office of Science [DE-AC02-06CH11357]; National Sciences and Engineering Research Council of Canada; University of Waterloo; Waterloo Institute for Nanotechnology	U.S. Department of Energy (DOE), Office of Energy Efficiency and Renewable Energy,Vehicle Technologies Office(United States Department of Energy (DOE)); DOE Office of Science(United States Department of Energy (DOE)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Waterloo; Waterloo Institute for Nanotechnology	We thank T. Liu for providing consultation on this topic. The work at Argonne National Laboratory was supported by the U.S. Department of Energy (DOE), Office of Energy Efficiency and Renewable Energy,Vehicle Technologies Office. Argonne National Laboratory is operated for the DOE Office of Science by UChicago Argonne,LLC,under contract no. DE-AC02-06CH11357. M.L. acknowledges financial support from the National Sciences and Engineering Research Council of Canada, University of Waterloo, and Waterloo Institute for Nanotechnology.	Hu EY, 2018, NAT ENERGY, V3, P690, DOI 10.1038/s41560-018-0207-z; Li HY, 2019, J ELECTROCHEM SOC, V166, pA429, DOI 10.1149/2.1381902jes; Li HY, 2018, J ELECTROCHEM SOC, V165, pA2985, DOI 10.1149/2.0381813jes; Li JY, 2019, ADV ENERGY MATER, V9, DOI 10.1002/aenm.201902731; LI W, 1992, PHYS REV B, V46, P3236, DOI 10.1103/PhysRevB.46.3236; Sovacool BK, 2019, EXTRACT IND SOC, V6, P915, DOI 10.1016/j.exis.2019.05.018; UEDA A, 1994, J ELECTROCHEM SOC, V141, P2010, DOI 10.1149/1.2055051; Wolff-Goodrich S, 2015, PHYS CHEM CHEM PHYS, V17, P21778, DOI 10.1039/c5cp03228h; Xiao YG, 2018, NANO ENERGY, V49, P77, DOI 10.1016/j.nanoen.2018.04.020; Yang J, 2019, CMES-COMP MODEL ENG, V120, P1, DOI 10.32604/cmes.2019.04727; Zheng JX, 2017, J PHYS CHEM LETT, V8, P5537, DOI 10.1021/acs.jpclett.7b02498; Zhu Z, 2016, NAT ENERGY, V1, DOI [10.1038/NENERGY.2016.111, 10.1038/nenergy.2016.111]	12	155	159	26	248	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2020	367	6481					979	980		10.1126/science.aba9168	http://dx.doi.org/10.1126/science.aba9168			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KS0CO	32108101				2022-12-28	WOS:000517979600020
J	Yang, JF; Faccenda, M				Yang, Jianfeng; Faccenda, Manuele			Intraplate volcanism originating from upwelling hydrous mantle transition zone	NATURE			English	Article							LOW-VELOCITY LAYER; SEISMIC EVIDENCE; EXPERIMENTAL CONSTRAINTS; PHASE-RELATIONS; SILICATE MELTS; BENEATH; SUBDUCTION; DEEP; TEMPERATURE; TRANSPORT	Most magmatism occurring on Earth is conventionally attributed to passive mantle upwelling at mid-ocean ridges, to slab devolatilization at subduction zones, or to mantle plumes. However, the widespread Cenozoic intraplate volcanism in northeast China(1-3) and the young petit-spot volcanoes(4-7) offshore of the Japan Trench cannot readily be associated with any of these mechanisms. In addition, the mantle beneath these types of volcanism is characterized by zones of anomalously low seismic velocity above and below the transition zone(8-12) (a mantle level located at depths between 410 and 660 kilometres). A comprehensive interpretation of these phenomena is lacking. Here we show that most (or possibly all) of the intraplate and petit-spot volcanism and low-velocity zones around the Japanese subduction zone can be explained by the Cenozoic interaction of the subducting Pacific slab with a hydrous mantle transition zone. Numerical modelling indicates that 0.2 to 0.3 weight per cent of water dissolved in mantle minerals that are driven out from the transition zone in response to subduction and retreat of a tectonic plate is sufficient to reproduce the observations. This suggests that a critical amount of water may have accumulated in the transition zone around this subduction zone, as well as in others of the Tethyan tectonic belt(13) that are characterized by intraplate or petit-spot volcanism and low-velocity zones in the underlying mantle. The widespread intraplate volcanism in northeast China and the unusual 'petit-spot' volcanoes offshore Japan could have resulted from the interaction of the subducting Pacific slab with a hydrous mantle transition zone.	[Yang, Jianfeng; Faccenda, Manuele] Univ Padua, Dipartimento Geosci, Padua, Italy	University of Padua	Faccenda, M (corresponding author), Univ Padua, Dipartimento Geosci, Padua, Italy.	manuel.e.faccenda@unipd.it	Yang, Jianfeng/ABH-1554-2020	Yang, Jianfeng/0000-0002-0140-3675; Yang, Jianfeng/0000-0002-8218-8080	Dipartimento di Geoscienze, Universita di Padova; European Research Council [758199]	Dipartimento di Geoscienze, Universita di Padova; European Research Council(European Research Council (ERC)European Commission)	T. Gerya provided the I2VIS code. We acknowledge discussions with A. Marzoli, C. Meyzen, P. Nimis, D. Novella, M. Lustrino, K. Litasov, S.-i. Karato and X. Xu. J.Y. was financially supported by Dipartimento di Geoscienze, Universita di Padova. M.F. acknowledges the European Research Council Starting Grant 758199.	Agee CB, 1998, PHYS EARTH PLANET IN, V107, P63, DOI 10.1016/S0031-9201(97)00124-6; Andrault D, 2018, NAT GEOSCI, V11, P139, DOI 10.1038/s41561-017-0053-9; Andrault D, 2014, SCIENCE, V344, P892, DOI 10.1126/science.1250466; Andrault D, 2011, EARTH PLANET SC LETT, V304, P251, DOI 10.1016/j.epsl.2011.02.006; Bajgain S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9578; Baron MA, 2017, EARTH PLANET SC LETT, V472, P186, DOI 10.1016/j.epsl.2017.05.020; Bercovici D, 2003, NATURE, V425, P39, DOI 10.1038/nature01918; Bezada MJ, 2016, GEOCHEM GEOPHY GEOSY, V17, P3164, DOI 10.1002/2016GC006507; Boukare CE, 2015, J GEOPHYS RES-SOL EA, V120, P6085, DOI 10.1002/2015JB011929; Chen CX, 2017, GEOPHYS J INT, V209, P68, DOI 10.1093/gji/ggw491; Chen Y, 2007, LITHOS, V96, P108, DOI 10.1016/j.lithos.2006.09.015; Cline CJ, 2018, NATURE, V555, P355, DOI 10.1038/nature25764; Connolly JAD, 2005, EARTH PLANET SC LETT, V236, P524, DOI 10.1016/j.epsl.2005.04.033; Faccenda M, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003860; Faccenda M, 2009, NAT GEOSCI, V2, P790, DOI 10.1038/NGEO656; Fiquet G, 2010, SCIENCE, V329, P1516, DOI 10.1126/science.1192448; Freitas D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02275-9; Fukao Y, 2013, J GEOPHYS RES-SOL EA, V118, P5920, DOI 10.1002/2013JB010466; Gerya TV, 2003, PHYS EARTH PLANET IN, V140, P293, DOI 10.1016/j.pepi.2003.09.006; Green HW, 2010, NATURE, V467, P828, DOI 10.1038/nature09401; Guillot B, 2007, GEOCHIM COSMOCHIM AC, V71, P4538, DOI 10.1016/j.gca.2007.05.029; Hier-Majumder S, 2017, EARTH PLANET SC LETT, V463, P25, DOI 10.1016/j.epsl.2016.12.041; Hirano N, 2006, SCIENCE, V313, P1426, DOI 10.1126/science.1128235; Irifune T, 2008, NATURE, V451, P814, DOI 10.1038/nature06551; Iwamori H, 2004, EARTH PLANET SC LETT, V227, P57, DOI 10.1016/j.epsl.2004.08.013; Jing ZC, 2012, GEOCHIM COSMOCHIM AC, V85, P357, DOI 10.1016/j.gca.2012.03.001; Kameyama M, 1999, EARTH PLANET SC LETT, V168, P159, DOI 10.1016/S0012-821X(99)00040-0; KARATO S, 1993, SCIENCE, V260, P771, DOI 10.1126/science.260.5109.771; Karato S, 2011, EARTH PLANET SC LETT, V301, P413, DOI 10.1016/j.epsl.2010.11.038; Kelbert A, 2009, NATURE, V460, P1003, DOI 10.1038/nature08257; Keller T, 2013, GEOPHYS J INT, V195, P1406, DOI 10.1093/gji/ggt306; Kuritani T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43103-y; Kuritani T, 2011, NAT GEOSCI, V4, P713, DOI [10.1038/NGEO1250, 10.1038/ngeo1250]; Lehmann R, 2016, MODELLING MAGMA DYNA; Li C, 2008, EARTH PLANET SC LETT, V274, P157, DOI 10.1016/j.epsl.2008.07.016; Litasov KD, 2011, RUSS GEOL GEOPHYS+, V52, P475, DOI 10.1016/j.rgg.2011.04.001; Litasov KD, 2005, PHYS EARTH PLANET IN, V150, P239, DOI 10.1016/j.pepi.2004.10.010; Litasov KD, 2013, GEOLOGY, V41, P79, DOI 10.1130/G33488.1; Liu Z, 2018, EARTH PLANET SC LETT, V482, P93, DOI 10.1016/j.epsl.2017.10.054; Liu Z, 2016, GEOPHYS RES LETT, V43, P2480, DOI 10.1002/2015GL067097; Lustrino M, 2007, EARTH-SCI REV, V81, P1, DOI 10.1016/j.earscirev.2006.09.002; Machida S, 2015, EARTH PLANET SC LETT, V426, P267, DOI 10.1016/j.epsl.2015.06.018; Mao Z, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035618; Mazza SE, 2019, NATURE, V569, P398, DOI 10.1038/s41586-019-1183-6; Nomura R, 2014, SCIENCE, V343, P522, DOI 10.1126/science.1248186; Obayashi M, 2006, EARTH PLANET SC LETT, V243, P149, DOI 10.1016/j.epsl.2005.12.032; Okumura S, 2013, GEOLOGY, V41, P1167, DOI 10.1130/G34620.1; Petitgirard S, 2015, P NATL ACAD SCI USA, V112, P14186, DOI 10.1073/pnas.1512386112; Pilet S, 2016, NAT GEOSCI, V9, P898, DOI [10.1038/NGEO2825, 10.1038/ngeo2825]; Pradhan GK, 2015, EARTH PLANET SC LETT, V431, P247, DOI 10.1016/j.epsl.2015.09.034; Rohrbach A, 2011, NATURE, V472, P209, DOI 10.1038/nature09899; Sakamaki T, 2006, NATURE, V439, P192, DOI 10.1038/nature04352; Sanloup C, 2013, GEOCHIM COSMOCHIM AC, V118, P118, DOI 10.1016/j.gca.2013.05.012; Schmandt B, 2014, SCIENCE, V344, P1265, DOI [10.1126/science.1253358, 10.1126/science.1253258]; Sizova E, 2010, LITHOS, V116, P209, DOI 10.1016/j.lithos.2009.05.028; Soltanmohammadi A, 2018, J PETROL, V59, P2273, DOI 10.1093/petrology/egy097; Takei Y, 2002, J GEOPHYS RES-SOL EA, V107, DOI [10.1029/2001JB000522, 10.1029/2001jb000522]; Tang YC, 2014, NAT GEOSCI, V7, P470, DOI [10.1038/ngeo2166, 10.1038/NGEO2166]; Tauzin B, 2010, NAT GEOSCI, V3, P718, DOI 10.1038/NGEO969; van Keken PE, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007922; VONBARGEN N, 1986, J GEOPHYS RES-SOLID, V91, P9261, DOI 10.1029/JB091iB09p09261; Walter MJ, 2015, CHEM GEOL, V418, P16, DOI 10.1016/j.chemgeo.2015.05.001; Wang X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7544; Wang XJ, 2017, EARTH PLANET SC LETT, V465, P16, DOI 10.1016/j.epsl.2017.02.028; Wei SS, 2017, J GEOPHYS RES-SOL EA, V122, P5144, DOI 10.1002/2017JB014100; Xu WB, 2008, EARTH PLANET SC LETT, V275, P70, DOI 10.1016/j.epsl.2008.08.012; Yoshino T, 2007, EARTH PLANET SC LETT, V256, P466, DOI 10.1016/j.epsl.2007.02.002; ZHANG JZ, 1994, J GEOPHYS RES-SOL EA, V99, P17729, DOI 10.1029/94JB01406; Zhao DP, 2013, GEOPHYS J INT, V195, P706, DOI 10.1093/gji/ggt289; Zhao DP, 2009, PHYS EARTH PLANET IN, V173, P197, DOI 10.1016/j.pepi.2008.11.009	70	63	67	15	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2020	579	7797					88	+		10.1038/s41586-020-2045-y	http://dx.doi.org/10.1038/s41586-020-2045-y		FEB 2020	15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE3BA	32103183	Green Submitted			2022-12-28	WOS:000516702000004
J	Mandl, KD; Kohane, IS				Mandl, Kenneth D.; Kohane, Isaac S.			Data Citizenship under the 21st Century Cures Act	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mandl, Kenneth D.] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA 02115 USA; Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Mandl, KD (corresponding author), Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA 02115 USA.			Mandl, Kenneth/0000-0002-9781-0477				Adler-Milstein J, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.9544; Allen A., 2018, POLITICO; Grande D, 2013, JAMA INTERN MED, V173, P1798, DOI 10.1001/jamainternmed.2013.9166; Mandl KD, 2001, BMJ-BRIT MED J, V322, P283, DOI 10.1136/bmj.322.7281.283; Mandl KD, 2009, NEW ENGL J MED, V360, P1278, DOI 10.1056/NEJMp0900411	5	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2020	382	19					1781	1783		10.1056/NEJMp1917640	http://dx.doi.org/10.1056/NEJMp1917640			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LO1TS	32160449				2022-12-28	WOS:000533411000008
J	Young, BE; Ong, SWX; Kalimuddin, S; Low, JG; Tan, SY; Loh, JS; Ng, OT; Marimuthu, K; Ang, LW; Mak, TM; Lau, SK; Anderson, DE; Chan, KS; Tan, TY; Ng, TY; Cui, L; Said, Z; Kurupatham, L; Chen, MIC; Chan, M; Vasoo, S; Wang, LF; Tan, BH; Lin, RTP; Lee, VJM; Leo, YS; Lye, DC				Young, Barnaby Edward; Ong, Sean Wei Xiang; Kalimuddin, Shirin; Low, Jenny G.; Tan, Seow Yen; Loh, Jiashen; Ng, Oon-Tek; Marimuthu, Kalisvar; Ang, Li Wei; Mak, Tze Minn; Lau, Sok Kiang; Anderson, Danielle E.; Chan, Kian Sing; Tan, Thean Yen; Ng, Tong Yong; Cui, Lin; Said, Zubaidah; Kurupatham, Lalitha; Chen, Mark I-Cheng; Chan, Monica; Vasoo, Shawn; Wang, Lin-Fa; Tan, Boon Huan; Lin, Raymond Tzer Pin; Lee, Vernon Jian Ming; Leo, Yee-Sin; Lye, David Chien		Singapore 2019 Novel Coronavirus	Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VIRAL LOAD; SARS; LOPINAVIR/RITONAVIR; SPECIMENS; PNEUMONIA	This case series describes the epidemiologic features, clinical presentation, treatment, and outcomes of the first 18 patients with confirmed coronavirus disease 2019 (COVID-19) in Singapore Importance Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, in December 2019 and has spread globally with sustained human-to-human transmission outside China. Objective To report the initial experience in Singapore with the epidemiologic investigation of this outbreak, clinical features, and management. Design, Setting, and Participants Descriptive case series of the first 18 patients diagnosed with polymerase chain reaction (PCR)-confirmed SARS-CoV-2 infection at 4 hospitals in Singapore from January 23 to February 3, 2020; final follow-up date was February 25, 2020. Exposures Confirmed SARS-CoV-2 infection. Main Outcomes and Measures Clinical, laboratory, and radiologic data were collected, including PCR cycle threshold values from nasopharyngeal swabs and viral shedding in blood, urine, and stool. Clinical course was summarized, including requirement for supplemental oxygen and intensive care and use of empirical treatment with lopinavir-ritonavir. Results Among the 18 hospitalized patients with PCR-confirmed SARS-CoV-2 infection (median age, 47 years; 9 [50%] women), clinical presentation was an upper respiratory tract infection in 12 (67%), and viral shedding from the nasopharynx was prolonged for 7 days or longer among 15 (83%). Six individuals (33%) required supplemental oxygen; of these, 2 required intensive care. There were no deaths. Virus was detectable in the stool (4/8 [50%]) and blood (1/12 [8%]) by PCR but not in urine. Five individuals requiring supplemental oxygen were treated with lopinavir-ritonavir. For 3 of the 5 patients, fever resolved and supplemental oxygen requirement was reduced within 3 days, whereas 2 deteriorated with progressive respiratory failure. Four of the 5 patients treated with lopinavir-ritonavir developed nausea, vomiting, and/or diarrhea, and 3 developed abnormal liver function test results. Conclusions and Relevance Among the first 18 patients diagnosed with SARS-CoV-2 infection in Singapore, clinical presentation was frequently a mild respiratory tract infection. Some patients required supplemental oxygen and had variable clinical outcomes following treatment with an antiretroviral agent. Question What was the initial experience in Singapore with the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)? Findings In this descriptive case series of the first 18 patients diagnosed with SARS-CoV-2 infection in Singapore between January 23 and February 3, 2020, clinical presentation was a respiratory tract infection with prolonged viral shedding from the nasopharynx of 7 days or longer in 15 patients (83%). Supplemental oxygen was required in 6 patients (33%), 5 of whom were treated with lopinavir-ritonavir, with variable clinical outcomes following treatment. Meaning These findings provide clinical features and course among patients diagnosed with SARS-CoV-2 infection in Singapore.	[Young, Barnaby Edward; Ong, Sean Wei Xiang; Ng, Oon-Tek; Marimuthu, Kalisvar; Ang, Li Wei; Mak, Tze Minn; Cui, Lin; Chen, Mark I-Cheng; Chan, Monica; Vasoo, Shawn; Lin, Raymond Tzer Pin; Leo, Yee-Sin; Lye, David Chien] Natl Centre Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, Singapore; [Young, Barnaby Edward; Ong, Sean Wei Xiang; Ng, Oon-Tek; Marimuthu, Kalisvar; Chan, Monica; Vasoo, Shawn; Leo, Yee-Sin; Lye, David Chien] Tan Tock Seng Hosp, Singapore, Singapore; [Young, Barnaby Edward; Ng, Oon-Tek; Tan, Boon Huan; Leo, Yee-Sin; Lye, David Chien] Lee Kong Chian Sch Med, Singapore, Singapore; [Kalimuddin, Shirin; Low, Jenny G.; Chan, Kian Sing] Singapore Gen Hosp, Singapore, Singapore; [Kalimuddin, Shirin; Low, Jenny G.; Anderson, Danielle E.; Tan, Thean Yen; Wang, Lin-Fa] Duke NUS Med Sch, Singapore, Singapore; [Tan, Seow Yen; Tan, Thean Yen] Changi Gen Hosp, Singapore, Singapore; [Loh, Jiashen; Ng, Tong Yong] Sengkang Gen Hosp, Singapore, Singapore; [Marimuthu, Kalisvar; Leo, Yee-Sin; Lye, David Chien] Yong Loo Lin Sch Med, Singapore, Singapore; [Lau, Sok Kiang; Tan, Boon Huan] DSO Natl Labs, Singapore, Singapore; [Said, Zubaidah; Kurupatham, Lalitha; Lee, Vernon Jian Ming] Minist Hlth, Singapore, Singapore; [Chen, Mark I-Cheng; Lee, Vernon Jian Ming; Leo, Yee-Sin] Saw Swee Hock Sch Publ Hlth, Singapore, Singapore	Tan Tock Seng Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore General Hospital; National University of Singapore; Changi General Hospital; National University of Singapore; Ministry of Health-Singapore	Young, BE; Leo, YS (corresponding author), Natl Centre Infect Dis, 16 Jln Tan Tock Seng, Singapore 308442, Singapore.; Young, BE; Leo, YS (corresponding author), Lee Kong Chian Sch Med, Singapore, Singapore.	Barnaby_young@ncid.sg; Yee_Sin_Leo@ncid.sg	Chen, Mark/AGC-5338-2022; Chia, Po Ying/AAN-9657-2020; Young, Barnaby/GVR-9935-2022; Chia, Po Ying/GSD-9737-2022; Anderson, Danielle/HCH-2004-2022; wang, lili/HDL-7210-2022; Vasoo, Shawn/H-3942-2019; Lye, David/ABF-4402-2021; Ong, Sean/AAO-9560-2020; wang, lin/GSE-3040-2022; Tan, Boon Huan/ABB-8381-2021	Chen, Mark/0000-0001-9369-5830; Chia, Po Ying/0000-0002-8797-9527; Chia, Po Ying/0000-0002-8797-9527; Vasoo, Shawn/0000-0001-7812-9881; Ong, Sean/0000-0002-8570-436X; Tan, Boon Huan/0000-0002-4976-7988; Lye, David/0000-0003-0324-0205; Anderson, Danielle/0000-0003-4791-5024; Mak, Tze Minn/0000-0002-8249-8353; Young, Barnaby/0000-0003-1010-2230	Singapore National Medical Research Council [TR19NMR119SD, CCGSFPOR200011];  [NRF2016NRFNSFC002-013]	Singapore National Medical Research Council(National Medical Research Council, Singapore); 	Recruitment of study participants and sample collection was funded by a seed grant from the Singapore National Medical Research Council (TR19NMR119SD [project CCGSFPOR200011). The polymerase chain reaction work on nonrespiratory clinical samples was partially supported by grant NRF2016NRFNSFC002-013 (Combating the Next SARS-or MERS-Like Emerging Infectious Disease Outbreak by Improving Active Surveillance).	Centers for Disease Control and Prevention, INT INF PREV CONTR R; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chan JFW, 2015, J INFECT DIS, V212, P1904, DOI 10.1093/infdis/jiv392; Chan K. S., 2003, Hong Kong Medical Journal, V9, P399; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Hung IFN, 2004, EMERG INFECT DIS, V10, P1550, DOI 10.3201/eid1009.040058; Lansbury LE, 2020, CRIT CARE MED, V48, pE98, DOI 10.1097/CCM.0000000000004093; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Oh MD, 2016, NEW ENGL J MED, V375, P1303, DOI 10.1056/NEJMc1511695; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wong JEL, 2020, JAMA-J AM MED ASSOC, V323, P1243, DOI 10.1001/jama.2020.2467; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	17	1198	1258	7	56	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2020	323	15					1488	1494		10.1001/jama.2020.3204	http://dx.doi.org/10.1001/jama.2020.3204			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LJ1ZH	32125362	Green Published, Bronze			2022-12-28	WOS:000529969700019
J	del Rio, C; Malani, PN				del Rio, Carlos; Malani, Preeti N.			COVID-19-New Insights on a Rapidly Changing Epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint provides an update on what's known and not yet known about the coronavirus disease 2019 (COVID-19) epidemic, reviewing advances over the initial weeks of the outbreak in understanding the epidemiology and clinical spectrum of the illness and in approaches to diagnosis, management, and infection control.	[del Rio, Carlos] Emory Univ, Sch Med, Dept Internal Med, Div Infect Dis, Atlanta, GA USA; [Malani, Preeti N.] Univ Michigan, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA	Emory University; University of Michigan System; University of Michigan	del Rio, C (corresponding author), Emory Univ, Sch Med, 49 Jesse Hill Jr Dr,FOB Room201, Atlanta, GA 30303 USA.	cdelrio@emory.edu	del Rio, Carlos/B-3763-2012	del Rio, Carlos/0000-0002-0153-3517				[Anonymous], REPORT 6 RELATIVE SE; [Anonymous], 2020, JAMA, DOI DOI 10.1001/JAMA.2020.2648; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Chang D, 2020, JAMA-J AM MED ASSOC, V323, P1092, DOI 10.1001/jama.2020.1623; Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3; del Rio C, 2020, JAMA-J AM MED ASSOC, V323, P1039, DOI 10.1001/jama.2020.1490; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Zhang W, 2020, SCI CHINA LIFE SCI, V9, P386, DOI [10.1080/22221751.2020.1729071, DOI 10.1080/22221751.2020.1729071]	8	356	368	3	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2020	323	14					1339	1340		10.1001/jama.2020.3072	http://dx.doi.org/10.1001/jama.2020.3072			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LH1YB	32108857	Bronze			2022-12-28	WOS:000528583600008
J	Nakazawa, Y; Hara, Y; Oka, Y; Komine, O; van den Heuvel, D; Guo, CW; Daigaku, Y; Isono, M; He, YX; Shimada, M; Kato, K; Jia, N; Hashimoto, S; Kotani, Y; Miyoshi, Y; Tanaka, M; Sobue, A; Mitsutake, N; Suganami, T; Masuda, A; Ohno, K; Nakada, S; Mashimo, T; Yamanaka, K; Luijsterburg, MS; Ogi, T				Nakazawa, Yuka; Hara, Yuichiro; Oka, Yasuyoshi; Komine, Okiru; van den Heuvel, Diana; Guo, Chaowan; Daigaku, Yasukazu; Isono, Mayu; He, Yuxi; Shimada, Mayuko; Kato, Kana; Jia, Nan; Hashimoto, Satoru; Kotani, Yuko; Miyoshi, Yuka; Tanaka, Miyako; Sobue, Akira; Mitsutake, Norisato; Suganami, Takayoshi; Masuda, Akio; Ohno, Kinji; Nakada, Shinichiro; Mashimo, Tomoji; Yamanaka, Koji; Luijsterburg, Martijn S.; Ogi, Tomoo			Ubiquitination of DNA Damage-Stalled RNAPII Promotes Transcription-Coupled Repair	CELL			English	Article							UV-SENSITIVE SYNDROME; NUCLEOTIDE EXCISION-REPAIR; COCKAYNE-SYNDROME; POLYMERASE-II; INDUCED UBIQUITYLATION; XERODERMA-PIGMENTOSUM; GENE-EXPRESSION; GENOME-WIDE; POL-II; DEGRADATION	Transcription-coupled nucleotide excision repair (TC-NER) is initiated by the stalling of elongating RNA polymerase H (RNAPIIo) at DNA lesions. The ubiquitination of RNAPIIo in response to DNA damage is an evolutionarily conserved event, but its function in mammals is unknown. Here, we identified a single DNA damage-induced ubiquitination site in RNAPII at RPB1-K1268, which regulates transcription recovery and DNA damage resistance. Mechanistically, RPB1-K1268 ubiquitination stimulates the association of the core-TFIIH complex with stalled RNAPIIo through a transfer mechanism that also involves UVSSA-K414 ubiquitination. We developed a strand-specific ChIP-seq method, which revealed RPB1-K1268 ubiquitination is important for repair and the resolution of transcriptional bottlenecks at DNA lesions. Finally, RPB1-K1268R knockin mice displayed a short life-span, premature aging, and neurodegeneration. Our results reveal RNAPII ubiquitination provides a two-tier protection mechanism by activating TC-NER and, in parallel, the processing of DNA damage-stalled RNAPIIo, which together prevent prolonged transcription arrest and protect against neurodegeneration.	[Nakazawa, Yuka; Hara, Yuichiro; Oka, Yasuyoshi; Guo, Chaowan; Isono, Mayu; He, Yuxi; Shimada, Mayuko; Kato, Kana; Jia, Nan; Hashimoto, Satoru; Ogi, Tomoo] Nagoya Univ, Res Inst Environm Med RIeM, Dept Genet, Nagoya, Aichi, Japan; [Nakazawa, Yuka; Hara, Yuichiro; Oka, Yasuyoshi; Guo, Chaowan; Isono, Mayu; He, Yuxi; Shimada, Mayuko; Kato, Kana; Jia, Nan; Hashimoto, Satoru; Ogi, Tomoo] Nagoya Univ, Grad Sch Med, Dept Human Genet & Mol Biol, Nagoya, Aichi, Japan; [Komine, Okiru; Miyoshi, Yuka; Sobue, Akira; Yamanaka, Koji] Nagoya Univ, Res Inst Environm Med RIeM, Dept Neurosci & Pathobiol, Nagoya, Aichi, Japan; [Komine, Okiru; Miyoshi, Yuka; Sobue, Akira; Yamanaka, Koji] Nagoya Univ, Grad Sch Med, Dept Neurosci & Pathobiol, Nagoya, Aichi, Japan; [van den Heuvel, Diana; Luijsterburg, Martijn S.] Leiden Univ, Med Ctr LUMC, Dept Human Genet, Leiden, Netherlands; [Daigaku, Yasukazu] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi, Japan; [Daigaku, Yasukazu] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan; [Kotani, Yuko; Mashimo, Tomoji] Osaka Univ, Grad Sch Med, Inst Expt Anim Sci, Osaka, Japan; [Kotani, Yuko; Mashimo, Tomoji] Osaka Univ, Genome Editing Res & Dev R&D Ctr, Grad Sch Med, Osaka, Japan; [Tanaka, Miyako; Suganami, Takayoshi] Nagoya Univ, Res Inst Environm Med RIeM, Dept Mol Med & Metab, Nagoya, Aichi, Japan; [Tanaka, Miyako; Suganami, Takayoshi] Nagoya Univ, Grad Sch Med, Dept Immunometab, Nagoya, Aichi, Japan; [Mitsutake, Norisato] Nagasaki Univ, Atom Bomb Dis Inst, Dept Radiat Med Sci, Nagasaki, Japan; [Masuda, Akio; Ohno, Kinji] Nagoya Univ, Ctr Neurol Dis & Canc, Grad Sch Med, Div Neurogenet, Nagoya, Aichi, Japan; [Nakada, Shinichiro] Osaka Univ, Grad Sch Med, Dept Bioregulat & Cellular Response, Osaka, Japan; [Nakada, Shinichiro] Osaka Univ, Inst Adv Cocreat Studies, Osaka, Japan; [Mashimo, Tomoji] Univ Tokyo, Lab Anim Res Ctr, Inst Med Sci, Div Anim Genet, Tokyo, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Tohoku University; Tohoku University; Osaka University; Osaka University; Nagoya University; Nagoya University; Nagasaki University; Nagoya University; Osaka University; Osaka University; University of Tokyo	Ogi, T (corresponding author), Nagoya Univ, Res Inst Environm Med RIeM, Dept Genet, Nagoya, Aichi, Japan.; Ogi, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Human Genet & Mol Biol, Nagoya, Aichi, Japan.	togi@riem.nagoya-u.ac.jp	Guo, Chaowan/AAF-3876-2022; 真由, 磯野/GPG-2740-2022; Yamanaka, Koji/ABD-1034-2020; Miyoshi, Yoshizumi/T-5748-2019; Yamanaka, Koji/H-5806-2011; Guo, Chaowan/AFI-6708-2022	Yamanaka, Koji/0000-0003-4655-0035; Miyoshi, Yoshizumi/0000-0001-7998-1240; Yamanaka, Koji/0000-0003-4655-0035; Nakazawa, Yuka/0000-0002-3835-3093; Daigaku, Yasukazu/0000-0002-8404-7492; Mitsutake, Norisato/0000-0002-2744-8046; Nakada, Shinichiro/0000-0001-9297-1565	Special Coordination Funds for Rare and Intractable Diseases from Japan Agency for Medical Research and Development (AMED) [JP19ek0109281, JP19ek0109229, JP19ek0109301]; Japan Society for the Promotion of Science [JP15H02654, JP17H00783]; Uehara Memorial Foundation; Daiko Foundation; Takeda Science Foundation; KAKENHI [JP17H01877]; Tokyo Biochemical Research Foundation (TBRF); LUMC research fellowship; NWO-VIDI [016.161.320]	Special Coordination Funds for Rare and Intractable Diseases from Japan Agency for Medical Research and Development (AMED); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Daiko Foundation(Daiko Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tokyo Biochemical Research Foundation (TBRF); LUMC research fellowship; NWO-VIDI(Netherlands Organization for Scientific Research (NWO))	This paper is dedicated to the memory of a wonderful lady, Amy Garton-Hughes, who made a huge difference in the lives of Cockayne syndrome children. We are grateful to Drs. Alan Lehman and Chikahide Masutani for their helpful comments and discussions on the manuscript. We are grateful to Dr. Masato Kanemaki for his advice on the CRISPR/Cas9-based gene targeting experiments. Bioinformatics data processing was partially performed using the super-computing resource provided by Human Genome Center, the Institute of Medical Science, the University of Tokyo. This work was supported by the Special Coordination Funds for Rare and Intractable Diseases from Japan Agency for Medical Research and Development (AMED) (JP19ek0109281, JP19ek0109229, and JP19ek0109301), Grants in Aid for Scientific Research KAKENHI (JP15H02654 and JP17H00783) from the Japan Society for the Promotion of Science, a Science Research Grant from the Uehara Memorial Foundation, a grant from the Daiko Foundation, and a medical research grant from the Takeda Science Foundation to T.O.; KAKENHI (JP17H01877) and a medical research grant from Takeda Science Foundation to Y.N.; TBRF Postdoctoral Fellowship for Asian Researchers in Japan from The Tokyo Biochemical Research Foundation (TBRF) to C.G. and T.O.; and an LUMC research fellowship and an NWO-VIDI grant (016.161.320) to M.S.L.	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Brooks P.J., 2008, DNA REPAIR AMST, V7, P1168; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Calmels N, 2018, J MED GENET, V55, P329, DOI 10.1136/jmedgenet-2017-104877; Chen M, 1996, NAT GENET, V12, P448, DOI 10.1038/ng0496-448; Elia AEH, 2015, MOL CELL, V59, P867, DOI 10.1016/j.molcel.2015.05.006; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fei J, 2012, J BIOL CHEM, V287, P35118, DOI 10.1074/jbc.M112.398131; Friedberg E.C., 2005, TRENDS BIOCHEM SCI; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; He Y, 2016, NATURE, V533, P359, DOI 10.1038/nature17970; Higa M, 2018, FEBS J, V285, P965, DOI 10.1111/febs.14382; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jia N, 2015, NAT PROTOC, V10, P12, DOI 10.1038/nprot.2014.194; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007; Kleiman FE, 2005, GENE DEV, V19, P1227, DOI 10.1101/gad.1309505; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Laposa RR, 2007, P NATL ACAD SCI USA, V104, P1389, DOI 10.1073/pnas.0610619104; Laugel V, 2013, MECH AGEING DEV, V134, P161, DOI 10.1016/j.mad.2013.02.006; Li H., 2013, ARXIV PREPRINT; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Limsirichaikul S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp023; Ljungman M, 1996, ONCOGENE, V13, P823; Lommel L, 2000, P NATL ACAD SCI USA, V97, P9088, DOI 10.1073/pnas.150130197; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Mayer A, 2017, CURR OPIN CELL BIOL, V46, P72, DOI 10.1016/j.ceb.2017.03.002; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Menoni H, 2018, NUCLEIC ACIDS RES, V46, P7747, DOI 10.1093/nar/gky579; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; NAKANE H, 1995, NATURE, V377, P165, DOI 10.1038/377165a0; Nakazawa Y, 2012, NAT GENET, V44, P586, DOI 10.1038/ng.2229; Nakazawa Y, 2010, DNA REPAIR, V9, P506, DOI 10.1016/j.dnarep.2010.01.015; Nouspikel T, 2011, MECH AGEING DEV, V132, P355, DOI 10.1016/j.mad.2011.03.003; Odawara J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-516; Okuda M, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx970; Parmar K, 2009, MUTAT RES-FUND MOL M, V668, P133, DOI 10.1016/j.mrfmmm.2009.03.015; Paulsen MT, 2014, METHODS, V67, P45, DOI 10.1016/j.ymeth.2013.08.015; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Reid-Bayliss KS, 2016, P NATL ACAD SCI USA, V113, P10151, DOI 10.1073/pnas.1610020113; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Somesh BP, 2007, CELL, V129, P57, DOI 10.1016/j.cell.2007.01.046; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Starita LM, 2005, J BIOL CHEM, V280, P24498, DOI 10.1074/jbc.M414020200; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sugaya K, 2000, J CELL SCI, V113, P2679; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tischler G, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-13; van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; Vidakovic AT, 2020, CELL, V180, P1245, DOI 10.1016/j.cell.2020.02.009; Wang YM, 2014, P NATL ACAD SCI USA, V111, P14454, DOI 10.1073/pnas.1412569111; Watson AT, 2008, GENE, V407, P63, DOI 10.1016/j.gene.2007.09.024; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; Xu J, 2017, NATURE, V551, P653, DOI 10.1038/nature24658; YAMAIZUMI M, 1994, ONCOGENE, V9, P2775; Yasukawa T, 2008, EMBO J, V27, P3256, DOI 10.1038/emboj.2008.249; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228	73	70	72	4	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2020	180	6					1228	+		10.1016/j.cell.2020.02.010	http://dx.doi.org/10.1016/j.cell.2020.02.010			41	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KW1IO	32142649	Bronze			2022-12-28	WOS:000520925300017
J	Neves, J				Neves, Joana			Aging eyes and the immune system	SCIENCE			English	Editorial Material									[Neves, Joana] Univ Lisbon, IMM, Fac Med, Lisbon, Portugal	Universidade de Lisboa	Neves, J (corresponding author), Univ Lisbon, IMM, Fac Med, Lisbon, Portugal.	joana.neves@medicina.ulisboa.pt		Mendes Neves, Joana/0000-0002-1027-3489				Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039; Lindahl M, 2017, NEUROBIOL DIS, V97, P90, DOI 10.1016/j.nbd.2016.07.009; Neves J., 2017, U.S. Patent, Patent No. [US20170274048A1, 20170274048A1]; Neves J, 2020, FEBS J, V287, P43, DOI 10.1111/febs.15061; Neves J, 2017, CELL STEM CELL, V20, P161, DOI 10.1016/j.stem.2017.01.008; Neves J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf3646; Neves J, 2015, DEV CELL, V32, P9, DOI 10.1016/j.devcel.2014.11.028; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Sousa-Victor P, 2019, NAT METAB, V1, P276, DOI 10.1038/s42255-018-0023-6	9	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1205	1206		10.1126/science.aba6114	http://dx.doi.org/10.1126/science.aba6114			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU9DP	32165578				2022-12-28	WOS:000520023800028
J	Zhao, K; Deng, H; Chen, H; Ross, KA; Petricek, V; Gunther, G; Russina, M; Hutanu, V; Gegenwart, P				Zhao, Kan; Deng, Hao; Chen, Hua; Ross, Kate A.; Petricek, Vaclav; Gunther, Gerrit; Russina, Margarita; Hutanu, Vladimir; Gegenwart, Philipp			Realization of the kagome spin ice state in a frustrated intermetallic compound	SCIENCE			English	Article							BILBAO CRYSTALLOGRAPHIC SERVER; MAGNETIC MONOPOLES; GROUND-STATE; ANTIFERROMAGNET; ENTROPY; LATTICE; LIQUID; SYSTEM; PHASE; ORDER	Spin ices are exotic phases of matter characterized by frustrated spins obeying local "ice rules," in analogy with the electric dipoles in water ice. In two dimensions, one can similarly define ice rules for in-plane Ising-like spins arranged on a kagome lattice. These ice rules require each triangle plaquette to have a single monopole and can lead to different types of orders and excitations. Using experimental and theoretical approaches including magnetometry, thermodynamic measurements, neutron scattering, and Monte Carlo simulations, we establish HoAgGe as a crystalline (i.e., nonartificial) system that realizes the kagome spin ice state. The system features a variety of partially and fully ordered states and a sequence of field-induced phases at low temperatures, all consistent with the kagome ice rule.	[Zhao, Kan; Gegenwart, Philipp] Univ Augsburg, Ctr Elect Correlat & Magnetism, Expt Phys 6, D-86159 Augsburg, Germany; [Deng, Hao; Hutanu, Vladimir] Rhein Westfal TH Aachen, Inst Crystallog, D-85747 Garching, Germany; [Deng, Hao; Hutanu, Vladimir] Heinz Maier Leibnitz Zentrum MLZ, JCNS, D-85747 Garching, Germany; [Chen, Hua; Ross, Kate A.] Colorado State Univ, Dept Phys, Ft Collins, CO 80523 USA; [Petricek, Vaclav] Acad Sci Czech Republ, Inst Phys, Prague 18221, Czech Republic; [Gunther, Gerrit; Russina, Margarita] Helmholtz Zentrum Berlin Mat & Energie, D-14109 Berlin, Germany	University of Augsburg; RWTH Aachen University; Colorado State University; Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Zhao, K; Gegenwart, P (corresponding author), Univ Augsburg, Ctr Elect Correlat & Magnetism, Expt Phys 6, D-86159 Augsburg, Germany.	kan.zhao@physik.uni-augsburg.de; philipp.gegenwart@physik.uni-augsburg.de	Gegenwart, Philipp/A-7291-2017; Deng, Hao/AAT-7239-2020; Russina, Margarita/E-9886-2016; Chen, Hua/H-3092-2013	Gegenwart, Philipp/0000-0003-4180-3785; Deng, Hao/0000-0002-4668-241X; Petricek, Vaclav/0000-0002-9731-8730; Gunther, Gerrit/0000-0001-6243-1728; Russina, Margarita/0000-0003-2067-606X; Hutanu, Vladimir/0000-0001-6772-8985; Chen, Hua/0000-0003-0676-3079; Ross, Kate/0000-0002-7385-7449	German Science Foundation [SPP1666, 220179758, TRR80, 107745057]; National Science Foundation [ACI-1532235, ACI-1532236]; University of Colorado-Boulder; Colorado State University; Czech Science Foundation [18-10504S]	German Science Foundation(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); University of Colorado-Boulder; Colorado State University; Czech Science Foundation(Grant Agency of the Czech Republic)	The work in Augsburg was supported by the German Science Foundation through SPP1666 (project no. 220179758) and TRR80 (project no. 107745057). The instrument POLI at Heinz Maier-Leibnitz Zentrum (MLZ), Garching, Germany, was operated by RWTH Aachen University in cooperation with FZ Julich (Julich Aachen Research Alliance JARA). Inelastic neutron experiments were conducted at the time-of-flight spectrometer NEAT operated by Helmholtz Zentrum Berlin. This work utilized the RMACC Summit supercomputer, which is supported by the National Science Foundation (awards ACI-1532235 and ACI-1532236), the University of Colorado-Boulder, and Colorado State University. The Summit supercomputer is a joint effort of the University of Colorado-Boulder and Colorado State University. The work in Prague was supported by the Czech Science Foundation through project no. 18-10504S.	Aroyo MI, 2006, Z KRISTALLOGR, V221, P15, DOI 10.1524/zkri.2006.221.1.15; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Baran S, 1998, J ALLOY COMPD, V281, P92, DOI 10.1016/S0925-8388(98)00721-X; Bramwell ST, 2001, SCIENCE, V294, P1495, DOI 10.1126/science.1064761; Carrasquilla J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8421; Castelnovo C, 2008, NATURE, V451, P42, DOI 10.1038/nature06433; Chen H, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.017205; Chern GW, 2012, PHILOS T R SOC A, V370, P5718, DOI 10.1098/rsta.2011.0388; Chern GW, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.207202; Chou YZ, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.132403; Donni A., 1998, J PHYS CONDENS MATT, V8, P11213; DUBOVIK VM, 1990, PHYS REP, V187, P145, DOI 10.1016/0370-1573(90)90042-Z; Dun ZL, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.157201; Fennell T, 2007, NAT PHYS, V3, P566, DOI 10.1038/nphys632; Fennell T, 2009, SCIENCE, V326, P415, DOI 10.1126/science.1177582; Gainov RR, 2019, NUCL INSTRUM METH A, V930, P42, DOI 10.1016/j.nima.2019.03.046; Gallego SV, 2012, J APPL CRYSTALLOGR, V45, P1236, DOI 10.1107/S0021889812042185; Gartside JC, 2018, NAT NANOTECHNOL, V13, P53, DOI 10.1038/s41565-017-0002-1; Gibson B, 1996, J ALLOY COMPD, V239, P34, DOI 10.1016/0925-8388(96)02201-3; Gingras MJP, 2000, PHYS REV B, V62, P6496, DOI 10.1103/PhysRevB.62.6496; Gorbunov DI, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.184412; Gunther G, 2019, J PHYS CONF SER, V1316, DOI 10.1088/1742-6596/1316/1/012008; Gunther G, 2016, NUCL INSTRUM METH A, V828, P250, DOI 10.1016/j.nima.2016.05.022; Harris MJ, 1997, PHYS REV LETT, V79, P2554, DOI 10.1103/PhysRevLett.79.2554; Huang YP, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.075130; Hutanu V., 2015, J LARGE SCALE RES FA, V1, pA16, DOI [10.17815/jlsrf-1-22, DOI 10.17815/JLSRF-1-22]; Jana YM, 2000, PHYS REV B, V61, P9657, DOI 10.1103/PhysRevB.61.9657; Javorsky P, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.014404; Kumar CMN, 2016, J PHYS-CONDENS MAT, V28, DOI 10.1088/0953-8984/28/47/476001; Ladak S, 2010, NAT PHYS, V6, P359, DOI 10.1038/NPHYS1628; Lhotel E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06212-2; Lhotel E, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.197202; Matsuhira K, 2002, J PHYS-CONDENS MAT, V14, pL559, DOI 10.1088/0953-8984/14/29/101; Mengotti E, 2011, NAT PHYS, V7, P68, DOI [10.1038/nphys1794, 10.1038/NPHYS1794]; MENTINK SAM, 1994, PHYS REV LETT, V73, P1031, DOI 10.1103/PhysRevLett.73.1031; Mirebeau I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.246402; Moller G, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.140409; Morosan E, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.014445; Morosan E, 2004, J MAGN MAGN MATER, V277, P298, DOI 10.1016/j.jmmm.2003.11.014; Morris DJP, 2009, SCIENCE, V326, P411, DOI 10.1126/science.1178868; Mun ED, 2010, J MAGN MAGN MATER, V322, P3527, DOI 10.1016/j.jmmm.2010.06.057; Nakatsuji S, 2015, NATURE, V527, P212, DOI 10.1038/nature15723; Nisoli C, 2013, REV MOD PHYS, V85, P1473, DOI 10.1103/RevModPhys.85.1473; Paddison JAM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13842; Pauling L, 1935, J AM CHEM SOC, V57, P2680, DOI 10.1021/ja01315a102; Petricek V, 2014, Z KRIST-CRYST MATER, V229, P345, DOI 10.1515/zkri-2014-1737; Prozorov R, 2018, PHYS REV APPL, V10, DOI 10.1103/PhysRevApplied.10.014030; Qi YB, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.184105; Qi Y, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.094418; Ramirez AP, 1999, NATURE, V399, P333, DOI 10.1038/20619; Rau JG, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.144417; Russina M, 2018, PHYSICA B, V551, P506, DOI 10.1016/j.physb.2017.12.026; Saito H, 2018, J PHYS SOC JPN, V87, DOI 10.7566/JPSJ.87.033702; Scheie A, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.180407; Shindou R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.116801; Stokes H.T., 2005, J APPL CRYSTALLOGR, V38, P237, DOI DOI 10.1107/S0021889804031528; Tabata Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.257205; Taguchi Y, 2001, SCIENCE, V291, P2573, DOI 10.1126/science.1058161; TAKAGI T, 1993, J PHYS SOC JPN, V62, P3943, DOI 10.1143/JPSJ.62.3943; Thoma H, 2018, J APPL CRYSTALLOGR, V51, P17, DOI 10.1107/S160057671800078X; Wang RF, 2006, NATURE, V439, P303, DOI 10.1038/nature04447; Wills AS, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.144407; WOLF M, 1988, J PHYS A-MATH GEN, V21, P2195, DOI 10.1088/0305-4470/21/9/032; Zhang S, 2013, NATURE, V500, P553, DOI 10.1038/nature12399	64	14	14	22	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1218	+		10.1126/science.aaw1666	http://dx.doi.org/10.1126/science.aaw1666			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9DP	32165582	Green Submitted			2022-12-28	WOS:000520023800036
J	Garrett, WS				Garrett, Wendy S.			Enterococcus in Graft-versus-Host Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Garrett, Wendy S.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Garrett, Wendy S.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Mol Metab, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Garrett, WS (corresponding author), Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.; Garrett, WS (corresponding author), Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Mol Metab, Boston, MA 02115 USA.			van den Brink, Marcel/0000-0003-0696-4401; Garrett, Wendy/0000-0002-5092-0150				Fredricks DN, 2019, J CLIN INVEST, V129, P1808, DOI 10.1172/JCI125797; Gill PA, 2018, ALIMENT PHARM THER, V48, P15, DOI 10.1111/apt.14689; Jenq RR, 2015, BIOL BLOOD MARROW TR, V21, P1373, DOI 10.1016/j.bbmt.2015.04.016; Kim SG, 2019, NATURE, V572, P665, DOI 10.1038/s41586-019-1501-z; Stein-Thoeringer CK, 2019, SCIENCE, V366, P1143, DOI 10.1126/science.aax3760	5	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2020	382	11					1064	1066		10.1056/NEJMcibr1915978	http://dx.doi.org/10.1056/NEJMcibr1915978			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU7TA	32160669				2022-12-28	WOS:000519914300014
J	Odor, PM; Bampoe, S; Gilhooly, D; Creagh-Brown, B; Moonesinghe, SR				Odor, Peter M.; Bampoe, Sohail; Gilhooly, David; Creagh-Brown, Benedict; Moonesinghe, S. Ramani			Perioperative interventions for prevention of postoperative pulmonary complications: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; UPPER ABDOMINAL-SURGERY; TIDAL-VOLUME VENTILATION; POSITIVE AIRWAY PRESSURE; END-EXPIRATORY PRESSURE; NEUROMUSCULAR-BLOCKING-AGENTS; PATIENT-CONTROLLED ANALGESIA; LUNG-PROTECTIVE VENTILATION; QUALITY IMPROVEMENT PROGRAM; MAJOR ELECTIVE SURGERY	OBJECTIVE To identify, appraise, and synthesise the best available evidence on the efficacy of perioperative interventions to reduce postoperative pulmonary complications (PPCs) in adult patients undergoing non-cardiac surgery. DESIGN Systematic review and meta-analysis of randomised controlled trials. DATA SOURCES Medline, Embase, CINHAL, and CENTRAL from January 1990 to December 2017. ELIGIBILITY CRITERIA Randomised controlled trials investigating short term, protocolised medical interventions conducted before, during, or after non-cardiac surgery were included. Trials with clinical diagnostic criteria for PPC outcomes were included. Studies of surgical technique or physiological or biochemical outcomes were excluded. DATA EXTRACTION AND SYNTHESIS Reviewers independently identified studies, extracted data, and assessed the quality of evidence. Meta analyses were conducted to calculate risk ratios with 95% confidence intervals. Quality of evidence was summarised in accordance with GRADE methods. The primary outcome was the incidence of PPCs. Secondary outcomes were respiratory infection, atelectasis, length of hospital stay, and mortality. Trial sequential analysis was used to investigate the reliability and conclusiveness of available evidence. Adverse effects of interventions were riot measured or compared. RESULTS 117 trials enrolled 21 940 participants, investigating 11 categories of intervention. 95 randomised controlled trials enrolling 18 062 participants were included in meta-analysis; 22 trials were excluded from meta-analysis because the interventions were riot sufficiently similar to be pooled. No high quality evidence was found for interventions to reduce the primary outcome (incidence of PPCs). Seven interventions had low or moderate quality evidence with confidence intervals indicating a probable reduction in PPCs: enhanced recovery pathways (risk ratio 0.35, 95% confidence interval 0,21 to 0.58), prophylactic mucolytics (0.40, 0.23 to 0.67), postoperative continuous positive airway pressure ventilation (0.49, 0.24 to 0.99), lung protective intraoperative ventilation (0,52, 0,30 to 0,88), prophylactic respiratory physiotherapy (0.55, 0.32 to 0.93), epidural analgesia (0.77, 0.65 to 0.92), and goal directed haemodynamic therapy (0.87, 0.77 to 0.98). Moderate quality evidence showed no benefit for incentive spirometry in preventing PPCs. Trial sequential analysis adjustment confidently supported a relative risk reduction of 25% in PPCs for prophylactic respiratory physiotherapy, epidural analgesia, enhanced recovery pathways, and goal directed haemodynamic therapies. Insufficient data were available to support or refute equivalent relative risk reductions for other interventions. CONCLUSIONS Predominantly low quality evidence favours multiple perioperative PPC reduction strategies. Clinicians may choose to reassess their perioperative care pathways, but the results indicate that new trials with a low risk of bias are needed to obtain conclusive evidence of efficacy for many of these interventions. STUDY REGISTRATION Prospero CRD42016035662.	[Odor, Peter M.; Bampoe, Sohail; Gilhooly, David; Moonesinghe, S. Ramani] Univ Coll Hosp, Dept Anaesthesia & Perioperat Med, London, England; [Creagh-Brown, Benedict] Royal Surrey Cty Hosp NHS Fdn Trust, Surrey Perioperat Anaesthesia Crit Care Collabora, Intens Care Unit, Guildford, Surrey, England; [Creagh-Brown, Benedict] Univ Surrey, Fac Hlth & Med Sci, Dept Clin & Expt Med, Guildford, Surrey, England; [Moonesinghe, S. Ramani] UCL, Div Surg & Intervent Sci, Res Dept Targeted Intervent, UCL UCLH Surg Outcomes Res Ctr,UCL Ctr Perioperat, London, England	University of London; University College London; Royal Surrey County Hospital; University of Surrey; University of London; University College London	Odor, PM (corresponding author), Univ Coll Hosp, Dept Anaesthesia & Perioperat Med, London, England.	peter.odor@nhs.net		Moonesinghe, Suneetha Ramani/0000-0002-6730-5824				Abbott TEF, 2018, BRIT J ANAESTH, V120, P1066, DOI 10.1016/j.bja.2018.02.007; Abraham-Nordling M, 2012, BRIT J SURG, V99, P186, DOI 10.1002/bjs.7702; Ackland GL, 2015, LANCET RESP MED, V3, P33, DOI [10.1016/s2213-2600(14)70205-X, 10.1016/S2213-2600(14)70205-X]; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Aretha D, 2017, INT J OBSTET ANESTH, V30, P30, DOI 10.1016/j.ijoa.2016.12.004; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Barbagallo M, 2012, RESP CARE, V57, P1418, DOI 10.4187/respcare.00838; Benes J, 2010, CRIT CARE, V14, DOI 10.1186/cc9070; Berg H, 1997, ACTA ANAESTH SCAND, V41, P1095, DOI 10.1111/j.1399-6576.1997.tb04851.x; Bohner H, 2002, LANGENBECK ARCH SURG, V387, P21, DOI 10.1007/s00423-002-0281-2; Boisseau N, 2001, BRIT J ANAESTH, V87, P564, DOI 10.1093/bja/87.4.564; BOYD O, 1993, JAMA-J AM MED ASSOC, V270, P2699, DOI 10.1001/jama.270.22.2699; Brandstrup B, 2003, ANN SURG, V238, P641, DOI 10.1097/01.sla.0000094387.50865.23; Brocki BC, 2016, EUR J CARDIO-THORAC, V49, P1483, DOI 10.1093/ejcts/ezv359; Brueckmann B, 2015, BRIT J ANAESTH, V115, P743, DOI 10.1093/bja/aev104; Buse GL, 2014, CAN MED ASSOC J, V186, pE52, DOI 10.1503/cmaj.130901; Bush HL, 1998, J VASC SURG, V27, P211; Butterly A, 2010, BRIT J ANAESTH, V105, P304, DOI 10.1093/bja/aeq157; Cai HW, 2007, J CLIN ANESTH, V19, P125, DOI 10.1016/j.jclinane.2006.08.008; Calvo-Vecino JM, 2018, BRIT J ANAESTH, V120, P734, DOI 10.1016/j.bja.2017.12.018; Canet J, 2015, EUR J ANAESTH, V32, P458, DOI 10.1097/EJA.0000000000000223; Canet J, 2010, ANESTHESIOLOGY, V113, P1338, DOI 10.1097/ALN.0b013e3181fc6e0a; Cassidy MR, 2013, JAMA SURG, V148, P740, DOI 10.1001/jamasurg.2013.358; Cecconi M, 2011, CRIT CARE, V15, DOI 10.1186/cc10246; Choi ES, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183311; Choi G, 2006, ANESTHESIOLOGY, V105, P689, DOI 10.1097/00000542-200610000-00013; Chopra V, 2013, BMJ QUAL SAF, V22, P93, DOI 10.1136/bmjqs-2012-001480; CHRISTENSEN EF, 1991, ACTA ANAESTH SCAND, V35, P97, DOI 10.1111/j.1399-6576.1991.tb03255.x; Chumillas S, 1998, ARCH PHYS MED REHAB, V79, P5, DOI 10.1016/S0003-9993(98)90198-8; Condie E, 1993, PHYSIOTHERAPY, V79, P547, DOI [10.1016/S0031-9406(10)60295-7, DOI 10.1016/S0031-9406(10)60295-7]; DAVIES MJ, 1993, ANAESTH INTENS CARE, V21, P790, DOI 10.1177/0310057X9302100607; de la Gala F, 2017, BRIT J ANAESTH, V119, P655, DOI 10.1093/bja/aex230; Denehy L, 2001, Physiother Res Int, V6, P236, DOI 10.1002/pri.231; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dronkers J, 2008, CLIN REHABIL, V22, P134, DOI 10.1177/0269215507081574; Edwards MR, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023455; Esme H, 2012, EUR J CARDIO-THORAC, V41, P10, DOI 10.1016/j.ejcts.2011.03.056; FEGIZ G, 1991, LUNG, V169, P69; Feng F, 2013, WORLD J GASTROENTERO, V19, P3642, DOI 10.3748/wjg.v19.i23.3642; Fernandez-Bustamante A, 2017, JAMA SURG, V152, P157, DOI 10.1001/jamasurg.2016.4065; Ferrando C, 2018, LANCET RESP MED, V6, P193, DOI 10.1016/S2213-2600(18)30024-9; Ferrando C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177399; Fisher BW, 2002, AM J MED, V112, P219, DOI 10.1016/S0002-9343(01)01082-8; Fleisher LA, 2014, CIRCULATION, V130, P2215, DOI 10.1161/CIR.0000000000000105; Fleron MH, 2003, ANESTH ANALG, V97, P2, DOI 10.1213/01.ANE.0000066355.07482.0C; Futier E, 2016, INTENS CARE MED, V42, P1888, DOI 10.1007/s00134-016-4594-y; Futier E, 2013, NEW ENGL J MED, V369, P428, DOI 10.1056/NEJMoa1301082; Futier E, 2010, ARCH SURG-CHICAGO, V145, P1193, DOI 10.1001/archsurg.2010.275; Gaitini LA, 2004, ANESTHESIOLOGY, V101, P316, DOI 10.1097/00000542-200408000-00011; Gan TJ, 2002, ANESTHESIOLOGY, V97, P820, DOI 10.1097/00000542-200210000-00012; Gao W, 2015, ANESTHESIOLOGY, V122, P1235, DOI 10.1097/ALN.0000000000000627; Garnett RL, 1996, CAN J ANAESTH, V43, P769, DOI 10.1007/BF03013027; Gilhooly D, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-019-0894-2; Gonenc M, 2014, AM J SURG, V207, P807, DOI 10.1016/j.amjsurg.2013.07.025; Grabitz SD, 2019, ANESTH ANALG, V128, P1129, DOI 10.1213/ANE.0000000000004028; Griffiths SV, 2018, PERIOPER MED-LONDON, V7, DOI 10.1186/s13741-018-0084-9; Guay J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011151.pub2; Hemmes SNT, 2014, LANCET, V384, P495, DOI 10.1016/S0140-6736(14)60416-5; Hewidy AA, 2016, EGYPT J CHEST DIS TU, V65, P701, DOI 10.1016/j.ejcdt.2016.01.012; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Holte K, 2007, BRIT J ANAESTH, V99, P500, DOI 10.1093/bja/aem211; Holte K, 2007, ANESTH ANALG, V105, P465, DOI 10.1213/01.ane.0000263268.08222.19; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Jakobsen JC, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-34; Jammer I, 2015, EUR J ANAESTH, V32, P88, DOI 10.1097/EJA.0000000000000118; Jia YT, 2014, LANGENBECK ARCH SURG, V399, P77, DOI 10.1007/s00423-013-1151-9; Remistico PPJ, 2011, REV BRAS ANESTESIOL, V61, P163, DOI 10.1016/S0034-7094(11)70021-6; Khan NA, 2006, J GEN INTERN MED, V21, P177, DOI 10.1111/j.1525-1497.2006.00319.x; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; KILBRIDE MJ, 1992, SURG GYNECOL OBSTET, V174, P137; Kindgen-Milles D, 2005, CHEST, V128, P821, DOI 10.1378/chest.128.2.821; Kirmeier E, 2019, LANCET RESP MED, V7, P129, DOI 10.1016/S2213-2600(18)30294-7; Kulkarni SR, 2010, ANN ROY COLL SURG, V92, P700, DOI 10.1308/003588410X12771863936648; Lai CJ, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-016-0291-1; Lawrence VA, 1995, J GEN INTERN MED, V10, P671, DOI 10.1007/BF02602761; Lawrence VA, 2006, ANN INTERN MED, V144, P596, DOI 10.7326/0003-4819-144-8-200604180-00011; Lee SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002854; Levin MA, 2014, BRIT J ANAESTH, V113, P97, DOI 10.1093/bja/aeu054; Lobo DN, 2002, LANCET, V359, P1812, DOI 10.1016/S0140-6736(02)08711-1; Lopes MR, 2007, CRIT CARE, V11, DOI 10.1186/cc6117; Lorut C, 2014, INTENS CARE MED, V40, P220, DOI 10.1007/s00134-013-3150-2; Lucangelo U, 2009, CRIT CARE MED, V37, P1663, DOI 10.1097/CCM.0b013e31819ef9e1; Ludwig Corinna, 2011, Asian Cardiovasc Thorac Ann, V19, P10, DOI 10.1177/0218492310394664; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mackay MR, 2005, AUST J PHYSIOTHER, V51, P151, DOI 10.1016/S0004-9514(05)70021-0; Mann C, 2000, ANESTHESIOLOGY, V92, P433, DOI 10.1097/00000542-200002000-00025; Mayer J, 2010, CRIT CARE, V14, DOI 10.1186/cc8875; Mazo V, 2014, ANESTHESIOLOGY, V121, P219, DOI 10.1097/ALN.0000000000000334; McAlister FA, 2005, AM J RESP CRIT CARE, V171, P514, DOI 10.1164/rccm.200408-1069OC; McArdle GT, 2009, ANN SURG, V250, P28, DOI 10.1097/SLA.0b013e3181ad61c8; McLean DJ, 2015, ANESTHESIOLOGY, V122, P1201, DOI 10.1097/ALN.0000000000000674; Meyer MJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1460; Miskovic A, 2017, BRIT J ANAESTH, V118, P317, DOI 10.1093/bja/aex002; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Monsel A, 2016, ANESTHESIOLOGY, V124, P1041, DOI 10.1097/ALN.0000000000001053; Moore JA, 2017, ANAESTHESIA, V72, P317, DOI 10.1111/anae.13763; Muller S, 2009, GASTROENTEROLOGY, V136, P842, DOI 10.1053/j.gastro.2008.10.030; Munday GS, 2014, AM J SURG, V208, P835, DOI 10.1016/j.amjsurg.2014.05.005; Myles PS, 2018, NEW ENGL J MED, V378, P2263, DOI 10.1056/NEJMoa1801601; National Institute for Health Research, 2019, EFF COST EFF INSPIRA; Neto AS, 2016, LANCET RESP MED, V4, P272, DOI 10.1016/S2213-2600(16)00057-6; Nielsen J, 2005, INTENS CARE MED, V31, P1189, DOI 10.1007/s00134-005-2732-z; Nisanevich V, 2005, ANESTHESIOLOGY, V103, P25, DOI 10.1097/00000542-200507000-00008; Nishimura M, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0084-5; Norris EJ, 2001, ANESTHESIOLOGY, V95, P1054, DOI 10.1097/00000542-200111000-00006; Olsen MF, 1999, SURG ENDOSC, V13, P260, DOI 10.1007/s004649900958; Olsen MF, 1997, BRIT J SURG, V84, P1535, DOI 10.1002/bjs.1800841111; Park SJ, 2016, SURG ENDOSC, V30, P4598, DOI 10.1007/s00464-016-4797-x; Park WY, 2001, ANN SURG, V234, P560; Parker MJ, 2015, INJURY, V46, P1562, DOI 10.1016/j.injury.2015.05.004; Patel JM, 2016, PERIOPER MED-LONDON, V5, DOI 10.1186/s13741-016-0033-4; Pearse R, 2005, CRIT CARE, V9, pR687, DOI 10.1186/cc3887; Pearse RM, 2017, MINERVA ANESTESIOL, V83, P175, DOI 10.23736/S0375-9393.16.11502-0; Pearse RM, 2014, JAMA-J AM MED ASSOC, V311, P2181, DOI 10.1001/jama.2014.5305; Perrin C, 2007, RESP MED, V101, P1572, DOI 10.1016/j.rmed.2006.12.002; Qutub H, 2014, EUR J ANAESTH, V31, P466, DOI 10.1097/EJA.0000000000000072; Radovanovic D, 2017, ACTA CLIN CROAT, V56, P244, DOI 10.20471/acc.2017.56.02.07; Reeve JC, 2010, EUR J CARDIO-THORAC, V37, P1158, DOI 10.1016/j.ejcts.2009.12.011; Refai M, 2009, EUR J CARDIO-THORAC, V35, P469, DOI 10.1016/j.ejcts.2008.11.015; Rigg JRA, 2002, LANCET, V359, P1276, DOI 10.1016/S0140-6736(02)08266-1; Sabate S, 2014, CURR OPIN ANESTHESIO, V27, P201, DOI 10.1097/ACO.0000000000000045; Sandham JD, 2003, NEW ENGL J MED, V348, P5, DOI 10.1056/NEJMoa021108; Schwulst SJ, 2012, SURG CLIN N AM, V92, P285, DOI 10.1016/j.suc.2012.01.011; Sen M, 2009, DIGEST DIS SCI, V54, P2742, DOI 10.1007/s10620-008-0677-0; Neto AS, 2015, ANESTHESIOLOGY, V123, P66, DOI 10.1097/ALN.0000000000000706; Severgnini P, 2013, ANESTHESIOLOGY, V118, P1307, DOI 10.1097/ALN.0b013e31829102de; Shander A, 2011, CRIT CARE MED, V39, P2163, DOI 10.1097/CCM.0b013e31821f0522; Shen Y, 2014, J THORAC CARDIOV SUR, V147, P544; Silva YR, 2013, PHYSIOTHERAPY, V99, P187, DOI 10.1016/j.physio.2012.09.006; Smith PR, 2010, RESPIRATION, V80, P269, DOI 10.1159/000253881; Sokouti Mohsen, 2011, Tanaffos, V10, P12; American Medical Association, 2004, MMWR Recomm Rep, V53, P1; Talab HF, 2009, ANESTH ANALG, V109, P1511, DOI 10.1213/ANE.0b013e3181ba7945; Tao TZ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005208; Thorlund K., 2017, USER MANUAL TRIAL SE, V2nd edition, P1; Treschan TA, 2012, BRIT J ANAESTH, V109, P263, DOI 10.1093/bja/aes140; Treschan TA, 2017, EUR J ANAESTH, V34, P534, DOI 10.1097/EJA.0000000000000626; TUMAN KJ, 1991, ANESTH ANALG, V73, P696; Tyagi A, 2010, J ANAESTHESIOL CLIN, V26, P345; Valentine RJ, 1998, J VASC SURG, V27, P203, DOI 10.1016/S0741-5214(98)70351-9; van Adrichem EJ, 2014, ANN SURG ONCOL, V21, P2353, DOI 10.1245/s10434-014-3612-y; Venn R, 2002, BRIT J ANAESTH, V88, P65, DOI 10.1093/bja/88.1.65; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; Warner DO, 2000, ANESTHESIOLOGY, V92, P1467, DOI 10.1097/00000542-200005000-00037; Watson X, 2018, BRIT J ANAESTH, V121, P909, DOI 10.1016/j.bja.2018.04.048; Weingarten TN, 2010, BRIT J ANAESTH, V104, P16, DOI 10.1093/bja/aep319; Wetterslev J, 2001, EUR J ANAESTH, V18, P358, DOI 10.1046/j.0265-0215.2000.00842.x; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wilson J, 1999, BRIT MED J, V318, P1099, DOI 10.1136/bmj.318.7191.1099; Wong PF, 2007, BRIT J SURG, V94, P421, DOI 10.1002/bjs.5631; Yang CK, 2015, J SURG RES, V198, P441, DOI 10.1016/j.jss.2015.03.028; Yang DJ, 2016, ANN SURG, V263, P881, DOI 10.1097/SLA.0000000000001443; Yang M, 2011, CHEST, V139, P530, DOI 10.1378/chest.09-2293; Yu WK, 2010, SURGERY, V147, P542, DOI 10.1016/j.surg.2009.10.036; Yu Y, 2017, RES ASTRON ASTROPHYS, V17, DOI 10.1088/1674-4527/17/3/28; Zhu ZX, 2013, GASTRIC CANCER, V16, P193, DOI 10.1007/s10120-012-0168-z	156	58	68	5	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2020	368								m540	10.1136/bmj.m540	http://dx.doi.org/10.1136/bmj.m540			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AR	32161042	Green Published, hybrid			2022-12-28	WOS:000520012800005
J	Gorgulla, C; Boeszoermenyi, A; Wang, ZF; Fischer, PD; Coote, PW; Das, KPM; Malets, YS; Radchenko, DS; Moroz, YS; Scott, DA; Fackeldey, K; Hoffmann, M; Iavniuk, I; Wagner, G; Arthanari, H				Gorgulla, Christoph; Boeszoermenyi, Andras; Wang, Zi-Fu; Fischer, Patrick D.; Coote, Paul W.; Padmanabha Das, Krishna M.; Malets, Yehor S.; Radchenko, Dmytro S.; Moroz, Yurii S.; Scott, David A.; Fackeldey, Konstantin; Hoffmann, Moritz; Iavniuk, Iryna; Wagner, Gerhard; Arthanari, Haribabu			An open-source drug discovery platform enables ultra-large virtual screens	NATURE			English	Article							INTERFERENCE COMPOUNDS PAINS; SCORING FUNCTION; ASSAY; DOCKING; AGGREGATION; LIBRARIES; NRF2	VirtualFlow, an open-source drug discovery platform, enables the efficient preparation and virtual screening of ultra-large ligand libraries to identify molecules that bind with high affinity to target proteins. On average, an approved drug currently costs US$2-3 billion and takes more than 10 years to develop(1). In part, this is due to expensive and time-consuming wet-laboratory experiments, poor initial hit compounds and the high attrition rates in the (pre-)clinical phases. Structure-based virtual screening has the potential to mitigate these problems. With structure-based virtual screening, the quality of the hits improves with the number of compounds screened(2). However, despite the fact that large databases of compounds exist, the ability to carry out large-scale structure-based virtual screening on computer clusters in an accessible, efficient and flexible manner has remained difficult. Here we describe VirtualFlow, a highly automated and versatile open-source platform with perfect scaling behaviour that is able to prepare and efficiently screen ultra-large libraries of compounds. VirtualFlow is able to use a variety of the most powerful docking programs. Using VirtualFlow, we prepared one of the largest and freely available ready-to-dock ligand libraries, with more than 1.4 billion commercially available molecules. To demonstrate the power of VirtualFlow, we screened more than 1 billion compounds and identified a set of structurally diverse molecules that bind to KEAP1 with submicromolar affinity. One of the lead inhibitors (iKeap1) engages KEAP1 with nanomolar affinity (dissociation constant (K-d) = 114 nM) and disrupts the interaction between KEAP1 and the transcription factor NRF2. This illustrates the potential of VirtualFlow to access vast regions of the chemical space and identify molecules that bind with high affinity to target proteins.	[Gorgulla, Christoph; Boeszoermenyi, Andras; Wang, Zi-Fu; Fischer, Patrick D.; Coote, Paul W.; Padmanabha Das, Krishna M.; Scott, David A.; Wagner, Gerhard; Arthanari, Haribabu] Harvard Univ, Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Gorgulla, Christoph] Harvard Univ, Dept Phys, Fac Arts & Sci, Cambridge, MA 02138 USA; [Gorgulla, Christoph; Boeszoermenyi, Andras; Fischer, Patrick D.; Coote, Paul W.; Padmanabha Das, Krishna M.; Scott, David A.; Arthanari, Haribabu] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Fischer, Patrick D.] Saarland Univ, Dept Pharm Pharmaceut & Med Chem, Saarbrucken, Germany; [Malets, Yehor S.; Radchenko, Dmytro S.; Iavniuk, Iryna] Enamine, Kiev, Ukraine; [Malets, Yehor S.; Radchenko, Dmytro S.; Moroz, Yurii S.] Natl Taras Shevchenko Univ Kyiv, Kiev, Ukraine; [Moroz, Yurii S.] Chemspace, Kiev, Ukraine; [Fackeldey, Konstantin] Zuse Inst Berlin, Berlin, Germany; [Fackeldey, Konstantin] Tech Univ Berlin, Inst Math, Berlin, Germany; [Hoffmann, Moritz] Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany	Harvard University; Harvard Medical School; Harvard University; Harvard University; Dana-Farber Cancer Institute; Saarland University; Enamine Ltd; Ministry of Education & Science of Ukraine; Taras Shevchenko National University Kiev; Zuse Institute Berlin; Technical University of Berlin; Free University of Berlin	Gorgulla, C; Arthanari, H (corresponding author), Harvard Univ, Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Gorgulla, C (corresponding author), Harvard Univ, Dept Phys, Fac Arts & Sci, Cambridge, MA 02138 USA.; Gorgulla, C; Arthanari, H (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	cgorgulla@g.harvard.edu; hari@hms.harvard.edu	Boeszoermenyi, Andras/AAD-9808-2020; Malets, Yehor/GYU-0499-2022; Gorgulla, Christoph/HGU-9277-2022; Das, Krishna Mohan Padmanabha/AAV-3476-2020; Radchenko, Dmytro/N-5005-2015	Boeszoermenyi, Andras/0000-0001-9810-7241; Malets, Yehor/0000-0002-3029-3065; Das, Krishna Mohan Padmanabha/0000-0002-0116-4256; Arthanari, Haribabu/0000-0002-7281-1289; Scott, David/0000-0003-3243-528X; Radchenko, Dmytro/0000-0001-5444-7754; Fischer, Patrick/0000-0003-4160-5295; Moroz, Yurii/0000-0001-6073-002X	Max Planck Institute for Molecular Genetics in Berlin; Einstein Center for Mathematics Berlin; Deutsche Forschungsgemeinschaft [CRC 958, CRC 1114]; Austrian Science Fund's Schrodinger Fellowship [J3872-B21]; American Heart Association [19POST34380800]; Templeton Religion Trust [TRT 0159]; ARO [W911NF1910302]; Max Kade Foundation; Austrian Academy of Sciences; Claudia Adams Barr Program for Innovative Cancer Research; NIH [CA200913, AI037581, GM129026]	Max Planck Institute for Molecular Genetics in Berlin; Einstein Center for Mathematics Berlin; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund's Schrodinger Fellowship(Austrian Science Fund (FWF)); American Heart Association(American Heart Association); Templeton Religion Trust; ARO; Max Kade Foundation; Austrian Academy of Sciences; Claudia Adams Barr Program for Innovative Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Zhang for help with the binding assays; the research computing teams of the Faculty of Arts and Sciences at Harvard University (especially S. Yockel, J. Cuff, F. Pontiggia and P. Edmon), the Julich Supercomputing Centre, the Freie Universitat (especially J. Dreger), the Harvard Medical School (HMS), the HLRN and the IT support of HMS (especially K. Bayer, G. Sekmokas and D. Morgan) for their support; K. E. Leigh, N. Gray, M. Kostic, A. Dubey, B. Klein, S. Schwaninger and S. Wu for discussions and manuscript preparation; the ICCB-Longwood Screening and East Quad NMR Facilities at HMS for assistance with the ligand screen; K. Arnett and the Center for Macromolecular Interactions at the HMS for advice on the SPR and BLI experiments; A. Jaffe for his support; and the teams from the Google Cloud Platform (especially S. Fang, R. Goldenbroit and D. Payne), Amazon Web Services, and Fluid Numerics for their support. This work was partially funded by a scholarship to C.G. from the Max Planck Institute for Molecular Genetics in Berlin and a scholarship from the Einstein Center for Mathematics Berlin. C.G. and K.F. thank the ECMath and MATHEON. C.G. is grateful to C. Schutte and P. Imhof for their support and supervision during his doctoral studies. We thank Z. Alirezaeizanjani, M. Bagherpoor and Anita Nivedha for testing VirtualFlow. M.H. acknowledges funding from Deutsche Forschungsgemeinschaft (CRC 958/Project A04, CRC 1114/Project A04). A.B. was supported by an Austrian Science Fund's Schrodinger Fellowship (J3872-B21) and an American Heart Association's fellowship (19POST34380800). This research was supported in part by grant TRT 0159 from the Templeton Religion Trust and by ARO Grant W911NF1910302 to A. Jaffe. K.M.P.D. was supported by a fellowship from the Max Kade Foundation and the Austrian Academy of Sciences. H.A. acknowledges funding from the Claudia Adams Barr Program for Innovative Cancer Research. G.W. acknowledges support from NIH grant CA200913, AI037581 and GM129026.	Alhossary A, 2015, BIOINFORMATICS, V31, P2214, DOI 10.1093/bioinformatics/btv082; Amaro RE, 2018, BIOPHYS J, V114, P2271, DOI 10.1016/j.bpj.2018.02.038; Andrei SA, 2017, EXPERT OPIN DRUG DIS, V12, P925, DOI 10.1080/17460441.2017.1346608; Baell JB, 2018, ACS CHEM BIOL, V13, P36, DOI 10.1021/acschembio.7b00903; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Bohacek RS, 1996, MED RES REV, V16, P3, DOI 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO;2-6; Capuzzi SJ, 2017, J CHEM INF MODEL, V57, P417, DOI 10.1021/acs.jcim.6b00465; Cuadrado A, 2019, NAT REV DRUG DISCOV, V18, P295, DOI 10.1038/s41573-018-0008-x; Davies TG, 2016, J MED CHEM, V59, P3991, DOI 10.1021/acs.jmedchem.6b00228; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; Gans P, 2010, ANGEW CHEM INT EDIT, V49, P1958, DOI 10.1002/anie.200905660; Hamalainen MD, 2008, J BIOMOL SCREEN, V13, P202, DOI 10.1177/1087057108314651; Hassan NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15571-7; Houston DR, 2013, J CHEM INF MODEL, V53, P384, DOI 10.1021/ci300399w; Hulme, 1992, RECEPTOR LIGAND INTE, V92; Hutsell SQ, 2010, METHODS MOL BIOL, V627, P75, DOI 10.1007/978-1-60761-670-2_4; Irwin JJ, 2015, J MED CHEM, V58, P7076, DOI 10.1021/acs.jmedchem.5b01105; Jiang XH, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-18; Koebel MR, 2016, J CHEMINFORMATICS, V8, DOI 10.1186/s13321-016-0139-1; Koes DR, 2013, J CHEM INF MODEL, V53, P1893, DOI 10.1021/ci300604z; LaPlante SR, 2013, J MED CHEM, V56, P5142, DOI 10.1021/jm400535b; Lu MC, 2018, EUR J MED CHEM, V146, P251, DOI 10.1016/j.ejmech.2018.01.063; Lyu J, 2019, NATURE, V566, P224, DOI 10.1038/s41586-019-0917-9; Marcotte D, 2013, BIOORGAN MED CHEM, V21, P4011, DOI 10.1016/j.bmc.2013.04.019; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nivedha AK, 2016, J CHEM THEORY COMPUT, V12, P892, DOI 10.1021/acs.jctc.5b00834; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Pallesen JS, 2018, J MED CHEM, V61, P8088, DOI 10.1021/acs.jmedchem.8b00358; Ragoza M, 2017, J CHEM INF MODEL, V57, P942, DOI 10.1021/acs.jcim.6b00740; Ravindranath PA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004586; Reymond JL, 2015, ACCOUNTS CHEM RES, V48, P722, DOI 10.1021/ar500432k; Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Yonchuk JG, 2017, J PHARMACOL EXP THER, V363, P114, DOI 10.1124/jpet.117.241794; Zhang SX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-126	35	171	173	39	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR	2020	580	7805					663	+		10.1038/s41586-020-2117-z	http://dx.doi.org/10.1038/s41586-020-2117-z		MAR 2020	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LI6NQ	32152607	Green Accepted			2022-12-28	WOS:000528161800001
J	Wang, QL; Boshoff, HIM; Harrison, JR; Ray, PC; Green, SR; Wyatt, PG; Barry, CE				Wang, Qinglan; Boshoff, Helena I. M.; Harrison, Justin R.; Ray, Peter C.; Green, Simon R.; Wyatt, Paul G.; Barry, Clifton E., III			PE/PPE proteins mediate nutrient transport across the outer membrane of Mycobacterium tuberculosis	SCIENCE			English	Article							BOVIS BCG; CELL-WALL; REPLICATION; SECRETION; CHANNEL; COMPLEX	Mycobacterium tuberculosis has an unusual outer membrane that lacks canonical porin proteins for the transport of small solutes to the periplasm. We discovered that 3,3-bis-di(methylsulfonyl)propionamide (3bMP1) inhibits the growth of M. tuberculosis, and resistance to this compound is conferred by mutation within a member of the proline-proline-glutamate (PPE) family, PPE51. Deletion of PPE51 rendered M. tuberculosis cells unable to replicate on propionamide, glucose, or glycerol. Growth was restored upon loss of the mycobacterial cell wall component phthiocerol dimycocerosate. Mutants in other proline-glutamate (PE)/PPE clusters, responsive to magnesium and phosphate, also showed a phthiocerol dimycocerosate-dependent growth compromise upon limitation of the corresponding substrate. Phthiocerol dimycocerosate determined the low permeability of the mycobacterial outer membrane, and the PE/PPE proteins apparently act as solute-specific channels.	[Wang, Qinglan; Boshoff, Helena I. M.; Barry, Clifton E., III] NIAID, TB Res Sect, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Harrison, Justin R.; Ray, Peter C.; Green, Simon R.; Wyatt, Paul G.] Univ Dundee, James Black Ctr, Coll Life Sci, Drug Discovery Unit, Dundee DD1 5EH, Scotland; [Ray, Peter C.] Exscientia Ltd, Oxford OX1 3LD, England; [Barry, Clifton E., III] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Dundee; University of Cape Town	Barry, CE (corresponding author), NIAID, TB Res Sect, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Barry, CE (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	cbarry@niaid.nih.gov	Wang, Qinglan/AAM-3023-2020; Barry, Clifton E/ABE-7992-2020	Barry, Clifton E/0000-0002-2927-270X; green, simon/0000-0001-5054-4792; Boshoff, Helena/0000-0002-4333-206X; Wang, Qinglan/0000-0002-7629-5058	Intramural Research Program of the NIAID, NIH; Bill and Melinda Gates Foundation through the TB Drug Accelerator program	Intramural Research Program of the NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation through the TB Drug Accelerator program	This work was funded, in part, by the Intramural Research Program of the NIAID, NIH, and by the Bill and Melinda Gates Foundation through the TB Drug Accelerator program.	Anderson RJ, 1929, J BIOL CHEM, V83, P505; Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Ates LS, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0011-2015; Ates LS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005190; Baker JJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22343-4; Belon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116052; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Burggraaf MJ, 2019, MICROB CELL FACT, V18, DOI 10.1186/s12934-019-1093-1; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Copin R, 2014, MBIO, V5, DOI 10.1128/mBio.00960-13; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Danilchanka O, 2014, P NATL ACAD SCI USA, V111, P6750, DOI 10.1073/pnas.1400136111; Delogu G, 2017, ADV EXP MED BIOL, V1019, P191, DOI 10.1007/978-3-319-64371-7_10; Domenech P, 2009, MICROBIOL-SGM, V155, P3532, DOI 10.1099/mic.0.029199-0; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Elliott SR, 2016, MOL MICROBIOL, V100, P510, DOI 10.1111/mmi.13332; Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114; Fishbein S, 2015, MOL MICROBIOL, V96, P901, DOI 10.1111/mmi.12981; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Huff J, 2010, GENE, V468, P8, DOI 10.1016/j.gene.2010.07.012; Kartmann B, 1999, J BACTERIOL, V181, P6543, DOI 10.1128/JB.181.20.6543-6546.1999; Lamrabet O, 2014, MICROB PATHOGENESIS, V76, P10, DOI 10.1016/j.micpath.2014.08.003; Lichtinger T, 1999, FEBS LETT, V454, P349, DOI 10.1016/S0014-5793(99)00844-3; Lovewell RR, 2016, CURR OPIN MICROBIOL, V29, P30, DOI 10.1016/j.mib.2015.10.002; Mailaender C, 2004, MICROBIOL-SGM, V150, P853, DOI 10.1099/mic.0.26902-0; McAdam RA, 2002, MICROBIOL-SGM, V148, P2975, DOI 10.1099/00221287-148-10-2975; Mitra A, 2017, MBIO, V8, DOI 10.1128/mBio.01720-16; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Queval CJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02284; Quigley J, 2017, MBIO, V8, DOI 10.1128/mBio.00148-17; Rock JM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.274; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Shell SS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005641; Solomonson M, 2015, STRUCTURE, V23, P571, DOI 10.1016/j.str.2015.01.002; Speer A, 2015, MOL MICROBIOL, V97, P881, DOI 10.1111/mmi.13073; Stanley SA, 2014, CURR TOP MICROBIOL, V374, P211, DOI 10.1007/82_2013_332; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	42	18	22	7	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1147	+		10.1126/science.aav5912	http://dx.doi.org/10.1126/science.aav5912			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9CD	32139546				2022-12-28	WOS:000520018400045
J	Bello, F; Fagni, F				Bello, Federica; Fagni, Filippo			Nasal Deformity in Granulomatosis with Polyangiitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bello, Federica; Fagni, Filippo] Univ Firenze, Florence, Italy	University of Florence	Bello, F (corresponding author), Univ Firenze, Florence, Italy.	cardioles@gmail.com	Fagni, Filippo/HHZ-0524-2022	Fagni, Filippo/0000-0002-6122-0774					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2020	382	10					951	951		10.1056/NEJMicm1909658	http://dx.doi.org/10.1056/NEJMicm1909658			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KT7TC	32130816				2022-12-28	WOS:000519214900010
J	Tikkanen, RS; Schneider, EC				Tikkanen, Roosa S.; Schneider, Eric C.			Social Spending to Improve Population Health - Does the United States Spend as Wisely as Other Countries?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								If U.S. social spending levels are similar to those of other high-income countries and health care spending is higher, why does U.S. health lag behind? Our social spending mix may be skewed so investments have less impact on population health outcomes than they might.	[Tikkanen, Roosa S.; Schneider, Eric C.] Commonwealth Fund, New York, NY 10021 USA	Commonwealth Fund	Tikkanen, RS (corresponding author), Commonwealth Fund, New York, NY 10021 USA.		Tikkanen, Roosa Sofia/AFO-1626-2022	Tikkanen, Roosa Sofia/0000-0002-9334-8043				[Anonymous], 2019, HLTH GLANCE 2019 OEC; [Anonymous], 2018, OECD EMPLOYMENT OUTL; Papanicolas I, 2019, HEALTH AFFAIR, V38, P1567, DOI 10.1377/hlthaff.2018.05187; Ramon I, 2018, J PUBLIC HEALTH MAN, V24, pE8, DOI 10.1097/PHH.0000000000000557; Rubin J, 2016, ARE BETTER HLTH OUTC	5	4	4	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2020	382	10					885	887		10.1056/NEJMp1916585	http://dx.doi.org/10.1056/NEJMp1916585			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KT7TC	32130810				2022-12-28	WOS:000519214900002
J	[Anonymous]				[Anonymous]			People injured during Delhi riots were denied appropriate care, says report	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Bhuyan A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m13	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2020	368								m922	10.1136/bmj.m922	http://dx.doi.org/10.1136/bmj.m922			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KI	32139444				2022-12-28	WOS:000519537000011
J	Dyer, C				Dyer, Clare			Gender reassignment: legal challenge over use of hormone blockers gets green light	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M146	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2020	368								m876	10.1136/bmj.m876	http://dx.doi.org/10.1136/bmj.m876			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KE	32132010				2022-12-28	WOS:000519536600019
J	Fessler, E; Eckl, EM; Schmitt, S; Mancilla, IA; Meyer-Bender, MF; Hanf, M; Philippou-Massier, J; Krebs, S; Zischka, H; Jae, LT				Fessler, Evelyn; Eckl, Eva-Maria; Schmitt, Sabine; Mancilla, Igor Alves; Meyer-Bender, Matthias F.; Hanf, Monika; Philippou-Massier, Julia; Krebs, Stefan; Zischka, Hans; Jae, Lucas T.			A pathway coordinated by DELE1 relays mitochondrial stress to the cytosol	NATURE			English	Article							CELLS; QUANTITATION; ONTOLOGY	Haploid genetic screening of cells under different types of mitochondrial perturbation shows that a pathway involving OMA1, DELE1 and the eIF2 alpha kinase HRI communicates mitochondrial stress to the cytosol to trigger the integrated stress response. Mitochondrial fidelity is tightly linked to overall cellular homeostasis and is compromised in ageing and various pathologies(1-3). Mitochondrial malfunction needs to be relayed to the cytosol, where an integrated stress response is triggered by the phosphorylation of eukaryotic translation initiation factor 2 alpha (eIF2 alpha) in mammalian cells(4,5). eIF2 alpha phosphorylation is mediated by the four eIF2 alpha kinases GCN2, HRI, PERK and PKR, which are activated by diverse types of cellular stress(6). However, the machinery that communicates mitochondrial perturbation to the cytosol to trigger the integrated stress response remains unknown(1,2,7). Here we combine genome engineering and haploid genetics to unbiasedly identify genes that affect the induction of C/EBP homologous protein (CHOP), a key factor in the integrated stress response. We show that the mitochondrial protease OMA1 and the poorly characterized protein DELE1, together with HRI, constitute the missing pathway that is triggered by mitochondrial stress. Mechanistically, stress-induced activation of OMA1 causes DELE1 to be cleaved into a short form that accumulates in the cytosol, where it binds to and activates HRI via its C-terminal portion. Obstruction of this pathway can be beneficial or adverse depending on the type of mitochondrial perturbation. In addition to the core pathway components, our comparative genetic screening strategy identifies a suite of additional regulators. Together, these findings could be used to inform future strategies to modulate the cellular response to mitochondrial dysfunction in the context of human disease.	[Fessler, Evelyn; Eckl, Eva-Maria; Mancilla, Igor Alves; Meyer-Bender, Matthias F.; Hanf, Monika; Philippou-Massier, Julia; Krebs, Stefan; Jae, Lucas T.] Ludwig Maximilians Univ Munchen, Gene Ctr, Munich, Germany; [Fessler, Evelyn; Eckl, Eva-Maria; Mancilla, Igor Alves; Meyer-Bender, Matthias F.; Hanf, Monika; Philippou-Massier, Julia; Krebs, Stefan; Jae, Lucas T.] Ludwig Maximilians Univ Munchen, Dept Biochem, Munich, Germany; [Schmitt, Sabine; Zischka, Hans] Tech Univ Munich, Sch Med, Inst Toxicol & Environm Hyg, Munich, Germany; [Zischka, Hans] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Mol Toxicol & Pharmacol, Neuherberg, Germany	University of Munich; University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Jae, LT (corresponding author), Ludwig Maximilians Univ Munchen, Gene Ctr, Munich, Germany.; Jae, LT (corresponding author), Ludwig Maximilians Univ Munchen, Dept Biochem, Munich, Germany.	jae@genzentrum.lmu.de	Jae, Lucas/AAH-5342-2020; Jae, Lucas/AAY-3438-2021; Zischka, Hans/M-1490-2017	Jae, Lucas/0000-0002-3531-1760; Meyer-Bender, Matthias/0000-0002-0448-4546; Zischka, Hans/0000-0002-4047-1566; Alves Mancilla, Igor/0000-0002-4361-4219	ERC [StG 804182]; Center for Integrated Protein Science Munich; German Research Foundation (Heinz-Maier-Leibnitz Prize)	ERC(European Research Council (ERC)European Commission); Center for Integrated Protein Science Munich; German Research Foundation (Heinz-Maier-Leibnitz Prize)(German Research Foundation (DFG))	We thank A. Graf and H. Blum for deep-sequencing infrastructure; C. Jung for assistance with confocal microscopy; N. Tafrishi for assistance with cell sorting; S. Theurich for access to Seahorse instrumentation; T. Brummelkamp and V. Hornung for valuable comments on the manuscript; and J. Stingele, R. Beckmann and all members of the Jae lab for helpful discussions. This work was supported by ERC StG 804182 (SOLID), the Center for Integrated Protein Science Munich and the German Research Foundation (Heinz-Maier-Leibnitz Prize) to L.T.J.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baker MJ, 2014, EMBO J, V33, P578, DOI 10.1002/embj.201386474; Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575; Baricault L, 2007, EXP CELL RES, V313, P3800, DOI 10.1016/j.yexcr.2007.08.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brockmann M, 2017, NATURE, V546, P307, DOI 10.1038/nature22376; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Han H, 2018, NUCLEIC ACIDS RES, V46, pD380, DOI 10.1093/nar/gkx1013; Harada T, 2010, APOPTOSIS, V15, P1247, DOI 10.1007/s10495-010-0519-3; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Higuchi-Sanabria R, 2018, DEV CELL, V44, P139, DOI 10.1016/j.devcel.2017.12.020; Jae LT, 2014, SCIENCE, V344, P1506, DOI 10.1126/science.1252480; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Munch C, 2016, NATURE, V534, P710, DOI 10.1038/nature18302; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quiros PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058; Quiros PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmid-Burgk JL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12338; Schmitt S, 2013, ANAL BIOCHEM, V443, P66, DOI 10.1016/j.ab.2013.08.007; Sekine S, 2019, MOL CELL, V73, P1028, DOI 10.1016/j.molcel.2019.01.002; Shah DI, 2012, NATURE, V491, P608, DOI 10.1038/nature11536; Shpilka T, 2018, NAT REV MOL CELL BIO, V19, P109, DOI 10.1038/nrm.2017.110; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Sorrentino V, 2017, NATURE, V552, P187, DOI 10.1038/nature25143; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; SURANI MAH, 1979, CELL, V18, P217; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Taniuchi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32886; Yore MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022862; Zamzami N, 2000, METHOD ENZYMOL, V322, P208; Zischka H, 2008, ANAL CHEM, V80, P5051, DOI 10.1021/ac800173r; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	45	121	123	6	55	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					433	+		10.1038/s41586-020-2076-4	http://dx.doi.org/10.1038/s41586-020-2076-4		MAR 2020	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32132706	Green Submitted, Green Accepted			2022-12-28	WOS:000518098200009
J	Oxtoby, K				Oxtoby, Kathy			Role model: Sakkarai Ambalavanan	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2020	368								m720	10.1136/bmj.m720	http://dx.doi.org/10.1136/bmj.m720			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KD	32127368	Bronze			2022-12-28	WOS:000519536500002
J	Zhao, EW; Liu, T; Jonsson, E; Lee, J; Temprano, I; Jethwa, RB; Wang, AQ; Smith, H; Carretero-Gonzalez, J; Song, QL; Grey, CP				Zhao, Evan Wenbo; Liu, Tao; Jonsson, Erlendur; Lee, Jeongjae; Temprano, Israel; Jethwa, Rajesh B.; Wang, Anqi; Smith, Holly; Carretero-Gonzalez, Javier; Song, Qilei; Grey, Clare P.			In situ NMR metrology reveals reaction mechanisms in redox flow batteries	NATURE			English	Article							ELECTRON-TRANSFER; SPIN-DENSITIES; SPECTROSCOPY; EXCHANGE; IONS; REDUCTION; KINETICS	Large-scale energy storage is becoming increasingly critical to balancing renewable energy production and consumption(1). Organic redox flow batteries, made from inexpensive and sustainable redox-active materials, are promising storage technologies that are cheaper and less environmentally hazardous than vanadium-based batteries, but they have shorter lifetimes and lower energy density(2,3). Thus, fundamental insight at the molecular level is required to improve performance(4,5). Here we report two in situ nuclear magnetic resonance (NMR) methods of studying redox flow batteries, which are applied to two redox-active electrolytes: 2,6-dihydroxyanthraquinone (DHAQ) and 4,4 '-((9,10-anthraquinone-2,6-diyl)dioxy) dibutyrate (DBEAQ). In the first method, we monitor the changes in the H-1 NMR shift of the liquid electrolyte as it flows out of the electrochemical cell. In the second method, we observe the changes that occur simultaneously in the positive and negative electrodes in the full electrochemical cell. Using the bulk magnetization changes (observed via the H-1 NMR shift of the water resonance) and the line broadening of the H-1 shifts of the quinone resonances as a function of the state of charge, we measure the potential differences of the two single-electron couples, identify and quantify the rate of electron transfer between the reduced and oxidized species, and determine the extent of electron delocalization of the unpaired spins over the radical anions. These NMR techniques enable electrolyte decomposition and battery self-discharge to be explored in real time, and show that DHAQ is decomposed electrochemically via a reaction that can be minimized by limiting the voltage used on charging. We foresee applications of these NMR methods in understanding a wide range of redox processes in flow and other electrochemical systems.	[Zhao, Evan Wenbo; Liu, Tao; Jonsson, Erlendur; Lee, Jeongjae; Temprano, Israel; Jethwa, Rajesh B.; Smith, Holly; Grey, Clare P.] Univ Cambridge, Dept Chem, Cambridge, England; [Jonsson, Erlendur] Chalmers Univ Technol, Dept Phys, Gothenburg, Sweden; [Wang, Anqi; Song, Qilei] Imperial Coll London, Dept Chem Engn, Barrer Ctr, London, England; [Carretero-Gonzalez, Javier] ICTP CSIC, Inst Polymer Sci & Technol, Madrid, Spain; [Liu, Tao] Tongji Univ, Shanghai Key Lab Chem Assessment & Sustainabil, Dept Chem, Shanghai, Peoples R China; [Lee, Jeongjae] Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea	University of Cambridge; Chalmers University of Technology; Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia & Tecnologia de Polimeros (ICTP); Tongji University; Seoul National University (SNU)	Grey, CP (corresponding author), Univ Cambridge, Dept Chem, Cambridge, England.	cpg27@cam.ac.uk	Jónsson, Erlendur/GLT-6890-2022; Liu, Tao/K-3098-2017; Jethwa, Rajesh Bharat/ABC-9058-2020; Song, Qilei/C-3729-2012; Temprano, Israel/K-4805-2015	Liu, Tao/0000-0002-6515-0427; Jethwa, Rajesh Bharat/0000-0002-0404-4356; WANG, Anqi/0000-0003-3409-823X; Carretero Gonzalez, Javier/0000-0002-8008-5715; Song, Qilei/0000-0001-8570-3626; Temprano, Israel/0000-0001-5610-8908	Centre of Advanced Materials for Integrated Energy Systems (CAM-IES), via EPSRC [EP/P007767/1]; Shell; Manifest exchange programme via EPSRC [EP/N032888/1]; Schlumberger Fellowship, Darwin College; Swedish Research Council; Imperial College start-up funding; CAM-IES seed funding; Spanish Ministry of Science, Innovation and Universities through a Ramon y Cajal Fellowship [RYC-2015-17722]; Spanish Ministry of Science, Innovation and Universities through the Retos Project [MAT2017-86796-R]; EPSRC [1944582, EP/P007767/1] Funding Source: UKRI	Centre of Advanced Materials for Integrated Energy Systems (CAM-IES), via EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Shell(Royal Dutch Shell); Manifest exchange programme via EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Schlumberger Fellowship, Darwin College; Swedish Research Council(Swedish Research CouncilEuropean Commission); Imperial College start-up funding; CAM-IES seed funding; Spanish Ministry of Science, Innovation and Universities through a Ramon y Cajal Fellowship; Spanish Ministry of Science, Innovation and Universities through the Retos Project; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	E.W.Z. and C.P.G. acknowledge support from Centre of Advanced Materials for Integrated Energy Systems (CAM-IES), via EPSRC grant number EP/P007767/1. E.W.Z., R.J. and C.P.G. acknowledge support from Shell. E.W.Z. acknowledges support from the Manifest exchange programme via EPSRC grant number EP/N032888/1. T.L. acknowledges support from the Schlumberger Fellowship, Darwin College. E.J. acknowledges support from the Swedish Research Council. We thank A. Brookfield for assistance with the EPR measurement; P. A. A. Klusener from Shell, H. Bronstein, I. Fleming, D. S. Wright, K. Marker, C. Xu, P. C. M. M. Magusin from the University of Cambridge and E. Castillo-Martinez from Universidad Complutense de Madrid for discussions; R. Tan from Imperial College London and D. Lyu, Y. Kim, Y. Jin, and J. Lu from the University of Cambridge for assistance setting up the redox flow battery. A.W. and Q.S. acknowledge Imperial College start-up funding and CAM-IES seed funding. J.C.G. acknowledges support from the Spanish Ministry of Science, Innovation and Universities through a Ramon y Cajal Fellowship (RYC-2015-17722) and the Retos Project (MAT2017-86796-R).	Bertini I, 2017, NMR OF PARAMAGNETIC MOLECULES: APPLICATIONS TO METALLOBIOMOLECULES AND MODELS, 2ND EDITION, P1; Boyer RD, 2003, J MAGN RESON, V165, P253, DOI 10.1016/j.jmr.2003.08.009; Cao SH, 2017, ANAL CHEM, V89, P3810, DOI 10.1021/acs.analchem.7b00249; Chen JJ, 2018, NAT CHEM, V10, P1042, DOI 10.1038/s41557-018-0109-5; Dalitz F, 2012, PROG NUCL MAG RES SP, V60, P52, DOI 10.1016/j.pnmrs.2011.11.003; DEBOER E, 1965, MOL PHYS, V9, P191, DOI 10.1080/00268976500100231; DEBOER E, 1966, J CHEM PHYS, V44, P1334, DOI 10.1063/1.1726861; DeBruler C, 2017, CHEM-US, V3, P961, DOI 10.1016/j.chempr.2017.11.001; Dieterich V, 2018, TRANSL MATER RES, V5, DOI 10.1088/2053-1613/aacb0e; Ding Y, 2018, CHEM SOC REV, V47, P69, DOI 10.1039/c7cs00569e; Ding Y, 2016, CHEM-US, V1, P790, DOI 10.1016/j.chempr.2016.09.004; Donovan PM, 2008, POLYCYCL AROMAT COMP, V28, P128, DOI 10.1080/10406630801970487; EVANS DF, 1959, J CHEM SOC, P2003, DOI 10.1039/jr9590002003; FILIPESCU N, 1977, J ORG CHEM, V42, P507, DOI 10.1021/jo00423a024; Friedl J, 2018, ENERG ENVIRON SCI, V11, P3010, DOI 10.1039/c8ee00422f; Gerhardt MR, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201601488; Goulet MA, 2019, J AM CHEM SOC, V141, P8014, DOI 10.1021/jacs.8b13295; GRAMPP G, 1995, BER BUNSEN PHYS CHEM, V99, P111, DOI 10.1002/bbpc.19950990204; Hogben HJ, 2011, J MAGN RESON, V208, P179, DOI 10.1016/j.jmr.2010.11.008; Holland-Cunz MV, 2018, FRONT ENERGY, V12, P198, DOI 10.1007/s11708-018-0552-4; Huskinson B, 2014, NATURE, V505, P195, DOI 10.1038/nature12909; Janoschka T, 2015, NATURE, V527, P78, DOI 10.1038/nature15746; Ji YL, 2019, ADV ENERGY MATER, V9, DOI 10.1002/aenm.201900039; JOHNSON CS, 1963, J CHEM PHYS, V39, P2111, DOI 10.1063/1.1701409; Johnson CS, 1999, PROG NUCL MAG RES SP, V34, P203, DOI 10.1016/S0079-6565(99)00003-5; Kowalski JA, 2016, CURR OPIN CHEM ENG, V13, P45, DOI 10.1016/j.coche.2016.08.002; Kwabi DG, 2018, JOULE, V2, P1894, DOI 10.1016/j.joule.2018.07.005; Kwon G, 2018, JOULE, V2, P1771, DOI 10.1016/j.joule.2018.0.5.014; Lawton JS, 2012, ECS TRANSACTIONS, V41, P53, DOI 10.1149/1.3697454; Leung P, 2017, J POWER SOURCES, V360, P243, DOI 10.1016/j.jpowsour.2017.05.057; Lin KX, 2015, SCIENCE, V349, P1529, DOI 10.1126/science.aab3033; MEISEL D, 1976, J AM CHEM SOC, V98, P7505, DOI 10.1021/ja00440a008; Orita A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13230; Pecher O, 2017, CHEM MATER, V29, P213, DOI 10.1021/acs.chemmater.6b03183; Pell AJ, 2019, PROG NUCL MAG RES SP, V111, P1, DOI 10.1016/j.pnmrs.2018.05.001; Rosokha SV, 2007, J AM CHEM SOC, V129, P3683, DOI 10.1021/ja069149m; ROSS RT, 1965, J CHEM PHYS, V42, P3919, DOI 10.1063/1.1695859; Rosso KM, 2004, J PHYS CHEM A, V108, P3292, DOI 10.1021/jp037134u; Service RF, 2018, SCIENCE, V362, P508, DOI 10.1126/science.362.6414.508; Shaw AA, 1996, J MAGN RESON SER A, V120, P110, DOI 10.1006/jmra.1996.0105; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Tong LC, 2017, PHYS CHEM CHEM PHYS, V19, P31684, DOI 10.1039/c7cp05881k; U.S. Energy Information Administration, 2018, ANN EN OUTL 2018; Wang H, 2013, J AM CHEM SOC, V135, P18968, DOI 10.1021/ja410287s; Webster RD, 2004, ANAL CHEM, V76, P1603, DOI 10.1021/ac0351724; Wei XL, 2017, ACS ENERGY LETT, V2, P2187, DOI 10.1021/acsenergylett.7b00650; Wei XL, 2014, ADV MATER, V26, P7649, DOI 10.1002/adma.201403746; WILLKER W, 1993, MAGN RESON CHEM, V31, P287, DOI 10.1002/mrc.1260310315; Winsberg J, 2017, ANGEW CHEM INT EDIT, V56, P686, DOI 10.1002/anie.201604925; Yang B, 2014, J ELECTROCHEM SOC, V161, pA1371, DOI 10.1149/2.1001409jes; Zhang HF, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201800795; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	52	70	73	41	312	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7798					224	+		10.1038/s41586-020-2081-7	http://dx.doi.org/10.1038/s41586-020-2081-7		MAR 2020	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU0CC	32123353	Green Submitted			2022-12-28	WOS:000517743700002
J	Kneebone, R				Kneebone, Roger			In practice Making sense	LANCET			English	Editorial Material									[Kneebone, Roger] Imperial Coll London, Surg Educ, Div Surg, Dept Surg & Canc,Fac Med, London, England; [Kneebone, Roger] Chelsea & Westminster Hosp, Ctr Engagement & Simulat Sci, Acad Surg, London SW10 9NH, England	Imperial College London; Imperial College London	Kneebone, R (corresponding author), Imperial Coll London, Surg Educ, Div Surg, Dept Surg & Canc,Fac Med, London, England.; Kneebone, R (corresponding author), Chelsea & Westminster Hosp, Ctr Engagement & Simulat Sci, Acad Surg, London SW10 9NH, England.	r.kneebone@imperial.ac.uk							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 29	2020	395	10225					677	677						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KQ2JO	32113496	Green Submitted			2022-12-28	WOS:000516755200015
J	Huang, C; Zhang, C; Xiao, SM; Wang, YH; Fan, YB; Liu, YL; Zhang, N; Qu, GY; Ji, HJ; Han, JC; Ge, L; Kivshar, Y; Song, QH				Huang, Can; Zhang, Chen; Xiao, Shumin; Wang, Yuhan; Fan, Yubin; Liu, Yilin; Zhang, Nan; Qu, Geyang; Ji, Hongjun; Han, Jiecai; Ge, Li; Kivshar, Yuri; Song, Qinghai			Ultrafast control of vortex microlasers	SCIENCE			English	Article							ORBITAL ANGULAR-MOMENTUM; BOUND-STATES; LIGHT; LASER; GENERATION; BEHAVIOR	The development of classical and quantum information-processing technology calls for on-chip integrated sources of structured light. Although integrated vortex microlasers have been previously demonstrated, they remain static and possess relatively high lasing thresholds, making them unsuitable for high-speed optical communication and computing. We introduce perovskite-based vortex microlasers and demonstrate their application to ultrafast all-optical switching at room temperature. By exploiting both mode symmetry and far-field properties, we reveal that the vortex beam lasing can be switched to linearly polarized beam lasing, or vice versa, with switching times of 1 to 1.5 picoseconds and energy consumption that is orders of magnitude lower than in previously demonstrated all-optical switching. Our results provide an approach that breaks the long-standing trade-off between low energy consumption and high-speed nanophotonics, introducing vortex microlasers that are switchable at terahertz frequencies.	[Huang, Can; Zhang, Chen; Xiao, Shumin; Wang, Yuhan; Fan, Yubin; Liu, Yilin; Zhang, Nan; Qu, Geyang; Ji, Hongjun; Song, Qinghai] Harbin Inst Technol, Key Lab MicroNano Optoelect Informat Syst, Minist Ind & Informat Technol, Shenzhen Grad Sch,State Key Lab Tunable Laser Tec, Shenzhen 518055, Peoples R China; [Xiao, Shumin; Han, Jiecai] Harbin Inst Technol, Natl Key Lab Sci & Technol Adv Composites Special, Harbin 150080, Peoples R China; [Ge, Li] CUNY, Grad Ctr, New York, NY 10016 USA; [Ge, Li] CUNY, Coll Staten Isl, Dept Phys & Astron, Staten Isl, NY 10314 USA; [Kivshar, Yuri] Australian Natl Univ, Res Sch Phys, Nonlinear Phys Ctr, Canberra, ACT 2601, Australia; [Song, Qinghai] Shanxi Univ, Collaborat Innovat Ctr Extreme Opt, Taiyuan 030006, Peoples R China	Harbin Institute of Technology; University Town of Shenzhen; Harbin Institute of Technology; City University of New York (CUNY) System; City University of New York (CUNY) System; College of Staten Island (CUNY); Australian National University; Shanxi University	Song, QH (corresponding author), Harbin Inst Technol, Key Lab MicroNano Optoelect Informat Syst, Minist Ind & Informat Technol, Shenzhen Grad Sch,State Key Lab Tunable Laser Tec, Shenzhen 518055, Peoples R China.; Ge, L (corresponding author), CUNY, Grad Ctr, New York, NY 10016 USA.; Ge, L (corresponding author), CUNY, Coll Staten Isl, Dept Phys & Astron, Staten Isl, NY 10314 USA.; Kivshar, Y (corresponding author), Australian Natl Univ, Res Sch Phys, Nonlinear Phys Ctr, Canberra, ACT 2601, Australia.; Song, QH (corresponding author), Shanxi Univ, Collaborat Innovat Ctr Extreme Opt, Taiyuan 030006, Peoples R China.	li.ge@csi.cuny.edu; ysk@internode.on.net; qinghai.song@hit.edu.cn	FAN, Yubin/GYE-2755-2022; Ge, Li/T-3955-2018; Ji, Hongjun/K-1107-2013; Kivshar, Yuri/ABA-7970-2020; Zhang, Nan/V-8744-2018	Ge, Li/0000-0002-1824-8034; Ji, Hongjun/0000-0002-4159-6838; Kivshar, Yuri/0000-0002-3410-812X; Zhang, Nan/0000-0002-2011-5986; Ge, Li/0000-0002-1922-4464; fan, yubin/0000-0002-6505-3432; Huang, Can/0000-0002-9528-5939; Qu, Geyang/0000-0002-5607-7467; song, qinghai/0000-0003-1048-411X	National Key Research and Development Program of China [SQ2018YFB220027]; Shenzhen Fundamental Research Fund [JCYJ20180507184613841]; Australian Research Council [DP200101168]; National Science Foundation [PHY-1847240]; Shenzhen Engineering Laboratory on Organic-Inorganic Perovskite Devices	National Key Research and Development Program of China; Shenzhen Fundamental Research Fund; Australian Research Council(Australian Research Council); National Science Foundation(National Science Foundation (NSF)); Shenzhen Engineering Laboratory on Organic-Inorganic Perovskite Devices	This research was supported by the National Key Research and Development Program of China (grant no. SQ2018YFB220027), the Shenzhen Fundamental Research Fund (grant no. JCYJ20180507184613841), the Australian Research Council (grant no. DP200101168), and the National Science Foundation (grant no. PHY-1847240). The authors also acknowledge support from the Shenzhen Engineering Laboratory on Organic-Inorganic Perovskite Devices.	ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; Bahari B., 2017, ARXIV170700181PHYSIC; Bulgakov EN, 2017, J OPT SOC AM A, V34, P949, DOI 10.1364/JOSAA.34.000949; Bulgakov EN, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.267401; Cai XL, 2012, SCIENCE, V338, P363, DOI 10.1126/science.1226528; Devlin RC, 2017, SCIENCE, V358, P896, DOI 10.1126/science.aao5392; Doeleman HM, 2018, NAT PHOTONICS, V12, P397, DOI 10.1038/s41566-018-0177-5; Fan SH, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.235112; Feldmann J, 2019, NATURE, V569, P208, DOI 10.1038/s41586-019-1157-8; Feng L, 2014, SCIENCE, V346, P972, DOI 10.1126/science.1258479; Ha ST, 2018, NAT NANOTECHNOL, V13, P1042, DOI 10.1038/s41565-018-0245-5; Hirose K, 2014, NAT PHOTONICS, V8, P406, DOI 10.1038/nphoton.2014.75; Hsu CW, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.48; Hsu CW, 2013, NATURE, V499, P188, DOI 10.1038/nature12289; Jin JC, 2019, NATURE, V574, P501, DOI 10.1038/s41586-019-1664-7; Kodigala A, 2017, NATURE, V541, P196, DOI 10.1038/nature20799; Koshelev K, 2020, SCIENCE, V367, P288, DOI 10.1126/science.aaz3985; Liu WZ, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.116104; Marrucci L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.163905; Miao P, 2016, SCIENCE, V353, P464, DOI 10.1126/science.aaf8533; Naidoo D, 2016, NAT PHOTONICS, V10, P327, DOI [10.1038/NPHOTON.2016.37, 10.1038/nphoton.2016.37]; Noda S, 2001, SCIENCE, V293, P1123, DOI 10.1126/science.1061738; Ozdemir SK, 2019, NAT MATER, V18, P783, DOI 10.1038/s41563-019-0304-9; Qiu CW, 2017, SCIENCE, V357, P645, DOI 10.1126/science.aan6359; Rybin MV, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.243901; Shao ZK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03237-5; Stellinga D, 2018, ACS NANO, V12, P2389, DOI 10.1021/acsnano.7b07703; von Neumann J, 1929, PHYS Z, V30, P467; Wang B., 2019, ARXIV190912618PHYSIC; Yang Y, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.037401; Yao AM, 2011, ADV OPT PHOTONICS, V3, P161, DOI 10.1364/AOP.3.000161; Zambon NC, 2019, NAT PHOTONICS, V13, P283, DOI 10.1038/s41566-019-0380-z; Zhang Q, 2014, NANO LETT, V14, P5995, DOI 10.1021/nl503057g; Zhang YW, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.186103; Zhen B, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.257401	35	252	254	62	453	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2020	367	6481					1018	+		10.1126/science.aba4597	http://dx.doi.org/10.1126/science.aba4597			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KS0CO	32108108	Green Submitted			2022-12-28	WOS:000517979600037
J	Stoddard, PR; Lynch, EM; Farrell, DP; Dosey, AM; DiMaio, F; Williams, TA; Kollman, JM; Murray, AW; Garner, EC				Stoddard, Patrick R.; Lynch, Eric M.; Farrell, Daniel P.; Dosey, Annie M.; DiMaio, Frank; Williams, Tom A.; Kollman, Justin M.; Murray, Andrew W.; Garner, Ethan C.			Polymerization in the actin ATPase clan regulates hexokinase activity in yeast	SCIENCE			English	Article							CRYSTAL-STRUCTURE; X-RAY; PROTEIN; GLUCOKINASE; EXPRESSION; MOLECULES; MECHANISM; EVOLUTION; REVEALS	The actin fold is found in cytoskeletal polymers, chaperones, and various metabolic enzymes. Many actin-fold proteins, such as the carbohydrate kinases, do not polymerize. We found that Glk1, a Saccharomyces cerevisiae glucokinase, forms two-stranded filaments with ultrastructure that is distinct from that of cytoskeletal polymers. In cells, Glk1 polymerized upon sugar addition and depolymerized upon sugar withdrawal. Polymerization inhibits enzymatic activity; the Glk1 monomer-polymer equilibrium sets a maximum rate of glucose phosphorylation regardless of Glk1 concentration. A mutation that eliminated Glk1 polymerization alleviated concentration-dependent enzyme inhibition. Yeast containing nonpolymerizing Glk1 were less fit when growing on sugars and more likely to die when refed glucose. Glk1 polymerization arose independently from other actin-related filaments and may allow yeast to rapidly modulate glucokinase activity as nutrient availability changes.	[Stoddard, Patrick R.; Murray, Andrew W.; Garner, Ethan C.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Stoddard, Patrick R.; Murray, Andrew W.; Garner, Ethan C.] Harvard Univ, Ctr Syst Biol, Cambridge, MA 02138 USA; [Lynch, Eric M.; Farrell, Daniel P.; Dosey, Annie M.; DiMaio, Frank; Kollman, Justin M.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Farrell, Daniel P.; DiMaio, Frank] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Williams, Tom A.] Univ Bristol, Sch Biol Sci, Bristol BS8 1TQ, Avon, England	Harvard University; Harvard University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Bristol	Murray, AW; Garner, EC (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.; Murray, AW; Garner, EC (corresponding author), Harvard Univ, Ctr Syst Biol, Cambridge, MA 02138 USA.	awm@mcb.harvard.edu; egarner@g.harvard.edu	; Garner, Ethan/J-4025-2014	Williams, Tom/0000-0003-1072-0223; Lynch, Eric/0000-0001-5897-5167; DOSEY, ANNE MICHELLE/0000-0001-6858-4725; Garner, Ethan/0000-0003-0141-3555; Farrell, Daniel/0000-0001-7024-7998	NIH [DP2AI117923-01, R01GM043987, R01GM118396, R01GM123089, F31GM116441]; NSF-Simons Center for Mathematical and Statistical Analysis of Biology at Harvard [1764269]; Harvard Quantitative Biology Initiative; Wellcome Grant [203276/Z/16/Z]; Volkswagen Foundation; Royal Society University Research Fellowship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF-Simons Center for Mathematical and Statistical Analysis of Biology at Harvard; Harvard Quantitative Biology Initiative; Wellcome Grant; Volkswagen Foundation(Volkswagen); Royal Society University Research Fellowship(Royal Society of London)	This work was supported by NIH grants DP2AI117923-01 to E.C.G., R01GM043987 to A.W.M., R01GM118396 to J.M.K., R01GM123089 to F.D., F31GM116441 to P.R.S., and by the NSF-Simons Center for Mathematical and Statistical Analysis of Biology at Harvard (1764269) and the Harvard Quantitative Biology Initiative. E.C.G. and P.R.S. were also supported by Wellcome Grant 203276/Z/16/Z and by the Volkswagen Foundation. T.A.W. is supported by a Royal Society University Research Fellowship.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Barry RM, 2014, ELIFE, V3, DOI 10.7554/eLife.03638; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; Bharat TAM, 2015, NATURE, V523, P106, DOI 10.1038/nature14356; BLAZQUEZ MA, 1993, FEBS LETT, V329, P51, DOI 10.1016/0014-5793(93)80191-V; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chojnacki S, 2017, NUCLEIC ACIDS RES, V45, pW550, DOI 10.1093/nar/gkx273; Conway P, 2014, PROTEIN SCI, V23, P47, DOI 10.1002/pro.2389; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Duveau F, 2018, ELIFE, V7, DOI 10.7554/eLife.37272; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franzmann TM, 2018, SCIENCE, V359, P47, DOI 10.1126/science.aao5654; Frenz B, 2017, NAT METHODS, V14, P797, DOI [10.1038/NMETH.4340, 10.1038/nmeth.4340]; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; GREEN JBA, 1988, MOL GEN GENET, V215, P100, DOI 10.1007/BF00331310; GRIFFITH LM, 1982, J BIOL CHEM, V257, P9135; Hagman A, 2014, FEBS J, V281, P4805, DOI 10.1111/febs.13019; Hilitski F, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.138102; JOHNSTON M, 1994, MOL CELL BIOL, V14, P3834, DOI 10.1128/MCB.14.6.3834; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kuettner EB, 2010, J BIOL CHEM, V285, P41019, DOI 10.1074/jbc.M110.185850; Kuser PR, 2000, J BIOL CHEM, V275, P20814, DOI 10.1074/jbc.M910412199; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lowe J, 2016, P NATL ACAD SCI USA, V113, P13396, DOI 10.1073/pnas.1612034113; Lynch E. M., 2020, PDB ID 6PDT, DOI [10.2210/pdb6PDT/pdb, DOI 10.2210/PDB6PDT/PDB]; Lynch EM, 2017, NAT STRUCT MOL BIOL, V24, P507, DOI 10.1038/nsmb.3407; MAITRA PK, 1970, J BIOL CHEM, V245, P2423; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrovska I, 2014, ELIFE, V3, DOI 10.7554/eLife.02409; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rodriguez A, 2001, BIOCHEM J, V355, P625, DOI 10.1042/bj3550625; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen XX, 2016, G3-GENES GENOM GENET, V6, P3927, DOI 10.1534/g3.116.034744; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Steinegger M, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3019-7; Stoddard P. R., 2020, PDB ID 6P4X CRYSTAL, DOI [10.2210/pdb6P4X/pdb., DOI 10.2210/PDB6P4X/PDB]; Stoddard PR, 2017, MOL BIOL CELL, V28, P2461, DOI 10.1091/mbc.E15-11-0778; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Takatsuki H, 2014, BBA-GEN SUBJECTS, V1840, P1933, DOI 10.1016/j.bbagen.2014.01.012; van den Ent F, 2014, ELIFE, V3, DOI 10.7554/eLife.02634; van Heerden JH, 2014, SCIENCE, V343, P987, DOI 10.1126/science.1245114; Wang RYR, 2016, ELIFE, V5, DOI 10.7554/eLife.17219; Wickstead B, 2011, J CELL BIOL, V194, P513, DOI 10.1083/jcb.201102065; Zhang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006304; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhu AP, 2011, ANAL BIOCHEM, V419, P266, DOI 10.1016/j.ab.2011.08.037	60	12	12	4	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2020	367	6481					1039	+		10.1126/science.aay5359	http://dx.doi.org/10.1126/science.aay5359			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KS0CO	32108112	Green Accepted, Green Submitted			2022-12-28	WOS:000517979600042
J	Wang, K; Wu, SD				Wang, Ke; Wu, ShengDong			Biliary Cast Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 62-year-old woman presented with a 2-month history of jaundice 3 months after undergoing orthotopic liver transplantation. Imaging revealed filling defects in the bile ducts. During repeat liver transplantation, biliary casts were found and removed (shown in a video).	[Wang, Ke; Wu, ShengDong] Li Huili Hosp, Ningbo, Peoples R China		Wang, K (corresponding author), Li Huili Hosp, Ningbo, Peoples R China.	kenwang1984@qq.com		ke, wang/0000-0002-9304-5608					0	0	0	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2020	382	9					E13	E13		10.1056/NEJMicm1909877	http://dx.doi.org/10.1056/NEJMicm1909877			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KS8TT	32101668				2022-12-28	WOS:000518581500001
J	Murthy, S; Gomersall, CD; Fowler, RA				Murthy, Srinivas; Gomersall, Charles D.; Fowler, Robert A.			Care for Critically Ill Patients With COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This JAMA Insights article reviews care for the most severely ill patients with coronavirus disease 2019 (COVID-19), including standards of management of ARDS, preventing SARS-CoV-2 spread in health care settings, and surge preparation.	[Murthy, Srinivas] Univ British Columbia, 4500 Oak St, Vancouver, BC V6H 3V4, Canada; [Gomersall, Charles D.] Chinese Univ Hong Kong, Hong Kong, Peoples R China; [Fowler, Robert A.] Univ Toronto, Sunnybrook Hosp, Toronto, ON, Canada	University of British Columbia; Chinese University of Hong Kong; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Murthy, S (corresponding author), Univ British Columbia, 4500 Oak St, Vancouver, BC V6H 3V4, Canada.	srinivas.murthy@cw.bc.ca	Murthy, Srinivas/AAS-7243-2020	Murthy, Srinivas/0000-0002-9476-839X				Alraddadi BM, 2019, INFLUENZA OTHER RESP, V13, P382, DOI 10.1111/irv.12635; Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3; De Backer D, 2017, JAMA-J AM MED ASSOC, V317, P807, DOI 10.1001/jama.2017.0059; Fan E, 2017, AM J RESP CRIT CARE, V195, P1253, DOI 10.1164/rccm.201703-0548ST; Han SW, 2020, CANCER MED-US, V9, P6667, DOI 10.1002/cam4.3289; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; World Health Organization, 2020, MAST PROT MULT AD RA; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	8	379	398	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2020	323	15					1499	1500		10.1001/jama.2020.3633	http://dx.doi.org/10.1001/jama.2020.3633			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LJ1ZH	32159735	Bronze			2022-12-28	WOS:000529969700022
J	Birtle, A; Johnson, M; Chester, J; Jones, R; Dolling, D; Bryan, RT; Harris, C; Winterbottom, A; Blacker, A; Catto, JWF; Chakraborti, P; Donovan, JL; Elliott, PA; French, A; Jagdev, S; Jenkins, B; Keeley, FX; Kockelbergh, R; Powles, T; Wagstaff, J; Wilson, C; Todd, R; Lewis, R; Hall, E				Birtle, Alison; Johnson, Mark; Chester, John; Jones, Robert; Dolling, David; Bryan, Richard T.; Harris, Christopher; Winterbottom, Andrew; Blacker, Anthony; Catto, James W. F.; Chakraborti, Prabir; Donovan, Jenny L.; Elliott, Paul Anthony; French, Ann; Jagdev, Satinder; Jenkins, Benjamin; Keeley, Francis Xavier, Jr.; Kockelbergh, Roger; Powles, Thomas; Wagstaff, John; Wilson, Caroline; Todd, Rachel; Lewis, Rebecca; Hall, Emma			Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial	LANCET			English	Article							NEOADJUVANT CHEMOTHERAPY; EUROPEAN ASSOCIATION; 1ST-LINE TREATMENT; SINGLE-ARM; CISPLATIN; NEPHROURETERECTOMY; METHOTREXATE; VINBLASTINE; COMBINATION; GEMCITABINE	Background Urothelial carcinomas of the upper urinary tract (UTUCs) are rare, with poorer stage-for-stage prognosis than urothelial carcinomas of the urinary bladder. No international consensus exists on the benefit of adjuvant chemotherapy for patients with UTUCs after nephroureterectomy with curative intent. The POUT (Peri-Operative chemotherapy versus sUrveillance in upper Tract urothelial cancer) trial aimed to assess the efficacy of systemic platinum-based chemotherapy in patients with UTUCs. Methods We did a phase 3, open-label, randomised controlled trial at 71 hospitals in the UK. We recruited patients with UTUC after nephroureterectomy staged as either pT2-T4 pN0-N3 M0 or pTany N1-3 M0. We randomly allocated participants centrally (1:1) to either surveillance or four 21-day cycles of chemotherapy, using a minimisation algorithm with a random element. Chemotherapy was either cisplatin (70 mg/m(2)) or carboplatin (area under the curve [AUC]4.5/AUC5, for glomerular filtration rate <50 mL/min only) administered intravenously on day 1 and gemcitabine (1000 mg/ m(2)) administered intravenously on days 1 and 8; chemotherapy was initiated within 90 days of surgery. Follow-up included standard cystoscopic, radiological, and clinical assessments. The primary endpoint was disease-free survival analysed by intention to treat with a Peto-Haybittle stopping rule for (in)efficacy. The trial is registered with ClinicalTrials.gov, NCT01993979. A preplanned interim analysis met the efficacy criterion for early closure after recruitment of 261 participants. Findings Between June 19, 2012, and Nov 8, 2017, we enrolled 261 participants from 57 of 71 open study sites. 132 patients were assigned chemotherapy and 129 surveillance. One participant allocated chemotherapy withdrew consent for data use after randomisation and was excluded from analyses. Adjuvant chemotherapy significantly improved disease-free survival (hazard ratio 0.45, 95% CI 0.30-0.68; p=0.0001) at a median follow-up of 30.3 months (IQR 18.0-47.5). 3-year event-free estimates were 71% (95% CI 61-78) and 46% (36-56) for chemotherapy and surveillance, respectively. 55 (44%) of 126 participants who started chemotherapy had acute grade 3 or worse treatment-emergent adverse events, which accorded with frequently reported events for the chemotherapy regimen. Five (4%) of 129 patients managed by surveillance had acute grade 3 or worse emergent adverse events. No treatment-related deaths were reported. Interpretation Gemcitabine-platinum combination chemotherapy initiated within 90 days after nephroureterectomy significantly improved disease-free survival in patients with locally advanced UTUC. Adjuvant platinum-based chemotherapy should be considered a new standard of care after nephroureterectomy for this patient population. Copyright (C) 2020 The Author(s). Published by Elsevier Ltd.	[Birtle, Alison] Lancashire Teaching Hosp NHS Fdn Trust, Preston, Lancs, England; [Birtle, Alison] Univ Manchester, Manchester, Lancs, England; [Johnson, Mark] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle, England; [Chester, John] Cardiff Univ, Cardiff, Wales; [Jones, Robert] Univ Glasgow, Glasgow, Lanark, Scotland; [Dolling, David; Jenkins, Benjamin; Todd, Rachel; Lewis, Rebecca; Hall, Emma] Inst Canc Res, Clin Trials & Stat Unit, London, England; [Bryan, Richard T.] Univ Birmingham, Birmingham, W Midlands, England; [Harris, Christopher] Patient & Publ Involvement Representat, London, England; [Winterbottom, Andrew] Fight Bladder Canc, Patient & Publ Involvement Representat, Chinnor, England; [Blacker, Anthony] Univ Hosp Coventry & Warwickshire NHS Trust, Coventry, W Midlands, England; [Catto, James W. F.] Univ Sheffield, Sheffield, S Yorkshire, England; [Chakraborti, Prabir] Derby Hosp NHS Fdn Trust, Derby, England; [Donovan, Jenny L.; Wilson, Caroline] Univ Bristol, Bristol, Avon, England; [Elliott, Paul Anthony] Christie NHS Fdn Trust, Manchester, Lancs, England; [French, Ann] Southend Univ Hosp NHS Fdn Trust, Southend On Sea, England; [Jagdev, Satinder] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Keeley, Francis Xavier, Jr.] North Bristol NHS Trust, Bristol, Avon, England; [Kockelbergh, Roger] Univ Hosp Leicester NHS Trust, Leicester, Leics, England; [Powles, Thomas] Barts Canc Inst, London, England; [Wagstaff, John] Singleton Hosp, Swansea, W Glam, Wales	University of Manchester; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Cardiff University; University of Glasgow; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Birmingham; University of Warwick; University of Sheffield; University of Bristol; Christie NHS Foundation Trust; University of Leeds; North Bristol NHS Trust; University Hospitals of Leicester NHS Trust; University of Leicester; University of London; Queen Mary University London; Singleton Hospital	Birtle, A (corresponding author), Royal Preston Hosp, Rosemere Canc Ctr, Preston PR2 9HT, Lancs, England.	alison.birtle@lthtr.nhs.uk	Bryan, Richard T/AAJ-9325-2021	Bryan, Richard T/0000-0003-2853-4293; catto, james/0000-0003-2787-8828; Hall, Emma/0000-0001-5999-5020	Cancer Research UK	Cancer Research UK(Cancer Research UK)	Cancer Research UK.	Audenet F, 2013, UROL ONCOL-SEMIN ORI, V31, P407, DOI 10.1016/j.urolonc.2010.07.016; Bahleda R, 2019, CLIN CANCER RES, V25, P4888, DOI 10.1158/1078-0432.CCR-18-3334; Balar AV, 2017, LANCET, V389, P67, DOI 10.1016/S0140-6736(16)32455-2; Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Chitale S, 2008, ANN ROY COLL SURG, V90, P45, DOI 10.1308/003588408X242268; De Santis M, 2012, J CLIN ONCOL, V30, P191, DOI 10.1200/JCO.2011.37.3571; Donovan JL, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1391-4; Galsky MD, 2012, ANN ONCOL, V23, P406, DOI 10.1093/annonc/mdr156; Galsky MD, 2013, CLIN GENITOURIN CANC, V11, P175, DOI 10.1016/j.clgc.2012.10.001; Geldart T, 2015, EUR UROL, V67, P599, DOI 10.1016/j.eururo.2014.11.003; Griffiths G, 2011, J CLIN ONCOL, V29, P2171, DOI 10.1200/JCO.2010.32.3139; Guo RQ, 2018, BMC UROL, V18, DOI 10.1186/s12894-018-0336-5; Hellenthal NJ, 2009, J UROLOGY, V182, P900, DOI 10.1016/j.juro.2009.05.011; Hoffman-Censits J, 2018, J UROLOGY, V199, pE1166; Leow JJ, 2014, EUR UROL, V66, P529, DOI 10.1016/j.eururo.2014.03.003; LOEHRER PJ, 1992, J CLIN ONCOL, V10, P1066, DOI 10.1200/JCO.1992.10.7.1066; Moschini M, 2018, J UROLOGY, V199, P1149, DOI 10.1016/j.juro.2017.11.068; Moss TJ, 2017, EUR UROL, V72, P641, DOI 10.1016/j.eururo.2017.05.048; Necchi A, 2018, BJU INT, V121, P252, DOI 10.1111/bju.14020; Nogova L, 2017, J CLIN ONCOL; Papadopoulos KP, 2017, BRIT J CANCER, V117, P1592, DOI 10.1038/bjc.2017.330; Porten S, 2014, CANCER-AM CANCER SOC, V120, P1794, DOI 10.1002/cncr.28655; Powles T, 2018, LANCET; Robinson BD, 2019, NAT COMMUN; Rosenberg JE, 2019, P SOC CLIN ONCOL S15, V37; Roupret M, 2018, EUR UROL, V73, P111, DOI 10.1016/j.eururo.2017.07.036; Siefker-Radtke AO, 2018, P SCO CLIN ONCOL S15, V36; Sternberg CN, 2015, LANCET ONCOL, V16, P76, DOI 10.1016/S1470-2045(14)71160-X; van Oers JMM, 2009, EUR UROL, V55, P650, DOI 10.1016/j.eururo.2008.06.013	29	177	177	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2020	395	10232					1268	1277		10.1016/S0140-6736(20)30415-3	http://dx.doi.org/10.1016/S0140-6736(20)30415-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LE6FH	32145825	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000526818800026
J	Pleguezuelos, O; Dille, J; de Groen, S; Oftung, F; Niesters, HGM; Islam, MA; Naess, LM; Hungnes, O; Aldarij, N; Idema, DL; Perez, AF; James, E; Frijlink, HW; Stoloff, G; Groeneveld, P; Hak, E				Pleguezuelos, Olga; Dille, Joep; de Groen, Sofie; Oftung, Fredrik; Niesters, Hubert G. M.; Islam, Md Atiqul; Naess, Lisbeth Meyer; Hungnes, Olav; Aldarij, Nuhoda; Idema, Demi L.; Perez, Ana Fernandez; James, Emma; Frijlink, Henderik W.; Stoloff, Gregory; Groeneveld, Paul; Hak, Eelko			Immunogenicity, Safety, and Efficacy of a Standalone Universal Influenza Vaccine, FLU-v, in Healthy Adults	ANNALS OF INTERNAL MEDICINE			English	Article							A VIRUS; IMMUNITY; ANTIBODIES; MICE	Background: FLU-v is a broad-spectrum influenza vaccine that induces antibodies and cell-mediated immunity. Objective: To compare the safety, immunogenicity, and exploratory efficacy of different formulations and dosing regimens of FLU-v versus placebo. Design: Randomized, double-blind, placebo-controlled, single-center phase 2b clinical trial. (ClinicalTrials.gov: NCT02962908; Eudra CT: 2015-001932-38) Setting: The Netherlands. Participants: 175 healthy adults aged 18 to 60 years. Intervention: 0.5-mL subcutaneous injection of 500 mu g of adjuvanted (1 dose) or nonadjuvanted (2 doses) FLU-v (A-FLU-v or NA-FLU-v) or adjuvanted or nonadjuvanted placebo (A-placebo or NA-placebo) (2:2:1:1 ratio). Measurements: Vaccine-specific cellular responses at days 0, 42, and 180 were assessed via flow cytometry and enzyme-linked immunosorbent assay. Solicited information on adverse events (AEs) was collected for 21 days after vaccination. Unsolicited information on AEs was collected throughout the study. Results: The AEs with the highest incidence were mild to moderate injection site reactions. The difference between A-FLU-v and A-placebo in the median fold increase in secreted interferon-gamma (IFN-gamma) was 38.2-fold (95% CI, 4.7- to 69.7-fold; P = 0.001) at day 42 and 25.0-fold (CI, 5.7- to 50.9-fold; P < 0.001) at day 180. The differences between A-FLU-v and A-placebo in median fold increase at day 42 were 4.5-fold (CI, 2.3- to 9.8-fold; P < 0.001) for IFN-gamma-producing CD4+ T cells, 4.9-fold (CI, 1.3- to 40.0-fold; P < 0.001) for tumor necrosis factor-alpha (TNF-alpha), 7.0-fold (CI, 3.5- to 18.0-fold; P < 0.001) for interleukin-2 (IL-2), and 1.7-fold (CI, 0.1- to 4.0-fold; P = 0.004) for CD107a. At day 180, differences were 2.1-fold (CI, 0.0- to 6.0-fold; P = 0.030) for IFN-gamma and 5.7-fold (CI, 2.0- to 15.0-fold; P < 0.001) for IL-2, with no difference for TNF-alpha or CD107a. No differences were seen between NA-FLU-v and NA-placebo. Limitation: The study was not powered to evaluate vaccine efficacy against influenza infection. Conclusion: Adjuvanted FLU-v is immunogenic and merits phase 3 development to explore efficacy. Primary Funding Source: SEEK and the European Commission Directorate-General for Research and Innovation, European Member States within the UNISEC (Universal Influenza Vaccines Secured) project.	[Pleguezuelos, Olga; Perez, Ana Fernandez; James, Emma; Stoloff, Gregory] SEEK, London, England; [Dille, Joep; de Groen, Sofie; Groeneveld, Paul] Isala Hosp, Dr van Heesweg 2, NL-8025 AB Zwolle, Netherlands; [Oftung, Fredrik; Naess, Lisbeth Meyer; Hungnes, Olav] Norwegian Inst Publ Hlth, Dept Infect Dis Immunol, POB 222, N-0213 Oslo, Norway; [Niesters, Hubert G. M.] Univ Groningen, Univ Med Ctr Groningen, Hanzepl 1,POB 30-0001, NL-9700 RB Groningen, Netherlands; [Aldarij, Nuhoda; Idema, Demi L.; Frijlink, Henderik W.; Hak, Eelko] Univ Groningen, Groningen Res Inst Pharm, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands; [Islam, Md Atiqul] Shahjalal Univ Sci & Technol, Dept Stat, Sylhet 3114, Bangladesh	Norwegian Institute of Public Health (NIPH); University of Groningen; University of Groningen; Shahjalal University of Science & Technology (SUST)	Pleguezuelos, O (corresponding author), SEEK, Cent Point, 45 Beech St, London EC2Y 8AD, England.	olga.pleguezuelos@seekacure.com	Frijlink, Henderik Willem/AAD-7382-2020	Frijlink, Henderik Willem/0000-0001-7901-8198; Idema, Demy/0000-0003-4667-6025; James, Emma/0000-0002-4031-4210	SEEK; European Commission Directorate-General for Research and Innovation, European Member States within the UNISEC (Universal Influenza Vaccines Secured) project (FP7-Health) [602012]	SEEK; European Commission Directorate-General for Research and Innovation, European Member States within the UNISEC (Universal Influenza Vaccines Secured) project (FP7-Health)	By SEEK and the European Commission Directorate-General for Research and Innovation, European Member States within the UNISEC (Universal Influenza Vaccines Secured) project (FP7-Health no. 602012).	Ascarateil S., 2015, J IMMUNOTHER CANC S2, V3, DOI [10.1186/2051-1426-3-S2-P428, DOI 10.1186/2051-1426-3-S2-P428]; Aucouturier Jerome, 2002, Expert Rev Vaccines, V1, P111, DOI 10.1586/14760584.1.1.111; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Finak G, 2014, BIOSTATISTICS, V15, P87, DOI 10.1093/biostatistics/kxt024; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Lin L, 2015, NAT BIOTECHNOL, V33, P610, DOI 10.1038/nbt.3187; MONTO AS, 1981, J CLIN MICROBIOL, V13, P54, DOI 10.1128/JCM.13.1.54-57.1981; Pleguezuelos O, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-020-0174-9; Pleguezuelos O, 2015, CLIN VACCINE IMMUNOL, V22, P828, DOI 10.1128/CVI.00098-15; Pleguezuelos O, 2012, VACCINE, V30, P4655, DOI 10.1016/j.vaccine.2012.04.089; R Core Team, 2019, LANG ENV STAT COMP V; Sambhara S, 2001, CELL IMMUNOL, V211, P143, DOI 10.1006/cimm.2001.1835; Soema PC, 2015, EUR J PHARM BIOPHARM, V94, P251, DOI 10.1016/j.ejpb.2015.05.023; Stoloff GA, 2007, EUR J IMMUNOL, V37, P2441, DOI 10.1002/eji.200737254; Teirlinck AC, 2001, 20170096 RIVM, DOI [10.21945/RIVM-2017-0096, DOI 10.21945/RIVM-2017-0096]; van Doorn E, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2341-9; Weiss ID, 2010, J INTERF CYTOK RES, V30, P439, DOI 10.1089/jir.2009.0084; World Health Organization, 2011, MAN LAB DIAGN VIR SU; YEWDELL JW, 1981, J IMMUNOL, V126, P1814; Zheng B, 2007, J IMMUNOL, V179, P6153, DOI 10.4049/jimmunol.179.9.6153; Zimmerman RK, 2016, CLIN INFECT DIS, V63, P1564, DOI 10.1093/cid/ciw635	25	14	14	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2020	172	7					453	+		10.7326/M19-0735	http://dx.doi.org/10.7326/M19-0735			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA6DM	32150750	Green Published			2022-12-28	WOS:000524036500004
J	Anderson, RM; Heesterbeek, H; Klinkenberg, D; Hollingsworth, TD				Anderson, Roy M.; Heesterbeek, Hans; Klinkenberg, Don; Hollingsworth, T. Deirdre			How will country-based mitigation measures influence the course of the COVID-19 epidemic?	LANCET			English	Editorial Material							TRANSMISSION DYNAMICS; IMPACT		[Anderson, Roy M.] Imperial Coll London, MRC Ctr Global Hlth Anal, Dept Infect Dis Epidemiol, London W2 1PG, England; [Heesterbeek, Hans] Univ Utrecht, Dept Populat Hlth Sci, Utrecht, Netherlands; [Klinkenberg, Don] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Hollingsworth, T. Deirdre] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Big Data Inst, Oxford, England	Imperial College London; Utrecht University; Netherlands National Institute for Public Health & the Environment; University of Oxford	Anderson, RM (corresponding author), Imperial Coll London, MRC Ctr Global Hlth Anal, Dept Infect Dis Epidemiol, London W2 1PG, England.	roy.anderson@imperial.ac.uk	Hollingsworth, Deirdre/D-2421-2009	Hollingsworth, Deirdre/0000-0001-5962-4238; Anderson, Roy/0000-0002-9528-3175; Heesterbeek, Hans/0000-0001-8537-6418	MRC [MC_PC_19012, MR/R015600/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; [Anonymous], DAIL RISK ASS COVID; [Anonymous], NEWS COVID 19 REP TR; Boelle PY, 2011, INFLUENZA OTHER RESP, V5, P306, DOI 10.1111/j.1750-2659.2011.00234.x; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Department of Health and Social Care, 2020, PROM UNH FOODS RESTR; Elston JWT, 2017, PUBLIC HEALTH, V143, P60, DOI 10.1016/j.puhe.2016.10.020; Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.46234/ccdcw2020.032; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Hollingsworth TD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001076; Keeling MJ, 2020, EFFICACY CONTACT TRA, DOI [2020.02.14.20023036, DOI 10.1136/JECH-2020-214051, 10.1101/2020.02.14.20023036]; Li L, 2018, AM J EPIDEMIOL, V187, P378, DOI 10.1093/aje/kwx270; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Lipsitch M., 2020, WILL COVID 19 GO AWA; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; WHO, 2020, WEEKLY EPIDEMIOLOGIC; World Health Organization, COR DIS COVID 2019 S; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	19	1720	1791	22	145	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2020	395	10228					931	934		10.1016/S0140-6736(20)30567-5	http://dx.doi.org/10.1016/S0140-6736(20)30567-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KX2XG	32164834	Green Published, Bronze			2022-12-28	WOS:000521744600010
J	Peckham, R				Peckham, Robert			COVID-19 and the anti-lessons of history	LANCET			English	Editorial Material									[Peckham, Robert] Univ Hong Kong, Dept Hist, Pokfulam, Centennial Campus, Hong Kong, Peoples R China; [Peckham, Robert] Univ Hong Kong, Ctr Humanities & Med, Pokfulam, Centennial Campus, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Peckham, R (corresponding author), Univ Hong Kong, Dept Hist, Pokfulam, Centennial Campus, Hong Kong, Peoples R China.; Peckham, R (corresponding author), Univ Hong Kong, Ctr Humanities & Med, Pokfulam, Centennial Campus, Hong Kong, Peoples R China.	rpeckham@hku.hk						[Anonymous], 2020, THE ECONOMIST; Burke K., 1984, PERMANENCE CHANGE AN, VIII edition; But KM, 2020, MING PAO; Economy EC, 2018, 3 REV XI JP NEW CHIN; Gorbalenya A.E., 2020, BIORXIV COLD SPRING, DOI 10.1101/2020.02.07.937862; Huang Y, 2004, LEARNING SARS PREPAR, P116, DOI DOI 10.17226/10915; Khan Natasha, 2019, WALL STREET J; Kock RA, 2020, LANCET PLANET HEALTH, V4, pE87, DOI 10.1016/S2542-5196(20)30035-8; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Puzder Andy, 2019, WALL STREET J; Roitman J., 2013, ANTICRISIS; Soucheray S, 2020, CIDRAP          0130; Specter M., 2020, NEW YORKER; Wang, 2020, NEW YORK TIMES; World Health Organization, 2020, 38 WHO	15	38	39	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2020	395	10227					850	852		10.1016/S0140-6736(20)30468-2	http://dx.doi.org/10.1016/S0140-6736(20)30468-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU9DZ	32135077	Bronze, Green Published			2022-12-28	WOS:000520024900014
J	Socal, MP; Greene, JA				Socal, Mariana P.; Greene, Jeremy A.			Interchangeable Insulins - New Pathways for Safe, Effective, Affordable Diabetes Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Human insulin was the first major product of the modern biotech industry and has been available in the U.S. market since 1982. Yet as insulin patents have expired in the early 21st	[Socal, Mariana P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; [Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Dept Hist Med, Baltimore, MD USA; [Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Ctr Med Humanities & Social Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Socal, MP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA.							[Anonymous], 2019, CMS DRUG SPEND DASHB; Center for Drug Evaluation and Research, 2019, CLIN IMM CONS BIOS I; Fineberg SE, 2007, ENDOCR REV, V28, P625, DOI 10.1210/er.2007-0002; Frank RG, 2018, NEW ENGL J MED, V378, P791, DOI 10.1056/NEJMp1714908; Lyman GH, 2018, NEW ENGL J MED, V378, P2036, DOI [10.1056/NEJMhle1800125, 10.1056/NEJMc1808348]	5	4	4	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2020	382	11					981	983		10.1056/NEJMp1916387	http://dx.doi.org/10.1056/NEJMp1916387			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU7TA	32160658				2022-12-28	WOS:000519914300002
J	Wise, J				Wise, Jacqui			The BMJ Awards 2020: Stroke and cardiovascular team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material														van Beurden, Samantha/0000-0001-7848-2159					0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2020	368								m844	10.1136/bmj.m844	http://dx.doi.org/10.1136/bmj.m844			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AU	32165369				2022-12-28	WOS:000520013500002
J	Jones, H				Jones, Helen			Why I... see a counsellor	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2020	368								m745	10.1136/bmj.m745	http://dx.doi.org/10.1136/bmj.m745			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AK	32152000	Bronze			2022-12-28	WOS:000520012000002
J	Harman, S				Harman, Sophie			The danger of stories in global health	LANCET			English	Editorial Material									[Harman, Sophie] Queen Mary Univ London, Sch Polit & Int Relat, London E1 4NS, England	University of London; Queen Mary University London	Harman, S (corresponding author), Queen Mary Univ London, Sch Polit & Int Relat, London E1 4NS, England.	s.harman@qmul.ac.uk							0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2020	395	10226					776	777						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU2KH	32145783	Green Published, Bronze			2022-12-28	WOS:000519536900019
J	Bode, L; Raman, AS; Murch, SH; Rollins, NC; Gordon, JI				Bode, Lars; Raman, Arjun S.; Murch, Simon H.; Rollins, Nigel C.; Gordon, Jeffrey I.			Understanding the mother-breastmilk-infant "triad"	SCIENCE			English	Editorial Material							NECROTIZING ENTEROCOLITIS		[Bode, Lars] Univ Calif San Diego, Dept Pediat, Mother Milk Infant Ctr Res Excellence, La Jolla, CA 92093 USA; [Bode, Lars] Univ Calif San Diego, Larsson Rosenquist Fdn, Mother Milk Infant Ctr Res Excellence, La Jolla, CA 92093 USA; [Raman, Arjun S.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Edison Family Ctr Genome Sci & Syst Biol, St Louis, MO USA; [Raman, Arjun S.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Gut Microbiome & Nutr Res, St Louis, MO USA; [Murch, Simon H.] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England; [Rollins, Nigel C.] WHO, Dept Maternal Newborn Child & Adolescent Hlth, Geneva, Switzerland; [Rollins, Nigel C.] WHO, Dept Ageing, Geneva, Switzerland	University of California System; University of California San Diego; University of California System; University of California San Diego; Washington University (WUSTL); Washington University (WUSTL); University of Warwick; World Health Organization; World Health Organization	Bode, L (corresponding author), Univ Calif San Diego, Dept Pediat, Mother Milk Infant Ctr Res Excellence, La Jolla, CA 92093 USA.; Bode, L (corresponding author), Univ Calif San Diego, Larsson Rosenquist Fdn, Mother Milk Infant Ctr Res Excellence, La Jolla, CA 92093 USA.	lbode@ucsd.edu; jgordon@wustl.edu			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Autran CA, 2018, GUT, V67, P1064, DOI 10.1136/gutjnl-2016-312819; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Boix-Amoros A, 2016, FRONT MICROBIOL, V7, DOI [10.5389/fmicb.7016.00492, 10.3389/fmicb.2016.00492]; Cowardin CA, 2019, P NATL ACAD SCI USA, V116, P11988, DOI 10.1073/pnas.1821770116; Feng LH, 2020, P NATL ACAD SCI USA, V117, P2622, DOI 10.1073/pnas.1918951117; Gehrig JL, 2019, SCIENCE, V365, P139, DOI 10.1126/science.aau4732; Henrick BM, 2019, PEDIATR RES, V86, P749, DOI 10.1038/s41390-019-0533-2; Jantscher-Krenn E, 2012, GUT, V61, P1417, DOI 10.1136/gutjnl-2011-301404; Lollo B, 2014, PROTEOMICS, V14, P638, DOI 10.1002/pmic.201300187; Meinzen-Derr J, 2009, J PERINATOL, V29, P57, DOI 10.1038/jp.2008.117; Mottram L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10854-5; Raman AS, 2019, SCIENCE, V365, P140, DOI 10.1126/science.aau4735; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Witkowska-Zimny M, 2017, CELL MOL BIOL LETT, V22, DOI 10.1186/s11658-017-0042-4	15	38	38	10	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1070	1072		10.1126/science.aaw6147	http://dx.doi.org/10.1126/science.aaw6147			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU9CD	32139527				2022-12-28	WOS:000520018400022
J	Powell, K				Powell, Kendall			BEHIND THE SCENES IN A BIOSAFETY OFFICE	NATURE			English	Editorial Material																			0	3	3	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2020	579	7797					159	161		10.1038/d41586-020-00593-5	http://dx.doi.org/10.1038/d41586-020-00593-5			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MD2BL	32132688	Bronze			2022-12-28	WOS:000543778500001
J	Cohen, D; Brown, E				Cohen, Deborah; Brown, Ed			New England Journal of Medicine reviews controversial stent study	BMJ-BRITISH MEDICAL JOURNAL			English	News Item									[Cohen, Deborah; Brown, Ed] BBC Newsnight, London, England		Cohen, D (corresponding author), BBC Newsnight, London, England.							Cohen D, 2019, BBC NEWSNIGHT   1209; Neumann FJ, 2019, EUR HEART J, V40, P87, DOI 10.1093/eurheartj/ehy394; Stone GW, 2019, NEW ENGL J MED, V381, P1820, DOI 10.1056/NEJMoa1909406; Stone GW, 2016, NEW ENGL J MED, V375, P2223, DOI 10.1056/NEJMoa1610227	4	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2020	368								m878	10.1136/bmj.m878	http://dx.doi.org/10.1136/bmj.m878			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KE	32132011				2022-12-28	WOS:000519536600020
J	Guo, XY; Aviles, G; Liu, Y; Tian, RL; Unger, BA; Lin, YHT; Wiita, AP; Xu, K; Correia, MA; Kampmann, M				Guo, Xiaoyan; Aviles, Giovanni; Liu, Yi; Tian, Ruilin; Unger, Bret A.; Lin, Yu-Hsiu T.; Wiita, Arun P.; Xu, Ke; Correia, M. Almira; Kampmann, Martin			Mitochondrial stress is relayed to the cytosol by an OMA1-DELE1-HRI pathway	NATURE			English	Article							UNFOLDED PROTEIN RESPONSE; FACTOR 2-ALPHA KINASE; INITIATION; METABOLISM; PLATFORM; CRISPR; INHIBITION; DISEASES; DEFICITS	In mammalian cells, mitochondrial dysfunction triggers the integrated stress response, in which the phosphorylation of eukaryotic translation initiation factor 2 alpha (eIF2 alpha) results in the induction of the transcription factor ATF4(1-3). However, how mitochondrial stress is relayed to ATF4 is unknown. Here we show that HRI is the eIF2 alpha kinase that is necessary and sufficient for this relay. In a genome-wide CRISPR interference screen, we identified factors upstream of HRI: OMA1, a mitochondrial stress-activated protease; and DELE1, a little-characterized protein that we found was associated with the inner mitochondrial membrane. Mitochondrial stress stimulates OMA1-dependent cleavage of DELE1 and leads to the accumulation of DELE1 in the cytosol, where it interacts with HRI and activates the eIF2 alpha kinase activity of HRI. In addition, DELE1 is required for ATF4 translation downstream of eIF2 alpha phosphorylation. Blockade of the OMA1-DELE1-HRI pathway triggers an alternative response in which specific molecular chaperones are induced. The OMA1-DELE1-HRI pathway therefore represents a potential therapeutic target that could enable fine-tuning of the integrated stress response for beneficial outcomes in diseases that involve mitochondrial dysfunction. A genome-wide CRISPR interference screen shows that a signalling pathway involving OMA1, DELE1 and the eIF2 alpha kinase HRI relays mitochondrial stress to the cytosol to trigger the integrated stress response.	[Guo, Xiaoyan; Aviles, Giovanni; Tian, Ruilin; Kampmann, Martin] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; [Guo, Xiaoyan; Aviles, Giovanni; Tian, Ruilin; Unger, Bret A.; Xu, Ke; Kampmann, Martin] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Liu, Yi; Correia, M. Almira] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Tian, Ruilin] Univ Calif San Francisco, Biophys Grad Program, San Francisco, CA 94143 USA; [Unger, Bret A.; Xu, Ke] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Lin, Yu-Hsiu T.; Wiita, Arun P.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA USA; [Correia, M. Almira] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Correia, M. Almira] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Correia, M. Almira] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA; [Kampmann, Martin] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kampmann, M (corresponding author), Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA.; Kampmann, M (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Kampmann, M (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA.	martin.kampmann@ucsf.edu	; Xu, Ke/A-9476-2011	Tian, Ruilin/0000-0001-7680-6682; Xu, Ke/0000-0002-2788-194X; Aviles, Giovanni/0000-0002-6768-1985; Kampmann, Martin/0000-0002-3819-7019; Guo, Xiaoyan/0000-0002-9388-484X	National Institutes of Health [GM119139, DK26506, GM44037, OD022552]; Beckman Young Investigator Program; Larry L. Hillblom Foundation Postdoctoral Fellowship; NIH Shared Instrumentation Grant [1S10OD010786-01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Young Investigator Program; Larry L. Hillblom Foundation Postdoctoral Fellowship; NIH Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Mohl, B. Herken and D. Swaney for contributions to preliminary experiments; J. Leong for support with FACS; C. Richards for contributions to data visualization; M. Boone, K. Shokat and members of the Kampmann lab for discussions; A. Frost, I. Jain, A. Samelson and E. Li for comments on the manuscript; E. Chow (UCSF Center for Advanced Technology) for support with next-generation sequencing; S. Elmes (UCSF Laboratory for Cell Analysis) for support with FACS; and D. Larson (UCSF Nikon Imaging Center) for support with fluorescence microscopy. This work was supported by the National Institutes of Health grants GM119139 (M.K.), DK26506 (M.A.C.), GM44037 (M.A.C.), OD022552 (A.P.W.), the Beckman Young Investigator Program (K.X.) and a Larry L. Hillblom Foundation Postdoctoral Fellowship (X.G.). M.K. and K.X. are Chan Zuckerberg Biohub Investigators. The DNA Technologies and Expression Analysis Core at the UC Davis Genome Center is supported by the NIH Shared Instrumentation Grant 1S10OD010786-01.	Acin-Perez R, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan4935; Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Adjibade P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14262-7; Baker MJ, 2014, EMBO J, V33, P578, DOI 10.1002/embj.201386474; Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575; Berlanga JJ, 1998, J BIOL CHEM, V273, P32340, DOI 10.1074/jbc.273.48.32340; Bossi M, 2008, NANO LETT, V8, P2463, DOI 10.1021/nl801471d; CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6; Chen JJ, 2019, J BIOL CHEM, V294, P18952, DOI 10.1074/jbc.RA119.009432; Chou A, 2017, P NATL ACAD SCI USA, V114, pE6420, DOI 10.1073/pnas.1707661114; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Das I, 2015, SCIENCE, V348, P239, DOI 10.1126/science.aaa4484; DELAUNAY J, 1977, P NATL ACAD SCI USA, V74, P2264, DOI 10.1073/pnas.74.6.2264; Dey M, 2005, MOL CELL BIOL, V25, P3063, DOI 10.1128/MCB.25.8.3063-3075.2005; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gorur A, 2017, J CELL BIOL, V216, P1745, DOI 10.1083/jcb.201702135; Han H, 2018, NUCLEIC ACIDS RES, V46, pD380, DOI 10.1093/nar/gkx1013; Harada T, 2010, APOPTOSIS, V15, P1247, DOI 10.1007/s10495-010-0519-3; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Kafina MD, 2017, METALLOMICS, V9, P1193, DOI [10.1039/c7mt00103g, 10.1039/C7MT00103G]; Kim HY, 2015, PROTEIN SCI, V24, P2063, DOI 10.1002/pro.2817; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lee H, 2017, J BIOL CHEM, V292, P7115, DOI 10.1074/jbc.M116.762567; Liao M, 2007, J PHARMACOL EXP THER, V323, P979, DOI 10.1124/jpet.107.124602; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; MATTS RL, 1991, J BIOL CHEM, V266, P12695; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Munch C, 2016, NATURE, V534, P710, DOI 10.1038/nature18302; Nagy T, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1759-9; Papa L, 2014, MOL CELL BIOL, V34, P699, DOI 10.1128/MCB.01337-13; Papa L, 2011, J CELL SCI, V124, P1396, DOI 10.1242/jcs.078220; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quiros PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058; Quiros PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Soneson C., 2016, F1000RES, V4, DOI [10.12688/F1000RESEARCH.7563.2. F1000Research, DOI 10.12688/F1000RESEARCH.7563.2]; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66; Tian RL, 2019, NEURON, V104, P239, DOI 10.1016/j.neuron.2019.07.014; Viader A, 2013, NEURON, V77, P886, DOI 10.1016/j.neuron.2013.01.012; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032870; Wojcik M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8384; Zhang SP, 2019, ELIFE, V8, DOI 10.7554/eLife.46976; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	57	149	152	7	86	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					427	+		10.1038/s41586-020-2078-2	http://dx.doi.org/10.1038/s41586-020-2078-2		MAR 2020	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32132707	Green Submitted, Green Accepted			2022-12-28	WOS:000518098200003
J	Hodskinson, MR; Bolner, A; Sato, K; Kamimae-Lanning, AN; Rooijers, K; Witte, M; Mahesh, M; Silhan, J; Petek, M; Williams, DM; Kind, J; Chin, JW; Patel, KJ; Puck, K				Hodskinson, Michael R.; Bolner, Alice; Sato, Koichi; Kamimae-Lanning, Ashley N.; Rooijers, Koos; Witte, Merlijn; Mahesh, Mohan; Silhan, Jan; Petek, Maya; Williams, David M.; Kind, Jop; Chin, Jason W.; Patel, Ketan J.; Knipscheer, Puck			Alcohol-derived DNA crosslinks are repaired by two distinct mechanisms	NATURE			English	Article							ENDOGENOUS ALDEHYDES; ACETALDEHYDE; ADDUCTS; VARIANT; BYPASS	Acetaldehyde is a highly reactive, DNA-damaging metabolite that is produced upon alcohol consumption(1). Impaired detoxification of acetaldehyde is common in the Asian population, and is associated with alcohol-related cancers(1,2). Cells are protected against acetaldehyde-induced damage by DNA crosslink repair, which when impaired causes Fanconi anaemia (FA), a disease resulting in failure to produce blood cells and a predisposition to cancer(3,4). The combined inactivation of acetaldehyde detoxification and the FA pathway induces mutation, accelerates malignancies and causes the rapid attrition of blood stem cells(5-7). However, the nature of the DNA damage induced by acetaldehyde and how this is repaired remains a key question. Here we generate acetaldehyde-induced DNA interstrand crosslinks and determine their repair mechanism in Xenopus egg extracts. We find that two replication-coupled pathways repair these lesions. The first is the FA pathway, which operates using excision-analogous to the mechanism used to repair the interstrand crosslinks caused by the chemotherapeutic agent cisplatin. However, the repair of acetaldehyde-induced crosslinks results in increased mutation frequency and an altered mutational spectrum compared with the repair of cisplatin-induced crosslinks. The second repair mechanism requires replication fork convergence, but does not involve DNA incisions-instead the acetaldehyde crosslink itself is broken. The Y-family DNA polymerase REV1 completes repair of the crosslink, culminating in a distinct mutational spectrum. These results define the repair pathways of DNA interstrand crosslinks caused by an endogenous and alcohol-derived metabolite, and identify an excision-independent mechanism. DNA interstrand crosslinks induced by acetaldehyde are repaired by both the Fanconi anaemia pathway and by a second, excision-independent repair mechanism.	[Hodskinson, Michael R.; Kamimae-Lanning, Ashley N.; Mahesh, Mohan; Silhan, Jan; Petek, Maya; Chin, Jason W.; Patel, Ketan J.] MRC Lab Mol Biol, Cambridge, England; [Bolner, Alice; Sato, Koichi; Rooijers, Koos; Witte, Merlijn; Kind, Jop; Knipscheer, Puck] Hubrecht Inst KNAW, Oncode Inst, Utrecht, Netherlands; [Bolner, Alice; Sato, Koichi; Rooijers, Koos; Witte, Merlijn; Kind, Jop; Knipscheer, Puck] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Williams, David M.] Univ Sheffield, Dept Chem, Sheffield, S Yorkshire, England; [Patel, Ketan J.] Univ Oxford, John Radcliffe Hosp, MRC Weatherall Inst Mol Med, Oxford, England; [Mahesh, Mohan] Imperial Coll London, Dept Chem, London, England; [Silhan, Jan] Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic; [Petek, Maya] Univ Cambridge, Dept Biochem, Cambridge, England	MRC Laboratory Molecular Biology; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Sheffield; University of Oxford; Imperial College London; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of Cambridge	Patel, KJ (corresponding author), MRC Lab Mol Biol, Cambridge, England.; Puck, K (corresponding author), Hubrecht Inst KNAW, Oncode Inst, Utrecht, Netherlands.; Puck, K (corresponding author), Univ Med Ctr Utrecht, Utrecht, Netherlands.; Patel, KJ (corresponding author), Univ Oxford, John Radcliffe Hosp, MRC Weatherall Inst Mol Med, Oxford, England.	kjp@mrc-lmb.cam.ac.uk; p.knipscheer@hubrecht.eu	Williams, David M/J-9627-2013; Petek, Maya/ABF-3556-2021	Petek, Maya/0000-0002-4597-4162; Kamimae-Lanning, Ashley/0000-0002-7516-4881; Rooijers, Koos/0000-0002-0412-468X; Sato, Koichi/0000-0002-0574-774X; Williams, David/0000-0002-5618-182X	Dutch Cancer Society [KWF HUBR 2015-7736]; Gravitation program CancerGenomiCs.nl from the Netherlands Organisation for Scientific Research (NWO), part of the Oncode Institute - Dutch Cancer Society; Uehara Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; JSPS Postdoctoral Fellowship for Research Abroad; Wellcome Trust; Cancer Research UK; European Research Council [ERC-STG 678423-EpiID]; NWO Veni grant [016.Veni.181.013]; MRC [MC_U105181009, MC_U105178811] Funding Source: UKRI	Dutch Cancer Society(KWF Kankerbestrijding); Gravitation program CancerGenomiCs.nl from the Netherlands Organisation for Scientific Research (NWO), part of the Oncode Institute - Dutch Cancer Society; Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; JSPS Postdoctoral Fellowship for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); NWO Veni grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank G. P. Crossan, J. T. P. Yeeles and members of the Knipscheer and Patel laboratories for critical reading of the manuscript; Hubrecht animal caretakers for animal support; J. C. Walter and D. R. Semlow for providing us with recombinant X. laevis NEIL3 proteins, the AP-ICL and lacO plasmids; and S. Y. Peak-Chew, S. Maslen and M. Skehel for mass spectrometry analysis. This work was supported by a project grant from the Dutch Cancer Society (KWF HUBR 2015-7736 to P.K.), the Gravitation program CancerGenomiCs.nl from the Netherlands Organisation for Scientific Research (NWO), part of the Oncode Institute, which is partly financed by the Dutch Cancer Society. K.S. was supported by the Uehara Memorial Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and the JSPS Postdoctoral Fellowship for Research Abroad. A.N.K.-L. was supported by the Wellcome Trust. J.S. was supported by Cancer Research UK. This work was supported by a European Research Council Starting Grant (ERC-STG 678423-EpiID) to J.K. and K.R. and an NWO Veni grant (016.Veni.181.013) to K.R.	Amunugama R, 2018, CELL REP, V23, P3419, DOI 10.1016/j.celrep.2018.05.061; Brooks PJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000050; Budzowska M, 2015, EMBO J, V34, P1971, DOI 10.15252/embj.201490878; Cho YJ, 2006, CHEM RES TOXICOL, V19, P195, DOI 10.1021/tx050239z; Cho YJ, 2007, BIOCHEMISTRY-US, V46, P2608, DOI 10.1021/bi061381h; Duxin JP, 2015, CURR OPIN CELL BIOL, V37, P49, DOI 10.1016/j.ceb.2015.09.002; Duxin JP, 2014, CELL, V159, P346, DOI 10.1016/j.cell.2014.09.024; Garaycoechea JI, 2018, NATURE, V553, P171, DOI 10.1038/nature25154; Garaycoechea JI, 2014, BLOOD, V123, P26, DOI 10.1182/blood-2013-09-427740; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Hira A, 2013, BLOOD, V122, P3206, DOI 10.1182/blood-2013-06-507962; HUANG HF, 1995, SCIENCE, V270, P1842, DOI 10.1126/science.270.5243.1842; Huang J, 2013, MOL CELL, V52, P434, DOI 10.1016/j.molcel.2013.09.021; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Klein D. D., 2014, CELL, V54, P460, DOI DOI 10.1016/j.molcel.2014.03.015; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Lai CL, 2014, ALCOHOL CLIN EXP RES, V38, P44, DOI 10.1111/acer.12215; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Matsuda T, 1998, NUCLEIC ACIDS RES, V26, P1769, DOI 10.1093/nar/26.7.1769; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Semlow DR, 2016, CELL, V167, P498, DOI 10.1016/j.cell.2016.09.008; Wang M, 2000, CHEM RES TOXICOL, V13, P1149, DOI 10.1021/tx000118t; Zhang JQ, 2015, NAT STRUCT MOL BIOL, V22, P242, DOI 10.1038/nsmb.2956	25	53	54	2	61	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					603	+		10.1038/s41586-020-2059-5	http://dx.doi.org/10.1038/s41586-020-2059-5		MAR 2020	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX4BT	32132710	Green Accepted			2022-12-28	WOS:000518098200005
J	Batista, L				Batista, Luis			Adapting to my brain	SCIENCE			English	Editorial Material									[Batista, Luis] Washington Univ, St Louis, MO 63110 USA	Washington University (WUSTL)	Batista, L (corresponding author), Washington Univ, St Louis, MO 63110 USA.								0	0	0	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2020	367	6481					1050	1050		10.1126/science.367.6481.1050	http://dx.doi.org/10.1126/science.367.6481.1050			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KS0CO	32108114				2022-12-28	WOS:000517979600044
J	Ferguson, J				Ferguson, Jane			Maternal microbial molecules affect offspring health	SCIENCE			English	Editorial Material							CHAIN FATTY-ACIDS; WEIGHT		[Ferguson, Jane] Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN 37232 USA	Vanderbilt University	Ferguson, J (corresponding author), Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN 37232 USA.	jane.f.ferguson@vumc.org		Ferguson, Jane/0000-0001-6896-1025				Blackmore HL, 2015, J MOL CELL CARDIOL, V83, P122, DOI 10.1016/j.yjmcc.2014.12.006; Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Chambers ES, 2019, GUT, V68, P1430, DOI 10.1136/gutjnl-2019-318424; Kimura I, 2020, SCIENCE, V367, P1002, DOI 10.1126/science.aaw8429; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589; McDonald B, 2019, SCIENCE, V365, P984, DOI 10.1126/science.aay0618; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Tirosh A, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav0120; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886	11	5	5	4	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2020	367	6481					978	979		10.1126/science.aba7673	http://dx.doi.org/10.1126/science.aba7673			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KS0CO	32108100				2022-12-28	WOS:000517979600019
J	Johnson, O; Pouncey, AL; Gardiner, S; Ross, D				Johnson, Oscar; Pouncey, Anna Louise; Gardiner, Sonya; Ross, David			A woman with spreading erythema after caesarean section	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NECROTIZING FASCIITIS; DIAGNOSIS		[Johnson, Oscar; Pouncey, Anna Louise; Gardiner, Sonya; Ross, David] Guys & St Thomas Hosp, London, England	Guy's & St Thomas' NHS Foundation Trust	Pouncey, AL (corresponding author), Guys & St Thomas Hosp, London, England.	anna-louise.pouncey@nhs.net		Pouncey, Anna Louise/0000-0003-2329-6193				Anaya DA, 2007, CLIN INFECT DIS, V44, P705, DOI 10.1086/511638; [Anonymous], 2014, CURR PROB SURG, V51, P344, DOI 10.1067/j.cpsurg.2014.06.001; Goepfert AR, 1997, OBSTET GYNECOL, V89, P409, DOI 10.1016/S0029-7844(96)00511-X; Goh T, 2014, BRIT J SURG, V101, pE119, DOI 10.1002/bjs.9371; OWEN J, 1994, CLIN OBSTET GYNECOL, V37, P842, DOI 10.1097/00003081-199412000-00009; ROUSE TM, 1982, SURGERY, V92, P765	6	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2020	368								m445	10.1136/bmj.m445	http://dx.doi.org/10.1136/bmj.m445			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2JX	32107271				2022-12-28	WOS:000519535800003
J	Vasanthakumar, A; Chisanga, D; Blume, J; Gloury, R; Britt, K; Henstridge, DC; Zhan, YF; Torres, SV; Liene, S; Collins, N; Cao, EY; Sidwell, T; Li, CR; Spallanzani, RG; Liao, Y; Beavis, PA; Gebhardt, T; Trevaskis, N; Nutt, SL; Zajac, JD; Davey, RA; Febbraio, MA; Mathis, D; Shi, W; Kallies, A				Vasanthakumar, Ajithkumar; Chisanga, David; Blume, Jonas; Gloury, Renee; Britt, Kara; Henstridge, Darren C.; Zhan, Yifan; Torres, Santiago Valle; Liene, Sebastian; Collins, Nicholas; Cao, Enyuan; Sidwell, Tom; Li, Chaoran; Spallanzani, Raul German; Liao, Yang; Beavis, Paul A.; Gebhardt, Thomas; Trevaskis, Natalie; Nutt, Stephen L.; Zajac, Jeffrey D.; Davey, Rachel A.; Febbraio, Mark A.; Mathis, Diane; Shi, Wei; Kallies, Axel			Sex-specific adipose tissue imprinting of regulatory T cells	NATURE			English	Article							IMMUNE CELLS; ANDROGEN RECEPTOR; DIFFERENTIATION; OBESITY; GAMMA; BIOSYNTHESIS; ACCUMULATION; INFLAMMATION; MAINTENANCE; MECHANISMS	Adipose tissue is an energy store and a dynamic endocrine organ(1,2). In particular, visceral adipose tissue (VAT) is critical for the regulation of systemic metabolism(3,4). Impaired VAT function-for example, in obesity-is associated with insulin resistance and type 2 diabetes(5,6). Regulatory T (T-reg) cells that express the transcription factor FOXP3 are critical for limiting immune responses and suppressing tissue inflammation, including in the VAT(7-9). Here we uncover pronounced sexual dimorphism in T-reg cells in the VAT. Male VAT was enriched for T-reg cells compared with female VAT, and T-reg cells from male VAT were markedly different from their female counterparts in phenotype, transcriptional landscape and chromatin accessibility. Heightened inflammation in the male VAT facilitated the recruitment of T-reg cells via the CCL2-CCR2 axis. Androgen regulated the differentiation of a unique IL-33-producing stromal cell population specific to the male VAT, which paralleled the local expansion of T-reg cells. Sex hormones also regulated VAT inflammation, which shaped the transcriptional landscape of VAT-resident T-reg cells in a BLIMP1 transcription factor-dependent manner. Overall, we find that sex-specific differences in T-reg cells from VAT are determined by the tissue niche in a sex-hormone-dependent manner to limit adipose tissue inflammation. Visceral adipose tissue contains populations of regulatory T cells that exhibit sexual dimorphism, determined by the surrounding niche, and differ between male and female mice in terms of cell number, phenotype, transcriptional landscape and chromatin accessibility.	[Vasanthakumar, Ajithkumar; Blume, Jonas; Gloury, Renee; Torres, Santiago Valle; Liene, Sebastian; Collins, Nicholas; Sidwell, Tom; Gebhardt, Thomas; Kallies, Axel] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Vasanthakumar, Ajithkumar; Chisanga, David; Blume, Jonas; Gloury, Renee; Zhan, Yifan; Sidwell, Tom; Liao, Yang; Nutt, Stephen L.; Shi, Wei; Kallies, Axel] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Chisanga, David; Zhan, Yifan; Liao, Yang; Nutt, Stephen L.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Britt, Kara; Beavis, Paul A.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Henstridge, Darren C.] Univ Tasmania, Coll Hlth & Med, Sch Hlth Sci, Launceston, Tas, Australia; [Liene, Sebastian] Univ Bonn, Inst Expt Immunol, Bonn, Germany; [Cao, Enyuan; Trevaskis, Natalie; Febbraio, Mark A.] Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Li, Chaoran; Spallanzani, Raul German; Mathis, Diane] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Zajac, Jeffrey D.; Davey, Rachel A.] Univ Melbourne, Dept Med, Austin Hlth, Melbourne, Vic, Australia; [Shi, Wei] Univ Melbourne, Dept Comp & Informat Syst, Melbourne, Vic, Australia	University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; Peter Maccallum Cancer Center; University of Tasmania; University of Bonn; Harvard University; Harvard Medical School; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne	Kallies, A (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.; Kallies, A (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia.	ajith.vasanthakumar@unimelb.edu.au; axel.kallies@unimelb.edu.au	Zajac, Jeffrey/ABC-3767-2021; Chisanga, David/AAB-1751-2019; Nutt, Stephen/C-9256-2013; Spallanzani, Raul German/B-7210-2016	Zajac, Jeffrey/0000-0003-3933-5708; Chisanga, David/0000-0002-0421-3957; Beavis, Paul/0000-0002-2116-013X; Nutt, Stephen/0000-0002-0020-6637; Febbraio, Mark/0000-0002-9296-4418; VASANTHAKUMAR, AJITHKUMAR/0000-0002-1620-7781; , Yang/0000-0002-9746-2839; Trevaskis, Natalie/0000-0001-9538-549X; Kallies, Axel/0000-0002-6312-6968; DAVEY, RACHEL A/0000-0001-5121-0209; Cao, Enyuan/0000-0002-9689-4517; Zhan, Yifan/0000-0001-6974-0486; Spallanzani, Raul German/0000-0001-5402-3687	National Health and Medical Research Council (NHMRC) [1106378, 1149062, 1139607]; Sylvia and Charles Viertel Foundation; Diabetes Australia [Y18G-VASA]; US NIH [R01DK092541]; JPB Foundation; Walter and Eliza Hall Institute Centenary Fellowship; NBCF Career Development Fellowship; American Diabetes Association [1-17-PMF-005]; Sir Edward Dunlop Medical Research Foundation; Austin Health Research Foundation; Les and Eva Erdi Research Grant; Australian and New Zealand Bone and Mineral Society	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Foundation; Diabetes Australia; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; Walter and Eliza Hall Institute Centenary Fellowship; NBCF Career Development Fellowship; American Diabetes Association(American Diabetes Association); Sir Edward Dunlop Medical Research Foundation; Austin Health Research Foundation; Les and Eva Erdi Research Grant; Australian and New Zealand Bone and Mineral Society	This work was funded by the National Health and Medical Research Council (NHMRC, project grants 1106378 and 1149062 and fellowship 1139607 to A.K.), the Sylvia and Charles Viertel Foundation (fellowship to A.K.), the Diabetes Australia (grant Y18G-VASA to A.V.) and grants from the US NIH (R01DK092541) and JPB Foundation (to D.M.). W.S. is funded by a Walter and Eliza Hall Institute Centenary Fellowship funded by a donation from CSL. M.A.F. is a senior Principal Research Fellow of the NHMRC. P.A.B. was funded by an NBCF Career Development Fellowship. R.G.S. is an American Diabetes Association Postdoctoral fellow (1-17-PMF-005). J.D.Z. and R.A.D. are supported by funding from The Sir Edward Dunlop Medical Research Foundation, The Austin Health Research Foundation and a Les and Eva Erdi Research Grant. R.A.D. was funded by a fellowship from the Australian and New Zealand Bone and Mineral Society. We thank T. Korn for help with experiments, and G. Risbridger, K. S. Korach, M. Ernst, J. Silke and W. C. Boon for mice.	Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cildir G, 2013, TRENDS MOL MED, V19, P487, DOI 10.1016/j.molmed.2013.05.001; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kamat A, 2002, TRENDS ENDOCRIN MET, V13, P122, DOI 10.1016/S1043-2760(02)00567-2; Karastergiou K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-13; Kissick HT, 2014, P NATL ACAD SCI USA, V111, P9887, DOI 10.1073/pnas.1402468111; Koga S, 2018, J EXP MED, V215, P1609, DOI 10.1084/jem.20172310; Kohlgruber AC, 2018, NAT IMMUNOL, V19, P464, DOI 10.1038/s41590-018-0094-2; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Kovats S, 2015, CELL IMMUNOL, V294, P63, DOI 10.1016/j.cellimm.2015.01.018; Lancaster GI, 2018, JOVE-J VIS EXP, DOI 10.3791/57280; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Li CR, 2018, CELL, V174, P285, DOI 10.1016/j.cell.2018.05.004; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Luo LP, 2016, J ENDOCRINOL, V231, pR77, DOI 10.1530/JOE-16-0211; Lynch L, 2015, NAT IMMUNOL, V16, P85, DOI 10.1038/ni.3047; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mahlakoiv T, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax0416; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Meseguer A, 2002, HORM METAB RES, V34, P731, DOI 10.1055/s-2002-38249; Michalakis K, 2013, METABOLISM, V62, P457, DOI 10.1016/j.metabol.2012.08.012; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mraz M, 2014, J ENDOCRINOL, V222, pR113, DOI 10.1530/JOE-14-0283; Notini AJ, 2005, J MOL ENDOCRINOL, V35, P547, DOI 10.1677/jme.1.01884; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Rana K, 2014, ENDOCR RES, V39, P130, DOI 10.3109/07435800.2013.864303; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Spallanzani RG, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw3658; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; White UA, 2014, BBA-MOL BASIS DIS, V1842, P377, DOI 10.1016/j.bbadis.2013.05.006	43	92	91	4	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					581	+		10.1038/s41586-020-2040-3	http://dx.doi.org/10.1038/s41586-020-2040-3		FEB 2020	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX4BT	32103173	Green Accepted			2022-12-28	WOS:000516702000008
J	Wang, F; Wang, KY; Forknall, N; Patrick, C; Yang, T; Parekh, R; Bock, D; Dickson, BJ				Wang, Fei; Wang, Kaiyu; Forknall, Nora; Patrick, Christopher; Yang, Tansy; Parekh, Ruchi; Bock, Davi; Dickson, Barry J.			Neural circuitry linking mating and egg laying in Drosophila females	NATURE			English	Article							NEURONS; RECEPTIVITY; SWITCH	Mating and egg laying are tightly cooordinated events in the reproductive life of all oviparous females. Oviposition is typically rare in virgin females but is initiated after copulation. Here we identify the neural circuitry that links egg laying to mating status in Drosophila melanogaster. Activation of female-specific oviposition descending neurons (oviDNs) is necessary and sufficient for egg laying, and is equally potent in virgin and mated females. After mating, sex peptide-a protein from the male seminal fluid-triggers many behavioural and physiological changes in the female, including the onset of egg laying(1). Sex peptide is detected by sensory neurons in the uterus(2-4), and silences these neurons and their postsynaptic ascending neurons in the abdominal ganglion(5). We show that these abdominal ganglion neurons directly activate the female-specific pC1 neurons. GABAergic (gamma-aminobutyric-acid-releasing) oviposition inhibitory neurons (oviINs) mediate feed-forward inhibition from pC1 neurons to both oviDNs and their major excitatory input, the oviposition excitatory neurons (oviENs). By attenuating the abdominal ganglion inputs to pC1 neurons and oviINs, sex peptide disinhibits oviDNs to enable egg laying after mating. This circuitry thus coordinates the two key events in female reproduction: mating and egg laying. Neuron-tracing and labelling experiments in Drosophila females reveal the neural circuitry that coordinates mating and egg laying, and the role of sex peptide from male seminal fluid in triggering these neurons.	[Wang, Fei; Wang, Kaiyu; Forknall, Nora; Patrick, Christopher; Yang, Tansy; Parekh, Ruchi; Bock, Davi; Dickson, Barry J.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Dickson, Barry J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Bock, Davi] Univ Vermont, Dept Neurol Sci, Burlington, VT USA	Howard Hughes Medical Institute; University of Queensland; University of Vermont	Dickson, BJ (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.; Dickson, BJ (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	dicksonb@janelia.hhmi.org		Wang, Fei/0000-0002-8646-2411; Dickson, Barry/0000-0003-0715-892X; Forknall, Nora/0000-0003-2139-7599; Patrick, Christopher/0000-0001-8830-1892	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank the Janelia FlyLight, Fly Facility, Project Technical Resources, Molecular Biology, Functional Connectome and Experimental Technology teams for technical assistance; A. Edmonson-Stait and G. Jefferis for initial tracing of one of the oviIN cells; U. Heberlein, K. Feng and V. Vijayan for comments on the manuscript; and V. Vijayan and G. Maimon for sharing preliminary oviDN calcium-imaging data. This work was funded by the Howard Hughes Medical Institute.	Auer T, 2016, CURR OPIN NEUROBIOL, V38, P18, DOI 10.1016/j.conb.2016.01.004; Bath DE, 2014, NAT METHODS, V11, P756, DOI [10.1038/nmeth.2973, 10.1038/NMETH.2973]; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cury KM, 2019, J NEUROGENET, V33, P75, DOI 10.1080/01677063.2019.1586898; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dickson BJ., 2017, 198648 BIORXIV, DOI [10.1101/198648, DOI 10.1101/198648]; Dionne H, 2018, GENETICS, V209, P31, DOI 10.1534/genetics.118.300682; Feng K, 2014, NEURON, V83, P135, DOI 10.1016/j.neuron.2014.05.017; Gou B, 2016, JOVE-J VIS EXP, DOI 10.3791/53716; Hasemeyer M, 2009, NEURON, V61, P511, DOI 10.1016/j.neuron.2009.01.009; Inagaki HK, 2014, NAT METHODS, V11, P325, DOI [10.1038/NMETH.2765, 10.1038/nmeth.2765]; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Kimura K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126445; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; KUBLI E, 1992, BIOESSAYS, V14, P779, DOI 10.1002/bies.950141111; KUPFERMANN I, 1978, BEHAV BRAIN SCI, V1, P3, DOI 10.1017/S0140525X00059057; Kvitsiani D, 2006, CURR BIOL, V16, pR355, DOI 10.1016/j.cub.2006.04.025; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; McKellar CE, 2019, CURR BIOL, V29, P426, DOI 10.1016/j.cub.2018.12.019; Meissner GW, 2019, GENETICS, V211, P473, DOI 10.1534/genetics.118.301749; Nern A, 2015, P NATL ACAD SCI USA, V112, pE2967, DOI 10.1073/pnas.1506763112; Otsuna H., 2018, COLOR DEPTH MIP MASK, DOI [10.1101/318006, DOI 10.1101/318006]; Ribeiro IMA, 2018, CELL, V174, P607, DOI 10.1016/j.cell.2018.06.020; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlote, 1984, DROS INFORM SERV, V60, P210; Schneider-Mizell CM, 2016, ELIFE, V5, DOI 10.7554/eLife.12059; Shirangi TR, 2016, DEV CELL, V37, P533, DOI 10.1016/j.devcel.2016.05.012; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; THOMAS A, 1979, J INSECT PHYSIOL, V25, P811, DOI 10.1016/0022-1910(79)90084-2; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; von Reyn CR, 2014, NAT NEUROSCI, V17, P962, DOI 10.1038/nn.3741; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wu M, 2016, ELIFE, V5, DOI 10.7554/eLife.21022; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Zheng ZH, 2018, CELL, V174, P730, DOI 10.1016/j.cell.2018.06.019; Zhou C, 2014, NEURON, V83, P149, DOI 10.1016/j.neuron.2014.05.038	38	44	45	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2020	579	7797					101	+		10.1038/s41586-020-2055-9	http://dx.doi.org/10.1038/s41586-020-2055-9		FEB 2020	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE3BA	32103180	Green Accepted			2022-12-28	WOS:000516702000001
J	Gates, B				Gates, Bill			Responding to Covid-19-A Once-in-a-Century Pandemic?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Bill Gates writes that in any crisis, leaders have two equally important responsibilities: solve the immediate problem and keep it from happening again. In the case of the Covid-19 pandemic, the first point is especially pressing, but the second has crucial long-term consequences.	[Gates, Bill] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA	Bill & Melinda Gates Foundation	Gates, B (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98109 USA.							[Anonymous], 2020, CCDC WEEKLY, V2, P1; Frieden TR, 2014, LANCET, V383, P764, DOI 10.1016/S0140-6736(14)60189-6; Gates B, 2018, NEW ENGL J MED, V378, P2057, DOI 10.1056/NEJMp1806283; Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918; Hoehl S, 2020, NEW ENGL J MED, V382, P1278, DOI 10.1056/NEJMc2001899	5	529	538	8	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2020	382	18					1677	1679		10.1056/NEJMp2003762	http://dx.doi.org/10.1056/NEJMp2003762			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LL1YQ	32109012	Bronze			2022-12-28	WOS:000531351300008
J	Hollander, JE; Carr, BG				Hollander, Judd E.; Carr, Brendan G.			Virtually Perfect? Telemedicine for Covid-19	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Telemedicine's payment and regulatory structures, licensing, credentialing, and implementation take time to work through, but health systems that have already invested in telemedicine are well positioned to ensure that patients with Covid-19 receive the care they need.	[Hollander, Judd E.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Carr, Brendan G.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Jefferson University; Icahn School of Medicine at Mount Sinai	Hollander, JE (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.							Duffy S, 2018, NEW ENGL J MED, V378, P104, DOI 10.1056/NEJMp1710735; Joshi AU, 2020, ACAD EMERG MED, V27, P139, DOI 10.1111/acem.13890; Lacktman NM, 2021, 50 STATE SURVEY TELE; Langabeer JR, 2016, WEST J EMERG MED, V17, P713, DOI 10.5811/westjem.2016.8.30660; Lurie N, 2018, JAMA INTERN MED, V178, P745, DOI 10.1001/jamainternmed.2018.1314	5	1531	1563	24	102	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2020	382	18					1679	1681		10.1056/NEJMp2003539	http://dx.doi.org/10.1056/NEJMp2003539			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LL1YQ	32160451	Bronze			2022-12-28	WOS:000531351300009
J	Fralick, M; Colacci, M; Schneeweiss, S; Huybrechts, KF; Lin, KJ; Gagne, JJ				Fralick, Michael; Colacci, Michael; Schneeweiss, Sebastian; Huybrechts, Krista F.; Lin, Kueiyu Joshua; Gagne, Joshua J.			Effectiveness and Safety of Apixaban Compared With Rivaroxaban for Patients With Atrial Fibrillation in Routine Practice A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							ORAL ANTICOAGULANTS; RISK-FACTORS; STROKE; WARFARIN; DABIGATRAN; MANAGEMENT; THERAPY	Background: Apixaban and rivaroxaban are the most commonly prescribed direct oral anticoagulants for adults with atrial fibrillation, but head-to-head data comparing their safety and effectiveness are lacking. Objective: To compare the safety and effectiveness of apixaban versus rivaroxaban for patients with nonvalvular atrial fibrillation. Design: New-user, active-comparator, retrospective cohort study. Setting: A U.S. nationwide commercial health care claims database from 28 December 2012 to 1 January 2019. Patients: Adults newly prescribed apixaban (n = 59 172) or rivaroxaban (n = 40 706). Measurements: The primary effectiveness outcome was a composite of ischemic stroke or systemic embolism. The primary safety outcome was a composite of intracranial hemorrhage or gastrointestinal bleeding. Results: 39 351 patients newly prescribed apixaban were propensity score matched to 39 351 patients newly prescribed rivaroxaban. Mean age was 69 years, 40% of patients were women, and mean follow-up was 288 days for new apixaban users and 291 days for new rivaroxaban users. The incidence rate of ischemic stroke or systemic embolism was 6.6 per 1000 person-years for adults prescribed apixaban compared with 8.0 per 1000 person-years for those prescribed rivaroxaban (hazard ratio [FIR], 0.82 [95% CI, 0.68 to 0.98]; rate difference, 1.4 fewer events per 1000 person-years [CI, 0.0 to 2.7]). Adults prescribed apixaban also had a lower rate of gastrointestinal bleeding or intracranial hemorrhage (12.9 per 1000 person-years) compared with those prescribed rivaroxaban (21.9 per 1000 person-years), corresponding to an HR of 0.58 (CI, 0.52 to 0.66) and a rate difference of 9.0 fewer events per 1000 person-years (CI, 6.9 to 11.1). Limitation: Unmeasured confounding, incomplete laboratory data. Conclusion: In routine care, adults with atrial fibrillation prescribed apixaban had a lower rate of both ischemic stroke or systemic embolism and bleeding compared with those prescribed rivaroxaban.	[Fralick, Michael; Schneeweiss, Sebastian; Huybrechts, Krista F.; Lin, Kueiyu Joshua; Gagne, Joshua J.] Brigham & Womens Hosp, Boston, MA 02120 USA; [Fralick, Michael; Schneeweiss, Sebastian; Huybrechts, Krista F.; Lin, Kueiyu Joshua; Gagne, Joshua J.] Harvard Med Sch, Boston, MA 02115 USA; [Fralick, Michael; Colacci, Michael] Sinai Hlth Syst, 60 Murray St, Toronto, ON M5T 3L9, Canada; [Fralick, Michael; Colacci, Michael] Univ Toronto, Dept Med, 60 Murray St, Toronto, ON M5T 3L9, Canada	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto	Fralick, M (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	mif823@mail.harvard.edu	Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X	Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital	Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital	By the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital.	Adcock DM, 2015, THROMB RES, V136, P7, DOI 10.1016/j.thromres.2015.05.001; Aguilar MI, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001927.pub2; Amin A, 2017, CURR MED RES OPIN, V33, P1595, DOI 10.1080/03007995.2017.1345729; Andersson NW, 2018, INT J CARDIOL, V268, P113, DOI 10.1016/j.ijcard.2018.03.047; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Barnes GD, 2015, AM J MED, V128, P1300, DOI 10.1016/j.amjmed.2015.05.044; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Cohen AT, 2018, INT J CARDIOL, V269, P174, DOI 10.1016/j.ijcard.2018.06.114; Fosbol EL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000110; Frost C, 2014, CLIN PHARMACOL-ADV A, V6, P179, DOI 10.2147/CPAA.S61131; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Gomes T, 2013, CAN MED ASSOC J, V185, pE121, DOI 10.1503/cmaj.121218; Graham DJ, 2019, AM J MED, V132, P596, DOI 10.1016/j.amjmed.2018.12.023; Graham DJ, 2016, JAMA INTERN MED, V176, P1662, DOI 10.1001/jamainternmed.2016.5954; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hellenbart EL, 2017, VASC HEALTH RISK MAN, V13, P325, DOI 10.2147/VHRM.S121661; Huiart L, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018180; Huybrechts KF, 2019, CLIN PHARMACOL THER, V105, P979, DOI 10.1002/cpt.1256; Ikeda K, 2016, J ARRYTHM, V32, P42, DOI 10.1016/j.joa.2015.08.001; Jensen PN, 2012, PHARMACOEPIDEM DR S, V21, P141, DOI 10.1002/pds.2317; Kim SC, 2017, ARTHRITIS RHEUMATOL, V69, P1154, DOI 10.1002/art.40084; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Larsen TB, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3189; Li L, 2013, INT J BIOSTAT, V9, P215, DOI 10.1515/ijb-2012-0030; Licata A, 2018, EUR J GASTROEN HEPAT, V30, P226, DOI 10.1097/MEG.0000000000001030; Lip GYH, 2018, STROKE, V49, P2933, DOI 10.1161/STROKEAHA.118.020232; Lip GYH, 2017, JAMA CARDIOL, V2, P872, DOI 10.1001/jamacardio.2017.1883; Lopez-Lopez JA, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5058; Macle L, 2016, CAN J CARDIOL, V32, P278, DOI 10.1016/j.cjca.2015.06.025; Madhavan M, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003163; Martinez BK, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008643; Noseworthy PA, 2016, CHEST, V150, P1302, DOI 10.1016/j.chest.2016.07.013; Olson KL, 2014, AM J MANAG CARE, V20, pE27; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Patorno E, 2019, DIABETES CARE, V42, P2204, DOI 10.2337/dc19-0069; Raghavan N, 2009, DRUG METAB DISPOS, V37, P74, DOI 10.1124/dmd.108.023143; Sainz-Gaspar L, 2018, INT J DERMATOL, V57, P622, DOI 10.1111/ijd.13952; Schneeweiss S, 2012, CIRC-CARDIOVASC QUAL, V5, P480, DOI 10.1161/CIRCOUTCOMES.112.965988; Siontis KC, 2018, CIRCULATION, V138, P1519, DOI 10.1161/CIRCULATIONAHA.118.035418; Svennberg E, 2015, CIRCULATION, V131, P2176, DOI 10.1161/CIRCULATIONAHA.114.014343; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Vinogradova Y, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2505; Wang SV, 2016, CLIN PHARMACOL THER, V99, P325, DOI 10.1002/cpt.329; Wang SV, 2014, EPIDEMIOLOGY, V25, P772, DOI 10.1097/EDE.0000000000000148	47	36	38	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2020	172	7					463	+						17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA6DM	32150751				2022-12-28	WOS:000524036500005
J	Yan, RH; Zhang, YY; Li, YN; Xia, L; Guo, YY; Zhou, Q				Yan, Renhong; Zhang, Yuanyuan; Li, Yaning; Xia, Lu; Guo, Yingying; Zhou, Qiang			Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2	SCIENCE			English	Article							ANGIOTENSIN-CONVERTING ENZYME-2; CORONAVIRUS SPIKE PROTEIN; AMINO-ACID-TRANSPORT; X-RAY STRUCTURES; HARTNUP DISORDER; RECEPTOR; ENTRY; GLYCOPROTEIN; ACTIVATION; MUTATIONS	Angiotensin-converting enzyme 2 (ACE2) is the cellular receptor for severe acute respiratory syndromecoronavirus (SARS-CoV) and the new coronavirus (SARS-CoV-2) that is causing the serious coronavirus disease 2019 (COVID-19) epidemic. Here, we present cryo-electron microscopy structures of full-length human ACE2 in the presence of the neutral amino acid transporter B0AT1 with or without the receptor binding domain (RBD) of the surface spike glycoprotein (S protein) of SARS-CoV-2, both at an overall resolution of 2.9 angstroms, with a local resolution of 3.5 angstroms at the ACE2-RBD interface. The ACE2-B0AT1 complex is assembled as a dimer of heterodimers, with the collectrin-like domain of ACE2 mediating homodimerization. The RBD is recognized by the extracellular peptidase domain of ACE2 mainly through polar residues. These findings provide important insights into the molecular basis for coronavirus recognition and infection.	[Yan, Renhong; Zhang, Yuanyuan; Xia, Lu; Guo, Yingying; Zhou, Qiang] Westlake Inst Adv Study, Key Lab Struct Biol Zhejiang Prov, Inst Biol, 18 Shilongshan Rd, Hangzhou 310024, Zhejiang, Peoples R China; [Yan, Renhong; Zhang, Yuanyuan; Xia, Lu; Guo, Yingying; Zhou, Qiang] Westlake Univ, Sch Life Sci, 18 Shilongshan Rd, Hangzhou 310024, Zhejiang, Peoples R China; [Li, Yaning] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Tsinghua Peking Joint Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China	Westlake University; Westlake University; Tsinghua University	Zhou, Q (corresponding author), Westlake Inst Adv Study, Key Lab Struct Biol Zhejiang Prov, Inst Biol, 18 Shilongshan Rd, Hangzhou 310024, Zhejiang, Peoples R China.; Zhou, Q (corresponding author), Westlake Univ, Sch Life Sci, 18 Shilongshan Rd, Hangzhou 310024, Zhejiang, Peoples R China.	zhouqiang@westlake.edu.cn		lu, xia/0000-0003-3007-3086; Yan, Renhong/0000-0002-7122-6547; Zhang, Yuanyuan/0000-0002-2500-0010	National Natural Science Foundation of China [31971123, 81920108015, 31930059]; Key RAMP;D Program of Zhejiang Province [2020C04001]; SARS-CoV-2 emergency project of the Science and Technology Department of Zhejiang Province [2020C03129]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key RAMP;D Program of Zhejiang Province; SARS-CoV-2 emergency project of the Science and Technology Department of Zhejiang Province	We thank the Cryo-EM Facility and Supercomputer Center of Westlake University for providing cryo-EM and computation support, respectively. This work was funded by the National Natural Science Foundation of China (projects 31971123, 81920108015, and 31930059), the Key R&D Program of Zhejiang Province (2020C04001), and the SARS-CoV-2 emergency project of the Science and Technology Department of Zhejiang Province (2020C03129).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2020, TRANSL PEDIATR, DOI DOI 10.21037/TP.2020.02.06; [Anonymous], NEW ENGL J MED; [Anonymous], NATURE; Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Hamming I, 2007, J PATHOL, V212, P1, DOI 10.1002/path.2162; Heurich A, 2014, J VIROL, V88, P1293, DOI 10.1128/JVI.02202-13; Hoffmann M., 2020, BIORXIV, DOI [10.1101/2020.01.31.929042, DOI 10.1101/2020.01.31.929042.]; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Jando J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184845; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kirchdoerfer RN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34171-7; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Kowalczuk S, 2008, FASEB J, V22, P2880, DOI 10.1096/fj.08-107300; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Lei JL, 2005, J STRUCT BIOL, V150, P69, DOI 10.1016/j.jsb.2005.01.002; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lin QS, 2004, BBA-MOL BASIS DIS, V1689, P175, DOI 10.1016/j.bbadis.2004.05.005; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; Millet JK, 2015, VIRUS RES, V202, P120, DOI 10.1016/j.virusres.2014.11.021; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Raizada MK, 2007, J CARDIOVASC PHARM, V50, P112, DOI 10.1097/FJC.0b013e3180986219; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Seow HF, 2004, NAT GENET, V36, P1003, DOI 10.1038/ng1406; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; Simmons G, 2013, ANTIVIR RES, V100, P605, DOI 10.1016/j.antiviral.2013.09.028; Song WF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007236; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Yan RH, 2019, NATURE, V568, P127, DOI 10.1038/s41586-019-1011-z; Yeo C., 2020, LANCET GASTROENTEROL, VS2468-1253, P30048; Yeo C, 2020, LANCET GASTROENTEROL, V5, P335, DOI 10.1016/S2468-1253(20)30048-0; Zhang H, 2001, J BIOL CHEM, V276, P17132, DOI 10.1074/jbc.M006723200; Zhang H., 2020, BIORXIV, DOI [10.1101/2020.01.30.927806, DOI 10.1101/2020.01.30.927806.]; Zhang H, 2020, GUT, V69, P1010, DOI 10.1136/gutjnl-2020-320953; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhao Y, 2020, SCI CHINA CHEM, DOI [10.1101/2020.01.26.919985, DOI 10.1007/s11426-020-9864-7]; Zhao Y, 2020, AM J RESP CRIT CARE, V202, P756, DOI 10.1164/rccm.202001-0179LE; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou P., 2020, NATURE, DOI DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zisman LS, 2003, CIRCULATION, V108, P1707, DOI 10.1161/01.CIR.0000094734.67990.99; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	59	2745	2886	73	655	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1444	+	eabb2762	10.1126/science.abb2762	http://dx.doi.org/10.1126/science.abb2762			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ4RP	32132184	Green Published			2022-12-28	WOS:000523251600029
J	Loganathan, SK; Schleicher, K; Malik, A; Quevedo, R; Langille, E; Teng, K; Oh, RH; Rathod, B; Tsai, R; Samavarchi-Tehrani, P; Pugh, TJ; Gingras, AC; Schramek, D				Loganathan, Sampath K.; Schleicher, Krista; Malik, Ahmad; Quevedo, Rene; Langille, Ellen; Teng, Katie; Oh, Robin H.; Rathod, Bhavisha; Tsai, Ricky; Samavarchi-Tehrani, Payman; Pugh, Trevor J.; Gingras, Anne-Claude; Schramek, Daniel			Rare driver mutations in head and neck squamous cell carcinomas converge on NOTCH signaling	SCIENCE			English	Article							CANCER; PATHWAY; AJUBA; COMMITMENT; ACTIVATION; NETWORKS; ADAM17; RNAI	In most human cancers, only a few genes are mutated at high frequencies; most are mutated at low frequencies. The functional consequences of these recurrent but infrequent "long tail" mutations are often unknown. We focused on 484 long tail genes in head and neck squamous cell carcinoma (HNSCC) and used in vivo CRISPR to screen for genes that, upon mutation, trigger tumor development in mice. Of the 15 tumor-suppressor genes identified, ADAM10 and AJUBA suppressed HNSCC in a haploinsufficient manner by promoting NOTCH receptor signaling. ADAM10 and AJUBA mutations or monoallelic loss occur in 28% of human HNSCC cases and are mutually exclusive with NOTCH receptor mutations. Our results show that oncogenic mutations in 67% of human HNSCC cases converge onto the NOTCH signaling pathway, making NOTCH inactivation a hallmark of HNSCC.	[Loganathan, Sampath K.; Schleicher, Krista; Malik, Ahmad; Langille, Ellen; Teng, Katie; Oh, Robin H.; Rathod, Bhavisha; Tsai, Ricky; Samavarchi-Tehrani, Payman; Gingras, Anne-Claude; Schramek, Daniel] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Ctr Mol & Syst Biol, Toronto, ON, Canada; [Schleicher, Krista; Malik, Ahmad; Langille, Ellen; Oh, Robin H.; Gingras, Anne-Claude; Schramek, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Quevedo, Rene; Pugh, Trevor J.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Quevedo, Rene; Pugh, Trevor J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Pugh, Trevor J.] Ontario Inst Canc Res, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Schramek, D (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Ctr Mol & Syst Biol, Toronto, ON, Canada.; Schramek, D (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	schramek@lunenfeld.ca	Pugh, Trevor/Y-2535-2019; Gingras, Anne-Claude/ABA-8341-2020; Loganathan, Sampath/AAB-6539-2022; Schramek, Daniel/AAL-1470-2020; Gingras, Anne-Claude/E-9982-2010	Pugh, Trevor/0000-0002-8073-5888; Gingras, Anne-Claude/0000-0002-6090-4437; Schramek, Daniel/0000-0001-9977-2104; Gingras, Anne-Claude/0000-0002-6090-4437; Teng, Katie/0000-0002-7459-4193; Loganathan, Sampath Kumar/0000-0002-8809-1466	Canadian Institute of Health Research [CIHR 365252]; Krembil Foundation; HFSP [CDA00080/2015]; Canadian Cancer Society fellowship [BC-F-16, 31919]; Terry Fox Research Institute program grant	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Krembil Foundation; HFSP(Human Frontier Science Program); Canadian Cancer Society fellowship; Terry Fox Research Institute program grant	This work was supported by a project grant to D.S. from the Canadian Institute of Health Research (CIHR 365252) and the Krembil Foundation. D. S. is the recipient of a career development award from HFSP (CDA00080/2015). S.K.L. is the recipient of a Canadian Cancer Society fellowship (BC-F-16#31919). A.C.G. was supported by a Terry Fox Research Institute program grant.	Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Adams JR, 2011, CANCER RES, V71, P2706, DOI 10.1158/0008-5472.CAN-10-0738; Al-Ahmadie H, 2014, CANCER DISCOV, V4, P1014, DOI 10.1158/2159-8290.CD-14-0380; Amemiya HM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45839-z; Beronja Slobodan, 2013, Methods Mol Biol, V961, P351, DOI 10.1007/978-1-62703-227-8_23; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Bian Y, 2012, ONCOGENE, V31, P3322, DOI 10.1038/onc.2011.494; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Campbell JD, 2018, CELL REP, V23, P194, DOI 10.1016/j.celrep.2018.03.063; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Castro-Giner F, 2015, NAT REV CANCER, V15, P680, DOI 10.1038/nrc3999; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; Dotto GP, 2016, CANCER CELL, V29, P622, DOI 10.1016/j.ccell.2016.04.004; Dutta S, 2018, EMBO REP, V19, P337, DOI 10.15252/embr.201744777; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Go C. D., 2019, PROXIMITY BIOTINYLAT, DOI [10.1101/796391v1, 10.1101/796391, DOI 10.1101/796391]; Guinea-Viniegra J, 2012, J CLIN INVEST, V122, P2898, DOI 10.1172/JCI63103; Haraguchi K, 2008, ONCOGENE, V27, P274, DOI 10.1038/sj.onc.1210644; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hesketh GG, 2017, METHODS MOL BIOL, V1550, P115, DOI 10.1007/978-1-4939-6747-6_10; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Kwan J, 2016, GENE DEV, V30, P2696, DOI 10.1101/gad.284539.116; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Leemans CR, 2018, NAT REV CANCER, V18, P269, DOI 10.1038/nrc.2018.11; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Meier-Stiegen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011481; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Mullooly M, 2016, CANCER BIOL THER, V17, P870, DOI 10.1080/15384047.2016.1177684; Murthy A, 2012, IMMUNITY, V36, P105, DOI 10.1016/j.immuni.2012.01.005; Nola S, 2011, J CELL BIOL, V195, P855, DOI 10.1083/jcb.201107162; Nowell CS, 2017, NAT REV CANCER, V17, P145, DOI 10.1038/nrc.2016.145; Oberbeck N, 2019, NATURE, V574, P249, DOI 10.1038/s41586-019-1615-3; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schramek D, 2014, SCIENCE, V343, P309, DOI 10.1126/science.1248627; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111	50	82	83	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1264	+		10.1126/science.aax0902	http://dx.doi.org/10.1126/science.aax0902			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9DP	32165588				2022-12-28	WOS:000520023800045
J	Rai, A; Pelkmans, L				Rai, Arpan; Pelkmans, Lucas			Liquid droplets in the skin	SCIENCE			English	Editorial Material									[Rai, Arpan; Pelkmans, Lucas] Univ Zurich, Dept Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland	University of Zurich	Pelkmans, L (corresponding author), Univ Zurich, Dept Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	lucas.pelkmans@mls.uzh.ch						Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; Delarue M, 2018, CELL, V174, P338, DOI 10.1016/j.cell.2018.05.042; Dubey J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00343; Elias PM, 2002, J INVEST DERMATOL, V119, P1269, DOI 10.1046/j.1523-1747.2002.19622.x; HOLBROOK KA, 1989, J INVEST DERMATOL, V92, pS84, DOI 10.1111/1523-1747.ep13075079; Quiroz FG, 2020, SCIENCE, V367, P1210, DOI 10.1126/science.aax9554; Rai AK, 2018, NATURE, V559, P211, DOI 10.1038/s41586-018-0279-8; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Schuster BS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05403-1; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Soding J, 2020, TRENDS CELL BIOL, V30, P4, DOI 10.1016/j.tcb.2019.10.006; Style RW, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.011028; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Yoo H, 2019, J BIOL CHEM, V294, P7151, DOI 10.1074/jbc.TM118.001191	15	3	3	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1193	1194		10.1126/science.abb0060	http://dx.doi.org/10.1126/science.abb0060			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU9DP	32165570				2022-12-28	WOS:000520023800031
J	Xiao, Y; Zhao, LD				Xiao, Yu; Zhao, Li-Dong			Seeking new, highly effective thermoelectrics	SCIENCE			English	Editorial Material							THERMAL-CONDUCTIVITY; PERFORMANCE; FIGURE; MERIT		[Xiao, Yu; Zhao, Li-Dong] Beihang Univ, Sch Mat Sci & Engn, Beijing 100191, Peoples R China	Beihang University	Zhao, LD (corresponding author), Beihang Univ, Sch Mat Sci & Engn, Beijing 100191, Peoples R China.	zhaolidong@buaa.edu.cn	Zhao, Li-Dong/B-1045-2019; Xiao, Yu/GYV-2423-2022; Xiao, Yu/P-9034-2019	Zhao, Li-Dong/0000-0003-1247-4345; Xiao, Yu/0000-0003-3369-6852	National Key Research and Development Program of China [2018YFA0702100, 2018YFB0703600]; National Natural Science Foundation ofChina [51772012, 51671015]; Beijing Natural Science Foundation [JQ18004]; Shenzhen Peacock Planteam [KQTD2016022619565991]; National Postdoctoral Program for InnovativeTalents [BX20190028]; 111 Project [B17002]; Postdoctoral Science Foundationof China [2019M660399]; National ScienceFoundation [51925101]	National Key Research and Development Program of China; National Natural Science Foundation ofChina(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Shenzhen Peacock Planteam; National Postdoctoral Program for InnovativeTalents; 111 Project(Ministry of Education, China - 111 Project); Postdoctoral Science Foundationof China(China Postdoctoral Science Foundation); National ScienceFoundation(National Science Foundation (NSF))	We acknowledge support from the National Key Research and Development Program of China (2018YFA0702100; 2018YFB0703600),National Natural Science Foundation ofChina(51772012; 51671015),Beijing Natural Science Foundation (JQ18004), Shenzhen Peacock Planteam (KQTD2016022619565991),National Postdoctoral Program for InnovativeTalents (BX20190028), 111 Project (B17002), and Postdoctoral Science Foundationof China (2019M660399). L.-D.Z. has support from the National ScienceFoundation for Distinguished Young Scholars (51925101).	Chang C, 2018, SCIENCE, V360, P778, DOI 10.1126/science.aaq1479; Chung DY, 1997, CHEM MATER, V9, P3060, DOI 10.1021/cm970397e; He WK, 2019, SCIENCE, V365, P1418, DOI 10.1126/science.aax5123; Lee YK, 2019, JOULE, V3, P719, DOI 10.1016/j.joule.2019.01.001; Liu WS, 2019, J MATERIOMICS, V5, P321, DOI 10.1016/j.jmat.2019.04.004; Luo YB, 2020, JOULE, V4, P159, DOI 10.1016/j.joule.2019.10.010; PLACHKOVA SK, 1984, PHYS STATUS SOLIDI A, V83, P349, DOI 10.1002/pssa.2210830140; Poudel B, 2008, SCIENCE, V320, P634, DOI 10.1126/science.1156446; Poudeu PFR, 2006, ANGEW CHEM INT EDIT, V45, P3835, DOI 10.1002/anie.200600865; Shi X, 2016, NAT MATER, V15, P691, DOI 10.1038/nmat4643; Vining CB, 2009, NAT MATER, V8, P83, DOI 10.1038/nmat2361; Wang SY, 2016, ENERG ENVIRON SCI, V9, P3436, DOI 10.1039/c6ee02674e; Zhao LD, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3485050; Zhao LD, 2016, SCIENCE, V351, P141, DOI 10.1126/science.aad3749; Zhao LD, 2014, NATURE, V508, P373, DOI 10.1038/nature13184	15	193	195	24	213	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1196	1197		10.1126/science.aaz9426	http://dx.doi.org/10.1126/science.aaz9426			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU9DP	32165572				2022-12-28	WOS:000520023800022
J	Consiglio, CR; Brodin, P				Consiglio, Camila Rosat; Brodin, Petter			Stressful Beginnings with Long-Term Consequences	CELL			English	Editorial Material							IMMUNE-SYSTEM	Early-life stress can have long-term health consequences, but the mechanisms of this are unknown. In this issue of Cell, Hong et al. demonstrate one such mechanism linking perinatal corticosteroid exposure to reduced CD8(+) T cell function later in life and impaired anti-cancer and anti-bacterial immune responses.	[Consiglio, Camila Rosat; Brodin, Petter] Karolinska Inst, Sci Life Lab, Dept Womens & Childrens Hlth, SE-17121 Stockholm, Sweden; [Brodin, Petter] Karolinska Univ Hosp, Unit Pediat Rheumatol, SE-17176 Solna, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Brodin, P (corresponding author), Karolinska Inst, Sci Life Lab, Dept Womens & Childrens Hlth, SE-17121 Stockholm, Sweden.; Brodin, P (corresponding author), Karolinska Univ Hosp, Unit Pediat Rheumatol, SE-17176 Solna, Sweden.	petter.brodin@ki.se		Rosat Consiglio, Camila/0000-0002-8901-2328				Al Nabhani Z, 2019, IMMUNITY, V50, P1276, DOI 10.1016/j.immuni.2019.02.014; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Grossman Z, 2015, ANNU REV IMMUNOL, V33, P677, DOI 10.1146/annurev-immunol-032712-100027; Hong J.Y., 2020, CELL, V180, P847; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Olin A, 2018, CELL, V174, P1277, DOI 10.1016/j.cell.2018.06.045; Pradeu T, 2012, LIMITS SELF IMMUNOLO; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581	10	3	3	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2020	180	5					820	821		10.1016/j.cell.2020.02.021	http://dx.doi.org/10.1016/j.cell.2020.02.021			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KT7JN	32142672	Bronze			2022-12-28	WOS:000519189800001
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Whose record is it anyway?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						BMA, 2019, ACC HLTH REC	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2020	368								m753	10.1136/bmj.m753	http://dx.doi.org/10.1136/bmj.m753			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KD	32127408	Bronze			2022-12-28	WOS:000519536500003
J	Dyer, C				Dyer, Clare			Doctors didn't breach duty of care by not telling woman her father had Huntington's disease	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2015, BMJ-BRIT MED J, V350, DOI DOI 10.1136/BMJ.H2864; DYER C, 2017, BMJ-BRIT MED J, V357, P94779, DOI DOI 10.1136/BMJ.J2433	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2020	368								m820	10.1136/bmj.m820	http://dx.doi.org/10.1136/bmj.m820			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KC	32122874				2022-12-28	WOS:000519536400005
J	Dance, A				Dance, Amber			A HOME FOR EVERY IMAGING DATA SET	NATURE			English	Editorial Material						Microscopy; Imaging; Computational biology and bioinformatics; Databases		Repositories let researchers store, share and access life-science images - and maybe even extract new findings.										McDole K, 2018, CELL, V175, P859, DOI 10.1016/j.cell.2018.09.031; Williams E, 2017, NAT METHODS, V14, P775, DOI [10.1038/NMETH.4326, 10.1038/nmeth.4326]; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081	3	3	3	1	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7797					162	163		10.1038/d41586-020-00594-4	http://dx.doi.org/10.1038/d41586-020-00594-4			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU1JA	32123362	Bronze			2022-12-28	WOS:000519464800006
J	Wise, J				Wise, Jacqui			Life as a neurosurgeon	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		BMA, WELLB SUPP SERV; Royal College of Surgeons of England, CONF SUPP ADV SERV S; Royal College of Surgeons of England, WOM SURG	3	4	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2020	368								m395	10.1136/bmj.m395	http://dx.doi.org/10.1136/bmj.m395			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KA	32111642	Bronze			2022-12-28	WOS:000519536200001
J	Schmidt, A; Pybus, JR; Weiss, R; Segarra, EP; Hrnjic, A; Denniston, A; Hen, O; Piasetzky, E; Weinstein, LB; Barnea, N; Strikman, M; Larionov, A; Higinbotham, D; Schmidt, A; Pybus, JR; Weiss, R; Segarra, EP; Hrnjic, A; Denniston, A; Hen, O; Piasetzky, E; Weinstein, LB; Barnea, N; Strikman, M; Larionov, A; Higinbotham, D; Adhikari, S; Amaryan, M; Angelini, G; Asryan, G; Atac, H; Avakian, H; Gayoso, CA; Baashen, L; Barion, L; Bashkanov, M; Battaglieri, M; Beck, A; Bedlinskiy, I; Benmokhtar, F; Bianconi, A; Biselli, AS; Bossu, F; Boiarinov, S; Brahim, M; Briscoe, WJ; Brooks, W; Burkert, VD; Cao, F; Carman, DS; Carvajal, JC; Celentano, A; Chatagnon, P; Chetry, T; Ciullo, G; Clark, L; Cohen, E; Cole, PL; Contalbrigo, M; Crede, V; Cruz-Torres, R; D'Angelo, A; Dashyan, N; De Vita, R; De Sanctis, E; Defurne, M; Deur, A; Diehl, S; Djalali, C; Duer, M; Dugger, M; Dupre, R; Egiyan, H; Ehrhart, M; El Alaoui, A; El Fassi, L; Eugenio, P; Filippi, A; Forest, TA; Gavalian, G; Gilad, S; Gilfoyle, GP; Giovanetti, KL; Girod, FX; Giuseppe, C; Glazier, DI; Golovatch, E; Gothe, RW; Griffioen, KA; Guo, L; Hafidi, K; Hakobyan, H; Hanretty, C; Harrison, N; Hattawy, M; Hauenstein, F; Hayward, TB; Hicks, K; Holtrop, M; Ilieva, Y; Illari, I; Ireland, D; Ishkanov, BS; Isupov, EL; Jenkins, D; Jo, HS; Joo, K; Keller, D; Khachatryan, M; Khanal, A; Khandaker, M; Kim, CW; Kim, W; Klein, FJ; Korover, I; Kubarovsky, V; Lanza, L; Leali, M; Lenisa, P; MacGregor, IJD; Marchand, D; Markov, N; Marsicano, L; Mascagna, V; Beck, SMT; McKinnon, B; Mirazita, M; Mokeev, V; Camacho, CM; Mustafa, B; Nadel-Turonski, P; Nanda, S; Niccolai, S; Niculescu, G; Osipenko, M; Ostrovidov, AI; Paolone, M; Pappalardo, LL; Paremuzyan, R; Park, K; Pasyuk, E; Patsyuk, M; Phelps, W; Pogorelko, O; Price, JW; Prok, Y; Protopopescu, D; Ripani, M; Riser, D; Rizzo, A; Rosner, G; Rossi, P; Sabatie, F; Salgado, C; Schmookler, B; Schumacher, RA; Sharabian, YG; Shrestha, U; Skorodumina, I; Sokhan, D; Soto, O; Sparveris, N; Stepanyan, S; Strakovsky, II; Strauch, S; Tan, JA; Tyler, N; Ungaro, M; Venturelli, L; Voskanyan, H; Voutier, E; Wang, R; Watts, DP; Wei, X; Wood, MH; Zachariou, N; Zhang, J; Zhao, ZW; Zheng, X				Schmidt, A.; Pybus, J. R.; Weiss, R.; Segarra, E. P.; Hrnjic, A.; Denniston, A.; Hen, O.; Piasetzky, E.; Weinstein, L. B.; Barnea, N.; Strikman, M.; Larionov, A.; Higinbotham, D.; Schmidt, A.; Pybus, J. R.; Weiss, R.; Segarra, E. P.; Hrnjic, A.; Denniston, A.; Hen, O.; Piasetzky, E.; Weinstein, L. B.; Barnea, N.; Strikman, M.; Larionov, A.; Higinbotham, D.; Adhikari, S.; Amaryan, M.; Angelini, G.; Asryan, G.; Atac, H.; Avakian, H.; Gayoso, C. Ayerbe; Baashen, L.; Barion, L.; Bashkanov, M.; Battaglieri, M.; Beck, A.; Bedlinskiy, I.; Benmokhtar, F.; Bianconi, A.; Biselli, A. S.; Bossu, F.; Boiarinov, S.; Brahim, M.; Briscoe, W. J.; Brooks, W.; Burkert, V. D.; Cao, F.; Carman, D. S.; Carvajal, J. C.; Celentano, A.; Chatagnon, P.; Chetry, T.; Ciullo, G.; Clark, L.; Cohen, E.; Cole, P. L.; Contalbrigo, M.; Crede, V.; Cruz-Torres, R.; D'Angelo, A.; Dashyan, N.; De Vita, R.; De Sanctis, E.; Defurne, M.; Deur, A.; Diehl, S.; Djalali, C.; Duer, M.; Dugger, M.; Dupre, R.; Egiyan, H.; Ehrhart, M.; El Alaoui, A.; El Fassi, L.; Eugenio, P.; Filippi, A.; Forest, T. A.; Gavalian, G.; Gilad, S.; Gilfoyle, G. P.; Giovanetti, K. L.; Girod, F. X.; Giuseppe, C.; Glazier, D. I.; Golovatch, E.; Gothe, R. W.; Griffioen, K. A.; Guo, L.; Hafidi, K.; Hakobyan, H.; Hanretty, C.; Harrison, N.; Hattawy, M.; Hauenstein, F.; Hayward, T. B.; Hicks, K.; Holtrop, M.; Ilieva, Y.; Illari, I.; Ireland, D.; Ishkanov, B. S.; Isupov, E. L.; Jenkins, D.; Jo, H. S.; Joo, K.; Keller, D.; Khachatryan, M.; Khanal, A.; Khandaker, M.; Kim, C. W.; Kim, W.; Klein, F. J.; Korover, I.; Kubarovsky, V.; Lanza, L.; Leali, M.; Lenisa, P.; MacGregor, I. J. D.; Marchand, D.; Markov, N.; Marsicano, L.; Mascagna, V.; Beck, S. May-Tal; McKinnon, B.; Mirazita, M.; Mokeev, V.; Camacho, C. Munoz; Mustafa, B.; Nadel-Turonski, P.; Nanda, S.; Niccolai, S.; Niculescu, G.; Osipenko, M.; Ostrovidov, A. I.; Paolone, M.; Pappalardo, L. L.; Paremuzyan, R.; Park, K.; Pasyuk, E.; Patsyuk, M.; Phelps, W.; Pogorelko, O.; Price, J. W.; Prok, Y.; Protopopescu, D.; Ripani, M.; Riser, D.; Rizzo, A.; Rosner, G.; Rossi, P.; Sabatie, F.; Salgado, C.; Schmookler, B.; Schumacher, R. A.; Sharabian, Y. G.; Shrestha, U.; Skorodumina, Iu.; Sokhan, D.; Soto, O.; Sparveris, N.; Stepanyan, S.; Strakovsky, I. I.; Strauch, S.; Tan, J. A.; Tyler, N.; Ungaro, M.; Venturelli, L.; Voskanyan, H.; Voutier, E.; Wang, R.; Watts, D. P.; Wei, X.; Wood, M. H.; Zachariou, N.; Zhang, J.; Zhao, Z. W.; Zheng, X.		CLAS Collaboration	Probing the core of the strong nuclear interaction	NATURE			English	Article							SHORT-RANGE CORRELATIONS; SPECTRAL-FUNCTION; ENERGY; DEPENDENCE; MODEL	High-energy electron scattering that can isolate pairs of nucleons in high-momentum configurations reveals a transition to spin-independent scalar forces at small separation distances, supporting the use of point-like nucleon models to describe dense nuclear systems. The strong nuclear interaction between nucleons (protons and neutrons) is the effective force that holds the atomic nucleus together. This force stems from fundamental interactions between quarks and gluons (the constituents of nucleons) that are described by the equations of quantum chromodynamics. However, as these equations cannot be solved directly, nuclear interactions are described using simplified models, which are well constrained at typical inter-nucleon distances(1-5) but not at shorter distances. This limits our ability to describe high-density nuclear matter such as that in the cores of neutron stars(6). Here we use high-energy electron scattering measurements that isolate nucleon pairs in short-distance, high-momentum configurations(7-9), accessing a kinematical regime that has not been previously explored by experiments, corresponding to relative momenta between the pair above 400 megaelectronvolts per c (c, speed of light in vacuum). As the relative momentum between two nucleons increases and their separation thereby decreases, we observe a transition from a spin-dependent tensor force to a predominantly spin-independent scalar force. These results demonstrate the usefulness of using such measurements to study the nuclear interaction at short distances and also support the use of point-like nucleon models with two- and three-body effective interactions to describe nuclear systems up to densities several times higher than the central density of the nucleus.	[Schmidt, A.; Pybus, J. R.; Segarra, E. P.; Hrnjic, A.; Denniston, A.; Hen, O.; Schmidt, A.; Pybus, J. R.; Segarra, E. P.; Hrnjic, A.; Denniston, A.; Hen, O.; Beck, A.; Cruz-Torres, R.; Gilad, S.; Hauenstein, F.; Beck, S. May-Tal; Patsyuk, M.; Schmookler, B.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Schmidt, A.; Schmidt, A.; Angelini, G.; Briscoe, W. J.; Ilieva, Y.; Illari, I.; Kim, C. W.; Phelps, W.; Strakovsky, I. I.; Strauch, S.] George Washington Univ, Washington, DC USA; [Weiss, R.; Barnea, N.; Weiss, R.; Barnea, N.] Hebrew Univ Jerusalem, Jerusalem, Israel; [Piasetzky, E.; Piasetzky, E.; Cohen, E.; Duer, M.; Korover, I.] Tel Aviv Univ, Tel Aviv, Israel; [Weinstein, L. B.; Weinstein, L. B.; Amaryan, M.; Hattawy, M.; Hauenstein, F.; Khachatryan, M.; Prok, Y.] Old Dominion Univ, Norfolk, VA USA; [Strikman, M.; Strikman, M.] Penn State Univ, University Pk, PA 16802 USA; [Larionov, A.; Larionov, A.] Giersch Sci Ctr, Frankfurt Inst Adv Studies, Frankfurt, Germany; [Higinbotham, D.; Higinbotham, D.; Avakian, H.; Battaglieri, M.; Boiarinov, S.; Burkert, V. D.; Carman, D. S.; Deur, A.; Egiyan, H.; Gavalian, G.; Girod, F. X.; Giuseppe, C.; Hanretty, C.; Harrison, N.; Kubarovsky, V.; Mokeev, V.; Nadel-Turonski, P.; Park, K.; Pasyuk, E.; Rossi, P.; Sharabian, Y. G.; Stepanyan, S.; Ungaro, M.; Wei, X.] Thomas Jefferson Natl Accelerator Facil, Newport News, VA USA; [Adhikari, S.; Baashen, L.; Carvajal, J. C.; Guo, L.; Khanal, A.] Florida Int Univ, Miami, FL 33199 USA; [Asryan, G.; Dashyan, N.; Hakobyan, H.; Voskanyan, H.] Yerevan Phys Inst, Yerevan, Armenia; [Atac, H.; Paolone, M.; Sparveris, N.] Temple Univ, Philadelphia, PA 19122 USA; [Gayoso, C. Ayerbe; Griffioen, K. A.; Hayward, T. B.] Coll William & Mary, Williamsburg, VA USA; [Barion, L.; Ciullo, G.; Contalbrigo, M.; Girod, F. X.; Giuseppe, C.; Lenisa, P.; Pappalardo, L. L.] Ist Nazl Fis Nucl, Sez Ferrara, Ferrara, Italy; [Bashkanov, M.; Watts, D. P.; Zachariou, N.] Univ York, York, N Yorkshire, England; [Battaglieri, M.; Celentano, A.; De Vita, R.; Marsicano, L.; Osipenko, M.; Ripani, M.] Ist Nazl Fis Nucl, Sez Genova, Genoa, Italy; [Bedlinskiy, I.; Pogorelko, O.] Natl Res Ctr, Kurchatov Inst ITEP, Moscow, Russia; [Benmokhtar, F.] Duquesne Univ, Pittsburgh, PA 15219 USA; [Bianconi, A.; Leali, M.; Venturelli, L.] Univ Brescia, Brescia, Italy; [Bianconi, A.; Leali, M.; Mascagna, V.; Venturelli, L.] Ist Nazl Fis Nucl, Sez Pavia, Pavia, Italy; [Biselli, A. S.] Fairfield Univ, Fairfield, CT 06430 USA; [Biselli, A. S.; Schumacher, R. A.] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Bossu, F.; Defurne, M.; Sabatie, F.] Univ Paris Saclay, IRFU, CEA, Gif Sur Yvette, France; [Brahim, M.; Hafidi, K.; Mustafa, B.] Argonne Natl Lab, 9700 S Cass Ave, Argonne, IL 60439 USA; [Brooks, W.; El Alaoui, A.; Hakobyan, H.] Univ Tecn Federico Santa Maria, Valparaiso, Chile; [Cao, F.; Diehl, S.; Joo, K.; Markov, N.; Riser, D.] Univ Connecticut, Storrs, CT USA; [Chatagnon, P.; Dupre, R.; Ehrhart, M.; Marchand, D.; Camacho, C. Munoz; Niccolai, S.; Voutier, E.; Wang, R.] Univ Paris Saclay, Univ Paris Sud, Inst Phys Nucl, CNRS,IN2P3, Orsay, France; [Chetry, T.; El Fassi, L.; Nanda, S.] Mississippi State Univ, Mississippi State, MS 39762 USA; [Ciullo, G.] Univ Ferrara, Ferrara, Italy; [Clark, L.; Glazier, D. I.; Ireland, D.; MacGregor, I. J. D.; McKinnon, B.; Protopopescu, D.; Rosner, G.; Sokhan, D.] Univ Glasgow, Glasgow, Lanark, Scotland; [Cole, P. L.] Lamar Univ, Beaumont, TX 77710 USA; [Cole, P. L.; Forest, T. A.] Idaho State Univ, Pocatello, ID 83209 USA; [Cole, P. L.; Klein, F. J.] Catholic Univ Amer, Washington, DC 20064 USA; [Crede, V.; Eugenio, P.; Ostrovidov, A. I.] Florida State Univ, Tallahassee, FL 32306 USA; [D'Angelo, A.; Lanza, L.; Rizzo, A.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, Rome, Italy; [D'Angelo, A.; Rizzo, A.] Univ Roma Tor Vergata, Rome, Italy; [De Sanctis, E.; Mirazita, M.; Rossi, P.; Soto, O.] Ist Nazl Fis Nucl, Lab Nazl Frascati, Frascati, Italy; [Djalali, C.; Hicks, K.; Shrestha, U.] Ohio Univ, Athens, OH 45701 USA; [Djalali, C.; Gothe, R. W.; Ilieva, Y.; Skorodumina, Iu.; Strauch, S.; Tyler, N.; Wood, M. H.] Univ South Carolina, Columbia, SC 29208 USA; [Dugger, M.; Pasyuk, E.] Arizona State Univ, Tempe, AZ USA; [Filippi, A.] Ist Nazl Fis Nucl, Sez Torino, Turin, Italy; [Gavalian, G.; Holtrop, M.; Paremuzyan, R.] Univ New Hampshire, Durham, NH 03824 USA; [Gilfoyle, G. P.] Univ Richmond, Richmond, VA 23173 USA; [Giovanetti, K. L.; Niculescu, G.] James Madison Univ, Harrisonburg, VA 22807 USA; [Golovatch, E.; Ishkanov, B. S.; Isupov, E. L.; Skorodumina, Iu.] Lomonosov Moscow State Univ, Skobeltsyn Inst Nucl Phys, Moscow, Russia; [Jenkins, D.] Virginia Tech, Blacksburg, VA USA; [Jo, H. S.; Kim, W.; Park, K.; Tan, J. A.] Kyungpook Natl Univ, Daegu, South Korea; [Keller, D.; Prok, Y.; Zhang, J.; Zheng, X.] Univ Virginia, Charlottesville, VA USA; [Khandaker, M.; Salgado, C.] Norfolk State Univ, Norfolk, VA USA; [Kubarovsky, V.; Ungaro, M.] Rensselaer Polytech Inst, Troy, NY USA; [Mascagna, V.] Univ Insubria, Como, Italy; [Price, J. W.] Calif State Univ Dominguez Hills, Carson, CA 90747 USA; [Wood, M. H.] Canisius Coll, Buffalo, NY 14208 USA; [Zhao, Z. W.] Duke Univ, Durham, NC USA; [Khandaker, M.] Idaho State Univ, Pocatello, ID 83209 USA; [Mascagna, V.] Univ Brescia, Brescia, Italy	Massachusetts Institute of Technology (MIT); George Washington University; Hebrew University of Jerusalem; Tel Aviv University; Old Dominion University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Energy (DOE); Jefferson National Accelerator; State University System of Florida; Florida International University; Yerevan Physics Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; William & Mary; Istituto Nazionale di Fisica Nucleare (INFN); University of York - UK; Istituto Nazionale di Fisica Nucleare (INFN); Duquesne University; University of Brescia; Istituto Nazionale di Fisica Nucleare (INFN); Fairfield University; Carnegie Mellon University; CEA; UDICE-French Research Universities; Universite Paris Saclay; United States Department of Energy (DOE); Argonne National Laboratory; Universidad Tecnica Federico Santa Maria; University of Connecticut; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Saclay; Mississippi State University; University of Ferrara; University of Glasgow; Texas State University System; Lamar University; Idaho; Idaho State University; Catholic University of America; State University System of Florida; Florida State University; Istituto Nazionale di Fisica Nucleare (INFN); University of Rome Tor Vergata; Istituto Nazionale di Fisica Nucleare (INFN); University System of Ohio; Ohio University; University of South Carolina System; University of South Carolina Columbia; Arizona State University; Arizona State University-Tempe; Istituto Nazionale di Fisica Nucleare (INFN); University System Of New Hampshire; University of New Hampshire; University of Richmond; James Madison University; Lomonosov Moscow State University; Virginia Polytechnic Institute & State University; Kyungpook National University; University of Virginia; Norfolk State University; Rensselaer Polytechnic Institute; University of Insubria; California State University System; California State University Dominguez Hills; Duke University; Idaho; Idaho State University; University of Brescia	Hen, O (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hen@mit.edu	Dugger, Michael/AAR-5206-2021; Brooks, William K/C-8636-2013; Jo, Hyon-Suk/HGC-7070-2022; Lanza, Lucilla/AAA-3006-2021; Pappalardo, Luciano/AAB-2380-2021; Rosner, Guenther/ABB-5516-2021; Deur, Alexandre/H-9778-2019; Barnea, Nir/F-8960-2011; Lanza, Lucilla/E-6479-2017; Rizzo, Alessandro/C-6397-2014; Schumacher, Reinhard A/K-6455-2013; Mascagna, Valerio/AAC-9914-2019; Denniston, Alastair/ABD-1238-2020; Celentano, Andrea/J-6190-2012; Bashkanov, Mikhail/R-1333-2018; Ciullo, Giuseppe/X-6539-2018	Dugger, Michael/0000-0001-5927-7045; Brooks, William K/0000-0001-6161-3570; Lanza, Lucilla/0000-0002-1280-532X; Deur, Alexandre/0000-0002-2203-7723; Barnea, Nir/0000-0001-8036-3052; Lanza, Lucilla/0000-0002-1280-532X; Rizzo, Alessandro/0000-0001-5597-8514; Schumacher, Reinhard A/0000-0002-3860-1827; Mascagna, Valerio/0000-0003-3612-1608; Denniston, Alastair/0000-0001-7849-0087; Celentano, Andrea/0000-0002-7104-2983; Benmokhtar, Fatiha/0000-0003-3670-4045; Soto, Orlando/0000-0002-8613-0310; Contalbrigo, Marco/0000-0002-8612-7998; Ehrhart, Mathieu/0000-0002-8076-9690; Schmidt, Axel/0000-0002-1109-2954; Ayerbe Gayoso, Carlos/0000-0001-8640-5380; Hen, Or/0000-0002-4890-6544; Bashkanov, Mikhail/0000-0001-9822-9433; Larionov, Alexei/0000-0002-8648-109X; Hakobyan, Hayk/0000-0002-9061-5257; Paolone, Michael/0000-0002-8980-6670; Ciullo, Giuseppe/0000-0001-8297-2206; Marsicano, Luca/0000-0002-8931-7498; Battaglieri, Marco/0000-0001-5002-8771; Isupov, Evgeny/0000-0001-7524-2408; ATAC, HAMZA/0000-0002-8945-5305; Weiss, Ronen/0000-0002-6372-9742	US Department of Energy (DOE); National Science Foundation; Israel Science Foundation; Pazi Foundation; Chilean Comision Nacional de Investigacion Cientifica y Tecnologica; French Centre National de la Recherche Scientifique; Commissariat a l'Energie Atomique; French-American Cultural Exchange; Italian Istituto Nazionale di Fisica Nucleare; National Research Foundation of Korea; UK Science and Technology Facilities Council; Jefferson Science Associates operates the Thomas Jefferson National Accelerator Facility for the DOE, Office of Science, Office of Nuclear Physics [DE-AC05-06OR23177]; STFC [ST/T002077/1, ST/V002570/1, ST/P004385/2, ST/P004385/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/T002077/1] Funding Source: researchfish	US Department of Energy (DOE)(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Israel Science Foundation(Israel Science Foundation); Pazi Foundation; Chilean Comision Nacional de Investigacion Cientifica y Tecnologica; French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); French-American Cultural Exchange; Italian Istituto Nazionale di Fisica Nucleare(Istituto Nazionale di Fisica Nucleare (INFN)); National Research Foundation of Korea(National Research Foundation of Korea); UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Jefferson Science Associates operates the Thomas Jefferson National Accelerator Facility for the DOE, Office of Science, Office of Nuclear Physics; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We acknowledge the efforts of the staff of the Accelerator and Physics Divisions at Jefferson Lab that made this experiment possible. The analysis presented here was carried out as part of the Jefferson Lab Hall B data-mining project supported by the US Department of Energy (DOE). The research was also supported by the National Science Foundation, the Israel Science Foundation, the Pazi Foundation, the Chilean Comision Nacional de Investigacion Cientifica y Tecnologica, the French Centre National de la Recherche Scientifique and Commissariat a l'Energie Atomique, the French-American Cultural Exchange, the Italian Istituto Nazionale di Fisica Nucleare, the National Research Foundation of Korea, and the UK Science and Technology Facilities Council. Jefferson Science Associates operates the Thomas Jefferson National Accelerator Facility for the DOE, Office of Science, Office of Nuclear Physics under contract DE-AC05-06OR23177.	Artiles O, 2016, PHYS REV C, V94, DOI 10.1103/PhysRevC.94.064318; ATTI CCD, 1991, PHYS REV C, V44, pR7; Benmokhtar F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.082305; Boeglin WU, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.262501; Carlson J, 2015, REV MOD PHYS, V87, P1067, DOI 10.1103/RevModPhys.87.1067; Ciofi degli Atti C, 1996, Phys Rev C Nucl Phys, V53, P1689; Ciofi degli Atti C, 2017, PHYS REV C, V96, P064317; degli Atti CC, 2015, PHYS REP, V590, P1, DOI 10.1016/j.physrep.2015.06.002; Cohen EO, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.092501; Colle C, 2015, PHYS REV C, V92, DOI 10.1103/PhysRevC.92.024604; Colle C, 2016, PHYS REV C, V93, DOI 10.1103/PhysRevC.93.034608; Colle C, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.024603; Cruz-Torres R, 2018, PHYS LETT B, V785, P304, DOI 10.1016/j.physletb.2018.07.069; Cruz-Torres R, 2019, PREPRINT; DEFOREST T, 1983, NUCL PHYS A, V392, P232, DOI 10.1016/0375-9474(83)90124-0; Duer M, 2019, PHYS LETT B, V797, DOI 10.1016/j.physletb.2019.07.039; Duer M, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.172502; Dutta D, 2013, PROG PART NUCL PHYS, V69, P1, DOI 10.1016/j.ppnp.2012.11.001; Egiyan KS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.262502; Ent R, 2001, PHYS REV C, V64, DOI 10.1103/PhysRevC.64.054610; Epelbaum E, 2009, REV MOD PHYS, V81, P1773, DOI 10.1103/RevModPhys.81.1773; Frankfurt L., 1992, MODERN TOPICS ELECT, P645; Frankfurt L, 2008, INT J MOD PHYS A, V23, P2991, DOI 10.1142/S0217751X08041207; FRANKFURT LL, 1981, PHYS REP, V76, P216, DOI 10.1016/0370-1573(81)90129-0; Frankfurt LL, 1997, PHYS REV C, V56, P1124, DOI 10.1103/PhysRevC.56.1124; Gezerlis A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.032501; Hakobyan H, 2008, NUCL INSTRUM METH A, V592, P218, DOI 10.1016/j.nima.2008.04.055; Hen O, 2014, SCIENCE, V346, P614, DOI 10.1126/science.1256785; Hen O, 2013, PHYS LETT B, V722, P63, DOI 10.1016/j.physletb.2013.04.011; Hen O, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.045002; Hoppe J, 2017, PHYS REV C, V96, DOI 10.1103/PhysRevC.96.054002; Kelly JJ, 1996, ADV NUCL PHYS, V23, P75; Korover I, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.022501; Kulagin SA, 2006, NUCL PHYS A, V765, P126, DOI 10.1016/j.nuclphysa.2005.10.011; Lattimer JM, 2007, PHYS REP, V442, P109, DOI 10.1016/j.physrep.2007.02.003; Lonardoni D, 2018, PHYS REV C, V98, DOI 10.1103/PhysRevC.98.014322; Lynn JE, 2017, PHYS REV C, V96, DOI 10.1103/PhysRevC.96.054007; MACHLEIDT R, 1987, PHYS REP, V149, P1, DOI 10.1016/S0370-1573(87)80002-9; Mecking BA, 2003, NUCL INSTRUM METH A, V503, P513, DOI 10.1016/S0168-9002(03)01001-5; Miller GA, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.035201; More SN, 2017, PHYS REV C, V96, DOI 10.1103/PhysRevC.96.054004; Norton PR, 2003, REP PROG PHYS, V66, P1253, DOI 10.1088/0034-4885/66/8/201; Piasetzky E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.162504; Rvachev MM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.192302; Sargsian MM, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.044615; Sargsian MM, 2001, INT J MOD PHYS E, V10, P405, DOI 10.1142/S0218301301000617; Schmookler B, 2019, NATURE, V566, P354, DOI 10.1038/s41586-019-0925-9; Shneor R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.072501; Subedi R, 2008, SCIENCE, V320, P1476, DOI 10.1126/science.1156675; Tang A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.042301; Weiss R, 2018, PHYS LETT B, V780, P211, DOI 10.1016/j.physletb.2018.01.061; Weiss R, 2019, PHYS LETT B, V791, P242, DOI 10.1016/j.physletb.2019.02.019; Weiss R, 2019, PHYS LETT B, V790, P484, DOI 10.1016/j.physletb.2019.01.053; Weiss R, 2015, PHYS REV C, V92, DOI 10.1103/PhysRevC.92.054311; Wiringa RB, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.024305; WIRINGA RB, 1995, PHYS REV C, V51, P38, DOI 10.1103/PhysRevC.51.38	56	31	31	2	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB	2020	578	7796					540	+		10.1038/s41586-020-2021-6	http://dx.doi.org/10.1038/s41586-020-2021-6			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KP9SJ	32103193	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000516571100014
J	Grasselli, G; Pesenti, A; Cecconi, M				Grasselli, Giacomo; Pesenti, Antonio; Cecconi, Maurizio			Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy Early Experience and Forecast During an Emergency Response	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint describes the organization of a regional ICU network in Lombardy, Italy, to handle the surge in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who require intensive care and uses demand experience in the first 2 weeks of the outbreak to estimate resources required in coming weeks.	[Grasselli, Giacomo; Pesenti, Antonio] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Grasselli, Giacomo; Pesenti, Antonio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dipartimento Anestesia Rianimaz & Emergenza Urgen, Milan, Italy; [Cecconi, Maurizio] Humanitas Rozzano, Dipartimento Anestesia & Terapie Intens, Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	Pesenti, A (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Via F Sforza 35, I-20122 Milan, Italy.	antonio.pesenti@unimi.it	Pesenti, Antonio/H-7483-2012; Cecconi, Maurizio/HDN-8785-2022; Cecconi, Maurizio/A-6241-2012; basal, iskandar monem iskandar/F-7488-2013	Pesenti, Antonio/0000-0003-2593-729X; Cecconi, Maurizio/0000-0002-4376-6538; Cecconi, Maurizio/0000-0002-4376-6538; basal, iskandar monem iskandar/0000-0003-2837-1199				Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Patroniti N, 2011, INTENS CARE MED, V37, P1447, DOI 10.1007/s00134-011-2301-6; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204	5	2484	2526	4	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2020	323	16					1545	1546		10.1001/jama.2020.4031	http://dx.doi.org/10.1001/jama.2020.4031			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LL2GR	32167538	Bronze, Green Published			2022-12-28	WOS:000531373700012
J	Hwang, SS; Lim, J; Yu, ZB; Kong, P; Sefik, E; Xu, H; Harman, CCD; Kim, LK; Lee, GR; Li, HB; Flavell, RA				Hwang, Soo Seok; Lim, Jaechul; Yu, Zhibin; Kong, Philip; Sefik, Esen; Xu, Hao; Harman, Christian C. D.; Kim, Lark Kyun; Lee, Gap Ryol; Li, Hua-Bing; Flavell, Richard A.			mRNA destabilization by BTG1 and BTG2 maintains T cell quiescence	SCIENCE			English	Article							DIFFERENTIATION; PROTEINS; HOMEOSTASIS; RESOLUTION; COMPONENT; HOMOLOG; REVEALS; COMPLEX; CAF1	T cells maintain a quiescent state prior to activation. As inappropriate T cell activation can cause disease, T cell quiescence must be preserved. Despite its importance, the mechanisms underlying the "quiescent state" remain elusive. Here, we identify BTG1 and BTG2 (BTG1/2) as factors responsible for T cell quiescence. BTG1/2-deficient T cells show an increased proliferation and spontaneous activation due to a global increase in messenger RNA (mRNA) abundance, which reduces the threshold to activation. BTG1/2 deficiency leads to an increase in polyadenylate tail length, resulting in a greater mRNA half-life. Thus, BTG1/2 promote the deadenylation and degradation of mRNA to secure T cell quiescence. Our study reveals a key mechanism underlying T cell quiescence and suggests that low mRNA abundance is a crucial feature for maintaining quiescence.	[Hwang, Soo Seok; Lim, Jaechul; Yu, Zhibin; Kong, Philip; Sefik, Esen; Xu, Hao; Harman, Christian C. D.; Li, Hua-Bing; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunol, 333 Cedar St, New Haven, CT 06510 USA; [Yu, Zhibin; Li, Hua-Bing] SJTU SM, Shanghai Inst Immunol, Dept Microbiol & Immunol, Shanghai 200025, Peoples R China; [Yu, Zhibin; Li, Hua-Bing] SJTU SM, Yale Ctr ImmunoMetabolism, Shanghai 200025, Peoples R China; [Kim, Lark Kyun] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Severance Biomed Sci Inst, Seoul 06230, South Korea; [Kim, Lark Kyun] Yonsei Univ, Gangnam Severance Hosp, Coll Med, BK21 PLUS Project Med Sci, Seoul 06230, South Korea; [Lee, Gap Ryol] Sogang Univ, Dept Life Sci, Seoul 04107, South Korea; [Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Sogang University; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunol, 333 Cedar St, New Haven, CT 06510 USA.; Flavell, RA (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	richard.flavell@yale.edu	Hwang, Soo Seok/AAL-3292-2020; Li, Huabing/M-5390-2013	Hwang, Soo Seok/0000-0002-1635-4191; Lee, Gap Ryol/0000-0002-6412-9482; Kim, Lark Kyun/0000-0001-5983-4470; Li, Huabing/0000-0003-3573-6803; Lim, Jaechul/0000-0002-6075-2656	Howard Hughes Medical Institute; Leslie H. Warner Fellowship from Yale Cancer Center (YCC); HFSPO [LT000037/2018-L]; Jane Coffin Childs Memorial Fund; National Research Foundation of Korea [NRF-2017R1A2B3008621]; National Natural Science Foundation of China [91753141]; Shanghai Jiao Tong University School of Medicine	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Leslie H. Warner Fellowship from Yale Cancer Center (YCC); HFSPO(Human Frontier Science Program); Jane Coffin Childs Memorial Fund; National Research Foundation of Korea(National Research Foundation of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University School of Medicine	This work was supported by the Howard Hughes Medical Institute (R.A. F.). The work of S.S.H. was supported by a Leslie H. Warner Fellowship from Yale Cancer Center (YCC). The work of J.L. was supported by postdoctoral fellowships from the HFSPO (LT000037/2018-L) and Jane Coffin Childs Memorial Fund. G.R.L was supported by National Research Foundation of Korea (NRF-2017R1A2B3008621). H.B.L. was supported by the National Natural Science Foundation of China (91753141) and the start-up fund from the Shanghai Jiao Tong University School of Medicine.	Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Doidge R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051331; Eliseeva IA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1377, DOI 10.1134/S0006297913130014; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Gadir N, 2011, RNA, V17, P1551, DOI 10.1261/rna.2621111; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Henao-Mejia J., 2016, COLD SPRING HARB PRO, V2016; Henao-Mejia Jorge, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot090704; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hwang SS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10789; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Lee N, 2015, CELL, V160, P607, DOI 10.1016/j.cell.2015.01.015; Lim J, 2016, GENE DEV, V30, P1671, DOI 10.1101/gad.284802.116; Lim J, 2014, CELL, V159, P1365, DOI 10.1016/j.cell.2014.10.055; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Mauxion F, 2008, EMBO J, V27, P1039, DOI 10.1038/emboj.2008.43; Mauxion F, 2009, TRENDS BIOCHEM SCI, V34, P640, DOI 10.1016/j.tibs.2009.07.008; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Ouyang WM, 2011, TRENDS IMMUNOL, V32, P26, DOI 10.1016/j.it.2010.10.005; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Prevot D, 2001, J BIOL CHEM, V276, P9640, DOI 10.1074/jbc.M008201200; Rouault JP, 1998, J BIOL CHEM, V273, P22563, DOI 10.1074/jbc.273.35.22563; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Stupfler B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10811; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; Waanders E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002533; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068; Yi H, 2018, MOL CELL, V70, P1081, DOI 10.1016/j.molcel.2018.05.009; Yuniati L, 2019, J CELL PHYSIOL, V234, P5379, DOI 10.1002/jcp.27407; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	34	55	59	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1255	+		10.1126/science.aax0194	http://dx.doi.org/10.1126/science.aax0194			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9DP	32165587				2022-12-28	WOS:000520023800043
J	Ramon, A; Berthod, PE				Ramon, Andre; Berthod, Pierre-Emmanuel			Osteitis Fibrosa Cystica	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 48-year-old man with end-stage renal disease presented with shortness of breath. Computed tomography of the face revealed mandibular hypertrophy and a heterogeneous appearance of the bone, findings consistent with osteitis fibrosa cystica.	[Ramon, Andre; Berthod, Pierre-Emmanuel] Ctr Hosp Univ Dijon Bourgogne, Dijon, France	CHU Dijon Bourgogne	Ramon, A (corresponding author), Ctr Hosp Univ Dijon Bourgogne, Dijon, France.	andre.ramon@chu-dijon.fr							0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2020	382	11					E15	E15		10.1056/NEJMicm1907828	http://dx.doi.org/10.1056/NEJMicm1907828			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU7TA	32160666				2022-12-28	WOS:000519914300001
J	Simon, TG; Duberg, AS; Aleman, S; Chung, RT; Chan, AT; Ludvigsson, JF				Simon, Tracey G.; Duberg, Ann-Sofi; Aleman, Soo; Chung, Raymond T.; Chan, Andrew T.; Ludvigsson, Jonas F.			Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CANCER REGISTER; CELL-GROWTH; RISK; HEPATITIS; REDUCTIONS; INHIBITION; NATIONWIDE; THERAPY; DISEASE; MODEL	This registry study examined the association between aspirin use and hepatocellular carcinoma and liver-related mortality in adults in Sweden with hepatitis B or hepatitis C. The 10-year cumulative incidences of hepatocellular carcinoma and liver-related death were lower among aspirin users than among nonusers. Background More information is needed about the long-term effects of low-dose aspirin (<= 160 mg) on incident hepatocellular carcinoma, liver-related mortality, and gastrointestinal bleeding in persons with chronic hepatitis B or hepatitis C virus infection. Methods Using nationwide Swedish registries, we identified all adults who received a diagnosis of chronic hepatitis B or hepatitis C from 2005 through 2015 and who did not have a history of aspirin use (50,275 patients). Patients who were starting to take low-dose aspirin (14,205 patients) were identified by their first filled prescriptions for 90 or more consecutive doses of aspirin. We constructed a propensity score and applied inverse probability of treatment weighting to balance baseline characteristics between groups. Using Cox proportional-hazards regression modeling, we estimated the risk of hepatocellular carcinoma and liver-related mortality, accounting for competing events. Results With a median of 7.9 years of follow-up, the estimated cumulative incidence of hepatocellular carcinoma was 4.0% among aspirin users and 8.3% among nonusers of aspirin (difference, -4.3 percentage points; 95% confidence interval [CI], -5.0 to -3.6; adjusted hazard ratio, 0.69; 95% CI, 0.62 to 0.76). This inverse association appeared to be duration-dependent; as compared with short-term use (3 months to <1 year), the adjusted hazard ratios were 0.90 (95% CI, 0.76 to 1.06) for 1 to less than 3 years of use, 0.66 (95% CI, 0.56 to 0.78) for 3 to less than 5 years of use, and 0.57 (95% CI, 0.42 to 0.70) for 5 or more years of use. Ten-year liver-related mortality was 11.0% among aspirin users and 17.9% among nonusers (difference, -6.9 percentage points [95% CI, -8.1 to -5.7]; adjusted hazard ratio, 0.73 [95% CI, 0.67 to 0.81]). However, the 10-year risk of gastrointestinal bleeding did not differ significantly between users and nonusers of aspirin (7.8% and 6.9%, respectively; difference, 0.9 percentage points; 95% CI, -0.6 to 2.4). Conclusions In a nationwide study of patients with chronic viral hepatitis in Sweden, use of low-dose aspirin was associated with a significantly lower risk of hepatocellular carcinoma and lower liver-related mortality than no use of aspirin, without a significantly higher risk of gastrointestinal bleeding. (Funded by the National Institutes of Health and others.)	[Simon, Tracey G.; Chung, Raymond T.; Chan, Andrew T.] Harvard Med Sch, Massachusetts Gen Hosp, Div Gastroenterol & Hepatol, Boston, MA 02115 USA; [Simon, Tracey G.; Chan, Andrew T.] Harvard Med Sch, Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02115 USA; [Simon, Tracey G.; Chung, Raymond T.; Chan, Andrew T.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA; [Chung, Raymond T.; Chan, Andrew T.] Harvard TH Chan Sch Publ Hlth, Broad Inst, Boston, MA USA; [Chan, Andrew T.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Duberg, Ann-Sofi] Orebro Univ Hosp, Fac Med & Hlth, Sch Med Sci, Dept Infect Dis, Orebro, Sweden; [Ludvigsson, Jonas F.] Orebro Univ Hosp, Dept Pediat, Orebro, Sweden; [Aleman, Soo] Karolinska Inst, Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Aleman, Soo] Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden; [Ludvigsson, Jonas F.] Karolinska Inst, Dept Med Epidemiol & Biostat, POB 281, SE-17177 Stockholm, Sweden; [Ludvigsson, Jonas F.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Orebro University; Orebro University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Columbia University	Ludvigsson, JF (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, POB 281, SE-17177 Stockholm, Sweden.	jonasludvigsson@yahoo.com	Ludvigsson, Jonas F/A-8560-2012	Ludvigsson, Jonas F/0000-0003-1024-5602	National Institutes of Health [K23 DK122104, R01 CA137178]; Nyckelfonden (Orebro University Hospital, Sweden); Region Stockholm County; American Association for the Study of Liver Diseases; Boston Nutrition Obesity Research Council; Region Orebro County; Karolinska Institutet	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nyckelfonden (Orebro University Hospital, Sweden); Region Stockholm County; American Association for the Study of Liver Diseases; Boston Nutrition Obesity Research Council; Region Orebro County; Karolinska Institutet(Karolinska Institutet)	Supported by grants from the National Institutes of Health (K23 DK122104, to Dr. Simon, and R01 CA137178, to Dr. Chan); Nyckelfonden (Orebro University Hospital, Sweden, to Dr. Duberg); and Region Stockholm County (to Dr. Aleman). The authors' work is also supported by the American Association for the Study of Liver Diseases, Boston Nutrition Obesity Research Council, Region Orebro County, and Karolinska Institutet.	Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Austin PC, 2010, STAT MED, V29, P2137, DOI 10.1002/sim.3854; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Beloribi-Djefaflia S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.49; Chan AT, 2008, GASTROENTEROLOGY, V134, P21, DOI 10.1053/j.gastro.2007.09.035; Chan TA, 1998, P NATL ACAD SCI USA, V95, P681, DOI 10.1073/pnas.95.2.681; Chen H, 2017, ONCOGENE, V36, P4415, DOI 10.1038/onc.2017.73; Duberg AS, 2008, J VIRAL HEPATITIS, V15, P538, DOI 10.1111/j.1365-2893.2008.00982.x; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fodera D, 2004, ANN NY ACAD SCI, V1028, P440, DOI 10.1196/annals.1322.052; Funk MJ, 2011, AM J EPIDEMIOL, V173, P761, DOI 10.1093/aje/kwq439; Gao JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069309; Gilligan MM, 2019, P NATL ACAD SCI USA, V116, P6292, DOI 10.1073/pnas.1804000116; Hagstrom H, 2017, J HEPATOL, V67, P1265, DOI 10.1016/j.jhep.2017.07.027; Hwang IC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23343-0; Jonsson F, 2013, BRIT J CANCER, V109, P1921, DOI 10.1038/bjc.2013.411; Kern MA, 2002, HEPATOLOGY, V36, P885, DOI 10.1053/jhep.2002.36125; Lee M, 2017, HEPATOLOGY, V66, P1556, DOI 10.1002/hep.29318; Lee TY, 2019, JAMA INTERN MED, V179, P633, DOI 10.1001/jamainternmed.2018.8342; Leng J, 2003, HEPATOLOGY, V38, P756, DOI 10.1053/jhep.2003.50380; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Malehmir M, 2019, NAT MED, V25, P641, DOI 10.1038/s41591-019-0379-5; Mohanty A, 2016, GASTROENTEROLOGY, V150; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Paik YH, 2009, GUT, V58, P1517, DOI 10.1136/gut.2008.157420; Parsons LS, 2001, SAS SUGI, P214; Petrick JL, 2015, CANCER PREV RES, V8, P1156, DOI 10.1158/1940-6207.CAPR-15-0126; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Ryerson AB, 2016, CANCER-AM CANCER SOC, V122, P1312, DOI 10.1002/cncr.29936; Sahasrabuddhe VV, 2012, JNCI-J NATL CANCER I, V104, P1808, DOI 10.1093/jnci/djs452; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Simon TG, 2018, JAMA ONCOL, V4, P1683, DOI 10.1001/jamaoncol.2018.4154; Simon TG, 2016, HEPATOLOGY, V64, P47, DOI 10.1002/hep.28506; Sundstrom J, 2017, CIRCULATION, V136, P1183, DOI 10.1161/CIRCULATIONAHA.117.028321; Torner A, 2017, HEPATOLOGY, V65, P885, DOI 10.1002/hep.28775; Tsan YT, 2012, J CLIN ONCOL, V30, P623, DOI 10.1200/JCO.2011.36.0917; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Yamamoto H, 2003, GASTROENTEROLOGY, V125, P556, DOI 10.1016/S0016-5085(03)00904-1	40	120	123	4	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2020	382	11					1018	1028		10.1056/NEJMoa1912035	http://dx.doi.org/10.1056/NEJMoa1912035			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU7TA	32160663	Green Accepted, Bronze			2022-12-28	WOS:000519914300008
J	Mahase, E				Mahase, Elisabeth			Covid-19: UK ramps up testing by 500% as health minister tests positive for virus	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2020	368								m1003	10.1136/bmj.m1003	http://dx.doi.org/10.1136/bmj.m1003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AR	32160996	Bronze			2022-12-28	WOS:000520012800019
J	Mahase, E				Mahase, Elisabeth			THE BIG PICTURE Activists in Argentina rally to demand legal abortion	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2020	368								m985	10.1136/bmj.m985	http://dx.doi.org/10.1136/bmj.m985			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AO	32156678				2022-12-28	WOS:000520012500016
J	Wadhera, RK; Wang, Y; Figueroa, JF; Dominici, F; Yeh, RBW; Maddox, KJE				Wadhera, Rishi K.; Wang, Yun; Figueroa, Jose F.; Dominici, Francesca; Yeh, Robert W.; Maddox, Karen E.			Mortality and Hospitalizations for Dually Enrolled and Nondually Enrolled Medicare Beneficiaries Aged 65 Years or Older, 2004 to 2017	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REDUCTION PROGRAM; ASSOCIATION; RISK; PENALTIES; INCOME	Importance Medicare beneficiaries who are also enrolled in Medicaid (dually enrolled beneficiaries) have drawn the attention of policy makers because they comprise the poorest subset of the Medicare population; however, it is unclear how their outcomes have changed over time compared with those only enrolled in Medicare (nondually enrolled beneficiaries). Objective To evaluate annual changes in all-cause mortality, hospitalization rates, and hospitalization-related mortality among dually enrolled beneficiaries and nondually enrolled beneficiaries. Design, Setting, and Participants Serial cross-sectional study of Medicare fee-for-service beneficiaries aged 65 years or older between January 2004 and December 2017. The final date of follow-up was September 30, 2018. Exposures Dual vs nondual enrollment status. Main Outcomes and Measures Annual all-cause mortality rates; all-cause hospitalization rates; and in-hospital, 30-day, 1-year hospitalization-related mortality rates. Results There were 71017608 unique Medicare beneficiaries aged 65 years or older (mean age, 75.6 [SD, 9.2] years; 54.9% female) enrolled in Medicare for at least 1 month from 2004 through 2017. Of these beneficiaries, 11697900 (16.5%) were dually enrolled in Medicare and Medicaid for at least 1 month. After adjusting for age, sex, and race, annual all-cause mortality rates declined from 8.5% (95% CI, 8.45%-8.56%) in 2004 to 8.1% (95% CI, 8.05%-8.13%) in 2017 among dually enrolled beneficiaries and from 4.1% (95% CI, 4.08%-4.13%) in 2004 to 3.8% (95% CI, 3.76%-3.79%) in 2017 among nondually enrolled beneficiaries. The difference in annual all-cause mortality between dually and nondually enrolled beneficiaries increased between 2004 (adjusted odds ratio, 2.09 [95% CI, 2.08-2.10]) and 2017 (adjusted odds ratio, 2.22 [95% CI, 2.21-2.23]) (P < .001 for interaction between dual enrollment status and time). All-cause hospitalizations per 100000 beneficiary-years declined from 49888 in 2004 to 41121 in 2017 among dually enrolled beneficiaries (P < .001) and from 29000 in 2004 to 22601 in 2017 among nondually enrolled beneficiaries (P < .001); however, the difference between these groups widened between 2004 (adjusted risk ratio, 1.72 [95% CI, 1.71-1.73]) and 2017 (adjusted risk ratio, 1.83 [95% CI, 1.82-1.83]) (P < .001 for interaction). Among hospitalized beneficiaries, the risk-adjusted 30-day mortality rates declined from 10.3% (95% CI, 10.22%-10.33%) in 2004 to 10.1% (95% CI, 10.02%-10.20%) in 2017 among dually enrolled beneficiaries and from 8.5% (95% CI, 8.50%-8.56%) in 2004 to 8.1% (95% CI, 8.06%-8.13%) in 2017 among nondually enrolled beneficiaries. In contrast, 1-year mortality increased among hospitalized beneficiaries from 23.1% (95% CI, 23.05%-23.20%) in 2004 to 26.7% (95% CI, 26.58%-26.84%) in 2017 among dually enrolled beneficiaries and from 18.1% (95% CI, 18.11%-18.17%) in 2004 to 20.3% (95% CI, 20.21%-20.31%) in 2017 among nondually enrolled beneficiaries. The difference in hospitalization-related outcomes between dually and nondually enrolled beneficiaries persisted during the study period. Conclusions and Relevance Among Medicare fee-for-service beneficiaries aged 65 years or older, dually enrolled beneficiaries had higher annual all-cause mortality, all-cause hospitalizations, and hospitalization-related mortality compared with nondually enrolled beneficiaries. Between 2004 and 2017, these differences did not decrease.	[Wadhera, Rishi K.; Wang, Yun; Yeh, Robert W.] Harvard Univ, Harvard Med Sch, Richard A & Susan F Smith Ctr Outcomes Res Cardio, Beth Israel Deaconess Med Ctr,Div Cardiol, Boston, MA 02115 USA; [Wang, Yun; Dominici, Francesca] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Figueroa, Jose F.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Figueroa, Jose F.] Harvard Univ, Harvard Med Sch, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Maddox, Karen E.] Washington Univ, Sch Med, Inst Publ Hlth, Ctr Hlth Econ & Policy, St Louis, MO 63110 USA; [Maddox, Karen E.] Washington Univ, Sch Med, Cardiovasc Div, St Louis, MO 63110 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Washington University (WUSTL); Washington University (WUSTL)	Wadhera, RK (corresponding author), Harvard Med Sch, Richard A & Susan F Smith Ctr Outcomes Res Cardio, Beth Israel Deaconess Med Ctr, 375 Longwood Ave, Boston, MA 02215 USA.	rwadhera@bidmc.harvard.edu			Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology	Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology	This work was supported by the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology.	Afendulis CC, 2011, HEALTH SERV RES, V46, P1022, DOI 10.1111/j.1475-6773.2011.01244.x; Bor J, 2017, LANCET, V389, P1475, DOI 10.1016/S0140-6736(17)30571-8; Chen LM, 2017, JAMA-J AM MED ASSOC, V318, P453, DOI 10.1001/jama.2017.9643; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Downing NS, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2044; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Figueroa JF, 2019, HEALTH AFFAIR, V38, P107, DOI 10.1377/hlthaff.2018.05160; Figueroa JF, 2018, ANN INTERN MED, V169, P528, DOI 10.7326/M18-0085; Figueroa JF, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2214; Grabowski DC, 2009, HEALTH AFFAIR, V28, P136, DOI 10.1377/hlthaff.28.1.136; Huh J, 2017, J HEALTH ECON, V53, P17, DOI 10.1016/j.jhealeco.2017.01.005; Jacobson GA, 2015, HEALTH AFFAIR, V34, P48, DOI 10.1377/hlthaff.2014.0218; Joynt KE, 2017, NEW ENGL J MED, V376, P510, DOI 10.1056/NEJMp1616278; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Ku L., BRIDGING GAP CONTINU; Maddox KEJ, 2018, NEW ENGL J MED, V378, P977, DOI 10.1056/NEJMp1715455; Medpac, MAN CAR PLANS DUAL E; Prabhu SM, 2019, 2019 4TH MEC INTERNATIONAL CONFERENCE ON BIG DATA AND SMART CITY (ICBDSC), P24; Riley GF, 2014, HEALTH AFFAIR, V33, P147, DOI 10.1377/hlthaff.2013.0396; Roberts ET, 2018, ANN INTERN MED, V168, P255, DOI 10.7326/M17-1740; Ryan AM, 2017, NEW ENGL J MED, V376, P2358, DOI 10.1056/NEJMsa1613412; Sankaran R, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4109; Tsugawa Y, 2019, JAMA INTERN MED, V179, P1287, DOI 10.1001/jamainternmed.2019.1005; Wadhera RK, 2019, NEW ENGL J MED, V380, P2289, DOI 10.1056/NEJMp1901225; Wadhera RK, 2018, JAMA-J AM MED ASSOC, V320, P2542, DOI 10.1001/jama.2018.19232; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	26	21	21	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2020	323	10					961	969		10.1001/jama.2020.1021	http://dx.doi.org/10.1001/jama.2020.1021			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KW1LV	32154858	Green Published, Bronze			2022-12-28	WOS:000520933900013
J	Mahase, E				Mahase, Elisabeth			Covid-19: UK records first death, as world's cases exceed 100 000	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m918	1	7	7	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2020	368								m943	10.1136/bmj.m943	http://dx.doi.org/10.1136/bmj.m943			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2LJ	32144096	Bronze			2022-12-28	WOS:000519539700014
J	Rimmer, A				Rimmer, Abi			Ethnic diversity: NHS chief pledges to improve representation across England	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		RIMMER A, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M618	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2020	368								m929	10.1136/bmj.m929	http://dx.doi.org/10.1136/bmj.m929			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2LJ	32144175				2022-12-28	WOS:000519539700008
J	Xu, JX; Boyd, CC; Yu, ZSJ; Palmstrom, AF; Witter, DJ; Larson, BW; France, RM; Werner, J; Harvey, SP; Wolf, EJ; Weigand, W; Manzoor, S; van Hest, MFAM; Berry, JJ; Luther, JM; Holman, ZC; McGehee, MD				Xu, Jixian; Boyd, Caleb C.; Yu, Zhengshan J.; Palmstrom, Axel F.; Witter, Daniel J.; Larson, Bryon W.; France, Ryan M.; Werner, Jeremie; Harvey, Steven P.; Wolf, Eli J.; Weigand, William; Manzoor, Salman; van Hest, Maikel F. A. M.; Berry, Joseph J.; Luther, Joseph M.; Holman, Zachary C.; McGehee, Michael D.			Triple-halide wide-band gap perovskites with suppressed phase segregation for efficient tandems	SCIENCE			English	Article							SOLAR-CELLS; HIGHLY EFFICIENT; IMPROVED STABILITY; FORMAMIDINIUM; TRIHALIDE; CHLORIDE; LOSSES; YIELD; SN	Wide-band gap metal halide perovskites are promising semiconductors to pair with silicon in tandem solar cells to pursue the goal of achieving power conversion efficiency (PCE) greater than 30% at low cost. However, wide-band gap perovskite solar cells have been fundamentally limited by photoinduced phase segregation and low open-circuit voltage. We report efficient 1.67-electron volt wide-band gap perovskite top cells using triple-halide alloys (chlorine, bromine, iodine) to tailor the band gap and stabilize the semiconductor under illumination. We show a factor of 2 increase in photocarrier lifetime and charge-carrier mobility that resulted from enhancing the solubility of chlorine by replacing some of the iodine with bromine to shrink the lattice parameter. We observed a suppression of light-induced phase segregation in films even at 100-sun illumination intensity and less than 4% degradation in semitransparent top cells after 1000 hours of maximum power point (MPP) operation at 60 degrees C. By integrating these top cells with silicon bottom cells, we achieved a PCE of 27% in two-terminal monolithic tandems with an area of 1 square centimeter.	[Xu, Jixian; Witter, Daniel J.; Werner, Jeremie; McGehee, Michael D.] Univ Colorado, Chem & Biol Engn, Boulder, CO 80309 USA; [Xu, Jixian; Boyd, Caleb C.; Palmstrom, Axel F.; Witter, Daniel J.; Larson, Bryon W.; France, Ryan M.; Werner, Jeremie; Harvey, Steven P.; Wolf, Eli J.; van Hest, Maikel F. A. M.; Berry, Joseph J.; Luther, Joseph M.; McGehee, Michael D.] Natl Renewable Energy Lab, Golden, CO 80401 USA; [Xu, Jixian] Univ Sci & Technol China, Dept Mat Sci & Engn, CAS Key Lab Mat Energy Convers, Hefei 230026, Peoples R China; [Boyd, Caleb C.] Stanford Univ, Mat Sci & Engn, Stanford, CA 94305 USA; [Yu, Zhengshan J.; Weigand, William; Manzoor, Salman; Holman, Zachary C.] Arizona State Univ, Sch Elect Comp & Energy Engn, Tempe, AZ 85281 USA; [McGehee, Michael D.] Univ Colorado, Mat Sci & Engn, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Stanford University; Arizona State University; Arizona State University-Tempe; University of Colorado System; University of Colorado Boulder	Xu, JX; McGehee, MD (corresponding author), Univ Colorado, Chem & Biol Engn, Boulder, CO 80309 USA.; Xu, JX; McGehee, MD (corresponding author), Natl Renewable Energy Lab, Golden, CO 80401 USA.; Xu, JX (corresponding author), Univ Sci & Technol China, Dept Mat Sci & Engn, CAS Key Lab Mat Energy Convers, Hefei 230026, Peoples R China.; McGehee, MD (corresponding author), Univ Colorado, Mat Sci & Engn, Boulder, CO 80309 USA.	jixianxu@ustc.edu.cn; michael.mcgehee@colorado.edu	McGehee, Michael/ABA-8400-2020; Manzoor, Salman/GOH-2436-2022; Yu, Zhengshan/C-4718-2015	McGehee, Michael/0000-0001-9609-9030; Wolf, Eli/0000-0002-5523-8812; berry, joseph/0000-0003-3874-3582; xu, jixian/0000-0001-8119-3411; France, Ryan/0000-0002-2040-4809; Yu, Zhengshan/0000-0002-4305-5912; Witter, Daniel/0000-0002-6430-5917; Palmstrom, Axel/0000-0001-6633-209X	U.S. Department of Energy's Office of Energy Efficiency and Renewable Energy (EERE) under Solar Energy Technologies Office (SETO) [DE-EE0008167]; NSF Graduate Research Fellowship [DGE-1656518]; Office of Naval Research [N00014-17-1-2525]; De-risking Halide Perovskite Solar Cells program of the National Center for Photovoltaics - U.S. Department of Energy, Office of Energy Efficiency and Renewable Energy, Solar Energy Technology Office; U.S. Department of Energy [DE-AC36-08GO23808]	U.S. Department of Energy's Office of Energy Efficiency and Renewable Energy (EERE) under Solar Energy Technologies Office (SETO)(United States Department of Energy (DOE)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); De-risking Halide Perovskite Solar Cells program of the National Center for Photovoltaics - U.S. Department of Energy, Office of Energy Efficiency and Renewable Energy, Solar Energy Technology Office(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This material is based on work supported by the U.S. Department of Energy's Office of Energy Efficiency and Renewable Energy (EERE) under Solar Energy Technologies Office (SETO) agreement number DE-EE0008167. Also supported by the NSF Graduate Research Fellowship under grant DGE-1656518 (C.C.B.); the Office of Naval Research under award number N00014-17-1-2525 (E.J.W.); and the De-risking Halide Perovskite Solar Cells program of the National Center for Photovoltaics, funded by the U.S. Department of Energy, Office of Energy Efficiency and Renewable Energy, Solar Energy Technology Office. Work at the National Renewable Energy Laboratory is supported by the U.S. Department of Energy under contract number DE-AC36-08GO23808.	Abdi-Jalebi M, 2018, NATURE, V555, P497, DOI 10.1038/nature25989; Anaya M, 2017, JOULE, V1, P769, DOI 10.1016/j.joule.2017.09.017; Barker AJ, 2017, ACS ENERGY LETT, V2, P1416, DOI 10.1021/acsenergylett.7b00282; Beal RE, 2016, J PHYS CHEM LETT, V7, P746, DOI 10.1021/acs.jpclett.6b00002; Belisle RA, 2018, ACS ENERGY LETT, V3, P2694, DOI 10.1021/acsenergylett.8b01562; Boyd CC, 2019, CHEM REV, V119, P3418, DOI 10.1021/acs.chemrev.8b00336; Boyd CC, 2018, ACS ENERGY LETT, V3, P1772, DOI 10.1021/acsenergylett.8b00926; BURSTEIN E, 1954, PHYS REV, V93, P632, DOI 10.1103/PhysRev.93.632; Bush KA, 2018, ACS ENERGY LETT, V3, P2173, DOI 10.1021/acsenergylett.8b01201; Bush KA, 2018, ACS ENERGY LETT, V3, P428, DOI 10.1021/acsenergylett.7b01255; Bush KA, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.9; Chen B, 2019, JOULE, V3, P177, DOI 10.1016/j.joule.2018.10.003; Chen B, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201601128; Cojocaru L, 2015, CHEM LETT, V44, P1089, DOI 10.1246/cl.150385; Colella S, 2013, CHEM MATER, V25, P4613, DOI 10.1021/cm402919x; Comin R, 2015, J MATER CHEM C, V3, P8839, DOI 10.1039/c5tc01718a; Correa-Baena JP, 2019, SCIENCE, V363, P627, DOI 10.1126/science.aah5065; Dastidar S, 2016, NANO LETT, V16, P3563, DOI 10.1021/acs.nanolett.6b00635; Dong QF, 2015, ENERG ENVIRON SCI, V8, P2464, DOI 10.1039/c5ee01179e; Du PP, 2019, ACS APPL MATER INTER, V11, P47083, DOI 10.1021/acsami.9b17164; Eperon GE, 2014, ENERG ENVIRON SCI, V7, P982, DOI 10.1039/c3ee43822h; Fu F, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2016.190; Fu JH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01360-3; Geisz JF, 2015, IEEE J PHOTOVOLT, V5, P1827, DOI 10.1109/JPHOTOV.2015.2478072; Gharibzadeh S, 2019, ADV ENERGY MATER, V9, DOI 10.1002/aenm.201803699; Green MA, 2019, PROG PHOTOVOLTAICS, V27, P565, DOI 10.1002/pip.3171; Han QF, 2018, SCIENCE, V361, P904, DOI 10.1126/science.aat5055; Hao F, 2014, J AM CHEM SOC, V136, P8094, DOI 10.1021/ja5033259; Harvey SP, 2019, ACS APPL MATER INTER, V11, P30911, DOI 10.1021/acsami.9b09445; Harvey SP, 2018, ACS APPL MATER INTER, V10, P28541, DOI 10.1021/acsami.8b07937; Hoke ET, 2015, CHEM SCI, V6, P613, DOI 10.1039/c4sc03141e; Horantner MT, 2017, ENERG ENVIRON SCI, V10, P1983, DOI 10.1039/c7ee01232b; Jacobs DA, 2019, J PHYS CHEM LETT, V10, P3159, DOI 10.1021/acs.jpclett.8b03721; Jang DM, 2015, NANO LETT, V15, P5191, DOI 10.1021/acs.nanolett.5b01430; Jeong J, 2016, ACS ENERGY LETT, V1, P712, DOI 10.1021/acsenergylett.6b00281; Kim DH, 2019, JOULE, V3, P1734, DOI 10.1016/j.joule.2019.04.012; Kohnen E, 2019, SUSTAIN ENERG FUELS, V3, P1995, DOI 10.1039/c9se00120d; Leijtens T, 2018, SUSTAIN ENERG FUELS, V2, P2450, DOI 10.1039/c8se00314a; Leijtens T, 2018, NAT ENERGY, V3, P828, DOI 10.1038/s41560-018-0190-4; Li C, 2016, ACS APPL MATER INTER, V8, P11526, DOI 10.1021/acsami.6b02692; Li Z, 2016, CHEM MATER, V28, P284, DOI 10.1021/acs.chemmater.5b04107; Li ZQ, 2018, JOULE, V2, P1559, DOI 10.1016/j.joule.2018.05.001; Liang PW, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201400960; Maculan G, 2015, J PHYS CHEM LETT, V6, P3781, DOI 10.1021/acs.jpclett.5b01666; Manzoor S, 2018, OPT EXPRESS, V26, P27441, DOI 10.1364/OE.26.027441; Mazzarella L, 2019, ADV ENERGY MATER, V9, DOI 10.1002/aenm.201803241; McMeekin DP, 2016, SCIENCE, V351, P151, DOI 10.1126/science.aad5845; Min H, 2019, SCIENCE, V366, P749, DOI 10.1126/science.aay7044; Nogay G, 2019, ACS ENERGY LETT, V4, P844, DOI 10.1021/acsenergylett.9b00377; Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; Ogomi Y, 2014, J PHYS CHEM LETT, V5, P1004, DOI 10.1021/jz5002117; Oku T, 2018, AIP CONF PROC, V1929, DOI 10.1063/1.5021923; OSTERWALD CR, 1986, SOL CELLS, V18, P269, DOI 10.1016/0379-6787(86)90126-2; Palmstrom AF, 2019, JOULE, V3, P2193, DOI 10.1016/j.joule.2019.05.009; Palmstrom AF, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201800591; Pellet N, 2015, CHEM MATER, V27, P2181, DOI 10.1021/acs.chemmater.5b00281; Peng J, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201601768; Pool VL, 2015, CHEM MATER, V27, P7240, DOI 10.1021/acs.chemmater.5b03581; Quiroz COR, 2018, J MATER CHEM A, V6, P3583, DOI 10.1039/c7ta10945h; Raiford JA, 2019, ADV ENERGY MATER, V9, DOI 10.1002/aenm.201902353; Rau U, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.085303; Rehman W, 2017, ENERG ENVIRON SCI, V10, P361, DOI 10.1039/c6ee03014a; Sahli F, 2018, NAT MATER, V17, P820, DOI 10.1038/s41563-018-0115-4; Saidaminov MI, 2018, NAT ENERGY, V3, P648, DOI 10.1038/s41560-018-0192-2; Saliba M, 2016, SCIENCE, V354, P206, DOI 10.1126/science.aah5557; Saliba M, 2016, ENERG ENVIRON SCI, V9, P1989, DOI 10.1039/c5ee03874j; Shen HP, 2018, ENERG ENVIRON SCI, V11, P394, DOI 10.1039/c7ee02627g; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Stolterfoht M, 2018, NAT ENERGY, V3, P847, DOI 10.1038/s41560-018-0219-8; Sutter-Fella CM, 2016, NANO LETT, V16, P800, DOI 10.1021/acs.nanolett.5b04884; Duong T, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201700228; Tong JH, 2019, SCIENCE, V364, P475, DOI 10.1126/science.aav7911; Ueoka N, 2018, AIP CONF PROC, V1929, DOI 10.1063/1.5021939; Unger EL, 2017, J MATER CHEM A, V5, P11401, DOI 10.1039/c7ta00404d; Werner J, 2017, IEEE PHOT SPEC CONF, P3256; Werner J, 2016, ACS ENERGY LETT, V1, P474, DOI 10.1021/acsenergylett.6b00254; Wu Y., 2019, P AS PAC SOL RES C; Xie FX, 2017, ENERG ENVIRON SCI, V10, P1942, DOI 10.1039/c7ee01675a; Yoon SJ, 2017, ACS ENERGY LETT, V2, P1507, DOI 10.1021/acsenergylett.7b00357; Yoshikawa K, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.32; Yu ZSJ, 2018, NAT ENERGY, V3, P747, DOI 10.1038/s41560-018-0201-5; Yu ZS, 2016, NAT ENERGY, V1, DOI [10.1038/nenergy.2016.137, 10.1038/NENERGY.2016.137]; Zhao YX, 2014, J PHYS CHEM C, V118, P9412, DOI 10.1021/jp502696w	83	432	435	89	653	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1097	+		10.1126/science.aaz5074	http://dx.doi.org/10.1126/science.aaz5074			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9CD	32139537				2022-12-28	WOS:000520018400036
J	Conradie, F; Diacon, AH; Ngubane, N; Howell, P; Everitt, D; Crook, AM; Mendel, CM; Egizi, E; Moreira, J; Timm, J; McHugh, TD; Wills, GH; Bateson, A; Hunt, R; Van Niekerk, C; Li, MC; Olugbosi, M; Spigelman, M				Conradie, Francesca; Diacon, Andreas H.; Ngubane, Nosipho; Howell, Pauline; Everitt, Daniel; Crook, Angela M.; Mendel, Carl M.; Egizi, Erica; Moreira, Joanna; Timm, Juliano; McHugh, Timothy D.; Wills, Genevieve H.; Bateson, Anna; Hunt, Robert; Van Niekerk, Christo; Li, Mengchun; Olugbosi, Morounfolu; Spigelman, Melvin		Nix-TB Trial Team	Treatment of Highly Drug-Resistant Pulmonary Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BACTERICIDAL ACTIVITY; MULTIDRUG-RESISTANT; BEDAQUILINE; MOXIFLOXACIN; PA-824; OUTCOMES	Background Patients with highly drug-resistant forms of tuberculosis have limited treatment options and historically have had poor outcomes. Methods In an open-label, single-group study in which follow-up is ongoing at three South African sites, we investigated treatment with three oral drugs - bedaquiline, pretomanid, and linezolid - that have bactericidal activity against tuberculosis and to which there is little preexisting resistance. We evaluated the safety and efficacy of the drug combination for 26 weeks in patients with extensively drug-resistant tuberculosis and patients with multidrug-resistant tuberculosis that was not responsive to treatment or for which a second-line regimen had been discontinued because of side effects. The primary end point was the incidence of an unfavorable outcome, defined as treatment failure (bacteriologic or clinical) or relapse during follow-up, which continued until 6 months after the end of treatment. Patients were classified as having a favorable outcome at 6 months if they had resolution of clinical disease, a negative culture status, and had not already been classified as having had an unfavorable outcome. Other efficacy end points and safety were also evaluated. Results A total of 109 patients were enrolled in the study and were included in the evaluation of efficacy and safety end points. At 6 months after the end of treatment in the intention-to-treat analysis, 11 patients (10%) had an unfavorable outcome and 98 patients (90%; 95% confidence interval, 83 to 95) had a favorable outcome. The 11 unfavorable outcomes were 7 deaths (6 during treatment and 1 from an unknown cause during follow-up), 1 withdrawal of consent during treatment, 2 relapses during follow-up, and 1 loss to follow-up. The expected linezolid toxic effects of peripheral neuropathy (occurring in 81% of patients) and myelosuppression (48%), although common, were manageable, often leading to dose reductions or interruptions in treatment with linezolid. Conclusions The combination of bedaquiline, pretomanid, and linezolid led to a favorable outcome at 6 months after the end of therapy in a high percentage of patients with highly drug-resistant forms of tuberculosis; some associated toxic effects were observed. (Funded by the TB Alliance and others; ClinicalTrials.gov number, .) Treatment options for highly drug-resistant tuberculosis are limited. In this study in South Africa, a new agent, pretomanid, was combined with bedaquiline and linezolid for a 26-week course to treat extensively drug-resistant and complicated multidrug-resistant pulmonary TB. Although there were toxic effects, 90% of patients had favorable outcomes.	[Conradie, Francesca; Ngubane, Nosipho; Howell, Pauline] Univ Witwatersrand, Fac Hlth Sci, Clin HIV Res Unit, Johannesburg, South Africa; [Conradie, Francesca; Howell, Pauline] Sizwe Trop Dis Hosp, Johannesburg, South Africa; [Diacon, Andreas H.] Task Appl Sci, Cape Town, South Africa; [Diacon, Andreas H.] Stellenbosch Univ, Cape Town, South Africa; [Ngubane, Nosipho] King DiniZulu Hosp Complex, Durban, South Africa; [Van Niekerk, Christo; Olugbosi, Morounfolu] TB Alliance, Pretoria, South Africa; [Everitt, Daniel; Crook, Angela M.; Egizi, Erica; Moreira, Joanna; Timm, Juliano; Li, Mengchun; Spigelman, Melvin] TB Alliance, New York, NY USA; [Crook, Angela M.; Wills, Genevieve H.] UCL, MRC Clin Trials Unit, 90 High Holborn, London WC1V 6LJ, England; [McHugh, Timothy D.; Bateson, Anna; Hunt, Robert] UCL, UCL Ctr Clin Microbiol, London, England	University of Witwatersrand; Stellenbosch University; Medical Research Council Clinical Trials Unit; University of London; University College London; University of London; University College London	Crook, AM (corresponding author), UCL, MRC Clin Trials Unit, 90 High Holborn, London WC1V 6LJ, England.	angela.crook@ucl.ac.uk	Li, Mengchun/AGW-0259-2022	Li, Mengchun/0000-0002-3489-4052; Upton, Caryn/0000-0002-7503-3320; McHugh, Timothy D/0000-0003-4658-8594; Ortiz Canseco, Julio/0000-0002-8789-7919	U.K. Department for International Development; U.K. Department of Health; Bill and Melinda Gates Foundation; U.S. Agency for International Development; Directorate General for International Cooperation of the Netherlands; Irish Aid; Australia Department of Foreign Affairs and Trade, the Federal Ministry for Education and Research of Germany through KfW; (German government) [MC_UU_12023/27]; Medical Research Council; National Research Foundation of South Africa; MRC [MC_UU_12023/27] Funding Source: UKRI	U.K. Department for International Development; U.K. Department of Health; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); U.S. Agency for International Development(United States Agency for International Development (USAID)); Directorate General for International Cooperation of the Netherlands; Irish Aid(CGIAR); Australia Department of Foreign Affairs and Trade, the Federal Ministry for Education and Research of Germany through KfW; (German government); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation of South Africa(National Research Foundation - South Africa); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the TB Alliance (Global Alliance for TB Drug Development), the U.K. Department for International Development, the U.K. Department of Health, the Bill and Melinda Gates Foundation, the U.S. Agency for International Development, the Directorate General for International Cooperation of the Netherlands, Irish Aid, the Australia Department of Foreign Affairs and Trade, the Federal Ministry for Education and Research of Germany through KfW (a state-owned development bank that handles the grants to product development partnerships, such as the TB Alliance, for the German government), a grant (MC_UU_12023/27 Tuberculosis Treatment Trials) from the Medical Research Council (to Dr. Crook), and a grant from the National Research Foundation of South Africa (to Dr. Diacon).	Ahmad N, 2018, LANCET, V392, P821, DOI 10.1016/S0140-6736(18)31644-1; Cherry CL, 2005, NEUROLOGY, V65, P1778, DOI 10.1212/01.wnl.0000187119.33075.41; Diacon AH, 2012, LANCET, V380, P986, DOI 10.1016/S0140-6736(12)61080-0; Gandhi NR, 2012, INT J TUBERC LUNG D, V16, P90, DOI 10.5588/ijtld.11.0153; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; Haagsma AC, 2009, ANTIMICROB AGENTS CH, V53, P1290, DOI 10.1128/AAC.01393-08; Ismail NA, 2018, EBIOMEDICINE, V28, P136, DOI 10.1016/j.ebiom.2018.01.005; Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210; LeeM Lee J, 2012, NEW ENGL J MED, V367, P1508, DOI DOI 10.1056/NEJMoa1201964; Manjunatha Ujjini, 2009, Commun Integr Biol, V2, P215; Mbuagbaw L, 2019, EMERG INFECT DIS, V25, P936, DOI 10.3201/eid2505.181823; Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817; National Institute of Allergy and Infectious Diseases, DIV MICR INF DIS DMI; Nunn AJ, 2010, INT J TUBERC LUNG D, V14, P241; Nunn AJ, 2019, NEW ENGL J MED, V380, P1201, DOI 10.1056/NEJMoa1811867; O'Donnell MR, 2013, EMERG INFECT DIS, V19, P416, DOI 10.3201/eid1903.120998; Olayanju O, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00544-2018; Pym AS, 2016, EUR RESPIR J, V47, P564, DOI 10.1183/13993003.00724-2015; Schnippel K, 2018, LANCET RESP MED, V6, P699, DOI 10.1016/S2213-2600(18)30235-2; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Tyagi S, 2005, ANTIMICROB AGENTS CH, V49, P2289, DOI 10.1128/AAC.49.6.2289-2293.2005; WHO, 2014, END TB STRAT; WHO, 2019, WHO CONS GUID DRUG R, DOI DOI 10.30978/TB2021-2-86; World Health Organization, 2018, TECHN REP CRIT CONC; Yang JS, 2018, ANN LAB MED, V38, P563, DOI 10.3343/alm.2018.38.6.563	27	253	282	21	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2020	382	10					893	902		10.1056/NEJMoa1901814	http://dx.doi.org/10.1056/NEJMoa1901814			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KT7TC	32130813	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000519214900005
J	Wise, J				Wise, Jacqui			The BMJ Awards 2020: Anaesthesia and perioperative medicine team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2020	368								m746	10.1136/bmj.m746	http://dx.doi.org/10.1136/bmj.m746			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KI	32139364				2022-12-28	WOS:000519537000003
J	Mahase, E				Mahase, Elisabeth			UK born children are often worse off than those in other rich countries, report finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Royal College of Paediatrics and Child Health, 2020, STAT CHILD HLTH 2020	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2020	368								m849	10.1136/bmj.m849	http://dx.doi.org/10.1136/bmj.m849			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KE	32127370				2022-12-28	WOS:000519536600014
J	Bromham, N; Kallioinen, M; Hoskin, P; Davies, RJ				Bromham, Nathan; Kallioinen, Maija; Hoskin, Peter; Davies, R. Justin		Guideline Comm	GUIDELINES Colorectal cancer: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bromham, Nathan; Kallioinen, Maija] Royal Coll Obstetricians & Gynaecologists, Natl Guideline Alliance, London SE1 1SZ, England; [Hoskin, Peter] Mt Vernon Hosp, Northwood HA6 2RN, Middx, England; [Hoskin, Peter] Univ Manchester, Manchester, Lancs, England; [Davies, R. Justin] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge Colorectal Unit, Cambridge CB2 0QQ, England	University of Manchester; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Davies, RJ (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge Colorectal Unit, Cambridge CB2 0QQ, England.	justindavies2000@yahoo.com	Monahan, Kevin/H-5753-2013	Monahan, Kevin/0000-0002-7918-4003; Hoskin, Peter/0000-0001-8323-9567; Salto-Tellez, Manuel/0000-0001-8586-282X; Shackcloth, Michael/0000-0002-6494-9907	NIHR Manchester Biomedical Centre; NICE	NIHR Manchester Biomedical Centre; NICE	NB and MK are employees of the National Guideline Alliance, which is commissioned and funded by NICE to develop clinical guidelines and write this BMJ summary. PH is supported by the NIHR Manchester Biomedical Centre. No authors received special funding from any other source to write this summary.	Brierley JD, 2017, TNM CLASSIFICATION M; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Cancer Research UK, BOW CANC STAT; Cancer Research UK, BOW CANC SURV STAT; European Society of Coloproctology, LARS SCOR THER JUUL; Juul T, 2015, COLORECTAL DIS, V17, P908, DOI 10.1111/codi.12952; Kohlmann W, 2004, GENE REV; National Institute for Health and Care Excellence, NICE PATHW COL CANC; National Institute for Health and Care Excellence, 2017, MOL TEST STRAT LYNCH; National Institute for Health and Care Excellence, 2019, COL CANC UPD NICE GU; National Institute of Health and Care Excellence, 2015, TRANS TOT MES EXC RE; National Institute of Health and Care Excellence, 2011, SEL INT RAD THER NON; NCIN, 2015, ROUT DIAGN CANC STAG; Renzi C, 2016, BRIT J CANCER, V115, P866, DOI 10.1038/bjc.2016.250	14	14	14	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2020	368								m461	10.1136/bmj.m461	http://dx.doi.org/10.1136/bmj.m461			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KC	32122877	Green Published			2022-12-28	WOS:000519536400002
J	Lee, A; Xie, YL; Barry, CE; Chen, RY				Lee, Anthony; Xie, Yingda Linda; Barry, Clifton E.; Chen, Ray Y.			Current and future treatments for tuberculosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ISONIAZID PREVENTIVE THERAPY; HIV-INFECTED ADULTS; ANTIRETROVIRAL THERAPY; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; MULTIDRUG-RESISTANT; LATENT TUBERCULOSIS; DELAYED INITIATION; RIFAPENTINE; MOXIFLOXACIN	Guidelines on the treatment of tuberculosis (TB) have essentially remained the same for the past 35 years, but are now starting to change. Ongoing clinical trials will hopefully transform the landscape for treatment of drug sensitive TB, drug resistant TB, and latent TB infection. Multiple trials are evaluating novel agents, repurposed agents, adjunctive host directed therapies, and novel treatment strategies that will increase the probability of success of future clinical trials. Guidelines for HIV-TB coinfection treatment continue to be updated and drug resistance testing has been revolutionized in recent years with the shift from phenotypic to genotypic testing and the concomitant increased speed of results. These coming changes are long overdue and are sorely needed to address the vast disparities in global TB incidence rates. TB is currently the leading cause of death globally from a single infectious agent, but the work of many researchers and the contributions of many patients in clinical trials will reduce the substantial global morbidity and mortality of the disease.	[Lee, Anthony] NIH, Med Res Scholars Program, Bldg 10, Bethesda, MD 20892 USA; [Lee, Anthony; Xie, Yingda Linda; Barry, Clifton E.; Chen, Ray Y.] NIAID, TB Res Sect, Lab Clin Immunol & Microbiol, Div Intramural Med,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Xie, Yingda Linda] Rutgers New Jersey Med Sch, Dept Med, Div Infect Dis, Newark, NJ USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rutgers State University New Brunswick; Rutgers State University Medical Center	Chen, RY (corresponding author), NIAID, TB Res Sect, Lab Clin Immunol & Microbiol, Div Intramural Med,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ray.chen@nih.gov	Chen, Ray/GRJ-6736-2022; Barry, Clifton E/ABE-7992-2020	Barry, Clifton E/0000-0002-2927-270X	Intramural Research Program of the US National Institutes of Health, National Institute of Allergy and Infectious Diseases	Intramural Research Program of the US National Institutes of Health, National Institute of Allergy and Infectious Diseases	This research was supported by the Intramural Research Program of the US National Institutes of Health, National Institute of Allergy and Infectious Diseases.	Abulfathi AA, 2019, CLIN PHARMACOKINET, V58, P1103, DOI 10.1007/s40262-019-00764-2; Allix-Beguec C, 2018, NEW ENGL J MED, V379, P1403, DOI 10.1056/NEJMoa1800474; [Anonymous], 2019, GUIDELINES USE ANTIR; [Anonymous], 2019, GUIDELINES PREVENTIO; Badje A, 2017, LANCET GLOB HEALTH, V5, pE1080, DOI 10.1016/S2214-109X(17)30372-8; Barry C, 2001, TUBERCULOSIS, V81, P1, DOI 10.1054/tube.2001.0288; Belknap R, 2017, ANN INTERN MED, V167, P689, DOI [10.7326/M17-1150, 10.7326/m17-1150]; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Boeree MJ, 2017, LANCET INFECT DIS, V17, P39, DOI 10.1016/S1473-3099(16)30274-2; Bonnett LJ, 2017, CLIN INFECT DIS, V65, P46, DOI 10.1093/cid/cix247; Borisov AS, 2018, MMWR-MORBID MORTAL W, V67, P723, DOI 10.15585/mmwr.mm6725a5; Brighenti S, 2018, J INTERN MED, V284, P145, DOI 10.1111/joim.12777; Centis R, 2019, LANCET RESP MED, V7, P193, DOI 10.1016/S2213-2600(18)30455-7; Chen Ray Y, 2017, Gates Open Res, V1, P9, DOI 10.12688/gatesopenres.12750.1; Colman RE, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002794; Cox H, 2018, NEW ENGL J MED, V379, P1474, DOI 10.1056/NEJMe1811861; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; DeLuca A, 2014, PUBLIC HEALTH ACTION, V4, P238, DOI 10.5588/pha.14.0089; Dheda K, 2019, LANCET RESP MED, V7, P820, DOI 10.1016/S2213-2600(19)30263-2; Diacon AH, 2014, EXPERT REV ANTI-INFE, V12, P223, DOI 10.1586/14787210.2014.870884; Dooley KE, 2019, C RETR OPP INF SEATT; Dooley KE, 2018, AM J RESP CRIT CARE, V198, P558, DOI 10.1164/rccm.201806-1140ED; Dorman SE, 2018, LANCET INFECT DIS, V18, P76, DOI [10.1016/S1473-3099(17)30691-6, 10.1016/s1473-3099(17)30691-6]; Dorman SE, 2015, AM J RESP CRIT CARE, V191, P333, DOI 10.1164/rccm.201410-1843OC; Fiore-Gartland A, 2018, TUBERCULOSIS, V109, P61, DOI [10.1016/j.tube.2017.11.009, 10]; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; FOX W, 1981, BRIT J DIS CHEST, V75, P331, DOI 10.1016/0007-0971(81)90022-X; Frick M, 2019, ACT GUID RIF TREATM; Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Iseman MD, 2002, EUR RESPIR J, V20, p87S, DOI 10.1183/09031936.02.00309102; Jaillon P, 2007, B ACAD NAT MED PARIS, V191, P739, DOI 10.1016/S0001-4079(19)33007-9; Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210; Johnson JL, 2009, AM J RESP CRIT CARE, V180, P558, DOI 10.1164/rccm.200904-0536OC; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Krishnan V, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6832; Lange C, 2019, INT J TUBERC LUNG D, V23, P645, DOI 10.5588/ijtld.18.0622; Lee M, 2012, NEW ENGL J MED, V367, P1508, DOI 10.1056/NEJMoa1201964; Libardo MDJ, 2018, CURR OPIN PHARMACOL, V42, P81, DOI 10.1016/j.coph.2018.08.001; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; MacLean E, 2019, NAT MICROBIOL, V4, P748, DOI 10.1038/s41564-019-0380-2; Mahomed S, 2017, TUBERCULOSIS, V107, P137, DOI 10.1016/j.tube.2017.09.005; McKenna L, 2019, LANCET RESP MED, V7, P999, DOI 10.1016/S2213-2600(19)30363-7; Meehan CJ, 2019, NAT REV MICROBIOL, V17, P533, DOI 10.1038/s41579-019-0214-5; Menzies D, 2018, NEW ENGL J MED, V379, P440, DOI 10.1056/NEJMoa1714283; Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817; Mfinanga SG, 2014, LANCET INFECT DIS, V14, P563, DOI 10.1016/S1473-3099(14)70733-9; Mitchison DA, 2005, AM J RESP CRIT CARE, V171, P699, DOI 10.1164/rccm.200411-1603OE; Murray JF, 2015, ANN AM THORAC SOC, V12, P1749, DOI 10.1513/AnnalsATS.201509-632PS; Nahid P, 2016, CLIN INFECT DIS, V63, pe147, DOI 10.1093/cid/ciw376; Nunn AJ, 2019, NEW ENGL J MED, V380, P1201, DOI 10.1056/NEJMoa1811867; Odone A, 2018, INT J TUBERC LUNG D, V22, P133, DOI 10.5588/ijtld.17.0608; Papineni P, 2016, INT J INFECT DIS, V45, P404, DOI 10.1016/j.ijid.2016.02.863; Prideaux B, 2015, NAT MED, V21, P1223, DOI 10.1038/nm.3937; Reid MJA, 2017, J INFECT DIS, V216, pS673, DOI 10.1093/infdis/jix373; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; Sterling Timothy R, 2020, MMWR Recomm Rep, V69, P1, DOI 10.15585/mmwr.rr6901a1; Sterling TR, 2016, AIDS, V30, P1607, DOI 10.1097/QAD.0000000000001098; Strydom N, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002773; Swindells S, 2019, NEW ENGL J MED, V380, P1001, DOI 10.1056/NEJMoa1806808; Takiff HE, 2015, LANCET INFECT DIS, V15, P1077, DOI 10.1016/S1473-3099(15)00071-7; Tanner L, 2018, IUBMB LIFE, V70, P926, DOI 10.1002/iub.1866; US Department of Health and Human Services, 2020, CLIN GUID; US Food and Drug Administration, 2013, GUID IND PULM TUB DE; US Food and Drug Administration, FDA APPR NEW DRUG TR; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; Velasquez GE, 2018, AM J RESP CRIT CARE, V198, P657, DOI 10.1164/rccm.201712-2524OC; WHO, 2019, GLOB TB REP 2019; WHO, 2019, RAPID COMMUNICATION; WHO, 2017, TREATMENT TUBERCULOS; World Health Organization, 2018, PAT CTR APPR TB CAR; World Health Organization, 2018, LAT TB INF UPD CONS; World Health Organization, 2018, WHO TREATM GUID IS R; World Health Organization, 2019, CONS GUID DRUG RES T; Xie YL, 2017, NEW ENGL J MED, V377, P1043, DOI 10.1056/NEJMoa1614915; Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1; Zhang RM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201025; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6	80	23	28	2	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2020	368								m216	10.1136/bmj.m216	http://dx.doi.org/10.1136/bmj.m216			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KC	32122882				2022-12-28	WOS:000519536400001
J	Xing, LD; O'Connor, JK; Schmitz, L; Chiappe, LM; McKellar, RC; Yi, QR; Li, G				Xing, Lida; O'Connor, Jingmai K.; Schmitz, Lars; Chiappe, Luis M.; McKellar, Ryan C.; Yi, Qiru; Li, Gang			Hummingbird-sized dinosaur from the Cretaceous period of Myanmar	NATURE			English	Article							BURMESE AMBER; BODY-SIZE; ENANTIORNITHINE; MINIATURIZATION; MORPHOLOGY; EVOLUTION; AGE	Skeletal inclusions in approximately 99-million-year-old amber from northern Myanmar provide unprecedented insights into the soft tissue and skeletal anatomy of minute fauna, which are not typically preserved in other depositional environments(1-3). Among a diversity of vertebrates, seven specimens that preserve the skeletal remains of enantiornithine birds have previously been described(1,4-8), all of which (including at least one seemingly mature specimen) are smaller than specimens recovered from lithic materials. Here we describe an exceptionally well-preserved and diminutive bird-like skull that documents a new species, which we name Oculudentavis khaungraae gen. et sp. nov. The find appears to represent the smallest known dinosaur of the Mesozoic era, rivalling the bee hummingbird (Mellisuga helenae)-the smallest living bird-in size. The O. khaungraae specimen preserves features that hint at miniaturization constraints, including a unique pattern of cranial fusion and an autapomorphic ocular morphology(9) that resembles the eyes of lizards. The conically arranged scleral ossicles define a small pupil, indicative of diurnal activity. Miniaturization most commonly arises in isolated environments, and the diminutive size of Oculudentavis is therefore consistent with previous suggestions that this amber formed on an island within the Trans-Tethyan arc(10). The size and morphology of this species suggest a previously unknown bauplan, and a previously undetected ecology. This discovery highlights the potential of amber deposits to reveal the lowest limits of vertebrate body size.	[Xing, Lida] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Beijing, Peoples R China; [Xing, Lida] China Univ Geosci, Sch Earth Sci & Resources, Beijing, Peoples R China; [O'Connor, Jingmai K.] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [O'Connor, Jingmai K.] Chinese Acad Sci, Ctr Excellence Life & Paleoenvironm, Beijing, Peoples R China; [Schmitz, Lars; Chiappe, Luis M.] Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA USA; [Schmitz, Lars] Claremont Mckenna Coll, WM Keck Sci Dept, Claremont, CA 91711 USA; [Schmitz, Lars] Scripps Coll, WM Keck Sci Dept, Claremont, CA 91711 USA; [Schmitz, Lars] Pitzer Coll, WM Keck Sci Dept, Claremont, CA 91711 USA; [McKellar, Ryan C.] Royal Saskatchewan Museum, Regina, SK, Canada; [McKellar, Ryan C.] Univ Regina, Dept Biol, Regina, SK, Canada; [Yi, Qiru; Li, Gang] Chinese Acad Sci, Beijing Adv Sci & Innovat Ctr, Beijing, Peoples R China; [Li, Gang] Chinese Acad Sci, Inst High Energy Phys, Beijing, Peoples R China	China University of Geosciences; China University of Geosciences; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; Claremont Colleges; Claremont Graduate School; Claremont McKenna College; Claremont Colleges; Scripps College; Claremont Colleges; Pitzer College; University of Regina; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of High Energy Physics, CAS	O'Connor, JK (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.; O'Connor, JK (corresponding author), Chinese Acad Sci, Ctr Excellence Life & Paleoenvironm, Beijing, Peoples R China.	jingmai@ivpp.ac.cn			National Natural Science Foundation of China [41888101, 41790455, 41772008]; National Geographic Society [EC0768-15]; Natural Sciences and Engineering Research Council of Canada [2015-00681]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Geographic Society(National Geographic Society); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was funded by the National Natural Science Foundation of China (no. 41888101, 41790455 and 41772008), the National Geographic Society (no. EC0768-15) and the Natural Sciences and Engineering Research Council of Canada (2015-00681). We thank BL13W of the Shanghai Synchrotron Radiation Facility for beamtime access based on proposal 16ssrf 01737, and the Beijing Synchrotron Radiation Facility for supplying the high MTF imaging detector. We thank S. Abramowicz for assistance with figures and D. Blackburn, D. Steadman and E. Stanley for making the computed tomography scan of M. minima accessible.	Bailleul AM, 2019, P NATL ACAD SCI USA, V116, P24696, DOI 10.1073/pnas.1911820116; Bout RG, 2001, COMP BIOCHEM PHYS A, V131, P197, DOI 10.1016/S1095-6433(01)00470-6; Chen RC, 2012, J SYNCHROTRON RADIAT, V19, P836, DOI 10.1107/S0909049512029731; Chiappe Luis M., 1999, Bulletin of the American Museum of Natural History, V242, P1; Daza J. D., 2018, Breviora, P1; Degrange FJ, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.912656; Edinger T, 1929, KNOCHERNE SCLERALRIN; ELZANOWSKI A, 1981, Palaeontologia Polonica, P147; Field DJ, 2018, NATURE, V557, P96, DOI 10.1038/s41586-018-0053-y; Glaw F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031314; Goloboff PA, 2008, CLADISTICS, V24, P758, DOI 10.1111/j.1096-0031.2008.00209.x; GRIFFITH H, 1990, COPEIA, P751, DOI 10.2307/1446441; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; Holliday CM, 2007, J MORPHOL, V268, P457, DOI 10.1002/jmor.10524; Hu H, 2019, P NATL ACAD SCI USA, V116, P19571, DOI 10.1073/pnas.1907754116; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jetz W, 2014, CURR BIOL, V24, P919, DOI 10.1016/j.cub.2014.03.011; JOLLIE MALCOLM T., 1957, J MORPH, V100, P389, DOI 10.1002/jmor.1051000302; LOVETTE IJ, 2004, HDB BIRD BIOL; O'Connor JK, 2019, PALAEOGEOGR PALAEOCL, V513, P178, DOI 10.1016/j.palaeo.2018.03.006; O'Connor JK, 2011, J SYST PALAEONTOL, V9, P135, DOI 10.1080/14772019.2010.526639; O'Connor JK., 2011, LIVING DINOSAURS EVO, P39, DOI [10.1002/9781119990475.ch3, DOI 10.1002/9781119990475.CH3]; Rauhut O.W.M., 2003, SPECIAL PAPERS PALAE, V69; Rayfield EJ, 2005, ZOOL J LINN SOC-LOND, V144, P309, DOI 10.1111/j.1096-3642.2005.00176.x; Rittmeyer EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029797; Schmitz L, 2011, SCIENCE, V332, P705, DOI 10.1126/science.1200043; Schmitz L, 2010, VISION RES, V50, P936, DOI 10.1016/j.visres.2010.03.009; Schmitz L, 2009, J MORPHOL, V270, P759, DOI 10.1002/jmor.10720; Shi GH, 2012, CRETACEOUS RES, V37, P155, DOI 10.1016/j.cretres.2012.03.014; Smith RDA, 2018, EARTH ENV SCI T R SO, V107, P239, DOI 10.1017/S1755691017000287; Symonds M. R. E., 2014, MODERN PHYLOGENETIC, P105, DOI DOI 10.1007/978-3-662-43550-2_5; Westerweel J, 2019, NAT GEOSCI, V12, P863, DOI 10.1038/s41561-019-0443-2; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Xing LD, 2020, CRETACEOUS RES, V110, DOI 10.1016/j.cretres.2020.104412; Xing LD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51929-9; Xing LD, 2019, CURR BIOL, V29, P2396, DOI 10.1016/j.cub.2019.05.077; Xing LD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37427-4; Xing LD, 2018, SCI BULL, V63, P235, DOI 10.1016/j.scib.2018.01.019; Xing LD, 2017, GONDWANA RES, V49, P264, DOI 10.1016/j.gr.2017.06.001; Xing LD, 2016, CURR BIOL, V26, P3352, DOI 10.1016/j.cub.2016.10.008; Xing LD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12089; Xu X, 2004, NATURE, V431, P838, DOI 10.1038/nature02898; Xu X, 2018, SCI BULL, V63, P812, DOI 10.1016/j.scib.2018.05.007; Yeh J, 2002, EVOLUTION, V56, P628; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930	46	16	17	7	51	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7798					245	+		10.1038/s41586-020-2068-4	http://dx.doi.org/10.1038/s41586-020-2068-4			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU0CC	32161388				2022-12-28	WOS:000519378900025
J	Isakoff, SJ; Lehman, CD; Shannon, KM; Basnet, KM				Isakoff, Steven J.; Lehman, Constance D.; Shannon, Kristen M.; Basnet, Kristen M.			Case 7-2020: A 52-Year-Old Man with a Mass in the Left Breast	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADJUVANT TREATMENT; CANCER; TAMOXIFEN; THERAPY; RISK; MAMMOGRAPHY	A 52-year-old man was referred to the hospital for management of a lump in the left breast. Mammography confirmed a round mass with irregular margins; ultrasonography of the left axilla revealed an abnormal lymph node. Biopsies showed intermediate-grade invasive ductal carcinoma and metastatic adenocarcinoma. Management decisions were made.	[Isakoff, Steven J.; Shannon, Kristen M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Lehman, Constance D.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Basnet, Kristen M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Isakoff, Steven J.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Lehman, Constance D.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Basnet, Kristen M.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Isakoff, SJ (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Isakoff, SJ (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.		Isakoff, Steven/ABE-3566-2020					Agalliu I, 2009, CLIN CANCER RES, V15, P1112, DOI 10.1158/1078-0432.CCR-08-1822; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Auvinen A, 2002, J NATL CANCER I, V94, P1330; Braunstein GD, 2007, NEW ENGL J MED, V357, P1229, DOI 10.1056/NEJMcp070677; Cardoso F, 2018, ANN ONCOL, V29, P405, DOI 10.1093/annonc/mdx651; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; Dong CH, 2001, BREAST CANCER RES TR, V66, P171, DOI 10.1023/A:1010639429207; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; Eggemann H, 2013, BREAST CANCER RES TR, V137, P465, DOI 10.1007/s10549-012-2355-3; El-Tamer MB, 2004, ARCH SURG-CHICAGO, V139, P1079, DOI 10.1001/archsurg.139.10.1079; Evans GFF, 2001, AM J SURG, V181, P96, DOI 10.1016/S0002-9610(00)00571-7; Foulkes WD, 2008, NEW ENGL J MED, V359, P2143, DOI 10.1056/NEJMra0802968; Francis PA, 2015, NEW ENGL J MED, V372, P436, DOI 10.1056/NEJMoa1412379; Giordano SH, 2005, CANCER, V104, P2359, DOI 10.1002/cncr.21526; Giordano SH, 2018, NEW ENGL J MED, V378, P2311, DOI 10.1056/NEJMra1707939; Golshan M, 2007, BREAST, V16, P653, DOI 10.1016/j.breast.2007.05.012; Goss PE, 2016, NEW ENGL J MED, V375, P209, DOI 10.1056/NEJMoa1604700; Hemminki K, 2005, BRIT J CANCER, V92, P1288, DOI 10.1038/sj.bjc.6602505; Hu CL, 2018, JAMA-J AM MED ASSOC, V319, P2401, DOI 10.1001/jama.2018.6228; Mainiero MB, 2015, J AM COLL RADIOL, V12, P678, DOI 10.1016/j.jacr.2015.03.024; Massarweh SA, 2018, J CLIN ONCOL, V36, P1396, DOI 10.1200/JCO.2017.76.8861; Carrasco RM, 2010, EUR RADIOL, V20, P2797, DOI 10.1007/s00330-010-1867-7; National Comprehensive Cancer Network, 2019, GEN FAM HIGH RISK AS; Pemmaraju N, 2012, ANN ONCOL, V23, P1471, DOI 10.1093/annonc/mdr459; Pritzlaff M, 2017, BREAST CANCER RES TR, V161, P575, DOI 10.1007/s10549-016-4085-4; Sickles EA, 2013, ACR BI RADS ATLAS BR, V5th, P46; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; van den Broek AJ, 2016, J CLIN ONCOL, V34, P409, DOI 10.1200/JCO.2015.62.3942; Visram H, 2010, CURR ONCOL, V17, P17; Xu SP, 2012, BREAST CANCER RES TR, V136, P495, DOI 10.1007/s10549-012-2286-z	32	0	0	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2020	382	9					856	864		10.1056/NEJMcpc1913470	http://dx.doi.org/10.1056/NEJMcpc1913470			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KS8TT	32101669				2022-12-28	WOS:000518581500012
J	Adibi, A; Sadatsafavi, M; Ioannidis, JPA				Adibi, Amin; Sadatsafavi, Mohsen; Ioannidis, John P. A.			Validation and Utility Testing of Clinical Prediction Models Time to Change the Approach	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Adibi, Amin; Sadatsafavi, Mohsen] Univ British Columbia, Fac Pharmaceut Sci, Collaborat Outcomes Res & Evaluat, Resp Evaluat Sci Program, Vancouver, BC, Canada; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Meta Res Innovat Ctr Stanford METRICS,Dept Med, Stanford, CA 94305 USA	University of British Columbia; Stanford University	Ioannidis, JPA (corresponding author), Stanford Prevent Res Ctr, 1265 Welch Rd, Stanford, CA 94305 USA.	jioannid@stanford.edu	Sadatsafayi, Mohsen/AAZ-1593-2020; Ioannidis, John P. A./G-9836-2011	Sadatsafayi, Mohsen/0000-0002-0419-7862; Ioannidis, John P./0000-0003-3118-6859; Adibi, Amin/0000-0003-2748-4781	Canada Foundation for Innovation John R. Evans Leaders Fund [38222]; Canadian Institutes of Health Research and Michael Smith Foundation for Health Research; Laura and John Arnold Foundation	Canada Foundation for Innovation John R. Evans Leaders Fund; Canadian Institutes of Health Research and Michael Smith Foundation for Health Research(Canadian Institutes of Health Research (CIHR)); Laura and John Arnold Foundation	This project is supported by a Canada Foundation for Innovation John R. Evans Leaders Fund (project 38222). Dr Sadatsafavi receives salary support from the Canadian Institutes of Health Research and Michael Smith Foundation for Health Research. The work of Dr Ioannidis is supported by an unrestricted gift from Sue and Bob O'Donnell. METRICS is supported with funding from the Laura and John Arnold Foundation.	Bellou V, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5358; Damen JAAG, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2416; Hozo I, 2018, J EVAL CLIN PRACT, V24, P65, DOI 10.1111/jep.12676; Janssen KJM, 2008, J CLIN EPIDEMIOL, V61, P76, DOI 10.1016/j.jclinepi.2007.04.018; Kohavi R, 2020, TRIALS, V21, DOI 10.1186/s13063-020-4084-y; Mandel JC, 2016, J AMMED INFORM ASS, V23, DOI 10.1111/jep.12895; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247	9	42	42	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2020	324	3					235	236		10.1001/jama.2020.1230	http://dx.doi.org/10.1001/jama.2020.1230			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MU9CI	32134437				2022-12-28	WOS:000555963000010
J	Chaudhry, HJ; Katsufrakis, PJ; Tallia, AF				Chaudhry, Humayun J.; Katsufrakis, Peter J.; Tallia, Alfred F.			The USMLE Step 1 Decision An Opportunity for Medical Education and Training	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERFORMANCE	This Viewpoint discusses the rationale for the announced 2022 change in USMLE Step 1 examination scoring from a 3-digit score to a pass/fail designation, addressing concerns that the change might lead to a shift in the importance of Step 2 Clinical Knowledge scores and emphasizing it as one part of a process to improve students' transition into graduate medical education (GME) training programs.	[Chaudhry, Humayun J.] Federat State Med Boards, 400 Fuller Wiser Rd,Ste 300, Euless, TX 76039 USA; [Katsufrakis, Peter J.] Natl Board Med Examiners, Philadelphia, PA USA; [Tallia, Alfred F.] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Chaudhry, HJ (corresponding author), Federat State Med Boards, 400 Fuller Wiser Rd,Ste 300, Euless, TX 76039 USA.	hchaudhry@fsmb.org						[Anonymous], 2018, RENEW TASK FORC SEEK; [Anonymous], INV C USMLE SCOR CUS; Chaudhry HJ, 2019, ACAD MED, V94, P1103, DOI 10.1097/ACM.0000000000002801; Committee to Evaluate the USMLE Program (CEUP), 2008, COMPR REV USMLE SUMM; Cuddy MM, 2017, ACAD MED, V92, P1780, DOI 10.1097/ACM.0000000000001747; Federation of State Medical Boards (FSMB), 2018, J MED REGUL, V104, P37, DOI [10.30770/2572-1852-104.2.37, DOI 10.30770/2572-1852-104.2.37]; Norcini JJ, 2014, ACAD MED, V89, P1157, DOI 10.1097/ACM.0000000000000310; Sunstein C. R., 2008, NUDGE	8	25	25	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					2017	2018		10.1001/jama.2020.3198	http://dx.doi.org/10.1001/jama.2020.3198			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LU8UM	32142115				2022-12-28	WOS:000538023900028
J	Sharfstein, JM; Becker, SJ; Mello, MM				Sharfstein, Joshua M.; Becker, Scott J.; Mello, Michelle M.			Diagnostic Testing for the Novel Coronavirus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint explains the technical and regulatory challenges that hampered diagnostic testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the early spread of infection in the US and considers the unintended consequences of making testing more widely available, including false-negative results and overtesting.	[Sharfstein, Joshua M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Becker, Scott J.] Assoc Publ Hlth Labs, Silver Spring, MD USA; [Mello, Michelle M.] Stanford Univ, Dept Med, Sch Med, Stanford Law Sch, Stanford, CA 94305 USA; [Mello, Michelle M.] Stanford Univ, Dept Med, Sch Med, Ctr Hlth Policy Primary Care & Outcomes Res, Stanford, CA 94305 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Stanford University; Stanford University	Sharfstein, JM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St,Room W1033F, Baltimore, MD 21205 USA.	joshua.sharfstein@jhu.edu		Mello, Michelle/0000-0003-2877-4270				Caliendo AM, 2016, CLIN INFECT DIS, V63, P151, DOI 10.1093/cid/ciw260; Centers for Disease Control and Prevention, 2020, EV REP PERS INV PUI; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; US Food and Drug Administration, 2020, INF LAB IMPL IVD TES; US Food and Drug Administration, 2020, POL DIAGN TEST LAB C	5	138	140	2	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2020	323	15					1437	1438		10.1001/jama.2020.3864	http://dx.doi.org/10.1001/jama.2020.3864			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LJ1ZH	32150622	Bronze			2022-12-28	WOS:000529969700006
J	Freeman, EE; McMahon, DE; Laker-Oketta, M				Freeman, Esther E.; McMahon, Devon E.; Laker-Oketta, Miriam			Time to address disparities in the standard of care for Kaposi sarcoma	LANCET			English	Editorial Material							PEGYLATED LIPOSOMAL DOXORUBICIN; TRIAL; CHEMOTHERAPY		[Freeman, Esther E.; McMahon, Devon E.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Laker-Oketta, Miriam] Makerere Univ, Infect Dis Inst, Kampala, Uganda	Harvard University; Harvard Medical School; Massachusetts General Hospital; Makerere University	Freeman, EE (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA.	efreeman@mgh.harvard.edu			NIAID NIH HHS [K23 AI136579] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chalya Phillipo L, 2015, BMC Res Notes, V8, P440, DOI 10.1186/s13104-015-1348-9; Cianfrocca M, 2010, CANCER-AM CANCER SOC, V116, P3969, DOI 10.1002/cncr.25362; Freeman E, 2020, T STAGING TREAT ALL, DOI [10.1101/2020.01.04.20016519, DOI 10.1101/2020.01.04.20016519]; Freeman EE, 2020, BMC CANCER, V20, DOI 10.1186/s12885-019-6506-3; Herce ME, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19929; Krown SE, 2020, LANCET, V395, P1195, DOI 10.1016/S0140-6736(19)33222-2; Medecins sans Frontieres, 2017, UNM PFIZ PAT PNEUM V; Mosam A, 2012, JAIDS-J ACQ IMM DEF, V60, P150, DOI 10.1097/QAI.0b013e318251aedd; Olweny CLM, 2005, INT J CANCER, V113, P632, DOI 10.1002/ijc.20606; Oyesiku L, 2019, J INVEST DERMATOL, V139, pS37; Rosenberg T., 2018, NY TIMES; Stewart S, 1998, J CLIN ONCOL, V16, P683, DOI 10.1200/JCO.1998.16.2.683	12	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2020	395	10231					1169	1170		10.1016/S0140-6736(20)30473-6	http://dx.doi.org/10.1016/S0140-6736(20)30473-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LE6DW	32145826				2022-12-28	WOS:000526814200007
J	Raphael, MP; Sheehan, PE; Vora, GJ				Raphael, Marc P.; Sheehan, Paul E.; Vora, Gary J.			A controlled trial for reproducibility	NATURE			English	Editorial Material									[Raphael, Marc P.; Vora, Gary J.] Naval Res Lab, Washington, DC 20375 USA; [Sheehan, Paul E.] DARPAs Biol Technol Off, Arlington, VA USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Raphael, MP (corresponding author), Naval Res Lab, Washington, DC 20375 USA.	marc.raphael@nrl.navy.mil	Vora, Gary J./AAT-7842-2021	Vora, Gary J./0000-0002-0657-8597				Ames CL, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0777-8; Langan RA, 2019, NATURE, V572, P205, DOI 10.1038/s41586-019-1432-8; Miao YC, 2017, NAT CELL BIOL, V19, P329, DOI 10.1038/ncb3495; Ng AH, 2019, NATURE, V572, P265, DOI 10.1038/s41586-019-1425-7; Niepel M, 2019, CELL SYST, V9, P35, DOI 10.1016/j.cels.2019.06.005; Riglar DT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12638-z	6	7	7	3	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2020	579	7798					190	192		10.1038/d41586-020-00672-7	http://dx.doi.org/10.1038/d41586-020-00672-7			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MD2CD	32157231	Bronze			2022-12-28	WOS:000543780300001
J	Arie, S				Arie, Sophie			CARE OF OLDER PEOPLE Welcome to the emergency department exclusively for the over 80s	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sophiearie@fmail.co.uk						Age UK, 2019, BRIEF HLTH CAR OLD P; Anandaciva S., 2019, KINGS FUND 0920; Campbell D., 2019, GUARDIAN; Steventon A, 2018, BRIEFING EMERGENCY H	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2020	368								m931	10.1136/bmj.m931	http://dx.doi.org/10.1136/bmj.m931			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AR	32161060				2022-12-28	WOS:000520012800008
J	Zarocostas, J				Zarocostas, John			Hope for the Ebola outbreak in DR Congo	LANCET			English	Editorial Material																			0	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2020	395	10226					773	773						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU2KH	32145780	Bronze			2022-12-28	WOS:000519536900016
J	Wesemann, DR; Nagler, CR				Wesemann, Duane R.; Nagler, Cathryn R.			Origins of peanut allergy-causing antibodies	SCIENCE			English	Editorial Material							FC-GAMMA-RIIB; FOOD; MICROBIOME		[Wesemann, Duane R.] Brigham & Womens Hosp, Dept Med, Div Allergy & Clin Immunol, 75 Francis St, Boston, MA 02115 USA; [Wesemann, Duane R.] Harvard Med Sch, Boston, MA 02115 USA; [Nagler, Cathryn R.] Univ Chicago, Dept Pathol, Biol Sci Div, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Nagler, Cathryn R.] Univ Chicago, Pritzker Sch Mol Engn, Chicago, IL 60637 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Chicago; University of Chicago	Wesemann, DR (corresponding author), Brigham & Womens Hosp, Dept Med, Div Allergy & Clin Immunol, 75 Francis St, Boston, MA 02115 USA.; Wesemann, DR (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	dwesemann@bwh.harvard.edu; cnagler@bsd.uchicago.edu		Wesemann, Duane/0000-0002-6690-944X	NIH [AI121394, AI139538, AI137940, AI106302, AI134923, AI146099]; Burroughs Wellcome Fund; Sunshine Charitable Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Sunshine Charitable Foundation	D.R.W. is supported by the NIH (AI121394, AI139538, and AI137940), the Burroughs Wellcome Fund, and an anonymous donor.C.R.N.is supported by the NIH (AI106302, AI134923, andAI146099) and the Sunshine Charitable Foundation. C.R.N.is president and co-founder of ClostraBio, Inc.	Asrat S, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aav8402; Burton OT, 2018, J ALLERGY CLIN IMMUN, V141, P189, DOI 10.1016/j.jaci.2017.03.045; Burton OT, 2014, J ALLERGY CLIN IMMUN, V134, P1310, DOI 10.1016/j.jaci.2014.05.042; Caffarelli C, 1998, PEDIATR RES, V44, P485, DOI 10.1203/00006450-199810000-00004; Croote D, 2018, SCIENCE, V362, P1306, DOI 10.1126/science.aau2599; Gocki J, 2016, POSTEP DERM ALERGOL, V33, P253, DOI 10.5114/ada.2016.61600; Hoh R. A., 2020, SCI IMMUNOL, V5; Iweala OI, 2019, ANNU REV IMMUNOL, V37, P377, DOI 10.1146/annurev-immunol-042718-041621; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Orengo JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03636-8; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; PROFET M, 1991, Q REV BIOL, V66, P23, DOI 10.1086/417049; Tong P, 2015, CURR TOP MICROBIOL, V388, P21, DOI 10.1007/978-3-319-13725-4_2; Wesemann DR, 2016, IMMUNITY, V44, P728, DOI 10.1016/j.immuni.2016.02.002	14	2	2	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1072	1073		10.1126/science.aba8974	http://dx.doi.org/10.1126/science.aba8974			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU9CD	32139528	Green Accepted			2022-12-28	WOS:000520018400023
J	Chen, GR; Sharpe, AL; Fox, EJ; Zhang, YH; Wang, SX; Jiang, LL; Lyu, B; Li, HY; Watanabe, KJ; Taniguchi, T; Shi, ZW; Senthil, T; Goldhaber-Gordon, D; Zhang, YB; Wang, F				Chen, Guorui; Sharpe, Aaron L.; Fox, Eli J.; Zhang, Ya-Hui; Wang, Shaoxin; Jiang, Lili; Lyu, Bosai; Li, Hongyuan; Watanabe, Kenji; Taniguchi, Takashi; Shi, Zhiwen; Senthil, T.; Goldhaber-Gordon, David; Zhang, Yuanbo; Wang, Feng			Tunable correlated Chern insulator and ferromagnetism in a moire superlattice	NATURE			English	Article							DIRAC FERMIONS; BAND-GAP; HALL; TRANSPORT	Studies of two-dimensional electron systems in a strong magnetic field revealed the quantum Hall effect(1), a topological state of matter featuring a finite Chern number C and chiral edge states(2,3). Haldane(4) later theorized that Chern insulators with integer quantum Hall effects could appear in lattice models with complex hopping parameters even at zero magnetic field. The ABC-trilayer graphene/hexagonal boron nitride (ABC-TLG/hBN) moire superlattice provides an attractive platform with which to explore Chern insulators because it features nearly flat moire minibands with a valley-dependent, electrically tunable Chern number(5,6). Here we report the experimental observation of a correlated Chern insulator in an ABC-TLG/hBN moire superlattice. We show that reversing the direction of the applied vertical electric field switches the moire minibands of ABC-TLG/hBN between zero and finite Chern numbers, as revealed by large changes in magneto-transport behaviour. For topological hole minibands tuned to have a finite Chern number, we focus on quarter filling, corresponding to one hole per moire unit cell. The Hall resistance is well quantized at h/2e(2) (where h is Planck's constant and e is the charge on the electron), which implies C = 2, for a magnetic field exceeding 0.4 tesla. The correlated Chern insulator is ferromagnetic, exhibiting substantial magnetic hysteresis and a large anomalous Hall signal at zero magnetic field. Our discovery of a C = 2 Chern insulator at zero magnetic field should open up opportunities for discovering correlated topological states, possibly with topological excitations(7), in nearly flat and topologically nontrivial moire minibands.	[Chen, Guorui; Li, Hongyuan; Wang, Feng] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Chen, Guorui; Wang, Shaoxin; Jiang, Lili; Li, Hongyuan; Wang, Feng] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Sharpe, Aaron L.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Sharpe, Aaron L.; Fox, Eli J.; Goldhaber-Gordon, David] Stanford Inst Mat & Energy Sci, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Sharpe, Aaron L.; Fox, Eli J.; Goldhaber-Gordon, David] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Zhang, Ya-Hui; Senthil, T.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Lyu, Bosai; Shi, Zhiwen] Shanghai Jiao Tong Univ, Sch Phys & Astron, Key Lab Artificial Struct & Quantum Control, Minist Educ, Shanghai, Peoples R China; [Lyu, Bosai; Shi, Zhiwen; Zhang, Yuanbo] Collaborat Innovat Ctr Adv Microstruct, Nanjing, Peoples R China; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [Zhang, Yuanbo] Fudan Univ, State Key Lab Surface Phys, Shanghai, Peoples R China; [Zhang, Yuanbo] Fudan Univ, Dept Phys, Shanghai, Peoples R China; [Zhang, Yuanbo] Fudan Univ, Inst Nanoelect Devices & Quantum Comp, Shanghai, Peoples R China; [Wang, Feng] Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Wang, Feng] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Massachusetts Institute of Technology (MIT); Shanghai Jiao Tong University; National Institute for Materials Science; Fudan University; Fudan University; Fudan University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Wang, F (corresponding author), Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA.; Wang, F (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.; Goldhaber-Gordon, D (corresponding author), Stanford Inst Mat & Energy Sci, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA.; Goldhaber-Gordon, D (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.; Zhang, YB (corresponding author), Collaborat Innovat Ctr Adv Microstruct, Nanjing, Peoples R China.; Zhang, YB (corresponding author), Fudan Univ, State Key Lab Surface Phys, Shanghai, Peoples R China.; Zhang, YB (corresponding author), Fudan Univ, Dept Phys, Shanghai, Peoples R China.; Zhang, YB (corresponding author), Fudan Univ, Inst Nanoelect Devices & Quantum Comp, Shanghai, Peoples R China.; Wang, F (corresponding author), Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA.; Wang, F (corresponding author), Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.	goldhaber-gordon@stanford.edu; zhyb@fudan.edu.cn; fengwang76@berkeley.edu	wang, Feng/I-5727-2015	wang, Feng/0000-0001-8369-6194	Center for Novel Pathways to Quantum Coherence in Materials, an Energy Frontier Research Center - US Department of Energy, Office of Science, Basic Energy Sciences; National Science Foundation Graduate Research Fellowship; Ford Foundation Predoctoral Fellowship; US Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC02-76SF00515]; Gordon and Betty Moore Foundation [GBMF3429]; National Key Research Program of China [2016YFA0300703, 2018YFA0305600]; NSF of China [U1732274, 11527805, 11425415, 11421404]; Strategic Priority Research Program of Chinese Academy of Sciences [XDB30000000]; National Key Research and Development Program of China [2016YFA0302001]; National Natural Science Foundation of China [11574204, 11774224]; Shanghai talent programme; NSF [DMR-1608505]; Simons Foundation; Elemental Strategy Initiative; CREST, JST [JPMJCR15F3]	Center for Novel Pathways to Quantum Coherence in Materials, an Energy Frontier Research Center - US Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Ford Foundation Predoctoral Fellowship; US Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Key Research Program of China; NSF of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai talent programme; NSF(National Science Foundation (NSF)); Simons Foundation; Elemental Strategy Initiative; CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	We thank Y. Yu and M. Sui for measurement assistance, and acknowledge discussions with M. Zaletel, E. Altman, J. Jung and M. A. Kastner. G.C. and F.W. were supported as part of the Center for Novel Pathways to Quantum Coherence in Materials, an Energy Frontier Research Center funded by the US Department of Energy, Office of Science, Basic Energy Sciences. A.L.S. was supported by a National Science Foundation Graduate Research Fellowship and a Ford Foundation Predoctoral Fellowship. The work of E.J.F. and D.G.-G. on this project was supported by the US Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division, under contract number DE-AC02-76SF00515. Low-temperature infrastructure (dilution fridges) and cryostat support were funded in part by the Gordon and Betty Moore Foundation through grant number GBMF3429. Part of the sample fabrication was conducted at the Nano-fabrication Laboratory at Fudan University. Part of the measurement was performed in Oxford Instrument Nanoscience Shanghai Demo Laboratory. Y.Z. acknowledges financial support from National Key Research Program of China (grant numbers 2016YFA0300703, 2018YFA0305600), NSF of China (grant numbers U1732274, 11527805, 11425415 and 11421404), and the Strategic Priority Research Program of Chinese Academy of Sciences (grant number XDB30000000). Z.S. acknowledges support from National Key Research and Development Program of China (grant number 2016YFA0302001) and National Natural Science Foundation of China (grant number 11574204, 11774224), and additional support from a Shanghai talent programme. T.S. was supported by NSF grant DMR-1608505, and partially through a Simons Investigator Award from the Simons Foundation. K.W. and T.T. acknowledge support from the Elemental Strategy Initiative conducted by the MEXT, Japan and the CREST (JPMJCR15F3), JST.	Bergholtz EJ, 2013, INT J MOD PHYS B, V27, DOI 10.1142/S021797921330017X; Bultinck N., 2019, PREPRINT; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Chang CZ, 2013, SCIENCE, V340, P167, DOI 10.1126/science.1234414; Chen GR, 2019, NATURE, V572, P215, DOI 10.1038/s41586-019-1393-y; Chen GR, 2019, NAT PHYS, V15, P237, DOI 10.1038/s41567-018-0387-2; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Ju L, 2015, NATURE, V520, P650, DOI 10.1038/nature14364; Jung J, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.205414; Lee Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6656; Li HY, 2018, NANO LETT, V18, P8011, DOI 10.1021/acs.nanolett.8b04166; Liu JP, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.031021; Liu Z, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.186805; Lu XB, 2019, NATURE, V574, P653, DOI 10.1038/s41586-019-1695-0; Lui CH, 2011, NAT PHYS, V7, P944, DOI [10.1038/nphys2102, 10.1038/NPHYS2102]; MACDONALD ML, 1991, CAN LITERATURE, P195; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; Sharpe AL, 2019, SCIENCE, V365, P605, DOI 10.1126/science.aaw3780; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Wang YF, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.201101; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959; Yoo H, 2019, NAT MATER, V18, P448, DOI 10.1038/s41563-019-0346-z; Zhang F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.156801; Zhang LY, 2011, NAT PHYS, V7, P953, DOI [10.1038/nphys2104, 10.1038/NPHYS2104]; Zhang Y., 2019, PREPRINT; Zhang YH, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.205150; Zhang YH, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.075127; Zhang YB, 2009, NATURE, V459, P820, DOI 10.1038/nature08105; Zou K, 2013, NANO LETT, V13, P369, DOI 10.1021/nl303375a	37	262	266	34	314	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2020	579	7797					56	+		10.1038/s41586-020-2049-7	http://dx.doi.org/10.1038/s41586-020-2049-7			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MD2AZ	32132694	Green Submitted			2022-12-28	WOS:000543777300004
J	Thornton, J				Thornton, Jacqui			Women are at serious risk of harm from late diagnosis of ectopic pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Healthcare Safety Investigation Branch, 2020, DIAGN ECT PREGN IND	1	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2020	368								m924	10.1136/bmj.m924	http://dx.doi.org/10.1136/bmj.m924			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KI	32139374				2022-12-28	WOS:000519537000012
J	Zhou, JJ; Chizhik, AI; Chu, S; Jin, DY				Zhou, Jiajia; Chizhik, Alexey I.; Chu, Steven; Jin, Dayong			Single-particle spectroscopy for functional nanomaterials	NATURE			English	Review							HALIDE PEROVSKITE NANOCRYSTALS; QUANTUM DOTS; UPCONVERTING NANOPARTICLES; PHOTON EMISSION; CARBON NANODOTS; ENERGY-TRANSFER; NON-BLINKING; LUMINESCENCE; MANIPULATION; MOLECULES	Tremendous progress in nanotechnology has enabled advances in the use of luminescent nanomaterials in imaging, sensing and photonic devices. This translational process relies on controlling the photophysical properties of the building block, that is, single luminescent nanoparticles. In this Review, we highlight the importance of single-particle spectroscopy in revealing the diverse optical properties and functionalities of nanomaterials, and compare it with ensemble fluorescence spectroscopy. The information provided by this technique has guided materials science in tailoring the synthesis of nanomaterials to achieve optical uniformity and to develop novel applications. We discuss the opportunities and challenges that arise from pushing the resolution limit, integrating measurement and manipulation modalities, and establishing the relationship between the structure and functionality of single nanoparticles.	[Zhou, Jiajia; Jin, Dayong] Univ Technol Sydney, Inst Biomed Mat & Devices IBMD, Fac Sci, Sydney, NSW, Australia; [Chizhik, Alexey I.] Georg August Univ Gottingen, Inst Phys, Gottingen, Germany; [Chu, Steven] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Chu, Steven] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Jin, Dayong] Southern Univ Sci & Technol, Dept Biomed Engn, UTS SUStech Joint Res Ctr Biomed Mat & Devices, Shenzhen, Peoples R China	University of Technology Sydney; University of Gottingen; Stanford University; Stanford University; Southern University of Science & Technology; University of Technology Sydney	Zhou, JJ; Jin, DY (corresponding author), Univ Technol Sydney, Inst Biomed Mat & Devices IBMD, Fac Sci, Sydney, NSW, Australia.; Chizhik, AI (corresponding author), Georg August Univ Gottingen, Inst Phys, Gottingen, Germany.; Chu, S (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.; Chu, S (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Jin, DY (corresponding author), Southern Univ Sci & Technol, Dept Biomed Engn, UTS SUStech Joint Res Ctr Biomed Mat & Devices, Shenzhen, Peoples R China.	jiajia.zhou@uts.edu.au; alexey.chizhik@phys.uni-goettingen.de; schu@stanford.edu; dayong.jin@uts.edu.au	Jin, Dayong/AAY-2402-2021; zhou, jiajia/ABA-7671-2021	Jin, Dayong/0000-0003-1046-2666; Zhou, Jiajia/0000-0002-0605-5745	Australian Research Council (ARC) [DE180100669]; Shenzhen Science and Technology Program [KQTD20170810110913065]; Australia China Science and Research Fund Joint Research Centre for POCT [ACSRF65827]	Australian Research Council (ARC)(Australian Research Council); Shenzhen Science and Technology Program; Australia China Science and Research Fund Joint Research Centre for POCT	We acknowledge support from the Australian Research Council (ARC) Discovery Early Career Researcher Award Scheme (DE180100669), Shenzhen Science and Technology Program (KQTD20170810110913065) and Australia China Science and Research Fund Joint Research Centre for POCT (ACSRF65827).	Akimov AV, 2007, NATURE, V450, P402, DOI 10.1038/nature06230; Akkerman QA, 2018, NAT MATER, V17, P394, DOI 10.1038/s41563-018-0018-4; AMBROSE WP, 1994, SCIENCE, V265, P364, DOI 10.1126/science.265.5170.364; Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Becker MA, 2018, NATURE, V553, P189, DOI 10.1038/nature25147; Berthelot J, 2014, NAT NANOTECHNOL, V9, P295, DOI [10.1038/nnano.2014.24, 10.1038/NNANO.2014.24]; Beveratos A, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.061802; Bradac C, 2010, NAT NANOTECHNOL, V5, P345, DOI [10.1038/NNANO.2010.56, 10.1038/nnano.2010.56]; Brokmann X, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.107403; Buchler BC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.063003; Butler KT, 2018, NATURE, V559, P547, DOI 10.1038/s41586-018-0337-2; Canneson D, 2017, NANO LETT, V17, P6177, DOI 10.1021/acs.nanolett.7b02827; Celebrano M, 2018, NAT PHOTONICS, V12, P309, DOI 10.1038/s41566-018-0159-7; Chang YR, 2008, NAT NANOTECHNOL, V3, P284, DOI 10.1038/nnano.2008.99; Chen CH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05842-w; Chen O, 2013, NAT MATER, V12, P445, DOI [10.1038/nmat3539, 10.1038/NMAT3539]; Chien MH, 2018, P NATL ACAD SCI USA, V115, P11150, DOI 10.1073/pnas.1804174115; Chizhik AI, 2014, NAT PHOTONICS, V8, P124, DOI 10.1038/nphoton.2013.345; Chizhik AI, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.223902; Chizhik AI, 2011, NANO LETT, V11, P1700, DOI 10.1021/nl200215v; Chizhik AM, 2016, NANO LETT, V16, P237, DOI 10.1021/acs.nanolett.5b03609; Chizhik AM, 2009, NANO LETT, V9, P3239, DOI 10.1021/nl901509k; Chu S, 1998, REV MOD PHYS, V70, P685, DOI 10.1103/RevModPhys.70.685; Cohen AE, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1872220; Cohen AE, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.118102; Crozier KB, 2019, LIGHT-SCI APPL, V8, DOI 10.1038/s41377-019-0146-x; Dordevic L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05561-2; Ebenstein Y, 2002, APPL PHYS LETT, V80, P4033, DOI 10.1063/1.1482785; Efros AL, 2016, NAT NANOTECHNOL, V11, P661, DOI [10.1038/NNANO.2016.140, 10.1038/nnano.2016.140]; Empedocles SA, 1996, PHYS REV LETT, V77, P3873, DOI 10.1103/PhysRevLett.77.3873; Fan FJ, 2017, NATURE, V544, P75, DOI 10.1038/nature21424; Fan Y, 2018, NAT NANOTECHNOL, V13, P941, DOI 10.1038/s41565-018-0221-0; Farka Z, 2017, ANAL CHEM, V89, P11825, DOI 10.1021/acs.analchem.7b03542; Feynman, 1960, ENG SCI, V23, P22, DOI DOI 10.1108/IJCST-06-2013-0067; Fischer S, 2017, J AM CHEM SOC, V139, P12325, DOI 10.1021/jacs.7b07496; Fu M, 2017, NANO LETT, V17, P2895, DOI 10.1021/acs.nanolett.7b00064; Galland C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1916; Galland C, 2011, NATURE, V479, P203, DOI 10.1038/nature10569; Gargas DJ, 2014, NAT NANOTECHNOL, V9, P300, DOI [10.1038/NNANO.2014.29, 10.1038/nnano.2014.29]; Geiselmann M, 2013, NAT NANOTECHNOL, V8, P175, DOI [10.1038/nnano.2012.259, 10.1038/NNANO.2012.259]; Ghosh S, 2014, NANO LETT, V14, P5656, DOI 10.1021/nl502372x; Gonell F, 2019, NANOSCALE ADV, V1, P2537, DOI 10.1039/c8na00412a; Hadar I, 2013, J PHYS CHEM LETT, V4, P502, DOI 10.1021/jz3021167; Hanne J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8127; Haziza S, 2017, NAT NANOTECHNOL, V12, P322, DOI [10.1038/nnano.2016.260, 10.1038/NNANO.2016.260]; Heylman KD, 2016, NAT PHOTONICS, V10, P788, DOI [10.1038/nphoton.2016.217, 10.1038/NPHOTON.2016.217]; Himmelstoss SF, 2019, METHODS APPL FLUORES, V7, DOI 10.1088/2050-6120/ab0bfa; Holzmeister P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6356; Hu FR, 2015, ACS NANO, V9, P12410, DOI 10.1021/acsnano.5b05769; Hu JT, 2001, SCIENCE, V292, P2060, DOI 10.1126/science.1060810; Isarov M, 2017, NANO LETT, V17, P5020, DOI 10.1021/acs.nanolett.7b02248; Javaux C, 2013, NAT NANOTECHNOL, V8, P206, DOI [10.1038/nnano.2012.260, 10.1038/NNANO.2012.260]; Jensen RA, 2016, ACS PHOTONICS, V3, P423, DOI 10.1021/acsphotonics.5b00575; Ji BT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07837-z; Jin DY, 2018, NAT METHODS, V15, P415, DOI 10.1038/s41592-018-0012-4; Khan S, 2018, CHEM SCI, V9, P175, DOI 10.1039/c7sc02528a; Khan S, 2017, J PHYS CHEM LETT, V8, P5751, DOI 10.1021/acs.jpclett.7b02521; Kianinia M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03290-0; Kucsko G, 2013, NATURE, V500, P54, DOI 10.1038/nature12373; Kukura P, 2009, NANO LETT, V9, P926, DOI 10.1021/nl801735y; Labeau O, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.257404; Laramy CR, 2019, NAT REV MATER, V4, P201, DOI 10.1038/s41578-019-0087-2; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li M, 2019, ANGEW CHEM INT EDIT, V58, P572, DOI 10.1002/anie.201810324; Li XM, 2013, THERANOSTICS, V3, P292, DOI 10.7150/thno.5289; Lin L, 2018, NAT PHOTONICS, V12, P195, DOI 10.1038/s41566-018-0134-3; Liu DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10254; Liu Q, 2018, NAT PHOTONICS, V12, P548, DOI 10.1038/s41566-018-0217-1; Liu WN, 2016, NANO LETT, V16, P6236, DOI 10.1021/acs.nanolett.6b02456; Liu YJ, 2017, NATURE, V543, P229, DOI 10.1038/nature21366; Lu YQ, 2014, NAT PHOTONICS, V8, P33, DOI [10.1038/NPHOTON.2013.322, 10.1038/nphoton.2013.322]; Ma CS, 2017, NANO LETT, V17, P2858, DOI 10.1021/acs.nanolett.6b05331; Macklin JJ, 1996, SCIENCE, V272, P255, DOI 10.1126/science.272.5259.255; Mahler B, 2008, NAT MATER, V7, P659, DOI 10.1038/nmat2222; Maletinsky P, 2012, NAT NANOTECHNOL, V7, P320, DOI [10.1038/nnano.2012.50, 10.1038/NNANO.2012.50]; Marago OM, 2013, NAT NANOTECHNOL, V8, P807, DOI [10.1038/NNANO.2013.208, 10.1038/nnano.2013.208]; Marshall JD, 2013, ACS NANO, V7, P4601, DOI 10.1021/nn401410k; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; McGuinness LP, 2011, NAT NANOTECHNOL, V6, P358, DOI [10.1038/NNANO.2011.64, 10.1038/nnano.2011.64]; MOERNER WE, 1989, PHYS REV LETT, V62, P2535, DOI 10.1103/PhysRevLett.62.2535; Ndukaife JC, 2016, NAT NANOTECHNOL, V11, P53, DOI [10.1038/nnano.2015.248, 10.1038/NNANO.2015.248]; Neukirch LP, 2015, NAT PHOTONICS, V9, P653, DOI [10.1038/NPHOTON.2015.162, 10.1038/nphoton.2015.162]; Nirmal M, 1996, NATURE, V383, P802, DOI 10.1038/383802a0; Oracz J, 2017, NANO LETT, V17, P2652, DOI 10.1021/acs.nanolett.7b00468; Orfield NJ, 2016, ACS NANO, V10, P1960, DOI 10.1021/acsnano.5b05876; ORRIT M, 1990, PHYS REV LETT, V65, P2716, DOI 10.1103/PhysRevLett.65.2716; Ouyang W, 2018, NAT BIOTECHNOL, V36, P460, DOI 10.1038/nbt.4106; Park K, 2018, SCI ADV, V4, DOI 10.1126/sciadv.1601453; Park K, 2012, ACS NANO, V6, P10013, DOI 10.1021/nn303719m; Park YI, 2009, ADV MATER, V21, P4467, DOI 10.1002/adma.200901356; Park YS, 2015, ACS NANO, V9, P10386, DOI 10.1021/acsnano.5b04584; Prigozhin MB, 2019, NAT NANOTECHNOL, V14, P420, DOI 10.1038/s41565-019-0395-0; PURCELL EM, 1946, PHYS REV, V69, P681; Raino G, 2016, ACS NANO, V10, P2485, DOI 10.1021/acsnano.5b07328; Ren W, 2018, CHEM SCI, V9, P4352, DOI 10.1039/c8sc01023d; Rendler T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14701; Ringler M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.203002; Rittweger E, 2009, NAT PHOTONICS, V3, P144, DOI 10.1038/NPHOTON.2009.2; Ropp C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2477; Streed EW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1944; Sun MZ, 2018, NAT CHEM, V10, P821, DOI 10.1038/s41557-018-0083-y; Tamarat P, 2019, NAT MATER, V18, P717, DOI 10.1038/s41563-019-0364-x; Tan CL, 2018, NAT REV MATER, V3, DOI 10.1038/natrevmats.2017.89; Tarpani L, 2016, NANO LETT, V16, P4312, DOI 10.1021/acs.nanolett.6b01361; Tatebayashi J, 2015, NAT PHOTONICS, V9, P501, DOI [10.1038/NPHOTON.2015.111, 10.1038/nphoton.2015.111]; Taylor RW, 2019, NAT PHOTONICS, V13, P480, DOI 10.1038/s41566-019-0414-6; Tessier MD, 2012, ACS NANO, V6, P6751, DOI 10.1021/nn3014855; Tian B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03737-4; Tian YX, 2015, NANO LETT, V15, P1603, DOI 10.1021/nl5041397; Trichet AAP, 2016, NANO LETT, V16, P6172, DOI 10.1021/acs.nanolett.6b02433; Vlasov II, 2014, NAT NANOTECHNOL, V9, P54, DOI [10.1038/NNANO.2013.255, 10.1038/nnano.2013.255]; Wang F, 2010, NATURE, V463, P1061, DOI 10.1038/nature08777; Wang MY, 2018, NANOSCALE, V10, P19757, DOI 10.1039/c8nr04808h; Wang X, 2005, NATURE, V437, P121, DOI 10.1038/nature03968; Watanabe TM, 2010, BIOPHYS J, V99, pL50, DOI 10.1016/j.bpj.2010.07.036; Wen SH, 2019, NAT PHOTONICS, V13, P828, DOI 10.1038/s41566-019-0528-x; Woll D, 2017, SMALL METHODS, V1, DOI 10.1002/smtd.201700191; Wu SW, 2009, P NATL ACAD SCI USA, V106, P10917, DOI 10.1073/pnas.0904792106; Xin HB, 2017, SMALL, V13, DOI 10.1002/smll.201603418; Xiong HQ, 2019, NAT PHOTONICS, V13, P412, DOI 10.1038/s41566-019-0396-4; Yang XS, 2016, ACS PHOTONICS, V3, P1611, DOI 10.1021/acsphotonics.6b00178; Yang XS, 2016, LIGHT-SCI APPL, V5, DOI 10.1038/lsa.2016.134; Zeng X, 2019, ANGEW CHEM INT EDIT, V58, P9262, DOI 10.1002/anie.201904208; Zhang PY, 2018, NAT METHODS, V15, P913, DOI 10.1038/s41592-018-0153-5; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373; Zhang YH, 2014, J AM CHEM SOC, V136, P4893, DOI 10.1021/ja5013646; Zhang ZY, 2015, NAT METHODS, V12, P935, DOI [10.1038/NMETH.3528, 10.1038/nmeth.3528]; Zhanghao K, 2016, LIGHT-SCI APPL, V5, DOI 10.1038/lsa.2016.166; Zhao JB, 2013, NAT NANOTECHNOL, V8, P729, DOI 10.1038/nnano.2013.171; Zhou JJ, 2019, LIGHT-SCI APPL, V8, DOI 10.1038/s41377-019-0192-4; Zhou JJ, 2015, NANOSCALE, V7, P15026, DOI 10.1039/c5nr02979a; Zhuo Z, 2017, CHEM SCI, V8, P5050, DOI 10.1039/c7sc01393k	132	105	106	55	446	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 5	2020	579	7797					41	50		10.1038/s41586-020-2048-8	http://dx.doi.org/10.1038/s41586-020-2048-8			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MD2AZ	32132689				2022-12-28	WOS:000543777300002
J	Kim, E; Kerssemakers, J; Shaltiel, IA; Haering, CH; Dekker, C				Kim, Eugene; Kerssemakers, Jacob; Shaltiel, Indra A.; Haering, Christian H.; Dekker, Cees			DNA-loop extruding condensin complexes can traverse one another	NATURE			English	Article							ORGANIZATION; MODEL	Condensin, a key component of the structure maintenance of chromosome (SMC) protein complexes, has recently been shown to be a motor that extrudes loops of DNA(1). It remains unclear, however, how condensin complexes work together to collectively package DNA into chromosomes. Here we use time-lapse single-molecule visualization to study mutual interactions between two DNA-loop-extruding yeast condensins. We find that these motor proteins, which, individually, extrude DNA in one direction only are able to dynamically change each other's DNA loop sizes, even when far apart. When they are in close proximity, condensin complexes are able to traverse each other and form a loop structure, which we term a Z-loop-three double-stranded DNA helices aligned in parallel with one condensin at each edge. Z-loops can fill gaps left by single loops and can form symmetric dimer motors that pull in DNA from both sides. These findings indicate that condensin may achieve chromosomal compaction using a variety of looping structures. Single-molecule visualization shows that condensin-a motor protein that extrudes DNA in one direction only-can encounter and pass a second condensin molecule to form a new type of DNA loop that gathers DNA from both sides.	[Kim, Eugene; Kerssemakers, Jacob; Dekker, Cees] Delft Univ Technol, Kavli Inst Nanosci Delft, Dept Bionanosci, Delft, Netherlands; [Shaltiel, Indra A.; Haering, Christian H.] European Mol Biol Lab, Struct & Computat Biol Unit, Cell Biol & Biophys Unit, Heidelberg, Germany	Delft University of Technology; European Molecular Biology Laboratory (EMBL)	Dekker, C (corresponding author), Delft Univ Technol, Kavli Inst Nanosci Delft, Dept Bionanosci, Delft, Netherlands.	C.Dekker@tudelft.nl	Kim, Eugene/ABF-6089-2021	Kim, Eugene/0000-0002-1759-6360; Kerssemakers, Jacob Willem Jozef/0000-0002-6184-7913; Shaltiel, Indra/0000-0002-5673-6741; Haering, Christian/0000-0001-8301-1722	Marie Skodowska-Curie individual fellowship; ERC grant SynDiv [669598]; ERC grant CondStruct [681365]; Netherlands Organization for Scientific Research (NWO/OCW) as part of the Frontiers of Nanoscience and Basyc programs; European Molecular Biology Laboratory (EMBL)	Marie Skodowska-Curie individual fellowship; ERC grant SynDiv; ERC grant CondStruct; Netherlands Organization for Scientific Research (NWO/OCW) as part of the Frontiers of Nanoscience and Basyc programs(Netherlands Organization for Scientific Research (NWO)); European Molecular Biology Laboratory (EMBL)	We thank S. Bravo, J. van der Torre and E. van der Sluis for technical support, and J. Eeftens, M. Ganji, A. Katan, B. Pradhan, B. Rowland, J.-K. Ryu and J. van der Torre for discussions. This work was supported by the Marie Skodowska-Curie individual fellowship (to E.K.), the ERC grants SynDiv 669598 (to C.D.) and CondStruct 681365 (to C.H.H.), the Netherlands Organization for Scientific Research (NWO/OCW) as part of the Frontiers of Nanoscience and Basyc programs, and the European Molecular Biology Laboratory (EMBL).	Alipour E, 2012, NUCLEIC ACIDS RES, V40, P11202, DOI 10.1093/nar/gks925; Banigan EJ, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.031007; Brandao HB, 2019, P NATL ACAD SCI USA, V116, P20489, DOI 10.1073/pnas.1907009116; Capelson M, 2004, BIOL CELL, V96, P617, DOI 10.1016/j.biolcel.2004.06.004; Cattoglio C, 2019, ELIFE, V8, DOI 10.7554/eLife.40164; Eng T, 2015, MOL BIOL CELL, V26, P4224, DOI 10.1091/mbc.E15-06-0331; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Ganji M, 2018, SCIENCE, V360, P102, DOI 10.1126/science.aar7831; Ganji M, 2016, NANO LETT, V16, P4699, DOI 10.1021/acs.nanolett.6b02213; Gibcus JH, 2018, SCIENCE, V359, P652, DOI 10.1126/science.aao6135; Goloborodko A, 2016, ELIFE, V5, DOI 10.7554/eLife.14864; Goloborodko A, 2016, BIOPHYS J, V110, P2162, DOI 10.1016/j.bpj.2016.02.041; Hassler M, 2018, CURR BIOL, V28, pR1266, DOI 10.1016/j.cub.2018.08.034; Ho B, 2018, CELL SYST, V6, P192, DOI 10.1016/j.cels.2017.12.004; Keenholtz RA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14701-5; Kschonsak M, 2017, CELL, V171, P588, DOI 10.1016/j.cell.2017.09.008; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Nolivos S, 2014, FEMS MICROBIOL REV, V38, P380, DOI 10.1111/1574-6976.12045; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Stigler J, 2016, CELL REP, V15, P988, DOI 10.1016/j.celrep.2016.04.003; Terakawa T, 2017, SCIENCE, V358, P672, DOI 10.1126/science.aan6516; Uhlmann F, 2016, NAT REV MOL CELL BIO, V17, P399, DOI 10.1038/nrm.2016.30; van Ruiten MS, 2018, TRENDS GENET, V34, P477, DOI 10.1016/j.tig.2018.03.003; Walther N, 2018, J CELL BIOL, V217, P2309, DOI 10.1083/jcb.201801048; Wang BD, 2005, MOL CELL BIOL, V25, P7216, DOI 10.1128/MCB.25.16.7216-7225.2005; Zhang NG, 2008, J CELL BIOL, V183, P1019, DOI 10.1083/jcb.200801157	28	51	51	0	30	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					438	+		10.1038/s41586-020-2067-5	http://dx.doi.org/10.1038/s41586-020-2067-5		MAR 2020	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32132705	Green Submitted			2022-12-28	WOS:000518098200004
J	Oliva, EM; Bowe, T; Manhapra, A; Kertesz, S; Hah, JM; Henderson, P; Robinson, A; Paik, M; Sandbrink, F; Gordon, AJ; Trafton, JA				Oliva, Elizabeth M.; Bowe, Thomas; Manhapra, Ajay; Kertesz, Stefan; Hah, Jennifer M.; Henderson, Patricia; Robinson, Amy; Paik, Meenah; Sandbrink, Friedhelm; Gordon, Adam J.; Trafton, Jodie A.			Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNITED-STATES; CHRONIC PAIN; USE DISORDER; DRUG; DISCONTINUATION; THERAPY; RISK; EPIDEMIC; SAFETY	OBJECTIVE To examine the associations between stopping treatment with opioids, length of treatment, and death from overdose or suicide in the Veterans Health Administration. DESIGN Observational evaluation. SETTING Veterans Health Administration. PARTICIPANTS 1 394 102 patients in the Veterans Health Administration with an outpatient prescription for an opioid analgesic from fiscal year 2013 to the end of fiscal year 2014 (1 October 2012 to 30 September 2014). MAIN OUTCOME MEASURES A multivariable Cox non-proportional hazards regression model examined death from overdose or suicide, with the interaction of time varying opioid cessation by length of treatment (<= 30, 31-90, 91-400, and >400 days) as the main covariates. Stopping treatment with opioids was measured as the time when a patient was estimated to have no prescription for opioids, up to the end of the next fiscal year (2014) or the patient's death. RESULTS 2887 deaths from overdose or suicide were found. The incidence of stopping opioid treatment was 57.4% (n=799 668) overall, and based on length of opioid treatment was 32.0% (<= 30 days), 8.7% (31-90 days), 22.7% (91-400 days), and 36.6% (>400 days). The interaction between stopping treatment with opioids and length of treatment was significant (P<0.001); stopping treatment was associated with an increased risk of death from overdose or suicide regardless of the length of treatment, with the risk increasing the longer patients were treated. Hazard ratios for patients who stopped opioid treatment (with reference values for all other covariates) were 1.67 (<= 30 days), 2.80 (31-90 days), 3.95 (91-400 days), and 6.77 (>400 days). Descriptive life table data suggested that death rates for overdose or suicide increased immediately after starting or stopping treatment with opioids, with the incidence decreasing over about three to 12 months. CONCLUSIONS Patients were at greater risk of death from overdose or suicide after stopping opioid treatment, with an increase in the risk the longer patients had been treated before stopping. Descriptive data suggested that starting treatment with opioids was also a risk period. Strategies to mitigate the risk in these periods are not currently a focus of guidelines for long term use of opioids. The associations observed cannot be assumed to be causal; the context in which opioid prescriptions were started and stopped might contribute to risk and was not investigated. Safer prescribing of opioids should take a broader view on patient safety and mitigate the risk from the patient's perspective. Factors to address are those that place patients at risk for overdose or suicide after beginning and stopping opioid treatment, especially in the first three months.	[Oliva, Elizabeth M.; Bowe, Thomas; Henderson, Patricia; Paik, Meenah; Trafton, Jodie A.] Vet Affairs Off Mental Hlth & Suicide Prevent, Vet Affairs Program, Evaluat & Resource Ctr, Menlo Pk, CA 94025 USA; [Oliva, Elizabeth M.; Bowe, Thomas; Trafton, Jodie A.] Vet Affairs Palo Alto Hlth Care Syst, Vet Affairs Ctr Innovat Implementat, 795 Willow Rd,Bldg 324, Menlo Pk, CA 94025 USA; [Manhapra, Ajay] Vet Affairs Hampton Med Ctr, Adv PACT Pain Clin, Hampton, VA USA; [Manhapra, Ajay] Yale Sch Med, Dept Psychiat, New Haven, CT USA; [Manhapra, Ajay] New England MIRECC, West Haven, CT USA; [Manhapra, Ajay] Eastern Virginia Med Sch, Dept Phys Med, Norfolk, VA 23501 USA; [Manhapra, Ajay] Eastern Virginia Med Sch, Dept Rehabil & Psychiat, Norfolk, VA 23501 USA; [Kertesz, Stefan] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; [Kertesz, Stefan] Univ Alabama Birmingham, Med Sch Birmingham, Birmingham, AL USA; [Hah, Jennifer M.] Stanford Univ, Dept Anesthesiol Perioperat & Pain Med, Div Pain Med, Stanford, CA 94305 USA; [Robinson, Amy] Vet Affairs Sierra Pacific Network, Pharm Serv, Palo Alto, CA USA; [Sandbrink, Friedhelm] Vet Hlth Adm, Natl Pain Management Program, Washington, DC USA; [Sandbrink, Friedhelm] Washington DC Vet Affairs Med Ctr, Dept Neurol, Washington, DC USA; [Sandbrink, Friedhelm] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA; [Sandbrink, Friedhelm] George Washington Univ, Washington, DC USA; [Gordon, Adam J.] Program Addict Res Clin Care Knowledge & Advocacy, Salt Lake City, UT USA; [Gordon, Adam J.] Univ Utah, Sch Med, Dept Internal Med, Div Epidemiol, Salt Lake City, UT USA; [Gordon, Adam J.] Vet Affairs Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci Ctr IDEAS, Salt Lake City, UT USA; [Trafton, Jodie A.] Stanford Univ, Dept Psychiat, Sch Med, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Yale University; Eastern Virginia Medical School; Eastern Virginia Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Uniformed Services University of the Health Sciences - USA; George Washington University; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Stanford University	Oliva, EM (corresponding author), Vet Affairs Off Mental Hlth & Suicide Prevent, Vet Affairs Program, Evaluat & Resource Ctr, Menlo Pk, CA 94025 USA.; Oliva, EM (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Vet Affairs Ctr Innovat Implementat, 795 Willow Rd,Bldg 324, Menlo Pk, CA 94025 USA.	elizabeth.oliva@va.gov	Gordon, Adam Joseph/AAX-9001-2020	Gordon, Adam Joseph/0000-0002-2453-8871; Hah, Jennifer/0000-0002-9739-3968	Veterans Affairs Office of Mental Health and Suicide Prevention	Veterans Affairs Office of Mental Health and Suicide Prevention	This project was supported by the Veterans Affairs Office of Mental Health and Suicide Prevention but the contents of this work do not represent the views of the Veterans Affairs or the US government.	Amour M., 2017, CENTRAL MAINE PATIEN; Bohnert ASB, 2019, NEW ENGL J MED, V380, P71, DOI 10.1056/NEJMra1802148; Bohnert ASB, 2018, ANN INTERN MED, V169, P367, DOI 10.7326/M18-1243; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Borucka J., 2014, EKONOMETRIA, V45, P85, DOI DOI 10.15611/EKT.2014.3.07; Breckenridge J, 2003, J PAIN, V4, P344, DOI 10.1016/S1526-5900(03)00638-2; Centers for Disease Control and Prevention, 2019, CALC TOT DAIL DOS OP; Centers for Medicare and Medicaid Services, 2017, CTR MED MED SERV CMS; CROWLEY J, 1977, J AM STAT ASSOC, V72, P27, DOI 10.2307/2286902; Davis C., 2017, STATE STATE SUMMARY; de Heer EW, 2020, GEN HOSP PSYCHIAT, V63, P54, DOI 10.1016/j.genhosppsych.2018.11.005; Demidenko MI, 2017, GEN HOSP PSYCHIAT, V47, P29, DOI 10.1016/j.genhosppsych.2017.04.011; Dowell D, 2019, JAMA-J AM MED ASSOC, V322, P1855, DOI 10.1001/jama.2019.16409; Dowell D, 2019, NEW ENGL J MED, V380, P2285, DOI 10.1056/NEJMp1904190; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Frank JW, 2017, ANN INTERN MED, V167, P181, DOI 10.7326/M17-0598; Fulton-Kehoe D, 2015, MED CARE, V53, P679, DOI 10.1097/MLR.0000000000000384; Garcia MC, 2016, MMWR-MORBID MORTAL W, V65, P1125, DOI 10.15585/mmwr.mm6541a1; Gellad WF, 2017, JAMA INTERN MED, V177, P611, DOI 10.1001/jamainternmed.2017.0147; Glanz JM, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.2613; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Hadlandsmyth K, 2018, J GEN INTERN MED, V33, P818, DOI 10.1007/s11606-017-4283-8; Ilgen MA, 2008, GEN HOSP PSYCHIAT, V30, P521, DOI 10.1016/j.genhosppsych.2008.09.003; James JR, 2019, J GEN INTERN MED, V34, P2749, DOI 10.1007/s11606-019-05301-2; Jawad I, 2018, THER ADV PSYCHOPHARM, V8, P349, DOI 10.1177/2045125318804364; Kertesz SG, 2017, SUBST ABUS, V38, P3, DOI 10.1080/08897077.2016.1261070; Lin LWA, 2017, PAIN, V158, P833, DOI 10.1097/j.pain.0000000000000837; Lovejoy TI, 2017, PAIN, V158, P526, DOI 10.1097/j.pain.0000000000000796; Mark TL, 2019, J SUBST ABUSE TREAT, V103, P58, DOI 10.1016/j.jsat.2019.05.001; Martins SS, 2017, JAMA PSYCHIAT, V74, P445, DOI 10.1001/jamapsychiatry.2017.0113; Meara E, 2016, NEW ENGL J MED, V375, P44, DOI 10.1056/NEJMsa1514387; Midboe AM, 2012, TRANSL BEHAV MED, V2, P57, DOI 10.1007/s13142-011-0104-5; Mokdad AH, 2018, JAMA-J AM MED ASSOC, V319, P1444, DOI 10.1001/jama.2018.0158; Murthy VH, 2016, NEW ENGL J MED, V375, P2413, DOI 10.1056/NEJMp1612578; Oliva EM, 2017, PSYCHOL SERV, V14, P34, DOI 10.1037/ser0000099; Racine M, 2018, PROG NEURO-PSYCHOPH, V87, P269, DOI 10.1016/j.pnpbp.2017.08.020; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Saha TD, 2016, J CLIN PSYCHIAT, V77, P772, DOI 10.4088/JCP.15m10386; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Sullivan MD, 2006, ARCH INTERN MED, V166, P2087, DOI 10.1001/archinte.166.19.2087; The Opioid Therapy for Chronic Pain Work Group, 2017, VA DOD CLIN PRACT GU; US Department of Health and Human Services, 2019, HHS GUID CLIN APPR D; Wilson M., P MIDW SAS US GROUP; Zedler B, 2014, PAIN MED, V15, P1911, DOI 10.1111/pme.12480	45	86	86	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2020	368								m283	10.1136/bmj.m283	http://dx.doi.org/10.1136/bmj.m283			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU2KE	32131996	hybrid, Green Published			2022-12-28	WOS:000519536600001
J	Masanet, E; Shehabi, A; Lei, N; Smith, S; Koomey, J				Masanet, Eric; Shehabi, Arman; Lei, Nuoa; Smith, Sarah; Koomey, Jonathan			Recalibrating global data center energy-use estimates	SCIENCE			English	Editorial Material									[Masanet, Eric; Lei, Nuoa] Northwestern Univ, McCormick Sch Engn & Appl Sci, Evanston, IL 60208 USA; [Masanet, Eric] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Shehabi, Arman; Smith, Sarah] Lawrence Berkeley Natl Lab, Energy Technol Area, Berkeley, CA USA; [Koomey, Jonathan] Koomey Analyt, Burlingame, CA USA	Northwestern University; University of California System; University of California Santa Barbara; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Masanet, E (corresponding author), Northwestern Univ, McCormick Sch Engn & Appl Sci, Evanston, IL 60208 USA.; Masanet, E (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	eric.masanet@northwestern.edu	Koomey, Jonathan/AAR-6685-2021; Shehabi, Arman/AAY-4097-2021	Koomey, Jonathan/0000-0002-2983-344X; Shehabi, Arman/0000-0002-1735-6973	U.S. Department of Energy (DOE)Advanced Manufacturing Office; Office of Science of the DOE;  [DE-AC02-05CH11231]	U.S. Department of Energy (DOE)Advanced Manufacturing Office(United States Department of Energy (DOE)); Office of Science of the DOE(United States Department of Energy (DOE)); 	This material includes work conducted by Lawrence Berkeley National Laboratory (LBNL) with support from the U.S. Department of Energy (DOE)Advanced Manufacturing Office. LBNL is supported by the Office of Science of the DOE and operated under contract grant No.DE-AC02-05CH11231. E.M. and N.L. are grateful for financial support provided by Leslie and Mac McQuown. The global data center analysis modeling file with all data inputs, results, methodological notes, figures, discussion of uncertainties, and sources is available on GitHub (doi: 10.5281/zenodo.3668743).	Andrae AS, 2015, CHALLENGES, V6, P117, DOI [10.3390/challe6010117, DOI 10.3390/CHALLE6010117]; Avgerinou M, 2017, ENERGIES, V10, DOI 10.3390/en10101470; Bawdy T., 2016, INDEPENDENT; Belkhir L, 2018, J CLEAN PROD, V177, P448, DOI 10.1016/j.jclepro.2017.12.239; Cisco, 2018, CISC VIS NETW IND GL; Fuchs H, 2020, ENERG EFFIC, V13, P379, DOI 10.1007/s12053-019-09809-8; IEA I.E.A., 2017, DIG EN; International Energy Agency, 2019, TRACK CLEAN EN PROGR; Jones N, 2018, NATURE, V561, P163, DOI 10.1038/d41586-018-06610-y; Koomey J., 2011, REPORT ANAL PRESS CO, V9, P161; Masanet E, 2013, NAT CLIM CHANGE, V3, P627, DOI [10.1038/nclimate1786, 10.1038/NCLIMATE1786]; Masanet ER, 2011, P IEEE, V99, P1440, DOI 10.1109/JPROC.2011.2155610; Shehabi A, 2016, US DATA CTR ENERGY U; Shehabi A, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaec9c; Wagner B., 2018, INTERGENERATIONAL EN	15	196	200	31	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2020	367	6481					984	986		10.1126/science.aba3758	http://dx.doi.org/10.1126/science.aba3758			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KS0CO	32108103				2022-12-28	WOS:000517979600023
J	Mons, B				Mons, Barend			Invest 5% of research funds in ensuring data are reusable	NATURE			English	Editorial Material									[Mons, Barend] Leiden Univ, Med Ctr, Leiden, Netherlands; [Mons, Barend] Leiden Ctr Data Sci, Leiden, Netherlands; [Mons, Barend] GO FAIR, Leiden, Netherlands; [Mons, Barend] Int Sci Councils Comm Data, Paris, France	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Mons, B (corresponding author), Leiden Univ, Med Ctr, Leiden, Netherlands.; Mons, B (corresponding author), Leiden Ctr Data Sci, Leiden, Netherlands.; Mons, B (corresponding author), GO FAIR, Leiden, Netherlands.; Mons, B (corresponding author), Int Sci Councils Comm Data, Paris, France.	barend.mons@go-fair.org							0	18	18	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2020	578	7796					491	491		10.1038/d41586-020-00505-7	http://dx.doi.org/10.1038/d41586-020-00505-7			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MD1WC	32099131	Bronze, Green Submitted			2022-12-28	WOS:000543764400001
J	Lawrie, E				Lawrie, Evelyn			How can I explain my high blood pressure to you?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2020	368								m443	10.1136/bmj.m443	http://dx.doi.org/10.1136/bmj.m443			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2JV	32102831	Bronze			2022-12-28	WOS:000519535600002
J	Abbas, YM; Wu, D; Bueler, SA; Robinson, CV; Rubinstein, JL				Abbas, Yazan M.; Wu, Di; Bueler, Stephanie A.; Robinson, Carol V.; Rubinstein, John L.			Structure of V-ATPase from the mammalian brain	SCIENCE			English	Article							VACUOLAR H+-ATPASE; CRYSTAL-STRUCTURE; CRYO-EM; SYNAPTIC VESICLES; MOLECULAR-CLONING; ATOMIC MODEL; SUBUNIT; PROTEIN; ACIDIFICATION; V-1-ATPASE	In neurons, the loading of neurotransmitters into synaptic vesicles uses energy from proton-pumping vesicular- or vacuolar-type adenosine triphosphatases (V-ATPases). These membrane protein complexes possess numerous subunit isoforms, which complicates their analysis. We isolated homogeneous rat brain V-ATPase through its interaction with SidK, a Legionella pneumophila effector protein. Cryoelectron microscopy allowed the construction of an atomic model, defining the enzyme's ATP:proton ratio as 3:10 and revealing a homolog of yeast subunit f in the membrane region, which we tentatively identify as RNAseK. The c ring encloses the transmembrane anchors for cleaved ATP6AP1/Ac45 and ATP6AP2/PRR, the latter of which is the (pro)renin receptor that, in other contexts, is involved in both Wnt signaling and the renin-angiotensin system that regulates blood pressure. This structure shows how ATP6AP1/Ac45 and ATP6AP2/PRR enable assembly of the enzyme's catalytic and membrane regions.	[Abbas, Yazan M.; Bueler, Stephanie A.; Rubinstein, John L.] Hosp Sick Children, Mol Med Program, Res Inst, Toronto, ON M5G 0A4, Canada; [Wu, Di; Robinson, Carol V.] Univ Oxford, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; [Rubinstein, John L.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Rubinstein, John L.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Oxford; University of Toronto; University of Toronto	Rubinstein, JL (corresponding author), Hosp Sick Children, Mol Med Program, Res Inst, Toronto, ON M5G 0A4, Canada.; Rubinstein, JL (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada.; Rubinstein, JL (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.	john.rubinstein@utoronto.ca	Wu, Di/AAF-2276-2020; Voelker, Antje H L/C-5427-2012	Voelker, Antje H L/0000-0001-6465-6023; Rubinstein, John/0000-0003-0566-2209; robinson, carol/0000-0001-7829-5505	Canadian Institutes of Health Research [PJT166152]; European Research Council [69551-ENABLE]; Wellcome Trust [104633/Z/14/Z]; Restracomp fellowship; Canada Research Chairs program; Canada Foundation for Innovation; Ontario Research Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Restracomp fellowship; Canada Research Chairs program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Research Fund	This work was supported by the Canadian Institutes of Health Research Grant PJT166152 (J.L.R.), grant 69551-ENABLE from the European Research Council (C.V.R.), and Wellcome Trust Investigator Award 104633/Z/14/Z (C.V.R.). Y.M.A. was supported by a Restracomp fellowship and a Canadian Institutes of Health Research Postdoctoral fellowship. J.L.R. was supported by the Canada Research Chairs program. Cryo-EM data was collected at the Toronto High-Resolution High-Throughput cryo-EM facility, supported by the Canada Foundation for Innovation and Ontario Research Fund.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Ahmed S, 2013, NAT PROTOC, V8, P998, DOI 10.1038/nprot.2013.053; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; BAUERLE C, 1993, J BIOL CHEM, V268, P12749; Blake-Palmer KG, 2007, GENE, V393, P94, DOI 10.1016/j.gene.2007.01.020; Bodzeta A, 2017, CELL REP, V20, P1348, DOI 10.1016/j.celrep.2017.07.040; Bueler SA, 2015, BIOCHEMISTRY-US, V54, P853, DOI 10.1021/bi5013172; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Burckle C, 2006, HYPERTENSION, V48, P549, DOI 10.1161/01.HYP.0000241132.48495.df; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cousin C, 2009, HYPERTENSION, V53, P1077, DOI 10.1161/HYPERTENSIONAHA.108.127258; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; DOHERTY RD, 1993, J BIOL CHEM, V268, P16845; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; Economopoulou MAI, 2007, NUCLEIC ACIDS RES, V35, P6389, DOI 10.1093/nar/gkm718; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farsi Z, 2018, ELIFE, V7, DOI 10.7554/eLife.32569; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Graham LA, 1998, J CELL BIOL, V142, P39, DOI 10.1083/jcb.142.1.39; Guida MC, 2018, MOL BIOL CELL, V29, P2156, DOI 10.1091/mbc.E18-04-0234; Guo H, 2019, ELIFE, V8, DOI 10.7554/eLife.43128; Guo H, 2017, SCIENCE, V358, P936, DOI 10.1126/science.aao4815; Hackett BA, 2015, P NATL ACAD SCI USA, V112, P7797, DOI 10.1073/pnas.1424098112; Hahn A, 2018, SCIENCE, V360, P620, DOI 10.1126/science.aat4318; Huss M, 2007, FEBS LETT, V581, P5566, DOI 10.1016/j.febslet.2007.11.004; Ichihara A, 2019, NAT REV NEPHROL, V15, P693, DOI 10.1038/s41581-019-0160-5; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jansen EJR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11600; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; LHuillier N., 2006, LOCAL CARDIAC RENIN, P17; Louagie E, 2008, P NATL ACAD SCI USA, V105, P12319, DOI 10.1073/pnas.0800340105; Ludwig J, 1998, J BIOL CHEM, V273, P10939, DOI 10.1074/jbc.273.18.10939; Marr CR, 2014, J STRUCT BIOL, V185, P42, DOI 10.1016/j.jsb.2013.11.002; Mazhab-Jafari MT, 2016, NATURE, V539, P118, DOI 10.1038/nature19828; Meyerson JR, 2014, SCI REP-UK, V4, DOI 10.1038/srep07084; Murata Y, 2002, J BIOL CHEM, V277, P36296, DOI 10.1074/jbc.M200586200; Murphy BJ, 2019, SCIENCE, V364, P1155, DOI 10.1126/science.aaw9128; Nagamatsu Y, 2013, J MOL BIOL, V425, P2699, DOI 10.1016/j.jmb.2013.04.022; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; NICHOLLS DG, 2013, BIOENERGETICS; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Oot RA, 2016, EMBO J, V35, P1694, DOI 10.15252/embj.201593447; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Pareja F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05886-y; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Perreira JM, 2015, CELL REP, V12, P850, DOI 10.1016/j.celrep.2015.06.076; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rampias TN, 2003, NUCLEIC ACIDS RES, V31, P3092, DOI 10.1093/nar/gkg414; Roh SH, 2018, MOL CELL, V69, P993, DOI 10.1016/j.molcel.2018.02.006; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rubinstein JL, 2015, J STRUCT BIOL, V192, P188, DOI 10.1016/j.jsb.2015.08.007; Russo CJ, 2014, SCIENCE, V346, P1377, DOI 10.1126/science.1259530; Ryan M, 2008, MOL BIOL CELL, V19, P5131, DOI 10.1091/mbc.E08-06-0629; Sambade M, 2004, J BIOL CHEM, V279, P17361, DOI 10.1074/jbc.M314104200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Suzuki K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13235; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tivol WF, 2008, MICROSC MICROANAL, V14, P375, DOI 10.1017/S1431927608080781; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Vasanthakumar T, 2019, P NATL ACAD SCI USA, V116, P7272, DOI 10.1073/pnas.1814818116; Wang RYR, 2016, ELIFE, V5, DOI 10.7554/eLife.17219; Watanabe S, 2014, NATURE, V515, P228, DOI 10.1038/nature13846; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; Zhao JH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006394; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365; Zhou L, 2019, SCIENCE, V365, P773, DOI 10.1126/science.aaw9144; Zhou ZM, 1999, J BIOL CHEM, V274, P15913, DOI 10.1074/jbc.274.22.15913; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	78	78	78	7	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1240	+		10.1126/science.aaz2924	http://dx.doi.org/10.1126/science.aaz2924			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9DP	32165585	Green Accepted, Green Submitted			2022-12-28	WOS:000520023800040
J	Bohossian, HB; Lopes, EW; Roller, LA; Ananthakrishnan, AN; Zukerberg, LR				Bohossian, Hacho B.; Lopes, Emily W.; Roller, Lauren A.; Ananthakrishnan, Ashwin N.; Zukerberg, Lawrence R.			Case 8-2020: An 89-Year-Old Man with Recurrent Abdominal Pain and Bloody Stools	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; CYTOMEGALOVIRUS-INFECTION; CLOSTRIDIUM-DIFFICILE; RISK-FACTORS; OUTCOMES; IMPACT; EMBOLIZATION; MORTALITY	An 89-year-old man was evaluated for recurrent abdominal pain and bloody stools. During the previous 4 months, he had been hospitalized three times for the same symptoms. Diverticulosis and Clostridioides difficile colitis had been diagnosed, but despite treatment, symptoms persisted. After a fourth admission, a diagnosis was made.	[Bohossian, Hacho B.] Newton Wellesley Hosp, Dept Med, Newton, MA 02462 USA; [Bohossian, Hacho B.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Lopes, Emily W.; Ananthakrishnan, Ashwin N.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Roller, Lauren A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Zukerberg, Lawrence R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Lopes, Emily W.; Ananthakrishnan, Ashwin N.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Roller, Lauren A.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA	Newton Wellesley Hospital; Tufts University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Bohossian, HB (corresponding author), Newton Wellesley Hosp, Dept Med, Newton, MA 02462 USA.; Bohossian, HB (corresponding author), Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA.		Roller, Lauren/AAN-3134-2021; Lopes, Emily/AGE-4429-2022	Lopes, Emily/0000-0002-7081-2376				Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Ananthakrishnan AN, 2016, J CROHNS COLITIS, V10, P1224, DOI 10.1093/ecco-jcc/jjw054; Ananthakrishnan AN, 2009, INFLAMM BOWEL DIS, V15, P182, DOI 10.1002/ibd.20628; Cambier J, 2005, IMMUNOL REV, V205, P5, DOI 10.1111/j.0105-2896.2005.00276.x; Cesarini M, 2017, J CROHNS COLITIS, V11, P335, DOI 10.1093/ecco-jcc/jjw159; Chan KS, 2016, J MICROBIOL IMMUNOL, V49, P829, DOI 10.1016/j.jmii.2015.12.007; Charpentier C, 2014, GUT, V63, P423, DOI 10.1136/gutjnl-2012-303864; Clayton EM, 2009, AM J GASTROENTEROL, V104, P1162, DOI 10.1038/ajg.2009.4; Clos-Parals A, 2019, J CROHNS COLITIS, V13, P385, DOI 10.1093/ecco-jcc/jjy173; Cowan AJ, 2013, HAEMATOLOGICA, V98, P141, DOI 10.3324/haematol.2012.068155; Delvincourt M, 2014, ALIMENT PHARM THER, V39, P712, DOI 10.1111/apt.12650; Domenech E, 2008, INFLAMM BOWEL DIS, V14, P1373, DOI 10.1002/ibd.20498; Goodhand JR, 2011, ALIMENT PHARM THER, V33, P428, DOI 10.1111/j.1365-2036.2010.04548.x; Horiki N, 2015, J INFECT CHEMOTHER, V21, P444, DOI 10.1016/j.jiac.2015.02.004; Issa M, 2007, CLIN GASTROENTEROL H, V5, P345, DOI 10.1016/j.cgh.2006.12.028; Kandiel A, 2006, AM J GASTROENTEROL, V101, P2857, DOI 10.1111/j.1572-0241.2006.00869.x; Kaplan GG, 2008, GASTROENTEROLOGY, V134, P680, DOI 10.1053/j.gastro.2008.01.004; Kedia S, 2018, INTEST RES, V16, P194, DOI 10.5217/ir.2018.16.2.194; Kim JJ, 2010, DIGEST DIS SCI, V55, P1059, DOI 10.1007/s10620-010-1126-4; Kristensen SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056944; Kronzon I, 2010, CIRCULATION, V122, P631, DOI 10.1161/CIRCULATIONAHA.109.886465; Lawlor G, 2010, INFLAMM BOWEL DIS, V16, P1620, DOI 10.1002/ibd.21275; Liao XY, 2016, GASTROENTEROL RES, V9, P92, DOI 10.14740/gr725e; Matsuoka K, 2007, AM J GASTROENTEROL, V102, P331, DOI 10.1111/j.1572-0241.2006.00989.x; Moolenaar W, 1996, GUT, V38, P196, DOI 10.1136/gut.38.2.196; Mylonaki M, 2004, EUR J GASTROEN HEPAT, V16, P775, DOI 10.1097/01.meg.0000131040.38607.09; Nguyen GC, 2017, INFLAMM BOWEL DIS, V23, P218, DOI 10.1097/MIB.0000000000000993; Papadakis KA, 2001, AM J GASTROENTEROL, V96, P2137, DOI 10.1111/j.1572-0241.2001.03949.x; Pillet S, 2016, WORLD J GASTROENTERO, V22, P2030, DOI 10.3748/wjg.v22.i6.2030; Pillet S, 2015, INFLAMM BOWEL DIS, V21, P1580, DOI 10.1097/MIB.0000000000000412; Qu ZH, 2009, HUM PATHOL, V40, P572, DOI 10.1016/j.humpath.2008.10.008; Rai TR, 2015, GASTROENTEROL REP, V3, P115, DOI 10.1093/gastro/gou082; Rubin DT, 2019, AM J GASTROENTEROL, V114, P384, DOI 10.14309/ajg.0000000000000152; Sager K, 2015, ALIMENT PHARM THER, V41, P725, DOI 10.1111/apt.13124; Shukla T, 2015, INFLAMM BOWEL DIS, V21, P2718, DOI 10.1097/MIB.0000000000000489; Singh R, 2015, INDIAN J PATHOL MICR, V58, P427, DOI 10.4103/0377-4929.168880; Toruner M, 2008, GASTROENTEROLOGY, V134, P929, DOI 10.1053/j.gastro.2008.01.012; Travis SPL, 1996, GUT, V38, P905, DOI 10.1136/gut.38.6.905; Tursi A, 2010, COLORECTAL DIS, V12, P464, DOI 10.1111/j.1463-1318.2009.01969.x; Zezos P, 2014, WORLD J GASTROENTERO, V20, P13863, DOI 10.3748/wjg.v20.i38.13863	40	0	0	2	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2020	382	11					1042	1052		10.1056/NEJMcpc1913476	http://dx.doi.org/10.1056/NEJMcpc1913476			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU7TA	32160667				2022-12-28	WOS:000519914300011
J	[Anonymous]				[Anonymous]			Covid-19: What's the current advice for UK doctors? (vol 368, m978, 2020)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		Rimmer A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m978	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2020	368								m991	10.1136/bmj.m991	http://dx.doi.org/10.1136/bmj.m991			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AR	32161035	Bronze			2022-12-28	WOS:000520012800013
J	[Anonymous]				[Anonymous]			Alcohol and School Physiologies (Reprinted from vol 34, pg 624, 1900)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		ATWATER, 1900, JAMA-J AM MED ASSOC, V34, P624	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2020	323	10					1004	1004		10.1001/jama.2019.13345	http://dx.doi.org/10.1001/jama.2019.13345			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KW1LV	32154850				2022-12-28	WOS:000520933900017
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: GP surgeries close for two weeks after staff test positive	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, PIRATE FM        FEB; [Anonymous], 2020, 4 MARCH 2020 COR UPD; Chelston Hall Surgery, IMP NOT ALL PAT; MAHASE E, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M611; Mid Essex Clinical Commissioning Group, 2020, UPD MOUNT CHAMB SURG; Nixon A., ROMSEY ADVERTIS 0227	6	1	2	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2020	368								m936	10.1136/bmj.m936	http://dx.doi.org/10.1136/bmj.m936			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2LJ	32144111	Bronze			2022-12-28	WOS:000519539700011
J	Sjostedt, E; Zhong, W; Fagerberg, L; Karlsson, M; Mitsios, N; Adori, C; Oksvold, P; Edfors, F; Limiszewska, A; Hikmet, F; Huang, JR; Du, YT; Lin, L; Dong, ZY; Yang, L; Liu, X; Jiang, H; Xu, X; Wang, J; Yang, HM; Bolund, L; Mardinoglu, A; Zhang, C; von Feilitzen, K; Lindskog, C; Ponten, F; Luo, YL; Hokfelt, T; Uhlen, M; Mulder, J				Sjostedt, Evelina; Zhong, Wen; Fagerberg, Linn; Karlsson, Max; Mitsios, Nicholas; Adori, Csaba; Oksvold, Per; Edfors, Fredrik; Limiszewska, Agnieszka; Hikmet, Feria; Huang, Jinrong; Du, Yutao; Lin, Lin; Dong, Zhanying; Yang, Ling; Liu, Xin; Jiang, Hui; Xu, Xun; Wang, Jian; Yang, Huanming; Bolund, Lars; Mardinoglu, Adil; Zhang, Cheng; von Feilitzen, Kalle; Lindskog, Cecilia; Ponten, Fredrik; Luo, Yonglun; Hokfelt, Tomas; Uhlen, Mathias; Mulder, Jan			An atlas of the protein-coding genes in the human, pig, and mouse brain	SCIENCE			English	Article							TYROSINE-HYDROXYLASE; EXPRESSION; RECEPTOR; NEURONS; PROMOTER; SYSTEM; CELLS; PITX3	The brain, with its diverse physiology and intricate cellular organization, is the most complex organ of the mammalian body. To expand our basic understanding of the neurobiology of the brain and its diseases, we performed a comprehensive molecular dissection of 10 major brain regions and multiple subregions using a variety of transcriptomics methods and antibody-based mapping. This analysis was carried out in the human, pig, and mouse brain to allow the identification of regional expression profiles, as well as to study similarities and differences in expression levels between the three species. The resulting data have been made available in an open-access Brain Atlas resource, part of the Human Protein Atlas, to allow exploration and comparison of the expression of individual protein-coding genes in various parts of the mammalian brain.	[Sjostedt, Evelina; Mitsios, Nicholas; Adori, Csaba; Limiszewska, Agnieszka; Hokfelt, Tomas; Uhlen, Mathias; Mulder, Jan] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Sjostedt, Evelina; Zhong, Wen; Fagerberg, Linn; Karlsson, Max; Oksvold, Per; Edfors, Fredrik; Mardinoglu, Adil; Zhang, Cheng; von Feilitzen, Kalle; Uhlen, Mathias] KTH Royal Inst Technol, Dept Prot Sci, Sci Life Lab, S-17121 Stockholm, Sweden; [Hikmet, Feria; Lindskog, Cecilia; Ponten, Fredrik] Uppsala Univ, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden; [Huang, Jinrong; Lin, Lin; Dong, Zhanying; Yang, Ling; Bolund, Lars; Luo, Yonglun] BGI Qingdao, Lars Bolund Inst Regenerat Med, Qingdao 266555, Peoples R China; [Huang, Jinrong; Du, Yutao; Dong, Zhanying; Yang, Ling; Liu, Xin; Xu, Xun; Wang, Jian; Yang, Huanming; Bolund, Lars; Luo, Yonglun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Huang, Jinrong; Lin, Lin; Dong, Zhanying; Yang, Ling; Bolund, Lars; Luo, Yonglun] Aarhus Univ, Dept Biomed, DK-80000 Aarhus, Denmark; [Huang, Jinrong] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen, Denmark; [Du, Yutao; Liu, Xin; Xu, Xun; Wang, Jian; Yang, Huanming] BGI Shenzhen, China Natl GeneBank, Shenzhen 518083, Peoples R China; [Jiang, Hui] BGI Shenzhen, MGI, Shenzhen 518083, Peoples R China	Karolinska Institutet; Royal Institute of Technology; Uppsala University; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Aarhus University; University of Copenhagen; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI)	Uhlen, M; Mulder, J (corresponding author), Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.; Uhlen, M (corresponding author), KTH Royal Inst Technol, Dept Prot Sci, Sci Life Lab, S-17121 Stockholm, Sweden.	mathias.uhlen@scilifelab.se; jan.mulder@ki.se	Zhang, Cheng/L-7906-2016; Xu, Xun/AAI-6763-2020; Lindskog, Cecilia/AAO-2441-2021; Mulder, Jan/G-3909-2011; Mardinoglu, Adil/AAS-6360-2021; Hikmet, Feria/AAX-4474-2021; Mulder, Jan/AAG-9761-2021; Edfors, Fredrik/ABA-4429-2021; Uhlen, Mathias/AAV-8746-2021; Huang, Jinrong/AAV-1225-2021; Luo, Yonglun/C-4708-2013	Zhang, Cheng/0000-0002-3721-8586; Xu, Xun/0000-0002-5338-5173; Mulder, Jan/0000-0003-3717-5018; Hikmet, Feria/0000-0002-3750-9308; Edfors, Fredrik/0000-0002-0017-7987; Huang, Jinrong/0000-0001-8085-9939; Liu, Xin/0000-0003-3256-2940; Mitsios, Nicholas/0000-0001-6243-4953; Karlsson, Max Jonatan/0000-0002-7000-4416; Zhong, Wen/0000-0002-7422-6104; Luo, Yonglun/0000-0002-0007-7759	Knut and Alice Wallenberg Foundation (WCPR); Erling Persson Foundation (KCAP); Sanming Project of Medicine in Shenzhen [SZSM201612074]; Lundbeck Foundation [R219-2016-1375]; DFF Sapere Aude Starting grant [8048-00072A]	Knut and Alice Wallenberg Foundation (WCPR); Erling Persson Foundation (KCAP); Sanming Project of Medicine in Shenzhen; Lundbeck Foundation(Lundbeckfonden); DFF Sapere Aude Starting grant	Main funding was provided by the Knut and Alice Wallenberg Foundation (WCPR) and the Erling Persson Foundation (KCAP). The pig atlas part is supported by Sanming Project of Medicine in Shenzhen (SZSM201612074). L.L. is supported by the Lundbeck Foundation (R219-2016-1375) and the DFF Sapere Aude Starting grant (8048-00072A).	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bhattacharya S, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.15; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Chantoux F, 2002, MOL CELL ENDOCRINOL, V194, P157, DOI 10.1016/S0303-7207(02)00133-8; Coate JE, 2015, CHROMOSOMA, V124, P27, DOI 10.1007/s00412-014-0496-3; Corvol JC, 2001, J NEUROCHEM, V76, P1585, DOI 10.1046/j.1471-4159.2001.00201.x; Daws LC, 2011, PHARMACOL THERAPEUT, V131, P61, DOI 10.1016/j.pharmthera.2011.03.013; Deneris ES, 2014, NAT NEUROSCI, V17, P899, DOI 10.1038/nn.3731; Ecker JR, 2017, NEURON, V96, P542, DOI 10.1016/j.neuron.2017.10.007; Gonda X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12776-8; Grailhe R, 2001, EUR J PHARMACOL, V418, P157, DOI 10.1016/S0014-2999(01)00933-5; Grailhe R, 1999, NEURON, V22, P581, DOI 10.1016/S0896-6273(00)80712-6; Guo HL, 2000, BIOCHEM BIOPH RES CO, V273, P661, DOI 10.1006/bbrc.2000.2870; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hodge RD, 2019, NATURE, V573, P61, DOI 10.1038/s41586-019-1506-7; Jean D, 1999, MECH DEVELOP, V84, P31, DOI 10.1016/S0925-4773(99)00068-4; Joshi PS, 2008, NEURON, V60, P258, DOI 10.1016/j.neuron.2008.08.006; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; KAUFMAN DL, 1995, J BIOL CHEM, V270, P15877, DOI 10.1074/jbc.270.26.15877; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kelley KW, 2018, NAT NEUROSCI, V21, P1171, DOI 10.1038/s41593-018-0216-z; KIM JW, 2014, PLOS ONE, V9; Lake BB, 2018, NAT BIOTECHNOL, V36, P70, DOI 10.1038/nbt.4038; Lebel M, 2001, J NEUROCHEM, V77, P558, DOI 10.1046/j.1471-4159.2001.00257.x; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Markram H, 2012, SCI AM, V306, P50, DOI 10.1038/scientificamerican0612-50; McInnes L., 2018, ARXIV180203426STATML; MEZEY E, 1989, P NATL ACAD SCI USA, V86, P347, DOI 10.1073/pnas.86.1.347; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Mizushima K, 2000, GENOMICS, V69, P314, DOI 10.1006/geno.2000.6340; Moraes MN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13939-3; Mortensen M, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00001; Mulder J, 2009, P NATL ACAD SCI USA, V106, P22492, DOI 10.1073/pnas.0912484106; Mulder J, 2009, MOL CELL PROTEOMICS, V8, P1612, DOI 10.1074/mcp.M800539-MCP200; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Noguchi S, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.112; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Peng JS, 2012, DRUG ALCOHOL DEPEN, V124, P223, DOI 10.1016/j.drugalcdep.2012.01.013; Puskas N, 2010, PEPTIDES, V31, P1589, DOI 10.1016/j.peptides.2010.04.020; R Core Team, 2018, R LANG ENV STAT COMP; Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041; Renier N, 2016, CELL, V165, P1789, DOI 10.1016/j.cell.2016.05.007; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Sjostedt E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130028; SMITH RL, 1991, BRAIN RES, V548, P140, DOI 10.1016/0006-8993(91)91115-H; Snyder MP, 2019, NATURE, V574, P187, DOI 10.1038/s41586-019-1629-x; SPEARMAN C, 1987, AM J PSYCHOL, V100, P441, DOI 10.2307/1422689; Takahashi H, 2012, METHODS MOL BIOL, V786, P181, DOI 10.1007/978-1-61779-292-2_11; Thompson CL, 2014, NEURON, V83, P309, DOI 10.1016/j.neuron.2014.05.033; Uhlen M, 2019, SCIENCE, V366, P1471, DOI 10.1126/science.aax9198; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Vermunt MW, 2016, NAT NEUROSCI, V19, P494, DOI 10.1038/nn.4229; Zainolabidin N, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00281; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	62	172	173	11	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1090	+	eaay5947	10.1126/science.aay5947	http://dx.doi.org/10.1126/science.aay5947			81	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9CD	32139519				2022-12-28	WOS:000520018400034
J	Wise, J				Wise, Jacqui			The BMJ Awards 2020: Dermatology team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2020	368								m748	10.1136/bmj.m748	http://dx.doi.org/10.1136/bmj.m748			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KI	32139396				2022-12-28	WOS:000519537000004
J	Mazzucato, M; Li, HL; Darzi, A				Mazzucato, Mariana; Li, Henry Lishi; Darzi, Ara			Is it time to nationalise the pharmaceutical industry?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mazzucato, Mariana; Li, Henry Lishi] UCL Inst Innovat & Publ Purpose, London, England; [Darzi, Ara] Imperial Coll London, Inst Global Hlth Innovat, London, England	Imperial College London	Li, HL (corresponding author), UCL Inst Innovat & Publ Purpose, London, England.; Darzi, A (corresponding author), Imperial Coll London, Inst Global Hlth Innovat, London, England.	henry.li@ucl.ac.uk; a.darzi@imperial.ac.uk						Andalo D, 2019, PHARM J; Association of the British Pharmaceutical Industry, 2019, WHAT IS NEW VOL SCHE; Boseley S., 2019, GUARDIAN; Brown D, 2019, MED ALL CASE PUBLIC; Herder M, 2020, J LAW BIOSCI, DOI [10.1093/jlb/lsz019/5706941, DOI 10.1093/JLB/LSZ019/5706941]; Labour Party, 2019, LAB PART MAN 2019, P35; Luo J, 2017, LANCET DIABETES ENDO, V5, P158, DOI 10.1016/S2213-8587(17)30041-4; Mazzoleni R, 1998, J ECON ISSUES, V32, P1031, DOI 10.1080/00213624.1998.11506108; Mazzucato M., 2013, ENTREPRENEURIAL STAT; Mazzucato M, 2018, J ECON POLICY REFORM, P1, DOI [10.1080/13506285.2012.670142, DOI 10.1080/13506285.2012.670142]; Mikulic M., 2019, GLAXOSMITHKLINES EXP; Moon S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001218; Organisation for Economic Co-operation and Development, 2020, PHARM SPEND IND, DOI [10.1787/998febf6-en, DOI 10.1787/998FEBF6-EN]; Pisano GP, 2012, HARVARD BUSINESS SCH; Sitaraman G, 2019, PUBLIC OPTION EXPAND; Sussex J, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0564-z; Tulum O, 2018, INT J POLIT ECON, V47, P281, DOI 10.1080/08911916.2018.1549842; UCL Institute for Innovation and Public Purpose, 2018, PEOPL PRESCR RE IM H; Venier S, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040937	19	8	9	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2020	368								m769	10.1136/bmj.m769	http://dx.doi.org/10.1136/bmj.m769			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KE	32132003	Green Submitted			2022-12-28	WOS:000519536600009
J	Wouters, OJ; McKee, M; Luyten, J				Wouters, Olivier J.; McKee, Martin; Luyten, Jeroen			Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEVELOPMENT SUCCESS RATES; DRUG DEVELOPMENT; DEVELOPMENT COSTS; INNOVATION	Importance The mean cost of developing a new drug has been the subject of debate, with recent estimates ranging from $314 million to $2.8 billion. Objective To estimate the research and development investment required to bring a new therapeutic agent to market, using publicly available data. Design and Setting Data were analyzed on new therapeutic agents approved by the US Food and Drug Administration (FDA) between 2009 and 2018 to estimate the research and development expenditure required to bring a new medicine to market. Data were accessed from the US Securities and Exchange Commission, Drugs@FDA database, and ClinicalTrials.gov, alongside published data on clinical trial success rates. Exposures Conduct of preclinical and clinical studies of new therapeutic agents. Main Outcomes and Measures Median and mean research and development spending on new therapeutic agents approved by the FDA, capitalized at a real cost of capital rate (the required rate of return for an investor) of 10.5% per year, with bootstrapped CIs. All amounts were reported in 2018 US dollars. Results The FDA approved 355 new drugs and biologics over the study period. Research and development expenditures were available for 63 (18%) products, developed by 47 different companies. After accounting for the costs of failed trials, the median capitalized research and development investment to bring a new drug to market was estimated at $985.3 million (95% CI, $683.6 million-$1228.9 million), and the mean investment was estimated at $1335.9 million (95% CI, $1042.5 million-$1637.5 million) in the base case analysis. Median estimates by therapeutic area (for areas with >= 5 drugs) ranged from $765.9 million (95% CI, $323.0 million-$1473.5 million) for nervous system agents to $2771.6 million (95% CI, $2051.8 million-$5366.2 million) for antineoplastic and immunomodulating agents. Data were mainly accessible for smaller firms, orphan drugs, products in certain therapeutic areas, first-in-class drugs, therapeutic agents that received accelerated approval, and products approved between 2014 and 2018. Results varied in sensitivity analyses using different estimates of clinical trial success rates, preclinical expenditures, and cost of capital. Conclusions and Relevance This study provides an estimate of research and development costs for new therapeutic agents based on publicly available data. Differences from previous studies may reflect the spectrum of products analyzed, the restricted availability of data in the public domain, and differences in underlying assumptions in the cost calculations. This study uses publicly available data to analyze research and development spending to win FDA approval and bring new drugs to market between 2009 and 2018. Question How much do drug companies spend on research and development to bring a new medicine to market? Findings In this study, which included 63 of 355 new therapeutic drugs and biologic agents approved by the US Food and Drug Administration between 2009 and 2018, the estimated median capitalized research and development cost per product was $985 million, counting expenditures on failed trials. Data were mainly accessible for smaller firms, products in certain therapeutic areas, orphan drugs, first-in-class drugs, therapeutic agents that received accelerated approval, and products approved between 2014 and 2018. Meaning This study provides an estimate of research and development costs for new therapeutic agents based on publicly available data; differences from previous studies may reflect the spectrum of products analyzed and the restricted availability of data in the public domain.	[Wouters, Olivier J.] London Sch Econ & Polit Sci, Dept Hlth Policy, Houghton St, London WC2A 2AE, England; [McKee, Martin] London Sch Econ & Polit Sci, Dept Hlth Serv Res & Policy, London, England; [Luyten, Jeroen] Katholieke Univ Leuven, Leuven Inst Healthcare Policy, Dept Publ Hlth & Primary Care, Leuven, Belgium	University of London; London School Economics & Political Science; University of London; London School Economics & Political Science; KU Leuven	Wouters, OJ (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, Houghton St, London WC2A 2AE, England.	o.j.wouters@lse.ac.uk	Wouters, Olivier/AAA-6345-2021	Wouters, Olivier/0000-0002-2514-476X; Luyten, Jeroen/0000-0001-6398-4025; Luyten, Jeroen/0000-0003-1770-6352				Adams CP, 2010, HEALTH ECON, V19, P130, DOI 10.1002/hec.1454; Adams CP, 2006, HEALTH AFFAIR, V25, P420, DOI 10.1377/hlthaff.25.2.420; Avorn J, 2015, NEW ENGL J MED, V372, P1877, DOI 10.1056/NEJMp1500848; Chit A, 2015, INQUIRY-J HEALTH CAR, V52, DOI 10.1177/0046958015584641; Darrow Jonathan J, 2014, N Engl J Med, V370, pe39, DOI 10.1056/NEJMp1402114; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; DiMasi JA, 2004, DRUG INF J, V38, P211, DOI 10.1177/009286150403800301; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; DiMasi JA, 2018, JAMA INTERN MED, V178, P587, DOI 10.1001/jamainternmed.2017.8703; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; DiMasi JA, 2007, MANAG DECIS ECON, V28, P469, DOI 10.1002/mde.1360; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Friedberg MW, 2017, JAMA INTERN MED, V177, P1058, DOI 10.1001/jamainternmed.2017.2142; Goozner M, 2017, JAMA INTERN MED, V177, P1575, DOI 10.1001/jamainternmed.2017.4997; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Jayasundara K, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-018-0990-4; Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V316, P858, DOI 10.1001/jama.2016.11237; Lanthier M, 2013, HEALTH AFFAIR, V32, P1433, DOI 10.1377/hlthaff.2012.0541; Light DW, 2005, J HEALTH ECON, V24, P1030, DOI 10.1016/j.jhealeco.2005.07.001; Mestre-Ferrandiz J, 2012, R D COST NEW MED; Morgan S, 2011, HEALTH POLICY, V100, P4, DOI 10.1016/j.healthpol.2010.12.002; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Prasad V, 2018, JAMA INTERN MED, V178, P588, DOI 10.1001/jamainternmed.2017.8737; Thomas DW, 2016, BIO IND ANAL; US Food and Drug Administration, 2018, STEP 3 CLIN RES PHAS; US Food and Drug Administration, NOV DRUG APPR 2011 2; US Food and Drug Administration, DRUGS FDA FDA APPR D; US Securities and Exchange Commission, 2019, EDGAR CO FIL; van der Gronde T, 2018, JAMA INTERN MED, V178, P587, DOI 10.1001/jamainternmed.2017.8737; WHO Collaborating Centre for Drug Statistics Methodology, ATC DDD IND 2020; Wong CH, 2019, BIOSTATISTICS, V20, P273, DOI 10.1093/biostatistics/kxx069	31	285	289	13	59	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2020	323	9			SI		844	853		10.1001/jama.2020.1166	http://dx.doi.org/10.1001/jama.2020.1166			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU3SD	32125404	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000519630600015
J	Knope, ML; Bush, AM; Frishkoff, LO; Heim, NA; Payne, JL				Knope, Matthew L.; Bush, Andrew M.; Frishkoff, Luke O.; Heim, Noel A.; Payne, Jonathan L.			Ecologically diverse clades dominate the oceans via extinction resistance	SCIENCE			English	Article							FUNCTIONAL DIVERSITY; MARINE; EVOLUTION; ECOLOGY	Ecological differentiation is correlated with taxonomic diversity in many clades, and ecological divergence is often assumed to be a cause and/or consequence of high speciation rate. However, an analysis of 30,074 genera of living marine animals and 19,992 genera of fossil marine animals indicates that greater ecological differentiation in the modern oceans is actually associated with lower rates of origination over evolutionary time. Ecologically differentiated clades became taxonomically diverse over time because they were better buffered against extinction, particularly during mass extinctions, which primarily affected genus-rich, ecologically homogeneous clades. The relationship between ecological differentiation and taxonomic richness was weak early in the evolution of animals but has strengthened over geological time as successive extinction events reshaped the marine fauna.	[Knope, Matthew L.] Univ Hawaii, Dept Biol, Hilo, HI 96720 USA; [Bush, Andrew M.] Univ Connecticut, Dept Geosci, Storrs, CT 06269 USA; [Bush, Andrew M.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Frishkoff, Luke O.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Heim, Noel A.] Tufts Univ, Dept Earth & Ocean Sci, Medford, MA 02115 USA; [Payne, Jonathan L.] Stanford Univ, Dept Geol Sci, Stanford, CA 94305 USA	University of Hawaii System; University Hawaii Hilo; University of Connecticut; University of Connecticut; University of Texas System; University of Texas Arlington; Tufts University; Stanford University	Knope, ML (corresponding author), Univ Hawaii, Dept Biol, Hilo, HI 96720 USA.	knope@hawaii.edu	Payne, Jonathan L/A-1240-2007; Heim, Noel A,/GRO-2700-2022	Payne, Jonathan L/0000-0002-9601-3310; Heim, Noel/0000-0002-4528-345X; Knope, Matthew/0000-0002-1372-6308	U.S. National Science Foundation [EAR-1151022]; School of Earth, Energy, and Environmental Sciences at Stanford University	U.S. National Science Foundation(National Science Foundation (NSF)); School of Earth, Energy, and Environmental Sciences at Stanford University	This Report is based on work supported by the U.S. National Science Foundation under grant 1345247 to M.L. K. Support for this research was also provided by the U.S. National Science Foundation (EAR-1151022 to J.L.P.) and the School of Earth, Energy, and Environmental Sciences at Stanford University. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.	Bambach RK, 2007, PALAEONTOLOGY, V50, P1, DOI 10.1111/j.1475-4983.2006.00611.x; Bush AM, 2015, GEOLOGY, V43, P979, DOI 10.1130/G37162.1; Clapham ME, 2017, GLOBAL CHANGE BIOL, V23, P1477, DOI 10.1111/gcb.13484; Cohen KM, 2013, EPISODES, V36, P199, DOI 10.18814/epiiugs/2013/v36i3/002; Darwin C., 1877, ORIGIN SPECIES; Edie SM, 2018, P NATL ACAD SCI USA, V115, P732, DOI 10.1073/pnas.1717636115; Elton C., 1927, ANIMAL ECOLOGY; Ezard THG, 2011, SCIENCE, V332, P349, DOI 10.1126/science.1203060; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Foster WJ, 2014, NAT GEOSCI, V7, P233, DOI [10.1038/ngeo2079, 10.1038/NGEO2079]; GILINSKY NL, 1994, PALEOBIOLOGY, V20, P445, DOI 10.1017/S0094837300012926; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jablonski D, 2017, EVOL BIOL, V44, P451, DOI 10.1007/s11692-017-9434-7; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Knope ML, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7455; Lack D., 1945, AUK, V62, P644, DOI DOI 10.2307/4079846; Losos JB, 2011, EVOLUTION, V65, P1827, DOI 10.1111/j.1558-5646.2011.01289.x; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; Payne JL, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0202; Peters SE, 2011, GEOL SOC SPEC PUBL, V358, P95, DOI 10.1144/SP358.7; R Core Team, R LANG ENV STAT COMP; RONOV AB, 1994, AM J SCI, V294, P777, DOI 10.2475/ajs.294.7.777; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sepkoski Jr J. J., 2002, B AM PALEONTOLOGY, V364; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Stanley S. M., 1979, MACROEVOLUTION PATTE; THAYER CW, 1979, SCIENCE, V203, P458, DOI 10.1126/science.203.4379.458; Vermeij G.J., 1987, EVOLUTION ESCALATION; Wake D.B., 1985, FUNCTIONAL VERTEBRAT	30	14	15	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2020	367	6481					1035	+		10.1126/science.aax6398	http://dx.doi.org/10.1126/science.aax6398			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KS0CO	32108111				2022-12-28	WOS:000517979600041
J	Gostin, LO; Wood, AJ; Cuff, PA				Gostin, Lawrence O.; Wood, Alastair J.; Cuff, Patricia A.			Regulating Medicines in a Globalized World With Increased Recognition and Reliance Among Regulators A National Academies Report	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint summarizes recommendations from a 2020 National Academies of Sciences, Engineering, and Medicine (NASEM) committee report on ways to improve regulatory oversight of drugs in an era of global pharmaceutical research and development.	[Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Wood, Alastair J.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Cuff, Patricia A.] Natl Acad Sci, 2101 Constitut Ave Nw, Washington, DC 20418 USA; [Cuff, Patricia A.] Natl Acad Engn, Washington, DC 20418 USA; [Cuff, Patricia A.] Natl Acad Med, Washington, DC USA	Georgetown University; Vanderbilt University; National Academies of Sciences, Engineering & Medicine; National Academies of Sciences, Engineering & Medicine; National Academies of Sciences, Engineering & Medicine	Gostin, LO (corresponding author), Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						European Medicines Agency, 2011, FIN REP INT API INSP; National Academies of Sciences Engineering and Medicine, 2019, REG MED GLOB WORLD N, DOI [10.17226/25594, DOI 10.17226/25594]; O'Brien J., 2019, THER INNOV REGUL SCI, V17, p216847901983452, DOI [10.1177/2168479019834529, DOI 10.1177/2168479019834529]; US Food and Drug Administration, 2018, FDA ANN VOL REC SEV; Valverde Jose Luis, 2016, Pharmaceuticals Policy and Law, V18, P19, DOI 10.3233/PPL-160429	5	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2020	324	2					145	146		10.1001/jama.2019.21793	http://dx.doi.org/10.1001/jama.2019.21793			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ8RW	32134427				2022-12-28	WOS:000553161000015
J	Parodi, SM; Liu, VCX				Parodi, Stephen M.; Liu, Vincent X.			From Containment to Mitigation of COVID-19 in the US	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses Kaiser Permanente in Northern California's transition from a containment strategy for coronavirus disease 2019 (COVID-19)-isolation or quarantine of exposed or infected patients-to a mitigation strategy comprising elements such as droplet and airborne precautions, telemedicine, staffing protocol revisions, and equipment allocation planning.	[Parodi, Stephen M.; Liu, Vincent X.] Kaiser Permanente, Permanente Med Grp, 1950 Franklin St, Oakland, CA 94612 USA; [Parodi, Stephen M.] Permanente Federat, Oakland, CA USA; [Liu, Vincent X.] Kaiser Permanente Div Res, Oakland, CA USA	Kaiser Permanente; Permanente Medical Groups; Kaiser Permanente	Parodi, SM (corresponding author), Kaiser Permanente, Permanente Med Grp, 1950 Franklin St, Oakland, CA 94612 USA.	stephen.m.parodi@kp.org			Permanente Medical Group [R35GM128672]; National Institute of General Medical Sciences	Permanente Medical Group; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by The Permanente Medical Group and grant R35GM128672 (awarded to Dr Liu) from the National Institute of General Medical Sciences.	[Anonymous], 2020, JAMA; Centers for Disease Control and Prevention, COR DIS 2019 COVID 1, DOI DOI 10.1016/S0140-6736(20)30211-7; Hellewell J, 2020, LANCET GLOB HLTH; Jernigan DB, 2020, MMWR-MORBID MORTAL W, V69, P216, DOI 10.15585/mmwr.mm6908e1; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	5	137	141	2	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2020	323	15					1441	1442		10.1001/jama.2020.3882	http://dx.doi.org/10.1001/jama.2020.3882			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LJ1ZH	32167525	Bronze			2022-12-28	WOS:000529969700008
J	Memish, ZA; Perlman, S; Van Kerkhove, MD; Zumla, A				Memish, Ziad A.; Perlman, Stanley; Van Kerkhove, Maria D.; Zumla, Alimuddin			Middle East respiratory syndrome	LANCET			English	Review							MERS-COV INFECTION; SYNDROME CORONAVIRUS INFECTION; DROMEDARY CAMELS; ANTIBODY-RESPONSE; SAUDI-ARABIA; VIRAL LOAD; OUTBREAK; TRANSMISSION; REPLICATION; INNATE	The Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal zoonotic pathogen that was first identified in humans in Saudi Arabia and Jordan in 2012. Intermittent sporadic cases, community clusters, and nosocomial outbreaks of MERS-CoV continue to occur. Between April 2012 and December 2019, 2499 laboratory-confirmed cases of MERS-CoV infection, including 858 deaths (34.3% mortality) were reported from 27 countries to WHO, the majority of which were reported by Saudi Arabia (2106 cases, 780 deaths). Large outbreaks of human-to-human transmission have occurred, the largest in Riyadh and Jeddah in 2014 and in South Korea in 2015. MERS-CoV remains a high-threat pathogen identified by WHO as a priority pathogen because it causes severe disease that has a high mortality rate, epidemic potential, and no medical countermeasures. This Seminar provides an update on the current knowledge and perspectives on MERS epidemiology, virology, mode of transmission, pathogenesis, diagnosis, clinical features, management, infection control, development of new therapeutics and vaccines, and highlights unanswered questions and priorities for research, improved management, and prevention.	[Memish, Ziad A.] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia; [Memish, Ziad A.] King Saud Med City Minist Hlth, Res Ctr, Riyadh, Saudi Arabia; [Memish, Ziad A.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Perlman, Stanley] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA USA; [Perlman, Stanley] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Van Kerkhove, Maria D.] WHO, Hlth Emergencies Programme, Infect Hazards Management, Geneva, Switzerland; [Zumla, Alimuddin] UCL, Ctr Clin Microbiol, Div Infect & Immun, Dept Infect, London NW3 OPE, England; [Zumla, Alimuddin] Univ Coll London Hosp, Natl Inst Hlth Res, Biomed Res Ctr, London, England	Alfaisal University; King Saud Medical City; Emory University; Rollins School Public Health; University of Iowa; University of Iowa; World Health Organization; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Zumla, A (corresponding author), UCL, Ctr Clin Microbiol, Div Infect & Immun, Dept Infect, London NW3 OPE, England.	a.zumla@ucl.ac.uk	ZUMLA, Alimuddin/ABA-8208-2020; Memish, Ziad Ahmed/AEJ-9424-2022	ZUMLA, Alimuddin/0000-0002-5111-5735; Memish, Ziad Ahmed/0000-0002-5099-0714; Perlman, Stanley/0000-0003-4213-2354	PANDORA-ID-NET - European and Developing Countries Clinical Trials Partnership (EDCTP2) under Horizon 2020, the EU's Framework Programme for Research and Innovation [RIA2016E-1609]; UK National Institutes of Health Research; US National Institutes of Health [PO1 AI060699 RO1 AI129269]	PANDORA-ID-NET - European and Developing Countries Clinical Trials Partnership (EDCTP2) under Horizon 2020, the EU's Framework Programme for Research and Innovation; UK National Institutes of Health Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	AZ acknowledges support from the PANDORA-ID-NET (grant RIA2016E-1609) funded by the European and Developing Countries Clinical Trials Partnership (EDCTP2) under Horizon 2020, the EU's Framework Programme for Research and Innovation. AZ is the recipient of a UK National Institutes of Health Research senior investigator award. SP is supported by grants from the US National Institutes of Health (PO1 AI060699 RO1 AI129269). We thank Samantha Mackin (University of Iowa) for creating figure 1 on the basis of a template provided by Benjamin W Neuman (Texas A&M-Texarkana) and Michael J Buchmeier (University of California, Irvine).	Adney DR, 2014, EMERG INFECT DIS, V20, P1999, DOI 10.3201/eid2012.141280; Agostini ML, 2019, J VIROL, V93, DOI 10.1128/JVI.01348-19; Aguanno R, 2018, ANTIVIR RES, V159, P35, DOI 10.1016/j.antiviral.2018.09.002; Ahmed AE, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2712-2; Ajlan AM, 2014, AM J ROENTGENOL, V203, P782, DOI 10.2214/AJR.14.13021; Al Hammadi ZM, 2015, EMERG INFECT DIS, V21, P2197, DOI 10.3201/eid2112.151132; Al Muhairi S, 2016, VIRUS GENES, V52, P848, DOI 10.1007/s11262-016-1367-1; Al-Abdallat MM, 2014, CLIN INFECT DIS, V59, P1225, DOI 10.1093/cid/ciu359; Al-Tawfiq Jaffar A, 2016, World J Clin Pediatr, V5, P391; Alanazi KH, 2019, INFECT CONT HOSP EP, V40, P79, DOI 10.1017/ice.2018.290; Alenazi TH, 2017, CLIN INFECT DIS, V65, P675, DOI 10.1093/cid/cix352; Alfaraj SH, 2019, AM J INFECT CONTROL, V47, P290, DOI 10.1016/j.ajic.2018.08.020; Alfaraj SH, 2019, J MICROBIOL IMMUNOL, V52, P501, DOI 10.1016/j.jmii.2018.04.005; Alfaraj SH, 2019, FRONT MED-PRC, V13, P126, DOI 10.1007/s11684-017-0603-y; Alfaraj SH, 2018, AM J INFECT CONTROL, V46, P165, DOI 10.1016/j.ajic.2017.08.010; Alraddadi BM, 2019, INFLUENZA OTHER RESP, V13, P382, DOI 10.1111/irv.12635; Alraddadi BM, 2016, EMERG INFECT DIS, V22, P1915, DOI 10.3201/eid2211.160920; Alsaad KO, 2018, HISTOPATHOLOGY, V72, P516, DOI 10.1111/his.13379; Alshukairi AN, 2016, EMERG INFECT DIS, V22, P1113, DOI 10.3201/eid2206.160010; Amer H, 2018, AM J INFECT CONTROL, V46, P1022, DOI 10.1016/j.ajic.2018.02.023; Amer H, 2018, INT J INFECT DIS, V71, P113, DOI 10.1016/j.ijid.2018.04.001; [Anonymous], 2015, METHODS MOL BIOL, DOI [DOI 10.1007/978-1-4939-2438-7_1, 10.1007/978-1-4939-2438-7_1]; Arabi Y, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1490-9; Arabi YM, 2019, INT J INFECT DIS, V81, P184, DOI 10.1016/j.ijid.2019.01.041; Arabi YM, 2018, AM J RESP CRIT CARE, V197, P757, DOI 10.1164/rccm.201706-1172OC; Arabi YM, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2427-0; Arabi YM, 2017, NEW ENGL J MED, V376, P584, DOI 10.1056/NEJMsr1408795; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Batawi S, 2019, HEALTH QUAL LIFE OUT, V17, DOI 10.1186/s12955-019-1165-2; Behzadi MA, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01327; Beigel JH, 2019, ANTIVIR RES, V167, P45, DOI 10.1016/j.antiviral.2019.04.006; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Bernard-Stoecklin S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43586-9; Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0; Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07; Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9; CDC, CDC LAB TEST MIDDL E; Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x; Choi S, 2018, J HOSP INFECT, V99, P162, DOI 10.1016/j.jhin.2017.09.017; Chu DKW, 2018, P NATL ACAD SCI USA, V115, P3144, DOI 10.1073/pnas.1718769115; Chu H, 2014, VIROLOGY, V454, P197, DOI 10.1016/j.virol.2014.02.018; Conzade R, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080425; Corman VM, 2016, CLIN INFECT DIS, V62, P477, DOI 10.1093/cid/civ951; Das Karuna M, 2017, Indian J Radiol Imaging, V27, P342, DOI 10.4103/ijri.IJRI_469_16; Das KM, 2016, AM J ROENTGENOL, V206, P1193, DOI 10.2214/AJR.15.15363; Das KM, 2015, AM J ROENTGENOL, V205, pW267, DOI 10.2214/AJR.15.14445; Das KM, 2015, AM J ROENTGENOL, V204, P736, DOI 10.2214/AJR.14.13671; Drosten C, 2014, NEW ENGL J MED, V371, P828, DOI 10.1056/NEJMoa1405858; Drosten C, 2013, LANCET INFECT DIS, V13, P745, DOI 10.1016/S1473-3099(13)70154-3; El-Kafrawy SA, 2019, LANCET PLANET HEALTH, V3, pE521, DOI 10.1016/S2542-5196(19)30243-8; Elkholy AA, 2020, J INFECT PUBLIC HEAL, V13, P418, DOI 10.1016/j.jiph.2019.04.011; Farag Elmoubasher A. B. A., 2015, Infection Ecology & Epidemiology, V5, P28305, DOI 10.3402/iee.v5.28305; Frans G, 2019, DIAGN MICR INFEC DIS, V94, P349, DOI 10.1016/j.diagmicrobio.2019.02.006; Grant R, 2019, EPIDEMIOL REV, V41, P69, DOI 10.1093/epirev/mxz009; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Hashem AM, 2019, J IMMUNOL METHODS, V466, P41, DOI 10.1016/j.jim.2019.01.005; Hemida MG, 2019, PEERJ, V7, DOI 10.7717/peerj.7556; Hemida MG, 2019, ONE HEALTH-AMSTERDAM, V8, DOI 10.1016/j.onehlt.2019.100102; Hijawi B, 2013, E MEDITERR HEALTH J, V19, pS12; Huang P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01101; Hui DS, 2018, LANCET INFECT DIS, V18, pE217, DOI 10.1016/S1473-3099(18)30127-0; Hui DS, 2015, AM J RESP CRIT CARE, V192, P278, DOI 10.1164/rccm.201506-1221ED; Hui DS, 2014, CURR OPIN PULM MED, V20, P233, DOI 10.1097/MCP.0000000000000046; Hunter JC, 2016, EMERG INFECT DIS, V22, P647, DOI 10.3201/eid2204.151615; Jo S, 2019, CHEM BIOL DRUG DES, V94, P2023, DOI 10.1111/cbdd.13604; KANDEIL A, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/V11080717; Kang CK, 2017, J KOREAN MED SCI, V32, P744, DOI 10.3346/jkms.2017.32.5.744; Kasem S, 2018, J INFECT PUBLIC HEAL, V11, P331, DOI [10.1016/j.jiph.2017.00.022, 10.1016/j.jiph.2017.09.022]; Kelly-Cirino C, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001105; Khalafalla AI, 2015, EMERG INFECT DIS, V21, P1153, DOI 10.3201/eid2107.150070; Kim JE, 2017, J CLIN NEUROL, V13, P227, DOI 10.3988/jcn.2017.13.3.227; Kim J, 2019, J BUS ECON MANAG, V20, P1, DOI 10.3846/jbem.2019.6262; Kim KH, 2017, J HOSP INFECT, V95, P207, DOI 10.1016/j.jhin.2016.10.008; Kim SH, 2017, J INFECT CHEMOTHER, V23, P769, DOI 10.1016/j.jiac.2017.04.004; Kirchdoerfer RN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10280-3; Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226; Ko JH, 2018, ANTIVIR THER, V23, P617, DOI 10.3851/IMP3243; Lamers MM, 2016, EMERG INFECT DIS, V22, P716, DOI 10.3201/eid2204.152065; Lau SKP, 2013, J GEN VIROL, V94, P2679, DOI 10.1099/vir.0.055533-0; Lee SM, 2018, COMPR PSYCHIAT, V87, P123, DOI 10.1016/j.comppsych.2018.10.003; Leist SR, 2020, METHODS MOL BIOL, V2099, P137, DOI 10.1007/978-1-0716-0211-9_12; Masters P, 2013, FIELDS VIROLOGY, P825; Memish ZA, 2014, J INFECT DIS, V210, P1590, DOI 10.1093/infdis/jiu292; Memish ZA, 2014, PEDIATR INFECT DIS J, V33, P904, DOI 10.1097/INF.0000000000000325; Mobaraki K, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3987-2; Momattin H, 2019, TRAVEL MED INFECT DI, V30, P9, DOI 10.1016/j.tmaid.2019.06.012; Mustafa S, 2018, J INFECT PUBLIC HEAL, V11, P9, DOI 10.1016/j.jiph.2017.08.009; Nam HS, 2017, INT J INFECT DIS, V58, P37, DOI 10.1016/j.ijid.2017.02.008; Ng DL, 2016, AM J PATHOL, V186, P652, DOI 10.1016/j.ajpath.2015.10.024; Ngai JC, 2010, RESPIROLOGY, V15, P543, DOI 10.1111/j.1440-1843.2010.01720.x; Oboho IK, 2015, NEW ENGL J MED, V372, P846, DOI 10.1056/NEJMoa1408636; Oh MD, 2018, KOREAN J INTERN MED, V33, P233, DOI 10.3904/kjim.2018.031; Oh MD, 2016, NEW ENGL J MED, V375, P1303, DOI 10.1056/NEJMc1511695; Okba NMA, 2019, EMERG INFECT DIS, V25, P1868, DOI [10.3201/eid2509.190051, 10.3201/eid2510.190051]; Paden CR, 2018, ZOONOSES PUBLIC HLTH, V65, P322, DOI 10.1111/zph.12435; Park JE, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5484-8; Park SW, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.41.30042; Park S, 2019, RESPIROLOGY, V24, P590, DOI 10.1111/resp.13558; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Perera RA, 2013, EUROSURVEILLANCE, V18, P8, DOI 10.2807/1560-7917.ES2013.18.36.20574; Rabaan AA, 2017, J MED MICROBIOL, V66, P1261, DOI 10.1099/jmm.0.000565; Rahman A, 2019, AM J PUBLIC HEALTH, V109, P1288, DOI [10.2105/AJPH.2019.305186, 10.21]; Raj VS, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aas9667; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Reusken CB, 2013, EUROSURVEILLANCE, V18, P14, DOI 10.2807/1560-7917.ES2013.18.50.20662; Sabir JSM, 2016, SCIENCE, V351, P81, DOI 10.1126/science.aac8608; Schindewolf C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010074; Seys LJM, 2018, CLIN INFECT DIS, V66, P45, DOI 10.1093/cid/cix741; Sha JP, 2017, ARCH VIROL, V162, P33, DOI 10.1007/s00705-016-3062-x; Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653; Shin HS, 2019, CLIN INFECT DIS, V68, P984, DOI 10.1093/cid/ciy595; Sikkema RS, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S095026881800345X, 10.1017/s0950268819000669]; Taylor R, 2016, J INFECT PUBLIC HEAL, V9, P220, DOI 10.1016/j.jiph.2016.04.002; Walls AC, 2016, NATURE, V531, P114, DOI 10.1038/nature16988; Wang L, 2018, J VIROL, V92, DOI 10.1128/JVI.01060-18; WHO, 2018, HOM CAR PAT MIDDL E; WHO, SARS SEV AC RESP SYN; WHO, LAB BIOR MAN LAB HAN; WHO, 2018, LAB TEST MIDDL E RES; WHO, RES DEV BLUEPR ACT P; Who Mers-Cov Research Group, 2013, PLoS Curr, V5, DOI 10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8; WIDAGDO W, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/V11030280; Widjaja I, 2019, EMERG MICROBES INFEC, V8, P516, DOI 10.1080/22221751.2019.1597644; World Health Organization, COR DIS COVID 19 OUT; World Health Organization, 2015, INF PREV CONTR HLTH; World Health Organization, MIDDL E RESP SYNDR C; World Health Organization [WHO], 2017, WHO TARG PROD PROF M; Xie Q, 2017, ARCH VIROL, V162, P2445, DOI 10.1007/s00705-017-3361-x; Yeung ML, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.4, 10.1038/nmicrobiol.2016.4]; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhao JC, 2015, J VIROL, V89, P6117, DOI 10.1128/JVI.00446-15; Zhao JX, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan5393; Zhou J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao4966; Zhou J, 2014, J INFECT DIS, V209, P1331, DOI 10.1093/infdis/jit504; Zhou YS, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010060; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8; Zumla A, 2016, INT J INFECT DIS, V47, P5, DOI 10.1016/j.ijid.2016.06.012; Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37	141	243	254	3	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2020	395	10229					1063	1077		10.1016/S0140-6736(19)33221-0	http://dx.doi.org/10.1016/S0140-6736(19)33221-0			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KY5YW	32145185	Bronze, Green Published			2022-12-28	WOS:000522650100034
J	Duscha, A; Gisevius, B; Hirschberg, S; Yissachar, N; Stangl, GI; Eilers, E; Bader, V; Haase, S; Kaisler, J; David, C; Schneider, R; Troisi, R; Zent, D; Hegelmaier, T; Dokalis, N; Gerstein, S; Del Mare-Roumani, S; Amidror, S; Staszewski, O; Poschmann, G; Stuhler, K; Hirche, F; Balogh, A; Kempa, S; Trager, P; Zaiss, MM; Holm, JB; Massa, MG; Nielsen, HB; Faissner, A; Lukas, C; Gatermann, SG; Scholz, M; Przuntek, H; Prinz, M; Forslund, SK; Winklhofer, KF; Muller, DN; Linker, RA; Gold, R; Haghikia, A				Duscha, Alexander; Gisevius, Barbara; Hirschberg, Sarah; Yissachar, Nissan; Stangl, Gabriele, I; Eilers, Eva; Bader, Verian; Haase, Stefanie; Kaisler, Johannes; David, Christina; Schneider, Ruth; Troisi, Riccardo; Zent, Daniel; Hegelmaier, Tobias; Dokalis, Nikolaos; Gerstein, Sara; Del Mare-Roumani, Sara; Amidror, Sivan; Staszewski, Ori; Poschmann, Gereon; Stuehler, Kai; Hirche, Frank; Balogh, Andras; Kempa, Stefan; Traeger, Pascal; Zaiss, Mario M.; Holm, Jacob Bak; Massa, Megan G.; Nielsen, Henrik Bjorn; Faissner, Andreas; Lukas, Carsten; Gatermann, Soeren G.; Scholz, Markus; Przuntek, Horst; Prinz, Marco; Forslund, Sofia K.; Winklhofer, Konstanze F.; Mueller, Dominik N.; Linker, Ralf A.; Gold, Ralf; Haghikia, Aiden			Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism	CELL			English	Article							CHAIN FATTY-ACIDS; DIFFERENTIAL EXPRESSION ANALYSIS; AUTOIMMUNE ENCEPHALOMYELITIS; NERVOUS-SYSTEM; GUT MICROBIOTA; BUTYRATE; BACTERIA; METABOLITES; SEQUENCES	Short-chain fatty acids are processed from indigestible dietary fibers by gut bacteria and have immunomodulatory properties. Here, we investigate propionic acid (PA) in multiple sclerosis (MS), an autoimmune and neurodegenerative disease. Serum and feces of subjects with MS exhibited significantly reduced PA amounts compared with controls, particularly after the first relapse. In a proof-of-concept study, we supplemented PA to therapy-naive MS patients and as an add-on to MS immunotherapy. After 2 weeks of PA intake, we observed a significant and sustained increase of functionally competent regulatory T (Treg) cells, whereas Th1 and Th17 cells decreased significantly. Post-hoc analyses revealed a reduced annual relapse rate, disability stabilization, and reduced brain atrophy after 3 years of PA intake. Functional microbiome analysis revealed increased expression of Treg-cell-inducing genes in the intestine after PA intake. Furthermore, PA normalized Treg cell mitochondria! function and morphology in MS. Our findings suggest that PA can serve as a potent immunomodulatory supplement to MS drugs.	[Duscha, Alexander; Gisevius, Barbara; Hirschberg, Sarah; Kaisler, Johannes; David, Christina; Schneider, Ruth; Troisi, Riccardo; Zent, Daniel; Hegelmaier, Tobias; Gold, Ralf; Haghikia, Aiden] Ruhr Univ Bochum, St Josef Hosp Bochum, Dept Neurol, D-44791 Bochum, Germany; [Yissachar, Nissan; Gerstein, Sara; Del Mare-Roumani, Sara; Amidror, Sivan] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel; [Yissachar, Nissan; Gerstein, Sara; Del Mare-Roumani, Sara; Amidror, Sivan] Bar Ilan Univ, Bar Ilan Inst Nanotechnol & Adv Mat, IL-5290002 Ramat Gan, Israel; [Stangl, Gabriele, I; Hirche, Frank] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Germany; [Eilers, Eva; Bader, Verian; Winklhofer, Konstanze F.] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Dept Mol Cell Biol, D-44801 Bochum, Germany; [Eilers, Eva] Leibniz Inst Analyt Wissensch ISAS eV, D-44139 Dortmund, Germany; [Haase, Stefanie; Linker, Ralf A.] Univ Regensburg, Dept Neurol, D-93053 Regensburg, Germany; [Dokalis, Nikolaos; Staszewski, Ori; Prinz, Marco] Univ Freiburg, Fac Med, Inst Neuropathol, D-79106 Freiburg, Germany; [Staszewski, Ori] Univ Freiburg, Fac Med, Berta Ottenstein Program Adv Clinician Scientists, D-79106 Freiburg, Germany; [Poschmann, Gereon; Stuehler, Kai] Heinrich Heine Univ, Biomed Res Ctr BMFZ, MPL, D-40225 Dusseldorf, Germany; [Poschmann, Gereon; Stuehler, Kai] Univ Hosp Dusseldorf, Inst Mol Med, D-40225 Dusseldorf, Germany; [Balogh, Andras; Forslund, Sofia K.; Mueller, Dominik N.] Joint Cooperat Max Delbruck Ctr Mol Med & Charite, Expt & Clin Res Ctr, D-13125 Berlin, Germany; [Kempa, Stefan] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Integrat Metabol & Prote, D-13125 Berlin, Germany; [Traeger, Pascal; Zaiss, Mario M.] Friedrich Alexander Univ FAU Erlangen Nurnberg, Dept Internal Med Rheumatol & Immunol 3, D-91054 Erlangen, Germany; [Holm, Jacob Bak; Nielsen, Henrik Bjorn] Clinical Microbiomics AS, DK-2200 Copenhagen, Denmark; [Massa, Megan G.] Univ Calif Los Angeles, Brain Res Inst, Dept Integrat Biol & Physiol, Lab Neuroendocrinol, Los Angeles, CA 90095 USA; [Faissner, Andreas] Ruhr Univ Bochum, Dept Cell Morphol & Mol Neurobiol, D-44801 Bochum, Germany; [Lukas, Carsten] Ruhr Univ Bochum, St Josef Hosp Bochum, Dept Radiol, D-44791 Bochum, Germany; [Gatermann, Soeren G.] Ruhr Univ Bochum, Dept Med Microbiol, D-44801 Bochum, Germany; [Scholz, Markus] Univ Leipzig, IMISE, D-04109 Leipzig, Germany; [Przuntek, Horst] EVK Hattingen, Clin Neurol 2, D-45525 Hattingen, Germany; [Prinz, Marco] Univ Freiburg, Signalling Res Centres BIOSS, Freiburg, Germany; [Prinz, Marco] Univ Freiburg, CIBSS, Freiburg, Germany; [Prinz, Marco] Univ Freiburg, Fac Med, Ctr Basics NeuroModulat NeuroModulBasics, D-79106 Freiburg, Germany; [Forslund, Sofia K.; Mueller, Dominik N.] Helmholtz Assoc, Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Ruhr University Bochum; Bar Ilan University; Bar Ilan University; Martin Luther University Halle Wittenberg; Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); University of Regensburg; University of Freiburg; University of Freiburg; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Leipzig University; University of Freiburg; University of Freiburg; University of Freiburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Haghikia, A (corresponding author), Ruhr Univ Bochum, St Josef Hosp Bochum, Dept Neurol, D-44791 Bochum, Germany.	aiden.haghikia@rub.de	Haghikia, Aiden/AAE-2427-2021; Faissner, Andreas/A-5314-2008; Lukas, Carsten/A-9767-2015; Holm, Jacob Bak/H-6899-2013	Faissner, Andreas/0000-0002-2211-8259; Lukas, Carsten/0000-0002-8562-9697; Yissachar, Nissan/0000-0002-7647-9754; Winklhofer, Konstanze/0000-0002-7256-8231; /0000-0001-8756-747X; Kaisler, Johannes/0000-0003-1753-700X; Forslund, Sofia K/0000-0003-4285-6993; Holm, Jacob Bak/0000-0003-1756-0875; Poschmann, Gereon/0000-0003-2448-0611	Deutsche Forschungsgemeinschaft [SFB TR128]; DMSG (Deutsche MS Gesellschaft in NRW); FoRUM (Ruhr-University Bochum); Rose-Stiftung; ProDi (Proteindiagnostik RUB); Ministerium fur Kultur und Wissenschaft des Landes Nordrhein-Westfalen; Regierende Burgermeister von Berlin - inkl. Wissenschaft und Forschung; Bundesministerium fur Bildung und Forschung; German Federal Ministry of Education and Research (BMBF) [FKZ 031 A 534A]; DZHK; DFG [SFB 1365]; German Research Foundation (DFG, Research Unit 2848); German Research Foundation; State Government of North Rhine-Westphalia [INST 213/840-1 FUGG]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DMSG (Deutsche MS Gesellschaft in NRW); FoRUM (Ruhr-University Bochum); Rose-Stiftung; ProDi (Proteindiagnostik RUB); Ministerium fur Kultur und Wissenschaft des Landes Nordrhein-Westfalen; Regierende Burgermeister von Berlin - inkl. Wissenschaft und Forschung; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); DZHK; DFG(German Research Foundation (DFG)); German Research Foundation (DFG, Research Unit 2848)(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); State Government of North Rhine-Westphalia	The study was funded by SFB TR128 (Deutsche Forschungsgemeinschaft), the DMSG (Deutsche MS Gesellschaft in NRW), FoRUM (Ruhr-University Bochum), the Rose-Stiftung, ProDi (Proteindiagnostik RUB), the Ministerium fur Kultur und Wissenschaft des Landes Nordrhein-Westfalen, the Regierende Burgermeister von Berlin - inkl. Wissenschaft und Forschung, and the Bundesministerium fur Bildung und Forschung. Statistical analyses and gene expression data were supported by the German Network for Bioinformatics Infrastructure (Karin Schork) - de.NBI, Service Center BioInfra.Prot, a project of the German Federal Ministry of Education and Research (BMBF) (FKZ 031 A 534A). D.N.M. is supported by the DZHK and the DFG (SFB 1365). K.F.W. is supported by the German Research Foundation (DFG, Research Unit 2848). SR-SIM microscopy was funded by the German Research Foundation and the State Government of North Rhine-Westphalia (INST 213/840-1 FUGG). We thank Anna Lena Fisse, Miriam Fels, Christoph Schroder, Katrin Strassburger-Krogias, Laura Tomaske, Daniel Richter, and Janina Kneiphof for identifying subjects with MS of interest for this study.	Andrews S., 2010, FASTQC QUALITY CONTR; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Berer K, 2017, P NATL ACAD SCI USA, V114, P10719, DOI 10.1073/pnas.1711233114; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bourens M, 2017, EMBO REP, V18, P477, DOI 10.15252/embr.201643103; Brunet-Ratnasingham E, 2019, TRENDS MOL MED, V25, P1, DOI 10.1016/j.molmed.2018.11.001; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Chan JCY, 2017, J PHARMACEUT BIOMED, V138, P43, DOI 10.1016/j.jpba.2017.01.044; Chen Yunshun, 2016, F1000Res, V5, P1438, DOI 10.12688/f1000research.8987.2; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Endo Y, 2015, CELL REP, V12, P1042, DOI 10.1016/j.celrep.2015.07.014; Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gaser C., 2016, HBM, V2016, P336; Goker M, 2011, STAND GENOMIC SCI, V4, P200, DOI 10.4056/sigs.1714269; Gomez-Arango LF, 2018, GUT MICROBES, V9, P189, DOI 10.1080/19490976.2017.1406584; Haghikia A, 2015, IMMUNITY, V43, P817, DOI 10.1016/j.immuni.2015.09.007; Haghikia A, 2013, TRENDS MOL MED, V19, P309, DOI 10.1016/j.molmed.2013.03.004; Hung CC, 2013, MOL MICROBIOL, V87, P1045, DOI 10.1111/mmi.12149; Kim HJ, 2009, J NEUROCHEM, V110, P1226, DOI 10.1111/j.1471-4159.2009.06212.x; Kleinewietfeld M, 2014, IMMUNOL REV, V259, P231, DOI 10.1111/imr.12169; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kwon HK, 2013, CLIN IMMUNOL, V146, P217, DOI 10.1016/j.clim.2013.01.001; Ledford H, 2017, NATURE, V541; Lemaire M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29971-w; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macia L, 2012, IMMUNOL REV, V245, P164, DOI 10.1111/j.1600-065X.2011.01080.x; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; MCARTHUR B, 1982, CLIN CHEM, V28, P1983; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704; Olsson T, 2017, NAT REV NEUROL, V13, P25, DOI 10.1038/nrneurol.2016.187; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saary P, 2017, BIOINFORMATICS, V33, P2594, DOI 10.1093/bioinformatics/btx206; Sakamoto M, 2009, INT J SYST EVOL MICR, V59, P1748, DOI 10.1099/ijs.0.007674-0; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; SWANK RL, 1952, NEW ENGL J MED, V246, P721, DOI 10.1056/NEJM195205082461901; Vieira SM, 2018, SCIENCE, V359, P1156, DOI 10.1126/science.aar7201; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Westin MAK, 2008, CELL MOL LIFE SCI, V65, P982, DOI 10.1007/s00018-008-7576-6; Yissachar N, 2017, CELL, V168, P1135, DOI 10.1016/j.cell.2017.02.009	57	191	197	20	124	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2020	180	6					1067	+		10.1016/j.cell.2020.02.035	http://dx.doi.org/10.1016/j.cell.2020.02.035			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KW1IO	32160527	Bronze			2022-12-28	WOS:000520925300007
J	Mahase, E				Mahase, Elisabeth			Covid-19: UK budget gives 94 pound a week statutory sick pay to self-isolators and their carers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Treasury HM, 2020, HC 121 BUDGET 2020 D; Treasury HM, 2020, BUDGET 2020 DOCUMENT	2	2	2	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2020	368								m1001	10.1136/bmj.m1001	http://dx.doi.org/10.1136/bmj.m1001			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AR	32161028	Bronze			2022-12-28	WOS:000520012800018
J	Welsh, C; Celis-Morales, CA; Ho, F; Lyall, DM; Mackay, D; Ferguson, L; Sattar, N; Gray, SR; Gill, JMR; Pell, JP; Welsh, P				Welsh, Claire; Celis-Morales, Carlos A.; Ho, Frederick; Lyall, Donald M.; Mackay, Daniel; Ferguson, Lyn; Sattar, Naveed; Gray, Stuart R.; Gill, Jason M. R.; Pell, Jill P.; Welsh, Paul			Association of injury related hospital admissions with commuting by bicycle in the UK: prospective population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TIME PHYSICAL-ACTIVITY; AGED FINNISH MEN; CYCLE TRACKS; RISK; WALKING; DISEASE; SAFETY; HEALTH; RATES	OBJECTIVE To determine whether bicycle commuting is associated with risk of injury. DESIGN Prospective population based study. SETTING UK Biobank. PARTICIPANTS 230390 commuters (52.1% women; mean age 52.4 years) recruited from 22 sites across the UK compared by mode of transport used (walking, cycling, mixed mode versus non-active (car or public transport)) to commute to and from work on a typical day. MAIN OUTCOME MEASURE First incident admission to hospital for injury. RESULTS 5704 (2.5%) participants reported cycling as their main form of commuter transport. Median follow-up was 8.9 years (interquartile range 8,29.5 years), and overall 10241 (4.4%) participants experienced an injury. Injuries occurred in 397 (7.0%) of the commuters who cycled and 7698 (4.3%) of the commuters who used a non-active mode of transport. After adjustment for major confounding sociodemographic, health, and lifestyle factors, cycling to work was associated with a higher risk of injury compared with commuting by a non-active mode (hazard ratio 1.45, 95% confidence interval 1.30 to 1.61). Similar trends were observed for commuters who used mixed mode cycling. Walking to work was not associated with a higher risk of injury. Longer cycling distances during commuting were associated with a higher risk of injury, but commute distance was not associated with injury in non-active commuters. Cycle commuting was also associated with a higher number of injuries when the external cause was a transport related incident (incident rate ratio 3.42, 95% confidence interval 3.00 to 3.90). Commuters who cycled to work had a lower risk of cardiovascular disease, cancer, and death than those who did not. If the associations are causal, an estimated 1000 participants changing their mode of commuting to include cycling for 10 years would result in 26 additional admissions to hospital for a first injury (of which three would require a hospital stay of a week or longer), 15 fewer first cancer diagnoses, four fewer cardiovascular disease events, and three fewer deaths. CONCLUSION Compared with non-active commuting to work, commuting by cycling was associated with a higher risk of hospital admission for a first injury and higher risk of transport related incidents specifically. These risks should be viewed in context of the health benefits of active commuting and underscore the need for a safer infrastructure for cycling in the UK.	[Welsh, Claire; Celis-Morales, Carlos A.; Ho, Frederick; Ferguson, Lyn; Sattar, Naveed; Gray, Stuart R.; Gill, Jason M. R.; Welsh, Paul] Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Celis-Morales, Carlos A.] Univ Mayor, Ctr Exercise Physiol Res CIFE, Santiago, San Pio, Chile; [Celis-Morales, Carlos A.; Lyall, Donald M.; Pell, Jill P.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Mackay, Daniel] Univ Glasgow, Sch Med Dent & Nursing, Glasgow, Lanark, Scotland	University of Glasgow; Universidad Mayor; University of Glasgow; University of Glasgow	Welsh, P (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland.	paul.welsh@glasgow.ac.uk	Ho, Frederick/AAS-2647-2021; Welsh, Claire E/AAB-3743-2019; Welsh, Paul/H-5249-2019; Gray, Stuart/L-2489-2017	Ho, Frederick/0000-0001-7190-9025; Welsh, Claire E/0000-0001-9477-0775; Welsh, Paul/0000-0002-7970-3643; Celis-Morales, Carlos/0000-0003-2612-3917; mackay, daniel/0000-0001-5381-7098; Ferguson, Lyn/0000-0002-6136-8349; Gill, Jason/0000-0003-3615-0986; Gray, Stuart/0000-0001-8969-9636; Lyall, Donald/0000-0003-3850-1487; Sattar, Naveed/0000-0002-1604-2593	Chest, Heart, and Stroke Association Scotland [Res16/A165]	Chest, Heart, and Stroke Association Scotland	This study was supported by a grant from Chest, Heart, and Stroke Association Scotland (Res16/A165]) The research was designed, conducted, analysed, and interpreted by the authors entirely independently of the funding sources.	Aldred R, 2018, ACCIDENT ANAL PREV, V117, P75, DOI 10.1016/j.aap.2018.03.003; [Anonymous], 2017, BRIT SOC ATT SURV 20; [Anonymous], 2010, CYCL DES; [Anonymous], 2017, PHYS IN SED BEH REP; [Anonymous], 2012, WALK CYCL LOC MEAS P; Audrey S, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-37; Baker BS, 2019, ECANCERMEDICALSCIENC, V13, DOI 10.3332/ecancer.2019.991; Bassett DR, 2008, J PHYS ACT HEALTH, V5, P795, DOI 10.1123/jpah.5.6.795; Blond MB, 2019, BRIT J SPORT MED, V53, P1183, DOI 10.1136/bjsports-2018-100036; Celis-Morales CA, 2019, MED SCI SPORT EXER, V51, P472, DOI 10.1249/MSS.0000000000001795; Celis-Morales CA, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1063-1; Celis-Morales CA, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1456; Department for Transport, 2016, CYCL WALK INV STRAT; Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; Fraser SDS, 2011, EUR J PUBLIC HEALTH, V21, P738, DOI 10.1093/eurpub/ckq145; Gill J, 2019, CONFIDENCE RIDE CONF; Golbuff L., 2011, CYCLING POLICY UK HI; Grundy C, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4469; Hilbe JM, 2014, MODELING COUNT DATA, P1, DOI 10.1017/CBO9781139236065; Hou L, 2004, AM J EPIDEMIOL, V160, P860, DOI 10.1093/aje/kwh301; Hu G, 2003, DIABETOLOGIA, V46, P322, DOI 10.1007/s00125-003-1031-x; Hu G, 2007, ATHEROSCLEROSIS, V194, P490, DOI 10.1016/j.atherosclerosis.2006.08.051; Hu G, 2007, EUR HEART J, V28, P492, DOI 10.1093/eurheartj/ehl475; Iwinska K, 2018, TRANSPORT RES A-POL, V113, P291, DOI 10.1016/j.tra.2018.04.014; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lusk AC, 2013, AM J PUBLIC HEALTH, V103, P1240, DOI 10.2105/AJPH.2012.301043; Lusk AC, 2011, INJURY PREV, V17, P131, DOI 10.1136/ip.2010.028696; Mindell JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050606; Morrison CN, 2019, ACCIDENT ANAL PREV, V123, P123, DOI 10.1016/j.aap.2018.11.017; Pucher J, 2008, TRANSPORT REV, V28, P495, DOI 10.1080/01441640701806612; Pucher J, 2010, AM J PUBLIC HEALTH, V100, P1986, DOI 10.2105/AJPH.2009.189324; Reynolds CCO, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-47; ROJASRUEDA D, 2011, BMJ-BRIT MED J, V343, DOI DOI 10.1136/BMJ.D4521; Teschke K, 2012, AM J PUBLIC HEALTH, V102, P2336, DOI 10.2105/AJPH.2012.300762; Thomas B, 2013, ACCIDENT ANAL PREV, V52, P219, DOI 10.1016/j.aap.2012.12.017; Woodcock J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g425; World Health Organization (WHO), 2018, MOR ACT PEOPL HEALTH; Zangenehpour S, 2016, ACCIDENT ANAL PREV, V86, P161, DOI 10.1016/j.aap.2015.10.025	38	14	14	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2020	368								m336	10.1136/bmj.m336	http://dx.doi.org/10.1136/bmj.m336			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU9AR	32161038	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000520012800001
J	Chou, R; Dana, T; Fu, RW; Zakher, B; Wagner, J; Ramirez, S; Grusing, S; Jou, JH				Chou, Roger; Dana, Tracy; Fu, Rongwei; Zakher, Bernadette; Wagner, Jesse; Ramirez, Shaun; Grusing, Sara; Jou, Janice H.			Screening for Hepatitis C Virus Infection in Adolescents and Adults Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HCV GENOTYPE 1; SUSTAINED VIROLOGICAL RESPONSE; TREATMENT-EXPERIENCED PATIENTS; FIXED-DOSE COMBINATION; DACLATASVIR PLUS SOFOSBUVIR; ALL-CAUSE MORTALITY; HEPATOCELLULAR-CARCINOMA; INTERFERON THERAPY; OPEN-LABEL; TREATMENT-NAIVE	Importance A 2013 review for the US Preventive Services Task Force (USPSTF) of hepatitis C virus (HCV) screening found interferon-based antiviral therapy associated with increased likelihood of sustained virologic response (SVR) and an association between achieving an SVR and improved clinical outcomes. New direct-acting antiviral (DAA) regimens are available. Objective To update the 2013 review on HCV screening to inform the USPSTF. Data Sources Ovid MEDLINE, the Cochrane Central Register of Controlled Trials, and the Cochrane Database of Systematic Reviews through February 2019, with surveillance through September 2019. Study Selection Randomized clinical trials (RCTs) and nonrandomized treatment studies of HCV screening and DAA therapy; cohort studies on screening, antiviral therapy, and the association between an SVR after antiviral therapy and clinical outcomes. Data Extraction and Synthesis One investigator abstracted data; a second checked accuracy. Two investigators independently rated study quality. Main Outcomes and Measures Mortality, morbidity, quality of life, screening and treatment harms, and screening diagnostic yield. Results Eight RCTs of DAA therapy vs placebo or an outdated antiviral regimen, 48 other treatment studies, and 33 cohort studies, with a total of 179 & x202f;230 participants, were included. No study evaluated effects of HCV screening vs no screening. One new study since the 2013 review (n = 5917) found similar diagnostic yield of risk-based screening (sensitivity, 82%; number needed to screen to identify 1 HCV case, 15) and birth cohort screening (sensitivity, 76%; number needed to screen, 29), assuming perfect implementation. Ten open-label studies (n = 3292) reported small improvements in some quality-of-life and functional outcomes (eg, less than 3 points on the 0 to 100 36-Item Short Form Health Survey physical and mental component summary scales) after DAA treatment compared with before treatment. Two cohort studies (n = 24 & x202f;686) found inconsistent associations of antiviral therapy vs no therapy with risk of hepatocellular carcinoma. Forty-nine treatment studies (n = 10 & x202f;181) found DAA regimens associated with pooled SVR rates greater than 95% across genotypes, and low short-term rates of serious adverse events (1.9%) and withdrawal due to adverse events (0.4%). An SVR after antiviral therapy was associated with decreased adjusted risk of all-cause mortality (13 studies, n = 36 & x202f;986; pooled hazard ratio [HR], 0.40 [95% CI, 0.28-0.56) and hepatocellular carcinoma (20 studies, n = 84 & x202f;491; pooled HR, 0.29 [95% CI, 0.23 to 0.38]) vs no SVR. Conclusions and Relevance Direct evidence on the effects of HCV screening on clinical outcomes remains unavailable, but DAA regimens were associated with SVR rates greater than 95% and few short-term harms relative to older antiviral therapies. An SVR after antiviral therapy was associated with improved clinical outcomes compared with no SVR. This systematic review to support the 2020 US Preventive Services Task Force Recommendation Statement on screening for hepatitis C virus (HCV) infection summarizes published evidence on the benefits and harms of HCV screening and treatment in adolescents and adults.	[Chou, Roger; Dana, Tracy; Fu, Rongwei; Zakher, Bernadette; Wagner, Jesse; Ramirez, Shaun; Grusing, Sara; Jou, Janice H.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Northwest Evidence Based Practice Ctr, Portland, OR 97201 USA; [Chou, Roger] Oregon Hlth & Sci Univ, Div Gen Internal Med & Geriatr, Portland, OR 97201 USA; [Fu, Rongwei] Portland State Univ, Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97207 USA; [Jou, Janice H.] Oregon Hlth & Sci Univ, Div Gastroenterol & Hepatol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Portland State University; Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	chour@ohsu.edu			Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA290201500009i]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract HHSA290201500009i, Task Order 7, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the US Preventive Services Task Force (USPSTF).	Abdel Ghaffar TY, 2019, J VIRAL HEPATITIS, V26, P263, DOI 10.1111/jvh.13032; Abergel A, 2016, HEPATOLOGY, V64, P1049, DOI 10.1002/hep.28706; Abergel A, 2016, LANCET INFECT DIS, V16, P459, DOI 10.1016/S1473-3099(15)00529-0; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Ahmed OA, 2018, INFECT DRUG RESIST, V11, P295, DOI 10.2147/IDR.S153060; American Association for the Study of Liver Diseases Infectious Diseases Society of America, HCV GUID REC TEST MA; Andreone P, 2014, GASTROENTEROLOGY, V147, P359, DOI 10.1053/j.gastro.2014.04.045; Arase Y, 2007, INTERVIROLOGY, V50, P16, DOI 10.1159/000096308; Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Asselah T, 2019, LANCET GASTROENTEROL, V4, P45, DOI 10.1016/S2468-1253(18)30341-8; Asselah T, 2018, CLIN GASTROENTEROL H, V16, P417, DOI 10.1016/j.cgh.2017.09.027; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Balistreri WF, 2017, HEPATOLOGY, V66, P371, DOI 10.1002/hep.28995; Bang CS, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0606-9; Bernardinello E, 1999, HEPATO-GASTROENTEROL, V46, P3216; Brown A, 2018, J VIRAL HEPATITIS, V25, P457, DOI 10.1111/jvh.12801; Bruix J, 2011, GASTROENTEROLOGY, V140, P1990, DOI 10.1053/j.gastro.2011.03.010; Butt AA, 2019, GASTROENTEROLOGY, V156, P987, DOI 10.1053/j.gastro.2018.11.022; Butt AA, 2017, CLIN INFECT DIS, V65, P1006, DOI 10.1093/cid/cix364; Cacoub P, 2018, GUT, V67, P2025, DOI 10.1136/gutjnl-2018-316234; Carrat F, 2019, LANCET, V393, P1453, DOI 10.1016/S0140-6736(18)32111-1; Centers for Disease Control (CDC), 2016, SURV VIR HEP US; Chayama K, 2018, J GASTROENTEROL, V53, P557, DOI 10.1007/s00535-017-1391-5; Chou R, 2012, AHRQ PUBLICATION; Chou R, 2012, TREATMENT HEPATITIS; Chou R, 2013, ANN INTERN MED, V158, P114, DOI 10.7326/0003-4819-158-2-201301150-00576; Chou R, 2013, ANN INTERN MED, V158, P101, DOI 10.7326/0003-4819-158-2-201301150-00574; Chuang WL, 2016, J GASTROEN HEPATOL, V31, P1323, DOI 10.1111/jgh.13305; Cozen ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061568; Dieperink E, 2014, DIGEST DIS SCI, V59, P872, DOI 10.1007/s10620-014-3050-5; Dohmen K, 2013, HEPATO-GASTROENTEROL, V60, P2034, DOI 10.5754/hge.11716; Dore GJ, 2016, J HEPATOL, V64, P19, DOI 10.1016/j.jhep.2015.08.015; El-Karaksy H, 2018, J PEDIATR GASTR NUTR, V67, P626, DOI 10.1097/MPG.0000000000002101; El-Serag HB, 2014, AM J GASTROENTEROL, V109, P1427, DOI 10.1038/ajg.2014.214; Everson GT, 2015, ANN INTERN MED, V163, P818, DOI 10.7326/M15-1000; Falade-Nwulia O, 2017, ANN INTERN MED, V166, P637, DOI [10.7326/M16-2575, 10.7326/m16-2575]; Fartoux L, 2007, CLIN GASTROENTEROL H, V5, P502, DOI 10.1016/j.cgh.2006.10.016; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Foster GR, 2015, NEW ENGL J MED, V373, P2608, DOI 10.1056/NEJMoa1512612; Francesco A, 2004, WORLD J GASTROENTERO, V10, P3099; Gane EJ, 2015, GASTROENTEROLOGY, V149, P1454, DOI 10.1053/j.gastro.2015.07.063; Grebely J, 2018, INT J DRUG POLICY, V62, P94, DOI 10.1016/j.drugpo.2018.10.004; Grebely J, 2018, LANCET GASTROENTEROL, V3, P153, DOI 10.1016/S2468-1253(17)30404-1; Hezode C, 2015, LANCET, V385, P2502, DOI 10.1016/S0140-6736(15)60159-3; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hofmeister MG, 2019, HEPATOLOGY, V69, P1020, DOI 10.1002/hep.30297; Ikeda K, 1999, HEPATOLOGY, V29, P1124, DOI 10.1002/hep.510290439; Imai Y, 1998, ANN INTERN MED, V129, P94, DOI 10.7326/0003-4819-129-2-199807150-00005; Imazeki F, 2003, HEPATOLOGY, V38, P493, DOI 10.1053/jhep.2003.50329; Indolfi G, 2018, LANCET CHILD ADOLESC, V2, P298, DOI 10.1016/S2352-4642(18)30037-3; Innes HA, 2011, HEPATOLOGY, V54, P2281, DOI [10.1002/hep.24776, 10.1002/hep.24561]; Ioannou GN, 2018, J HEPATOL, V68, P25, DOI 10.1016/j.jhep.2017.08.030; Izumi N, 2005, INTERVIROLOGY, V48, P59, DOI 10.1159/000082096; Jakobsen JC, 2017, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD012143.pub2, 10.1002/14651858.CD012143.pub3]; Jonas MM, 2019, HEPATOLOGY, DOI [10.1002/hep.30840/suppinfo, 10.1002/hep.30840]; Kasahara A, 2004, J VIRAL HEPATITIS, V11, P148, DOI 10.1046/j.1365-2893.2003.00481.x; Kasahara A, 1998, HEPATOLOGY, V27, P1394, DOI 10.1002/hep.510270529; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Kumada H, 2017, J GASTROENTEROL, V52, P520, DOI 10.1007/s00535-016-1285-y; Kumada H, 2015, HEPATOLOGY, V62, P1037, DOI 10.1002/hep.27972; Kurokawa M, 2009, HEPATOL RES, V39, P432, DOI 10.1111/j.1872-034X.2008.00477.x; Kwo P, 2016, HEPATOLOGY, V64, P370, DOI 10.1002/hep.28467; Lalezari J, 2015, J HEPATOL, V63, P364, DOI 10.1016/j.jhep.2015.03.029; Lawitz E, 2015, GASTROENTEROLOGY, V149, P971, DOI 10.1053/j.gastro.2015.07.001; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lee SH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006193; Leung DH, 2018, HEPATOL COMMUN, V2, P1311, DOI 10.1002/hep4.1250; Li DK, 2018, HEPATOLOGY, V67, P2244, DOI 10.1002/hep.29707; Lim YS, 2016, HEPATOL INT, V10, P947, DOI 10.1007/s12072-016-9726-5; Lok AS, 2011, GASTROENTEROLOGY, V140, P840, DOI 10.1053/j.gastro.2010.11.050; Maruoka D, 2012, J GASTROEN HEPATOL, V27, P291, DOI 10.1111/j.1440-1746.2011.06871.x; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Ng X, 2018, PATIENT PREFER ADHER, V12, P2631, DOI 10.2147/PPA.S172732; Nishiguchi S, 2001, LANCET, V357, P196, DOI 10.1016/S0140-6736(00)03595-9; Okanoue T, 2002, HEPATOL RES, V23, P62, DOI 10.1016/S1386-6346(02)00016-5; Osaki Y, 2012, J GASTROENTEROL, V47, P444, DOI 10.1007/s00535-011-0505-8; Pianko S, 2015, ANN INTERN MED, V163, P809, DOI 10.7326/M15-1014; Poordad F, 2017, HEPATOLOGY, V66, P389, DOI 10.1002/hep.29081; Pott H, 2019, CLIN MICROBIOL INFEC, V25, P365, DOI 10.1016/j.cmi.2018.06.007; Singal AG, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003231; Sinn DH, 2008, LIVER INT, V28, P1363, DOI 10.1111/j.1478-3231.2008.01860.x; Soga K, 2005, HEPATO-GASTROENTEROL, V52, P1154; Sperl J, 2016, J HEPATOL, V65, P1112, DOI 10.1016/j.jhep.2016.07.050; Squires JE, 2017, HEPATOL COMMUN, V1, P87, DOI 10.1002/hep4.1028; Su F, 2017, HEPATOLOGY, V65, P426, DOI 10.1002/hep.28901; Sulkowski M, 2015, LANCET, V385, P1087, DOI 10.1016/S0140-6736(14)61793-1; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Tanaka H, 2000, INT J CANCER, V87, P741, DOI 10.1002/1097-0215(20000901)87:5&lt;741::AID-IJC18&gt;3.0.CO;2-B; Tateyama M, 2011, J GASTROENTEROL, V46, P92, DOI 10.1007/s00535-010-0293-6; Tomaszewski Kenneth J, 2012, Am J Public Health, V102, pe101, DOI 10.2105/AJPH.2011.300488; Toyoda H, 2018, HEPATOLOGY, V67, P505, DOI 10.1002/hep.29510; Tseng CW, 2016, CLIN INTERV AGING, V11, P327, DOI 10.2147/CIA.S97242; Valla DC, 1999, HEPATOLOGY, V29, P1870, DOI 10.1002/hep.510290616; Waked I, 2016, LANCET GASTROENTEROL, V1, P36, DOI 10.1016/S2468-1253(16)30002-4; Waziry R, 2017, J HEPATOL, V67, P1204, DOI 10.1016/j.jhep.2017.07.025; Wei L, 2019, LANCET GASTROENTEROL, V4, P127, DOI 10.1016/S2468-1253(18)30343-1; Wei L, 2019, J GASTROEN HEPATOL, V34, P12, DOI 10.1111/jgh.14509; Wei L, 2018, HEPATOL INT, V12, P126, DOI 10.1007/s12072-018-9856-z; Wirth S, 2017, HEPATOLOGY, V66, P1102, DOI 10.1002/hep.29278; Yakoot M, 2018, J PEDIATR GASTR NUTR, V67, P86, DOI [10.1097/MPG.0000000000001968, 10.1097/mpg.0000000000001968]; Yek C, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0969-3; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; Yoshida H, 2002, GASTROENTEROLOGY, V123, P483, DOI 10.1053/gast.2002.34785; Younossi ZM, 2018, J VIRAL HEPATITIS, V25, P354, DOI 10.1111/jvh.12830; Younossi ZM, 2018, J PEDIATR GASTR NUTR, V66, P112, DOI 10.1097/MPG.0000000000001754; Younossi ZM, 2017, CLIN GASTROENTEROL H, V15, P421, DOI 10.1016/j.cgh.2016.10.037; Younossi ZM, 2015, J HEPATOL, V63, P337, DOI 10.1016/j.jhep.2015.03.014; Yu ML, 2006, ANTIVIR THER, V11, P985; Zeuzem S, 2018, NEW ENGL J MED, V378, P354, DOI 10.1056/NEJMoa1702417; Zeuzem S, 2015, ANN INTERN MED, V163, P1, DOI 10.7326/M15-0785	115	32	32	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2020	323	10					976	991		10.1001/jama.2019.20788	http://dx.doi.org/10.1001/jama.2019.20788			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KW1LV	32119034	Bronze			2022-12-28	WOS:000520933900015
J	Mathew, R				Mathew, Rammya			Rammya Mathew: Learning to manage multimorbidity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rammya.mathew@nhs.net						Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; National Institute for Health and Care Excellence, 2016, MULT CLIN ASS MAN NI	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2020	368								m871	10.1136/bmj.m871	http://dx.doi.org/10.1136/bmj.m871			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AO	32156683	Bronze			2022-12-28	WOS:000520012500003
J	Dyer, C				Dyer, Clare			Four drug firms are fined 3.4m pound for fixing price of nortriptyline	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2020	368								m925	10.1136/bmj.m925	http://dx.doi.org/10.1136/bmj.m925			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KI	32139357				2022-12-28	WOS:000519537000013
J	Frazier, KC				Frazier, Kenneth C.			Affording Medicines for Today's Patients and Sustaining Innovation for Tomorrow	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Frazier, Kenneth C.] Merck & Co Inc, 2000 Galloping Hill Rd, Kenilworth, NJ 07033 USA	Merck & Company	Frazier, KC (corresponding author), Merck & Co Inc, 2000 Galloping Hill Rd, Kenilworth, NJ 07033 USA.	ken_frazier@merck.com						Brownlee, 2020, REVISITING PHARM SUP; Chhabra KR, 2020, JAMA-J AM MED ASSOC, V323, P538, DOI 10.1001/jama.2019.21463; Fendrick AM, 2019, AM J MANAG CARE, V25, P57; Furlow B, 2015, LANCET RESP MED, V3, P840, DOI 10.1016/S2213-2600(15)00410-5; Hernandez I, 2020, JAMA-J AM MED ASSOC, V323, P854, DOI 10.1001/jama.2020.1012; Kirzinger A., 2019, KFF HLTH TRACKING PO; Ledley FD, 2020, JAMA-J AM MED ASSOC, V323, P834, DOI 10.1001/jama.2020.0442; Steedman M., 2019, 10 YEARS MEASURING R; Wouters OJ, 2020, JAMA-J AM MED ASSOC, V323, P844, DOI 10.1001/jama.2020.1166	9	8	8	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2020	323	9			SI		831	833		10.1001/jama.2020.0167	http://dx.doi.org/10.1001/jama.2020.0167			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU3SD	32125383				2022-12-28	WOS:000519630600013
J	Fischer-Godde, M; Elfers, BM; Munker, C; Szilas, K; Maier, WD; Messling, N; Morishita, T; Van Kranendonk, M; Smithies, H				Fischer-Goedde, Mario; Elfers, Bo-Magnus; Muenker, Carsten; Szilas, Kristoffer; Maier, Wolfgang D.; Messling, Nils; Morishita, Tomoaki; Van Kranendonk, Martin; Smithies, Hugh			Ruthenium isotope vestige of Earth's pre-late-veneer mantle preserved in Archaean rocks	NATURE			English	Article							HIGHLY SIDEROPHILE ELEMENT; SOUTHERN WEST GREENLAND; ISUA SUPRACRUSTAL BELT; PLATINUM-GROUP; ULTRAMAFIC ROCKS; BUSHVELD COMPLEX; W-182 EVIDENCE; 3.8 GA; SILICATE; DIFFERENTIATION	The accretion of volatile-rich material from the outer Solar System represents a crucial prerequisite for Earth to develop oceans and become a habitable planet(1-4). However, the timing of this accretion remains controversial(5-8). It has been proposed that volatile elements were added to Earth by the late accretion of a late veneer consisting of carbonaceous-chondrite-like material after core formation had ceased(6,9,10). This view could not be reconciled with the ruthenium (Ru) isotope composition of carbonaceous chondrites(5,11), which is distinct from that of the modern mantle(12), or of any known meteorite group(5). As a possible solution, Earth's pre-late-veneer mantle could already have contained a fraction of Ru that was not fully extracted by core formation(13). The presence of such pre-late-veneer Ru can only be established if its isotope composition is distinct from that of the modern mantle. Here we report the first high-precision, mass-independent Ru isotope compositions for Eoarchaean ultramafic rocks from southwest Greenland, which display a relative Ru-100 excess of 22 parts per million compared with the modern mantle value. This Ru-100 excess indicates that the source of the Eoarchaean rocks already contained a substantial fraction of Ru before the accretion of the late veneer. By 3.7 billion years ago, the mantle beneath southwest Greenland had not yet fully equilibrated with late accreted material. Otherwise, no Ru isotopic difference relative to the modern mantle would be observed. If constraints from other highly siderophile elements besides Ru are also considered(14), the composition of the modern mantle can only be reconciled if the late veneer contained substantial amounts of carbonaceous-chondrite-like materials with their characteristic Ru-100 deficits. These data therefore relax previous constraints on the late veneer and are consistent with volatile-rich material from the outer Solar System being delivered to Earth during late accretion.	[Fischer-Goedde, Mario; Elfers, Bo-Magnus; Muenker, Carsten; Messling, Nils] Univ Cologne, Inst Geol & Mineral, Cologne, Germany; [Szilas, Kristoffer] Univ Copenhagen, Dept Geosci & Nat Resource Management, Copenhagen, Denmark; [Maier, Wolfgang D.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff, Wales; [Morishita, Tomoaki] Kanazawa Univ, Inst Sci & Engn, Fac Geosci & Civil Engn, Kanazawa, Ishikawa, Japan; [Morishita, Tomoaki] Columbia Univ, Lamont Doherty Earth Observ, New York, NY USA; [Morishita, Tomoaki] Japan Agcy Marine Earth Sci & Technol, Volcanoes & Earths Interior Res Ctr, Res Inst Marine Geodynam, Yokosuka, Kanagawa, Japan; [Van Kranendonk, Martin] Univ New South Wales, Australian Ctr Astrobiol, Sydney, NSW, Australia; [Smithies, Hugh] Geol Survey Western Australia, East Perth, WA, Australia	University of Cologne; University of Copenhagen; Cardiff University; Kanazawa University; Columbia University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of New South Wales Sydney; Geological Survey of Western Australia	Fischer-Godde, M (corresponding author), Univ Cologne, Inst Geol & Mineral, Cologne, Germany.	mfisch48@uni-koeln.de	Szilas, Kristoffer/P-4477-2014; Van Kranendonk, Martin J/J-8755-2012	Szilas, Kristoffer/0000-0002-5541-306X; Van Kranendonk, Martin J/0000-0002-0611-2703; Messling, Nils/0000-0003-0977-4689; Munker, Carsten/0000-0001-6406-559X; Elfers, Bo-Magnus/0000-0003-0548-772X; Fischer-Godde, Mario/0000-0001-6839-9001	DFG within the priority programme SPP 1833 'Building a Habitable Earth' [FI 1704/5-1]; European Commission through ERC [669666]; Carlsberg Foundation [CF18-0090]; Kanazawa University "SAKIGAKE"	DFG within the priority programme SPP 1833 'Building a Habitable Earth'(German Research Foundation (DFG)); European Commission through ERC; Carlsberg Foundation(Carlsberg Foundation); Kanazawa University "SAKIGAKE"	We thank F. Wombacher and A. Katzemich for support in the laboratory and K. Tani and I. Nishio for help during fieldwork. This research was supported through DFG grant number FI 1704/5-1 within the priority programme SPP 1833 'Building a Habitable Earth' to M.F.-G., by the European Commission through ERC grant number 669666 'Infant Earth' to C.M., by the Carlsberg Foundation grant number CF18-0090 to K.S., and by Kanazawa University "SAKIGAKE 2018" to T.M. H.S. publishes with the permission of the Executive Director, Geological Survey of Western Australia.	Albarede F, 2009, NATURE, V461, P1227, DOI 10.1038/nature08477; Alexander CMO, 2012, SCIENCE, V337, P721, DOI 10.1126/science.1223474; Becker H, 2006, GEOCHIM COSMOCHIM AC, V70, P4528, DOI 10.1016/j.gca.2006.06.004; Becker JS, 1996, J ANAL ATOM SPECTROM, V11, P643, DOI 10.1039/ja9961100643; Bennett VC, 2002, GEOCHIM COSMOCHIM AC, V66, P2615, DOI 10.1016/S0016-7037(02)00862-1; Bermingham KR, 2018, EARTH PLANET SC LETT, V487, P221, DOI 10.1016/j.epsl.2018.01.017; Bermingham KR, 2017, EARTH PLANET SC LETT, V474, P466, DOI 10.1016/j.epsl.2017.06.052; Braukmuller N, 2019, NAT GEOSCI, V12, P564, DOI 10.1038/s41561-019-0375-x; Brenan JM, 2009, NAT GEOSCI, V2, P798, DOI 10.1038/NGEO658; Budde G, 2019, NAT ASTRON, V3, P736, DOI 10.1038/s41550-019-0779-y; Chen JH, 2010, GEOCHIM COSMOCHIM AC, V74, P3851, DOI 10.1016/j.gca.2010.04.013; Chen K, 2016, GEOCHIM COSMOCHIM AC, V191, P1, DOI 10.1016/j.gca.2016.07.004; Chou CL., 1978, P 9 LUN SCI C, V1, P219; Coggon JA, 2013, NAT GEOSCI, V6, P871, DOI [10.1038/NGEO1911, 10.1038/ngeo1911]; Dale CW, 2017, EARTH PLANET SC LETT, V458, P394, DOI 10.1016/j.epsl.2016.11.001; Day JMD, 2016, REV MINERAL GEOCHEM, V81, P161, DOI 10.2138/rmg.2016.81.04; Fischer-Godde M, 2015, GEOCHIM COSMOCHIM AC, V168, P151, DOI 10.1016/j.gca.2015.07.032; Friend CRL, 2011, GEOLOGY, V39, P663, DOI 10.1130/G31904.1; Friend CRL, 2010, AM J SCI, V310, P826, DOI 10.2475/09.2010.04; Friend CRL, 2002, CONTRIB MINERAL PETR, V143, P71, DOI 10.1007/s00410-001-0332-7; Fujii T, 2006, ASTROPHYS J, V647, P1506, DOI 10.1086/505459; Hidaka H, 1998, GEOCHIM COSMOCHIM AC, V62, P89, DOI 10.1016/S0016-7037(97)00319-0; HIDAKA H, 1993, CHEM GEOL, V106, P187, DOI 10.1016/0009-2541(93)90172-F; Kaufmann FED, 2019, ECON GEOL, V114, P569, DOI 10.5382/econgeo.4641; Maier WD, 2009, NATURE, V460, P620, DOI 10.1038/nature08205; Marchi S, 2018, NAT GEOSCI, V11, P77, DOI 10.1038/s41561-017-0022-3; Marechal CN, 1999, CHEM GEOL, V156, P251, DOI 10.1016/S0009-2541(98)00191-0; Marty B, 2012, EARTH PLANET SC LETT, V313, P56, DOI 10.1016/j.epsl.2011.10.040; Mundl A, 2017, SCIENCE, V356, P66, DOI 10.1126/science.aal4179; Nutman AP, 2007, DEV PREC G, V15, P187, DOI 10.1016/S0166-2635(07)15033-7; Nutman AP, 1996, PRECAMBRIAN RES, V78, P1, DOI 10.1016/0301-9268(95)00066-6; Peslier AH, 2017, SPACE SCI REV, V212, P743, DOI 10.1007/s11214-017-0387-z; Rehkamper M, 1997, TALANTA, V44, P663, DOI 10.1016/S0039-9140(96)02100-5; Rizo H, 2019, GEOCHEM PERSPECT LET, V11, P6, DOI 10.7185/geochemlet.1917; Rizo H, 2016, GEOCHIM COSMOCHIM AC, V175, P319, DOI 10.1016/j.gca.2015.12.007; Rizo H, 2016, SCIENCE, V352, P809, DOI 10.1126/science.aad8563; Rollinson H, 2002, J PETROL, V43, P2143, DOI 10.1093/petrology/43.11.2143; Rubie DC, 2016, SCIENCE, V353, P1141, DOI 10.1126/science.aaf6919; Savard D, 2010, GEOSTAND GEOANAL RES, V34, P281, DOI 10.1111/j.1751-908X.2010.00090.x; Savina MR, 2004, SCIENCE, V303, P649, DOI 10.1126/science.3030649; Schonbachler M, 2010, SCIENCE, V328, P884, DOI 10.1126/science.1186239; Schoenberg R, 1999, EARTH PLANET SC LETT, V172, P49, DOI 10.1016/S0012-821X(99)00198-3; Szilas K, 2018, GEOSCI FRONT, V9, P689, DOI 10.1016/j.gsf.2017.05.003; Szilas K, 2015, GONDWANA RES, V28, P565, DOI 10.1016/j.gr.2014.07.010; Touboul M, 2014, CHEM GEOL, V383, P63, DOI 10.1016/j.chemgeo.2014.05.030; Touboul M, 2012, SCIENCE, V335, P1065, DOI 10.1126/science.1216351; Tusch J, 2019, GEOCHIM COSMOCHIM AC, V257, P284, DOI 10.1016/j.gca.2019.05.012; van de Locht J, 2018, GEOLOGY, V46, P199, DOI 10.1130/G39709.1; Van Kranendonk MJ, 2010, PRECAMBRIAN RES, V177, P145, DOI 10.1016/j.precamres.2009.11.007; Varas-Reus MI, 2019, NAT GEOSCI, V12, P779, DOI 10.1038/s41561-019-0414-7; Walker RJ, 2009, CHEM ERDE-GEOCHEM, V69, P101, DOI 10.1016/j.chemer.2008.10.001; Wang ZC, 2013, NATURE, V499, P328, DOI 10.1038/nature12285; Willbold M, 2015, EARTH PLANET SC LETT, V419, P168, DOI 10.1016/j.epsl.2015.02.040; Willbold M, 2011, NATURE, V477, P195, DOI 10.1038/nature10399	56	37	38	6	38	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7798					240	+		10.1038/s41586-020-2069-3	http://dx.doi.org/10.1038/s41586-020-2069-3			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU0CC	32161386	Green Accepted, Green Submitted			2022-12-28	WOS:000519378900024
J	Constantin, T; Zanini, M; Regni, A; Sheikh, NS; Julia, F; Leonori, D				Constantin, Timothee; Zanini, Margherita; Regni, Alessio; Sheikh, Nadeem S.; Julia, Fabio; Leonori, Daniele			Aminoalkyl radicals as halogen-atom transfer agents for activation of alkyl and aryl halides	SCIENCE			English	Article							LIGHT PHOTOREDOX CATALYSIS; CROSS-COUPLING REACTIONS; ABSOLUTE RATE CONSTANTS; HECK REACTION; UNACTIVATED ALKYL; CARBOXYLIC-ACIDS; FUNCTIONALIZATION; POTENTIALS; OXIDATION; ARYLATION	Organic halides are important building blocks in synthesis, but their use in (photo)redox chemistry is limited by their low reduction potentials. Halogen-atom transfer remains the most reliable approach to exploit these substrates in radical processes despite its requirement for hazardous reagents and initiators such as tributyltin hydride. In this study, we demonstrate that alpha-aminoalkyl radicals, easily accessible from simple amines, promote the homolytic activation of carbon-halogen bonds with a reactivity profile mirroring that of classical tin radicals. This strategy conveniently engages alkyl and aryl halides in a wide range of redox transformations to construct sp(3)-sp(3), sp(3)-sp(2), and sp(2)-sp(2) carbon-carbon bonds under mild conditions with high chemoselectivity.	[Constantin, Timothee; Zanini, Margherita; Regni, Alessio; Julia, Fabio; Leonori, Daniele] Univ Manchester, Dept Chem, Manchester M13 9PL, Lancs, England; [Sheikh, Nadeem S.] King Faisal Univ, Dept Chem, Coll Sci, Al Hasa 31982, Saudi Arabia	University of Manchester; King Faisal University	Julia, F; Leonori, D (corresponding author), Univ Manchester, Dept Chem, Manchester M13 9PL, Lancs, England.	fabio.juliahernandez@manchester.ac.uk; daniele.leonori@manchester.ac.uk	Sheikh, Nadeem S/A-2061-2010; Zanini, Margherita/GQR-0668-2022; Julia, Fabio/E-7414-2012	Sheikh, Nadeem S/0000-0002-0716-7562; Julia, Fabio/0000-0001-8903-4482; Constantin, Timothee/0000-0001-5376-1557; Leonori, Daniele/0000-0002-7692-4504; Regni, Alessio/0000-0002-2188-1789	EPSRC [EP/P004997/1]; European Research Council [758427]	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission)	D.L. thanks EPSRC for a Fellowship (EP/P004997/1) and the European Research Council for a research grant (758427).	ACHAB S, 1990, J CHEM SOC PERK T 1, P2863, DOI 10.1039/p19900002863; Akram MO, 2017, ORG LETT, V19, P3075, DOI 10.1021/acs.orglett.7b01148; Alacid E, 2009, J ORG CHEM, V74, P2321, DOI 10.1021/jo802356n; Alpers D, 2017, ANGEW CHEM INT EDIT, V56, P1402, DOI 10.1002/anie.201610974; [Anonymous], 2014, ECTROCHEMICAL SERIES; Aycock RA, 2018, ACS CATAL, V8, P9115, DOI 10.1021/acscatal.8b03031; Basu B, 2003, TETRAHEDRON LETT, V44, P8931, DOI 10.1016/j.tetlet.2003.10.019; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Cao JJ, 2010, ANGEW CHEM INT EDIT, V49, P4976, DOI 10.1002/anie.201000896; Chatgilialoglu C, 2018, CHEM REV, V118, P6516, DOI 10.1021/acs.chemrev.8b00109; Chatupheeraphat A, 2018, J AM CHEM SOC, V140, P3724, DOI 10.1021/jacs.7b12865; Chen WC, 2012, CHEM COMMUN, V48, P6702, DOI 10.1039/c2cc32519e; COHEN SG, 1973, CHEM REV, V73, P141, DOI 10.1021/cr60282a004; Dennington R., 2009, GAUSS VIEW VERSION 5; DiLabio GA, 2000, J PHYS CHEM A, V104, P1938, DOI 10.1021/jp9938617; Dong JY, 2019, J ORG CHEM, V84, P7532, DOI 10.1021/acs.joc.9b00972; Duncton MAJ, 2009, J ORG CHEM, V74, P6354, DOI 10.1021/jo9010624; Everson DA, 2014, J ORG CHEM, V79, P4793, DOI 10.1021/jo500507s; Fawcett A, 2017, SCIENCE, V357, DOI 10.1126/science.aan3679; Frisch M. J., 2016, GAUSSIAN 16 REV C01; Fujiwara Y, 2012, NATURE, V492, P95, DOI 10.1038/nature11680; Ghosh I, 2014, SCIENCE, V346, P725, DOI 10.1126/science.1258232; Gianatassio R, 2019, ORG LETT, V21, P2060, DOI 10.1021/acs.orglett.9b00321; Gianatassio R, 2014, ANGEW CHEM INT EDIT, V53, P9851, DOI 10.1002/anie.201406622; Gonnard L, 2015, CHEM-EUR J, V21, P12797, DOI 10.1002/chem.201501543; GRILLER D, 1981, J AM CHEM SOC, V103, P619, DOI 10.1021/ja00393a020; Grimme S, 2011, J COMPUT CHEM, V32, P1456, DOI 10.1002/jcc.21759; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Huihui KMM, 2017, ORG LETT, V19, P340, DOI 10.1021/acs.orglett.6b03509; INGOLD KU, 1984, J AM CHEM SOC, V106, P343, DOI 10.1021/ja00314a016; Ishimatsu R, 2013, J PHYS CHEM A, V117, P5607, DOI 10.1021/jp404120s; Jeffrey JL, 2015, J AM CHEM SOC, V137, P8404, DOI 10.1021/jacs.5b05376; Jiao ZW, 2018, ANGEW CHEM INT EDIT, V57, P6294, DOI 10.1002/anie.201801967; Kim H, 2012, ANGEW CHEM INT EDIT, V51, P12303, DOI 10.1002/anie.201203599; Koeller J, 2019, SYNTHESIS-STUTTGART, V51, P1284, DOI 10.1055/s-0037-1611633; Koy M, 2018, CHEM-EUR J, V24, P4552, DOI 10.1002/chem.201800813; Kuhn HJ, 2004, PURE APPL CHEM, V76, P2105, DOI 10.1351/pac200476122105; Kuo JL, 2018, J AM CHEM SOC, V140, P4512, DOI 10.1021/jacs.8b02119; Kurandina D, 2017, ANGEW CHEM INT EDIT, V56, P14212, DOI 10.1002/anie.201706554; Lafrance M, 2012, ANGEW CHEM INT EDIT, V51, P3470, DOI 10.1002/anie.201108287; Laha JK, 2015, J ORG CHEM, V80, P11351, DOI 10.1021/acs.joc.5b01872; Lalevee J, 2008, CHEM PHYS LETT, V454, P415, DOI 10.1016/j.cplett.2008.02.052; Lalevee J, 2007, J PHYS CHEM A, V111, P6991, DOI 10.1021/jp071720w; Le C, 2018, SCIENCE, V360, P1010, DOI 10.1126/science.aat4133; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lee KN, 2017, J AM CHEM SOC, V139, P5003, DOI 10.1021/jacs.7b01373; Leveque C, 2016, CHEM COMMUN, V52, P9877, DOI 10.1039/c6cc04636c; Liu YX, 2013, SYNLETT, V24, P507, DOI 10.1055/s-0032-1318155; Liu ZW, 2019, TETRAHEDRON LETT, V60, P485, DOI 10.1016/j.tetlet.2019.01.010; Loh YY, 2017, SCIENCE, V358, P1182, DOI 10.1126/science.aap9674; Luo J, 2016, ACS CATAL, V6, P873, DOI 10.1021/acscatal.5b02204; Matsui JK, 2017, ACS CATAL, V7, P2563, DOI 10.1021/acscatal.7b00094; McTiernan CD, 2014, ACS CATAL, V4, P4034, DOI 10.1021/cs501030f; Mennucci B, 1997, J PHYS CHEM B, V101, P10506, DOI 10.1021/jp971959k; Nacsa ED, 2018, J AM CHEM SOC, V140, P3322, DOI 10.1021/jacs.7b12768; Nakajima K, 2016, ACCOUNTS CHEM RES, V49, P1946, DOI 10.1021/acs.accounts.6b00251; Nawrat CC, 2015, J AM CHEM SOC, V137, P11270, DOI 10.1021/jacs.5b07678; Netherton MR, 2005, TOP ORGANOMETAL CHEM, V14, P85; NEUMANN WP, 1987, SYNTHESIS-STUTTGART, P665; Nguyen JD, 2012, NAT CHEM, V4, P854, DOI 10.1038/NCHEM.1452; Nocera G, 2018, J AM CHEM SOC, V140, P9751, DOI 10.1021/jacs.8b06089; OLAH GA, 1993, J AM CHEM SOC, V115, P7246, DOI 10.1021/ja00069a024; Parr R. G., 1989, INT SERIES MONOGRAPH, V16; Pavlishchuk VV, 2000, INORG CHIM ACTA, V298, P97, DOI 10.1016/S0020-1693(99)00407-7; Pitre SP, 2019, J AM CHEM SOC, V141, P2800, DOI 10.1021/jacs.8b11790; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Richmond E, 2018, SYNTHESIS-STUTTGART, V50, P499, DOI 10.1055/s-0036-1591853; Rossler SL, 2020, ANGEW CHEM INT EDIT, V59, P9264, DOI 10.1002/anie.201911660; Romero NA, 2016, CHEM REV, V116, P10075, DOI 10.1021/acs.chemrev.6b00057; Roth HG, 2016, SYNLETT, V27, P714, DOI 10.1055/s-0035-1561297; Scaiano J. C., 2005, REACTIVE INTERMEDIAT, P847; Sevrin MJ, 2018, TETRAHEDRON, V74, P3246, DOI 10.1016/j.tet.2018.04.053; Shen YY, 2017, ACS CATAL, V7, P409, DOI 10.1021/acscatal.6b03205; Shin JA, 2019, J ORG CHEM, V84, P4558, DOI 10.1021/acs.joc.9b00369; Silvi M, 2019, J AM CHEM SOC, V141, P9511, DOI 10.1021/jacs.9b03653; Smith JM, 2018, ACCOUNTS CHEM RES, V51, P1807, DOI 10.1021/acs.accounts.8b00209; Soulard V, 2018, J AM CHEM SOC, V140, P155, DOI 10.1021/jacs.7b12105; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Sun GQ, 2016, ORG LETT, V18, P544, DOI 10.1021/acs.orglett.5b03581; Sun X, 2018, NAT CHEM, V10, P1229, DOI 10.1038/s41557-018-0142-4; TAMBLYN WH, 1980, J ORG CHEM, V45, P3912, DOI 10.1021/jo01307a037; Tan SLJ, 2012, J AM CHEM SOC, V134, P5954, DOI 10.1021/ja300191u; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Tuyishime M, 2016, BIOORG MED CHEM LETT, V26, P228, DOI 10.1016/j.bmcl.2015.10.080; Wang GZ, 2018, ORG LETT, V20, P888, DOI 10.1021/acs.orglett.8b00023; Wang GZ, 2017, J AM CHEM SOC, V139, P18307, DOI 10.1021/jacs.7b10009; Wang GZ, 2015, ORG LETT, V17, P3682, DOI 10.1021/acs.orglett.5b01612; Wang X, 2011, J AM CHEM SOC, V133, P16410, DOI 10.1021/ja207775a; WAYNER DDM, 1986, CHEM PHYS LETT, V131, P189, DOI 10.1016/0009-2614(86)80542-5; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Wu JJ, 2019, ANGEW CHEM INT EDIT, V58, P5697, DOI 10.1002/anie.201814452; Xia ZH, 2018, ORG LETT, V20, P3496, DOI 10.1021/acs.orglett.8b01268; Xuan J, 2015, ANGEW CHEM INT EDIT, V54, P15632, DOI 10.1002/anie.201505731; Yorimitsu H, 2005, ANGEW CHEM INT EDIT, V44, P4435, DOI 10.1002/anie.200500653; Yorimitsu H., 2008, RADICALS ORGANIC SYN, P11; Zhang P, 2016, J AM CHEM SOC, V138, P8084, DOI 10.1021/jacs.6b04818; Zheng ZR, 2000, J ORG CHEM, V65, P1793, DOI 10.1021/jo991709v; Zhou CS, 2011, GREEN CHEM, V13, P2100, DOI 10.1039/c1gc15060j; Zhou F, 2018, ANGEW CHEM INT EDIT, V57, P4058, DOI 10.1002/anie.201712731	99	160	159	27	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2020	367	6481					1021	+		10.1126/science.aba2419	http://dx.doi.org/10.1126/science.aba2419			193	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KS0CO	32108109	Green Submitted			2022-12-28	WOS:000517979600038
J	Xu, SY; Ma, Q; Gao, Y; Kogar, A; Zong, A; Valdivia, AMM; Dinh, TH; Huang, SM; Singh, B; Hsu, CH; Chang, TR; Ruff, JPC; Watanabe, K; Taniguchi, T; Lin, H; Karapetrov, G; Xiao, D; Jarillo-Herrero, P; Gedik, N				Xu, Su-Yang; Ma, Qiong; Gao, Yang; Kogar, Anshul; Zong, Alfred; Mier Valdivia, Andres M.; Dinh, Thao H.; Huang, Shin-Ming; Singh, Bahadur; Hsu, Chuang-Han; Chang, Tay-Rong; Ruff, Jacob P. C.; Watanabe, Kenji; Taniguchi, Takashi; Lin, Hsin; Karapetrov, Goran; Xiao, Di; Jarillo-Herrero, Pablo; Gedik, Nuh			Spontaneous gyrotropic electronic order in a transition-metal dichalcogenide	NATURE			English	Article							SUPERCONDUCTIVITY	Chirality is ubiquitous in nature, and populations of opposite chiralities are surprisingly asymmetric at fundamental levels(1,2). Examples range from parity violation in the subatomic weak force to homochirality in biomolecules. The ability to achieve chirality-selective synthesis (chiral induction) is of great importance in stereochemistry, molecular biology and pharmacology(2). In condensed matter physics, a crystalline electronic system is geometrically chiral when it lacks mirror planes, space-inversion centres or rotoinversion axes(1). Typically, geometrical chirality is predefined by the chiral lattice structure of a material, which is fixed on formation of the crystal. By contrast, in materials with gyrotropic order(3-6), electrons spontaneously organize themselves to exhibit macroscopic chirality in an originally achiral lattice. Although such order-which has been proposed as the quantum analogue of cholesteric liquid crystals-has attracted considerable interest(3-15), no clear observation or manipulation of gyrotropic order has been achieved so far. Here we report the realization of optical chiral induction and the observation of a gyrotropically ordered phase in the transition-metal dichalcogenide semimetal 1T-TiSe2. We show that shining mid-infrared circularly polarized light on 1T-TiSe2 while cooling it below the critical temperature leads to the preferential formation of one chiral domain. The chirality of this state is confirmed by the measurement of an out-of-plane circular photogalvanic current, the direction of which depends on the optical induction. Although the role of domain walls requires further investigation with local probes, the methodology demonstrated here can be applied to realize and control chiral electronic phases in other quantum materials(4,16). Optical chiral induction and spontaneous gyrotropic electronic order are realized in the transition-metal chalcogenide 1T-TiSe2 by using illumination with mid-infrared circularly polarized light and simultaneous cooling below the critical temperature.	[Xu, Su-Yang; Ma, Qiong; Kogar, Anshul; Zong, Alfred; Mier Valdivia, Andres M.; Dinh, Thao H.; Jarillo-Herrero, Pablo; Gedik, Nuh] MIT, Dept Phys, Cambridge, MA 02139 USA; [Gao, Yang; Xiao, Di] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; [Huang, Shin-Ming] Natl Sun Yat Sen Univ, Dept Phys, Kaohsiung, Taiwan; [Singh, Bahadur] Shenzhen Univ, SZU NUS Collaborat Ctr & Int Collaborat Lab 2D Ma, Engn Technol Res Ctr 2D Mat Informat Funct Device, Coll Optoelect Engn, Shenzhen, Peoples R China; [Singh, Bahadur] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Hsu, Chuang-Han] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore, Singapore; [Chang, Tay-Rong] Natl Cheng Kung Univ, Dept Phys, Tainan, Taiwan; [Ruff, Jacob P. C.] Cornell Univ, CHESS, Ithaca, NY USA; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [Lin, Hsin] Acad Sinica, Inst Phys, Taipei, Taiwan; [Karapetrov, Goran] Drexel Univ, Dept Phys, Philadelphia, PA 19104 USA; [Karapetrov, Goran] Drexel Univ, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA	Massachusetts Institute of Technology (MIT); Carnegie Mellon University; National Sun Yat Sen University; Shenzhen University; Northeastern University; National University of Singapore; National Cheng Kung University; Cornell University; National Institute for Materials Science; Academia Sinica - Taiwan; Drexel University; Drexel University	Jarillo-Herrero, P; Gedik, N (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	pjarillo@mit.edu; gedik@mit.edu	Singh, Bahadur/GPW-6401-2022; Lin, Hsin/F-9568-2012; Chang, Tay-Rong/K-3943-2015; Karapetrov, Goran/C-2840-2008; Xiao, Di/B-1830-2008; Hsu, Chuang-Han/N-4505-2019; Singh, Bahadur/H-3883-2016; Jarillo-Herrero, Pablo/E-3755-2013	Lin, Hsin/0000-0002-4688-2315; Chang, Tay-Rong/0000-0003-1222-2527; Karapetrov, Goran/0000-0003-1113-0137; Xiao, Di/0000-0003-0165-6848; Hsu, Chuang-Han/0000-0002-2394-8537; Singh, Bahadur/0000-0002-2013-1126; Zong, Alfred/0000-0003-2047-3801; Jarillo-Herrero, Pablo/0000-0001-8217-8213	US Department of Energy, Office of Science, Office of Basic Energy Sciences; Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF 4541]; AFOSR [FA9550-16-1-0382]; US Department of Energy Office of Science, Office of Basic Energy Sciences, through the Ames Laboratory [DE-AC02-07CH11358]; National Science Foundation (NSF) [DMR-0819762]; NSF [DMR-1332208, DMR-1829070]; Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division [DE-SC0012509]; JSPS KAKENHI [JP18K19136]; CREST [JPMJCR15F3]; JST; Young Scholar Fellowship Program of the Ministry of Science and Technology (MOST) in Taiwan; MOST grant for the Columbus Program [MOST108-2636-M-006-002]; National Center for Theoretical Sciences, Taiwan; MOST, Taiwan [MOST107-2627-E-006-001]; Higher Education Sprout Project, Ministry of Education from the Headquarters of University Advancement at National Cheng Kung University (NCKU); Ministry of Science and Technology (MoST) in Taiwan [105-2112-M-110-014-MY3]; Academia Sinica, Taiwan [AS-iMATE-107-11]	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation's EPiQS Initiative; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); US Department of Energy Office of Science, Office of Basic Energy Sciences, through the Ames Laboratory(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST(Core Research for Evolutional Science and Technology (CREST)); JST(Japan Science & Technology Agency (JST)); Young Scholar Fellowship Program of the Ministry of Science and Technology (MOST) in Taiwan; MOST grant for the Columbus Program; National Center for Theoretical Sciences, Taiwan; MOST, Taiwan(Ministry of Science and Technology, Taiwan); Higher Education Sprout Project, Ministry of Education from the Headquarters of University Advancement at National Cheng Kung University (NCKU); Ministry of Science and Technology (MoST) in Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica, Taiwan(Academia Sinica - Taiwan)	We thank X. Xu, V. Fatemi, E. J. Sie and S. Fang for discussions. N.G., S.-Y.X., A.K. and A.Z. acknowledge support from the US Department of Energy, Office of Science, Office of Basic Energy Sciences, DMSE (data taking and analysis) and the Gordon and Betty Moore Foundation's EPiQS Initiative through grant GBMF4540 (manuscript writing). Work in P.J.-H. group was supported through AFOSR grant FA9550-16-1-0382 (fabrication and measurement), as well as through the Center for the Advancement of Topological Semimetals, an Energy Frontier Research Center funded by the US Department of Energy Office of Science, Office of Basic Energy Sciences, through the Ames Laboratory under contract DE-AC02-07CH11358 (data analysis), and the Gordon and Betty Moore Foundation's EPiQS Initiative through grant GBMF 4541 to P.J.-H. This work made use of the Materials Research Science and Engineering Center Shared Experimental Facilities supported by the National Science Foundation (NSF) (grant number DMR-0819762). The work at Drexel University was supported by NSF through grant number ECCS-1711015. Research conducted at CHESS is supported by the NSF via awards DMR-1332208 and DMR-1829070. Work at CMU was supported by the Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division, through grant number DE-SC0012509. K.W. and T.T. acknowledge support from the Elemental Strategy Initiative conducted by MEXT, Japan, JSPS KAKENHI grant numbers JP18K19136 and CREST (JPMJCR15F3), JST. T.-R.C. was supported by the Young Scholar Fellowship Program of the Ministry of Science and Technology (MOST) in Taiwan, under a MOST grant for the Columbus Program MOST108-2636-M-006-002, National Cheng Kung University, Taiwan, and National Center for Theoretical Sciences, Taiwan. This work was supported partially by MOST, Taiwan, via grant MOST107-2627-E-006-001. This research was supported in part by a Higher Education Sprout Project, Ministry of Education from the Headquarters of University Advancement at National Cheng Kung University (NCKU). S.-M.H. acknowledges support by the Ministry of Science and Technology (MoST) in Taiwan under grant number 105-2112-M-110-014-MY3. H.L. acknowledges Academia Sinica, Taiwan for support under Innovative Materials and Analysis Technology Exploration (AS-iMATE-107-11).	Armitage NP, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.035135; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Castellan JP, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.196404; Chang GQ, 2018, NAT MATER, V17, P978, DOI 10.1038/s41563-018-0169-3; Chen P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9943; de Juan F, 2017, NAT COMMUN, V8; Dhara S, 2015, SCIENCE, V349, P726, DOI 10.1126/science.aac6275; Feringa BL, 1999, ANGEW CHEM INT EDIT, V38, P3419; Fradkin E, 2010, ANNU REV CONDEN MA P, V1, P153, DOI 10.1146/annurev-conmatphys-070909-103925; Fu L, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.026401; Ganesh R, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.177001; Gradhand M, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.041111; Hildebrand B, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.136404; Holt M, 2001, PHYS REV LETT, V86, P3799, DOI 10.1103/PhysRevLett.86.3799; Hosur P, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115116; Hosur P, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.035309; Iavarone M, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.155103; Ishioka J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.176401; Ivchenko EL, 2008, SPRINGER SER SOLID-S, V157, P245, DOI 10.1007/978-3-540-78820-1_9; Ji ZR, 2019, NAT MATER, V18, P955, DOI 10.1038/s41563-019-0421-5; Kidd TE, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.226402; Kirilyuk A, 2010, REV MOD PHYS, V82, P2731, DOI 10.1103/RevModPhys.82.2731; Kogar A, 2017, SCIENCE, V358, P1315, DOI 10.1126/science.aam6432; Kozii V, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.207002; LAKHANI AA, 1983, PHYS REV B, V28, P1978, DOI 10.1103/PhysRevB.28.1978; Li G, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.027404; Li LJ, 2016, NATURE, V529, P185, DOI 10.1038/nature16175; Lim S, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.121301; Ma Q, 2017, NAT PHYS, V13, P842, DOI [10.1038/nphys4146, 10.1038/NPHYS4146]; McIver JW, 2012, NAT NANOTECHNOL, V7, P96, DOI [10.1038/nnano.2011.214, 10.1038/NNANO.2011.214]; Morimoto T, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501524; Morosan E, 2006, NAT PHYS, V2, P544, DOI 10.1038/nphys360; Olbrich P, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.121302; Orenstein J, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.165110; Plank H, 2018, SOLID STATE ELECTRON, V147, P44, DOI 10.1016/j.sse.2018.06.002; Porer M, 2014, NAT MATER, V13, P857, DOI [10.1038/nmat4042, 10.1038/NMAT4042]; Sipe JE, 2000, PHYS REV B, V61, P5337, DOI 10.1103/PhysRevB.61.5337; Sugawara Y., 2018, PREPRINT; van Wezel J, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/67011; Varma CM, 2014, EPL-EUROPHYS LETT, V106, DOI 10.1209/0295-5075/106/27001; Wagniere G. H, 2008, CHIRALITY UNIVERSAL; Xu SY, 2018, NAT PHYS, V14, P900, DOI 10.1038/s41567-018-0189-6; Yuan HT, 2014, NAT NANOTECHNOL, V9, P851, DOI [10.1038/NNANO.2014.183, 10.1038/nnano.2014.183]; Zenker B, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.075138	46	48	48	11	147	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB	2020	578	7796					545	+		10.1038/s41586-020-2011-8	http://dx.doi.org/10.1038/s41586-020-2011-8			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KP9SJ	32103195	Green Published, Green Submitted			2022-12-28	WOS:000516571100015
J	Rucker, DW				Rucker, Donald W.			Implementing the Cures Act - Bringing Consumer Computing to Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rucker, Donald W.] US Dept HHS, Off Natl Coordinator Hlth Informat Technol, Washington, DC 20201 USA		Rucker, DW (corresponding author), US Dept HHS, Off Natl Coordinator Hlth Informat Technol, Washington, DC 20201 USA.							[Anonymous], 2019, NY TIMES; Himmelstein DU, 2019, AM J PUBLIC HEALTH, V109, P431, DOI 10.2105/AJPH.2018.304901; Mandl KD, 2009, NEW ENGL J MED, V360, P1278, DOI 10.1056/NEJMp0900411; Office of the National Coordinator for Health Information Technology, 2020, UN COR DAT INT USCDI	4	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2020	382	19					1779	1781		10.1056/NEJMp2003890	http://dx.doi.org/10.1056/NEJMp2003890			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LO1TS	32160450				2022-12-28	WOS:000533411000007
J	Chinazzi, M; Davis, JT; Ajelli, M; Gioannini, C; Litvinova, M; Merler, S; Piontti, APY; Mu, KP; Rossi, L; Sun, KY; Viboud, C; Xiong, XY; Yu, HJ; Halloran, ME; Longini, IM; Vespignani, A				Chinazzi, Matteo; Davis, Jessica T.; Ajelli, Marco; Gioannini, Corrado; Litvinova, Maria; Merler, Stefano; Pastore y Piontti, Ana; Mu, Kunpeng; Rossi, Luca; Sun, Kaiyuan; Viboud, Cecile; Xiong, Xinyue; Yu, Hongjie; Halloran, M. Elizabeth; Longini, Ira M., Jr.; Vespignani, Alessandro			The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak	SCIENCE			English	Article							TRANSMISSION DYNAMICS; WUHAN	Motivated by the rapid spread of coronavirus disease 2019 (COVID-19) in mainland China, we use a global metapopulation disease transmission model to project the impact of travel limitations on the national and international spread of the epidemic. The model is calibrated on the basis of internationally reported cases and shows that, at the start of the travel ban from Wuhan on 23 January 2020, most Chinese cities had already received many infected travelers. The travel quarantine of Wuhan delayed the overall epidemic progression by only 3 to 5 days in mainland China but had a more marked effect on the international scale, where case importations were reduced by nearly 80% until mid-February. Modeling results also indicate that sustained 90% travel restrictions to and from mainland China only modestly affect the epidemic trajectory unless combined with a 50% or higher reduction of transmission in the community.	[Chinazzi, Matteo; Davis, Jessica T.; Pastore y Piontti, Ana; Mu, Kunpeng; Xiong, Xinyue; Vespignani, Alessandro] Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA; [Ajelli, Marco; Merler, Stefano] Bruno Kessler Fdn, Trento, Italy; [Gioannini, Corrado; Litvinova, Maria; Rossi, Luca; Vespignani, Alessandro] ISI Fdn, Turin, Italy; [Sun, Kaiyuan; Viboud, Cecile] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA; [Yu, Hongjie] Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ, Shanghai, Peoples R China; [Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Halloran, M. Elizabeth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Longini, Ira M., Jr.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Gainesville, FL 32611 USA	Northeastern University; Fondazione Bruno Kessler; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Fudan University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; State University System of Florida; University of Florida	Vespignani, A (corresponding author), Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA.; Vespignani, A (corresponding author), ISI Fdn, Turin, Italy.; Longini, IM (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Gainesville, FL 32611 USA.	ilongini@ufl.edu; a.vespignani@northeastern.edu	Litvinova, Maria/AAX-1115-2020; Ajelli, Marco/AAX-1113-2020; Yu, Hongjie/GZK-5351-2022; Pastore y Piontti, Ana/M-6624-2014	Litvinova, Maria/0000-0001-6393-1943; Ajelli, Marco/0000-0003-1753-4749; Pastore y Piontti, Ana/0000-0002-2894-0489; Vespignani, Alessandro/0000-0003-3419-4205; Chinazzi, Matteo/0000-0002-5955-1929	EU H2020 MOOD project; EU H2020 Icarus project; Google Cloud Healthcare and Life Sciences Solutions via the GCP research credits program;  [MIDAS-U54GM111274]	EU H2020 MOOD project; EU H2020 Icarus project; Google Cloud Healthcare and Life Sciences Solutions via the GCP research credits program(Google Incorporated); 	M.E.H. acknowledges the support of the MIDAS-U54GM111274. S.M. and M.A. acknowledge support from the EU H2020 MOOD project. C.G. and L.R. acknowledge support from the EU H2020 Icarus project. M.C. and A.V. acknowledge support from Google Cloud Healthcare and Life Sciences Solutions via the GCP research credits program. The findings and conclusions in this study are those of the authors and do not necessarily represent the official position of the funding agencies, the National Institutes of Health, or the U.S. Department of Health and Human Services.	Anderson, 2020, CLOCK TMRCA BASED 27; [Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], 2020, JAPAN TIMES; [Anonymous], 2020, CHANNEL NEWS ASIA CN; [Anonymous], 2020, THE NATIONAL; [Anonymous], 2020, HUFFPOST; [Anonymous], 2020, REUTERS; [Anonymous], 2020, ABC NEWS; [Anonymous], 2020, CNA; [Anonymous], 2020, BUSINESS INSIDER; [Anonymous], 2020, STRAITS TIMES; [Anonymous], 2020, 7NEWS; [Anonymous], 2020, MALAY MAIL; [Anonymous], 2020, S CHINA MORNING POST; [Anonymous], 2020, TAIWAN NEWS; [Anonymous], 2020, IL MESSAGGERO; [Anonymous], 2020, AUSTRALIAN; [Anonymous], 2020, The New Strait Times; [Anonymous], 2020, NY TIMES; [Anonymous], 2020, THE KOREA HERALD; [Anonymous], 2020, XINHUANET; [Anonymous], 2020, EC TIMES; [Anonymous], 2020, GUARDIAN 1026; [Anonymous], 2020, HELSINKI TIMES; [Anonymous], 2020, GLOBAL NEWS; Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Bedford T, 2020, GENOMIC ANAL NCOV SP; CDC, 2020, GLOB COVID 19 PAND N; CDC, 2020, 1 TRAV REL CAS 2019; Center for Systems Science Engineering at Johns Hopkins, 2020, COR COVID 19 GLOB CA; CNN, 2020, CNN; Drake JM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000020; Du ZW, 2020, EMERG INFECT DIS, V26, P1341, DOI [10.1101/2020.02.19.20025452, 10.3201/eid2606.200357]; Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5; Huang C.; Kraemer M., 2020, EPIDEMIOLOGICAL DATA; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Ministry of Health Labour and Welfare Japan., 2020, OUTBR PAT PNEUM ASS; Ministry of Health Singapore, 2020, 2 MOR CAS CONF IMP C; Niehus R., 2020, MEDRXIV, DOI 10.1101/2020.02.13.20022707v2; Rambaut A, 2020, PRELIMINARY PHYLOGEN; Read J. M., 2020, MEDRXIV, DOI 10.1101/2020.01.23.20018549; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Riley S., 2020, REPORT 3 TRANSMISSIB, DOI DOI 10.25561/77148; Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058; Sun KY, 2020, LANCET DIGIT HEALTH, V2, pE201, DOI 10.1016/S2589-7500(20)30026-1; Sunnaker M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002803; Tian H., 2020, MEDRXIV; VNExpress, 2020, VNEXPRESS; WHO, 2020, NOV COR REP KOR EX C; World Health Organization, 2020, WHO; World Health Organization, 2020, WHO NOV COR JAP EXCH; World Health Organization, 2020, MENT HLTH PSYCH CONS; World Health Organization, 2020, NOV COR THAIL EX CHI; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050; MAN RET WUH CHIN 1 C; AB S CBN NEWS; JAP CONF 4 CAS NEW C; CDC CONF 7 CAS 2019; MIN PUBL HLTH REC 2; TOUI IRE NEWS; 4 NOV COR CAS VICT; SINCHEW; P NATL ACAD SCI US; CAMB CONF 1 COR CAS; 2 MOR CONF IMP CAS N; THE ONLINE CITIZEN; 3 OTH COR CAS BAV CO; UPD NOV COR INF KOR; TOUI TRE NEWS; ZENODO; 2019 NOV COR CAS CON; 3 MOR CONF IMP CAS W; 5 CONF IMP CAS WUH C; 7NEWS COM AU; NEWS COM; OUTBR PNEUM PAT REL; PATTAYA NEWS; OUTBR PAT PNEUM REL; VIS TOUR DEM WUH COR; NEW COR CAS JAP RIS; UPD NOV COR INF ON M; MIN PUBL HLTH RAIS S; REPRO 3 TRANSMISSIBI; ABC 7 NEWS; WLTZ FIRST NEWS; MEDRXIV; ZENADO; GENORRIC ANAL NCOV S; OUTBR PNEUM REL NEW; 4 MOR CAS NOV COR HA	98	1702	1742	74	476	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2020	368	6489					395	+		10.1126/science.aba9757	http://dx.doi.org/10.1126/science.aba9757			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LH0XH	32144116	Green Published, Green Accepted			2022-12-28	WOS:000528513300038
J	Stensrud, MJ; Hernan, MA				Stensrud, Mats J.; Hernan, Miguel A.			Why Test for Proportional Hazards?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ESTROGEN PLUS PROGESTIN; WOMEN	This JAMA Guide to Statistics and Methods explains the meaning underlying the proportional hazards (PH) assumption underlying Cox regression and survival analyses, and proposes that reports of survival differences might replace statistical tests of the PH assumption because they are more meaningful.	[Stensrud, Mats J.; Hernan, Miguel A.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA; [Stensrud, Mats J.] Univ Oslo, Dept Biostat, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [Hernan, Miguel A.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Hernan, Miguel A.] Harvard MIT Div Hlth Sci & Technol, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Stensrud, MJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	mstensrud@hsph.harvard.edu						COX DR, 1972, J R STAT SOC B, V34, P187; DiRienzo AG, 2001, J R STAT SOC B, V63, P745, DOI 10.1111/1467-9868.00310; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; Holme O, 2014, JAMA-J AM MED ASSOC, V312, P606, DOI 10.1001/jama.2014.8266; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Pak K, 2017, JAMA ONCOL, V3, P1692, DOI 10.1001/jamaoncol.2017.2797; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321	8	89	89	8	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2020	323	14					1401	1402		10.1001/jama.2020.1267	http://dx.doi.org/10.1001/jama.2020.1267			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LH1YB	32167523				2022-12-28	WOS:000528583600020
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: Trump proposes tax cuts and improved health insurance, but millions are not covered	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Calla M., 2020, TRUMP PITCHED 0 PAYR; Collins SR, 2020, LOS ANGELES TIMES; Goldstein J., 2020, NEW YORK TIMES; Nir S.M., 2020, NEW YORK TIMES; US Capitol Washington DC, 2020, PRES TRUMP M REP SEN	5	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2020	368								m993	10.1136/bmj.m993	http://dx.doi.org/10.1136/bmj.m993			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AR	32161091	Bronze			2022-12-28	WOS:000520012800014
J	McNutt, M				McNutt, Marcia			Frank Press (1924-2020) Policy adviser and National Academy of Sciences president	SCIENCE			English	Biographical-Item									[McNutt, Marcia] Natl Acad Sci, 2101 Constitut Ave Nw, Washington, DC 20418 USA; [McNutt, Marcia] Natl Acad Sci Engn & Med, Natl Res Council, Washington, DC 63028 USA	National Academies of Sciences, Engineering & Medicine; National Academies of Sciences, Engineering & Medicine	McNutt, M (corresponding author), Natl Acad Sci, 2101 Constitut Ave Nw, Washington, DC 20418 USA.; McNutt, M (corresponding author), Natl Acad Sci Engn & Med, Natl Res Council, Washington, DC 63028 USA.	mmcnutt@nas.edu						PRESS F, PUBLICATION LIST	1	0	0	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1077	1077		10.1126/science.abb2626	http://dx.doi.org/10.1126/science.abb2626			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9CD	32139531				2022-12-28	WOS:000520018400026
J	Key, TJ; Bradbury, KE; Perez-Cornago, A; Sinha, R; Tsilidis, KK; Tsugane, S				Key, Timothy J.; Bradbury, Kathryn E.; Perez-Cornago, Aurora; Sinha, Rashmi; Tsilidis, Konstantinos K.; Tsugane, Shoichiro			Diet, nutrition, and cancer risk: what do we know and what is the way forward?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SQUAMOUS-CELL CARCINOMA; HIGH-SALT DIET; COLORECTAL-CANCER; PROSTATE-CANCER; BREAST-CANCER; RANDOMIZED-TRIAL; LUNG-CANCER; BETA-CAROTENE; ESOPHAGEAL; MORTALITY		[Key, Timothy J.; Perez-Cornago, Aurora] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England; [Bradbury, Kathryn E.] Univ Auckland, Natl Inst Hlth Innovat, Sch Populat Hlth, Auckland, New Zealand; [Sinha, Rashmi] NCI, Metab Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Tsilidis, Konstantinos K.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Ioannina, Greece; [Tsilidis, Konstantinos K.] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Tsugane, Shoichiro] Natl Canc Ctr, Ctr Publ Hlth Sci, Tokyo, Japan	University of Oxford; University of Auckland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Ioannina; Imperial College London; National Cancer Center - Japan	Key, TJ (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England.	tim.key@ndph.ox.ac.uk	Bradbury, Kathryn/I-2132-2019; Perez-Cornago, Aurora/C-1097-2016	Bradbury, Kathryn/0000-0003-3345-7333; Perez-Cornago, Aurora/0000-0002-5652-356X; Tsilidis, Konstantinos/0000-0002-8452-8472	Cancer Research UK [C8221/A19170]; Wellcome Trust Our Planet Our Health (Livestock, Environment and People, LEAP) [205212/Z/16/Z]; Girdlers' New Zealand Health Research Council Fellowship; WCRF [2014/1180]; MRC [MR/M012190/1] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Wellcome Trust Our Planet Our Health (Livestock, Environment and People, LEAP); Girdlers' New Zealand Health Research Council Fellowship; WCRF; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was partly supported by Cancer Research UK (C8221/A19170) and the Wellcome Trust Our Planet Our Health (Livestock, Environment and People, LEAP 205212/Z/16/Z). KEB is supported by the Girdlers' New Zealand Health Research Council Fellowship. KKT is supported by WCRF (2014/1180).	Abnet C., 2018, TXB CANC EPIDEMIOLOG, P183, DOI [10.1093/oso/9780190676827.001.0001/oso-9780190676827-chapter-9, DOI 10.1093/OSO/9780190676827.001.0001/OSO-9780190676827-CHAPTER-9]; Aleksandrova K, 2015, AM J CLIN NUTR, V102, P1498, DOI 10.3945/ajcn.115.116095; Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, NEW ENGL J MED, V330, P1029, DOI DOI 10.1056/NEJM199404143301501; Appleby PN, 2016, P NUTR SOC, V75, P287, DOI 10.1017/S0029665115004334; Araghi SO, 2019, CANCER EPIDEM BIOMAR, V28, P275, DOI [10.1158/1055-9965.EPI-17-1198, 10.1158/1055-9965.epi-17-1198]; ARMSTRONG B, 1975, INT J CANCER, V15, P617, DOI 10.1002/ijc.2910150411; Aune D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6617; Bagnardi V, 2015, BRIT J CANCER, V112, P580, DOI 10.1038/bjc.2014.579; Bamia C, 2018, TXB CANC EPIDEMIOLOG, P277; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Bouvard V, 2015, LANCET ONCOL, V16, P1599, DOI 10.1016/S1470-2045(15)00444-1; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brown KF, 2018, BRIT J CANCER, V118, P1130, DOI 10.1038/s41416-018-0029-6; BURKITT DP, 1975, J NATL CANCER I, V54, P3, DOI 10.1093/jnci/54.1.3; Carreras-Torres R, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djx012; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Chang ET, 2018, TXB CANC EPIDEMIOLOG, P159; Chen YW, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1185-1; Cheng KK, 2000, BRIT J CANCER, V83, P127; Cho E, 2004, JNCI-J NATL CANCER I, V96, P1015, DOI 10.1093/jnci/djh185; Correa P, 2000, JNCI-J NATL CANCER I, V92, P1881, DOI 10.1093/jnci/92.23.1881; Dimitrakopoulou VI, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4761; Dong JY, 2011, BREAST CANCER RES TR, V125, P315, DOI 10.1007/s10549-010-1270-8; Farvid MS, 2019, INT J CANCER, V144, P1496, DOI 10.1002/ijc.31653; Fox JG, 1999, CANCER RES, V59, P4823; Gaziano JM, 2009, JAMA-J AM MED ASSOC, V301, P52, DOI 10.1001/jama.2008.862; Giovannucci E, 2019, BRIT J CANCER, V120, P575, DOI 10.1038/s41416-018-0370-9; GRODIN JM, 1973, J CLIN ENDOCR METAB, V36, P207, DOI 10.1210/jcem-36-2-207; HAENSZEL W, 1968, JNCI-J NATL CANCER I, V40, P43; Hashemian M, 2017, CANCER MED-US, V6, P3052, DOI 10.1002/cam4.1247; Hashemian M, 2015, AM J CLIN NUTR, V102, P102, DOI 10.3945/ajcn.115.107847; He YZ, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1119-2; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Inoue M, 2012, ANN ONCOL, V23, P1362, DOI 10.1093/annonc/mdr437; Inoue M, 2009, GUT, V58, P1323, DOI 10.1136/gut.2008.166710; International Agency for Research on Cancer, 2012, IARC MON EV CARC R F, V100F; International Agency for Research on Cancer, 1994, IARC MONOGRAPHS EVAL; International Agency for Research on Cancer, 2018, IARC MONOGRAPHS EVAL, V114; Ioannidis JPA, 2018, JAMA-J AM MED ASSOC, V320, P969, DOI 10.1001/jama.2018.11025; Jung S, 2013, JNCI-J NATL CANCER I, V105, P219, DOI 10.1093/jnci/djs635; Kennedy DA, 2012, J CANCER EPIDEMIOL, V2012, DOI 10.1155/2012/952508; Key TJ, 2019, INT J EPIDEMIOL, V48, P489, DOI 10.1093/ije/dyy238; Kim YI, 2006, GUT, V55, P1387, DOI 10.1136/gut.2006.095463; Kono S, 2004, EUR J CANCER PREV, V13, P127, DOI 10.1097/00008469-200404000-00006; Kyrgiou M, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j477; Lam TK, 2013, AM J CLIN NUTR, V98, P1289, DOI 10.3945/ajcn.113.061267; Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Liu B, 2011, PUBLIC HEALTH NUTR, V14, P1998, DOI 10.1017/S1368980011000942; Loomis D, 2016, LANCET ONCOL, V17, P877, DOI 10.1016/S1470-2045(16)30239-X; Lubin JH, 2014, CANCER EPIDEM BIOMAR, V23, P107, DOI 10.1158/1055-9965.EPI-13-0796; de Rezende LFM, 2019, CANCER EPIDEMIOL, V59, P148, DOI 10.1016/j.canep.2019.01.021; Martin LJ, 2011, CANCER RES, V71, P123, DOI 10.1158/0008-5472.CAN-10-1436; McCAY CLIVE M., 1956, BULL NEW YORK ACAD MED, V32, P91; McCullough ML, 2019, JNCI-J NATL CANCER I, V111, P158, DOI 10.1093/jnci/djy087; Moreschi C, 1909, Z IMMUNITATSFORSCH, V2, P651; MOZAFFARIAN D, 2018, BMJ-BRIT MED J, V361, DOI DOI 10.1136/BMJ.K2392; Murphy N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072715; Nozaki K, 2002, JPN J CANCER RES, V93, P1083, DOI 10.1111/j.1349-7006.2002.tb01209.x; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Pelucchi C, 2015, INT J CANCER, V136, P2912, DOI 10.1002/ijc.29339; Perez-Cornago A, 2018, INT J CANCER, V143, P2677, DOI 10.1002/ijc.31640; Pierce BL, 2018, CURR EPIDEMIOL REP, V5, P184, DOI 10.1007/s40471-018-0144-1; Pirie K, 2016, INT J CANCER, V139, P347, DOI 10.1002/ijc.30084; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Plummer M, 2007, JNCI-J NATL CANCER I, V99, P137, DOI 10.1093/jnci/djk017; Prentice RL, 2006, JAMA-J AM MED ASSOC, V295, P629, DOI 10.1001/jama.295.6.629; Price AJ, 2017, OXFORD TXB UROLOGICA; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Reynolds A, 2019, LANCET, V393, P434, DOI 10.1016/S0140-6736(18)31809-9; Rider JR, 2018, TXB CANC EPIDEMIOLOG, P137; Schoemaker MJ, 2018, JAMA ONCOL, V4, DOI 10.1001/jamaoncol.2018.1771; Schwingshackl L, 2018, INT J CANCER, V142, P1748, DOI 10.1002/ijc.31198; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; SHIMIZU H, 1987, JNCI-J NATL CANCER I, V78, P223; Swerdlow AJ, 2010, OXFORD TXB MED, P193, DOI 10.1093/med/9780199204854.003.0601; Takachi R, 2010, AM J CLIN NUTR, V91, P456, DOI 10.3945/ajcn.2009.28587; Terry P, 2001, EUR J CANCER PREV, V10, P365, DOI 10.1097/00008469-200108000-00010; Travis RC, 2016, CANCER RES, V76, P2288, DOI 10.1158/0008-5472.CAN-15-1551; Tsugane S, 2005, CANCER SCI, V96, P1, DOI 10.1111/j.1349-7006.2005.00006.x; Vieira AR, 2016, ANN ONCOL, V27, P81, DOI 10.1093/annonc/mdv381; Vingeliene S, 2017, ANN ONCOL, V28, P2409, DOI 10.1093/annonc/mdx338; Vollset SE, 2013, LANCET, V381, P1029, DOI 10.1016/S0140-6736(12)62001-7; [World Cancer Research Fund American Institute for Cancer Research], 2007, FOOD NUTR PHYS ACT P; World Cancer Research Fund/American Institute for Cancer Research, 2018, HEIGHT BIRTHW RISK C; World Cancer Research Fund American Institute for Cancer Research, DIET NUTR PHYS ACT C; Yan L, 2009, AM J CLIN NUTR, V89, P1155, DOI 10.3945/ajcn.2008.27029; Yang TO, 2015, AM J CLIN NUTR, V101, P570, DOI 10.3945/ajcn.113.081836; Ye W, 2018, TXB CANC EPIDEMIOLOG, P213; Yu CQ, 2018, ANN INTERN MED, V168, P489, DOI [10.7326/M17-2000, 10.7326/m17-2000]; Zhang XH, 2016, INT J CANCER, V139, P2232, DOI 10.1002/ijc.30293; Zhivagui M, 2019, GENOME RES, V29, P521, DOI 10.1101/gr.242453.118	94	69	71	4	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2020	368								m511	10.1136/bmj.m511	http://dx.doi.org/10.1136/bmj.m511			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KI	32139373	Green Published, hybrid			2022-12-28	WOS:000519537000001
J	Shen, B; Zhang, YJ; Komijani, Y; Nicklas, M; Borth, R; Wang, A; Chen, Y; Nie, ZY; Li, R; Lu, X; Lee, H; Smidman, M; Steglich, F; Coleman, P; Yuan, HQ				Shen, Bin; Zhang, Yongjun; Komijani, Yashar; Nicklas, Michael; Borth, Robert; Wang, An; Chen, Ye; Nie, Zhiyong; Li, Rui; Lu, Xin; Lee, Hanoh; Smidman, Michael; Steglich, Frank; Coleman, Piers; Yuan, Huiqiu			Strange-metal behaviour in a pure ferromagnetic Kondo lattice	NATURE			English	Article							FERMI-LIQUID; SUPERCONDUCTIVITY; ELECTRON	A wide range of metals exhibit anomalous electrical and thermodynamic properties when tuned to a quantum critical point (QCP), although the origins of such strange metals have posed a long-standing mystery. The frequent association of strange metals with unconventional superconductivity and antiferromagnetic QCPs(1-4) has led to the belief that they are highly entangled quantum states(5). By contrast, ferromagnets are regarded as an unlikely setting for strange metals, because they are weakly entangled and their QCPs are often interrupted by competing phases or first-order phase transitions(6-8). Here we provide evidence that the pure ferromagnetic Kondo lattice(9,10) CeRh6Ge4 becomes a strange metal at a pressure-induced QCP. Measurements of the specific heat and resistivity under pressure demonstrate that the ferromagnetic transition is continuously suppressed to zero temperature, revealing a strange-metal behaviour around the QCP. We argue that strong magnetic anisotropy has a key role in this process, injecting entanglement in the form of triplet resonating valence bonds into the ordered ferromagnet. We show that a singular transformation in the patterns of the entanglement between local moments and conduction electrons, from triplet resonating valence bonds to Kondo-entangled singlet pairs at the QCP, causes a jump in the Fermi surface volume-a key driver of strange-metallic behaviour. Our results open up a direction for research into ferromagnetic quantum criticality and establish an alternative setting for the strange-metal phenomenon. Most importantly, strange-metal behaviour at a ferromagnetic QCP suggests that quantum entanglement-not the destruction of antiferromagnetism-is the common driver of the varied behaviours of strange metals.	[Shen, Bin; Zhang, Yongjun; Wang, An; Chen, Ye; Nie, Zhiyong; Li, Rui; Lu, Xin; Lee, Hanoh; Smidman, Michael; Steglich, Frank; Yuan, Huiqiu] Zhejiang Univ, Ctr Correlated Matter, Hangzhou, Peoples R China; [Shen, Bin; Zhang, Yongjun; Wang, An; Chen, Ye; Nie, Zhiyong; Li, Rui; Lu, Xin; Lee, Hanoh; Smidman, Michael; Steglich, Frank; Yuan, Huiqiu] Zhejiang Univ, Dept Phys, Hangzhou, Peoples R China; [Komijani, Yashar; Coleman, Piers] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ USA; [Nicklas, Michael; Borth, Robert; Steglich, Frank] Max Planck Inst Chem Phys Solids, Dresden, Germany; [Coleman, Piers] Royal Holloway Univ London, Dept Phys, Hubbard Theory Consortium, Egham, Surrey, England; [Yuan, Huiqiu] Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Nanjing, Peoples R China; [Lee, Hanoh] Sungkyunkwan Univ, Dept Phys, Ctr Quantum Mat & Superconduct, Suwon, South Korea	Zhejiang University; Zhejiang University; Rutgers State University New Brunswick; Max Planck Society; University of London; Royal Holloway University London; Nanjing University; Sungkyunkwan University (SKKU)	Smidman, M; Yuan, HQ (corresponding author), Zhejiang Univ, Ctr Correlated Matter, Hangzhou, Peoples R China.; Smidman, M; Yuan, HQ (corresponding author), Zhejiang Univ, Dept Phys, Hangzhou, Peoples R China.; Coleman, P (corresponding author), Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ USA.; Coleman, P (corresponding author), Royal Holloway Univ London, Dept Phys, Hubbard Theory Consortium, Egham, Surrey, England.; Yuan, HQ (corresponding author), Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Nanjing, Peoples R China.	msmidman@zju.edu.cn; coleman@physics.rutgers.edu; hqyuan@zju.edu.cn	Nicklas, Michael/B-6344-2008	Nicklas, Michael/0000-0001-6272-2162; Komijani, Yashar/0000-0002-5439-9964; Shen, Bin/0000-0002-2897-0047; Smidman, Michael/0000-0002-6545-0526	National Key R&D Program of China [2017YFA0303100, 2016YFA0300202]; National Natural Science Foundation of China [U1632275, 11974306]; Science Challenge Project of China [TZ2016004]; National Science Foundation of the United States of America [DMR-1830707]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Challenge Project of China; National Science Foundation of the United States of America(National Science Foundation (NSF))	We thank C. Krellner and M. Brando for discussions, G. Cao and Z. Wang for assisting with <SUP>3</SUP>He-SQUID measurements and X. Xiao for assistance with single-crystal X-ray diffraction. This work was supported by the National Key R&D Program of China (grants 2017YFA0303100, 2016YFA0300202), the National Natural Science Foundation of China (grants U1632275, 11974306), the Science Challenge Project of China (grant number TZ2016004) and the National Science Foundation of the United States of America, grant number DMR-1830707.	Belitz D, 1999, PHYS REV LETT, V82, P4707, DOI 10.1103/PhysRevLett.82.4707; Brando M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.026401; Brando M, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.025006; Chubukov AV, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.147003; Custers J, 2003, NATURE, V424, P524, DOI 10.1038/nature01774; Daou R, 2009, NAT PHYS, V5, P31, DOI [10.1038/nphys1109, 10.1038/NPHYS1109]; Gegenwart P, 2008, NAT PHYS, V4, P186, DOI 10.1038/nphys892; Komijani Y, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.217001; Komijani Y, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.157206; Legros A, 2019, NAT PHYS, V15, P142, DOI 10.1038/s41567-018-0334-2; Levy F, 2005, SCIENCE, V309, P1343, DOI 10.1126/science.1115498; Matsuoka E, 2015, J PHYS SOC JPN, V84, DOI 10.7566/JPSJ.84.073704; Nicklas M., 2015, SPRINGER SERIES SOLI, V180, P173; Paschen S, 2004, NATURE, V432, P881, DOI 10.1038/nature03129; Pfleiderer C, 1997, PHYS REV B, V55, P8330, DOI 10.1103/PhysRevB.55.8330; Sachdev S., 2011, QUANTUM PHASE TRANSI; Saxena SS, 2000, NATURE, V406, P587, DOI 10.1038/35020500; Schroder A, 2000, NATURE, V407, P351, DOI 10.1038/35030039; Senthil T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.035111; Shishido H, 2005, J PHYS SOC JPN, V74, P1103, DOI 10.1143/JPSJ.74.1103; SMITH TF, 1971, PHYS REV LETT, V27, P1732, DOI 10.1103/PhysRevLett.27.1732; Steppke A, 2013, SCIENCE, V339, P933, DOI 10.1126/science.1230583; Sullow S, 1999, PHYS REV LETT, V82, P2963, DOI 10.1103/PhysRevLett.82.2963; Trovarelli O, 2000, PHYS REV LETT, V85, P626, DOI 10.1103/PhysRevLett.85.626; Uhlarz M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.256404; VONLOHNEYSEN H, 1994, PHYS REV LETT, V72, P3262, DOI 10.1103/PhysRevLett.72.3262; Vosswinkel D, 2012, Z NATURFORSCH B, V67, P1241, DOI 10.5560/ZNB.2012-0265; Wang J., 2019, PREPRINT; Westerkamp T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.206404; Yamamoto SJ, 2010, P NATL ACAD SCI USA, V107, P15704, DOI 10.1073/pnas.1009498107	31	66	68	26	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2020	579	7797					51	+		10.1038/s41586-020-2052-z	http://dx.doi.org/10.1038/s41586-020-2052-z			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MD2AZ	32132691	Green Submitted			2022-12-28	WOS:000543777300003
J	Freedman, SB; Schnadower, D; Tarr, PI				Freedman, Stephen B.; Schnadower, David; Tarr, Phillip I.			The Probiotic Conundrum Regulatory Confusion, Conflicting Studies, and Safety Concerns	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PLACEBO	This Viewpoint characterizes reasons for the lack of evidence about the health effects of probiotic supplements and cautions against a "can't hurt, can't help" presumption made by consumers and clinicians.	[Freedman, Stephen B.] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada; [Freedman, Stephen B.] Univ Calgary, Alberta Childrens Hosp, Cumming Sch Med, Res Inst, Calgary, AB, Canada; [Schnadower, David] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Schnadower, David] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Tarr, Phillip I.] St Louis Childrens Hosp, St Louis, MO 63178 USA; [Tarr, Phillip I.] Washington Univ St Louis, Sch Med, St Louis, MO USA	Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL)	Freedman, SB (corresponding author), Univ Calgary, Pediat Emergency Med, 28 Oki Dr NW, Calgary, AB T3B 6A8, Canada.	stephen.freedman@albertahealthservices.ca	Freedman, Stephen/H-9102-2012	Freedman, Stephen/0000-0003-2319-6192				[Anonymous], 2018, COMMUNICATION   0816; Bafeta A, 2018, ANN INTERN MED, V169, P240, DOI 10.7326/M18-0343; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Goldenberg JZ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006095.pub4; Harris RG, 2019, AM J CLIN NUTR, V110, P177, DOI 10.1093/ajcn/nqz071; Rubin R, 2020, JAMA-J AM MED ASSOC, V323, P401, DOI 10.1001/jama.2019.21441; Schnadower D, 2019, ALIMENT PHARM THER, V50, P620, DOI 10.1111/apt.15418; Suez J, 2019, NAT MED, V25, P716, DOI 10.1038/s41591-019-0439-x; Yelin I, 2019, NAT MED, V25, P1728, DOI 10.1038/s41591-019-0626-9	9	13	13	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2020	323	9			SI		823	824		10.1001/jama.2019.22268	http://dx.doi.org/10.1001/jama.2019.22268			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU3SD	32125410				2022-12-28	WOS:000519630600009
J	Gostin, LO; Rai, AK				Gostin, Lawrence O.; Rai, Arti K.			Expanding Access and Reducing Prices for Drugs to Prevent HIV Should Government Enforce Its Patent Rights Against the Pharmaceutical Industry?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint considers the lawsuit United States v Gilead Sciences in the context of intellectual property rights and the patents held on medications for preexposure prophylaxis (PrEP) for HIV infection, leading to a trade-off between affordability and future pharmaceutical collaboration and innovation.	[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, Washington, DC USA; [Rai, Arti K.] Duke Univ, Sch Law, Durham, NC 27706 USA	Georgetown University; Duke University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Centers for Disease Control and Prevention, 2019, PREP; Conti RM, 2016, JAMA-J AM MED ASSOC, V316, P2083, DOI 10.1001/jama.2016.15397; Department of Health and Human Services, 2019, WHAT IS END HIV EP P; Feldman R, 2018, J LAW BIOSCI, V5, P590, DOI 10.1093/jlb/lsy022; Mancini DP, 2019, FINANCIAL TIMES; Nayak RK, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5766; Rai AK, 2012, NAT BIOTECHNOL, V30, P953, DOI 10.1038/nbt.2382; Sagonowsky E., 2019, FIERCE PHARMA   0509; US Food & Drug Administration, OR BOOK APPR DRUG PR	9	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2020	323	9			SI		821	822		10.1001/jama.2019.22357	http://dx.doi.org/10.1001/jama.2019.22357			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU3SD	32125411				2022-12-28	WOS:000519630600008
J	Iacobucci, G				Iacobucci, Gareth			Chinese doctors admitted in undercover calls that harvested organs were available, informal tribunal finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		HURLEY R, 2019, BMJ-BRIT MED J, V365, DOI DOI 10.1136/BMJ.L4287	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2020	368								m859	10.1136/bmj.m859	http://dx.doi.org/10.1136/bmj.m859			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KD	32127369				2022-12-28	WOS:000519536500014
J	Li, JT; Mara, P; Schubotz, F; Sylvan, JB; Burgaud, G; Klein, F; Beaudoin, D; Wee, SY; Dick, HJB; Lott, S; Cox, R; Meyer, LAE; Quemener, M; Blackman, DK; Edgcomb, VP				Li, Jiangtao; Mara, Paraskevi; Schubotz, Florence; Sylvan, Jason B.; Burgaud, Gaetan; Klein, Frieder; Beaudoin, David; Wee, Shu Ying; Dick, Henry J. B.; Lott, Sarah; Cox, Rebecca; Meyer, Lara A. E.; Quemener, Maxence; Blackman, Donna K.; Edgcomb, Virginia P.			Recycling and metabolic flexibility dictate life in the lower oceanic crust	NATURE			English	Article							ELEMENTAL ORGANIC-ANALYSIS; MASS-SPECTROMETRY; BACTERIA; SEQUENCE; CONTAMINATION; COMMUNITY; INSIGHTS; DATABASE; BIOMASS; FLUIDS	The lithified lower oceanic crust is one of Earth's last biological frontiers as it is difficult to access. It is challenging for microbiota that live in marine subsurface sediments or igneous basement to obtain sufficient carbon resources and energy to support growth(1-3) or to meet basal power requirements(4) during periods of resource scarcity. Here we show how limited and unpredictable sources of carbon and energy dictate survival strategies used by low-biomass microbial communities that live 10-750 m below the seafloor at Atlantis Bank, Indian Ocean, where Earth's lower crust is exposed at the seafloor. Assays of enzyme activities, lipid biomarkers, marker genes and microscopy indicate heterogeneously distributed and viable biomass with ultralow cell densities (fewer than 2,000 cells per cm(3)). Expression of genes involved in unexpected heterotrophic processes includes those with a role in the degradation of polyaromatic hydrocarbons, use of polyhydroxyalkanoates as carbon-storage molecules and recycling of amino acids to produce compounds that can participate in redox reactions and energy production. Our study provides insights into how microorganisms in the plutonic crust are able to survive within fractures or porous substrates by coupling sources of energy to organic and inorganic carbon resources that are probably delivered through the circulation of subseafloor fluids or seawater.	[Li, Jiangtao] Tongji Univ, State Key Lab Marine Geol, Shanghai, Peoples R China; [Li, Jiangtao; Mara, Paraskevi; Beaudoin, David; Dick, Henry J. B.; Lott, Sarah; Cox, Rebecca; Edgcomb, Virginia P.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Schubotz, Florence; Meyer, Lara A. E.] Univ Bremen, MARUM, Bremen, Germany; [Schubotz, Florence; Meyer, Lara A. E.] Univ Bremen, Dept Geosci, Bremen, Germany; [Sylvan, Jason B.; Wee, Shu Ying] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Burgaud, Gaetan; Quemener, Maxence] Univ Brest, ESIAB, Lab Univ Biodivers & Ecol Microbienne, EA 3882, Technopole Brest Iroise, Plouzane, France; [Klein, Frieder] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Blackman, Donna K.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Tongji University; Woods Hole Oceanographic Institution; University of Bremen; University of Bremen; Texas A&M University System; Texas A&M University College Station; Universite de Bretagne Occidentale; Woods Hole Oceanographic Institution; University of California System; University of California San Diego; Scripps Institution of Oceanography	Edgcomb, VP (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	vedgcomb@whoi.edu		Sylvan, Jason/0000-0001-7361-7472	National Science Foundation [OCE-1658031, OCE-1658118, OCE-1450528, OCE-1637130]; DFG under Germany's Excellence Strategy [EXC-2077-390741603]; Gottfried Wilhelm Leibniz Program [HI 616-14-1]; National Science Foundation of China [41772358]; Ministry of Science and Technology of China [2012CB417302]	National Science Foundation(National Science Foundation (NSF)); DFG under Germany's Excellence Strategy(German Research Foundation (DFG)); Gottfried Wilhelm Leibniz Program; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank the captain, crew and all who sailed on JOIDES Resolution for IODP Expedition 360, whose support was essential; T. Sehein and M. Torres-Beltran for assistance with statistical analyses; Q. Ma, E. S. Taylor (WHOI Creative) and Andrew Newman Design for assistance with figures; S. Yvon-Lewis for providing materials and assistance with methane measurements; and M. Sogin, J. Huber, B. Orcutt, K. Lloyd, J. Biddle and S. D'Hondt for helpful discussions on the relative merits of different molecular data-handling options for contamination controls. This study was funded by National Science Foundation grants OCE-1658031 to V.P.E. and F.K., OCE-1658118 to J.B.S., and OCE-1450528 and OCE-1637130 to H.J.B.D. F.S. acknowledges funding from the DFG under Germany's Excellence Strategy (no. EXC-2077-390741603) and the Gottfried Wilhelm Leibniz Program (HI 616-14-1). Support to J.L. was provided by the National Science Foundation of China (no. 41772358) and the Ministry of Science and Technology of China (no. 2012CB417302).	Baines AG, 2003, GEOLOGY, V31, P1105; Becker KW, 2013, ORG GEOCHEM, V61, P34, DOI 10.1016/j.orggeochem.2013.05.007; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burgaud G, 2010, FEMS MICROBIOL ECOL, V73, P121, DOI 10.1111/j.1574-6941.2010.00881.x; Cai L, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-88; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Coolen MJL, 2000, APPL ENVIRON MICROB, V66, P2589, DOI 10.1128/AEM.66.6.2589-2598.2000; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; Dick HJB, 2019, J GEOPHYS RES-SOL EA, V124, P12631, DOI 10.1029/2018JB016858; Dick HJB, 2019, PROG EARTH PLANET SC, V6, DOI 10.1186/s40645-019-0307-9; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fonknechten N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-555; FOX PJ, 1984, TECTONOPHYSICS, V104, P205, DOI 10.1016/0040-1951(84)90124-0; Fruh-Green GL, 2018, LITHOS, V323, P137, DOI 10.1016/j.lithos.2018.09.012; Glassing A, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0103-7; Grossi V, 2015, APPL ENVIRON MICROB, V81, P3157, DOI 10.1128/AEM.03794-14; Han J, 2012, J BACTERIOL, V194, P4463, DOI 10.1128/JB.00880-12; Hawley AK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01376-9; Hoehler TM, 2013, NAT REV MICROBIOL, V11, P83, DOI 10.1038/nrmicro2939; Jendrossek D, 2002, ANNU REV MICROBIOL, V56, P403, DOI 10.1146/annurev.micro.56.012302.160838; Jorgensen BB, 2011, P NATL ACAD SCI USA, V108, P18193, DOI 10.1073/pnas.1115421108; Jungbluth SP, 2016, ISME J, V10, P2033, DOI 10.1038/ismej.2015.248; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Klein AT, 2015, ANAL CHEM, V87, P5294, DOI 10.1021/acs.analchem.5b00459; Klein F, 2019, P NATL ACAD SCI USA, V116, P17666, DOI 10.1073/pnas.1907871116; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Calvez T, 2009, APPL ENVIRON MICROB, V75, P6415, DOI 10.1128/AEM.00653-09; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin HT, 2012, GEOCHIM COSMOCHIM AC, V85, P213, DOI 10.1016/j.gca.2012.02.017; Lipp JS, 2009, GEOCHIM COSMOCHIM AC, V73, P6816, DOI 10.1016/j.gca.2009.08.003; Liu GM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24015; LUNDIN A, 1986, METHOD ENZYMOL, V133, P27; Mason OU, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015399; Morono Y, 2013, ENVIRON MICROBIOL, V15, P2841, DOI 10.1111/1462-2920.12153; Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023; PELLA E, 1990, AM LAB, V22, P28; PELLA E, 1990, AM LAB, V22, P116; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Puente-Sanchez F, 2018, P NATL ACAD SCI USA, V115, P10702, DOI 10.1073/pnas.1808176115; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Santelli CM, 2009, ENVIRON MICROBIOL, V11, P86, DOI 10.1111/j.1462-2920.2008.01743.x; Santos-Beneit F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00402; Schrenk MO, 2010, ANNU REV MAR SCI, V2, P279, DOI 10.1146/annurev-marine-120308-081000; Sheik CS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00840; Sheik CS, 2014, ENVIRON MICROBIOL, V16, P304, DOI 10.1111/1462-2920.12165; Sturt HF, 2004, RAPID COMMUN MASS SP, V18, P617, DOI 10.1002/rcm.1378; Summons R. E., 2012, FUNDAMENTALS GEOBIOL, P269; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Tully BJ, 2018, ISME J, V12, P1, DOI 10.1038/ismej.2017.187; Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619; Valentine DL, 2010, SCIENCE, V330, P208, DOI 10.1126/science.1196830; Walter SRS, 2018, NAT GEOSCI, V11, P334, DOI 10.1038/s41561-018-0109-5; Whiteside JH, 2011, PALAEOGEOGR PALAEOCL, V301, P1, DOI 10.1016/j.palaeo.2010.11.025; Zhang XX, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00363; Zinke LA, 2017, ENV MICROBIOL REP, V9, P528, DOI 10.1111/1758-2229.12578; Zolotov M, 1999, J GEOPHYS RES-PLANET, V104, P14033, DOI 10.1029/1998JE000627	59	20	20	3	63	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7798					250	+		10.1038/s41586-020-2075-5	http://dx.doi.org/10.1038/s41586-020-2075-5			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU0CC	32161389				2022-12-28	WOS:000519378900026
J	Mehta, MC; Katz, IT; Jha, AK				Mehta, Mehul C.; Katz, Ingrid T.; Jha, Ashish K.			Transforming Global Health with AI	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Artificial intelligence could revolutionize health and health care in low- and middle-income countries by addressing the large knowledge and judgment gaps that make care delivery poor. But for AI to fulfill this promise, some key challenges will need to be addressed.	[Mehta, Mehul C.; Katz, Ingrid T.; Jha, Ashish K.] Harvard Global Hlth Inst, Cambridge, MA 02138 USA; [Mehta, Mehul C.; Katz, Ingrid T.; Jha, Ashish K.] Harvard Med Sch, Boston, MA 02115 USA; [Mehta, Mehul C.] Partners Healthcare Int, Boston, MA 02114 USA; [Katz, Ingrid T.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Jha, Ashish K.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Mehta, MC (corresponding author), Harvard Global Hlth Inst, Cambridge, MA 02138 USA.; Mehta, MC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Mehta, MC (corresponding author), Partners Healthcare Int, Boston, MA 02114 USA.							[Anonymous], 2019, ART INT GLOB HLTH DE; [Anonymous], 2018, CROSSING GLOBAL QUAL; Char DS, 2018, NEW ENGL J MED, V378, P981, DOI 10.1056/NEJMp1714229; Price WN, 2019, NAT MED, V25, P37, DOI 10.1038/s41591-018-0272-7; Villasenor J., 2019, ARTIFICIAL INTELLIGE	5	17	21	4	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2020	382	9					791	793		10.1056/NEJMp1912079	http://dx.doi.org/10.1056/NEJMp1912079			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KS8TT	32101661				2022-12-28	WOS:000518581500003
J	Klompas, M				Klompas, Michael			Coronavirus Disease 2019 (COVID-19): Protecting Hospitals From the Invisible	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Klompas, Michael] Harvard Med Sch, Harvard Pilgrim Hlth Care Inst, Boston, MA 02115 USA; [Klompas, Michael] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Klompas, M (corresponding author), Harvard Med Sch, Dept Populat Med, 401 Pk Dr,Suite 401 East, Boston, MA 02215 USA.; Klompas, M (corresponding author), Harvard Pilgrim Hlth Care Inst, 401 Pk Dr,Suite 401 East, Boston, MA 02215 USA.	mklompas@bwh.harvard.edu						Centers for Disease Control and Prevention,, 2020, COR DIS 2019 COVID 1; Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432; Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.46234/ccdcw2020.032; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hoehl S, 2020, NEW ENGL J MED, V382, P1278, DOI 10.1056/NEJMc2001899; HOLSHUE ML, 2020, NEW ENGL J MED, V382, P929, DOI [10.1056/NEJMoa2001191, DOI 10.1056/NEJMOA2001191, DOI 10.1056/NEJM0A2001191]; Lan L, 2020, JAMA-J AM MED ASSOC, V323, P1502, DOI 10.1001/jama.2020.2783; Rolfes MA, 2018, INFLUENZA OTHER RESP, V12, P132, DOI 10.1111/irv.12486; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468	9	69	71	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2020	172	9					619	+		10.7326/M20-0751	http://dx.doi.org/10.7326/M20-0751			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK7EH	32160299	Green Published			2022-12-28	WOS:000531024900014
J	Morens, DM; Daszak, P; Taubenberger, JK				Morens, David M.; Daszak, Peter; Taubenberger, Jeffery K.			Escaping Pandora's Box - Another Novel Coronavirus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								With luck, public health control measures may be able to put the Covid-19 demons back in the jar. If they do not, we face a daunting challenge equal to, or perhaps greater than, that posed by the influenza pandemic of a century ago.	[Morens, David M.] NIAID, Off Director, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Taubenberger, Jeffery K.] NIAID, Viral Pathogenesis & Evolut Sect, Lab Infect Dis, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Daszak, Peter] Ecohlth Alliance, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); EcoHealth Alliance	Morens, DM (corresponding author), NIAID, Off Director, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Taubenberger, Jeffery/AAQ-1407-2021					Allen T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00923-8; Carlin E.P., 2019, BUILDING RESILIENCE; Morens DM, 2018, NEW ENGL J MED, V379, P2285, DOI 10.1056/NEJMp1814447; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08	5	139	145	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2020	382	14					1293	1295		10.1056/NEJMp2002106	http://dx.doi.org/10.1056/NEJMp2002106			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LB3FH	32101660	Bronze			2022-12-28	WOS:000524522800003
J	Dyer, C				Dyer, Clare			Anaesthetist is second doctor this year to be restored to GMC register	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer C, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m723	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2020	368								m1039	10.1136/bmj.m1039	http://dx.doi.org/10.1136/bmj.m1039			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AU	32165396				2022-12-28	WOS:000520013500014
J	Gershon, AA; Edwards, K; Orenstein, W; Schaffner, W				Gershon, Anne A.; Edwards, Kathryn; Orenstein, Walter; Schaffner, William			Freedom, Measles, and Freedom from Measles	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								False rumors about purported dangers of vaccination continue to circulate. People who reject the scientific facts about vaccines and pathogens in favor of an emotional or faith-based choice risk the health and lives not only of their own children, but of us all.	[Gershon, Anne A.] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY 10027 USA; [Edwards, Kathryn; Schaffner, William] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Orenstein, Walter] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Columbia University; Vanderbilt University; Emory University	Gershon, AA (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, New York, NY 10027 USA.							Hester G, 2019, PEDIATR INFECT DIS J, V38, P547, DOI 10.1097/INF.0000000000002221; Hoffman Jan, 2019, NY TIMES; Isaacs D, 2020, J PAEDIATR CHILD H, V56, P175, DOI 10.1111/jpc.14752; Khetsuriani N, 2019, CLIN MICROBIOL INFEC; Mina MJ, 2019, SCIENCE, V366, P599, DOI 10.1126/science.aay6485	5	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2020	382	11					983	985		10.1056/NEJMp2000807	http://dx.doi.org/10.1056/NEJMp2000807			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU7TA	32160659				2022-12-28	WOS:000519914300003
J	Rimmer, A				Rimmer, Abi			Covid-19: UK trade talks with EU must not hinder cooperation in tackling threat, BMA warns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2020	368								m988	10.1136/bmj.m988	http://dx.doi.org/10.1136/bmj.m988			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AO	32156677	Bronze			2022-12-28	WOS:000520012500019
J	Hampton, T				Hampton, Tracy			New Insight on Preventing EGFR Inhibitor-Induced Adverse Effects	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2020	323	9			SI		814	814		10.1001/jama.2020.0812	http://dx.doi.org/10.1001/jama.2020.0812			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU3SD	32125381				2022-12-28	WOS:000519630600002
J	Kar, P				Kar, Partha			Partha Kar: Is being a doctor a vocation?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kar, Partha] Portsmouth Hosp NHS Trust, Portsmouth, Hants, England	Portsmouth Hospitals NHS Trust	Kar, P (corresponding author), Portsmouth Hosp NHS Trust, Portsmouth, Hants, England.	drparthakar@gmail.com	Kar, Partha/AAT-4839-2020						0	1	1	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2020	368								m227	10.1136/bmj.m227	http://dx.doi.org/10.1136/bmj.m227			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KD	32127358	Bronze			2022-12-28	WOS:000519536500001
J	Kassir, Z; Sarpatwari, A; Kocak, B; Kuza, CC; Gellad, WF				Kassir, Zachary; Sarpatwari, Ameet; Kocak, Brian; Kuza, Courtney C.; Gellad, Walid F.			Sponsorship and Funding for Gene Therapy Trials in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study characterizes government, academia, and private funding for gene therapy trials in the United States by technology type and therapeutic and disease area.	[Kassir, Zachary; Kocak, Brian] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Sarpatwari, Ameet] Brigham & Womens Hosp, Program Regulat Therapeut & Law PORTAL, 75 Francis St, Boston, MA 02115 USA; [Kuza, Courtney C.; Gellad, Walid F.] Univ Pittsburgh, Ctr Pharmaceut Policy & Prescribing, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gellad, WF (corresponding author), Univ Pittsburgh, Div Gen Internal Med, 3609 Forbes Ave, Pittsburgh, PA 15261 USA.	walid.gellad@pitt.edu	Kocak, Brian/AAV-6121-2020					Ehrhardt S, 2015, JAMA-J AM MED ASSOC, V314, P2566, DOI 10.1001/jama.2015.12206; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198; Meyer K, 2015, MOL THER, V23, P477, DOI 10.1038/mt.2014.210; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849	6	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2020	323	9			SI		890	891		10.1001/jama.2019.22214	http://dx.doi.org/10.1001/jama.2019.22214			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU3SD	32125392	Bronze, Green Published			2022-12-28	WOS:000519630600020
J	Yau, CWH; Leigh, B; Liberati, E; Punch, D; Dixon-Woods, M; Draycott, T				Yau, Christopher Wai Hung; Leigh, Bertie; Liberati, Elisa; Punch, Daniel; Dixon-Woods, Mary; Draycott, Tim			Clinical negligence costs: taking action to safeguard NHS sustainability	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PATIENT SAFETY; CARE; QUALITY; PERFORMANCE; PREVENTION		[Yau, Christopher Wai Hung; Draycott, Tim] North Bristol NHS Trust Dept Womens Hlth, Westbury On Trym, England; [Leigh, Bertie] Hempsons Solicitors, London, England; [Liberati, Elisa; Punch, Daniel; Dixon-Woods, Mary] Univ Cambridge, THIS Inst, Cambridge, England	University of Cambridge	Draycott, T (corresponding author), North Bristol NHS Trust Dept Womens Hlth, Westbury On Trym, England.	Tim.Draycott@bristol.ac.uk						Aiken Linda H, 2012, BMJ, V344, pe1717, DOI 10.1136/bmj.e1717; Armstrong N, 2018, SOC SCI MED, V198, P157, DOI 10.1016/j.socscimed.2017.12.033; Aveling EL, 2016, SOCIOL HEALTH ILL, V38, P216, DOI 10.1111/1467-9566.12370; Black BS, 2017, AM J HEALTH ECON, V3, P109, DOI 10.1162/ajhe_a_00069; Bourne T, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030968; Bradley EH, 2012, ANN INTERN MED, V156, P618, DOI 10.7326/0003-4819-156-9-201205010-00003; Braithwaite J, 2015, INT J QUAL HEALTH C, V27, P418, DOI 10.1093/intqhc/mzv063; Brocklehurst P, 2017, LANCET, V389, P1719, DOI 10.1016/S0140-6736(17)30568-8; Buchan J., 2019, CRITICAL MOMENT NHS; Checkland K, 2007, SOC POLICY ADMIN, V41, P693, DOI 10.1111/j.1467-9515.2007.00580.x; Crofts JF, 2016, BJOG-INT J OBSTET GY, V123, P111, DOI 10.1111/1471-0528.13302; Curry LA, 2018, BMJ QUAL SAF, V27, P207, DOI 10.1136/bmjqs-2017-006989; Dahlin KB, 2018, ACAD MANAG ANN, V12, P252, DOI 10.5465/annals.2016.0049; Dixon-Woods M, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5514; Dixon-Woods M, 2019, CLIN MED, V19, P47, DOI 10.7861/clinmedicine.19-1-47; Dixon-Woods Mary, 2016, Future Hosp J, V3, P191, DOI 10.7861/futurehosp.3-3-191; Dixon-Woods M, 2016, BMJ QUAL SAF, V25, P485, DOI 10.1136/bmjqs-2016-005232; Dixon-Woods M, 2014, BMJ QUAL SAF, V23, P106, DOI 10.1136/bmjqs-2013-001947; Donaldson L., 2005, ORG MEMORY REPORT EX; Draycott T, 2006, BJOG-INT J OBSTET GY, V113, P177, DOI 10.1111/j.1471-0528.2006.00800.x; Draycott T, 2015, BEST PRACT RES CL OB, V29, P1126, DOI 10.1016/j.bpobgyn.2015.07.002; DYER C, 2019, BMJ-BRIT MED J, V364, P10905, DOI DOI 10.1136/BMJ.L1362; Fulop NJ, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1773; Greenberg MD, 2010, IS BETTER PATIENT SA; Himmelstein DU, 2014, INT J HEALTH SERV, V44, P203, DOI 10.2190/HS.44.2.a; Hollnagel E, 2015, RESILIENT HLTH CARE; Holmes A., 2015, INFECT PREVENTION CO; Horton TJ, 2018, HEALTH AFFAIR, V37, P191, DOI 10.1377/hlthaff.2017.1161; House of Commons Committee of Public Accounts, MAN COSTS CLIN NEGL; IACOBUCCI G, 2018, BMJ-BRIT MED J, V361, DOI DOI 10.1136/BMJ.K2682; Khullar D, 2018, JAMA-J AM MED ASSOC, V320, P2419, DOI 10.1001/jama.2018.17719; Lawton R, 2014, BMJ QUAL SAF, V23, P880, DOI 10.1136/bmjqs-2014-003115; Liberati EG, 2019, SOC SCI MED, V223, P64, DOI 10.1016/j.socscimed.2019.01.035; Machin JT, 2018, EUR SPINE J, V27, P2693, DOI 10.1007/s00586-018-5739-1; Magro M, 2017, 5 YEARS CEREBRAL PAL; Mannion R, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4907; National Advisory Group on the Safety of Patients in England, 2013, PROMISE LEARN COMMIT; National Audit Office, 2017, HC 305; National Health Service Litigation Authority, 2009, REP ACC 2009 HC 576; NHS Resolution, 2019, ANN REP ACC 2018 201; Nuclear Decommissioning Authority, 2019, NUCL PROV COST CLEAN; Share DA, 2011, HEALTH AFFAIR, V30, P636, DOI 10.1377/hlthaff.2010.0526; Sujan M, 2015, RELIAB ENG SYST SAFE, V144, P45, DOI 10.1016/j.ress.2015.07.011; Vaughn VM, 2019, BMJ QUAL SAF, V28, P74, DOI 10.1136/bmjqs-2017-007573; Viscusi WK, 2019, DENVER LAW REV, V96, P775; Vu JV, 2018, J AM COLL SURGEONS, V226, P91, DOI 10.1016/j.jamcollsurg.2017.10.013; Walsh JM, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.020; Wears B., 2020, STILL NOT SAFE PATIE, DOI [10.1093/oso/9780190271268.001.0001, DOI 10.1093/OSO/9780190271268.001.0001]; Woolhandler S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5015; Yang Qian, 2018, CMAJ Open, V6, pE561, DOI 10.9778/cmajo.20180077	50	20	20	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2020	368								m552	10.1136/bmj.m552	http://dx.doi.org/10.1136/bmj.m552			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU2KC	32122934	hybrid, Green Published			2022-12-28	WOS:000519536400003
J	Morgan, DJ; Scherer, LD; Korenstein, D				Morgan, Daniel J.; Scherer, Laura D.; Korenstein, Deborah			Improving Physician Communication About Treatment Decisions Reconsideration of "Risks vs Benefits"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint emphasizes the importance of precise language to help patients make evidence-informed decisions in shared decision-making, and argues that references to "chances of harms and benefits" will be more understandable to patients than discussions of "probabilities of risks and benefits."	[Morgan, Daniel J.] Univ Maryland, Dept Epidemiol & Publ Hlth, Sch Med & Hosp Epidemiol, Baltimore, MD 21201 USA; [Morgan, Daniel J.] Vet Affairs Maryland Hlth Care Syst, Baltimore, MD USA; [Scherer, Laura D.] Univ Colorado, Sch Med, Div Cardiol, Adult & Child Consortium Hlth Outcomes Res & Deli, Aurora, CO USA; [Scherer, Laura D.] VA Denver, Vet Ctr & Value Driven Care, Ctr Innovat, Denver, VA USA; [Korenstein, Deborah] Mem Sloan Kettering Canc Ctr, Dept Med, Ctr Hlth Policy & Outcomes, 1275 York Ave, New York, NY 10021 USA; [Korenstein, Deborah] Weill Cornell Med Coll, Dept Med, New York, NY USA	University System of Maryland; University of Maryland Baltimore; University of Colorado System; University of Colorado Anschutz Medical Campus; Memorial Sloan Kettering Cancer Center; Cornell University	Morgan, DJ (corresponding author), Univ Maryland, 685 W Baltimore St,MSTF 334, Baltimore, MD 21201 USA.	dmorgan@som.umaryland.edu						Hoffmann TC, 2017, JAMA INTERN MED, V177, P407, DOI 10.1001/jamainternmed.2016.8254; Hoffmann TC, 2014, JAMA-J AM MED ASSOC, V312, P1295, DOI 10.1001/jama.2014.10186; Keating NL, 2018, JAMA-J AM MED ASSOC, V319, P1814, DOI 10.1001/jama.2018.3388; Omer ZB, 2013, JAMA INTERN MED, V173, P1830, DOI 10.1001/jamainternmed.2013.8405; Schoenborn NL, 2017, JAMA INTERN MED, V177, P1121, DOI 10.1001/jamainternmed.2017.1778; US Food and Drug Administration, 2018, BEN RISK ASS DRUG RE	6	12	12	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2020	324	10					937	938		10.1001/jama.2020.0354	http://dx.doi.org/10.1001/jama.2020.0354			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR9EX	32150219				2022-12-28	WOS:000571867000012
J	Guan, W; Ni, Z; Hu, Y; Liang, W; Ou, C; He, J; Liu, L; Shan, H; Lei, C; Hui, DSC; Du, B; Li, L; Zeng, G; Yuen, KY; Chen, R; Tang, C; Wang, T; Chen, P; Xiang, J; Li, S; Wang, JL; Liang, Z; Peng, Y; Wei, L; Liu, Y; Hu, YH; Peng, P; Wang, JM; Liu, J; Chen, Z; Li, G; Zheng, Z; Qiu, S; Luo, J; Ye, C; Zhu, S; Zhong, N				Guan, W.; Ni, Z.; Hu, Yu; Liang, W.; Ou, C.; He, J.; Liu, L.; Shan, H.; Lei, C.; Hui, D. S. C.; Du, B.; Li, L.; Zeng, G.; Yuen, K. -Y.; Chen, R.; Tang, C.; Wang, T.; Chen, P.; Xiang, J.; Li, S.; Wang, Jin-lin; Liang, Z.; Peng, Y.; Wei, L.; Liu, Y.; Hu, Ya-hua; Peng, P.; Wang, Jian-ming; Liu, J.; Chen, Z.; Li, G.; Zheng, Z.; Qiu, S.; Luo, J.; Ye, C.; Zhu, S.; Zhong, N.		China Med Treatment Expert Grp	Clinical Characteristics of Coronavirus Disease 2019 in China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLUENZA; TRANSMISSION; PNEUMONIA; VIRUS; WUHAN; SARS	In this study, researchers describe the clinical characteristics of coronavirus disease 2019 in a selected cohort of 1099 patients with laboratory-confirmed disease throughout mainland China during the first 2 months of the current outbreak. Background Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, data have been needed on the clinical characteristics of the affected patients. Methods We extracted data regarding 1099 patients with laboratory-confirmed Covid-19 from 552 hospitals in 30 provinces, autonomous regions, and municipalities in mainland China through January 29, 2020. The primary composite end point was admission to an intensive care unit (ICU), the use of mechanical ventilation, or death. Results The median age of the patients was 47 years; 41.9% of the patients were female. The primary composite end point occurred in 67 patients (6.1%), including 5.0% who were admitted to the ICU, 2.3% who underwent invasive mechanical ventilation, and 1.4% who died. Only 1.9% of the patients had a history of direct contact with wildlife. Among nonresidents of Wuhan, 72.3% had contact with residents of Wuhan, including 31.3% who had visited the city. The most common symptoms were fever (43.8% on admission and 88.7% during hospitalization) and cough (67.8%). Diarrhea was uncommon (3.8%). The median incubation period was 4 days (interquartile range, 2 to 7). On admission, ground-glass opacity was the most common radiologic finding on chest computed tomography (CT) (56.4%). No radiographic or CT abnormality was found in 157 of 877 patients (17.9%) with nonsevere disease and in 5 of 173 patients (2.9%) with severe disease. Lymphocytopenia was present in 83.2% of the patients on admission. Conclusions During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness. Patients often presented without fever, and many did not have abnormal radiologic findings. (Funded by the National Health Commission of China and others.)	[Guan, W.; Liang, W.; He, J.; Chen, R.; Tang, C.; Wang, T.; Li, S.; Wang, Jin-lin; Zhong, N.] Guangzhou Med Univ, State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Hlth,Affiliated Hosp 1, 151 Yanjiang Rd, Guangzhou, Guangdong, Peoples R China; [Liang, W.] Guangzhou Med Univ, Affiliated Hosp 1, Dept Thorac Oncol, Guangzhou, Peoples R China; [He, J.] Guangzhou Med Univ, Affiliated Hosp 1, Dept Thorac Surg & Oncol, Guangzhou, Peoples R China; [Liang, Z.] Guangzhou Med Univ, Affiliated Hosp 1, Dept Emergency Med, Guangzhou, Peoples R China; [Lei, C.] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Peoples R China; [Ou, C.; Chen, P.] Southern Med Univ, Sch Publ Hlth, Guangdong Prov Key Lab Trop Dis Res, State Key Lab Organ Failure Res,Dept Biostat, Guangzhou, Peoples R China; [Ni, Z.; Xiang, J.] Wuhan Jinyintan Hosp, Wuhan, Peoples R China; [Hu, Yu] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China; [Peng, Y.] Cent Hosp Wuhan, Wuhan, Peoples R China; [Wei, L.] Wuhan Hosp Tradit Chinese & Western Med, Wuhan 1 Hosp, Wuhan, Peoples R China; [Peng, P.] Wuhan Pulm Hosp, Wuhan, Peoples R China; [Wang, Jian-ming] Wuhan Univ Sci & Technol, Tianyou Hosp, Wuhan, Peoples R China; [Zhu, S.] Peoples Hosp Huangpi Dist, Wuhan, Peoples R China; [Liu, L.] Shenzhen Third Peoples Hosp, Shenzhen, Peoples R China; [Liu, L.] Southern Univ Sci & Technol, Natl Clin Res Ctr Infect Dis, Affiliated Hosp 2, Shenzhen, Peoples R China; [Yuen, K. -Y.] Univ Hong Kong, Shenzhen Hosp, Dept Clin Microbiol & Infect Control, Shenzhen, Peoples R China; [Shan, H.] Sun Yat Sen Univ, Affiliated Hosp 5, Zhuhai, Peoples R China; [Hui, D. S. C.] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Yuen, K. -Y.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Pok Fu Lam, Hong Kong, Peoples R China; [Yuen, K. -Y.] Univ Hong Kong, Li Ka Shing Fac Med, Carol Yu Ctr Infect, Pok Fu Lam, Hong Kong, Peoples R China; [Du, B.] Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Med ICU, Beijing, Peoples R China; [Zeng, G.] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Li, L.] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Natl Cl, Hangzhou, Peoples R China; [Liu, Y.] Chengdu Publ Hlth Clin Med Ctr, Chengdu, Peoples R China; [Hu, Ya-hua] Hubei Polytech Univ, Affiliated Hosp, Huangshi Cent Hosp, Edong Healthcare Grp, Huangshi, Hubei, Peoples R China; [Liu, J.] First Hosp Changsha, Changsha, Peoples R China; [Chen, Z.] Third Peoples Hosp Hainan Prov, Sanya, Peoples R China; [Li, G.] Huanggang Cent Hosp, Huanggang, Peoples R China; [Zheng, Z.] Wenling First Peoples Hosp, Wenling, Peoples R China; [Qiu, S.] Third Peoples Hosp Yichang, Yichang, Peoples R China; [Luo, J.] Hubei Univ Med, Affiliated Taihe Hosp, Shiyan, Peoples R China; [Ye, C.] Xiantao First Peoples Hosp, Xiantao, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University; Southern Medical University - China; Wuhan Jinyintan Hospital; Huazhong University of Science & Technology; Wuhan University of Science & Technology; Southern University of Science & Technology; University of Hong Kong; Sun Yat Sen University; Chinese University of Hong Kong; University of Hong Kong; University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Center for Disease Control & Prevention; Zhejiang University; Hubei Polytechnic University; Hubei University of Medicine	Zhong, N (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Hlth,Affiliated Hosp 1, 151 Yanjiang Rd, Guangzhou, Guangdong, Peoples R China.	nanshan@vip.163.com	Hui, David Shu-Cheong/O-2754-2015; 11, Xu/AAE-7347-2022; , Eva/ABD-6876-2020	Hui, David Shu-Cheong/0000-0003-4382-2445; Ou, Chun-Quan/0000-0001-6866-7213; Wenhua, Liang/0000-0002-1391-8238	National Health Commission of China; National Natural Science Foundation; Department of Science and Technology of Guangdong Province	National Health Commission of China; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Guangdong Province	Supported by the National Health Commission of China, the National Natural Science Foundation, and the Department of Science and Technology of Guangdong Province.	[Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Lei H, 2018, INDOOR AIR, V28, P394, DOI 10.1111/ina.12445; Leung WK, 2003, GASTROENTEROLOGY, V125, P1011, DOI [10.1016/j.gastro.2003.08.001, 10.1053/S0016-5085(03)01215-0]; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Metlay JP, 2019, AM J RESP CRIT CARE, V200, pE45, DOI 10.1164/rccm.201908-1581ST; Minodier L, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0448-4; Otter JA, 2016, J HOSP INFECT, V92, P235, DOI 10.1016/j.jhin.2015.08.027; Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; World Health Organization, COR DIS COVID 2019 S; World Health Organization, COR DIS COVID 19 OUT; World Health Organization, COR DIS COVID 19 TEC; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8	23	15736	17228	464	465	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2020	382	18					1708	1720		10.1056/NEJMoa2002032	http://dx.doi.org/10.1056/NEJMoa2002032			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LL1YQ	32109013	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000531351300014
J	Singh, K; Graf, B; Linden, A; Sautner, V; Urlaub, H; Tittmann, K; Stark, H; Chari, A				Singh, Kashish; Graf, Benjamin; Linden, Andreas; Sautner, Viktor; Urlaub, Henning; Tittmann, Kai; Stark, Holger; Chari, Ashwin			Discovery of a Regulatory Subunit of the Yeast Fatty Acid Synthase	CELL			English	Article							ACYL-CARRIER PROTEIN; CRYSTAL-STRUCTURE; INHIBITION; IDENTIFICATION; SYNTHETASE; METABOLISM; MECHANISM; VISUALIZATION; DYNAMICS; PLATFORM	Fatty acid synthases (FASs) are central to metabolism but are also of biotechnological interest for the production of fine chemicals and biofuels from renewable resources. During fatty acid synthesis, the growing fatty acid chain is thought to be shuttled by the dynamic acyl carrier protein domain to several enzyme active sites. Here, we report the discovery of a gamma subunit of the 2.6 megadalton alpha(6)-beta(6) S. cerevisiae FAS, which is shown by high-resolution structures to stabilize a rotated FAS conformation and rearrange ACP domains from equatorial to axial positions. The gamma subunit spans the length the FAS inner cavity, impeding reductase activities of FAS, regulating NADPH turnover by kinetic hysteresis at the ketoreductase, and suppressing off-pathway reactions at the enoylreductase. The gamma subunit delineates the functional compartment within FAS. As a scaffold, it may be exploited to incorporate natural and designed enzymatic activities that are not present in natural FAS.	[Singh, Kashish; Graf, Benjamin; Sautner, Viktor; Tittmann, Kai; Stark, Holger; Chari, Ashwin] Max Planck Inst Biophys Chem, Dept Struct Dynam, D-37077 Gottingen, Germany; [Linden, Andreas; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry, D-37077 Gottingen, Germany; [Linden, Andreas; Urlaub, Henning] Univ Med Ctr Gottingen, Inst Clin Chem Bioanalyt, D-37075 Gottingen, Germany; [Sautner, Viktor; Tittmann, Kai] Georg August Univ Gottingen, Gottinger Zentrum Mol Biowissensch & Schwann Schl, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society; University of Gottingen; University of Gottingen	Stark, H; Chari, A (corresponding author), Max Planck Inst Biophys Chem, Dept Struct Dynam, D-37077 Gottingen, Germany.	holger.stark@mpibpc.mpg.de; ashwin.chari@mpibpc.mpg.de	Chari, Ashwin/ABC-5304-2020	Chari, Ashwin/0000-0001-6220-9828; Linden, Andreas/0000-0002-6365-1164; Singh, Kashish/0000-0002-9891-8148	Deutsche Forschungsgemeinschaft [DFG SFB860]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Thomas Schultz for yeast fermentation, Ulf Diederichsen and Patrick Menzel for help purifying acetyl-and malonyl-CoA, Arwen Pearson for critical comments on the manuscript, and Gabi Heyne as well as Suzan van Gerwen for technical assistance. Gleb Bourenkov and Thomas Schneider are gratefully thanked for their help in X-ray data collection at the EMBL beamline P14 on the PETRA III storage ring of DESY in Hamburg, Germany. H.S. (TP A05) and H.U. (TP A10) are supported by a grant from the Deutsche Forschungsgemeinschaft (DFG SFB860). A.C. and K.T. are associated members of the DFG SFB860.	[Anonymous], 2015, PYMOL MOL GRAPH SYST; Anselmi C, 2010, J AM CHEM SOC, V132, P12357, DOI 10.1021/ja103354w; Biermann U, 2011, ANGEW CHEM INT EDIT, V50, P3854, DOI 10.1002/anie.201002767; Burr GO, 1933, P SOC EXP BIOL MED, V30, P1349; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Drozdetskiy A., 2015, NUCLEIC ACIDS RES, V43, P71; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Gajewski J, 2017, NAT CHEM BIOL, V13, P363, DOI 10.1038/nchembio.2314; Gajewski J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14650; GANCEDO JM, 1973, BIOCHIMIE, V55, P205, DOI 10.1016/S0300-9084(73)80393-1; Gietz RD, 2014, METHODS MOL BIOL, V1163, P33, DOI 10.1007/978-1-4939-0799-1_4; Gipson P, 2010, P NATL ACAD SCI USA, V107, P9164, DOI 10.1073/pnas.0913547107; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; GRABER R, 1994, J LIPID MEDIAT CELL, V9, P91; Hanssum A, 2014, MOL CELL, V55, P566, DOI 10.1016/j.molcel.2014.06.017; Haselbach D, 2018, CELL, V172, P454, DOI 10.1016/j.cell.2018.01.010; Haselbach D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15578; Humphrey SJ, 2015, NAT BIOTECHNOL, V33, P990, DOI 10.1038/nbt.3327; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Johansson P, 2008, P NATL ACAD SCI USA, V105, P12803, DOI 10.1073/pnas.0805827105; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; Lopez M, 2007, BIOESSAYS, V29, P248, DOI 10.1002/bies.20539; LUST G, 1968, EUR J BIOCHEM, V7, P68, DOI 10.1111/j.1432-1033.1968.tb19575.x; LYNEN F, 1980, EUR J BIOCHEM, V112, P431; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Marella ER, 2018, CURR OPIN BIOTECH, V50, P39, DOI 10.1016/j.copbio.2017.10.002; Muller CS, 2015, BIOCHEMISTRY-US, V54, P711, DOI 10.1021/bi5011656; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nelson D. L, 2012, LEHNINGER PRINCIPLES; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POLAKIS ES, 1966, BIOCHEM J, V99, P521, DOI 10.1042/bj0990521; Prajapati S, 2019, STRUCTURE, V27, P1124, DOI 10.1016/j.str.2019.04.009; Ronnett GV, 2006, OBESITY, V14, P201; Rousseau A, 2016, NATURE, V536, P184, DOI 10.1038/nature18943; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schrader J, 2016, SCIENCE, V353, P594, DOI 10.1126/science.aaf8993; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; Shpilka T, 2015, P NATL ACAD SCI USA, V112, P1434, DOI 10.1073/pnas.1409476112; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; STOOPS JK, 1978, BIOCHEM BIOPH RES CO, V84, P225, DOI 10.1016/0006-291X(78)90286-3; Tickle I.J., 2018, STARANISO; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Wang DZ, 2012, JNCI-J NATL CANCER I, V104, P343, DOI 10.1093/jnci/djs010; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; WIELAND F, 1978, P NATL ACAD SCI USA, V75, P5792, DOI 10.1073/pnas.75.12.5792; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu P, 2016, P NATL ACAD SCI USA, V113, P10848, DOI 10.1073/pnas.1607295113; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Yu AQ, 2014, FRONT BIOENG BIOTECH, V2, DOI 10.3389/fbioe.2014.00078; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou Yongjin J, 2014, Front Bioeng Biotechnol, V2, P32, DOI 10.3389/fbioe.2014.00032; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	65	18	20	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2020	180	6					1130	+		10.1016/j.cell.2020.02.034	http://dx.doi.org/10.1016/j.cell.2020.02.034			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KW1IO	32160528	Green Published, Bronze			2022-12-28	WOS:000520925300011
J	Horton, R				Horton, Richard			Offline: Failure, and why we should fear	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2020	395	10226					770	770						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU2KH	32145778				2022-12-28	WOS:000519536900014
J	Qiao, J				Qiao, Jie			What are the risks of COVID-19 infection in pregnant women?	LANCET			English	Editorial Material							TISSUE DISTRIBUTION; CORONAVIRUS; RECEPTOR; OUTCOMES; SARS		[Qiao, Jie] Peking Univ, Hosp 3, Ctr Reprod Med, Dept Obstet & Gynecol, Beijing 100191, Peoples R China; [Qiao, Jie] Natl Clin Res Ctr Obstet & Gynecol, Beijing 100191, Peoples R China; [Qiao, Jie] Peking Univ, Key Lab Assisted Reprod, Minist Educ, Beijing 100191, Peoples R China; [Qiao, Jie] Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing 100191, Peoples R China	Peking University; Peking University	Qiao, J (corresponding author), Peking Univ, Hosp 3, Ctr Reprod Med, Dept Obstet & Gynecol, Beijing 100191, Peoples R China.; Qiao, J (corresponding author), Natl Clin Res Ctr Obstet & Gynecol, Beijing 100191, Peoples R China.; Qiao, J (corresponding author), Peking Univ, Key Lab Assisted Reprod, Minist Educ, Beijing 100191, Peoples R China.; Qiao, J (corresponding author), Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing 100191, Peoples R China.	jie.qiao@263.net		Qiao, Jie/0000-0003-2126-1376				[Anonymous], NOT LAUNCH GUID DIAG; [Anonymous], NOT GEN OFF NAT HLTH; [Anonymous], TRANSCR PRESS C; [Anonymous], NOT STRENGTH MAT DIS; Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Lam CM, 2004, BJOG-INT J OBSTET GY, V111, P771, DOI 10.1111/j.1471-0528.2004.00199.x; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Shen L, 2020, J MED ECON, V23, P456, DOI 10.1080/13696998.2020.1717500; To KF, 2004, J PATHOL, V203, P740, DOI 10.1002/path.1597; Wong SF, 2004, AM J OBSTET GYNECOL, V191, P292, DOI 10.1016/j.ajog.2003.11.019; Zhu HP, 2020, TRANSL PEDIATR, V9, P51, DOI 10.21037/tp.2020.02.06	13	221	239	4	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2020	395	10226					760	762		10.1016/S0140-6736(20)30365-2	http://dx.doi.org/10.1016/S0140-6736(20)30365-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU2KH	32151334	Green Published, Bronze			2022-12-28	WOS:000519536900008
J	Brennan, EKW				Brennan, Ellen K. W.			Learning to say 'yes, and'	SCIENCE			English	Editorial Material									[Brennan, Ellen K. W.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Brennan, EKW (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	SciCareerEditor@aaas.org							0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1162	1162						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU9CD	32139548				2022-12-28	WOS:000520018400047
J	Scriba, TJ; Mizrahi, V				Scriba, Thomas J.; Mizrahi, Valerie			Renewing the Fight Against TB with an Old Vaccine	CELL			English	Editorial Material							TUBERCULOSIS; BCG; PREVENTION; MACAQUES	Prevention of pulmonary tuberculosis by vaccination has proven an elusive goal. In a recent study, Darrah et al. show that prevention of infection and disease can be achieved in non-human primates by intravenous administration of the century-old vaccine BCG. This finding heralds a step-change in the approach to TB vaccine development.	[Scriba, Thomas J.] Univ Cape Town, South African TB Vaccine Initiat, Cape Town, South Africa; [Scriba, Thomas J.] Univ Cape Town, Inst Infect Dis & Mol Med, Div Immunol, Dept Pathol, Cape Town, South Africa; [Mizrahi, Valerie] Univ Cape Town, SAMRC NHLS UCT Mol Mycobacteriol Res Unit, Cape Town, South Africa; [Mizrahi, Valerie] Univ Cape Town, Inst Infect Dis & Mol Med, Div Med Microbiol, Dept Pathol, Cape Town, South Africa; [Mizrahi, Valerie] Univ Cape Town, Wellcome Ctr Infect Dis Res Africa, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town	Mizrahi, V (corresponding author), Univ Cape Town, SAMRC NHLS UCT Mol Mycobacteriol Res Unit, Cape Town, South Africa.; Mizrahi, V (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Div Med Microbiol, Dept Pathol, Cape Town, South Africa.; Mizrahi, V (corresponding author), Univ Cape Town, Wellcome Ctr Infect Dis Res Africa, Cape Town, South Africa.	valerie.mizrahi@uct.ac.za	Scriba, Thomas/AAH-9413-2020; Scriba, Thomas/GPX-2573-2022	Scriba, Thomas/0000-0002-0641-1359				Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Cadena AM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007305; Darrah PA, 2020, NATURE, V577, P95, DOI 10.1038/s41586-019-1817-8; Dijkman K, 2019, NAT MED, V25, P255, DOI 10.1038/s41591-018-0319-9; Gideon HP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004603; Hansen SG, 2018, NAT MED, V24, P130, DOI 10.1038/nm.4473; Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110; Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790; Nemes E, 2018, NEW ENGL J MED, V379, P138, DOI [10.1056/NEJMoa1714021, 10.1056/nejmoa1714021]; Tait DR, 2019, NEW ENGL J MED, V381, P2429, DOI 10.1056/NEJMoa1909953	10	6	6	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2020	180	5					829	831		10.1016/j.cell.2020.02.024	http://dx.doi.org/10.1016/j.cell.2020.02.024			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KT7JN	32142676	Bronze			2022-12-28	WOS:000519189800005
J	Sun, JK; Sobolev, YI; Zhang, WY; Zhuang, Q; Grzybowski, BA				Sun, Jian-Ke; Sobolev, Yaroslav I.; Zhang, Weiyi; Zhuang, Qiang; Grzybowski, Bartosz A.			Enhancing crystal growth using polyelectrolyte solutions and shear flow	NATURE			English	Article							SECONDARY NUCLEATION; POLYMER-SOLUTIONS; FLUID SHEAR; CRYSTALLIZATION	The ability to grow properly sized and good quality crystals is one of the cornerstones of single-crystal diffraction, is advantageous in many industrial-scale chemical processes(1-3), and is important for obtaining institutional approvals of new drugs for which high-quality crystallographic data are required(4-7). Typically, single crystals suitable for such processes and analyses are grown for hours to days during which any mechanical disturbances-believed to be detrimental to the process-are carefully avoided. In particular, stirring and shear flows are known to cause secondary nucleation, which decreases the final size of the crystals (though shear can also increase their quantity(8-14)). Here we demonstrate that in the presence of polymers (preferably, polyionic liquids), crystals of various types grow in common solvents, at constant temperature, much bigger and much faster when stirred, rather than kept still. This conclusion is based on the study of approximately 20 diverse organic molecules, inorganic salts, metal-organic complexes, and even some proteins. On typical timescales of a few to tens of minutes, these molecules grow into regularly faceted crystals that are always larger (with longest linear dimension about 16 times larger) than those obtained in control experiments of the same duration but without stirring or without polymers. We attribute this enhancement to two synergistic effects. First, under shear, the polymers and their aggregates disentangle, compete for solvent molecules and thus effectively 'salt out' (that is, induce precipitation by decreasing solubility of) the crystallizing species. Second, the local shear rate is dependent on particle size, ultimately promoting the growth of larger crystals (but not via surface-energy effects as in classical Ostwald ripening). This closed-system, constant-temperature crystallization driven by shear could be a valuable addition to the repertoire of crystal growth techniques, enabling accelerated growth of crystals required by the materials and pharmaceutical industries.	[Sun, Jian-Ke; Sobolev, Yaroslav I.; Zhuang, Qiang; Grzybowski, Bartosz A.] Inst Basic Sci, Ctr Soft & Living Matter, Ulsan, South Korea; [Grzybowski, Bartosz A.] Ulsan Natl Inst Sci & Technol, Dept Chem, Ulsan, South Korea; [Sun, Jian-Ke] Beijing Inst Technol, Sch Chem & Chem Engn, Beijing, Peoples R China; [Zhang, Weiyi] Stockholm Univ, Dept Mat & Environm Chem, Stockholm, Sweden; [Zhuang, Qiang] Northwestern Polytech Univ, Sch Nat & Appl Sci, Dept Appl Chem, Xian, Peoples R China	Institute for Basic Science - Korea (IBS); Ulsan National Institute of Science & Technology (UNIST); Beijing Institute of Technology; Stockholm University; Northwestern Polytechnical University	Grzybowski, BA (corresponding author), Inst Basic Sci, Ctr Soft & Living Matter, Ulsan, South Korea.; Grzybowski, BA (corresponding author), Ulsan Natl Inst Sci & Technol, Dept Chem, Ulsan, South Korea.	nanogrzybowski@gmail.com	Grzybowski, Bartosz A/H-5741-2017	Sobolev, Yaroslav I./0000-0002-2194-1630; Grzybowski, Bartosz/0000-0001-6613-4261	Institute for Basic Science Korea [IBS-R020-D1]	Institute for Basic Science Korea	We acknowledge support from the Institute for Basic Science Korea (Project Code IBS-R020-D1). We thank S. Lach for his help in the design and manufacture of the Couette cells, M. Siek for DLS measurements, C. Cahoon and K. K. Zheng for rheological measurements, J. Yuan for help with PIL synthesis, and W. Adamkiewicz for discussions.	ANDERECK CD, 1986, J FLUID MECH, V164, P155, DOI 10.1017/S0022112086002513; Antonietti M, 2004, ANGEW CHEM INT EDIT, V43, P4988, DOI 10.1002/anie.200460091; Berry G. C., 1968, ADV POLYM SCI, V5, P261; Botsaris G. D., 1976, IND CRYSTALLIZATION, P3, DOI DOI 10.1007/978-1-4615-7258-9_1; Burrell GL, 2010, SOFT MATTER, V6, P2080, DOI 10.1039/b916049n; Censi R, 2015, MOLECULES, V20, P18759, DOI 10.3390/molecules201018759; Chatterjee S, 2000, J MOL STRUCT, V520, P107, DOI 10.1016/S0022-2860(99)00322-1; Cohn EJ, 1925, PHYSIOL REV, V5, P349, DOI 10.1152/physrev.1925.5.3.349; COTTRELL FR, 1969, J POLYM SCI A2, V7, P1415, DOI 10.1002/pol.1969.160070811; Del Galdo S, 2016, PHYS CHEM CHEM PHYS, V18, P28175, DOI 10.1039/c6cp05029h; Forsyth C, 2016, CRYST GROWTH DES, V16, P136, DOI 10.1021/acs.cgd.5b01042; Forsyth C, 2015, CRYST GROWTH DES, V15, P94, DOI 10.1021/cg5008878; Gao MR, 2016, ANGEW CHEM INT EDIT, V55, P12812, DOI 10.1002/anie.201607221; Hasell T, 2012, J AM CHEM SOC, V134, P588, DOI 10.1021/ja209156v; ICH Q6A Specifications, 2000, CPMPICH36796 EUR MED; Lampart F, 2013, LINGUAE LITT, V19, P1; Larson R. G., 1988, CONSTITUTIVE EQUATIO; Lee EC, 1997, MACROMOLECULES, V30, P7313, DOI 10.1021/ma9706945; Lee EH, 2014, ASIAN J PHARM SCI, V9, P163, DOI 10.1016/j.ajps.2014.05.002; Lewis G.N., 2020, THERMODYNAMICS; LINK A, 1993, MACROMOLECULES, V26, P464, DOI 10.1021/ma00055a010; Ma Z, 2010, ADV MATER, V22, P261, DOI 10.1002/adma.200900603; Marcus Y., 1998, PROPERTIES SOLVENTS; McCabe W.L., 2001, UNIT OPERATIONS CHEM, DOI [10.1016/0009-2509(57)85034-9., DOI 10.1016/0009-2509(57)85034-9]; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Norman AI, 2007, MACROMOLECULES, V40, P2559, DOI 10.1021/ma0622783; Noyes AA, 1904, SCIENCE, V20, P577, DOI 10.1126/science.20.514.577; Ramel PR, 2018, CRYST GROWTH DES, V18, P1002, DOI 10.1021/acs.cgd.7b01472; Schmid D. W., 2002, THESIS; Shamlou P. A., 1993, PROCESSING SOLID LIQ, P1; Shekunov BY, 2000, J CRYST GROWTH, V211, P122, DOI 10.1016/S0022-0248(99)00819-2; Smith DE, 1999, SCIENCE, V283, P1724, DOI 10.1126/science.283.5408.1724; Sun J. K., 2017, J AM CHEM SOC, V139, P8971, DOI DOI 10.1021/JACS.7B03357; SUNG CY, 1973, AICHE J, V19, P957, DOI 10.1002/aic.690190511; Szymanski J, 2006, J PHYS CHEM B, V110, P25593, DOI 10.1021/jp0666784; USFDA, 2007, GUID IND ANDAS PHARM; Variankaval N, 2008, AICHE J, V54, P1682, DOI 10.1002/aic.11555; Wang JM, 1996, CHEM ENG COMMUN, V153, P275	40	46	48	23	285	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2020	579	7797					73	+		10.1038/s41586-020-2042-1	http://dx.doi.org/10.1038/s41586-020-2042-1			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MD2BD	32132690				2022-12-28	WOS:000543777700001
J	Wise, J				Wise, Jacqui			The BMJ Awards 2020: Clinical leadership	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2020	368								m798	10.1136/bmj.m798	http://dx.doi.org/10.1136/bmj.m798			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KI	32139406				2022-12-28	WOS:000519537000005
J	Ho, D				Ho, Dean			Artificial intelligence in cancer therapy	SCIENCE			English	Editorial Material									[Ho, Dean] Natl Univ Singapore, Dept Biomed Engn, Inst Digital Med WisDM, Inst Hlth 1, Singapore, Singapore; [Ho, Dean] Natl Univ Singapore, Dept Pharmacol, Singapore, Singapore	National University of Singapore; National University of Singapore	Ho, D (corresponding author), Natl Univ Singapore, Dept Biomed Engn, Inst Digital Med WisDM, Inst Hlth 1, Singapore, Singapore.; Ho, D (corresponding author), Natl Univ Singapore, Dept Pharmacol, Singapore, Singapore.	biedh@nus.edu.sg	Ho, Dean/AAV-4505-2020	Ho, Dean/0000-0002-7337-296X	AI Singapore (NRF); National Medical Research Council; Ministry of Education	AI Singapore (NRF); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education	D.H. holds pending patents on AI-based personalized medicine. D.H. acknowledges support from AI Singapore (NRF), the National Medical Research Council, and the Ministry of Education.	Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; Enriquez-Navas PM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7842; Harrer S, 2019, TRENDS PHARMACOL SCI, V40, P577, DOI 10.1016/j.tips.2019.05.005; Jedeszko C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010722; Lin A, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw8412; Lou B, 2019, LANCET DIGIT HEALTH, V1, pE136, DOI 10.1016/S2589-7500(19)30058-5; Menden MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061318; Palmer AC, 2017, CELL, V171, P1678, DOI 10.1016/j.cell.2017.11.009; Pantuck AJ, 2018, ADV THER-GERMANY, V1, DOI 10.1002/adtp.201800104; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Rashid MBMA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan0941; Wong CH, 2019, BIOSTATISTICS, V20, P273, DOI 10.1093/biostatistics/kxx069; Zarrinpar A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac5954; Zhang X, 2017, NAT COMMUN, V8, P1, DOI [10.1038/ncomms14542, 10.1038/s41467-017-00321-0, 10.1038/s41467-017-01968-5]; Zhavoronkov A, 2019, NAT BIOTECHNOL, V37, P1038, DOI 10.1038/s41587-019-0224-x	15	39	41	9	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2020	367	6481					982	983		10.1126/science.aaz3023	http://dx.doi.org/10.1126/science.aaz3023			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KS0CO	32108102	Bronze			2022-12-28	WOS:000517979600022
J	Roberts, K; Macleod, J; Metcalfe, C; Hollingworth, W; Williams, J; Muir, P; Vickerman, P; Clement, C; Gordon, F; Irving, W; Waldron, CA; North, P; Moore, P; Simmons, R; Miners, A; Horwood, J; Hickman, M				Roberts, Kirsty; Macleod, John; Metcalfe, Chris; Hollingworth, Will; Williams, Jack; Muir, Peter; Vickerman, Peter; Clement, Clare; Gordon, Fiona; Irving, Will; Waldron, Cherry-Ann; North, Paul; Moore, Philippa; Simmons, Ruth; Miners, Alec; Horwood, Jeremy; Hickman, Matthew			Cost effectiveness of an intervention to increase-uptake of hepatitis C virus testing and treatment (HepCATT): cluster randomised controlled trial in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INJECTING DRUG-USERS; GENERAL-PRACTICE; LIVER-DISEASE; EXCELLENCE; INFECTION; LINKAGE; HEALTH	OBJECTIVE To evaluate the effectiveness and cost effectiveness of a complex intervention in primary care that aims to increase uptake of hepatitis C virus (HCV) case finding and treatment. DESIGN Pragmatic, two armed, practice level, cluster randomised controlled trial and economic evaluation. SETTING AND PARTICIPANTS 45 general practices in South West England (22 randomised to intervention and 23 to control arm). Outcome data were collected from all intervention practices and 21/23 control practices. Total number of flagged patients was 24 473 (about 5% of practice list). INTERVENTION Electronic algorithm and flag on practice systems identifying patients with HCV risk markers (such as history of opioid dependence or HCV tests with no evidence of referral to hepatology), staff educational training in HCV, and practice posters/leaflets to increase patients' awareness. Flagged patients were invited by letter for an HCV test (with one follow-up) and had on-screen pop-ups to encourage opportunistic testing. The intervention lasted one year, with practices recruited April to December 2016. MAIN OUTCOME MEASURES Primary outcome: uptake of HCV testing. SECONDARY OUTCOMES number of positive HCV tests and yield (proportion HCV positive); HCV treatment assessment at hepatology; cost effectiveness. RESULTS Baseline HCV testing of flagged patients (six months before study start) was 608/13 097 (4.6%) in intervention practices and 380/11 376 (3.3%) in control practices. During the study 2071 (16%) of flagged patients in the intervention practices and 1163 (10%) in control practices were tested for HCV: overall intervention effect as an adjusted rate ratio of 1.59 (95% confidence interval 1.21 to 2.08; P<0.001). HCV antibodies were detected in 129 patients from intervention practices and 51 patients from control practices (adjusted rate ratio 2.24, 1.47 to 3.42) with weak evidence of an increase in yield (6.2% v 4.4%; adjusted risk ratio 1.40, 0.99 to 1.95). Referral and assessment increased in intervention practices compared with control practices (adjusted rate ratio 5.78, 1.6 to 21.6) with a risk difference of 1.3 per 1000 and a "number needed to help" of one extra HCV diagnosis, referral, and assessment per 792 (95% confidence interval 558 to 1883) patients flagged. The average cost of HCV case finding was 4.03 pound (95% confidence interval 2.27 pound to 5.80) pound per at risk patient and 3165 pound per additional patient assessed at hepatology. The incremental cost effectiveness ratio was 6212 pound per quality adjusted life year (QALY), with 92.5% probability of being below 20 pound 000 per QALY. CONCLUSION HepCATT had a modest impact but is a low cost intervention that merits optimisation and implementation as part of an NHS strategy to increase HCV testing and treatment.	[Roberts, Kirsty; Macleod, John; Metcalfe, Chris; Hollingworth, Will; Vickerman, Peter; Horwood, Jeremy; Hickman, Matthew] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [Macleod, John; Vickerman, Peter; Clement, Clare; Horwood, Jeremy; Hickman, Matthew] Univ Bristol, NIHR Hlth Protect Res Unit HPRU Evaluat Intervent, Bristol, Avon, England; [Metcalfe, Chris] Univ Bristol Sch Med, BRTC, Populat Hlth Sci, Bristol, Avon, England; [Williams, Jack; Miners, Alec] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England; [Williams, Jack; Simmons, Ruth; Miners, Alec] UCL, NIHR HPRU Blood Borne Viruses & STI, London, England; [Muir, Peter; North, Paul; Moore, Philippa] Southmead Hosp, Publ Hlth England, Natl Infect Serv, Publ Hlth Lab Bristol, Pathol Sci Bldg, Bristol, Avon, England; [Gordon, Fiona] Bristol Royal Infirm & Gen Hosp, Univ Hosp Bristol, Bristol, Avon, England; [Irving, Will] Univ Hosp Nottingham, NIHR Nottingham Digest Dis Biomed Res Unit, Nottingham, England; [Waldron, Cherry-Ann] Cardiff Univ, Ctr Trials Res, Cardiff, Wales; [Simmons, Ruth] Publ Hlth England, Natl Infect Serv, London, England	University of Bristol; University of Bristol; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Public Health England; Southmead Hospital; Bristol Royal Infirmary; University of Bristol; University of Nottingham; Cardiff University; Public Health England	Hickman, M (corresponding author), Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England.; Hickman, M (corresponding author), Univ Bristol, NIHR Hlth Protect Res Unit HPRU Evaluat Intervent, Bristol, Avon, England.	matthew.hickman@bristol.ac.uk	Roberts, Kirsty/AAH-3485-2021; Hickman, Matthew/Y-2400-2019	Hickman, Matthew/0000-0001-9864-459X; Hollingworth, William/0000-0002-0840-6254; Metcalfe, Chris/0000-0001-8318-8907; Roberts, Kirsty/0000-0003-0765-3752; Vickerman, Peter/0000-0002-8291-5890; Macleod, John/0000-0001-8202-1144; Waldron, Cherry-Ann/0000-0001-8465-2492; clement, clare/0000-0002-5555-433X; horwood, jeremy/0000-0001-7092-4960	University of Bristol; NIHR; Department of Health Policy Research Programme [015/0309]; NIHR HPRU Evaluation of Interventions; NIHR HPRU BBVSTI; NIHR Programme Grants for Applied Research programme [RP-PG-0616-20008]; NIHR CTU; MRC [MR/K025643/1, MR/N00616X/1] Funding Source: UKRI	University of Bristol; NIHR(National Institute for Health Research (NIHR)); Department of Health Policy Research Programme; NIHR HPRU Evaluation of Interventions; NIHR HPRU BBVSTI; NIHR Programme Grants for Applied Research programme; NIHR CTU; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The trial was sponsored by the University of Bristol. This report is independent research funded by the NIHR and Department of Health Policy Research Programme (grant code 015/0309), with additional support from NIHR HPRU Evaluation of Interventions and NIHR HPRU BBV&STI and NIHR Programme Grants for Applied Research programme (grant reference number RP-PG-0616-20008). The BRTC, as part of the Bristol Trials Centre, is in receipt of NIHR CTU support funding. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health and Social Care, arm's length bodies, or other government departments.	Bajis S, 2017, INT J DRUG POLICY, V47, P34, DOI 10.1016/j.drugpo.2017.07.002; Castrejon M, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx109; Claxton K, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19140; Cooke GS, 2019, LANCET GASTROENTEROL, V4, P135, DOI 10.1016/S2468-1253(18)30270-X; Cullen BL, 2012, J PUBLIC HEALTH-UK, V34, P14, DOI 10.1093/pubmed/fdr097; Cullen W, 2006, BRIT J GEN PRACT, V56, P848; Degenhardt L, 2016, LANCET INFECT DIS, V16, P1385, DOI 10.1016/S1473-3099(16)30325-5; Dore GJ, 2015, CLIN INFECT DIS, V60, P1829, DOI 10.1093/cid/civ197; Fathi H, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2820-z; Flanagan S, 2019, LANCET GASTROENTEROL, V4, P32, DOI 10.1016/S2468-1253(18)30318-2; Harris RJ, 2019, J VIRAL HEPATITIS, V26, P541, DOI 10.1111/jvh.13063; Harris RJ, 2014, J HEPATOL, V61, P530, DOI 10.1016/j.jhep.2014.05.008; Harrison GI, 2019, ADDICTION, V114, P1113, DOI 10.1111/add.14569; Horwood J, 2020, BRIT J GEN PRACT, V70, pE581, DOI 10.3399/bjgp20X708785; Lattimore S, 2014, HEPATOLOGY, V59, P1343, DOI 10.1002/hep.26926; Martin M, 2012, BRIT J EDUC TECHNOL, V43, DOI 10.1111/j.1467-8535.2012.01297.x; Martin N, 2012, ASSESSING COST EFFEC; Martin NK, 2016, J HEPATOL, V65, P17, DOI 10.1016/j.jhep.2016.02.007; Martin NK, 2016, HEPATOLOGY, V63, P1796, DOI 10.1002/hep.28497; Martin NK, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003153; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; McGarry LJ, 2012, HEPATOLOGY, V55, P1344, DOI 10.1002/hep.25510; Miners AH, 2014, J VIRAL HEPATITIS, V21, P616, DOI 10.1111/jvh.12190; National Institute for Health and Care Excellence, 2013, GUID METH TECHN AMGP; National Institute for Health and Care Excellence, 2012, HEP B C WAYS PROM OF; Norton EC, 2013, STATA J, V13, P492, DOI 10.1177/1536867X1301300304; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Roberts K, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1501-3; Sculpher M, 2000, FAM PRACT, V17, pS26, DOI 10.1093/fampra/17.suppl_1.S26; Simmons R, 2018, J VIRAL HEPATITIS, V25, P482, DOI 10.1111/jvh.12844; Suwanthawornkul T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145953; Turner BJ, 2015, J HOSP MED, V10, P510, DOI 10.1002/jhm.2376; WHO, 2016, MYANM NATL SIMPL TRE; Williams J, 2019, VALUE HEALTH, V22, P1248, DOI 10.1016/j.jval.2019.06.006; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9	35	14	14	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2020	368								m322	10.1136/bmj.m322	http://dx.doi.org/10.1136/bmj.m322			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2JV	32102782	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000519535600001
J	Lauer, SA; Grantz, KH; Bi, QF; Jones, FK; Zheng, QL; Meredith, HR; Azman, AS; Reich, NG; Lessler, J				Lauer, Stephen A.; Grantz, Kyra H.; Bi, Qifang; Jones, Forrest K.; Zheng, Qulu; Meredith, Hannah R.; Azman, Andrew S.; Reich, Nicholas G.; Lessler, Justin			The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application	ANNALS OF INTERNAL MEDICINE			English	Article								Background: A novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in China in December 2019. There is limited support for many of its key epidemiologic features, including the incubation period for clinical disease (coronavirus disease 2019 [COVID-19]), which has important implications for surveillance and control activities. Objective: To estimate the length of the incubation period of COVID-19 and describe its public health implications. Design: Pooled analysis of confirmed COVID-19 cases reported between 4 January 2020 and 24 February 2020. Setting: News reports and press releases from 50 provinces, regions, and countries outside Wuhan, Hubei province, China. Participants: Persons with confirmed SARS-CoV-2 infection outside Hubei province, China. Measurements: Patient demographic characteristics and dates and times of possible exposure, symptom onset, fever onset, and hospitalization. Results: There were 181 confirmed cases with identifiable exposure and symptom onset windows to estimate the incubation period of COVID-19. The median incubation period was estimated to be 5.1 days (95% CI, 4.5 to 5.8 days), and 97.5% of those who develop symptoms will do so within 11.5 days (CI, 8.2 to 15.6 days) of infection. These estimates imply that, under conservative assumptions, 101 out of every 10 000 cases (99th percentile, 482) will develop symptoms after 14 days of active monitoring or quarantine. Limitation: Publicly reported cases may overrepresent severe cases, the incubation period for which may differ from that of mild cases. Conclusion: This work provides additional evidence for a median incubation period for COVID-19 of approximately 5 days, similar to SARS. Our results support current proposals for the length of quarantine or active monitoring of persons potentially exposed to SARS-CoV-2, although longer monitoring periods might be justified in extreme cases.	[Lauer, Stephen A.; Grantz, Kyra H.; Bi, Qifang; Jones, Forrest K.; Zheng, Qulu; Meredith, Hannah R.; Azman, Andrew S.; Lessler, Justin] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Reich, Nicholas G.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; [Reich, Nicholas G.] Ludwig Maximilians Univ Munchen, Munich, Germany; [Lauer, Stephen A.; Grantz, Kyra H.; Bi, Qifang; Jones, Forrest K.; Zheng, Qulu; Meredith, Hannah R.; Lessler, Justin] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 North Wolfe St, Baltimore, MD 21205 USA; [Azman, Andrew S.] Medecins Sans Frontieres, Rue Lausanne 72, CH-1202 Geneva, Switzerland; [Reich, Nicholas G.] Univ Massachusetts, Amherst Sch Publ Hlth & Hlth Sci, Dept Biostat & Epidemiol, 715 North Pleasant St, Amherst, MA 01003 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Massachusetts System; University of Massachusetts Amherst; University of Munich; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Doctors Without Borders; University of Massachusetts System; University of Massachusetts Amherst	Lessler, J (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 North Wolfe St, Baltimore, MD 21205 USA.	justin@jhu.edu		Azman, Andrew/0000-0001-8662-9077; Meredith, Hannah/0000-0002-5315-7568	U.S. Centers for Disease Control and Prevention [NU2GGH002000]; National Institute of Allergy and Infectious Diseases [R01 AI135115]; National Institute of General Medical Sciences [R35 GM119582]; Alexander von Humboldt Foundation	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	By the U.S. Centers for Disease Control and Prevention (NU2GGH002000), the National Institute of Allergy and Infectious Diseases (R01 AI135115), the National Institute of General Medical Sciences (R35 GM119582), and the Alexander von Humboldt Foundation.	[Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], 2020, GENOMIC EPIDEMIOLOGY; [Anonymous], [No title captured]; [Anonymous], 2020, LANCET, DOI DOI 10.1016/S0140-6736(20)30183-5; Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538; Reich NG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19406-x; Reich NG, 2009, STAT MED, V28, P2769, DOI 10.1002/sim.3659; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Shen L, 2020, J MED ECON, V23, P456, DOI 10.1080/13696998.2020.1717500; The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WEEKLY, V41, P145, DOI DOI 10.1056/NEJMcp2009249; Varia M, 2003, CAN MED ASSOC J, V169, P285; Virlogeux V, 2016, SCI REP-UK, V6, DOI 10.1038/srep35839; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	16	2992	3086	28	299	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2020	172	9					577	+		10.7326/M20-0504	http://dx.doi.org/10.7326/M20-0504			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK7EH	32150748	Green Published, Green Submitted			2022-12-28	WOS:000531024900007
J	Hoffmann, M; Kleine-Weber, H; Schroeder, S; Kruger, N; Herrler, T; Erichsen, S; Schiergens, TS; Herrler, G; Wu, NH; Nitsche, A; Muller, MA; Drosten, C; Pohlmann, S				Hoffmann, Markus; Kleine-Weber, Hannah; Schroeder, Simon; Krueger, Nadine; Herrler, Tanja; Erichsen, Sandra; Schiergens, Tobias S.; Herrler, Georg; Wu, Nai-Huei; Nitsche, Andreas; Mueller, Marcel A.; Drosten, Christian; Poehlmann, Stefan			SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor	CELL			English	Article							ACUTE RESPIRATORY SYNDROME; ANGIOTENSIN-CONVERTING ENZYME-2; SARS-ASSOCIATED CORONAVIRUS; TO-HUMAN TRANSMISSION; SPIKE PROTEIN; FUNCTIONAL RECEPTOR; S-PROTEIN; VIRUS; INFECTION; LUNG	The recent emergence of the novel, pathogenic SARS-coronavirus 2 (SARS-CoV-2) in China and its rapid national and international spread pose a global health emergency. Cell entry of coronaviruses depends on binding of the viral spike (S) proteins to cellular receptors and on S protein priming by host cell proteases. Unravelling which cellular factors are used by SARS-CoV-2 for entry might provide insights into viral transmission and reveal therapeutic targets. Here, we demonstrate that SARS-CoV-2 uses the SARS-CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming. A TMPRSS2 inhibitor approved for clinical use blocked entry and might constitute a treatment option. Finally, we show that the sera from convalescent SARS patients cross-neutralized SARS-2-S-driven entry. Our results reveal important commonalities between SARS-CoV-2 and SARS-CoV infection and identify a potential target for antiviral intervention.	[Hoffmann, Markus; Kleine-Weber, Hannah; Poehlmann, Stefan] Leibniz Inst Primate Res, German Primate Ctr, Infect Biol Unit, Gottingen, Germany; [Kleine-Weber, Hannah; Poehlmann, Stefan] Univ Gottingen, Fac Biol & Psychol, Gottingen, Germany; [Schroeder, Simon; Mueller, Marcel A.; Drosten, Christian] Charite Univ Med Berlin, Berlin, Germany; [Schroeder, Simon; Mueller, Marcel A.; Drosten, Christian] Free Univ Berlin, Berlin, Germany; [Schroeder, Simon; Mueller, Marcel A.; Drosten, Christian] Humboldt Univ, Berlin, Germany; [Schroeder, Simon; Mueller, Marcel A.; Drosten, Christian] Berlin Inst Hlth, Inst Virol, Berlin, Germany; [Schroeder, Simon; Mueller, Marcel A.; Drosten, Christian] German Ctr Infect Res, Associated Partner Charite, Berlin, Germany; [Krueger, Nadine; Herrler, Georg; Wu, Nai-Huei] Univ Vet Med Hannover, Inst Virol, Hannover, Germany; [Krueger, Nadine] Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonoses, Hannover, Germany; [Herrler, Tanja] BG Unfallklin Murnau, Murnau, Germany; [Erichsen, Sandra] BG Unfallklin Murnau, Inst Biomech, Murnau, Germany; [Erichsen, Sandra] Paracelsus Med Univ Salzburg, Inst Biomech, Salzburg, Austria; [Schiergens, Tobias S.] Ludwig Maximilians Univ Munchen, Dept Gen Visceral & Transplant Surg, Biobank, Munich, Germany; [Nitsche, Andreas] Robert Koch Inst, WHO Collaborating Ctr Emerging Infect & Biol Thre, ZBS Highly Pathogen Viruses 1, Berlin, Germany; [Mueller, Marcel A.] Sechenov Univ, Martsinovsky Inst Med Parasitol Trop & Vector Bor, Moscow, Russia	Deutsches Primatenzentrum (DPZ); University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; German Center for Infection Research; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Paracelsus Private Medical University; University of Munich; Robert Koch Institute; Sechenov First Moscow State Medical University	Hoffmann, M; Pohlmann, S (corresponding author), Leibniz Inst Primate Res, German Primate Ctr, Infect Biol Unit, Gottingen, Germany.; Pohlmann, S (corresponding author), Univ Gottingen, Fac Biol & Psychol, Gottingen, Germany.	mhoffmann@dpz.eu; spoehlmann@dpz.eu	Pöhlmann, Stefan/H-2395-2011; Ganesh, Dunna Sai/AGX-5170-2022; Gw, Safwan/ABG-4675-2020; Krüger, Nadine/V-2282-2019; Müller, Marcel A./O-2425-2019; Hoffmann, Markus/J-7836-2018	Pöhlmann, Stefan/0000-0001-6086-9136; Gw, Safwan/0000-0001-6764-1038; Krüger, Nadine/0000-0002-4413-8699; Müller, Marcel A./0000-0003-2242-5117; Hoffmann, Markus/0000-0003-4603-7696; Schroeder, Simon/0000-0003-2085-767X	BMBF (RAPID Consortium) [01KI1723D, 01KI1723A]; German Research Foundation (DFG) [WU 929/1-1]; non-profit foundation HTCR	BMBF (RAPID Consortium)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); non-profit foundation HTCR	We thank Heike Hofmann-Winkler for discussion, Andrea Maisner for Nipah F and G expression plasmids, Anette Teichmann for technical assistance, and Roberto Cattaneo for plasmid pCG1. We acknowledge the support of the non-profit foundation HTCR, which holds human tissue on trust, making it broadly available for research on an ethical and legal basis. We gratefully acknowledge the authors and the originating and submitting laboratories for their sequence and metadata shared through GISAID, on which this research is based. This work was supported by BMBF (RAPID Consortium, 01KI1723D and 01KI1723A to C.D. and S.P.) and German Research Foundation (DFG) (WU 929/1-1 to N.-H.W.).	[Anonymous], 23 WHO; Bertram S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035876; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bossart KN, 2002, J VIROL, V76, P11186, DOI 10.1128/JVI.76.22.11186-11198.2002; Brinkmann C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189073; Buchholz U, 2013, EUROSURVEILLANCE, V18, P6; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Corman VM, 2019, INTERNIST, V60, P1136, DOI 10.1007/s00108-019-00671-5; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Ding YQ, 2004, J PATHOL, V203, P622, DOI 10.1002/path.1560; Fehr AR, 2017, ANNU REV MED, V68, P387, DOI 10.1146/annurev-med-051215-031152; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Haga S, 2008, P NATL ACAD SCI USA, V105, P7809, DOI 10.1073/pnas.0711241105; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; He YX, 2006, J VIROL, V80, P5757, DOI 10.1128/JVI.00083-06; Hoffmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072942; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; Hofmann H, 2004, J VIROL, V78, P6134, DOI 10.1128/JVI.78.12.6134-6142.2004; Hofmann H, 2004, BIOCHEM BIOPH RES CO, V319, P1216, DOI 10.1016/j.bbrc.2004.05.114; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Iwata-Yoshikawa N, 2019, J VIROL, V93, DOI 10.1128/JVI.01815-18; Kawase M, 2012, J VIROL, V86, P6537, DOI 10.1128/JVI.00094-12; Kim TS, 2006, MOL CELL BIOL, V26, P965, DOI 10.1128/MCB.26.3.965-975.2006; Kleine-Weber H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34859-w; Kleine-Weber H, 2019, J VIROL, V93, DOI 10.1128/JVI.01381-18; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li WT, 2017, P NATL ACAD SCI USA, V114, pE8508, DOI 10.1073/pnas.1712592114; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Lin JT, 2007, ANTIVIR THER, V12, P1107; Liu W, 2006, J INFECT DIS, V193, P792, DOI 10.1086/500469; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Menachery VD, 2020, J VIROL, V94, DOI 10.1128/JVI.01774-19; Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929; Park JE, 2016, P NATL ACAD SCI USA, V113, P12262, DOI 10.1073/pnas.1608147113; Park YJ, 2019, NAT STRUCT MOL BIOL, V26, P1151, DOI 10.1038/s41594-019-0334-7; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Rentsch MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025858; Shieh WJ, 2005, HUM PATHOL, V36, P303, DOI 10.1016/j.humpath.2004.11.006; Shirato K, 2018, VIROLOGY, V517, P9, DOI 10.1016/j.virol.2017.11.012; Shirato K, 2017, J VIROL, V91, DOI [10.1128/JVI.01387-16, 10.1128/jvi.01387-16]; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; World Health Organization (WHO), 2003, SUMM PROB SARS CAS O; Wu NH, 2016, SCI REP-UK, V6, DOI 10.1038/srep39668; Yamamoto M, 2016, ANTIMICROB AGENTS CH, V60, P6532, DOI 10.1128/AAC.01043-16; Yang Y, 2015, J VIROL, V89, P9119, DOI 10.1128/JVI.01279-15; Yang Y, 2014, P NATL ACAD SCI USA, V111, P12516, DOI 10.1073/pnas.1405889111; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhou Y, 2015, ANTIVIR RES, V116, P76, DOI 10.1016/j.antiviral.2015.01.011; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	61	9944	10097	238	1174	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2020	181	2					271	+		10.1016/j.cell.2020.02.052	http://dx.doi.org/10.1016/j.cell.2020.02.052			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LD7BL	32142651	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000526184900011
J	Rabi, DM; Kunneman, M; Montori, VM				Rabi, Doreen M.; Kunneman, Marleen; Montori, Victor M.			When Guidelines Recommend Shared Decision-making	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses the importance of shared decision-making (SDM) for providing care that takes into account the experience, expertise, and specific situations of patients; and stresses the importance of developing clinical practice guidelines that consider known barriers and costs of SDM implementation and when SDM is most relevant and useful.	[Rabi, Doreen M.] Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada; [Kunneman, Marleen] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands; [Kunneman, Marleen; Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res Unit, 200 First St SW,Plummer 4-402, Rochester, MN 55902 USA	University of Calgary; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Mayo Clinic	Montori, VM (corresponding author), Mayo Clin, Knowledge & Evaluat Res Unit, 200 First St SW,Plummer 4-402, Rochester, MN 55902 USA.	Montori.Victor@Mayo.edu						Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013; [Anonymous], 2020, DEC AIDS; Garber JR, 2012, ENDOCR PRACT, V18, P989, DOI 10.4158/EP12280.GL; Gartner FR, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032483; Keating NL, 2018, JAMA-J AM MED ASSOC, V319, P1814, DOI 10.1001/jama.2018.3388; Knuuti J, 2020, EUR HEART J, V41, P407, DOI 10.1093/eurheartj/ehz425; Montori VM, 2017, JAMA-J AM MED ASSOC, V318, P617, DOI 10.1001/jama.2017.10168; multicenter collaboration group of Department of S Technology of Guangdong P Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus p, 2020, ZHONGHUA JIE HE HE H, V43, pE019, DOI DOI 10.2337/DC20-S006; Redberg RF, 2018, JAMA INTERN MED, V178, P1295, DOI 10.1001/jamainternmed.2018.3527; Shekelle PG, 2018, JAMA-J AM MED ASSOC, V320, P757, DOI 10.1001/jama.2018.9660	10	20	20	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2020	323	14					1345	1346		10.1001/jama.2020.1525	http://dx.doi.org/10.1001/jama.2020.1525			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LH1YB	32167526				2022-12-28	WOS:000528583600011
J	Grundy, Q; Dunn, AG; Bero, L				Grundy, Quinn; Dunn, Adam G.; Bero, Lisa			Improving researchers' conflict of interest declarations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Grundy, Quinn] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada; [Grundy, Quinn; Bero, Lisa] Univ Sydney, Sch Pharm, Charles Perkins Ctr, Sydney, NSW, Australia; [Dunn, Adam G.] Macquarie Univ, Australian Inst Hlth Innovat, Ctr Hlth Informat, Sydney, NSW, Australia; [Dunn, Adam G.] Univ Sydney, Sch Med Sci, Fac Med & Hlth, Discipline Biomed Informat & Digital Hlth, Sydney, NSW, Australia	University of Toronto; University of Sydney; Macquarie University; University of Sydney	Grundy, Q (corresponding author), Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada.; Grundy, Q (corresponding author), Univ Sydney, Sch Pharm, Charles Perkins Ctr, Sydney, NSW, Australia.	quinn.grundy@utoronto.ca	Dunn, Adam/E-6828-2011	Dunn, Adam/0000-0002-1720-8209				AHN R, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.I6770; Bauchner H, 2018, JAMA-J AM MED ASSOC, V320, P2315, DOI 10.1001/jama.2018.17593; Centers for Medicare & Medicaid Services, 2019, OP PAYM PUBL US FIL; Collins M., 2017, NLM TECH B, pe2; Dunn AG, 2016, NATURE, V533, P9, DOI 10.1038/533009a; FLEISCHMAN W, 2016, BMJ-BRIT MED J, V354, DOI DOI 10.1136/BMJ.I4189; Grundy Q, 2018, JAMA-J AM MED ASSOC, V319, P408, DOI 10.1001/jama.2017.20738; Hadland SE, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.6007; Hakoum MB, 2017, J CLIN EPIDEMIOL, V87, P78, DOI 10.1016/j.jclinepi.2017.04.002; Hakoum MB, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011997; Institute of Medicine, 2009, CONFL INT MED RES ED; International Committee of Medica Journal Editors, 2018, REC; Kuehn HS, 2016, NEW ENGL J MED, V374, P1032, DOI 10.1056/NEJMoa1512234; Lichter A, 2012, HARMONIZING REPORTIN; Lichter AS, 2012, JAMA-J AM MED ASSOC, V308, P2093, DOI 10.1001/jama.2012.51172; Lundh A, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j176; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Menkes DB, 2018, J GEN INTERN MED, V33, P139, DOI 10.1007/s11606-017-4225-5; van den Wijngaard IR, 2016, STROKE, V47, P762, DOI 10.1161/STROKEAHA.115.012279; Woodruff PG, 2016, NEW ENGL J MED, V374, P1811, DOI 10.1056/NEJMoa1505971	20	13	13	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2020	368								m422	10.1136/bmj.m422	http://dx.doi.org/10.1136/bmj.m422			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AR	32161006				2022-12-28	WOS:000520012800002
J	Mahase, E				Mahase, Elisabeth			Covid-19: out-of-hours providers are drafted in to manage non-urgent patients in community	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	7	7	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2020	368								m959	10.1136/bmj.m959	http://dx.doi.org/10.1136/bmj.m959			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AK	32152010	Bronze			2022-12-28	WOS:000520012000010
J	Lynch, HF; Greiner, DJ; Cohen, IG				Lynch, H. Fernandez; Greiner, D. J.; Cohen, I. G.			Overcoming obstacles to experiments in legal practice	SCIENCE			English	Editorial Material							ETHICS; TRIALS		[Lynch, H. Fernandez] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lynch, H. Fernandez] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Greiner, D. J.] Harvard Law Sch, Access Justice Lab, Cambridge, MA USA; [Cohen, I. G.] Harvard Law Sch, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Harvard University; Harvard University	Lynch, HF (corresponding author), Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA.; Lynch, HF (corresponding author), Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA.	lynchhf@pennmedicine.upenn.edu			Arnold Ventures; Chan Zuckerberg Initiative; Charles Koch Foundation; NOMIS Foundation; Robert Wood Johnson Foundation; Greenwall Foundation	Arnold Ventures; Chan Zuckerberg Initiative; Charles Koch Foundation; NOMIS Foundation; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Greenwall Foundation	Some of Access to Justice Lab's work is supported by Arnold Ventures, The Chan Zuckerberg Initiative, The Charles Koch Foundation, The NOMIS Foundation, and The Robert Wood Johnson Foundation. Support for elements of this article was provided in part by The Pew Charitable Trusts. The opinions, findings,and conclusions or recommendations expressed here do not necessarily reflect the views of any of the entities listed. H.F.L. is funded by the Greenwall Foundation as a Faculty Scholar.	Abramowicz M, 2011, U PENN LAW REV, V159, P929; Blustein J, 2005, J POLICY ANAL MANAG, V24, P824, DOI 10.1002/pam.20141; Crouch RA, 1998, HASTINGS CENT REP, V28, P26, DOI 10.2307/3528266; Emanuel EJ, 2005, AM J BIOETHICS, V5, P9, DOI 10.1080/15265160500244959; Greiner DJ, 2016, ANNU REV LAW SOC SCI, V12, P295, DOI 10.1146/annurev-lawsocsci-110413-030732; Joffe Steven, 2014, IRB, V36, P16; Joffe S, 2012, NAT REV CLIN ONCOL, V9, P230, DOI 10.1038/nrclinonc.2011.211; MacKay D, 2019, PUBLIC HEALTH ETH-UK, V12, P188, DOI 10.1093/phe/phy015; MacKay D, 2018, BIOETHICS, V32, P59, DOI 10.1111/bioe.12403; Meyer MN, 2019, P NATL ACAD SCI USA, V116, P10723, DOI 10.1073/pnas.1820701116; Shah SK, 2018, SCIENCE, V360, P158, DOI 10.1126/science.aaq0917; Venkataramani AS, 2020, JAMA-J AM MED ASSOC, V323, P21, DOI 10.1001/jama.2019.18061; Wertheimer A., 2016, COERCION; World Health Organization, 2019, ETH CONS HLTH POL SY	14	5	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1078	1080		10.1126/science.aay3005	http://dx.doi.org/10.1126/science.aay3005			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU9CD	32139532				2022-12-28	WOS:000520018400027
J	O'Dowd, A				O'Dowd, Adrian			Impaired consciousness: new guidelines aim to ensure people aren't "lost in system"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2018, BMJ-BRIT MED J, V362, DOI DOI 10.1136/bmj.k3332; Royal College of Physicians, 2020, PROL DIS CONS FOLL S	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2020	368								m928	10.1136/bmj.m928	http://dx.doi.org/10.1136/bmj.m928			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2LJ	32144126				2022-12-28	WOS:000519539700007
J	Geitmann, A				Geitmann, Anja			Form Follows Function: How to Build a Deadly Trap	CELL			English	Editorial Material								The carnivorous plant Utricularia gibba forms cup-shaped leaflets to capture prey. Whitewoods et al. (2020) use computational modeling to simulate the formation of the trap's 3D geometry. Directional expansion of the young leaflet is proposed to be a crucial morphogenetic driver, pointing at a fundamental principle of plant development.	[Geitmann, Anja] McGill Univ, Dept Plant Sci, Montreal, PQ, Canada	McGill University	Geitmann, A (corresponding author), McGill Univ, Dept Plant Sci, Montreal, PQ, Canada.	geitmann.aes@mcgill.ca	Geitmann, Anja/D-4696-2012	Geitmann, Anja/0000-0003-0390-0517				Bidhendi AJ, 2019, CELL REP, V28, P1237, DOI 10.1016/j.celrep.2019.07.006; Darwin C., 1875, INSECTIVOROUS PLANTS; Fukushima K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7450; Fukushima K, 2014, GENESIS, V52, P1, DOI 10.1002/dvg.22728; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Lee KJI, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000427; McConnell JR, 1998, DEVELOPMENT, V125, P2935; Whitewoods CD, 2020, SCIENCE, V367, P91, DOI 10.1126/science.aay5433	8	0	0	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2020	180	5					826	828		10.1016/j.cell.2020.02.023	http://dx.doi.org/10.1016/j.cell.2020.02.023			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KT7JN	32142675	Bronze			2022-12-28	WOS:000519189800004
J	Melmed, S				Melmed, Shlomo			Pituitary-Tumor Endocrinopathies	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GROWTH-HORMONE; STEREOTACTIC RADIOSURGERY; TRANSSPHENOIDAL SURGERY; RECEPTOR ANTAGONIST; CUSHINGS-SYNDROME; EXCESS MORTALITY; ADENOMAS; DIAGNOSIS; SOCIETY; DISEASE	Pituitary adenomas account for about 15% of intracranial tumors. Clinical manifestations of disease reflect the oversecretion of the involved hormone, most commonly growth hormone, prolactin, corticotropin, or thyrotropin. Diagnosis and management of these disorders are reviewed.	[Melmed, Shlomo] Cedars Sinai Med Ctr, Dept Med, Pituitary Ctr, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Melmed, S (corresponding author), Cedars Sinai Med Ctr, 8700 Beverly Blvd,Rm 2015, Los Angeles, CA 90048 USA.							Agustsson TT, 2015, EUR J ENDOCRINOL, V173, P655, DOI 10.1530/EJE-15-0189; Alexopoulou O, 2014, PITUITARY, V17, P81, DOI 10.1007/s11102-013-0471-7; Annamalai AK, 2013, J CLIN ENDOCR METAB, V98, P1040, DOI 10.1210/jc.2012-3072; [Anonymous], 2012, REGEN MED S3, V7, pS14; Ayuk J, 2004, J CLIN ENDOCR METAB, V89, P1613, DOI 10.1210/jc.2003-031584; Azzalin A, 2016, PITUITARY, V19, P183, DOI 10.1007/s11102-015-0697-7; Babu H, 2017, NEUROSURGERY, V81, P357, DOI 10.1093/neuros/nyx020; Barkan AL, 2005, J CLIN ENDOCR METAB, V90, P5684, DOI 10.1210/jc.2005-0331; Bernard V, 2015, NAT REV ENDOCRINOL, V11, P265, DOI 10.1038/nrendo.2015.36; Bi WL, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0811-0; Biller BMK, 1996, J CLIN ENDOCR METAB, V81, P2338, DOI 10.1210/jc.81.6.2338; Bronstein Marcello Delano, 2005, Pituitary, V8, P31, DOI 10.1007/s11102-005-5083-4; Brzana J, 2013, PITUITARY, V16, P490, DOI 10.1007/s11102-012-0445-1; Buchfelder M, 2017, PITUITARY, V20, P76, DOI 10.1007/s11102-016-0765-7; Burke WT, 2019, J NEUROSURG; Burton T, 2016, PITUITARY, V19, P262, DOI 10.1007/s11102-015-0701-2; Carmichael JD, 2014, J CLIN ENDOCR METAB, V99, P1825, DOI 10.1210/jc.2013-3757; Casanueva FF, 2017, PITUITARY, V20, P489, DOI 10.1007/s11102-017-0838-2; Casini AF, 2011, CLIN ENDOCRINOL, V75, P495, DOI 10.1111/j.1365-2265.2011.04067.x; Castinetti F, 2014, J CLIN ENDOCR METAB, V99, P1623, DOI 10.1210/jc.2013-3628; Chen LK, 2011, J NEURO-ONCOL, V102, P129, DOI 10.1007/s11060-010-0302-x; Chesnokova V, 2008, P NATL ACAD SCI USA, V105, P17498, DOI 10.1073/pnas.0804810105; CLEMMONS DR, 1979, NEW ENGL J MED, V301, P1138, DOI 10.1056/NEJM197911223012102; Colao A, 2003, NEW ENGL J MED, V349, P2023, DOI 10.1056/NEJMoa022657; Colao A, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0071-6; Colao A, 2012, NEW ENGL J MED, V366, P914, DOI 10.1056/NEJMoa1105743; Correa R, 2015, EUR J ENDOCRINOL, V173, pM85, DOI 10.1530/EJE-15-0209; Cuevas-Ramos D, 2015, J CLIN ENDOCR METAB, V100, P122, DOI 10.1210/jc.2014-2468; Dal J, 2018, J CLIN ENDOCR METAB, V103, P2182, DOI 10.1210/jc.2017-02457; Dal J, 2016, EUR J ENDOCRINOL, V175, P181, DOI 10.1530/EJE-16-0117; De Caro MD, 2017, NEUROSURG REV, V40, P105, DOI 10.1007/s10143-016-0740-9; Delgrange E, 1997, J CLIN ENDOCR METAB, V82, P2102, DOI 10.1210/jc.82.7.2102; Ding D, 2019, NEUROSURGERY, V84, P717, DOI 10.1093/neuros/nyy178; Drummond J, 2019, J CLIN ENDOCR METAB, V104, P2473, DOI 10.1210/jc.2018-00688; Faje AT, 2010, J CLIN ENDOCR METAB, V95, P2486, DOI 10.1210/jc.2009-2634; Famini P, 2011, J CLIN ENDOCR METAB, V96, P1633, DOI 10.1210/jc.2011-0168; Feelders RA, 2019, LANCET DIABETES ENDO, V7, P300, DOI 10.1016/S2213-8587(18)30155-4; Fernandez A, 2010, CLIN ENDOCRINOL, V72, P377, DOI 10.1111/j.1365-2265.2009.03667.x; Fleseriu M, 2016, J CLIN ENDOCR METAB, V101, P3888, DOI 10.1210/jc.2016-2118; Fleseriu M, 2012, J CLIN ENDOCR METAB, V97, P2039, DOI 10.1210/jc.2011-3350; Fountas A, 2018, J CLIN ENDOCRINOL ME; Freda PU, 2011, J CLIN ENDOCR METAB, V96, P894, DOI 10.1210/jc.2010-1048; Gittleman H, 2014, J NEUROSURG, V121, P527, DOI 10.3171/2014.5.JNS131819; Giustina A, 2017, J CLIN ENDOCR METAB, V102, P2454, DOI 10.1210/jc.2017-00142; Goldenberg N, 2008, J CLIN ENDOCR METAB, V93, P2953, DOI 10.1210/jc.2007-2283; Gonzalez B, 2017, ENDOCR PRACT, V23, P594, DOI 10.4158/EP161724.OR; Hage M, 2018, J CLIN ENDOCR METAB, V103, P1929, DOI 10.1210/jc.2017-02287; Huang WY, 2018, PITUITARY, V21, P162, DOI 10.1007/s11102-017-0856-0; Ioachimescu AG, 2019, EUR J ENDOCRINOL, V180, P31, DOI 10.1530/EJE-18-0682; Katznelson L, 2014, J CLIN ENDOCR METAB, V99, P3933, DOI 10.1210/jc.2014-2700; Kim JH, 2017, WORLD NEUROSURG, V104, P272, DOI 10.1016/j.wneu.2017.04.141; Kopchick JJ, 2002, ENDOCR REV, V23, P623, DOI 10.1210/er.2001-0022; Kuhn E, 2017, PITUITARY, V20, P121, DOI 10.1007/s11102-016-0782-6; Lacroix A, 2018, LANCET DIABETES ENDO, V6, P17, DOI 10.1016/S2213-8587(17)30326-1; Lamberts SWJ, 1996, NEW ENGL J MED, V334, P246, DOI 10.1056/NEJM199601253340408; Lee CC, 2014, J CLIN ENDOCR METAB, V99, P1273, DOI 10.1210/jc.2013-3743; Liu WN, 2018, PITUITARY, V21, P454, DOI 10.1007/s11102-018-0898-y; Lopes MBS, 2017, ACTA NEUROPATHOL, V134, P521, DOI 10.1007/s00401-017-1769-8; Loriaux DL, 2017, NEW ENGL J MED, V376, P1451, DOI 10.1056/NEJMra1505550; Lucas JW, 2016, NEUROSURGERY, V79, pE533, DOI 10.1227/NEU.0000000000001389; Mehta GU, 2017, J CLIN ENDOCR METAB, V102, P4284, DOI 10.1210/jc.2017-01385; MELMED S, 1985, NEW ENGL J MED, V312, P9, DOI 10.1056/NEJM198501033120103; Melmed S, 2018, NAT REV ENDOCRINOL, V14, P552, DOI 10.1038/s41574-018-0058-5; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Melmed S, 2011, J CLIN ENDOCR METAB, V96, P273, DOI 10.1210/jc.2010-1692; Molitch ME, 2017, JAMA-J AM MED ASSOC, V317, P516, DOI 10.1001/jama.2016.19699; Neggers SJCMM, 2014, J CLIN ENDOCR METAB, V99, P3644, DOI 10.1210/jc.2014-2032; Nieman LK, 2015, J CLIN ENDOCR METAB, V100, P2807, DOI 10.1210/jc.2015-1818; Nieman LK, 2018, ENDOCRIN METAB CLIN, V47, P259, DOI 10.1016/j.ecl.2018.02.001; Olsson DS, 2015, J CLIN ENDOCR METAB, V100, P2651, DOI 10.1210/jc.2015-1475; Paluzzi A, 2014, PITUITARY, V17, P307, DOI 10.1007/s11102-013-0502-4; Pappy AL, 2019, PITUITARY, V22, P520, DOI 10.1007/s11102-019-00982-8; Post KD, 2017, TRANSSPHENOIDAL SURG, P427; Ragnarsson O, 2019, J CLIN ENDOCR METAB, V104, P2375, DOI 10.1210/jc.2018-02524; Ragnarsson O, 2019, PITUITARY, V22, P179, DOI 10.1007/s11102-019-00951-1; Raverot G, 2018, EUR J ENDOCRINOL, V178, pG1, DOI 10.1530/EJE-17-0796; Reid TJ, 2010, CLIN ENDOCRINOL, V72, P203, DOI 10.1111/j.1365-2265.2009.03626.x; Reincke M, 2015, NAT GENET, V47, P31, DOI 10.1038/ng.3166; Resmini E, 2009, J CLIN ENDOCR METAB, V94, P218, DOI 10.1210/jc.2008-1479; Ritvonen E, 2016, ENDOCR-RELAT CANCER, V23, P469, DOI 10.1530/ERC-16-0106; Schmid HA, 2016, ENDOCRINE, V53, P210, DOI 10.1007/s12020-016-0895-8; Sheehan JP, 2013, J NEUROSURG, V119, P446, DOI 10.3171/2013.3.JNS12766; Sherlock M, 2014, J CLIN ENDOCR METAB, V99, P478, DOI 10.1210/jc.2013-2450; Stiles CE, 2019, J CLIN ENDOCR METAB, V104, P523, DOI 10.1210/jc.2018-01071; Syro LV, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00097; Tampourlou M, 2017, J CLIN ENDOCR METAB, V102, P1889, DOI 10.1210/jc.2016-4061; Tampourlou M, 2016, EUR J ENDOCRINOL, V175, pR89, DOI 10.1530/EJE-16-0087; Terzolo M, 2017, ENDOCR-RELAT CANCER, V24, P495, DOI 10.1530/ERC-16-0553; THORNER MO, 1982, J CLIN INVEST, V70, P965, DOI 10.1172/JCI110708; Trivellin G, 2014, NEW ENGL J MED, V371, P2363, DOI 10.1056/NEJMoa1408028; van der Lely AJ, 2012, J CLIN ENDOCR METAB, V97, P1589, DOI 10.1210/jc.2011-2508; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Wassenaar MJE, 2010, J CLIN ENDOCR METAB, V95, P2073, DOI 10.1210/jc.2009-1714; WEBSTER J, 1994, NEW ENGL J MED, V331, P904, DOI 10.1056/NEJM199410063311403	94	167	179	12	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2020	382	10					937	950		10.1056/NEJMra1810772	http://dx.doi.org/10.1056/NEJMra1810772			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KT7TC	32130815				2022-12-28	WOS:000519214900009
J	Hernandez, I; Hershey, TB; Donohue, JM				Hernandez, Inmaculada; Hershey, Tina Batra; Donohue, Julie M.			Drug Shortages in the United States Are Some Prices Too Low?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses underlying causes of generic drug shortages in the United States and proposes solutions to address those shortages, including financial incentives for manufacturers that provide a steady supply of high-quality products.	[Hernandez, Inmaculada] Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, Pittsburgh, PA 15261 USA; [Hernandez, Inmaculada; Hershey, Tina Batra] Univ Pittsburgh, Ctr Pharmaceut Policy & Prescribing CP3, Pittsburgh, PA USA; [Hershey, Tina Batra; Donohue, Julie M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, 130 DeSoto St, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Donohue, JM (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, 130 DeSoto St, Pittsburgh, PA 15261 USA.	jdonohue@pitt.edu	Hernandez, Inmaculada/AGZ-4219-2022	Hernandez, Inmaculada/0000-0002-0118-4986; Hershey, Tina/0000-0002-8600-6168	NHLBI NIH HHS [K01 HL142847] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2011, COMMUNICATION   1207; Fox ER, 2014, MAYO CLIN PROC, V89, P361, DOI 10.1016/j.mayocp.2013.11.014; Hernandez I, 2019, ANN INTERN MED, V170, P74, DOI 10.7326/M18-1137; Rosenberg M, 2018, IDENTIFYING ROOT CAU; U.S. Food and Drug Administration, 2019, DRUG SHORT ROOT CAUS; Vail E, 2017, JAMA-J AM MED ASSOC, V317, P1433, DOI 10.1001/jama.2017.2841	6	6	6	2	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2020	323	9			SI		819	820		10.1001/jama.2019.20504	http://dx.doi.org/10.1001/jama.2019.20504			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU3SD	32125409	Green Accepted			2022-12-28	WOS:000519630600007
J	Dehollain, JP; Mukhopadhyay, U; Michal, VP; Wang, Y; Wunsch, B; Reichl, C; Wegscheider, W; Rudner, MS; Demler, E; Vandersypen, LMK				Dehollain, J. P.; Mukhopadhyay, U.; Michal, V. P.; Wang, Y.; Wunsch, B.; Reichl, C.; Wegscheider, W.; Rudner, M. S.; Demler, E.; Vandersypen, L. M. K.			Nagaoka ferromagnetism observed in a quantum dot plaquette	NATURE			English	Article							ELECTRON-SPIN; SIMULATION; EXCHANGE; NARROW; MODEL	A quantum dot device designed to host four electrons is used to demonstrate Nagaoka ferromagnetism-a model of itinerant magnetism that has so far been limited to theoretical investigation. Engineered, highly controllable quantum systems are promising simulators of emergent physics beyond the simulation capabilities of classical computers(1). An important problem in many-body physics is itinerant magnetism, which originates purely from long-range interactions of free electrons and whose existence in real systems has been debated for decades(2,3). Here we use a quantum simulator consisting of a four-electron-site square plaquette of quantum dots(4) to demonstrate Nagaoka ferromagnetism(5). This form of itinerant magnetism has been rigorously studied theoretically(6-9) but has remained unattainable in experiments. We load the plaquette with three electrons and demonstrate the predicted emergence of spontaneous ferromagnetic correlations through pairwise measurements of spin. We find that the ferromagnetic ground state is remarkably robust to engineered disorder in the on-site potentials and we can induce a transition to the low-spin state by changing the plaquette topology to an open chain. This demonstration of Nagaoka ferromagnetism highlights that quantum simulators can be used to study physical phenomena that have not yet been observed in any experimental system. The work also constitutes an important step towards large-scale quantum dot simulators of correlated electron systems.	[Dehollain, J. P.; Mukhopadhyay, U.; Michal, V. P.; Vandersypen, L. M. K.] Delft Univ Technol, QuTech, Delft, Netherlands; [Dehollain, J. P.; Mukhopadhyay, U.; Michal, V. P.; Vandersypen, L. M. K.] Delft Univ Technol, Kavli Inst Nanosci, Delft, Netherlands; [Wang, Y.; Wunsch, B.; Demler, E.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Reichl, C.; Wegscheider, W.] Swiss Fed Inst Technol, Solid State Phys Lab, Zurich, Switzerland; [Rudner, M. S.] Univ Copenhagen, Niels Bohr Inst, Ctr Quantum Devices, Copenhagen, Denmark; [Rudner, M. S.] Univ Copenhagen, Niels Bohr Int Acad, Niels Bohr Inst, Copenhagen, Denmark; [Dehollain, J. P.] Univ Technol Sydney, Sch Math & Phys Sci, Sydney, NSW, Australia	Delft University of Technology; Delft University of Technology; Harvard University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Copenhagen; Niels Bohr Institute; University of Copenhagen; Niels Bohr Institute; University of Technology Sydney	Vandersypen, LMK (corresponding author), Delft Univ Technol, QuTech, Delft, Netherlands.; Vandersypen, LMK (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Delft, Netherlands.	l.m.k.vandersypen@tudelft.nl	Dehollain, Juan Pablo/G-9915-2012; Mukhopadhyay, Uditendu/AAN-2034-2020; Demler, Eugene/ABG-1933-2021; Wang, Yao/L-8653-2018; Rudner, Mark/C-9325-2015	Dehollain, Juan Pablo/0000-0002-0425-4345; Mukhopadhyay, Uditendu/0000-0001-5290-3613; Demler, Eugene/0000-0002-2499-632X; Wang, Yao/0000-0003-1736-0187; Rudner, Mark/0000-0002-5150-6234	NSF; Netherlands Organisation for Scientific Research (FOM projectruimte); Netherlands Organisation for Scientific Research (NWO Vici); European Research Council (ERC-Synergy); Postdoctoral Fellowship in Quantum Science of the Harvard-MPQ Center for Quantum Optics; AFOSR-MURI Quantum Phases of Matter [FA9550-14-1-0035]; Swiss National Science Foundation; Villum Foundation	NSF(National Science Foundation (NSF)); Netherlands Organisation for Scientific Research (FOM projectruimte); Netherlands Organisation for Scientific Research (NWO Vici)(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC-Synergy); Postdoctoral Fellowship in Quantum Science of the Harvard-MPQ Center for Quantum Optics; AFOSR-MURI Quantum Phases of Matter; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Villum Foundation(Villum Fonden)	We acknowledge input and discussions with M. Chan, S. Philips, Y. Nazarov, F. Liu, L. Janssen, T. Hensgens, T. Fujita and all of the Vandersypen team, as well as experimental support by L. Blom, C. van Diepen, P. Eendebak, F. van Riggelen, R. Schouten, R. Vermeulen, R. van Ooijik, H. van der Does, M. Ammerlaan, J. Haanstra, S. Visser and R. Roeleveld. L.M.K.V. thanks the NSF-funded MIT-Harvard Center for Ultracold Atoms for its hospitality. This work was supported by grants from the Netherlands Organisation for Scientific Research (FOM projectruimte and NWO Vici) (J.P.D., U.M., L.M.K.V.), the European Research Council (ERC-Synergy) (V.P.M., L.M.K.V.), the Postdoctoral Fellowship in Quantum Science of the Harvard-MPQ Center for Quantum Optics and AFOSR-MURI Quantum Phases of Matter (grant number FA9550-14-1-0035) (Y.W.), the Swiss National Science Foundation (C.R., W.W.) and The Villum Foundation (M.S.R.).	AHARONOV Y, 1959, PHYS REV, V115, P485, DOI 10.1103/PhysRev.115.485; Auerbach A., 1994, INTERACTING ELECT QU; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Barends R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8654; Barthelemy P, 2013, ANN PHYS-BERLIN, V525, P808, DOI 10.1002/andp.201300124; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; Byrnes T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075320; Chekhovich EA, 2013, NAT MATER, V12, P494, DOI [10.1038/NMAT3652, 10.1038/nmat3652]; Dai HN, 2017, NAT PHYS, V13, P1195, DOI 10.1038/NPHYS4243; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Georgescu IM, 2014, REV MOD PHYS, V86, P153, DOI 10.1103/RevModPhys.86.153; Gorg F, 2018, NATURE, V553, P481, DOI 10.1038/nature25135; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hensgens T, 2017, NATURE, V548, P70, DOI 10.1038/nature23022; HUBBARD J, 1963, PROC R SOC LON SER-A, V276, P238, DOI 10.1098/rspa.1963.0204; Khaetskii AV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.186802; Koppens FHL, 2005, SCIENCE, V309, P1346, DOI 10.1126/science.1113719; Kouwenhoven LP, 2001, REP PROG PHYS, V64, P701, DOI 10.1088/0034-4885/64/6/201; LIEB E, 1962, PHYS REV, V125, P164, DOI 10.1103/PhysRev.125.164; Malinowski FK, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.011045; Manousakis E, 2002, J LOW TEMP PHYS, V126, P1501, DOI 10.1023/A:1014295416763; Mattis D., 2003, INT J NANOSCIENCE, V2, P165; Mattis D. C., 2006, THEORY MAGNETISM MAD; Merkulov IA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.205309; Mortemousque P. A, 2018, COHERENT CONTROL IND; Mukhopadhyay U, 2018, APPL PHYS LETT, V112, DOI 10.1063/1.5025928; NAGAOKA Y, 1966, PHYS REV, V147, P392, DOI 10.1103/PhysRev.147.392; Nascimbene S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.205301; Nichols MA, 2019, SCIENCE, V363, P383, DOI 10.1126/science.aat4387; Nielsen E, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.161202; Noiri A, 2017, SEMICOND SCI TECH, V32, DOI 10.1088/1361-6641/aa7596; Nowack KC, 2007, SCIENCE, V318, P1430, DOI 10.1126/science.1148092; Oguri A, 2007, J MAGN MAGN MATER, V310, P1139, DOI 10.1016/j.jmmm.2006.10.890; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Salfi J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11342; SCALAPINO DJ, 1995, PHYS REP, V250, P330; Seo M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.046803; Singha A, 2011, SCIENCE, V332, P1176, DOI 10.1126/science.1204333; Tasaki H, 1998, PROG THEOR PHYS, V99, P489, DOI 10.1143/PTP.99.489; Thalineau R, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4749811; THOULESS DJ, 1965, P PHYS SOC LOND, V86, P893, DOI 10.1088/0370-1328/86/5/301; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; van der Wiel WG, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/028; van der Wiel WG, 2003, REV MOD PHYS, V75, P1, DOI 10.1103/RevModPhys.75.1; von Stecher J, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/055009; Wang Y, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.155133	49	48	48	4	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					528	533		10.1038/s41586-020-2051-0	http://dx.doi.org/10.1038/s41586-020-2051-0		MAR 2020	6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX4BT	32123352	Green Submitted, Green Published			2022-12-28	WOS:000517743700001
J	Dyer, O				Dyer, Owen			Medically assisted dying: Canada tables legislation to broaden accessibility criteria	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Angus Reid Institute, 2020, SOC VAL CAN CONS ASS; DYER O, 2019, BMJ-BRIT MED J, V366, DOI DOI 10.1136/BMJ.L5566	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2020	368								m827	10.1136/bmj.m827	http://dx.doi.org/10.1136/bmj.m827			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KC	32122886				2022-12-28	WOS:000519536400007
J	Asaad, S; Mourik, V; Joecker, B; Johnson, MAI; Baczewski, AD; Firgau, HR; Madzik, MT; Schmitt, V; Pla, JJ; Hudson, FE; Itoh, KM; McCallum, JC; Dzurak, AS; Laucht, A; Morello, A				Asaad, Serwan; Mourik, Vincent; Joecker, Benjamin; Johnson, Mark A. I.; Baczewski, Andrew D.; Firgau, Hannes R.; Madzik, Mateusz T.; Schmitt, Vivien; Pla, Jarryd J.; Hudson, Fay E.; Itoh, Kohei M.; McCallum, Jeffrey C.; Dzurak, Andrew S.; Laucht, Arne; Morello, Andrea			Coherent electrical control of a single high-spin nucleus in silicon	NATURE			English	Article							TOTAL-ENERGY CALCULATIONS; QUANTUM; QUBIT; ALGORITHM; READOUT	Nuclear spins are highly coherent quantum objects. In large ensembles, their control and detection via magnetic resonance is widely exploited, for example, in chemistry, medicine, materials science and mining. Nuclear spins also featured in early proposals for solid-state quantum computers(1) and demonstrations of quantum search(2) and factoring(3) algorithms. Scaling up such concepts requires controlling individual nuclei, which can be detected when coupled to an electron(4-6). However, the need to address the nuclei via oscillating magnetic fields complicates their integration in multi-spin nanoscale devices, because the field cannot be localized or screened. Control via electric fields would resolve this problem, but previous methods(7-9) relied on transducing electric signals into magnetic fields via the electron-nuclear hyperfine interaction, which severely affects nuclear coherence. Here we demonstrate the coherent quantum control of a single Sb-123 (spin-7/2) nucleus using localized electric fields produced within a silicon nanoelectronic device. The method exploits an idea proposed in 1961(10) but not previously realized experimentally with a single nucleus. Our results are quantitatively supported by a microscopic theoretical model that reveals how the purely electrical modulation of the nuclear electric quadrupole interaction results in coherent nuclear spin transitions that are uniquely addressable owing to lattice strain. The spin dephasing time, 0.1 seconds, is orders of magnitude longer than those obtained by methods that require a coupled electron spin to achieve electrical driving. These results show that high-spin quadrupolar nuclei could be deployed as chaotic models, strain sensors and hybrid spin-mechanical quantum systems using all-electrical controls. Integrating electrically controllable nuclei with quantum dots(11,12) could pave the way to scalable, nuclear- and electron-spin-based quantum computers in silicon that operate without the need for oscillating magnetic fields.	[Asaad, Serwan; Mourik, Vincent; Joecker, Benjamin; Johnson, Mark A. I.; Firgau, Hannes R.; Madzik, Mateusz T.; Schmitt, Vivien; Hudson, Fay E.; Dzurak, Andrew S.; Laucht, Arne; Morello, Andrea] UNSW Sydney, Sch Elect Engn & Telecommun, Ctr Quantum Computat & Commun Technol, Sydney, NSW, Australia; [Baczewski, Andrew D.] Sandia Natl Labs, Ctr Comp Res, POB 5800, Albuquerque, NM 87185 USA; [Pla, Jarryd J.] UNSW Sydney, Sch Elect Engn & Telecommun, Sydney, NSW, Australia; [Itoh, Kohei M.] Keio Univ, Sch Fundamental Sci & Technol, Yokohama, Kanagawa, Japan; [McCallum, Jeffrey C.] Univ Melbourne, Sch Phys, Ctr Quantum Computat & Commun Technol, Melbourne, Vic, Australia	University of New South Wales Sydney; United States Department of Energy (DOE); Sandia National Laboratories; University of New South Wales Sydney; Keio University; University of Melbourne	Morello, A (corresponding author), UNSW Sydney, Sch Elect Engn & Telecommun, Ctr Quantum Computat & Commun Technol, Sydney, NSW, Australia.	a.morello@unsw.edu.au	Pla, Jarryd J/J-4987-2015; Asaad, Serwan/ABA-5373-2021; Morello, Andrea/B-6475-2008; Dzurak, Andrew S/C-5973-2009; Mourik, Vincent/AAS-8612-2020; Itoh, Kohei/C-5738-2014; Madzik, Mateusz/ABD-2737-2021; Johnson, Mark A. I./F-3980-2017; Laucht, Arne/J-6892-2012; SCHMITT, Vivien/A-3472-2016	Pla, Jarryd J/0000-0002-7152-3453; Asaad, Serwan/0000-0002-6407-4434; Morello, Andrea/0000-0001-7445-699X; Dzurak, Andrew S/0000-0003-1389-5096; Mourik, Vincent/0000-0003-1522-7403; Madzik, Mateusz/0000-0003-4857-3257; Johnson, Mark A. I./0000-0002-5818-0134; Baczewski, Andrew/0000-0001-8553-9934; Firgau, Hannes/0000-0002-9655-6227; McCallum, Jeffrey/0000-0002-6692-7728; Laucht, Arne/0000-0001-7892-7963; SCHMITT, Vivien/0000-0002-6495-1679	Australian Research Council Discovery Projects [DP150101863, DP180100969]; Australian Department of Industry, Innovation and Science [AUSMURI00002]; Niels Stensen Fellowship; Australian Government Research Training Program Scholarships; Australian Research Council Discovery Early Career Research Award [DE190101397]; Weston Visiting Professorship at the Weizmann Institute of Science; Australian National Fabrication Facility (ANFF); laboratory of R. Elliman at the Australian National University; Laboratory Directed Research and Development programme at Sandia National Laboratories [213048]; National Nuclear Security Administration of the US Department of Energy [DE-NA0003525]; MEXT	Australian Research Council Discovery Projects(Australian Research Council); Australian Department of Industry, Innovation and Science; Niels Stensen Fellowship; Australian Government Research Training Program Scholarships(Australian Government); Australian Research Council Discovery Early Career Research Award(Australian Research Council); Weston Visiting Professorship at the Weizmann Institute of Science; Australian National Fabrication Facility (ANFF); laboratory of R. Elliman at the Australian National University; Laboratory Directed Research and Development programme at Sandia National Laboratories; National Nuclear Security Administration of the US Department of Energy(National Nuclear Security Administration); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Botzem and J. T. Muhonen for discussions. The research was funded by the Australian Research Council Discovery Projects (grants DP150101863 and DP180100969) and the Australian Department of Industry, Innovation and Science (grant AUSMURI00002). V.M. acknowledges support from a Niels Stensen Fellowship. M.A.I.J. and H.R.F. acknowledge the support of Australian Government Research Training Program Scholarships. J.J.P. is supported by an Australian Research Council Discovery Early Career Research Award (DE190101397). A.M. was supported by a Weston Visiting Professorship at the Weizmann Institute of Science during part of the writing of this manuscript. We acknowledge support from the Australian National Fabrication Facility (ANFF), and from the laboratory of R. Elliman at the Australian National University for the ion implantation facilities. A.D.B. was supported by the Laboratory Directed Research and Development programme at Sandia National Laboratories, Project 213048. Sandia National Laboratories is a multi-missions laboratory managed and operated by National Technology and Engineering Solutions of Sandia, LLC, a wholly owned subsidiary of Honeywell International Inc., for the National Nuclear Security Administration of the US Department of Energy under contract DE-NA0003525. The views expressed in this manuscript do not necessarily represent the views of the US Department of Energy or the US Government. K.M.I. acknowledges support from Grant-in-Aid for Scientific Research by MEXT.	BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Bloembergen N., 1961, SCIENCE, V133, P1363, DOI 10.1126/science.133.3461.1363; Dehollain JP, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/1/015202; DIXON RW, 1964, J CHEM PHYS, V41, P1739, DOI 10.1063/1.1726153; Dolde F, 2011, NAT PHYS, V7, P459, DOI [10.1038/nphys1969, 10.1038/NPHYS1969]; Falk AL, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.187601; Franke DP, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.246401; Franke DP, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.057601; Ghaffari S, 2013, SCI REP-UK, V3, DOI 10.1038/srep03244; GILL D, 1963, PHYS REV, V129, P2398, DOI 10.1103/PhysRev.129.2398; Godfrin C, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.187702; Hensen B, 2020, NAT NANOTECHNOL, V15, P13, DOI 10.1038/s41565-019-0587-7; Jelezko F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.130501; Jones JA, 1998, NATURE, V393, P344, DOI 10.1038/30687; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Kurizki G, 2015, P NATL ACAD SCI USA, V112, P3866, DOI 10.1073/pnas.1419326112; Laucht A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500022; Mansir J, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.167701; Morello A, 2010, NATURE, V467, P687, DOI 10.1038/nature09392; Mourik V, 2018, PHYS REV E, V98, DOI 10.1103/PhysRevE.98.042206; Muhonen JT, 2014, NAT NANOTECHNOL, V9, P986, DOI [10.1038/nnano.2014.211, 10.1038/NNANO.2014.211]; Ono M, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.033002; Pla JJ, 2018, PHYS REV APPL, V9, DOI 10.1103/PhysRevApplied.9.044014; Pla JJ, 2013, NATURE, V496, P334, DOI 10.1038/nature12011; Pla JJ, 2012, NATURE, V489, P541, DOI 10.1038/nature11449; Saeedi K, 2013, SCIENCE, V342, P830, DOI 10.1126/science.1239584; Sieberer LM, 2019, NPJ QUANTUM INFORM, V5, DOI 10.1038/s41534-019-0192-5; Sigillito AJ, 2017, NAT NANOTECHNOL, V12, P958, DOI [10.1038/nnano.2017.154, 10.1038/NNANO.2017.154]; Thiele S, 2014, SCIENCE, V344, P1135, DOI 10.1126/science.1249802; Thompson SE, 2006, IEEE T ELECTRON DEV, V53, P1010, DOI 10.1109/TED.2006.872088; Thorbeck T, 2015, AIP ADV, V5, DOI 10.1063/1.4928320; Tosi G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00378-x; Vandersypen LMK, 2001, NATURE, V414, P883, DOI 10.1038/414883a; Waldherr G, 2014, NATURE, V506, P204, DOI 10.1038/nature12919; Willke P, 2018, SCIENCE, V362, P336, DOI 10.1126/science.aat7047; Yoneda J, 2018, NAT NANOTECHNOL, V13, P102, DOI 10.1038/s41565-017-0014-x	39	51	51	10	74	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7798					205	+		10.1038/s41586-020-2057-7	http://dx.doi.org/10.1038/s41586-020-2057-7			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU0CC	32161384	Green Submitted			2022-12-28	WOS:000519378900017
J	Iacobucci, G				Iacobucci, Gareth			Hancock vows to stamp out "absurd" rationing of some NHS services	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2020	368								m804	10.1136/bmj.m804	http://dx.doi.org/10.1136/bmj.m804			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KA	32111621				2022-12-28	WOS:000519536200012
J	Pagano, JK; Xie, J; Erickson, KA; Cope, SK; Scott, BL; Wu, RL; Waterman, R; Morris, DE; Yang, P; Gagliardi, L; Kiplinger, JL				Pagano, Justin K.; Xie, Jing; Erickson, Karla A.; Cope, Stephen K.; Scott, Brian L.; Wu, Ruilian; Waterman, Rory; Morris, David E.; Yang, Ping; Gagliardi, Laura; Kiplinger, Jaqueline L.			Actinide 2-metallabiphenylenes that satisfy Huckel's rule	NATURE			English	Article							2ND-ORDER PERTURBATION-THEORY; MOLECULAR-ORBITAL METHODS; BASIS-SETS; ELECTRONIC-STRUCTURE; HALIDE-COMPLEXES; THERMOCHEMISTRY; PHENYLSILANE; AROMATICITY; THORIUM(IV); REACTIVITY	Aromaticity and antiaromaticity, as defined by Huckel's rule, are key ideas in organic chemistry, and are both exemplified in biphenylene(1-3)-a molecule that consists of two benzene rings joined by a four-membered ring at its core. Biphenylene analogues in which one of the benzene rings has been replaced by a different (4n + 2) pi-electron system have so far been associated only with organic compounds(4,5). In addition, efforts to prepare a zirconabiphenylene compound resulted in the isolation of a bis(alkyne) zirconocene complex instead(6). Here we report the synthesis and characterization of, to our knowledge, the first 2-metallabiphenylene compounds. Single-crystal X-ray diffraction studies reveal that these complexes have nearly planar, 11-membered metallatricycles with metrical parameters that compare well with those reported for biphenylene. Nuclear magnetic resonance spectroscopy, in addition to nucleus-independent chemical shift calculations, provides evidence that these complexes contain an antiaromatic cyclobutadiene ring and an aromatic benzene ring. Furthermore, spectroscopic evidence, Kohn-Sham molecular orbital compositions and natural bond orbital calculations suggest covalency and delocalization of the uranium f(2) electrons with the carbon-containing ligand. The synthesis of uranium- and thorium-containing metallabiphenylenes demonstrates the ability of the actinides to stabilize aromatic/antiaromatic structures where transition metals have failed.	[Pagano, Justin K.; Erickson, Karla A.; Cope, Stephen K.; Morris, David E.; Kiplinger, Jaqueline L.] Los Alamos Natl Lab, Chem Div, Los Alamos, NM 87545 USA; [Pagano, Justin K.; Waterman, Rory] Univ Vermont, Dept Chem, Burlington, VT 05405 USA; [Xie, Jing; Gagliardi, Laura] Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA; [Scott, Brian L.] Los Alamos Natl Lab, Mat Phys & Applicat Div, Los Alamos, NM USA; [Wu, Ruilian] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA; [Yang, Ping] Los Alamos Natl Lab, Theoret Div, Los Alamos, NM 87545 USA; [Xie, Jing] Beijing Inst Technol, Key Lab Cluster Sci, Minist Educ, Sch Chem & Engn, Beijing, Peoples R China	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Vermont; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Beijing Institute of Technology	Morris, DE; Kiplinger, JL (corresponding author), Los Alamos Natl Lab, Chem Div, Los Alamos, NM 87545 USA.; Gagliardi, L (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.; Yang, P (corresponding author), Los Alamos Natl Lab, Theoret Div, Los Alamos, NM 87545 USA.	demorris@lanl.gov; pyang@lanl.gov; gagliard@umn.edu; kiplinger@lanl.gov	Erickson, Karla/ABG-1832-2021; Waterman, Rory/A-4596-2008; Xie, Jing/ABA-1999-2021	Erickson, Karla/0000-0003-3964-2345; Waterman, Rory/0000-0001-8761-8759; Xie, Jing/0000-0001-9676-5734	US Department of Energy (DOE) through the Los Alamos National Laboratory (LANL) Laboratory Directed Research and Development Program; LANL G. T. Seaborg Institute for Transactinium Science; Office of Workforce Development for Teachers and Scientists, Office of Science Graduate Student Research (SCGSR) program (GRA Fellowship); Office of Basic Energy Sciences, Heavy Element Chemistry program; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US DOE [USDOE/DESC002183]; US National Science Foundation [CHE-1265608, CHE-1565658]; DOE [DE-AC05-06OR23100]; National Nuclear Security Administration of the US DOE [DE-AC52-06NA25396]	US Department of Energy (DOE) through the Los Alamos National Laboratory (LANL) Laboratory Directed Research and Development Program; LANL G. T. Seaborg Institute for Transactinium Science; Office of Workforce Development for Teachers and Scientists, Office of Science Graduate Student Research (SCGSR) program (GRA Fellowship); Office of Basic Energy Sciences, Heavy Element Chemistry program; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US DOE(United States Department of Energy (DOE)); US National Science Foundation(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); National Nuclear Security Administration of the US DOE(National Nuclear Security Administration)	For financial support of this work, we acknowledge the US Department of Energy (DOE) through the Los Alamos National Laboratory (LANL) Laboratory Directed Research and Development Program; the LANL G. T. Seaborg Institute for Transactinium Science (Postdoctoral Fellowships to J.K.P., K.A.E. and S.K.C.); the Office of Workforce Development for Teachers and Scientists, Office of Science Graduate Student Research (SCGSR) program (GRA Fellowship to J.K.P.); and the Office of Basic Energy Sciences, Heavy Element Chemistry program (to J.L.K., P.Y. and B.L.S., for materials and supplies). We thank R. Michalczyk and L. A. Silks (LANL) for assistance with two-dimensional NMR experiments, and J. Thompson and P. Rosa (LANL) for assistance in collecting magnetometry data. This work was in part funded by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US DOE through grant USDOE/DESC002183 (to J.X. and L.G.). We also acknowledge the US National Science Foundation (grants CHE-1265608 and CHE-1565658 to R. Waterman). The SCGSR program is administered by the Oak Ridge Institute for Science and Education for the DOE (contract DE-AC05-06OR23100). LANL is operated by Los Alamos National Security, LLC, for the National Nuclear Security Administration of the US DOE (contract DE-AC52-06NA25396).	Adamo C, 1999, J CHEM PHYS, V110, P6158, DOI 10.1063/1.478522; ANDERSSON K, 1992, J CHEM PHYS, V96, P1218, DOI 10.1063/1.462209; ANDERSSON K, 1990, J PHYS CHEM-US, V94, P5483, DOI 10.1021/j100377a012; [Anonymous], 2014, APEX2 V 2014 7 1; [Anonymous], 2009, GAUSSIAN 09 REVISION; [Anonymous], 2013, SAINT V 8 34A; [Anonymous], 2000, SHELXTL V 6 14; [Anonymous], 2013, SADABS V 2014 3; Aquilante F, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2777146; Aquilante F, 2016, J COMPUT CHEM, V37, P506, DOI 10.1002/jcc.24221; Balaban A.T., 2011, OPEN ORG CHEM J, V5, P117, DOI [10.2174/1874364101105010117, DOI 10.2174/1874364101105010117]; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bettinger HF, 1998, CHEM COMMUN, P769, DOI 10.1039/a800741a; BOESE R, 1999, ACTA CRYSTALLOGR C, V55; Cantat T, 2009, INORG CHEM, V48, P2114, DOI 10.1021/ic802061x; Cantat T, 2008, J AM CHEM SOC, V130, P17537, DOI 10.1021/ja8067287; Cao XY, 2003, J CHEM PHYS, V118, P487, DOI 10.1063/1.1521431; Da Re RE, 2005, J AM CHEM SOC, V127, P682, DOI 10.1021/ja044315g; DOUGLAS M, 1974, ANN PHYS-NEW YORK, V82, P89, DOI 10.1016/0003-4916(74)90333-9; Evans WJ, 2005, CHEM COMMUN, P4681, DOI 10.1039/b508612d; FAGAN PJ, 1981, J AM CHEM SOC, V103, P6650, DOI 10.1021/ja00412a021; Fang B, 2015, DALTON T, V44, P7927, DOI 10.1039/c5dt00838g; FAWCETT JK, 1966, ACTA CRYSTALLOGR, V20, P87, DOI 10.1107/S0365110X66000161; Garratt P. J., 1970, CHEM COMMUN, V109; Graves CR, 2008, J AM CHEM SOC, V130, P5272, DOI 10.1021/ja711010h; Gutowski KE, 2007, J AM CHEM SOC, V129, P526, DOI 10.1021/ja064592i; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; Heit YN, 2018, J PHYS CHEM LETT, V9, P887, DOI 10.1021/acs.jpclett.7b03441; HESS BA, 1985, PHYS REV A, V32, P756, DOI 10.1103/PhysRevA.32.756; Hu HS, 2014, J AM CHEM SOC, V136, P1427, DOI 10.1021/ja409527u; Jantunen KC, 2004, ORGANOMETALLICS, V23, P4682, DOI 10.1021/om0343824; Karadakov PB, 2016, J ORG CHEM, V81, P11346, DOI 10.1021/acs.joc.6b02460; KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955; Kubicki JD, 2009, CHEM CENT J, V3, DOI 10.1186/1752-153X-3-10; Lever ABP, 1999, INORGANIC ELECTRONIC STRUCTURE AND SPECTROSCOPY, VOL I, P1; Lothrop WC, 1941, J AM CHEM SOC, V63, P2564, DOI 10.1021/ja01855a006; Lu EL, 2014, ANGEW CHEM INT EDIT, V53, P6696, DOI 10.1002/anie.201403892; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; Merino G, 2004, CHEM-EUR J, V10, P4367, DOI 10.1002/chem.200400457; Minasian SG, 2014, CHEM SCI, V5, P351, DOI 10.1039/c3sc52030g; Minasian SG, 2012, J AM CHEM SOC, V134, P5586, DOI 10.1021/ja2105015; Morris DE, 2004, ORGANOMETALLICS, V23, P5142, DOI 10.1021/om049634v; Pagano JK, 2017, J ORGANOMET CHEM, V829, P79, DOI 10.1016/j.jorganchem.2016.10.034; Pagano JK, 2016, ORGANOMETALLICS, V35, P617, DOI 10.1021/acs.organomet.6b00091; Pagano JK, 2015, CHEM COMMUN, V51, P17379, DOI 10.1039/c5cc06856h; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Peterson PW, 2016, J AM CHEM SOC, V138, P15617, DOI 10.1021/jacs.6b08540; ROOS BO, 1980, CHEM PHYS, V48, P157, DOI 10.1016/0301-0104(80)80045-0; Roos BO, 2005, CHEM PHYS LETT, V409, P295, DOI 10.1016/j.cplett.2005.05.011; Roos BO, 2004, J PHYS CHEM A, V108, P2851, DOI 10.1021/jp031064+; Safi S, 2013, CHEM-EUR J, V19, P11261, DOI 10.1002/chem.201300989; Schelter EJ, 2007, INORG CHEM, V46, P7477, DOI 10.1021/ic700455b; Schelter EJ, 2010, INORG CHEM, V49, P924, DOI 10.1021/ic901636f; Schleyer PV, 1996, J AM CHEM SOC, V118, P6317, DOI 10.1021/ja960582d; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Su J, 2018, J AM CHEM SOC, V140, P17977, DOI 10.1021/jacs.8b09436; Toda F, 2000, EUR J ORG CHEM, V2000, P1377, DOI 10.1002/(SICI)1099-0690(200004)2000:8<1377::AID-EJOC1377>3.0.CO;2-I; Tsushima S, 2010, DALTON T, V39, P10953, DOI 10.1039/c0dt00974a; Vollhardt K. P. C., 1996, ADV STR ORG, V5, P121; Vukovic S, 2015, INORG CHEM, V54, P3995, DOI 10.1021/acs.inorgchem.5b00264; WARNER BP, 1994, J AM CHEM SOC, V116, P5471, DOI 10.1021/ja00091a062; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; WOLINSKI K, 1990, J AM CHEM SOC, V112, P8251, DOI 10.1021/ja00179a005; Yanai T, 2004, CHEM PHYS LETT, V393, P51, DOI 10.1016/j.cplett.2004.06.011; Zhao Y, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2370993	65	25	25	4	55	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB	2020	578	7796					563	+		10.1038/s41586-020-2004-7	http://dx.doi.org/10.1038/s41586-020-2004-7			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KP9SJ	32103196	Green Submitted			2022-12-28	WOS:000516571100017
J	del Rio, C; Armstrong, WS				del Rio, Carlos; Armstrong, Wendy S.			How Much Are We Willing to Pay for Preexposure Prophylaxis in the United States?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[del Rio, Carlos] Emory Univ, Sch Med, Dept Med, 49 Jesse Hill Jr Dr,FOB Room 201, Atlanta, GA 30303 USA; [Armstrong, Wendy S.] Emory Univ, Sch Med, Dept Med, Grady Infect Dis Program, 341 Ponce Leon Ave, Atlanta, GA 30308 USA; [del Rio, Carlos; Armstrong, Wendy S.] Grady Hlth Syst, Atlanta, GA USA	Emory University; Emory University	del Rio, C (corresponding author), Emory Univ, Sch Med, Dept Med, 49 Jesse Hill Jr Dr,FOB Room 201, Atlanta, GA 30303 USA.	cdelrio@emory.edu	del Rio, Carlos/B-3763-2012	del Rio, Carlos/0000-0002-0153-3517				[Anonymous], 2019, PAN ANT GUID AD AD G; Grulich AE, 2018, LANCET HIV, V5, pE629, DOI 10.1016/S2352-3018(18)30215-7; Health Resources & Services Administration, 2020, END HIV EP PLAN AM; IQVIA Institute for Human Data Science, 2019, MED US SPEND US REV; Morne J, 2019, COMMUNICATION; Nwokolo N, 2017, LANCET HIV, V4, pE482, DOI 10.1016/S2352-3018(17)30181-9; Walensky RP, 2020, ANN INTERN MED, V172, P583, DOI [10.7326/M19-3478, 10.7326/L20-0693]	7	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2020	172	9					623	+		10.7326/M20-0799	http://dx.doi.org/10.7326/M20-0799			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK7EH	32150617				2022-12-28	WOS:000531024900016
J	Ong, SWX; Tan, YK; Chia, PY; Lee, TH; Ng, OT; Wong, MSY; Marimuthu, K				Ong, Sean Wei Xiang; Tan, Yian Kim; Chia, Po Ying; Lee, Tau Hong; Ng, Oon Tek; Wong, Michelle Su Yen; Marimuthu, Kalisvar			Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study documents results of SARS-CoV-2 polymerase chain reaction (PCR) testing of environmental surfaces and personal protective equipment surrounding 3 COVID-19 patients in isolation rooms in a Singapore hospital.	[Ong, Sean Wei Xiang; Chia, Po Ying; Lee, Tau Hong; Ng, Oon Tek; Marimuthu, Kalisvar] Natl Ctr Infect Dis, 16 Jalan Tan Tock Seng, Singapore 308442, Singapore; [Tan, Yian Kim; Wong, Michelle Su Yen] DSO Natl Labs, Singapore, Singapore	National Centre for Infectious Diseases Singapore	Ng, OT; Marimuthu, K (corresponding author), Natl Ctr Infect Dis, 16 Jalan Tan Tock Seng, Singapore 308442, Singapore.	oon_tek_ng@ncid.sg; kalisvar_marimuthu@ncid.sg	Chia, Po Ying/AAN-9657-2020; Ong, Sean/AAO-9560-2020; Chia, Po Ying/GSD-9737-2022	Chia, Po Ying/0000-0002-8797-9527; Ong, Sean/0000-0002-8570-436X; Chia, Po Ying/0000-0002-8797-9527	National Medical Research Council (NMRC) Seed Funding Program [TR19NMR119SD]; DSO National Laboratories; NMRC Clinician Scientist Award [MOH-000276]; NMRC Clinician-Scientist Individual Research Grant [CIRG18Nov-0034]	National Medical Research Council (NMRC) Seed Funding Program; DSO National Laboratories(DSO National Laboratories); NMRC Clinician Scientist Award(National Medical Research Council, Singapore); NMRC Clinician-Scientist Individual Research Grant	Funding for this study was supported by the National Medical Research Council (NMRC) Seed Funding Program (TR19NMR119SD) and internal funds from DSO National Laboratories. Dr Ng is supported by NMRC Clinician Scientist Award MOH-000276. Dr Marimuthu is supported by an NMRC Clinician-Scientist Individual Research Grant (CIRG18Nov-0034).	[Anonymous], 2020, JAMA; Bin SY, 2016, CLIN INFECT DIS, V62, P755, DOI 10.1093/cid/civ1020; Chowell G, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0450-0; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]	5	1248	1298	19	119	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2020	323	16					1610	1612		10.1001/jama.2020.3227	http://dx.doi.org/10.1001/jama.2020.3227			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LL2GR	32129805	Green Published, Bronze			2022-12-28	WOS:000531373700027
J	Adams, JG; Walls, RM				Adams, James G.; Walls, Ron M.			Supporting the Health Care Workforce During the COVID-19 Global Epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses the importance of protecting health care workers caring for patients with coronavirus disease 2019 (COVID-19) and measures that can be taken in and out of the hospital to prevent their and their families' exposure to SARS-CoV-2.	[Adams, James G.] Northwestern Mem HealthCare, Chicago, IL USA; [Adams, James G.] Northwestern Univ, Feinberg Sch Med, Dept Emergency Med, Chicago, IL 60611 USA; [Walls, Ron M.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Walls, Ron M.] Harvard Med Sch, Boston, MA 02115 USA	Northwestern University; Feinberg School of Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Adams, JG (corresponding author), Northwestern Univ, 211 E Ontario St,Ste 200, Chicago, IL 60611 USA.	jadams@nm.org						Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Centers for Disease Control and Prevention, 2020, CENT DIS CONTROL PRE; DelRio C, 2020, JAMA, P2020; JAMA Network, COR DIS 2019 COVID 1; Ong SWX, 2020, JAMA, DOI 10.1001/jama.2020.3227; Radonovich LJ, 2019, JAMA-J AM MED ASSOC, V322, P824, DOI 10.1001/jama.2019.11645	6	756	781	6	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2020	323	15					1439	1440		10.1001/jama.2020.3972	http://dx.doi.org/10.1001/jama.2020.3972			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LJ1ZH	32163102	Bronze			2022-12-28	WOS:000529969700007
J	Greendale, GA; Karlamangla, AS; Maki, PM				Greendale, Gail A.; Karlamangla, Arun S.; Maki, Pauline M.			The Menopause Transition and Cognition	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEMORY PERFORMANCE; OBJECTIVE MEMORY	This JAMA Insights article summarizes the subjective cognitive problems experienced by some women during perimenopause (menopausal transition) and provides guidance to physicians on how to effectively answer patients' questions and recognize when these symptoms may require clinical intervention.	[Greendale, Gail A.; Karlamangla, Arun S.] Univ Calif Los Angeles, Dept Med, Div Geriatr, 10945 Le Conte Ave,Ste 2339, Los Angeles, CA 90095 USA; [Maki, Pauline M.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Maki, Pauline M.] Univ Illinois, Dept Psychol, Chicago, IL 60680 USA; [Maki, Pauline M.] Univ Illinois, Dept Obstet & Gynecol, Chicago, IL 60612 USA	University of California System; University of California Los Angeles; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Greendale, GA (corresponding author), Univ Calif Los Angeles, Dept Med, Div Geriatr, 10945 Le Conte Ave,Ste 2339, Los Angeles, CA 90095 USA.	ggreenda@mednet.ucla.edu	Maki, Pauline/AAF-1554-2021					Epperson CN, 2013, J CLIN ENDOCR METAB, V98, P3829, DOI 10.1210/jc.2013-1808; Greendale GA, 2009, NEUROLOGY, V72, P1850, DOI 10.1212/WNL.0b013e3181a71193; Greendale GA, 2010, AM J EPIDEMIOL, V171, P1214, DOI 10.1093/aje/kwq067; Harlow SD, 2012, J CLIN ENDOCR METAB, V97, P1159, DOI 10.1210/jc.2011-3362; Maki PM, 2008, MENOPAUSE, V15, P848, DOI 10.1097/gme.0b013e31816d815e; Mitchell ES, 2001, J WOMEN HEALTH GEN-B, V10, P351, DOI 10.1089/152460901750269670; Unkenstein AE, 2016, MENOPAUSE, V23, P1319, DOI 10.1097/GME.0000000000000705; Weber MT, 2014, J STEROID BIOCHEM, V142, P90, DOI 10.1016/j.jsbmb.2013.06.001; Weber MT, 2012, MENOPAUSE, V19, P735, DOI 10.1097/gme.0b013e318241fd22; Woods NF, 2011, MENOPAUSE, V18, P654, DOI 10.1097/gme.0b013e318205bd76	10	10	11	2	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2020	323	15					1495	1496		10.1001/jama.2020.1757	http://dx.doi.org/10.1001/jama.2020.1757			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LJ1ZH	32163094				2022-12-28	WOS:000529969700020
J	Richterman, A; Ivers, LC				Richterman, Aaron; Ivers, Louise C.			Misguided Changes to SNAP - Defending a Public Health Intervention for the Poor	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FOOD INSECURITY	Three proposed changes to the Supplemental Nutrition Assistance Program for the poor would leave millions of Americans hungry and have profound and long-lasting consequences for their health.	[Richterman, Aaron] Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA; [Richterman, Aaron; Ivers, Louise C.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Ivers, Louise C.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Richterman, A (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.; Richterman, A (corresponding author), Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA.		Ivers, Louise C/Q-4164-2018	Ivers, Louise C/0000-0003-2314-9230; Richterman, Aaron/0000-0001-7920-7191				Coleman-Jensen A, 2019, 270 ERR USDA EC RES; Gundersen C, 2015, HEALTH AFFAIR, V34, P1830, DOI 10.1377/hlthaff.2015.0645; Keith-Jennings B, 2019, AM J PUBLIC HEALTH, V109, P1636, DOI 10.2105/AJPH.2019.305325; Nord M, 2011, 116 ERR USDA EC RES; USDA Food and Nutrition Service, 2019, NAT STAT LEV MONTHL	5	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2020	382	13					1191	1193		10.1056/NEJMp2000253	http://dx.doi.org/10.1056/NEJMp2000253			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KY1UO	32130807				2022-12-28	WOS:000522357300004
J	Chaturvedi, M; Maharana, J; Shukla, AK				Chaturvedi, Madhu; Maharana, Jagannath; Shukla, Arun K.			Terminating G-Protein Coupling: Structural Snapshots of GPCR-beta-Arrestin Complexes	CELL			English	Editorial Material							RECRUITMENT	beta-arrestins (beta arrs) play multifaceted roles in the signaling and regulation of G-protein-coupled receptors (GPCRs) including their desensitization and endocytosis. Recently determined cryo-EM structures of two different GPCRs in complex with beta arr1 provide the first glimpse of GPCR-beta arr engagement and a structural framework to understand their interaction.	[Chaturvedi, Madhu; Maharana, Jagannath; Shukla, Arun K.] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Shukla, AK (corresponding author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.	arshukla@iitk.ac.in		Maharana, Jagannath/0000-0003-4590-7637; shukla, arun/0000-0003-2910-8288	DBT-Wellcome Trust India Alliance [IA/I/14/1/501285] Funding Source: Medline	DBT-Wellcome Trust India Alliance(Wellcome Trust DBT India Alliance)		Ghosh E, 2019, CELL REP, V28, P3287, DOI 10.1016/j.celrep.2019.08.053; Gurevich VV, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00125; Huang WJ, 2020, NATURE, V579, P303, DOI 10.1038/s41586-020-1953-1; Lally CCM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14258; Ranjan R, 2017, TRENDS CELL BIOL, V27, P861, DOI 10.1016/j.tcb.2017.05.008; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Sriram K, 2018, MOL PHARMACOL, V93, P251, DOI 10.1124/mol.117.111062; Staus DP, 2020, NATURE, V579, P297, DOI 10.1038/s41586-020-1954-0; Yin WC, 2019, CELL RES, V29, P971, DOI 10.1038/s41422-019-0256-2; Zhou XE, 2017, CELL, V170, P457, DOI 10.1016/j.cell.2017.07.002	10	15	15	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2020	180	6					1041	1043		10.1016/j.cell.2020.02.047	http://dx.doi.org/10.1016/j.cell.2020.02.047			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KW1IO	32169216	Green Accepted, Bronze			2022-12-28	WOS:000520925300005
J	Mahase, E				Mahase, Elisabeth			NICE recommends migraine drug that could treat 10 000 patients in England	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Institute for Health and Care Excellence, FREM PREV MIGR	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2020	368								m1050	10.1136/bmj.m1050	http://dx.doi.org/10.1136/bmj.m1050			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AU	32165370				2022-12-28	WOS:000520013500018
J	Wise, J				Wise, Jacqui			The BMJ Awards 2020: Diagnostics team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2020	368								m851	10.1136/bmj.m851	http://dx.doi.org/10.1136/bmj.m851			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AU	32165397				2022-12-28	WOS:000520013500003
J	O'Dowd, A				O'Dowd, Adrian			Ageing and longevity in UK need more funding and research, peers are told	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2020	368								m999	10.1136/bmj.m999	http://dx.doi.org/10.1136/bmj.m999			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AR	32160995				2022-12-28	WOS:000520012800017
J	Rimmer, A				Rimmer, Abi			Covid-19: What's the current advice for UK doctors?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		General Medical Council, 2020, WE WILL CONT REG LIG; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m918; Public Health England, 2020, GUID TOP 4 EQ ACC CE; Public Health England, 2020, COVID 19 INV IN CLIN	4	3	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2020	368								m978	10.1136/bmj.m978	http://dx.doi.org/10.1136/bmj.m978			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AO	32156682	Bronze			2022-12-28	WOS:000520012500015
J	Rimmer, A				Rimmer, Abi			Sixty seconds on . . . Hospify	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Staines R., 2020, NHS STAFF TOLD STOP	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2020	368								m930	10.1136/bmj.m930	http://dx.doi.org/10.1136/bmj.m930			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2LJ	32144114				2022-12-28	WOS:000519539700009
J	Cowper, A				Cowper, Andy			Emerging tensions will affect how the NHS uses its new money Power play and lack of appetite for reform are getting in the way of delivery	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cowper, Andy] Hlth Policy Insight, London, England		Cowper, A (corresponding author), Hlth Policy Insight, London, England.	andycowper@hotmail.com						[Anonymous], 2017, HLTH POLICY INSIGHT; Cowper A., 2020, HSJ; COWPER A, 2019, BMJ-BRIT MED J, V366, DOI DOI 10.1136/BMJ.L4936; Cowper A, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l4036; Dunhill L., 2020, HSJ; Gallagher P, 2019, NHS STAFF BRACED WOR; Mclellan A., 2018, HSJ; National Audit Office, 2020, NHS FIN MAN SUST; NHS England, LOC SUST TRANSF PART; NHS England, 2019, NHS REC GOV PARL NHS; Smyth C, 2020, TIMES; West D, 2020, HSJ	12	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2020	368								m767	10.1136/bmj.m767	http://dx.doi.org/10.1136/bmj.m767			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KA	32111646				2022-12-28	WOS:000519536200007
J	Anderson, ML; Dobkin, C; Gorry, D				Anderson, Michael L.; Dobkin, Carlos; Gorry, Devon			The Effect of Influenza Vaccination for the Elderly on Hospitalization and Mortality An Observational Study With a Regression Discontinuity Design	ANNALS OF INTERNAL MEDICINE			English	Article							DOUBLE-BLIND; EFFICACY; CHILDREN; PEOPLE; SCHOOLCHILDREN; IMMUNIZATION; MORBIDITY; VACCINES; COST	Background: Observational studies using traditional research designs suggest that influenza vaccination reduces hospitalizations and mortality among elderly persons. Accordingly, health authorities in some countries prioritize vaccination of this population. Nevertheless, questions remain about this policy's effectiveness given the potential for bias and confounding in observational data. Objective: To determine the effectiveness of the influenza vaccine in reducing hospitalizations and mortality among elderly persons by using an observational research design that reduces the possibility of bias and confounding. Design: A regression discontinuity design was applied to the sharp change in vaccination rate at age 65 years that resulted from an age-based vaccination policy in the United Kingdom. In this design, comparisons were limited to individuals who were near the age-65 threshold and were thus plausibly similar along most dimensions except vaccination rate. Setting: England and Wales. Participants: Adults aged 55 to 75 years residing in the study area during 2000 to 2014. Intervention: Seasonal influenza vaccine. Measurements: Hospitalization and mortality rates by month of age. Results: The data included 170 million episodes of care and 7.6 million deaths. Turning 65 was associated with a statistically and clinically significant increase in rate of seasonal influenza vaccination. However, no evidence indicated that vaccination reduced hospitalizations or mortality among elderly persons. The estimates were precise enough to rule out results from many previous studies. Limitation: The study relied on observational data, and its focus was limited to individuals near age 65 years. Conclusion: Current vaccination strategies prioritizing elderly persons may be less effective than believed at reducing serious morbidity and mortality in this population, which suggests that supplementary strategies may be necessary.	[Anderson, Michael L.] Univ Calif Berkeley, 714 Univ Hall,MC3310, Berkeley, CA 94720 USA; [Anderson, Michael L.; Dobkin, Carlos] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Dobkin, Carlos] Univ Calif Santa Cruz, 441 Engn 2,1156 High St, Santa Cruz, CA 95064 USA; [Gorry, Devon] Clemson Univ, Clemson, SC USA; [Gorry, Devon] John E Walker Dept Econ, 228 Sirrine Hall, Clemson, SC 29634 USA	University of California System; University of California Berkeley; National Bureau of Economic Research; University of California System; University of California Santa Cruz; Clemson University	Anderson, ML (corresponding author), Univ Calif Berkeley, 714 Univ Hall,MC3310, Berkeley, CA 94720 USA.	mlanderson@berkeley.edu			National Institute on Aging of the National Institutes of Health [R01AG044796]; Hatch project from the National Institute of Food and Agriculture of the U.S. Department of Agriculture [233535]	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Hatch project from the National Institute of Food and Agriculture of the U.S. Department of Agriculture	By award R01AG044796 from the National Institute on Aging of the National Institutes of Health and by Hatch project 233535 from the National Institute of Food and Agriculture of the U.S. Department of Agriculture. Eighty percent of the project was funded by federal sources, and none was funded by nongovernmental sources.	AHMED AEH, 1995, LANCET, V346, P591, DOI 10.1016/S0140-6736(95)91434-X; Ahmed AH, 1997, EPIDEMIOL INFECT, V118, P27, DOI 10.1017/S0950268896007121; Allsup S, 2004, VACCINE, V23, P639, DOI 10.1016/j.vaccine.2004.07.008; Basta NE, 2009, AM J EPIDEMIOL, V170, P679, DOI 10.1093/aje/kwp237; Baxter R, 2010, VACCINE, V28, P7267, DOI 10.1016/j.vaccine.2010.08.088; Bor J, 2014, EPIDEMIOLOGY, V25, P729, DOI 10.1097/EDE.0000000000000138; Chen H, 2018, LANCET PLANET HEALTH, V2, pE19, DOI 10.1016/S2542-5196(17)30185-7; Correa A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011092; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Fireman B, 2009, AM J EPIDEMIOL, V170, P650, DOI 10.1093/aje/kwp173; Fleming DM, 1995, EPIDEMIOL INFECT, V115, P581, DOI 10.1017/S095026880005874X; Ghendon YZ, 2006, EPIDEMIOL INFECT, V134, P71, DOI 10.1017/S0950268805005650; Glezen WP, 2006, J CLIN VIROL, V37, P237, DOI 10.1016/j.jcv.2006.08.020; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; GROSS PA, 1978, J PEDIATR-US, V92, P30, DOI 10.1016/S0022-3476(78)80065-1; Hurwitz ES, 2000, JAMA-J AM MED ASSOC, V284, P1677, DOI 10.1001/jama.284.13.1677; Imbens GW, 2008, J ECONOMETRICS, V142, P615, DOI 10.1016/j.jeconom.2007.05.001; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; KiecoltGlaser JK, 1996, P NATL ACAD SCI USA, V93, P3043, DOI 10.1073/pnas.93.7.3043; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; KUMAR SS, 1978, JAMA-J AM MED ASSOC, V239, P840; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; Mangtani P, 2004, J INFECT DIS, V190, P1, DOI 10.1086/421274; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Melamed A, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5463; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; MILLER RA, 1991, INT REV CYTOL, V124, P187; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; O'Keeffe AG, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5293; Peasah SK, 2013, VACCINE, V31, P5339, DOI 10.1016/j.vaccine.2013.09.013; RUDENKO LG, 1993, J INFECT DIS, V168, P881, DOI 10.1093/infdis/168.4.881; Shrestha S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005982; Sood N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5114; Stevenson AJ, 2016, NEW ENGL J MED, V374, P853, DOI 10.1056/NEJMsa1511902; Tasker SA, 1999, ANN INTERN MED, V131, P430, DOI 10.7326/0003-4819-131-6-199909210-00006; Venkataramani AS, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1216; Ward CJ, 2014, AM ECON J-APPL ECON, V6, P38, DOI 10.1257/app.6.1.38; Yung RL, 2000, RHEUM DIS CLIN N AM, V26, P455, DOI 10.1016/S0889-857X(05)70151-4	41	14	18	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2020	172	7					445	+		10.7326/M19-3075	http://dx.doi.org/10.7326/M19-3075			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA6DM	32120383				2022-12-28	WOS:000524036500003
J	Saini, A				Saini, Angela			Want to do better science? Admit you're not objective	NATURE			English	Editorial Material																			0	6	6	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2020	579	7798					175	175		10.1038/d41586-020-00669-2	http://dx.doi.org/10.1038/d41586-020-00669-2			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MD2CB	32152605	Bronze			2022-12-28	WOS:000543780100001
J	Sievert, A				Sievert, Alex			Against Medical Advice	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sievert, Alex] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Sievert, A (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2020	382	11					985	987		10.1056/NEJMp1914671	http://dx.doi.org/10.1056/NEJMp1914671			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU7TA	32160660				2022-12-28	WOS:000519914300004
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: Trump cancels all flights from Europe, apart from the UK	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Chinazzi M, 2020, SCIENCE	1	1	1	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2020	368								m1037	10.1136/bmj.m1037	http://dx.doi.org/10.1136/bmj.m1037			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AU	32165415	Bronze			2022-12-28	WOS:000520013500012
J	Chen, HJ; Guo, JJ; Wang, C; Luo, F; Yu, XC; Zhang, W; Li, JF; Zhao, DC; Xu, D; Gong, Q; Liao, J; Yang, HX; Hou, W; Zhang, YZ				Chen, Huijun; Guo, Juanjuan; Wang, Chen; Luo, Fan; Yu, Xuechen; Zhang, Wei; Li, Jiafu; Zhao, Dongchi; Xu, Dan; Gong, Qing; Liao, Jing; Yang, Huixia; Hou, Wei; Zhang, Yuanzhen			Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records	LANCET			English	Article								Background Previous studies on the pneumonia outbreak caused by the 2019 novel coronavirus disease (COVID-19) were based on information from the general population. Limited data are available for pregnant women with COVID-19 pneumonia. This study aimed to evaluate the clinical characteristics of COVID-19 in pregnancy and the intrauterine vertical transmission potential of COVID-19 infection. Methods Clinical records, laboratory results, and chest CT scans were retrospectively reviewed for nine pregnant women with laboratory-confirmed COVID-19 pneumonia (ie, with maternal throat swab samples that were positive for severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) who were admitted to Zhongnan Hospital of Wuhan University, Wuhan, China, from Jan 20 to Jan 31, 2020. Evidence of intrauterine vertical transmission was assessed by testing for the presence of SARS-CoV-2 in amniotic fluid, cord blood, and neonatal throat swab samples. Breastmilk samples were also collected and tested from patients after the first lactation. Findings All nine patients had a caesarean section in their third trimester. Seven patients presented with a fever. Other symptoms, including cough (in four of nine patients), myalgia (in three), sore throat (in two), and malaise (in two), were also observed. Fetal distress was monitored in two cases. Five of nine patients had lymphopenia (<1.0 x 10(9) cells per L). Three patients had increased aminotransferase concentrations. None of the patients developed severe COVID-19 pneumonia or died, as of Feb 4, 2020. Nine livebirths were recorded. No neonatal asphyxia was observed in newborn babies. All nine livebirths had a 1-min Apgar score of 8-9 and a 5-min Apgar score of 9-10. Amniotic fluid, cord blood, neonatal throat swab, and breastmilk samples from six patients were tested for SARS-CoV-2, and all samples tested negative for the virus. Interpretation The clinical characteristics of COVID-19 pneumonia in pregnant women were similar to those reported for non-pregnant adult patients who developed COVID-19 pneumonia. Findings from this small group of cases suggest that there is currently no evidence for intrauterine infection caused by vertical transmission in women who develop COVID-19 pneumonia in late pregnancy. Copyright (C) 2020 Elsevier Ltd. All rights reserved.	[Chen, Huijun; Guo, Juanjuan; Yu, Xuechen; Li, Jiafu; Xu, Dan; Gong, Qing; Liao, Jing; Zhang, Yuanzhen] Wuhan Univ, Zhongnan Hosp, Dept Gynaecol & Obstet, Wuhan 430071, Hubei, Peoples R China; [Zhao, Dongchi] Wuhan Univ, Zhongnan Hosp, Dept Paediat, Wuhan, Hubei, Peoples R China; [Chen, Huijun; Guo, Juanjuan; Yu, Xuechen; Li, Jiafu; Xu, Dan; Gong, Qing; Liao, Jing; Zhang, Yuanzhen] Clin Med Res Ctr Prenatal Diag & Birth Hlth Hubei, Wuhan, Hubei, Peoples R China; [Luo, Fan; Hou, Wei] Wuhan Univ, Sch Basic Med Sci, State Key Lab Virol, Inst Med Virol, Wuhan 430071, Hubei, Peoples R China; [Wang, Chen; Yang, Huixia] Peking Univ, Dept Obstet & Gynaecol, Hosp 1, Beijing 100034, Peoples R China; [Zhang, Wei] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA	Wuhan University; Wuhan University; Wuhan University; Peking University; Northwestern University; Feinberg School of Medicine	Zhang, YZ (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Gynaecol & Obstet, Wuhan 430071, Hubei, Peoples R China.; Hou, W (corresponding author), Wuhan Univ, Sch Basic Med Sci, State Key Lab Virol, Inst Med Virol, Wuhan 430071, Hubei, Peoples R China.; Yang, HX (corresponding author), Peking Univ, Dept Obstet & Gynaecol, Hosp 1, Beijing 100034, Peoples R China.	yanghuixia@bjmu.edu.cn; houwei@whu.edu.cn; zhangyuanzhen@whu.edu.cn	GUO, JUAN/HIK-2220-2022; hou, wei/GWM-4800-2022	Zhang, Wei/0000-0003-0875-263X; Zhang, Yuan zhen/0000-0003-0437-423X	Hubei Science and Technology Plan [2017ACB640]; Wuhan University Medical Development Plan [TFJC2018001]	Hubei Science and Technology Plan; Wuhan University Medical Development Plan	This study was supported by Hubei Science and Technology Plan (grant number 2017ACB640) and Wuhan University Medical Development Plan (grant number TFJC2018001).	Bouthry E, 2014, PRENATAL DIAG, V34, P1246, DOI 10.1002/pd.4467; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Gottfredsson M, 2008, LAEKNABLADID, V94, P737; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Li GZ, 2020, INT CONF PERVAS COMP; Li Q., 2020, NEW ENGL J MED, V382, P1199; National Health Commission of China, 2020, NEW COR PNEUM PREV C; Niu Y, 2020, WUHAN TONGJI HOSP DI; Schoeman D, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1182-0; Shek CC, 2003, PEDIATRICS, V112, pE254, DOI 10.1542/peds.112.4.e254; The State Council's Joint Prevention and Control Mechanism for Pneumonia Epidemic in Response to New Coronavirus Infection, 2020, NOT PREV CONTR PNEUM; WHO, 2020, INTERIM GUIDANC 0117; WHO, 2020, INTERIM GUIDANC 0112; Wong SF, 2004, AM J OBSTET GYNECOL, V191, P292, DOI 10.1016/j.ajog.2003.11.019; Zhang Y-Z., 2020, NOVEL 2019 CORONAVIR; Zhou P, NATURE, DOI [10.1101,2020.01.2.9452, DOI 10.1038/S41586-020-2797-4, 10.1038/s41586-020-2797-4, DOI 10.1038/s41586-020-2012-7]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	19	2015	2186	21	583	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2020	395	10226					809	815		10.1016/S0140-6736(20)30360-3	http://dx.doi.org/10.1016/S0140-6736(20)30360-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KH	32151335	Green Published, Bronze			2022-12-28	WOS:000519536900037
J	Cowper, A				Cowper, Andy			Covid-19: are we getting the communications right?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cowper, Andy] Hlth Policy Insight, London, England		Cowper, A (corresponding author), Hlth Policy Insight, London, England.	andycowper@hotmail.com						[Anonymous], 2020, IPSOS MORI       MAR; [Anonymous], 2016, SKY NEWS; [Anonymous], 2020, SUMM 2020 SESS C WHI; Benen S., TRUMPS CONFUSION DIS; Department of Health and Social Care, 2020, COR ACT PLAN; Foster P., 2020, TELEGRAPH; Honeycombe-Foster M., 2020, TODAY PROGRAMME BOYC; Kupferschmidt K, 2020, SCIENCE; Kynge J, 2020, FINANCIAL TIMES; Turak N., 2020, CNBC	10	26	27	0	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2020	368								m919	10.1136/bmj.m919	http://dx.doi.org/10.1136/bmj.m919			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2LJ	32144115	Bronze			2022-12-28	WOS:000519539700006
J	Gauthier, L; Vivier, E				Gauthier, Laurent; Vivier, Eric			Boosting Cytotoxic Antibodies against Cancer	CELL			English	Editorial Material							RECEPTOR POLYMORPHISMS; EFFICACY	Monoclonal antibodies (mAbs) targeting antigens expressed at the surface of tumor cells are widely used for cancer control in clinics, but these treatments need to be improved. Chew et al. show how an old drug, prochlorperazine, could be repurposed to enhance the efficacy of anti-tumor mAbs by increasing the cell-surface expression of tumor antigens.	[Gauthier, Laurent; Vivier, Eric] Innate Pharma, Innate Pharma Res Labs, Marseille, France; [Vivier, Eric] Aix Marseille Univ prime, CNRS, INSERM, CIML, Marseille, France; [Vivier, Eric] Hop la Timone, APHM, Serv Immunol, Marseille Immunopole, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Gauthier, L (corresponding author), Innate Pharma, Innate Pharma Res Labs, Marseille, France.	laurent.gauthier@innate-pharma.fr	Vivier, Eric/F-8939-2010	Vivier, Eric/0000-0001-7022-8287	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (TILC) [694502, 875102 -MInfla-Tilc]; Agence Nationale de la Recherche; PIONEER Project [ANR17-RHUS-0007]; Equipe labelisee "La Ligue'' (Ligue Nationale contre le Cancer); MSDAvenir; Innate Pharma	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (TILC)(European Research Council (ERC)); Agence Nationale de la Recherche(French National Research Agency (ANR)); PIONEER Project; Equipe labelisee "La Ligue'' (Ligue Nationale contre le Cancer); MSDAvenir; Innate Pharma	The E.V. laboratory at CIML and Assistance-Publique des Hopitaux de Marseille is supported by funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (TILC, grant agreement no. 694502, grant agreement no. 875102 -MInfla-Tilc), the Agence Nationale de la Recherche including the PIONEER Project (ANR17-RHUS-0007), Equipe labelisee "La Ligue'' (Ligue Nationale contre le Cancer), MSDAvenir, Innate Pharma, and institutional grants to the CIML (INSERM, CNRS, and Aix-Marseille University) and to Marseille Immunopole.	Abes R, 2010, PHARMACEUTICALS, V3, P146, DOI 10.3390/ph3010146; Andre P, 2018, CELL, V175, P1731, DOI 10.1016/j.cell.2018.10.014; Chew H.Y., 2020, CELL, V180, P895; Gauthier L, 2019, CELL, V177, P1701, DOI 10.1016/j.cell.2019.04.041; Joseph SR, 2019, J INVEST DERMATOL, V139, P213, DOI 10.1016/j.jid.2018.06.190; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168; Rodriguez J, 2012, EUR J CANCER, V48, P1774, DOI 10.1016/j.ejca.2012.01.007; Rothe A, 2015, BLOOD, V125, P4024, DOI 10.1182/blood-2014-12-614636; Schmohl JU, 2017, CANCER RES TREAT, V49, P1140, DOI 10.4143/crt.2016.491	10	1	1	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2020	180	5					822	824		10.1016/j.cell.2020.02.025	http://dx.doi.org/10.1016/j.cell.2020.02.025			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KT7JN	32142673	Bronze			2022-12-28	WOS:000519189800002
J	Koff, A; Malinis, M; Delgado, S; Grant, M; Ahmad, T				Koff, Alan; Malinis, Maricar; Delgado, Santiago; Grant, Matthew; Ahmad, Tariq			Under Our Very Eyes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ORGAN TRANSPLANT RECIPIENTS; CHAGAS-DISEASE; TRYPANOSOMA-CRUZI; RECOMMENDATIONS	A 64-year-old man presented to the emergency department in the summer with intermittent fevers that began 7 weeks after he underwent heart transplantation at that hospital. The patient had a history of ischemic cardiomyopathy for which he had received a HeartMate II left ventricular assist device (LVAD) that remained implanted for 2 years. An infection with coagulase-negative staphylococcus had developed in the drive-line of the device, a finding that led to the patient's name being placed higher on the waiting list for transplantation; before transplantation, he had received long-term treatment with doxycycline for suppression. His initial postoperative course was uneventful. After receiving induction therapy with basiliximab, the patient was treated with mycophenolate mofetil, tacrolimus, and prednisone to prevent allograft rejection. He received trimethoprim-sulfamethoxazole and valganciclovir for prophylaxis against pneumocystis and cytomegalovirus (CMV) infections (the patient and donor were both CMV-seropositive). Four weeks after heart transplantation, an endomyocardial biopsy showed grade 2 acute cellular rejection, which prompted administration of pulse therapy with methylprednisolone for 3 days and increased maintenance doses of immunosuppressive therapy. His treatment with tacrolimus was changed to cyclosporine because of tremors. Seven weeks after transplantation, he began to have intermittent high fevers with temperatures of up to 40 degrees C, along with chills, nausea, and headaches.	[Koff, Alan; Malinis, Maricar; Grant, Matthew] Yale Univ, Sch Med, Infect Dis Sect, New Haven, CT USA; [Ahmad, Tariq] Yale Univ, Sch Med, Cardiovasc Med, New Haven, CT USA; [Koff, Alan; Malinis, Maricar; Grant, Matthew; Ahmad, Tariq] Yale Univ, Sch Med, Div Internal Med, New Haven, CT USA; [Delgado, Santiago] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University	Ahmad, T (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06517 USA.	tariq.ahmad@yale.edu	; Ahamed, Tariq/E-8985-2016	Koff, Alan/0000-0003-1229-7860; Ahamed, Tariq/0000-0002-4525-0738; Malinis, Maricar/0000-0002-5720-9994				[Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; Chin-Hong PV, 2011, AM J TRANSPLANT, V11, P672, DOI 10.1111/j.1600-6143.2011.03444.x; Cordova E, 2008, INT J INFECT DIS, V12, P587, DOI 10.1016/j.ijid.2007.12.007; Hemmige V, 2012, INT J DERMATOL, V51, P501, DOI 10.1111/j.1365-4632.2011.05380.x; Huprikar S, 2013, AM J TRANSPLANT, V13, P2418, DOI 10.1111/ajt.12340; KIRCHHOFF LV, 1993, NEW ENGL J MED, V329, P639, DOI 10.1056/NEJM199308263290909; Kun H, 2009, CLIN INFECT DIS, V48, P1534, DOI 10.1086/598931; Malinis M, 2019, CLIN TRANSPLANT, V33, DOI 10.1111/ctr.13548; Montgomery SP, 2016, AM J TROP MED HYG, V95, P1225, DOI 10.4269/ajtmh.16-0213; Morillo CA, 2015, NEW ENGL J MED, V373, P1295, DOI 10.1056/NEJMoa1507574; Perez-Molina JA, 2018, LANCET, V391, P82, DOI 10.1016/S0140-6736(17)31612-4; Pierrotti LC, 2018, TRANSPLANTATION, V102, pS1, DOI [10.1097/TP.0000000000002019, 10.1097/tp.0000000000002019]	12	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2020	382	10					952	957		10.1056/NEJMcps1902835	http://dx.doi.org/10.1056/NEJMcps1902835			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KT7TC	32130818				2022-12-28	WOS:000519214900011
J	Mahase, E				Mahase, Elisabeth			Covid-19: 90% of cases will hit NHS over nine week period, chief medical officer warns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m854	1	3	3	0	39	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2020	368								m918	10.1136/bmj.m918	http://dx.doi.org/10.1136/bmj.m918			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KI	32139397	Bronze			2022-12-28	WOS:000519537000010
J	Mennel, L; Symonowicz, J; Wachter, S; Polyushkin, DK; Molina-Mendoza, AJ; Mueller, T				Mennel, Lukas; Symonowicz, Joanna; Wachter, Stefan; Polyushkin, Dmitry K.; Molina-Mendoza, Aday J.; Mueller, Thomas			Ultrafast machine vision with 2D material neural network image sensors	NATURE			English	Article							DIODES	Machine vision technology has taken huge leaps in recent years, and is now becoming an integral part of various intelligent systems, including autonomous vehicles and robotics. Usually, visual information is captured by a frame-based camera, converted into a digital format and processed afterwards using a machine-learning algorithm such as an artificial neural network (ANN)(1). The large amount of (mostly redundant) data passed through the entire signal chain, however, results in low frame rates and high power consumption. Various visual data preprocessing techniques have thus been developed(2-7) to increase the efficiency of the subsequent signal processing in an ANN. Here we demonstrate that an image sensor can itself constitute an ANN that can simultaneously sense and process optical images without latency. Our device is based on a reconfigurable two-dimensional (2D) semiconductor(8,9) photodiode(10-12) array, and the synaptic weights of the network are stored in a continuously tunable photoresponsivity matrix. We demonstrate both supervised and unsupervised learning and train the sensor to classify and encode images that are optically projected onto the chip with a throughput of 20 million bins per second.	[Mennel, Lukas; Symonowicz, Joanna; Wachter, Stefan; Polyushkin, Dmitry K.; Molina-Mendoza, Aday J.; Mueller, Thomas] Vienna Univ Technol, Inst Photon, Vienna, Austria	Technische Universitat Wien	Mennel, L; Mueller, T (corresponding author), Vienna Univ Technol, Inst Photon, Vienna, Austria.	lukas.mennel@tuwien.ac.at; thomas.mueller@tuwien.ac.at	Mueller, Thomas/AAB-7126-2019	Mueller, Thomas/0000-0003-1343-5719; Mennel, Lukas/0000-0002-3361-1671	Austrian Science Fund FWF [START Y 539-N16]; European Union [785219, 791536]	Austrian Science Fund FWF(Austrian Science Fund (FWF)); European Union(European Commission)	We thank B. Limbacher for discussions and A. Kleinl, M. Paur and F. Dona for technical assistance. We acknowledge financial support by the Austrian Science Fund FWF (START Y 539-N16) and the European Union (grant agreement number 785219 Graphene Flagship and Marie Sklodowska-Curie Individual Fellowship OPTOvanderWAALS, grant ID 791536).	Bengio Yoshua, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P437, DOI 10.1007/978-3-642-35289-8_26; Bertolazzi S, 2013, ACS NANO, V7, P3246, DOI 10.1021/nn3059136; Bratschitsch R, 2014, NAT NANOTECHNOL, V9, P247, DOI 10.1038/nnano.2014.66; Castellanos-Gomez A, 2014, 2D MATER, V1, DOI 10.1088/2053-1583/1/2/025001; Chen JF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08451-3; Choi C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01824-6; Cottini N, 2013, IEEE J SOLID-ST CIRC, V48, P850, DOI 10.1109/JSSC.2012.2235031; GERCHBERG RW, 1972, OPTIK, V35, P237; Goossens S, 2017, NAT PHOTONICS, V11, P366, DOI [10.1038/nphoton.2017.75, 10.1038/NPHOTON.2017.75]; Hamerly R, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.021032; Jeong KH, 2006, SCIENCE, V312, P557, DOI 10.1126/science.1123053; Kim KH, 2012, NANO LETT, V12, P389, DOI 10.1021/nl203687n; Kolb H, 2003, AM SCI, V91, P28, DOI 10.1511/2003.11.841; KYUMA K, 1994, NATURE, V372, P197, DOI 10.1038/372197a0; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li C, 2018, IEEE INT SYMP CIRC S, DOI 10.1109/ISCAS.2018.8351877; Li D, 2017, NAT NANOTECHNOL, V12, P901, DOI [10.1038/nnano.2017.104, 10.1038/NNANO.2017.104]; Lichtsteiner Patrick, 2008, IEEE Journal of Solid-State Circuits, V43, P566, DOI 10.1109/JSSC.2007.914337; Lin X, 2018, SCIENCE, V361, P1004, DOI 10.1126/science.aat8084; Manzeli S, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2017.33; Massicotte M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03864-y; MEAD CA, 1988, NEURAL NETWORKS, V1, P91, DOI 10.1016/0893-6080(88)90024-X; Mueller T, 2018, NPJ 2D MATER APPL, V2, DOI 10.1038/s41699-018-0074-2; Posch C, 2014, P IEEE, V102, P1470, DOI 10.1109/JPROC.2014.2346153; Pospischil A, 2014, NAT NANOTECHNOL, V9, P257, DOI [10.1038/nnano.2014.14, 10.1038/NNANO.2014.14]; Prezioso M, 2015, NATURE, V521, P61, DOI 10.1038/nature14441; PSALTIS D, 1990, NATURE, V343, P325, DOI 10.1038/343325a0; Ross JS, 2014, NAT NANOTECHNOL, V9, P268, DOI [10.1038/nnano.2014.26, 10.1038/NNANO.2014.26]; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Schwarte R, 1997, P SOC PHOTO-OPT INS, V3100, P245, DOI 10.1117/12.287751; Shen YC, 2017, NAT PHOTONICS, V11, P441, DOI [10.1038/NPHOTON.2017.93, 10.1038/nphoton.2017.93]; Sheridan PM, 2017, NAT NANOTECHNOL, V12, P784, DOI [10.1038/nnano.2017.83, 10.1038/NNANO.2017.83]; SUGETA T, 1980, JPN J APPL PHYS, V19, P459, DOI 10.7567/JJAPS.19S1.459; Wachter S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14948; Zhou FC, 2019, NAT NANOTECHNOL, V14, P776, DOI 10.1038/s41565-019-0501-3	37	268	273	132	494	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 5	2020	579	7797					62	+		10.1038/s41586-020-2038-x	http://dx.doi.org/10.1038/s41586-020-2038-x			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MD2AZ	32132692				2022-12-28	WOS:000543777300005
J	Ndodo, N				Ndodo, Nnaemeka			Extended US travel ban harms global science	NATURE			English	Editorial Material						Developing world; Policy		From preparing for pandemics to boosting crop yields, Nigerian scientists who work and train abroad are making the world safer. Now that's under threat. From preparing for pandemics to boosting crop yields, Nigerian scientists who work and train abroad are making the world safer. Now that's under threat.	[Ndodo, Nnaemeka] Nigerias Ctr Dis Control, Natl Reference Lab, Abuja, Nigeria		Ndodo, N (corresponding author), Nigerias Ctr Dis Control, Natl Reference Lab, Abuja, Nigeria.	nnaemeka.ndodo@ncdc.gov.ng							0	0	0	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7797					9	9		10.1038/d41586-020-00588-2	http://dx.doi.org/10.1038/d41586-020-00588-2			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KR9HW	32127713				2022-12-28	WOS:000517925200001
J	Sun, PZ; Yang, Q; Kuang, WJ; Stebunov, YV; Xiong, WQ; Yu, J; Nair, RR; Katsnelson, MI; Yuan, SJ; Grigorieva, IV; Lozada-Hidalgo, M; Wang, FC; Geim, AK				Sun, P. Z.; Yang, Q.; Kuang, W. J.; Stebunov, Y. V.; Xiong, W. Q.; Yu, J.; Nair, R. R.; Katsnelson, M. I.; Yuan, S. J.; Grigorieva, I. V.; Lozada-Hidalgo, M.; Wang, F. C.; Geim, A. K.			Limits on gas impermeability of graphene	NATURE			English	Article							TRANSPORT; PERMEATION; ADHESION	Despite being only one-atom thick, defect-free graphene is considered to be completely impermeable to all gases and liquids(1-10). This conclusion is based on theory(3-8) and supported by experiments(1,9,10) that could not detect gas permeation through micrometre-size membranes within a detection limit of 10(5) to 10(6) atoms per second. Here, using small monocrystalline containers tightly sealed with graphene, we show that defect-free graphene is impermeable with an accuracy of eight to nine orders of magnitude higher than in the previous experiments. We are capable of discerning (but did not observe) permeation of just a few helium atoms per hour, and this detection limit is also valid for all other gases tested (neon, nitrogen, oxygen, argon, krypton and xenon), except for hydrogen. Hydrogen shows noticeable permeation, even though its molecule is larger than helium and should experience a higher energy barrier. This puzzling observation is attributed to a two-stage process that involves dissociation of molecular hydrogen at catalytically active graphene ripples, followed by adsorbed atoms flipping to the other side of the graphene sheet with a relatively low activation energy of about 1.0 electronvolt, a value close to that previously reported for proton transport(11,12). Our work provides a key reference for the impermeability of two-dimensional materials and is important from a fundamental perspective and for their potential applications.	[Sun, P. Z.; Yang, Q.; Kuang, W. J.; Stebunov, Y. V.; Grigorieva, I. V.; Lozada-Hidalgo, M.; Wang, F. C.; Geim, A. K.] Univ Manchester, Dept Phys & Astron, Manchester, Lancs, England; [Sun, P. Z.; Yang, Q.; Stebunov, Y. V.; Nair, R. R.; Wang, F. C.; Geim, A. K.] Univ Manchester, Natl Graphene Inst, Manchester, Lancs, England; [Xiong, W. Q.; Yuan, S. J.] Wuhan Univ, Sch Phys & Technol, Key Lab Artificial Micro & Nanostruct, Minist Educ, Wuhan, Peoples R China; [Yu, J.; Katsnelson, M. I.; Yuan, S. J.] Radboud Univ Nijmegen, Inst Mol & Mat, Nijmegen, Netherlands; [Wang, F. C.] Univ Sci & Technol China, Chinese Acad Sci, Dept Modern Mech, Key Lab Mech Behav & Design Mat, Hefei, Peoples R China	University of Manchester; University of Manchester; Wuhan University; Radboud University Nijmegen; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Geim, AK (corresponding author), Univ Manchester, Dept Phys & Astron, Manchester, Lancs, England.; Geim, AK (corresponding author), Univ Manchester, Natl Graphene Inst, Manchester, Lancs, England.; Yuan, SJ (corresponding author), Wuhan Univ, Sch Phys & Technol, Key Lab Artificial Micro & Nanostruct, Minist Educ, Wuhan, Peoples R China.; Yuan, SJ (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, Nijmegen, Netherlands.	s.yuan@whu.edu.cn; geim@manchester.ac.uk	Yuan, Shengjun/B-4518-2008; Yang, Qian/AAJ-3206-2021; Geim, Andre K/J-7888-2012; Katsnelson, Mikhail I./D-4359-2012; Yu, Jin/AAA-4460-2020; Lozada-Hidalgo, Marcelo/U-1642-2017	Yang, Qian/0000-0002-6203-7867; Geim, Andre K/0000-0003-2861-8331; Yu, Jin/0000-0003-1074-2465; Sun, Pengzhan/0000-0002-5838-0945; Lozada-Hidalgo, Marcelo/0000-0003-3216-7537; Sun, Phillip Zhe/0000-0003-4872-1192; Yuan, Shengjun/0000-0001-6208-1502; Kuang, Wenjun/0000-0003-4309-365X	Lloyd's Register Foundation; European Research Council; Graphene Flagship; Royal Society; National Key R&D Program of China [2018YFA0305800]; Supercomputing Center of Wuhan University; EPSRC [EP/K005014/1] Funding Source: UKRI	Lloyd's Register Foundation; European Research Council(European Research Council (ERC)European Commission); Graphene Flagship; Royal Society(Royal Society of London); National Key R&D Program of China; Supercomputing Center of Wuhan University; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Lloyd's Register Foundation, the European Research Council (grants ARTIMATTER and VANDER), Graphene Flagship and the Royal Society. S.J.Y. acknowledges support from the National Key R&D Program of China (grant 2018YFA0305800) and Supercomputing Center of Wuhan University.	Berry V, 2013, CARBON, V62, P1, DOI 10.1016/j.carbon.2013.05.052; Bissett MA, 2013, ACS NANO, V7, P10335, DOI 10.1021/nn404746h; Boukhvalov DW, 2009, J PHYS CHEM C, V113, P14176, DOI 10.1021/jp905702e; Bukola S, 2019, ELECTROCHIM ACTA, V296, P1, DOI 10.1016/j.electacta.2018.11.005; Bunch JS, 2008, NANO LETT, V8, P2458, DOI 10.1021/nl801457b; Bunch JS, 2007, SCIENCE, V315, P490, DOI 10.1126/science.1136836; Deveau ND, 2013, J MEMBRANE SCI, V437, P298, DOI 10.1016/j.memsci.2013.02.047; Fasolino A, 2007, NAT MATER, V6, P858, DOI 10.1038/nmat2011; Feng YX, 2017, J PHYS CHEM LETT, V8, P6009, DOI 10.1021/acs.jpclett.7b02820; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Geringer V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.076102; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; Haigh SJ, 2012, NAT MATER, V11, P764, DOI [10.1038/nmat3386, 10.1038/NMAT3386]; Hencky H., 1915, Z MATH PHYS, V63, P311; HERZBERG G, 1960, J MOL SPECTROSC, V5, P482; Hornekaer L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.186102; Hu S, 2018, NAT NANOTECHNOL, V13, P468, DOI 10.1038/s41565-018-0088-0; Hu S, 2014, NATURE, V516, P227, DOI 10.1038/nature14015; Kelly DJ, 2018, NANO LETT, V18, P1168, DOI 10.1021/acs.nanolett.7b04713; Kerber T, 2008, J COMPUT CHEM, V29, P2088, DOI 10.1002/jcc.21069; Koenig SP, 2012, NAT NANOTECHNOL, V7, P728, DOI [10.1038/NNANO.2012.162, 10.1038/nnano.2012.162]; Koenig SP, 2011, NAT NANOTECHNOL, V6, P543, DOI [10.1038/nnano.2011.123, 10.1038/NNANO.2011.123]; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kroes JMH, 2017, PHYS CHEM CHEM PHYS, V19, P5813, DOI 10.1039/c6cp08923b; Kunc J, 2018, AIP ADV, V8, DOI 10.1063/1.5024132; Landau L.D., 1980, COURSE THEORETICAL P, V5; Leenaerts O, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3021413; Lozada-Hidalgo M, 2016, SCIENCE, V351, P68, DOI 10.1126/science.aac9726; Mazzuca JW, 2018, J CHEM PHYS, V148, DOI 10.1063/1.5027821; McKay H, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.075425; Meyer JC, 2007, SOLID STATE COMMUN, V143, P101, DOI 10.1016/j.ssc.2007.02.047; Miao M, 2013, PHYS CHEM CHEM PHYS, V15, P16132, DOI 10.1039/c3cp52318g; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.16.1746; Paris A, 2013, ADV FUNCT MATER, V23, P1628, DOI 10.1002/adfm.201202355; Park HG, 2014, CHEM SOC REV, V43, P565, DOI 10.1039/c3cs60253b; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Poltavsky I, 2018, J CHEM PHYS, V148, DOI 10.1063/1.5024317; Radha B, 2016, NATURE, V538, P222, DOI 10.1038/nature19363; Riedl C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.246804; Seel M, 2016, 2D MATER, V3, DOI 10.1088/2053-1583/3/2/025004; Sheppard PW, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3677230; Tsetseris L, 2014, CARBON, V67, P58, DOI 10.1016/j.carbon.2013.09.055; Wang GR, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.036101; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Wang LD, 2015, NAT NANOTECHNOL, V10, P785, DOI [10.1038/NNANO.2015.158, 10.1038/nnano.2015.158]; Wang WL, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125012; Whittaker JD, 2006, NANO LETT, V6, P953, DOI 10.1021/nl060018t; Wu QZ, 2013, CHEM COMMUN, V49, P677, DOI 10.1039/c2cc36747e	49	137	137	33	340	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7798					229	+		10.1038/s41586-020-2070-x	http://dx.doi.org/10.1038/s41586-020-2070-x			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU0CC	32161387	Green Published, Green Submitted			2022-12-28	WOS:000519378900022
J	Zhang, W; Seo, DH; Chen, T; Wu, LJ; Topsakal, M; Zhu, YM; Lu, DY; Ceder, G; Wang, F				Zhang, Wei; Seo, Dong-Hwa; Chen, Tina; Wu, Lijun; Topsakal, Mehmet; Zhu, Yimei; Lu, Deyu; Ceder, Gerbrand; Wang, Feng			Kinetic pathways of ionic transport in fast-charging lithium titanate	SCIENCE			English	Article							LOCAL-STRUCTURE; ENERGY; INTERCALATION; TRANSITION; LI4TI5O12; INSERTION; 2-PHASE; STORAGE; SURFACE	Fast-charging batteries typically use electrodes capable of accommodating lithium continuously by means of solid-solution transformation because they have few kinetic barriers apart from ionic diffusion. One exception is lithium titanate (Li4Ti5O12), an anode exhibiting extraordinary rate capability apparently inconsistent with its two-phase reaction and slow Li diffusion in both phases. Through real-time tracking of Li+ migration using operando electron energy-loss spectroscopy, we reveal that facile transport in Li4+xTi5O12 is enabled by kinetic pathways comprising distorted Li polyhedra in metastable intermediates along two-phase boundaries. Our work demonstrates that high-rate capability may be enabled by accessing the energy landscape above the ground state, which may have fundamentally different kinetic mechanisms from the ground-state macroscopic phases. This insight should present new opportunities in searching for high-rate electrode materials.	[Zhang, Wei; Wang, Feng] Brookhaven Natl Lab, Sustainable Energy Technol Dept, Upton, NY 11973 USA; [Seo, Dong-Hwa; Chen, Tina; Ceder, Gerbrand] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Chen, Tina; Ceder, Gerbrand] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Wu, Lijun; Zhu, Yimei] Brookhaven Natl Lab, Dept Condensed Matter Phys & Mat Sci, Upton, NY 11973 USA; [Topsakal, Mehmet; Lu, Deyu] Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA; [Zhang, Wei] Nankai Univ, Coll Chem, Minist Educ, Key Lab Adv Energy Mat Chem, Tianjin 300071, Peoples R China; [Seo, Dong-Hwa] UNIST, Sch Energy & Chem Engn, Dept Energy Engn, Ulsan 44919, South Korea	United States Department of Energy (DOE); Brookhaven National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory; Nankai University; Ulsan National Institute of Science & Technology (UNIST)	Wang, F (corresponding author), Brookhaven Natl Lab, Sustainable Energy Technol Dept, Upton, NY 11973 USA.; Ceder, G (corresponding author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.; Ceder, G (corresponding author), Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA.	gceder@berkeley.edu; fwang@bnl.gov	Seo, Dong-Hwa/D-1446-2011; Lu, Deyu/O-4418-2016	Seo, Dong-Hwa/0000-0002-7200-7186; Zhu, Yimei/0000-0002-1638-7217; Zhang, Wei/0000-0001-7031-162X; Wu, Lijun/0000-0002-8443-250X; Lu, Deyu/0000-0003-4351-6085; Ceder, Gerbrand/0000-0001-9275-3605; Chen, Tina/0000-0003-0254-8339	Laboratory Directed Research and Development program at the Brookhaven National Lab (BNL) [DE-SC0012704]; U.S. Department of Energy (DOE) Office of Science facility [DE-SC0012704]; Assistant Secretary for Energy Efficiency and Renewable Energy, Vehicle Technologies Office, of the U.S. DOE; Advanced Battery Materials Research (BMR) Program; National Science Foundation Graduate Research Fellowship [DGE 1106400]; U.S. DOE, Office of Energy Efficiency and Renewable Energy, Vehicle Technologies Office [DE-SC0012704]; U.S. DOE, Office of Basic Energy Science, Division of Materials Science and Engineering [DE-SC0012704]; National Science Foundation's Extreme Science and Engineering Development Environment; National Science Foundation [ACI-1548562]	Laboratory Directed Research and Development program at the Brookhaven National Lab (BNL); U.S. Department of Energy (DOE) Office of Science facility(United States Department of Energy (DOE)); Assistant Secretary for Energy Efficiency and Renewable Energy, Vehicle Technologies Office, of the U.S. DOE(United States Department of Energy (DOE)); Advanced Battery Materials Research (BMR) Program; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); U.S. DOE, Office of Energy Efficiency and Renewable Energy, Vehicle Technologies Office(United States Department of Energy (DOE)); U.S. DOE, Office of Basic Energy Science, Division of Materials Science and Engineering(United States Department of Energy (DOE)); National Science Foundation's Extreme Science and Engineering Development Environment; National Science Foundation(National Science Foundation (NSF))	This work was partially supported by the Laboratory Directed Research and Development program at the Brookhaven National Lab (BNL) (contract no. DE-SC0012704). This research used resources of the Center for Functional Nanomaterials, which is a U.S. Department of Energy (DOE) Office of Science facility, and the Scientific Data and Computing Center, a component of the BNL Computational Science Initiative, at BNL (contract no. DE-SC0012704). This work was supported in part by the Assistant Secretary for Energy Efficiency and Renewable Energy, Vehicle Technologies Office, of the U.S. DOE (contract no. DE-AC02-05CH11231), under the Advanced Battery Materials Research (BMR) Program and by the National Science Foundation Graduate Research Fellowship (grant no. DGE 1106400). Efforts by F.W. involving writing and revision of the manuscript were supported by U.S. DOE, Office of Energy Efficiency and Renewable Energy, Vehicle Technologies Office (contract no. DE-SC0012704). Efforts on EELS data analysis by L.W. and Y.Z. were supported by the U.S. DOE, Office of Basic Energy Science, Division of Materials Science and Engineering (contract no. DE-SC0012704). T.C. thanks the National Science Foundation's Extreme Science and Engineering Development Environment (XSEDE) supercomputer Stampede2 (allocation TG-DMR970008S), which is supported by the National Science Foundation (grant no. ACI-1548562), for providing computing resources.	Armand M, 2009, NAT MATER, V8, P621, DOI [10.1038/nmat2448, 10.1038/NMAT2448]; Aydinol MK, 1997, J POWER SOURCES, V68, P664, DOI 10.1016/S0378-7753(96)02638-9; Brydson R, 1995, J MICROSC-OXFORD, V180, P238, DOI 10.1111/j.1365-2818.1995.tb03683.x; Dolotko O, 2014, SOLID STATE SCI, V36, P101, DOI 10.1016/j.solidstatesciences.2014.08.002; Egerton R.F., 2011, ELECT ENERGY LOSS SP; Elsasser C, 2001, ULTRAMICROSCOPY, V86, P325, DOI 10.1016/S0304-3991(00)00123-6; Ganapathy S, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201601781; Ganapathy S, 2012, ACS NANO, V6, P8702, DOI 10.1021/nn302278m; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Grey CP, 2017, NAT MATER, V16, P45, DOI [10.1038/NMAT4777, 10.1038/nmat4777]; Hain H, 2012, SOLID STATE NUCL MAG, V42, P9, DOI 10.1016/j.ssnmr.2011.11.007; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Li YY, 2014, NAT MATER, V13, P1149, DOI [10.1038/NMAT4084, 10.1038/nmat4084]; Liu H, 2014, SCIENCE, V344, DOI 10.1126/science.1252817; Maier J, 2005, NAT MATER, V4, P805, DOI 10.1038/nmat1513; Malik R, 2011, NAT MATER, V10, P587, DOI [10.1038/NMAT3065, 10.1038/nmat3065]; Pang WK, 2014, CHEM MATER, V26, P2318, DOI 10.1021/cm5002779; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; ROBINSON K, 1971, SCIENCE, V172, P567, DOI 10.1126/science.172.3983.567; Rong ZQ, 2015, CHEM MATER, V27, P6016, DOI 10.1021/acs.chemmater.5b02342; Ross FM, 2015, SCIENCE, V350, DOI 10.1126/science.aaa9886; SALPETER EE, 1951, PHYS REV, V84, P1232, DOI 10.1103/PhysRev.84.1232; Scharner S, 1999, J ELECTROCHEM SOC, V146, P857, DOI 10.1149/1.1391692; Schmidt W, 2015, CHEM MATER, V27, P1740, DOI 10.1021/cm504564k; Sheppard D, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2841941; Sun JW, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.036402; Vinson J, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.045101; Wagemaker M, 2006, ADV MATER, V18, P3169, DOI 10.1002/adma.200601636; Wagemaker M, 2009, ADV MATER, V21, P2703, DOI 10.1002/adma.200803038; Wang F, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/42/424006; Wang F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2185; Wang F, 2011, ACS NANO, V5, P1190, DOI 10.1021/nn1028168; Wilkening M, 2007, PHYS CHEM CHEM PHYS, V9, P6199, DOI [10.1039/b616269j, 10.1039/b713311a, 10.1039/B616269J]; Yamamoto T, 2008, X-RAY SPECTROM, V37, P572, DOI 10.1002/xrs.1103; Yi TF, 2015, J MATER CHEM A, V3, P5750, DOI 10.1039/c4ta06882c; Zhang W, 2017, J AM CHEM SOC, V139, P16591, DOI 10.1021/jacs.7b07628; Zhu CB, 2017, SCIENCE, V358, DOI 10.1126/science.aao2808; Ziebarth B, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.174301	39	112	116	58	355	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2020	367	6481					1030	+		10.1126/science.aax3520	http://dx.doi.org/10.1126/science.aax3520			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KS0CO	32108110	Green Published, Green Submitted			2022-12-28	WOS:000517979600040
J	Porcino, AJ; Shamseer, L; Chan, AW; Kravitz, RL; Orkin, A; Punja, S; Ravaud, P; Schmid, CH; Vohra, S				Porcino, Antony J.; Shamseer, Larissa; Chan, An-Wen; Kravitz, Richard L.; Orkin, Aaron; Punja, Salima; Ravaud, Philippe; Schmid, Christopher H.; Vohra, Sunita		SPENT Grp	SPIRIT extension and elaboration for n-of-1 trials: SPENT 2019 checklist	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED-TRIALS; CLINICAL-TRIALS; DESIGN; METHODOLOGY; METAANALYSIS; STATEMENT; OUTCOMES; IMPROVE	Randomised clinical trials are the preferred method for establishing average intervention effects for groups. Using key methodological elements of these trials, n-of-1 trials provide rigorous evidence of intervention effects for individuals. N-of-1 trials are particularly useful for situations where randomised clinical trials are not always feasible or appropriate, such as for individuals with rare diseases, comorbid conditions, or using concurrent treatments. N-of-1 trials enhance precision when intervention effects are heterogeneous between individuals. Here, we describe an extension to the SPIRIT (standard protocol items: recommendations for interventional trials) guideline, SPENT (SPIRIT extension for n-of-1 trials), to improve the completeness and transparency of n-of-1 trial protocols. SPENT is also aligned with the CONSORT (consolidated standards of reporting trials) extension for n-of-1 trials (CENT). The guideline development group followed the development strategy for reporting guidelines endorsed by the EQUATOR Network. SPENT began with a systematic review for n-of-1 protocol recommendations. After analysis to identify possible SPENT items, a three round Delphi process was implemented, with international participation involving researchers, patient advocates, and other stakeholders. This was followed by in-person meetings and email discussion of the SPENT group to achieve consensus. SPENT has 14 extension items specific to n-of-1 trials, a checklist for n-of-1 trial protocol abstracts, and additional guidance for eight SPIRIT items where trialists could encounter issues specific to n-of-1 trials. This paper describes the rationale and development process, and provides examples and explanations for each SPENT checklist item.	[Porcino, Antony J.] BC Canc, Support Canc Care, Vancouver, BC, Canada; [Shamseer, Larissa] Ottawa Hosp Res Inst, Ctr Journalol, Ottawa, ON, Canada; [Chan, An-Wen] Univ Toronto, Dept Med, Toronto, ON, Canada; [Chan, An-Wen] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Kravitz, Richard L.] Univ Calif Davis, Sch Med, Dept Internal Med, Sacramento, CA 95817 USA; [Orkin, Aaron] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Orkin, Aaron] St Josephs Hlth Ctr, Dept Emergency Med, Toronto, ON, Canada; [Orkin, Aaron] Inner City Hlth Associates, Unity Hlth, Toronto, ON, Canada; [Punja, Salima; Vohra, Sunita] Univ Alberta, Integrat Hlth Inst, 1702 Coll Plaza,8215-112 St NW, Edmonton, AB T6G 2C8, Canada; [Ravaud, Philippe] Hop Hotel Dieu, Ctr Clin Epidemiol, Paris, France; [Ravaud, Philippe] EQUATOR France, Paris, France; [Ravaud, Philippe] Cochrane France, Paris, France; [Ravaud, Philippe] Sorbonne Paris Cite, Ctr Res Epidemiol & Stat, Paris, France; [Schmid, Christopher H.] Brown Univ, Dept Biostat, Providence, RI 02912 USA; [Schmid, Christopher H.] Brown Univ, Ctr Evidence Synth Hlth, Providence, RI 02912 USA; [Vohra, Sunita] Univ Alberta, Dept Pediat, Fac Med & Dent, Edmonton, AB, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of California System; University of California Davis; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Joseph's Health Centre, Toronto; Western University (University of Western Ontario); University of Alberta; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Brown University; Brown University; University of Alberta	Vohra, S (corresponding author), Univ Alberta, Integrat Hlth Inst, 1702 Coll Plaza,8215-112 St NW, Edmonton, AB T6G 2C8, Canada.; Vohra, S (corresponding author), Univ Alberta, Dept Pediat, Fac Med & Dent, Edmonton, AB, Canada.	svohra@ualberta.ca	Shamseer, Larissa/E-9645-2017; Schmid, Christopher H./J-2398-2014; Orkin, Aaron/K-2500-2014; Kravitz, Richard/AAF-7425-2021	Shamseer, Larissa/0000-0003-3690-3378; Schmid, Christopher H./0000-0002-0855-5313; Orkin, Aaron/0000-0002-1111-8720; Porcino, Antony/0000-0002-4053-5654; Kravitz, Richard/0000-0001-5575-529X; Ravaud, Philippe/0000-0001-8264-9206				Alemayehu C, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2212-0; Baek EK, 2014, NEUROPSYCHOL REHABIL, V24, P590, DOI 10.1080/09602011.2013.835740; Barr C, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0590-8; Berger VW, 2011, J BIOPHARM STAT, V21, P263, DOI 10.1080/10543406.2011.550107; Boutron I, 2017, ANN INTERN MED, V167, P40, DOI 10.7326/M17-0046; Brookes ST, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-10; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Clarke M, 2010, LANCET, V376, P20, DOI 10.1016/S0140-6736(10)61045-8; Duan NH, 2013, J CLIN EPIDEMIOL, V66, pS21, DOI 10.1016/j.jclinepi.2013.04.006; Emanuel EJ, 2001, NEW ENGL J MED, V345, P915, DOI 10.1056/NEJM200109203451211; Gage NA, 2014, J SPEC EDUC, V48, P3, DOI 10.1177/0022466912443894; Goetz LH, 2018, FERTIL STERIL, V109, P952, DOI 10.1016/j.fertnstert.2018.05.006; GUYATT G, 1988, CAN MED ASSOC J, V139, P497; Guyatt GH, 2002, USERS GUIDES MED LIT, P275; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Horner RH, 2012, EDUC TREAT CHILD, V35, P269, DOI 10.1353/etc.2012.0011; Hugh EJ, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-17; Julian DG, 2003, J CARDIOVASC ELECTR, V14, pS2, DOI 10.1046/j.1540-8167.14.s9.18.x; Kravitz RL, 2014, DECIDE METHODS CTR F; Maggin DM, 2011, J SCHOOL PSYCHOL, V49, P301, DOI 10.1016/j.jsp.2011.03.004; Maggin DM, 2011, EXCEPTIONALITY, V19, P109, DOI 10.1080/09362835.2011.565725; Mehran R, 2018, JAMA-J AM MED ASSOC, V319, P450, DOI 10.1001/jama.2017.21541; Mirza RD, 2017, J ROY SOC MED, V110, P330, DOI 10.1177/0141076817721131; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Mullins CD, 2014, VALUE HEALTH, V17, P471, DOI 10.1016/j.jval.2014.02.012; Nikles CJ, 2005, BRIT J GEN PRACT, V55, P175; Nikles J, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-39; Pablos-Mendez A, 1998, JAMA-J AM MED ASSOC, V279, P222, DOI 10.1001/jama.279.3.222; Paterson C, 1996, BRIT MED J, V312, P1016; Porcino AJ, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0525-4; Price A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020452; Punja S, 2014, DESIGN IMPLEMENTATIO, P13; Punja S, 2016, J CLIN EPIDEMIOL, V76, P47, DOI 10.1016/j.jclinepi.2016.03.023; Punja S, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1499-6; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Sacristan Jose A, 2016, Patient Prefer Adherence, V10, P631, DOI 10.2147/PPA.S104259; Schork NJ, 2015, NATURE, V520, P609, DOI 10.1038/520609a; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Schulz KF, 2005, LANCET, V365, P1657, DOI 10.1016/S0140-6736(05)66516-6; Senior HEJ, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-89; Senn SS, 2002, CROSS OVER TRIALS CL, V2; Senn S, 2019, STAT METHODS MED RES, V28, P372, DOI 10.1177/0962280217726801; Shamseer L, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1793; Stang A, 2005, PLOS MED, V2, P177, DOI 10.1371/journal.pmed.0020072; Tate RL, 2014, NEUROPSYCHOL REHABIL, V24, P315, DOI 10.1080/09602011.2013.875043; Tetzlaff JM, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-43; Tsapas A, 2008, DIABETOLOGIA, V51, P921, DOI 10.1007/s00125-008-0983-2; Tsapas A, 2009, JAMA-J AM MED ASSOC, V301, P1022, DOI 10.1001/jama.2009.276; Vohra S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1738; Vrinten C, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007863; Wallace BC, 2014, CLINICAL DECISION SUPPORT: THE ROAD TO BROAD ADOPTION, 2ND EDITION, P339; Wang T, 2016, J DIABETES, V8, P610, DOI 10.1111/1753-0407.12412; Zucker DR, 2010, J CLIN EPIDEMIOL, V63, P1312, DOI 10.1016/j.jclinepi.2010.04.020	56	26	27	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2020	368								m122	10.1136/bmj.m122	http://dx.doi.org/10.1136/bmj.m122			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2JX	32107202	Bronze			2022-12-28	WOS:000519535800001
J	Thornton, J				Thornton, Jacqui			People with severe mental health conditions are let down by lack of local rehabilitation services	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Royal College of Psychiatrists, 2020, RETH MENT ILLN SIGHT	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2020	368								m801	10.1136/bmj.m801	http://dx.doi.org/10.1136/bmj.m801			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU2JX	32107209				2022-12-28	WOS:000519535800018
J	Brennan, R; Hajjeh, R; Al-Mandhari, A				Brennan, Richard; Hajjeh, Rana; Al-Mandhari, Ahmed			Responding to health emergencies in the Eastern Mediterranean region in times of conflict	LANCET			English	Editorial Material									[Brennan, Richard; Hajjeh, Rana; Al-Mandhari, Ahmed] WHO, Reg Off Eastern Mediterranean, POB 7608, Nasr City 11371, Egypt	Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization	Hajjeh, R (corresponding author), WHO, Reg Off Eastern Mediterranean, POB 7608, Nasr City 11371, Egypt.	hajjehr@who.int						Global Health Cluster, 2020, GENDER BASED VIOLENC; Global Polio Eradication Programme, 2020, END COUNTR; Johns Hopkins Center for Humanitarian Health, 2018, MOSULTRAUMA RESP CAS; Lowcock Mark, 2019, SECR GEN HUM AFF EM; Mbaeyi C, 2017, MMWR-MORBID MORTAL W, V66, P27, DOI 10.15585/mmwr.mm6608a6; OCHA, 2019, GLOBAL HUMANITARIAN; Pettersson T, 2019, J PEACE RES, V56, P589, DOI 10.1177/0022343319856046; UN Assistance Mission in Afghanistan, 2019, Q REP PROT CIV ARM C; UN Population Fund, 2020, IMPACT COVID 19 PAND; UNHCR, UNHCR GLOB TRENDS FO; UNICEF, STRENGTH SUBN CAP YE; United Nations Development Programme, 2017, HUMAN DEV REPORT 201; Uppsala Conflict Data Program, UCDP PRIO ARM CONFL; WHO, 2019, WHO GLOB REP TRAD CO, P2019, DOI DOI 10.18502/JEHSD.V4I3.1495; WHO, WHOS STRAT E MED REG; WHO, 2019, WEEKL AWD CHOL SIT R; WHO, 2018, ATT HLTH CAR DASHB 1; WHO, SUMM KEY IND WHOL SY; WHO, 2017, STAT UNICEF EX DIR A; WHO, EM TRAUM RESP GAZ MA; WHO  IFRC  OCHA, 2020, COVID 19 INCL MARG V; WHO Regional Office for the Eastern Mediterranean, 2019, WEEKLY EPIDEMIOL MON, V28, P1; WHO Regional Office forthe Eastern Mediterranean, 2019, DIS OUTBR E MED REG; World Bank, YEM EM HLTH NUTR PRO; World Health Organisation (WHO), 2019 NOV COR 2019 NC; World Health Organization, 2019, STRONG COLL BETT HLT; World Health Organization, SURV SYST ATT HLTH C; World Health Organization, 2018, WHOS WORK EM PREP PR, P1; World Health Organization (WHO), 2015, FRAM PUBL HLTH EM OP	29	9	9	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2022	399	10332					E20	E22		10.1016/S0140-6736(20)30069-6	http://dx.doi.org/10.1016/S0140-6736(20)30069-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2F3QY	32135078	Bronze, Green Published			2022-12-28	WOS:000812828300001
J	Desai, A; Hegde, A; Das, D				Desai, Aakash; Hegde, Aparna; Das, Devika			Change in Reporting of USMLE Step 1 Scores and Potential Implications for International Medical Graduates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint reviews the roles international medical graduates (IMGs) play in US health care systems and discusses the potential challenges that the announced 2022 change in USMLE Step 1 examination scoring from a 3-digit score to a pass/fail designation will pose for this workforce segment.	[Desai, Aakash] Univ Connecticut, Dept Med, 263 Farmington Ave, Farmington, CT 06030 USA; [Hegde, Aparna; Das, Devika] Univ Alabama Birmingham, Dept Hematol & Oncol, Birmingham, AL USA	University of Connecticut; University of Alabama System; University of Alabama Birmingham	Desai, A (corresponding author), Univ Connecticut, Dept Med, 263 Farmington Ave, Farmington, CT 06030 USA.	dr.aakashdesai@gmail.com	Desai, Aakash/ABD-6423-2020; Hegde, Aparna/AAC-5512-2022; Desai, Aakash/AAB-5803-2021	Hegde, Aparna/0000-0001-6616-4882; 				[Anonymous], ECFMG STAT USMLE POL; [Anonymous], USMLE STEP 1; [Anonymous], ECFMG OV; Association of American Medical Colleges, 2019, RES 2018 MED SCH ENR; Baer L, 2001, 71 U N CAR CHAP HILL; InCUS Planning Committee, 2019, SUMM REP PREL REC IN; National Resident Matching Program, RES 2018 NRMP PROGR; National Resident Matching Program, 2018, CHART OUTC MATCH INT; Rural Health Information Hub, RUR J 1 VIS WAIV; United States Medical License Examination, USMLE PROGR ANN UPC	10	14	14	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					2015	2016		10.1001/jama.2020.2956	http://dx.doi.org/10.1001/jama.2020.2956			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LU8UM	32142104				2022-12-28	WOS:000538023900027
J	Fitzgerald, KA; Kagan, JC				Fitzgerald, Katherine A.; Kagan, Jonathan C.			Toll-like Receptors and the Control of Immunity	CELL			English	Review							NF-KAPPA-B; INTERFERON REGULATORY FACTOR-3; DORSAL-VENTRAL POLARITY; DOUBLE-STRANDED-RNA; NLRP3 INFLAMMASOME ACTIVATION; 4 TLR4 ENDOCYTOSIS; CYCLIC GMP-AMP; CUTTING EDGE; DENDRITIC CELL; ADAPTER MOLECULE	The study of innate immunity and its link to inflammation and host defense encompasses diverse areas of biology, ranging from genetics and biophysics to signal transduction and physiology. Central to our understanding of these events are the Toll-like receptors (TLRs), an evolutionarily ancient family of pattern recognition receptors. Herein, we describe the mechanisms and consequences of TLR-mediated signal transduction with a focus on themes identified in the TLR pathways that also explain the operation of other immune signaling pathways. These themes include the detection of conserved microbial structures to identify infectious agents and the use of supramolecular organizing centers (SMOCs) as signaling organelles that ensure digital cellular responses. Further themes include mechanisms of inducible gene expression, the coordination of gene regulation and metabolism, and the influence of these activities on adaptive immunity. Studies in these areas have informed the development of next-generation therapeutics, thus ensuring a bright future for research in this area.	[Kagan, Jonathan C.] Harvard Med Sch, Boston, MA 02115 USA; [Kagan, Jonathan C.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Fitzgerald, Katherine A.] Univ Massachusetts, Med Sch, Dept Med, Program Innate Immun,Div Infect Dis & Immunol, Worcester, MA 01605 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Massachusetts System; University of Massachusetts Worcester	Kagan, JC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Kagan, JC (corresponding author), Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA.; Fitzgerald, KA (corresponding author), Univ Massachusetts, Med Sch, Dept Med, Program Innate Immun,Div Infect Dis & Immunol, Worcester, MA 01605 USA.	kate.fitzgerald@umassmed.edu; jonathan.kagan@childrens.harvard.edu	Fitzgerald, Katherine/ABE-6317-2020		NIH [AI067497, AI133524, AI093589, AI116550, P30DK34854]; Burroughs Wellcome Fund	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	The authors would like to acknowledge Kerstin Nundel (Umass Medical School) for helpful discussions and funding from the NIH (AI067497 to K.A.F. and AI133524, AI093589, AI116550, and P30DK34854 to J.C.K.). J.C.K. holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Akira S, 2003, J INFECT DIS, V187, pS356, DOI 10.1086/374749; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Anders HJ, 2005, LUPUS, V14, P417, DOI 10.1191/0961203305lu2102rr; Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Anderson DA, 2019, ADV IMMUNOL, V143, P99, DOI 10.1016/bs.ai.2019.09.001; ANDERSON KV, 1985, CELL, V42, P791, DOI 10.1016/0092-8674(85)90275-2; ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Andre FE, 2008, B WORLD HEALTH ORGAN, V86, P140, DOI 10.2471/BLT.07.040089; Arts RJW, 2016, SEMIN IMMUNOL, V28, P425, DOI 10.1016/j.smim.2016.09.002; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Atianand MK, 2016, CELL, V165, P1672, DOI 10.1016/j.cell.2016.05.075; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bhatta A, 2020, J IMMUNOL, V204, P428, DOI 10.4049/jimmunol.1900791; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Blok BA, 2015, J LEUKOCYTE BIOL, V98, P347, DOI 10.1189/jlb.5RI0315-096R; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Castellanos-Rubio A, 2016, SCIENCE, V352, P91, DOI 10.1126/science.aad0467; Chan J, 2015, J IMMUNOL, V195, P1359, DOI 10.4049/jimmunol.1500264; Chan MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6853; Chandler C.E., 2017, F1000RES, V6, DOI [10.12688/f1000research.11388.1, DOI 10.12688/F1000RESEARCH.11388.1.]; Chen YZ, 2018, J EXP MED, V215, P3136, DOI 10.1084/jem.20181031; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Chiang CY, 2012, J BIOL CHEM, V287, P3704, DOI 10.1074/jbc.C111.328559; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Christensen SR, 2007, SEMIN IMMUNOL, V19, P11, DOI 10.1016/j.smim.2006.12.005; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Collins B, 2014, PROTEINS, V82, P2874, DOI 10.1002/prot.24616; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Corcoran SE, 2016, J CLIN INVEST, V126, P3699, DOI 10.1172/JCI84431; Cullen TW, 2015, SCIENCE, V347, P170, DOI 10.1126/science.1260580; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; de Diego RP, 2010, IMMUNITY, V33, P400, DOI 10.1016/j.immuni.2010.08.014; DeLaney AA, 2019, P NATL ACAD SCI USA, V116, P11926, DOI 10.1073/pnas.1820529116; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Du M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02229-1; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Fernandes-Alnemri T, 2013, J IMMUNOL, V191, P3995, DOI 10.4049/jimmunol.1301681; Ferrao R, 2014, MOL CELL, V55, P891, DOI 10.1016/j.molcel.2014.08.006; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Fischer C, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aao5820; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; Fukui R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01491; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gewirtz AT, 2004, J INFECT DIS, V189, P1914, DOI 10.1086/386289; Gioannini TL, 2007, IMMUNOL RES, V39, P249, DOI 10.1007/s12026-007-0069-0; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Greulich W, 2019, CELL, V179, P1264, DOI 10.1016/j.cell.2019.11.001; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hafner A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00198; Han S, 2015, J BIOL CHEM, V290, P18124, DOI 10.1074/jbc.M115.645549; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; HAZIOT A, 1993, J IMMUNOL, V151, P1500; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Heyninck K, 1999, FEBS LETT, V442, P147, DOI 10.1016/S0014-5793(98)01645-7; Hidmark A, 2012, J IMMUNOL, V189, P2717, DOI 10.4049/jimmunol.1200898; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hu GK, 2016, J IMMUNOL, V196, P2799, DOI 10.4049/jimmunol.1502146; Iijima J, 2017, GLYCOBIOLOGY, V27, P1006, DOI 10.1093/glycob/cwx075; Imler JL, 2002, CURR TOP MICROBIOL, V270, P63; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Israel L, 2017, CELL, V168, P789, DOI 10.1016/j.cell.2017.01.039; Jackson R, 2018, NATURE, V564, P434, DOI 10.1038/s41586-018-0794-7; Jain A, 2020, NAT IMMUNOL, V21, P65, DOI 10.1038/s41590-019-0559-y; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kagan JC, 2014, NAT REV IMMUNOL, V14, P821, DOI 10.1038/nri3757; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kleinnijenhuis J, 2015, T ROY SOC TROP MED H, V109, P29, DOI 10.1093/trstmh/tru168; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; Kreuk LSM, 2019, ELIFE, V8, DOI 10.7554/eLife.47015; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Kruger A, 2015, EMBO REP, V16, P1656, DOI 10.15252/embr.201540861; Kutschera A, 2019, SCIENCE, V364, P178, DOI 10.1126/science.aau1279; Labeta MO, 2000, J EXP MED, V191, P1807, DOI 10.1084/jem.191.10.1807; Langston PK, 2019, NAT IMMUNOL, V20, P1186, DOI 10.1038/s41590-019-0453-7; Lanzavecchia A, 2001, CURR OPIN IMMUNOL, V13, P291, DOI 10.1016/S0952-7915(00)00218-1; Latty SL, 2018, ELIFE, V7, DOI 10.7554/eLife.31377; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; LEE JD, 1993, P NATL ACAD SCI USA, V90, P9930, DOI 10.1073/pnas.90.21.9930; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Lin KM, 2014, P NATL ACAD SCI USA, V111, P775, DOI 10.1073/pnas.1320294111; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lin YC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003973; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Lopez-Pelaez M, 2014, P NATL ACAD SCI USA, V111, P17432, DOI 10.1073/pnas.1418399111; Maglione PJ, 2014, BLOOD, V124, P3561, DOI 10.1182/blood-2014-07-587824; Majer O, 2019, NATURE, V575, P371, DOI 10.1038/s41586-019-1611-7; MANIATIS T, 1988, HARVEY LECT, V82, P71; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matskevich AA, 2010, EUR J IMMUNOL, V40, P1244, DOI 10.1002/eji.200940164; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Miller YI, 2012, BRIT J PHARMACOL, V167, P990, DOI 10.1111/j.1476-5381.2012.02097.x; Mitchell S, 2016, WIRES SYST BIOL MED, V8, P227, DOI 10.1002/wsbm.1331; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Moreno C, 2004, MICROBES INFECT, V6, P990, DOI 10.1016/j.micinf.2004.05.010; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Mouchess ML, 2011, IMMUNITY, V35, P721, DOI 10.1016/j.immuni.2011.10.009; Moynagh PN, 2009, TRENDS IMMUNOL, V30, P33, DOI 10.1016/j.it.2008.10.001; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Nair-Gupta P, 2014, CELL, V158, P506, DOI 10.1016/j.cell.2014.04.054; Navarro L, 1999, J BIOL CHEM, V274, P35535, DOI 10.1074/jbc.274.50.35535; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; Ni MJ, 2012, P NATL ACAD SCI USA, V109, P267, DOI 10.1073/pnas.1111957108; Nilsen NJ, 2015, J BIOL CHEM, V290, P3209, DOI 10.1074/jbc.M114.593426; NUSSENZWEIG MC, 1980, J EXP MED, V151, P1196, DOI 10.1084/jem.151.5.1196; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Odendall C, 2017, J IMMUNOL, V199, P3270, DOI 10.4049/jimmunol.1700250; Ohto U, 2018, IMMUNITY, V48, P649, DOI 10.1016/j.immuni.2018.03.013; Ohto U, 2015, NATURE, V520, P702, DOI 10.1038/nature14138; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Olguin Y, 2013, ANAL BIOANAL CHEM, V405, P1267, DOI 10.1007/s00216-012-6523-4; Onji M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2949; Orning P, 2019, J EXP MED, V216, P2453, DOI 10.1084/jem.20190545; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pasare C, 2004, MICROBES INFECT, V6, P1382, DOI 10.1016/j.micinf.2004.08.018; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pelka K, 2018, IMMUNITY, V48, P911, DOI 10.1016/j.immuni.2018.04.011; Perkins DJ, 2018, NAT IMMUNOL, V19, P1309, DOI 10.1038/s41590-018-0243-7; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Pohar J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15363; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Rapicavoli NA, 2013, ELIFE, V2, DOI 10.7554/eLife.00762; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Ren JY, 2014, P NATL ACAD SCI USA, V111, P17438, DOI 10.1073/pnas.1418516111; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Roy S, 2014, J BIOL CHEM, V289, P1174, DOI 10.1074/jbc.M113.523167; Ryu JK, 2017, IMMUNITY, V46, P38, DOI 10.1016/j.immuni.2016.11.007; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Sarhan J, 2019, CELL DEATH DIFFER, V26, P332, DOI 10.1038/s41418-018-0122-7; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Satake H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00034; Sato M, 1998, FEBS LETT, V425, P112, DOI 10.1016/S0014-5793(98)00210-5; Schappe MS, 2018, IMMUNITY, V48, P59, DOI 10.1016/j.immuni.2017.11.026; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; Schauvliege R, 2007, J CELL MOL MED, V11, P453, DOI 10.1111/j.1582-4934.2007.00040.x; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Shaffer SA, 2007, J AM SOC MASS SPECTR, V18, P1080, DOI 10.1016/j.jasms.2007.03.008; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sharma S, 2015, J IMMUNOL, V195, P3507, DOI 10.4049/jimmunol.1500964; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shibata T, 2016, INT IMMUNOL, V28, P211, DOI 10.1093/intimm/dxv062; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Shouval DS, 2016, GASTROENTEROLOGY, V151, P1100, DOI 10.1053/j.gastro.2016.08.055; Song H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13727; Song N, 2017, MOL CELL, V68, P185, DOI 10.1016/j.molcel.2017.08.017; Stack J, 2014, J IMMUNOL, V193, P6090, DOI 10.4049/jimmunol.1401605; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; Strickson S, 2017, P NATL ACAD SCI USA, V114, pE3481, DOI 10.1073/pnas.1702367114; Sun J, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aab2191; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sung MH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004764; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tan YH, 2019, CELL, V177, P384, DOI 10.1016/j.cell.2019.01.039; Tan YH, 2015, IMMUNITY, V43, P909, DOI 10.1016/j.immuni.2015.10.008; Tanji H, 2016, P NATL ACAD SCI USA, V113, P3012, DOI 10.1073/pnas.1516000113; Tanji H, 2015, NAT STRUCT MOL BIOL, V22, P109, DOI 10.1038/nsmb.2943; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Triantafilou M, 2002, J CELL SCI, V115, P2603; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Troutman TD, 2012, P NATL ACAD SCI USA, V109, P273, DOI 10.1073/pnas.1118579109; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Vasselon T, 2004, J IMMUNOL, V173, P7401, DOI 10.4049/jimmunol.173.12.7401; Vigano E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9761; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang LH, 2006, EMBO J, V25, P5005, DOI 10.1038/sj.emboj.7601363; Ward TL, 2014, IMMUNOBIOLOGY, V219, P537, DOI 10.1016/j.imbio.2014.03.008; Weinlich R, 2017, NAT REV MOL CELL BIO, V18, P127, DOI 10.1038/nrm.2016.149; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zanoni I, 2013, CELL REP, V4, P1235, DOI 10.1016/j.celrep.2013.08.021; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhang ZK, 2016, IMMUNITY, V45, P737, DOI 10.1016/j.immuni.2016.09.011	270	518	539	83	344	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2020	180	6					1044	1066		10.1016/j.cell.2020.02.041	http://dx.doi.org/10.1016/j.cell.2020.02.041			23	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KW1IO	32164908	Green Accepted, Bronze			2022-12-28	WOS:000520925300006
J	Kondo, KK; Morasco, BJ; Nugent, SM; Ayers, CK; O'Neil, ME; Freeman, M; Kansagara, D				Kondo, Karli K.; Morasco, Benjamin J.; Nugent, Shannon M.; Ayers, Chelsea K.; O'Neil, Maya E.; Freeman, Michele; Kansagara, Devan			Pharmacotherapy for the Treatment of Cannabis Use Disorder A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; MARIJUANA DEPENDENCE; N-ACETYLCYSTEINE; WITHDRAWAL; THERAPY; DRONABINOL; YOUTH; RISK	Background: Cannabis use disorder (CUD) is a growing concern, and evidence-based data are needed to inform treatment options. Purpose: To review the benefits and risks of pharmacotherapies for the treatment of CUD. Data Sources: MEDLINE, PsycINFO, Cochrane Database of Systematic Reviews, and clinical trial registries from inception through September 2019. Study Selection: Pharmacotherapy trials of adults or adolescents with CUD that targeted cannabis abstinence or reduction, treatment retention, withdrawal symptoms, and other outcomes. Data Extraction: Data were abstracted by 1 investigator and confirmed by a second. Study quality was dually assessed, and strength of evidence (SOE) was determined by consensus according to standard criteria. Data Synthesis: Across 26 trials, the evidence was largely insufficient. Low-strength evidence was found that selective serotonin reuptake inhibitors (SSRIs) do not reduce cannabis use or improve treatment retention. Low- to moderate-strength evidence was found that buspirone does not improve outcomes and that cannabinoids do not increase abstinence rates (moderate SOE), reduce cannabis use (low SOE), or increase treatment retention (low SOE). Across all drug studies, no consistent evidence of increased harm was found. Limitations: Few methodologically rigorous trials have been done. Existing trials are hampered by small sample sizes, high attrition rates, and heterogeneity of concurrent interventions and outcomes assessment. Conclusion: Although data on pharmacologic interventions for CUD are scarce, evidence exists that several drug classes, including cannabinoids and SSRIs, are ineffective. Because of increasing access to and use of cannabis in the general population, along with a high prevalence of CUD among current cannabis users, an urgent need exists for more research to identify effective pharmacologic treatments.	[Kondo, Karli K.; Morasco, Benjamin J.; Nugent, Shannon M.; Ayers, Chelsea K.; O'Neil, Maya E.; Freeman, Michele; Kansagara, Devan] Vet Affairs Portland Hlth Care Syst, Mail Code R&D 71,3710 Southwest US Vet Hosp Rd, Portland, OR 97239 USA; [Kondo, Karli K.; Morasco, Benjamin J.; Nugent, Shannon M.; O'Neil, Maya E.; Kansagara, Devan] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Morasco, Benjamin J.] 3710 Southwest US Vet Hosp Rd,Mail Code R&D 99, Portland, OR 97239 USA; [Nugent, Shannon M.; O'Neil, Maya E.] 3710 Southwest US Vet Hosp Rd,Mail Code R&D 66, Portland, OR 97239 USA; [Ayers, Chelsea K.] 3710 Southwest US Vet Hosp Rd,Mail Code R&D 71, Portland, OR 97239 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University	Kondo, KK (corresponding author), Vet Affairs Portland Hlth Care Syst, Mail Code R&D 71,3710 Southwest US Vet Hosp Rd, Portland, OR 97239 USA.	kondo@ohsu.edu		Kondo, Karli/0000-0002-4635-5056	U.S. Department of Veterans Affairs [PROSPERO: CRD42018108064]	U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	U.S. Department of Veterans Affairs. (PROSPERO: CRD42018108064)	Allsop DJ, 2014, JAMA PSYCHIAT, V71, P281, DOI 10.1001/jamapsychiatry.2013.3947; Allsop DJ, 2011, DRUG ALCOHOL DEPEN, V119, P123, DOI 10.1016/j.drugalcdep.2011.06.003; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2015, STAT STAT SOFTW COMP; Aslam AA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012040.pub2; Azofeifa A, MMWR SURVEILLANCE SU; Berkman N, 2016, GRADING STRENGTH BOD; Blanco C, 2016, JAMA PSYCHIAT, V73, P388, DOI 10.1001/jamapsychiatry.2015.3229; Buchan BJ, 2002, ADDICTION, V97, P98, DOI 10.1046/j.1360-0443.97.s01.1.x; Carpenter K, 2009, AM J ADDICTION, V18, P53, DOI 10.1080/10550490802408936; Cornelius JR, 2010, DRUG ALCOHOL DEPEN, V112, P39, DOI 10.1016/j.drugalcdep.2010.05.010; D'Souza DC, 2019, LANCET PSYCHIAT, V6, P35, DOI 10.1016/S2215-0366(18)30427-9; Danovitch I, 2012, PSYCHIAT CLIN N AM, V35, P309, DOI 10.1016/j.psc.2012.03.003; Davenport S, 2018, DRUG ALCOHOL DEPEN, V191, P52, DOI 10.1016/j.drugalcdep.2018.06.025; Gray KM, 2017, DRUG ALCOHOL DEPEN, V177, P249, DOI 10.1016/j.drugalcdep.2017.04.020; Gray KM, 2012, AM J PSYCHIAT, V169, P805, DOI 10.1176/appi.ajp.2012.12010055; Hasin DS, 2016, AM J PSYCHIAT, V173, P588, DOI 10.1176/appi.ajp.2015.15070907; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hill KP, 2017, AM J ADDICTION, V26, P795, DOI 10.1111/ajad.12622; Hoch E, 2014, DRUG ALCOHOL DEPEN, V134, P185, DOI 10.1016/j.drugalcdep.2013.09.028; Johnston J, 2014, PSYCHOPHARMACOLOGY, V231, P4623, DOI 10.1007/s00213-014-3611-5; Keyhani S, 2018, ANN INTERN MED, V169, P282, DOI 10.7326/M18-0810; Kondo K, 2019, PROSPERO; Kondo K, 2018, 05225 ESP US DEP VET; Laprevote V, 2015, CURR PHARM DESIGN, V21, P3298, DOI 10.2174/1381612821666150619093940; Lee CM, 2013, J CONSULT CLIN PSYCH, V81, P702, DOI 10.1037/a0033285; Levin FR, 2004, AM J ADDICTION, V13, P21, DOI 10.1080/10550490490265280; Levin FR, 2016, DRUG ALCOHOL DEPEN, V159, P53, DOI 10.1016/j.drugalcdep.2015.11.025; Levin FR, 2013, ADDICTION, V108, P1084, DOI 10.1111/add.12108; Levin FR, 2011, DRUG ALCOHOL DEPEN, V116, P142, DOI 10.1016/j.drugalcdep.2010.12.010; Lintzeris N, 2019, JAMA INTERN MED, V179, P1242, DOI 10.1001/jamainternmed.2019.1993; Marshall K, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008940.pub2; Mason BJ, 2012, NEUROPSYCHOPHARMACOL, V37, P1689, DOI 10.1038/npp.2012.14; McGowan J, 2016, J CLIN EPIDEMIOL, V69, P8, DOI 10.1016/j.jclinepi.2015.05.001; McRae-Clark AL, 2016, AM J ADDICTION, V25, P69, DOI 10.1111/ajad.12324; McRae-Clark AL, 2015, DRUG ALCOHOL DEPEN, V156, P29, DOI 10.1016/j.drugalcdep.2015.08.013; McRae-Clark AL, 2010, AM J ADDICTION, V19, P481, DOI 10.1111/j.1521-0391.2010.00076.x; McRae-Clark AL, 2009, DRUG ALCOHOL DEPEN, V105, P132, DOI 10.1016/j.drugalcdep.2009.06.022; Metrik J, 2018, ALCOHOL CLIN EXP RES, V42, P1096, DOI 10.1111/acer.13639; Miranda R, 2017, ADDICT BIOL, V22, P779, DOI 10.1111/adb.12350; Nielsen S, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008940.pub3; Nordic Cochrane Centre, 2014, REV MAN REVMAN COMP; Pacek LR, 2015, DRUG ALCOHOL DEPEN, V149, P232, DOI 10.1016/j.drugalcdep.2015.02.009; Penetar DM, 2012, SUBST ABUS-RES TREAT, V6, P63, DOI 10.4137/SART.S9706; Robinson SM, 2014, PSYCHOL ADDICT BEHAV, V28, P154, DOI 10.1037/a0030992; Schnell T, 2014, AM J ADDICTION, V23, P308, DOI 10.1111/j.1521-0391.2014.12126.x; Sherman BJ, 2019, PHARMACOL BIOCHEM BE, V179, P22, DOI 10.1016/j.pbb.2019.01.008; Sherman BJ, 2017, PSYCHIAT RES, V249, P318, DOI 10.1016/j.psychres.2017.01.027; Stein MD, 2010, J SUBST ABUSE TREAT, V39, P157, DOI 10.1016/j.jsat.2010.05.014; Stephens RS, 2007, ADDICTION, V102, P947, DOI 10.1111/j.1360-0443.2007.01821.x; Stephens RS, 2000, J CONSULT CLIN PSYCH, V68, P898, DOI 10.1037/0022-006X.68.5.898; Sugarman DE, 2019, PHARMACOL BIOCHEM BE, V181, P86, DOI 10.1016/j.pbb.2019.05.004; Trigo JM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190768; Wall MM, 2019, DRUG ALCOHOL DEPEN, V195, P13, DOI 10.1016/j.drugalcdep.2018.11.009; Weinstein AM, 2014, AM J DRUG ALCOHOL AB, V40, P16, DOI 10.3109/00952990.2013.819362	55	15	15	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2020	172	6					398	+		10.7326/M19-1105	http://dx.doi.org/10.7326/M19-1105			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KV1FY	32120384				2022-12-28	WOS:000520170800026
J	Leste-Lasserre, C				Leste-Lasserre, Christa			SAVING GRACE	SCIENCE			English	Editorial Material																			0	3	3	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1182	1187		10.1126/science.367.6483.1182	http://dx.doi.org/10.1126/science.367.6483.1182			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU9DP	32165568				2022-12-28	WOS:000520023800019
J	Ehrenreich, D; Lovis, C; Allart, R; Osorio, MRZ; Pepe, F; Cristiani, S; Rebolo, R; Santos, NC; Borsa, F; Demangeon, O; Dumusque, X; Hernandez, JIG; Casasayas-Barris, N; Segransan, D; Sousa, S; Abreu, M; Adibekyan, V; Affolter, M; Prieto, CA; Alibert, Y; Aliverti, M; Alves, D; Amate, M; Avila, G; Baldini, V; Bandy, T; Benz, W; Bianco, A; Bolmont, E; Bouchy, F; Bourrier, V; Broeg, C; Cabral, A; Calderone, G; Palle, E; Cegla, HM; Cirami, R; Coelho, JMP; Conconi, P; Coretti, I; Cumani, C; Cupani, G; Dekker, H; Delabre, B; Deiries, S; D'Odorico, V; Di Marcantonio, P; Figueira, P; Fragoso, A; Genolet, L; Genoni, M; Santos, RG; Hara, N; Hughes, I; Iwert, O; Kerber, F; Knudstrup, J; Landoni, M; Lavie, B; Lizon, JL; Lendl, M; Lo Curto, G; Maire, C; Manescau, A; Martins, CJAP; Megevand, D; Mehner, A; Micela, G; Modigliani, A; Molaro, P; Monteiro, M; Monteiro, M; Moschetti, M; Muller, E; Nunes, N; Oggioni, L; Oliveira, A; Pariani, G; Pasquini, L; Poretti, E; Rasilla, JL; Redaelli, E; Riva, M; Tschudi, SS; Santin, P; Santos, P; Milla, AS; Seidel, JV; Sosnowska, D; Sozzetti, A; Spano, P; Mascareno, AS; Tabernero, H; Tenegi, F; Udry, S; Zanutta, A; Zerbi, F				Ehrenreich, David; Lovis, Christophe; Allart, Romain; Osorio, Maria Rosa Zapatero; Pepe, Francesco; Cristiani, Stefano; Rebolo, Rafael; Santos, Nuno C.; Borsa, Francesco; Demangeon, Olivier; Dumusque, Xavier; Hernandez, Jonay I. Gonzalez; Casasayas-Barris, Nuria; Segransan, Damien; Sousa, Sergio; Abreu, Manuel; Adibekyan, Vardan; Affolter, Michael; Prieto, Carlos Allenda; Alibert, Yann; Aliverti, Matteo; Alves, David; Amate, Manuel; Avila, Gerardo; Baldini, Veronica; Bandy, Timothy; Benz, Willy; Bianco, Andrea; Bolmont, Emeline; Bouchy, Francois; Bourrier, Vincent; Broeg, Christopher; Cabral, Alexandre; Calderone, Giorgio; Palle, Enric; Cegla, H. M.; Cirami, Roberto; Coelho, Joao M. P.; Conconi, Paolo; Coretti, Igor; Cumani, Claudio; Cupani, Guido; Dekker, Hans; Delabre, Bernard; Deiries, Sebastian; D'Odorico, Valentina; Di Marcantonio, Paolo; Figueira, Pedro; Fragoso, Ana; Genolet, Ludovic; Genoni, Matteo; Santos, Ricardo Genova; Hara, Nathan; Hughes, Ian; Iwert, Olaf; Kerber, Florian; Knudstrup, Jens; Landoni, Marco; Lavie, Baptiste; Lizon, Jean-Louis; Lendl, Monika; Lo Curto, Gaspare; Maire, Charles; Manescau, Antonio; Martins, C. J. A. P.; Megevand, Denis; Mehner, Andrea; Micela, Giusi; Modigliani, Andrea; Molaro, Paolo; Monteiro, Manuel; Monteiro, Mario; Moschetti, Manuele; Mueller, Eric; Nunes, Nelson; Oggioni, Luca; Oliveira, Antonio; Pariani, Giorgio; Pasquini, Luca; Poretti, Ennio; Rasilla, Jose Luis; Redaelli, Edoardo; Riva, Marco; Tschudi, Samuel Santana; Santin, Paolo; Santos, Pedro; Milla, Alex Segovia; Seidel, Julia V.; Sosnowska, Danuta; Sozzetti, Alessandro; Spano, Paolo; Mascareno, Alejandro Suarez; Tabernero, Hugo; Tenegi, Fabio; Udry, Stephane; Zanutta, Alessio; Zerbi, Filippo			Nightside condensation of iron in an ultrahot giant exoplanet	NATURE			English	Article							HOT JUPITERS; ATMOSPHERIC CIRCULATION; EXTRASOLAR PLANET; STELLAR ROTATION; HOST STARS; TRANSIT; SEARCH; MASS; DISSOCIATION; SIMULATIONS	Ultrahot giant exoplanets receive thousands of times Earth's insolation(1,2). Their high-temperature atmospheres (greater than 2,000 kelvin) are ideal laboratories for studying extreme planetary climates and chemistry(3-5). Daysides are predicted to be cloud-free, dominated by atomic species(6) and much hotter than nightsides(5,7,8). Atoms are expected to recombine into molecules over the nightside(9), resulting in different day and night chemistries. Although metallic elements and a large temperature contrast have been observed(10-14), no chemical gradient has been measured across the surface of such an exoplanet. Different atmospheric chemistry between the day-to-night ('evening') and night-to-day ('morning') terminators could, however, be revealed as an asymmetric absorption signature during transit(4,7,15). Here we report the detection of an asymmetric atmospheric signature in the ultrahot exoplanet WASP-76b. We spectrally and temporally resolve this signature using a combination of high-dispersion spectroscopy with a large photon-collecting area. The absorption signal, attributed to neutral iron, is blueshifted by -11 +/- 0.7 kilometres per second on the trailing limb, which can be explained by a combination of planetary rotation and wind blowing from the hot dayside(16). In contrast, no signal arises from the nightside close to the morning terminator, showing that atomic iron is not absorbing starlight there. We conclude that iron must therefore condense during its journey across the nightside. Absorption lines of iron in the dayside atmosphere of an ultrahot giant exoplanet disappear after travelling across the nightside, showing that the iron has condensed during its travel.	[Ehrenreich, David; Lovis, Christophe; Allart, Romain; Pepe, Francesco; Dumusque, Xavier; Segransan, Damien; Bolmont, Emeline; Bouchy, Francois; Bourrier, Vincent; Cegla, H. M.; Genolet, Ludovic; Hara, Nathan; Hughes, Ian; Lavie, Baptiste; Lendl, Monika; Maire, Charles; Megevand, Denis; Milla, Alex Segovia; Seidel, Julia V.; Sosnowska, Danuta; Udry, Stephane] Univ Geneva, Observ Astron, Versoix, Switzerland; [Osorio, Maria Rosa Zapatero; Tabernero, Hugo] CSIC, INTA, Ctr Astrobiol, Torrejon De Ardoz, Spain; [Cristiani, Stefano; Baldini, Veronica; Calderone, Giorgio; Cirami, Roberto; Coretti, Igor; Cupani, Guido; D'Odorico, Valentina; Di Marcantonio, Paolo; Molaro, Paolo; Santin, Paolo] INAF Osservatorio Astron Trieste, Trieste, Italy; [Rebolo, Rafael; Hernandez, Jonay I. Gonzalez; Casasayas-Barris, Nuria; Abreu, Manuel; Prieto, Carlos Allenda; Amate, Manuel; Palle, Enric; Fragoso, Ana; Santos, Ricardo Genova; Rasilla, Jose Luis; Mascareno, Alejandro Suarez; Tenegi, Fabio] Inst Astrofis Canarias, Tenerife, Spain; [Santos, Nuno C.; Demangeon, Olivier; Sousa, Sergio; Adibekyan, Vardan; Figueira, Pedro; Martins, C. J. A. P.; Monteiro, Manuel; Monteiro, Mario; Tabernero, Hugo] Univ Porto, CAUP, Inst Astrofis & Ciencias Espaco, Porto, Portugal; [Santos, Nuno C.; Monteiro, Mario] Univ Porto, Fac Ciencias, Dept Fis & Astron, Porto, Portugal; [Pepe, Francesco; Borsa, Francesco; Aliverti, Matteo; Bianco, Andrea; Conconi, Paolo; Genoni, Matteo; Landoni, Marco; Moschetti, Manuele; Oggioni, Luca; Pariani, Giorgio; Poretti, Ennio; Redaelli, Edoardo; Riva, Marco; Spano, Paolo; Zanutta, Alessio; Zerbi, Filippo] INAF Osservatorio Astron Brera, Merate, Italy; [Abreu, Manuel; Alves, David; Cabral, Alexandre; Coelho, Joao M. P.; Nunes, Nelson; Oliveira, Antonio; Santos, Pedro] Univ Lisbon, Inst Astrofis & Ciencias Espaco, Lisbon, Portugal; [Abreu, Manuel; Alves, David; Cabral, Alexandre; Coelho, Joao M. P.; Oliveira, Antonio; Santos, Pedro] Univ Lisbon, Dept Fis, Fac Ciencias, Lisbon, Portugal; [Affolter, Michael; Alibert, Yann; Bandy, Timothy; Benz, Willy; Broeg, Christopher] Univ Bern, Phys Inst, Bern, Switzerland; [Affolter, Michael; Alibert, Yann; Bandy, Timothy; Benz, Willy; Broeg, Christopher] Univ Bern, Ctr Space & Habitabil, Bern, Switzerland; [Avila, Gerardo; Cumani, Claudio; Dekker, Hans; Delabre, Bernard; Deiries, Sebastian; Iwert, Olaf; Kerber, Florian; Knudstrup, Jens; Lizon, Jean-Louis; Manescau, Antonio; Modigliani, Andrea; Mueller, Eric; Pasquini, Luca] European Southern Observ, Garching, Germany; [D'Odorico, Valentina] Scuola Normale Super Pisa, Pisa, Italy; [Figueira, Pedro; Lo Curto, Gaspare; Mehner, Andrea; Tschudi, Samuel Santana] European Southern Observ, Santiago, Chile; [Lendl, Monika] Austrian Acad Sci, Space Res Inst, Graz, Austria; [Martins, C. J. A. P.] Univ Porto, Ctr Astrofis, Porto, Portugal; [Micela, Giusi] INAF Osservatorio Astron Palermo, Palermo, Italy; [Molaro, Paolo] Inst Fundamental Phys Universe, Miramare, Italy; [Poretti, Ennio] Fdn Galileo Galilei, INAF, Brena Baja, Spain; [Sozzetti, Alessandro] INAF Osservatorio Astrofis Torino, Pino Torinese, Italy	University of Geneva; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Istituto Nazionale Astrofisica (INAF); Instituto de Astrofisica de Canarias; Universidade do Porto; Universidade do Porto; Istituto Nazionale Astrofisica (INAF); Universidade de Lisboa; Universidade de Lisboa; University of Bern; University of Bern; European Southern Observatory; Scuola Normale Superiore di Pisa; European Southern Observatory; Austrian Academy of Sciences; Universidade do Porto; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF)	Ehrenreich, D (corresponding author), Univ Geneva, Observ Astron, Versoix, Switzerland.	david.ehrenreich@unige.ch	Sousa, Sérgio G./I-7466-2013; Monteiro, Mario J. P. F. G./B-4715-2008; Coelho, João M. P./M-1812-2015; Nunes, Nelson J./ABA-3428-2020; Tabernero, Hugo/ABI-6402-2020; Santos, Nuno C/E-9957-2011; Mascareño, Alejandro Suárez/AAB-5674-2021; Micela, Giusi/AAB-6602-2021; Seidel, Julia Victoria/ABC-1979-2021; Curto, Gaspare Lo/AAB-2630-2021; Adibekyan, Vardan/AAD-6544-2022; Molaro, Paolo/AAE-8956-2021; Figueira, Pedro/J-4916-2013; Cabral, Alexandre/AAC-2802-2020; Abreu, Manuel/AAY-8740-2020; Zapatero Osorio, Maria Rosa/C-2744-2017; Sozzetti, Alessandro/F-2943-2018; Castro Alves, David/B-9701-2019	Sousa, Sérgio G./0000-0001-9047-2965; Monteiro, Mario J. P. F. G./0000-0003-0513-8116; Coelho, João M. P./0000-0002-4339-0550; Nunes, Nelson J./0000-0002-3837-6914; Tabernero, Hugo/0000-0002-8087-4298; Santos, Nuno C/0000-0003-4422-2919; Mascareño, Alejandro Suárez/0000-0002-3814-5323; Seidel, Julia Victoria/0000-0002-7990-9596; Adibekyan, Vardan/0000-0002-0601-6199; Molaro, Paolo/0000-0002-0571-4163; Figueira, Pedro/0000-0001-8504-283X; Cabral, Alexandre/0000-0002-9433-871X; Abreu, Manuel/0000-0002-0716-9568; Pepe, Francesco/0000-0002-9815-773X; Bouchy, Francois/0000-0002-7613-393X; Zerbi, Filippo Maria/0000-0002-9996-973X; Monteiro, Manuel/0000-0001-5644-0898; Landoni, Marco/0000-0001-5570-5081; udry, Stephane/0000-0001-7576-6236; Cupani, Guido/0000-0002-6830-9093; Bolmont, Emeline/0000-0001-5657-4503; Cegla, Heather/0000-0001-8934-7315; Alibert, Yann/0000-0002-4644-8818; Aliverti, Matteo/0000-0002-2525-3202; Borsa, Francesco/0000-0003-4830-0590; Amaro Parente Martins, Carlos Jose/0000-0002-4886-9261; Lo Curto, Gaspare/0000-0002-1158-9354; Zapatero Osorio, Maria Rosa/0000-0001-5664-2852; Mehner, Andrea/0000-0002-9564-3302; Sozzetti, Alessandro/0000-0002-7504-365X; D'Odorico, Valentina/0000-0003-3693-3091; Rebolo, Rafael/0000-0003-3767-7085; Coretti, Igor/0000-0001-9374-3249; Allart, Romain/0000-0002-1199-9759; Redaelli, Edoardo Maria Alberto/0000-0001-8185-2122; Riva, Marco/0000-0003-1580-6966; Cristiani, Stefano/0000-0002-2115-5234; Castro Alves, David/0000-0001-7026-2514	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (project FOUR ACES) [724427]; Swiss National Science Foundation (SNSF); FCT/MCTES through national funds; FEDER (Fundo Europeu de Desenvolvimento Regional) through COMPETE2020 (Programa Operacional Competitividade e Internacionalizacao) [UID/FIS/04434/2019, PTDC/FIS-AST/32113/2017, POCI-01-0145-FEDER-032113, PTDC/FIS-AST/28953/2017, POCI-01-0145-FEDER-028953]; FCT through Investigador FCT [IF/00650/2015, IF/00028/2014]; FEDER funding through the programme "Programa Operacional de Factores de Competitividade-COMPETE"; FEDER funds through the COMPETE 2020-Operational Programme for Competitiveness and Internationalisation (POCI); Portuguese funds through FCT (Fundacao para a Ciencia e a Tecnologia) [UID/FIS/04434/2019, POCI-01-0145-FEDER-028987]; Spanish Ministry for Science, Innovation and Universities (MICIU) [AYA2016-79425-C3-2-P]; MICIU under the 2013 Ramon y Cajal programme MICIU [RYC-2013-14875]; MICIU [AYA2017-86389-P]; ESO Very Large Telescope (Paranal, Chile) [1102.C-744]; ESO 3.6-m telescope (La Silla, Chile) [090.C-0540, 100.C-0750];  [DL 57/2016/CP1364/CT0004]	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (project FOUR ACES)(European Research Council (ERC)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); FCT/MCTES through national funds(Portuguese Foundation for Science and Technology); FEDER (Fundo Europeu de Desenvolvimento Regional) through COMPETE2020 (Programa Operacional Competitividade e Internacionalizacao); FCT through Investigador FCT(Portuguese Foundation for Science and Technology); FEDER funding through the programme "Programa Operacional de Factores de Competitividade-COMPETE"; FEDER funds through the COMPETE 2020-Operational Programme for Competitiveness and Internationalisation (POCI); Portuguese funds through FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); Spanish Ministry for Science, Innovation and Universities (MICIU); MICIU under the 2013 Ramon y Cajal programme MICIU; MICIU; ESO Very Large Telescope (Paranal, Chile); ESO 3.6-m telescope (La Silla, Chile); 	We thank G. Fu for sharing information regarding the binary companion of WASP-76A and D. Kitzmann for discussion about how iron can condense. This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (project FOUR ACES; grant agreement no. 724427). It has also been carried out in the frame of the National Centre for Competence in Research PlanetS supported by the Swiss National Science Foundation (SNSF). This work was supported by FCT/MCTES through national funds and by FEDER (Fundo Europeu de Desenvolvimento Regional) through COMPETE2020 (Programa Operacional Competitividade e Internacionalizacao) by these grants: UID/FIS/04434/2019; PTDC/FIS-AST/32113/2017 and POCI-01-0145-FEDER-032113; PTDC/FIS-AST/28953/2017 and POCI-01-0145-FEDER-028953. V.A. and S.S. acknowledge support from FCT through Investigador FCT contracts IF/00650/2015 and IF/00028/2014, and POPH/FSE (EC) by FEDER funding through the programme "Programa Operacional de Factores de Competitividade-COMPETE". This work of C.J.A.P.M. was financed by FEDER funds through the COMPETE 2020-Operational Programme for Competitiveness and Internationalisation (POCI), and by Portuguese funds through FCT (Fundacao para a Ciencia e a Tecnologia) in the framework of the projects POCI-01-0145-FEDER-028987 and UID/FIS/04434/2019. O.D. is supported by a work contract (DL 57/2016/CP1364/CT0004). M.R.Z.O. acknowledges financial support from AYA2016-79425-C3-2-P from the Spanish Ministry for Science, Innovation and Universities (MICIU). J.I.G.H. acknowledges financial support from the MICIU under the 2013 Ramon y Cajal programme MICIU RYC-2013-14875. J.I.G.H., R.R., C.A.P. and A. Suarez Mascareno also acknowledge financial support from the MICIU for project AYA2017-86389-P. This publication makes use of The Data and Analysis Center for Exoplanets (DACE), which is a facility based at the University of Geneva (CH) dedicated to extrasolar planet data visualization, exchange and analysis. DACE is a platform of the Swiss National Centre of Competence in Research (NCCR) PlanetS, federating the Swiss expertise in Exoplanet research. The DACE platform is available at https://dace.unige.ch. This paper is based on observations made at the ESO Very Large Telescope (Paranal, Chile) under programme 1102.C-744 and at the ESO 3.6-m telescope (La Silla, Chile) under programmes 090.C-0540 and 100.C-0750.	Arcangeli J, 2019, ASTRON ASTROPHYS, V625, DOI 10.1051/0004-6361/201834891; Arcangeli J, 2018, ASTROPHYS J LETT, V855, DOI 10.3847/2041-8213/aab272; Beatty TG, 2019, ASTRON J, V158, DOI 10.3847/1538-3881/ab33fc; Bell TJ, 2018, ASTROPHYS J LETT, V857, DOI 10.3847/2041-8213/aabcc8; Bolmont E, 2011, ASTRON ASTROPHYS, V535, DOI 10.1051/0004-6361/201117734; Borsa F, 2019, ASTRON ASTROPHYS, V631, DOI 10.1051/0004-6361/201935718; Bourrier V, 2017, ASTRON ASTROPHYS, V599, DOI 10.1051/0004-6361/201629973; Bourrier V, 2018, NATURE, V553, P477, DOI 10.1038/nature24677; Bressan A, 2012, MON NOT R ASTRON SOC, V427, P127, DOI 10.1111/j.1365-2966.2012.21948.x; Brown DJA, 2017, MON NOT R ASTRON SOC, V464, P810, DOI 10.1093/mnras/stw2316; Cameron AC, 2010, MON NOT R ASTRON SOC, V407, P507, DOI 10.1111/j.1365-2966.2010.16922.x; Cegla HM, 2016, ASTRON ASTROPHYS, V588, DOI 10.1051/0004-6361/201527794; Da Silva R, 2006, ASTRON ASTROPHYS, V446, P717, DOI 10.1051/0004-6361:20054116; Delisle JB, 2018, ASTRON ASTROPHYS, V614, DOI 10.1051/0004-6361/201732529; Delrez L, 2016, MON NOT R ASTRON SOC, V458, P4025, DOI 10.1093/mnras/stw522; Di Gloria E, 2015, ASTRON ASTROPHYS, V580, DOI 10.1051/0004-6361/201526218; Dobbs-Dixon I, 2010, ASTROPHYS J, V710, P1395, DOI 10.1088/0004-637X/710/2/1395; Espinoza N, 2015, MON NOT R ASTRON SOC, V450, P1879, DOI 10.1093/mnras/stv744; Evans TM, 2017, NATURE, V548, P58, DOI 10.1038/nature23266; Fossati L, 2010, ASTROPHYS J LETT, V714, pL222, DOI 10.1088/2041-8205/714/2/L222; Gallet F, 2017, ASTRON ASTROPHYS, V604, DOI 10.1051/0004-6361/201730661; Garhart E, 2020, ASTRON J, V159, DOI 10.3847/1538-3881/ab6cff; Gaudi BS, 2017, NATURE, V546, P514, DOI 10.1038/nature22392; Ginski C, 2016, MON NOT R ASTRON SOC, V457, P2173, DOI 10.1093/mnras/stw049; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Hansen BMS, 2010, ASTROPHYS J, V723, P285, DOI 10.1088/0004-637X/723/1/285; Hebb L, 2009, ASTROPHYS J, V693, P1920, DOI 10.1088/0004-637X/693/2/1920; Helling C, 2019, ASTRON ASTROPHYS, V631, DOI 10.1051/0004-6361/201935771; Heng K, 2011, MON NOT R ASTRON SOC, V418, P2669, DOI 10.1111/j.1365-2966.2011.19658.x; Keating D, 2019, NAT ASTRON, V3, P1092, DOI 10.1038/s41550-019-0859-z; Kempton EMR, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/117; Kitzmann D, 2018, ASTROPHYS J, V863, DOI 10.3847/1538-4357/aace5a; Komacek TD, 2016, ASTROPHYS J, V821, DOI 10.3847/0004-637X/821/1/16; Kreidberg L, 2018, ASTRON J, V156, DOI 10.3847/1538-3881/aac3df; Lavie B, 2017, ASTRON J, V154, DOI 10.3847/1538-3881/aa7ed8; Leconte J, 2010, ASTRON ASTROPHYS, V516, DOI 10.1051/0004-6361/201014337; Lendl M, 2017, ASTRON ASTROPHYS, V606, DOI 10.1051/0004-6361/201731242; Lendl M, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219585; Lothringer JD, 2018, ASTROPHYS J, V866, DOI 10.3847/1538-4357/aadd9e; Louden T, 2015, ASTROPHYS J LETT, V814, DOI 10.1088/2041-8205/814/2/L24; Malik M, 2019, ASTRON J, V157, DOI 10.3847/1538-3881/ab1084; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Parmentier V, 2018, ASTRON ASTROPHYS, V617, DOI 10.1051/0004-6361/201833059; Pepe F, 2014, ASTRON NACHR, V335, P8, DOI 10.1002/asna.201312004; Queloz D, 2000, ASTRON ASTROPHYS, V359, pL13; Rauscher E, 2010, ASTROPHYS J, V714, P1334, DOI 10.1088/0004-637X/714/2/1334; Seidel JV, 2019, ASTRON ASTROPHYS, V623, DOI 10.1051/0004-6361/201834776; Showman AP, 2009, ASTROPHYS J, V699, P564, DOI 10.1088/0004-637X/699/1/564; Sokal A, 1997, NATO ADV SCI I B-PHY, V361, P131; Sousa SG, 2008, ASTRON ASTROPHYS, V487, P373, DOI 10.1051/0004-6361:200809698; Sousa SG, 2014, GEOPLANET-EARTH PLAN, P297, DOI 10.1007/978-3-319-06956-2_26; Southworth J, 2015, MON NOT R ASTRON SOC, V447, P711, DOI 10.1093/mnras/stu2394; Mascareno AS, 2016, ASTRON ASTROPHYS, V595, DOI 10.1051/0004-6361/201628586; Mascareno AS, 2015, MON NOT R ASTRON SOC, V452, P2745, DOI 10.1093/mnras/stv1441; Talens GJJ, 2018, ASTRON ASTROPHYS, V612, DOI 10.1051/0004-6361/201731512; West RG, 2016, ASTRON ASTROPHYS, V585, DOI 10.1051/0004-6361/201527276; Winn JN, 2010, ASTROPHYS J LETT, V718, pL145, DOI 10.1088/2041-8205/718/2/L145; Wollert M, 2015, ASTRON ASTROPHYS, V579, DOI 10.1051/0004-6361/201526525; Zhang JS, 2017, ASTROPHYS J, V851, DOI 10.3847/1538-4357/aa9891	67	120	120	3	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR	2020	580	7805					597	+		10.1038/s41586-020-2107-1	http://dx.doi.org/10.1038/s41586-020-2107-1		MAR 2020	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LI6NQ	32161364	Green Submitted, Green Accepted			2022-12-28	WOS:000526613500001
J	Hou, Y; Aydin, E; De Bastiani, M; Xiao, CX; Isikgor, FH; Xue, DJ; Chen, B; Chen, H; Bahrami, B; Chowdhury, AH; Johnston, A; Baek, SW; Huang, ZR; Wei, MY; Dong, YT; Troughton, J; Jalmood, R; Mirabelli, AJ; Allen, TG; Van Kerschaver, E; Saidaminov, MI; Baran, D; Qiao, QQ; Zhu, K; De Wolf, S; Sargent, EH				Hou, Yi; Aydin, Erkan; De Bastiani, Michele; Xiao, Chuanxiao; Isikgor, Furkan H.; Xue, Ding-Jiang; Chen, Bin; Chen, Hao; Bahrami, Behzad; Chowdhury, Ashraful H.; Johnston, Andrew; Baek, Se-Woong; Huang, Ziru; Wei, Mingyang; Dong, Yitong; Troughton, Joel; Jalmood, Rawan; Mirabelli, Alessandro J.; Allen, Thomas G.; Van Kerschaver, Emmanuel; Saidaminov, Makhsud I.; Baran, Derya; Qiao, Qiquan; Zhu, Kai; De Wolf, Stefaan; Sargent, Edward H.			Efficient tandem solar cells with solution-processed perovskite on textured crystalline silicon	SCIENCE			English	Article							ELECTRON-TRANSPORT; HALIDE PEROVSKITES; IMPACT; LAYER; FILMS	Stacking solar cells with decreasing band gaps to form tandems presents the possibility of overcoming the single-junction Shockley-Queisser limit in photovoltaics. The rapid development of solution-processed perovskites has brought perovskite single-junction efficiencies >20%. However, this process has yet to enable monolithic integration with industry-relevant textured crystalline silicon solar cells. We report tandems that combine solution-processed micrometer-thick perovskite top cells with fully textured silicon heterojunction bottom cells. To overcome the charge-collection challenges in micrometer-thick perovskites, we enhanced threefold the depletion width at the bases of silicon pyramids. Moreover, by anchoring a self-limiting passivant (1-butanethiol) on the perovskite surfaces, we enhanced the diffusion length and further suppressed phase segregation. These combined enhancements enabled an independently certified power conversion efficiency of 25.7% for perovskite-silicon tandem solar cells. These devices exhibited negligible performance loss after a 400-hour thermal stability test at 85 degrees C and also after 400 hours undermaximumpower point tracking at 40 degrees C.	[Hou, Yi; Xue, Ding-Jiang; Chen, Bin; Chen, Hao; Johnston, Andrew; Baek, Se-Woong; Huang, Ziru; Wei, Mingyang; Dong, Yitong; Saidaminov, Makhsud I.; Sargent, Edward H.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 1A4, Canada; [Aydin, Erkan; De Bastiani, Michele; Isikgor, Furkan H.; Troughton, Joel; Jalmood, Rawan; Mirabelli, Alessandro J.; Allen, Thomas G.; Van Kerschaver, Emmanuel; Baran, Derya; De Wolf, Stefaan] KAUST, Phys Sci & Engn Div PSE, Solar Ctr KSC, Thuwal 239556900, Saudi Arabia; [Xiao, Chuanxiao; Zhu, Kai] NREL, Golden, CO 80401 USA; [Bahrami, Behzad; Chowdhury, Ashraful H.; Qiao, Qiquan] South Dakota State Univ, Dept Elect Engn, Ctr Adv Photovolta, Brookings, SD 57007 USA	University of Toronto; King Abdullah University of Science & Technology; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; South Dakota State University	Sargent, EH (corresponding author), Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 1A4, Canada.; De Wolf, S (corresponding author), KAUST, Phys Sci & Engn Div PSE, Solar Ctr KSC, Thuwal 239556900, Saudi Arabia.	stefaan.dewolf@kaust.edu.sa; ted.sargent@utoronto.ca	Zhu, Kai/AAF-1940-2019; Hou, Yi/AAE-9581-2019; Xue, Ding-Jiang/A-1776-2012; Aydin, Erkan/AAZ-4740-2021; Wei, Mingyang/AAC-1337-2022; Chen, Hao/AAJ-9466-2020; Sargent, Edward H./O-9520-2014; Chen, Bin/H-7618-2019; De Wolf, Stefaan/AAE-8096-2019; Troughton, Joel/AAF-7045-2021; Chen, Hao/AAZ-6231-2021; Baran, Derya/A-6969-2011	Hou, Yi/0000-0002-1532-816X; Xue, Ding-Jiang/0000-0002-7599-0008; Aydin, Erkan/0000-0002-8849-2788; Sargent, Edward H./0000-0003-0396-6495; Chen, Bin/0000-0002-2106-7664; Baran, Derya/0000-0003-2196-8187; De Wolf, Stefaan/0000-0003-1619-9061; Saidaminov, Makhsud/0000-0002-3850-666X; Dong, Yitong/0000-0002-7069-3725; ISIKGOR, FURKAN/0000-0003-0787-7991; De Bastiani, Michele/0000-0002-4870-2699; Chen, Hao/0000-0002-6995-0288	King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research (OSR) [OSR-2018-CPF-3669.02, KAUST OSR-CARF URF/1/3079-33-01, KAUST OSR-CRG URF/1/3383, KAUST OSR-CRG2018-3737]; U.S. Department of the Navy, Office of Naval Research [N00014-17-1-2524]; U.S. Department of Energy (DOE) [DE-AC36-08GO28308]; NSF MRI [1428992]; U.S.-Egypt Science and Technology (ST) Joint Fund; EDA University Center Program [ED18DEN3030025]; NAS; USAID	King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research (OSR); U.S. Department of the Navy, Office of Naval Research(Office of Naval Research); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); NSF MRI(National Science Foundation (NSF)NSF - Office of the Director (OD)); U.S.-Egypt Science and Technology (ST) Joint Fund(United States Agency for International Development (USAID)); EDA University Center Program; NAS; USAID(United States Agency for International Development (USAID))	This publication is based upon work supported by the King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research (OSR) under award no. OSR-2018-CPF-3669.02, KAUST OSR-CARF URF/1/3079-33-01, KAUST OSR-CRG URF/1/3383, and KAUST OSR-CRG2018-3737, and in part on work supported by the U.S. Department of the Navy, Office of Naval Research (grant award no. N00014-17-1-2524). This work was authored in part by the National Renewable Energy Laboratory, operated by Alliance for Sustainable Energy, LLC, for the U.S. Department of Energy (DOE) under contract no. DE-AC36-08GO28308 (De-risking Halide Perovskite Solar Cells program of the National Center for Photovoltaics, funded by the DOE Office of Energy Efficiency and Renewable Energy, Solar Energy Technologies Office). The views expressed in the article do not necessarily represent the views of the DOE or the U.S. government. The U.S. government retains and the publisher, by accepting the article for publication, acknowledges that the U.S. government retains a nonexclusive, paid-up, irrevocable, worldwide license to publish or reproduce the published form of this work, or allow others to do so, for U.S. government purposes. This work has been partially supported by NSF MRI (1428992), the U.S.-Egypt Science and Technology (S&T) Joint Fund, and the EDA University Center Program (ED18DEN3030025). This work is derived from the subject data supported in whole or part by NAS and USAID, and any opinions, findings, conclusions, or recommendations expressed in the paper are those of the authors alone, and do not necessarily reflect the views of USAID or NAS.	Aydin E, 2019, ADV MATER, V31, DOI 10.1002/adma.201900428; Aydin E, 2018, ACS APPL ENERG MATER, V1, P6227, DOI 10.1021/acsaem.8b01263; Belisle RA, 2018, ACS ENERGY LETT, V3, P2694, DOI 10.1021/acsenergylett.8b01562; Braly IL, 2018, NAT PHOTONICS, V12, P355, DOI 10.1038/s41566-018-0154-z; Bush KA, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.9; Chen B, 2019, JOULE, V3, P177, DOI 10.1016/j.joule.2018.10.003; De Wolf S, 2014, J PHYS CHEM LETT, V5, P1035, DOI 10.1021/jz500279b; Deng YH, 2018, NAT ENERGY, V3, P560, DOI 10.1038/s41560-018-0153-9; deQuilettes DW, 2015, SCIENCE, V348, P683, DOI 10.1126/science.aaa5333; Eperon GE, 2016, SCIENCE, V354, P861, DOI 10.1126/science.aaf9717; Essig S, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.144; Fu F, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2016.190; Gil-Escrig L, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201703506; Han QF, 2018, SCIENCE, V361, P904, DOI 10.1126/science.aat5055; Jiang Q, 2019, NAT PHOTONICS, V13, P460, DOI 10.1038/s41566-019-0398-2; Jost M, 2018, ENERG ENVIRON SCI, V11, P3511, DOI 10.1039/c8ee02469c; Kohnen E, 2019, SUSTAIN ENERG FUELS, V3, P1995, DOI 10.1039/c9se00120d; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Maharjan PP, 2013, PHYS CHEM CHEM PHYS, V15, P6856, DOI 10.1039/c3cp51070k; Manser JS, 2016, ACCOUNTS CHEM RES, V49, P330, DOI 10.1021/acs.accounts.5b00455; Martinson ABF, 2009, J PHYS CHEM A, V113, P4015, DOI 10.1021/jp810406q; Mazzarella L, 2019, ADV ENERGY MATER, V9, DOI 10.1002/aenm.201803241; McMeekin DP, 2016, SCIENCE, V351, P151, DOI 10.1126/science.aad5845; National Renewable Energy Laboratory, 2020, BEST RES CELL EFF; National Renewable Energy Laboratory, 2020, BEST RESEARCH CELL E; Sahli F, 2018, NAT MATER, V17, P820, DOI 10.1038/s41563-018-0115-4; Saliba M, 2016, SCIENCE, V354, P206, DOI 10.1126/science.aah5557; Shen HP, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau9711; Tong JH, 2019, SCIENCE, V364, P475, DOI 10.1126/science.aav7911; Xie Y, 2010, J PHYS CHEM C, V114, P17880, DOI 10.1021/jp106302m; Yang WS, 2017, SCIENCE, V356, P1376, DOI 10.1126/science.aan2301; Zheng JH, 2018, ENERG ENVIRON SCI, V11, P2432, DOI 10.1039/c8ee00689j	32	347	347	89	586	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1135	+		10.1126/science.aaz3691	http://dx.doi.org/10.1126/science.aaz3691			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9CD	32139544	Green Submitted			2022-12-28	WOS:000520018400043
J	Ma, S; Sun, SH; Geng, LL; Song, MS; Wang, W; Ye, YX; Ji, QZ; Zou, ZR; Wang, S; He, XJ; Li, W; Esteban, CR; Long, X; Guo, GJ; Chan, P; Zhou, Q; Belmonte, JCI; Zhang, WQ; Qu, J; Liu, GH				Ma, Shuai; Sun, Shuhui; Geng, Lingling; Song, Moshi; Wang, Wei; Ye, Yanxia; Ji, Qianzhao; Zou, Zhiran; Wang, Si; He, Xiaojuan; Li, Wei; Esteban, Concepcion Rodriguez; Long, Xiao; Guo, Guoji; Chan, Piu; Zhou, Qi; Belmonte, Juan Carlos Izpisua; Zhang, Weiqi; Qu, Jing; Liu, Guang-Hui			Caloric Restriction Reprograms the Single-Cell Transcriptional Landscape of Rattus Norvegicus Aging	CELL			English	Article							SPONTANEOUS TUMORIGENESIS; LIFE-SPAN; RNA-SEQ; MARROW; INFLAMMATION; VARIABILITY; NEUTROPHILS; DEFICIENCY; MECHANISMS; MEMORY	Aging causes a functional decline in tissues throughout the body that may be delayed by caloric restriction (CR). However, the cellular profiles and signatures of aging, as well as those ameliorated by CR, remain unclear. Here, we built comprehensive single-cell and single-nucleus transcriptomic atlases across various rat tissues undergoing aging and CR. CR attenuated aging-related changes in cell type composition, gene expression, and core transcriptional regulatory networks. Immune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosystem. Computational prediction revealed that the abnormal cell-cell communication patterns observed during aging, including the excessive proinflammatory ligand-receptor interplay, were reversed by CR. Our work provides multi-tissue single-cell transcriptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how metabolic intervention can act upon the immune system to modify the process of aging.	[Ma, Shuai; Song, Moshi; Wang, Wei; Ji, Qianzhao; Zou, Zhiran; Wang, Si; Liu, Guang-Hui] Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing 100101, Peoples R China; [Ma, Shuai; Sun, Shuhui; Liu, Guang-Hui] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Geng, Lingling; Ye, Yanxia; Zhou, Qi; Qu, Jing] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Geng, Lingling; Wang, Si; He, Xiaojuan; Li, Wei; Chan, Piu; Zhang, Weiqi; Liu, Guang-Hui] Capital Med Univ, Xuanwu Hosp, Adv Innovat Ctr Human Brain Protect, Beijing 100053, Peoples R China; [Geng, Lingling; Wang, Si; He, Xiaojuan; Li, Wei; Chan, Piu; Zhang, Weiqi; Liu, Guang-Hui] Capital Med Univ, Natl Clin Res Ctr Geriatr Disorders, Xuanwu Hosp, Beijing 100053, Peoples R China; [Song, Moshi; Ye, Yanxia; Wang, Si; Zhou, Qi; Zhang, Weiqi; Qu, Jing; Liu, Guang-Hui] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing 100101, Peoples R China; [Song, Moshi; Wang, Wei; Ji, Qianzhao; Zou, Zhiran; Zhou, Qi; Zhang, Weiqi; Qu, Jing; Liu, Guang-Hui] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Esteban, Concepcion Rodriguez; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Long, Xiao] Peking Union Med Coll Hosp, Div Plast Surg, Beijing 100032, Peoples R China; [Guo, Guoji] Zhejiang Univ, Ctr Stem Cell & Regenerat Med, Sch Med, Hangzhou 310058, Peoples R China; [Zhang, Weiqi] Chinese Acad Sci, Beijing Inst Genom, Dis Genom & Individualized Med Lab, Beijing 100101, Peoples R China; [Zhang, Weiqi] China Natl Ctr Bioinformat, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Capital Medical University; Capital Medical University; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Salk Institute; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Zhejiang University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Liu, GH (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing 100101, Peoples R China.; Liu, GH (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Qu, J (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Zhang, WQ; Liu, GH (corresponding author), Capital Med Univ, Xuanwu Hosp, Adv Innovat Ctr Human Brain Protect, Beijing 100053, Peoples R China.; Zhang, WQ; Liu, GH (corresponding author), Capital Med Univ, Natl Clin Res Ctr Geriatr Disorders, Xuanwu Hosp, Beijing 100053, Peoples R China.; Zhang, WQ; Qu, J; Liu, GH (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Zhang, WQ (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Dis Genom & Individualized Med Lab, Beijing 100101, Peoples R China.; Zhang, WQ (corresponding author), China Natl Ctr Bioinformat, Beijing 100101, Peoples R China.	belmonte@salk.edu; zhangwq@big.ac.cr; qujing@ioz.ac.cn; ghliu@ioz.ac.cn	Zou, Zhiran/GSI-9024-2022; Qu, Jing/ABB-9088-2020; 龙, 笑/GPW-6382-2022	Guo, Guoji/0000-0002-1716-4621; Zhang, Weiqi/0000-0002-8885-5104	National Key Research and Development Program of China [2018YFC2000100, 2018YFA0107203, 2017YFA0102802, 2017YFA0103304]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA16010100]; National Natural Science Foundation of China [81921006, 81625009, 91749202, 81861168034, 31671429, 91949209, 81671377, 91749123, 81771515, 31601158, 81701388, 81601233, 31601109, 81822018, 81870228, 81801399, 31801010, 81801370, 81922027, 31900523, 81901432, 81901433, 31900524]; Program of Beijing Municipal Science and Technology Commission [Z191100001519005]; Beijing Natural Science Foundation [Z190019]; Beijing Municipal Commission of Health and Family Planning [PXM2018_026283_000002]; Advanced Innovation Center for HumanBrain Protection [3500-1192012]; K.C. Wong Education Foundation [GJTD-2019-06, GJTD-2019-08]; Key Research Program of the Chinese Academy of Sciences [KFZD-SW-221]; State Key Laboratory of StemCell and Reproductive Biology; State Key Laboratory of Membrane Biology; Moxie Foundation; Glenn Foundation	National Key Research and Development Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Beijing Municipal Science and Technology Commission; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Municipal Commission of Health and Family Planning; Advanced Innovation Center for HumanBrain Protection; K.C. Wong Education Foundation; Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of StemCell and Reproductive Biology; State Key Laboratory of Membrane Biology; Moxie Foundation; Glenn Foundation	We thank Zhiheng He for his help in rat food intake. We thank Kai Du and Chunyu Chen from the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences for their help in animal breeding. We thank Jinghui Lei and Jingyi Jia for assisting with animal experiments. We thank Yifang He, Yaobin Jing, Zunpeng Liu, Zehua Wang, Jinghui Lei, Xuling Han, Yiyuan Zhang, Guoxing Liu, Xing Zhang, Yaxin Wang, Jingyi Jia, Liyun Zhao, and Zeming Wu for participating in the single-cell isolation from specific rat tissues. We thank Yandong Zheng and Jiaming Li for bioinformatic analysis. We are also grateful to Lei Bai, Ruijun Bai, Jing Lu, Qun Chu, Ying Yang, May Schwarz, and Shikun Ma for administrative assistance, to Junying Jia from Institute of Biophysics, Chinese Academy of Sciences for the fluorescence-activated cell sorting (FACS), and to Junfeng Hao from Institute of Biophysics, Chinese Academy of Sciences for image scanning and analysis of Hematoxylin and eosin (H&E) staining. We would like to thank Hezhen Shan for her assistance with frozen tissue sections. We thank Prof. Zhengwei Xie for his advice on manuscript writing. This work was supported by the National Key Research and Development Program of China (2018YFC2000100), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA16010100), the National Key Research and Development Program of China (2018YFA0107203, 2017YFA0102802, 2017YFA0103304), the National Natural Science Foundation of China (81921006, 81625009, 91749202, 81861168034, 31671429, 91949209, 81671377, 91749123, 81771515, 31601158, 81701388, 81601233, 31601109, 81822018, 81870228, 81801399, 31801010, 81801370, 81922027, 31900523, 81901432, 81901433, 31900524), Program of Beijing Municipal Science and Technology Commission (Z191100001519005), Beijing Natural Science Foundation (Z190019), Beijing Municipal Commission of Health and Family Planning (PXM2018_026283_000002), Advanced Innovation Center for HumanBrain Protection (3500-1192012), K.C. Wong Education Foundation (GJTD-2019-06, GJTD-2019-08), the Key Research Program of the Chinese Academy of Sciences (KFZD-SW-221), the State Key Laboratory of StemCell and Reproductive Biology, and the State Key Laboratory of Membrane Biology. J.C.I.B. was supported by the Moxie Foundation and the Glenn Foundation.	Ahmet I, 2011, J MOL CELL CARDIOL, V51, P263, DOI 10.1016/j.yjmcc.2011.04.015; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Angelidis I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08831-9; Anisimov VN, 2010, AGING-US, V2, P945, DOI 10.18632/aging.100245; Bi SR, 2018, MECH AGEING DEV, V175, P46, DOI 10.1016/j.mad.2018.07.005; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Buono R, 2019, CELL, V178, P1038, DOI 10.1016/j.cell.2019.07.052; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2; Cheng F, 2019, PROTEIN CELL, V10, P846, DOI 10.1007/s13238-019-00659-9; Childs B, 2019, NATURE, V566, P46, DOI 10.1038/d41586-018-07553-0; Collins N, 2019, CELL, V178, P1088, DOI 10.1016/j.cell.2019.07.049; Contreras NA, 2018, GEROSCIENCE, V40, P279, DOI 10.1007/s11357-018-0022-2; Davie K, 2018, CELL, V174, P982, DOI 10.1016/j.cell.2018.05.057; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Di Giammartino DC, 2019, NAT CELL BIOL, V21, P1179, DOI 10.1038/s41556-019-0390-6; Dulken B, 2019, NATURE, V571, P205, DOI 10.1038/s41586-019-1362-5; Enge M, 2017, CELL, V171, P321, DOI 10.1016/j.cell.2017.09.004; Evrard M, 2018, IMMUNITY, V48, P364, DOI 10.1016/j.immuni.2018.02.002; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Forni MF, 2017, CELL REP, V20, P2678, DOI 10.1016/j.celrep.2017.08.052; Fujii N, 2019, EXP GERONTOL, V118, P55, DOI 10.1016/j.exger.2019.01.001; Geng LL, 2019, PROTEIN CELL, V10, P770, DOI 10.1007/s13238-019-0646-8; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Griffiths JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05083-x; Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022; Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957; Haase VH, 2015, KIDNEY INT, V88, P213, DOI 10.1038/ki.2015.89; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Jackaman C, 2017, AGEING RES REV, V36, P105, DOI 10.1016/j.arr.2017.03.008; Jordan S, 2019, CELL, V178, P1102, DOI 10.1016/j.cell.2019.07.050; Jung N, 2019, BIOCHEM PHARMACOL, V165, P170, DOI 10.1016/j.bcp.2019.03.010; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kretov DA, 2019, NUCLEIC ACIDS RES, V47, P3127, DOI 10.1093/nar/gky1303; Krishnaswami SR, 2016, NAT PROTOC, V11, P499, DOI 10.1038/nprot.2016.015; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Levay EA, 2007, PHYSIOL BEHAV, V92, P889, DOI 10.1016/j.physbeh.2007.06.018; LEVINE BL, 1995, INT IMMUNOL, V7, P891, DOI 10.1093/intimm/7.6.891; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; Lomako VV, 2019, ADV GERONTOL, V9, P298, DOI 10.1134/S2079057019030093; Lopez-Lluch G, 2016, J PHYSIOL-LONDON, V594, P2043, DOI 10.1113/JP270543; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma Y., 2018, TRANSL RES, V191, P15; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mahmoudi S, 2019, NATURE, V574, P553, DOI 10.1038/s41586-019-1658-5; Martinez-Jimenez CP, 2017, SCIENCE, V355, P1433, DOI 10.1126/science.aah4115; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; McGinnis CS, 2019, CELL SYST, V8, P329, DOI 10.1016/j.cels.2019.03.003; Menard C, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00081; Nagai M, 2019, CELL, V178, P1072, DOI 10.1016/j.cell.2019.07.047; Niederberger C, 2018, FERTIL STERIL, V110, P185, DOI 10.1016/j.fertnstert.2018.06.005; Oh HJ, 2016, NEUROPSYCHOPHARMACOL, V41, P3080, DOI 10.1038/npp.2016.126; Papalexi E, 2018, NAT REV IMMUNOL, V18, P35, DOI 10.1038/nri.2017.76; Pazhakh V, 2017, SCI REP-UK, V7, DOI 10.1038/srep44455; Pifferi F, 2019, PROG NEURO-PSYCHOPH, V95, DOI 10.1016/j.pnpbp.2019.109702; Pioli PD, 2019, IMMUNITY, V51, P351, DOI 10.1016/j.immuni.2019.06.006; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Reckless J, 2001, IMMUNOLOGY, V103, P244, DOI 10.1046/j.1365-2567.2001.01228.x; Redman LM, 2018, CELL METAB, V27, P805, DOI 10.1016/j.cmet.2018.02.019; Rhoads TW, 2018, CELL METAB, V27, P677, DOI 10.1016/j.cmet.2018.01.014; Rojek A, 2013, AM J PHYSIOL-GASTR L, V304, pG501, DOI 10.1152/ajpgi.00208.2012; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Sarkar D, 2006, CANCER LETT, V236, P13, DOI 10.1016/j.canlet.2005.04.009; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spindler SR, 2010, AGEING RES REV, V9, P324, DOI 10.1016/j.arr.2009.10.003; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tangye SG, 2011, TRENDS IMMUNOL, V32, P595, DOI 10.1016/j.it.2011.09.001; Trim W, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00169; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Verfaillie A., 2015, CURR PROTOC BIOINFOR, V52, P1; Wang S, 2020, CELL, V180, P585, DOI 10.1016/j.cell.2020.01.009; Wang S, 2020, PROTEIN CELL, V11, P1, DOI 10.1007/s13238-019-0623-2; Wang Z, 2018, ONCOGENE, V37, P18, DOI 10.1038/onc.2017.310; Wasinski F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/395672; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wood SH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0847-2; Zhang R, 2015, CELL SYST, V1, P180, DOI 10.1016/j.cels.2015.09.002; Zhang WQ, 2020, NAT REV MOL CELL BIO, V21, P137, DOI 10.1038/s41580-019-0204-5; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6; Zou K, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3483-2	86	101	107	19	118	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2020	180	5					984	+		10.1016/j.cell.2020.02.008	http://dx.doi.org/10.1016/j.cell.2020.02.008			40	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KT7JN	32109414	Bronze			2022-12-28	WOS:000519189800016
J	Cutler, DM				Cutler, David M.			Are Pharmaceutical Companies Earning Too Much?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cutler, David M.] Harvard Univ, Dept Econ, 1805 Cambridge St, Cambridge, MA 02138 USA	Harvard University	Cutler, DM (corresponding author), Harvard Univ, Dept Econ, 1805 Cambridge St, Cambridge, MA 02138 USA.	dcutler@harvard.edu		Cutler, David/0000-0002-4949-8917				[Anonymous], 2006, RES DEV PHARM IND; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; Howard DH, 2015, J ECON PERSPECT, V29, P139, DOI 10.1257/jep.29.1.139; Lakdawalla DN, 2018, J ECON LIT, V56, P397, DOI 10.1257/jel.20161327; Ledley FD, 2020, JAMA-J AM MED ASSOC, V323, P834, DOI 10.1001/jama.2020.0442; Philipson Thomas J, 2005, 11810 NAT BUR EC RES; Wouters OJ, 2020, JAMA-J AM MED ASSOC, V323, P844, DOI 10.1001/jama.2020.1166	7	8	8	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2020	323	9			SI		829	830		10.1001/jama.2020.0351	http://dx.doi.org/10.1001/jama.2020.0351			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU3SD	32125384				2022-12-28	WOS:000519630600012
J	Armstrong, S				Armstrong, Stephen			The prison service is still failing inmates' healthcare needs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												stephen.armstrong@me.com						[Anonymous], 2019, BBC NEWS; HM Prison and Probation Service, 2014, HEALTHC OFF HEALTHC; Ministry of Justice HM Prison and Probation Service, 2019, HM PRIS PROB SERV WO; Nuffield Trust, 2020, LOCK OUT PRIS US HOS; Shaw D, 2019, BBC NEWS	5	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2020	368								m724	10.1136/bmj.m724	http://dx.doi.org/10.1136/bmj.m724			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2JV	32102792				2022-12-28	WOS:000519535600008
J	Doshi, P				Doshi, Peter			WHO's malaria vaccine study represents a "serious breach of international ethical standards"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MALE MORTALITY; FEMALE					pdoshi@bmj.com						Aaby P, 2007, PEDIATR INFECT DIS J, V26, P247, DOI 10.1097/01.inf.0000256735.05098.01; Aaby P, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.l6920; Aaby P, 2016, T ROY SOC TROP MED H, V110, P570, DOI 10.1093/trstmh/trw073; Andersen A, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00013; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P33; [Anonymous], 2019, WHO SECRETARIAT MALA; Fisker AB, 2016, VACCINE, V34, P4551, DOI 10.1016/j.vaccine.2016.07.034; Garly ML, 2004, PEDIATR INFECT DIS J, V23, P1086, DOI 10.1097/01.inf.0000145700.77286.94; Klein SL, 2016, MBIO, V7, DOI 10.1128/mBio.00514-16; MAHASE E, 2019, BMJ-BRIT MED J, V365, P23647, DOI DOI 10.1136/BMJ.L1901; Weijer C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001346; World Health Organization, 2019, PROP FRAM POL DEC RT; World Health Organization, 2020, RES ETH REV COMM 202	13	10	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2020	368								m734	10.1136/bmj.m734	http://dx.doi.org/10.1136/bmj.m734			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2JV	32102785				2022-12-28	WOS:000519535600010
J	Oliver, D				Oliver, David			David Oliver: "Considerably transformed"-changing the narrative on admitting older patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Banerjee J, 2012, SILVER BOOK QUALITY; Better Care Support Programme, 2017, BETTER CARE SUPPORT; Briggs R, 2017, COCHRANE DB SYST REV, V6, DOI 10.1002/14651858.CD012705; Clegg A, 2016, AGE AGEING, V45, P353, DOI 10.1093/ageing/afw039; Ellis G, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006211.pub3; Goncalves-Bradley DC, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000356.pub4; Healthcare Improvement Scotland, CAR OLD PEOPL HOSP S; Healthwatch, 2018, EM READM WHATS CHANG; Healthwatch, 2015, SAF HOM WHAT HAPP PE; Keeble E, 2019, BRIT J GEN PRACT, V69, pE555, DOI 10.3399/bjgp19X704621; King's Fund, 2019, NUMB HOSP BEDS; King's Fund, 2017, NHS HOSP BED NUMB PA; Maguire D, 2018, DELAYED TRANSFERS CA; National Audit Office, 2016, DISCHARGING OLDER PA; NHS England, 2018, 70 DAYS END PYJ PAR; NHS Improvement, 2019, GUID RED LONG HOSP S; NHS Improvement, RED2GREEN CAMP; Nuffield Trust, 2019, EV INT CAR WHY AR EV; Nuffield Trust, 2013, EVALUATING INTEGRATE; OLIVER D, 2017, BMJ-BRIT MED J, V358, P74343, DOI DOI 10.1136/BMJ.J3954; Oliver D, 2017, BMJ OPINION; Shepperd S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007491; University of Birmingham School of Social Policy, 2016, WHO KNOWL BEST OLD P	23	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2020	368								m652	10.1136/bmj.m652	http://dx.doi.org/10.1136/bmj.m652			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2JV	32102790	Bronze			2022-12-28	WOS:000519535600004
J	Lan, L; Xu, D; Ye, GM; Xia, C; Wang, SK; Li, YR; Xu, HB				Lan, Lan; Xu, Dan; Ye, Guangming; Xia, Chen; Wang, Shaokang; Li, Yirong; Xu, Haibo			Positive RT-PCR Test Results in Patients Recovered From COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This case series describes reverse transcriptase-polymerase chain reaction (RT-PCR) test results in 4 health professionals discharged from hospitalization or quarantine after 2 negative RT-PCR test results and resolution of clinical COVID-19 infection.	[Lan, Lan; Xu, Dan; Xu, Haibo] Wuhan Univ, Zhongnan Hosp, Dept Radiol, Donghu Rd, Wuhan 430071, Hubei, Peoples R China; [Ye, Guangming; Li, Yirong] Wuhan Univ, Zhongnan Hosp, Dept Lab Med, Donghu Rd, Wuhan 430071, Hubei, Peoples R China; [Xia, Chen; Wang, Shaokang] Beijing Infervis Technol Co Ltd, Beijing, Peoples R China	Wuhan University; Wuhan University	Xu, HB (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Radiol, Donghu Rd, Wuhan 430071, Hubei, Peoples R China.; Li, YR (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Lab Med, Donghu Rd, Wuhan 430071, Hubei, Peoples R China.	liyirong838@163.com; xuhaibo1120@hotmail.com			National Natural Science Foundation of China [81771819]; National Key Research and Development Plan of China [2017YFC0108803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Plan of China	This study was supported by grant 81771819 from the National Natural Science Foundation of China and grant 2017YFC0108803 from the National Key Research and Development Plan of China.	[Anonymous], 2020, RADIOLOGY; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; *CHIN NAT HLTH COM, 2020, DIAGN TREATM 2019 NC; Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wei M, 2020, JAMA-J AM MED ASSOC, V323, P1313, DOI 10.1001/jama.2020.2131	6	487	508	6	52	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2020	323	15					1502	1503		10.1001/jama.2020.2783	http://dx.doi.org/10.1001/jama.2020.2783			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LJ1ZH	32105304	Green Published, Bronze			2022-12-28	WOS:000529969700023
J	Dyer, C				Dyer, Clare			Hospital trust at centre of inquiry into babies' deaths to repay 1m pound it received for "good care"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2020, BMJ-BRIT MED J, V368, P80463, DOI DOI 10.1136/BMJ.M309; WISE J, 2019, BMJ-BRIT MED J, V367, DOI DOI 10.1136/BMJ.L6656	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2020	368								m963	10.1136/bmj.m963	http://dx.doi.org/10.1136/bmj.m963			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AK	32152003				2022-12-28	WOS:000520012000011
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Is general practice prepared for a pandemic?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2020	368								m944	10.1136/bmj.m944	http://dx.doi.org/10.1136/bmj.m944			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AK	32152148	Bronze			2022-12-28	WOS:000520012000007
J	Wang, K; Sun, Q; Zhong, X; Zeng, MX; Zeng, H; Shi, XY; Li, ZL; Wang, YP; Zhao, Q; Shao, F; Ding, JJ				Wang, Kun; Sun, Qi; Zhong, Xiu; Zeng, Mengxue; Zeng, Huan; Shi, Xuyan; Li, Zilin; Wang, Yupeng; Zhao, Qiang; Shao, Feng; Ding, Jingjin			Structural Mechanism for GSDMD Targeting by Autoprocessed Caspases in Pyroptosis	CELL			English	Article							NONCANONICAL INFLAMMASOME ACTIVATION; CELL-DEATH; MOLECULAR-MECHANISMS; GASDERMIN D; CYSTEINE PROTEASE; CLEAVAGE; AUTOPROTEOLYSIS; AUTOINHIBITION; SPECIFICITY; RECEPTORS	The pyroptosis execution protein GSDMD is cleaved by inflammasome-activated caspase-1 and LPS-activated caspase-11/4/5. The cleavage unmasks the pore-forming domain from GSDMD-C-terminal domain. How the caspases recognize GSDMD and its connection with caspase activation are unknown. Here, we show site-specific caspase- 4/11 autoprocessing, generating a p10 product, is required and sufficient for cleaving GSDMD and inducing pyroptosis. The p10-form autoprocessed caspase-4/11 binds the GSDMD-C domain with a high affinity. Structural comparison of autoprocessed and unprocessed capase-11 identifies a beta sheet induced by the autoprocessing. In caspase-4/11-GSDMD-C complex crystal structures, the beta sheet organizes a hydrophobic GSDMD-binding interface that is only possible for p10-form caspase-4/11. The binding promotes dimerization-mediated caspase activation, rendering a cleavage independently of the cleavage-site tetrapeptide sequence. Crystal structure of caspase-1-GSDMD-C complex shows a similar GSDMD-recognition mode. Our study reveals an unprecedented substrate-targeting mechanism for caspases. The hydrophobic interface suggests an additional space for developing inhibitors specific for pyroptotic caspases.	[Wang, Kun; Zhong, Xiu; Shao, Feng] Peking Univ, Tsinghua Univ, Natl Inst Biol Sci, Joint Grad Program, Beijing 102206, Peoples R China; [Zeng, Huan; Ding, Jingjin] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Sun, Qi; Li, Zilin; Wang, Yupeng; Shao, Feng] Chinese Acad Med Sci 2019RU076, Res Unit Pyroptosis & Immun, Beijing 102206, Peoples R China; [Wang, Kun; Sun, Qi; Zhong, Xiu; Zeng, Mengxue; Zeng, Huan; Shi, Xuyan; Li, Zilin; Wang, Yupeng; Shao, Feng; Ding, Jingjin] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Zhao, Qiang] Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou 510080, Peoples R China; [Shao, Feng] Tsinghua Univ, Tsinghua Inst Multidisciplinary Biomed Res, Beijing 102206, Peoples R China	National Institute of Biological Sciences, Beijing; Peking University; Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS; National Institute of Biological Sciences, Beijing; Sun Yat Sen University; Tsinghua University	Shao, F (corresponding author), Peking Univ, Tsinghua Univ, Natl Inst Biol Sci, Joint Grad Program, Beijing 102206, Peoples R China.; Ding, JJ (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Shao, F (corresponding author), Chinese Acad Med Sci 2019RU076, Res Unit Pyroptosis & Immun, Beijing 102206, Peoples R China.; Shao, F; Ding, JJ (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.; Shao, F (corresponding author), Tsinghua Univ, Tsinghua Inst Multidisciplinary Biomed Res, Beijing 102206, Peoples R China.	shaofeng@nibs.ac.cn; jding@ibp.ac.cn		Ding, Jingjin/0000-0001-9941-7997	CAS Strategic Priority Research Program of the Chinese Academy of Sciences [XDB29020202, XDB37000000]; Basic Science Center Project of the National Natural Science Foundation of China (NSFC) [81788104]; Excellent Young Scholar Program of the National Natural Science Foundation of China (NSFC) [81922043]; National Key Research and Development Programs of China [2017YFA0504000, 2017YFA0505900, 2016YFA0501500]; Chinese Academy of Medical Sciences Initiative for Innovative Medicine [2019-I2M-5-084]; CAS Youth Innovation Promotion Association [2017127]	CAS Strategic Priority Research Program of the Chinese Academy of Sciences; Basic Science Center Project of the National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Excellent Young Scholar Program of the National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Research and Development Programs of China; Chinese Academy of Medical Sciences Initiative for Innovative Medicine; CAS Youth Innovation Promotion Association	We thank the staff of BL17U and BL19U1 beamlines at National Center for Protein Science Shanghai and Shanghai Synchrotron Radiation Facility for assistance during data collection. We thank Y. Chen and Z. Yang at the Institute of Biophysics, Chinese Academy of Sciences (CAS) for assistance with SPR experiments, and the staff at the Technology Center for Protein Science, Tsinghua University for assistance with AUC experiments. This work was supported by CAS Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29020202 and XDB37000000), Basic Science Center Project (81788104) and Excellent Young Scholar Program (81922043) of the National Natural Science Foundation of China (NSFC), National Key Research and Development Programs of China (2017YFA0504000, 2017YFA0505900, and 2016YFA0501500), Chinese Academy of Medical Sciences Initiative for Innovative Medicine (2019-I2M-5-084), and a grant from the CAS Youth Innovation Promotion Association (2017127).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boucher D, 2018, J EXP MED, V215, P827, DOI 10.1084/jem.20172222; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Casson CN, 2015, P NATL ACAD SCI USA, V112, P6688, DOI 10.1073/pnas.1421699112; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Crawford ED, 2011, ANNU REV BIOCHEM, V80, P1055, DOI 10.1146/annurev-biochem-061809-121639; Datta D, 2013, J BIOL CHEM, V288, P9971, DOI 10.1074/jbc.M112.426460; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Guey B, 2014, P NATL ACAD SCI USA, V111, P17254, DOI 10.1073/pnas.1415756111; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; Jorgensen I, 2015, IMMUNOL REV, V265, P130, DOI 10.1111/imr.12287; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kajiwara Y, 2014, J IMMUNOL, V193, P335, DOI 10.4049/jimmunol.1303424; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Khanova E, 2018, HEPATOLOGY, V67, P1737, DOI 10.1002/hep.29645; Kuang SY, 2017, P NATL ACAD SCI USA, V114, P10642, DOI 10.1073/pnas.1708194114; Lee BL, 2018, J EXP MED, V215, P2279, DOI 10.1084/jem.20180589; Lee BL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21998-3; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Liu ZH, 2019, IMMUNITY, V51, P43, DOI 10.1016/j.immuni.2019.04.017; Liu Z, 2018, STRUCTURE, V26, P778, DOI 10.1016/j.str.2018.03.002; Macdonald S, 2018, HEPATOLOGY, V67, P989, DOI 10.1002/hep.29581; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Manthiram K, 2017, NAT IMMUNOL, V18, P832, DOI 10.1038/ni.3777; Mascarenhas DPA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006502; Mulvihill E, 2018, EMBO J, V37, DOI 10.15252/embj.201798321; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Poreba M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008680; Ramirez MLG, 2018, J BIOL CHEM, V293, P7058, DOI 10.1074/jbc.RA117.001329; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rathinam VAK, 2019, NAT IMMUNOL, V20, P527, DOI 10.1038/s41590-019-0368-3; Rauch I, 2017, IMMUNITY, V46, P649, DOI 10.1016/j.immuni.2017.03.016; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rogers C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14128; Roschitzki-Voser H, 2012, PROTEIN EXPRES PURIF, V84, P236, DOI 10.1016/j.pep.2012.05.009; Ross C, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800237; Ruan JB, 2018, NATURE, V557, P62, DOI 10.1038/s41586-018-0058-6; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Sarhan J, 2018, P NATL ACAD SCI USA, V115, pE10888, DOI 10.1073/pnas.1809548115; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Xu B, 2018, J HEPATOL, V68, P773, DOI 10.1016/j.jhep.2017.11.040; Yang J, 2018, P NATL ACAD SCI USA, V115, P6792, DOI 10.1073/pnas.1800562115; Yang JL, 2013, P NATL ACAD SCI USA, V110, P14408, DOI 10.1073/pnas.1306376110; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	69	193	210	30	161	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2020	180	5					941	+		10.1016/j.cell.2020.02.002	http://dx.doi.org/10.1016/j.cell.2020.02.002			35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KT7JN	32109412	Bronze			2022-12-28	WOS:000519189800013
J	Peron, S; Pancholi, R; Voelcker, B; Wittenbach, JD; Olafsdottir, HF; Freeman, J; Svoboda, K				Peron, Simon; Pancholi, Ravi; Voelcker, Bettina; Wittenbach, Jason D.; olafsdottir, H. Freyja; Freeman, Jeremy; Svoboda, Karel			Recurrent interactions in local cortical circuits	NATURE			English	Article							EXCITATORY NEURONS; GABAERGIC NEURONS; CORTEX; NETWORKS; DYNAMICS	Most cortical synapses are local and excitatory. Local recurrent circuits could implement amplification, allowing pattern completion and other computations(1-4). Cortical circuits contain subnetworks that consist of neurons with similar receptive fields and increased connectivity relative to the network average(5,6). Cortical neurons that encode different types of information are spatially intermingled and distributed over large brain volumes(5-7), and this complexity has hindered attempts to probe the function of these subnetworks by perturbing them individually(8). Here we use computational modelling, optical recordings and manipulations to probe the function of recurrent coupling in layer 2/3 of the mouse vibrissal somatosensory cortex during active tactile discrimination. A neural circuit model of layer 2/3 revealed that recurrent excitation enhances sensory signals by amplification, but only for subnetworks with increased connectivity. Model networks with high amplification were sensitive to damage: loss of a few members of the subnetwork degraded stimulus encoding. We tested this prediction by mapping neuronal selectivity(7) and photoablating(9,10) neurons with specific selectivity. Ablation of a small proportion of layer 2/3 neurons (10-20, less than 5% of the total) representing touch markedly reduced responses in the spared touch representation, but not in other representations. Ablations most strongly affected neurons with stimulus responses that were similar to those of the ablated population, which is also consistent with network models. Recurrence among cortical neurons with similar selectivity therefore drives input-specific amplification during behaviour.	[Peron, Simon; Wittenbach, Jason D.; olafsdottir, H. Freyja; Freeman, Jeremy; Svoboda, Karel] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Peron, Simon; Pancholi, Ravi; Voelcker, Bettina] NYU, Ctr Neural Sci, New York, NY 10003 USA; [olafsdottir, H. Freyja] UCL, Dept Cell & Dev Biol, London, England; [olafsdottir, H. Freyja] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	Howard Hughes Medical Institute; New York University; University of London; University College London; Radboud University Nijmegen	Peron, S (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.; Peron, S (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	speron@nyu.edu		Peron, Simon/0000-0001-8265-6940	Howard Hughes Medical Institute; National Institutes of Health (NIH) [T32GM007308]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Druckmann, S. Romani, D. Gutnisky, N. Li, J. Yu, H. Inagaki, N. Sofroniew and M. Economo for comments on the manuscript, A. Hu for histology, and H. Zeng for the Ai162 transgenic mice. Funding was provided by the Howard Hughes Medical Institute. R.P. was supported by the National Institutes of Health (NIH) T32GM007308.	Ahrens MB, 2008, NETWORK-COMP NEURAL, V19, P35, DOI 10.1080/09548980701813936; Allegra Mascaro Anna Letizia, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00021; Avermann M, 2012, J NEUROPHYSIOL, V107, P3116, DOI 10.1152/jn.00917.2011; Barrett DGT, 2016, ELIFE, V5, DOI 10.7554/eLife.12454; Brette R, 2007, J COMPUT NEUROSCI, V23, P349, DOI 10.1007/s10827-007-0038-6; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; Canty AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3038; Carrillo-Reid L, 2019, CELL, V178, P447, DOI 10.1016/j.cell.2019.05.045; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chettih SN, 2019, NATURE, V567, P334, DOI 10.1038/s41586-019-0997-6; Christie IK, 2017, J NEUROPHYSIOL, V118, P874, DOI 10.1152/jn.00177.2017; Clack NG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002591; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; Daie K., 2019, TARGETED PHOTOSTIMUL, DOI DOI 10.1101/623785V1; Daigle TL, 2018, CELL, V174, P465, DOI 10.1016/j.cell.2018.06.035; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gorski JA, 2002, J NEUROSCI, V22, P6309; Guo ZCV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088678; Guo ZCV, 2014, NEURON, V81, P179, DOI 10.1016/j.neuron.2013.10.020; Hansel D, 2012, J NEUROSCI, V32, P4049, DOI 10.1523/JNEUROSCI.6284-11.2012; Harris KD, 2013, NATURE, V503, P51, DOI 10.1038/nature12654; Hires SA, 2015, ELIFE, V4, DOI 10.7554/eLife.06619; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Konig K, 1999, OPT LETT, V24, P113, DOI 10.1364/OL.24.000113; Lee WCA, 2016, NATURE, V532, P370, DOI 10.1038/nature17192; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Li N, 2016, NATURE, V532, P459, DOI 10.1038/nature17643; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; Marshel JH, 2019, SCIENCE, V365, P558, DOI 10.1126/science.aaw5202; Mateo C, 2011, CURR BIOL, V21, P1593, DOI 10.1016/j.cub.2011.08.028; Miller KD, 2016, CURR OPIN NEUROBIOL, V37, P75, DOI 10.1016/j.conb.2016.01.008; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Orger MB, 2008, NAT NEUROSCI, V11, P327, DOI 10.1038/nn2048; Peron S, 2011, NAT METHODS, V8, P30, DOI 10.1038/NMETH.F.325; Peron SP, 2015, NEURON, V86, P783, DOI 10.1016/j.neuron.2015.03.027; Petersen CCH, 2019, NAT REV NEUROSCI, V20, P533, DOI 10.1038/s41583-019-0200-y; Petersen CCH, 2013, NEURON, V78, P28, DOI 10.1016/j.neuron.2013.03.020; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rubin DB, 2015, NEURON, V85, P402, DOI 10.1016/j.neuron.2014.12.026; Stimberg M, 2019, ELIFE, V8, DOI 10.7554/eLife.47314; Vladimirov N, 2018, NAT METHODS, V15, P1117, DOI 10.1038/s41592-018-0221-x; Xue MS, 2014, NATURE, V511, P596, DOI 10.1038/nature13321; Yu JN, 2019, NEURON, V104, P412, DOI 10.1016/j.neuron.2019.07.027; Yu JN, 2016, NAT NEUROSCI, V19, P1647, DOI 10.1038/nn.4412	50	39	39	6	35	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7798					256	+		10.1038/s41586-020-2062-x	http://dx.doi.org/10.1038/s41586-020-2062-x		MAR 2020	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU0CC	32132709	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000518098200007
J	Bair, MJ; Krebs, EE				Bair, Matthew J.; Krebs, Erin E.			Fibromyalgia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COGNITIVE-BEHAVIORAL THERAPY; AMERICAN-COLLEGE; ECONOMIC-EVALUATION; HEALTH-STATUS; DOUBLE-BLIND; USUAL CARE; LONG-TERM; PAIN; EXERCISE; RISK		[Bair, Matthew J.] Richard L Roudebush VA Med Ctr, Indianapolis, IN 46202 USA; [Krebs, Erin E.] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Bair, MJ (corresponding author), Richard L Roudebush VA Med Ctr, Indianapolis, IN 46202 USA.			Krebs, Erin/0000-0003-0843-7410	American College of Physicians	American College of Physicians	American College of Physicians.	Ang DC, 2013, CLIN J PAIN, V29, P296, DOI 10.1097/AJP.0b013e318254ac76; Arnold LM, 2007, ARTHRITIS RHEUM-US, V56, P1336, DOI 10.1002/art.22457; Arnold LM, 2019, J PAIN, V20, P611, DOI 10.1016/j.jpain.2018.10.008; Bernardy K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009796.pub2; Bidonde J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012700; Bidonde J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011336; Busch AJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010884; Clauw DJ, 2014, JAMA-J AM MED ASSOC, V311, P1547, DOI 10.1001/jama.2014.3266; de Souza Nascimento Desantana JM, 2013, EVID-BASED COMPL ALT, V2013; Deare JC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007070.pub2; Dreyer L, 2010, ARTHRITIS RHEUM-US, V62, P3101, DOI 10.1002/art.27623; Fitzcharles MA, 2018, EUR J PAIN, V22, P1565, DOI 10.1002/ejp.1252; Fitzcharles MA, 2003, J RHEUMATOL, V30, P154; Fitzcharles MA, 2013, J RHEUMATOL, V40, P1388, DOI 10.3899/jrheum.130127; Friesen LN, 2017, PAIN, V158, P593, DOI 10.1097/j.pain.0000000000000802; Goldenberg DL, 2016, MAYO CLIN PROC, V91, P640, DOI 10.1016/j.mayocp.2016.02.002; Hauser W, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010292; Hauser W, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3002; Hauser W, 2009, PAIN, V145, P69, DOI 10.1016/j.pain.2009.05.014; Jones GT, 2015, ARTHRITIS RHEUMATOL, V67, P568, DOI 10.1002/art.38905; Kaleth AS, 2014, ARTHRIT CARE RES, V66, P1887, DOI 10.1002/acr.22398; Kerr JI, 2017, J PAIN RES, V10, P2021, DOI 10.2147/JPR.S143869; Koffel E, 2018, HEALTH INFORM J, V24, P3, DOI 10.1177/1460458216656472; LAUCHE R, 2015, ALTERNAT MED; Lee YC, 2013, ANN RHEUM DIS, V72, P949, DOI 10.1136/annrheumdis-2012-201506; Lodahl M, 2018, PAIN REP, V3, DOI 10.1097/PR9.0000000000000633; Loge-Hagen JS, 2019, J AFFECT DISORDERS, V245, P1098, DOI 10.1016/j.jad.2018.12.001; Luciano JV, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0451-y; Lunn MPT, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007115.pub3; Macfarlane GJ, 2017, ANN RHEUM DIS, V76, P318, DOI 10.1136/annrheumdis-2016-209724; Mcdowell CP, 2017, MED SCI SPORT EXER, V49, P1868, DOI 10.1249/MSS.0000000000001290; McKernan LC, 2019, ARTHRIT CARE RES, V71, P1255, DOI 10.1002/acr.23748; Mease PJ, 2009, J RHEUMATOL, V36, P398, DOI 10.3899/jrheum.080734; Moore A, 2014, JAMA-J AM MED ASSOC, V312, P182, DOI 10.1001/jama.2014.6336; Moore S., 2017, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD012332.PUB2; Mork PJ, 2010, ARTHRIT CARE RES, V62, P611, DOI 10.1002/acr.20118; Mundal I, 2014, PAIN, V155, P1555, DOI 10.1016/j.pain.2014.04.033; Murakami M, 2017, MOD RHEUMATOL, V27, P688, DOI 10.1080/14397595.2016.1245237; Neumann Lily, 2003, Curr Pain Headache Rep, V7, P362, DOI 10.1007/s11916-003-0035-z; O'Brien AT, 2018, J PAIN, V19, P819, DOI 10.1016/j.jpain.2018.01.010; O'Malley PG, 2000, J GEN INTERN MED, V15, P659, DOI 10.1046/j.1525-1497.2000.06279.x; Peterson K, 2018, J GEN INTERN MED, V33, pS71, DOI 10.1007/s11606-018-4328-7; Prados G, 2013, CLIN EXP RHEUMATOL, V31, pS102; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Reisine S, 2008, ARTHRIT RHEUM-ARTHR, V59, P1735, DOI 10.1002/art.24309; SALARI M, 2017, COCHRANE DB SYST REV, V1; Schroder A, 2017, J PSYCHOSOM RES, V94, P73, DOI 10.1016/j.jpsychores.2017.01.005; Silva AR, 2019, ANN MED, V51, pS2, DOI 10.1080/07853890.2018.1564360; Skarpsno ES, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028684; Theadom A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001980.pub3; Tofferi JK, 2004, ARTHRIT RHEUM-ARTHR, V51, P9, DOI 10.1002/art.20076; Viola-Saltzman M, 2010, J CLIN SLEEP MED, V6, P423; Walitt B, 2011, J RHEUMATOL, V38, P2238, DOI 10.3899/jrheum.110026; Williams DA, 2010, PAIN, V151, P694, DOI 10.1016/j.pain.2010.08.034; Wolfe F, 1997, ARTHRITIS RHEUM, V40, P1560, DOI 10.1002/art.1780400904; Wolfe F, 1997, ARTHRITIS RHEUM, V40, P1571, DOI 10.1002/art.1780400905; Wolfe F, 2016, SEMIN ARTHRITIS RHEU, V46, P319, DOI 10.1016/j.semarthrit.2016.08.012; Wolfe F, 2014, ARTHRIT CARE RES, V66, P1354, DOI 10.1002/acr.22305; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Younger J, 2013, ARTHRITIS RHEUM-US, V65, P529, DOI 10.1002/art.37734; Zhang XC, 2019, J PAIN RES, V12, P527, DOI 10.2147/JPR.S186227	61	61	64	6	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2020	172	5					ITC33	ITC46		10.7326/AITC202003030	http://dx.doi.org/10.7326/AITC202003030			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KV1BP	32120395				2022-12-28	WOS:000520159500001
J	Bloch, JS; Pesciullesi, G; Boilevin, J; Nosol, K; Irobalieva, RN; Darbre, T; Aebi, M; Kossiakoff, AA; Reymond, JL; Locher, KP				Bloch, Joel S.; Pesciullesi, Giorgio; Boilevin, Jeremy; Nosol, Kamil; Irobalieva, Rossitza N.; Darbre, Tamis; Aebi, Markus; Kossiakoff, Anthony A.; Reymond, Jean-Louis; Locher, Kaspar P.			Structure and mechanism of the ER-based glucosyltransferase ALG6	NATURE			English	Article							LINKED OLIGOSACCHARIDE; SYNTHETIC ANTIBODIES; CONGENITAL DISORDER; GLUCOSYLATION STEPS; MEMBRANE-PROTEINS; MOLECULAR-BASIS; PHAGE DISPLAY; GLYCOSYLATION; INSIGHTS; YEAST	In eukaryotic protein N-glycosylation, a series of glycosyltransferases catalyse the biosynthesis of a dolichylpyrophosphate-linked oligosaccharide before its transfer onto acceptor proteins(1). The final seven steps occur in the lumen of the endoplasmic reticulum (ER) and require dolichylphosphate-activated mannose and glucose as donor substrates(2). The responsible enzymes-ALG3, ALG9, ALG12, ALG6, ALG8 and ALG10-are glycosyltransferases of the C-superfamily (GT-Cs), which are loosely defined as containing membrane-spanning helices and processing an isoprenoid-linked carbohydrate donor substrate(3,4). Here we present the cryo-electron microscopy structure of yeast ALG6 at 3.0 angstrom resolution, which reveals a previously undescribed transmembrane protein fold. Comparison with reported GT-C structures suggests that GT-C enzymes contain a modular architecture with a conserved module and a variable module, each with distinct functional roles. We used synthetic analogues of dolichylphosphate-linked and dolichylpyrophosphate-linked sugars and enzymatic glycan extension to generate donor and acceptor substrates using purified enzymes of the ALG pathway to recapitulate the activity of ALG6 in vitro. A second cryo-electron microscopy structure of ALG6 bound to an analogue of dolichylphosphate-glucose at 3.9 angstrom resolution revealed the active site of the enzyme. Functional analysis of ALG6 variants identified a catalytic aspartate residue that probably acts as a general base. This residue is conserved in the GT-C superfamily. Our results define the architecture of ER-luminal GT-C enzymes and provide a structural basis for understanding their catalytic mechanisms. Analyses reveal a previously undescribed transmembrane protein fold in the endoplasmic reticulum-based glucosyltransferase ALG6 and provide a structural basis for understanding the glucose transfer mechanism.	[Bloch, Joel S.; Nosol, Kamil; Irobalieva, Rossitza N.; Locher, Kaspar P.] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Zurich, Switzerland; [Pesciullesi, Giorgio; Boilevin, Jeremy; Darbre, Tamis; Reymond, Jean-Louis] Univ Bern, Dept Chem & Biochem, Bern, Switzerland; [Nosol, Kamil; Kossiakoff, Anthony A.] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Aebi, Markus] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; University of Chicago; Swiss Federal Institutes of Technology Domain; ETH Zurich	Locher, KP (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Zurich, Switzerland.	Locher@mol.biol.ethz.ch		Reymond, Jean-Louis/0000-0003-2724-2942; Bloch, Joel/0000-0002-5786-0488; Nosol, Kamil/0000-0003-2865-9125; Irobalieva, Rossitza/0000-0003-3540-4294	Swiss National Science Foundation (SNF) Sinergia programme TransGlyco [CRSII3_147632]; Swiss National Science Foundation (SNF) Sinergia programme GlycoStart [CRSII5_173709]; SNF [310030B_166672]; US National Institutes of Health [GM117372]	Swiss National Science Foundation (SNF) Sinergia programme TransGlyco(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation (SNF) Sinergia programme GlycoStart(Swiss National Science Foundation (SNSF)); SNF; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the Swiss National Science Foundation (SNF) Sinergia programmes TransGlyco (CRSII3_147632) and GlycoStart (CRSII5_173709) to M.A., J.-L.R. and K.P.L, SNF grant 310030B_166672 to K.P.L., as well as by the US National Institutes of Health grant GM117372 to A.A.K. Cryo-EM data were collected at the ScopeM facility at ETH Zurich. We thank the staff of ScopeM for technical support; J. Zurcher for technical support with protein expression and purification; J. Kowal and I. Manolaridis for help with EM data collection; and A. Ramirez and A. Alam for helpful discussions.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P814, DOI 10.1107/S2059798318009324; Albesa-Jove D, 2019, METHOD ENZYMOL, V621, P261, DOI 10.1016/bs.mie.2019.02.034; Albuquerque-Wendt A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194842; Ardevol A, 2015, J AM CHEM SOC, V137, P7528, DOI 10.1021/jacs.5b01156; Bai L, 2019, NAT STRUCT MOL BIOL, V26, P704, DOI 10.1038/s41594-019-0262-6; Bai L, 2018, NATURE, V555, P328, DOI 10.1038/nature25755; Borowska MT, 2015, STRUCTURE, V23, P1715, DOI 10.1016/j.str.2015.06.025; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Chang A, 2011, CURR OPIN BIOTECH, V22, P800, DOI 10.1016/j.copbio.2011.04.013; Davies GJ, 2012, ACCOUNTS CHEM RES, V45, P308, DOI 10.1021/ar2001765; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Dercksen M, 2013, JIMD REP, V8, P17, DOI 10.1007/8904_2012_150; Dominik PK, 2016, STRUCTURE, V24, P300, DOI 10.1016/j.str.2015.11.014; Dominik PK, 2015, METHOD ENZYMOL, V557, P219, DOI 10.1016/bs.mie.2014.12.032; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Gouw M, 2018, NUCLEIC ACIDS RES, V46, pD428, DOI 10.1093/nar/gkx1077; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hornsby M, 2015, MOL CELL PROTEOMICS, V14, P2833, DOI 10.1074/mcp.O115.052209; Imbach T, 2000, HUM GENET, V106, P538, DOI 10.1007/s004390050022; Imbach T, 1999, P NATL ACAD SCI USA, V96, P6982, DOI 10.1073/pnas.96.12.6982; Jaeken J, 2015, EUR J HUM GENET, V23, DOI 10.1038/ejhg.2014.146; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lee BC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05724-1; Li ST, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09752-3; Li TL, 2014, ORG LETT, V16, P5628, DOI 10.1021/ol5026876; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Malet C, 1996, J ORG CHEM, V61, P4649, DOI 10.1021/jo960284z; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Matsumoto S, 2013, P NATL ACAD SCI USA, V110, P17868, DOI 10.1073/pnas.1309777110; Maunier V, 1997, CARBOHYD RES, V299, P49, DOI 10.1016/S0008-6215(96)00336-9; Morava E, 2016, J INHERIT METAB DIS, V39, P713, DOI 10.1007/s10545-016-9945-x; Moremen KW, 2019, NAT CHEM BIOL, V15, P853, DOI 10.1038/s41589-019-0350-2; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Napiorkowska M, 2017, NAT STRUCT MOL BIOL, V24, P1100, DOI 10.1038/nsmb.3491; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Notenboom V, 1998, NAT STRUCT BIOL, V5, P812, DOI 10.1038/1852; Petrou VI, 2016, SCIENCE, V351, P608, DOI 10.1126/science.aad1172; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramirez AS, 2017, GLYCOBIOLOGY, V27, P726, DOI 10.1093/glycob/cwx045; Ramirez AS, 2017, GLYCOBIOLOGY, V27, P525, DOI 10.1093/glycob/cwx017; Reiss G, 1996, GLYCOBIOLOGY, V6, P493, DOI 10.1093/glycob/6.5.493; RUNGE KW, 1984, J BIOL CHEM, V259, P412; RUNGE KW, 1986, J BIOL CHEM, V261, P5582; SABESAN S, 1992, CARBOHYD RES, V223, P169, DOI 10.1016/0008-6215(92)80015-S; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sharma CB, 2001, BIOL CHEM, V382, P321, DOI 10.1515/BC.2001.039; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Westphal V, 2000, MOL GENET METAB, V70, P219, DOI 10.1006/mgme.2000.3017; Wild R, 2018, SCIENCE, V359, P545, DOI 10.1126/science.aar5140; Williams RJ, 2014, ANGEW CHEM INT EDIT, V53, P1087, DOI 10.1002/anie.201308334; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	63	25	25	7	49	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					443	+		10.1038/s41586-020-2044-z	http://dx.doi.org/10.1038/s41586-020-2044-z		FEB 2020	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32103179	Green Accepted			2022-12-28	WOS:000516702000002
J	Shepherd, A				Shepherd, Alison			Rebuilding lives and faces ruined by noma	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2020	368								m742	10.1136/bmj.m742	http://dx.doi.org/10.1136/bmj.m742			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2JV	32102780				2022-12-28	WOS:000519535600011
J	Yuan, J; Chang, SY; Yin, SG; Liu, ZY; Cheng, X; Liu, XJ; Jiang, Q; Gao, G; Lin, DY; Kang, XL; Ye, SW; Chen, Z; Yin, JA; Hao, P; Jiang, LB; Cai, SQ				Yuan, Jie; Chang, Si-Yuan; Yin, Shi-Gang; Liu, Zhi-Yang; Cheng, Xiu; Liu, Xi-Juan; Jiang, Qiang; Gao, Ge; Lin, De-Ying; Kang, Xin-Lei; Ye, Shi-Wei; Chen, Zheng; Yin, Jiang-An; Hao, Pei; Jiang, Lubin; Cai, Shi-Qing			Two conserved epigenetic regulators prevent healthy ageing	NATURE			English	Article							LIFE-SPAN; MITOCHONDRIAL UPR; LONGEVITY; STRESS; DOPAMINE; PATHWAY; MEMORY; DNA	It has long been assumed that lifespan and healthspan correlate strongly, yet the two can be clearly dissociated(1-6). Although there has been a global increase in human life expectancy, increasing longevity is rarely accompanied by an extended healthspan(4,7). Thus, understanding the origin of healthy behaviours in old people remains an important and challenging task. Here we report a conserved epigenetic mechanism underlying healthy ageing. Through genome-wide RNA-interference-based screening of genes that regulate behavioural deterioration in ageing Caenorhabditis elegans, we identify 59 genes as potential modulators of the rate of age-related behavioural deterioration. Among these modulators, we found that a neuronal epigenetic reader, BAZ-2, and a neuronal histone 3 lysine 9 methyltransferase, SET-6, accelerate behavioural deterioration in C. elegans by reducing mitochondrial function, repressing the expression of nuclear-encoded mitochondrial proteins. This mechanism is conserved in cultured mouse neurons and human cells. Examination of human databases(8,9) shows that expression of the human orthologues of these C. elegans regulators, BAZ2B and EHMT1, in the frontal cortex increases with age and correlates positively with the progression of Alzheimer's disease. Furthermore, ablation of Baz2b, the mouse orthologue of BAZ-2, attenuates age-dependent body-weight gain and prevents cognitive decline in ageing mice. Thus our genome-wide RNA-interference screen in C. elegans has unravelled conserved epigenetic negative regulators of ageing, suggesting possible ways to achieve healthy ageing. Two epigenetic regulators-identified in an RNA interference screen in Caenhorhabditis elegans, and conserved in mammals-diminish mitochondrial function and accelerate the age-related deterioration of behaviour.	[Yuan, Jie; Chang, Si-Yuan; Liu, Zhi-Yang; Liu, Xi-Juan; Jiang, Qiang; Gao, Ge; Lin, De-Ying; Kang, Xin-Lei; Ye, Shi-Wei; Yin, Jiang-An; Cai, Shi-Qing] Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Neurosci & State Key Lab Neurosci, Shanghai, Peoples R China; [Yin, Shi-Gang; Cheng, Xiu; Hao, Pei; Jiang, Lubin] Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Yuan, Jie; Chang, Si-Yuan; Yin, Shi-Gang; Liu, Zhi-Yang; Cheng, Xiu; Gao, Ge; Lin, De-Ying] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yin, Shi-Gang] Southwest Med Univ, Academician Expert Workstn Sichuan Prov, Affiliated Hosp, Luzhou, Peoples R China; [Chen, Zheng] Zhejiang Wanli Univ, Coll Biol & Environm Sci, Ningbo, Peoples R China; [Jiang, Lubin] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Cai, Shi-Qing] Shanghai Ctr Brain Sci & Brain Inspired Intellige, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Southwest Medical University; Zhejiang Wanli University; ShanghaiTech University	Cai, SQ (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Neurosci & State Key Lab Neurosci, Shanghai, Peoples R China.; Jiang, LB (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.; Jiang, LB (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.; Cai, SQ (corresponding author), Shanghai Ctr Brain Sci & Brain Inspired Intellige, Shanghai, Peoples R China.	lbjiang@ips.ac.cn; sqcai@ion.ac.cn		Gao, Ge/0000-0002-9907-8216; Yin, Jiang-An/0000-0002-2134-8693; Hao, Pei/0000-0002-1498-7059	National Institutes of Health (NIH) Office of Research Infrastructure Programs [P40 OD010440]; National Natural Science Foundation of China [31925022, 91949206, 81527901, 31771455]; National Key RAMP;D Program of China [2018YFC2000400, 2018YFA0507300]; Strategic Priority Research Program of the Chinese Academy of Science [XDB32020100]; Shanghai Municipal Science and Technology Major Project [2018SHZDZX05]	National Institutes of Health (NIH) Office of Research Infrastructure Programs; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key RAMP;D Program of China; Strategic Priority Research Program of the Chinese Academy of Science(Chinese Academy of Sciences); Shanghai Municipal Science and Technology Major Project	We thank M-m. Poo and X. Shi for critical reading of the manuscript; Q. Sun, Y.-J. Cai and Y.-Z. Li for generating Baz2b-knockout mice; the C. elegans Genetics Center (funded by the National Institutes of Health (NIH) Office of Research Infrastructure Programs P40 OD010440) for providing strains; members of C.-y. Li's laboratory for helping with mouse behavioural assays; M. Sun for helping to prepare the H3K9 ChIP-seq DNA libraries; and the Institute of Neuroscience Molecular and Cellular Biology Core Facility, the Optical Imaging Facility, and the Animal Facility (Chinese Academy of Sciences) for technical support. This work was supported by grants to S.-Q.C. (from the National Natural Science Foundation of China, grants 31925022, 91949206 and 81527901; and from the National Key R&D Program of China, grant 2018YFC2000400); the Strategic Priority Research Program of the Chinese Academy of Science (grant XDB32020100); the Shanghai Municipal Science and Technology Major Project (grant 2018SHZDZX05); and grants to L.J. (from the National Key R&D Program of China, grant 2018YFA0507300; and the National Natural Science Foundation of China, grant 31771455).	Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Bansal A, 2015, P NATL ACAD SCI USA, V112, pE277, DOI 10.1073/pnas.1412192112; Beard JR, 2016, LANCET, V387, P2145, DOI 10.1016/S0140-6736(15)00516-4; Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Chowdhury R, 2013, NAT NEUROSCI, V16, P648, DOI 10.1038/nn.3364; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P75, DOI 10.1093/geronb/gbq088; Dale RK, 2014, NUCLEIC ACIDS RES, V42, P9158, DOI 10.1093/nar/gku644; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Guarente L, 2014, CELL, V159, P15, DOI 10.1016/j.cell.2014.08.041; Hansen M, 2016, TRENDS CELL BIOL, V26, P565, DOI 10.1016/j.tcb.2016.05.002; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hope IA., 1999, C ELEGANS PRACTICAL; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee Hae Young, 2009, J Vis Exp, DOI 10.3791/990; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McKay JP, 2004, GENETICS, V166, P161, DOI 10.1534/genetics.166.1.161; Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Mukhopadhyay A, 2008, NAT PROTOC, V3, P698, DOI 10.1038/nprot.2008.38; Ohno H, 2013, NATURE, V504, P163, DOI 10.1038/nature12652; Patel JC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2144; Patil SS, 2009, BEHAV BRAIN RES, V198, P58, DOI 10.1016/j.bbr.2008.10.029; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Sarov M, 2012, CELL, V150, P855, DOI 10.1016/j.cell.2012.08.001; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050; Tian Y, 2016, CELL, V165, P1197, DOI 10.1016/j.cell.2016.04.011; Viesselmann C, 2011, JOVE-J VIS EXP, DOI 10.3791/2373; Wimmer ME, 2012, NEUROBIOL AGING, V33, P2220, DOI 10.1016/j.neurobiolaging.2011.07.007; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; Yin JA, 2017, NATURE, V551, P198, DOI 10.1038/nature24463; Yin JA, 2014, J NEUROSCI, V34, P3947, DOI 10.1523/JNEUROSCI.4013-13.2014; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	50	29	37	11	115	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 5	2020	579	7797					118	+		10.1038/s41586-020-2037-y	http://dx.doi.org/10.1038/s41586-020-2037-y		FEB 2020	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE3BA	32103178				2022-12-28	WOS:000516702000006
J	Adalja, AA; Toner, E; Inglesby, TV				Adalja, Amesh A.; Toner, Eric; Inglesby, Thomas V.			Priorities for the US Health Community Responding to COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses the preparedness plans that need to be implemented in the US to combat the SARS-CoV-2 virus (the cause of COVID-19 disease), including shoring up resources in hospitals and clinics, updating of triage and isolation protocols, expanding PCR manufacturing and patient testing, and communicating to the public with unified public health messages.	[Adalja, Amesh A.; Toner, Eric; Inglesby, Thomas V.] Johns Hopkins Univ, Johns Hopkins Ctr Hlth Secur, Baltimore, MD USA; [Adalja, Amesh A.; Toner, Eric; Inglesby, Thomas V.] Johns Hopkins Univ, Dept Environm Hlth & Engn, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Inglesby, TV (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 621 E Pratt St,Ste 210, Baltimore, MD 21202 USA.	tinglesby@jhu.edu						Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; MacLaren G, 2020, JAMA-J AM MED ASSOC, V323, P1245, DOI 10.1001/jama.2020.2342; Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757; United States Food & Drug Administration, 2020, COR COVID 19 UPD FDA; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585	5	143	146	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2020	323	14					1343	1344		10.1001/jama.2020.3413	http://dx.doi.org/10.1001/jama.2020.3413			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LH1YB	32125355	Bronze			2022-12-28	WOS:000528583600010
J	Tisdale, JF; Thein, SL; Eaton, WA				Tisdale, John F.; Thein, Swee Lay; Eaton, William A.			Treating sickle cell anemia	SCIENCE			English	Editorial Material							DISEASE		[Tisdale, John F.] NHLBI, Cellular & Mol Therapeut Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Thein, Swee Lay] NHLBI, Sickle Cell Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Eaton, William A.] NIDDK, Lab Chem Phys, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Tisdale, JF (corresponding author), NHLBI, Cellular & Mol Therapeut Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	johntis@nhlbi.nih.gov; eaton@nih.gov; sweelay.thein@nih.gov			National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung,and Blood Institute of the National Institutes of Health	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung,and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	LThe authors are supported by the intramural research programs of the National Institute of Diabetes and Digestive and Kidney Diseases and the National Heart, Lung,and Blood Institute of the National Institutes of Health.	Ataga KI, 2017, NEW ENGL J MED, V376, P429, DOI 10.1056/NEJMoa1611770; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Eapen M, 2019, LANCET HAEMATOL, V6, pE585, DOI 10.1016/S2352-3026(19)30154-1; Eaton WA, 2003, BIOPHYS CHEM, V100, P109, DOI 10.1016/S0301-4622(02)00269-7; Eaton WA, 2017, BLOOD, V129, P2719, DOI 10.1182/blood-2017-02-765891; Magrin E, 2019, BLOOD, V134, P1203, DOI 10.1182/blood.2019000949; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Orkin SH, 2019, ANNU REV MED, V70, P257, DOI 10.1146/annurev-med-041817-125507; PLATT OS, 1984, J CLIN INVEST, V74, P652, DOI 10.1172/JCI111464; Ribeil JA, 2017, NEW ENGL J MED, V376, P848, DOI 10.1056/NEJMoa1609677; Telen MJ, 2019, NAT REV DRUG DISCOV, V18, P139, DOI 10.1038/s41573-018-0003-2; Tisdale JF, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-113480; Vichinsky E, 2019, NEW ENGL J MED, V381, P509, DOI 10.1056/NEJMoa1903212; Vinjamur DS, 2018, BRIT J HAEMATOL, V180, P630, DOI 10.1111/bjh.15038	15	20	20	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1198	1199		10.1126/science.aba3827	http://dx.doi.org/10.1126/science.aba3827			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU9DP	32165573	Green Accepted			2022-12-28	WOS:000520023800023
J	Dyer, C				Dyer, Clare			Doctor who tried to smuggle ecstasy tablets into UK is struck off while in French prison	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2020	368								m1048	10.1136/bmj.m1048	http://dx.doi.org/10.1136/bmj.m1048			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AU	32165420				2022-12-28	WOS:000520013500017
J	Loper, PL				Loper, Peter L., Jr.			Trauma Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this narrative medicine essay a psychiatrist finds parallels between his attempts to locate the source of a patient's psychological trauma and those of trauma surgeons opening up patients to reveal their injuries and shares how a successful connection heals both doctor and patient.	[Loper, Peter L., Jr.] Univ South Carolina, Prisma Hlth USC, Sch Med, Dept Neuropsychiat & Behav Hlth, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia	Loper, PL (corresponding author), 15 Med Pk,Ste 141,3555 Harden St Extens, Columbia, SC 29203 USA.	peter.loper@uscmed.sc.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2020	323	10					929	930		10.1001/jama.2020.1331	http://dx.doi.org/10.1001/jama.2020.1331			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KW1LV	32154860				2022-12-28	WOS:000520933900007
J	Iacobucci, G; Malasi, J; Mathew, R; Oliver, D; Vaughan, L				Iacobucci, Gareth; Malasi, Jihad; Mathew, Rammya; Oliver, David; Vaughan, Louella			Are we failing people with multiple health conditions? An expert discussion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Malasi, Jihad] Thanet Clin Commissioning Grp, Margate, England; [Malasi, Jihad] East Kent Hosp Transformat Serv, Margate, England; [Mathew, Rammya] Islington GP Federat, Qual Improvement, London, England; [Oliver, David] Royal Berkshire Hosp, Geriatr & Acute Internal Med, Reading, Berks, England; [Oliver, David] Royal Coll Physicians, London, England; [Oliver, David] British Geriatr Soc, London, England; [Vaughan, Louella] Nuffield Trust, London, England; [Vaughan, Louella] Royal London Hosp, London, England	Royal Berkshire Hospital; Royal College of Physicians; Barts Health NHS Trust; Royal London Hospital	Malasi, J (corresponding author), Thanet Clin Commissioning Grp, Margate, England.; Malasi, J (corresponding author), East Kent Hosp Transformat Serv, Margate, England.								0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2020	368								m921	10.1136/bmj.m921	http://dx.doi.org/10.1136/bmj.m921			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AK	32152036				2022-12-28	WOS:000520012000006
J	Harvey, ZH; Chakravarty, AK; Futia, RA; Jarosz, DF				Harvey, Zachary H.; Chakravarty, Anupam K.; Futia, Raymond A.; Jarosz, Daniel F.			A Prion Epigenetic Switch Establishes an Active Chromatin State	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; HISTONE DEACETYLASE; GENETIC-VARIATION; FISSION YEAST; INHERITANCE; PROTEIN; COMPLEX; BINDING; REPRESSION; URE3	Covalent modifications to histones are essential for development, establishing distinct and functional chromatin domains from a common genetic sequence. Whereas repressed chromatin is robustly inherited, no mechanism that facilitates inheritance of an activated domain has been described. Here, we report that the Set3C histone deacetylase scaffold Snt1 can act as a prion that drives the emergence and transgenerational inheritance of an activated chromatin state. This prion, which we term [ESI+] for expressed sub-telomeric information, is triggered by transient Snt1 phosphorylation upon cell cycle arrest. Once engaged, the prion reshapes the activity of Snt1 and the Set3C complex, recruiting RNA pol II and interfering with Rap1 binding to activate genes in otherwise repressed sub-telomeric domains. This transcriptional state confers broad resistance to environmental stress, including antifungal drugs. Altogether, our results establish a robust means by which a prion can facilitate inheritance of an activated chromatin state to provide adaptive benefit.	[Harvey, Zachary H.; Chakravarty, Anupam K.; Jarosz, Daniel F.] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA; [Futia, Raymond A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Jarosz, Daniel F.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Jarosz, DF (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA.; Jarosz, DF (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	danjarosz.aa@gmail.com		Jarosz, Daniel/0000-0003-3497-5888; Harvey, Zachary/0000-0002-6468-550X	NSF [MCB1453762]; NIH [DP2GM119140, T32GM113854, S10OD018220]; Vallee Foundation; David and Lucile Packard Foundation [2015-63121]; NSF GRFP; Howard Hughes Medical Institute [DRG2221-15]; NIH Pathway to independence award [1K99GM128180]	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vallee Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH Pathway to independence award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Crabtree, J. Kirkland, F.Berger, and members of the Jarosz laboratory for critical reading of the manuscript and helpful discussions. This work was supported by grants to D.F.J. from the NSF (MCB1453762), NIH (DP2GM119140), the Vallee Foundation, and the David and Lucile Packard Foundation (2015-63121). Z.H.H. was funded through NIH T32GM113854, and R.A.F. is funded by an NSF GRFP. A.K.C. was supported as a Howard Hughes Medical Institute fellow of the Damon Runyon Cancer Research Foundation (DRG2221-15) and by an NIH Pathway to independence award (1K99GM128180). Sequencing was performed on an Illumina HiSeq 4000 purchased with funds from NIH (S10OD018220).	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; [Anonymous], 1991, Methods Enzymol, V194, P1; Audergon PNCB, 2015, SCIENCE, V348, P132, DOI 10.1126/science.1260638; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; BRINDLE PK, 1990, MOL CELL BIOL, V10, P4872, DOI 10.1128/MCB.10.9.4872; Brown CA, 2010, CURR BIOL, V20, P895, DOI 10.1016/j.cub.2010.04.027; Buhler M, 2009, EMBO J, V28, P2149, DOI 10.1038/emboj.2009.185; Calarco JP, 2012, CELL, V151, P194, DOI 10.1016/j.cell.2012.09.001; Candelli T, 2018, EMBO J, V37, DOI 10.15252/embj.201797490; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Chakrabortee S, 2016, CELL, V167, P369, DOI 10.1016/j.cell.2016.09.017; Chakrabortee S, 2016, P NATL ACAD SCI USA, V113, P6065, DOI 10.1073/pnas.1604478113; Chakravarty AK, 2020, MOL CELL, V77, P251, DOI 10.1016/j.molcel.2019.10.028; Coleman RT, 2017, SCIENCE, V356, DOI 10.1126/science.aai8236; CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; DICKIES MM, 1962, J HERED, V53, P84, DOI 10.1093/oxfordjournals.jhered.a107129; Dodson AE, 2015, ELIFE, V4, DOI 10.7554/eLife.05007; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Fioriti L, 2015, NEURON, V86, P1433, DOI 10.1016/j.neuron.2015.05.021; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Guarente L, 2000, GENE DEV, V14, P1021; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Harvey ZH, 2018, MOL CELL, V69, P195, DOI 10.1016/j.molcel.2017.10.030; Hoepfner D, 2014, MICROBIOL RES, V169, P107, DOI 10.1016/j.micres.2013.11.004; Hoke SM, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-46; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Holmes DL, 2013, CELL, V153, P153, DOI 10.1016/j.cell.2013.02.026; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Huang J, 2006, GENE DEV, V20, P2887, DOI 10.1101/gad.1472706; Jarosz DF, 2017, CELL, V171, P1001, DOI 10.1016/j.cell.2017.10.047; Jarosz DF, 2014, CELL, V158, P1072, DOI 10.1016/j.cell.2014.07.024; Jarosz DF, 2014, CELL, V158, P1083, DOI 10.1016/j.cell.2014.07.025; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Jiang DH, 2017, SCIENCE, V357, P1146, DOI 10.1126/science.aan4965; Kazachenka A, 2018, CELL, V175, P1717, DOI 10.1016/j.cell.2018.11.017; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; Kim T, 2012, CELL, V150, P1158, DOI 10.1016/j.cell.2012.08.016; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kruttner S, 2012, NEURON, V76, P383, DOI 10.1016/j.neuron.2012.08.028; Kubik S, 2015, MOL CELL, V60, P422, DOI 10.1016/j.molcel.2015.10.002; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lancaster AK, 2009, EVOLUTION, V63, P2350, DOI 10.1111/j.1558-5646.2009.00729.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laprell F, 2017, SCIENCE, V356, P85, DOI 10.1126/science.aai8266; Logie C, 1999, METHOD ENZYMOL, V304, P726; LOO S, 1994, SCIENCE, V264, P1768, DOI 10.1126/science.8209257; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Majumdar A, 2012, CELL, V148, P515, DOI 10.1016/j.cell.2012.01.004; Malovichko YV, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030212; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013; NANNEY DL, 1958, P NATL ACAD SCI USA, V44, P712, DOI 10.1073/pnas.44.7.712; Nusinzon Inna, 2005, Sci STKE, V2005, pre11, DOI 10.1126/stke.2962005re11; PALLADINO F, 1993, CELL, V75, P543, DOI 10.1016/0092-8674(93)90388-7; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Peter J, 2018, NATURE, V556, P339, DOI 10.1038/s41586-018-0030-5; Petryk N, 2018, SCIENCE, V361, P1389, DOI 10.1126/science.aau0294; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Ragunathan K, 2015, SCIENCE, V348, DOI 10.1126/science.1258699; Rechavi O, 2014, CELL, V158, P277, DOI 10.1016/j.cell.2014.06.020; Reinberg D, 2018, SCIENCE, V361, P33, DOI 10.1126/science.aat7871; Riggs A. D., 1996, TORRENTS SPRING, P1; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Sharma U, 2016, SCIENCE, V351, P391, DOI 10.1126/science.aad6780; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; SHORE D, 1994, TRENDS GENET, V10, P408, DOI 10.1016/0168-9525(94)90058-2; Smith JD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0900-9; Stephan JS, 2015, CELL REP, V11, P1772, DOI 10.1016/j.celrep.2015.04.060; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, METHOD ENZYMOL, V412, P185, DOI 10.1016/S0076-6879(06)12012-1; Tapia H, 2014, CURR BIOL, V24, P2758, DOI 10.1016/j.cub.2014.10.005; Thurtle DM, 2014, GENE DEV, V28, P245, DOI 10.1101/gad.230532.113; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Usaj M, 2017, G3-GENES GENOM GENET, V7, P1539, DOI 10.1534/g3.117.040220; Vandenbosch D, 2013, FEMS YEAST RES, V13, P720, DOI 10.1111/1567-1364.12071; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Wang XY, 2017, SCIENCE, V356, P88, DOI 10.1126/science.aaj2114; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2006, METHODS, V39, P3, DOI 10.1016/j.ymeth.2006.04.009; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; YOUNG CSH, 1971, HEREDITY, V26, P413, DOI 10.1038/hdy.1971.52; Yu CH, 2018, SCIENCE, V361, P1386, DOI 10.1126/science.aat8849; Yu R, 2018, NATURE, V558, P615, DOI 10.1038/s41586-018-0239-3; Yuan AH, 2017, SCIENCE, V355, P198, DOI 10.1126/science.aai7776	111	35	36	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2020	180	5					928	+		10.1016/j.cell.2020.02.014	http://dx.doi.org/10.1016/j.cell.2020.02.014			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KT7JN	32109413	Green Accepted, Bronze			2022-12-28	WOS:000519189800012
J	Taylor, A				Taylor, Anne			Overstretched NHS services are sending suicidal students back to universities for help	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												annetaylor.writer@gmail.com						Children's Commissioner, 2020, CHILDR MENT HLTH REP; Davies SC, ANN REPORT CHIEF MED; Gunnell D, 2020, J AFFECT DISORDERS, V261, P113, DOI 10.1016/j.jad.2019.09.079; Hughes G., 2019, U MENTAL HLTH CHARTE; McManus S, 2014, MENTAL HLTH WELLBEIN; Office for Students, 2019, UND EFF PRACT IMPR M; Sadler K., 2018, MENTAL HLTH CHILDREN; Thorley C., 2017, NOT DEGREES IMPROVIN; Universities UK, STEPCH MENT HLTH HIG	9	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2020	368								m814	10.1136/bmj.m814	http://dx.doi.org/10.1136/bmj.m814			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KE	32132103				2022-12-28	WOS:000519536600012
J	Groce, NE; Groce, N				Groce, Nora Ellen; Groce, Nancy			In the US, even those with excellent healthcare insurance plans struggle	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Groce, Nora Ellen] UCL, Dept Epidemiol & Hlth Care, London, England	University of London; University College London	Groce, NE (corresponding author), UCL, Dept Epidemiol & Hlth Care, London, England.	nora.groce@ucl.ac.uk						[Anonymous], 2019, OPINION OBSERVER VIE; [Anonymous], 2019, THE GUARDIAN; Dobkin C, 2018, NEW ENGL J MED, V378, P1076, DOI 10.1056/NEJMp1716604; Meyer D, 2019, THERES ONE SUBJECT U; Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2020	368								m808	10.1136/bmj.m808	http://dx.doi.org/10.1136/bmj.m808			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KD	32127366				2022-12-28	WOS:000519536500005
J	Andrist, E				Andrist, Erica			Is He OK?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								In the middle of the night, the teenage boy is awake, coughing, desaturated, hypotensive. His monitors are squalling. Soon, it is better: some fentanyl, rocuronium, a little fluid. The room quiets. "Is he OK?" his mother asks. "Yes," I say, squeezing her shoulder.	[Andrist, Erica] Univ Michigan, CS Mott Childrens Hosp, Med Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Andrist, E (corresponding author), Univ Michigan, CS Mott Childrens Hosp, Med Ctr, Ann Arbor, MI 48109 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2020	382	9					795	797		10.1056/NEJMp1912072	http://dx.doi.org/10.1056/NEJMp1912072			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KS8TT	32101662				2022-12-28	WOS:000518581500005
J	Watts, G				Watts, Geoff			Research Focus: beyond the 100 000 genomes	LANCET			English	Editorial Material																			0	2	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2019	393	10166					15	16		10.1016/S0140-6736(18)33252-5	http://dx.doi.org/10.1016/S0140-6736(18)33252-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HG4DR	32145832				2022-12-28	WOS:000454925000012
J	Krown, SE; Moser, CB; MacPhail, P; Matining, RM; Godfrey, C; Caruso, SR; Hosseinipour, MC; Samaneka, W; Nyirenda, M; Busakhala, NW; Okuku, FM; Kosgei, J; Hoagland, B; Mwelase, N; Oliver, VO; Burger, H; Mngqibisa, R; Nokta, M; Campbell, TB; Borok, MZ				Krown, Susan E.; Moser, Carlee B.; MacPhail, Patrick; Matining, Roy M.; Godfrey, Catherine; Caruso, Stephanie R.; Hosseinipour, Mina C.; Samaneka, Wadzanai; Nyirenda, Mulinda; Busakhala, Naftali W.; Okuku, Fred M.; Kosgei, Josphat; Hoagland, Brenda; Mwelase, Noluthando; Oliver, Vincent O.; Burger, Henriette; Mngqibisa, Rosie; Nokta, Mostafa; Campbell, Thomas B.; Borok, Margaret Z.		A5263 AMC066 Protocol Team	Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial	LANCET			English	Article							PEGYLATED-LIPOSOMAL DOXORUBICIN; ORAL ETOPOSIDE; ANTIRETROVIRAL THERAPY; PACLITAXEL; VINCRISTINE; BLEOMYCIN; EFFICACY	Background Optimal treatment regimens for AIDS-associated Kaposi sarcoma, a frequent contributor to morbidity and mortality among people with HIV, have not been systematically evaluated in low-income and middle-income countries, where the disease is most common. In this study, we aimed to investigate optimal treatment strategies for advanced stage disease in areas of high prevalence and limited resources. Methods In this open-label, non-inferiority trial, we enrolled people with HIV and advanced stage AIDS-associated Kaposi sarcoma attending 11 AIDS Clinical Trials Group sites in Brazil, Kenya, Malawi, South Africa, Uganda, and Zimbabwe. Eligible participants were randomly assigned (1:1:1) with a centralised computer system to receive either intravenous bleomycin and vincristine or oral etoposide (the investigational arms), or intravenous paclitaxel (the control arm), together with antiretroviral therapy (ART; combined efavirenz, tenofovir disoproxil fumarate, and emtricitabine). The primary outcome was progression-free survival (PFS) at week 48, using a 15% non-inferiority margin to compare the investigational groups against the active control group. Safety was assessed in all eligible treated study participants. The study was registered with ClinicalTrials.gov, NCT01435018. Findings 334 participants were enrolled between Oct 1, 2013, and March 8, 2018, when the study was closed early due to inferiority of the bleomycin and vincristine plus ART arm, as per the recommendations of the Data and Safety Monitoring Board (DSMB). The etoposide plus ART arm also closed due to inferiority in March, 2016, following a DSMB recommendation. Week-48 PFS rates were higher in the paclitaxel plus ART arm than in both investigational arms. The absolute differences in PFS were -30% (95% CI -52 to -8) for the comparison of paclitaxel plus ART (week 48 PFS 50%, 32 to 67; n=59) and etoposide plus ART (20%, 6 to 33; n=59), and -20% (-33% to -7%) for the comparison of paclitaxel plus ART (64%, 55 to 73; n=138) and bleomycin and vincristine plus ART (44%, 35 to 53; n=132). Both CIs overlapped the non-inferiority margin. The most common adverse events, in 329 eligible participants who began treatment, were neutropenia (48 [15%]), low serum albumin (33 [10%]), weight loss (29 [9%]), and anaemia (28 [9%]), occurring at similar frequency across treatment arms. Interpretation Non-inferiority of either investigational intervention was not shown, with paclitaxel plus ART showing superiority to both oral etoposide plus ART and bleomycin and vincristine plus ART, supporting its use in treating advanced AIDS-associated Kaposi sarcoma in resource-limited settings. Copyright (c) 2020 Elsevier Ltd. All rights reserved.	[Krown, Susan E.] AIDS Malignancy Consortium, New York, NY 10024 USA; [Moser, Carlee B.; Matining, Roy M.] Harvard TH Chan Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA USA; [MacPhail, Patrick; Mwelase, Noluthando] Univ Witwatersrand, Dept Internal Med, Clin HIV Res Unit, Johannesburg, South Africa; [Godfrey, Catherine] NIAID, Div Aids, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Caruso, Stephanie R.] Frontier Sci Fdn, Amherst, NY USA; [Hosseinipour, Mina C.] UNC Project Malawi, Lilongwe, Malawi; [Hosseinipour, Mina C.] Univ N Carolina, Sch Med, Dept Med, Div Infect Dis, Chapel Hill, NC 27515 USA; [Samaneka, Wadzanai] Parirenyatwa Clin Res Site, Harare, Zimbabwe; [Nyirenda, Mulinda] Univ Malawi, Coll Med, Johns Hopkins Res Project, Blantyre, Malawi; [Busakhala, Naftali W.] Moi Univ, Sch Med, Eldoret, Kenya; [Okuku, Fred M.] Uganda Canc Inst, Kampala, Uganda; [Kosgei, Josphat] Kenya Govt Med Res Ctr, USA Med Directorate Africa Kenya, Kericho, Kenya; [Hoagland, Brenda] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil; [Oliver, Vincent O.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Ctr Dis Control & Prevent, Kisumu CRS,HIV Res Branch, Kisumu, Kenya; [Burger, Henriette] Stellenbosch Univ, Family Clin Res Unit CRS, Cape Town, South Africa; [Burger, Henriette] Stellenbosch Univ, Div Radiat Oncol, Cape Town, South Africa; [Burger, Henriette] Tygerberg Hosp, Cape Town, South Africa; [Mngqibisa, Rosie] Enhancing Care Fdn, Durban Int Clin Res Site, Durban, South Africa; [Nokta, Mostafa] NCI, Off HIV & AIDS Malignancy, NIH, Bethesda, MD 20892 USA; [Campbell, Thomas B.] Univ Colorado, Sch Med, Dept Med, Div Infect Dis, Aurora, CO USA; [Borok, Margaret Z.] Univ Zimbabwe, Coll Hlth Sci, Dept Med, Harare, Zimbabwe	Harvard University; Harvard T.H. Chan School of Public Health; University of Witwatersrand; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Frontier Science Foundation; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Malawi; Moi University; Kenya Medical Research Institute; Fundacao Oswaldo Cruz; Kenya Medical Research Institute; Stellenbosch University; Stellenbosch University; Tygerberg Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Zimbabwe	Krown, SE (corresponding author), AIDS Malignancy Consortium, New York, NY 10024 USA.	krowns@mskcc.org	Oliver, Vincent/AAC-1792-2019	Oliver, Vincent/0000-0003-3061-1593; dittmer, dirk/0000-0003-4968-5656; Nyirenda, Mulinda/0000-0003-2037-7449	US National Institute of Allergy and Infectious Diseases; National Cancer Institute, National Institutes of Health	US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	US National Institute of Allergy and Infectious Diseases and National Cancer Institute, National Institutes of Health.	Bekolo CE, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3771-x; Burger H, 2018, SAMJ S AFR MED J, V108, P1059, DOI [10.7196/samj.2018.v108i12.13202, 10.7196/SAMJ.2018.v108i12.13202]; Busakhala NW, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00077; Cesarman E, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0060-9; Chalya Phillipo L, 2015, BMC Res Notes, V8, P440, DOI 10.1186/s13104-015-1348-9; Cianfrocca M, 2010, CANCER-AM CANCER SOC, V116, P3969, DOI 10.1002/cncr.25362; Clinton Health Access Initiative, 2017, AM CANC SOC CLIN HLT, V2020; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Ely S., 2015, 15 INT C MALIGNANCIE; Evans SR, 2002, J CLIN ONCOL, V20, P3236, DOI 10.1200/JCO.2002.12.038; Gill PS, 1999, J CLIN ONCOL, V17, P1876, DOI 10.1200/JCO.1999.17.6.1876; Goebel FD, 1996, BRIT J CANCER, V73, P989, DOI 10.1038/bjc.1996.193; Greenwood M., 1926, REP PUBLIC HLTH MED, V33, P1; Herce ME, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19929; Hosseinipour MC, 2018, CLIN INFECT DIS, V67, P251, DOI 10.1093/cid/ciy044; Krown SE, 2004, SEMIN ONCOL, V31, P36, DOI 10.1053/j.seminoncol.2004.08.003; KROWN SE, 1989, J CLIN ONCOL, V7, P1201, DOI 10.1200/JCO.1989.7.9.1201; Mosam A, 2012, JAIDS-J ACQ IMM DEF, V60, P150, DOI 10.1097/QAI.0b013e318251aedd; Mtonga W, 2018, CURR HIV RES, V16, P231, DOI 10.2174/1570162X16666180711103610; Mwafongo AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091020; Nalwoga A, 2015, TROP MED INT HEALTH, V20, P665, DOI 10.1111/tmi.12464; National Institute of Allergy and Infectious Diseases, DAIDS ADV EV GRAD TA; Northfelt DW, 1998, J CLIN ONCOL, V16, P2445, DOI 10.1200/JCO.1998.16.7.2445; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Olweny CLM, 2005, INT J CANCER, V113, P632, DOI 10.1002/ijc.20606; PAREDES J, 1995, J ACQ IMMUN DEF SYND, V9, P138; Reid E, 2019, J NATL COMPR CANC NE, V17, P171, DOI 10.6004/jnccn.2019.0008; Rohner E, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.261.11300; Rohner E, 2017, CLIN INFECT DIS, V65, P1316, DOI 10.1093/cid/cix480; Schwartsmann G, 1997, J CLIN ONCOL, V15, P2118, DOI 10.1200/JCO.1997.15.5.2118; Semeere AS, 2012, CURR OPIN ONCOL, V24, P522, DOI 10.1097/CCO.0b013e328355e14b; Stefan Daniela Cristina, 2015, J Glob Oncol, V1, P30, DOI 10.1200/JGO.2015.000406; Stewart S, 1998, J CLIN ONCOL, V16, P683, DOI 10.1200/JCO.1998.16.2.683; Strother RM, 2010, ONCOLOGY-BASEL, V78, P5, DOI 10.1159/000292356; Welles L, 1998, J CLIN ONCOL, V16, P1112, DOI 10.1200/JCO.1998.16.3.1112; World Health Organization, 2014, GUIDELINES TREATMENT	36	29	29	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2020	395	10231					1195	1207		10.1016/S0140-6736(19)33222-2	http://dx.doi.org/10.1016/S0140-6736(19)33222-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LE6DW	32145827	Green Accepted			2022-12-28	WOS:000526814200029
J	Vidakovic, AT; Mitter, R; Kelly, GP; Neumann, M; Harreman, M; Rodriguez-Martinez, M; Herlihy, A; Weems, JC; Boeing, S; Encheva, V; Gaul, L; Milligan, L; Tollervey, D; Conaway, RC; Conaway, JW; Snijders, AP; Stewart, A; Svejstrup, JQ				Vidakovic, Ana Tufegdzic; Mitter, Richard; Kelly, Gavin P.; Neumann, Michelle; Harreman, Michelle; Rodriguez-Martinez, Marta; Herlihy, Anna; Weems, Juston C.; Boeing, Stefan; Encheva, Vesela; Gaul, Liam; Milligan, Laura; Tollervey, David; Conaway, Ronald C.; Conaway, Joan W.; Snijders, Ambrosius P.; Stewart, Aengus; Svejstrup, Jesper Q.			Regulation of the RNAPII Pool Is Integral to the DNA Damage Response	CELL			English	Article							MULTIPLE SEQUENCE ALIGNMENT; COCKAYNE-SYNDROME; POLYMERASE-II; STRUCTURAL BASIS; CELLULAR-RESPONSE; GENE-EXPRESSION; READ ALIGNMENT; UV-IRRADIATION; POL-II; TRANSCRIPTION	In response to transcription-blocking DNA damage, cells orchestrate a multi-pronged reaction, involving transcription-coupled DNA repair, degradation of RNA polymerase II (RNAPII), ane genome-wide transcription shutdown. Here, we provide insight into how these responses are connected by the finding that ubiquitylation of RNAPII itself, at a single lysine (RPB1 K-1268), is the focal point for DNA-damageresponse coordination. K-1268 ubiquitylation affects DNA repair and signals RNAP11 degradation, essential for surviving genotoxic insult. RNAPII degradation results in a shutdown of transcriptional initiation, in the absence of which cells display dramatic transcriptome alterations. Additionally, regulation of RNAPII stability is central to transcription recovery-persistent RNAPII depletion underlies the failure of this process in Cockayne syndrome B cells. These data expose regulation of global RNAPII levels as integral to the cellular DNA-damage response and open the intriguing possibility that RNAPII pool size generally affects cell-specific transcription programs in genome instability disorders and even normal cells.	[Vidakovic, Ana Tufegdzic; Neumann, Michelle; Harreman, Michelle; Rodriguez-Martinez, Marta; Herlihy, Anna; Boeing, Stefan; Gaul, Liam; Svejstrup, Jesper Q.] Francis Crick Inst, Mech Transcript Lab, 1 Midland Rd, London NW1 1AT, England; [Mitter, Richard; Kelly, Gavin P.; Stewart, Aengus] Francis Crick Inst, Bioinformat & Biostat, 1 Midland Rd, London NW1 1AT, England; [Encheva, Vesela; Snijders, Ambrosius P.] Francis Crick Inst, Prot Anal & Prote Lab, 1 Midland Rd, London NW1 1AT, England; [Weems, Juston C.; Conaway, Ronald C.; Conaway, Joan W.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Conaway, Ronald C.; Conaway, Joan W.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Milligan, Laura; Tollervey, David] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland	Francis Crick Institute; Francis Crick Institute; Francis Crick Institute; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Edinburgh	Svejstrup, JQ (corresponding author), Francis Crick Inst, Mech Transcript Lab, 1 Midland Rd, London NW1 1AT, England.	jesper.svejstrup@crick.ac.uk	Kelly, Gavin/ABG-2715-2021; Tollervey, David/AAR-6662-2020	Kelly, Gavin/0000-0001-7219-560X; Tollervey, David/0000-0003-2894-2772; Snijders, Bram/0000-0002-5416-8592; Tufegdzic Vidakovic, Ana/0000-0001-7494-4387; Rodriguez-Martinez, Marta/0000-0001-9728-166X; Gaul, Liam/0000-0002-3159-8127	Francis Crick Institute (FCI) (Cancer Research UK) [FC001166]; Francis Crick Institute (FCI) (UK Medical Research Council) [FC001166]; Francis Crick Institute (FCI) (Wellcome Trust) [FC001166]; European Research Council [693327]; Wellcome Trust [1099160]	Francis Crick Institute (FCI) (Cancer Research UK); Francis Crick Institute (FCI) (UK Medical Research Council); Francis Crick Institute (FCI) (Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Francis Crick Institute (FCI receives its core funding from Cancer Research UK [FC001166], the UK Medical Research Council [FC001166], and the Wellcome Trust [FC001166]), the European Research Council (Agreement 693327 to J.Q.S.), and the Wellcome Trust (1099160 to D.T.). We thank FCI's Advanced Sequencing Facility, Cell Services, and the High Throughput Screening Facility for their help with this project. The Flp-In-compatible destination vector was kindly provided by Markus Landthaler. The RNAPII CTD S2 phosphorylation-specific antibody (3E10) was a kind gift from Dirk Eick. We thank Eric Forgy for adapting his Pages.jl package, Melvin Gonzalez and Yanfeng He for their input, members of the Svejstrup laboratory for discussions, and Peter Verrijzer and Barbara Dirac-Svejstrup for helpful comments on the manuscript.	Adam S, 2013, CELL, V155, P94, DOI 10.1016/j.cell.2013.08.029; Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12; Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Anindya R, 2010, MOL CELL, V38, P637, DOI 10.1016/j.molcel.2010.04.017; Bahrami Shahram, 2016, Advances in Biological Regulation, V62, P37, DOI 10.1016/j.jbior.2016.05.001; Bernecky C, 2016, NATURE, V529, P551, DOI 10.1038/nature16482; Boeing S, 2016, CELL REP, V15, P1597, DOI 10.1016/j.celrep.2016.04.047; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Brooks PJ, 2013, DNA REPAIR, V12, P656, DOI 10.1016/j.dnarep.2013.04.018; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Dinant C, 2013, MOL CELL, V51, P469, DOI 10.1016/j.molcel.2013.08.007; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ehrensberger AH, 2013, CELL, V154, P713, DOI 10.1016/j.cell.2013.07.032; Elia AEH, 2015, MOL CELL, V59, P867, DOI 10.1016/j.molcel.2015.05.006; Epanchintsev A, 2017, MOL CELL, V68, P1054, DOI 10.1016/j.molcel.2017.11.009; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Garinis GA, 2009, NAT CELL BIOL, V11, P604, DOI 10.1038/ncb1866; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; Gnatt A, 1997, J BIOL CHEM, V272, P30799, DOI 10.1074/jbc.272.49.30799; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gregersen LH, 2020, NAT PROTOC, V15, P604, DOI 10.1038/s41596-019-0262-3; Gregersen LH, 2019, CELL, V177, P1797, DOI 10.1016/j.cell.2019.04.038; Gregersen LH, 2018, TRENDS BIOCHEM SCI, V43, P327, DOI 10.1016/j.tibs.2018.02.010; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Gyenis A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004483; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; He JS, 2017, ONCOTARGET, V8, P11004, DOI 10.18632/oncotarget.14205; Healy S, 2013, PHARMACOL THERAPEUT, V137, P64, DOI 10.1016/j.pharmthera.2012.09.001; Jimenez-Sanchez M, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024240; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kristensen U, 2013, P NATL ACAD SCI USA, V110, pE2261, DOI 10.1073/pnas.1220071110; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Kuznetsova AV, 2003, P NATL ACAD SCI USA, V100, P2706, DOI 10.1073/pnas.0436037100; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lavigne MD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02145-4; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SS, 2002, EMBO J, V21, P5921, DOI 10.1093/emboj/cdf589; Lommel L, 2000, P NATL ACAD SCI USA, V97, P9088, DOI 10.1073/pnas.150130197; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mattiroli F, 2014, NAT STRUCT MOL BIOL, V21, P308, DOI 10.1038/nsmb.2792; MAYNE LV, 1982, CANCER RES, V42, P1473; McKay BC, 2004, P NATL ACAD SCI USA, V101, P6582, DOI 10.1073/pnas.0308181101; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Milligan L, 2017, ELIFE, V6, DOI 10.7554/eLife.27082; MITCHELL DL, 1988, PHOTOCHEM PHOTOBIOL, V48, P51; Mourgues S, 2013, P NATL ACAD SCI USA, V110, P17927, DOI 10.1073/pnas.1305009110; Oksenych V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003611; Povlsen LK, 2012, NAT CELL BIOL, V14, P1089, DOI 10.1038/ncb2579; Proietti-De-Santis L, 2006, EMBO J, V25, P1915, DOI 10.1038/sj.emboj.7601071; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797; Rolig RL, 2000, TRENDS NEUROSCI, V23, P417, DOI 10.1016/S0166-2236(00)01625-8; Romero JP, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2816-x; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tullai JW, 2007, J BIOL CHEM, V282, P23981, DOI 10.1074/jbc.M702044200; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; van den Boom V, 2004, J CELL BIOL, V166, P27, DOI 10.1083/jcb.200401056; Velez-Cruz R, 2013, MECH AGEING DEV, V134, P234, DOI 10.1016/j.mad.2013.03.004; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; Verbruggen P, 2011, J BIOL CHEM, V286, P3681, DOI 10.1074/jbc.M110.154799; Vermeulen W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012625; Vichi P, 1997, EMBO J, V16, P7444, DOI 10.1093/emboj/16.24.7444; Vidakovic AT, 2019, METHODS, V159, P146, DOI 10.1016/j.ymeth.2019.02.005; Wang YM, 2016, CELL REP, V14, P2554, DOI 10.1016/j.celrep.2016.02.051; Wang YM, 2014, P NATL ACAD SCI USA, V111, P14454, DOI 10.1073/pnas.1412569111; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weems JC, 2019, METHODS, V159, P157, DOI 10.1016/j.ymeth.2019.02.015; Williamson L, 2017, CELL, V168, P843, DOI 10.1016/j.cell.2017.01.019; Wilson MD, 2013, CELL, V154, P983, DOI 10.1016/j.cell.2013.07.028; Wilson MD, 2013, BBA-GENE REGUL MECH, V1829, P151, DOI 10.1016/j.bbagrm.2012.08.002; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; Xu J, 2017, NATURE, V551, P653, DOI 10.1038/nature24658	85	63	64	4	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2020	180	6					1245	+		10.1016/j.cell.2020.02.009	http://dx.doi.org/10.1016/j.cell.2020.02.009			38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KW1IO	32142654	Green Published, hybrid			2022-12-28	WOS:000520925300018
J	Rimmer, A				Rimmer, Abi			Covid-19: GPs call for appraisals and CQC inspections to be suspended	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		RIMMER A, 2019, BMJ-BRIT MED J, V364, DOI DOI 10.1136/BMJ.L1331	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2020	368								m1038	10.1136/bmj.m1038	http://dx.doi.org/10.1136/bmj.m1038			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AU	32165414	Bronze			2022-12-28	WOS:000520013500013
J	Smith, H; Wernham, A; Patel, A				Smith, H.; Wernham, A.; Patel, A.			PRACTICE POINTER When to suspect a non-melanoma skin cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SQUAMOUS-CELL CARCINOMA; ACTINIC KERATOSIS; RISK; EPIDEMIOLOGY; GUIDELINES; MANAGEMENT; DERMOSCOPY; HISTORY		[Smith, H.; Wernham, A.; Patel, A.] Nottingham NHS Treatment Ctr, Dept Dermatol, Nottingham NG7 2FT, England		Smith, H (corresponding author), Nottingham NHS Treatment Ctr, Dept Dermatol, Nottingham NG7 2FT, England.	Hayley.smith14@nhs.net						Alfonso JH, 2016, J AM ACAD DERMATOL, V75, P548, DOI 10.1016/j.jaad.2016.03.033; Ammasaigoundan V, 2017, INT J RES MED SCI, V5, P2712, DOI [10.18203/2320-6012.ijrms20172475, DOI 10.18203/2320-6012.IJRMS20172475]; Apalla Zoe, 2017, Dermatol Pract Concept, V7, P1, DOI 10.5826/dpc.0702a01; Bandyopadhyay MR, 2016, INDIAN J DERMATOL, V61, DOI 10.4103/0019-5154.174131; Baxter JM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5342; Criscione VD, 2009, CANCER-AM CANCER SOC, V115, P2523, DOI 10.1002/cncr.24284; de Berker D, 2017, BRIT J DERMATOL, V176, P20, DOI 10.1111/bjd.15107; Deepadarshan K, 2013, J CLIN DIAGN RES, V7, P3010, DOI 10.7860/JCDR/2013/7568.3831; Flohil SC, 2013, J INVEST DERMATOL, V133, P913, DOI 10.1038/jid.2012.431; Franceschi S, 1996, INT J CANCER, V67, P24, DOI 10.1002/(SICI)1097-0215(19960703)67:1<24::AID-IJC6>3.0.CO;2-1; Gupta AK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-158; Heath M, 2008, J AM ACAD DERMATOL, V58, P375, DOI 10.1016/j.jaad.2007.11.020; Iorizzo LJ, 2011, DERMATOL SURG, V37, P146, DOI 10.1111/j.1524-4725.2010.01843.x; Krutmann J, 2015, SKIN PHARMACOL PHYS, V28, P281, DOI 10.1159/000437272; Marcil I, 2000, ARCH DERMATOL, V136, P1524, DOI 10.1001/archderm.136.12.1524; Mehrany K, 2005, J AM ACAD DERMATOL, V53, P1067, DOI 10.1016/j.jaad.2005.08.055; Montague M, 2001, HEALTH EDUC BEHAV, V28, P290, DOI 10.1177/109019810102800304; National Institute for Health and Clinical Excellence, 2010, IMPR OUTC PEOPL SKIN; NICE, 2015, SUSP CANC REC REF; Roewert-Huber J, 2007, BRIT J DERMATOL, V157, P47, DOI 10.1111/j.1365-2133.2007.08273.x; Telfer NR, 2008, BRIT J DERMATOL, V159, P35, DOI 10.1111/j.1365-2133.2008.08666.x; THOMPSON SC, 1993, NEW ENGL J MED, V329, P1147, DOI 10.1056/NEJM199310143291602; Tierney P, 2015, BRIT J DERMATOL, V173, P201, DOI 10.1111/bjd.13714; Venables ZC, 2019, JAMA DERMATOL, V155, P298, DOI 10.1001/jamadermatol.2018.4219; Zaballos P, 2005, ARCH DERMATOL, V141, P808, DOI 10.1001/archderm.141.6.808; Zalaudek I, 2004, BRIT J DERMATOL, V150, P1112, DOI 10.1111/j.1365-2133.2004.05924.x; Zwald FO, 2011, J AM ACAD DERMATOL, V65, P253, DOI 10.1016/j.jaad.2010.11.062	27	2	2	3	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2020	368								m692	10.1136/bmj.m692	http://dx.doi.org/10.1136/bmj.m692			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AR	32161002				2022-12-28	WOS:000520012800006
J	[Anonymous]				[Anonymous]			Coronavirus disease 2019 (covid-19): a guide for UK GPs (vol 368, m800, 2020)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		Razai MS, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m800	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2020	368								m989	10.1136/bmj.m989	http://dx.doi.org/10.1136/bmj.m989			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AR	32160998	Bronze			2022-12-28	WOS:000520012800012
J	Mahase, E				Mahase, Elisabeth			Social prescribing: is it working?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		World Health Organization (WHO), 2019, 67 WHO	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2020	368								m950	10.1136/bmj.m950	http://dx.doi.org/10.1136/bmj.m950			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AK	32151998				2022-12-28	WOS:000520012000008
J	Ghebreyesus, TA; Swaminathan, S				Ghebreyesus, Tedros Adhanom; Swaminathan, Soumya			Scientists are sprinting to outpace the novel coronavirus	LANCET			English	Editorial Material									[Ghebreyesus, Tedros Adhanom; Swaminathan, Soumya] World Hlth Org, CH-1211 Geneva, Switzerland	World Health Organization	Ghebreyesus, TA (corresponding author), World Hlth Org, CH-1211 Geneva, Switzerland.	DGOffice@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Global Preparedness Monitoring Board, 2019, FLAGSH REP; The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WEEKLY 202; WHO, 2019, WHO; WHO, 2020, WORLD EXP FUND SET P; World Health Organization, WHO DIR GEN OP REM M, DOI DOI 10.1016/J.ENVPOL.2020.114280; World Health Organization, 2020, NAT CAP REV TOOL NOV; World Health Organization, 2020, 64 WHO; World Health Organization, 2020, WHO CHIN LEAD DISC N	8	20	23	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2020	395	10226					762	764		10.1016/S0140-6736(20)30420-7	http://dx.doi.org/10.1016/S0140-6736(20)30420-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU2KH	32105610	Bronze, Green Published			2022-12-28	WOS:000519536900009
J	Cook, R; Davidson, P; Martin, R				Cook, Rob; Davidson, Peter; Martin, Rosie		NIHR Dissemination Ctr	Group cognitive behavioural courses may reduce fatigue from rheumatoid arthritis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								The study Hewlett S, Almeida C, Ambler N, et al. Reducing arthritis fatigue impact: two-year randomised controlled trial of cognitive behavioural approaches by rheumatology teams (RAFT). Ann Rheum Dis 2019;78:465-72. Hewlett S, Almeida C, Ambler N, et al. Group cognitive behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations. Health Technol Assess 2019;23:57. This project was funded by the NIHR Health Technology Assessment Programme (project number 11/112/01).	[Cook, Rob; Martin, Rosie] Intelligence Unit Healthcare, London, England; [Davidson, Peter] Univ Southampton, Wessex Inst, Southampton, Hants, England	University of Southampton	Cook, R (corresponding author), Intelligence Unit Healthcare, London, England.	rob.cook@bazian.com						[Anonymous], 2019, NHS WEBS RHEUM ARTHR; Arthritis Foundation, 2017, FIGHT FAT RA; National Institute for Health and Care Excellence, 2018, RHEUM ARTHR AD MAN; Versus Arthritis, 2018, WHAT IS RHEUM ARTHR	4	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2020	368								m512	10.1136/bmj.m512	http://dx.doi.org/10.1136/bmj.m512			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2LJ	32144210				2022-12-28	WOS:000519539700001
J	Leslie, M				Leslie, Mitch			THE BODY'S DANGEROUS DEFENDERS	SCIENCE			English	Editorial Material																			0	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1067	1069		10.1126/science.367.6482.1067	http://dx.doi.org/10.1126/science.367.6482.1067			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU9CD	32139526				2022-12-28	WOS:000520018400021
J	Chen, TA; Chuu, CP; Tseng, CC; Wen, CK; Wong, HSP; Pan, SY; Li, RT; Chao, TA; Chueh, WC; Zhang, YF; Fu, Q; Yakobson, BI; Chang, WH; Li, LJ				Chen, Tse-An; Chuu, Chih-Piao; Tseng, Chien-Chih; Wen, Chao-Kai; Wong, H. -S. Philip; Pan, Shuangyuan; Li, Rongtan; Chao, Tzu-Ang; Chueh, Wei-Chen; Zhang, Yanfeng; Fu, Qiang; Yakobson, Boris I.; Chang, Wen-Hao; Li, Lain-Jong			Wafer-scale single-crystal hexagonal boron nitride monolayers on Cu (111)	NATURE			English	Article							GRAPHENE; GROWTH; METALS; BN	The epitaxial growth of single-crystal hexagonal boron nitride monolayers on a copper (111) thin film across a sapphire wafer suggests a route to the broad adoption of two-dimensional layered semiconductor materials in industry. Ultrathin two-dimensional (2D) semiconducting layered materials offer great potential for extending Moore's law of the number of transistors in an integrated circuit(1). One key challenge with 2D semiconductors is to avoid the formation of charge scattering and trap sites from adjacent dielectrics. An insulating van der Waals layer of hexagonal boron nitride (hBN) provides an excellent interface dielectric, efficiently reducing charge scattering(2,3). Recent studies have shown the growth of single-crystal hBN films on molten gold surfaces(4) or bulk copper foils(5). However, the use of molten gold is not favoured by industry, owing to its high cost, cross-contamination and potential issues of process control and scalability. Copper foils might be suitable for roll-to-roll processes, but are unlikely to be compatible with advanced microelectronic fabrication on wafers. Thus, a reliable way of growing single-crystal hBN films directly on wafers would contribute to the broad adoption of 2D layered materials in industry. Previous attempts to grow hBN monolayers on Cu (111) metals have failed to achieve mono-orientation, resulting in unwanted grain boundaries when the layers merge into films(6,7). Growing single-crystal hBN on such high-symmetry surface planes as Cu (111)(5,8) is widely believed to be impossible, even in theory. Nonetheless, here we report the successful epitaxial growth of single-crystal hBN monolayers on a Cu (111) thin film across a two-inch c-plane sapphire wafer. This surprising result is corroborated by our first-principles calculations, suggesting that the epitaxial growth is enhanced by lateral docking of hBN to Cu (111) steps, ensuring the mono-orientation of hBN monolayers. The obtained single-crystal hBN, incorporated as an interface layer between molybdenum disulfide and hafnium dioxide in a bottom-gate configuration, enhanced the electrical performance of transistors. This reliable approach to producing wafer-scale single-crystal hBN paves the way to future 2D electronics.	[Chen, Tse-An; Chuu, Chih-Piao; Wong, H. -S. Philip; Chao, Tzu-Ang; Li, Lain-Jong] TSMC, Corp Res, Hsinchu, Taiwan; [Tseng, Chien-Chih; Wen, Chao-Kai; Chao, Tzu-Ang; Chueh, Wei-Chen; Chang, Wen-Hao] Natl Chiao Tung Univ, Dept Electrophys, Hsinchu, Taiwan; [Pan, Shuangyuan; Zhang, Yanfeng] Peking Univ, Dept Mat Sci & Engn, Coll Engn, Beijing, Peoples R China; [Li, Rongtan; Fu, Qiang] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Catalysis, Dalian, Peoples R China; [Li, Rongtan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yakobson, Boris I.] Rice Univ, Dept Mat Sci & Nanoengn, Houston, TX USA; [Yakobson, Boris I.] Rice Univ, Dept Chem, Houston, TX USA; [Yakobson, Boris I.] Rice Univ, Smalley Curl Inst Nanoscale Sci & Technol, Houston, TX USA; [Chang, Wen-Hao] Natl Chiao Tung Univ, CEFMS, Hsinchu, Taiwan	Taiwan Semiconductor Manufacturing Company; National Yang Ming Chiao Tung University; Peking University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; State Key Laboratory of Catalysis, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Rice University; Rice University; Rice University; National Yang Ming Chiao Tung University	Li, LJ (corresponding author), TSMC, Corp Res, Hsinchu, Taiwan.; Chang, WH (corresponding author), Natl Chiao Tung Univ, Dept Electrophys, Hsinchu, Taiwan.; Yakobson, BI (corresponding author), Rice Univ, Dept Mat Sci & Nanoengn, Houston, TX USA.; Yakobson, BI (corresponding author), Rice Univ, Dept Chem, Houston, TX USA.; Yakobson, BI (corresponding author), Rice Univ, Smalley Curl Inst Nanoscale Sci & Technol, Houston, TX USA.; Chang, WH (corresponding author), Natl Chiao Tung Univ, CEFMS, Hsinchu, Taiwan.	biy@rice.edu; whchang@mail.nctu.edu.tw; ljliv@tsmc.com	Fu, Qiang/E-7109-2015; Li, Lain-Jong/D-5244-2011; Chang, Wen-Hao/C-4906-2013; Yakobson, Boris/ABA-3897-2020; Chuu, Chih-Piao/E-5677-2018	Fu, Qiang/0000-0001-5316-6758; Li, Lain-Jong/0000-0002-4059-7783; Chang, Wen-Hao/0000-0003-4880-6006; Yakobson, Boris/0000-0001-8369-3567; Li, Rongtan/0000-0003-2061-3368	Taiwan Semiconductor Manufacturing Company (TSMC); Ministry of Science and Technology of Taiwan [MOST-108-2119-M-009-011-MY3, MOST-107-2112-M-009-024-MY3]; CEFMS of the National Chiao Tung University; Ministry of Education of Taiwan; National Natural Science Foundation of China [51861135201, 21688102, 21825203]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB17020000]; US Department of Energy [DE-SC0012547]	Taiwan Semiconductor Manufacturing Company (TSMC); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); CEFMS of the National Chiao Tung University; Ministry of Education of Taiwan(Ministry of Education, Taiwan); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); US Department of Energy(United States Department of Energy (DOE))	Tse-An Chen, C.-P.C., H.-S.P.W. and L.-J.L. acknowledge support from the Taiwan Semiconductor Manufacturing Company (TSMC). W.-H.C. acknowledges support from the Ministry of Science and Technology of Taiwan (grants MOST-108-2119-M-009-011-MY3 and MOST-107-2112-M-009-024-MY3) and from the CEFMS of the National Chiao Tung University, supported by the Ministry of Education of Taiwan. Y.Z. acknowledges financial support from the National Natural Science Foundation of China (grant 51861135201). Q.F. thanks the National Natural Science Foundation of China (grants 21688102 and 21825203) and the Strategic Priority Research Program of the Chinese Academy of Sciences (grant XDB17020000) for financial support. B.I.Y. acknowledges support from the US Department of Energy (grant DE-SC0012547) and a stimulating discussion with T. Ivanov (US Army Research Laboratory). Tse-An Chen and L.-J.L. acknowledge useful discussions with S. Brems at Imec.	[Anonymous], 2016, MEDEA; Bets KV, 2019, NANO LETT, V19, P2027, DOI 10.1021/acs.nanolett.9b00136; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Deng B, 2017, ACS NANO, V11, P12337, DOI 10.1021/acsnano.7b06196; Hsu WF, 2019, ACS APPL NANO MATER, V2, P1964, DOI 10.1021/acsanm.8b02358; Jin L, 2011, PHYS CHEM CHEM PHYS, V13, P16655, DOI 10.1039/c1cp21843c; Jin S, 2018, SCIENCE, V362, P1021, DOI 10.1126/science.aao3373; Joshi S, 2012, NANO LETT, V12, P5821, DOI 10.1021/nl303170m; Kim G, 2013, NANO LETT, V13, P1834, DOI 10.1021/nl400559s; Klimes J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.195131; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Lee JS, 2018, SCIENCE, V362, P817, DOI 10.1126/science.aau2132; Li G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1675; Li JD, 2016, SMALL, V12, P3645, DOI 10.1002/smll.201600681; Li MY, 2019, NATURE, V567, P169, DOI 10.1038/d41586-019-00793-8; Liu YY, 2011, NANO LETT, V11, P3113, DOI 10.1021/nl2011142; Novoselov KS, 2016, SCIENCE, V353, DOI 10.1126/science.aac9439; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Song XJ, 2015, NANO RES, V8, P3164, DOI 10.1007/s12274-015-0816-9; Uchida Y, 2017, PHYS CHEM CHEM PHYS, V19, P8230, DOI 10.1039/c6cp08903h; Verguts K, 2016, J PHYS CHEM C, V120, P297, DOI 10.1021/acs.jpcc.5b09461; Wang L, 2019, NATURE, V570, P91, DOI 10.1038/s41586-019-1226-z; Zhao RQ, 2017, NANOSCALE, V9, P3561, DOI 10.1039/c6nr09368j	24	248	247	95	732	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 12	2020	579	7798					219	+		10.1038/s41586-020-2009-2	http://dx.doi.org/10.1038/s41586-020-2009-2		MAR 2020	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SE4SW	32132712	Green Submitted			2022-12-28	WOS:000518098200001
J	Drouin-Chartier, JP; Chen, SY; Li, YP; Schwab, AL; Stampfer, MJ; Sacks, FM; Rosner, B; Willett, WC; Hu, FB; Bhupathiraju, SN				Drouin-Chartier, Jean-Philippe; Chen, Siyu; Li, Yanping; Schwab, Amanda L.; Stampfer, Meir J.; Sacks, Frank M.; Rosner, Bernard; Willett, Walter C.; Hu, Frank B.; Bhupathiraju, Shilpa N.			Egg consumption and risk of cardiovascular disease: three large prospective US cohort studies, systematic review, and updated meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CORONARY-HEART-DISEASE; DIETARY-PROTEIN SOURCES; CAUSE-SPECIFIC MORTALITY; SERUM TOTAL CHOLESTEROL; ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; STROKE MORTALITY; TREND ESTIMATION; QUESTIONNAIRE; REPRODUCIBILITY	OBJECTIVE To evaluate the association between egg intake and cardiovascular disease risk among women and men in the United States, and to conduct a meta-analysis of prospective cohort studies. DESIGN Prospective cohort study, and a systematic review and meta-analysis of prospective cohort studies. SETTING Nurses' Health Study (NHS, 1980-2012), NHS II (1991-2013), Health Professionals' Follow-Up Study (HPFS, 1986-2012). PARTICIPANTS Cohort analyses included 83 349 women from NHS, 90 214 women from NHS II, and 42 055 men from HPFS who were free of cardiovascular disease, type 2 diabetes, and cancer at baseline. MAIN OUTCOME MEASURES Incident cardiovascular disease, which included non-fatal myocardial infarction, fatal coronary heart disease, and stroke. RESULTS Over up to 32 years of follow-up (>5.54 million person years), 14 806 participants with incident cardiovascular disease were identified in the three cohorts. Participants with a higher egg intake had a higher body mass index, were less likely to be treated with statins, and consumed more red meats. Most people consumed between one and less than five eggs per week. In the pooled multivariable analysis, consumption of at least one egg per day was not associated with incident cardiovascular disease risk after adjustment for updated lifestyle and dietary factors associated with egg intake (hazard ratio for at least one egg per day v less than one egg per month 0.93, 95% confidence interval 0.82 to 1.05). In the updated meta-analysis of prospective cohort studies (33 risk estimates, 1 720 108 participants, 139 195 cardiovascular disease events), an increase of one egg per day was not associated with cardiovascular disease risk (pooled relative risk 0.98, 95% confidence interval 0.93 to 1.03, I-2=62.3%). Results were similar for coronary heart disease (21 risk estimates, 1 411 261 participants, 59 713 coronary heart disease events; 0.96, 0.91 to 1.03, I-2=38.2%), and stroke (22 risk estimates, 1 059 315 participants, 53 617 stroke events; 0.99, 0.91 to 1.07, I-2=71.5%). In analyses stratified by geographical location (P for interaction=0.07), no association was found between egg consumption and cardiovascular disease risk among US cohorts (1.01, 0.96 to 1.06, I-2=30.8%) or European cohorts (1.05, 0.92 to 1.19, I-2=64.7%), but an inverse association was seen in Asian cohorts (0.92, 0.85 to 0.99, I-2=44.8%). CONCLUSIONS Results from the three cohorts and from the updated meta-analysis show that moderate egg consumption (up to one egg per day) is not associated with cardiovascular disease risk overall, and is associated with potentially lower cardiovascular disease risk in Asian populations.	[Drouin-Chartier, Jean-Philippe; Chen, Siyu; Li, Yanping; Schwab, Amanda L.; Stampfer, Meir J.; Sacks, Frank M.; Rosner, Bernard; Willett, Walter C.; Hu, Frank B.; Bhupathiraju, Shilpa N.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, 677 Huntington Ave, Boston, MA 02115 USA; [Stampfer, Meir J.; Willett, Walter C.; Hu, Frank B.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Stampfer, Meir J.; Sacks, Frank M.; Rosner, Bernard; Willett, Walter C.; Hu, Frank B.; Bhupathiraju, Shilpa N.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Rosner, Bernard] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Drouin-Chartier, JP (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, 677 Huntington Ave, Boston, MA 02115 USA.	drouinchartier@hsph.harvard.edu	li, yan/GTI-4638-2022		National Institutes of Health (NIH) [P01 CA87969, R01 HL034594, R01 HL088521, UM1 CA186107, UM1 CA176726, UM1 CA167552, R01 HL35464, R01 HL60712, U01 CA167552]; Banting postdoctoral fellowship from the Canadian Institutes of Health Research [BPF-156628]; NIH [HL60712, HL118264, DK112940, K01 DK107804]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Banting postdoctoral fellowship from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Nurses' Health Study (NHS), NHS II, and Health Professionals' Follow-Up Study cohorts are supported by the following National Institutes of Health (NIH) grants: P01 CA87969, R01 HL034594, R01 HL088521, UM1 CA186107, UM1 CA176726, UM1 CA167552, R01 HL35464, R01 HL60712, U01 CA167552. JPDC is supported by a Banting postdoctoral fellowship from the Canadian Institutes of Health Research (BPF-156628). FBH is supported by grants HL60712, HL118264, and DK112940 from the NIH. SNB is supported by a career development grant from the NIH (K01 DK107804). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Abdollahi AM, 2019, AM J CLIN NUTR, V110, P169, DOI 10.1093/ajcn/nqz066; Alexander DD, 2016, J AM COLL NUTR, V35, P704, DOI 10.1080/07315724.2016.1152928; [Anonymous], 1971, REP 5 WORK GROUP INC; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bao Y, 2016, AM J PUBLIC HEALTH, V106, P1573, DOI 10.2105/AJPH.2016.303338; Bechthold A, 2019, CRIT REV FOOD SCI, V59, P1071, DOI 10.1080/10408398.2017.1392288; BELANGER CF, 1978, AM J NURS, V78, P1039, DOI 10.2307/3462013; Bernstein AM, 2010, CIRCULATION, V122, P876, DOI 10.1161/CIRCULATIONAHA.109.915165; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Diez-Espino J, 2017, CLIN NUTR, V36, P1015, DOI 10.1016/j.clnu.2016.06.009; Djousse L, 2008, AM J CLIN NUTR, V87, P964, DOI 10.1093/ajcn/87.4.964; Eshel G, 2014, P NATL ACAD SCI USA, V111, P11996, DOI 10.1073/pnas.1402183111; Farvid MS, 2017, AM J PREV MED, V52, P237, DOI 10.1016/j.amepre.2016.10.041; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Fuller NR, 2018, AM J CLIN NUTR, V107, P921, DOI 10.1093/ajcn/nqy048; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Goldberg S, 2014, ATHEROSCLEROSIS, V235, P273, DOI 10.1016/j.atherosclerosis.2014.04.019; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Guo J, 2018, EUR J NUTR, V57, P2943, DOI 10.1007/s00394-017-1566-0; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Houston DK, 2011, NUTR METAB CARDIOVAS, V21, P430, DOI 10.1016/j.numecd.2009.11.007; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1999, JAMA-J AM MED ASSOC, V281, P1387, DOI 10.1001/jama.281.15.1387; Jang J, 2018, NUTR DIABETES, V8, DOI 10.1038/s41387-018-0033-1; Key TJ, 2019, CIRCULATION, V139, P2835, DOI 10.1161/CIRCULATIONAHA.118.038813; Khawaja O, 2017, FRONT NUTR, V4, DOI 10.3389/fnut.2017.00010; Krauss RM, 2000, CIRCULATION, V102, P2284; Kuang HQ, 2018, CHOLESTEROL, DOI 10.1155/2018/6303810; Larsson SC, 2015, AM J CLIN NUTR, V102, P1007, DOI 10.3945/ajcn.115.119263; Li YH, 2013, ATHEROSCLEROSIS, V229, P524, DOI 10.1016/j.atherosclerosis.2013.04.003; Mann JI, 1997, HEART, V78, P450, DOI 10.1136/hrt.78.5.450; Misirli G, 2012, AM J EPIDEMIOL, V176, P1185, DOI 10.1093/aje/kws205; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Nakamura Y, 2004, AM J CLIN NUTR, V80, P58; Nakamura Y, 2006, BRIT J NUTR, V96, P921, DOI 10.1017/BJN20061937; Nakamura Y, 2018, EUR J CLIN NUTR, V72, P841, DOI 10.1038/s41430-017-0051-4; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Orsini N, 2010, COMPUT METH PROG BIO, V98, P90, DOI 10.1016/j.cmpb.2009.11.005; Prevention CfDCa, 2017, HEART DIS FACT 2017; Qin CX, 2018, HEART, V104, P1803, DOI 10.1136/heartjnl-2018-313781; Qin CX, 2018, HEART, V104, P1756, DOI 10.1136/heartjnl-2017-312651; Qureshi AI, 2007, MED SCI MONITOR, V13, pCR1; Richard C, 2017, CAN J DIABETES, V41, P453, DOI 10.1016/j.jcjd.2016.12.002; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Sauvaget C, 2003, INT J EPIDEMIOL, V32, P536, DOI 10.1093/ije/dyg151; Scrafford CG, 2011, PUBLIC HEALTH NUTR, V14, P261, DOI 10.1017/S1368980010001874; SHEKELLE RB, 1982, AM J EPIDEMIOL, V115, P506, DOI 10.1093/oxfordjournals.aje.a113332; Shin JY, 2012, DIABETES, V61, pA379; Song MY, 2018, EUR J EPIDEMIOL, V33, P137, DOI 10.1007/s10654-018-0371-2; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Trichopoulou A, 2006, J INTERN MED, V259, P583, DOI 10.1111/j.1365-2796.2006.01638.x; USDA, 2015, SCI REP 2015 DIET GU; van den Brandt PA, 2019, EUR J EPIDEMIOL, V34, P351, DOI 10.1007/s10654-019-00483-9; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Verges B, 2015, DIABETOLOGIA, V58, P886, DOI 10.1007/s00125-015-3525-8; Virtanen JK, 2016, AM J CLIN NUTR, V103, P895, DOI 10.3945/ajcn.115.122317; Wang JB, 2016, SCI REP-UK, V6, DOI 10.1038/srep22619; Weinfeld, 1981, STROKE S1, V12, pI13; Wells G.A., 2000, VIS COMMUN Q; Willett W.C., 1998, SAUPTIKAPARVAN MAHAB, DOI [10.1093/acprof:oso/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.003.11]; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; WILLETT WC, 1988, AM J EPIDEMIOL, V127, P188, DOI 10.1093/oxfordjournals.aje.a114780; WILLETT WC, 1987, NEW ENGL J MED, V317, P1303, DOI 10.1056/NEJM198711193172102; Xu L, 2019, EUR J NUTR, V58, P785, DOI 10.1007/s00394-018-1692-3; Yaemsiri S, 2012, ANN NEUROL, V72, P704, DOI 10.1002/ana.23555; Zazpe I, 2011, EUR J CLIN NUTR, V65, P676, DOI 10.1038/ejcn.2011.30; Zhong VW, 2019, JAMA-J AM MED ASSOC, V321, P1081, DOI 10.1001/jama.2019.1572	70	65	68	4	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2020	368								m513	10.1136/bmj.m513	http://dx.doi.org/10.1136/bmj.m513			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KE	32132002	Green Published, hybrid			2022-12-28	WOS:000519536600003
J	Christie, B				Christie, Bryan			Summit on drug deaths ends with no agreement	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2019, DRUG REL DEATHS 2019; Christie B, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4731; Hurley R, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m802; NHS Digital, 2019, STAT DRUG MIS ENGL 2	4	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2020	368								m822	10.1136/bmj.m822	http://dx.doi.org/10.1136/bmj.m822			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KC	32122933				2022-12-28	WOS:000519536400006
J	Luo, ZC; Hrabec, A; Dao, TP; Sala, G; Finizio, S; Feng, JX; Mayr, S; Raabe, J; Gambardella, P; Heyderman, LJ				Luo, Zhaochu; Hrabec, Ales; Dao, Trong Phuong; Sala, Giacomo; Finizio, Simone; Feng, Junxiao; Mayr, Sina; Raabe, Joerg; Gambardella, Pietro; Heyderman, Laura J.			Current-driven magnetic domain-wall logic	NATURE			English	Article							MAJORITY GATE; SPIN TORQUE; DYNAMICS; PROPOSAL	Spin-based logic architectures provide nonvolatile data retention, near-zero leakage, and scalability, extending the technology roadmap beyond complementary metal-oxide-semiconductor logic(1-13). Architectures based on magnetic domain walls take advantage of the fast motion, high density, non-volatility and flexible design of domain walls to process and store information(1,3,14-16). Such schemes, however, rely on domain-wall manipulation and clocking using an external magnetic field, which limits their implementation in dense, large-scale chips. Here we demonstrate a method for performing all-electric logic operations and cascading using domain-wall racetracks. We exploit the chiral coupling between neighbouring magnetic domains induced by the interfacial Dzyaloshinskii-Moriya interaction(17-20), which promotes non-collinear spin alignment, to realize a domain-wall inverter, the essential basic building block in all implementations of Boolean logic. We then fabricate reconfigurable NAND and NOR logic gates, and perform operations with current-induced domain-wall motion. Finally, we cascade several NAND gates to build XOR and full adder gates, demonstrating electrical control of magnetic data and device interconnection in logic circuits. Our work provides a viable platform for scalable all-electric magnetic logic, paving the way for memory-in-logic applications.	[Luo, Zhaochu; Hrabec, Ales; Dao, Trong Phuong; Mayr, Sina; Heyderman, Laura J.] Swiss Fed Inst Technol, Dept Mat, Lab Mesoscop Syst, Zurich, Switzerland; [Luo, Zhaochu; Hrabec, Ales; Dao, Trong Phuong; Finizio, Simone; Mayr, Sina; Raabe, Joerg; Heyderman, Laura J.] Paul Scherrer Inst, Villigen, Switzerland; [Hrabec, Ales; Dao, Trong Phuong; Sala, Giacomo; Feng, Junxiao; Gambardella, Pietro] Swiss Fed Inst Technol, Dept Mat, Lab Magnetism & Interface Phys, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Luo, ZC; Heyderman, LJ (corresponding author), Swiss Fed Inst Technol, Dept Mat, Lab Mesoscop Syst, Zurich, Switzerland.; Luo, ZC; Heyderman, LJ (corresponding author), Paul Scherrer Inst, Villigen, Switzerland.; Gambardella, P (corresponding author), Swiss Fed Inst Technol, Dept Mat, Lab Magnetism & Interface Phys, Zurich, Switzerland.	zhaochu.luo@psi.ch; pietro.gambardella@mat.ethz.ch; laura.heyderman@psi.ch	Finizio, Simone/AAE-2533-2020; Gambardella, Pietro/B-1880-2009; Heyderman, Laura/E-7959-2015; Luo, Zhaochu/AAM-2983-2021; Raabe, Jörg/C-4818-2012	Finizio, Simone/0000-0002-1792-0626; Gambardella, Pietro/0000-0003-0031-9217; Heyderman, Laura/0000-0003-3843-6611; Raabe, Jörg/0000-0002-2071-6896; Feng, Junxiao/0000-0001-8915-9103; Sala, Giacomo/0000-0001-5696-5627	Swiss National Science Foundation [200020-172775, 200021-172517]; European Union's Horizon 2020 research and innovation programme through Marie Skodowska-Curie grant [794207]; Chinese Scholarship Council; German Bundesministerium fur Bildung und Forschung [05KS4WE1/6, 05KS7WE1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union's Horizon 2020 research and innovation programme through Marie Skodowska-Curie grant; Chinese Scholarship Council(China Scholarship Council); German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	We thank A. Weber, V. Guzenko and X. Wang for technical support with sample fabrication and measurements. This work was supported by the Swiss National Science Foundation through grant number 200020-172775. S.M. acknowledges funding from the Swiss National Science Foundation under grant agreement number 200021-172517. A.H. was funded by the European Union's Horizon 2020 research and innovation programme through Marie Skodowska-Curie grant agreement number 794207 (ASIQS). J.F. was partially supported by a fellowship from the Chinese Scholarship Council. Part of this work was performed at the PolLux (X07DA) endstation of the Swiss Light Source, Paul Scherrer Institut, Villigen, Switzerland. The PolLux endstation was financed by the German Bundesministerium fur Bildung und Forschung under grant agreements 05KS4WE1/6 and 05KS7WE1. Part of this work was performed at the Scanning Probe Microscopy Laboratory, Laboratory for Micro and Nanotechnology, Paul Scherrer Institut, Villigen, Switzerland.	Allwood DA, 2005, SCIENCE, V309, P1688, DOI 10.1126/science.1108813; Allwood DA, 2002, SCIENCE, V296, P2003, DOI 10.1126/science.1070595; Baumgartner M, 2017, NAT NANOTECHNOL, V12, P980, DOI [10.1038/nnano.2017.151, 10.1038/NNANO.2017.151]; Behin-Aein B, 2010, NAT NANOTECHNOL, V5, P266, DOI [10.1038/nnano.2010.31, 10.1038/NNANO.2010.31]; Benitez MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9957; Bode M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.237205; Breitkreutz S, 2012, IEEE T MAGN, V48, P4336, DOI 10.1109/TMAG.2012.2197184; Chumak AV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5700; Currivan-Incorvia JA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10275; Dery H, 2007, NATURE, V447, P573, DOI 10.1038/nature05833; Emori S, 2013, NAT MATER, V12, P611, DOI [10.1038/NMAT3675, 10.1038/nmat3675]; Franken JH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05248; Franken JH, 2012, NAT NANOTECHNOL, V7, P499, DOI [10.1038/nnano.2012.111, 10.1038/NNANO.2012.111]; Haazen PPJ, 2013, NAT MATER, V12, P299, DOI [10.1038/nmat3553, 10.1038/NMAT3553]; Heide M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.140403; Imre A, 2006, SCIENCE, V311, P205, DOI 10.1126/science.1120506; Joo S, 2013, NATURE, V494, P72, DOI 10.1038/nature11817; Luo ZC, 2019, SCIENCE, V363, P1435, DOI 10.1126/science.aau7913; Manchon A, 2019, REV MOD PHYS, V91, DOI 10.1103/RevModPhys.91.035004; Manfrini M, 2018, AIP ADV, V8, DOI 10.1063/1.5007622; Manipatruni S, 2019, NATURE, V565, P35, DOI 10.1038/s41586-018-0770-2; Matsunaga S, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.091301; Miron IM, 2011, NAT MATER, V10, P419, DOI [10.1038/nmat3020, 10.1038/NMAT3020]; Ney A, 2003, NATURE, V425, P485, DOI 10.1038/nature02014; Nikonov DE, 2011, IEEE ELECTR DEVICE L, V32, P1128, DOI 10.1109/LED.2011.2156379; Parkin S, 2015, NAT NANOTECHNOL, V10, P195, DOI 10.1038/nnano.2015.41; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Ryu KS, 2013, NAT NANOTECHNOL, V8, P527, DOI [10.1038/nnano.2013.102, 10.1038/NNANO.2013.102]; Thiaville A, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/57002; Vansteenkiste A, 2014, AIP ADV, V4, DOI 10.1063/1.4899186	30	156	157	38	214	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7798					214	+		10.1038/s41586-020-2061-y	http://dx.doi.org/10.1038/s41586-020-2061-y			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU0CC	32161383	Green Accepted			2022-12-28	WOS:000519378900019
J	Jaffe, S				Jaffe, Susan			Medicare for All scrutinised in Democratic primaries	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 29	2020	395	10225					673	674						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KQ2JO	32113493				2022-12-28	WOS:000516755200012
J	Porter, AS; Harman, S; Lakin, JR				Porter, Amy S.; Harman, Stephanie; Lakin, Joshua R.			Power and perils of prediction in palliative care	LANCET			English	Editorial Material									[Porter, Amy S.] Rainbow Babies & Childrens Hosp, Ctr Comprehens Care, 2101 Adelbert Rd, Cleveland, OH 44106 USA; [Harman, Stephanie] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Lakin, Joshua R.] Dana Farber Canc Inst, Dept Psychosocial Oncol & Palliat Care, Boston, MA 02115 USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Stanford University; Harvard University; Dana-Farber Cancer Institute	Porter, AS (corresponding author), Rainbow Babies & Childrens Hosp, Ctr Comprehens Care, 2101 Adelbert Rd, Cleveland, OH 44106 USA.	amy.porter@uhhospitals.org		Lakin, Joshua/0000-0002-7659-6512	Cambia Health Foundation through the Sojourns Scholar Leadership Program	Cambia Health Foundation through the Sojourns Scholar Leadership Program	SH and JRL have received funding from the Cambia Health Foundation through the Sojourns Scholar Leadership Program. SH and JRL both advise informatics teams at their local institutions about development of predictive algorithms but receive no financial support from that work. SH is a faculty teacher for VitalTalk.org, a not-for-profit that trains and supports clinicians who care for patients with serious illness. The authors would like to thank Arthur Kleinman and Nora Kenworthy for their guidance on applying social scientific analysis and social theory to clinical practice.		0	6	8	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 29	2020	395	10225					680	681						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KQ2JO	32113499				2022-12-28	WOS:000516755200017
J	Iacobucci, G				Iacobucci, Gareth			Row over Babylon's chatbot shows lack of regulation	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Hammersmith and Fulham Clinical Commissioning Group, 2018, UPD GP HAND CLIN SAF; Royal Society of Medicine, 2020, REC DEV AI DIG HLHT	2	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2020	368								m815	10.1136/bmj.m815	http://dx.doi.org/10.1136/bmj.m815			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KA	32111647				2022-12-28	WOS:000519536200015
J	Wang, WL; Xu, YL; Gao, RQ; Lu, RJ; Han, K; Wu, GZ; Tan, WJ				Wang, Wenling; Xu, Yanli; Gao, Ruqin; Lu, Roujian; Han, Kai; Wu, Guizhen; Tan, Wenjie			Detection of SARS-CoV-2 in Different Types of Clinical Specimens	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study describes results of PCR and viral RNA testing for SARS-CoV-2 in bronchoalveolar fluid, sputum, feces, blood, and urine specimens from patients with COVID-19 infection in China to identify possible means of non-respiratory transmission.	[Wang, Wenling; Lu, Roujian; Wu, Guizhen; Tan, Wenjie] China CDC, Natl Inst Viral Dis Control & Prevent, 155 Changbai Rd, Beijing 102206, Peoples R China; [Xu, Yanli; Han, Kai] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China; [Gao, Ruqin] Qingdao Municipal Ctr Dis Control & Prevent, Qingdao, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Capital Medical University	Tan, WJ (corresponding author), China CDC, Natl Inst Viral Dis Control & Prevent, 155 Changbai Rd, Beijing 102206, Peoples R China.	tanwj@ivdc.chinacdc.cn			National Key Research and Development Program of China [2016YFD0500301, 2020YFC0840900]; National Major Project for Control and Prevention of Infectious Disease in China [2018ZX10101002]	National Key Research and Development Program of China; National Major Project for Control and Prevention of Infectious Disease in China	This work was supported by grants 2016YFD0500301 and 2020YFC0840900 from the National Key Research and Development Program of China and 2018ZX10101002 from the National Major Project for Control and Prevention of Infectious Disease in China.	Pan Y, 2020, LANCET INFECT DIS, V20, P411, DOI 10.1016/S1473-3099(20)30113-4; Tan WJ, 2020, CHINA CDC WEEKLY, V2, P61; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071	4	2118	2199	12	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2020	323	18					1843	1844		10.1001/jama.2020.3786	http://dx.doi.org/10.1001/jama.2020.3786			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LS2LS	32159775	Green Published, Bronze			2022-12-28	WOS:000536221500025
J	Orkin, C; Arasteh, K; Hernandez-Mora, MG; Pokrovsky, V; Overton, ET; Girard, PM; Oka, S; Walmsley, S; Bettacchi, C; Brinson, C; Philibert, P; Lombaard, J; Clair, MS; Crauwels, H; Ford, SL; Patel, P; Chounta, V; D'Amico, R; Vanveggel, S; Dorey, D; Cutrell, A; Griffith, S; Margolis, DA; Williams, PE; Parys, W; Smith, KY; Spreen, WR				Orkin, Chloe O. C.; Arasteh, Keikawus A. K.; Hernandez-Mora, M. Gorgolas M. G. H. M.; Pokrovsky, Vadim P. V.; Overton, Edgar T. O. E. T.; Girard, Pierre-Marie G. P. M.; Oka, Shinichi O. S.; Walmsley, Sharon W. S.; Bettacchi, Chris B. C.; Brinson, Cynthia B. C.; Philibert, Patrick P. P.; Lombaard, Johan L. J.; Clair, Marty C. M.; Crauwels, Herta C. H.; Ford, Susan L. F. S. L.; Patel, Parul P. P.; Chounta, Vasiliki C. V.; D'Amico, Ronald D. R.; Vanveggel, Simon V. S.; Dorey, David D. D.; Cutrell, Amy C. A.; Griffith, Sandy G. S.; Margolis, David A. M. D. A.; Williams, Peter E. W. P. E.; Parys, Wim P. W.; Smith, Kimberly Y. S. K. Y.; Spreen, William R. S. W. R.			Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIRETROVIRAL THERAPY; PHASE 2B; ADULTS	Background Long-acting injectable regimens may simplify therapy for patients with human immunodeficiency virus type 1 (HIV-1) infection. Methods We conducted a phase 3, randomized, open-label trial in which adults with HIV-1 infection who had not previously received antiretroviral therapy were given 20 weeks of daily oral induction therapy with dolutegravir-abacavir-lamivudine. Participants who had an HIV-1 RNA level of less than 50 copies per milliliter after 16 weeks were randomly assigned (1:1) to continue the current oral therapy or switch to oral cabotegravir plus rilpivirine for 1 month followed by monthly injections of long-acting cabotegravir plus rilpivirine. The primary end point was the percentage of participants who had an HIV-1 RNA level of 50 copies per milliliter or higher at week 48 (Food and Drug Administration snapshot algorithm). Results At week 48, an HIV-1 RNA level of 50 copies per milliliter or higher was found in 6 of 283 participants (2.1%) who received long-acting therapy and in 7 of 283 (2.5%) who received oral therapy (adjusted difference, -0.4 percentage points; 95% confidence interval [CI], -2.8 to 2.1), a result that met the criterion for noninferiority for the primary end point (margin, 6 percentage points). An HIV-1 RNA level of less than 50 copies per milliliter at week 48 was found in 93.6% who received long-acting therapy and in 93.3% who received oral therapy (adjusted difference, 0.4 percentage points; 95% CI, -3.7 to 4.5), a result that met the criterion for noninferiority for this end point (margin, -10 percentage points). Of the participants who received long-acting therapy, 86% reported injection-site reactions (median duration, 3 days; mild or moderate severity, 99% of cases); 4 participants withdrew from the trial for injection-related reasons. Grade 3 or higher adverse events and events that met liver-related stopping criteria occurred in 11% and 2%, respectively, who received long-acting therapy and in 4% and 1% who received oral therapy. Treatment satisfaction increased after participants switched to long-acting therapy; 91% preferred long-acting therapy at week 48. Conclusions Therapy with long-acting cabotegravir plus rilpivirine was noninferior to oral therapy with dolutegravir-abacavir-lamivudine with regard to maintaining HIV-1 suppression. Injection-site reactions were common. (Funded by ViiV Healthcare and Janssen; FLAIR ClinicalTrials.gov number, NCT02938520.)	[Orkin, Chloe O. C.] Queen Mary Univ London, London, England; [Chounta, Vasiliki C. V.] ViiV Healthcare, Brentford, England; [Arasteh, Keikawus A. K.] EPIMED, Berlin, Germany; [Hernandez-Mora, M. Gorgolas M. G. H. M.] Fdn Jimenez Diaz, Madrid, Spain; [Pokrovsky, Vadim P. V.] Cent Res Inst Epidemiol, Moscow, Russia; [Overton, Edgar T. O. E. T.] Univ Alabama Birmingham, Birmingham, AL USA; [Girard, Pierre-Marie G. P. M.] Hop St Antoine, Paris, France; [Philibert, Patrick P. P.] Hop Europeen, Marseille, France; [Oka, Shinichi O. S.] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Walmsley, Sharon W. S.] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [Ford, Susan L. F. S. L.; Dorey, David D. D.] GlaxoSmithKline, Mississauga, ON, Canada; [Bettacchi, Chris B. C.] North Texas Infect Dis Consultants, Dallas, TX USA; [Brinson, Cynthia B. C.] Cent Texas Clin Res, Austin, TX USA; [Lombaard, Johan L. J.] Josha Res, Bloemfontein, South Africa; [Clair, Marty C. M.; Patel, Parul P. P.; D'Amico, Ronald D. R.; Cutrell, Amy C. A.; Griffith, Sandy G. S.; Margolis, David A. M. D. A.; Smith, Kimberly Y. S. K. Y.; Spreen, William R. S. W. R.] ViiV Healthcare, Res Triangle Pk, NC USA; [Crauwels, Herta C. H.; Vanveggel, Simon V. S.; Williams, Peter E. W. P. E.; Parys, Wim P. W.] Janssen Res & Dev, Beerse, Belgium	University of London; Queen Mary University London; GlaxoSmithKline; University of Alabama System; University of Alabama Birmingham; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; National Center for Global Health & Medicine - Japan; University of Toronto; University Toronto Affiliates; University Health Network Toronto; GlaxoSmithKline; GlaxoSmithKline; Johnson & Johnson; Janssen Pharmaceuticals	Orkin, C (corresponding author), Queen Mary Univ London, Barts Hlth NHS Trust, Royal London Hosp, Dept Infect & Immun, London E1 1BB, England.	c.m.orkin@qmul.ac.uk		Overton, Edgar/0000-0002-4013-536X; Griffith, Sandy/0000-0002-3430-5131; Walmsley, Sharon/0000-0002-3959-5692	ViiV Healthcare; Janssen	ViiV Healthcare; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Supported by ViiV Healthcare and Janssen.	[Anonymous], 2018, OD PRESCR INF; [Anonymous], 2019, GUID US ANT AG AD AD; [Anonymous], 2019, ED RILP PRESCR INF; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Cahn P, 2019, LANCET, V393, P143, DOI 10.1016/S0140-6736(18)32462-0; Crauwels HM, 2010, 10 INT C DRUG THER H; FDA Center for Drug Evaluation and Research, 2015, HUM IMM VIR 1 INF DE; Glass TR, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14016; Hemelaar J, 2019, LANCET INFECT DIS, V19, P143, DOI 10.1016/S1473-3099(18)30647-9; Karmon SL, 2015, JAIDS-J ACQ IMM DEF, V68, pe39, DOI 10.1097/QAI.0000000000000469; Llibre JM, 2018, LANCET, V391, P839, DOI 10.1016/S0140-6736(17)33095-7; Margolis DA, 2018, HIV GLASG 2018 GLASG; Margolis DA, 2017, LANCET, V390, P1499, DOI 10.1016/S0140-6736(17)31917-7; Margolis DA, 2015, LANCET INFECT DIS, V15, P1145, DOI 10.1016/S1473-3099(15)00152-8; NIH, 2009, DIV AIDS TABL GRAD S; Ortego C, 2011, AIDS BEHAV, V15, P1381, DOI 10.1007/s10461-011-9942-x; Singh S, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-138; Stanford University, 2019, HIV DRUG RES DAT; Swindells S, 2020, NEW ENGL J MED, V382, P1112, DOI 10.1056/NEJMoa1904398; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Weld ED, 2019, JAIDS-J ACQ IMM DEF, V80, P190, DOI 10.1097/QAI.0000000000001896; Wensing AM, 2017, TOP ANTIVIR MED, V24, P132; Williams J, 2013, NANOMEDICINE-UK, V8, P1807, DOI 10.2217/nnm.12.214; Woodcock A, 2001, QUAL LIFE RES, V10, P517, DOI 10.1023/A:1013050904635	24	130	133	2	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2020	382	12					1124	1135		10.1056/NEJMoa1909512	http://dx.doi.org/10.1056/NEJMoa1909512			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KW7AJ	32130806	Bronze, Green Published			2022-12-28	WOS:000521333700012
J	Poch, O; Istiqomah, I; Quirico, E; Beck, P; Schmitt, B; Theule, P; Faure, A; Hily-Blant, P; Bonal, L; Raponi, A; Ciarniello, M; Rousseau, B; Potin, S; Brissaud, O; Flandinet, L; Filacchione, G; Pommerol, A; Thomas, N; Kappel, D; Mennella, V; Moroz, L; Vinogradoff, V; Arnold, G; Erard, S; Bockelee-Morvan, D; Leyrat, C; Capaccioni, F; De Sanctis, MC; Longobardo, A; Mancarella, F; Palomba, E; Tosi, F				Poch, Olivier; Istiqomah, Istiqomah; Quirico, Eric; Beck, Pierre; Schmitt, Bernard; Theule, Patrice; Faure, Alexandre; Hily-Blant, Pierre; Bonal, Lydie; Raponi, Andrea; Ciarniello, Mauro; Rousseau, Batiste; Potin, Sandra; Brissaud, Olivier; Flandinet, Laurene; Filacchione, Gianrico; Pommerol, Antoine; Thomas, Nicolas; Kappel, David; Mennella, Vito; Moroz, Lyuba; Vinogradoff, Vassilissa; Arnold, Gabriele; Erard, Stephane; Bockelee-Morvan, Dominique; Leyrat, Cedric; Capaccioni, Fabrizio; De Sanctis, Maria Cristina; Longobardo, Andrea; Mancarella, Francesca; Palomba, Ernesto; Tosi, Federico			Ammonium salts are a reservoir of nitrogen on a cometary nucleus and possibly on some asteroids	SCIENCE			English	Article							RESOLUTION INFRARED-SPECTROSCOPY; ICE ABSORPTION FEATURES; YOUNG STELLAR OBJECTS; EXPOSED WATER ICE; MU-M; BIDIRECTIONAL REFLECTANCE; MURCHISON METEORITE; INTERSTELLAR ICE; SPECTRA; SURFACE	The measured nitrogen-to-carbon ratio in comets is lower than for the Sun, a discrepancy which could be alleviated if there is an unknown reservoir of nitrogen in comets. The nucleus of comet 67P/Churyumov-Gerasimenko exhibits an unidentified broad spectral reflectance feature around 3.2 micrometers, which is ubiquitous across its surface. On the basis of laboratory experiments, we attribute this absorption band to ammonium salts mixed with dust on the surface. The depth of the band indicates that semivolatile ammonium salts are a substantial reservoir of nitrogen in the comet, potentially dominating over refractory organic matter and more volatile species. Similar absorption features appear in the spectra of some asteroids, implying a compositional link between asteroids, comets, and the parent interstellar cloud.	[Poch, Olivier; Istiqomah, Istiqomah; Quirico, Eric; Beck, Pierre; Schmitt, Bernard; Faure, Alexandre; Hily-Blant, Pierre; Bonal, Lydie; Rousseau, Batiste; Potin, Sandra; Brissaud, Olivier; Flandinet, Laurene] Univ Grenoble Alpes, CNRS, IPAG, F-38000 Grenoble, France; [Beck, Pierre] IUF, Paris, France; [Theule, Patrice] Aix Marseille Univ, CNRS, CNES, LAM, Marseille, France; [Raponi, Andrea; Ciarniello, Mauro; Rousseau, Batiste; Filacchione, Gianrico; Capaccioni, Fabrizio; De Sanctis, Maria Cristina; Longobardo, Andrea; Palomba, Ernesto; Tosi, Federico] Ist Nazl Astrofis INAF, IAPS, I-00133 Rome, Italy; [Pommerol, Antoine; Thomas, Nicolas] Univ Bern, Phys Inst, Sidlerstr 5, CH-3012 Bern, Switzerland; [Kappel, David] Univ Potsdam, Inst Phys & Astron, D-14476 Potsdam, Germany; [Kappel, David; Moroz, Lyuba; Arnold, Gabriele] German Aerosp Ctr DLR, Inst Planetary Res, D-12489 Berlin, Germany; [Mennella, Vito] Ist Nazl Astrofis INAF, Osservatorio Astron Capodimonte, Naples, Italy; [Vinogradoff, Vassilissa] Aix Marseille Univ, CNRS, Lab Phys Interact Ion & Mol PIIM, UMR,CNRS 7345, F-13397 Marseille, France; [Erard, Stephane; Bockelee-Morvan, Dominique; Leyrat, Cedric] Univ Paris, LESIA, Observ Paris, Univ Paris Sci & Lettres PSL,CNRS,Sorbonne Univ, F-92195 Meudon, France; [Longobardo, Andrea] Univ Parthenope, Dipartimento Sci & Tecnol DIST, I-80143 Naples, Italy; [Mancarella, Francesca] Univ Salento, Dipartimento Matemat & Fis E De Giorgi, Lecce, Italy	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Istituto Nazionale Astrofisica (INAF); University of Bern; University of Potsdam; Helmholtz Association; German Aerospace Centre (DLR); Istituto Nazionale Astrofisica (INAF); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Parthenope University Naples; University of Salento	Poch, O (corresponding author), Univ Grenoble Alpes, CNRS, IPAG, F-38000 Grenoble, France.	olivier.poch@univ-grenoble-alpes.fr	Tosi, Federico/F-2321-2018; Schmitt, Bernard/A-1064-2009; Potin, Sandra Manigand/G-7061-2019; Poch, Olivier/I-4159-2012; De Sanctis, Maria Cristina/G-5232-2013; Filacchione, Gianrico/S-2320-2017; Thomas, Nicolas/G-4693-2015; quirico, eric/K-9650-2013	Tosi, Federico/0000-0003-4002-2434; Schmitt, Bernard/0000-0002-1230-6627; Potin, Sandra Manigand/0000-0001-6907-3409; Poch, Olivier/0000-0001-6777-8296; De Sanctis, Maria Cristina/0000-0002-3463-4437; Capaccioni, Fabrizio/0000-0003-1631-4314; Erard, Stephane/0000-0002-9099-8366; Raponi, Andrea/0000-0003-4996-0099; Longobardo, Andrea/0000-0002-1797-2741; Filacchione, Gianrico/0000-0001-9567-0055; Rousseau, Batiste/0000-0001-9247-7890; Thomas, Nicolas/0000-0002-0146-0071; BONAL, Lydie/0000-0002-0655-4034; Mennella, Vito/0000-0001-9525-895X; quirico, eric/0000-0003-2768-0694; Faure, Alexandre/0000-0001-7199-2535	Centre National d'Etudes Spatiales (CNES); Lembaga Pengelola Dana Pendidikan (LPDP) Indonesian scholarship; Deutsche Forschungsgemeinschaft (DFG) [MO 3007/1-1]; CNES; French Agence Nationale de la Recherche [ANR-17-CE31-0004]; European Research Council under the SOLARYS grant [ERC-CoG2017-771691]; LabEx Observatoire des Sciences de l'Univers de Grenoble OSUG @ 2020; Initiatives de Recherche Strategiques (IRS); French National Program of Planetology (PNP); University of Grenoble Alpes (Initiative de Recherche Strategique); Universite Grenoble Alpes (UGA); Italian Space Agency (ASI, Italy); Centre National d'Etudes Spatiales (CNES, France); Deutsches Zentrum fur Luft-und Raumfahrt (DLR, Germany); National Aeronautic and Space Administration (NASA, United States) Rosetta Program; Science and Technology Facilities Council (United Kingdom); National Institute for Astrophysics (INAF, Italy); Italian Space Agency (ASI, Italy) [I/024/12/2]; Swiss National Science Foundation; DFG [KA 3757/2-1]; Initiatives d'Excellence UGA (IDEX UGA; ASI; Observatoire de Meudon - CNES; DLR	Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); Lembaga Pengelola Dana Pendidikan (LPDP) Indonesian scholarship; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); CNES(Centre National D'etudes Spatiales); French Agence Nationale de la Recherche(French National Research Agency (ANR)); European Research Council under the SOLARYS grant; LabEx Observatoire des Sciences de l'Univers de Grenoble OSUG @ 2020; Initiatives de Recherche Strategiques (IRS); French National Program of Planetology (PNP); University of Grenoble Alpes (Initiative de Recherche Strategique); Universite Grenoble Alpes (UGA); Italian Space Agency (ASI, Italy)(Agenzia Spaziale Italiana (ASI)); Centre National d'Etudes Spatiales (CNES, France)(Centre National D'etudes Spatiales); Deutsches Zentrum fur Luft-und Raumfahrt (DLR, Germany); National Aeronautic and Space Administration (NASA, United States) Rosetta Program; Science and Technology Facilities Council (United Kingdom)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); National Institute for Astrophysics (INAF, Italy); Italian Space Agency (ASI, Italy)(Agenzia Spaziale Italiana (ASI)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); DFG(German Research Foundation (DFG)); Initiatives d'Excellence UGA (IDEX UGA; ASI(Agenzia Spaziale Italiana (ASI)); Observatoire de Meudon - CNES; DLR(Helmholtz AssociationGerman Aerospace Centre (DLR))	Y O.P. acknowledges a postdoctoral fellowship from the Centre National d'Etudes Spatiales (CNES). I.I. acknowledges a thesis grant from the Lembaga Pengelola Dana Pendidikan (LPDP) Indonesian scholarship. L.M. acknowledges the Deutsche Forschungsgemeinschaft (DFG) grant MO 3007/1-1. D.K. acknowledges DFG-grant KA 3757/2-1. The work of O.P., I.I., E.Q., P.B., B.S., and L.B. was supported by the CNES and the French Agence Nationale de la Recherche (program Classy, ANR-17-CE31-0004). P.B. acknowledges funding from the European Research Council under the SOLARYS grant (ERC-CoG2017-771691). P.H.-B. acknowledges the LabEx Observatoire des Sciences de l'Univers de Grenoble OSUG @ 2020 for funding. S.P. is supported by Universite Grenoble Alpes (UGA), Initiatives de Recherche Strategiques (IRS), and Initiatives d'Excellence UGA (IDEX UGA). The development of the CarboN-IR environmental chamber was supported by the French National Program of Planetology (PNP), the development of the reflectance goniometers was supported by the University of Grenoble Alpes (Initiative de Recherche Strategique). Universite Grenoble Alpes (UGA) and CNES supported the instrumental facilities and activities at IPAG. The following institutions and agencies supported the Rosetta mission: the Italian Space Agency (ASI, Italy), Centre National d'Etudes Spatiales (CNES, France), Deutsches Zentrum fur Luft-und Raumfahrt (DLR, Germany), the National Aeronautic and Space Administration (NASA, United States) Rosetta Program and the Science and Technology Facilities Council (United Kingdom). VIRTIS was built by a consortium including Italy, France, and Germany, under the scientific responsibility of the Istituto di Astrofisica e Planetologia Spaziali of INAF, Italy, which also guided scientific operations. The development of the VIRTIS instrument was funded and managed by ASI, with contributions from Observatoire de Meudon, financed by CNES, and from DLR. A.R., M.C., G.F., F.C., M.C.D.S., A.L., E.P., and F.T. acknowledge financial support from the National Institute for Astrophysics (INAF, Italy) and the Italian Space Agency (ASI, Italy) through contract I/024/12/2. Computational resources were provided by INAF-IAPS through the DataWell project. The work of A.P. and N.T. was carried out within the framework of the National Centre of Competence in Research (NCCR) PlanetS supported by the Swiss National Science Foundation.	Altwegg K, 2017, MON NOT R ASTRON SOC, V469, pS130, DOI 10.1093/mnras/stx1415; Bardyn A, 2017, MON NOT R ASTRON SOC, V469, pS712, DOI 10.1093/mnras/stx2640; Berg BL, 2016, ICARUS, V265, P218, DOI 10.1016/j.icarus.2015.10.028; Bergner JB, 2016, ASTROPHYS J, V829, DOI 10.3847/0004-637X/829/2/85; Bonnefoy N., 2001, THESIS; Boogert ACA, 2008, ASTROPHYS J, V678, P985, DOI 10.1086/533425; Bossa JB, 2008, ASTRON ASTROPHYS, V492, P719, DOI 10.1051/0004-6361:200810536; BOVEY LFH, 1951, J OPT SOC AM, V41, P836, DOI 10.1364/JOSA.41.000836; Brissaud O, 2004, APPL OPTICS, V43, P1926, DOI 10.1364/AO.43.001926; Brown ME, 2016, ASTRON J, V152, DOI 10.3847/0004-6256/152/6/159; Brown ME, 2014, ASTROPHYS J LETT, V793, DOI 10.1088/2041-8205/793/2/L44; Brown RH, 2004, SPACE SCI REV, V115, P111, DOI 10.1007/s11214-004-1453-x; Burcar B, 2016, ANGEW CHEM INT EDIT, V55, P13249, DOI 10.1002/anie.201606239; Callahan MP, 2011, P NATL ACAD SCI USA, V108, P13995, DOI 10.1073/pnas.1106493108; Capaccioni F, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0628; Carrasco E, 2013, PHYS CHEM CHEM PHYS, V15, P1699, DOI 10.1039/c2cp43438e; Ciarniello M, 2016, MON NOT R ASTRON SOC, V462, pS443, DOI 10.1093/mnras/stw3177; Ciarniello M, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201526307; CLUTTER DR, 1969, J CHEM PHYS, V51, P153, DOI 10.1063/1.1671702; Coradini A, 2007, SPACE SCI REV, V128, P529, DOI 10.1007/s11214-006-9127-5; Coradini A, 2011, SCIENCE, V334, P492, DOI 10.1126/science.1204062; Danger G, 2011, ASTRON ASTROPHYS, V535, DOI 10.1051/0004-6361/201117602; Dartois E, 2018, ASTRON ASTROPHYS, V609, DOI 10.1051/0004-6361/201731322; De Sanctis MC, 2018, METEORIT PLANET SCI, V53, P1844, DOI 10.1111/maps.13104; De Sanctis MC, 2015, NATURE, V525, P500, DOI 10.1038/nature14869; Dello Russo N, 2016, ICARUS, V266, P152, DOI 10.1016/j.icarus.2015.11.030; Dello Russo N, 2016, ICARUS, V278, P301, DOI 10.1016/j.icarus.2016.05.039; Demyk K, 1998, ASTRON ASTROPHYS, V339, P553; DiSanti MA, 2016, ASTROPHYS J, V820, DOI 10.3847/0004-637X/820/1/34; Dziedzic P, 2009, TETRAHEDRON LETT, V50, P7242, DOI 10.1016/j.tetlet.2009.10.014; Emery JP, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/1/25; Filacchione G, 2016, NATURE, V529, P368, DOI 10.1038/nature16190; Filacchione G., 2006, THESIS; Filacchione G, 2019, SPACE SCI REV, V215, DOI 10.1007/s11214-019-0580-3; Filacchione G, 2016, ICARUS, V274, P334, DOI 10.1016/j.icarus.2016.02.055; Fortin TJ, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000677; Fray N, 2017, MON NOT R ASTRON SOC, V469, pS506, DOI 10.1093/mnras/stx2002; Furi E, 2015, NAT GEOSCI, V8, P515, DOI [10.1038/NGEO2451, 10.1038/ngeo2451]; Galvez O, 2010, ASTROPHYS J, V724, P539, DOI 10.1088/0004-637X/724/1/539; Goesmann F, 2015, SCIENCE, V349, DOI 10.1126/science.aab0689; Gounelle M, 2014, METEORIT PLANET SCI, V49, P1769, DOI 10.1111/maps.12351; Grisolle F., 2014, EUR PLAN SCI C CASC; HAMANN SD, 1977, AUST J CHEM, V30, P2591, DOI 10.1071/CH9772591; Hanni N, 2019, J PHYS CHEM A, V123, P5805, DOI 10.1021/acs.jpca.9b03534; Hapke B., 2012, THEORY REFLECTANCE E; KARGEL JS, 1992, ICARUS, V100, P556, DOI 10.1016/0019-1035(92)90118-Q; Keane JV, 2001, ASTRON ASTROPHYS, V376, P254, DOI 10.1051/0004-6361:20010936; Le Roy L, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201526450; Lerner NR, 2005, GEOCHIM COSMOCHIM AC, V69, P2901, DOI 10.1016/j.gca.2004.12.024; Levasseur-Regourd AC, 2018, SPACE SCI REV, V214, DOI 10.1007/s11214-018-0496-3; Licandro J, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201015339; Lide D., 2009, CRC HDB CHEM PHYS, V90; Lodders K, 2010, ASTROPHYSICS SPACE, P379, DOI 10.1007/978-3-642-10352-0_8; Marboeuf U, 2014, ICARUS, V242, P225, DOI 10.1016/j.icarus.2014.07.001; Mate B, 2009, ASTROPHYS J LETT, V703, pL178, DOI 10.1088/0004-637X/703/2/L178; Moore MH, 2003, EARTH MOON PLANETS, V92, P291, DOI 10.1023/B:MOON.0000031946.53696.f6; Mumma M. J., 2018, 50 AM ASTR SOC DPS M; PIZZARELLO S, 1994, GEOCHIM COSMOCHIM AC, V58, P5579, DOI 10.1016/0016-7037(94)90251-8; Poch O., 2018, VIS NIR BIDIRECTIONA, DOI [10.26302/SSHADE/EXPERIMENT_OP_ 20200212_001, DOI 10.26302/SSHADE/EXPERIMENT_OP_20200212_001]; Poch O., 2018, VIS NIR BIDIRECTIONA; Poch O., 2018, VIS NIR BIDIRECTIONA, DOI [10.26302/SSHADE/EXPERIMENT_OP_20191119_001, DOI 10.26302/SSHADE/EXPERIMENT_OP_20191119_001]; Poch O, 2016, ICARUS, V267, P154, DOI 10.1016/j.icarus.2015.12.017; Poch O, 2016, ICARUS, V266, P288, DOI 10.1016/j.icarus.2015.11.006; Pontoppidan KM, 2003, ASTRON ASTROPHYS, V408, P981, DOI 10.1051/0004-6361:20031030; Potapov A, 2019, ASTROPHYS J LETT, V878, DOI 10.3847/2041-8213/ab2538; Potin S, 2018, APPL OPTICS, V57, P8279, DOI 10.1364/AO.57.008279; Raponi A, 2020, NAT ASTRON, V4, P500, DOI 10.1038/s41550-019-0992-8; Raponi A, 2016, MON NOT R ASTRON SOC, V462, pS476, DOI 10.1093/mnras/stw3281; Raunier S, 2003, CHEM PHYS LETT, V368, P594, DOI 10.1016/S0009-2614(02)01919-X; Rivkin A.S., 2015, ASTEROIDS, P65, DOI DOI 10.2458/AZU_UAPRESS_9780816532131-CH004; Rivkin AS, 2010, NATURE, V464, P1322, DOI 10.1038/nature09028; Rotundi A, 2015, SCIENCE, V347, DOI 10.1126/science.aaa3905; Rousseau B, 2018, ICARUS, V306, P306, DOI 10.1016/j.icarus.2017.10.015; Rubin M, 2015, SCIENCE, V348, P232, DOI 10.1126/science.aaa6100; Schmitt B., 2004, NEAR MID IR OPTICAL, DOI [10.26302/SSHADE/EXPERIMENT_BS_20200103_001, DOI 10.26302/SSHADE/EXPERIMENT_BS_20200103_001]; Schmitt B., NEAR MID IR OPTICAL; Schutte WA, 1999, ASTRON ASTROPHYS, V343, P966; Schutte WA, 2003, ASTRON ASTROPHYS, V398, P1049, DOI 10.1051/0004-6361:20021705; Stewart PN, 2015, ASTROPHYS J SUPPL S, V221, DOI 10.1088/0067-0049/221/2/30; Takir D, 2013, METEORIT PLANET SCI, V48, P1618, DOI 10.1111/maps.12171; Takir D, 2012, ICARUS, V219, P641, DOI 10.1016/j.icarus.2012.02.022; Theule P, 2013, ADV SPACE RES, V52, P1567, DOI 10.1016/j.asr.2013.06.034; van Broekhuizen FA, 2005, ASTRON ASTROPHYS, V441, P249, DOI 10.1051/0004-6361:20041711; Vinogradoff V, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201116688; WAGNER EL, 1950, J CHEM PHYS, V18, P296, DOI 10.1063/1.1747622; Weis DD, 1996, J GEOPHYS RES-ATMOS, V101, P18709, DOI 10.1029/96JD01543; WYCKOFF S, 1991, ASTROPHYS J, V367, P641, DOI 10.1086/169659	90	46	46	6	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1212	+	eaaw7462	10.1126/science.aaw7462	http://dx.doi.org/10.1126/science.aaw7462			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9DP	32165559	Green Submitted			2022-12-28	WOS:000520023800034
J	Blumenthal, D; Abrams, M				Blumenthal, David; Abrams, Melinda			The Affordable Care Act at 10 Years - Payment and Delivery System Reforms	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							READMISSIONS REDUCTION PROGRAM; HOSPITAL READMISSIONS; ASSOCIATION; QUALITY; INCENTIVES; MORTALITY; OUTCOMES; RATES		[Blumenthal, David; Abrams, Melinda] Commonwealth Fund, New York, NY 10021 USA	Commonwealth Fund	Blumenthal, D (corresponding author), Commonwealth Fund, New York, NY 10021 USA.							*AG HEALTHC RES QU, 2019, 2018 NAT HEALTHC QUA; [Anonymous], 2010, COMMUNICATION   0320; [Anonymous], 2018, REP C EV IND HOM DEM; [Anonymous], 2009, 2009 ANN REP BOARDS; [Anonymous], 2019, 2019 ANN REP BOARDS; [Anonymous], 2018, VOX             0919; [Anonymous], 2013, READMISSIONS US HOSP; [Anonymous], 2015, NAT SCOR RAT HOSP AC; Barnett ML, 2019, NEW ENGL J MED, V381, P302, DOI 10.1056/NEJMp1901896; Blumenthal D, 2020, NEW ENGL J MED, V382, P963, DOI 10.1056/NEJMhpr1916091; Center on Budget and Policy Priorities, 2019, CHART BOOK ACC AFF C; Centers for Medicare and Medicaid Services, HOSP READM RED PROGR; Centers for Medicare and Medicaid Services, BUND PAYM CAR IMPR I; Centers for Medicare & Medicaid Services, COMPR PRIM CAR PLUS; Chernew ME, 2019, MSSP PARTICIPATION F, DOI 10.1377/hblog20191120.903566/full/; CMS, 2018, FIN RUL CREAT PATHW; CMS Innovation Center, 2018, MOD IMPL CTR PERF; Collins SR., 2018, COST EMPLOYER INSURA; Cubanski J., 2019, FACTS MEDICARE SPEND; Desai NR, 2016, JAMA-J AM MED ASSOC, V316, P2647, DOI 10.1001/jama.2016.18533; Doran T, 2017, ANNU REV PUBL HEALTH, V38, P449, DOI 10.1146/annurev-publhealth-032315-021457; Douven R, 2015, HEALTH AFFAIR, V34, P143, DOI 10.1377/hlthaff.2014.0444; Dummit LA, 2016, JAMA-J AM MED ASSOC, V316, P1267, DOI 10.1001/jama.2016.12717; Elmendorf DW, 2011, CBOS ANAL MAJOR HLTH; Figueroa JF, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2214; Gupta A, 2018, JAMA CARDIOL, V3, P44, DOI 10.1001/jamacardio.2017.4265; Hadley Mark, 2016, TESTIMONY COMMITTEE, P6; Ibrahim AM, 2018, JAMA INTERN MED, V178, P290, DOI 10.1001/jamainternmed.2017.6148; Kamal R, 2018, HAS US SPENDING HEAL; Kennell and Associates, 2018, SYST REV CMMI PRIM C; Kurihama National Hospital, 2019, GETT WELL ALC; Maddox KEJ, 2019, HEALTH SERV RES, V54, P327, DOI 10.1111/1475-6773.13133; Maddox KEJ, 2018, NEW ENGL J MED, V379, P260, DOI [10.1056/NEJMsa1801369, 10.1056/NEJMsa1801569]; McWilliams JM, 2019, HEALTH AFFAIR, V38, P1840, DOI 10.1377/hlthaff.2019.00411; McWilliams JM, 2018, NEW ENGL J MED, V379, P1139, DOI 10.1056/NEJMsa1803388; Muhlestein D, 2019, SPREAD ACOS VALUEBAS; Muhlestein D, 2016, MEDICARE ACCOUNTABLE, DOI 10.1377/hblog20160909.056418/full/; Ody C, 2019, HEALTH AFFAIR, V38, P36, DOI 10.1377/hlthaff.2018.05178; Peikes D, 2019, INDEPENDENT EVALUATI; Peikes D, 2018, HEALTH AFFAIR, V37, P890, DOI 10.1377/hlthaff.2017.1678; Pham H, 2018, NEW ENGL J MED, V379, P1594, DOI 10.1056/NEJMp1805593; Ryan AM, 2017, NEW ENGL J MED, V376, P2358, DOI 10.1056/NEJMsa1613412; Wadhera RK, 2018, JAMA-J AM MED ASSOC, V320, P2542, DOI 10.1001/jama.2018.19232; White Chapin., 2019, PRICES PAID HOSP PRI; Zuckerman RB, 2016, NEW ENGL J MED, V374, P1543, DOI 10.1056/NEJMsa1513024; 2019, BMJ, V366, pL4109; 2019, BMJ, V366, pL4563	47	14	15	3	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2020	382	11					1057	1063		10.1056/NEJMhpr1916092	http://dx.doi.org/10.1056/NEJMhpr1916092			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU7TA	32101657				2022-12-28	WOS:000519914300013
J	Wise, J				Wise, Jacqui			The BMJ Awards 2020: Cancer care team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2020	368								m843	10.1136/bmj.m843	http://dx.doi.org/10.1136/bmj.m843			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AU	32165428				2022-12-28	WOS:000520013500001
J	Kuehn, BM				Kuehn, Bridget M.			US Zika-Related Birth Defects in High-Transmission Areas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2020	323	10					917	917		10.1001/jama.2020.1934	http://dx.doi.org/10.1001/jama.2020.1934			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KW1LV	32154863				2022-12-28	WOS:000520933900022
J	Beard, DJ; Campbell, MK; Blazeby, JM; Carr, AJ; Weijer, C; Cuthbertson, BH; Buchbinder, R; Pinkney, T; Bishop, FL; Pugh, J; Cousins, S; Harris, IA; Lohmander, LS; Blencowe, N; Gillies, K; Probst, P; Brennan, C; Cook, A; Farrar-Hockley, D; Savulescu, J; Huxtable, R; Rangan, A; Tracey, I; Brocklehurst, P; Ferreira, ML; Nicholl, J; Reeves, BC; Hamdy, F; Rowley, SCS; Cook, JA				Beard, David J.; Campbell, Marion K.; Blazeby, Jane M.; Carr, Andrew J.; Weijer, Charles; Cuthbertson, Brian H.; Buchbinder, Rachelle; Pinkney, Thomas; Bishop, Felicity L.; Pugh, Jonathan; Cousins, Sian; Harris, Ian A.; Lohmander, L. Stefan; Blencowe, Natalie; Gillies, Katie; Probst, Pascal; Brennan, Carol; Cook, Andrew; Farrar-Hockley, Dair; Savulescu, Julian; Huxtable, Richard; Rangan, Amar; Tracey, Irene; Brocklehurst, Peter; Ferreira, Manuela L.; Nicholl, Jon; Reeves, Barnaby C.; Hamdy, Freddie; Rowley, Samuel C. S.; Cook, Jonathan A.			Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines)	LANCET			English	Review							SHAM SURGERY; ETHICS	Placebo comparisons are increasingly being considered for randomised trials assessing the efficacy of surgical interventions. The aim of this Review is to provide a summary of knowledge on placebo controls in surgical trials. A placebo control is a complex type of comparison group in the surgical setting and, although powerful, presents many challenges. This Review outlines what a placebo control entails and present understanding of this tool in the context of surgery. We consider when placebo controls in surgery are acceptable (and when they are desirable) in terms of ethical arguments and regulatory requirements, how a placebo control should be designed, how to identify and mitigate risk for participants in these trials, and how such trials should be done and interpreted. Use of placebo controls is justified in randomised controlled trials of surgical interventions provided there is a strong scientific and ethical rationale. Surgical placebos might be most appropriate when there is poor evidence for the efficacy of the procedure and a justified concern that results of a trial would be associated with high risk of bias, particularly because of the placebo effect. Feasibility work is recommended to optimise the design and implementation of randomised controlled trials. This Review forms an outline for best practice and provides guidance, in the form of the Applying Surgical Placebo in Randomised Evaluations (known as ASPIRE) checklist, for those considering the use of a placebo control in a surgical randomised controlled trial.	[Beard, David J.; Carr, Andrew J.; Cook, Jonathan A.] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Pugh, Jonathan; Savulescu, Julian] Univ Oxford, Oxford Uehiro Ctr Pract Eth, Oxford, England; [Tracey, Irene] Univ Oxford, Nuffield Dept Clin Neurosci, John Radcliffe Hosp, Oxford, England; [Hamdy, Freddie] Univ Oxford, Nuffield Dept Surg Sci, John Radcliffe Hosp, Oxford, England; [Hamdy, Freddie] Univ Oxford, Old Rd Campus Res Bldg, Oxford, England; [Campbell, Marion K.; Gillies, Katie] Univ Aberdeen, Hlth Serv Res Unit, Hlth Sci Bldg, Aberdeen, Scotland; [Blazeby, Jane M.; Cousins, Sian; Blencowe, Natalie; Huxtable, Richard] Univ Bristol, Ctr Surg Res Populat Hlth Sci, Beacon House, Bristol, Avon, England; [Reeves, Barnaby C.] Univ Bristol, Bristol Trials Ctr, Bristol, Avon, England; [Weijer, Charles] Western Univ, Rotman Inst Philosophy, Western Interdisciplinary Res Bldg, London, ON, Canada; [Cuthbertson, Brian H.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON, Canada; [Buchbinder, Rachelle] Cabrini Inst & Monash Univ, Cabrini Monash Dept Clin Epidemiol, Melbourne, Vic, Australia; [Pinkney, Thomas] Univ Birmingham, Queen Elizabeth Hosp Birmingham, Acad Dept Surg, Heritage Bldg, Birmingham, W Midlands, England; [Brocklehurst, Peter] Univ Birmingham, Birmingham Clin Trials Unit, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Bishop, Felicity L.] Univ Southampton, Fac Environm & Life Sci, Southampton, Hants, England; [Cook, Andrew] Univ Southampton, Wessex Inst, Southampton, Hants, England; [Harris, Ian A.] Univ New South Wales, South Western Sydney Clin Sch, Ingham Inst Appl Med Res, Sydney, NSW, Australia; [Ferreira, Manuela L.] Univ Sydney, Fac Med & Hlth, Inst Bone & Joint Res, Northern Clin Sch, Sydney, NSW, Australia; [Lohmander, L. Stefan] Lund Univ, Dept Clin Sci Lund, Dept Orthopaed Lund, Lund, Sweden; [Probst, Pascal] Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany; [Brennan, Carol; Farrar-Hockley, Dair] Patient Representat, Oxford, England; [Cook, Andrew] Univ Hosp Southampton Natl Hlth Serv Fdn Trust, Southampton, Hants, England; [Rangan, Amar] Univ York, Dept Hlth Sci, Seebohm Rowntree Bldg, York, N Yorkshire, England; [Nicholl, Jon] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Rowley, Samuel C. S.] MRC, London, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Aberdeen; University of Bristol; University of Bristol; Western University (University of Western Ontario); University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Birmingham; University of Birmingham; University of Southampton; University of Southampton; Ingham Institute for Applied Medical Research; University of New South Wales Sydney; University of Sydney; Lund University; Ruprecht Karls University Heidelberg; University of York - UK; University of Sheffield	Beard, DJ (corresponding author), Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England.	david.beard@ndorms.ox.ac.uk	Cook, Andrew/A-8652-2015; Cook, Jonathan/D-3648-2015; Buchbinder, Rachelle/G-2952-2011; Ferreira, Manuela/AAQ-5446-2020; Pinkney, Thomas/HGA-4022-2022; Weijer, Charles/ABC-5433-2020; Probst, Pascal/GSD-6170-2022; Campbell, Marion/ABB-7063-2020; Lohmander, Stefan/AAL-8314-2021	Cook, Andrew/0000-0002-6680-439X; Cook, Jonathan/0000-0002-4156-6989; Buchbinder, Rachelle/0000-0002-0597-0933; Ferreira, Manuela/0000-0002-3479-0683; Pinkney, Thomas/0000-0001-7320-6673; Weijer, Charles/0000-0002-5510-1074; Lohmander, Stefan/0000-0002-5424-9448; Campbell, Marion/0000-0001-5386-4097; Tracey, Irene/0000-0003-4134-6115; Reeves, Barnaby/0000-0002-5101-9487; Rowley, Samuel/0000-0002-2468-801X; Huxtable, Richard/0000-0002-5802-1870; Blencowe, Natalie/0000-0002-6111-2175; Blazeby, Jane/0000-0002-3354-3330; Rangan, Amar/0000-0002-5452-8578; Beard, David/0000-0001-7884-6389; Hamdy, Freddie/0000-0003-2627-2154; Bishop, Felicity/0000-0002-8737-6662; Gillies, Katie/0000-0001-7890-2854	Medical Research Council UK; National Institute for Health Research UK Methodology Research Programme; NIHR Biomedical Research Centres at the University Hospitals Bristol National Health Service Foundation Trust; University of Bristol; MRC [MC_PC_17155, MR/K025643/1] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research UK Methodology Research Programme; NIHR Biomedical Research Centres at the University Hospitals Bristol National Health Service Foundation Trust; University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was co-commissioned and jointly funded by the Medical Research Council UK and the National Institute for Health Research UK Methodology Research Programme in response to a commissioned call for a workshop on this topic. The NIHR Biomedical Research Centres at the University Hospitals Bristol National Health Service Foundation Trust, the University of Bristol, Oxford Health National Health Service Foundation Trust, and the University of Oxford also funded this work. Applicants for the commission were: David Beard, Jonathan Cook, Marion Campbell, Jane Blazeby, Andrew Carr, Thomas Pinkney, Brian Cuthbertson, Irene Tracey, Rachelle Buchbinder, Julian Savulescu, Dair Farrar-Hockley, and Natalie Blencowe. As part of the process of developing the guidance, a two-day workshop was held in St Anne's College, Oxford in December, 2018. In addition to the applicants, the academic workshop participants were: Jonathan Pugh, Felicity Bishop, Sian Cousins, Charles Weijer, Richard Huxtable, Jon Nicholl, Pascal Probst, Peter Brocklehurst, Andrew Cook, Katie Gillies, Freddie Hamdy, Ian Harris, Naomi Lee, Stefan Lohmander, Amar Rangan, Baruaby Reeves, and Samual Rowley Carol Brennan and Dair Farrar-Hockley kindly participated and contributed as patient representatives. Dair Farrar-Hockley was also a co-applicant on the workshop grant application. Sian Cousins and Natalie Blencowe kindly took detailed cross-referenced notes throughout and recorded the workshop discussions. Katie Chegwin was responsible for administration and organisation. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, the MRC, or the Department of Health and Social Care. AC, FH, and JMB are NIHR senior investigators.	Al-Lamee R, 2018, LANCET, V391, P31, DOI 10.1016/S0140-6736(17)32714-9; [Anonymous], PLACEBO CONTROLLED T; [Anonymous], BRIT J SURG; APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0605-9; Beard DJ, 2018, LANCET, V391, P329, DOI 10.1016/S0140-6736(17)32457-1; Binik Ariella, 2019, Ethics Hum Res, V41, P2, DOI 10.1002/eahr.500007; Bishop FL, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015516; Bishop FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039661; Blencowe NS, 2016, BRIT J SURG, V103, P1377, DOI 10.1002/bjs.10254; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Campbell MK, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-50; Campbell MK, 2010, HEALTH TECHNOL ASSES, V14, pIX, DOI [10.3310/hta14050, 10.3310/hta14040]; Colloca L, 2011, PHILOS T R SOC B, V366, P1859, DOI 10.1098/rstb.2010.0398; Colloca L, 2011, PAIN, V152, P1215, DOI 10.1016/j.pain.2011.02.043; Colloca L, 2009, PAIN, V144, P28, DOI 10.1016/j.pain.2009.01.033; Colwell B, 2012, BRIT J GEN PRACT, V62, P496, DOI 10.3399/bjgp12X654759; Cook JA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2820; Cousins S, 2020, J CLIN EPIDEMIOL, V119, P109, DOI 10.1016/j.jclinepi.2019.11.016; Cousins S, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028576; Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142; Davey C, 2015, LANCET, V386, P1066, DOI 10.1016/S0140-6736(15)60001-0; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Donovan JL, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1391-4; Francis JJ, 2009, PSYCHOL HEALTH, V24, P1125, DOI 10.1080/08870440802071157; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Galli L, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-182; Gu AP, 2017, J CLIN EPIDEMIOL, V87, P108, DOI 10.1016/j.jclinepi.2017.03.006; Hall KT, 2015, TRENDS MOL MED, V21, P285, DOI 10.1016/j.molmed.2015.02.009; Hare KB, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-167; Hey SP, 2016, MONASH BIOETH REV, V34, P23, DOI 10.1007/s40592-016-0057-z; Horng S, 2002, NEW ENGL J MED, V347, P137, DOI 10.1056/NEJMsb021025; Horng S, 2003, CRIT CARE MED, V31, pS126, DOI 10.1097/01.CCM.0000054906.49187.67; Kaptchuk TJ, 2011, PHILOS T R SOC B, V366, P1849, DOI 10.1098/rstb.2010.0385; McDonald AM, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-74; Mehta S, 2007, J BONE JOINT SURG AM, V89A, P1650, DOI 10.2106/JBJS.F.00563; Miller FG, 2003, AM J BIOETHICS, V3, P41, DOI 10.1162/152651603322614580; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Mowbray CT, 2003, AM J EVAL, V24, P315, DOI 10.1177/109821400302400303; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1978, BELM REP ETH PRINC G; National Institute for Health and Care Excellence, 2014, DEV NICE GUID MAN; Nishimura A, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-28; Rogers W, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-78; Savulescu J, 2016, J MED ETHICS, V42, P776, DOI 10.1136/medethics-2015-103333; Shaheen NJ, 2009, NEW ENGL J MED, V360, P2277, DOI 10.1056/NEJMoa0808145; Stewart-Williams S, 2004, HEALTH PSYCHOL, V23, P198, DOI 10.1037/0278-6133.23.2.198; Townsend D, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0908-6; Wartolowska K, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010194; Wartolowska K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3253; Wartolowska KA, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2070-9; Weijer C, 2004, NAT MED, V10, P570, DOI 10.1038/nm0604-570; WICKRAMASEKERA I, 1980, BIOFEEDBACK SELF-REG, V5, P5, DOI 10.1007/BF00999060; World Medical Association, 2018, WMA DECL HELS ETH PR	53	26	26	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2020	395	10226					828	838						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU2KH	32145797	Green Submitted, Green Accepted			2022-12-28	WOS:000519536900040
J	Larson, H; Simas, C; Horton, R				Larson, Heidi; Simas, Clarissa; Horton, Richard			The emotional determinants of health: The Lancet-London School of Hygiene & Tropical Medicine Commission	LANCET			English	Editorial Material							POLITICS		[Larson, Heidi; Simas, Clarissa; Horton, Richard] London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Larson, H (corresponding author), London Sch Hyg & Trop Med, London WC1E 7HT, England.	heidi.larson@Ishtm.acuk	Larson, Heidi J./N-1018-2017	Larson, Heidi J./0000-0002-8477-7583; Simas, Clarissa/0000-0003-0035-8419				Albertson B, 2015, PS-POLIT SCI POLIT, V48, P8; Barrett L.F., 2017, EMOTIONS ARE MADE; Curtis V, 2011, PHILOS T R SOC B, V366, P3478, DOI 10.1098/rstb.2011.0165; Gilson L, 2003, SOC SCI MED, V56, P1453, DOI 10.1016/S0277-9536(02)00142-9; Good MJD, 2007, ETHNOG STUD SUBJ, V7, P362; Gronke P, 2015, PS-POLIT SCI POLIT, V48, P3, DOI 10.1017/S1049096514001851; Kahneman D, 2015, FORTUNE, V172, P20; Kickbusch I, 2016, LANCET GLOB HEALTH, V4, pE895, DOI 10.1016/S2214-109X(16)30217-0; Luz PM, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268819000517; Mazzocco K, 2019, ECANCERMEDICALSCIENC, V13, DOI 10.3332/ecancer.2019.914; McKee M, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2966; Piot P, 2007, AM J PUBLIC HEALTH, V97, P1934, DOI 10.2105/AJPH.2007.121418; World Health Organization, 2020, SOC DET HLTH	13	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2020	395	10226					768	769						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU2KH	32145776				2022-12-28	WOS:000519536900012
J	Willis, EF; MacDonald, KPA; Nguyen, QH; Garrido, AL; Gillespie, ER; Harley, SBR; Bartlett, PF; Schroder, WA; Yates, AG; Anthony, DC; Rose-John, S; Ruitenberg, MJ; Vukovic, J				Willis, Emily F.; MacDonald, Kelli P. A.; Nguyen, Quan H.; Garrido, Adahir Labrador; Gillespie, Ellen R.; Harley, Samuel B. R.; Bartlett, Perry F.; Schroder, Wayne A.; Yates, Abi G.; Anthony, Daniel C.; Rose-John, Stefan; Ruitenberg, Marc J.; Vukovic, Jana			Repopulating Microglia Promote Brain Repair in an IL-6-Dependent Manner	CELL			English	Article							PROGENITOR-CELL; STEM-CELLS; IN-VIVO; INTERLEUKIN-6; NEURONS; INFLAMMATION; INJURY; DEGENERATION; REVEALS; DOUBLECORTIN	Cognitive dysfunction and reactive microglia are hallmarks of traumatic brain injury (TBI), yet whether these cells contribute to cognitive deficits and secondary inflammatory pathology remains poorly understood. Here, we show that removal of microglia from the mouse brain has little effect on the outcome of TBI, but inducing the turnover of these cells through either pharmacologic or genetic approaches can yield a neuroprotective microglial phenotype that profoundly aids recovery. The beneficial effects of these repopulating microglia are critically dependent on interleukin-6 (IL-6) trans-signaling via the soluble IL-6 receptor (IL-6R) and robustly support adult neurogenesis, specifically by augmenting the survival of newborn neurons that directly support cognitive function. We conclude that microglia in the mammalian brain can be manipulated to adopt a neuroprotective and pro-regenerative phenotype that can aid repair and alleviate the cognitive deficits arising from brain injury.	[Willis, Emily F.; Garrido, Adahir Labrador; Gillespie, Ellen R.; Harley, Samuel B. R.; Ruitenberg, Marc J.; Vukovic, Jana] Univ Queensland, Fac Med, Sch Biomed Sci, Brisbane, Qld, Australia; [Willis, Emily F.; Harley, Samuel B. R.; Bartlett, Perry F.; Vukovic, Jana] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [MacDonald, Kelli P. A.; Schroder, Wayne A.] QIMR Berghofer Med Res Inst, Dept Immunol, Brisbane, Qld, Australia; [Nguyen, Quan H.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Yates, Abi G.; Anthony, Daniel C.] Univ Oxford, Dept Pharmacol, Lab Expt Neuropathol, Oxford OX1 3QT, England; [Rose-John, Stefan] Christian Albrechts Univ Kiel, Biochem Inst, Kiel, Germany; [Schroder, Wayne A.] Griffith Univ, Sch Environm & Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland; QIMR Berghofer Medical Research Institute; University of Queensland; University of Oxford; University of Kiel; Griffith University	Vukovic, J (corresponding author), Univ Queensland, Fac Med, Sch Biomed Sci, Brisbane, Qld, Australia.; Vukovic, J (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	j.vukovic@uq.edu.au	Anthony, Daniel/F-7765-2010; Willis, Emily/ABF-7570-2020; MacDonald, Kelli/AAV-5365-2020; MacDonald, Kelli/O-2722-2016; Vukovic, Jana/B-4845-2013	Anthony, Daniel/0000-0003-1380-6655; MacDonald, Kelli/0000-0003-3451-4221; Yates, Abi G./0000-0002-8501-2160; Willis, Emily/0000-0002-3756-5318; Vukovic, Jana/0000-0002-3739-1688; Labrador-Garrido, Adahir/0000-0001-5098-9601	Australian Research Council Discovery Early Career Research Award [DE150101578]; National Health and Medical Research Council (NHMRC) project [1124503]; Herdsman Fellowship in Medical Science (UQ); SpinalCure Australia; Wings for Life Spinal Cord Research Foundation; NHMRC [1060538, 1163835]; UQ-StemCARE funding	Australian Research Council Discovery Early Career Research Award(Australian Research Council); National Health and Medical Research Council (NHMRC) project(National Health and Medical Research Council (NHMRC) of Australia); Herdsman Fellowship in Medical Science (UQ); SpinalCure Australia; Wings for Life Spinal Cord Research Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); UQ-StemCARE funding	We thank J. Yu, K.C. Leong, R. Adams, and N. Kurniawan for experimental assistance; the staff of UQ's Biological Resources Facility for breeding and maintaining the animals in this study; G.R. Hill for vavcre x IL6R mouse line, Alan Ho for statistical assistance; T. Bruxner for RNA-seq assistance; V. Nink for flow cytometry assistance; R. Tweedale for editorial assistance; N. Valmas for graphic design; and S. Millard, S. Thor, J. Goetz, and B. Key for critical reading and comments on the manuscript. Imaging was performed at the School of Biomedical Sciences and the Queensland Brain Institute (QBI)'s Advanced Microscopy Facilities. Behavioral tests were performed at the QBI's Behavior and Surgical Facility. FACS was performed at the QBI's Flow Cytometry Facility. RNA-seq library preparation and sequencing was performed at the Institute for Molecular Bioscience Sequencing Facility (UQ). We acknowledge QIMR Berghofer scientific services, the Genome Informatics Group and Medical Genomics Groups for their support in the RNA-seq analysis, and A. Lam and D. Pham for assisting with generating and analyzing the spatial transcriptomics data. J.V. is the recipient of an Australian Research Council Discovery Early Career Research Award (DE150101578) and National Health and Medical Research Council (NHMRC) project grant (1124503). E.F.W. is supported by the Herdsman Fellowship in Medical Science (UQ). M.J.R. is supported by SpinalCure Australia, the Wings for Life Spinal Cord Research Foundation, and the NHMRC (1060538 and 1163835). A.L.G. was supported by UQ-StemCARE funding.	Bellver-Landete V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08446-0; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Biber K, 2008, NEUROPSYCHOPHARMACOL, V33, P2237, DOI 10.1038/sj.npp.1301612; Bradley CK, 2007, GENESIS, V45, P145, DOI 10.1002/dvg.20274; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Campbell IL, 2014, J NEUROSCI, V34, P2503, DOI 10.1523/JNEUROSCI.2830-13.2014; Cheng XW, 2011, CELL RES, V21, P338, DOI 10.1038/cr.2010.141; Codeluppi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092649; Dagher NN, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0366-9; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Elmore MRP, 2018, AGING CELL, V17, DOI 10.1111/acel.12832; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Garbers C, 2018, METHODS MOL BIOL, V1725, P127, DOI 10.1007/978-1-4939-7568-6_11; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Gothert JR, 2005, BLOOD, V105, P2724, DOI 10.1182/blood-2004-08-3037; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Haage V, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0665-y; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hickman S, 2018, NAT NEUROSCI, V21, P1359, DOI 10.1038/s41593-018-0242-x; Hilla AM, 2017, J NEUROSCI, V37, P6113, DOI 10.1523/JNEUROSCI.0584-17.2017; Hodge RD, 2012, J NEUROSCI, V32, P6275, DOI 10.1523/JNEUROSCI.0532-12.2012; Hoeffel G, 2018, CELL IMMUNOL, V330, P5, DOI 10.1016/j.cellimm.2018.01.001; Hong H, 2016, INT NEUROUROL J, V20, pS2, DOI 10.5213/inj.1632604.302; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jin WN, 2017, J CEREBR BLOOD F MET, V37, P2224, DOI 10.1177/0271678X17694185; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Ma SH, 2015, CELL CALCIUM, V58, P286, DOI 10.1016/j.ceca.2015.06.006; Martin M., 2011, EMBNET J, V17, P200; Marz P, 1998, P NATL ACAD SCI USA, V95, P3251, DOI 10.1073/pnas.95.6.3251; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Ngwenya LB, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01014; Nybo L, 2002, J PHYSIOL-LONDON, V542, P991, DOI 10.1113/jphysiol.2002.022285; Ogilvy S, 1999, BLOOD, V94, P1855; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Rice RA, 2017, GLIA, V65, P931, DOI 10.1002/glia.23135; Rice RA, 2015, J NEUROSCI, V35, P9977, DOI 10.1523/JNEUROSCI.0336-15.2015; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rothaug M, 2016, BBA-MOL CELL RES, V1863, P1218, DOI 10.1016/j.bbamcr.2016.03.018; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Szalay G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11499; Tawara Ken, 2011, Cancer Manag Res, V3, P177, DOI 10.2147/CMR.S18101; Timper K, 2017, CELL REP, V19, P267, DOI 10.1016/j.celrep.2017.03.043; Vukovic J, 2013, J NEUROSCI, V33, P6603, DOI 10.1523/JNEUROSCI.3064-12.2013; Vukovic J, 2012, J NEUROSCI, V32, P6435, DOI 10.1523/JNEUROSCI.5925-11.2012; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Weber MD, 2019, BIOL PSYCHIAT, V85, P667, DOI 10.1016/j.biopsych.2018.10.009; Willis EF, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00197; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Yang P, 2012, EXP NEUROL, V236, P19, DOI 10.1016/j.expneurol.2012.03.019; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	67	163	172	10	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2020	180	5					833	+		10.1016/j.cell.2020.02.013	http://dx.doi.org/10.1016/j.cell.2020.02.013			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KT7JN	32142677	Bronze			2022-12-28	WOS:000519189800006
J	Dyer, C				Dyer, Clare			Doctors suspended after trans patient has vagina removed without consent	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2020	368								m852	10.1136/bmj.m852	http://dx.doi.org/10.1136/bmj.m852			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KD	32127371				2022-12-28	WOS:000519536500010
J	Torjesen, I				Torjesen, Ingrid			Health groups criticise EU funded breast cancer screening study as a "missed opportunity"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Group de Recherche et d'Action pour le Sante No Grazie Cancer Rose HealthWatch, 2020, J INTERN MED	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2020	368								m855	10.1136/bmj.m855	http://dx.doi.org/10.1136/bmj.m855			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KD	32127373				2022-12-28	WOS:000519536500012
J	Voelker, R				Voelker, Rebecca			New Nonsurgical Option Approved for Thyroid Eye Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2020	323	9			SI		817	817		10.1001/jama.2020.1480	http://dx.doi.org/10.1001/jama.2020.1480			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU3SD	32125386				2022-12-28	WOS:000519630600005
J	Friberg, P; Fewer, S; Clark, J; Horton, R				Friberg, Peter; Fewer, Sara; Clark, Jocalyn; Horton, Richard		Lancet SIGHT Commission	The Lancet-SIGHT Commission on peaceful societies through health and gender equality	LANCET			English	Editorial Material									[Friberg, Peter; Fewer, Sara] Royal Swedish Acad Sci, Swedish Inst Global Hlth Transformat, SE-11418 Stockholm, Sweden; [Friberg, Peter] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Fewer, Sara] Univ Calif San Francisco, Inst Global Hlth Sci, Evidence Policy Initiat Global Hlth Grp, San Francisco, CA 94143 USA; [Clark, Jocalyn; Horton, Richard] The Lancet, London, England	Royal Swedish Academy of Sciences; University of Gothenburg; University of California System; University of California San Francisco	Friberg, P (corresponding author), Royal Swedish Acad Sci, Swedish Inst Global Hlth Transformat, SE-11418 Stockholm, Sweden.; Friberg, P (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden.	peter.friberg@kva.se		Clark, Jocalyn/0000-0002-8014-3989				Balch-Lindsay D, 2008, J PEACE RES, V45, P345, DOI 10.1177/0022343308088815; Gupta GR, 2019, LANCET, V393, P2550, DOI 10.1016/S0140-6736(19)30651-8; Krause J, 2018, INT INTERACT, V44, P985, DOI 10.1080/03050629.2018.1492386; MacQueen G, 2000, BRIT MED J, V321, P293, DOI 10.1136/bmj.321.7256.293; Melander E, 2005, INT STUD QUART, V49, P695, DOI 10.1111/j.1468-2478.2005.00384.x; Melander E, 2005, J PEACE RES, V42, P149, DOI 10.1177/0022343305050688; Percival V, 2017, INT STUD REV, V19, P70, DOI 10.1093/isr/vix003; Pettersson T, 2019, J PEACE RES, V56, P589, DOI 10.1177/0022343319856046; Physicians for Human Rights, 2020, PHYS HUMAN RIGHTS IL; UNICEF, 1996, STAT WORLDS CHILDR 1; United Nations, 2019, SPEC ED PROGR SUST D; United Nations and World Bank, 2018, PATHW PEAC INCL APPR; United Nations High Commissioner for Refugees, 2019, GLOB TRENDS FORC DIS; Vass A, 2001, BRIT MED J, V323, P1020, DOI 10.1136/bmj.323.7320.1020; WHO, 2020, SURV SYST ATT HLTH C; WHO, 2020, WHAT IS HLTH BRIDG P	16	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 29	2020	395	10225					670	671						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KQ2JO	32113491				2022-12-28	WOS:000516755200010
J	Horton, R				Horton, Richard			Offline: The pretensions of global health elites	LANCET			English	Editorial Material												richard.horton@lancet.com							0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 29	2020	395	10225					672	672						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KQ2JO	32113492	Bronze			2022-12-28	WOS:000516755200011
J	Foy, R; Skrypak, M; Alderson, S; Ivers, NM; McInerney, B; Stoddart, J; Ingham, J; Keenan, D				Foy, Robbie; Skrypak, Mirek; Alderson, Sarah; Ivers, Noah Michael; McInerney, Bren; Stoddart, Jill; Ingham, Jane; Keenan, Danny			Revitalising audit and feedback to improve patient care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTERVENTIONS		[Foy, Robbie] Leeds Inst Hlth Sci, Primary Care, Leeds, W Yorkshire, England; [Skrypak, Mirek] Healthcare Qual Improvement Partnership, Qual & Dev, London, England; [Stoddart, Jill; Ingham, Jane; Keenan, Danny] Healthcare Qual Improvement Partnership, London, England; [Alderson, Sarah] Womens Coll Hosp, Primary Care, Toronto, ON, Canada; [Alderson, Sarah; Ivers, Noah Michael] Womens Coll Hosp, Toronto, ON, Canada	University of Leeds; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Womens College Hospital	Skrypak, M (corresponding author), Healthcare Qual Improvement Partnership, Qual & Dev, London, England.	mirek.skrypak@hqip.org.uk	Ivers, Noah/O-7643-2018	Ivers, Noah/0000-0003-2500-2435; Foy, Robbie/0000-0003-0605-7713; Skrypak, Mirek/0000-0003-1016-2743; Alderson, Sarah/0000-0002-5418-0495	Department of Family and Community Medicine at the University of Toronto; Canada Research Chair in Implementation of Evidence Based Practice; Academy of Medical Sciences (AMS) [SGL017\\1033] Funding Source: researchfish; National Institute for Health Research [NIHR300012] Funding Source: researchfish	Department of Family and Community Medicine at the University of Toronto; Canada Research Chair in Implementation of Evidence Based Practice; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))	NMI is supported by the Department of Family and Community Medicine at the University of Toronto and by a Canada Research Chair in Implementation of Evidence Based Practice.	Brehaut JC, 2016, ANN INTERN MED, V164, P435, DOI 10.7326/M15-2248; Brown B, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-019-0883-5; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Dixon-Woods M, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5514; Dixon-Woods Mary, 2016, Future Hosp J, V3, P191, DOI 10.7861/futurehosp.3-3-191; Eccles M, 1999, BRIT J GEN PRACT, V49, P35; Elouafkaoui P, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002115; Grimshaw JM, 2019, BMJ QUAL SAF, V28, P416, DOI 10.1136/bmjqs-2018-008355; Gude WT, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-019-0937-8; Gude WT, 2017, BMJ QUAL SAF, V26, P279, DOI 10.1136/bmjqs-2015-004795; Hallsworth M, 2016, LANCET, V387, P1743, DOI 10.1016/S0140-6736(16)00215-4; Halpern D, 2015, EVALUATION-US, V21, P143, DOI 10.1177/1356389015578895; Horwitz LI, 2019, NEW ENGL J MED, V381, P1175, DOI 10.1056/NEJMsb1900856; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Ivers NM, 2018, CAN MED ASSOC J, V190, pS42, DOI 10.1503/cmaj.180334; Ivers NM, 2014, J GEN INTERN MED, V29, P1534, DOI 10.1007/s11606-014-2913-y; Johnston G, 2000, QUAL HEALTH CARE, V9, P23, DOI 10.1136/qhc.9.1.23; Levine DM, 2016, JAMA INTERN MED, V176, P1778, DOI 10.1001/jamainternmed.2016.6217; Lloyd R, 2017, QUALITY HLTH CARE GU; Majeed A, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3036; National Blood Transfusion Committee, 2014, PAT BLOOD MAN EV BAS; Roos-Blom MJ, 2019, BMJ QUAL SAF, V28, P1007, DOI 10.1136/bmjqs-2019-009588; Royal College of Physicians, 2019, NAT LUNG CANC AUD AN; Rushforth B, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0350-6; Sentinel Stroke National Audit Programme, 2019, ANN PUBL REP APR 201; Wagner DJ, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4226-7	26	32	32	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2020	368								m213	10.1136/bmj.m213	http://dx.doi.org/10.1136/bmj.m213			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2JX	32107249	Green Published, hybrid			2022-12-28	WOS:000519535800002
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: Trump says risk to Americans is "very low"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, STEALTH TRANSM FUELS; Colarossi N, 2020, CDC IS WARNING TRAVE; Conarck B, 2020, MIAMI HERALD; De Nova J, 2020, ORANGE COUNTY OFFICI; Hanna J., 2020, CNN; Li R, 2020, SUBSTANTIAL UNDOCUME, DOI [10.1101/2020.02.14.20023127v1, DOI 10.1101/2020.02.14.20023127V1]	6	3	3	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2020	368								m793	10.1136/bmj.m793	http://dx.doi.org/10.1136/bmj.m793			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2JX	32107254	Bronze			2022-12-28	WOS:000519535800017
J	Dyer, O				Dyer, Owen			Abortion: US appeal court upholds Trump's "gag rule" that stops doctors from facilitating provision	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2019, FED REG; TANNE JH, 2019, BMJ-BRIT MED J, V366, DOI DOI 10.1136/BMJ.L5227	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2020	368								m762	10.1136/bmj.m762	http://dx.doi.org/10.1136/bmj.m762			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2JV	32102781				2022-12-28	WOS:000519535600013
J	van Gastel, N; Stegen, S; Eelen, G; Schoors, S; Carlier, A; Daniels, VW; Baryawno, N; Przybylski, D; Depypere, M; Stiers, PJ; Lambrechts, D; Van Looveren, R; Torrekens, S; Sharda, A; Agostinis, P; Lambrechts, D; Maes, F; Swinnen, JV; Geris, L; Van Oosterwyck, H; Thienpont, B; Carmeliet, P; Scadden, DT; Carmeliet, G				van Gastel, Nick; Stegen, Steve; Eelen, Guy; Schoors, Sandra; Carlier, Aurelie; Daniels, Veerle W.; Baryawno, Ninib; Przybylski, Dariusz; Depypere, Maarten; Stiers, Pieter-Jan; Lambrechts, Dennis; Van Looveren, Riet; Torrekens, Sophie; Sharda, Azeem; Agostinis, Patrizia; Lambrechts, Diether; Maes, Frederik; Swinnen, Johan, V; Geris, Liesbet; Van Oosterwyck, Hans; Thienpont, Bernard; Carmeliet, Peter; Scadden, David T.; Carmeliet, Geert			Lipid availability determines fate of skeletal progenitor cells via SOX9	NATURE			English	Article							STEM-CELL; GENE-EXPRESSION; BONE-MARROW; DIFFERENTIATION; CARTILAGE; MOUSE; AUTOPHAGY; GROWTH; IDENTIFICATION; ANGIOGENESIS	Lipid starvation results in skeletal progenitors favouring commitment to chondrogenic over osteogenic fate, a process mediated by FOXO transcription factors and SOX9. The avascular nature of cartilage makes it a unique tissue(1-4), but whether and how the absence of nutrient supply regulates chondrogenesis remain unknown. Here we show that obstruction of vascular invasion during bone healing favours chondrogenic over osteogenic differentiation of skeletal progenitor cells. Unexpectedly, this process is driven by a decreased availability of extracellular lipids. When lipids are scarce, skeletal progenitors activate forkhead box O (FOXO) transcription factors, which bind to the Sox9 promoter and increase its expression. Besides initiating chondrogenesis, SOX9 acts as a regulator of cellular metabolism by suppressing oxidation of fatty acids, and thus adapts the cells to an avascular life. Our results define lipid scarcity as an important determinant of chondrogenic commitment, reveal a role for FOXO transcription factors during lipid starvation, and identify SOX9 as a critical metabolic mediator. These data highlight the importance of the nutritional microenvironment in the specification of skeletal cell fate.	[van Gastel, Nick; Stegen, Steve; Stiers, Pieter-Jan; Van Looveren, Riet; Torrekens, Sophie; Carmeliet, Geert] Katholieke Univ Leuven, Lab Clin & Expt Endocrinol, Dept Chron Dis Metab & Ageing, Leuven, Belgium; [van Gastel, Nick; Stegen, Steve; Carlier, Aurelie; Stiers, Pieter-Jan; Lambrechts, Dennis; Geris, Liesbet; Van Oosterwyck, Hans; Carmeliet, Geert] Katholieke Univ Leuven, Div Skeletal Tissue Engn, Prometheus, Leuven, Belgium; [van Gastel, Nick; Baryawno, Ninib; Sharda, Azeem; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [van Gastel, Nick; Baryawno, Ninib; Sharda, Azeem; Scadden, David T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [van Gastel, Nick; Baryawno, Ninib; Sharda, Azeem; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Eelen, Guy; Schoors, Sandra; Carmeliet, Peter] Katholieke Univ Leuven, Lab Angiogenesis & Vasc Metab, Dept Oncol, Leuven, Belgium; [Eelen, Guy; Schoors, Sandra; Carmeliet, Peter] VIB, Lab Angiogenesis & Vasc Metab, Ctr Canc Biol, Leuven, Belgium; [Carlier, Aurelie; Geris, Liesbet; Van Oosterwyck, Hans] Katholieke Univ Leuven, Biomech Sect, Dept Mech Engn, Leuven, Belgium; [Carlier, Aurelie; Geris, Liesbet] Univ Liege, Biomech Res Unit, GIGA Silico Med, Liege, Belgium; [Carlier, Aurelie] Maastricht Univ, MERLN Inst Technol Inspired Regenerat Med, Maastricht, Netherlands; [Daniels, Veerle W.; Swinnen, Johan, V] Katholieke Univ Leuven, Lab Lipid Metab & Canc, Dept Oncol, Leuven, Belgium; [Daniels, Veerle W.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Baryawno, Ninib] Karolinska Inst, Dept Childrens & Womens Hlth, Childhood Canc Res Unit, Stockholm, Sweden; [Przybylski, Dariusz] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02254 USA; [Przybylski, Dariusz] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Depypere, Maarten; Maes, Frederik] Katholieke Univ Leuven, Med Imaging Res Ctr, Leuven, Belgium; [Depypere, Maarten; Maes, Frederik] Katholieke Univ Leuven, Dept Elect Engn, Med Image Comp, ESAT PSI, Leuven, Belgium; [Lambrechts, Dennis] Katholieke Univ Leuven, Dept Microbial & Mol Syst, Ctr Surface Chem & Catalysis, Leuven, Belgium; [Lambrechts, Dennis] Katholieke Univ Leuven, Dept Dev & Regenerat, Tissue Engn Lab, Skeletal Biol & Engn Res Ctr, Leuven, Belgium; [Agostinis, Patrizia] Katholieke Univ Leuven, Lab Cell Death Res & Therapy, Dept Cellular & Mol Med, Leuven, Belgium; [Lambrechts, Diether; Thienpont, Bernard] Katholieke Univ Leuven, Lab Translat Genet, Dept Human Genet, Leuven, Belgium; [Lambrechts, Diether; Thienpont, Bernard] Katholieke Univ Leuven, Lab Funct Epigenet, Dept Human Genet, Leuven, Belgium; [Lambrechts, Diether; Thienpont, Bernard] VIB, Lab Translat Genet, Ctr Canc Biol, Leuven, Belgium	KU Leuven; KU Leuven; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Liege; Maastricht University; Maastricht University Medical Centre (MUMC); KU Leuven; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Karolinska Institutet; Brandeis University; Howard Hughes Medical Institute; Brandeis University; KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB)	Carmeliet, G (corresponding author), Katholieke Univ Leuven, Lab Clin & Expt Endocrinol, Dept Chron Dis Metab & Ageing, Leuven, Belgium.; Carmeliet, G (corresponding author), Katholieke Univ Leuven, Div Skeletal Tissue Engn, Prometheus, Leuven, Belgium.	geert.carmeliet@kuleuven.be	Swinnen, Johannes V/AAA-2214-2022; Agostinis, Patrizia/AAO-2468-2020; Agostinis, Patrizia/ABI-1177-2020; van Gastel, Nick/AFQ-4727-2022; van Gastel, Nick/P-7610-2018; Lambrechts, Diether/AAJ-3167-2020; Carmeliet, Peter/AAQ-5140-2020; Van Oosterwyck, Hans/C-2528-2016; geris, liesbet/D-2343-2016; Maes, Frederik/I-7572-2013	Swinnen, Johannes V/0000-0002-7720-5077; Agostinis, Patrizia/0000-0003-1314-2115; van Gastel, Nick/0000-0002-0563-3590; Lambrechts, Diether/0000-0002-3429-302X; Carmeliet, Peter/0000-0001-7961-1821; Van Oosterwyck, Hans/0000-0002-2142-9717; Stegen, Steve/0000-0002-4471-6401; geris, liesbet/0000-0002-8180-1445; Daniels, Veerle/0000-0002-2052-1423; Thienpont, Bernard/0000-0002-8772-6845; Baryawno, Ninib/0000-0001-6054-4163; Maes, Frederik/0000-0003-0027-1479; Carlier, Aurelie/0000-0002-2305-5667; Lambrechts, Dennis/0000-0002-2373-2795	Research Fund Flanders (FWO) [G096414, G0A4216N, G0B3418N]; KUL grant [C24/17/07]; European Research Council (ERC) [308223, 279100, 269073]; long-term structural Methusalem funding by the Flemish Government; BOF-KU Leuven GOA project [3M120209]	Research Fund Flanders (FWO)(FWO); KUL grant; European Research Council (ERC)(European Research Council (ERC)); long-term structural Methusalem funding by the Flemish Government; BOF-KU Leuven GOA project	We thank K. Moermans, I. Stockmans, C. MacGillivray and H. Soled for technical assistance, A. Nagy for the CAG-eGFP mice, S. Murakami for the Col1a1-cre/ERT2 and DsRed mice, T. Yoshimori for the RFP-GFP-LC3 plasmid, R. A. Weinberg for the pLKO.1-sh-mSOX9-5 lentiviral plasmid, M. Mazzone for hypoxic glove box use, the histology core of the Harvard Department of Stem Cell and Regenerative Biology for histology services, the FACS cores of the KU Leuven and the Harvard Department of Stem Cell and Regenerative Biology for access to the flow cytometers, and the Cell Imaging Core and the Molecular Imaging and Photonics division of the KU Leuven and the Harvard Center for Biological Imaging for access to the confocal microscopes. This work was supported by grants from the Research Fund Flanders (FWO; G096414, G0A4216N and G0B3418N to G.C.), KUL grant C24/17/07 (G.C.), grants from the European Research Council (ERC 308223 to H.V.O., ERC 279100 to L.G. and ERC 269073 to P.C.), and long-term structural Methusalem funding by the Flemish Government (P.C.). N.v.G. is funded by BOF-KU Leuven GOA project 3M120209. P.J.S. is a fellow from the Agency for Innovation by Science and Technology in Flanders (IWT). S. Stegen, A.C. and Dennis L. are postdoctoral fellows of the FWO. V.W.D. is a fellow of the FWO and the Flemish League against Cancer (VLK). This work is part of Prometheus, the KU Leuven R&D Division of Skeletal Tissue Engineering.	Akasaki Y, 2014, OSTEOARTHR CARTILAGE, V22, P162, DOI 10.1016/j.joca.2013.11.004; Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Ashraf S, 2008, CURR OPIN RHEUMATOL, V20, P573, DOI 10.1097/BOR.0b013e3283103d12; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Baryawno N, 2019, CELL, V177, P1915, DOI 10.1016/j.cell.2019.04.040; Carlier A, 2015, J THEOR BIOL, V365, P247, DOI 10.1016/j.jtbi.2014.10.012; Carlier A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002724; Chan CKF, 2015, CELL, V160, P285, DOI 10.1016/j.cell.2014.12.002; Daniels VW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106913; de Lageneste OD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03124-z; Debnath S, 2018, NATURE, V562, P133, DOI 10.1038/s41586-018-0554-8; Depypere M, 2011, PROC SPIE, V7961, DOI 10.1117/12.878162; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Eyckmans J, 2012, BIOL OPEN, V1, P1058, DOI 10.1242/bio.20122162; Frey JL, 2015, MOL CELL BIOL, V35, P1979, DOI 10.1128/MCB.01343-14; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; HALLMANN R, 1987, DIFFERENTIATION, V34, P98, DOI 10.1111/j.1432-0436.1987.tb00055.x; Imrichova H, 2015, NUCLEIC ACIDS RES, V43, pW57, DOI 10.1093/nar/gkv395; Kim C, 2013, NATURE, V494, P105, DOI 10.1038/nature11799; Kim SP, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92704; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lambrechts D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097572; Maes C, 2006, J CLIN INVEST, V116, P1230, DOI 10.1172/JCI26772; Maes C, 2004, J CLIN INVEST, V113, P188, DOI 10.1172/JCI200419383; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Miclau KR, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00045; Nuyts J, 1998, PHYS MED BIOL, V43, P729, DOI 10.1088/0031-9155/43/4/003; Ouyang ZF, 2014, BONE, V58, P136, DOI 10.1016/j.bone.2013.10.016; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ranall MV, 2011, BIOTECHNIQUES, V51, P35, DOI 10.2144/000113702; Ratneswaran A, 2015, ARTHRITIS RHEUMATOL, V67, P454, DOI 10.1002/art.38915; Roberts SJ, 2015, BONE, V70, P10, DOI 10.1016/j.bone.2014.08.007; Robins JC, 2005, BONE, V37, P313, DOI 10.1016/j.bone.2005.04.040; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Shang J, 2014, CURR STEM CELL RES T, V9, P141, DOI 10.2174/1574888X09666131230142459; Shapiro IM, 2007, BONE, V40, P561, DOI 10.1016/j.bone.2006.09.030; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Stegen S, 2019, NATURE, V565, P511, DOI 10.1038/s41586-019-0874-3; Stegen S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04679-7; Stegen S, 2016, CELL METAB, V23, P265, DOI 10.1016/j.cmet.2016.01.002; Stegen S, 2015, BONE, V70, P19, DOI 10.1016/j.bone.2014.09.017; Stiers PJ, 2019, J BONE MINER RES, V34, P333, DOI 10.1002/jbmr.3599; Stiers PJ, 2018, JBMR PLUS, V2, P92, DOI 10.1002/jbm4.10028; Taylor DK, 2009, J BONE MINER RES, V24, P1043, DOI [10.1359/jbmr.090101, 10.1359/JBMR.090101]; Tiyapatanaputi P, 2004, J ORTHOP RES, V22, P1254, DOI 10.1016/j.orthres.2004.03.017; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; van Gastel N, 2012, STEM CELLS, V30, P2460, DOI 10.1002/stem.1210; Vandersmissen I, 2015, J CELL BIOL, V210, P1239, DOI 10.1083/jcb.201502003; Yin M, 2001, DEV DYNAM, V222, P522, DOI 10.1002/dvdy.1212; Zhao L, 2009, CALCIFIED TISSUE INT, V84, P56, DOI 10.1007/s00223-008-9189-3; Zhong LL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071126	56	74	74	10	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2020	579	7797					111	+		10.1038/s41586-020-2050-1	http://dx.doi.org/10.1038/s41586-020-2050-1		FEB 2020	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE3BA	32103177	Green Submitted, Green Accepted			2022-12-28	WOS:000516702000007
J	Chopra, V; Toner, E; Waldhorn, R; Washer, L				Chopra, Vineet; Toner, Eric; Waldhorn, Richard; Washer, Laraine			How Should US Hospitals Prepare for Coronavirus Disease 2019 (COVID-19)?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chopra, Vineet] Univ Michigan, 2800 Plymouth Rd,Bldg 16 432W, Ann Arbor, MI USA; [Washer, Laraine] Univ Michigan, F4151 Univ Hosp South, Ann Arbor, MI 48109 USA; [Toner, Eric; Waldhorn, Richard] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Hlth Secur, 621 East Pratt St, Baltimore, MD 21202 USA; [Waldhorn, Richard] Georgetown Univ, 3800 Reservoir Rd, Washington, DC 20007 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Georgetown University	Chopra, V (corresponding author), Univ Michigan, 2800 Plymouth Rd,Bldg 16 432W, Ann Arbor, MI USA.	vineetc@umich.edu						Centers for Disease Control and Prevention, COR DIS 2019 COVID 1, DOI DOI 10.1016/S0140-6736(20)30211-7; MacLaren G, 2020, JAMA-J AM MED ASSOC, V323, P1245, DOI 10.1001/jama.2020.2342; Society of Critical Care Medicine, CRIT CAR STAT; Swerdlow DL, 2020, JAMA-J AM MED ASSOC, V323, P1129, DOI 10.1001/jama.2020.1960; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9	5	97	98	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2020	172	9					621	+		10.7326/M20-0907	http://dx.doi.org/10.7326/M20-0907			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK7EH	32160273	Green Published			2022-12-28	WOS:000531024900015
J	Falson, J; Xu, Y; Liao, MH; Zang, YY; Zhu, KJ; Wang, C; Zhang, ZT; Liu, HC; Duan, WH; He, K; Liu, HW; Smet, JH; Zhang, D; Xue, QK				Falson, Joseph; Xu, Yong; Liao, Menghan; Zang, Yunyi; Zhu, Kejing; Wang, Chong; Zhang, Zetao; Liu, Hongchao; Duan, Wenhui; He, Ke; Liu, Haiwen; Smet, Jurgen H.; Zhang, Ding; Xue, Qi-Kun			Type-II Ising pairing in few-layer stanene	SCIENCE			English	Article							UPPER CRITICAL-FIELD; SPIN; SUPERCONDUCTIVITY	Spin-orbit coupling has proven indispensable in the realization of topological materials and, more recently, Ising pairing in two-dimensional superconductors. This pairing mechanism relies on inversion symmetry-breaking and sustains anomalously large in-plane polarizing magnetic fields whose upper limit is predicted to diverge at low temperatures. Here, we show that the recently discovered superconductor few-layer stanene, epitaxially strained gray tin (alpha-Sn), exhibits a distinct type of Ising pairing between carriers residing in bands with different orbital indices near the G-point. The bands are split as a result of spin-orbit locking without the participation of inversion symmetry-breaking. The in-plane upper critical field is strongly enhanced at ultralow temperature and reveals the predicted upturn.	[Falson, Joseph; Smet, Jurgen H.] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; [Xu, Yong; Liao, Menghan; Zang, Yunyi; Zhu, Kejing; Wang, Chong; Zhang, Zetao; Duan, Wenhui; He, Ke; Zhang, Ding; Xue, Qi-Kun] Tsinghua Univ, Dept Phys, State Key Lab Low Dimens Quantum Phys, Beijing 100084, Peoples R China; [Xu, Yong] RIKEN Ctr Emergent Matter Sci CEMS, Wako, Saitama 3510198, Japan; [Duan, Wenhui; He, Ke; Zhang, Ding] Frontier Sci Ctr Quantum Informat, Beijing 100084, Peoples R China; [Liu, Hongchao] Peking Univ, Int Ctr Quantum Mat, Beijing 100871, Peoples R China; [Duan, Wenhui] Tsinghua Univ, Inst Adv Study, Beijing 100084, Peoples R China; [He, Ke; Zhang, Ding; Xue, Qi-Kun] Beijing Acad Quantum Informat Sci, Beijing 100193, Peoples R China; [Liu, Haiwen] Beijing Normal Univ, Dept Phys, Ctr Adv Quantum Studies, Beijing 100875, Peoples R China; [Falson, Joseph] CALTECH, Dept Appl Phys & Mat Sci, Pasadena, CA 91125 USA	Max Planck Society; Tsinghua University; RIKEN; Peking University; Tsinghua University; Beijing Normal University; California Institute of Technology	Smet, JH (corresponding author), Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany.; Zhang, D (corresponding author), Tsinghua Univ, Dept Phys, State Key Lab Low Dimens Quantum Phys, Beijing 100084, Peoples R China.; Zhang, D (corresponding author), Frontier Sci Ctr Quantum Informat, Beijing 100084, Peoples R China.; Zhang, D (corresponding author), Beijing Acad Quantum Informat Sci, Beijing 100193, Peoples R China.; Liu, HW (corresponding author), Beijing Normal Univ, Dept Phys, Ctr Adv Quantum Studies, Beijing 100875, Peoples R China.	haiwen.liu@bnu.edu.cn; j.smet@fkf.mpg.de; dingzhang@mail.tsinghua.edu.cn	Zang, Yunyi/ABA-3911-2020; Xu, Yong/L-1526-2015; Duan, Wenhui/H-4992-2011; Zhang, Ding/AAE-7473-2022; Liu, Hongchao/AAI-1646-2020; Liu, Haiwen/F-2518-2014	Xu, Yong/0000-0002-4844-2460; Duan, Wenhui/0000-0001-9685-2547; Zhang, Ding/0000-0002-8334-8349; Liu, Hongchao/0000-0003-0331-3814; Liu, Haiwen/0000-0002-0007-3117; Liao, Menghan/0000-0001-9108-3013	National Natural Science Foundation of China [11790311, 11922409, 11674028, 51788104]; Ministry of Science and Technology of China [2017YFA0304600, 2017YFA0302902, 2017YFA0303301, 2018YFA0307100, 2018YFA0305603, 2016YFA0301001]; Beijing Advanced Innovation Center for Future Chip (ICFC)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Beijing Advanced Innovation Center for Future Chip (ICFC)	This work is financially supported by the National Natural Science Foundation of China (grants 11790311, 11922409, 11674028, and 51788104); the Ministry of Science and Technology of China (2017YFA0304600, 2017YFA0302902, 2017YFA0303301, 2018YFA0307100, 2018YFA0305603, and 2016YFA0301001); and the Beijing Advanced Innovation Center for Future Chip (ICFC).	Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; de la Barrera SC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03888-4; Devarakonda A., 2019, ARXIV190602065CONDMA; Falson J, 2015, NAT PHYS, V11, P347, DOI [10.1038/NPHYS3259, 10.1038/nphys3259]; Falson J, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat8742; FULDE P, 1964, PHYS REV, V135, pA550, DOI 10.1103/PhysRev.135.A550; Gores J., 2004, THESIS; Gurevich A, 2007, PHYSICA C, V456, P160, DOI 10.1016/j.physc.2007.01.008; Gurevich A, 2011, NAT MATER, V10, P255, DOI 10.1038/nmat2991; Ilic S, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.117001; KLEMM RA, 1975, PHYS REV B, V12, P877, DOI 10.1103/PhysRevB.12.877; Konig M, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.031007; LARKIN AI, 1965, SOV PHYS JETP-USSR, V20, P762; Liao MH, 2018, NAT PHYS, V14, P344, DOI 10.1038/s41567-017-0031-6; Liu Y., 2019, ARXIV190412719CONDMA; Liu Y, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.021002; Lu JM, 2015, SCIENCE, V350, P1353, DOI 10.1126/science.aab2277; Lu JM, 2018, P NATL ACAD SCI USA, V115, P3551, DOI 10.1073/pnas.1716781115; Matsuda Y, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.051005; Mayorov AS, 2011, NANO LETT, V11, P2396, DOI 10.1021/nl200758b; Saito Y, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2016.94; Saito Y, 2016, NAT PHYS, V12, P144, DOI [10.1038/NPHYS3580, 10.1038/nphys3580]; SHIMAHARA H, 1994, PHYS REV B, V50, P12760, DOI 10.1103/PhysRevB.50.12760; Tamir I, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3826; Wakatsuki R., 2016, ARXIV160404898CONDMA; Wang C, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.126402; WERTHAME.NR, 1966, PHYS REV, V147, P295, DOI 10.1103/PhysRev.147.295; Wosnitza J, 2018, ANN PHYS-BERLIN, V530, DOI 10.1002/andp.201700282; Xi XX, 2016, NAT PHYS, V12, P139, DOI [10.1038/NPHYS3538, 10.1038/nphys3538]; Xu Y, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.226801; Xu Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.136804; Yue D, 2017, J PHYS SOC JPN, V86, DOI 10.7566/JPSJ.86.011006; Zang YY, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201802723; Zhang D, 2016, PHYS REV LETT, V116; Zhang D., 2020, HARVARD DATAVERSE; Zhang D., 2020, HARVARD DATAVERSE, DOI [10.7910/DVN/O38NC2, DOI 10.7910/DVN/O38NC2]; Zhang D, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.076804; Zhao A., 2019, ARXIV190503127CONDMA; ZORIN AB, 1995, REV SCI INSTRUM, V66, P4296, DOI 10.1063/1.1145385; Zwicknagl G, 2017, J PHYS SOC JPN, V86, DOI 10.7566/JPSJ.86.083701	43	54	55	13	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1454	+		10.1126/science.aax3873	http://dx.doi.org/10.1126/science.aax3873			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ4RP	32165427	Green Accepted, Green Submitted			2022-12-28	WOS:000523251600031
J	Rimmer, A				Rimmer, Abi			Flexible working: all trainees will be able to work less than full time by 2022	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2020	368								m987	10.1136/bmj.m987	http://dx.doi.org/10.1136/bmj.m987			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AO	32156685				2022-12-28	WOS:000520012500018
J	Bartolo, D				Bartolo, Denis			Rings rule three-dimensional active matter	SCIENCE			English	Editorial Material									[Bartolo, Denis] Univ Lyon, Lab Phys, Ecole Normale Super Lyon, Lyon, France	Ecole Normale Superieure de Lyon (ENS de LYON)	Bartolo, D (corresponding author), Univ Lyon, Lab Phys, Ecole Normale Super Lyon, Lyon, France.	denis.bartolo@ens-lyon.fr	bartolo, denis/B-5537-2015	bartolo, denis/0000-0001-5035-6898				Alexander GP, 2012, REV MOD PHYS, V84, P497, DOI 10.1103/RevModPhys.84.497; BOULIGAND Y, 1974, J PHYS-PARIS, V35, P215, DOI 10.1051/jphys:01974003503021500; Dogic Z, 2006, CURR OPIN COLLOID IN, V11, P47, DOI 10.1016/j.cocis.2005.10.004; Doostmohammadi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05666-8; Duclos G, 2020, SCIENCE, V367, P1120, DOI 10.1126/science.aaz4547; Giomi L, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031003; Krzic U, 2012, NAT METHODS, V9, P730, DOI [10.1038/nmeth.2064, 10.1038/NMETH.2064]; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Sanchez T, 2012, NATURE, V491, P431, DOI 10.1038/nature11591; Tkalec U, 2011, SCIENCE, V333, P62, DOI 10.1126/science.1205705; Zhang J, 2017, CHEM SOC REV, V46, P5551, DOI 10.1039/c7cs00461c	11	1	1	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1075	1076		10.1126/science.aba5319	http://dx.doi.org/10.1126/science.aba5319			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU9CD	32139530				2022-12-28	WOS:000520018400025
J	Battich, N; Beumer, J; de Barbanson, B; Krenning, L; Baron, CS; Tanenbaum, ME; Clevers, H; van Oudenaarden, A				Battich, Nico; Beumer, Joep; de Barbanson, Buys; Krenning, Lenno; Baron, Chloe S.; Tanenbaum, Marvin E.; Clevers, Hans; van Oudenaarden, Alexander			Sequencing metabolically labeled transcripts in single cells reveals mRNA turnover strategies	SCIENCE			English	Article							GENE-EXPRESSION; SEQ	The regulation of messenger RNA levels in mammalian cells can be achieved by the modulation of synthesis and degradation rates. Metabolic RNA-labeling experiments in bulk have quantified these rates using relatively homogeneous cell populations. However, to determine these rates during complex dynamical processes, for instance during cellular differentiation, single-cell resolution is required. Therefore, we developed a method that simultaneously quantifies metabolically labeled and preexisting unlabeled transcripts in thousands of individual cells. We determined synthesis and degradation rates during the cell cycle and during differentiation of intestinal stem cells, revealing major regulatory strategies. These strategies have distinct consequences for controlling the dynamic range and precision of gene expression. These findings advance our understanding of how individual cells in heterogeneous populations shape their gene expression dynamics.	[Battich, Nico; Beumer, Joep; de Barbanson, Buys; Krenning, Lenno; Baron, Chloe S.; Tanenbaum, Marvin E.; Clevers, Hans; van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, Oncode Inst, NL-3584 CT Utrecht, Netherlands; [Battich, Nico; Beumer, Joep; de Barbanson, Buys; Krenning, Lenno; Baron, Chloe S.; Tanenbaum, Marvin E.; Clevers, Hans; van Oudenaarden, Alexander] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Krenning, Lenno] Netherlands Canc Inst, Oncode Inst, Div Cell Biol, Amsterdam, Netherlands; [Baron, Chloe S.] Harvard Univ, Boston Childrens Hosp, Stem Cell Program, 1 Blackfan Circle, Boston, MA 02115 USA; [Baron, Chloe S.] Harvard Univ, Boston Childrens Hosp, Div Hematol Oncol, 1 Blackfan Circle, Boston, MA 02115 USA; [Baron, Chloe S.] Harvard Univ, Dana Farber Canc Inst, Howard Hughes Med Inst,Harvard Med Sch, Harvard Stem Cell Inst,Stem Cell & Regenerat Biol, 1 Blackfan Circle, Boston, MA 02115 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Battich, N; van Oudenaarden, A (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, Oncode Inst, NL-3584 CT Utrecht, Netherlands.	n.battich@hubrecht.eu; a.vanoudenaarden@hubrecht.eu	Battich, Nico/AAL-3955-2020; Krenning, Lenno/AAT-2272-2021	Battich, Nico/0000-0002-1700-1590; Krenning, Lenno/0000-0001-6696-0512; Tanenbaum, Marvin/0000-0001-8762-0090; de Barbanson, Buys/0000-0002-6967-5757	European Research Council [ERC-AdG 742225-IntScOmics, EU/ERC-677936]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) TOP award [NWO-CW714.016.001]; Swiss National Science Foundation [P2ZHP3_171695]; Human Frontier Science Program [LT 000877/2017]; Dutch Cancer Society	European Research Council(European Research Council (ERC)European Commission); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) TOP award; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontier Science Program(Human Frontier Science Program); Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the European Research Council (grants ERC-AdG 742225-IntScOmics and EU/ERC-677936 RNAREG) and a Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) TOP award (NWO-CW714.016.001). N.B. was supported by the Swiss National Science Foundation (P2ZHP3_171695) and the Human Frontier Science Program (LT 000877/2017). This work is part of the Oncode Institute that is partly financed by the Dutch Cancer Society.	Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Berchtold D, 2018, MOL CELL, V72, P1035, DOI 10.1016/j.molcel.2018.10.036; Gehart H, 2019, CELL, V176, P1158, DOI 10.1016/j.cell.2018.12.029; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Krenning L, 2014, MOL CELL, V55, P59, DOI 10.1016/j.molcel.2014.05.007; Little SC, 2013, CELL, V154, P789, DOI 10.1016/j.cell.2013.07.025; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Pijuan-Sala B, 2019, NATURE, V566, P490, DOI 10.1038/s41586-019-0933-9; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Rabani M, 2014, CELL, V159, P1698, DOI 10.1016/j.cell.2014.11.015; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; Rosenberg AB, 2018, SCIENCE, V360, P176, DOI 10.1126/science.aam8999; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schofield JA, 2018, NAT METHODS, V15, P221, DOI [10.1038/NMETH.4582, 10.1038/nmeth.4582]; Schwalb B, 2016, SCIENCE, V352, P1225, DOI 10.1126/science.aad9841; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Sun W, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800052; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437; Xie F, 2016, ACTA PHARMACOL SIN B, V6, P374, DOI 10.1016/j.apsb.2016.07.012; Zerjatke T, 2017, CELL REP, V19, P1953, DOI 10.1016/j.celrep.2017.05.022	37	31	31	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1151	+		10.1126/science.aax3072	http://dx.doi.org/10.1126/science.aax3072			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9CD	32139547				2022-12-28	WOS:000520018400046
J	Dyer, O				Dyer, Owen			US Supreme Court hears pivotal abortion case as pro-lifers seek to undermine Roe v Wade	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2020	368								m917	10.1136/bmj.m917	http://dx.doi.org/10.1136/bmj.m917			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KI	32139371				2022-12-28	WOS:000519537000009
J	Mahase, E				Mahase, Elisabeth			Covid-19: UK could delay non-urgent care and call doctors back from leave and retirement	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	6	6	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2020	368								m854	10.1136/bmj.m854	http://dx.doi.org/10.1136/bmj.m854			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KD	32127353	Bronze			2022-12-28	WOS:000519536500011
J	Dyer, C				Dyer, Clare			Coroner to ask GMC to check vulnerability of doctors it investigates	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], STOP INH TREATM DOCT	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2020	368								m835	10.1136/bmj.m835	http://dx.doi.org/10.1136/bmj.m835			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KC	32122883				2022-12-28	WOS:000519536400011
J	Zarocostas, J				Zarocostas, John			How to fight an infodemic	LANCET			English	Editorial Material																			0	812	853	40	134	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 29	2020	395	10225					676	676						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KQ2JO	32113495	Green Published, Bronze			2022-12-28	WOS:000516755200014
J	Graham, DB; Xavier, RJ				Graham, Daniel B.; Xavier, Ramnik J.			Pathway paradigms revealed from the genetics of inflammatory bowel disease	NATURE			English	Review							GENOME-WIDE ASSOCIATION; INTESTINAL INFLAMMATION; ER STRESS; SELECTIVE AUTOPHAGY; SUSCEPTIBILITY LOCI; CROHN-DISEASE; IMMUNE CELLS; VARIANT; ATG16L1; ACTIVATION	Inflammatory bowel disease (IBD) is a complex genetic disease that is instigated and amplified by the confluence of multiple genetic and environmental variables that perturb the immune-microbiome axis. The challenge of dissecting pathological mechanisms underlying IBD has led to the development of transformative approaches in human genetics and functional genomics. Here we describe IBD as a model disease in the context of leveraging human genetics to dissect interactions in cellular and molecular pathways that regulate homeostasis of the mucosal immune system. Finally, we synthesize emerging insights from multiple experimental approaches into pathway paradigms and discuss future prospects for disease-subtype classification and therapeutic intervention. This Review examines inflammatory bowel disease in the context of human genetics studies that help to identify pathways that regulate homeostasis of the mucosal immune system and discusses future prospects for disease-subtype classification and therapeutic intervention.	[Graham, Daniel B.; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Graham, Daniel B.; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Graham, Daniel B.; Xavier, Ramnik J.] Harvard Med Sch, Boston, MA 02115 USA; [Graham, Daniel B.; Xavier, Ramnik J.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Graham, Daniel B.; Xavier, Ramnik J.] MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Graham, DB; Xavier, RJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Graham, DB; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.; Graham, DB; Xavier, RJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Graham, DB; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Graham, DB; Xavier, RJ (corresponding author), MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dgraham@broadinstitute.org; xavier@molbio.mgh.harvard.edu			Helmsley Charitable Trust; NIH	Helmsley Charitable Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by grants from the Helmsley Charitable Trust and NIH (to R.J.X.). We thank H. Kang for valuable scientific input, editorial assistance and illustrative design.	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Arnadottir GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06964-x; Bastaki F, 2018, ANN HUM GENET, V82, P35, DOI 10.1111/ahg.12220; Bauche D, 2018, IMMUNITY, V49, P342, DOI 10.1016/j.immuni.2018.07.007; Beaudoin M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003723; Bein A, 2018, CELL MOL GASTROENTER, V5, P659, DOI 10.1016/j.jcmgh.2017.12.010; Belarif L, 2019, J CLIN INVEST, V129, P1910, DOI 10.1172/JCI121668; Bernshtein B, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6571; Beumer J, 2018, NAT CELL BIOL, V20, P909, DOI 10.1038/s41556-018-0143-y; Biton M, 2018, CELL, V175, P1307, DOI 10.1016/j.cell.2018.10.008; Bunker JJ, 2018, IMMUNITY, V49, P211, DOI 10.1016/j.immuni.2018.08.011; Cader MZ, 2016, NAT IMMUNOL, V17, P1046, DOI 10.1038/ni.3532; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Calderon D, 2019, NAT GENET, V51, P1494, DOI 10.1038/s41588-019-0505-9; Campbell EL, 2014, IMMUNITY, V40, P66, DOI 10.1016/j.immuni.2013.11.020; Cao ZF, 2015, IMMUNITY, V43, P715, DOI 10.1016/j.immuni.2015.10.005; Caruso R, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw4341; Castro-Dopico T, 2019, IMMUNITY, V50, P1099, DOI 10.1016/j.immuni.2019.02.006; Charbit-Henrion F, 2018, J CROHNS COLITIS, V12, P1104, DOI 10.1093/ecco-jcc/jjy068; Chirieleison SM, 2017, J BIOL CHEM, V292, P9666, DOI 10.1074/jbc.M117.781500; Christophersen A, 2019, NAT MED, V25, P734, DOI 10.1038/s41591-019-0403-9; Curtis VF, 2015, FASEB J, V29, P208, DOI 10.1096/fj.14-259663; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; de Luca A, 2014, P NATL ACAD SCI USA, V111, P3526, DOI 10.1073/pnas.1322831111; Dendrou CA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1974; Denson LA, 2018, GASTROENTEROLOGY, V154, P2097, DOI 10.1053/j.gastro.2018.02.016; Deuring JJ, 2014, GUT, V63, P1081, DOI 10.1136/gutjnl-2012-303527; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Emond B, 2019, CURR MED RES OPIN, V35, P1751, DOI 10.1080/03007995.2019.1620713; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Flynn RS, 2011, INFLAMM BOWEL DIS, V17, P193, DOI 10.1002/ibd.21351; Friedrich M, 2019, IMMUNITY, V50, P992, DOI 10.1016/j.immuni.2019.03.017; Frizinsky S, 2019, J CLIN IMMUNOL, V39, P401, DOI 10.1007/s10875-019-00629-0; Fujimoto K, 2017, MUCOSAL IMMUNOL, V10, P446, DOI 10.1038/mi.2016.58; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Geesala R, 2019, J LEUKOCYTE BIOL, V105, P767, DOI 10.1002/JLB.4A0718-283RR; Gehart H, 2019, CELL, V176, P1158, DOI 10.1016/j.cell.2018.12.029; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Glover LE, 2013, P NATL ACAD SCI USA, V110, P19820, DOI 10.1073/pnas.1302840110; Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176; Graham DB, 2018, CELL REP, V24, P838, DOI 10.1016/j.celrep.2018.06.081; Graham DB, 2016, CELL REP, V17, P2955, DOI 10.1016/j.celrep.2016.11.042; Graham DB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8838; Grootjans J, 2019, SCIENCE, V363, P993, DOI 10.1126/science.aat7186; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Haile PA, 2019, J MED CHEM, V62, P6482, DOI 10.1021/acs.jmedchem.9b00575; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Hartono S, 2019, CLIN REV ALLERG IMMU, V57, P145, DOI 10.1007/s12016-018-8689-9; He ZG, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1223-4; Holt-Danborg L, 2019, HUM MOL GENET, V28, P828, DOI 10.1093/hmg/ddy394; Hosomi S, 2017, J EXP MED, V214, P2985, DOI 10.1084/jem.20162041; Hrdinka M, 2018, EMBO J, V37, DOI 10.15252/embj.201899372; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Huang HL, 2017, NATURE, V547, P173, DOI 10.1038/nature22969; Hui KY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aai7795; Hyams JS, 2019, LANCET, V393, P1708, DOI 10.1016/S0140-6736(18)32592-3; Jardine S, 2019, CELL MOL GASTROENTER, V7, P555, DOI 10.1016/j.jcmgh.2018.12.001; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaplan GG, 2017, GASTROENTEROLOGY, V152, P313, DOI 10.1053/j.gastro.2016.10.020; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Kim YG, 2011, J IMMUNOL, V187, P2849, DOI 10.4049/jimmunol.1001854; Kinchen J, 2018, CELL, V175, P372, DOI 10.1016/j.cell.2018.08.067; Knoop KA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aao1314; Kotlarz D, 2018, NAT GENET, V50, P344, DOI 10.1038/s41588-018-0063-6; Lahiri A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15614; Lassen KG, 2016, IMMUNITY, V44, P1392, DOI 10.1016/j.immuni.2016.05.007; Lassen KG, 2014, P NATL ACAD SCI USA, V111, P7741, DOI 10.1073/pnas.1407001111; Latour S, 2015, SEMIN CELL DEV BIOL, V39, P115, DOI 10.1016/j.semcdb.2015.01.015; Lee JC, 2017, NAT GENET, V49, P262, DOI 10.1038/ng.3755; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Leshchiner ES, 2017, P NATL ACAD SCI USA, V114, P11392, DOI 10.1073/pnas.1705748114; Li Q, 2016, GASTROENTEROLOGY, V150, P1196, DOI 10.1053/j.gastro.2016.01.031; Li Y, 2019, P NATL ACAD SCI USA, V116, P970, DOI 10.1073/pnas.1813582116; Limon JJ, 2019, CELL HOST MICROBE, V25, P377, DOI 10.1016/j.chom.2019.01.007; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; Ma C, 2019, DRUGS, V79, P1321, DOI 10.1007/s40265-019-01169-y; Malik A, 2017, J CELL SCI, V130, P3955, DOI 10.1242/jcs.207365; Manzanillo Paolo, 2018, Immunohorizons, V2, P164, DOI 10.4049/immunohorizons.1800027; Martin JC, 2019, CELL, V178, P1493, DOI 10.1016/j.cell.2019.08.008; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martins F, 2019, NAT REV CLIN ONCOL, V16, P563, DOI 10.1038/s41571-019-0218-0; Maxwell JR, 2015, IMMUNITY, V43, P739, DOI 10.1016/j.immuni.2015.08.019; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; Metidji A, 2018, IMMUNITY, V49, P353, DOI 10.1016/j.immuni.2018.07.010; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Mohanan V, 2018, SCIENCE, V359, P1161, DOI 10.1126/science.aan0814; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Momozawa Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04365-8; Mukherjee T, 2019, ARCH BIOCHEM BIOPHYS, V670, P69, DOI 10.1016/j.abb.2018.12.022; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Nadjsombati MS, 2018, IMMUNITY, V49, P33, DOI 10.1016/j.immuni.2018.06.016; Nair S, 2018, J EXP MED, V215, P1035, DOI 10.1084/jem.20180118; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pagnini C, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00671; Parikh K, 2019, NATURE, V567, P49, DOI 10.1038/s41586-019-0992-y; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Pentinmikko N, 2019, NATURE, V571, P398, DOI 10.1038/s41586-019-1383-0; Plichta DR, 2019, CELL, V178, P1041, DOI 10.1016/j.cell.2019.07.045; Ramakrishnan SK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08581-8; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rivas MA, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007329; Rivas MA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12869; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Samie M, 2018, NAT IMMUNOL, V19, P246, DOI 10.1038/s41590-017-0042-6; Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676; Scheibe K, 2019, GASTROENTEROLOGY, V156, P1082, DOI 10.1053/j.gastro.2018.11.029; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schneider C, 2019, NAT REV IMMUNOL, V19, P584, DOI 10.1038/s41577-019-0176-x; Schwerd T, 2017, GUT, V66, P1060, DOI 10.1136/gutjnl-2015-310382; Serra D, 2019, NATURE, V569, P66, DOI 10.1038/s41586-019-1146-y; Shouval DS, 2016, GASTROENTEROLOGY, V151, P1100, DOI 10.1053/j.gastro.2016.08.055; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Simeonov DR, 2017, NATURE, V549, P111, DOI 10.1038/nature23875; Skon-Hegg C, 2019, J IMMUNOL, V202, P183, DOI 10.4049/jimmunol.1800636; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Solanki S, 2019, AM J PHYSIOL-GASTR L, V317, pG98, DOI 10.1152/ajpgi.00081.2019; Sveinbjornsson G, 2014, HUM MOL GENET, V23, P6935, DOI 10.1093/hmg/ddu399; Takagawa T, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan8162; Takeda H, 2019, P NATL ACAD SCI USA, V116, P15635, DOI 10.1073/pnas.1904714116; Tang C, 2018, NAT IMMUNOL, V19, P755, DOI 10.1038/s41590-018-0134-y; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Taylor CT, 2017, NAT REV IMMUNOL, V17, P774, DOI 10.1038/nri.2017.103; Tong X, 2018, CELL SIGNAL, V52, P155, DOI 10.1016/j.cellsig.2018.09.008; Tronstad RR, 2018, SCAND J GASTROENTERO, V53, P1264, DOI 10.1080/00365521.2018.1521867; Umiker B, 2019, INNATE IMMUN-LONDON, V25, P132, DOI 10.1177/1753425919826367; VanDussen KL, 2018, GASTROENTEROLOGY, V155, P815, DOI 10.1053/j.gastro.2018.05.028; VanDussen KL, 2014, GASTROENTEROLOGY, V146, P200, DOI 10.1053/j.gastro.2013.09.048; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Weiss ES, 2018, BLOOD, V131, P1442, DOI 10.1182/blood-2017-12-820852; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307; Wu J, 2018, MUCOSAL IMMUNOL, V11, P1487, DOI 10.1038/s41385-018-0046-z; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Xu X, 2018, NAT IMMUNOL, V19, P547, DOI 10.1038/s41590-018-0112-4; Xue X, 2013, GASTROENTEROLOGY, V145, P831, DOI 10.1053/j.gastro.2013.07.010; Zammit NW, 2019, NAT IMMUNOL, V20, P1299, DOI 10.1038/s41590-019-0492-0; Zhou L, 2019, NATURE, V568, P405, DOI 10.1038/s41586-019-1082-x; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	148	199	202	26	123	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB	2020	578	7796					527	539		10.1038/s41586-020-2025-2	http://dx.doi.org/10.1038/s41586-020-2025-2			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KP9SJ	32103191	Green Accepted			2022-12-28	WOS:000516571100013
J	Wilkinson, AC				Wilkinson, Adam C.			Hope for hematological diseases	SCIENCE			English	Editorial Material							HEMATOPOIETIC STEM-CELLS		[Wilkinson, Adam C.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Lorry I Lokey Stem Cell Res Bldg,265 Campus Dr, Stanford, CA 94305 USA; [Wilkinson, Adam C.] Stanford Univ, Dept Genet, Sch Med, Lorry I Lokey Stem Cell Res Bldg,265 Campus Dr, Stanford, CA 94305 USA	Stanford University; Stanford University	Wilkinson, AC (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Lorry I Lokey Stem Cell Res Bldg,265 Campus Dr, Stanford, CA 94305 USA.; Wilkinson, AC (corresponding author), Stanford Univ, Dept Genet, Sch Med, Lorry I Lokey Stem Cell Res Bldg,265 Campus Dr, Stanford, CA 94305 USA.	adamcw@stanford.edu						Bhattacharya D, 2006, J EXP MED, V203, P73, DOI 10.1084/jem.20051714; Chabannon C, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9630; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Dever DP, 2017, CURR OPIN HEMATOL, V24, P481, DOI 10.1097/MOH.0000000000000385; Eaves CJ, 2015, BLOOD, V125, P2605, DOI 10.1182/blood-2014-12-570200; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; Ieyasu A, 2017, STEM CELL REP, V8, P500, DOI 10.1016/j.stemcr.2017.01.015; Kumar S, 2017, TRENDS MOL MED, V23, P799, DOI 10.1016/j.molmed.2017.07.003; Taya Y, 2016, SCIENCE, V354, P1152, DOI 10.1126/science.aag3145; Wilkinson AC, 2019, NATURE, V571, P117, DOI 10.1038/s41586-019-1244-x; Wilkinson AC, 2018, EXP HEMATOL, V63, P12, DOI 10.1016/j.exphem.2018.04.004	11	4	4	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1206	1206		10.1126/science.aba6108	http://dx.doi.org/10.1126/science.aba6108			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU9DP	32165580				2022-12-28	WOS:000520023800030
J	Zucker, JR; Rosen, JB; Iwamoto, M; Arciuolo, RJ; Langdon-Embry, M; Vora, NM; Rakeman, JL; Isaac, BM; Jean, A; Asfaw, M; Hawkins, SC; Merrill, TG; Kennelly, MO; Morgenthau, BM; Daskalakis, DC; Barbot, O				Zucker, Jane R.; Rosen, Jennifer B.; Iwamoto, Martha; Arciuolo, Robert J.; Langdon-Embry, Marisa; Vora, Neil M.; Rakeman, Jennifer L.; Isaac, Beth M.; Jean, Antonine; Asfaw, Mekete; Hawkins, Simone C.; Merrill, Thomas G.; Kennelly, Maura O.; Morgenthau, Beth; Daskalakis, Demetre C.; Barbot, Oxiris			Consequences of Undervaccination - Measles Outbreak, New York City, 2018-2019	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MUMPS; ELIMINATION; RUBELLA; VIRUS	Measles was eliminated in the United States in 2000. However, an outbreak occurred in New York City from 2018 to 2019 that was associated with the importation of measles into an undervaccinated community, leading to 649 confirmed cases, with 49 patients being hospitalized and 20 receiving care in an intensive care unit. Background Measles was declared eliminated in the United States in 2000, but the risk of outbreaks owing to international importations remains. An outbreak of measles in New York City began when one unvaccinated child returned home from Israel with measles; onset of rash occurred on September 30, 2018, 9 days after the child returned home. Methods We investigated suspected cases of measles by conducting interviews, reviewing medical and immunization records, identifying exposed persons, and performing diagnostic testing. Measles-mumps-rubella (MMR) vaccine (given as either MMR or measles-mumps-rubella-varicella vaccine and collectively referred to as MMR vaccine) uptake was monitored with the use of the Citywide Immunization Registry. The total direct cost to the New York City Department of Health and Mental Hygiene was calculated. Results A total of 649 cases of measles were confirmed, with onsets of rash occurring between September 30, 2018, and July 15, 2019. A majority of the patients (93.4%) were part of the Orthodox Jewish community, and 473 of the patients (72.9%) resided in the Williamsburg area of Brooklyn, New York. The median age was 3 years; 81.2% of the patients were 18 years of age or younger, and 85.8% of the patients with a known vaccination history were unvaccinated. Serious complications included pneumonia (in 37 patients [5.7%]) and hospitalization (in 49 patients [7.6%]); among the patients who were hospitalized, 20 (40.8%) were admitted to an intensive care unit. As a result of efforts to promote vaccination, the percentage of children in Williamsburg who received at least one dose of MMR vaccine increased from 79.5% to 91.1% among children 12 to 59 months of age. As of September 9, 2019, a total of 559 staff members at the Department of Health and Mental Hygiene (7% of the agency) had been involved in the measles response. The cost of the Department of Health and Mental Hygiene response was $8.4 million. Conclusions Importation of measles and vaccination delays among young children led to an outbreak of measles in New York City. The outbreak response was resource intensive and caused serious illness, particularly among unvaccinated children.	[Zucker, Jane R.; Rosen, Jennifer B.; Iwamoto, Martha; Arciuolo, Robert J.; Langdon-Embry, Marisa; Vora, Neil M.; Rakeman, Jennifer L.; Isaac, Beth M.; Jean, Antonine; Asfaw, Mekete; Hawkins, Simone C.; Merrill, Thomas G.; Kennelly, Maura O.; Morgenthau, Beth; Daskalakis, Demetre C.; Barbot, Oxiris] New York City Dept Hlth & Mental Hyg, New York, NY USA; [Zucker, Jane R.; Vora, Neil M.] Ctr Dis Control & Prevent, Atlanta, GA USA	New York City Department of Health & Mental Hygiene; Centers for Disease Control & Prevention - USA	Zucker, JR (corresponding author), New York City Dept Hlth & Mental Hyg, Bur Immunizat, 42-09 28th St,CN21,Rm 5-97, Queens, NY 11101 USA.	jzucker@health.nyc.gov	Vora, Neil Manhar/AAJ-7269-2021	Vora, Neil Manhar/0000-0002-4989-3108				[Anonymous], 2019, LANCET CHILD ADOLESC, V3, P281, DOI 10.1016/S2352-4642(19)30092-6; [Anonymous], 2014, Public Health Rep, V129 Suppl 3, P12; [Anonymous], 1998, Wkly Epidemiol Rec, V73, P265; [Anonymous], 2014, AL 12 UPD MEASL NEW; [Anonymous], HUDS VALL HLTH COAL; [Anonymous], HLTH COD 11 03 REP D; [Anonymous], HLTH COD 11 07 REP D; [Anonymous], 2017, PEACH MAGAZINES HD A; [Anonymous], ORD COMM; [Anonymous], 2019, SLIC PIE PAR INF ED; Barskey AE, 2012, NEW ENGL J MED, V367, P1704, DOI 10.1056/NEJMoa1202865; Cantor JD, 2019, NEW ENGL J MED, V381, P101, DOI 10.1056/NEJMp1905941; Centers for Disease Control and Prevention, IMM INF SYST IIS SEN; Centers for Disease Control and Prevention, MEASL CAS 2019; Dabbagh A, 2018, MMWR-MORBID MORTAL W, V67, P1323, DOI 10.15585/mmwr.mm6747a6; FEMA.gov, FEMA INC COMM SYST I; Guerra FM, 2017, LANCET INFECT DIS, V17, pE420, DOI 10.1016/S1473-3099(17)30307-9; Hamborsky J, 2015, EPIDEMIOLOGY PREVENT, P209; Hummel KB, 2006, J VIROL METHODS, V132, P166, DOI 10.1016/j.jviromet.2005.10.006; Katz SL, 2004, J INFECT DIS, V189, pS43, DOI 10.1086/377696; Lievano F, 2012, VACCINE, V30, P6918, DOI 10.1016/j.vaccine.2012.08.057; McLean HQ, 2013, MMWR RECOMM REP, V62, P1; Metroka AE, 2016, PUBLIC HEALTH REP, V131, P583, DOI 10.1177/0033354916662217; New York City Department of Health, HLTH TOP MEASL; New York City Department of Health and Mental Hygiene, 2015, AL 40 PERT NEW YORK; New York City Department of Health and Mental Hygiene, 2016, AL 12 VAR NEW YORK C; Patel M, 2019, MMWR-MORBID MORTAL W, V68, P402, DOI 10.15585/mmwr.mm6817e1; Rosen JB, 2018, JAMA PEDIATR, V172, P811, DOI 10.1001/jamapediatrics.2018.1024; WHO Regional Office for Europe, 2019, 1 WHO REG OFF EUR; Zimmerman CM, 2009, 43 NAT IMM C DALL MA	30	42	43	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2020	382	11					1009	1017		10.1056/NEJMoa1912514	http://dx.doi.org/10.1056/NEJMoa1912514			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU7TA	32160662	Bronze			2022-12-28	WOS:000519914300007
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: roundup of latest news	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2020	368								m969	10.1136/bmj.m969	http://dx.doi.org/10.1136/bmj.m969			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AO	32156680	Bronze			2022-12-28	WOS:000520012500013
J	Luteijn, RD; Zaver, SA; Gowen, BG; Wyman, SK; Garelis, NE; Onia, L; McWhirter, SM; Katibah, GE; Corn, JE; Woodward, JJ; Raulet, DH				Luteijn, Rutger D.; Zaver, Shivam A.; Gowen, Benjamin G.; Wyman, Stacia K.; Garelis, Nick E.; Onia, Liberty; McWhirter, Sarah M.; Katibah, George E.; Corn, Jacob E.; Woodward, Joshua J.; Raulet, David H.			SLC19A1 transports immunoreactive cyclic dinucleotides (vol 75, pg 372, 2019)	NATURE			English	Correction								An amendment to this paper has been published and can be accessed via a link at the top of the paper.				raulet@berkeley.edu		Luteijn, Rutger/0000-0002-6183-4573	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI137758] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ritchie C, 2019, MOL CELL, V75, P372, DOI 10.1016/j.molcel.2019.05.006	1	1	1	2	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					E12	E12		10.1038/s41586-020-2064-8	http://dx.doi.org/10.1038/s41586-020-2064-8		MAR 2020	1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX4BT	32144410	Bronze			2022-12-28	WOS:000518309000001
J	Richter, LM; Ghent, L; Issa, GM; Okengo, L; Santiago, E				Richter, Linda M.; Ghent, Liana; Issa, Ghassan M.; Okengo, Lynette; Santiago, Evelyn			Guidance for the health sector to partner with parents and families for early childhood development	LANCET			English	Editorial Material							DEVELOPING-COUNTRIES; CHILDREN; STRATEGIES; CARE		[Richter, Linda M.] Univ Witwatersrand, DSI NRF Ctr Excellence, ZA-2193 Parktown, South Africa; [Ghent, Liana] Int Step By Step Assoc, Leiden, Netherlands; [Issa, Ghassan M.] Arab Network Early Childhood Dev, Beirut, Lebanon; [Okengo, Lynette] African Early Child Network, Nairobi, Kenya; Asia Pacific Reg Network Early Childhood, Singapore, Singapore	University of Witwatersrand	Richter, LM (corresponding author), Univ Witwatersrand, DSI NRF Ctr Excellence, ZA-2193 Parktown, South Africa.	linda.richter@wits.ac.za						Bamford L, 2019, S AFR HLTH REV, P145; Bernal R, 2019, EARLY CHILD RES Q, V47, P418, DOI 10.1016/j.ecresq.2018.08.005; Black MM, 2017, LANCET, V389, P77, DOI 10.1016/S0140-6736(16)31389-7; Britto PR, 2017, LANCET, V389, P91, DOI 10.1016/S0140-6736(16)31390-3; Chang SM, 2015, PEDIATRICS, V136, P272, DOI 10.1542/peds.2015-0119; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Engle PL, 2011, LANCET, V378, P1339, DOI 10.1016/S0140-6736(11)60889-1; G20 Development Working Group, 2018, G20 IN EARL CHILDH D; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Prado EL, 2019, LANCET GLOB HEALTH, V7, pE1398, DOI 10.1016/S2214-109X(19)30361-4; Richter Linda, 2004, IMPORTANCE CAREGIVER; Richter LM, 2017, LANCET, V389, P103, DOI 10.1016/S0140-6736(16)31698-1; Vikram K, 2020, WORLD DEV, V127, DOI 10.1016/j.worlddev.2019.104697; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; WHO, 2022, WHO RECOMMENDATIONS; WHO, 2020, WHO GUID IMPR EARL C; WHO United Nations Children's Fund World Bank Group, 2018, NURT CAR EARL CHILDH; World Health Organization, 2018, GUID COUNS WOM IMPR; World Health Organization Department of Maternal N, 2013, WHO REC POSTN CAR MO	19	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2020	395	10226					766	768						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU2KH	32145775				2022-12-28	WOS:000519536900011
J	Wei, LH; Guo, JJU				Wei, Lian-Huan; Guo, Junjie U.			Coding functions of "noncoding" RNAs	SCIENCE			English	Editorial Material							TRANSLATION; ORFS		[Wei, Lian-Huan; Guo, Junjie U.] Yale Univ, Sch Med, Dept Neurosci, 333 Cedar St, New Haven, CT 06520 USA	Yale University	Guo, JJU (corresponding author), Yale Univ, Sch Med, Dept Neurosci, 333 Cedar St, New Haven, CT 06520 USA.	junjie.guo@yale.edu			Yale Scholar in Neuroscience Fund; Ludwig Family Foundation; NIH New Innovator Award [DP2 GM132930]; Muscular Dystrophy Association [MDA602934]	Yale Scholar in Neuroscience Fund; Ludwig Family Foundation; NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association)	We thank A. Giraldez,I. Ulitsky, N. DeRuiter, and other members of the Guo lab for comments. J.U.G. is a NARSAD Young Investigator and a Klingenstein-Simons Fellow in Neuroscience. Our work is supported by the Yale Scholar in Neuroscience Fund, the Ludwig Family Foundation, an NIH New Innovator Award (DP2 GM132930), and the Muscular Dystrophy Association (MDA602934).	Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Bazzini AA, 2014, EMBO J, V33, P981, DOI 10.1002/embj.201488411; Chen J, 2020, SCIENCE, V367, P1140, DOI 10.1126/science.aay0262; Doolittle WF, 2014, GENOME BIOL EVOL, V6, P1234, DOI 10.1093/gbe/evu098; Gao FB, 2017, CELL, V171, P994, DOI 10.1016/j.cell.2017.10.042; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Ingolia NT, 2014, CELL REP, V8, P1365, DOI 10.1016/j.celrep.2014.07.045; Ji Z, 2015, ELIFE, V4, DOI 10.7554/eLife.08890; Johnstone TG, 2016, EMBO J, V35, P706, DOI 10.15252/embj.201592759; Kearse MG, 2016, MOL CELL, V62, P314, DOI 10.1016/j.molcel.2016.02.034; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Starck SR, 2016, SCIENCE, V351, DOI 10.1126/science.aad3867; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020	15	15	15	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1074	1075		10.1126/science.aba6117	http://dx.doi.org/10.1126/science.aba6117			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU9CD	32139529				2022-12-28	WOS:000520018400024
J	Hubau, W; Lewis, SL; Phillips, OL; Affum-Baffoe, K; Beeckman, H; Cuni-Sanchez, A; Daniels, AK; Ewango, CEN; Fauset, S; Mukinzi, JM; Sheil, D; Sonke, B; Sullivan, MJP; Sunderland, TCH; Taedoumg, H; Thomas, SC; White, LJT; Abernethy, KA; Adu-Bredu, S; Amani, CA; Baker, TR; Banin, LF; Baya, F; Begne, SK; Bennett, AC; Benedet, F; Bitariho, R; Bocko, YE; Boeckx, P; Boundja, P; Brienen, RJW; Brncic, T; Chezeaux, E; Chuyong, GB; Clark, CJ; Collins, M; Comiskey, JA; Coomes, DA; Dargie, GC; de Haulleville, T; Kamdem, MND; Doucet, JL; Esquivel-Muelbert, A; Feldpausch, TR; Fofanah, A; Foli, EG; Gilpin, M; Gloor, E; Gonmadje, C; Gourlet-Fleury, S; Hall, JS; Hamilton, AC; Harris, DJ; Hart, TB; Hockemba, MBN; Hladik, A; Ifo, SA; Jeffery, KJ; Jucker, T; Yakusu, EK; Kearsley, E; Kenfack, D; Koch, A; Leal, ME; Levesley, A; Lindsell, JA; Lisingo, J; Lopez-Gonzalez, G; Lovett, JC; Makana, JR; Malhi, Y; Marshall, AR; Martin, J; Martin, EH; Mbayu, FM; Medjibe, VP; Mihindou, V; Mitchard, ETA; Moore, S; Munishi, PKT; Bengone, NN; Ojo, L; Ondo, FE; Peh, KSH; Pickavance, GC; Poulsen, AD; Poulsen, JR; Qie, L; Reitsma, J; Rovero, F; Swaine, MD; Talbot, J; Taplin, J; Taylor, DM; Thomas, DW; Toirambe, B; Mukendi, JT; Tuagben, D; Umunay, PM; van der Heijden, GMF; Verbeeck, H; Vleminckx, J; Willcock, S; Woll, H; Woods, JT; Zemagho, L				Hubau, Wannes; Lewis, Simon L.; Phillips, Oliver L.; Affum-Baffoe, Kofi; Beeckman, Hans; Cuni-Sanchez, Aida; Daniels, Armandu K.; Ewango, Corneille E. N.; Fauset, Sophie; Mukinzi, Jacques M.; Sheil, Douglas; Sonke, Bonaventure; Sullivan, Martin J. P.; Sunderland, Terry C. H.; Taedoumg, Hermann; Thomas, Sean C.; White, Lee J. T.; Abernethy, Katharine A.; Adu-Bredu, Stephen; Amani, Christian A.; Baker, Timothy R.; Banin, Lindsay F.; Baya, Fidele; Begne, Serge K.; Bennett, Amy C.; Benedet, Fabrice; Bitariho, Robert; Bocko, Yannick E.; Boeckx, Pascal; Boundja, Patrick; Brienen, Roel J. W.; Brncic, Terry; Chezeaux, Eric; Chuyong, George B.; Clark, Connie J.; Collins, Murray; Comiskey, James A.; Coomes, David A.; Dargie, Greta C.; de Haulleville, Thales; Kamdem, Marie Noel Djuikouo; Doucet, Jean-Louis; Esquivel-Muelbert, Adriane; Feldpausch, Ted R.; Fofanah, Alusine; Foli, Ernest G.; Gilpin, Martin; Gloor, Emanuel; Gonmadje, Christelle; Gourlet-Fleury, Sylvie; Hall, Jefferson S.; Hamilton, Alan C.; Harris, David J.; Hart, Terese B.; Hockemba, Mireille B. N.; Hladik, Annette; Ifo, Suspense A.; Jeffery, Kathryn J.; Jucker, Tommaso; Yakusu, Emmanuel Kasongo; Kearsley, Elizabeth; Kenfack, David; Koch, Alexander; Leal, Miguel E.; Levesley, Aurora; Lindsell, Jeremy A.; Lisingo, Janvier; Lopez-Gonzalez, Gabriela; Lovett, Jon C.; Makana, Jean-Remy; Malhi, Yadvinder; Marshall, Andrew R.; Martin, Jim; Martin, Emanuel H.; Mbayu, Faustin M.; Medjibe, Vincent P.; Mihindou, Vianet; Mitchard, Edward T. A.; Moore, Sam; Munishi, Pantaleo K. T.; Bengone, Natacha Nssi; Ojo, Lucas; Ondo, Fidele Evouna; Peh, Kelvin S. -H.; Pickavance, Georgia C.; Poulsen, Axel Dalberg; Poulsen, John R.; Qie, Lan; Reitsma, Jan; Rovero, Francesco; Swaine, Michael D.; Talbot, Joey; Taplin, James; Taylor, David M.; Thomas, Duncan W.; Toirambe, Benjamin; Mukendi, John Tshibamba; Tuagben, Darlington; Umunay, Peter M.; van der Heijden, Geertje M. F.; Verbeeck, Hans; Vleminckx, Jason; Willcock, Simon; Woll, Hannsjorg; Woods, John T.; Zemagho, Lise			Asynchronous carbon sink saturation in African and Amazonian tropical forests	NATURE			English	Article							RAIN-FORESTS; DROUGHT SENSITIVITY; WOOD PRODUCTIVITY; CO2 FERTILIZATION; CLIMATE; BIOMASS; PHOTOSYNTHESIS; ACCLIMATION; RESPIRATION; PATTERNS	Structurally intact tropical forests sequestered about half of the global terrestrial carbon uptake over the 1990s and early 2000s, removing about 15 per cent of anthropogenic carbon dioxide emissions(1-3). Climate-driven vegetation models typically predict that this tropical forest 'carbon sink' will continue for decades(4,5). Here we assess trends in the carbon sink using 244 structurally intact African tropical forests spanning 11 countries, compare them with 321 published plots from Amazonia and investigate the underlying drivers of the trends. The carbon sink in live aboveground biomass in intact African tropical forests has been stable for the three decades to 2015, at 0.66 tonnes of carbon per hectare per year (95 per cent confidence interval 0.53-0.79), in contrast to the long-term decline in Amazonian forests(6). Therefore the carbon sink responses of Earth's two largest expanses of tropical forest have diverged. The difference is largely driven by carbon losses from tree mortality, with no detectable multi-decadal trend in Africa and a long-term increase in Amazonia. Both continents show increasing tree growth, consistent with the expected net effect of rising atmospheric carbon dioxide and air temperature(7-9). Despite the past stability of the African carbon sink, our most intensively monitored plots suggest a post-2010 increase in carbon losses, delayed compared to Amazonia, indicating asynchronous carbon sink saturation on the two continents. A statistical model including carbon dioxide, temperature, drought and forest dynamics accounts for the observed trends and indicates a long-term future decline in the African sink, whereas the Amazonian sink continues to weaken rapidly. Overall, the uptake of carbon into Earth's intact tropical forests peaked in the 1990s. Given that the global terrestrial carbon sink is increasing in size, independent observations indicating greater recent carbon uptake into the Northern Hemisphere landmass(10) reinforce our conclusion that the intact tropical forest carbon sink has already peaked. This saturation and ongoing decline of the tropical forest carbon sink has consequences for policies intended to stabilize Earth's climate.	[Hubau, Wannes; Lewis, Simon L.; Phillips, Oliver L.; Sullivan, Martin J. P.; Baker, Timothy R.; Begne, Serge K.; Bennett, Amy C.; Brienen, Roel J. W.; Dargie, Greta C.; Esquivel-Muelbert, Adriane; Gilpin, Martin; Gloor, Emanuel; Levesley, Aurora; Lopez-Gonzalez, Gabriela; Lovett, Jon C.; Pickavance, Georgia C.; Qie, Lan; Talbot, Joey] Univ Leeds, Sch Geog, Leeds, W Yorkshire, England; [Hubau, Wannes; Beeckman, Hans; de Haulleville, Thales; Yakusu, Emmanuel Kasongo; Kearsley, Elizabeth; Toirambe, Benjamin; Mukendi, John Tshibamba] Royal Museum Cent Africa, Serv Wood Biol, Tervuren, Belgium; [Hubau, Wannes; Yakusu, Emmanuel Kasongo] Univ Ghent, Lab Wood Technol Woodlab, Dept Environm, Ghent, Belgium; [Lewis, Simon L.; Cuni-Sanchez, Aida; Koch, Alexander] UCL, Dept Geog, London, England; [Affum-Baffoe, Kofi; Kearsley, Elizabeth] Forestry Commiss Ghana, Mensurat Unit, Kumasi, Ghana; [Cuni-Sanchez, Aida; Kearsley, Elizabeth; Marshall, Andrew R.] Univ York, Dept Geog & Environm, York, N Yorkshire, England; [Daniels, Armandu K.; Tuagben, Darlington] Forestry Dev Author Govt Liberia FDA, Monrovia, Liberia; [Ewango, Corneille E. N.] Wildlife Conservat Soc, DR Congo Programme, Kinshasa, DEM REP CONGO; [Ewango, Corneille E. N.] Ctr Format & Rech Conservat Forestiere CEFRECOF, Epulu, DEM REP CONGO; [Ewango, Corneille E. N.; Yakusu, Emmanuel Kasongo; Mbayu, Faustin M.; Mukendi, John Tshibamba] Univ Kisangani, Fac Gest Ressources Nat Renouvelables, Kisangani, DEM REP CONGO; [Fauset, Sophie] Univ Plymouth, Sch Geog Earth & Environm Sci, Plymouth, Devon, England; [Mukinzi, Jacques M.] Salonga Natl Pk, Kinshasa, DEM REP CONGO; [Mukinzi, Jacques M.] World Wide Fund Nat, Gland, Switzerland; [Sheil, Douglas] Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway; [Sonke, Bonaventure; Taedoumg, Hermann; Begne, Serge K.; Zemagho, Lise] Univ Yaounde I, Higher Teachers Training Coll, Plant Systemat & Ecol Lab, Yaounde, Cameroon; [Sullivan, Martin J. P.; Sunderland, Terry C. H.] Manchester Metropolitan Univ, Dept Nat Sci, Manchester, Lancs, England; [Sunderland, Terry C. H.; Amani, Christian A.; Boundja, Patrick] Ctr Int Forestry Res CIFOR, Bogor, Indonesia; Univ British Columbia, Fac Forestry, Vancouver, BC, Canada; [Taedoumg, Hermann] Biovers Int, Yaounde, Cameroon; [Thomas, Sean C.] Univ Toronto, Fac Forestry, Toronto, ON, Canada; [White, Lee J. T.; Mihindou, Vianet; Bengone, Natacha Nssi] Minist Forests Seas Environm & Climate, Libreville, Gabon; [White, Lee J. T.; Abernethy, Katharine A.] Inst Rech Ecol Tropicale, Libreville, Gabon; [White, Lee J. T.; Abernethy, Katharine A.; Jeffery, Kathryn J.] Univ Stirling, Dept Biol & Environm Sci, Stirling, Scotland; [Adu-Bredu, Stephen; Foli, Ernest G.] Forestry Res Inst Ghana FORIG, Kumasi, Ghana; [Amani, Christian A.] Univ Officielle Bukavu, Bukavu, DEM REP CONGO; [Banin, Lindsay F.] UK Ctr Ecol & Hydrol, Penicuik, Midlothian, Scotland; [Baya, Fidele] Minist Eaux Forets Chasse & Peche MEFCP, Bangui, Cent Afr Republ; [Baya, Fidele] Inst Centrafricain Rech Agron ICRA, Bangui, Cent Afr Republ; [Benedet, Fabrice; Gourlet-Fleury, Sylvie] Ctr Cooperat Int Rech Agron Dev CIRAD, Forets & Soc F&S, Montpellier, France; [Benedet, Fabrice; Gourlet-Fleury, Sylvie] Univ Montpellier, Forets & Soc F&S, Montpellier, France; [Bitariho, Robert] Mbarara Univ Sci & Technol MUST, Inst Trop Forest Conservat ITFC, Mbarara, Uganda; [Bocko, Yannick E.] Univ Marien Ngouabi, Lab Bot & Ecol, Fac Sci & Tech, Brazzaville, Rep Congo; [Boeckx, Pascal] Univ Ghent, Isotope Biosci Lab ISOFYS, Ghent, Belgium; [Boundja, Patrick; Brncic, Terry; Hockemba, Mireille B. N.] Wildlife Conservat Soc, Congo Programme, Brazzaville, Rep Congo; [Chezeaux, Eric] Rougier Gabon, Libreville, Gabon; [Chuyong, George B.; Kamdem, Marie Noel Djuikouo; Mitchard, Edward T. A.] Univ Buea, Dept Bot & Plant Physiol, Fac Sci, Buea, Cameroon; [Clark, Connie J.; Medjibe, Vincent P.; Poulsen, John R.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Collins, Murray] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Collins, Murray] Grantham Res Inst Climate Change & Environm, London, England; [Comiskey, James A.] Natl Pk Serv, Inventory & Monitoring Program, Fredericksburg, VA USA; [Comiskey, James A.] Smithsonian Inst, Washington, DC 20560 USA; [Coomes, David A.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Doucet, Jean-Louis] Univ Liege, Gembloux AgroBio Tech, Forest Life, TERRA, Liege, Belgium; [Esquivel-Muelbert, Adriane] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Feldpausch, Ted R.] Univ Exeter, Coll Life & Environm Sci, Dept Geog, Exeter, Devon, England; [Fofanah, Alusine; Kenfack, David] Gola Rainforest Natl Pk, Kenema, Sierra Leone; [Gonmadje, Christelle] Natl Herbarium, Yaounde, Cameroon; [Hall, Jefferson S.] Smithsonian Trop Res Inst, Forest Global Earth Observ ForestGEO, Washington, DC USA; [Hamilton, Alan C.] Chinese Acad Sci, Kunming Inst Bot, Kunming, Yunnan, Peoples R China; [Harris, David J.; Poulsen, Axel Dalberg] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Hart, Terese B.] Lukuru Wildlife Res Fdn, Kinshasa, DEM REP CONGO; [Hart, Terese B.] Yale Peabody Museum Nat Hist, Div Vertebrate Zool, New Haven, CT USA; [Hladik, Annette] Museum Natl Hist Nat, Dept Hommes & Environm, Paris, France; [Ifo, Suspense A.] Univ Marien Ngouabi, Lab Geomat & Ecol Tropicale Appliquee, Dept Sci & Vie Terre, Ecole Normale Super ENS, Brazzaville, Rep Congo; [Jucker, Tommaso] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Koch, Alexander; Verbeeck, Hans] Univ Ghent, Lab Computat & Appl Vegetat Ecol Cavelab, Dept Environm, Ghent, Belgium; [Kenfack, David; Martin, Emanuel H.] Trop Ecol Assessment & Monitoring TEAM Network, Arlington, VA USA; [Martin, Emanuel H.] Univ Hong Kong, Dept Earth Sci, Hong Kong, Peoples R China; [Leal, Miguel E.] Wildlife Conservat Soc, Uganda Programme, Kampala, Uganda; [Lindsell, Jeremy A.] Rocha Int, Cambridge, England; [Lindsell, Jeremy A.] Royal Soc Protect Birds, Ctr Conservat Sci, Sandy, Beds, England; [Lisingo, Janvier; Makana, Jean-Remy] Univ Kisangani, Fac Sci, Lab Ecol & Amenagement Forestier, Kisangani, DEM REP CONGO; [Lovett, Jon C.] Royal Bot Gardens, London, England; [Malhi, Yadvinder; Moore, Sam] Univ Oxford, Sch Geog & Environm, Environm Change Inst, Oxford, England; [Marshall, Andrew R.] Univ Sunshine Coast, Trop Forests & People Res Ctr, Sippy Downs, Qld, Australia; [Marshall, Andrew R.] Flamingo Land Ltd, Kirby Misperton, England; [Martin, Jim] Fleming Coll, Peterborough, ON, Canada; Udzungwa Ecol Monitoring Ctr, Mangula, Tanzania; [Medjibe, Vincent P.] Commiss Cent African Forests COMIFAC, Yaounde, Cameroon; [Mihindou, Vianet; Ondo, Fidele Evouna] Agence Natl Parcs Nationaux, Libreville, Gabon; [Munishi, Pantaleo K. T.] Sokoine Univ Agr, Morogoro, Tanzania; [Ojo, Lucas] Univ Abeokuta, Abeokuta, Nigeria; [Peh, Kelvin S. -H.] Univ Southampton, Sch Biol Sci, Southampton, Hants, England; [Peh, Kelvin S. -H.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England; [Qie, Lan] Univ Lincoln, Sch Life Sci, Lincoln, England; [Reitsma, Jan] Bur Waardenburg, Culemborg, Netherlands; [Rovero, Francesco] Univ Florence, Dept Biol, Florence, Italy; [Rovero, Francesco] MUSE Museo Sci, Trop Biodivers Sect, Trento, Italy; [Swaine, Michael D.] Univ Aberdeen, Sch Biol Sci, Dept Plant & Soil Sci, Aberdeen, Scotland; [Talbot, Joey] Univ Leeds, Inst Transport Studies, Leeds, W Yorkshire, England; [Taplin, James] Innovate UK, UK Res & Innovat, London, England; [Taylor, David M.] Natl Univ Singapore, Dept Geog, Singapore, Singapore; [Thomas, Duncan W.; Toirambe, Benjamin] Washington State Univ, Dept Biol, Vancouver, WA USA; [Toirambe, Benjamin] Minist Environm & Dev Durable, Kinshasa, DEM REP CONGO; [Mukendi, John Tshibamba] Univ Mbujimayi, Fac Sci Appl, Mbujimayi, DEM REP CONGO; Friends Ecosyst & Environm, Monrovia, Liberia; [Umunay, Peter M.] Yale Univ, Yale Sch Forestry & Environm Studies, New Haven, CT USA; [Umunay, Peter M.] Wildlife Conservat Soc, New York, NY USA; [van der Heijden, Geertje M. F.] Univ Nottingham, Sch Geog, Nottingham, England; [Vleminckx, Jason] Florida Int Univ, Dept Biol Sci, Int Ctr Trop Bot, Miami, FL 33199 USA; [Vleminckx, Jason] Univ Libre Bruxelles, Serv Evolut Biol & Ecol, Fac Sci, Brussels, Belgium; [Willcock, Simon] Univ Bangor, Sch Nat Sci, Bangor, Gwynedd, Wales; [Woods, John T.] Univ Liberia, WRT Coll Agr & Forestry, Monrovia, Liberia	University of Leeds; Royal Museum for Central Africa; Ghent University; University of London; University College London; University of York - UK; University of Plymouth; Norwegian University of Life Sciences; University of Yaounde I; Manchester Metropolitan University; CGIAR; Center for International Forestry Research (CIFOR); University of British Columbia; Alliance; Bioversity International; University of Toronto; University of Stirling; UK Centre for Ecology & Hydrology (UKCEH); CIRAD; Universite de Montpellier; Ghent University; Duke University; University of Edinburgh; United States Department of the Interior; Smithsonian Institution; University of Cambridge; University of Liege; University of Birmingham; University of Exeter; Smithsonian Institution; Smithsonian Tropical Research Institute; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Yale University; Museum National d'Histoire Naturelle (MNHN); University of Bristol; Ghent University; University of Hong Kong; Royal Society for Protection of Birds; Royal Botanic Gardens, Kew; University of Oxford; University of the Sunshine Coast; Sokoine University of Agriculture; University of Southampton; University of Cambridge; University of Lincoln; University of Florence; University of Aberdeen; University of Leeds; UK Research & Innovation (UKRI); Innovate UK; National University of Singapore; Washington State University; Yale University; Wildlife Conservation Society; University of Nottingham; State University System of Florida; Florida International University; Universite Libre de Bruxelles; Bangor University	Hubau, W (corresponding author), Univ Leeds, Sch Geog, Leeds, W Yorkshire, England.; Hubau, W (corresponding author), Royal Museum Cent Africa, Serv Wood Biol, Tervuren, Belgium.; Hubau, W (corresponding author), Univ Ghent, Lab Wood Technol Woodlab, Dept Environm, Ghent, Belgium.	whubau@gmail.com	Martin, Emanuel H./ABD-1876-2020; hubau, wannes/AAA-8502-2019; Foli, Ernest/GYE-0219-2022; Koch, Alexander/F-2741-2019; Hubau, Wannes/ABA-7432-2020; Jucker, Tommaso/S-4724-2017; Feldpausch, Ted/ABH-3123-2020; Phillips, Oliver/A-1523-2011; Poulsen, John/O-5332-2019; Sunderland, Terence/AAS-5080-2021; Adu-Bredu, Stephen/AAF-6484-2020; Brienen, Roel/AAU-9959-2020; Sheil, Douglas/A-3867-2015	Foli, Ernest/0000-0003-4069-5620; Koch, Alexander/0000-0002-4693-4453; Hubau, Wannes/0000-0003-3795-4986; Jucker, Tommaso/0000-0002-0751-6312; Feldpausch, Ted/0000-0002-6631-7962; Phillips, Oliver/0000-0002-8993-6168; Poulsen, John/0000-0002-1532-9808; Brienen, Roel/0000-0002-5397-5755; Talbot, Joey/0000-0002-6520-4560; Comiskey, James/0000-0001-6710-1269; Sheil, Douglas/0000-0002-1166-6591; Bitariho, Robert/0000-0002-3461-0013; Taylor, David/0000-0002-6098-5636; Verbeeck, Hans/0000-0003-1490-0168; Esquivel-Muelbert, Adriane/0000-0001-5335-1259; amani, christian/0000-0002-7474-2213; Coomes, David/0000-0002-8261-2582; Sunderland, Terence/0000-0002-1985-9849; Makana, Jean-Remy/0000-0002-6006-2938; Kenfack, David/0000-0001-8208-3388	European Research Council Advanced Grant [291585]; NERC grant [NER/A/S/2000/01002]; Royal Society University Research Fellowship; NERC New Investigators Grant; Philip Leverhulme Award; European Union FP7 grant [283080]; Valuing the Arc Leverhulme Program Grant; Natural Environment Research Council (NERC) [NE/D005590/]; David and Lucile Packard Foundation; Centre for International Forestry Research; Gabon's National Parks Agency (ANPN); T-FORCES; Brain programme of the Belgian Federal Government [BR/132/A1/AFRIFORD, BR/143/A3/HERBAXYLAREDD]; US National Science Foundation; ERC [AdG 291585]; NERC [NE/B503384/1, NE/I028122/1, NE/P008755/1]; Gordon and Betty Moore Foundation [1656]; University of Leeds; Gordon and Betty Moore Foundation (`MonANPeru'); NERC Impact Accelerator grant; NERC New Investigators Award;  [NE/F005806/1]; Natural Environment Research Council [NE/N012453/1, NE/P001092/1] Funding Source: researchfish; NERC [NE/I02982X/1, NE/N011570/1, NE/P001092/1, NE/R016860/1, NE/S01537X/1, NE/N012453/1] Funding Source: UKRI	European Research Council Advanced Grant(European Research Council (ERC)); NERC grant(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society University Research Fellowship(Royal Society of London); NERC New Investigators Grant; Philip Leverhulme Award; European Union FP7 grant; Valuing the Arc Leverhulme Program Grant; Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Centre for International Forestry Research; Gabon's National Parks Agency (ANPN); T-FORCES; Brain programme of the Belgian Federal Government; US National Science Foundation(National Science Foundation (NSF)); ERC(European Research Council (ERC)European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); University of Leeds; Gordon and Betty Moore Foundation (`MonANPeru'); NERC Impact Accelerator grant; NERC New Investigators Award; ; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This paper is a product of the African Tropical Rainforest Observatory Network (AfriTRON), curated at ForestPlots.net. AfriTRON has been supported by numerous people and grants since its inception. We sincerely thank the people of the many villages and local communities who welcomed our field teams and without whose support this work would not have been possible: Sierra Leone (villages: Barrie, Gaura, Koya, Makpele, Malema, Nomo, Tunkia; teams in protected areas: the Gola Rainforest National Park), Liberia (villages: Garley town, River Gbeh, Glaro Freetown), Ghana (villages: Nkwanta, Asenanyo, Bonsa, Agona, Boekrom, Dadieso, Enchi, Dabiasem, Mangowase, Draw, Fure, Esuboni, Okumaninin, Kade, Asamankese, Tinte Bepo, Tonton), Nigeria (Oban village), Gabon (villages: Ekobakoba, Mikongo, Babilone, Makokou, Tchimbele, Mondah, Ivindo, Ebe, Ekouk, Oveng, Sette Cama; teams in protected areas: Ivindo National Park, Lope National Park, Waka National Park; teams in concessions: Ipassa station, Kingele station, Leke/Moyabi Rougier Forestry Concession), Cameroon (villages: Campo, Nazareth, Lomie, Djomedjo, Alat-Makay, Somalomo, Deng Deng, Eyumojok, Mbakaou, Myere, Nguti, Bejange, Kekpane, Basho, Mendhi, Matene, Mboh, Takamanda, Obonyi, Ngoila; teams in protected areas: Ejagham forest reserve), Democratic Republic of Congo (villages: Yoko, Yangambi, Epulu, Monkoto), Republic of Congo (villages: Bomassa, Ekolongouma, Bolembe, Makao, Mbeli, Kabo, Niangui, Ngubu, Goualaki, Essimbi). We thank the field assistants whose expertise and enthusiasm is indispensable to successful fieldwork, including: M. E. Abang, U. P. Achui, F. Addai, E. J. Agbachon, J. Agnaka, A. J. Akaza, G. Alaman, G. Alaman, A. E. Alexander, K. Allen, M. Amalphi, D. Amandus, J. Andju, L. A. Limbanga, S. Asamoah, T. M. Ashu, M. Ashu, J. Asse, B. Augustine, H. Badjoko, M. Balimu, J. Baviogui-Baviogui, S. Benteh, A. Bertrand, A. Bettus, A. Bias, A. Bikoula, A. Bimba, P. Bissiemou, M. Boateng, E. Bonyenga, M. B. Ekaya, G. Bouka, J. Boussengui, D. B. Ngomo, C. Chalange, S. Chenikan, J. Dabo, E. Dadize, T. Degraft, J. Dibakou, J.-T. Dikangadissi, P. Dimbonda, E. Dimoto, C. Ditougou, D. Dorbor, M. Dorbor, V. Droissart, K. Duah, E. Ebe, O. J. Eji, E. B. Ekamam, J.-R. Ekomindong, E. J. Enow, H. Entombo, E. M. Ernest, C. Esola, J. Essouma, A. Gabriel, N. Genesis, B. Gideon, A. Godwin, E. Grear, D. J. Grear, M. Ismael, M. Iwango, M. Iyafo, N. Kamdem, B. Kibinda, A. Kidimbu, E. Kimumbu, J. Kintsieri, C. K. Opepa, A. Kitegile, T. Komo, P. Koue, A. Kouanga, J. J. Koumikaka, I. Liengola, E. Litonga, L. Louvouando, O. Luis, N. M. Mady, F. Mahoula, A. Mahundu, C. A. Mandebet, P. Maurice, K. Y. Mayossa, R. M. Nkogue, I. D. Mbe, C. Mbina, H. Mbona, A. Mboni, A. Mbouni, P. Menzo, M. Menge, A. Michael, A. Mindoumou, J. Minpsa, J. P. Mondjo, E. Mounoumoulossi, S. Mpouam, T. Msigala, J. Msirikale, S. Mtoka, R. Mwakisoma, D. Ndong-Nguema, G. Ndoyame, G. Ngongbo, F. Ngowa, D. Nguema, L. Nguye, R. Niangadouma, Y. Nkrumah, S. Nshimba, M. N. Mboumba, F. N. Obiang, L. Obi, R. Obi, E. L. Odjong, F. Okon, F. Olivieira, A. L. Owemicho, L. Oyeni-Amoni, A. Platini, P. Ploton, S. Quausah, E. Ramazani, B. S. Jean, L. Sagang, R. Salter, A. Seki, D. Shirima, M. Simo, I. Singono, A. E. Tabi, T. G. Tako, N. G. Tambe, T. Tcho, A. Teah, V. Tehtoe, B. J. Telephas, M. L. Tonda, A. Tresor, H. Umenendo, R. Votere, C. K. Weah, S. Weah, B. Wursten, E. Yalley, D. Zebaze, L. Cerbonney, E. Dubiez, H. Moinecourt, F. Lanckriet, S. Samai, M. Swaray, P. Lamboi, M. Sullay, D. Bannah, I. Kanneh, M. Kannah, A. Kemokai, J. Kenneh and M.; Lukulay. For logistical and administrative support, we are indebted to international, national and local institutions: the Forestry Department of the Government of Sierra Leone, the Conservation Society of Sierra Leone, the Royal Society for the Protection of Birds (RSPB, UK), The Gola Rainforest National Park (Sierra Leone), the Forestry Development Authority of the Government of Liberia (FDA), the University of Liberia, the Forestry Commission of Ghana (FC), the Forestry Research Institute of Ghana (FORIG), University of Ibadan (Nigeria), the University of Abeokuta (Nigeria), the Ministere des Eaux, Forets, Chasse et Peche (MEFCP, Central African Republic), the Institut Centrafricain de Recherche Agronomique (ICRA, Central African Republic), The Service de Cooperation et d'Actions Culturelles (SCAC/MAE, Central African Republic), The University of Bangui (Central African Republic), the Societe Centrafricaine de Deroulage (SCAD, Central African Republic), the University of Yaounde I (Cameroon), the National Herbarium of Yaounde (Cameroon), the University of Buea (Cameroon), Bioversity International (Cameroon), the Ministry of Forests, Seas, Environment and Climate (Gabon), the Agence Nationale des Parcs Nationaux de Gabon (ANPN), Institut de Recherche en Ecologie Tropicale du Gabon, Rougier-Gabon, the Marien Ngouabi University of Brazzaville (Republic of Congo), the Ministere des Eaux et Forets (Republic of Congo), the Ministere de la Rercherche Scientifique et de l'Innovation Technologique (Republic of Congo), the Nouabale-Ndoki Foundation (Republic of Congo), WCS-Congo, Salonga National Park (Democratic Republic of Congo), The Centre de Formation et de Recherche en Conservation Forestiere (CEFRECOF, Epulu, Democratic Republic of Congo), the Institut National pour l'Etude et la Recherche Agronomiques (INERA, Democratic Republic of Congo), the Ecole Regionale Postuniversitaire d'Amenagement et de Gestion integres des Forets et Territoires tropicaux (ERAIFT Kinshasa, Democratic Republic of Congo), WWF-Democratic Republic of Congo, WCS-Democratic Republic of Congo, the Universite de Kisangani (Democratic Republic of Congo), Universite Officielle de Bukavu (Democratic Republic of Congo), Universite de Mbujimayi (Democratic Republic of Congo), le Ministere de l'Environnement et Developpement Durable (Democratic Republic of Congo), the FORETS project in Yangambi (CIFOR, CGIAR and the European Union; Democratic Republic of Congo), the Lukuru Wildlife Research Foundation (Democratic Republic of Congo), Mbarara University of Science and Technology (MUST, Uganda), WCS-Uganda, the Uganda Forest Department, the Commission of Central African Forests (COMIFAC), the Udzungwa Ecological Monitoring Centre (Tanzania) and the Sokoine University of Agriculture (Tanzania). We thank C. Chatelain (Geneva Botanic Gardens) for access to the African Plants Database. Grants that have funded the AfriTRON network including data in this paper are: a European Research Council Advanced Grant to O.L.P. and S.L.L. (T-FORCES; 291585; Tropical Forests in the Changing Earth System), a NERC grant to O.L.P., Y.M., and S.L.L. (NER/A/S/2000/01002), a Royal Society University Research Fellowship to S.L.L., a NERC New Investigators Grant to S.L.L., a Philip Leverhulme Award to S.L.L., a European Union FP7 grant to E.G. and S.L.L. (GEOCARBON; 283080), Valuing the Arc Leverhulme Program Grant to Andrew Balmford and S.L.L., a Natural Environment Research Council (NERC) Consortium Grant to Jon Lloyd and S.L.L. (TROBIT; NE/D005590/), the Gordon and Betty Moore Foundation to L.J.; T.W and S.L.L., the David and Lucile Packard Foundation to L.J.T.W. and S.L.L., the Centre for International Forestry Research to T.S. and S.L.L. (CIFOR), and Gabon's National Parks Agency (ANPN) to S.L.L. W.H. was funded by T-FORCES and the Brain programme of the Belgian Federal Government (BR/132/A1/AFRIFORD grant to Olivier Hardy and the BR/143/A3/HERBAXYLAREDD grant to H.B.). O.L.P., S.L.L., M.J.P.S, A.E.-M., A.L., G.L.-G., G.P. and L.Q. were supported by T-FORCES. Eight plots (codes ANK, IVI, LPG, MNG) included in AfriTRON are also part of the Global Ecosystem Monitoring network (GEM). Additional African data were included from the consortium MEFCP-ICRA-CIRAD (Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement), the Tropical Ecology Assessment and Monitoring Network (TEAM), and the Forest Global Earth Observatory Network (ForestGEO; formerly the Center for Tropical Forest Science, CTFS). The TEAM network is a collaboration between Conservation International, the Missouri Botanical Garden, the Smithsonian Institution and the Wildlife Conservation Society, and funded by the Gordon and Betty Moore Foundation and other donors. The ForestGEO Network is a collaboration between the Smithsonian Institution, other federal agencies of the United States, the Wildlife Conservation Society (WCS) and the World Wide Fund for Nature (WWF), and funded by the US National Science Foundation and other donors. The paper was made possible by the RAINFOR network in Amazonia, with multiple funding agencies and hundreds of investigators working in Amazonia, acknowledged in ref. 6, providing comprehensive published data and code and assisting in the onward analysis of their data; see ref. 6. Data from AfriTRON and RAINFOR are stored and curated by ForestPlots.net, a long-term cyberinfrastructure initiative hosted at the University of Leeds that unites permanent plot records and their contributing scientists from the world's tropical forests. The development of ForestPlots.net and curation of most data analysed here was funded by many sources, including grants to O.L.P. (principally from ERC AdG 291585 'T-FORCES', NERC NE/B503384/1 and the Gordon and Betty Moore Foundation 1656 'RAINFOR'), T.R.B. (the University of Leeds contribution to `AMAZALERT', NERC (NE/I028122/1) with T. Pennington, the Gordon and Betty Moore Foundation (`MonANPeru') and a NERC Impact Accelerator grant for the initial development of the BiomasaFP R package), E.G. ('GEOCARBON' and NE/F005806/1 'AMAZONICA') and S.L.L. (Royal Society University Research Fellowship, NERC New Investigators Award, NERC NE/P008755/1). We acknowledge the contributions of the ForestPlots.net developers (M. Burkitt, G. Lopez-Gonzalez) and the steering committee (T.R.B., A.L., S.L.L., O.L.P., L.Q., E. N. H. Coronado and B. S. Marimon) for advice on database development and management.	Aleixo I, 2019, NAT CLIM CHANGE, V9, P384, DOI 10.1038/s41558-019-0458-0; Anderegg WRL, 2015, P NATL ACAD SCI USA, V112, P15591, DOI 10.1073/pnas.1521479112; Anderson-Teixeira KJ, 2015, GLOBAL CHANGE BIOL, V21, P528, DOI 10.1111/gcb.12712; Aragao LEOC, 2014, BIOL REV, V89, P913, DOI 10.1111/brv.12088; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Aspinwall MJ, 2016, NEW PHYTOL, V212, P354, DOI 10.1111/nph.14035; Auguie B, 2017, GRIDEXTRA MISCELLANE; Baker TR, 2003, PERSPECT PLANT ECOL, V6, P21, DOI 10.1078/1433-8319-00040; Barton K, 2019, R PACKAGE VERSION, V1, P6, DOI DOI 10.1016/J.AGEE.2019.04.009; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bauters M, 2018, P NATL ACAD SCI USA, V115, P549, DOI 10.1073/pnas.1714597115; Bonal D, 2016, ANN FOREST SCI, V73, P27, DOI 10.1007/s13595-015-0522-5; Booth BBB, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024002; Brienen RJW, 2015, NATURE, V519, P344, DOI 10.1038/nature14283; Chambers JQ, 2000, OECOLOGIA, V122, P380, DOI 10.1007/s004420050044; Chave J, 2008, PLOS BIOL, V6, P455, DOI 10.1371/journal.pbio.0060045; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chen C, 2019, NAT SUSTAIN, V2, P122, DOI 10.1038/s41893-019-0220-7; Ciais P, 2019, NATURE, V568, P221, DOI 10.1038/s41586-019-1078-6; Claeys F, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/aafb81; Feldpausch TR, 2016, GLOBAL BIOGEOCHEM CY, V30, P964, DOI 10.1002/2015GB005133; Feldpausch TR, 2012, BIOGEOSCIENCES, V9, P3381, DOI 10.5194/bg-9-3381-2012; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fleischer K, 2019, NAT GEOSCI, V12, P736, DOI 10.1038/s41561-019-0404-9; Fox J, 2008, APPL REGRESSION ANAL; Galbraith D, 2013, PLANT ECOL DIVERS, V6, P139, DOI 10.1080/17550874.2013.770578; Gatti LV, 2014, NATURE, V506, P76, DOI 10.1038/nature12957; Gaubert B, 2019, BIOGEOSCIENCES, V16, P117, DOI 10.5194/bg-16-117-2019; Gelman A., 2007, DATA ANAL USING REGR; Gloor M, 2015, GLOBAL BIOGEOCHEM CY, V29, P1384, DOI 10.1002/2014GB005080; Gourlet-Fleury S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0302; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hockemba M. B. N., 2010, TEAM DATAPACKAGE 201; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Huntingford C, 2013, NAT GEOSCI, V6, P268, DOI [10.1038/ngeo1741, 10.1038/NGEO1741]; James R, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0298; Jiang Y, 2019, NAT CLIM CHANGE, V9, P617, DOI 10.1038/s41558-019-0512-y; Jung M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001566; Jung M, 2010, NATURE, V467, P951, DOI 10.1038/nature09396; Keenan TF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13428; Kenfack D., 2011, TEAM DATAPACKAGE 201; Kohyama TS, 2018, METHODS ECOL EVOL, V9, P809, DOI 10.1111/2041-210X.12929; Kume T, 2011, AGR FOREST METEOROL, V151, P1183, DOI 10.1016/j.agrformet.2011.04.005; Le Quere C, 2018, EARTH SYST SCI DATA, V10, P2141, DOI 10.5194/essd-10-2141-2018; Lewis SL, 2019, NATURE, V568, P25, DOI 10.1038/d41586-019-01026-8; Lewis SL, 2015, SCIENCE, V349, P827, DOI 10.1126/science.aaa9932; Lewis SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0295; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; Lloyd J, 1996, FUNCT ECOL, V10, P4, DOI 10.2307/2390258; Lombardozzi DL, 2015, GEOPHYS RES LETT, V42, P8624, DOI 10.1002/2015GL065934; Lopez-Gonzalez G., 2009, FORESTPLOTSNET DATAB; Lopez-Gonzalez G, 2011, J VEG SCI, V22, P610, DOI 10.1111/j.1654-1103.2011.01312.x; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Martin AR, 2018, NAT GEOSCI, V11, P915, DOI 10.1038/s41561-018-0246-x; Mayaux P, 2000, REMOTE SENS ENVIRON, V71, P183, DOI 10.1016/S0034-4257(99)00073-5; Mayaux P., 2003, LAND COVER MAP AFRIC; McDowell N, 2018, NEW PHYTOL, V219, P851, DOI 10.1111/nph.15027; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Mercado LM, 2018, NEW PHYTOL, V218, P1462, DOI 10.1111/nph.15100; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Olejnik S, 2000, J EXP EDUC, V68, P365, DOI 10.1080/00220970009600643; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Parmentier I, 2007, J ECOL, V95, P1058, DOI 10.1111/j.1365-2745.2007.01273.x; Pearson TRH, 2017, CARBON BAL MANAGE, V12, DOI 10.1186/s13021-017-0072-2; Phillips O, 2016, RAINFOR FIELD MANUAL; Phillips OL, 2002, NATURE, V418, P770, DOI 10.1038/nature00926; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Piao SL, 2013, GLOBAL CHANGE BIOL, V19, P2117, DOI 10.1111/gcb.12187; Pinheiro JC, 2000, MIXED EFFECTS MODELS; Pugh TAM, 2019, P NATL ACAD SCI USA, V116, P4382, DOI 10.1073/pnas.1810512116; Qie L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01997-0; Quesada CA, 2012, BIOGEOSCIENCES, V9, P2203, DOI 10.5194/bg-9-2203-2012; Quesada CA, 2010, BIOGEOSCIENCES, V7, P1515, DOI 10.5194/bg-7-1515-2010; Ramirez-Villegas J, 2010, DECISION POLICY ANAL; Reich PB, 2016, NATURE, V531, P633, DOI 10.1038/nature17142; Rovero F., 2009, TEAM DATAPACKAGE 201; Schimel D, 2015, P NATL ACAD SCI USA, V112, P436, DOI 10.1073/pnas.1407302112; Schneider U., 2011, GPCC DATA REP; Schnitzer SA, 2011, ECOL LETT, V14, P397, DOI 10.1111/j.1461-0248.2011.01590.x; Schwartz NB, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa708b; Sheil D., 2009, TEAM DATAPACKAGE 201; Sitch S, 2015, BIOGEOSCIENCES, V12, P653, DOI 10.5194/bg-12-653-2015; Slik JWF, 2018, P NATL ACAD SCI USA, V115, P1837, DOI 10.1073/pnas.1714977115; Smith WK, 2016, NAT CLIM CHANGE, V6, P306, DOI [10.1038/nclimate2879, 10.1038/NCLIMATE2879]; Sullivan MJP, 2018, METHODS ECOL EVOL, V9, P1179, DOI 10.1111/2041-210X.12962; Sun QH, 2018, REV GEOPHYS, V56, P79, DOI 10.1002/2017RG000574; Talbot J, 2014, FOREST ECOL MANAG, V320, P30, DOI 10.1016/j.foreco.2014.02.021; Tans P., 2016, TRENDS ATMOSPHERIC C; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Terrer C, 2019, NAT CLIM CHANGE, V9, P684, DOI 10.1038/s41558-019-0545-2; Venables WN, 2002, MODERN APPL STAT S, V12, P1, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Yu KL, 2019, P NATL ACAD SCI USA, V116, P24662, DOI 10.1073/pnas.1821387116; Yuen JQ, 2013, FOREST ECOL MANAG, V310, P915, DOI 10.1016/j.foreco.2013.09.042; Zelazowski P, 2011, PHILOS T R SOC A, V369, P137, DOI 10.1098/rsta.2010.0238	100	225	231	128	570	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 5	2020	579	7797					80	+		10.1038/s41586-020-2035-0	http://dx.doi.org/10.1038/s41586-020-2035-0			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MD2BD	32132693	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000543777700002
J	Sokol, D				Sokol, Daniel			ABC of medical confidentiality	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sokol, Daniel] 12 Kings Bench Walk, London, England		Sokol, D (corresponding author), 12 Kings Bench Walk, London, England.	daniel.sokol@talk21.com						Dyer C, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m820	1	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2020	368								m857	10.1136/bmj.m857	http://dx.doi.org/10.1136/bmj.m857			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KE	32132014				2022-12-28	WOS:000519536600015
J	Moberly, T				Moberly, Tom			THE BIG PICTURE Locusts devastate east African crops	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2020	368								m856	10.1136/bmj.m856	http://dx.doi.org/10.1136/bmj.m856			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KD	32127351				2022-12-28	WOS:000519536500013
J	Stern, AP				Stern, Adam Philip			The Secret About Achieving Your Dreams	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this narrative medicine essay, a 35-year-old psychiatrist reflects on his dreams in childhood, as an academic, and as a parent of a young child as he faces his own mortality.	[Stern, Adam Philip] Beth Israel Deaconess Med Ctr, 330 Brookline Ave,KS 178, Boston, MA 02215 USA; [Stern, Adam Philip] Harvard Med Sch, 330 Brookline Ave,KS 178, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Stern, AP (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave,KS 178, Boston, MA 02215 USA.; Stern, AP (corresponding author), Harvard Med Sch, 330 Brookline Ave,KS 178, Boston, MA 02215 USA.	astern2@bidmc.harvard.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2020	323	9			SI		825	825		10.1001/jama.2020.1033	http://dx.doi.org/10.1001/jama.2020.1033			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU3SD	32125407				2022-12-28	WOS:000519630600010
J	Sindhu, KK; Adashi, EY				Sindhu, Kunal K.; Adashi, Eli Y.			Over-the-Counter Oral Contraceptives to Reduce Unintended Pregnancies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint reviews progress and challenges to date in federal and state efforts to transition combination oral contraceptives (COCs) from being prescription only to over-the-counter status in the US.	[Sindhu, Kunal K.] Icahn Sch Med, Dept Radiat Oncol, New York, NY USA; [Adashi, Eli Y.] Brown Univ, Dept Med Sci, Warren Alpert Med Sch, Providence, RI 02912 USA	Icahn School of Medicine at Mount Sinai; Brown University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 272 George St, Providence, RI 02906 USA.	eli_adashi@brown.edu	Sindhu, Kunal/AAX-1948-2021	Sindhu, Kunal/0000-0001-9376-8307				[Anonymous], 2019, Obstet Gynecol, V134, pe96, DOI 10.1097/AOG.0000000000003473; Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575; Foster DG, 2011, OBSTET GYNECOL, V117, P566, DOI 10.1097/AOG.0b013e3182056309; Grossman D, 2019, JAMA INTERN MED, V179, P1209, DOI 10.1001/jamainternmed.2019.1676; Guttmacher Institute, INS COV CONTR; Leischow SJ, 2019, JAMA-J AM MED ASSOC, V321, P541, DOI 10.1001/jama.2018.21557; Rodriguez MI, 2019, OBSTET GYNECOL, V133, P1238, DOI 10.1097/AOG.0000000000003265; Woodhams EJ, 2019, ANN INTERN MED, V170, pITC17, DOI 10.7326/AITC201902050; World Health Organization, 2014, ENS HUM RIGHT PROV C	9	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2020	324	10					939	940		10.1001/jama.2019.21862	http://dx.doi.org/10.1001/jama.2019.21862			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR9EX	32108868				2022-12-28	WOS:000571867000013
J	Springer, SA; Merluzzi, AP; del Rio, C				Springer, Sandra A.; Merluzzi, Andrew P.; del Rio, Carlos			Integrating Responses to the Opioid Use Disorder and Infectious Disease Epidemics: A Report From the National Academies of Sciences, Engineering, and Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; OVERDOSE DEATHS; INCREASES; DRUG		[Springer, Sandra A.] Yale Sch Med, Dept Med, Infect Dis Sect, Yale AIDS Program, 135 Coll St,Ste 323, New Haven, CT 06510 USA; [Merluzzi, Andrew P.] Natl Acad Sci Engn & Med, Hlth & Med Div, Board Populat Hlth & Publ Hlth Practice, Washington, DC USA; [del Rio, Carlos] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA	Yale University; National Academies of Sciences, Engineering & Medicine; Emory University	Springer, SA (corresponding author), Yale Sch Med, Dept Med, Infect Dis Sect, Yale AIDS Program, 135 Coll St,Ste 323, New Haven, CT 06510 USA.	sandra.springer@yale.edu	Springer, Sandra/ABC-4569-2020; del Rio, Carlos/B-3763-2012	del Rio, Carlos/0000-0002-0153-3517	DHHS Office of Infectious Disease and HIV/AIDS Policy; National Institute on Drug Abuse [K02 DA032322]	DHHS Office of Infectious Disease and HIV/AIDS Policy; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The original NASEM consensus study was funded by the DHHS Office of Infectious Disease and HIV/AIDS Policy, and the writing of this article was funded for career development by the National Institute on Drug Abuse (grant K02 DA032322 to Dr Springer).	Fiscella K, 2019, JAMA PSYCHIAT, V76, P229, DOI 10.1001/jamapsychiatry.2018.3685; National Academies of Sciences Engineering and Medicine 2020, 2020, OPP IMPR OP US DIS I; Olfson M, 2019, JAMA-J AM MED ASSOC, V322, P2340, DOI 10.1001/jama.2019.16566; Peters PJ, 2016, NEW ENGL J MED, V375, P229, DOI 10.1056/NEJMoa1515195; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Schranz AJ, 2019, ANN INTERN MED, V170, P31, DOI 10.7326/M18-2124; Substance Abuse and Mental Health Services Administration, 2018, DHHS PUBLICATION, V18-5093; Zibbell JE, 2018, AM J PUBLIC HEALTH, V108, P175, DOI 10.2105/AJPH.2017.304132	8	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2020	324	1					37	38		10.1001/jama.2020.2559	http://dx.doi.org/10.1001/jama.2020.2559			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NM5FX	32159771	Green Accepted			2022-12-28	WOS:000568123600016
J	Rao, KN; Malani, PN				Rao, Krishna; Malani, Preeti N.			Diagnosis and Treatment of Clostridioides (Clostridium) difficile Infection in Adults in 2020	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BEZLOTOXUMAB; PREVENTION	This JAMA Insights Clinical Update summarizes updated evidence regarding diagnosis and management of Clostridioides (formerly Clostridium) difficile infection (CDI) in adults, including review of new toxin detection assays and biologic treatments.	[Rao, Krishna; Malani, Preeti N.] Univ Michigan, Dept Internal Med, Med Sch, Div Infect Dis, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Rao, KN (corresponding author), Univ Michigan, Dept Internal Med, Med Sch, Div Infect Dis, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	krirao@med.umich.edu	Rao, Krishna/R-3726-2019	Rao, Krishna/0000-0002-9213-7850				Bagdasarian N, 2015, JAMA-J AM MED ASSOC, V313, P398, DOI 10.1001/jama.2014.17103; Dieterle MG, 2019, ANN NY ACAD SCI, V1435, P110, DOI 10.1111/nyas.13958; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Ma GK, 2017, ANN INTERN MED, V167, P152, DOI [10.7326/M16-2733, 10.7326/m16-2733]; McDonald LC, 2018, CLIN INFECT DIS, V66, pE1, DOI [10.1093/cid/ciy149, 10.1093/cid/cix1085]; Pollock NR, 2019, CLIN INFECT DIS, V68, P78, DOI 10.1093/cid/ciy415; Prabhu VS, 2018, CLIN INFECT DIS, V66, P355, DOI 10.1093/cid/cix809; Tariq R, 2019, CLIN INFECT DIS, V68, P1351, DOI 10.1093/cid/ciy721; Wilcox MH, 2017, NEW ENGL J MED, V376, P305, DOI 10.1056/NEJMoa1602615; Wong KK, 2017, AM J INFECT CONTROL, V45, P306, DOI 10.1016/j.ajic.2016.09.007	10	12	13	2	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2020	323	14					1403	1404		10.1001/jama.2019.3849	http://dx.doi.org/10.1001/jama.2019.3849			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LH1YB	32150234				2022-12-28	WOS:000528583600021
J	Lu, YW; Zhao, QY; Liao, JY; Song, EW; Xia, QD; Pan, JY; Li, YH; Li, JQ; Zhou, BX; Ye, YY; Di, C; Yu, SB; Zeng, YJ; Su, SC				Lu, Yiwen; Zhao, Qiyi; Liao, Jian-You; Song, Erwei; Xia, Qidong; Pan, Jiayao; Li, Yihong; Li, Jiaqian; Zhou, Boxuan; Ye, Yingying; Di, Can; Yu, Shubin; Zeng, Yunjie; Su, Shicheng			Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity	CELL			English	Article							CD4(+) T-CELLS; CANCER; PROMOTES; DEATH; INFLAMMATION; MECHANISMS; EXPRESSION; IMMUNOSUPPRESSION; IMMUNOTHERAPY; MACROPHAGES	Understanding molecular mechanisms that dictate B cell diversity is important for targeting B cells as anti-cancer treatment. Through the single-cell dissection of B cell heterogeneity in longitudinal samples of patients with breast cancer before and after neoadjuvant chemotherapy, we revealed that an ICOSL+ B cell subset emerges after chemotherapy. Using three immunocompetent mouse models, we recapitulated the subset switch of human tumor-infiltrating B cells during chemotherapy. By employing B-cell-specific deletion mice, we showed that ICOSL+ in B cells boosts anti-tumor immunity by enhancing the effector to regulatory T cell ratio. The signature of ICOSL+ B cells is imprinted by complement-CR2 signaling, which is triggered by immunogenic cell death. Moreover, we identified that CD55, a complement inhibitory protein, determines the opposite roles of B cells in chemotherapy. Collectively, we demonstrated a critical role of the B cell subset switch in chemotherapy response, which has implications in designing novel anti-cancer therapies.	[Lu, Yiwen; Liao, Jian-You; Song, Erwei; Xia, Qidong; Pan, Jiayao; Li, Yihong; Li, Jiaqian; Zhou, Boxuan; Ye, Yingying; Di, Can; Yu, Shubin; Su, Shicheng] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Peoples R China; [Lu, Yiwen; Song, Erwei; Xia, Qidong; Pan, Jiayao; Li, Yihong; Li, Jiaqian; Zhou, Boxuan; Ye, Yingying; Di, Can; Yu, Shubin; Su, Shicheng] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou 510120, Peoples R China; [Zhao, Qiyi; Su, Shicheng] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510630, Peoples R China; [Su, Shicheng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Immunol, Guangzhou 510080, Peoples R China; [Zeng, Yunjie] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Pathol, Guangzhou 510120, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Su, SC (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Peoples R China.; Su, SC (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou 510120, Peoples R China.; Su, SC (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510630, Peoples R China.; Su, SC (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Immunol, Guangzhou 510080, Peoples R China.	sushch@mail.sysu.edu.cn		Boxuan, Zhou/0000-0002-1103-0059	National Key Research and Development Program of China [2017YFA0106300]; Natural Science Foundation of China [91942309, 81672614, 81971481, 81672621, 81872155]; Natural Science Foundation of Guangdong Province [2016A030306023, 2017A030313878, 2018A030313769]; Pearl River S&T Nova Program of Guangzhou [201710010083, 201710010048]; Tip-top Scientific and Technical Innovative Youth Talents of Guangdong special support program [2016TQ03R553]	National Key Research and Development Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Pearl River S&T Nova Program of Guangzhou; Tip-top Scientific and Technical Innovative Youth Talents of Guangdong special support program	This work was supported by grants from the National Key Research and Development Program of China (2017YFA0106300), the Natural Science Foundation of China (91942309, 81672614, 81971481, 81672621, and 81872155), the Natural Science Foundation of Guangdong Province (2016A030306023, 2017A030313878, and 2018A030313769), Pearl River S&T Nova Program of Guangzhou (201710010083 and 201710010048), and Tip-top Scientific and Technical Innovative Youth Talents of Guangdong special support program (2016TQ03R553).	Affara NI, 2014, CANCER CELL, V25, P809, DOI 10.1016/j.ccr.2014.04.026; Aicher A, 2000, J IMMUNOL, V164, P4689, DOI 10.4049/jimmunol.164.9.4689; Aklilu M, 2004, ANN ONCOL, V15, P1109, DOI 10.1093/annonc/mdh280; Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Berraondo P, 2016, IMMUNOL REV, V274, P290, DOI 10.1111/imr.12464; Bodogai M, 2013, CANCER RES, V73, P2127, DOI 10.1158/0008-5472.CAN-12-4184; Bonavita E, 2015, CELL, V160, P700, DOI 10.1016/j.cell.2015.01.004; Brown JR, 2019, BIOL METHODS PROTOC, V4, DOI 10.1093/biomethods/bpz010; Carroll MC, 2012, IMMUNITY, V37, P199, DOI 10.1016/j.immuni.2012.08.002; Chen F, 2019, NAT CELL BIOL, V21, P498, DOI 10.1038/s41556-019-0299-0; Dieci MV, 2018, SEMIN CANCER BIOL, V52, P16, DOI 10.1016/j.semcancer.2017.10.003; Erdei A, 2016, IMMUNOL REV, V274, P127, DOI 10.1111/imr.12498; Fan XZ, 2014, J EXP MED, V211, P715, DOI 10.1084/jem.20130590; Fayanju OM, 2018, ANN SURG, V268, P591, DOI 10.1097/SLA.0000000000002953; Franzese O, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1114203; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Gunderson AJ, 2013, EXP CELL RES, V319, P1644, DOI 10.1016/j.yexcr.2013.03.005; Hajishengallis G, 2017, NAT IMMUNOL, V18, P1288, DOI 10.1038/ni.3858; Hamy AS, 2017, ANN ONCOL, V28, P2233, DOI 10.1093/annonc/mdx309; Heesters BA, 2014, NAT REV IMMUNOL, V14, P495, DOI 10.1038/nri3689; Hennequin A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1054598; Horikawa M, 2011, J CLIN INVEST, V121, P4268, DOI 10.1172/JCI59266; Huang D, 2018, NAT IMMUNOL, V19, P1112, DOI 10.1038/s41590-018-0207-y; Inoue S, 2006, CANCER RES, V66, P7741, DOI 10.1158/0008-5472.CAN-05-3766; Joly-Battaglini Albane, 2016, F1000Res, V5, P38, DOI 10.12688/f1000research.7599.1; Keren Z, 2011, BLOOD, V117, P3104, DOI 10.1182/blood-2010-09-307983; Khandelwal S, 2016, BLOOD, V128, P1789, DOI 10.1182/blood-2016-04-709634; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Lehrman EK, 2018, NEURON, V100, P120, DOI 10.1016/j.neuron.2018.09.017; Liu XJ, 2015, NAT MED, V21, P1209, DOI 10.1038/nm.3931; Lyubchenko T, 2007, J IMMUNOL, V179, P2695, DOI 10.4049/jimmunol.179.5.2695; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Mastellos D, 2004, MOL IMMUNOL, V40, P1213, DOI 10.1016/j.molimm.2003.10.019; Metzger TC, 2016, CANCER RES, V76, P3684, DOI 10.1158/0008-5472.CAN-15-3412; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Olkhanud PB, 2011, CANCER RES, V71, P3505, DOI 10.1158/0008-5472.CAN-10-4316; PEPYS MB, 1972, NATURE-NEW BIOL, V237, P157, DOI 10.1038/newbio237157a0; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Reis ES, 2018, NAT REV IMMUNOL, V18, P5, DOI 10.1038/nri.2017.97; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Sautes-Fridman C, 2019, NAT REV CANCER, V19, P307, DOI 10.1038/s41568-019-0144-6; Schalper KA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju435; Schmid P, 2018, NEW ENGL J MED, V379, P2108, DOI 10.1056/NEJMoa1809615; Shalapour S, 2017, NATURE, V551, P340, DOI 10.1038/nature24302; Shalapour S, 2015, NATURE, V521, P94, DOI 10.1038/nature14395; Spendlove I, 2006, CANCER IMMUNOL IMMUN, V55, P987, DOI 10.1007/s00262-006-0136-8; Su SC, 2018, CELL, V175, P442, DOI 10.1016/j.cell.2018.09.007; Su SC, 2018, CELL, V172, P841, DOI 10.1016/j.cell.2018.01.009; Su SC, 2017, CELL RES, V27, P461, DOI 10.1038/cr.2017.34; Su SC, 2014, CANCER CELL, V25, P605, DOI 10.1016/j.ccr.2014.03.021; Surace L, 2015, IMMUNITY, V42, P767, DOI 10.1016/j.immuni.2015.03.009; Taylor RP, 2016, SEMIN IMMUNOL, V28, P309, DOI 10.1016/j.smim.2016.03.003; Untch M, 2018, J CLIN ONCOL, V36, P1308, DOI 10.1200/JCO.2017.75.9175; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; von Minckwitz G, 2013, J CLIN ONCOL, V31, P3623, DOI 10.1200/JCO.2012.45.0940; WANG RH, 1993, J CLIN INVEST, V92, P1326, DOI 10.1172/JCI116706; Wang Y, 2019, CLIN CANCER RES, V25, P1957, DOI 10.1158/1078-0432.CCR-18-2544; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Xiao X, 2016, CANCER DISCOV, V6, P546, DOI 10.1158/2159-8290.CD-15-1408; Zhang CY, 2016, IMMUNITY, V44, P913, DOI 10.1016/j.immuni.2016.04.003; Zhang Y, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1141857; Zhu W, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1051922; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	68	84	88	15	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2020	180	6					1081	+		10.1016/j.cell.2020.02.015	http://dx.doi.org/10.1016/j.cell.2020.02.015			41	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KW1IO	32142650	Bronze			2022-12-28	WOS:000520925300008
J	Nkengasong, JN; Mankoula, W				Nkengasong, John N.; Mankoula, Wessam			Looming threat of COVID-19 infection in Africa: act collectively, and fast	LANCET			English	Editorial Material									[Nkengasong, John N.; Mankoula, Wessam] Africa Ctr Dis Control & Prevent, W21K19, Addis Ababa, Ethiopia		Nkengasong, JN (corresponding author), Africa Ctr Dis Control & Prevent, W21K19, Addis Ababa, Ethiopia.	nkengasongJ@africa-union.org						[Anonymous], 2020, OUTBREAK NEWS TODAY; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6; Nkengasong J, 2020, NAT MED, V26, P310, DOI 10.1038/s41591-020-0771-1; Steenhuysen J, 2020, REUTERS; Tobacco Tactics, 2020, E MED REG	6	178	181	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2020	395	10227					841	842		10.1016/S0140-6736(20)30464-5	http://dx.doi.org/10.1016/S0140-6736(20)30464-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU9DZ	32113508	Green Published, Bronze			2022-12-28	WOS:000520024900009
J	Kuehn, BM				Kuehn, Bridget M.			Rising Emergency Department Visits for Suicidal Ideation and Self-harm	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2020	323	10					917	917		10.1001/jama.2020.1596	http://dx.doi.org/10.1001/jama.2020.1596			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KW1LV	32154862				2022-12-28	WOS:000520933900023
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: emergency departments lack proper isolation facilities, senior medic warns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Getting it Right First Time, EMERGENCY MED	1	7	7	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2020	368								m953	10.1136/bmj.m953	http://dx.doi.org/10.1136/bmj.m953			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AK	32152001	Bronze			2022-12-28	WOS:000520012000009
J	Chen, SM; Yang, JT; Yang, WZ; Wang, C; Barnighausen, T				Chen, Simiao; Yang, Juntao; Yang, Weizhong; Wang, Chen; Barnighausen, Till			COVID-19 control in China during mass population movements at New Year	LANCET			English	Editorial Material							INTERVENTIONS		[Chen, Simiao; Barnighausen, Till] Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg Med Sch, Heidelberg, Germany; [Yang, Juntao] Chinese Acad Med Sci, State Key Lab Med Mol Biol, Inst Basic Med Sci, Beijing, Peoples R China; [Yang, Juntao; Yang, Weizhong; Wang, Chen] Peking Union Med Coll, Beijing, Peoples R China; [Yang, Weizhong; Wang, Chen] Chinese Acad Med Sci, Beijing, Peoples R China; [Wang, Chen] Chinese Acad Engn, Beijing, Peoples R China; [Barnighausen, Till] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Ruprecht Karls University Heidelberg; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Harvard University; Harvard T.H. Chan School of Public Health	Wang, C (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.; Wang, C (corresponding author), Chinese Acad Med Sci, Beijing, Peoples R China.; Wang, C (corresponding author), Chinese Acad Engn, Beijing, Peoples R China.	wangchen@pumc.edu.cn	Chen, Simiao/O-4017-2017; Yang, Wei/HIA-0360-2022; wang, chen/GWM-9481-2022; Bärnighausen, Till/Y-2388-2019	Chen, Simiao/0000-0003-0555-2157; Wang, Chen/0000-0001-7857-5435				Ahmed F, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5446-1; [Anonymous], 2020, BIG DAT TRAV VOL PRE; [Anonymous], 2020, CLIN CHARACTERISTICS; [Anonymous], 2020, CHINA NEWS; Caley P, 2008, J R SOC INTERFACE, V5, P631, DOI 10.1098/rsif.2007.1197; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fong MW, 2020, EMERG INFECT DIS, V26, P976, DOI 10.3201/eid2605.190995; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Li Q., 2020, NEW ENGL J MED, V382, P1199; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; National Health Commission of the People's Republic of China, 2020, UPD EP; Poletti P, 2009, J THEOR BIOL, V260, P31, DOI 10.1016/j.jtbi.2009.04.029; The People's Government of Beijing Municipality, 2020, C CAN FLEX ARR JOBS; The People's Government of Beijing Municipality, 2020, ANN CANC MAJ EV INCL; The People's Government of Hangzhou Municipality, 2020, ANN POSTP REOP DAT C; The People's Government of Hubei Province, 2020, ANN HUB PROV NOV COR; The People's Government of Shanghai Municipality, 2020, ANN POSTP REOP DAT C; The State Council of the People's Republic of China, 2019, STAT COUNC ANN ARR P; The State Council of the People's Republic of China, 2020, STAT COUNC ANN EXT L; The State Council of the People's Republic of China, 2020, ANN WUH HEADQ NOV CO	22	450	473	10	95	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2020	395	10226					764	766		10.1016/S0140-6736(20)30421-9	http://dx.doi.org/10.1016/S0140-6736(20)30421-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU2KH	32105609	Green Published, Bronze			2022-12-28	WOS:000519536900010
J	Geri, JB; Oakley, JV; Reyes-Robles, T; Wang, T; McCarver, SJ; White, CH; Rodriguez-Rivera, FP; Parker, DL; Hett, EC; Fadeyi, OO; Oslund, RC; MacMillan, DWC				Geri, Jacob B.; Oakley, James V.; Reyes-Robles, Tamara; Wang, Tao; McCarver, Stefan J.; White, Cory H.; Rodriguez-Rivera, Frances P.; Parker, Dann L., Jr.; Hett, Erik C.; Fadeyi, Olugbeminiyi O.; Oslund, Rob C.; MacMillan, David W. C.			Microenvironment mapping via Dexter energy transfer on immune cells	SCIENCE			English	Article							PROTEOMIC ANALYSIS; LIVING CELLS; RECEPTOR; BIOTINYLATION; MECHANISM; DYNAMICS; STRATEGY; INSIGHTS; ANTIBODY; SOLVENT	Many disease pathologies can be understood through the elucidation of localized biomolecular networks, or microenvironments. To this end, enzymatic proximity labeling platforms are broadly applied for mapping the wider spatial relationships in subcellular architectures. However, technologies that can map microenvironments with higher precision have long been sought. Here, we describe a microenvironment-mapping platform that exploits photocatalytic carbene generation to selectively identify protein-protein interactions on cell membranes, an approach we term MicroMap (mMap). By using a photocatalyst-antibody conjugate to spatially localize carbene generation, we demonstrate selective labeling of antibody binding targets and their microenvironment protein neighbors. This technique identified the constituent proteins of the programmed-death ligand 1 (PD-L1) microenvironment in live lymphocytes and selectively labeled within an immunosynaptic junction.	[Geri, Jacob B.; Oakley, James V.; Wang, Tao; McCarver, Stefan J.; MacMillan, David W. C.] Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA; [Reyes-Robles, Tamara; White, Cory H.; Hett, Erik C.; Fadeyi, Olugbeminiyi O.; Oslund, Rob C.] Merck & Co Inc, Merck Exploratory Sci Ctr, Cambridge, MA 02141 USA; [Rodriguez-Rivera, Frances P.; Parker, Dann L., Jr.] Merck & Co Inc, Discovery Chem, Kenilworth, NJ 07033 USA	Princeton University; Merck & Company; Merck & Company	MacMillan, DWC (corresponding author), Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA.; Fadeyi, OO; Oslund, RC (corresponding author), Merck & Co Inc, Merck Exploratory Sci Ctr, Cambridge, MA 02141 USA.	olugbeminiyi.fadeyi@merck.com; rob.oslund@merck.com; dmacmill@princeton.edu		Reyes-Robles, Tamara/0000-0001-7753-7971; Wang, Tao/0000-0003-2587-0494; Oakley, James/0000-0003-4774-5205; White, Cory/0000-0002-1619-0174	NIH National Institute of General Medical Sciences [R01-GM103558-03]; NIH [F32-GM133133-01]; NSF [DGE-1656466]	NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	Research reported in this publication was supported by the NIH National Institute of General Medical Sciences (R01-GM103558-03) and gifts from Merck & Co., Inc., Kenilworth, New Jersey, USA. J.B.G. acknowledges the NIH for a postdoctoral fellowship (F32-GM133133-01). J.V.O. acknowledges the NSF for a predoctoral fellowship (DGE-1656466).	Admasu A, 1998, J CHEM SOC PERK T 2, P1093, DOI 10.1039/a707586c; Alsaab HO, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00561; Arias-Rotondo DM, 2016, CHEM SOC REV, V45, P5803, DOI 10.1039/c6cs00526h; Bar DZ, 2018, NAT METHODS, V15, P749, DOI 10.1038/s41592-018-0073-4; Bar DZ, 2018, NAT METHODS, V15, P127, DOI 10.1038/nmeth.4533; Bauer NC, 2015, TRAFFIC, V16, P1039, DOI 10.1111/tra.12310; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg, 2018, RANDOM WALKS BIOL; Bersuker K, 2018, DEV CELL, V44, P97, DOI 10.1016/j.devcel.2017.11.020; Bhagwat B, 2018, J IMMUNOL METHODS, V456, P7, DOI 10.1016/j.jim.2018.02.003; BOURGUIGNON LYW, 1977, P NATL ACAD SCI USA, V74, P5031, DOI 10.1073/pnas.74.11.5031; BOURGUIGNON LYW, 1979, J CELL BIOL, V83, P649, DOI 10.1083/jcb.83.3.649; BRUNNER J, 1980, J BIOL CHEM, V255, P3313; Carbone CB, 2017, P NATL ACAD SCI USA, V114, pE9338, DOI 10.1073/pnas.1710358114; Choi-Rhee E, 2004, PROTEIN SCI, V13, P3043, DOI 10.1110/ps.04911804; Dustin ML, 2014, CANCER IMMUNOL RES, V2, P1023, DOI 10.1158/2326-6066.CIR-14-0161; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Folkes LK, 2011, ARCH BIOCHEM BIOPHYS, V506, P242, DOI 10.1016/j.abb.2010.12.006; Ge SS, 2018, RSC ADV, V8, P29428, DOI 10.1039/c8ra03538e; Hanoun M, 2015, NEURON, V86, P360, DOI 10.1016/j.neuron.2015.01.026; Hashimoto N, 2012, PROTEOMICS, V12, P3154, DOI 10.1002/pmic.201200279; Hayashi T, 2015, J AM CHEM SOC, V137, P5372, DOI 10.1021/jacs.5b02867; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hung V, 2016, NAT PROTOC, V11, P456, DOI 10.1038/nprot.2016.018; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; James JR, 2012, NATURE, V487, P64, DOI 10.1038/nature11220; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Kotani N, 2008, P NATL ACAD SCI USA, V105, P7405, DOI 10.1073/pnas.0710346105; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Le Saux S, 2017, J IMMUNOL, V198; Li XW, 2014, J BIOL CHEM, V289, P14434, DOI 10.1074/jbc.M113.529578; Loh KH, 2016, CELL, V166, P1295, DOI 10.1016/j.cell.2016.07.041; Lundberg E, 2019, NAT REV MOL CELL BIO, V20, P285, DOI 10.1038/s41580-018-0094-y; Minter Ralph R, 2017, Drug Discov Today Technol, V23, P83, DOI 10.1016/j.ddtec.2017.03.004; Miyagawa-Yamaguchi A, 2015, GLYCOCONJUGATE J, V32, P531, DOI 10.1007/s10719-015-9595-5; Montoya MC, 2002, NAT IMMUNOL, V3, P159, DOI 10.1038/ni753; Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712; Pinchuk IV, 2010, TOXINS, V2, P2177, DOI 10.3390/toxins2082177; R Development Core Team, 2011, R FDN STAT COMP VIEN; Rees J. S., 2015, CURR PROTOC PROTEIN, V80, P18; Rees JS, 2015, MOL CELL PROTEOMICS, V14, P2848, DOI 10.1074/mcp.R115.052902; Rees Johanna Susan, 2015, Curr Protoc Protein Sci, V80, DOI 10.1002/0471140864.ps1927s80; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Singh A, 2015, J ORGANOMET CHEM, V776, P51, DOI 10.1016/j.jorganchem.2014.10.037; Stanton BZ, 2018, SCIENCE, V359, DOI 10.1126/science.aao5902; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Teegardin K, 2016, ORG PROCESS RES DEV, V20, P1156, DOI 10.1021/acs.oprd.6b00101; TERRY LA, 1988, IMMUNOLOGY, V64, P331; van der Weyden CA, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.85; Wang J, 2008, J AM CHEM SOC, V130, P6604, DOI 10.1021/ja711385t; White C., 2020, FLOW CYTOMETRY DATA; White C., 2020, FLOW CYTOMETRY DATA, DOI [10.7910/DVN/O6O04O, DOI 10.7910/DVN/O6O04O]; White C., 2020, MERCK PHOTOPROXIMITY, DOI [10.5281/zenodo.3608233., DOI 10.5281/ZENODO.3608233]; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Yu HH, 2017, CHEM COMMUN, V53, P9745, DOI 10.1039/c7cc05315k; Zenarruzabeitia O, 2015, J IMMUNOL, V194, P5053, DOI 10.4049/jimmunol.1500304	60	85	85	27	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1091	+		10.1126/science.aay4106	http://dx.doi.org/10.1126/science.aay4106			129	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9CD	32139536	Green Accepted			2022-12-28	WOS:000520018400035
J	Wise, J				Wise, Jacqui			Developing your career as a neurosurgeon	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		BMA, VOL SAS DOCT CONS; British Society of Neurological Surgeons, NEUR UN; National Institute for Health Research, CLIN RES NETW; Royal College of Surgeons of England, REV GUID; Royal College of Surgeons of England, NEUR FELL	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2020	368								m522	10.1136/bmj.m522	http://dx.doi.org/10.1136/bmj.m522			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2LJ	32144113	Bronze			2022-12-28	WOS:000519539700002
J	Iacobucci, G				Iacobucci, Gareth			British GPs are more stressed and time pressured than international colleagues, survey shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Fisher R, 2020, FEELING STRAIN WHAT	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2020	368								m926	10.1136/bmj.m926	http://dx.doi.org/10.1136/bmj.m926			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KI	32139554				2022-12-28	WOS:000519537000014
J	Kumar, P; Rao, PN				Kumar, Pramod; Rao, Padaki N.			Hepatopulmonary Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Hepatopulmonary syndrome (HPS) is characterized by an oxygenation defect induced by pulmonary vascular dilatation in the setting of liver cirrhosis or portal hypertension. It is defined by an alveolar-arterial gradient > 15 mm Hg measured at sea level. This syndrome is seen in 15 to 30% of cirrhotic patients and has been associated with worse survival. Most HPS patients are either asymptomatic or develop the insidious onset of dyspnea. The key event in its pathogenesis is the development of intrapulmonary vascular dilatation (IPVD), which has been linked to increased pulmonary levels of nitric oxide. Pulse oximetry is a useful screening test for HPS, which can guide subsequent use of arterial blood gases. Contrast-enhanced transthoracic echocardiography is the most effective test to demonstrate IPVD. Another method for detecting IPVD is the radionuclide lung perfusion scanning, using technetium-labeled macroaggregated albumin particles. Liver transplantation is the only available treatment for HPS, resulting in complete resolution or significant improvement in gas exchange in over 85% of patients.	[Kumar, Pramod; Rao, Padaki N.] Asian Inst Gastroenterol, Hyderabad, Telangana, India		Kumar, P (corresponding author), Asian Inst Gastroenterol, Hyderabad, Telangana, India.	dapramod@gmail.com							0	3	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2020	382	10					E14	E14		10.1056/NEJMicm1901205	http://dx.doi.org/10.1056/NEJMicm1901205			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KT7TC	32130817				2022-12-28	WOS:000519214900001
J	Rolph, R; Morgan, C; Chapman, G; Marsh, S				Rolph, Rachel; Morgan, Catrin; Chapman, Gareth; Marsh, Simon			Groin pain in athletes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HERNIA		[Rolph, Rachel; Morgan, Catrin] Guys & St Thomas NHS Fdn Trust, London, England; [Chapman, Gareth] Ball Tree Surg, Lancing, W Sussex, England; [Marsh, Simon] Colchester Hosp Univ Fdn NHS Trust, Colchester, Essex, England; [Marsh, Simon] Gilmore Groin & Hernia Clin, London, England	Guy's & St Thomas' NHS Foundation Trust	Rolph, R (corresponding author), Guys & St Thomas NHS Fdn Trust, London, England.	r.rolph@nhs.net		Morgan, Catrin/0000-0003-1273-8312				AKERMARK C, 1992, AM J SPORT MED, V20, P640, DOI 10.1177/036354659202000604; Almeida Neogelia Pereira, 2013, BMC Res Notes, V6, P387, DOI 10.1186/1756-0500-6-387; Banks A J, 1982, Br J Sports Med, V16, P101; Dimitrakopoulou A, 2016, J HIP PRESERV SURG, V3, P16, DOI 10.1093/jhps/hnv083; Gilmore J, 1998, CLIN SPORT MED, V17, P787, DOI 10.1016/S0278-5919(05)70119-8; Gilmore J., 1999, SURG MANAGEMENT ABDO, P151; Hamid MSA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090538; King E, 2018, BRIT J SPORT MED, V52, P1054, DOI 10.1136/bjsports-2016-097089; Serner A, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094256; Sheen AJ, 2014, BRIT J SPORT MED, V48, P1079, DOI 10.1136/bjsports-2013-092872; Suarez JC, 2013, J AM ACAD ORTHOP SUR, V21, P558, DOI [10.5435/00124635-201309020-00007, 10.5435/JAAOS-21-09-558]	11	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2020	368								m559	10.1136/bmj.m559	http://dx.doi.org/10.1136/bmj.m559			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KE	32132013				2022-12-28	WOS:000519536600004
J	Dyer, O				Dyer, Owen			Ten years of clinical trial data cannot legally be hidden from the public, US court rules	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Piller C, 2020, SCIENCE, V367, P240, DOI 10.1126/science.367.6475.240	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2020	368								m832	10.1136/bmj.m832	http://dx.doi.org/10.1136/bmj.m832			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KC	32122878				2022-12-28	WOS:000519536400009
J	Mahase, E				Mahase, Elisabeth			Universal credit linked to psychological distress but not employment	BMJ-BRITISH MEDICAL JOURNAL			English	News Item															Wellcome Trust, UK National Institute for Health Research; Medical Research Council	Wellcome Trust, UK National Institute for Health Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Wellcome Trust, UK National Institute for Health Research, and the Medical Research Council.	Wickham S, 2020, LANCET PUBLIC HEALTH, V5, pE157, DOI 10.1016/S2468-2667(20)30026-8	1	0	0	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2020	368								m817	10.1136/bmj.m817	http://dx.doi.org/10.1136/bmj.m817			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU2KA	32111655				2022-12-28	WOS:000519536200016
J	Lu, ZH; Zou, JL; Li, S; Topper, MJ; Tao, Y; Zhang, H; Jiao, X; Xie, WB; Kong, XQ; Vaz, M; Li, HL; Cai, Y; Xia, LM; Huang, P; Rodgers, K; Lee, B; Riemer, JB; Day, CP; Yen, RWC; Cui, Y; Wang, YJ; Wang, YN; Zhang, WQ; Easwaran, H; Hulbert, A; Kim, K; Juergens, RA; Yang, SC; Battafarano, RJ; Bush, EL; Broderick, SR; Cattaneo, SM; Brahmer, JR; Rudin, CM; Wrangle, J; Mei, YP; Kim, YJ; Zhang, B; Wang, KKH; Forde, PM; Margolick, JB; Nelkin, BD; Zahnow, CA; Pardoll, DM; Housseau, F; Baylin, SB; Shen, L; Brock, MV				Lu, Zhihao; Zou, Jianling; Li, Shuang; Topper, Michael J.; Tao, Yong; Zhang, Hao; Jiao, Xi; Xie, Wenbing; Kong, Xiangqian; Vaz, Michelle; Li, Huili; Cai, Yi; Xia, Limin; Huang, Peng; Rodgers, Kristen; Lee, Beverly; Riemer, Joanne B.; Day, Chi-Ping; Yen, Ray-Whay Chiu; Cui, Ying; Wang, Yujiao; Wang, Yanni; Zhang, Weiqiang; Easwaran, Hariharan; Hulbert, Alicia; Kim, KiBem; Juergens, Rosalyn A.; Yang, Stephen C.; Battafarano, Richard J.; Bush, Errol L.; Broderick, Stephen R.; Cattaneo, Stephen M.; Brahmer, Julie R.; Rudin, Charles M.; Wrangle, John; Mei, Yuping; Kim, Young J.; Zhang, Bin; Wang, Ken Kang-Hsin; Forde, Patrick M.; Margolick, Joseph B.; Nelkin, Barry D.; Zahnow, Cynthia A.; Pardoll, Drew M.; Housseau, Franck; Baylin, Stephen B.; Shen, Lin; Brock, Malcolm V.			Epigenetic therapy inhibits metastases by disrupting premetastatic niches	NATURE			English	Article							MYELOID CELLS; GENE; EXPRESSION; MONOCYTES	Cancer recurrence after surgery remains an unresolved clinical problem(1-3). Myeloid cells derived from bone marrow contribute to the formation of the premetastatic microenvironment, which is required for disseminating tumour cells to engraft distant sites(4-6). There are currently no effective interventions that prevent the formation of the premetastatic microenvironment(6,7). Here we show that, after surgical removal of primary lung, breast and oesophageal cancers, low-dose adjuvant epigenetic therapy disrupts the premetastatic microenvironment and inhibits both the formation and growth of lung metastases through its selective effect on myeloid-derived suppressor cells (MDSCs). In mouse models of pulmonary metastases, MDSCs are key factors in the formation of the premetastatic microenvironment after resection of primary tumours. Adjuvant epigenetic therapy that uses low-dose DNA methyltransferase and histone deacetylase inhibitors, 5-azacytidine and entinostat, disrupts the premetastatic niche by inhibiting the trafficking of MDSCs through the downregulation of CCR2 and CXCR2, and by promoting MDSC differentiation into a more-interstitial macrophage-like phenotype. A decreased accumulation of MDSCs in the premetastatic lung produces longer periods of disease-free survival and increased overall survival, compared with chemotherapy. Our data demonstrate that, even after removal of the primary tumour, MDSCs contribute to the development of premetastatic niches and settlement of residual tumour cells. A combination of low-dose adjuvant epigenetic modifiers that disrupts this premetastatic microenvironment and inhibits metastases may permit an adjuvant approach to cancer therapy.	[Lu, Zhihao; Rodgers, Kristen; Lee, Beverly; Zhang, Weiqiang; Hulbert, Alicia; Yang, Stephen C.; Battafarano, Richard J.; Bush, Errol L.; Broderick, Stephen R.; Mei, Yuping; Brock, Malcolm V.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Lu, Zhihao; Zou, Jianling; Li, Shuang; Jiao, Xi; Wang, Yujiao; Wang, Yanni] Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China; [Lu, Zhihao; Topper, Michael J.; Tao, Yong; Xie, Wenbing; Kong, Xiangqian; Vaz, Michelle; Li, Huili; Cai, Yi; Xia, Limin; Huang, Peng; Riemer, Joanne B.; Yen, Ray-Whay Chiu; Cui, Ying; Easwaran, Hariharan; Kim, KiBem; Brahmer, Julie R.; Mei, Yuping; Forde, Patrick M.; Nelkin, Barry D.; Zahnow, Cynthia A.; Pardoll, Drew M.; Housseau, Franck; Baylin, Stephen B.; Shen, Lin; Brock, Malcolm V.] Johns Hopkins Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Zhang, Hao; Margolick, Joseph B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Xia, Limin] Air Force Med Univ, State Key Lab Canc Biol, Natl Clin Res Ctr Digest Dis, Xijing Hosp Digest Dis, Xian, Peoples R China; [Day, Chi-Ping] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Zhang, Weiqiang] Peoples Liberat Army Gen Hosp, Dept Thorac Surg, Med Ctr 7, Beijing, Peoples R China; [Hulbert, Alicia] Univ Illinois, Coll Med, Dept Surg, Chicago, IL USA; [Juergens, Rosalyn A.] McMaster Univ, Juravinski Canc Ctr, Div Med Oncol, Hamilton, ON, Canada; [Cattaneo, Stephen M.] Anne Arundel Med Ctr, Dept Surg, Annapolis, MD USA; [Rudin, Charles M.] Mem Sloan Kettering Canc Ctr, Thorac Oncol Serv, 1275 York Ave, New York, NY 10021 USA; [Wrangle, John] Med Univ South Carolina, Div Hematol Oncol, Charleston, SC 29425 USA; [Kim, Young J.] Vanderbilt Univ, Dept Otolaryngol Head & Neck Surg, 221 Kirkland Hall, Nashville, TN 37235 USA; [Zhang, Bin; Wang, Ken Kang-Hsin] Johns Hopkins Univ, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA; [Zhang, Bin] Dalian Univ Technol, Sch Biomed Engn, Dalian, Peoples R China; [Pardoll, Drew M.; Housseau, Franck] Johns Hopkins Univ, Sch Med, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD 21218 USA	Johns Hopkins University; Peking University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Air Force Military Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chinese People's Liberation Army General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; McMaster University; Memorial Sloan Kettering Cancer Center; Medical University of South Carolina; Vanderbilt University; Johns Hopkins University; Dalian University of Technology; Johns Hopkins University	Brock, MV (corresponding author), Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA.; Housseau, F; Baylin, SB; Shen, L; Brock, MV (corresponding author), Johns Hopkins Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA.; Housseau, F (corresponding author), Johns Hopkins Univ, Sch Med, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD 21218 USA.	fhousse1@jhmi.edu; sbaylin@jhmi.edu; shenlin@bjmu.edu.cn; mabrock@jhmi.edu	Hulbert, Alicia/AAP-5714-2021; Forde, Patrick/AAX-2936-2021; Xie, Wenbing/J-7962-2014	Xie, Wenbing/0000-0003-2546-2415; Bush, Errol/0000-0003-1251-8467; Hulbert, Alicia/0000-0002-1196-1953; Juergens, Rosalyn/0000-0001-8627-4704	Brockman Foundation; Skalka-Kronsberg family; Banks Family Foundation, Bermuda; Van Andel Institute through the Van Andel Institute-Stand Up To Cancer	Brockman Foundation; Skalka-Kronsberg family; Banks Family Foundation, Bermuda; Van Andel Institute through the Van Andel Institute-Stand Up To Cancer	This work was supported by grants from the Brockman Foundation, the Skalka-Kronsberg family as well as the Banks Family Foundation, Bermuda. Research funding was provided by the Van Andel Institute through the Van Andel Institute-Stand Up To Cancer Epigenetics Dream Team. Stand Up To Cancer is a division of the Entertainment Industry Foundation, administered by AACR. We acknowledge G. Merlino for providing the LLC tissue (P3 working stock); S. Singhal, who provided HNM007, a p53-null mouse oesophageal squamous cell carcinoma cell line transformed by Hras<SUP>G12V</SUP>; S. A. McGrath-Morrow, who provided B6.129S4 Ccr2<SUP>tm1Ifc</SUP>/J mice; L. W. Kwak, who provided synthetic, complementary double-stranded oligonucleotides encoding H6 peptide (TIK), and an irrelevant control peptibody (Irr-pep) (D1); A. Tam and R. L. Blosser for their help with flow cytometry; P. Ordentlich from Syndax Pharmaceuticals for providing entinostat; S. Zhou for advice and consultation; L. Bois and J. Murphy for expert technical help; Y. Lai for histological analysis with H&E staining; and W. Zhu for data analysis.	Allum WH, 2009, J CLIN ONCOL, V27, P5062, DOI 10.1200/JCO.2009.22.2083; Arriagada R, 2010, J CLIN ONCOL, V28, P35, DOI 10.1200/JCO.2009.23.2272; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Day CP, 2012, INT J CANCER, V130, P190, DOI 10.1002/ijc.25978; Di Mitri D, 2014, NATURE, V515, P134, DOI 10.1038/nature13638; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Forde PM, 2018, NEW ENGL J MED, V378, P1976, DOI 10.1056/NEJMoa1716078; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Highfill SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007974; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kim K, 2014, P NATL ACAD SCI USA, V111, P11774, DOI 10.1073/pnas.1410626111; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Kris MG, 2017, J CLIN ONCOL, V35, P2960, DOI 10.1200/JCO.2017.72.4401; Liu Y, 2016, CANCER CELL, V30, P668, DOI 10.1016/j.ccell.2016.09.011; Mahvi DA, 2018, CA-CANCER J CLIN, V68, P488, DOI 10.3322/caac.21498; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Pan HC, 2017, NEW ENGL J MED, V377, P1836, DOI 10.1056/NEJMoa1701830; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Phillips Roderick J, 2005, J Inflamm (Lond), V2, P14, DOI 10.1186/1476-9255-2-14; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Postmus PE, 2017, ANN ONCOL, V28, P1, DOI 10.1093/annonc/mdx222; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qin H, 2014, NAT MED, V20, P676, DOI 10.1038/nm.3560; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Shapiro J, 2015, LANCET ONCOL, V16, P1090, DOI 10.1016/S1470-2045(15)00040-6; Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun SC, 2017, NAT REV IMMUNOL, V17, P545, DOI 10.1038/nri.2017.52; Topper MJ, 2017, CELL, V171, P1284, DOI 10.1016/j.cell.2017.10.022; Youn JI, 2013, NAT IMMUNOL, V14, P211, DOI 10.1038/ni.2526; YU J, 2016, MED PHYS, V43, P2619, DOI DOI 10.1118/1.4947481	36	123	128	18	167	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7798					284	+		10.1038/s41586-020-2054-x	http://dx.doi.org/10.1038/s41586-020-2054-x		FEB 2020	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU0CC	32103175	Green Accepted			2022-12-28	WOS:000516702000011
J	Shao, ZP; Flynn, RA; Crowe, JL; Zhu, YM; Liang, JL; Jiang, WX; Aryan, F; Aoude, P; Bertozzi, CR; Estes, VM; Lee, BJ; Bhagat, G; Zha, S; Calo, E				Shao, Zhengping; Flynn, Ryan A.; Crowe, Jennifer L.; Zhu, Yimeng; Liang, Jialiang; Jiang, Wenxia; Aryan, Fardin; Aoude, Patrick; Bertozzi, Carolyn R.; Estes, Verna M.; Lee, Brian J.; Bhagat, Govind; Zha, Shan; Calo, Eliezer			DNA-PKcs has KU-dependent function in rRNA processing and haematopoiesis	NATURE			English	Article							TELOMERASE RECRUITMENT; CATALYTIC SUBUNIT; PROTEIN-KINASE; STEM-CELLS; GENE; BINDING; REPAIR; MICE; P53; DYSFUNCTION	The DNA-dependent protein kinase (DNA-PK), which comprises the KU heterodimer and a catalytic subunit (DNA-PKcs), is a classical non-homologous end-joining (cNHEJ) factor(1). KU binds to DNA ends, initiates cNHEJ, and recruits and activates DNA-PKcs. KU also binds to RNA, but the relevance of this interaction in mammals is unclear. Here we use mouse models to show that DNA-PK has an unexpected role in the biogenesis of ribosomal RNA (rRNA) and in haematopoiesis. The expression of kinase-dead DNA-PKcs abrogates cNHEJ(2). However, most mice that both expressed kinase-dead DNA-PKcs and lacked the tumour suppressor TP53 developed myeloid disease, whereas all other previously characterized mice deficient in both cNHEJ and TP53 expression succumbed to pro-B cell lymphoma(3). DNA-PK autophosphorylates DNA-PKcs, which is its best characterized substrate. Blocking the phosphorylation of DNA-PKcs at the T2609 cluster, but not the S2056 cluster, led to KU-dependent defects in 18S rRNA processing, compromised global protein synthesis in haematopoietic cells and caused bone marrow failure in mice. KU drives the assembly of DNA-PKcs on a wide range of cellular RNAs, including the U3 small nucleolar RNA, which is essential for processing of 18S rRNA(4). U3 activates purified DNA-PK and triggers phosphorylation of DNA-PKcs at T2609. DNA-PK, but not other cNHEJ factors, resides in nucleoli in an rRNA-dependent manner and is co-purified with the small subunit processome. Together our data show that DNA-PK has RNA-dependent, cNHEJ-independent functions during ribosome biogenesis that require the kinase activity of DNA-PKcs and its phosphorylation at the T2609 cluster.	[Shao, Zhengping; Crowe, Jennifer L.; Zhu, Yimeng; Jiang, Wenxia; Estes, Verna M.; Lee, Brian J.; Zha, Shan] Columbia Univ, Vagelos Coll Phys & Surg, Inst Canc Genet, New York, NY 10027 USA; [Shao, Zhengping; Zhu, Yimeng; Jiang, Wenxia; Estes, Verna M.; Lee, Brian J.; Bhagat, Govind; Zha, Shan] Columbia Univ, Vagelos Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA; [Flynn, Ryan A.; Bertozzi, Carolyn R.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Crowe, Jennifer L.] Columbia Univ, Vagelos Coll Phys & Surg, Grad Program Pathobiol & Mol Med, New York, NY USA; [Liang, Jialiang; Aryan, Fardin; Aoude, Patrick; Calo, Eliezer] MIT, Dept Biol, Cambridge, MA 02139 USA; [Bertozzi, Carolyn R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Bhagat, Govind; Zha, Shan] Columbia Univ, Dept Pediat, Vagelos Coll Phys & Surg, New York, NY 10027 USA; [Bhagat, Govind; Zha, Shan] Columbia Univ, Dept Pathol & Cell Biol, Vagelos Coll Phys & Surg, New York, NY 10027 USA; [Bhagat, Govind; Zha, Shan] Columbia Univ, Dept Immunol & Microbiol, Vagelos Coll Phys & Surg, New York, NY 10027 USA; [Calo, Eliezer] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Columbia University; Columbia University; Stanford University; Columbia University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Stanford University; Columbia University; Columbia University; Columbia University; Massachusetts Institute of Technology (MIT)	Zha, S (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, Inst Canc Genet, New York, NY 10027 USA.; Zha, S (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA.; Calo, E (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Zha, S (corresponding author), Columbia Univ, Dept Pediat, Vagelos Coll Phys & Surg, New York, NY 10027 USA.; Zha, S (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Vagelos Coll Phys & Surg, New York, NY 10027 USA.; Zha, S (corresponding author), Columbia Univ, Dept Immunol & Microbiol, Vagelos Coll Phys & Surg, New York, NY 10027 USA.; Calo, E (corresponding author), MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.	sz2296@columbia.edu; calo@mit.edu	Bhagat, Govind/AAE-9493-2021	Bhagat, Govind/0000-0001-6250-048X; Lee, Brian/0000-0001-5550-1468; Zha, Shan/0000-0002-6568-1818	Damon Runyon Cancer Research Foundation; Howard Hughes Medical Institute; Pew Charitable Trusts; Charles H. Hood Foundation; March of Dime Foundation; Charles E. Reed Faculty Initiative; Irwin and Helen Sizer Career Development Professorship; NIH/NCI Cancer Center Support Grant [P30CA013696];  [R01CA184187];  [R01CA158073];  [CA215067];  [1F31CA183504]	Damon Runyon Cancer Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Pew Charitable Trusts; Charles H. Hood Foundation; March of Dime Foundation; Charles E. Reed Faculty Initiative; Irwin and Helen Sizer Career Development Professorship; NIH/NCI Cancer Center Support Grant; ; ; ; 	We thank B. Sleckman and A. Smogorzewska for providing the control cell lines; W. Gu and T. Li for helping with Tp53 analyses in DNA-PKcs mouse models; R. Baer for commenting on the manuscript; L. Ding for discussion on hematopoietic stem cell analyses; T. Xiang and L. Berchowitz for assistance with the ribosomal and nucleoli analyses; C. S. Lin for germline injection and ES cell derivation; E. Zhang and S. Kaplan for help with telomere analyses; L. Zhang and the Elias laboratory for assistance running samples for MS analysis; J. Coller, D. Wagh, and the Stanford Functional Genomics Facility for assistance running samples for deep sequencing; and the Swanson Biotechnology Center at the Koch Institute for Integrative Cancer Research, especially the MIT BioMicro Center. Owing to space constraints, we often cited reviews rather than original publications. We apologize to the colleagues whose original works were not cited here. R.A.F is supported by the Damon Runyon Cancer Research Foundation. C.R.B is supported by the Howard Hughes Medical Institute. E.C. is supported by the Pew Charitable Trusts, Charles H. Hood and March of Dime Foundations, Charles E. Reed Faculty Initiative and Irwin and Helen Sizer Career Development Professorship. The project is in part supported by R01CA184187, R01CA158073 and CA215067 to S.Z. S.Z. was a Leukemia Lymphomas Society Scholar. J.L.C. was supported by 1F31CA183504. This research was funded in part through the NIH/NCI Cancer Center Support Grant P30CA013696 to Herbert Irving Comprehensive Cancer Center (HICCC) of Columbia University.	Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Avagyan S, 2014, BLOOD, V124, P1622, DOI 10.1182/blood-2014-05-574863; Barandun J, 2018, CURR OPIN STRUC BIOL, V49, P85, DOI 10.1016/j.sbi.2018.01.008; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Britton S, 2013, J CELL BIOL, V202, P579, DOI 10.1083/jcb.201303073; Calo E, 2015, NATURE, V518, P249, DOI 10.1038/nature13923; Chen HW, 2018, CELL, V172, P331, DOI 10.1016/j.cell.2017.12.008; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Crowe JL, 2018, P NATL ACAD SCI USA, V115, P8615, DOI 10.1073/pnas.1808490115; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Davis AJ, 2014, DNA REPAIR, V17, P21, DOI 10.1016/j.dnarep.2014.02.020; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Flygare J, 2007, BLOOD, V109, P980, DOI 10.1182/blood-2006-07-038232; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jiang WX, 2019, J IMMUNOL, V203, P178, DOI 10.4049/jimmunol.1801657; Jiang WX, 2015, MOL CELL, V58, P172, DOI 10.1016/j.molcel.2015.02.024; Khajuria RK, 2018, CELL, V173, P90, DOI 10.1016/j.cell.2018.02.036; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; Lee BS, 2013, MOL CELL BIOL, V33, P3568, DOI 10.1128/MCB.00308-13; Li G, 2008, MOL CELL, V31, P631, DOI 10.1016/j.molcel.2008.07.017; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu X, 2017, CELL DEATH DIS, V8, pe273; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Morchikh M, 2017, MOL CELL, V67, P387, DOI 10.1016/j.molcel.2017.06.020; Nacht M, 1996, GENE DEV, V10, P2055, DOI 10.1101/gad.10.16.2055; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; PARKER KA, 1987, MOL CELL BIOL, V7, P2899, DOI 10.1128/MCB.7.8.2899; Pfingsten JS, 2012, CELL, V148, P922, DOI 10.1016/j.cell.2012.01.033; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; STRAUSS ME, 1986, J CLIN EXP NEUROPSYC, V8, P210, DOI 10.1080/01688638608401313; SYMONDS H, 1994, CELL, V78, P703, DOI 10.1016/0092-8674(94)90534-7; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; Unnikrishnan I, 1999, MOL CELL BIOL, V19, P4825, DOI 10.1128/mcb.19.7.4825; van Sluis M, 2015, GENE DEV, V29, P1151, DOI 10.1101/gad.260703.115; Wang MS, 2015, RNA, V21, P1240, DOI 10.1261/rna.051169.115; Wang MS, 2011, NUCLEIC ACIDS RES, V39, P1811, DOI 10.1093/nar/gkq1050; Weterings E, 2003, NUCLEIC ACIDS RES, V31, P7238, DOI 10.1093/nar/gkg889; Williams ES, 2009, CANCER RES, V69, P2100, DOI 10.1158/0008-5472.CAN-08-2854; Yoo S, 1998, BIOCHEMISTRY-US, V37, P1336, DOI 10.1021/bi972100w; Zarnegar BJ, 2016, NAT METHODS, V13, P489, DOI [10.1038/NMETH.3840, 10.1038/nmeth.3840]; Zhang S, 2016, ONCOGENE, V35, P3909, DOI 10.1038/onc.2015.459; Zhang SC, 2011, J CELL BIOL, V193, P295, DOI 10.1083/jcb.201009074; Zhou F, 2010, J PROTEOME RES, V9, P6242, DOI 10.1021/pr1004696; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	53	35	35	1	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7798					291	+		10.1038/s41586-020-2041-2	http://dx.doi.org/10.1038/s41586-020-2041-2		FEB 2020	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU0CC	32103174				2022-12-28	WOS:000516702000009
J	Venkadesan, M; Yawar, A; Eng, CM; Dias, MA; Singh, DK; Tommasini, SM; Haims, AH; Bandi, MM; Mandre, S				Venkadesan, Madhusudhan; Yawar, Ali; Eng, Carolyn M.; Dias, Marcelo A.; Singh, Dhiraj K.; Tommasini, Steven M.; Haims, Andrew H.; Bandi, Mahesh M.; Mandre, Shreyas			Stiffness of the human foot and evolution of the transverse arch	NATURE			English	Article							LONGITUDINAL ARCH; FOOTPRINTS; ENDURANCE; ANATOMY; LAETOLI; WALKING; JOINT	The transverse tarsal arch, acting through the inter-metatarsal tissues, is important for the longitudinal stiffness of the foot and its appearance is a key step in the evolution of human bipedalism. The stiff human foot enables an efficient push-off when walking or running, and was critical for the evolution of bipedalism(1-6). The uniquely arched morphology of the human midfoot is thought to stiffen it(5-9), whereas other primates have flat feet that bend severely in the midfoot(7,10,11). However, the relationship between midfoot geometry and stiffness remains debated in foot biomechanics(12,13), podiatry(14,15) and palaeontology(4-6). These debates centre on the medial longitudinal arch(5,6) and have not considered whether stiffness is affected by the second, transverse tarsal arch of the human foot(16). Here we show that the transverse tarsal arch, acting through the inter-metatarsal tissues, is responsible for more than 40% of the longitudinal stiffness of the foot. The underlying principle resembles a floppy currency note that stiffens considerably when it curls transversally. We derive a dimensionless curvature parameter that governs the stiffness contribution of the transverse tarsal arch, demonstrate its predictive power using mechanical models of the foot and find its skeletal correlate in hominin feet. In the foot, the material properties of the inter-metatarsal tissues and the mobility of the metatarsals may additionally influence the longitudinal stiffness of the foot and thus the curvature-stiffness relationship of the transverse tarsal arch. By analysing fossils, we track the evolution of the curvature parameter among extinct hominins and show that a human-like transverse arch was a key step in the evolution of human bipedalism that predates the genus Homo by at least 1.5 million years. This renewed understanding of the foot may improve the clinical treatment of flatfoot disorders, the design of robotic feet and the study of foot function in locomotion.	[Venkadesan, Madhusudhan; Yawar, Ali; Eng, Carolyn M.] Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT 06511 USA; [Dias, Marcelo A.] Aalto Univ, Sch Sci, Espoo, Finland; [Dias, Marcelo A.] Nordic Inst Theoret Phys NORDITA, Stockholm, Sweden; [Dias, Marcelo A.] Aarhus Univ, Dept Engn, Aarhus, Denmark; [Singh, Dhiraj K.; Bandi, Mahesh M.] OIST Grad Univ, Nonlinear & Nonequilibrium Phys Unit, Onna, Japan; [Tommasini, Steven M.; Haims, Andrew H.] Yale Univ, Sch Med, Dept Orthopaed & Rehabil, New Haven, CT 06510 USA; [Haims, Andrew H.] Yale Univ, Dept Radiol & Biomed Imaging, New Haven, CT USA; [Mandre, Shreyas] Univ Warwick, Math Inst, Coventry, W Midlands, England; [Singh, Dhiraj K.] Jawaharlal Nehru Ctr Adv Sci Res, Engn Mech Unit, Bangalore, Karnataka, India	Yale University; Aalto University; Nordic Institute for Theoretical Physics; Aarhus University; Okinawa Institute of Science & Technology Graduate University; Yale University; Yale University; University of Warwick; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Venkadesan, M (corresponding author), Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT 06511 USA.; Bandi, MM (corresponding author), OIST Grad Univ, Nonlinear & Nonequilibrium Phys Unit, Onna, Japan.; Mandre, S (corresponding author), Univ Warwick, Math Inst, Coventry, W Midlands, England.	m.venkadesan@yale.edu; bandi@oist.jp; shreyas.mandre@warwick.ac.uk	Venkadesan, Madhusudhan/B-4697-2008; Yawar, Ali/ABF-4932-2020; Dias, Marcelo A./ABE-7741-2021	Venkadesan, Madhusudhan/0000-0001-5754-7478; Yawar, Ali/0000-0001-8631-9044; Dias, Marcelo A./0000-0002-1668-0501	Human Frontier Science Program	Human Frontier Science Program(Human Frontier Science Program)	We thank D. Lieberman for discussions on the manuscript and S. Piazza for constructive contributions. Access to skeletal specimens was provided by G. Aronsen, K. Zyskowski, E. Sargis, Yale Biological Anthropology Laboratories and the Yale Peabody Museum. K. J. Meacham III provided experimental support. S. James helped with figures. Funding support came from the Human Frontier Science Program.	Anapol F, 2005, AM J PHYS ANTHROPOL, V127, P231, DOI 10.1002/ajpa.20055; Bates KT, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1818; Baxter JR, 2015, FOOT ANKLE INT, V36, P424, DOI 10.1177/1071100714558512; BENNETT MB, 1989, J ZOOL, V217, P469, DOI 10.1111/j.1469-7998.1989.tb02502.x; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Crompton RH, 2012, J R SOC INTERFACE, V9, P707, DOI 10.1098/rsif.2011.0258; D'Aout K, 2002, AM J PHYS ANTHROPOL, V119, P37, DOI 10.1002/ajpa.10112; DAY MH, 1964, NATURE, V201, P969, DOI 10.1038/201969a0; DeSilva JM, 2015, AM J PHYS ANTHROPOL, V156, P543, DOI 10.1002/ajpa.22699; DeSilva J, 2019, AM J PHYS ANTHROPOL, V168, P63, DOI 10.1002/ajpa.23750; Farris DJ, 2019, P NATL ACAD SCI USA, V116, P1645, DOI 10.1073/pnas.1812820116; Gomberg D. N., 1981, THESIS; Griffin NL, 2015, AM J PHYS ANTHROPOL, V156, P1, DOI 10.1002/ajpa.22636; Haile-Selassie Y, 2012, NATURE, V483, P565, DOI 10.1038/nature10922; HAMADA Y, 1994, ANTHROPOL SCI, V102, P57, DOI 10.1537/ase.102.Supplement_57; Harcourt-Smith WEH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9432; Hayafune N, 1999, FOOT, V9, P88, DOI DOI 10.1054/F00T.1999; Heard-Booth AN, 2017, THESIS THESIS; Hessman F. V, 2009, FIGURE CALIBRATION P; HICKS JH, 1954, J ANAT, V88, P25; Holowka NB, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.174425; Holowka NB, 2017, J HUM EVOL, V104, P23, DOI 10.1016/j.jhevol.2016.12.002; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; Nguyen K, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0247; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; MacKenzie AJ, 2012, J PEDIATR ORTHOPED, V32, P830, DOI 10.1097/BPO.0b013e3182648c95; Morton DJ, 1924, J BONE JOINT SURG, V6, P56; Morton DJ, 1924, AM J PHYS ANTHROPOL, V7, P1, DOI 10.1002/ajpa.1330070114; Pontzer H, 2017, CURR BIOL, V27, pR613, DOI 10.1016/j.cub.2017.05.031; Pontzer H, 2010, J HUM EVOL, V58, P492, DOI 10.1016/j.jhevol.2010.03.006; Raichlen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009769; RODMAN PS, 1979, AM J PHYS ANTHROPOL, V51, P51, DOI 10.1002/ajpa.1330510107; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCHULTZ ADOLPH H., 1963, FOLIA PRIMATOLOGICA [BASEL], V1, P150, DOI 10.1159/000165791; SIRIANNI JE, 1975, FOLIA PRIMATOL, V24, P16, DOI 10.1159/000155682; SUSMAN RL, 1983, FOOT ANKLE, V3, P365, DOI 10.1177/107110078300300605; Takahashi KZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep29870; Wang WJ, 2004, J BIOMECH, V37, P1831, DOI 10.1016/j.jbiomech.2004.02.036; Ward CV, 2011, SCIENCE, V331, P750, DOI 10.1126/science.1201463; Williams DS, 2000, PHYS THER, V80, P864, DOI 10.1093/ptj/80.9.864	40	47	49	23	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2020	579	7797					97	+		10.1038/s41586-020-2053-y	http://dx.doi.org/10.1038/s41586-020-2053-y		FEB 2020	16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NE3BA	32103182	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000516702000010
J	Cooper, A; Carson-Stevens, A; Hughes, T; Edwards, A				Cooper, Alison; Carson-Stevens, Andrew; Hughes, Thomas; Edwards, Adrian			Is streaming patients in emergency departments to primary care services effective and safe?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACCIDENT		[Cooper, Alison] Cardiff Univ, Sch Med, Div Populat Med, Cardiff, S Glam, Wales; [Carson-Stevens, Andrew] Cardiff Univ, Sch Med, Div Populat Med, Patient Safety & Qual Improvement, Cardiff, S Glam, Wales; [Edwards, Adrian] Cardiff Univ, Sch Med, Div Populat Med, Gen Practice, Cardiff, S Glam, Wales; [Hughes, Thomas] John Radcliffe Hosp, Oxford, England	Cardiff University; Cardiff University; Cardiff University; University of Oxford	Cooper, A (corresponding author), Cardiff Univ, Sch Med, Div Populat Med, Cardiff, S Glam, Wales.	CooperA8@cardiff.ac.uk		Hughes, Thomas/0000-0001-5490-1267				Coleman P, 2001, EMERG MED J, V18, P482, DOI 10.1136/emj.18.6.482; Cooper A, 2019, EMERG MED J, V36, P625, DOI 10.1136/emermed-2018-208305; Cooper A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024501; DALE J, 1995, BRIT MED J, V311, P423, DOI 10.1136/bmj.311.7002.423; Edwards, EVALUATING EFFECTIVE; Goncalves-Bradley D, 2018, COCHRANE DB SYST REV, V2; Khangura JK, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002097.pub3; Morton K, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-024012; National Institute for Health and Care Excellence guideline consultation, 2017, GPS SAM SIT EM DEP; NHS England, 2017, PRIM CAR STREAM ROLL; NHS England, NEXT STEPS NHS 5 YEA; Ramlakhan S, 2016, EMERG MED J, V33, P495, DOI 10.1136/emermed-2015-204900; Thompson MIW, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003612; UK Department of Health and Social Care, 2017, A E DEP GET MOR FUND; Ward P, 1996, J ACCID EMERG MED, V13, P11	15	19	19	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2020	368								m462	10.1136/bmj.m462	http://dx.doi.org/10.1136/bmj.m462			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2IV	32098900	Green Accepted			2022-12-28	WOS:000519533000002
J	McCall, B				McCall, Becky			Sub-Saharan Africa leads the way in medical drones	LANCET			English	Editorial Material																			0	10	10	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2019	393	10166					17	18		10.1016/S0140-6736(18)33253-7	http://dx.doi.org/10.1016/S0140-6736(18)33253-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HG4DR	32145833				2022-12-28	WOS:000454925000013
J	Keshavan, MS; Price, BH; Martin, JB				Keshavan, Matcheri S.; Price, Bruce H.; Martin, Joseph B.			The Convergence of Neurology and Psychiatry The Importance of Cross-Disciplinary Education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint reviews the historical convergence and then divergence of psychiatry and neurology as clinical disciplines and calls for a transformation of graduate and postgraduate education to integrate the two and span intersections of the humanities, philosophy, and science.	[Keshavan, Matcheri S.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, 75 Fenwood Rd, Boston, MA 02115 USA; [Price, Bruce H.] Harvard Med Sch, McLean Hosp, Boston, MA 02115 USA; [Price, Bruce H.] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Martin, Joseph B.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; McLean Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Keshavan, MS (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, 75 Fenwood Rd, Boston, MA 02115 USA.	keshavanms@gmail.com						Clementz BA, 2016, AM J PSYCHIAT, V173, P373, DOI 10.1176/appi.ajp.2015.14091200; Hager M, 2005, P C CHAIR; Heckers S, 2017, JAMA PSYCHIAT, V74, P315, DOI 10.1001/jamapsychiatry.2016.3392; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Josephson SA, 2019, JAMA NEUROL, V76, P1279, DOI 10.1001/jamaneurol.2019.3056; Ongur D, 2019, JAMA PSYCHIAT, V76, P1115, DOI 10.1001/jamapsychiatry.2019.3127; Perez DL, 2018, J NEUROPSYCH CLIN N, V30, P271, DOI 10.1176/appi.neuropsych.17100200; Ross DA, 2017, JAMA PSYCHIAT, V74, P407, DOI 10.1001/jamapsychiatry.2016.3325; Torous J, 2015, ASIAN J PSYCHIATR, V17, P116, DOI 10.1016/j.ajp.2015.05.007	9	16	16	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2020	324	6					554	555		10.1001/jama.2020.0062	http://dx.doi.org/10.1001/jama.2020.0062			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NE8HM	32163095				2022-12-28	WOS:000562845100015
J	Crabb, SJ				Crabb, Simon J.			Treatment of upper urinary tract urothelial carcinoma	LANCET			English	Editorial Material							RADICAL NEPHROURETERECTOMY; ADJUVANT CHEMOTHERAPY; EUROPEAN ASSOCIATION; SURVIVAL		[Crabb, Simon J.] Univ Southampton, Southampton Gen Hosp, Canc Sci Unit, Southampton SO16 6YD, Hants, England	University of Southampton	Crabb, SJ (corresponding author), Univ Southampton, Southampton Gen Hosp, Canc Sci Unit, Southampton SO16 6YD, Hants, England.	s.j.crabb@southampton.ac.uk		Crabb, Simon/0000-0003-3521-9064	Cancer Research UK [13324] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Audenet F, 2019, CLIN CANCER RES, V25, P967, DOI 10.1158/1078-0432.CCR-18-2039; Birtle A, 2020, LANCET, V395, P1268, DOI 10.1016/S0140-6736(20)30415-3; Crabb SJ, 2018, BRIT MED BULL, V128, P85, DOI 10.1093/bmb/ldy034; Fajkovic H, 2013, WORLD J UROL, V31, P5, DOI 10.1007/s00345-012-0939-5; Fujita K, 2017, BMC UROL, V17, DOI 10.1186/s12894-017-0305-4; Goldberg Hanan, 2018, Oncotarget, V9, P18797, DOI 10.18632/oncotarget.24694; Kamoun A, 2020, EUR UROL, V77, P420, DOI 10.1016/j.eururo.2019.09.006; Kim DK, 2019, CRIT REV ONCOL HEMAT, V135, P59, DOI 10.1016/j.critrevonc.2019.01.019; Necchi A, 2018, BJU INT, V121, P252, DOI 10.1111/bju.14020; Roupret M, 2018, EUR UROL, V73, P111, DOI 10.1016/j.eururo.2017.07.036; Seisen T, 2017, J CLIN ONCOL, V35, P852, DOI 10.1200/JCO.2016.69.4141; Winters BR, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.128728	12	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2020	395	10232					1232	1234		10.1016/S0140-6736(20)30519-5	http://dx.doi.org/10.1016/S0140-6736(20)30519-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LE6FH	32145828	hybrid			2022-12-28	WOS:000526818800005
J	Wang, CJ; Ng, CY; Brook, RH				Wang, C. Jason; Ng, Chun Y.; Brook, Robert H.			Response to COVID-19 in Taiwan Big Data Analytics, New Technology, and Proactive Testing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint describes the outbreak response infrastructure developed by the Taiwanese government following the SARS epidemic in 2003 and actions in response to COVID-19, including dedicated hotlines for symptom reporting, mobile phone messaging and case tracking, and the ramping up of facemask production.	[Wang, C. Jason] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Wang, C. Jason] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Wang, C. Jason] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA; [Wang, C. Jason; Ng, Chun Y.] Koo Fdn Sun Yat Sen Canc Ctr, New Sch Leadership Hlth Care, Taipei, Taiwan; [Brook, Robert H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Brook, Robert H.] RAND Corp, Pardee RAND Grad Sch, Santa Monica, CA USA	Stanford University; Stanford University; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RAND Corporation; Pardee RAND Graduate School	Wang, CJ (corresponding author), Stanford Univ, CHP PCOR, 117 Encina Commons, Stanford, CA 94305 USA.	cjwang1@stanford.edu		Ng, Chun/0000-0003-2340-3905				[Anonymous], 2019, FOCUS TAIWAN; Gardner J., 2020, UPDATE JANUARY 31 MO; Wang S, 2020, FOCUS TAIWAN	3	841	855	26	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2020	323	14					1341	1342		10.1001/jama.2020.3151	http://dx.doi.org/10.1001/jama.2020.3151			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LH1YB	32125371	Bronze			2022-12-28	WOS:000528583600009
J	Hyde, R				Hyde, Rob			Germany overturns ban on assisted suicide	LANCET			English	Editorial Material																			0	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2020	395	10226					774	774						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU2KH	32145781				2022-12-28	WOS:000519536900017
J	Lane, R				Lane, Richard			Pascale Allotey: midwife turned global health supremo	LANCET			English	Biographical-Item																			0	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2020	395	10226					775	775						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KH	32145782				2022-12-28	WOS:000519536900018
J	Dyer, O				Dyer, Owen			Trump claims public health warnings on covid-19 are a conspiracy against him	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Chen C, 2020, KEY MISSTEPS CDC HAV; Dyer O, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m833	2	20	21	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2020	368								m941	10.1136/bmj.m941	http://dx.doi.org/10.1136/bmj.m941			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2LJ	32144176	Bronze			2022-12-28	WOS:000519539700012
J	Iacobucci, G				Iacobucci, Gareth			UK will still attract overseas doctors despite ending free movement, government insists	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Home Office, IMM SOC SEC COORD EU; RIMMER A, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M654; TORJESEN I, 2019, BMJ-BRIT MED J, V367, DOI DOI 10.1136/BMJ.L6593	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2020	368								m942	10.1136/bmj.m942	http://dx.doi.org/10.1136/bmj.m942			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2LJ	32144174				2022-12-28	WOS:000519539700013
J	Kataoka, N; Shima, Y; Nakajima, K; Nakamura, K				Kataoka, Naoya; Shima, Yuta; Nakajima, Keisuke; Nakamura, Kazuhiro			A central master driver of psychosocial stress responses in the rat	SCIENCE			English	Article							BROWN ADIPOSE-TISSUE; SYMPATHETIC PREMOTOR NEURONS; MEDIAL PREFRONTAL CORTEX; MEDULLARY RAPHE; DORSOMEDIAL HYPOTHALAMUS; PSYCHOLOGICAL STRESS; SOCIAL DEFEAT; THERMOGENESIS; PATHWAYS; DYSFUNCTION	The mechanism by which psychological stress elicits various physiological responses is unknown. We discovered a central master neural pathway in rats that drives autonomic and behavioral stress responses by connecting the corticolimbic stress circuits to the hypothalamus. Psychosocial stress signals from emotion-related forebrain regions activated a VGLUT1-positive glutamatergic pathway from the dorsal peduncular cortex and dorsal tenia tecta (DP/DTT), an unexplored prefrontal cortical area, to the dorsomedial hypothalamus (DMH), a hypothalamic autonomic center. Genetic ablation and optogenetics revealed that the DP/DTT -> DMH pathway drives thermogenic, hyperthermic, and cardiovascular sympathetic responses to psychosocial stress without contributing to basal homeostasis. This pathway also mediates avoidance behavior from psychosocial stressors. Given the variety of stress responses driven by the DP/DTT -> DMH pathway, the DP/DTT can be a potential target for treating psychosomatic disorders.	[Kataoka, Naoya; Shima, Yuta; Nakajima, Keisuke; Nakamura, Kazuhiro] Nagoya Univ, Dept Integrat Physiol, Grad Sch Med, Nagoya, Aichi 4668550, Japan	Nagoya University	Nakamura, K (corresponding author), Nagoya Univ, Dept Integrat Physiol, Grad Sch Med, Nagoya, Aichi 4668550, Japan.	kazu@med.nagoya-u.ac.jp	Nakamura, Kazuhiro/A-5431-2008; Kataoka, Naoya/AGY-5263-2022	Nakamura, Kazuhiro/0000-0002-6095-8996; Kataoka, Naoya/0000-0002-2339-5522	JSPS NEXT program [LS070]; MEXT KAKENHI [16H05128, 15H05932, 26118508, 26713009, 22689007, 19K06954, 16K19006]; JST PRESTO [JPMJPR13M9]; AMED [JP19gm5010002]; Takeda Science Foundation; Nakajima Foundation; Uehara Memorial Foundation; Ono Medical Research Foundation; Brain Science Foundation; Kowa Life Science Foundation; Kato Memorial Bioscience Foundation	JSPS NEXT program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST PRESTO(Japan Science & Technology Agency (JST)); AMED; Takeda Science Foundation(Takeda Science Foundation (TSF)); Nakajima Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Ono Medical Research Foundation; Brain Science Foundation; Kowa Life Science Foundation; Kato Memorial Bioscience Foundation	This study was supported by the JSPS NEXT program (LS070 to Ka.N.); MEXT KAKENHI (16H05128, 15H05932, 26118508, 26713009, and 22689007 to Ka.N.; 19K06954 and 16K19006 to N.K.); JST PRESTO (JPMJPR13M9 to Ka.N.); AMED (JP19gm5010002 to Ka.N.); and grants from the Takeda Science Foundation, Nakajima Foundation, Uehara Memorial Foundation, Ono Medical Research Foundation, Brain Science Foundation, Kowa Life Science Foundation (to Ka.N.), and Kato Memorial Bioscience Foundation (to N.K.).	Adhikari A, 2015, NATURE, V527, P179, DOI 10.1038/nature15698; Bjorkqvist K, 2001, PHYSIOL BEHAV, V73, P435, DOI 10.1016/S0031-9384(01)00490-5; Dampney RAL, 2008, AUTON NEUROSCI-BASIC, V142, P3, DOI 10.1016/j.autneu.2008.07.005; DiMicco JA, 2006, AUTON NEUROSCI-BASIC, V126, P106, DOI 10.1016/j.autneu.2006.02.010; DIORIO D, 1993, J NEUROSCI, V13, P3839; Felix-Ortiz AC, 2014, J NEUROSCI, V34, P586, DOI 10.1523/JNEUROSCI.4257-13.2014; Hassan SF, 2013, J PHYSIOL-LONDON, V591, P6069, DOI 10.1113/jphysiol.2013.262071; Hioki H, 2003, NEUROSCIENCE, V117, P1, DOI 10.1016/S0306-4522(02)00943-0; Horiuchi J, 2004, AM J PHYSIOL-REG I, V287, pR824, DOI 10.1152/ajpregu.00221.2004; Johnson PL, 2008, NEUROPSYCHOPHARMACOL, V33, P2093, DOI 10.1038/sj.npp.1301621; Johnson PL, 2006, J NEUROSCI, V26, P7093, DOI 10.1523/JNEUROSCI.0408-06.2006; Johnson SB, 2019, J NEUROSCI, V39, P1405, DOI 10.1523/JNEUROSCI.1421-18.2018; Kataoka N, 2014, CELL METAB, V20, P346, DOI 10.1016/j.cmet.2014.05.018; Laubach M, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0315-18.2018; Li XB, 2004, BRAIN RES, V1008, P261, DOI 10.1016/j.brainres.2004.02.038; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Lkhagvasuren B, 2011, EUR J NEUROSCI, V34, P1442, DOI 10.1111/j.1460-9568.2011.07863.x; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Nakamura K, 2004, J NEUROSCI, V24, P5370, DOI 10.1523/JNEUROSCI.1219-04.2004; Nakamura K, 2008, NAT NEUROSCI, V11, P62, DOI 10.1038/nn2027; Nakamura K, 2007, AM J PHYSIOL-REG I, V292, pR127, DOI 10.1152/ajpregu.00427.2006; Nakamura K, 2011, AM J PHYSIOL-REG I, V301, pR1207, DOI 10.1152/ajpregu.00109.2011; Nakamura Y, 2005, EUR J NEUROSCI, V22, P3137, DOI 10.1111/j.1460-9568.2005.04515.x; Oka Takakazu, 2015, Temperature (Austin), V2, P368, DOI 10.1080/23328940.2015.1056907; Ootsuka Y, 2005, AM J PHYSIOL-REG I, V289, pR1107, DOI 10.1152/ajpregu.00005.2005; Ootsuka Y, 2008, STRESS, V11, P125, DOI 10.1080/10253890701638303; Park J, 2017, J PHYSIOL-LONDON, V595, P4893, DOI 10.1113/JP274269; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Penzo MA, 2015, NATURE, V519, P455, DOI 10.1038/nature13978; Pinol RA, 2018, NAT NEUROSCI, V21, P1530, DOI 10.1038/s41593-018-0249-3; Robinson LJ, 2016, EXP PHYSIOL, V101, P549, DOI 10.1113/EP085642; Sarkar S, 2007, EUR J NEUROSCI, V26, P2228, DOI 10.1111/j.1460-9568.2007.05843.x; Tanaka M, 2008, AM J PHYSIOL-REG I, V294, pR477, DOI 10.1152/ajpregu.00633.2007; Tavares RF, 2006, NEUROSCIENCE, V143, P231, DOI 10.1016/j.neuroscience.2006.07.030; Toth I, 2013, CELL TISSUE RES, V354, P107, DOI 10.1007/s00441-013-1636-4; Wietek J, 2015, SCI REP-UK, V5, DOI 10.1038/srep14807; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Zhang W, 2010, J PHYSIOL-LONDON, V588, P4117, DOI 10.1113/jphysiol.2010.195099	38	47	48	4	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1105	+		10.1126/science.aaz4639	http://dx.doi.org/10.1126/science.aaz4639			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9CD	32139538				2022-12-28	WOS:000520018400037
J	Armstrong, K; Asch, DA				Armstrong, Katrina; Asch, David A.			Bridging Polarization in Medicine - From Biology to Social Causes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The medical community is often reminded how far we are from consensus regarding how to address today's most important clinical problems. For generations, two apparently opposing models of disease - the biologic model and the social model - have dominated our approach.	[Armstrong, Katrina] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Armstrong, Katrina] Harvard Med Sch, Boston, MA 02115 USA; [Asch, David A.] Univ Penn, Philadelphia, PA 19104 USA; [Asch, David A.] Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Pennsylvania	Armstrong, K (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Armstrong, K (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.							Brandt AM, 2000, AM J PUBLIC HEALTH, V90, P707, DOI 10.2105/AJPH.90.5.707; Fox D M, 1975, Bull Hist Med, V49, P169; Goldfarb Stanley, 2019, WALL STREET J; Lantz PM, 1998, SOC SCI MED, V46, P907, DOI 10.1016/S0277-9536(97)00218-9; Tawakol A, 2019, J AM COLL CARDIOL, V73, P3243, DOI 10.1016/j.jacc.2019.04.042	5	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2020	382	10					888	889		10.1056/NEJMp1913051	http://dx.doi.org/10.1056/NEJMp1913051			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KT7TC	32130811				2022-12-28	WOS:000519214900003
J	Jiang, WY; Oikonomou, P; Tavazoie, S				Jiang, Wenyan; Oikonomou, Panos; Tavazoie, Saeed			Comprehensive Genome-wide Perturbations via CRISPR Adaptation Reveal Complex Genetics of Antibiotic Sensitivity	CELL			English	Article							STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; CAS SYSTEMS; EVOLUTION; RNA; ACQUISITION; REPRESSION; RESISTANCE; EPISTASIS; SEQUENCES	Genome-wide CRISPR screens enable systematic interrogation of gene function. However, guide RNA libraries are costly to synthesize, and their limited diversity compromises the sensitivity of CRISPR screens. Using the Streptococcus pyogenes CRISPR-Cas adaptation machinery, we developed CRISPR adaptation-mediated library manufacturing (CALM), which turns bacterial cells into "factories'' for generating hundreds of thousands of crRNAs covering 95% of all targetable genomic sites. With an average gene targeted by more than 100 distinct crRNAs, these highly comprehensive CRISPRi libraries produced varying degrees of transcriptional repression critical for uncovering novel antibiotic resistance determinants. Furthermore, by iterating CRISPR adaptation, we rapidly generated dual-crRNA libraries representing more than 100,000 dual-gene perturbations. The polarized nature of spacer adaptation revealed the historical contingency in the stepwise acquisition of genetic perturbations leading to increasing antibiotic resistance. CALM circumvents the expense, labor, and time required for synthesis and cloning of gRNAs, allowing generation of CRISPRi libraries in wild-type bacteria refractory to routine genetic manipulation.	[Jiang, Wenyan; Oikonomou, Panos; Tavazoie, Saeed] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Jiang, Wenyan; Oikonomou, Panos; Tavazoie, Saeed] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Jiang, Wenyan; Oikonomou, Panos; Tavazoie, Saeed] Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Tavazoie, S (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.; Tavazoie, S (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10032 USA.; Tavazoie, S (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	st2744@columbia.edu	Oikonomou, Panos/J-5106-2014	Oikonomou, Panos/0000-0001-7387-0312	NIH/NIAID [R01AI077562]	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Tavazoie laboratory for insightful comments on the project. We are indebted to L. Marraffini (Rockefeller University) and J. Modell (Johns Hopkins University) for reagents and experimental assistance. W.J. is a Fellow of the Jane Coffin Childs Memorial Fund for Medical Research. This work was supported by a grant from NIH/NIAID (R01AI077562 to S.T.).	Amundsen SK, 2012, ACS CHEM BIOL, V7, P879, DOI 10.1021/cb300018x; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassett AR, 2015, J GENET GENOMICS, V42, P301, DOI 10.1016/j.jgg.2015.03.011; Bayer AS, 2006, J BACTERIOL, V188, P211, DOI 10.1128/JB.188.1.211-222.2006; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chen JS, 2017, NATURE, V550, P407, DOI 10.1038/nature24268; Cui L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04209-5; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Drider D, 2004, J MOL MICROB BIOTECH, V8, P195, DOI 10.1159/000086700; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Gharehbeglou M, 2015, CHOLESTEROL, DOI 10.1155/2015/147601; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Girgis HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005629; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Good BH, 2017, NATURE, V551, P45, DOI 10.1038/nature24287; Hammer ND, 2013, MBIO, V4; Han K, 2017, NAT BIOTECHNOL, V35, P463, DOI 10.1038/nbt.3834; Heler R, 2017, MOL CELL, V65, P168, DOI 10.1016/j.molcel.2016.11.031; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Hinz A, 2011, J BACTERIOL, V193, P4790, DOI 10.1128/JB.05133-11; Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kahl BC, 2016, CLIN MICROBIOL REV, V29, P401, DOI 10.1128/CMR.00069-15; Kinkel TL, 2013, MBIO, V4, DOI 10.1128/mBio.00696-13; Lannergard J, 2008, ANTIMICROB AGENTS CH, V52, P4017, DOI 10.1128/AAC.00668-08; Lee HH, 2019, NAT MICROBIOL, V4, P1105, DOI 10.1038/s41564-019-0423-8; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo ML, 2015, NUCLEIC ACIDS RES, V43, P674, DOI 10.1093/nar/gku971; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; McGinn J, 2019, NAT REV MICROBIOL, V17, P7, DOI 10.1038/s41579-018-0071-7; Modell JW, 2017, NATURE, V544, P101, DOI 10.1038/nature21719; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Monk IR, 2015, MBIO, V6, DOI 10.1128/mBio.00308-15; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; MURPHY KC, 1991, J BACTERIOL, V173, P5808, DOI 10.1128/jb.173.18.5808-5821.1991; Nair D, 2011, J BACTERIOL, V193, P2332, DOI 10.1128/JB.00027-11; Palmer AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8385; Peters JM, 2016, CELL, V165, P1493, DOI 10.1016/j.cell.2016.05.003; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rajagopal M, 2016, MBIO, V7, DOI 10.1128/mBio.00950-16; Rousset F, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007749; Sanjana NE, 2017, ANAL BIOCHEM, V532, P95, DOI 10.1016/j.ab.2016.05.014; Sanson KR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07901-8; Schmidt F, 2018, NATURE, V562, P380, DOI 10.1038/s41586-018-0569-1; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen JP, 2017, NAT METHODS, V14, P573, DOI 10.1038/nmeth.4225; Sheth RU, 2017, SCIENCE, V358, P1457, DOI 10.1126/science.aao0958; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Vejnar CE, 2019, GENOME RES, V29, P1100, DOI 10.1101/gr.245159.118; Vestergaard M., 2017, MBIO, V8; Wang TM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04899-x; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wigley DB, 2013, NAT REV MICROBIOL, V11, P9, DOI 10.1038/nrmicro2917; Wiser MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126210; Yang SJ, 2012, INFECT IMMUN, V80, P74, DOI 10.1128/IAI.05669-11; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zhang YM, 2006, J BIOL CHEM, V281, P17541, DOI 10.1074/jbc.R600004200	71	16	16	8	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2020	180	5					1002	+		10.1016/j.cell.2020.02.007	http://dx.doi.org/10.1016/j.cell.2020.02.007			47	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KT7JN	32109417	Green Accepted, Bronze			2022-12-28	WOS:000519189800017
J	Xiao, HP; Jedrychowski, MP; Schweppe, DK; Huttlin, EL; Yu, Q; Heppner, DE; Li, JM; Long, JN; Mills, EL; Szpyt, J; He, ZX; Du, GY; Garrity, R; Reddy, A; Vaites, LP; Paulo, JA; Zhang, TH; Gray, NS; Gygi, SP; Chouchani, ET				Xiao, Haopeng; Jedrychowski, Mark P.; Schweppe, Devin K.; Huttlin, Edward L.; Yu, Qing; Heppner, David E.; Li, Jiaming; Long, Jiani; Mills, Evanna L.; Szpyt, John; He, Zhixiang; Du, Guangyan; Garrity, Ryan; Reddy, Anita; Vaites, Laura Pontano; Paulo, Joao A.; Zhang, Tinghu; Gray, Nathanael S.; Gygi, Steven P.; Chouchani, Edward T.			A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging	CELL			English	Article							CYSTEINE RESIDUES; S-NITROSATION; THIOL; PHOSPHORYLATION; IDENTIFICATION; CANCER; INACTIVATION; TRANSITION; PROTEOMICS; COMPLEXES	Mammalian tissues engage in specialized physiology that is regulated through reversible modification of protein cysteine residues by reactive oxygen species (ROS). ROS regulate a myriad of biological processes, but the protein targets of ROS modification that drive tissue-specific physiology in vivo are largely unknown. Here, we develop Oximouse, a comprehensive and quantitative mapping of the mouse cysteine redox proteome in vivo. We use Oximouse to establish several paradigms of physiological redox signaling. We define and validate cysteine redox networks within each tissue that are tissue selective and underlie tissue-specific biology. We describe a common mechanism for encoding cysteine redox sensitivity by electrostatic gating. Moreover, we comprehensively identify redox-modified disease networks that remodel in aged mice, establishing a systemic molecular basis for the long-standing proposed links between redox dysregulation and tissue aging. We provide the Oximouse compendium as a framework for understanding mechanisms of redox regulation in physiology and aging.	[Xiao, Haopeng; Jedrychowski, Mark P.; Heppner, David E.; Mills, Evanna L.; Garrity, Ryan; Reddy, Anita; Zhang, Tinghu; Gray, Nathanael S.; Chouchani, Edward T.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Xiao, Haopeng; Jedrychowski, Mark P.; Schweppe, Devin K.; Huttlin, Edward L.; Yu, Qing; Li, Jiaming; Mills, Evanna L.; Szpyt, John; Reddy, Anita; Vaites, Laura Pontano; Paulo, Joao A.; Gygi, Steven P.; Chouchani, Edward T.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Heppner, David E.; He, Zhixiang; Du, Guangyan; Zhang, Tinghu; Gray, Nathanael S.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Long, Jiani] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University System of Georgia; Georgia Institute of Technology	Chouchani, ET (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.; Chouchani, ET (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.	edwardt_chouchani@dfci.harvard.edu	Yu, Qing/J-3251-2019; Paulo, Joao/AAO-3981-2020; Heppner, David E./A-7029-2018; Chouchani, Edward T./HCH-3775-2022; Li, Jiaming/AAQ-4220-2021; Xiao, Haopeng/AAA-9610-2022	Yu, Qing/0000-0003-0468-5353; Paulo, Joao/0000-0002-4291-413X; Heppner, David E./0000-0002-0722-5160; Li, Jiaming/0000-0002-9065-6913; Xiao, Haopeng/0000-0002-4166-647X; Huttlin, Edward/0000-0002-1822-1173	Claudia Adams Barr Program; Calico Life Sciences; NIH [DK123095, GM132129, GM96745, HG006673]; National Cancer Center	Claudia Adams Barr Program; Calico Life Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Center	This work is supported by the Claudia Adams Barr Program (to E.T.C. and M.P.J.), Calico Life Sciences (to E.T.C.), NIH DK123095 (to E.T.C.), the National Cancer Center (to H.X.), NIH GM132129 (to J.P.), NIH GM96745 (to S.P.G.), and NIH HG006673 (to S.P.G. and E.L.H.). Miljan Kuljanin and Keegan Stricker are acknowledged for technical assistance.	Alvarez-Zaldiernas C, 2016, J BIOL CHEM, V291, P17197, DOI 10.1074/jbc.M115.708230; Atkuri KR, 2007, CURR OPIN PHARMACOL, V7, P355, DOI 10.1016/j.coph.2007.04.005; Backus KM, 2016, NATURE, V534, P570, DOI 10.1038/nature18002; Bak DW, 2019, CURR OPIN CHEM BIOL, V48, P96, DOI 10.1016/j.cbpa.2018.11.002; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bertholet AM, 2019, NATURE, V571, P515, DOI 10.1038/s41586-019-1400-3; Brandes N, 2013, ELIFE, V2, DOI 10.7554/eLife.00306; Chen Z, 2009, BBA-BIOENERGETICS, V1787, P553, DOI 10.1016/j.bbabio.2009.03.003; Chouchani ET, 2017, J BIOL CHEM, V292, P16810, DOI 10.1074/jbc.R117.789628; Chouchani ET, 2017, J BIOL CHEM, V292, P14486, DOI 10.1074/jbc.M117.798744; Chouchani ET, 2016, NATURE, V532, P112, DOI 10.1038/nature17399; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Chouchani ET, 2011, CURR OPIN CHEM BIOL, V15, P120, DOI 10.1016/j.cbpa.2010.11.003; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Franz M, 2016, BIOINFORMATICS, V32, P309, DOI 10.1093/bioinformatics/btv557; Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200; Go Young-Mi, 2011, J Proteomics Bioinform, V4, P196; Gupta V, 2016, BIOCONJUGATE CHEM, V27, P1411, DOI 10.1021/acs.bioconjchem.6b00181; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Heppner DE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06790-1; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Huang HG, 2016, MOL CELL PROTEOMICS, V15, P3282, DOI 10.1074/mcp.M115.054551; Hurd TR, 2012, J BIOL CHEM, V287, P35153, DOI 10.1074/jbc.M112.400002; Huttlin EL, 2007, J PROTEOME RES, V6, P392, DOI 10.1021/pr0603194; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Hyeon DY, 2019, J BIOL CHEM, V294, P5340, DOI 10.1074/jbc.REV118.002958; Ko YH, 2001, CANCER LETT, V173, P83, DOI 10.1016/S0304-3835(01)00667-X; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Li YX, 2018, J PROTEOME RES, V17, P129, DOI 10.1021/acs.jproteome.7b00431; Lim MY, 2017, J PROTEOME RES, V16, P4217, DOI 10.1021/acs.jproteome.7b00571; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Menger KE, 2015, CELL REP, V11, P1856, DOI [10.1016/j.celrep.2015.05.033, 10.1016/j.celrep.2015.10.048]; Mills EL, 2018, NATURE, V560, P102, DOI 10.1038/s41586-018-0353-2; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Navarrete-Perea J, 2018, J PROTEOME RES, V17, P2226, DOI 10.1021/acs.jproteome.8b00217; O'Shea JP, 2013, NAT METHODS, V10, P1211, DOI [10.1038/NMETH.2646, 10.1038/nmeth.2646]; Pan KT, 2014, ANTIOXID REDOX SIGN, V20, P1365, DOI 10.1089/ars.2013.5326; Paulo JA, 2018, J AM SOC MASS SPECTR, V29, P1505, DOI 10.1007/s13361-018-1946-6; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pinero J, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav028; Poole LB, 2015, FREE RADICAL BIO MED, V80, P148, DOI 10.1016/j.freeradbiomed.2014.11.013; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Reczek CR, 2015, CURR OPIN CELL BIOL, V33, P8, DOI 10.1016/j.ceb.2014.09.010; Requejo R, 2010, FEBS J, V277, P1465, DOI 10.1111/j.1742-4658.2010.07576.x; Ristow M, 2014, NAT MED, V20, P709, DOI 10.1038/nm.3624; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Rosenwasser S, 2014, P NATL ACAD SCI USA, V111, P2740, DOI 10.1073/pnas.1319773111; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Schweppe D.K., 2019, BIORXIV, DOI [10.1101/668533, DOI 10.1101/668533]; Schweppe DK, 2019, ANAL CHEM, V91, P4010, DOI 10.1021/acs.analchem.8b05399; Schweppe DK, 2018, J PROTEOME RES, V17, P722, DOI 10.1021/acs.jproteome.7b00572; Shakir S, 2017, ANAL BIOANAL CHEM, V409, P3821, DOI 10.1007/s00216-017-0326-6; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Topf U, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02694-8; van der Reest J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04003-3; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WOLLENBERGER A, 1960, PFLUG ARCH GES PHYS, V270, P399, DOI 10.1007/BF00362995; Yang J, 2016, MOL CELL PROTEOMICS, V15, P1, DOI 10.1074/mcp.O115.056051	73	114	115	4	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2020	180	5					968	+		10.1016/j.cell.2020.02.012	http://dx.doi.org/10.1016/j.cell.2020.02.012			40	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KT7JN	32109415	Green Accepted, Bronze			2022-12-28	WOS:000519189800015
J	Dieleman, JL; Cao, J; Chapin, A; Chen, C; Li, ZY; Liu, A; Horst, C; Kaldjian, A; Matyasz, T; Scott, KW; Bui, AL; Campbell, M; Duber, HC; Dunn, AC; Flaxman, AD; Fitzmaurice, C; Naghavi, M; Sadat, N; Shieh, P; Squires, E; Yeung, K; Murray, CJL				Dieleman, Joseph L.; Cao, Jackie; Chapin, Abby; Chen, Carina; Li, Zhiyin; Liu, Angela; Horst, Cody; Kaldjian, Alexander; Matyasz, Taylor; Scott, Kirstin Woody; Bui, Anthony L.; Campbell, Madeline; Duber, Herbert C.; Dunn, Abe C.; Flaxman, Abraham D.; Fitzmaurice, Christina; Naghavi, Mohsen; Sadat, Nafis; Shieh, Peter; Squires, Ellen; Yeung, Kai; Murray, Christopher J. L.			US Health Care Spending by Payer and Health Condition, 1996-2016	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES	Importance US health care spending has continued to increase and now accounts for 18% of the US economy, although little is known about how spending on each health condition varies by payer, and how these amounts have changed over time. Objective To estimate US spending on health care according to 3 types of payers (public insurance [including Medicare, Medicaid, and other government programs], private insurance, or out-of-pocket payments) and by health condition, age group, sex, and type of care for 1996 through 2016. Design and Setting Government budgets, insurance claims, facility records, household surveys, and official US records from 1996 through 2016 were collected to estimate spending for 154 health conditions. Spending growth rates (standardized by population size and age group) were calculated for each type of payer and health condition. Exposures Ambulatory care, inpatient care, nursing care facility stay, emergency department care, dental care, and purchase of prescribed pharmaceuticals in a retail setting. Main Outcomes and Measures National spending estimates stratified by health condition, age group, sex, type of care, and type of payer and modeled for each year from 1996 through 2016. Results Total health care spending increased from an estimated $1.4 trillion in 1996 (13.3% of gross domestic product [GDP]; $5259 per person) to an estimated $3.1 trillion in 2016 (17.9% of GDP; $9655 per person); 85.2% of that spending was included in this study. In 2016, an estimated 48.0% (95% CI, 48.0%-48.0%) of health care spending was paid by private insurance, 42.6% (95% CI, 42.5%-42.6%) by public insurance, and 9.4% (95% CI, 9.4%-9.4%) by out-of-pocket payments. In 2016, among the 154 conditions, low back and neck pain had the highest amount of health care spending with an estimated $134.5 billion (95% CI, $122.4-$146.9 billion) in spending, of which 57.2% (95% CI, 52.2%-61.2%) was paid by private insurance, 33.7% (95% CI, 30.0%-38.4%) by public insurance, and 9.2% (95% CI, 8.3%-10.4%) by out-of-pocket payments. Other musculoskeletal disorders accounted for the second highest amount of health care spending (estimated at $129.8 billion [95% CI, $116.3-$149.7 billion]) and most had private insurance (56.4% [95% CI, 52.6%-59.3%]). Diabetes accounted for the third highest amount of the health care spending (estimated at $111.2 billion [95% CI, $105.7-$115.9 billion]) and most had public insurance (49.8% [95% CI, 44.4%-56.0%]). Other conditions estimated to have substantial health care spending in 2016 were ischemic heart disease ($89.3 billion [95% CI, $81.1-$95.5 billion]), falls ($87.4 billion [95% CI, $75.0-$100.1 billion]), urinary diseases ($86.0 billion [95% CI, $76.3-$95.9 billion]), skin and subcutaneous diseases ($85.0 billion [95% CI, $80.5-$90.2 billion]), osteoarthritis ($80.0 billion [95% CI, $72.2-$86.1 billion]), dementias ($79.2 billion [95% CI, $67.6-$90.8 billion]), and hypertension ($79.0 billion [95% CI, $72.6-$86.8 billion]). The conditions with the highest spending varied by type of payer, age, sex, type of care, and year. After adjusting for changes in inflation, population size, and age groups, public insurance spending was estimated to have increased at an annualized rate of 2.9% (95% CI, 2.9%-2.9%); private insurance, 2.6% (95% CI, 2.6%-2.6%); and out-of-pocket payments, 1.1% (95% CI, 1.0%-1.1%). Conclusions and Relevance Estimates of US spending on health care showed substantial increases from 1996 through 2016, with the highest increases in population-adjusted spending by public insurance. Although spending on low back and neck pain, other musculoskeletal disorders, and diabetes accounted for the highest amounts of spending, the payers and the rates of change in annual spending growth rates varied considerably. Question How does spending on different health conditions vary by payer (public insurance, private insurance, or out-of-pocket payments) and how has this spending changed over time? Findings From 1996 to 2016, total health care spending increased from an estimated $1.4 trillion to an estimated $3.1 trillion. In 2016, private insurance accounted for 48.0% (95% CI, 48.0%-48.0%) of health care spending, public insurance for 42.6% (95% CI, 42.5%-42.6%) of health care spending, and out-of-pocket payments for 9.4% (95% CI, 9.4%-9.4%) of health care spending. After adjusting for population size and aging, the annualized spending growth rate was 2.6% (95% CI, 2.6%-2.6%) for private insurance, 2.9% (95% CI, 2.9%-2.9%) for public insurance, and 1.1% (95% CI, 1.0%-1.1%) for out-of-pocket payments. Meaning Understanding how much each payer spent on each health condition and how these amounts have changed over time can inform health care policy. This study estimates health care spending for the most common health conditions in the United States, including low back pain and musculoskeletal disorders, diabetes, and ischemic heart disease, between 1996 and 2016.	[Dieleman, Joseph L.; Cao, Jackie; Chapin, Abby; Chen, Carina; Li, Zhiyin; Liu, Angela; Horst, Cody; Kaldjian, Alexander; Matyasz, Taylor; Duber, Herbert C.; Flaxman, Abraham D.; Fitzmaurice, Christina; Naghavi, Mohsen; Murray, Christopher J. L.] Inst Hlth Metr & Evaluat, 2301 Fifth Ave,Ste 600, Seattle, WA 98121 USA; [Scott, Kirstin Woody] Harvard Med Sch, Boston, MA 02115 USA; [Bui, Anthony L.] Univ Washington, Dept Pediat, Seattle Childrens Hosp, Seattle, WA 98195 USA; [Campbell, Madeline] Facebook, Menlo Pk, CA USA; [Duber, Herbert C.] Univ Washington, Dept Emergency Med, Seattle, WA 98195 USA; [Dunn, Abe C.; Shieh, Peter] Bur Econ Anal, Suitland, MD USA; [Fitzmaurice, Christina] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Sadat, Nafis] Microsoft, Redmond, WA USA; [Squires, Ellen] Improve Grp, St Paul, MN USA; [Yeung, Kai] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA	Institute for Health Metrics & Evaluation; Harvard University; Harvard Medical School; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Facebook Inc; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Microsoft; Kaiser Permanente	Dieleman, JL (corresponding author), Inst Hlth Metr & Evaluat, 2301 Fifth Ave,Ste 600, Seattle, WA 98121 USA.	dieleman@uw.edu		Scott, Kirstin/0000-0002-5415-6479	Peterson Center on Healthcare; National Institute on Aging [P30AG047845]	Peterson Center on Healthcare; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Peterson Center on Healthcare and by grant P30AG047845 from the National Institute on Aging.	Aitchison J., 2003, STAT ANAL COMPOSITIO; Australian Sports Commission, 2017, AUSPLAY SURV NAT DAT; Bui AL, 2017, JAMA PEDIATR, V171, P181, DOI 10.1001/jamapediatrics.2016.4086; Centers for Medicare & Medicaid Services, 2015, NHEA REL STUD; Centers for Medicare & Medicaid Services, 2018, HIST; Chang AY, 2019, LANCET, V393, P2233, DOI 10.1016/S0140-6736(19)30841-4; Chou R, 2017, ANN INTERN MED, V166, P493, DOI 10.7326/M16-2459; Chou R, 2017, ANN INTERN MED, V166, P480, DOI 10.7326/M16-2458; Coughlin T, UNCOMPENSATED CARE U; Currie J, WHO WILL BE OUR MORA; Dieleman JL, 2017, JAMA-J AM MED ASSOC, V318, P1668, DOI 10.1001/jama.2017.15927; Dieleman JL, 2017, HEALTH ECON REV, V7, DOI 10.1186/s13561-017-0166-2; Dieleman JL, 2016, JAMA-J AM MED ASSOC, V316, P2627, DOI 10.1001/jama.2016.16885; Foreman KJ, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0082-4; Hamavid H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157912; Hwang W, 2001, HEALTH AFFAIR, V20, P267, DOI 10.1377/hlthaff.20.6.267; Morrisey M, HLTH INSURANCE, P1; Patrick SW, 2012, JAMA-J AM MED ASSOC, V307, P1934, DOI 10.1001/jama.2012.3951; Rae M, TAX SUBSIDIES PRIVAT; Smithson M, 2006, PSYCHOL METHODS, V11, P54, DOI 10.1037/1082-989X.11.1.54; Squires E, 2018, DIABETES CARE, V41, P1423, DOI 10.2337/dc17-1376; Tangka FK, 2010, CANCER-AM CANCER SOC, V116, P3477, DOI 10.1002/cncr.25150; US Centers for Disease Control and Prevention, 2017, NAMCS NHAMCS WEB TAB; US Centers for Disease Control and Prevention, 2018, NAT NURS HOM SURV; US Office of Personnel Management, HEALTHC PLAN INF; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]	26	271	275	11	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2020	323	9			SI		863	884		10.1001/jama.2020.0734	http://dx.doi.org/10.1001/jama.2020.0734			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU3SD	32125402	Green Published, Bronze			2022-12-28	WOS:000519630600017
J	Rimmer, A				Rimmer, Abi			Sixty seconds on... beards	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2020	368								m811	10.1136/bmj.m811	http://dx.doi.org/10.1136/bmj.m811			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KD	32127387				2022-12-28	WOS:000519536500006
J	Mahase, E				Mahase, Elisabeth			Covid-19: retired doctors could be asked to return to work, says Hancock	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	5	5	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2020	368								m831	10.1136/bmj.m831	http://dx.doi.org/10.1136/bmj.m831			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KC	32122881	Bronze			2022-12-28	WOS:000519536400008
J	DeBerardinis, RJ				DeBerardinis, Ralph J.			Tumor Microenvironment, Metabolism, and Immunotherapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GLUTAMINE	The newly diversified experimental strategies to treat cancer include those that involve tweaks to host immunity. A recently described strategy, conducted in mouse models of cancer, targets tumor cells while simultaneously boosting T-cell function.	[DeBerardinis, Ralph J.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Res Inst, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	DeBerardinis, RJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.; DeBerardinis, RJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Childrens Med Res Inst, Dallas, TX 75390 USA.							BRAND K, 1985, BIOCHEM J, V228, P353, DOI 10.1042/bj2280353; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Leone RD, 2019, SCIENCE, V366, P1013, DOI 10.1126/science.aav2588; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Venneti S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1009	5	95	98	4	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2020	382	9					869	871		10.1056/NEJMcibr1914890	http://dx.doi.org/10.1056/NEJMcibr1914890			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KS8TT	32101671				2022-12-28	WOS:000518581500015
J	Quinn, RA; Melnik, AV; Vrbanac, A; Fu, T; Patras, KA; Christy, MP; Bodai, Z; Belda-Ferre, P; Tripathi, A; Chung, LK; Downes, M; Welch, RD; Quinn, M; Humphrey, G; Panitchpakdi, M; Weldon, KC; Aksenov, A; da Silva, R; Avila-Pacheco, J; Clish, C; Bae, S; Mallick, H; Franzosa, EA; Lloyd-Price, J; Bussell, R; Thron, T; Nelson, AT; Wang, MX; Leszczynski, E; Vargas, F; Gauglitz, JM; Meehan, MJ; Gentry, E; Arthur, TD; Komor, AC; Poulsen, O; Boland, BS; Chang, JT; Sandborn, WJ; Lim, M; Garg, N; Lumeng, JC; Xavier, RJ; Kazmierczak, BI; Jain, R; Egan, M; Rhee, KE; Ferguson, D; Raffatellu, M; Vlamakis, H; Haddad, GG; Siegel, D; Huttenhower, C; Mazmanian, SK; Evans, RM; Nizet, V; Knight, R; Dorrestein, PC				Quinn, Robert A.; Melnik, Alexey, V; Vrbanac, Alison; Fu, Ting; Patras, Kathryn A.; Christy, Mitchell P.; Bodai, Zsolt; Belda-Ferre, Pedro; Tripathi, Anupriya; Chung, Lawton K.; Downes, Michael; Welch, Ryan D.; Quinn, Melissa; Humphrey, Greg; Panitchpakdi, Morgan; Weldon, Kelly C.; Aksenov, Alexander; da Silva, Ricardo; Avila-Pacheco, Julian; Clish, Clary; Bae, Sena; Mallick, Himel; Franzosa, Eric A.; Lloyd-Price, Jason; Bussell, Robert; Thron, Taren; Nelson, Andrew T.; Wang, Mingxun; Leszczynski, Eric; Vargas, Fernando; Gauglitz, Julia M.; Meehan, Michael J.; Gentry, Emily; Arthur, Timothy D.; Komor, Alexis C.; Poulsen, Orit; Boland, Brigid S.; Chang, John T.; Sandborn, William J.; Lim, Meerana; Garg, Neha; Lumeng, Julie C.; Xavier, Ramnik J.; Kazmierczak, Barbara, I; Jain, Ruchi; Egan, Marie; Rhee, Kyung E.; Ferguson, David; Raffatellu, Manuela; Vlamakis, Hera; Haddad, Gabriel G.; Siegel, Dionicio; Huttenhower, Curtis; Mazmanian, Sarkis K.; Evans, Ronald M.; Nizet, Victor; Knight, Rob; Dorrestein, Pieter C.			Global chemical effects of the microbiome include new bile-acid conjugations	NATURE			English	Article							COLONIZATION RESISTANCE; MOLECULAR NETWORKING; METABOLISM; BINDING; IMPACT	Metabolomics data from germ-free and specific-pathogen-free mice reveal effects of the microbiome on host chemistry, identifying conjugations of bile acids that are also enriched in patients with inflammatory bowel disease or cystic fibrosis. A mosaic of cross-phylum chemical interactions occurs between all metazoans and their microbiomes. A number of molecular families that are known to be produced by the microbiome have a marked effect on the balance between health and disease(1-9). Considering the diversity of the human microbiome (which numbers over 40,000 operational taxonomic units(10)), the effect of the microbiome on the chemistry of an entire animal remains underexplored. Here we use mass spectrometry informatics and data visualization approaches(11-13) to provide an assessment of the effects of the microbiome on the chemistry of an entire mammal by comparing metabolomics data from germ-free and specific-pathogen-free mice. We found that the microbiota affects the chemistry of all organs. This included the amino acid conjugations of host bile acids that were used to produce phenylalanocholic acid, tyrosocholic acid and leucocholic acid, which have not previously been characterized despite extensive research on bile-acid chemistry(14). These bile-acid conjugates were also found in humans, and were enriched in patients with inflammatory bowel disease or cystic fibrosis. These compounds agonized the farnesoid X receptor in vitro, and mice gavaged with the compounds showed reduced expression of bile-acid synthesis genes in vivo. Further studies are required to confirm whether these compounds have a physiological role in the host, and whether they contribute to gut diseases that are associated with microbiome dysbiosis.	[Quinn, Robert A.; Melnik, Alexey, V; Christy, Mitchell P.; Tripathi, Anupriya; Panitchpakdi, Morgan; Weldon, Kelly C.; Aksenov, Alexander; da Silva, Ricardo; Nelson, Andrew T.; Wang, Mingxun; Vargas, Fernando; Gauglitz, Julia M.; Meehan, Michael J.; Gentry, Emily; Siegel, Dionicio; Nizet, Victor; Dorrestein, Pieter C.] Univ Calif San Diego, Collaborat Mass Spectrometry Innovat Ctr, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA; [Quinn, Robert A.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Vrbanac, Alison; Patras, Kathryn A.; Belda-Ferre, Pedro; Tripathi, Anupriya; Chung, Lawton K.; Humphrey, Greg; Arthur, Timothy D.; Poulsen, Orit; Lim, Meerana; Rhee, Kyung E.; Raffatellu, Manuela; Haddad, Gabriel G.; Nizet, Victor; Knight, Rob; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Fu, Ting; Downes, Michael; Welch, Ryan D.; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, San Diego, CA USA; [Bodai, Zsolt; Komor, Alexis C.] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92103 USA; [Quinn, Melissa; Leszczynski, Eric; Ferguson, David] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Avila-Pacheco, Julian; Clish, Clary; Mallick, Himel; Franzosa, Eric A.; Lloyd-Price, Jason; Arthur, Timothy D.; Xavier, Ramnik J.; Vlamakis, Hera; Huttenhower, Curtis] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Bae, Sena; Mallick, Himel; Franzosa, Eric A.; Lloyd-Price, Jason; Huttenhower, Curtis] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Bae, Sena] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Bussell, Robert] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Thron, Taren; Mazmanian, Sarkis K.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Boland, Brigid S.; Chang, John T.; Sandborn, William J.] Univ Calif San Diego, Dept Med, Div Gastroenterol, San Diego, CA 92103 USA; [Garg, Neha] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Garg, Neha] Emory Childrens Cyst Fibrosis Ctr, Atlanta, GA USA; [Lumeng, Julie C.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Kazmierczak, Barbara, I; Jain, Ruchi] Yale Sch Med, Dept Internal Med, New Haven, CT USA; [Egan, Marie] Yale Sch Med, Dept Pediat, New Haven, CT USA; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, San Diego, CA USA; [Weldon, Kelly C.; Nizet, Victor; Knight, Rob; Dorrestein, Pieter C.] Univ Calif San Diego, UCSD Ctr Microbiome Innovat, San Diego, CA 92103 USA; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA 92103 USA; [Knight, Rob] Univ Calif San Diego, Dept Engn, San Diego, CA 92103 USA	University of California System; University of California San Diego; Michigan State University; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego; Michigan State University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Diego; California Institute of Technology; University of California System; University of California San Diego; University System of Georgia; Georgia Institute of Technology; University of Michigan System; University of Michigan; Yale University; Yale University; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dorrestein, PC (corresponding author), Univ Calif San Diego, Collaborat Mass Spectrometry Innovat Ctr, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA.; Dorrestein, PC (corresponding author), Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA.; Dorrestein, PC (corresponding author), Univ Calif San Diego, UCSD Ctr Microbiome Innovat, San Diego, CA 92103 USA.	pdorrestein@ucsd.edu	Wang, Mingxun/HGV-1545-2022; Sandborn, William/ABE-8342-2020; Dorrestein, Pieter/ABF-2930-2020; Patras, Kathryn/AAA-3286-2021; Bodai, Zsolt/AAG-2693-2021; Ferguson, David/AAE-5992-2022; Mallick, Himel/L-7702-2018; Clish, Clary B/ABB-9374-2021; da Silva, Ricardo/F-8354-2019; Fu, Shirley Ting/B-7632-2018; Garg, Neha/L-3120-2018	Wang, Mingxun/0000-0001-7647-6097; Patras, Kathryn/0000-0003-2631-8810; Mallick, Himel/0000-0003-4956-2429; Clish, Clary B/0000-0001-8259-9245; da Silva, Ricardo/0000-0001-6378-0479; Quinn, Melissa/0000-0002-0657-6364; Knight, Rob/0000-0002-0975-9019; Chang, John/0000-0003-0873-6218; Evans, Ronald/0000-0002-9986-5965; Bodai, Zsolt/0000-0002-2203-9163; Garg, Neha/0000-0002-2760-7123	National Institutes of Health (NIH) [5U01AI124316-03, 1R03CA211211-01, 1R01HL116235 U54DE023798, R24DK110499, GMS10RR029121, 1 DP1 AT010885, P30 DK120515, R01HD084163]; UCSD [KL2 (1KL2TR001444)]; National Library of Medicine Training Grant NIH [T15LM011271]; March of Dimes Chair in Molecular and Developmental Biology at the Salk Institute - NIH [DK057978, HL105278, HL088093, ES010337]; Samuel Waxman Cancer Research Foundation; UC San Diego Center for Microbiome Innovation - NIH [DK057978, HL105278, HL088093]; National Cancer Institute [CA014195]; Leona M. and Harry B. Helmsley Charitable Trust [2017PG-MED001]; SWCRF Investigator Award; Ipsen/Biomeasure [EIA14660045]; American Heart Association Established Investigator Award; Hewitt Medical Foundation Fellowship; Salk Alumni Fellowship; Crohn's & Colitis Foundation (CCFA); Stand Up to Cancer (SU2C) - Cancer Research UK-Lustgarten Foundation Pancreatic Cancer Dream Team Research Grant [SU2C-AACR-DT-20-16]; scientific partner of SU2C; National Institute of Environmental Health Sciences of the NIH [P42ES010337]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD; National Library of Medicine Training Grant NIH; March of Dimes Chair in Molecular and Developmental Biology at the Salk Institute - NIH; Samuel Waxman Cancer Research Foundation; UC San Diego Center for Microbiome Innovation - NIH; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leona M. and Harry B. Helmsley Charitable Trust; SWCRF Investigator Award; Ipsen/Biomeasure(Ipsen); American Heart Association Established Investigator Award(American Heart Association); Hewitt Medical Foundation Fellowship; Salk Alumni Fellowship; Crohn's & Colitis Foundation (CCFA); Stand Up to Cancer (SU2C) - Cancer Research UK-Lustgarten Foundation Pancreatic Cancer Dream Team Research Grant; scientific partner of SU2C; National Institute of Environmental Health Sciences of the NIH	The authors acknowledge funding from the National Institutes of Health (NIH), grants 5U01AI124316-03, 1R03CA211211-01, 1R01HL116235 U54DE023798, R24DK110499, GMS10RR029121, 1 DP1 AT010885, P30 DK120515 and R01HD084163. Additionally, B.S.B. was supported by UCSD KL2 (1KL2TR001444), T.D.A. by the National Library of Medicine Training Grant NIH grant T15LM011271. R.M.E. is an investigator of the Howard Hughes Medical Institute and March of Dimes Chair in Molecular and Developmental Biology at the Salk Institute. R.M.E. was funded by grants from the NIH (DK057978, HL105278, HL088093 and ES010337), and Samuel Waxman Cancer Research Foundation. We acknowledge G. Ackermann for her contributions. This work was also supported in part by Seed Grants from the UC San Diego Center for Microbiome Innovation. This work was funded by grants from the NIH (DK057978, HL105278 and HL088093), National Cancer Institute (CA014195), the Leona M. and Harry B. Helmsley Charitable Trust (2017PG-MED001), SWCRF Investigator Award and Ipsen/Biomeasure. J.L. is supported by grant EIA14660045, an American Heart Association Established Investigator Award. T.F. is supported by a Hewitt Medical Foundation Fellowship, a Salk Alumni Fellowship. T.F., R.K. and P.C.D. acknowledge support from the Crohn's & Colitis Foundation (CCFA). R.M.E. and M.D. are supported in part by a Stand Up to Cancer (SU2C) - Cancer Research UK-Lustgarten Foundation Pancreatic Cancer Dream Team Research Grant (SU2C-AACR-DT-20-16). SU2C is a programme of the Entertainment Industry Foundation. Research grants are administered by the American Association for Cancer Research, the scientific partner of SU2C. Research reported in this publication was also supported by the National Institute of Environmental Health Sciences of the NIH under Award Number P42ES010337. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Caballero S, 2017, CELL HOST MICROBE, V21, P592, DOI 10.1016/j.chom.2017.04.002; Dehoux P, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3152-x; Downes M, 2003, MOL CELL, V11, P1079, DOI 10.1016/S1097-2765(03)00104-7; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Gerard Philippe, 2013, Pathogens, V3, P14, DOI 10.3390/pathogens3010014; Gilbert JA, 2016, NATURE, V535, P94, DOI 10.1038/nature18850; GILLNER M, 1985, MOL PHARMACOL, V28, P357; GORDON BA, 1963, CAN J BIOCHEM PHYS, V41, P77; GUSTAFSSON BE, 1966, ACTA CHEM SCAND, V20, P1827, DOI 10.3891/acta.chem.scand.20-1827; Hagey LR, 1998, J LIPID RES, V39, P2119; Hartmann AC, 2017, P NATL ACAD SCI USA, V114, P11685, DOI 10.1073/pnas.1710248114; HIRANO S, 1981, APPL ENVIRON MICROB, V42, P394, DOI 10.1128/AEM.42.3.394-399.1981; HIRANO S, 1982, APPL ENVIRON MICROB, V43, P1057, DOI 10.1128/AEM.43.5.1057-1063.1982; Hofmann AF, 2014, J LIPID RES, V55, P1553, DOI 10.1194/jlr.R049437; HUIJGHEBAERT SM, 1986, J LIPID RES, V27, P742; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; Manor O, 2016, SCI REP-UK, V6, DOI 10.1038/srep22493; Marcobal A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11589; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; McDonald D, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00031-18; McDonald JAK, 2013, J MICROBIOL METH, V95, P167, DOI 10.1016/j.mimet.2013.08.008; MIDTVEDT T, 1974, AM J CLIN NUTR, V27, P1341, DOI 10.1093/ajcn/27.11.1341; Miller TL, 1996, APPL ENVIRON MICROB, V62, P1589, DOI 10.1128/AEM.62.5.1589-1592.1996; Moriya T, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-017-1240-9; MYHER JJ, 1975, CAN J BIOCHEM CELL B, V53, P583, DOI 10.1139/o75-079; NAIR PP, 1978, LIPIDS, V13, P966, DOI 10.1007/BF02533857; PERICGOLIA L, 1963, SCIENCE, V142, P245, DOI 10.1126/science.142.3589.245; Protsyuk I, 2018, NAT PROTOC, V13, P134, DOI 10.1038/nprot.2017.122; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Shalapour S, 2017, NATURE, V551, P340, DOI 10.1038/nature24302; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; TAMARI M, 1976, J BIOCHEM-TOKYO, V80, P371, DOI 10.1093/oxfordjournals.jbchem.a131286; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wang MX, 2020, NAT BIOTECHNOL, V38, P23, DOI 10.1038/s41587-019-0375-9; Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597; Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Winston JA, 2016, ANAEROBE, V41, P44, DOI 10.1016/j.anaerobe.2016.05.003; Yang JY, 2013, J NAT PROD, V76, P1686, DOI 10.1021/np400413s; YOUSEF IM, 1975, CAN J PHYSIOL PHARM, V53, P880, DOI 10.1139/y75-121	43	171	179	13	185	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7797					123	+		10.1038/s41586-020-2047-9	http://dx.doi.org/10.1038/s41586-020-2047-9		FEB 2020	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU0ZP	32103176	Green Accepted			2022-12-28	WOS:000516702000005
J	Ruhl, CR; Pasko, BL; Khan, HS; Kindt, LM; Stamm, CE; Franco, LH; Hsia, CC; Zhou, M; Davis, CR; Qin, T; Gautron, L; Burton, MD; Mejia, GL; Naik, DK; Dussor, G; Price, TJ; Shiloh, MU				Ruhl, Cody R.; Pasko, Breanna L.; Khan, Haaris S.; Kindt, Lexy M.; Stamm, Chelsea E.; Franco, Luis H.; Hsia, Connie C.; Zhou, Min; Davis, Colton R.; Qin, Tian; Gautron, Laurent; Burton, Michael D.; Mejia, Galo L.; Naik, Dhananjay K.; Dussor, Gregory; Price, Theodore J.; Shiloh, Michael U.			Mycobacterium tuberculosis Sulfolipid-1 Activates Nociceptive Neurons and Induces Cough	CELL			English	Article							SENSORY NEURONS; GUINEA-PIG; STRAIN H37RV; CITRIC-ACID; VIRULENCE; BIOSYNTHESIS; MECHANISMS; PURIFICATION; TRANSMISSION; INFECTIONS	Pulmonary tuberculosis, a disease caused by Mycobacterium tuberculosis (Mtb), manifests with a persistent cough as both a primary symptom and mechanism of transmission. The cough reflex can be triggered by nociceptive neurons innervating the lungs, and some bacteria produce neuron-targeting molecules. However, how pulmonary Mtb infection causes cough remains undefined, and whether Mtb produces a neuron-activating, cough-inducing molecule is unknown. Here, we show that an Mtb organic extract activates nociceptive neurons in vitro and identify the Mtb glycolipid sulfolipid-1 (SL-1) as the nociceptive molecule. Mtb organic extracts from mutants lacking SL-1 synthesis cannot activate neurons in vitro or induce cough in a guinea pig model. Finally, Mtb-infected guinea pigs cough in a manner dependent on SL-1 synthesis. Thus, we demonstrate a heretofore unknown molecular mechanism for cough induction by a virulent human pathogen via its production of a complex lipid.	[Ruhl, Cody R.; Pasko, Breanna L.; Khan, Haaris S.; Kindt, Lexy M.; Stamm, Chelsea E.; Franco, Luis H.; Hsia, Connie C.; Gautron, Laurent; Shiloh, Michael U.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Zhou, Min; Davis, Colton R.; Qin, Tian] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Gautron, Laurent] Univ Texas Southwestern Med Ctr Dallas, Ctr Hypothalam Res, Dallas, TX 75390 USA; [Burton, Michael D.; Mejia, Galo L.; Naik, Dhananjay K.; Dussor, Gregory; Price, Theodore J.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75080 USA; [Burton, Michael D.; Mejia, Galo L.; Naik, Dhananjay K.; Dussor, Gregory; Price, Theodore J.] Univ Texas Dallas, Ctr Adv Pain Studies, Richardson, TX 75080 USA; [Shiloh, Michael U.] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Franco, Luis H.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, BR-30270901 Belo Horizonte, MG, Brazil	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Universidade Federal de Minas Gerais	Shiloh, MU (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.; Shiloh, MU (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	michael.shiloh@utsouthwestern.edu	gautron, laurent/AAQ-5983-2021; Shiloh, Michael/AAS-8883-2020; Franco, Luis H/M-4636-2017; Price, Theodore/M-3810-2018	Shiloh, Michael/0000-0003-4329-2253; Franco, Luis H/0000-0002-8143-1384; Price, Theodore/0000-0002-6971-6221; Ruhl, Cody/0000-0001-9440-1013; Burton, Michael D./0000-0002-0628-824X; Pasko, Breanna/0000-0001-6071-6893	Burroughs Wellcome Fund [1017894]; Welch Foundation [I-1964-20180324, I-2010-20190330]; NIH [R01 NS104200, R01 NS065926, U01 AI125939, U19 AI142784, R21 AI137545, 5T32AI005284-40, T32AI007520, T32GM127216]; Eugene McDermott Endowed Scholarship at University of Texas Southwestern; Disease Oriented Clinical Scholars Program at University of Texas Southwestern	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eugene McDermott Endowed Scholarship at University of Texas Southwestern; Disease Oriented Clinical Scholars Program at University of Texas Southwestern	We thank B. Levine and members of the Shiloh lab for constructive feedback on the manuscript. We thank G. Dias do Vale and J. McDonald for help with mass spectrometry, C. Bertozzi (Stanford University) for providing Mtb strains, and M. Nassar (University of Sheffield, United Kingdom) for providing MED17.11 cells. We thank BEI Resources, NIAID, NIH, for providing many valuable reagents used in this study as indicated in the STAR Methods. This work is supported by the Burroughs Wellcome Fund (1017894 to M.U.S.), the Welch Foundation (I-1964-20180324 to M.U.S. and I-2010-20190330 to T.Q.), and NIH (R01 NS104200 to G.D.; R01 NS065926 to T.J.P.; U01 AI125939, U19 AI142784, and R21 AI137545 to M.U.S.; 5T32AI005284-40 to H.S.K.; T32AI007520 to C.E.S. and B.L.P.; and T32GM127216 to C.R.D.). T.Q. is supported by the Eugene McDermott Endowed Scholarship, and M.U.S. acknowledges the support of the Disease Oriented Clinical Scholars Program, both at University of Texas Southwestern.	Abdullah H, 2014, THORAX, V69, P46, DOI 10.1136/thoraxjnl-2013-203894; Abdulqawi R, 2015, LANCET, V385, P1198, DOI 10.1016/S0140-6736(14)61255-1; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Baral P, 2018, NAT MED, V24, P417, DOI 10.1038/nm.4501; Basaraba RJ, 2006, TUBERCULOSIS, V86, P386, DOI 10.1016/j.tube.2005.11.003; Bonvini SJ, 2017, PULM PHARMACOL THER, V47, P21, DOI 10.1016/j.pupt.2017.06.009; Brooks Stuart M, 2011, Cough, V7, P10, DOI 10.1186/1745-9974-7-10; Bryant JM, 2016, SCIENCE, V354, P751, DOI 10.1126/science.aaf8156; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Burton MD, 2017, NEUROSCIENCE, V359, P119, DOI 10.1016/j.neuroscience.2017.07.020; Canning BJ, 2008, LUNG, V186, pS23, DOI 10.1007/s00408-007-9054-6; Canning BJ, 2007, PULM PHARMACOL THER, V20, P396, DOI 10.1016/j.pupt.2006.12.003; Canning BJ, 2010, OTOLARYNG CLIN N AM, V43, P15, DOI 10.1016/j.otc.2009.11.012; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cherry J.D., 2013, PLOS PATHOG, V9, DOI [DOI 10.1371/journal.ppat.1003418, 10.1371/journal.ppat.1003418]; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Daffe M, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0021-2013; Daley CL, 2010, INT J TUBERC LUNG D, V14, P665; DANKNER WM, 1993, MEDICINE, V72, P11, DOI 10.1097/00005792-199301000-00002; Davidson S, 2014, PAIN, V155, P1861, DOI 10.1016/j.pain.2014.06.017; De Proost I, 2007, HISTOCHEM CELL BIOL, V128, P301, DOI 10.1007/s00418-007-0318-2; De Proost I, 2007, CELL TISSUE RES, V329, P421, DOI 10.1007/s00441-007-0431-5; Dicpinigaitis PV, 2014, J THORAC DIS, V6, pS708, DOI 10.3978/j.issn.2072-1439.2013.12.02; Doran C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128670; Doyle RM, 2020, CLIN INFECT DIS, V70, P1855, DOI 10.1093/cid/ciz526; Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC; FOLCH J, 1957, J BIOL CHEM, V226, P497; Footitt J, 2009, PULM PHARMACOL THER, V22, P108, DOI 10.1016/j.pupt.2008.12.022; Garceau D, 2019, PULM PHARMACOL THER, V56, P56, DOI 10.1016/j.pupt.2019.03.007; George KM, 1998, INFECT IMMUN, V66, P587, DOI 10.1128/IAI.66.2.587-593.1998; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; Gilmore SA, 2012, ACS CHEM BIOL, V7, P863, DOI 10.1021/cb200311s; Glaser T, 2016, METHODS MOL BIOL, V1341, P245, DOI 10.1007/7651_2015_271; Gonzalo-Asensio J, 2014, P NATL ACAD SCI USA, V111, P11491, DOI 10.1073/pnas.1406693111; GOREN MB, 1970, BIOCHIM BIOPHYS ACTA, V210, P116, DOI 10.1016/0005-2760(70)90067-6; GOREN MB, 1970, BIOCHIM BIOPHYS ACTA, V210, P127, DOI 10.1016/0005-2760(70)90068-8; GOREN MB, 1974, INFECT IMMUN, V9, P142, DOI 10.1128/IAI.9.1.142-149.1974; GOREN MB, 1971, BIOCHEMISTRY-US, V10, P72, DOI 10.1021/bi00777a012; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guiard J, 2008, ANGEW CHEM INT EDIT, V47, P9734, DOI 10.1002/anie.200803835; Hewlett EL, 2014, J INFECT DIS, V209, P982, DOI 10.1093/infdis/jit639; IATRIDOU H, 1994, CELL CALCIUM, V15, P190, DOI 10.1016/0143-4160(94)90058-2; Jankute M, 2015, ANNU REV MICROBIOL, V69, P405, DOI 10.1146/annurev-micro-091014-104121; Jeon D, 2019, TUBERC RESPIR DIS, V82, P94, DOI 10.4046/trd.2018.0026; Jones-Lopez EC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138358; Kao JPY, 2010, METHOD CELL BIOL, V99, P113, DOI [10.1016/S0091-679X(10)99005-5, 10.1016/B978-0-12-374841-6.00005-0]; Karmakar M, 2019, J INFECTION, V79, P572, DOI 10.1016/j.jinf.2019.09.016; Kato-Maeda M, 2010, INT J TUBERC LUNG D, V14, P538; Koch R., 1912, GESAMMELTE WERKE R K; Koskela Heikki, 2012, Inflammation & Allergy Drug Targets, V11, P102; Kumar P, 2007, P NATL ACAD SCI USA, V104, P11221, DOI 10.1073/pnas.0611649104; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; LAUDE EA, 1993, PULM PHARMACOL, V6, P171, DOI 10.1006/pulp.1993.1023; Layre E, 2011, J LIPID RES, V52, P1098, DOI 10.1194/jlr.M013482; Lomask J, 2006, US patent, Patent No. [USOO7104962B2, 7104962]; LURIE MAX B., 1930, JOUR EXP MED, V51, P753, DOI 10.1084/jem.51.5.753; LURIE MAX B., 1930, JOUR EXP MED, V51, P769, DOI 10.1084/jem.51.5.769; LURIE MAX B., 1930, JOUR EXP MED, V51, P729, DOI 10.1084/jem.51.5.729; Lurie MB, 1929, J EXP MED, V50, P747, DOI [10.1084/jem.50.6.747, 10.1084/jem.51.5.743]; Marion E, 2014, CELL, V157, P1565, DOI 10.1016/j.cell.2014.04.040; Martiniano SL, 2016, CLIN CHEST MED, V37, P83, DOI 10.1016/j.ccm.2015.11.001; Mazzone Stuart B, 2005, Cough, V1, P2, DOI 10.1186/1745-9974-1-2; Mazzone SB, 2016, PHYSIOL REV, V96, P975, DOI 10.1152/physrev.00039.2015; MIDDLEBROOK G, 1959, P NATL ACAD SCI USA, V45, P1801, DOI 10.1073/pnas.45.12.1801; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Morice AH, 2007, EUR RESPIR J, V29, P1256, DOI 10.1183/09031936.00101006; Mougous JD, 2002, CHEM BIOL, V9, P767, DOI 10.1016/S1074-5521(02)00175-8; Mougous JD, 2004, NAT STRUCT MOL BIOL, V11, P721, DOI 10.1038/nsmb802; Mougous JD, 2002, P NATL ACAD SCI USA, V99, P17037, DOI 10.1073/pnas.252514899; Nadel JA, 2013, PULM PHARMACOL THER, V26, P510, DOI 10.1016/j.pupt.2013.02.003; Ochoa-Cortes F, 2010, AM J PHYSIOL-GASTR L, V299, pG723, DOI 10.1152/ajpgi.00494.2009; Omar S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171681; ORME IM, 2016, MICROBIOL SPECTR, V4, DOI DOI 10.1128/MICROBIOLSPEC.TBTB2-0002-2015; Perla D, 1927, J EXP MED, V45, P209, DOI 10.1084/jem.45.2.209; Pinho-Ribeiro FA, 2018, CELL, V173, P1083, DOI 10.1016/j.cell.2018.04.006; Pintelon I, 2007, AM J RESP CELL MOL, V36, P541, DOI 10.1165/rcmb.2006-0256OC; Price TJ, 2015, PROG MOL BIOL TRANSL, V131, P409, DOI 10.1016/bs.pmbts.2014.11.010; REICH JM, 1992, CHEST, V101, P1605, DOI 10.1378/chest.101.6.1605; Reichling DB, 2009, TRENDS NEUROSCI, V32, P611, DOI 10.1016/j.tins.2009.07.007; Rivera-Marrero CA, 2002, MICROBIOL-SGM, V148, P783, DOI 10.1099/00221287-148-3-783; Rousseau C, 2003, INFECT IMMUN, V71, P4684, DOI 10.1128/IAI.71.8.4684-4690.2003; Schelle MW, 2006, CHEMBIOCHEM, V7, P1516, DOI 10.1002/cbic.200600224; Schmid R, 2019, ANNU REV PHYSIOL, V81, P43, DOI 10.1146/annurev-physiol-020518-114259; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seeliger JC, 2012, J BIOL CHEM, V287, P7990, DOI 10.1074/jbc.M111.315473; Shiloh MU, 2016, FUTURE MICROBIOL, V11, P1503, DOI 10.2217/fmb-2016-0185; Steenken W, 1934, J EXP MED, V60, P515, DOI 10.1084/jem.60.4.515; STEENKEN W, 1946, AM REV TUBERC PULM, V54, P62; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; Takahashi T, 2012, J LIPID RES, V53, P1437, DOI 10.1194/jlr.R026682; Tanaka M, 2005, J PHARMACOL SCI, V99, P77, DOI 10.1254/jphs.FPJ05014X; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Turner OC, 2003, INFECT IMMUN, V71, P864, DOI 10.1128/IAI.71.2.864-871.2003; Turner RD, 2015, J INFECT DIS, V211, P1367, DOI 10.1093/infdis/jiu625; Turner RD, 2019, PULM PHARMACOL THER, V55, P89, DOI 10.1016/j.pupt.2019.01.008; Vayr F, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006208; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Zaccone EJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155526; [No title captured]	103	46	47	11	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2020	181	2					293	+		10.1016/j.cell.2020.02.026	http://dx.doi.org/10.1016/j.cell.2020.02.026			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LD7BL	32142653	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000526184900013
J	Hobbins, M; Barsugli, J				Hobbins, Mike; Barsugli, Joseph			CLIMATE CHANGE Threatening the vigor of the Colorado River	SCIENCE			English	Editorial Material									[Hobbins, Mike] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; NOAA, Phys Sci Div, Earth Syst Res Lab, Boulder, CO 80305 USA	University of Colorado System; University of Colorado Boulder; National Oceanic Atmospheric Admin (NOAA) - USA	Hobbins, M (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.	mike.hobbins@noaa.gov	Hobbins, Mike/N-4630-2014	Hobbins, Mike/0000-0001-5540-8466				Barsugl J.J., 2019, EOS, DOI [10.1029/2019EO117173, DOI 10.1029/2019EO117173]; Hobbins MT, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033840; Hobbins MT, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019846; Hoerling M, 2019, J CLIMATE, V32, P8181, DOI 10.1175/JCLI-D-19-0207.1; James T., 2014, EC IMPORTANCE COLORA; Lehner F, 2019, NAT CLIM CHANGE, V9, P926, DOI 10.1038/s41558-019-0639-x; Meredith M., 2019, IPCC SPECIAL REPORT; Milly PCD, 2020, SCIENCE, V367, P1252, DOI 10.1126/science.aay9187; Milly PCD, 2016, NAT CLIM CHANGE, V6, P946, DOI [10.1038/NCLIMATE3046, 10.1038/nclimate3046]; Roderick ML, 2009, GEOGR COMPASS, V3, P761, DOI 10.1111/j.1749-8198.2008.00214.x; Sheffield J, 2012, NATURE, V491, P435, DOI 10.1038/nature11575; Vano JA, 2014, B AM METEOROL SOC, V95, P59, DOI 10.1175/BAMS-D-12-00228.1	12	6	6	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1192	1193		10.1126/science.abb3624	http://dx.doi.org/10.1126/science.abb3624			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU9DP	32165569				2022-12-28	WOS:000520023800020
J	Tsunoda, K; Endo, R				Tsunoda, Koichi; Endo, Rinako			SPOT DIAGNOSIS Intranasal pain in a patient with Behcet's disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Tsunoda, Koichi; Endo, Rinako] Natl Hosp Org Tokyo Med Ctr, Tokyo, Japan		Tsunoda, K (corresponding author), Natl Hosp Org Tokyo Med Ctr, Tokyo, Japan.	tsunodakoichi@kankakuki.go.jp						Dixon WG, 2012, ANN RHEUM DIS, V71, P1128, DOI 10.1136/annrheumdis-2011-200702; Hull CM, 2010, POSTGRAD MED, V122, P1, DOI 10.3810/pgm.2010.09.2216	2	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2020	368								m525	10.1136/bmj.m525	http://dx.doi.org/10.1136/bmj.m525			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AR	32161027				2022-12-28	WOS:000520012800004
J							US Preventive Serv Task Force	Screening for Hepatitis C Virus Infection in Adolescents and Adults US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							UNITED-STATES; TRANSMISSION; PREVALENCE; WOMEN; RISK; HCV	This 2020 Recommendation Statement from the US Preventive Services Task Force recommends screening for hepatitis C virus infection in adults aged 18 to 79 years (B recommendation). Importance Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in the US and a leading cause of complications from chronic liver disease. HCV is associated with more deaths than the top 60 other reportable infectious diseases combined, including HIV. Cases of acute HCV infection have increased approximately 3.8-fold over the last decade because of increasing injection drug use and improved surveillance. Objective To update its 2013 recommendation, the USPSTF commissioned a review of the evidence on screening for HCV infection in adolescents and adults. Population This recommendation applies to all asymptomatic adults aged 18 to 79 years without known liver disease. Evidence Assessment The USPSTF concludes with moderate certainty that screening for HCV infection in adults aged 18 to 79 years has substantial net benefit. Recommendation The USPSTF recommends screening for HCV infection in adults aged 18 to 79 years. (B recommendation)					Epling, John W/J-1097-2019	Epling, John W/0000-0001-9445-8669; Wong, John/0000-0003-4203-9010				AASLD-IDSA Hepatitis C Guidance, 2020, HEPATOLOGY, V71, P686, DOI 10.1002/hep.31060; American Association for the Study of Liver Diseases Infectious Diseases Society of America, INF DIS SOC AM HCV T; [Anonymous], 2007, OBSTET GYNECOL, V110, P941; [Anonymous], 2018, PROC MAN; Barocas JA, 2018, CLIN INFECT DIS, V67, P549, DOI 10.1093/cid/ciy098; Centers for Disease Control and Prevention, CDC REC HEP C SCREEN; Centers for Disease Control and Prevention, TEST REC HEP C VIR I; Centers for Disease Control and Prevention, 2017, HEP C QUEST ANSW HLT; Centers for Disease Control and Prevention (CDC), 2019, SURV VIR HEP US; Chou R., 2020, 229 AG HEALTHC RES Q; Chou R, 2012, AHRQ PUBLICATION; Chou R, 2020, JAMA; Chou R, 2004, SCREENING HEPATITIS; Chou R, 2013, ANN INTERN MED, V158, P807, DOI 10.7326/0003-4819-158-11-201306040-00005; Edlin BR, 2015, HEPATOLOGY, V62, P1353, DOI 10.1002/hep.27978; Hofmeister MG, 2019, HEPATOLOGY, V69, P1020, DOI 10.1002/hep.30297; Koneru A, 2016, MMWR-MORBID MORTAL W, V65, P705, DOI 10.15585/mmwr.mm6528a2; LeFevre ML, 2014, ANN INTERN MED, V161, P58, DOI 10.7326/M14-1018; Ly KN, 2017, ANN INTERN MED, V166, P775, DOI 10.7326/M16-2350; Ly KN, 2016, CLIN INFECT DIS, V62, P1287, DOI 10.1093/cid/ciw111; Mast EE, 2005, J INFECT DIS, V192, P1880, DOI 10.1086/497701; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; Owens DK, 2019, JAMA-J AM MED ASSOC, V322, P349, DOI 10.1001/jama.2019.9365; Owens DK, 2019, JAMA-J AM MED ASSOC, V321, P2326, DOI 10.1001/jama.2019.6587; Rosenberg ES, 2017, CLIN INFECT DIS, V64, P1573, DOI 10.1093/cid/cix202; Tran TT, 2016, AM J GASTROENTEROL, V111, P176, DOI 10.1038/ajg.2015.430; Turner BJ, 2019, ANN INTERN MED, V171, P865, DOI 10.7326/M18-3573	27	115	115	5	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2020	323	10					970	975		10.1001/jama.2020.1123	http://dx.doi.org/10.1001/jama.2020.1123			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KW1LV	32119076	Bronze			2022-12-28	WOS:000520933900014
J	Blumenthal, D; Collins, SR; Fowler, EJ				Blumenthal, David; Collins, Sara R.; Fowler, Elizabeth J.			The Affordable Care Act at 10 Years - Its Coverage and Access Provisions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEDICAID EXPANSION; HEALTH		[Blumenthal, David; Collins, Sara R.; Fowler, Elizabeth J.] Commonwealth Fund, New York, NY 10021 USA	Commonwealth Fund	Blumenthal, D (corresponding author), Commonwealth Fund, New York, NY 10021 USA.							[Anonymous], 2019, EARL 2019 EFF ENR SN; [Anonymous], 2012, UPD EST INS COV PROV; [Anonymous], 2019, FED SUBS HLTH INS CO; [Anonymous], 2019, COST SHAR PLANS OFF; Antonisse L., 2019, EFFECTS MEDICAID EXP; Bhatt CB, 2018, AM J PUBLIC HEALTH, V108, P565, DOI 10.2105/AJPH.2017.304218; Blumenthal D, 2020, NEW ENGL J MED, V382, P1057, DOI 10.1056/NEJMhpr1916092; Board on Health Care Services Committee on the Consequences of Uninsurance, 2003, HIDD COSTS VAL LOST; Breslau J, 2018, MED CARE RES REV, V75, P131, DOI 10.1177/1077558716682171; Brown CC, 2019, JAMA-J AM MED ASSOC, V321, P1598, DOI 10.1001/jama.2019.3678; Brueck H, 2019, AVAILABLE THIS IS WH; Busch SH, 2014, HEALTH AFFAIR, V33, P1361, DOI 10.1377/hlthaff.2014.0155; Cohen R. A., 2019, HLTH INSURANCE COVER; Collins SR, 2015, ARE MARKETPLACE PLAN; Collins SR, 2020, SUPREME COURT DENIES; Frean M, 2017, J HEALTH ECON, V53, P72, DOI 10.1016/j.jhealeco.2017.02.004; GARFIELD R, 2020, COVERAGE GAP UNINSUR; Glied Sherry, 2015, CBOS CRYSTAL BALL WE; Goldin J., 2019, 26533 NBER, DOI 10.3386/w26533; Gunja MZ., 2019, WHO ARE REMAINING UN; Jost TS, 2019, 5 CIRCUIT SENDS AFFO; Keith K, 2019, MORE INSURERS WIN LA; Khatana SAM, 2019, JAMA CARDIOL, V4, P671, DOI 10.1001/jamacardio.2019.1651; Miller S., 2019, 26081 NBER; Palanker D, 2019, SEEING FRAUD MISLEAD; Radley DC, 2019, 2019 SCORECARD STATE; Seervai S, 2019, HLTH PLANS DONT COMP; Sommers BD, 2019, NEW ENGL J MED, V381, P1073, DOI 10.1056/NEJMsr1901772; Sommers BD, 2017, NEW ENGL J MED, V377, P586, DOI 10.1056/NEJMsb1706645; Sommers BD, 2016, HEALTH AFFAIR, V35, P96, DOI 10.1377/hlthaff.2015.0917; Swaminathan S, 2018, JAMA-J AM MED ASSOC, V320, P2242, DOI 10.1001/jama.2018.16504	31	29	29	4	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2020	382	10					963	969		10.1056/NEJMhpr1916091	http://dx.doi.org/10.1056/NEJMhpr1916091			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KT7TC	32101659				2022-12-28	WOS:000519214900014
J	Hong, JY; Lim, J; Carvalho, F; Cho, JY; Vaidyanathan, B; Yu, S; Annicelli, C; Ip, WKE; Medzhitov, R				Hong, Jun Young; Lim, Jaechul; Carvalho, Fernando; Cho, Jen Young; Vaidyanathan, Bharat; Yu, Shuang; Annicelli, Charles; Ip, W. K. Eddie; Medzhitov, Ruslan			Long-Term Programming of CD8 T Cell Immunity by Perinatal Exposure to Glucocorticoids	CELL			English	Article							PITUITARY-ADRENAL AXIS; PRENATAL STRESS; READ ALIGNMENT; RECEPTOR; FETAL; CORTICOSTERONE; DISEASE; SUSCEPTIBILITY; MECHANISMS; MATURATION	Early life environmental exposure, particularly during perinatal period, can have a life-long impact on organismal development and physiology. The biological rationale for this phenomenon is to promote physiological adaptations to the anticipated environment based on early life experience. However, perinatal exposure to adverse environments can also be associated with adult-onset disorders. Multiple environmental stressors induce glucocorticoids, which prompted us to investigate their role in developmental programming. Here, we report that perinatal glucocorticoid exposure had long-term consequences and resulted in diminished CD8 T cell response in adulthood and impaired control of tumor growth and bacterial infection. We found that perinatal glucocorticoid exposure resulted in persistent alteration of the hypothalamic-pituitary-adrenal (HPA) axis. Consequently, the level of the hormone in adults was significantly reduced, resulting in decreased CD8 T cell function. Our study thus demonstrates that perinatal stress can have long-term consequences on CD8 T cell immunity by altering HPA axis activity.	[Hong, Jun Young; Lim, Jaechul; Carvalho, Fernando; Cho, Jen Young; Vaidyanathan, Bharat; Yu, Shuang; Annicelli, Charles; Ip, W. K. Eddie; Medzhitov, Ruslan] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06510 USA; [Medzhitov, Ruslan] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Vaidyanathan, Bharat] EMD Serono Res & Dev Inst, Billerica, MA 01821 USA; [Ip, W. K. Eddie] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA	Yale University; Howard Hughes Medical Institute; Mayo Clinic	Medzhitov, R (corresponding author), Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06510 USA.; Medzhitov, R (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	ruslan.medzhitov@yale.edu	Ip, W. K. Eddie/C-3042-2012	Ip, W. K. Eddie/0000-0003-1953-972X; Hong, Jun Young/0000-0002-4963-7147	Howard Hughes Medical Institute (HHMI); Blavatnik Family Foundation; Else Kroner-Fresenius Foundation; NIH [1R01 AI144152-01]; Cancer Research Institute/Bristol-Myers Squibb postdoctoral fellowship; Jane Coffin Childs Memorial Fund for Medical Research; Human Frontier Science Program Long-Term Fellowship [LT000037/2018-L]	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Blavatnik Family Foundation; Else Kroner-Fresenius Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute/Bristol-Myers Squibb postdoctoral fellowship; Jane Coffin Childs Memorial Fund for Medical Research; Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program)	We thank Dr. Marcus Bosenberg for providing YUMMER1.7 cell line. We want to thank all current and former members of the Medzhitov lab for discussions. Work in the R.M. lab was supported by Howard Hughes Medical Institute (HHMI), the Blavatnik Family Foundation, the Else Kroner-Fresenius Foundation, and a grant from the NIH (1R01 AI144152-01). J.Y.H. is supported by the Cancer Research Institute/Bristol-Myers Squibb postdoctoral fellowship. J.L. is supported by Jane Coffin Childs Memorial Fund for Medical Research and the Human Frontier Science Program Long-Term Fellowship (LT000037/2018-L).	Alexander N, 2012, J CLIN ENDOCR METAB, V97, P3538, DOI 10.1210/jc.2012-1970; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Barbazanges A, 1996, J NEUROSCI, V16, P3943; Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Beijers R, 2010, PEDIATRICS, V126, pE401, DOI 10.1542/peds.2009-3226; BRADBURY MJ, 1994, ENDOCRINOLOGY, V134, P1286, DOI 10.1210/en.134.3.1286; Braun T, 2013, ENDOCR REV, V34, P885, DOI 10.1210/er.2013-1012; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; CATALANI A, 1993, BRAIN RES, V624, P209, DOI 10.1016/0006-8993(93)90079-3; Catalani A, 2011, NEUROSCI BIOBEHAV R, V35, P1502, DOI 10.1016/j.neubiorev.2010.10.017; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen YW, 2010, FASEB J, V24, P5043, DOI 10.1096/fj.10-168724; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Di Meco A, 2016, MOL PSYCHIATR, V21, P403, DOI 10.1038/mp.2015.78; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gollwitzer ES, 2015, TRENDS IMMUNOL, V36, P684, DOI 10.1016/j.it.2015.09.009; Han F, 2005, NEUROSCI RES, V51, P371, DOI 10.1016/j.neures.2004.12.013; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Henriksen R, 2011, NEUROSCI BIOBEHAV R, V35, P1484, DOI 10.1016/j.neubiorev.2011.04.010; Henriksen RE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137304; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Janusek LW, 2013, BRAIN BEHAV IMMUN, V30, pS149, DOI 10.1016/j.bbi.2012.05.014; Kapoor A, 2008, BRAIN RES REV, V57, P586, DOI 10.1016/j.brainresrev.2007.06.013; Karmaus PWF, 2019, NATURE, V565, P101, DOI 10.1038/s41586-018-0806-7; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Kay G, 1998, PHYSIOL BEHAV, V63, P397, DOI 10.1016/S0031-9384(97)00456-3; Kelly-Irving M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-767; Kim D, 2001, CELL IMMUNOL, V207, P13, DOI 10.1006/cimm.2000.1749; Kim Myoungjoo V, 2014, Bio Protoc, V4, DOI 10.21769/BioProtoc.1172; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LEVINE S, 1994, ANN NY ACAD SCI, V746, P275, DOI 10.1111/j.1749-6632.1994.tb39245.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Mairesse J, 2007, AM J PHYSIOL-ENDOC M, V292, pE1526, DOI 10.1152/ajpendo.00574.2006; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mittelstadt PR, 2018, J IMMUNOL, V200, P1988, DOI 10.4049/jimmunol.1701328; Mittelstadt PR, 2012, J CLIN INVEST, V122, P2384, DOI 10.1172/JCI63067; Moore SE, 2006, P NUTR SOC, V65, P311, DOI 10.1079/PNS2006503; Mueller NT, 2015, TRENDS MOL MED, V21, P109, DOI 10.1016/j.molmed.2014.12.002; Nielsen NM, 2011, AM J EPIDEMIOL, V173, P990, DOI 10.1093/aje/kwq492; O'Connor TG, 2013, BRAIN BEHAV IMMUN, V32, P21, DOI 10.1016/j.bbi.2013.02.002; Okin D, 2012, CURR BIOL, V22, pR733, DOI 10.1016/j.cub.2012.07.029; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Ralevski A, 2015, FRONT NEUROENDOCRIN, V39, P52, DOI 10.1016/j.yfrne.2015.09.002; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Reyes-Contreras M, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0119; Ross SH, 2016, IMMUNITY, V45, P685, DOI 10.1016/j.immuni.2016.07.022; SAPOLSKY RM, 1986, BRAIN RES REV, V11, P65, DOI 10.1016/0165-0173(86)90010-X; Schmidt MV, 2011, PSYCHONEUROENDOCRINO, V36, P330, DOI 10.1016/j.psyneuen.2010.07.001; Schoenfeld TJ, 2012, EXP NEUROL, V233, P12, DOI 10.1016/j.expneurol.2011.01.008; Shimba A, 2018, IMMUNITY, V48, P286, DOI 10.1016/j.immuni.2018.01.004; Spracklen CN, 2014, CANCER EPIDEMIOL, V38, P538, DOI 10.1016/j.canep.2014.07.004; Stearns S.C., 1992, pi; Stonawski V, 2019, DEV PSYCHOPATHOL, V31, P419, DOI 10.1017/S0954579418000056; Taves MD, 2019, CELL REP, V26, P3629, DOI 10.1016/j.celrep.2019.02.108; Tegethoff M, 2009, ENDOCR REV, V30, P753, DOI 10.1210/er.2008-0014; Valles SL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-72; van Bodegom M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00087; Venihaki M, 2000, P NATL ACAD SCI USA, V97, P7336, DOI 10.1073/pnas.97.13.7336; Wang A, 2019, SCIENCE, V363, P140, DOI 10.1126/science.aar3932; Wang J, 2017, PIGM CELL MELANOMA R, V30, P428, DOI 10.1111/pcmr.12591; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wilckens T, 1997, IMMUNOL TODAY, V18, P418, DOI 10.1016/S0167-5699(97)01111-0; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	68	31	31	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2020	180	5					847	+		10.1016/j.cell.2020.02.018	http://dx.doi.org/10.1016/j.cell.2020.02.018			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KT7JN	32142678	Green Accepted, Bronze			2022-12-28	WOS:000519189800007
J	Hurley, R				Hurley, Richard			Drug use: more enforcement is unlikely to be the answer to rising harms, review finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2019, DRUG REL DEATHS 2019; Black C., 2020, REV DRUGS PHASE ONE; NHS Digital, 2019, STAT DRUG MIS ENG 20	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2020	368								m802	10.1136/bmj.m802	http://dx.doi.org/10.1136/bmj.m802			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2JX	32107210				2022-12-28	WOS:000519535800019
J	Pleguezuelos-Manzano, C; Puschhof, J; Huber, AR; van Hoeck, A; Wood, HM; Nomburg, J; Gurjao, C; Manders, F; Dalmasso, G; Stege, PB; Paganelli, FL; Geurts, MH; Beumer, J; Mizutani, T; Miao, Y; van der Linden, R; van der Elst, S; Garcia, KC; Top, J; Willems, RJL; Giannakis, M; Bonnet, R; Quirke, P; Meyerson, M; Cuppen, E; van Boxtel, R; Clevers, H				Pleguezuelos-Manzano, Cayetano; Puschhof, Jens; Huber, Axel Rosendahl; van Hoeck, Arne; Wood, Henry M.; Nomburg, Jason; Gurjao, Carino; Manders, Freek; Dalmasso, Guillaume; Stege, Paul B.; Paganelli, Fernanda L.; Geurts, Maarten H.; Beumer, Joep; Mizutani, Tomohiro; Miao, Yi; van der Linden, Reinier; van der Elst, Stefan; Garcia, K. Christopher; Top, Janetta; Willems, Rob J. L.; Giannakis, Marios; Bonnet, Richard; Quirke, Phil; Meyerson, Matthew; Cuppen, Edwin; van Boxtel, Ruben; Clevers, Hans		Genomics England Res Consortium	Mutational signature in colorectal cancer caused by genotoxic pks(+)E. coli	NATURE			English	Article							ADULT STEM-CELLS; ACCUMULATION; ORGANOIDS; EXPANSION; INSIGHTS	Various species of the intestinal microbiota have been associated with the development of colorectal cancer(1,2), but it has not been demonstrated that bacteria have a direct role in the occurrence of oncogenic mutations. Escherichia coli can carry the pathogenicity island pks, which encodes a set of enzymes that synthesize colibactin(3). This compound is believed to alkylate DNA on adenine residues(4,5) and induces double-strand breaks in cultured cells(3). Here we expose human intestinal organoids to genotoxic pks(+)E. coli by repeated luminal injection over five months. Whole-genome sequencing of clonal organoids before and after this exposure revealed a distinct mutational signature that was absent from organoids injected with isogenic pks-mutant bacteria. The same mutational signature was detected in a subset of 5,876 human cancer genomes from two independent cohorts, predominantly in colorectal cancer. Our study describes a distinct mutational signature in colorectal cancer and implies that the underlying mutational process results directly from past exposure to bacteria carrying the colibactin-producing pks pathogenicity island. Organoids derived from human intestinal cells that are co-cultured with bacteria carrying the genotoxic pks(+) island develop a distinct mutational signature associated with colorectal cancer.	[Pleguezuelos-Manzano, Cayetano; Puschhof, Jens; Geurts, Maarten H.; Beumer, Joep; Mizutani, Tomohiro; van der Linden, Reinier; van der Elst, Stefan; Clevers, Hans] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, Utrecht, Netherlands; [Pleguezuelos-Manzano, Cayetano; Puschhof, Jens; Geurts, Maarten H.; Beumer, Joep; Mizutani, Tomohiro; van der Linden, Reinier; van der Elst, Stefan; Clevers, Hans] UMC Utrecht, Utrecht, Netherlands; [Pleguezuelos-Manzano, Cayetano; Puschhof, Jens; Huber, Axel Rosendahl; van Hoeck, Arne; Manders, Freek; Geurts, Maarten H.; Mizutani, Tomohiro; Cuppen, Edwin; van Boxtel, Ruben; Clevers, Hans] Oncode Inst, Utrecht, Netherlands; [Huber, Axel Rosendahl; Manders, Freek; van Boxtel, Ruben; Clevers, Hans] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands; [van Hoeck, Arne; Cuppen, Edwin] Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands; [Wood, Henry M.; Quirke, Phil] St Jamess Univ Leeds, Leeds Inst Med Res, Pathol & Data Analyt, Leeds, W Yorkshire, England; [Nomburg, Jason] Harvard Med Sch, Div Med Sci, Grad Program Virol, Boston, MA 02115 USA; [Nomburg, Jason; Gurjao, Carino; Giannakis, Marios; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Nomburg, Jason; Gurjao, Carino; Giannakis, Marios; Meyerson, Matthew] Harvard Med Sch, Boston, MA 02115 USA; [Puschhof, Jens; Giannakis, Marios; Meyerson, Matthew] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Dalmasso, Guillaume; Bonnet, Richard] Univ Clermont Auvergne, INSERM, U1071, INRA,USC2018,M2iSH, Clermont Ferrand, France; [Stege, Paul B.; Paganelli, Fernanda L.; Top, Janetta; Willems, Rob J. L.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Miao, Yi; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Miao, Yi; Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Miao, Yi; Garcia, K. Christopher] Stanford Univ, Dept Struct Biol, Sch Med, Stanford, CA 94305 USA; [Bonnet, Richard] Univ Hosp Clermont Ferrand, Dept Bacteriol, Clermont Ferrand, France; [Meyerson, Matthew] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Meyerson, Matthew] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Cuppen, Edwin] Hartwig Med Fdn, Amsterdam, Netherlands; [Cuppen, Edwin] CPCT Consortium, Rotterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Saint James's University Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Utrecht University; Utrecht University Medical Center; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; CHU Clermont Ferrand; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Clevers, H (corresponding author), Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, Utrecht, Netherlands.; Clevers, H (corresponding author), UMC Utrecht, Utrecht, Netherlands.; van Boxtel, R; Clevers, H (corresponding author), Oncode Inst, Utrecht, Netherlands.; van Boxtel, R; Clevers, H (corresponding author), Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands.	R.vanBoxtel@prinsesmaximacentrum.nl; h.clevers@hubrecht.eu	Mizutani, Tomohiro/AAX-5650-2021; Willems, Rob JL/E-3681-2010; Cuppen, Edwin/H-2389-2016; Polychronopoulos, Dimitris/G-8214-2014; Zarowiecki, Magdalena/F-5037-2013; Dalmasso, Guillaume/N-2443-2018	Mizutani, Tomohiro/0000-0002-8373-7969; Willems, Rob JL/0000-0002-7370-0812; Cuppen, Edwin/0000-0002-0400-9542; Stege, Paul Bastiaan/0000-0003-2020-2702; Manders, Freek/0000-0001-6197-347X; Pleguezuelos-Manzano, Cayetano/0000-0003-4676-9838; GURJAO, Carino/0000-0002-4813-5460; Tucci, Arianna/0000-0001-5644-0070; Meyerson, Matthew/0000-0002-9133-8108; Top, Janetta/0000-0002-4620-8128; Quirke, Philip/0000-0002-3597-5444; Wood, Henry/0000-0003-3009-5904; van Boxtel, Ruben/0000-0003-1285-2836; McDonagh, Ellen M/0000-0001-5806-6174; Polychronopoulos, Dimitris/0000-0001-9427-3082; Van Hoeck, Arne/0000-0002-6570-1452; Zarowiecki, Magdalena/0000-0001-6102-7731; Fowler, Tom/0000-0002-7258-2279; Riesgo-Ferreiro, Pablo/0000-0003-2739-1315; Dalmasso, Guillaume/0000-0002-3433-870X; Rosendahl Huber, Axel/0000-0003-4001-5605	National Institute for Health Research; NHS England; Wellcome Trust; Cancer Research UK; Medical Research Council; CRUK grant OPTIMISTICC [C10674/A27140]; Gravitation projects CancerGenomiCs.nl; Netherlands Organ-on-Chip Initiative from the Netherlands Organisation for Scientific Research (NWO) - Ministry of Education, Culture and Science of the government of the Netherlands [024.003.001]; Oncode Institute - Dutch Cancer Society; European Research Council under ERC Advanced Grant [67013]; VIDI grant from the NWO [016.Vidi.171.023]; NWO building blocks of life project: Cell dynamics within lung and intestinal organoids [737.016.009]; ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante, National Alliance for Life Sciences AMP; Health) within the framework of the Cancer Plan [HTE201601]; Howard Hughes Medical Institute; Mathers Foundation; NIH [1R01DK115728-01A1]	National Institute for Health Research(National Institute for Health Research (NIHR)); NHS England; Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK grant OPTIMISTICC; Gravitation projects CancerGenomiCs.nl; Netherlands Organ-on-Chip Initiative from the Netherlands Organisation for Scientific Research (NWO) - Ministry of Education, Culture and Science of the government of the Netherlands; Oncode Institute - Dutch Cancer Society; European Research Council under ERC Advanced Grant; VIDI grant from the NWO; NWO building blocks of life project: Cell dynamics within lung and intestinal organoids; ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante, National Alliance for Life Sciences AMP; Health) within the framework of the Cancer Plan; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Mathers Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. H. J. Hoeijmakers, P. Knipscheer and J. I. Garaycoechea for discussions on DNA damage, and P. Robinson, K. Vervier, T. Lawley, and M. Stratton for explorative analysis and discussions. This publication and the underlying study have been made possible partly on the basis of the data that Hartwig Medical Foundation and the Center of Personalised Cancer Treatment (CPCT) have made available to the study. This research was made possible through access to the data and findings generated by the 100,000 Genomes Project. The 100,000 Genomes Project is managed by Genomics England Limited (a wholly owned company of the Department of Health and Social Care). The 100,000 Genomes Project is funded by the National Institute for Health Research and NHS England. The Wellcome Trust, Cancer Research UK and the Medical Research Council have also funded research infrastructure. The 100,000 Genomes Project uses data provided by patients and collected by the National Health Service as part of their care and support. This work was supported by CRUK grant OPTIMISTICC (C10674/A27140), the Gravitation projects CancerGenomiCs.nl and the Netherlands Organ-on-Chip Initiative (024.003.001) from the Netherlands Organisation for Scientific Research (NWO) funded by the Ministry of Education, Culture and Science of the government of the Netherlands (C.P.-M., J.P.), the Oncode Institute (partly financed by the Dutch Cancer Society), the European Research Council under ERC Advanced Grant Agreement no. 67013 (J.P., T.M., H.C.), a VIDI grant from the NWO (no. 016.Vidi.171.023) to R.v.B. that supports A.R.H. and NWO building blocks of life project: Cell dynamics within lung and intestinal organoids (737.016.009) (M.H.G.). With financial support from ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante, National Alliance for Life Sciences & Health) within the framework of the Cancer Plan (HTE201601) (G.D., R.B.) as well as Howard Hughes Medical Institute, Mathers Foundation, and NIH-1R01DK115728-01A1 (Y.M., K.C.G.).	Alexandrov LB, 2020, NATURE, V578, P94, DOI 10.1038/s41586-020-1943-3; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Allen J, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0621-2; [Anonymous], 2019, GRIDSS PURPLE LINX U, DOI [10.1101/781013, DOI 10.1101/781013]; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Banerjee S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03466-6; Bartfeld S, 2015, GASTROENTEROLOGY, V148, P126, DOI 10.1053/j.gastro.2014.09.042; Blokzijl F, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0539-0; Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768; Boot A, 2019, IDENTIFICATION NOVEL, DOI [10.1101/368753, DOI 10.1101/368753]; Bossuet-Greif N, 2018, MBIO, V9, DOI 10.1128/mBio.02393-17; Buc E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056964; Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240; Cougnoux A, 2014, GUT, V63, P1932, DOI 10.1136/gutjnl-2013-305257; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Dejea CM, 2018, SCIENCE, V359, P592, DOI 10.1126/science.aah3648; Drost J, 2017, SCIENCE, V358, P234, DOI 10.1126/science.aao3130; Gagnaire A, 2017, NAT REV MICROBIOL, V15, P109, DOI 10.1038/nrmicro.2016.171; Genomics England, 2017, NAT GEN RES HEALTHC; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Heo I, 2018, NAT MICROBIOL, V3, P814, DOI 10.1038/s41564-018-0177-8; Jacobi CA, 2011, DIGEST DIS, V29, P600, DOI 10.1159/000333307; Jager M, 2018, NAT PROTOC, V13, P59, DOI 10.1038/nprot.2017.111; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kucab JE, 2019, CELL, V177, P821, DOI 10.1016/j.cell.2019.03.001; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee-Six H, 2019, NATURE, V574, P532, DOI 10.1038/s41586-019-1672-7; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li ZR, 2016, NAT CHEM BIOL, V12, P773, DOI 10.1038/nchembio.2157; McLellan LK, 2016, TRENDS MOL MED, V22, P946, DOI 10.1016/j.molmed.2016.09.003; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Olier M, 2012, GUT MICROBES, V3, P501, DOI 10.4161/gmic.21737; Osorio FG, 2018, CELL REP, V25, P2308, DOI 10.1016/j.celrep.2018.11.014; Pace P, 2002, EMBO J, V21, P3414, DOI 10.1093/emboj/cdf355; Payros D, 2014, GUT MICROBES, V5, P313, DOI 10.4161/gmic.28932; Priestley P, 2019, NATURE, V575, P210, DOI 10.1038/s41586-019-1689-y; Raczy C, 2013, BIOINFORMATICS, V29, P2041, DOI 10.1093/bioinformatics/btt314; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Tuveson D, 2019, SCIENCE, V364, P952, DOI 10.1126/science.aaw6985; Wilson MR, 2019, SCIENCE, V363, P709, DOI 10.1126/science.aar7785; Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6; Xue MZ, 2019, SCIENCE, V365, P1000, DOI 10.1126/science.aax2685; Zawadzki PJ, 2016, ANN AGR ENV MED, V23, P566, DOI 10.5604/12321966.1226847	44	324	329	20	140	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR	2020	580	7802					269	+		10.1038/s41586-020-2080-8	http://dx.doi.org/10.1038/s41586-020-2080-8		FEB 2020	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LB8SC	32106218	Green Accepted, Green Submitted			2022-12-28	WOS:000521704600001
J	Rimmer, A				Rimmer, Abi			Promoting professionalism: five minutes with... Sheona MacLeod	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2020	368								m768	10.1136/bmj.m768	http://dx.doi.org/10.1136/bmj.m768			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2JX	32107253				2022-12-28	WOS:000519535800015
J	Schmid, P; Cortes, J; Pusztai, L; McArthur, H; Kummel, S; Bergh, J; Denkert, C; Park, YH; Hui, R; Harbeck, N; Takahashi, M; Foukakis, T; Fasching, PA; Cardoso, F; Untch, M; Jia, LY; Karantza, V; Zhao, J; Aktan, G; Dent, R; O'Shaughnessy, J				Schmid, Peter; Cortes, Javier; Pusztai, Lajos; McArthur, Heather; Kuemmel, Sherko; Bergh, Jonas; Denkert, Carsten; Park, Yeon Hee; Hui, Rina; Harbeck, Nadia; Takahashi, Masato; Foukakis, Theodoros; Fasching, Peter A.; Cardoso, Fatima; Untch, Michael; Jia, Liyi; Karantza, Vassiliki; Zhao, Jing; Aktan, Gursel; Dent, Rebecca; O'Shaughnessy, Joyce		Keynote-522 Investigators	Pembrolizumab for Early Triple-Negative Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADVERSE EVENTS; CHEMOTHERAPY; CARBOPLATIN; IMPACT	Background Previous trials showed promising antitumor activity and an acceptable safety profile associated with pembrolizumab in patients with early triple-negative breast cancer. Whether the addition of pembrolizumab to neoadjuvant chemotherapy would significantly increase the percentage of patients with early triple-negative breast cancer who have a pathological complete response (defined as no invasive cancer in the breast and negative nodes) at definitive surgery is unclear. Methods In this phase 3 trial, we randomly assigned (in a 2:1 ratio) patients with previously untreated stage II or stage III triple-negative breast cancer to receive neoadjuvant therapy with four cycles of pembrolizumab (at a dose of 200 mg) every 3 weeks plus paclitaxel and carboplatin (784 patients; the pembrolizumab-chemotherapy group) or placebo every 3 weeks plus paclitaxel and carboplatin (390 patients; the placebo-chemotherapy group); the two groups then received an additional four cycles of pembrolizumab or placebo, and both groups received doxorubicin-cyclophosphamide or epirubicin-cyclophosphamide. After definitive surgery, the patients received adjuvant pembrolizumab or placebo every 3 weeks for up to nine cycles. The primary end points were a pathological complete response at the time of definitive surgery and event-free survival in the intention-to-treat population. Results At the first interim analysis, among the first 602 patients who underwent randomization, the percentage of patients with a pathological complete response was 64.8% (95% confidence interval [CI], 59.9 to 69.5) in the pembrolizumab-chemotherapy group and 51.2% (95% CI, 44.1 to 58.3) in the placebo-chemotherapy group (estimated treatment difference, 13.6 percentage points; 95% CI, 5.4 to 21.8; P<0.001). After a median follow-up of 15.5 months (range, 2.7 to 25.0), 58 of 784 patients (7.4%) in the pembrolizumab-chemotherapy group and 46 of 390 patients (11.8%) in the placebo-chemotherapy group had disease progression that precluded definitive surgery, had local or distant recurrence or a second primary tumor, or died from any cause (hazard ratio, 0.63; 95% CI, 0.43 to 0.93). Across all treatment phases, the incidence of treatment-related adverse events of grade 3 or higher was 78.0% in the pembrolizumab-chemotherapy group and 73.0% in the placebo-chemotherapy group, including death in 0.4% (3 patients) and 0.3% (1 patient), respectively. Conclusions Among patients with early triple-negative breast cancer, the percentage with a pathological complete response was significantly higher among those who received pembrolizumab plus neoadjuvant chemotherapy than among those who received placebo plus neoadjuvant chemotherapy. (Funded by Merck Sharp & Dohme [a subsidiary of Merck]; KEYNOTE-522 ClinicalTrials.gov number, NCT03036488.).) The addition of pembrolizumab to platinum-based neoadjuvant chemotherapy significantly increased the percentage of patients with a pathological complete response among patients with locally advanced triple-negative breast cancer. Side effects of the immunotherapy were added to the usual toxic effects of chemotherapy, but most patients completed planned treatment.	[Schmid, Peter] Queen Mary Univ London, Barts Canc Inst, London, England; [Cortes, Javier] Quiron Grp, Int Oncol Bur Inst Oncol, Madrid, Spain; [Cortes, Javier] Vall dHebron Inst Oncol, Barcelona, Spain; [Pusztai, Lajos] Yale Canc Ctr, Yale Sch Med, New Haven, CT USA; [McArthur, Heather] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Kuemmel, Sherko] Kliniken Essen Mitte, Essen, Germany; [Denkert, Carsten] Philipps Univ Marburg, Inst Pathol, Marburg, Germany; [Denkert, Carsten] Univ Marburg, Marburg, Germany; [Harbeck, Nadia] Univ Munich, Ludwig Maximilian Univ Munich, Breast Ctr, Dept Obstet & Gynecol, Munich, Germany; [Harbeck, Nadia] Univ Munich, Ludwig Maximilian Univ Munich, Ctr Comprehens Canc, Munich, Germany; [Fasching, Peter A.] Erlangen European Metropolitan Reg Nuremberg, Univ Hosp Erlangen, Dept Gynecol & Obstet, Ctr Comprehens Canc, Erlangen, Germany; [Untch, Michael] Helios Klinikum Berlin Buch, Breast Canc Ctr, Berlin, Germany; [Bergh, Jonas; Foukakis, Theodoros] Karolinska Inst, Dept Oncol Pathol, Solna, Sweden; [Bergh, Jonas; Foukakis, Theodoros] Karolinska Univ Hosp, Breast Canc Ctr, Theme Canc, Solna, Sweden; [Park, Yeon Hee] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Hui, Rina] Westmead Hosp, Westmead Breast Canc Inst, Sydney, NSW, Australia; [Hui, Rina] Univ Sydney, Sydney, NSW, Australia; [Takahashi, Masato] Natl Hosp Org Hokkaido Canc Ctr, Dept Breast Surg, Sapporo, Hokkaido, Japan; [Cardoso, Fatima] Champalimaud Fdn, Champalimaud Clin Ctr, Breast Unit, Lisbon, Portugal; [Jia, Liyi; Karantza, Vassiliki; Zhao, Jing; Aktan, Gursel] Merck, Kenilworth, NJ USA; [Dent, Rebecca] Duke Natl Univ Singapore, Sch Med, Natl Canc Ctr Singapore, Singapore, Singapore; [O'Shaughnessy, Joyce] Baylor Univ, Med Ctr, Texas Oncol, Dallas, TX USA; [O'Shaughnessy, Joyce] US Oncol, Dallas, TX USA	University of London; Queen Mary University London; Vall d'Hebron Institut d'Oncologia (VHIO); Yale University; Cedars Sinai Medical Center; Kliniken Essen-Mitte; Philipps University Marburg; Philipps University Marburg; University of Munich; University of Munich; University of Erlangen Nuremberg; Helios Kliniken; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Sydney; University of Sydney; Fundacao Champalimaud; Merck & Company; National Cancer Centre Singapore (NCCS); National University of Singapore; Baylor University; Baylor University Medical Center; Texas Oncology; US Oncology Network	Schmid, P (corresponding author), Queen Mary Univ London, Ctr Expt Canc Med, Barts Canc Inst, Old Anat Bldg,Charterhouse Sq, London EC1M 6BQ, England.	p.schmid@qmul.ac.uk	Uslu, Ruchan/CAA-9946-2022; Tarnawski, Rafal/N-7526-2016; Ganshina, Inna/AAJ-5754-2021; GIROTTO, GUSTAVO COLAGIOVANNI/AAF-4533-2021; Denkert, Carsten/AHE-2675-2022; Watanabe, Junichiro/AAI-8481-2021; Kuemmel, Sherko/AFV-3420-2022; Fasching, Peter A/ABH-9912-2020; Takahashi, Masato/ABC-2223-2020; Uslu, Ruchan/C-6855-2008	Tarnawski, Rafal/0000-0001-6802-5093; Ganshina, Inna/0000-0002-0105-9376; GIROTTO, GUSTAVO COLAGIOVANNI/0000-0002-4098-1320; Watanabe, Junichiro/0000-0001-9226-895X; Kuemmel, Sherko/0000-0001-9355-494X; Fasching, Peter A/0000-0003-4885-8471; AKSOY, SERCAN/0000-0003-4984-1049; Uslu, Ruchan/0000-0002-9584-6134; Bergh, Jonas/0000-0001-5526-1847; Evron, Ella/0000-0002-1003-5042; Diamond, Jennifer/0000-0002-0703-2772	Merck Sharp AMP; Dohme, a subsidiary of Merck	Merck Sharp AMP; Dohme, a subsidiary of Merck	Supported by Merck Sharp & Dohme, a subsidiary of Merck.	Adams S, 2019, ANN ONCOL, V30, P405, DOI 10.1093/annonc/mdy518; Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; Agency E.M., 2014, ROL PATH COMPL RESP; [Anonymous], 2017, PASCO S; Bretz F, 2009, STAT MED, V28, P586, DOI 10.1002/sim.3495; Briggs A, 2019, ISPOR NEW ORL MAY 18; Burstein HJ, 2019, ANN ONCOL, V30, P1541, DOI 10.1093/annonc/mdz235; Cardoso F, 2019, ANN ONCOL, V30, P1194, DOI 10.1093/annonc/mdz173; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Emens LA, 2018, SAN ANT BREAST CANC; Farkona S, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0623-5; FDA, 2014, GUID IND PATH COMPL; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hassett MJ, 2006, JNCI-J NATL CANCER I, V98, P1108, DOI 10.1093/jnci/djj305; Huang M, 2019, ESMO BREAST CANC BER; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Loibl S, 2018, LANCET ONCOL, V19, P497, DOI 10.1016/S1470-2045(18)30111-6; Masuda N, 2017, NEW ENGL J MED, V376, P2147, DOI 10.1056/NEJMoa1612645; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Nanda R, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.506; Nanda R, 2016, J CLIN ONCOL, V34, P2460, DOI 10.1200/JCO.2015.64.8931; National Cancer Institute (U.S.), 2009, COMMON TERMINOLOGY C; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pusztai L, 2019, LANCET ONCOL, V20, pE390, DOI 10.1016/S1470-2045(19)30158-5; Qi C, 2019, NCCN ANN C ORL MARCH; Rashid N, 2015, J MANAG CARE SPEC PH, V21, P863, DOI 10.18553/jmcp.2015.21.10.863; Schmid P, 2018, NEW ENGL J MED, V379, P2108, DOI 10.1056/NEJMoa1809615; Sikov WM, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.591; Sikov WM, 2015, J CLIN ONCOL, V33, P13, DOI 10.1200/JCO.2014.57.0572; Spring LM, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.SABCS18-GS2-03; von Minckwitz G, 2014, LANCET ONCOL, V15, P747, DOI 10.1016/S1470-2045(14)70160-3; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yoest JM, 2017, IMMUNOTARGETS THER, V6, P73, DOI 10.2147/ITT.S126227	35	785	804	17	120	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2020	382	9					810	821		10.1056/NEJMoa1910549	http://dx.doi.org/10.1056/NEJMoa1910549			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KS8TT	32101663	Bronze			2022-12-28	WOS:000518581500007
J	Cook, R; Davidson, P; Martin, R				Cook, Rob; Davidson, Peter; Martin, Rosie		NIHR Dissemination Ctr	Twenty miles per hour speed zones reduce the danger to pedestrians and cyclists	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cook, Rob; Martin, Rosie] Bazian, Economist Intelligence Unit Healthcare, London, England; [Davidson, Peter] Univ Southampton, Wessex Inst, Southampton, Hants, England	University of Southampton	Cook, R (corresponding author), Bazian, Economist Intelligence Unit Healthcare, London, England.	rob.cook@bazian.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2020	368								m453	10.1136/bmj.m453	http://dx.doi.org/10.1136/bmj.m453			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2JV	32102784				2022-12-28	WOS:000519535600003
J	Crane, MA; Chang, HA; Azamfirei, R				Crane, Matthew A.; Chang, Howard A.; Azamfirei, Razvan			Medical Education Takes a Step in the Right Direction Where Does That Leave Students?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses possible unforeseen consequences of the announced 2022 change to USMLE Step 1 licensure examination results reporting from a 3-digit score to a pass/fail designation, including increased emphasis by programs on the scored Step 2 Clinical Knowledge examination and increased reliance on institutional reputations as criteria to recruit trainees.	[Crane, Matthew A.; Chang, Howard A.; Azamfirei, Razvan] Johns Hopkins Univ, Sch Med, 733 N Broadway,Edward D Miller Res Bldg,Ste 137, Baltimore, MD 21205 USA	Johns Hopkins University	Crane, MA (corresponding author), Johns Hopkins Univ, Sch Med, 733 N Broadway,Edward D Miller Res Bldg,Ste 137, Baltimore, MD 21205 USA.	mcrane9@jhmi.edu	Azamfirei, Razvan/AAD-2899-2019	Azamfirei, Razvan/0000-0003-3301-0566; Crane, Matthew/0000-0002-0529-8948				Association of American Medical Colleges, GRAD SYST US US MED; Carmody JB, 2019, ACAD RADIOL, V26, P1403, DOI 10.1016/j.acra.2019.06.002; Chen DR, 2019, ACAD MED, V94, P302, DOI 10.1097/ACM.0000000000002565; Hammoud MM, 2020, JAMA-J AM MED ASSOC, V323, P503, DOI 10.1001/jama.2019.21212; National Resident Matching Program, RES 2018 NRMP PROGR; Swails JL, 2019, JAMA-J AM MED ASSOC, V322, P605, DOI 10.1001/jama.2019.9669; United States Medical Licensing Examination,, CHANG PASS FAIL SCOR	7	17	17	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					2013	2014		10.1001/jama.2020.2950	http://dx.doi.org/10.1001/jama.2020.2950			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LU8UM	32142102				2022-12-28	WOS:000538023900026
J	Emanuel, EJ				Emanuel, Ezekiel J.			The Inevitable Reimagining of Medical Education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Emanuel, Ezekiel J.] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, 423 Guardian Dr,Blockley Hall,Ste 1412, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Emanuel, EJ (corresponding author), Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, 423 Guardian Dr,Blockley Hall,Ste 1412, Philadelphia, PA 19104 USA.	MEHPchair@upenn.edu						Andrews JS, 2018, ACAD MED, V93, P414, DOI 10.1097/ACM.0000000000002020; [Anonymous], 2020, RETENTION GRADUATION; [Anonymous], 2018, MED SCH YEAR 2 QUEST; [Anonymous], 2019, FACTS GLANCE FALL 20; Berg R, 2014, ONLINE CLASSROOM, V14, P5; Hart C, 2012, J INTERACT ONLINE LE, V11, P19; Parr C, 2013, TIMES HIGHER ED; Raymond JR, 2015, ACAD MED, V90, P1318, DOI 10.1097/ACM.0000000000000862	8	111	117	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1127	1128		10.1001/jama.2020.1227	http://dx.doi.org/10.1001/jama.2020.1227			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK4BZ	32105294				2022-12-28	WOS:000530807000010
J	Cook, R; Lyon-Maris, J; Martin, R				Cook, Rob; Lyon-Maris, Johnny; Martin, Rosie		NIHR Dissemination Ctr	NIHR SIGNALS Tranexamic acid is safe to use following mild-to-moderate traumatic brain injury	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cook, Rob; Martin, Rosie] Bazian, Economist Intelligence Unit Healthcare, London, England; [Lyon-Maris, Johnny] Univ Southampton, Wessex Inst, Southampton, Hants, England	University of Southampton	Cook, R (corresponding author), Bazian, Economist Intelligence Unit Healthcare, London, England.	rob.cook@bazian.com						National Institute for Health and Care Excellence, 2016, MAJ TRAUM ASS IN MAN, VNG39; National Institute for Health and Care Excellence, 2014, HEAD INJ ASS EARL MA; Parsonage M., 2016, TRAUMATIC BRAIN INJU; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5	4	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2020	368								m514	10.1136/bmj.m514	http://dx.doi.org/10.1136/bmj.m514			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AR	32161036				2022-12-28	WOS:000520012800003
J	O'Brien, H; Paniker, J				O'Brien, Henry; Paniker, Jayanth			A painful swollen hand	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[O'Brien, Henry] Scunthorpe Gen Hosp, Scunthorpe, North Lincolnsh, England; [Paniker, Jayanth] Rotherham Hosp, Rotherham, S Yorkshire, England		O'Brien, H (corresponding author), Scunthorpe Gen Hosp, Scunthorpe, North Lincolnsh, England.	henry.o'brien1@nhs.net						Armstrong D, 2016, SURGERY, V34, P115; Chase J M, 1997, Am J Orthop (Belle Mead NJ), V26, P568; Suh N, 2014, J HAND SURG-AM, V39, P785, DOI 10.1016/j.jhsa.2013.10.030; Wharton DM, 2010, J HAND SURG-EUR VOL, V35E, P146, DOI 10.1177/1753193408098907	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2020	368								m614	10.1136/bmj.m614	http://dx.doi.org/10.1136/bmj.m614			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KI	32139356				2022-12-28	WOS:000519537000002
J	Ghanem, KG; Ram, S; Rice, PA				Ghanem, Khalil G.; Ram, Sanjay; Rice, Peter A.			The Modern Epidemic of Syphilis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BENZATHINE PENICILLIN-G; SEXUALLY-TRANSMITTED INFECTIONS; CEREBROSPINAL-FLUID; SEROLOGICAL RESPONSE; ORAL AMOXICILLIN; OCULAR SYPHILIS; UNITED-STATES; HIGH-RISK; NEUROSYPHILIS; MEN	Over the past two decades, the incidence of syphilis has increased sharply. The courses of both untreated and treated disease can be unpredictable. This review presents guidance on clinical recognition of syphilis, diagnostic-test algorithms, and recommended treatment regimens.	[Ghanem, Khalil G.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; [Ram, Sanjay; Rice, Peter A.] Univ Massachusetts, Med Ctr, Dept Med, Worcester, MA USA; [Ram, Sanjay; Rice, Peter A.] Univ Massachusetts, Med Ctr, Div Infect Dis & Immunol, Worcester, MA 01605 USA	Johns Hopkins University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Rice, PA (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Lazar Res Bldg,Rm 321,364 Plantat St, Worcester, MA 01605 USA.	peter.rice@umassmed.edu		Ghanem, Khalil/0000-0002-0033-302X				[Anonymous], 2018, MED BALTIMORE, V97, pe9654; [Anonymous], 2016, ANN ONCOL, V27, P58, DOI https://doi.org/10.1093/annonc/; [Anonymous], 2018, CANCER DISCOV, V8, pOF6; [Anonymous], 2014, NAT REV UROL, V12, P63; [Anonymous], 2019, ANIM BEHAV, V147, pI; [Anonymous], 2017, J ADOLESCENT HEALT S, V61, pS1; Bolan RK, 2015, SEX TRANSM DIS, V42, P98, DOI 10.1097/OLQ.0000000000000216; BROWN ST, 1985, JAMA-J AM MED ASSOC, V253, P1296, DOI 10.1001/jama.253.9.1296; Cai SN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15641-w; Cao YP, 2017, CLIN INFECT DIS, V65, P1683, DOI 10.1093/cid/cix611; CDC, 2017, CDC CALL ACT LETS WO; Centers for Disease Control and Prevention, 2019, SEX TRANSM DIS SURV; Chanem KG, 2008, AIDS, V22, P1145, DOI 10.1097/QAD.0b013e32830184df; Chen XS, 2013, CLIN MICROBIOL INFEC, V19, P975, DOI 10.1111/1469-0691.12098; CLARK E G, 1955, J Chronic Dis, V2, P311, DOI 10.1016/0021-9681(55)90139-9; Creegan L, 2007, SEX TRANSM DIS, V34, P1016, DOI 10.1097/OLQ.0b013e3181124473; CUDDY PG, 1982, DRUG INTEL CLIN PHAR, V16, P205, DOI 10.1177/106002808201600303; Davis AP, 2018, CLIN INFECT DIS, V66, P363, DOI 10.1093/cid/cix799; de Voux A, 2019, CLIN INFECT DIS, V68, P934, DOI 10.1093/cid/ciy571; FABER WR, 1983, SEX TRANSM DIS, V10, P148, DOI 10.1097/00007435-198307000-00011; Ghanem KG, 2007, SEX TRANSM INFECT, V83, P97, DOI 10.1136/sti.2006.021402; Ghanem KG, 2015, CLIN INFECT DIS, V61, pS818, DOI 10.1093/cid/civ714; Harding AS, 2012, SEX TRANSM DIS, V39, P291, DOI 10.1097/OLQ.0b013e31824c0e62; Harper KN, 2011, AM J PHYS ANTHROPOL, V146, P99, DOI 10.1002/ajpa.21613; Ho EL, 2011, J CLIN INVEST, V121, P4584, DOI 10.1172/JCI57173; Idsoe O, 1972, Bull World Health Organ, V47 Suppl, P1; Kidd SE, 2019, MMWR-MORBID MORTAL W, V68, P144, DOI 10.15585/mmwr.mm6806a4; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Lapere S, 2019, OCUL IMMUNOL INFLAMM, V27, P126, DOI 10.1080/09273948.2018.1521436; Li HY, 2018, TROP J PHARM RES, V17, P345, DOI 10.4314/tjpr.v17i2.21; Liang Z, 2016, INT J ANTIMICROB AG, V47, P6, DOI 10.1016/j.ijantimicag.2015.10.020; Lithgow KV, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14273; Lukehard SA, 2008, SEXUALLY TRANSMITTED, P647; Marra C.M., 2018, SEX TRANSM DIS S1, V45, pS10, DOI DOI 10.1097/OLQ.0000000000000851; Marra CM, 2008, CLIN INFECT DIS, V47, P893, DOI 10.1086/591534; Marra CM, 2010, J INFECT DIS, V202, P1380, DOI 10.1086/656533; Marra CM, 2004, J INFECT DIS, V189, P369, DOI 10.1086/381227; Merritt HH., 1946, NEUROSYPHILIS; Molina JM, 2018, LANCET INFECT DIS, V18, P308, DOI [10.1016/S1473-3099(17)30725-9, 10.1016/s1473-3099(17)30725-9]; Molini BJ, 2016, SEX TRANSM DIS, V43, P579, DOI 10.1097/OLQ.0000000000000486; MORRISON RE, 1985, GENITOURIN MED, V61, P359; Musher DM, 2008, CLIN INFECT DIS, V47, P900, DOI 10.1086/591535; NATHAN L, 1993, OBSTET GYNECOL, V82, P338; OLANSKY SIDNEY, 1950, AMER JOUR SYPHILIS GONORRHEA AND VENEREAL DIS, V34, P436; Oliver SE, 2016, MMWR-MORBID MORTAL W, V65, P1185, DOI 10.15585/mmwr.mm6543a2; Park IU, 2019, CLIN INFECT DIS, V68, P913, DOI 10.1093/cid/ciy558; PARRAN T, 1937, SHADOW LAND; Peterman TA, 2015, SEX HEALTH, V12, P126, DOI 10.1071/SH14156; Pillay Allan, 2018, Sex Transm Dis, V45, pS13, DOI [10.1097/olq.0000000000000843, 10.1097/OLQ.0000000000000843]; Plotzker Rosalyn E, 2018, Sex Transm Dis, V45, pS29, DOI [10.1097/olq.0000000000000846, 10.1097/OLQ.0000000000000846]; POLNIKORN N, 1980, BRIT J VENER DIS, V56, P363; ROMANOWSKI B, 1991, ANN INTERN MED, V114, P1005, DOI 10.7326/0003-4819-114-12-1005; Ropper AH, 2019, NEW ENGL J MED, V381, P1358, DOI 10.1056/NEJMra1906228; Salado-Rasmussen K, 2016, ACTA DERM-VENEREOL, V96, P807, DOI 10.2340/00015555-2289; Schon MP, 2016, NEW ENGL J MED, V374, P372, DOI 10.1056/NEJMicm1502476; Sena AC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1209-0; Sena AC, 2013, CLIN INFECT DIS, V56, P420, DOI 10.1093/cid/cis918; SHORT DH, 1966, ARCH DERMATOL, V93, P87, DOI 10.1001/archderm.93.1.87; Sparling PF., 2008, SEX TRANSM DIS, V4th ed, pp. 661; STOKES JH, 1944, MODERN CLIN SYPHILOL; Su JR, 2012, SEX TRANSM DIS, V39, P794, DOI 10.1097/OLQ.0b013e31826f36de; Tanizaki R, 2015, CLIN INFECT DIS, V61, P177, DOI 10.1093/cid/civ270; Tao YS, 2020, CLIN INFECT DIS, V70, P136, DOI 10.1093/cid/ciz331; Theeuwen H, 2019, LARYNGOSCOPE, V129, P1680, DOI 10.1002/lary.27635; Towns JM, 2016, SEX TRANSM INFECT, V92, P110, DOI 10.1136/sextrans-2015-052219; Traeger MW, 2019, JAMA-J AM MED ASSOC, V321, P1380, DOI 10.1001/jama.2019.2947; Tuddenham S, 2018, SEX TRANSM DIS, V45, P147, DOI [10.1097/OLQ.0000000000000723, 10.1097/olq.0000000000000723]; Woolston S, 2015, MMWR-MORBID MORTAL W, V64, P1150, DOI 10.15585/mmwr.mm6440a6; Woolston SL, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0542-9; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; Xiao Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10387-x; Yimtae K, 2007, OTOLARYNG HEAD NECK, V136, P67, DOI 10.1016/j.otohns.2006.08.026; Zhou CL, 2019, J CLIN LAB ANAL, V33, DOI 10.1002/jcla.22890; 2014, REG ANESTH PAIN MED, V9, pE1098	74	100	106	3	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2020	382	9					845	854		10.1056/NEJMra1901593	http://dx.doi.org/10.1056/NEJMra1901593			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KS8TT	32101666				2022-12-28	WOS:000518581500010
J	Wahlin, AK; Steiger, N; Darelius, E; Assmann, KM; Glessmer, MS; Ha, HK; Herraiz-Borreguero, L; Heuze, C; Jenkins, A; Kim, TW; Mazur, AK; Sommeria, J; Viboud, S				Wahlin, A. K.; Steiger, N.; Darelius, E.; Assmann, K. M.; Glessmer, M. S.; Ha, H. K.; Herraiz-Borreguero, L.; Heuze, C.; Jenkins, A.; Kim, T. W.; Mazur, A. K.; Sommeria, J.; Viboud, S.			Ice front blocking of ocean heat transport to an Antarctic ice shelf	NATURE			English	Article							CIRCUMPOLAR DEEP-WATER; CIRCULATION; DRIVEN; RETREAT; BENEATH; INFLOW	The front of the Getz Ice Shelf in West Antarctica creates an abrupt topographic step that deflects ocean currents, suppressing 70% of the heat delivery to the ice sheet. Mass loss from the Antarctic Ice Sheet to the ocean has increased in recent decades, largely because the thinning of its floating ice shelves has allowed the outflow of grounded ice to accelerate(1,2). Enhanced basal melting of the ice shelves is thought to be the ultimate driver of change(2,3), motivating a recent focus on the processes that control ocean heat transport onto and across the seabed of the Antarctic continental shelf towards the ice(4-6). However, the shoreward heat flux typically far exceeds that required to match observed melt rates(2,7,8), suggesting that other critical controls exist. Here we show that the depth-independent (barotropic) component of the heat flow towards an ice shelf is blocked by the marked step shape of the ice front, and that only the depth-varying (baroclinic) component, which is typically much smaller, can enter the sub-ice cavity. Our results arise from direct observations of the Getz Ice Shelf system and laboratory experiments on a rotating platform. A similar blocking of the barotropic component may occur in other areas with comparable ice-bathymetry configurations, which may explain why changes in the density structure of the water column have been found to be a better indicator of basal melt rate variability than the heat transported onto the continental shelf(9). Representing the step topography of the ice front accurately in models is thus important for simulating ocean heat fluxes and induced melt rates.	[Wahlin, A. K.; Assmann, K. M.; Mazur, A. K.] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden; [Steiger, N.; Darelius, E.] Univ Bergen, Bjerknes Ctr Climate Res, Bergen, Norway; [Steiger, N.; Darelius, E.] Univ Bergen, Geophys Inst, Bergen, Norway; [Glessmer, M. S.] Leibniz Inst Sci & Math Educ, Kiel, Germany; [Ha, H. K.] Inha Univ, Dept Ocean Sci, Incheon, South Korea; [Herraiz-Borreguero, L.] CSIRO, Hobart, Tas, Australia; [Herraiz-Borreguero, L.] Ctr Southern Hemisphere Oceans Res, Hobart, Tas, Australia; [Heuze, C.] Univ Gothenburg, Dept Earth Sci, Gothenburg, Sweden; [Jenkins, A.] British Antarctic Survey, Cambridge, England; [Kim, T. W.] Korea Polar Res Inst, Incheon, South Korea; [Sommeria, J.; Viboud, S.] Univ Grenoble Alpes, Lab Ecoulements Geophys & Ind, Grenoble, France; [Assmann, K. M.] Inst Marine Res, Tromso, Norway; [Jenkins, A.] Northumbria Univ, Dept Geog & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England	University of Gothenburg; Bjerknes Centre for Climate Research; University of Bergen; University of Bergen; Leibniz Institut fur die Padagogik der Naturwissenschaften und Mathematik an der Universitat Kiel (IPN); Inha University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Gothenburg; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Korea Polar Research Institute (KOPRI); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institute of Marine Research - Norway; Northumbria University	Wahlin, AK (corresponding author), Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden.	awahlin@gu.se	Heuzé, Céline/U-5058-2017; Ha, Ho Kyung/HCH-4138-2022; Steiger, Nadine/GLR-3736-2022; Wahlin, Anna/U-3790-2017	Heuzé, Céline/0000-0002-8850-5868; Steiger, Nadine/0000-0002-7533-6583; Jenkins, Adrian/0000-0002-9117-0616; Wahlin, Anna/0000-0003-1799-6476; viboud, samuel/0000-0002-6518-3165; Kim, Tae-Wan/0000-0001-5257-7256	European Union [654110]; Norwegian Research Council [267660, 231549]; UK Natural Environment Research Council [NE/L013770/1]; Swedish Research Council; Swedish Foundation for Strategic Research through the Swedish Maritime Robotics Center (SMaRC); Korea Polar Research Institute [KOPRI PE19060]; H2020 grant [661015]; Centre for Southern Hemisphere Oceans Research; NERC [NE/L013770/1] Funding Source: UKRI	European Union(European Commission); Norwegian Research Council(Research Council of NorwayEuropean Commission); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research through the Swedish Maritime Robotics Center (SMaRC); Korea Polar Research Institute(Korea Polar Research Institute of Marine Research Placement (KOPRI)); H2020 grant; Centre for Southern Hemisphere Oceans Research; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Our experiments were supported by the European Union's H2020 programme through the grant to Hydralab-plus, contract number 654110. We gratefully acknowledge grant support for the authors as follows: E.D. and N.S. from the Norwegian Research Council through grants 267660 (TOBACO) and 231549 (WARM); A.J. from the UK Natural Environment Research Council through grant number NE/L013770/1 (FISS); A.K.W. from the Swedish Research Council and the Swedish Foundation for Strategic Research through the Swedish Maritime Robotics Center (SMaRC); T.W.K. from the Korea Polar Research Institute, grant KOPRI PE19060; and L.H.B. from the H2020 grant number 661015 and the Centre for Southern Hemisphere Oceans Research. We thank I. Fer for lending instrumentation for GW1 and GW2.	Arndt JE, 2013, GEOPHYS RES LETT, V40, P3111, DOI 10.1002/grl.50413; Assmann KM, 2019, GEOPHYS RES LETT, V46, P870, DOI 10.1029/2018GL081354; CALLAHAN JE, 1972, DEEP-SEA RES, V19, P563, DOI 10.1016/0011-7471(72)90040-X; Cushman-Roisin B., 2011, INTRO GEOPHYS FLUID; Darelius E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12300; Darelius E., 2018, PHYS OCEANOGRAPHY MO, DOI [10.21335/NMDC-1721053841, DOI 10.21335/NMDC-1721053841]; DeConto RM, 2016, NATURE, V531, P591, DOI 10.1038/nature17145; Depoorter MA, 2013, NATURE, V502, P89, DOI 10.1038/nature12567; Fofonoff N.P., 1983, UNESCO TECHNICAL PAP, V44; GADE HG, 1979, J PHYS OCEANOGR, V9, P189, DOI 10.1175/1520-0485(1979)009<0189:MOIISW>2.0.CO;2; Grosfeld K, 1997, J GEOPHYS RES-OCEANS, V102, P15595, DOI 10.1029/97JC00891; Ha HK, 2014, J PHYS OCEANOGR, V44, P1493, DOI 10.1175/JPO-D-13-0240.1; Herraiz-Borreguero L, 2015, J GEOPHYS RES-OCEANS, V120, P3098, DOI 10.1002/2015JC010697; IOC SCOR & IAPSO, 2010, IOC MAN GUID; Jacobs S, 2013, J GEOPHYS RES-OCEANS, V118, P4152, DOI 10.1002/jgrc.20298; Jenkins A, 2018, NAT GEOSCI, V11, P733, DOI 10.1038/s41561-018-0207-4; Jenkins A, 2010, NAT GEOSCI, V3, P468, DOI 10.1038/NGEO890; Kalen O, 2016, DEEP-SEA RES PT II, V123, P7, DOI 10.1016/j.dsr2.2015.07.014; Little CM, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005197; Liu Y, 2015, P NATL ACAD SCI USA, V112, P3263, DOI 10.1073/pnas.1415137112; Miles T, 2016, DEEP-SEA RES PT II, V123, P16, DOI 10.1016/j.dsr2.2015.08.008; Nakayama Y, 2014, NAT COMMUN, V9, P1; Nicholls KW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025998; NOF D, 1983, DEEP-SEA RES, V30, P171, DOI 10.1016/0198-0149(83)90067-5; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Paloczy A, 2018, J GEOPHYS RES-OCEANS, V123, P7678, DOI 10.1029/2018JC014345; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Rignot E, 2013, SCIENCE, V341, P266, DOI 10.1126/science.1235798; Scambos TA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020670; Shepherd A, 2018, NATURE, V558, P219, DOI 10.1038/s41586-018-0179-y; Shepherd A, 2018, NATURE, V558, P223, DOI 10.1038/s41586-018-0171-6; St-Laurent P, 2013, J PHYS OCEANOGR, V43, P51, DOI 10.1175/JPO-D-11-0237.1; Taylor JA, 2008, WORK C CURR MEASUREM, P80; Thoma M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034939; Thompson AF, 2018, REV GEOPHYS, V56, P741, DOI 10.1029/2018RG000624; Wahlin AK, 2013, J PHYS OCEANOGR, V43, P2054, DOI 10.1175/JPO-D-12-0157.1; Wahlin AK, 2012, J PHYS OCEANOGR, V42, P1461, DOI 10.1175/JPO-D-11-041.1; Wahlin AK, 2010, J PHYS OCEANOGR, V40, P1427, DOI 10.1175/2010JPO4431.1; Wahlin AK, 2004, J FLUID MECH, V510, P95, DOI 10.1017/S0022112004009590; Wesche C, 2013, REMOTE SENS-BASEL, V5, P6305, DOI 10.3390/rs5126305	40	16	17	1	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB	2020	578	7796					568	+		10.1038/s41586-020-2014-5	http://dx.doi.org/10.1038/s41586-020-2014-5			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KP9SJ	32103192	Green Submitted, Green Accepted			2022-12-28	WOS:000516571100018
J	Patz, JA; Stull, VJ; Limaye, VS				Patz, Jonathan A.; Stull, Valerie J.; Limaye, Vijay S.			A Low-Carbon Future Could Improve Global Health and Achieve Economic Benefits	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint proposes that framing climate change as a human health crisis could accelerate climate action, and reviews evidence pointing toward the health benefits of transitioning to renewable energy, plant-based diets, and a global lower carbon footprint.	[Patz, Jonathan A.; Stull, Valerie J.] Univ Wisconsin Madison, Global Hlth Inst, Madison, WI USA; [Patz, Jonathan A.] Univ Wisconsin Madison, Dept Populat Hlth Sci, Madison, WI USA; [Patz, Jonathan A.] Univ Wisconsin Madison, Nelson Inst Environm Studies, Madison, WI USA; [Limaye, Vijay S.] Nat Resources Def Council, New York, NY USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Patz, JA (corresponding author), Univ Wisconsin Madison, Global Hlth Inst, Dept Populat Hlth Sci, Nelson Inst Environm Studies, 1710 Univ Ave, Madison, WI 53726 USA.	patz@wisc.edu		Limaye, Vijay/0000-0003-3118-6912; Stull, Valerie/0000-0003-4309-859X				Anenberg SC, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab35fc; Clark M, 2018, ANNU REV ENV RESOUR, V43, P109, DOI 10.1146/annurev-environ-102017-025957; Dimanchev EG, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab31d9; Limaye VS, 2019, GEOHEALTH, V3, P245, DOI 10.1029/2019GH000202; Markandya A, 2018, LANCET PLANET HEALTH, V2, pE126, DOI [10.1016/S2542-5196(18)30029-9, 10.1016/s2542-5196(18)30029-9]; Patz JA, 2014, JAMA-J AM MED ASSOC, V312, P1565, DOI 10.1001/jama.2014.13186; Poore J, 2018, SCIENCE, V360, P987, DOI 10.1126/science.aaq0216; Watts N, 2019, LANCET, V394, P1836, DOI 10.1016/S0140-6736(19)32596-6; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4	9	17	17	4	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2020	323	13					1247	1248		10.1001/jama.2020.1313	http://dx.doi.org/10.1001/jama.2020.1313			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LE3DZ	32108863				2022-12-28	WOS:000526602700010
J	Liang, JR; Lingeman, E; Luong, T; Ahmed, S; Muhar, M; Nguyen, T; Olzmann, JA; Corn, JE				Liang, Jin Rui; Lingeman, Emily; Thao Luong; Ahmed, Saba; Muhar, Matthias; Truc Nguyen; Olzmann, James A.; Corn, Jacob E.			A Genome-wide ER-phagy Screen Highlights Key Roles of Mitochondria! Metabolism and ER-Resident UFMylation	CELL			English	Article							ENDOPLASMIC-RETICULUM TURNOVER; RIBOPHORIN-I; MEMBRANE-PROTEINS; ATLASTIN GTPASES; PARKIN; PHOSPHORYLATION; MUTATIONS; PINK1; UFM1; UBIQUITINATION	Selective autophagy of organelles is critical for cellular differentiation, homeostasis, and organismal health. Autophagy of the ER (ER-phagy) is implicated in human neuropathy but is poorly understood beyond a few autophagosomal receptors and remodelers. By using an ER-phagy reporter and genome-wide CRISPRi screening, we identified 200 high-confidence human ER-phagy factors. Two pathways were unexpectedly required for ER-phagy. First, reduced mitochondrial metabolism represses ER-phagy, which is opposite of general autophagy and is independent of AMPK. Second, ER-localized UFMylation is required for ER-phagy to repress the unfolded protein response via IRE1 alpha. The UFL1 ligase is brought to the ER surface by DDRGK1 to UFMylate RPN1 and RPL26 and preferentially targets ER sheets for degradation, analogous to PINK1-Parkin regulation during mitophagy. Our data provide insight into the cellular logic of ER-phagy, reveal parallels between organelle autophagies, and provide an entry point to the relatively unexplored process of degrading the ER network.	[Liang, Jin Rui; Lingeman, Emily; Thao Luong; Ahmed, Saba; Corn, Jacob E.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Liang, Jin Rui; Lingeman, Emily; Thao Luong; Ahmed, Saba; Corn, Jacob E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Truc Nguyen; Olzmann, James A.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Liang, Jin Rui; Muhar, Matthias; Corn, Jacob E.] Swiss Fed Inst Technol, Dept Biol, CH-8093 Zurich, Switzerland; [Olzmann, James A.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; ETH Zurich	Corn, JE (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Corn, JE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Corn, JE (corresponding author), Swiss Fed Inst Technol, Dept Biol, CH-8093 Zurich, Switzerland.	jacob.corn@biol.ethz.ch		Olzmann, James/0000-0001-7751-8316; Liang, Jin Rui/0000-0002-8774-6061; Corn, Jacob/0000-0002-7798-5309	National Institutes of Health [DP2-HL-141006]; NOMIS Foundation; Lotte and Adolf Hotz-Sprenger Stiftung; Li Ka Shing Foundation; Heritage Medical Research Institute; National Institute of Health [R01GM112948]; National Science Foundation; NIH [S10 OD018174]; Gordon and Betty Moore Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NOMIS Foundation; Lotte and Adolf Hotz-Sprenger Stiftung; Li Ka Shing Foundation; Heritage Medical Research Institute; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	J.E.C. and J.R.L. were supported by the National Institutes of Health (DP2-HL-141006), the NOMIS Foundation, the Lotte and Adolf Hotz-Sprenger Stiftung, the Li Ka Shing Foundation, and the Heritage Medical Research Institute. This research was also supported by a grant from the National Institute of Health (R01GM112948 to J.A.O.). J.A.O. is a Chan Zuckerberg Biohub investigator. E.L. was supported by the National Science Foundation. This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, which is supported by NIH Instrumentation grant S10 OD018174. Confocal live- and fixed-cell imaging experiments were conducted at the Cancer Research Laboratory-Molecular Imaging Center Berkeley (supported by the Gordon and Betty Moore Foundation) and the Scientific Center for Optical and Electron Microscopy facility at ETH Zurich. Mass spectrometry experiments were performed by the Functional Genomics Center Zurich (ETH Zurich/University of Zurich).	Abel A, 2004, NEUROGENETICS, V5, P239, DOI 10.1007/s10048-004-0191-2; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Amin-Wetzel N, 2017, CELL, V171, P1625, DOI 10.1016/j.cell.2017.10.040; An H, 2019, MOL CELL, V74, P891, DOI 10.1016/j.molcel.2019.03.034; Binder J.X., 2014, DATABASE, V2014; Braunger K, 2018, SCIENCE, V360, P215, DOI 10.1126/science.aar7899; Cai YF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005643; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Chen QZ, 2019, CURR BIOL, V29, P846, DOI 10.1016/j.cub.2019.01.041; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; Chino H, 2019, MOL CELL, V74, P909, DOI 10.1016/j.molcel.2019.03.033; Daida A, 2018, EPILEPTIC DISORD, V20, P313, DOI 10.1684/epd.2018.0981; Daniel J, 2014, CELLS-BASEL, V3, P627, DOI 10.3390/cells3020627; Deas E, 2011, BBA-MOL CELL RES, V1813, P623, DOI 10.1016/j.bbamcr.2010.08.007; DeJesus R, 2016, ELIFE, V5, DOI [10.7554/elife.17290, 10.7554/eLife.17290]; Dodson MW, 2007, CURR OPIN NEUROBIOL, V17, P331, DOI 10.1016/j.conb.2007.04.010; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Egunsola AT, 2017, J CLIN INVEST, V127, P1475, DOI 10.1172/JCI90193; Elangovan M, 2017, J CELL COMMUN SIGNAL, V11, P265, DOI 10.1007/s12079-017-0386-6; Fregno I, 2018, EMBO J, V37, DOI 10.15252/embj.201899259; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Fumagalli F, 2016, NAT CELL BIOL, V18, P1173, DOI 10.1038/ncb3423; Geisler S, 2010, AUTOPHAGY, V6, P871, DOI 10.4161/auto.6.7.13286; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Grumati P, 2017, ELIFE, V6, DOI 10.7554/eLife.25555; Guo X., 2019, MITOCHONDRIAL DYSFUN, DOI [10.1101/715896., DOI 10.1101/715896.]; Hamasaki M, 2005, TRAFFIC, V6, P56, DOI 10.1111/j.1600-0854.2004.00245.x; Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Johnson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093597; Karbowski M, 2011, CURR OPIN CELL BIOL, V23, P476, DOI 10.1016/j.ceb.2011.05.007; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Kurth I, 2009, NAT GENET, V41, P1179, DOI 10.1038/ng.464; Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Leto DE, 2019, MOL CELL, V73, P377, DOI 10.1016/j.molcel.2018.11.015; Li W, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0843-6; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liang JR, 2018, J CELL BIOL, V217, P3354, DOI 10.1083/jcb.201804185; Lingeman E., 2017, CURRENT PROTOCOLS MO, V120; Liu J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14186; Lombardi AA, 2017, SCIENCE, V358, P591, DOI 10.1126/science.aaq0141; Mader BJ, 2012, ACS CHEM NEUROSCI, V3, P1063, DOI 10.1021/cn300145z; Mignon-Ravix C, 2018, HUM MUTAT, V39, P934, DOI 10.1002/humu.23534; Milev MP, 2017, AM J HUM GENET, V101, P291, DOI 10.1016/j.ajhg.2017.07.006; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nahorski MS, 2018, BRAIN, V141, P1934, DOI 10.1093/brain/awy135; Nguyen TN, 2016, TRENDS CELL BIOL, V26, P733, DOI 10.1016/j.tcb.2016.05.008; Nordgren M, 2015, AUTOPHAGY, V11, P1326, DOI 10.1080/15548627.2015.1061846; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; Oikawa D, 2009, EXP CELL RES, V315, P2496, DOI 10.1016/j.yexcr.2009.06.009; Olenych SG., 2007, CURR PROTOC CELL BIO, V33; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Phillips AR, 2008, GENETICS, V178, P1339, DOI 10.1534/genetics.107.086199; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Pilsl A, 2012, ACTA NEUROPATHOL, V123, P173, DOI 10.1007/s00401-011-0902-3; Qin B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09175-0; Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Schwarz DS, 2016, CELL MOL LIFE SCI, V73, P79, DOI 10.1007/s00018-015-2052-6; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Simsek D, 2017, CELL, V169, P1051, DOI 10.1016/j.cell.2017.05.022; Smith MD, 2018, DEV CELL, V44, P217, DOI 10.1016/j.devcel.2017.11.024; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; TSAO YS, 1992, J CELL BIOL, V116, P57, DOI 10.1083/jcb.116.1.57; Walczak CP, 2019, P NATL ACAD SCI USA, V116, P1299, DOI 10.1073/pnas.1816202116; Wang LH, 2020, CELL RES, V30, DOI 10.1038/s41422-019-0236-6; Wang S, 2016, ELIFE, V5, DOI 10.7554/eLife.14211; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wang ZF, 2019, NUCLEIC ACIDS RES, V47, P4124, DOI 10.1093/nar/gkz110; Wartosch L, 2015, TRAFFIC, V16, P727, DOI 10.1111/tra.12283; Wei Y, 2016, GENOM PROTEOM BIOINF, V14, P140, DOI 10.1016/j.gpb.2016.04.001; Wilson CM, 2005, J BIOL CHEM, V280, P4195, DOI 10.1074/jbc.M410329200; Wu JC, 2010, J BIOL CHEM, V285, P15126, DOI 10.1074/jbc.M110.110619; Xiao B, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00076; Yamano K, 2014, ELIFE, V3, DOI 10.7554/eLife.01612; Yan AX, 2005, GLYCOBIOLOGY, V15, P1407, DOI 10.1093/glycob/cwj026; Yoo HM, 2014, MOL CELL, V56, P261, DOI 10.1016/j.molcel.2014.08.007; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yuan HX, 2013, AUTOPHAGY, V9, P1983, DOI 10.4161/auto.26058; Zhang JW, 2015, NAT CELL BIOL, V17, P1259, DOI 10.1038/ncb3230; Zhang M, 2015, CELL DEATH DIFFER, V22, P1922, DOI 10.1038/cdd.2015.51; Zhao GH, 2016, EXP CELL RES, V349, P32, DOI 10.1016/j.yexcr.2016.09.015; Zhu HB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08908-5	99	65	66	9	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2020	180	6					1160	+		10.1016/j.cell.2020.02.017	http://dx.doi.org/10.1016/j.cell.2020.02.017			38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KW1IO	32160526	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000520925300013
J	Wenham, C; Smith, J; Morgan, R				Wenham, Clare; Smith, Julia; Morgan, Rosemary		Gender Covid 19 Working Grp	COVID-19: the gendered impacts of the outbreak	LANCET			English	Editorial Material									[Wenham, Clare] London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England; [Smith, Julia] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Morgan, Rosemary] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of London; London School Economics & Political Science; Simon Fraser University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wenham, C (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England.	c.wenham@lse.ac.uk		Morgan, Rosemary/0000-0001-5009-8470; Smith, Julia/0000-0002-5175-1109; Al-Rawi, Ahmed/0000-0001-7336-1550				[Anonymous], 2020, EB146CONF17 WHO; [Anonymous], 2020, EC TIMES; Campbell J., 2019, HLTH RES WORKING PAP; Carvalho R., 2020, S CHINA MORNING POST; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Davies SE, 2016, INT AFF, V92, P1041, DOI 10.1111/1468-2346.12704; Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.46234/ccdcw2020.032; Harman S, 2016, THIRD WORLD Q, V37, P524, DOI 10.1080/01436597.2015.1108827; Liu SW, 2017, J EPIDEMIOL COMMUN H, V71, P154, DOI 10.1136/jech-2016-207805; Smith J., 2019, Gender and Development, V27, P355, DOI 10.1080/13552074.2019.1615288; Sochas L, 2017, HEALTH POLICY PLANN, V32, P32, DOI 10.1093/heapol/czx108; Wenham C, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0007954; Wenham C, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0489-3	13	779	819	14	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2020	395	10227					846	848		10.1016/S0140-6736(20)30526-2	http://dx.doi.org/10.1016/S0140-6736(20)30526-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU9DZ	32151325	Green Published, Bronze			2022-12-28	WOS:000520024900012
J	Hervas, R; Rau, MJ; Park, Y; Zhang, WJ; Murzin, AG; Fitzpatrick, JAJ; Scheres, SHW; Si, K				Hervas, Ruben; Rau, Michael J.; Park, Younshim; Zhang, Wenjuan; Murzin, Alexey G.; Fitzpatrick, James A. J.; Scheres, Sjors H. W.; Si, Kausik			Cryo-EM structure of a neuronal functional amyloid implicated in memory persistence in Drosophila	SCIENCE			English	Article							BEAM-INDUCED MOTION; APLYSIA CPEB; PROTEIN; PRION; ORB2; FORM; POLYMORPHISM; PEPTIDES; ISOFORM; FIBRILS	How long-lived memories withstand molecular turnover is a fundamental question. Aggregates of a prion-like RNA-binding protein, cytoplasmic polyadenylation element-binding (CPEB) protein, is a putative substrate of long-lasting memories. We isolated aggregated Drosophila CPEB, Orb2, from adult heads and determined its activity and atomic structure, at 2.6-angstrom resolution, using cryo-electron microscopy. Orb2 formed similar to 75-nanometer-long threefold-symmetric amyloid filaments. Filament formation transformed Orb2 from a translation repressor to an activator and "seed" for further translationally active aggregation. The 31-amino acid protofilament core adopted a cross-beta unit with a single hydrophilic hairpin stabilized through interdigitated glutamine packing. Unlike the hydrophobic core of pathogenic amyloids, the hydrophilic core of Orb2 filaments suggests how some neuronal amyloids could be a stable yet regulatable substrate of memory.	[Hervas, Ruben; Park, Younshim; Si, Kausik] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Rau, Michael J.; Fitzpatrick, James A. J.] Washington Univ, Sch Med, Ctr Cellular Imaging, St Louis, MO 63110 USA; [Park, Younshim; Si, Kausik] Univ Kansas, Dept Mol & Integrat Physiol, Med Ctr, Kansas City, KS 66160 USA; [Zhang, Wenjuan; Murzin, Alexey G.; Scheres, Sjors H. W.] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England; [Fitzpatrick, James A. J.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA; [Fitzpatrick, James A. J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Fitzpatrick, James A. J.] Washington Univ St Louis, Dept Biomed Engn, St Louis, MO 63130 USA	Stowers Institute for Medical Research; Washington University (WUSTL); University of Kansas; University of Kansas Medical Center; MRC Laboratory Molecular Biology; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Si, K (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.; Si, K (corresponding author), Univ Kansas, Dept Mol & Integrat Physiol, Med Ctr, Kansas City, KS 66160 USA.	ksi@stowers.org	Scheres, Sjors H.W./AAY-2265-2021	Scheres, Sjors H.W./0000-0002-0462-6540; Rau, Michael/0000-0001-5170-2000; Zhang, Wenjuan/0000-0002-3011-9956; Hervas, Ruben/0000-0001-6393-6058	UK Medical Research Council [MC_UP_A025_1013]; Stowers Institute for Medical Research; MRC [MC_UP_A025_1013] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stowers Institute for Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council (MC_UP_A025_1013, to S.H.W.S.) and Stowers Institute for Medical Research (to K.S).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afroz T, 2014, GENE DEV, V28, P1498, DOI 10.1101/gad.241133.114; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; Didelot G, 2006, SCIENCE, V313, P851, DOI 10.1126/science.1127215; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fioriti L, 2015, NEURON, V86, P1433, DOI 10.1016/j.neuron.2015.05.021; Florens Laurence, 2006, V328, P159; He SD, 2017, J STRUCT BIOL, V198, P163, DOI 10.1016/j.jsb.2017.02.003; Heo S, 2018, P NATL ACAD SCI USA, V115, pE3827, DOI 10.1073/pnas.1720956115; Hervas R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002361; Hughes MP, 2018, SCIENCE, V359, P698, DOI 10.1126/science.aan6398; Iglesias V, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00314; Josselyn SA, 2020, SCIENCE, V367, P39, DOI 10.1126/science.aaw4325; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Khan MR, 2015, CELL, V163, P1468, DOI 10.1016/j.cell.2015.11.020; Kruttner S, 2015, CELL REP, V11, P1953, DOI 10.1016/j.celrep.2015.05.037; Kruttner S, 2012, NEURON, V76, P383, DOI 10.1016/j.neuron.2012.08.028; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Li LY, 2016, CURR BIOL, V26, P3143, DOI 10.1016/j.cub.2016.09.054; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; Majumdar A, 2012, CELL, V148, P515, DOI 10.1016/j.cell.2012.01.004; Mastushita-Sakai T, 2010, P NATL ACAD SCI USA, V107, P11987, DOI 10.1073/pnas.1004433107; Mompean M, 2018, CELL, V173, P1244, DOI 10.1016/j.cell.2018.03.032; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Peretti D, 2015, NATURE, V518, P236, DOI 10.1038/nature14142; Qiang W, 2013, J AM CHEM SOC, V135, P6860, DOI 10.1021/ja311963f; Raveendra BL, 2013, NAT STRUCT MOL BIOL, V20, P495, DOI 10.1038/nsmb.2503; Scheres SHW, 2020, ACTA CRYSTALLOGR D, V76, P94, DOI 10.1107/S2059798319016577; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Stephan JS, 2015, CELL REP, V11, P1772, DOI 10.1016/j.celrep.2015.04.060; Stepien BK, 2016, P NATL ACAD SCI USA, V113, pE7030, DOI 10.1073/pnas.1603715113; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tsien RY, 2013, P NATL ACAD SCI USA, V110, P12456, DOI 10.1073/pnas.1310158110; Tycko R, 2015, NEURON, V86, P632, DOI 10.1016/j.neuron.2015.03.017; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wu H, 2016, CELL, V165, P1055, DOI 10.1016/j.cell.2016.05.004; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	53	73	74	4	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1230	+		10.1126/science.aba3526	http://dx.doi.org/10.1126/science.aba3526			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9DP	32165583	Green Accepted			2022-12-28	WOS:000520023800038
J	Laird, S; Wynberg, R; Rourke, M; Humphries, F; Muller, MR; Lawson, C				Laird, Sarah; Wynberg, Rachel; Rourke, Michelle; Humphries, Fran; Muller, Manuel Ruiz; Lawson, Charles			Rethink the expansion of access and benefit sharing	SCIENCE			English	Editorial Material							CBD		[Laird, Sarah] People & Plants Int, Bristol, VT 05443 USA; [Wynberg, Rachel] Univ Cape Town, Dept Environm & Geog Sci, Rondebosch, South Africa; [Rourke, Michelle] CSIRO, Synthet Biol Future Sci Platform, Canberra, ACT 2601, Australia; [Rourke, Michelle; Humphries, Fran] Griffith Univ, Griffith Law Sch, Law Futures Ctr, Nathan, Qld 4111, Australia; [Muller, Manuel Ruiz] Peruvian Soc Environm Law, Lima, Peru; [Lawson, Charles] Griffith Univ, Environm Futures Res Inst, Griffith Law Sch, Nathan, Qld 4111, Australia	University of Cape Town; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Griffith University; Griffith University	Laird, S (corresponding author), People & Plants Int, Bristol, VT 05443 USA.	laird@peopleandplants.org		Rourke, Michelle/0000-0003-1560-8943; Wynberg, Rachel/0000-0002-2984-9759	UK Government's Darwin Initiative; South African Research Chairs Initiative of the Department of Science and Innovation; National Research Foundation of SouthAfrica	UK Government's Darwin Initiative; South African Research Chairs Initiative of the Department of Science and Innovation; National Research Foundation of SouthAfrica(National Research Foundation - South Africa)	Supported by the UK Government's Darwin Initiative and by the South African Research Chairs Initiative of the Department of Science and Innovation and National Research Foundation of SouthAfrica.	Bockmann FA, 2018, SCIENCE, V360, P865, DOI 10.1126/science.aat7540; GISAID, 2019, GISAIDS COMM WHO REP; Humphries C, 2018, EUR INTELL PROP R, V40; IPBES, 2019, GLOBAL ASSESSMENT RE, DOI DOI 10.5281/ZENODO.3831673; Laird S.A, 2018, FACT FINDING SCOPING; Laird SA, 2002, SELLING FOREST ENVIRONMENTAL SERVICES, P151; Laird SA, 2016, NANOETHICS, V10, P189, DOI 10.1007/s11569-016-0268-z; Lawson C, 2019, J WORLD INTELLECT PR, V22, P103, DOI 10.1111/jwip.12118; Neumann D, 2018, ORG DIVERS EVOL, V18, P1, DOI 10.1007/s13127-017-0347-1; Prathapan KD, 2018, SCIENCE, V360, P1405, DOI 10.1126/science.aat9844; Ruiz Muller M, 2015, GENETIC RESOURCES NA; Welch E. W., 2018, POTENTIAL IMPLICATIO; World Health Organization, 2018, APPR SEAS INFL GEN S; Wynberg R, 2017, S AFR J BOT, V110, P39, DOI 10.1016/j.sajb.2016.09.015; Wynberg R, 2009, INDIGENOUS PEOPLES, CONSENT AND BENEFIT SHARING: LESSONS FROM THE SAN-HOODIA CASE, P69, DOI 10.1007/978-90-481-3123-5_5	15	41	41	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1200	1202		10.1126/science.aba9609	http://dx.doi.org/10.1126/science.aba9609			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU9DP	32165574				2022-12-28	WOS:000520023800024
J	Moss, J; Williams, A				Moss, Jonathan; Williams, Anna			Opening the floodgates to the brain	SCIENCE			English	Editorial Material							MIGRAINE; STROKE; MODEL		[Moss, Jonathan; Williams, Anna] Univ Edinburgh, Med Res Council, Ctr Regenerat Med, 5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh	Williams, A (corresponding author), Univ Edinburgh, Med Res Council, Ctr Regenerat Med, 5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.	anna.williams@ed.ac.uk			UK Dementia Research Institute; MRC [UKDRI-4002] Funding Source: UKRI	UK Dementia Research Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors are fundedby the UK Dementia Research Institute.	Cherian I, 2018, J NEUROSCI RES, V96, P744, DOI 10.1002/jnr.24145; Costa C, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-62; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Huang Y, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00584; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Kramer DR, 2016, J CLIN NEUROSCI, V24, P22, DOI 10.1016/j.jocn.2015.08.004; Kurth T, 2012, LANCET NEUROL, V11, P92, DOI 10.1016/S1474-4422(11)70266-6; Mestre H., 2020, SCIENCE, V367; National Institute for Health and Care Excellence (NICE) Guidelines, 2019, STROK TRANS ISCH ATT; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252	15	2	2	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2020	367	6483					1195	1196		10.1126/science.aba8801	http://dx.doi.org/10.1126/science.aba8801			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU9DP	32165571				2022-12-28	WOS:000520023800021
J	Mil, A; Zache, TV; Hegde, A; Xia, A; Bhatt, RP; Oberthaler, MK; Hauke, P; Berges, J; Jendrzejewski, F				Mil, Alexander; Zache, Torsten V.; Hegde, Apoorva; Xia, Andy; Bhatt, Rohit P.; Oberthaler, Markus K.; Hauke, Philipp; Berges, Juergen; Jendrzejewski, Fred			A scalable realization of local U(1) gauge invariance in cold atomic mixtures	SCIENCE			English	Article							QUANTUM SIMULATION; DYNAMICS; MODELS; GASES	In the fundamental laws of physics, gauge fields mediate the interaction between charged particles. An example is the quantum theory of electrons interacting with the electromagnetic field, based on U(1) gauge symmetry. Solving such gauge theories is in general a hard problem for classical computational techniques. Although quantum computers suggest a way forward, large-scale digital quantum devices for complex simulations are difficult to build. We propose a scalable analog quantum simulator of a U(1) gauge theory in one spatial dimension. Using interspecies spin-changing collisions in an atomic mixture, we achieve gauge-invariant interactions between matter and gauge fields with spin- and species-independent trapping potentials. We experimentally realize the elementary building block as a key step toward a platform for quantum simulations of continuous gauge theories.	[Mil, Alexander; Hegde, Apoorva; Xia, Andy; Bhatt, Rohit P.; Oberthaler, Markus K.; Hauke, Philipp; Jendrzejewski, Fred] Heidelberg Univ, Kirchhoff Inst Phys, Neuenheimer Feld 227, D-69120 Heidelberg, Germany; [Zache, Torsten V.; Hauke, Philipp; Berges, Juergen] Heidelberg Univ, Inst Theoret Phys, Philosophenweg 16, D-69120 Heidelberg, Germany; [Hauke, Philipp] Univ Trento, INO CNR BEC Ctr, Via Sommar 14, I-38123 Trento, Italy; [Hauke, Philipp] Univ Trento, Dept Phys, Via Sommar 14, I-38123 Trento, Italy	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); University of Trento; University of Trento	Mil, A (corresponding author), Heidelberg Univ, Kirchhoff Inst Phys, Neuenheimer Feld 227, D-69120 Heidelberg, Germany.	block@synqs.org	Berges, Jürgen/AAW-6472-2020; Jendrzejewski, Fred/L-2998-2016; Zache, Torsten Victor/ACZ-8730-2022; Hauke, Philipp/H-5304-2015	Jendrzejewski, Fred/0000-0003-1488-7901; Zache, Torsten Victor/0000-0003-3549-7160; Hauke, Philipp/0000-0002-0414-1754; Bhatt, Rohit Prasad/0000-0003-0478-2866; Xia, Andy/0000-0002-7486-1589; Hegde, Apoorva/0000-0001-9996-9126	DFG Collaborative Research Centre [SFB 1225]; ERC [804305, 694561]; Excellence Initiative of the German federal government; state governments funding line Institutional Strategy (Zukunftskonzept): DFG [ZUK 49/U]; DFG [FOR 2724]; Emmy-Noether grant [377616843]; Juniorprofessorenprogramm Baden-Wurttemberg (MWK); Provincia Autonoma di Trento, Quantum Science and Technology in Trento	DFG Collaborative Research Centre(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); Excellence Initiative of the German federal government; state governments funding line Institutional Strategy (Zukunftskonzept): DFG(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Emmy-Noether grant(German Research Foundation (DFG)); Juniorprofessorenprogramm Baden-Wurttemberg (MWK); Provincia Autonoma di Trento, Quantum Science and Technology in Trento	We acknowledge funding from the DFG Collaborative Research Centre "SFB 1225 (ISOQUANT)," the ERC Advanced Grant "EntangleGen" (Project-ID 694561), the ERC Starting Grant "StrEnQTh" (Project-ID 804305), and the Excellence Initiative of the German federal government and the state governments funding line Institutional Strategy (Zukunftskonzept): DFG project number ZUK 49/U. F.J. acknowledges the DFG support through the project FOR 2724, the Emmy-Noether grant (project-id 377616843) and from the Juniorprofessorenprogramm Baden-Wurttemberg (MWK). P.H. acknowledges support by Provincia Autonoma di Trento, Quantum Science and Technology in Trento.	Aidelsburger M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.255301; Berges J, 2019, NATURE, V569, P339, DOI 10.1038/d41586-019-01483-1; Bernien H, 2017, NATURE, V551, P579, DOI 10.1038/nature24622; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Chevy F, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/11/112401; Cirac JI, 2012, NAT PHYS, V8, P264, DOI 10.1038/nphys2275; Clark LW, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.030402; Dalmonte M, 2016, CONTEMP PHYS, V57, P388, DOI 10.1080/00107514.2016.1151199; Dao TL, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.023627; Gorg F, 2019, NAT PHYS, V15, P1161, DOI 10.1038/s41567-019-0615-4; Goldman N, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/12/126401; Gross C, 2010, NATURE, V464, P1165, DOI 10.1038/nature08919; Grusdt F, 2016, P INT SCH PHYS, V191, P325, DOI 10.3254/978-1-61499-694-1-325; HORN D, 1981, PHYS LETT B, V100, P149, DOI 10.1016/0370-2693(81)90763-2; Jaksch D, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/356; Kasper V, 2016, PHYS LETT B, V760, P742, DOI 10.1016/j.physletb.2016.07.036; Kasper V, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.025016; KOGUT JB, 1979, REV MOD PHYS, V51, P659, DOI 10.1103/RevModPhys.51.659; Li XK, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.255301; Luo M, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.043609; Nicklas E, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.193001; Ockeloen CF, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.061606; Reinaudi G, 2007, OPT LETT, V32, P3143, DOI 10.1364/OL.32.003143; Rentrop T, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.041041; Riedel MF, 2010, NATURE, V464, P1170, DOI 10.1038/nature08988; Stamper-Kurn DM, 2013, REV MOD PHYS, V85, P1191, DOI 10.1103/RevModPhys.85.1191; Surace F. M., 2019, ARXIV190209551CONDMA; Tai ME, 2017, NATURE, V546, P519, DOI 10.1038/nature22811; Weinberg S., 1995, QUANTUM THEORY FIELD, V2; Zache TV, 2018, QUANTUM SCI TECHNOL, V3, DOI 10.1088/2058-9565/aac33b	40	84	84	3	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2020	367	6482					1128	+		10.1126/science.aaz5312	http://dx.doi.org/10.1126/science.aaz5312			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU9CD	32139542	Green Submitted			2022-12-28	WOS:000520018400041
J	Iacobucci, G				Iacobucci, Gareth			Obesity: medical leaders call for end to "stigmatising" language	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Rubino F, 2020, LANCET DIABETES ENDO, V8, P374, DOI 10.1038/s41591-020-0803-x	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2020	368								m858	10.1136/bmj.m858	http://dx.doi.org/10.1136/bmj.m858			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KE	32132108				2022-12-28	WOS:000519536600016
J	Keller, MD; Ching, KL; Liang, FX; Dhabaria, A; Tam, K; Ueberheide, BM; Unutmaz, D; Torres, VJ; Cadwell, K				Keller, Matthew D.; Ching, Krystal L.; Liang, Feng-Xia; Dhabaria, Avantika; Tam, Kayan; Ueberheide, Beatrix M.; Unutmaz, Derya; Torres, Victor J.; Cadwell, Ken			Decoy exosomes provide protection against bacterial toxins	NATURE			English	Article							AUTOPHAGY; RECEPTOR; MECHANISM; VESICLES; CELLS	The production of pore-forming toxins that disrupt the plasma membrane of host cells is a common virulence strategy for bacterial pathogens such as methicillin-resistant Staphylococcus aureus (MRSA)(1-3). It is unclear, however, whether host species possess innate immune mechanisms that can neutralize pore-forming toxins during infection. We previously showed that the autophagy protein ATG16L1 is necessary for protection against MRSA strains encoding alpha-toxin(4)-a pore-forming toxin that binds the metalloprotease ADAM10 on the surface of a broad range of target cells and tissues(2,5,6). Autophagy typically involves the targeting of cytosolic material to the lysosome for degradation. Here we demonstrate that ATG16L1 and other ATG proteins mediate protection against alpha-toxin through the release of ADAM10 on exosomes-extracellular vesicles of endosomal origin. Bacterial DNA and CpG DNA induce the secretion of ADAM10-bearing exosomes from human cells as well as in mice. Transferred exosomes protect host cells in vitro by serving as scavengers that can bind multiple toxins, and improve the survival of mice infected with MRSA in vivo. These findings indicate that ATG proteins mediate a previously unknown form of defence in response to infection, facilitating the release of exosomes that serve as decoys for bacterially produced toxins.	[Keller, Matthew D.; Ching, Krystal L.; Tam, Kayan; Torres, Victor J.; Cadwell, Ken] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Keller, Matthew D.; Ching, Krystal L.; Cadwell, Ken] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Liang, Feng-Xia; Dhabaria, Avantika; Ueberheide, Beatrix M.] New York Univ Langone Hlth, Div Adv Res Technol, New York, NY USA; [Liang, Feng-Xia] New York Univ Langone Hlth, Microscopy Labratory, New York, NY USA; [Dhabaria, Avantika; Ueberheide, Beatrix M.] New York Univ Langone Hlth, Prote Lab, New York, NY USA; [Ueberheide, Beatrix M.] Laura & Isaac Perlmutter Canc Ctr, New York, NY USA; [Unutmaz, Derya] Jackson Lab Genom Med, Farmington, CT USA; [Cadwell, Ken] New York Univ Langone Hlth, Dept Med, Div Gastroenterol & Hepatol, New York, NY 10016 USA	New York University; New York University; New York University; New York University; New York University; Jackson Laboratory; New York University	Torres, VJ; Cadwell, K (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.; Cadwell, K (corresponding author), NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA.; Cadwell, K (corresponding author), New York Univ Langone Hlth, Dept Med, Div Gastroenterol & Hepatol, New York, NY 10016 USA.	Victor.Torres@nyulangone.org; Ken.Cadwell@nyulangone.org		Ching, Krystal/0000-0002-1181-0119; Torres, Victor/0000-0002-7126-0489; Unutmaz, Derya/0000-0001-8898-6633; Cadwell, Ken/0000-0002-5860-0661; Liang, Fengxia/0000-0003-0037-4590; Ueberheide, Beatrix/0000-0003-2512-0204; Tam, Kayan/0000-0003-0534-1691	US National Institute of Health (NIH) [R01 AI121244, R01 HL123340, R01 DK093668, R01 DK103788, R01 AI130945, R01 HL125816, R01 AI099394, R01 AI105129, T32 AI007180, F31 HL137304]; NYU CTSA grant from the National Center for Advancing Translational Sciences (NCATS) [UL1TR001445]; NYU Cancer Center grant [P30CA016087]	US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYU CTSA grant from the National Center for Advancing Translational Sciences (NCATS); NYU Cancer Center grant	We thank members of the Cadwell and Torres laboratory for constructive comments over the years, and particularly I. Irnov and E. Anderson for providing purified S. aureus DNA and assisting with the LukED protection experiments, respectively. This work was supported in part by US National Institute of Health (NIH) grants R01 AI121244 (to K.C. and V.J.T.); R01 HL123340, R01 DK093668, R01 DK103788, R01 AI130945 and R01 HL125816 (to K.C.); R01 AI099394 and R01 AI105129 (to V.J.T.); T32 AI007180 and F31 HL137304 (to M.D.K.); and pilot awards from the NYU CTSA grant UL1TR001445 from the National Center for Advancing Translational Sciences (NCATS) (to K.C.) and NYU Cancer Center grant P30CA016087 (to K.C.). Cell sorting/flow cytometry (NYU Langone Health's Cytometry and Cell Sorting Laboratory), mass spectrometry (The Proteomics Labratory at NYU Langone Health) and electronmicroscopy studies (The Microscopy Labratory at NYU Langone Health) are supported in part by NYU Langone Health's Laura and Isaac Perlmutter Cancer Center Support (grant P30CA016087) from the National Cancer Institute Langone. This work was also supported by a Faculty Scholar grant from the Howard Hughes Medical Institute, the Merieux Institute, the Kenneth Rainin Foundation, the Crohn's & Colitis Foundation and the Stony Wold-Herbert Fund (all to K.C.). K.C. and V.J.T. are Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Diseases.	Alonzo F, 2013, NATURE, V493, P51, DOI 10.1038/nature11724; Becker REN, 2014, J INNATE IMMUN, V6, P619, DOI 10.1159/000360006; Cadwell K, 2018, J CELL BIOL, V217, P813, DOI 10.1083/jcb.201706157; Cho YE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172463; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; DuMont AL, 2013, P NATL ACAD SCI USA, V110, P10794, DOI 10.1073/pnas.1305121110; Ejlerskov P, 2013, J BIOL CHEM, V288, P17313, DOI 10.1074/jbc.M112.401174; Guo HS, 2017, DEV CELL, V43, P716, DOI 10.1016/j.devcel.2017.11.018; Henry BD, 2015, NAT BIOTECHNOL, V33, P81, DOI 10.1038/nbt.3037; Hubbard-Lucey VM, 2014, IMMUNITY, V41, P579, DOI 10.1016/j.immuni.2014.09.011; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Kimura T, 2017, EMBO J, V36, P42, DOI 10.15252/embj.201695081; Marchiando AM, 2013, CELL HOST MICROBE, V14, P216, DOI 10.1016/j.chom.2013.07.013; Matsuzawa-Ishimoto Y, 2018, ANNU REV IMMUNOL, V36, P73, DOI 10.1146/annurev-immunol-042617-053253; Matsuzawa-Ishimoto Y, 2017, J EXP MED, V214, P3687, DOI 10.1084/jem.20170558; Maurer K, 2015, CELL HOST MICROBE, V17, P429, DOI 10.1016/j.chom.2015.03.001; Miao YX, 2015, CELL, V161, P1306, DOI 10.1016/j.cell.2015.05.009; MITAMURA T, 1995, J BIOL CHEM, V270, P1015, DOI 10.1074/jbc.270.3.1015; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Murrow L, 2015, NAT CELL BIOL, V17, P300, DOI 10.1038/ncb3112; Presley JF, 1997, J BIOL CHEM, V272, P13929, DOI 10.1074/jbc.272.21.13929; Seilie ES, 2017, SEMIN CELL DEV BIOL, V72, P101, DOI 10.1016/j.semcdb.2017.04.003; Shimoda M, 2014, NAT CELL BIOL, V16, P889, DOI 10.1038/ncb3021; Spaan AN, 2017, NAT REV MICROBIOL, V15, P435, DOI 10.1038/nrmicro.2017.27; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Tan JMJ, 2018, NAT MICROBIOL, V3, P1472, DOI 10.1038/s41564-018-0293-5; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; van der Vlist EJ, 2012, NAT PROTOC, V7, P1311, DOI 10.1038/nprot.2012.065	32	82	84	13	155	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7798					260	+		10.1038/s41586-020-2066-6	http://dx.doi.org/10.1038/s41586-020-2066-6		MAR 2020	14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU0CC	32132711	Green Accepted			2022-12-28	WOS:000518098200002
J	Mahase, E				Mahase, Elisabeth			Covid-19: hoarding and misuse of protective gear is jeopardising the response, WHO warns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		MAHASE E, 2020, BMJ-BRIT MED J, V368, P7164, DOI DOI 10.1136/BMJ.M477; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m831	2	11	16	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2020	368								m869	10.1136/bmj.m869	http://dx.doi.org/10.1136/bmj.m869			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2KE	32132096	Bronze			2022-12-28	WOS:000519536600017
J	Kimura, I; Miyamoto, J; Ohue-Kitano, R; Watanabe, K; Yamada, T; Onuki, M; Aoki, R; Isobe, Y; Kashihara, D; Inoue, D; Inaba, A; Takamura, Y; Taira, S; Kumaki, S; Watanabe, M; Ito, M; Nakagawa, F; Irie, J; Kakuta, H; Shinohara, M; Iwatsuki, K; Tsujimoto, G; Ohno, H; Arita, M; Itoh, H; Hase, K				Kimura, Ikuo; Miyamoto, Junki; Ohue-Kitano, Ryuji; Watanabe, Keita; Yamada, Takahiro; Onuki, Masayoshi; Aoki, Ryo; Isobe, Yosuke; Kashihara, Daiji; Inoue, Daisuke; Inaba, Akihiko; Takamura, Yuta; Taira, Satsuki; Kumaki, Shunsuke; Watanabe, Masaki; Ito, Masato; Nakagawa, Fumiyuki; Irie, Junichiro; Kakuta, Hiroki; Shinohara, Masakazu; Iwatsuki, Ken; Tsujimoto, Gozoh; Ohno, Hiroaki; Arita, Makoto; Itoh, Hiroshi; Hase, Koji			Maternal gut microbiota in pregnancy influences offspring metabolic phenotype in mice	SCIENCE			English	Article							CHAIN FATTY-ACIDS; INTESTINAL MICROBIOTA; GENERATED METABOLITES; BIRTH-WEIGHT; RECEPTOR; OBESITY; DIET; SECRETION; INFLAMMATION; CHILDHOOD	Antibiotics and dietary habits can affect the gut microbial community, thus influencing disease susceptibility. Although the effect of microbiota on the postnatal environment has been well documented, much less is known regarding the impact of gut microbiota at the embryonic stage. Here we show that maternal microbiota shapes the metabolic system of offspring in mice. During pregnancy, short-chain fatty acids produced by the maternal microbiota dictate the differentiation of neural, intestinal, and pancreatic cells through embryonic GPR41 and GPR43. This developmental process helps maintain postnatal energy homeostasis, as evidenced by the fact that offspring from germ-free mothers are highly susceptible to metabolic syndrome, even when reared under conventional conditions. Thus, our findings elaborate on a link between the maternal gut environment and the developmental origin of metabolic syndrome.	[Kimura, Ikuo; Miyamoto, Junki; Ohue-Kitano, Ryuji; Watanabe, Keita; Taira, Satsuki] Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, Fuchu, Tokyo 1838509, Japan; [Kimura, Ikuo; Miyamoto, Junki; Ohue-Kitano, Ryuji; Irie, Junichiro; Ohno, Hiroaki; Itoh, Hiroshi] AMED CREST, Japan Agcy Med Res & Dev, Chiyoda Ku, Tokyo 1000004, Japan; [Yamada, Takahiro; Onuki, Masayoshi; Ito, Masato; Hase, Koji] Keio Univ, Fac Pharm, Div Biochem, Tokyo 1058512, Japan; [Yamada, Takahiro; Onuki, Masayoshi; Ito, Masato; Hase, Koji] Keio Univ, Grad Sch Pharmaceut Sci, Tokyo 1058512, Japan; [Aoki, Ryo] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo 1608582, Japan; [Aoki, Ryo] Ezaki Glico Co Ltd, Inst Hlth Sci, Osaka 5558502, Japan; [Isobe, Yosuke; Arita, Makoto] RIKEN Ctr Integrat Med Sci, Lab Metabol, Yokohama, Kanagawa 2300045, Japan; [Kashihara, Daiji; Inoue, Daisuke; Tsujimoto, Gozoh] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Kyoto 6068501, Japan; [Inaba, Akihiko; Kumaki, Shunsuke; Iwatsuki, Ken] Tokyo Univ Agr, Dept Nutr Sci & Food Safety, Tokyo 1568502, Japan; [Takamura, Yuta; Watanabe, Masaki; Kakuta, Hiroki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Div Pharmaceut Sci, Okayama 7008530, Japan; [Nakagawa, Fumiyuki] Shiga Univ Med Sci, Dept Med, Shiga 5202192, Japan; [Nakagawa, Fumiyuki] CMIC Pharma Sci Co Ltd, Nishiwaki Lab, Nishiwaki, Hyogo 6770032, Japan; [Irie, Junichiro; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Endocrinol Metab & Nephrol, Tokyo 1608582, Japan; [Shinohara, Masakazu] Kobe Univ, Grad Sch Med, Div Epidemiol, Kobe, Hyogo 6500017, Japan; [Ohno, Hiroaki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Bioorgan Med Chem, Kyoto 6068501, Japan; [Arita, Makoto] Keio Univ, Fac Pharm, Div Physiol Chem & Metab, Tokyo, Japan; [Arita, Makoto] Yokohama City Univ, Grad Sch Med Life Sci, Cellular & Mol Epigenet Lab, Yokohama, Kanagawa 2300045, Japan; [Hase, Koji] Univ Tokyo IMSUT, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Tokyo 1088639, Japan	Tokyo University of Agriculture & Technology; Keio University; Keio University; Keio University; Ezaki Glico Co., Ltd.; RIKEN; Kyoto University; Tokyo University of Agriculture; Okayama University; Shiga University of Medical Science; Keio University; Kobe University; Kyoto University; Keio University; Yokohama City University	Kimura, I (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, Fuchu, Tokyo 1838509, Japan.; Kimura, I (corresponding author), AMED CREST, Japan Agcy Med Res & Dev, Chiyoda Ku, Tokyo 1000004, Japan.; Hase, K (corresponding author), Keio Univ, Fac Pharm, Div Biochem, Tokyo 1058512, Japan.; Hase, K (corresponding author), Keio Univ, Grad Sch Pharmaceut Sci, Tokyo 1058512, Japan.; Hase, K (corresponding author), Univ Tokyo IMSUT, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Tokyo 1088639, Japan.	ikimura@cc.tuat.ac.jp; hase-kj@pha.keio.ac.jp	宮本, 潤基/ABG-8169-2020; Kakuta, Hiroki/X-6328-2018; Irie, Junichiro/H-7795-2019; Kimura, Ikuo/B-4193-2015; Ohno, Hiroaki/I-9010-2019	Kakuta, Hiroki/0000-0002-3633-8121; Irie, Junichiro/0000-0003-2662-4121; Ohno, Hiroaki/0000-0002-3246-4809; Takahiro, Yamada/0000-0003-2613-5600; Takamura, Yuta/0000-0001-9799-7123; Arita, Makoto/0000-0001-9902-0463; Watanabe, Masaki/0000-0003-1061-2679	JSPS KAKENHI [JP17H05344, JP15H05897, JP15H05898, JP18H04680, JP17KT0055]; AMED [JP18gm1010007, JP18gm1010004h0103]; Lotte Foundation; Institute for Fermentation Osaka; Takeda Science Foundation; Asahi Grass Foundation; Yakult Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED; Lotte Foundation; Institute for Fermentation Osaka(Institute for Fermentation (IFO)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Asahi Grass Foundation; Yakult Science Foundation	This work was supported by research grants from the JSPS KAKENHI (JP17H05344 to I.K., JP15H05897 and JP15H05898 to M.A., and JP18H04680 and JP17KT0055 to K.H.), AMED (JP18gm1010007 to I.K. and JP18gm1010004h0103 to K.H.), the Lotte Foundation (to I.K.), the Institute for Fermentation Osaka (to I.K.), the Takeda Science Foundation (to H.K.), the Asahi Grass Foundation (to K.H.), and the Yakult Science Foundation (to K.H.).	Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; BINKIN NJ, 1988, PEDIATRICS, V82, P828; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Dominguez-Bello MG, 2016, NAT MED, V22, P250, DOI 10.1038/nm.4039; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611; Fujisaka S, 2018, CELL REP, V22, P3072, DOI 10.1016/j.celrep.2018.02.060; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Huber K, 2011, J BIOL CHEM, V286, P22211, DOI 10.1074/jbc.M110.180224; Jawerbaum A, 2010, ENDOCR REV, V31, P680, DOI 10.1210/er.2009-0038; Kasubuchi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05423-9; Khan MT, 2014, CELL METAB, V20, P753, DOI 10.1016/j.cmet.2014.07.006; Kimura I., 2020, MATERNAL GUT MICROBI, V6, DOI https://doi.org/10.5061/dryad.5hqbzkh29.; Kimura I, 2020, PHYSIOL REV, V100, P171, DOI 10.1152/physrev.00041.2018; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee WJ, 2014, NAT CHEM BIOL, V10, P416, DOI 10.1038/nchembio.1535; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; McNelis JC, 2015, DIABETES, V64, P3203, DOI 10.2337/db14-1938; Miyamoto J, 2019, P NATL ACAD SCI USA, V116, P23813, DOI 10.1073/pnas.1912573116; Nam HK, 2018, ANN PEDIATR ENDOCRIN, V23, P9, DOI 10.6065/apem.2018.23.1.9; Oberdorfer F., 1995, APPL RADIAT ISOTOPES, V46, P317, DOI [10.1016/0969-8043(95)00008-2, DOI 10.1016/0969-8043(95)00008-2]; Parlee SD, 2014, BBA-MOL BASIS DIS, V1842, P495, DOI 10.1016/j.bbadis.2013.07.007; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Sanford JA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah4609; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Tanaka K, 2015, J CLIN INVEST, V125, P1591, DOI 10.1172/JCI78239; Tang C, 2015, NAT MED, V21, P173, DOI 10.1038/nm.3779; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ussar S, 2015, CELL METAB, V22, P516, DOI 10.1016/j.cmet.2015.07.007; Wadhwa PD, 2009, SEMIN REPROD MED, V27, P358, DOI 10.1055/s-0029-1237424; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347	52	139	144	28	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2020	367	6481					1002	+	eaaw8429	10.1126/science.aaw8429	http://dx.doi.org/10.1126/science.aaw8429			52	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KS0CO	32108090				2022-12-28	WOS:000517979600033
J	Perrotta, S; Roberti, D; Bencivenga, D; Corsetto, P; O'Brien, KA; Caiazza, M; Stampone, E; Allison, L; Fleck, RA; Scianguetta, S; Tartaglione, I; Robbins, PA; Casale, M; West, JA; Franzini-Armstrong, C; Griffin, JL; Rizzo, AM; Sinisi, AA; Murray, AJ; Borriello, A; Formenti, F; Della Ragione, F				Perrotta, Silverio; Roberti, Domenico; Bencivenga, Debora; Corsetto, Paola; O'Brien, Katie A.; Caiazza, Martina; Stampone, Emanuela; Allison, Leanne; Fleck, Roland A.; Scianguetta, Saverio; Tartaglione, Immacolata; Robbins, Peter A.; Casale, Maddalena; West, James A.; Franzini-Armstrong, Clara; Griffin, Julian L.; Rizzo, Angela M.; Sinisi, Antonio A.; Murray, Andrew J.; Borriello, Adriana; Formenti, Federico; Della Ragione, Fulvio			Effects of Germline VHL Deficiency on Growth, Metabolism, and Mitochondria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IRON-DEFICIENCY; CHUVASH POLYCYTHEMIA; HYPOXIA; MUTATION; GENE; ERYTHROCYTOSIS; PROTEIN; IDENTIFICATION; TRANSCRIPTION; ASSOCIATION	A young man with polycythemia, reduced growth rate, persistent hypoglycemia, and mitochondrial defects first appearing at birth was found to have a synonymous homozygous mutation in VHL (c.222C -> A) that created a cryptic splice site leading to the production of a truncated VHL protein. Mutations in VHL, which encodes von Hippel-Lindau tumor suppressor (VHL), are associated with divergent diseases. We describe a patient with marked erythrocytosis and prominent mitochondrial alterations associated with a severe germline VHL deficiency due to homozygosity for a novel synonymous mutation (c.222C -> A, p.V74V). The condition is characterized by early systemic onset and differs from Chuvash polycythemia (c.598C -> T) in that it is associated with a strongly reduced growth rate, persistent hypoglycemia, and limited exercise capacity. We report changes in gene expression that reprogram carbohydrate and lipid metabolism, impair muscle mitochondrial respiratory function, and uncouple oxygen consumption from ATP production. Moreover, we identified unusual intermitochondrial connecting ducts. Our findings add unexpected information on the importance of the VHL-hypoxia-inducible factor (HIF) axis to human phenotypes. (Funded by Associazione Italiana Ricerca sul Cancro and others.)	[Perrotta, Silverio; Roberti, Domenico; Caiazza, Martina; Scianguetta, Saverio; Tartaglione, Immacolata; Casale, Maddalena] Univ Campania Luigi Vanvitelli, Dept Woman Child & Gen & Specialized Surg, Naples, Italy; [Bencivenga, Debora; Stampone, Emanuela; Borriello, Adriana; Della Ragione, Fulvio] Univ Campania Luigi Vanvitelli, Dept Precis Med, Via De Crecchio 7, I-80138 Naples, Italy; [Sinisi, Antonio A.] Univ Campania Luigi Vanvitelli, Dept Adv Med & Surg Sci, Naples, Italy; [Corsetto, Paola; Rizzo, Angela M.] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [O'Brien, Katie A.; Murray, Andrew J.] Univ Cambridge, Dept Physiol Dev Neurosci, Cambridge, England; [West, James A.; Griffin, Julian L.] Univ Cambridge, Dept Biochem, Cambridge, England; [Allison, Leanne; Fleck, Roland A.] Kings Coll London, Ctr Ultrastruct Imaging, London, England; [Formenti, Federico] Kings Coll London, Ctr Human & Appl Physiol Sci, Fac Life Sci & Med, London SE1 1UL, England; [Robbins, Peter A.; Formenti, Federico] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Formenti, Federico] Univ Oxford, Nuffield Div Anaesthet, Oxford, England; [Franzini-Armstrong, Clara] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University of Milan; University of Cambridge; University of Cambridge; University of London; King's College London; University of London; King's College London; University of Oxford; University of Oxford; University of Pennsylvania	Della Ragione, F (corresponding author), Univ Campania Luigi Vanvitelli, Dept Precis Med, Via De Crecchio 7, I-80138 Naples, Italy.; Formenti, F (corresponding author), Kings Coll London, Ctr Human & Appl Physiol Sci, Fac Life Sci & Med, London SE1 1UL, England.	federico.formenti@kcl.ac.uk; fulvio.dellaragione@unicampania.it	Fleck, Roland/AAL-1292-2020; Formenti, Federico/F-3501-2012; Borriello, Adriana/K-3464-2018; Stampone, Emanuela/ABA-4795-2021; Tartaglione, Immacolata/AAY-9511-2020; RIZZO, ANGELA MARIA/E-4786-2012; CORSETTO, PAOLA ANTONIA/O-2244-2015	Fleck, Roland/0000-0003-1542-6218; Formenti, Federico/0000-0003-4289-0761; Perrotta, Silverio/0000-0001-6149-6845; RIZZO, ANGELA MARIA/0000-0002-8582-0432; BORRIELLO, Adriana/0000-0002-9026-8048; BENCIVENGA, Debora/0000-0003-0977-5374; Allison, Leanne/0000-0003-2954-9892; tartaglione, immacolata/0000-0003-1278-2372; STAMPONE, Emanuela/0000-0001-5828-1739; CORSETTO, PAOLA ANTONIA/0000-0003-3849-8548; Murray, Andrew/0000-0002-0929-9315	Associazione Italiana Ricerca sul Cancro [11653]; Programma VALERE; Vanvitelli per la Ricerca; 2015 Campania Regional funding for rare diseases; Evelyn Trust; King's College London; University of Oxford; Physiological Society; MRC [MC_PC_13030, MR/P01836X/1, MR/P011705/1, MC_UP_A090_1006, MR/P011705/2] Funding Source: UKRI	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Programma VALERE; Vanvitelli per la Ricerca; 2015 Campania Regional funding for rare diseases; Evelyn Trust; King's College London(General Electric); University of Oxford; Physiological Society; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a grant from the Associazione Italiana Ricerca sul Cancro (11653, to Dr. Della Ragione), Programma VALERE, Vanvitelli per la Ricerca (to Dr. Bencivenga and Ms. Caiazza), 2015 Campania Regional funding for rare diseases (to Dr. Perrotta), the Evelyn Trust (to Dr. Murray), and King's College London, University of Oxford, and the Physiological Society (to Dr. Formenti).	Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Baxter RC, 2013, J CELL COMMUN SIGNAL, V7, P179, DOI 10.1007/s12079-013-0203-9; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bento C, 2014, HUM MUTAT, V35, P15, DOI 10.1002/humu.22448; Corn PG, 2005, CANCER BIOL THER, V4, P1285, DOI 10.4161/cbt.4.11.2299; Dziegala M, 2018, J CACHEXIA SARCOPENI, V9, P802, DOI 10.1002/jcsm.12314; Formenti F, 2010, P NATL ACAD SCI USA, V107, P12722, DOI 10.1073/pnas.1002339107; Gordeuk VR, 2004, BLOOD, V103, P3924, DOI 10.1182/blood-2003-07-2535; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Hoes MF, 2018, EUR J HEART FAIL, V20, P910, DOI 10.1002/ejhf.1154; Horscroft JA, 2017, P NATL ACAD SCI USA, V114, P6382, DOI 10.1073/pnas.1700527114; Hwang S, 2017, J BIOL CHEM, V292, P9382, DOI 10.1074/jbc.M117.788562; KANNO H, 1994, CANCER RES, V54, P4845; Kartal O, 2016, METAB BRAIN DIS, V31, P827, DOI 10.1007/s11011-016-9816-z; Lemieux I, 2001, ARCH INTERN MED, V161, P2685, DOI 10.1001/archinte.161.22.2685; Lenglet M, 2018, BLOOD, V132, P469, DOI 10.1182/blood-2018-03-838235; Maher ER, 2011, EUR J HUM GENET, V19, P617, DOI 10.1038/ejhg.2010.175; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McClain DA, 2013, J MOL MED, V91, P59, DOI 10.1007/s00109-012-0961-5; McMullin MFF, 2019, BRIT J HAEMATOL, V184, P161, DOI 10.1111/bjh.15647; Percy MJ, 2009, AM J HEMATOL, V84, P46, DOI 10.1002/ajh.21313; Perrotta S, 2006, BLOOD, V107, P514, DOI 10.1182/blood-2005-06-2422; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rizzo AM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-7; Sable CA, 2012, HAEMATOL-HEMATOL J, V97, P193, DOI 10.3324/haematol.2011.051839; Sarangi S, 2014, PEDIATR BLOOD CANCER, V61, P2104, DOI 10.1002/pbc.25056; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Sergeyeva A, 1997, BLOOD, V89, P2148, DOI 10.1182/blood.V89.6.2148; Sergueeva A, 2015, BLOOD, V126; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Slingo ME, 2014, J APPL PHYSIOL, V116, P885, DOI 10.1152/japplphysiol.00530.2013; Smith TG, 2006, PLOS MED, V3, P1178, DOI 10.1371/journal.pmed.0030290; Solomon EI, 2003, P NATL ACAD SCI USA, V100, P3589, DOI 10.1073/pnas.0336792100; Vincent AE, 2019, CELL REP, V27, P321, DOI 10.1016/j.celrep.2019.03.051; Vincent AE, 2017, TRENDS CELL BIOL, V27, P797, DOI 10.1016/j.tcb.2017.08.009; Vincent AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30610; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Young AC, 2009, CLIN CANCER RES, V15, P7582, DOI 10.1158/1078-0432.CCR-09-2131; Zhang X, 2014, BLOOD CELL MOL DIS, V52, P35, DOI 10.1016/j.bcmd.2013.07.016	40	16	17	2	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2020	382	9					835	844		10.1056/NEJMoa1907362	http://dx.doi.org/10.1056/NEJMoa1907362			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KS8TT	32101665	Bronze, Green Published			2022-12-28	WOS:000518581500009
J	Bindman, AB				Bindman, Andrew B.			Rising Prices and Health Care "Empires"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Bindman, Andrew B.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bindman, AB (corresponding author), Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA.	andrew.bindman@ucsf.edu							0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2020	323	9			SI		815	816		10.1001/jama.2020.1370	http://dx.doi.org/10.1001/jama.2020.1370			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU3SD	32125390	Bronze			2022-12-28	WOS:000519630600003
J	Walensky, RP; Horn, T; McCann, NC; Freedberg, KA; Paltiel, AD				Walensky, Rochelle P.; Horn, Tim; McCann, Nicole C.; Freedberg, Kenneth A.; Paltiel, A. David			Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis	ANNALS OF INTERNAL MEDICINE			English	Article							COST-EFFECTIVENESS; UNITED-STATES	Background: Tenofovir alafenamide- emtricitabine (F/TAF) was recently approved as a noninferior and potentially safer option than tenofovir disoproxil fumarate- emtricitabine (F/TDF) for HIV preexposure prophylaxis (PrEP) in the United States. Objective: To estimate the greatest possible clinical benefits and economic savings attributable to the improved safety profile of F/TAF and the maximum price payers should be willing to pay for F/TAF over generic F/TDF. Design: Cost-effectiveness analysis. Data Sources: Published literature on F/TDF safety (in persons with and those without HIV) and the cost and quality-of-life effects of fractures and end-stage renal disease (ESRD). Target Population: Age-stratified U.S. men who have sex with men (MSM) using PrEP. Time Horizon: Five years. Perspective: Health care sector. Intervention: Preexposure prophylaxis with F/TAF versus F/TDF. Outcome Measures: Fractures averted, cases of ESRD averted, quality-adjusted life-years (QALYs) saved, costs, incremental cost-effectiveness ratios (ICERs), and maximum justifiable price for F/TAF compared with generic F/TDF. Results of Base-Case Analysis: Over a 5-year horizon, compared with F/TDF, F/TAF averted 2101 fractures and 25 cases of ESRD for the 123 610 MSM receiving PrEP, with an ICER of more than $7 million per QALY. At a 50% discount for generic F/TDF ($8300 per year) and a societal willingness to pay up to $100 000 per QALY, the maximum fair price for F/TAF was $8670 per year. Results of Sensitivity Analysis: Among persons older than 55 years, the ICER for F/TAF remained more than $3 million per QALY and the maximum permissible fair price for F/TAF was $8970 per year. Results were robust to alternative time horizons and PrEP-using population sizes. Limitation: Intermittent use and on- demand PrEP were not considered. Conclusion: In the presence of a generic F/TDF alternative, the improved safety of F/TAF is worth no more than an additional $370 per person per year.	[Walensky, Rochelle P.] Harvard Univ, Massachusetts Gen Hosp, Harvard Med Sch, Ctr AIDS Res,Med Practice Evaluat Ctr, Boston, MA 02115 USA; [Horn, Tim] Natl Alliance State & Terr AIDS Directors, 444 North Capitol St NW,Suite 339, Washington, DC 20001 USA; [McCann, Nicole C.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Freedberg, Kenneth A.] Harvard Univ, Harvard Med Sch, Ctr AIDS Res, Boston, MA 02115 USA; [Paltiel, A. David] Yale Sch Publ Hlth, 60 Coll St, New Haven, CT 06510 USA; [Walensky, Rochelle P.] Massachusetts Gen Hosp, Div Infect Dis, 55 Fruit St,GJ504, Boston, MA 02114 USA; [McCann, Nicole C.; Freedberg, Kenneth A.] Med Practice Evaluat Ctr, 100 Cambridge St, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Yale University; Harvard University; Massachusetts General Hospital	Walensky, RP (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, 55 Fruit St,Bul 130, Boston, MA 02114 USA.; Walensky, RP (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, 55 Fruit St,GJ504, Boston, MA 02114 USA.	rwalensky@mgh.harvard.edu		McCann, Nicole/0000-0002-4916-4319	National Institute of Allergy and Infectious Diseases [R01 AI042006]; National Institute on Drug Abuse [R37 DA015612]; National Institute of Mental Health [R01 MH105203]; Massachusetts General Hospital Executive Committee on Research	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Massachusetts General Hospital Executive Committee on Research	By the National Institute of Allergy and Infectious Diseases (R01 AI042006), National Institute on Drug Abuse (R37 DA015612), and National Institute of Mental Health (R01 MH105203), and the Massachusetts General Hospital Executive Committee on Research (Steve and Deborah Gorlin Research Scholars Award to Dr. Walensky).	AIDSVu, 2020, LOC DAT US; [Anonymous], 2019, HEALIO INFECT DIS NE; Cambiano V, 2016, CURR OPIN HIV AIDS, V11, P56, DOI 10.1097/COH.0000000000000217; Centers for Disease Control and Prevention, 2019, INDICATOR DETAILS IN; Cutler DM, 2006, NEW ENGL J MED, V355, P920, DOI 10.1056/NEJMsa054744; Eckman MH, 2018, ANN INTERN MED, V169, P214, DOI 10.7326/M17-3088; FDA, 2019, FDA APPR 2 DRUG PREV; Gilead Sciences, 2020, CEO DAN ODAY PRESENT; Gilead Sciences Inc. (GILD), 2019, CEO DAN ODAY Q2 2019; Gopalappa C, 2012, JAIDS-J ACQ IMM DEF, V61, P99, DOI 10.1097/QAI.0b013e31825bd862; Gu Q, 2014, CLIN ORTHOP RELAT R, V472, P3536, DOI 10.1007/s11999-014-3820-6; Hare C, 2019, C RETR OPP INF SEATT; Henry J., 2019, US FEDERAL FUNDING H; Hill A, 2018, J VIRUS ERAD, V4, P72; HIV.gov, 2019, WHAT IS END HIV EP P; IMS Institute for Health Informatics, 2016, PRICE DECLINES BRAND; Institute of Medicine Committee on the Consequences of Uninsurance, 2003, HIDDEN COSTS VALUE L; Komatsu A, 2018, DRUG SAFETY, V41, P843, DOI 10.1007/s40264-018-0665-z; Krakower DS, 2020, ANN INTERN MED, V172, P281, DOI 10.7326/M19-3337; Nkhoma ET, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166982; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Parthan A, 2013, APPL HEALTH ECON HEA, V11, P485, DOI 10.1007/s40258-013-0047-8; Sax PE, 2020, CLIN INFECT DIS, V71, P1379, DOI 10.1093/cid/ciz999; Schafer JJ, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz414; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4; Surial B, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4454-9; Svedbom A, 2018, OSTEOPOROSIS INT, V29, P557, DOI 10.1007/s00198-017-4317-4; U.S. Department of Veterans Affairs, NATL ACQUISITION CTR; U.S. Food and Drug Administration, 2019, FDA BRIEF DOC M ANT; U.S. Renal Data System, 2018, 2018 ADR REFERENCE T; US Preventive Services Task Force, 2019, FINAL RECOMMENDATION; Yacoub R, 2016, JAIDS-J ACQ IMM DEF, V71, pe115, DOI 10.1097/QAI.0000000000000906	32	22	22	2	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2020	172	9					583	+		10.7326/M19-3478	http://dx.doi.org/10.7326/M19-3478			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK7EH	32926822	Green Accepted			2022-12-28	WOS:000531024900008
J	Xu, XW; Wu, XX; Jiang, XG; Xu, KJ; Ying, LJ; Ma, CL; Li, SB; Wang, HY; Zhang, S; Gao, HN; Sheng, JF; Cai, HL; Qiu, YQ; Li, LJ				Xu, Xiao-Wei; Wu, Xiao-Xin; Jiang, Xian-Gao; Xu, Kai-Jin; Ying, Ling-Jun; Ma, Chun-Lian; Li, Shi-Bo; Wang, Hua-Ying; Zhang, Sheng; Gao, Hai-Nv; Sheng, Ji-Fang; Cai, Hong-Liu; Qiu, Yun-Qing; Li, Lan-Juan			Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVE To study the clinical characteristics of patients in Zhejiang province, China, infected with the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) responsible for coronavirus disease 2019 (covid-2019). DESIGN Retrospective case series. SETTING Seven hospitals in Zhejiang province, China. PARTICIPANTS 62 patients admitted to hospital with laboratory confirmed SARS-Cov-2 infection. Data were collected from 10 January 2020 to 26 January 2020. MAIN OUTCOME MEASURES Clinical data, collected using a standardised case report form, such as temperature, history of exposure, incubation period. If information was not clear, the working group in Hangzhou contacted the doctor responsible for treating the patient for clarification. RESULTS Of the 62 patients studied (median age 41 years), only one was admitted to an intensive care unit, and no patients died during the study. According to research, none of the infected patients in Zhejiang province were ever exposed to the Huanan seafood market, the original source of the virus; all studied cases were infected by human to human transmission. The most common symptoms at onset of illness were fever in 48 (77%) patients, cough in 50 (81%), expectoration in 35 (56%), headache in 21 (34%), myalgia or fatigue in 32 (52%), diarrhoea in 3 (8%), and haemoptysis in 2 (3%). Only two patients (3%) developed shortness of breath on admission. The median time from exposure to onset of illness was 4 days (interquartile range 3-5 days), and from onset of symptoms to first hospital admission was 2 (1-4) days. CONCLUSION As of early February 2020, compared with patients initially infected with SARS-Cov-2 in Wuhan, the symptoms of patients in Zhejiang province are relatively mild.	[Xu, Xiao-Wei; Wu, Xiao-Xin; Xu, Kai-Jin; Sheng, Ji-Fang; Cai, Hong-Liu; Qiu, Yun-Qing; Li, Lan-Juan] Zhejiang Univ, Affiliated Hosp 1, Coll Med,State Key Lab Diag & Treatment Infect Di, Natl Clin Res Ctr Infect Dis,Collaborat Innovat C, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Xian-Gao] Wenzhou Cent Hosp, Dept Infect Dis, Wenzhou, Zhejiang, Peoples R China; [Ying, Ling-Jun] Enze Hosp, Taizhou Enze Med Ctr Grp, Dept Infect Dis, Taizhou, Zhejiang, Peoples R China; [Ma, Chun-Lian] First Peoples Hosp Wenling, Dept Infect Dis, Wenling, Zhejiang, Peoples R China; [Li, Shi-Bo] Wenzhou Med Univ, Affiliated Zhoushan Hosp, Dept Infect Dis, Zhoushan, Zhejiang, Peoples R China; [Wang, Hua-Ying] Ningbo Univ, Affiliated Yinzhou Hosp, Yinzhou Peoples Hosp, Coll Med,Dept Resp & Crit Care Med, Ningbo, Zhejiang, Peoples R China; [Zhang, Sheng] Taizhou Hosp, Dept Infect Dis, Taizhou, Zhejiang, Peoples R China; [Gao, Hai-Nv] Zhejiang Shuren Univ, ShuLan Hangzhou Hosp, Shulan Int Med Coll, Dept Infect Dis, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Wenzhou Medical University; Ningbo University; Zhejiang Shuren University	Li, LJ (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med,State Key Lab Diag & Treatment Infect Di, Natl Clin Res Ctr Infect Dis,Collaborat Innovat C, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn	Wu, Xiao-Xin/ABG-7736-2021	LI, Lanjuan/0000-0001-6945-0593; Wu, Xiaoxin/0000-0001-9785-8916				[Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chan K. S., 2003, Hong Kong Medical Journal, V9, P399; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Gaidai O, 2021, SHIPS OFFSHORE STRUC, V16, P135, DOI 10.1080/17445302.2019.1710936; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682; Kim KH, 2017, J HOSP INFECT, V95, P207, DOI 10.1016/j.jhin.2016.10.008; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; WHO, 2019, WHO; World Health Organization, 2020, WHO; World Health Organization, MIDDL E RESP SYNDR C; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	15	1757	1851	8	125	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2020	368								m606	10.1136/bmj.m606	http://dx.doi.org/10.1136/bmj.m606			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KO0KS	32107200	Green Published, hybrid			2022-12-28	WOS:000515235300008
J	Koh, HK; Gellin, BG				Koh, Howard K.; Gellin, Bruce G.			Measles as Metaphor-What Resurgence Means for the Future of Immunization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Koh, Howard K.] Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA; [Koh, Howard K.] Harvard Kennedy Sch, Cambridge, MA USA; [Gellin, Bruce G.] Sabin Vaccine Inst, Washington, DC USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Koh, HK (corresponding author), Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA.								0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2020	323	10					914	915		10.1001/jama.2020.1372	http://dx.doi.org/10.1001/jama.2020.1372			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KW1LV	36218538	Bronze			2022-12-28	WOS:000520933900002
J	van den Brink, SC; Alemany, A; van Batenburg, V; Moris, N; Blotenburg, M; Vivie, J; Baillie-Johnson, P; Nichols, J; Sonnen, KF; Arias, AM; van Oudenaarden, A				van den Brink, Susanne C.; Alemany, Anna; van Batenburg, Vincent; Moris, Naomi; Blotenburg, Marloes; Vivie, Judith; Baillie-Johnson, Peter; Nichols, Jennifer; Sonnen, Katharina F.; Martinez Arias, Alfonso; van Oudenaarden, Alexander			Single-cell and spatial transcriptomics reveal somitogenesis in gastruloids	NATURE			English	Article							GENE-EXPRESSION; MOUSE; SPECIFICATION; DYNAMICS; PLURIPOTENCY	Single-cell RNA sequencing and spatial transcriptomics reveal that the somitogenesis clock is active in mouse gastruloids, which can be induced to generate somites with the correct rostral-caudal patterning. Gastruloids are three-dimensional aggregates of embryonic stem cells that display key features of mammalian development after implantation, including germ-layer specification and axial organization(1-3). To date, the expression pattern of only a small number of genes in gastruloids has been explored with microscopy, and the extent to which genome-wide expression patterns in gastruloids mimic those in embryos is unclear. Here we compare mouse gastruloids with mouse embryos using single-cell RNA sequencing and spatial transcriptomics. We identify various embryonic cell types that were not previously known to be present in gastruloids, and show that key regulators of somitogenesis are expressed similarly between embryos and gastruloids. Using live imaging, we show that the somitogenesis clock is active in gastruloids and has dynamics that resemble those in vivo. Because gastruloids can be grown in large quantities, we performed a small screen that revealed how reduced FGF signalling induces a short-tail phenotype in embryos. Finally, we demonstrate that embedding in Matrigel induces gastruloids to generate somites with the correct rostral-caudal patterning, which appear sequentially in an anterior-to-posterior direction over time. This study thus shows the power of gastruloids as a model system for exploring development and somitogenesis in vitro in a high-throughput manner.	[van den Brink, Susanne C.; Alemany, Anna; van Batenburg, Vincent; Blotenburg, Marloes; Vivie, Judith; van Oudenaarden, Alexander] KNAW Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Oncode Inst, Utrecht, Netherlands; [van den Brink, Susanne C.; Alemany, Anna; van Batenburg, Vincent; Blotenburg, Marloes; Vivie, Judith; Sonnen, Katharina F.; van Oudenaarden, Alexander] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Moris, Naomi; Baillie-Johnson, Peter; Martinez Arias, Alfonso] Univ Cambridge, Dept Genet, Cambridge, England; [Nichols, Jennifer] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge, England; [Nichols, Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Sonnen, Katharina F.] KNAW Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Cambridge; University of Cambridge; University of Cambridge; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	van den Brink, SC; van Oudenaarden, A (corresponding author), KNAW Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Oncode Inst, Utrecht, Netherlands.; van den Brink, SC; van Oudenaarden, A (corresponding author), Univ Med Ctr Utrecht, Utrecht, Netherlands.	s.c.vandenbrink@gmail.com; a.vanoudenaarden@hubrecht.eu	Alemany, Anna/AAO-9622-2021; Sonnen, Katharina F/R-7747-2018; Moris, Naomi/AAT-3606-2020; huang, dezhi/ABC-6566-2021	Sonnen, Katharina F/0000-0002-2902-9419; Moris, Naomi/0000-0003-1910-5454; van den Brink, Susanne Carina/0000-0003-3683-7737	European Research Council [ERC-AdG 742225-IntScOmics]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) TOP award [NWO-CW 714.016.001]; Foundation for Fundamental Research on Matter - NWO [FOM-14NOISE01]; Biotechnology and Biological Sciences Research Council [BB/P003184/1]; Newton Trust [INT16.24b]; Medical Research Council [MR/R017190/1]; Newnham College Cambridge Junior Research Fellowship; Engineering and Physical Sciences Research Council; Wellcome Trust; Medical Research Council; University of Cambridge; Hubrecht Institute; Dutch Cancer Society; BBSRC [BB/M004023/1, BB/P003184/1, BB/S001816/1] Funding Source: UKRI; MRC [MR/R017190/1, MC_PC_17230] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) TOP award; Foundation for Fundamental Research on Matter - NWO; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newton Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Newnham College Cambridge Junior Research Fellowship; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Cambridge(University of Cambridge); Hubrecht Institute; Dutch Cancer Society(KWF Kankerbestrijding); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by an European Research Council Advanced grant (ERC-AdG 742225-IntScOmics), a Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) TOP award (NWO-CW 714.016.001) and the Foundation for Fundamental Research on Matter, financially supported by NWO (FOM-14NOISE01) to S.C.v.d.B., A.A., V.v.B., M.B., J.V. and A.v.O., a Biotechnology and Biological Sciences Research Council (no. BB/P003184/1), Newton Trust (INT16.24b) and Medical Research Council (MR/R017190/1) grant to A.M.A., a Newnham College Cambridge Junior Research Fellowship to N.M. and a studentship from the Engineering and Physical Sciences Research Council to P.B.-J. The Cambridge Stem Cell Institute is supported by core funding from the Wellcome Trust and Medical Research Council; J.N. was funded by the University of Cambridge and K.F.S. by core funding from the Hubrecht Institute. This work is part of the Oncode Institute, which is partly financed by the Dutch Cancer Society. We thank A. Ebbing and M. Betist for the robotized tomo-seq protocol; G. Keller for the Brachyury-GFP cell line; J. Collignon for the Nodal-YFP line; K. Hadjantonakis for the TCF/LEF-mCherry line; S. van den Brink and E. R. Maandag for the E14-IB10 cells; J. Kress and A. Aulehla for the LfngT2AVenus mouse ES cell line; I. Misteli Guerreiro, J. Peterson-Maduro and J. Hoeksma for suggestions for in situ hybridization experiments; W. Thomas, Y. el Azhar, J. Juksar and J. Beumer for reagents and inhibitors; A. de Graaff and A. Stokkermans for help with multiphoton microscopy and analysis of the microscopy data; D. A. Turner for microscopy panels that were used for tomo-seq validation; J. Korving for help with the somite-size measurements in embryos; the Hubrecht FACS facility and R. van der Linden for FACS experiments; Single Cell Discoveries for 10x Genomics scRNA-seq; the Utrecht Sequencing facility for sequencing; and P. Zeller, H. Vinas Gaza, M. Vaninsberghe, V. Bhardwaj and all members of the van Oudenaarden, Sonnen and Martinez Arias laboratories for discussions.	Baillie-Johnson P, 2015, JOVE-J VIS EXP, DOI 10.3791/53252; Beccari L, 2018, NATURE, V562, P272, DOI 10.1038/s41586-018-0578-0; Chakraborty S, 2012, BIOINFORMATICS, V28, P799, DOI 10.1093/bioinformatics/bts022; Chal J, 2017, DEVELOPMENT, V144, P2104, DOI 10.1242/dev.151035; Chal J, 2015, NAT BIOTECHNOL, V33, P962, DOI 10.1038/nbt.3297; CHOI HMT, 2018, DEVELOPMENT, V145, DOI DOI 10.1242/DEV.165753; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Faunes F, 2013, DEVELOPMENT, V140, P1171, DOI 10.1242/dev.085654; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Ferrer-Vaquer A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-121; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Hubaud A, 2017, CELL, V171, P668, DOI 10.1016/j.cell.2017.08.043; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Junker JP, 2014, CELL, V159, P662, DOI 10.1016/j.cell.2014.09.038; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Koch F, 2017, DEV CELL, V42, P514, DOI 10.1016/j.devcel.2017.07.021; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; Laurent F, 2017, CELL REP, V19, P1602, DOI 10.1016/j.celrep.2017.05.004; Lauschke VM, 2013, NATURE, V493, P101, DOI 10.1038/nature11804; Matsumiya M, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156836; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Naiche LA, 2011, P NATL ACAD SCI USA, V108, P4018, DOI 10.1073/pnas.1007417108; Nowotschin S, 2019, NATURE, V569, P361, DOI 10.1038/s41586-019-1127-1; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Papanayotou C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001890; Pijuan-Sala B, 2019, NATURE, V566, P490, DOI 10.1038/s41586-019-0933-9; Richardson L, 2014, NUCLEIC ACIDS RES, V42, pD835, DOI 10.1093/nar/gkt1155; Sawada A, 2001, DEVELOPMENT, V128, P4873; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Scotti M, 2012, DEVELOPMENT, V139, P731, DOI 10.1242/dev.075408; Sonnen KF, 2018, CELL, V172, P1079, DOI 10.1016/j.cell.2018.01.026; Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z; Turner DA, 2017, DEVELOPMENT, V144, P3894, DOI 10.1242/dev.150391; Turner DA, 2014, DEVELOPMENT, V141, P4243, DOI 10.1242/dev.112979; Turner DA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0063-7; Turner DA, 2014, BIOL OPEN, V3, P614, DOI 10.1242/bio.20148409; van Batenburg V., 2020, PROTOC EXCH, DOI [10.21203/rs.2.18203/v1, DOI 10.21203/RS.2.18203/V1]; van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437; van den Brink SC, 2014, DEVELOPMENT, V141, P4231, DOI 10.1242/dev.113001; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0	42	114	115	10	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 18	2020	582	7812					405	+		10.1038/s41586-020-2024-3	http://dx.doi.org/10.1038/s41586-020-2024-3		FEB 2020	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QP4IP	32132714	Green Submitted			2022-12-28	WOS:000518097900001
J	Walls, AC; Park, YJ; Tortorici, MA; Wall, A; McGuire, AT; Veesler, D				Walls, Alexandra C.; Park, Young-Jun; Tortorici, M. Alejandra; Wall, Abigail; McGuire, Andrew T.; Veesler, David			Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein	CELL			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; HUMAN MONOCLONAL-ANTIBODY; CRYO-EM STRUCTURE; SYNDROME SARS CORONAVIRUS; TO-HUMAN TRANSMISSION; MERS-COV; BAT CORONAVIRUS; CELL ENTRY; POTENT NEUTRALIZATION; MOLECULAR EVOLUTION	The emergence of SARS-CoV-2 has resulted in >90,000 infections and >3,000 deaths. Coronavirus spike (S) glycoproteins promote entry into cells and are the main target of antibodies. We show that SARS-CoV-2 S uses ACE2 to enter cells and that the receptor-binding domains of SARS-CoV-2 S and SARS-CoV S bind with similar affinities to human ACE2, correlating with the efficient spread of SARS-CoV-2 among humans. We found that the SARS-CoV-2 S glycoprotein harbors a furin cleavage site at the boundary between the S-1/S-2 subunits, which is processed during biogenesis and sets this virus apart from SARS-CoV and SARS-related CoVs. We determined cryo-EM structures of the SARS-CoV-2 S ectodomain trimer, providing a blueprint for the design of vaccines and inhibitors of viral entry. Finally, we demonstrate that SARS-CoV S murine polyclonal antibodies potently inhibited SARS-CoV-2 S mediated entry into cells, indicating that cross-neutralizing antibodies targeting conserved S epitopes can be elicited upon vaccination.	[Walls, Alexandra C.; Park, Young-Jun; Tortorici, M. Alejandra; Veesler, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Tortorici, M. Alejandra] Inst Pasteur, F-75015 Paris, France; [Tortorici, M. Alejandra] CNRS, UMR 3569, Unite Virol Struct, F-75015 Paris, France; [Wall, Abigail; McGuire, Andrew T.] Fred Hutchinson Canc Res Ctr, Vaccines & Infect Dis Div, Seattle, WA 98195 USA; [McGuire, Andrew T.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Veesler, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dveesler@uw.edu	Veesler, David/HCH-3986-2022; Park, Young-Jun/AAF-6249-2021	Park, Young-Jun/0000-0003-2901-6949; Wall, Abigail/0000-0001-8198-2138; Tortorici, M. Alejandra/0000-0002-2260-2577; Walls, Alexandra/0000-0002-9636-8330	National Institute of General Medical Sciences [R01GM120553]; National Institute of Allergy and Infectious Diseases [HHSN272201700059C]; Pew Biomedical Scholars Award; Burroughs Wellcome Fund; Washington Research Foundation; Pasteur Institute; University of Washington Arnold and Mabel Beckman cryoEM center	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pew Biomedical Scholars Award; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Washington Research Foundation; Pasteur Institute; University of Washington Arnold and Mabel Beckman cryoEM center	This study was supported by the National Institute of General Medical Sciences (R01GM120553 to D.V.), the National Institute of Allergy and Infectious Diseases (HHSN272201700059C to D.V.), a Pew Biomedical Scholars Award (D.V.), an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund (D.V.), the University of Washington Arnold and Mabel Beckman cryoEM center, the Washington Research Foundation, and the Pasteur Institute (M.A.T.). We are grateful to Lynda Stuart for sharing the full-length hACE2 plasmid, to Gary Whittaker for the MLV pseudotyping system, and to Ning Zheng for providing access to the Octet device.	Agirre J, 2015, NAT STRUCT MOL BIOL, V22, P833, DOI 10.1038/nsmb.3115; Anthony SJ, 2017, MBIO, V8, DOI [10.1128/mBio.00373-17, 10.1128/mbio.00373-17]; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106; Bosch BJ, 2008, J VIROL, V82, P8887, DOI 10.1128/JVI.00415-08; Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Burkard C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004502; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corti D, 2015, P NATL ACAD SCI USA, V112, P10473, DOI 10.1073/pnas.1510199112; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frenz B, 2019, STRUCTURE, V27, P134, DOI 10.1016/j.str.2018.09.006; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Gui M, 2017, CELL RES, V27, P119, DOI 10.1038/cr.2016.152; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; He JF, 2004, SCIENCE, V303, P1666, DOI 10.1126/science.1092002; Heald-Sargent T, 2012, VIRUSES-BASEL, V4, P557, DOI 10.3390/v4040557; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698; Huang C., 2020, CLIN FEATURES PATIEN, DOI 10.1101/2020.05.14.093583; Hulswit RJG, 2019, P NATL ACAD SCI USA, V116, P2681, DOI 10.1073/pnas.1809667116; Hwang WC, 2006, J BIOL CHEM, V281, P34610, DOI 10.1074/jbc.M603275200; Kan B, 2005, J VIROL, V79, P11892, DOI 10.1128/JVI.79.18.11892-11900.2005; Kirchdoerfer RN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34171-7; Kirchdoerfer RN, 2016, NATURE, V531, P118, DOI 10.1038/nature17200; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; Letko M., 2020, NAT MICROBIOL, V5, P562, DOI [DOI 10.1038/s41564-020-0688-y, 10.1038/s41564-020-0688-y]; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li F, 2008, J VIROL, V82, P6984, DOI 10.1128/JVI.00442-08; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li WT, 2017, P NATL ACAD SCI USA, V114, pE8508, DOI 10.1073/pnas.1712592114; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Li WH, 2004, J VIROL, V78, P11429, DOI 10.1128/JVI.78.20.11429-11433.2004; Li ZJ, 2019, ELIFE, V8, DOI 10.7554/eLife.51230; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328; Madu IG, 2009, J VIROL, V83, P7411, DOI 10.1128/JVI.00079-09; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Menachery VD, 2016, P NATL ACAD SCI USA, V113, P3048, DOI 10.1073/pnas.1517719113; Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985; Millet Jean Kaoru, 2016, Bio Protoc, V6, DOI 10.21769/BioProtoc.2035; Millet JK, 2015, VIRUS RES, V202, P120, DOI 10.1016/j.virusres.2014.11.021; Millet JK, 2014, P NATL ACAD SCI USA, V111, P15214, DOI 10.1073/pnas.1407087111; Miroshnikov KA, 1998, PROTEIN ENG, V11, P329, DOI 10.1093/protein/11.4.329; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Park JE, 2016, P NATL ACAD SCI USA, V113, P12262, DOI 10.1073/pnas.1608147113; Park YJ, 2019, NAT STRUCT MOL BIOL, V26, P1151, DOI 10.1038/s41594-019-0334-7; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Ren W, 2008, J VIROL, V82, P1899, DOI 10.1128/JVI.01085-07; Rockx B, 2008, J VIROL, V82, P3220, DOI 10.1128/JVI.02377-07; Rockx B, 2010, J INFECT DIS, V201, P946, DOI 10.1086/651022; Rossen JWA, 1998, J VIROL, V72, P497, DOI 10.1128/JVI.72.1.497-503.1998; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Song WF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007236; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tian XL, 2020, EMERG MICROBES INFEC, V9, P382, DOI 10.1080/22221751.2020.1729069; Tortorici MA, 2019, ADV VIRUS RES, V105, P93, DOI 10.1016/bs.aivir.2019.08.002; Tortorici MA, 2019, NAT STRUCT MOL BIOL, V26, P481, DOI 10.1038/s41594-019-0233-y; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; VLASAK R, 1988, P NATL ACAD SCI USA, V85, P4526, DOI 10.1073/pnas.85.12.4526; Walls A, 2017, PROTEIN SCI, V26, P113, DOI 10.1002/pro.3048; Walls AC, 2019, CELL, V176, P1026, DOI 10.1016/j.cell.2018.12.028; Walls AC, 2017, P NATL ACAD SCI USA, V114, P11157, DOI 10.1073/pnas.1708727114; Walls AC, 2016, NAT STRUCT MOL BIOL, V23, P899, DOI 10.1038/nsmb.3293; Walls AC, 2016, NATURE, V531, P114, DOI 10.1038/nature16988; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20; Wang M, 2005, EMERG INFECT DIS, V11, P1860, DOI 10.3201/eid1112.041293; Wang QH, 2014, CELL HOST MICROBE, V16, P328, DOI 10.1016/j.chom.2014.08.009; Wang RYR, 2016, ELIFE, V5, DOI 10.7554/eLife.17219; Wong AHM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01706-x; Wong SK, 2004, J BIOL CHEM, V279, P3197, DOI 10.1074/jbc.C300520200; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu KL, 2009, P NATL ACAD SCI USA, V106, P19970, DOI 10.1073/pnas.0908837106; Xiong XL, 2018, J VIROL, V92; Yang XL, 2016, J VIROL, V90, P3253, DOI 10.1128/JVI.02582-15; Yang Y, 2015, J VIROL, V89, P9119, DOI 10.1128/JVI.01279-15; Yang Y, 2014, P NATL ACAD SCI USA, V111, P12516, DOI 10.1073/pnas.1405889111; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang H, 2004, J VIROL, V78, P6938, DOI 10.1128/JVI.78.13.6938-6945.2004; Zhou P., 2020, NATURE, V579, P270, DOI DOI 10.1038/S41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	99	4791	4971	123	844	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2020	181	2					281	+		10.1016/j.cell.2020.02.058	http://dx.doi.org/10.1016/j.cell.2020.02.058			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LD7BL	32155444	Green Published, Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000526184900012
